data_2rm5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rm5 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 121.03 0.443 . . . . 2.22 109.937 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.5 p -132.0 -179.47 5.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.905 -0.589 . . . . 1.06 109.899 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.728 HD12 HG21 ' A' ' 144' ' ' ILE . 23.6 pt -65.75 -28.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.073 0.463 . . . . 1.08 111.198 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.809 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 38.3 m-85 -78.81 -1.06 33.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.863 0.363 . . . . 0.3 111.618 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.06 -11.87 60.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.219 -0.66 . . . . 1.96 109.219 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 62.0 m-85 -110.68 160.18 16.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.081 -0.963 . . . . 0.4 109.541 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.31 149.62 27.61 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.216 -0.291 . . . . 2.77 110.216 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.55 HG21 HD12 ' A' ' 30' ' ' LEU . 70.3 t -114.91 147.5 18.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.149 0.499 . . . . 1.39 112.257 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.959 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 75.8 mt -100.92 132.36 46.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.854 -0.612 . . . . 1.33 109.875 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -65.69 177.32 1.27 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.824 -1.08 . . . . 1.59 109.858 176.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.755 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . . . -46.51 -37.57 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.496 0.319 . . . . 1.14 111.743 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.45 21.31 17.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.864 0.32 . . . . 2.22 111.864 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.959 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 39.1 m-70 68.23 16.43 9.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.113 0.565 . . . . 0.88 110.759 172.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.836 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -76.76 146.88 77.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 106.059 -1.83 . . . . 3.67 106.059 167.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.08 113.5 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 120.672 0.915 . . . . 1.19 111.806 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' HH ' ' CB ' ' A' ' 103' ' ' PRO . 68.3 t80 -86.97 117.57 25.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.532 -0.758 . . . . 0.98 110.866 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.46 82.75 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.716 -0.675 . . . . 1.65 109.767 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.809 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.46 -33.09 70.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.445 0.64 . . . . 1.08 110.469 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.762 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.0 p -76.73 -1.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.248 -0.887 . . . . 1.15 112.811 -168.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 2.8 pt20 -81.45 -5.64 58.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 1.94 109.349 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -92.94 -3.79 53.9 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.317 -0.994 . . . . 0.38 108.317 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 34.8 ttpt -74.15 146.45 43.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.879 -1.055 . . . . 2.22 109.827 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.81 -13.67 65.89 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.964 -1.254 . . . . 0.36 109.964 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.647 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 6.0 m -130.91 145.42 57.67 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 114.538 -0.831 . . . . 1.58 108.766 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.976 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -74.84 151.91 40.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.02 1.814 . . . . 0.86 110.664 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.556 ' HB2' HG21 ' A' ' 70' ' ' THR . 2.0 pt? -154.61 154.03 32.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.142 0.496 . . . . 1.63 111.161 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.89 HD23 HG21 ' A' ' 163' ' ' ILE . 6.8 mp -107.47 154.17 21.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.094 -0.706 . . . . 1.69 109.094 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.655 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 85.1 mt -141.0 115.34 5.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.205 -0.665 . . . . 1.05 109.205 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.59 ' HD2' ' HB2' ' A' ' 139' ' ' PHE . 3.9 m-85 -102.04 123.38 45.83 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 121.059 -0.256 . . . . 0.93 111.334 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.791 HD22 ' HB ' ' A' ' 140' ' ' THR . 1.0 OUTLIER -81.88 90.11 6.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.07 -1.085 . . . . 1.97 108.07 167.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 8.3 p -119.1 141.78 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.163 0.801 . . . . 1.48 113.163 -162.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.9 108.98 3.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.926 -1.139 . . . . 1.17 107.926 170.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.995 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 29.8 t -73.88 80.81 1.64 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.857 -0.61 . . . . 2.3 112.216 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 67.25 55.6 0.66 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.935 -1.029 . . . . 2.81 111.348 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -139.05 118.7 13.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.092 -0.504 . . . . 1.18 109.941 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 -93.67 1.24 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.655 -0.783 . . . . 1.42 112.131 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.37 151.91 17.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 3.45 111.301 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 52' ' ' GLY . 69.2 p -119.83 141.96 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.891 -0.781 . . . . 1.94 108.891 169.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 156' ' ' PRO . 33.4 ttmt -77.51 44.12 0.42 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.335 0.588 . . . . 2.51 110.794 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 50' ' ' THR . . . 92.44 28.37 13.07 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.744 -0.662 . . . . 0.55 112.271 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 139' ' ' PHE . . . -80.8 -48.73 6.02 Favored Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.879 -0.676 . . . . 0.39 112.28 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -55.84 -50.69 69.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.79 0.329 . . . . 1.05 110.387 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -60.21 -53.2 60.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.091 -0.504 . . . . 2.46 111.203 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.4 m -57.94 -47.06 84.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 122.728 0.411 . . . . 1.06 110.932 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.689 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -61.66 -49.25 77.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.46 . . . . 1.03 111.195 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -61.03 -47.17 87.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.163 0.506 . . . . 1.09 110.516 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -59.48 -49.8 76.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.362 -0.835 . . . . 1.69 111.172 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.663 HD23 HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -61.13 -44.48 97.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.033 -0.53 . . . . 1.46 110.964 -175.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.798 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 67.8 t80 -53.15 -57.1 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 123.492 0.495 . . . . 0.92 110.476 176.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -68.52 -39.2 81.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.336 -0.393 . . . . 1.88 111.369 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -70.82 -45.18 65.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 2.27 111.66 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.611 ' CD1' HD12 ' A' ' 171' ' ' LEU . 61.2 m-85 -101.53 6.67 42.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.332 0.864 . . . . 0.9 113.332 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -62.33 -19.79 63.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.63 0.252 . . . . 2.62 110.918 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.4 m -66.85 -38.06 85.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 1.59 111.246 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -88.85 4.63 47.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 1.9 110.66 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 82.44 71.61 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.892 -0.671 . . . . 1.32 111.514 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.58 ' CZ ' HD11 ' A' ' 39' ' ' LEU . 76.8 t80 -133.04 138.64 46.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.612 0.244 . . . . 0.4 110.436 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.556 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -126.82 142.91 51.41 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.93 0.395 . . . . 1.11 110.04 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.798 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.6 t -110.77 118.64 57.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 O-C-N 122.188 -0.32 . . . . 1.06 110.27 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.773 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 21.4 mt -105.34 122.92 46.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.91 -0.774 . . . . 1.23 108.91 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.85 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -109.82 112.74 24.96 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.006 -0.677 . . . . 1.04 110.591 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.606 ' CE1' ' HG2' ' A' ' 105' ' ' MET . 1.8 m-85 -93.29 112.59 57.07 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.116 -1.068 . . . . 0.45 108.116 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.024 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.7 Cg_exo -60.03 167.2 7.62 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.025 2.483 . . . . 0.73 111.235 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.433 -1.275 0 C-N-CA 119.435 -0.906 . . . . 2.02 111.738 -178.129 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 31.1 m . . . . . 0 CA--C 1.506 -0.737 0 CA-C-O 120.9 0.381 . . . . 0.91 110.453 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.452 ' CG2' ' HE3' ' A' ' 97' ' ' LYS . 28.3 m -153.26 116.57 4.63 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.755 -0.657 . . . . 2.41 109.906 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.755 ' HD2' ' HB3' ' A' ' 23' ' ' ALA . 0.5 OUTLIER 13.27 97.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.824 1.328 . . . . 3.5 114.323 -173.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.672 ' HZ ' ' HZ ' ' A' ' 102' ' ' PHE . 23.7 p90 -64.03 -21.3 66.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.107 -0.497 . . . . 1.74 110.73 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 66.94 150.07 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.998 0.811 . . . . 3.53 111.613 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.446 ' HB2' ' HE1' ' A' ' 54' ' ' TYR . . . -171.29 -165.65 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.589 -0.278 . . . . 1.09 111.483 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -82.77 -4.73 58.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.367 0.603 . . . . 2.19 110.386 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.695 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 53.1 p90 -121.68 163.16 32.64 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.428 -0.953 . . . . 0.39 108.428 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 27.3 Cg_exo -67.71 117.47 4.9 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 123.195 2.597 . . . . 0.48 113.206 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.85 HG13 ' HB2' ' A' ' 73' ' ' ALA . 2.9 mp -105.57 138.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.131 -0.692 . . . . 1.13 109.131 171.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.773 ' HE2' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -103.24 -162.26 0.9 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.319 0.859 . . . . 2.08 113.319 -163.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.16 41.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.158 -0.928 . . . . 1.11 109.948 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.024 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 14.0 pttt -70.25 126.09 28.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.735 -0.786 . . . . 2.12 109.876 172.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 pt -124.64 161.39 28.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.707 -1.133 . . . . 1.19 108.307 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 15.1 t-20 -79.35 88.25 4.98 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.845 -0.798 . . . . 2.16 108.845 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -74.28 85.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 119.315 -0.954 . . . . 1.1 108.86 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 115' ' ' ALA . 9.6 t-20 171.84 -178.88 0.06 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.806 -0.813 . . . . 1.98 108.806 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.96 -142.15 42.18 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 115.116 0.806 . . . . 0.78 115.116 156.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.87 -16.69 15.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.501 -0.85 . . . . 1.98 109.612 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -91.62 1.84 56.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.856 -1.066 . . . . 2.1 110.613 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -60.89 140.58 57.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.252 -0.885 . . . . 1.17 111.861 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.868 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 33.2 t-80 -50.29 132.48 24.78 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.25 -0.886 . . . . 0.51 108.792 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.21 -33.27 53.9 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.429 2.753 . . . . 0.43 112.457 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.868 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 19.4 tp -62.99 -41.12 99.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 1.69 111.056 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.419 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.7 m-85 -74.83 -30.39 61.37 Favored 'General case' 0 C--O 1.21 -0.99 0 N-CA-C 110.378 -0.23 . . . . 1.84 110.378 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.86 -33.89 70.98 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.058 -0.657 . . . . 2.37 109.868 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.6 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 66.9 t80 -71.69 -52.46 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.357 0.411 . . . . 1.09 110.536 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.578 ' HE1' HD13 ' A' ' 118' ' ' LEU . 66.8 mtt -56.99 -51.91 67.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 1.06 111.333 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.527 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 35.4 mtpt -58.15 -50.62 72.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.817 -0.629 . . . . 1.42 110.652 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.21 -30.2 71.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.664 0.269 . . . . 2.63 111.283 -177.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.54 HG21 ' HD2' ' A' ' 150' ' ' PRO . 87.1 m -72.54 -52.51 15.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.366 -0.379 . . . . 1.09 111.727 -176.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 8.0 mmtt . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 112.869 0.692 . . . . 2.26 112.869 -171.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.958 0.409 . . . . 1.51 111.519 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.834 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 37.6 mt -99.15 106.17 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.787 -0.642 . . . . 1.5 110.423 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 136' ' ' LYS . 9.9 ptpt -131.98 21.29 4.53 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.631 0.604 . . . . 1.99 112.631 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.834 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.2 174.44 15.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.068 0.396 . . . . 1.1 112.068 -175.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.489 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 8.3 m120 -46.66 -161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.422 1.489 . . . . 1.8 114.575 173.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.818 ' CZ ' ' HA ' ' A' ' 156' ' ' PRO . 44.7 p90 -34.37 -46.49 0.27 Allowed 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 113.145 -1.843 . . . . 1.68 115.346 -164.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.793 HG21 ' HA ' ' A' ' 155' ' ' SER . 22.4 m 37.78 94.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.36 0.874 . . . . 1.05 113.36 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.439 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 13.0 p -85.63 146.64 26.77 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.183 -0.607 . . . . 1.38 110.345 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.7 m-85 -102.17 133.4 47.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.407 -0.961 . . . . 0.53 108.407 169.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.896 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.87 104.66 12.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.095 -0.705 . . . . 1.2 109.095 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.728 HG21 HD12 ' A' ' 15' ' ' ILE . 12.7 mm -102.44 128.51 55.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.086 -0.709 . . . . 1.05 109.086 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.31 -174.59 5.22 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.028 -0.269 . . . . 1.3 111.274 -175.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.469 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 43.9 mtt180 -63.3 -12.51 30.11 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.378 0.51 . . . . 4.43 112.378 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -108.86 -19.24 13.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.374 0.607 . . . . 1.18 109.741 -171.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.503 ' O ' HG22 ' A' ' 15' ' ' ILE . . . 102.37 26.87 7.11 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.199 -0.909 . . . . 0.25 112.36 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.1 t -106.44 126.33 30.7 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.732 -0.47 . . . . 1.32 109.732 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.54 ' HD2' HG21 ' A' ' 125' ' ' THR . 10.5 Cg_exo -67.56 111.35 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.342 2.028 . . . . 0.46 111.361 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.49 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 39.2 t -91.41 -25.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.017 -0.538 . . . . 1.09 110.504 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -152.37 163.6 39.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 1.22 111.226 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.527 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 11.9 ttm180 -131.01 102.62 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.618 -0.719 . . . . 2.25 109.247 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.896 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.9 m-85 -92.22 109.8 21.18 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.267 -0.642 . . . . 0.38 109.267 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.904 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 81.2 p -67.5 -178.65 0.38 Allowed Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.763 -0.458 . . . . 1.49 109.763 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.904 ' HD2' ' HB2' ' A' ' 155' ' ' SER . 30.8 Cg_endo -63.92 10.99 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.138 1.892 . . . . 0.74 113.227 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 155' ' ' SER . . . -99.16 -9.46 51.47 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.06 -0.591 . . . . 0.56 111.877 -177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -96.16 134.7 38.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 1.14 111.067 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.7 m -95.23 -174.02 3.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 1.64 110.265 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.663 HG11 HD23 ' A' ' 60' ' ' LEU . 77.5 t -51.38 -55.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 1.14 111.923 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -72.88 -26.0 61.29 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.606 -0.27 . . . . 3.84 111.126 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -34.45 72.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.644 -0.502 . . . . 1.86 109.644 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.89 HG21 HD23 ' A' ' 39' ' ' LEU . 61.8 mt -82.73 -38.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.608 -0.724 . . . . 1.05 110.762 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.1 mt-10 -56.22 -41.13 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.278 0.474 . . . . 0.88 112.278 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.554 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.9 pt-20 -57.21 -26.65 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.75 111.703 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.583 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.4 mmtp -102.51 -18.45 15.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.841 0.353 . . . . 2.11 110.751 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.688 ' HG ' HD11 ' A' ' 171' ' ' LEU . 60.4 tp -92.31 -45.66 8.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.901 -0.59 . . . . 1.06 112.043 -171.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.643 ' HA ' HD13 ' A' ' 171' ' ' LEU . 66.6 mt -49.73 -49.87 70.59 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 112.999 0.74 . . . . 1.14 112.999 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.9 Cg_exo -55.38 -39.44 91.0 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.116 1.878 . . . . 0.74 112.701 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.0 -40.16 63.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.511 -0.313 . . . . 1.35 110.975 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.976 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 18.6 mt -55.8 -48.4 75.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.296 0.57 . . . . 1.16 109.578 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.82 -69.82 1.05 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.585 -1.188 . . . . 1.52 111.621 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.331 -0.202 0 N-CA-C 109.78 -0.452 . . . . 2.89 109.78 177.234 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.066 0.46 . . . . 2.22 110.613 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.5 p -157.53 -174.61 4.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.493 -0.776 . . . . 1.06 109.184 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.78 HD13 HG23 ' A' ' 144' ' ' ILE . 27.9 pt -64.2 -25.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.48 . . . . 1.08 110.649 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.79 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.3 m-85 -81.94 5.55 18.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.3 111.202 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.94 -19.67 60.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.259 -1.015 . . . . 1.96 108.259 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 73.8 m-85 -107.86 175.67 5.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.869 -1.059 . . . . 0.4 111.263 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -112.62 138.8 48.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 2.77 110.382 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.586 HG23 HD11 ' A' ' 30' ' ' LEU . 77.4 t -115.04 144.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.093 0.473 . . . . 1.39 111.514 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.969 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 91.0 mt -104.32 133.23 49.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.545 -0.752 . . . . 1.33 109.546 173.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 23' ' ' ALA . 18.3 t70 -68.53 -176.43 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.672 -0.862 . . . . 1.59 108.672 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -53.96 -35.45 61.79 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.165 0.507 . . . . 1.14 111.624 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -92.96 3.13 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 2.22 111.528 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.969 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 33.6 m-70 74.43 17.59 3.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.414 0.626 . . . . 0.88 109.972 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 12.8 mtmt -69.89 151.85 96.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.149 -1.797 . . . . 3.67 106.149 163.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.98 113.74 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 CA-C-N 120.168 1.096 . . . . 1.19 110.848 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.877 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 65.4 t80 -82.5 120.73 25.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.635 . . . . 0.98 110.232 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.9 t-20 -69.9 85.44 0.5 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.869 -0.605 . . . . 1.65 109.786 176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.79 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -73.4 -32.35 64.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.262 0.553 . . . . 1.08 110.544 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.754 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.3 p -77.19 -0.68 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.522 -0.763 . . . . 1.15 112.686 -168.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.0 pt20 -78.77 -6.62 56.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.574 0.702 . . . . 1.94 109.376 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.877 ' HE2' ' HH ' ' A' ' 28' ' ' TYR . 89.4 m-70 -96.99 3.81 51.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.96 -1.018 . . . . 0.38 108.314 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.529 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 22.1 ttpt -81.2 146.63 30.39 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.723 -1.126 . . . . 2.22 109.298 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.11 -2.1 86.77 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.228 -1.149 . . . . 0.36 110.228 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 13.6 m -140.56 152.31 65.94 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 1.58 108.747 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.961 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 74.3 Cg_endo -82.52 154.78 16.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.826 1.684 . . . . 0.86 111.576 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.644 ' CB ' HG21 ' A' ' 70' ' ' THR . 1.8 pt? -156.98 150.57 24.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.164 0.507 . . . . 1.63 111.749 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.86 151.49 25.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.376 -0.972 . . . . 1.69 108.376 172.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 86.5 mt -140.55 115.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.84 -0.43 . . . . 1.05 109.84 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.754 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 29.8 m-85 -103.02 124.74 49.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.609 0.226 . . . . 0.93 111.609 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.777 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -80.44 93.26 5.98 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.246 -0.65 . . . . 1.97 109.246 167.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.809 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 15.2 m -105.06 150.08 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 114.095 1.146 . . . . 1.48 114.095 -158.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 102.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.683 -1.599 . . . . 1.17 106.683 163.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.607 ' HG ' ' HB3' ' A' ' 95' ' ' CYS . 0.0 OUTLIER -76.07 81.17 2.91 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 113.879 1.066 . . . . 2.3 113.879 -163.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 84.4 tttt 76.18 31.97 0.63 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.558 -0.746 . . . . 2.81 111.488 169.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.28 132.34 16.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.507 -0.477 . . . . 1.18 111.488 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -92.69 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.688 -0.687 . . . . 1.42 114.734 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.417 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 66.8 m-85 -110.98 153.77 25.08 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.999 0.37 . . . . 3.45 111.999 -167.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 52' ' ' GLY . 26.9 p -137.24 -38.67 0.61 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.778 0.659 . . . . 1.94 112.778 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 69.47 -12.88 0.41 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.432 0.693 . . . . 2.51 112.791 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 50' ' ' THR . . . 112.01 12.08 14.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.942 -0.647 . . . . 0.55 112.478 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.84 -31.7 61.98 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.156 -0.545 . . . . 0.39 112.051 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.695 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -68.72 -52.05 34.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.534 0.206 . . . . 1.05 110.504 -177.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.95 -47.06 78.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.431 0.634 . . . . 2.46 110.397 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 160' ' ' VAL . 85.5 m -63.03 -47.53 82.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.818 -1.083 . . . . 1.06 110.719 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.82 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -62.16 -50.43 71.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 1.03 111.651 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.654 HG23 ' HG2' ' A' ' 101' ' ' GLU . 24.5 m -56.1 -45.55 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 1.09 110.792 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.674 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 40.7 m -66.57 -45.98 77.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.69 111.31 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 88.5 mt -58.09 -51.38 69.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.538 0.208 . . . . 1.46 111.188 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.498 ' HE1' ' HG1' ' A' ' 70' ' ' THR . 49.7 t80 -52.5 -52.76 52.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.997 0.811 . . . . 0.92 109.785 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.674 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 3.9 p30 -73.93 -33.35 63.91 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.504 -0.478 . . . . 1.88 111.429 -171.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -76.11 -38.17 57.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.277 -0.419 . . . . 2.27 111.309 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.727 ' CD1' HD11 ' A' ' 171' ' ' LEU . 70.9 m-85 -109.07 8.91 26.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.071 0.767 . . . . 0.9 113.071 -174.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -22.53 64.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.861 0.363 . . . . 2.62 110.226 173.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -62.12 -37.93 87.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 1.59 110.785 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.44 5.57 38.23 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.908 0.385 . . . . 1.9 110.923 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.35 25.09 34.46 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.99 -0.624 . . . . 1.32 112.289 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 39' ' ' LEU . 75.7 t80 -85.05 143.72 28.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.775 0.321 . . . . 0.4 110.913 -174.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.644 HG21 ' CB ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -131.03 146.32 52.34 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.062 0.458 . . . . 1.11 110.183 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.82 HG11 ' HB2' ' A' ' 57' ' ' ALA . 37.4 t -116.52 114.71 46.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.19 -0.459 . . . . 1.06 109.84 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.1 mt -100.23 122.78 43.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.103 -0.702 . . . . 1.23 109.103 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.988 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -109.63 116.74 32.3 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.22 -0.592 . . . . 1.04 110.731 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.752 ' HB2' ' HH ' ' A' ' 119' ' ' TYR . 2.8 m-85 -99.11 109.43 54.21 Favored Pre-proline 0 C--N 1.31 -1.134 0 CA-C-N 115.789 -0.641 . . . . 0.45 109.611 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.776 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 75.1 Cg_exo -50.37 160.61 1.48 Allowed 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 124.185 3.256 . . . . 0.73 113.568 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.433 -1.307 0 CA-C-O 122.65 1.214 . . . . 2.02 111.227 171.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.607 ' HB3' ' HG ' ' A' ' 45' ' ' SER . 75.8 m . . . . . 0 N--CA 1.437 -1.112 0 CA-C-O 121.184 0.516 . . . . 0.91 110.111 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -154.56 120.36 5.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.336 -0.847 . . . . 2.41 109.761 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.742 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 7.7 pttt 33.36 77.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.333 1.021 . . . . 3.5 113.271 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.695 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 1.6 p90 -57.9 135.41 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.062 -1.458 . . . . 1.74 107.062 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HE2' ' HG3' ' A' ' 97' ' ' LYS . 70.0 mmtt -102.46 122.88 45.19 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.858 -0.737 . . . . 3.53 112.011 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.681 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . . . -125.11 -162.22 1.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.053 -0.976 . . . . 1.09 110.517 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.654 ' HG2' HG23 ' A' ' 58' ' ' THR . 7.4 pt-20 -90.64 -11.25 40.43 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.068 -0.653 . . . . 2.19 110.129 175.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.775 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.0 p90 -103.15 167.86 9.61 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.225 -0.898 . . . . 0.39 108.889 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.664 ' HB2' ' HE2' ' A' ' 105' ' ' MET . 22.1 Cg_exo -71.95 120.9 7.15 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.749 2.966 . . . . 0.48 113.348 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.988 HG13 ' HB1' ' A' ' 73' ' ' ALA . 3.8 mp -113.71 140.15 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.341 -0.614 . . . . 1.13 109.341 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.664 ' HE2' ' HB2' ' A' ' 103' ' ' PRO . 11.4 mmt -110.79 -151.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.107 0.78 . . . . 2.08 113.107 -164.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -79.64 143.84 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.855 -1.066 . . . . 1.11 110.738 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.776 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 21.4 pttt -78.67 137.74 37.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 2.12 109.995 172.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.44 HD13 ' CE1' ' A' ' 119' ' ' TYR . 3.8 pt -143.66 158.04 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.357 -1.349 . . . . 1.19 107.357 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -73.9 91.45 1.99 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.269 -0.572 . . . . 2.16 109.754 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.6 HG13 ' CB ' ' A' ' 42' ' ' ASN . 1.3 m -82.55 84.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 119.18 -1.008 . . . . 1.1 108.943 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' O ' ' HB1' ' A' ' 115' ' ' ALA . 20.1 t-20 171.93 179.23 0.07 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.09 -1.078 . . . . 1.98 108.09 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.49 -149.09 19.81 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 116.024 1.17 . . . . 0.78 116.024 153.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 1.5 28.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.886 -1.157 . . . . 1.98 110.029 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.433 ' HB3' ' OD1' ' A' ' 109' ' ' ASN . 35.3 t-20 -108.6 2.83 22.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.917 -1.038 . . . . 2.1 109.559 -171.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.8 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -58.25 139.87 54.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.117 -0.947 . . . . 1.17 112.618 -177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.815 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 38.9 t-80 -48.32 133.52 12.83 Favored Pre-proline 0 C--O 1.226 -0.135 0 N-CA-C 109.012 -0.736 . . . . 0.51 109.012 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 9.2 Cg_endo -53.19 -33.17 63.32 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.37 2.713 . . . . 0.43 112.829 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.815 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 18.2 tp -65.72 -37.0 85.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 1.69 111.042 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.752 ' HH ' ' HB2' ' A' ' 74' ' ' PHE . 8.1 m-85 -75.55 -29.56 59.43 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.572 -0.285 . . . . 1.84 110.668 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 48.6 mt-10 -57.81 -40.2 79.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.883 -0.784 . . . . 2.37 108.883 167.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 77.7 t80 -68.08 -47.76 67.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 1.09 110.53 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.519 ' HE2' HD13 ' A' ' 118' ' ' LEU . 67.0 mtt -62.85 -55.03 29.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.097 -0.501 . . . . 1.06 111.136 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -57.54 -43.15 84.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.201 -0.454 . . . . 1.42 111.474 -176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -69.58 -39.73 77.13 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.479 -0.328 . . . . 2.63 111.009 -176.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 150' ' ' PRO . 52.3 m -69.73 -33.9 73.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.118 -0.492 . . . . 1.09 111.448 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.595 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.3 tmtt? . . . . . 0 C--N 1.323 -0.557 0 C-N-CA 120.702 -0.399 . . . . 2.26 111.317 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.132 0.492 . . . . 1.51 111.327 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.801 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 63.8 mt -105.83 110.96 33.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.221 -0.9 . . . . 1.5 110.791 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -139.06 42.06 2.09 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.407 0.891 . . . . 1.99 113.407 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.801 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -156.4 174.82 14.85 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.458 0.703 . . . . 1.1 110.699 176.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.518 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 17.0 m120 -47.9 -158.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.735 1.214 . . . . 1.8 113.596 167.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.809 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 7.3 m-85 -30.66 -58.71 0.21 Allowed 'General case' 0 C--O 1.204 -1.295 0 C-N-CA 125.416 1.486 . . . . 1.68 114.35 -166.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.779 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 21.5 m 48.51 104.68 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.575 0.954 . . . . 1.05 113.575 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.754 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.9 t -96.35 149.52 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.012 -0.675 . . . . 1.38 111.26 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.2 m-85 -104.48 131.96 51.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.218 -0.66 . . . . 0.53 109.218 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.844 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.1 tp -81.03 106.07 12.74 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.157 -0.683 . . . . 1.2 109.157 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.78 HG23 HD13 ' A' ' 15' ' ' ILE . 12.2 mm -106.36 124.0 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 108.911 -0.774 . . . . 1.05 108.911 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.445 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 39.2 p30 -75.34 -177.72 3.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.135 -0.484 . . . . 1.3 111.404 -175.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 36' ' ' SER . 75.3 mtp180 -70.92 -1.17 11.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 4.43 111.897 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.25 -19.16 12.33 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.597 0.713 . . . . 1.18 109.45 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 103.77 27.76 6.22 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.913 -1.04 . . . . 0.25 112.126 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.466 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 84.2 t -109.62 129.64 23.69 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.651 -0.323 . . . . 1.32 110.411 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 125' ' ' THR . 6.9 Cg_exo -71.86 114.98 4.12 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.719 2.279 . . . . 0.46 111.573 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.595 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.7 t -100.24 -21.61 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.596 . . . . 1.09 110.562 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.0 mm-40 -152.64 164.54 37.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.155 -0.475 . . . . 1.22 110.364 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.431 HH11 ' HG2' ' A' ' 153' ' ' ARG . 34.4 ttp85 -139.53 102.32 4.43 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.115 -0.698 . . . . 2.25 109.115 169.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.844 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 14.4 m-85 -90.92 109.24 20.46 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.23 -0.656 . . . . 0.38 109.23 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.777 ' HA ' HG21 ' A' ' 140' ' ' THR . 5.0 p -63.43 164.98 12.65 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 109.153 -0.684 . . . . 1.49 109.153 175.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.779 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 61.0 Cg_endo -68.24 -4.45 12.76 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.65 2.234 . . . . 0.74 112.944 -163.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.83 -10.3 76.11 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.021 -0.991 . . . . 0.56 111.831 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.35 139.5 36.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.461 -0.57 . . . . 1.14 109.461 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.1 m -95.09 178.65 5.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.346 -0.388 . . . . 1.64 111.102 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 62.7 t -54.58 -48.62 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 1.14 110.968 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -29.42 69.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.782 -0.645 . . . . 3.84 110.727 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.32 -34.31 77.1 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.451 -0.795 . . . . 1.86 110.125 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.558 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 53.5 mt -81.26 -41.27 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 1.05 110.74 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 50.8 mt-10 -58.2 -38.83 77.53 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.035 0.383 . . . . 0.88 112.035 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.54 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 11.6 pt-20 -59.93 -18.53 45.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 0.75 111.594 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.607 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.6 mmtp -111.15 -17.76 13.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.078 0.466 . . . . 2.11 110.509 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.588 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.5 tp -92.44 -39.43 11.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.77 -0.65 . . . . 1.06 111.96 -172.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' A' ' 171' ' ' LEU . 76.7 mt -49.96 -51.24 63.14 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.663 0.616 . . . . 1.14 112.663 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.9 Cg_endo -55.71 -38.76 93.95 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.121 1.881 . . . . 0.74 112.246 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.62 -35.74 65.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 1.35 110.969 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.961 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 22.0 mt -57.12 -57.61 11.84 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.368 0.604 . . . . 1.16 109.646 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -50.35 -62.73 4.88 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.286 -1.324 . . . . 1.52 112.201 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 2.89 110.285 177.83 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.413 0.625 . . . . 2.22 110.324 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.0 p -150.29 174.95 12.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 1.06 108.573 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.683 HD13 HG22 ' A' ' 144' ' ' ILE . 24.3 pt -62.28 -27.04 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.913 0.387 . . . . 1.08 111.427 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.866 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 34.7 m-85 -80.34 7.99 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.3 111.125 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.05 -16.28 60.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.231 -1.026 . . . . 1.96 108.231 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 71.9 m-85 -111.73 155.14 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.677 -1.147 . . . . 0.4 111.211 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -100.95 144.31 30.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.529 -0.545 . . . . 2.77 109.529 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.56 ' CG2' ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -125.93 167.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 1.39 110.493 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.974 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 93.6 mt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.292 -0.413 . . . . 1.33 110.245 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.52 -172.9 2.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.177 -0.675 . . . . 1.59 109.177 176.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.704 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . . . -54.0 -30.96 49.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.828 0.347 . . . . 1.14 111.304 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 18.8 t70 -89.56 -16.38 30.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 2.22 111.469 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.974 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 15.3 m-70 83.74 25.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.998 0.919 . . . . 0.88 109.68 -175.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.739 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 mmpt? -84.67 146.51 46.82 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 105.515 -2.032 . . . . 3.67 105.515 164.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.92 113.08 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 119.722 0.936 . . . . 1.19 111.292 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.56 ' HB3' ' CG2' ' A' ' 20' ' ' VAL . 89.3 t80 -79.63 120.86 24.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.542 -0.753 . . . . 0.98 109.816 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.562 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -67.84 84.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.477 -0.783 . . . . 1.65 109.728 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.866 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -72.74 -35.12 67.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.525 0.679 . . . . 1.08 110.142 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.762 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.5 p -76.55 -1.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 1.15 112.919 -167.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.1 pt20 -82.4 -5.1 58.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.303 0.573 . . . . 1.94 109.669 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.407 ' CG ' HG21 ' A' ' 70' ' ' THR . 88.1 m-70 -92.54 -8.55 44.11 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.95 -1.13 . . . . 0.38 107.95 177.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 36.4 ttpt -71.86 133.88 45.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.235 -0.893 . . . . 2.22 109.341 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 -1.25 57.65 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 109.862 -1.295 . . . . 0.36 109.862 -168.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 33.6 m -142.21 124.97 9.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.518 -0.841 . . . . 1.58 108.879 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.816 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 14.6 Cg_endo -59.0 147.86 88.03 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.58 1.52 . . . . 0.86 110.755 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.523 ' HB2' HG23 ' A' ' 70' ' ' THR . 2.0 pt? -150.68 151.29 32.24 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.243 0.544 . . . . 1.63 111.506 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.765 HD23 HG22 ' A' ' 163' ' ' ILE . 7.1 mp -108.51 152.14 25.13 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.69 -0.686 . . . . 1.69 109.266 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.675 HG22 ' HH ' ' A' ' 119' ' ' TYR . 72.6 mt -140.98 118.77 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 110.147 -0.316 . . . . 1.05 110.147 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.823 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 20.6 m-85 -105.11 124.27 49.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.426 0.155 . . . . 0.93 111.324 -173.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.521 ' HB3' HG13 ' A' ' 110' ' ' VAL . 1.3 p30 -81.0 91.67 6.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.841 -1.17 . . . . 1.97 107.841 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.587 HG13 ' HE1' ' A' ' 98' ' ' PHE . 2.4 p -109.05 135.41 48.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 113.288 0.848 . . . . 1.48 113.288 -162.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.63 107.89 0.75 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.766 -1.198 . . . . 1.17 107.766 170.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.034 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -71.62 84.67 0.87 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.775 -1.102 . . . . 2.3 113.0 -165.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.0 tmtp? 60.44 53.56 4.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.631 -0.713 . . . . 2.81 110.733 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 p -163.69 136.56 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.757 -0.656 . . . . 1.18 110.43 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.78 -113.57 4.38 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.626 -0.797 . . . . 1.42 112.561 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 169.26 17.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.097 0.475 . . . . 3.45 111.736 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.664 HG21 ' HE1' ' A' ' 139' ' ' PHE . 40.0 p -126.07 139.65 53.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.432 -0.804 . . . . 1.94 109.41 171.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.617 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 27.7 mtpp -106.16 18.87 21.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 2.51 111.09 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.63 13.34 32.7 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.822 -0.704 . . . . 0.55 111.709 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 -43.22 16.53 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.866 -0.494 . . . . 0.39 111.866 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.608 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.2 t80 -68.05 -49.14 63.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 1.05 110.331 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -54.82 -55.14 33.44 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.88 -0.6 . . . . 2.46 110.486 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 160' ' ' VAL . 93.4 m -62.61 -46.96 85.85 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.009 -0.996 . . . . 1.06 111.287 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.539 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -59.89 -49.29 78.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.858 0.361 . . . . 1.03 111.152 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.9 m -59.6 -50.58 73.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.721 -0.672 . . . . 1.09 110.749 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 p -65.7 -37.68 87.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 1.69 112.045 -175.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.48 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 84.5 mt -61.55 -52.4 64.62 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 121.158 -0.217 . . . . 1.46 110.951 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.613 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 53.1 t80 -51.89 -51.82 54.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.777 -0.823 . . . . 0.92 108.777 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.47 -30.32 68.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.304 -0.862 . . . . 1.88 112.036 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -86.06 -39.68 16.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.598 0.222 . . . . 2.27 111.598 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.648 ' CD1' HD12 ' A' ' 171' ' ' LEU . 60.5 m-85 -108.35 9.91 27.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.485 1.291 . . . . 0.9 114.485 -170.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 18.3 mtmm -59.34 -26.81 65.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.941 -0.704 . . . . 2.62 110.061 170.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 m -60.5 -30.21 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.593 -0.73 . . . . 1.59 111.627 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -104.44 12.98 32.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 1.9 111.206 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.47 65.58 1.66 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.592 -0.813 . . . . 1.32 112.299 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 65.5 t80 -129.03 137.72 51.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.75 0.31 . . . . 0.4 110.639 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.523 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -129.17 143.06 50.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 120.928 0.394 . . . . 1.11 110.746 177.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.708 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 29.9 t -114.31 120.95 65.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.935 0.398 . . . . 1.06 110.621 171.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.63 ' HB3' ' HE1' ' A' ' 105' ' ' MET . 20.0 mt -105.69 122.87 46.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.297 -0.631 . . . . 1.23 109.297 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.015 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -111.53 116.19 30.45 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.298 -0.561 . . . . 1.04 110.904 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.1 m-85 -100.06 110.04 58.23 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.018 -0.734 . . . . 0.45 109.018 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.034 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 53.2 Cg_exo -54.67 165.81 2.28 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 123.606 2.871 . . . . 0.73 111.421 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.436 -1.14 0 C-N-CA 118.569 -1.252 . . . . 2.02 113.943 -176.451 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 83.9 m . . . . . 0 N--CA 1.435 -1.217 0 CA-C-O 121.157 0.503 . . . . 0.91 111.388 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -127.39 157.33 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.279 -0.873 . . . . 2.41 109.331 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.704 ' HD2' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -38.97 111.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.135 0.574 . . . . 3.5 111.33 175.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.608 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 46.4 p90 -64.35 -22.07 66.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.872 -0.604 . . . . 1.74 111.794 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 66.66 146.6 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.79 0.681 . . . . 3.53 111.72 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.416 ' CB ' ' HE1' ' A' ' 54' ' ' TYR . . . -166.63 -165.87 0.79 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 1.09 111.371 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.9 1.78 53.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.287 0.565 . . . . 2.19 110.497 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.754 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 51.7 p90 -123.83 165.3 24.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 108.56 -0.904 . . . . 0.39 108.56 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.708 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 29.1 Cg_exo -67.87 120.97 7.97 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.732 2.955 . . . . 0.48 113.256 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.015 HG13 ' HB2' ' A' ' 73' ' ' ALA . 3.2 mp -114.93 140.29 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.22 -0.659 . . . . 1.13 109.22 173.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.63 ' HE1' ' HB3' ' A' ' 72' ' ' LEU . 8.3 mmt -115.37 -150.44 0.46 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.046 0.758 . . . . 2.08 113.046 -165.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.98 135.39 43.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.831 -1.077 . . . . 1.11 110.756 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.872 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttp -74.03 116.9 15.2 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.316 -0.994 . . . . 2.12 108.316 167.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.484 HD12 ' CB ' ' A' ' 116' ' ' HIS . 4.8 pt -122.67 175.99 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.615 -1.175 . . . . 1.19 107.986 -174.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.1 m120 -73.33 114.92 12.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.057 -1.09 . . . . 2.16 108.057 169.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -114.49 83.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 118.992 -1.083 . . . . 1.1 108.913 166.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.3 t-20 170.52 179.41 0.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.428 -0.953 . . . . 1.98 108.428 169.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 59.9 -146.22 45.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.78 113.879 165.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.11 -14.28 15.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.654 0.74 . . . . 1.98 109.475 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.06 -12.19 50.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.962 -1.017 . . . . 2.1 110.866 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.603 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -43.98 149.49 0.32 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.707 1.003 . . . . 1.17 113.707 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.7 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 41.2 t-80 -55.06 133.57 68.15 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 114.847 -1.07 . . . . 0.51 110.507 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -46.86 -47.77 15.64 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.917 2.411 . . . . 0.43 112.788 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.7 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.956 -0.565 . . . . 1.69 111.414 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.675 ' HH ' HG22 ' A' ' 40' ' ' ILE . 2.0 m-85 -75.42 -29.92 59.9 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 122.24 -0.287 . . . . 1.84 111.077 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 8.9 mm-40 -58.0 -42.21 84.73 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.31 -0.556 . . . . 2.37 109.622 168.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 83.9 t80 -61.59 -52.25 65.19 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.923 0.392 . . . . 1.09 110.483 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.507 ' HE1' HD21 ' A' ' 118' ' ' LEU . 66.0 mtt -60.05 -50.04 75.29 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.325 0.583 . . . . 1.06 110.752 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' HZ1' ' HB3' ' A' ' 123' ' ' LYS . 2.9 ttpm? -61.51 -38.21 86.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.729 -1.123 . . . . 1.42 111.396 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 16.2 ptpt -76.57 -35.9 57.92 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.77 0.285 . . . . 2.63 111.77 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.548 HG21 ' HD2' ' A' ' 150' ' ' PRO . 86.4 m -63.47 -42.61 98.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.088 0.471 . . . . 1.09 110.798 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.662 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.0 ttmt . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 109.327 -0.62 . . . . 2.26 109.327 169.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 113.577 0.954 . . . . 1.51 113.577 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.854 HG21 ' HZ3' ' A' ' 137' ' ' TRP . 23.7 mt -83.24 168.29 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 114.225 -1.352 . . . . 1.5 109.142 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.855 ' HB3' ' HZ3' ' A' ' 136' ' ' LYS . 0.5 OUTLIER 179.02 -35.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.279 0.945 . . . . 1.99 112.873 -176.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.854 ' HZ3' HG21 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.13 171.76 8.25 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.904 0.882 . . . . 1.1 112.201 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 17.6 m120 -44.46 -157.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.407 1.483 . . . . 1.8 114.122 169.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.823 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 31.7 m-85 -28.56 -56.96 0.13 Allowed 'General case' 0 C--O 1.208 -1.111 0 C-N-CA 125.259 1.424 . . . . 1.68 114.323 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.813 HG22 ' HA ' ' A' ' 155' ' ' SER . 7.0 m 42.87 95.73 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.398 0.888 . . . . 1.05 113.398 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.5 p -85.12 152.07 23.66 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.328 -0.549 . . . . 1.38 110.722 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.464 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 6.1 m-85 -103.36 137.71 41.11 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.802 -1.184 . . . . 0.53 107.802 166.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.953 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 44.7 tp -82.58 104.91 13.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.838 -0.801 . . . . 1.2 108.838 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.683 HG22 HD13 ' A' ' 15' ' ' ILE . 16.9 mm -102.69 119.27 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.775 -0.824 . . . . 1.05 108.775 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.12 179.72 3.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.133 0.492 . . . . 1.3 110.292 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -61.83 -12.58 18.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.519 -0.764 . . . . 4.43 112.554 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -111.12 -21.36 11.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 1.18 110.294 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.451 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 110.55 35.56 2.05 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.554 -0.748 . . . . 0.25 112.864 177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 96.0 t -112.08 124.36 32.38 Favored Pre-proline 0 C--N 1.319 -0.75 0 O-C-N 122.584 -0.363 . . . . 1.32 110.361 175.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.548 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -66.9 99.87 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.46 111.761 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.5 t -84.03 -21.19 8.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.581 . . . . 1.09 110.798 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.662 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 mm-40 -159.16 164.55 35.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.786 -0.45 . . . . 1.22 109.786 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.61 HH11 ' HH2' ' A' ' 137' ' ' TRP . 26.2 ttm180 -131.59 97.56 4.26 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.344 -0.614 . . . . 2.25 109.344 171.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.953 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 40.7 m-85 -81.92 111.13 17.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.224 -0.658 . . . . 0.38 109.224 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.813 ' HA ' HG22 ' A' ' 140' ' ' THR . 0.9 OUTLIER -58.72 163.66 5.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.519 -0.549 . . . . 1.49 109.519 174.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.783 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 50.8 Cg_endo -67.69 -7.03 18.21 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.463 2.109 . . . . 0.74 112.06 -169.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -86.1 -0.57 87.05 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.08 -0.963 . . . . 0.56 112.694 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.88 135.36 36.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.942 0.401 . . . . 1.14 110.538 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 172.79 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 1.64 110.62 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.457 ' HA ' HG22 ' A' ' 56' ' ' THR . 31.2 t -50.45 -53.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.532 -0.303 . . . . 1.14 110.829 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.674 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 64.0 tttm -63.41 -35.28 79.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 3.84 111.44 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -54.3 -40.87 68.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.541 0.686 . . . . 1.86 109.485 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.765 HG22 HD23 ' A' ' 39' ' ' LEU . 61.2 mt -82.27 -40.66 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.838 -1.074 . . . . 1.05 111.507 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 41.3 mt-10 -53.14 -42.26 65.91 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.282 0.475 . . . . 0.88 112.282 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.674 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 1.7 pt-20 -69.31 -2.37 10.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.408 0.521 . . . . 0.75 112.408 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.618 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 33.3 mmtm -116.66 -20.83 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.577 . . . . 2.11 109.705 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.555 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.1 tp -93.29 -41.12 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 1.06 111.95 -168.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.644 ' HA ' HD13 ' A' ' 171' ' ' LEU . 77.5 mt -49.86 -50.8 65.86 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.703 0.631 . . . . 1.14 112.703 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.5 Cg_exo -54.24 -36.56 86.6 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.236 1.958 . . . . 0.74 112.835 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -75.99 -37.38 58.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.675 -0.239 . . . . 1.35 110.966 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.816 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.8 mt -59.7 -48.59 81.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.716 0.77 . . . . 1.16 109.033 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -49.29 -65.23 2.86 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 114.241 -1.345 . . . . 1.52 112.42 167.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 p . . . . . 0 CA--C 1.533 0.294 0 CA-C-N 116.767 0.284 . . . . 2.89 110.658 178.116 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 111.848 0.314 . . . . 2.22 111.848 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 p -151.7 154.93 37.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.417 0.627 . . . . 1.06 110.369 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.622 HD12 HG23 ' A' ' 144' ' ' ILE . 13.8 pt -61.6 -21.46 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.913 -1.039 . . . . 1.08 112.497 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.786 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 62.2 m-85 -77.7 -2.57 36.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.39 0.515 . . . . 0.3 112.39 -171.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -70.47 -17.46 62.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.632 0.73 . . . . 1.96 109.363 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.55 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 79.3 m-85 -100.38 162.6 12.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.191 -0.913 . . . . 0.4 111.477 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 25.9 tt0 -93.97 153.61 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 2.77 110.733 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.504 HG12 ' CE2' ' A' ' 74' ' ' PHE . 75.6 t -133.05 139.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.037 0.446 . . . . 1.39 111.186 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.957 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 95.6 mt -104.96 140.56 38.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.826 -0.805 . . . . 1.33 108.826 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.82 -172.35 1.9 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.268 -0.641 . . . . 1.59 109.268 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -54.36 -33.06 58.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.753 0.311 . . . . 1.14 111.306 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 19.6 t70 -86.85 -11.67 50.14 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.418 -0.355 . . . . 2.22 111.287 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.957 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 42.3 m-70 79.37 22.31 0.57 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.618 0.767 . . . . 0.88 109.745 -176.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.74 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -84.13 146.0 47.37 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 105.857 -1.905 . . . . 3.67 105.857 166.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.89 114.6 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.157 1.238 . . . . 1.19 112.695 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.895 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 64.2 t80 -87.38 116.49 25.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.312 -0.858 . . . . 0.98 110.134 172.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -66.73 93.85 0.27 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.102 -0.703 . . . . 1.65 109.102 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.786 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -77.31 -34.3 55.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.361 0.6 . . . . 1.08 110.454 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.74 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.8 p -76.64 -0.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.271 -0.877 . . . . 1.15 112.296 -168.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.64 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 4.0 pt20 -80.85 -5.24 57.04 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.963 -0.754 . . . . 1.94 108.963 173.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.895 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 88.7 m-70 -101.35 20.64 15.49 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.897 -1.047 . . . . 0.38 108.341 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -96.94 150.95 20.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.462 -1.245 . . . . 2.22 108.742 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 -6.05 81.38 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.636 -0.985 . . . . 0.36 110.636 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.2 m -140.72 141.75 26.0 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.798 -1.186 . . . . 1.58 107.798 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.839 ' HG2' HD22 ' A' ' 171' ' ' LEU . 3.2 Cg_exo -75.99 157.54 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.019 1.813 . . . . 0.86 111.365 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.532 ' HB2' HG23 ' A' ' 70' ' ' THR . 1.8 pt? -154.67 148.61 25.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.249 0.547 . . . . 1.63 111.251 -174.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.617 HD23 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.29 150.7 26.39 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.262 -1.014 . . . . 1.69 108.262 171.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 66.9 mt -139.64 118.7 12.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.623 -0.51 . . . . 1.05 109.623 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.826 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 38.8 m-85 -103.07 124.15 47.99 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 121.154 -0.218 . . . . 0.93 111.359 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.646 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -78.56 92.0 4.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.901 -1.148 . . . . 1.97 107.901 166.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.6 p -108.62 143.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 113.363 0.875 . . . . 1.48 113.363 -161.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.623 ' HA ' ' OG ' ' A' ' 76' ' ' SER . . . -67.04 110.43 3.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.438 -1.319 . . . . 1.17 107.438 170.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.995 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -67.89 81.27 0.2 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.061 -0.972 . . . . 2.3 111.869 -167.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.622 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 14.1 ptpt 46.01 66.37 0.96 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.274 1.43 . . . . 2.81 112.46 -173.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -162.65 138.07 7.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -1.02 . . . . 1.18 110.154 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.13 -140.97 30.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.842 -0.694 . . . . 1.42 113.346 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -84.07 170.09 14.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.075 0.464 . . . . 3.45 111.77 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.15 -28.44 2.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.949 -0.569 . . . . 1.94 111.424 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.859 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.4 mmmt 66.27 3.52 2.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.255 0.622 . . . . 2.51 111.917 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.04 1.9 59.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.818 -0.706 . . . . 0.55 112.28 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.4 81.92 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.468 -0.653 . . . . 0.39 111.468 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.692 ' HE1' ' HB3' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -66.21 -49.34 67.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.203 -0.498 . . . . 1.05 110.185 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.63 -43.51 89.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.505 -0.771 . . . . 2.46 110.119 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 160' ' ' VAL . 55.1 m -57.94 -53.26 60.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.516 -0.765 . . . . 1.06 110.527 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -58.68 -49.48 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.719 -0.673 . . . . 1.03 111.846 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.634 HG22 ' HB2' ' A' ' 101' ' ' GLU . 63.0 m -59.22 -45.39 91.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 1.09 110.754 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.9 m -64.07 -48.44 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.652 -0.704 . . . . 1.69 110.78 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 95.1 mt -56.59 -53.04 62.28 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.803 0.298 . . . . 1.46 111.803 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.636 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 70.9 t80 -53.23 -53.35 52.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.788 -0.642 . . . . 0.92 109.755 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.96 -27.43 60.99 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.371 -0.832 . . . . 1.88 111.815 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.75 -48.34 12.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.839 0.352 . . . . 2.27 111.411 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.677 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.8 m-85 -99.1 6.17 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.258 0.836 . . . . 0.9 113.258 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -57.81 -29.85 65.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.808 0.337 . . . . 2.62 110.316 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -63.57 -32.8 74.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 1.59 111.061 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -96.5 10.78 37.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 1.9 110.689 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 80.66 64.07 1.85 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.945 -0.645 . . . . 1.32 112.19 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.617 ' CE1' HD23 ' A' ' 39' ' ' LEU . 70.6 t80 -129.66 143.85 51.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.727 0.299 . . . . 0.4 110.912 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.6 146.77 52.37 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.853 0.358 . . . . 1.11 110.416 177.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.742 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 42.5 t -116.52 120.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.96 -0.385 . . . . 1.06 109.96 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 26.7 mt -106.38 123.07 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.654 -0.498 . . . . 1.23 109.654 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.989 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -104.91 131.32 52.56 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.103 0.478 . . . . 1.04 110.266 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.504 ' CE2' HG12 ' A' ' 20' ' ' VAL . 8.2 m-85 -117.27 106.98 46.07 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.219 -0.66 . . . . 0.45 109.219 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.003 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 52.6 Cg_exo -56.69 169.06 1.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.993 3.129 . . . . 0.73 112.04 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.623 ' OG ' ' HA ' ' A' ' 44' ' ' ALA . 3.7 p . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 115.419 1.637 . . . . 2.02 115.419 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.482 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 31.1 m . . . . . 0 N--CA 1.44 -0.974 0 CA-C-O 121.096 0.474 . . . . 0.91 110.218 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.664 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 95.7 m -153.99 128.63 9.33 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.378 -0.828 . . . . 2.41 110.38 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 96' ' ' THR . 44.4 pttt 68.21 -44.73 0.5 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.584 1.328 . . . . 3.5 114.584 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.622 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 62.03 -67.92 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.461 0.573 . . . . 1.74 111.577 -175.314 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.665 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 8.9 mmpt? 71.23 147.68 0.08 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.898 0.879 . . . . 3.53 111.795 173.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.692 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . . . -168.44 -166.66 0.71 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.101 0.477 . . . . 1.09 111.968 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.634 ' HB2' HG22 ' A' ' 58' ' ' THR . 29.0 mm-40 -88.79 27.69 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 2.19 110.547 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.847 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 39.1 p90 -149.6 174.76 3.21 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.153 -1.425 . . . . 0.39 107.153 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.742 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 22.4 Cg_exo -71.1 125.59 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.802 2.334 . . . . 0.48 113.322 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.989 HG13 ' HB2' ' A' ' 73' ' ' ALA . 3.9 mp -124.43 141.49 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.247 -0.649 . . . . 1.13 109.247 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.695 ' HE2' ' HB2' ' A' ' 103' ' ' PRO . 6.4 mmt -115.48 -152.16 0.5 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.542 0.687 . . . . 2.08 112.714 -164.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . . . -73.04 137.26 45.23 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.577 -1.192 . . . . 1.11 110.707 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.003 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 26.7 pttt -73.13 120.97 19.49 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.764 -0.828 . . . . 2.12 108.764 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.497 HD11 ' CB ' ' A' ' 116' ' ' HIS . 5.2 pt -122.53 169.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.795 -1.093 . . . . 1.19 108.343 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.779 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.2 m120 -68.6 121.37 16.29 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.77 -1.196 . . . . 2.16 107.77 169.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.646 HG12 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -119.16 83.57 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 C-N-CA 119.127 -1.029 . . . . 1.1 109.587 170.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 46.5 t30 170.96 177.97 0.06 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.076 -1.083 . . . . 1.98 108.076 167.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.76 -141.52 35.93 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.955 -0.641 . . . . 0.78 113.779 164.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.23 1.52 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.121 -0.539 . . . . 1.98 110.601 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -87.75 -24.94 23.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.821 -0.627 . . . . 2.1 110.681 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.779 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -44.59 142.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.779 1.029 . . . . 1.17 113.779 -175.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.497 ' CB ' HD11 ' A' ' 108' ' ' ILE . 49.3 t-80 -53.23 136.3 49.84 Favored Pre-proline 0 C--O 1.225 -0.236 0 CA-C-N 114.679 -1.146 . . . . 0.51 110.012 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.55 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.2 Cg_exo -40.95 -45.34 5.03 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.172 2.581 . . . . 0.43 112.845 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.558 HD13 ' HE3' ' A' ' 122' ' ' MET . 30.0 tp -54.02 -51.49 63.82 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.783 -0.644 . . . . 1.69 111.884 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.487 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.5 m-85 -71.28 -30.4 66.22 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 116.517 -0.31 . . . . 1.84 111.0 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 9.6 mm-40 -56.26 -43.3 78.62 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.726 -0.79 . . . . 2.37 109.413 170.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.9 t80 -66.03 -45.03 82.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.614 -0.434 . . . . 1.09 110.508 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.558 ' HE3' HD13 ' A' ' 118' ' ' LEU . 66.9 mtt -60.76 -53.11 61.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.873 0.368 . . . . 1.06 111.236 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 2.5 mtpm? -62.33 -38.24 88.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 1.42 110.838 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 17.1 ptpt -74.82 -27.35 60.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.718 -0.219 . . . . 2.63 110.816 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.542 HG21 ' HD2' ' A' ' 150' ' ' PRO . 59.1 m -65.02 -55.18 20.44 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.945 -0.302 . . . . 1.09 111.068 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 31.7 ttmt . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.278 -0.569 . . . . 2.26 111.574 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 113.357 0.873 . . . . 1.51 113.357 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.899 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 26.0 mt -103.19 90.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.845 -1.07 . . . . 1.5 110.79 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -111.48 -2.38 15.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.451 0.537 . . . . 1.99 112.451 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.899 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -120.41 170.29 9.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.465 0.543 . . . . 1.1 112.465 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 16.3 m120 -47.98 -156.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.901 1.681 . . . . 1.8 113.745 172.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.826 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 33.2 m-85 -27.48 -57.96 0.1 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 125.175 1.39 . . . . 1.68 114.022 -164.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.762 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 24.2 m 42.94 95.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.046 0.758 . . . . 1.05 113.046 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.675 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.3 t -88.33 147.13 24.92 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.997 -0.681 . . . . 1.38 110.786 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.439 ' O ' HD13 ' A' ' 39' ' ' LEU . 5.2 m-85 -102.32 133.99 46.33 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.371 -0.974 . . . . 0.53 108.371 169.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.881 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.35 104.05 11.53 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.001 -0.74 . . . . 1.2 109.001 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.622 HG23 HD12 ' A' ' 15' ' ' ILE . 10.7 mm -104.07 116.86 48.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.92 -0.582 . . . . 1.05 109.737 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.416 ' HB2' HD11 ' A' ' 170' ' ' LEU . 6.9 t70 -74.68 169.85 17.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.017 -0.538 . . . . 1.3 109.846 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.867 ' HD3' ' HA ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -60.36 -9.66 3.81 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.329 -0.851 . . . . 4.43 112.09 -168.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.2 8.78 28.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.864 -0.791 . . . . 1.18 108.864 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.522 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 71.57 45.49 45.41 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.25 112.559 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 79.7 t -123.24 123.06 26.69 Favored Pre-proline 0 C--N 1.321 -0.671 0 O-C-N 122.85 -0.206 . . . . 1.32 110.664 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.542 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -68.12 102.75 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.244 2.63 . . . . 0.46 112.417 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.49 ' HB ' HD23 ' A' ' 143' ' ' LEU . 18.8 t -88.49 -15.35 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 1.09 110.806 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.485 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 28.2 mm-40 -168.08 164.54 13.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.094 0.474 . . . . 1.22 111.273 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -133.95 99.31 4.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 2.25 109.546 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.881 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.5 m-85 -87.25 125.31 34.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.738 -0.838 . . . . 0.38 108.738 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.742 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 95.4 p -69.01 174.29 2.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.617 0.644 . . . . 1.49 109.357 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.859 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 62.8 Cg_endo -68.31 -13.8 38.66 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.062 1.841 . . . . 0.74 111.48 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.13 1.72 79.06 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.835 -1.075 . . . . 0.56 111.699 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.92 133.77 35.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.981 0.42 . . . . 1.14 110.306 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.6 m -90.95 178.52 6.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.109 -0.496 . . . . 1.64 110.221 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.548 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 45.1 t -54.61 -55.9 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 1.14 111.034 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.8 tptp -62.91 -29.23 70.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 3.84 111.265 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.65 -41.12 89.81 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.347 -0.612 . . . . 1.86 109.347 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.693 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.9 mt -82.31 -38.44 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.891 . . . . 1.05 111.344 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 49.0 mt-10 -54.59 -41.86 70.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.297 0.48 . . . . 0.88 112.297 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.1 pt-20 -65.62 -11.78 47.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.444 0.535 . . . . 0.75 112.444 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 73.6 mmtt -109.89 -16.2 13.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.492 . . . . 2.11 110.386 174.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.585 ' HG ' HD12 ' A' ' 171' ' ' LEU . 67.1 tp -95.61 -42.68 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.742 -0.663 . . . . 1.06 111.845 -171.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.632 ' HA ' HD11 ' A' ' 171' ' ' LEU . 80.6 mt -49.79 -51.31 61.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.547 0.573 . . . . 1.14 112.547 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 57.0 Cg_exo -55.09 -30.94 72.94 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.271 1.981 . . . . 0.74 113.154 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 145' ' ' ASP . 64.7 mt -81.73 -34.21 30.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.52 0.2 . . . . 1.35 110.75 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.839 HD22 ' HG2' ' A' ' 37' ' ' PRO . 12.6 mt -64.31 -41.4 96.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.694 0.759 . . . . 1.16 109.245 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.47 12.21 2.72 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 114.411 -1.268 . . . . 1.52 113.278 171.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.867 ' HA ' ' HD3' ' A' ' 146' ' ' ARG . 19.3 t . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 124.413 1.085 . . . . 2.89 111.562 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 108.726 -0.842 . . . . 2.22 108.726 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.0 p -145.08 174.85 10.69 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.979 -1.01 . . . . 1.06 108.543 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.677 HD13 HG22 ' A' ' 144' ' ' ILE . 13.0 pt -65.15 -22.92 32.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 1.08 111.203 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.844 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 52.6 m-85 -79.79 -0.28 33.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.195 -0.457 . . . . 0.3 111.951 -172.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.91 -12.37 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.395 0.616 . . . . 1.96 109.52 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 91.2 m-85 -109.9 140.32 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.435 -0.802 . . . . 0.4 110.991 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.99 140.6 33.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.698 -0.683 . . . . 2.77 110.631 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.589 HG22 HD13 ' A' ' 30' ' ' LEU . 70.0 t -114.46 148.74 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.935 0.398 . . . . 1.39 110.914 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.809 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 81.6 mt -111.54 141.62 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 1.33 109.246 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.03 -171.75 2.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.487 -0.561 . . . . 1.59 109.487 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.24 -32.93 57.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.605 -0.27 . . . . 1.14 111.671 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.6 t70 -90.86 -8.33 49.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.597 -0.274 . . . . 2.22 111.402 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.809 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.9 m-70 80.71 22.55 0.39 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.88 110.239 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -81.61 160.68 63.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 105.685 -1.968 . . . . 3.67 105.685 166.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.8 113.67 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 120.093 1.069 . . . . 1.19 111.727 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 1.004 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 58.2 t80 -80.67 130.07 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 0.98 109.969 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.752 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.5 t-20 -80.67 81.99 6.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.07 -0.715 . . . . 1.65 109.07 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.844 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -67.86 -32.38 72.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.198 0.523 . . . . 1.08 110.219 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.701 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.33 -0.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.428 -0.806 . . . . 1.15 112.634 -169.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.752 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.6 pt20 -83.55 -6.04 59.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.609 0.719 . . . . 1.94 109.164 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 1.004 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 87.0 m-70 -91.73 -9.78 42.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.991 -1.114 . . . . 0.38 107.991 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -70.9 137.48 49.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.19 -1.368 . . . . 2.22 109.157 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 -10.56 53.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 109.913 -1.275 . . . . 0.36 109.913 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 49.6 m -141.0 144.78 36.49 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.822 -0.807 . . . . 1.58 108.822 177.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.994 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 60.8 Cg_endo -71.89 155.69 57.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.909 1.739 . . . . 0.86 111.259 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HB2' HG23 ' A' ' 70' ' ' THR . 1.7 pt? -154.19 152.68 30.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.153 0.501 . . . . 1.63 111.217 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.88 HD23 HG23 ' A' ' 163' ' ' ILE . 6.8 mp -108.0 152.5 24.4 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.775 -0.824 . . . . 1.69 108.775 172.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 78.9 mt -140.84 115.48 5.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.542 -0.54 . . . . 1.05 109.542 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.903 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 17.7 m-85 -102.42 123.65 46.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 121.166 -0.213 . . . . 0.93 110.982 -173.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.681 ' HB3' HG12 ' A' ' 110' ' ' VAL . 1.1 p30 -82.23 91.3 6.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.545 -0.909 . . . . 1.97 108.545 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.614 HG12 ' HE2' ' A' ' 98' ' ' PHE . 1.7 p -111.95 125.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 112.455 0.539 . . . . 1.48 112.455 -165.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.63 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.27 107.16 0.45 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.744 -1.576 . . . . 1.17 106.744 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.054 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 3.3 p -76.71 75.67 3.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.28 -1.327 . . . . 2.3 113.483 -156.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 82.6 tttt 92.45 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.627 1.171 . . . . 2.81 111.538 174.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.6 m -141.57 143.26 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.446 -0.343 . . . . 1.18 110.674 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.28 -136.69 19.15 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.031 -0.604 . . . . 1.42 114.222 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.58 111.84 24.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 3.45 111.815 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 p -73.33 -26.7 61.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.981 -0.554 . . . . 1.94 110.648 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.834 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 39.2 mtpt 64.54 3.02 1.77 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.33 -0.85 . . . . 2.51 112.259 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.84 -3.94 34.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.824 -0.703 . . . . 0.55 112.641 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.15 79.83 Favored Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 111.702 -0.559 . . . . 0.39 111.702 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.579 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -69.25 -52.72 24.9 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.073 0.463 . . . . 1.05 110.138 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.29 -41.55 93.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.488 -0.778 . . . . 2.46 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.6 m -68.51 -40.82 80.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.816 -0.629 . . . . 1.06 110.876 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.673 ' HB3' HG12 ' A' ' 71' ' ' VAL . . . -64.98 -49.3 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 1.03 111.283 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -59.18 -48.9 79.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.835 -0.621 . . . . 1.09 111.177 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -63.8 -46.16 86.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.816 -0.629 . . . . 1.69 111.27 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.677 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.78 -46.0 90.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 1.46 111.338 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.671 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 59.0 t80 -53.74 -57.34 11.19 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 123.277 0.361 . . . . 0.92 110.427 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -67.14 -41.57 85.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.291 -0.413 . . . . 1.88 111.555 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.77 -42.79 73.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 2.27 111.717 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.741 ' CD1' HD13 ' A' ' 171' ' ' LEU . 67.7 m-85 -103.9 3.78 34.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.445 0.905 . . . . 0.9 113.445 -172.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -58.48 -29.74 66.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 2.62 110.788 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.6 p -65.32 -38.55 90.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.59 111.237 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -89.24 1.89 55.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.816 0.341 . . . . 1.9 111.255 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 93.08 73.43 1.23 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.701 -0.761 . . . . 1.32 112.006 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.585 ' CE1' HD12 ' A' ' 39' ' ' LEU . 76.7 t80 -143.09 142.13 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.526 0.203 . . . . 0.4 111.06 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.555 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.98 141.45 49.29 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 120.823 0.344 . . . . 1.11 110.207 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.673 HG12 ' HB3' ' A' ' 57' ' ' ALA . 52.9 t -108.01 114.06 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.74 0.305 . . . . 1.06 110.448 168.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 31.2 mt -98.48 122.63 41.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.828 -0.804 . . . . 1.23 108.828 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -109.51 113.42 26.19 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.388 -0.525 . . . . 1.04 110.345 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.751 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.4 m-85 -95.05 108.22 36.9 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.54 -0.911 . . . . 0.45 108.54 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.054 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.2 Cg_exo -59.76 167.67 6.56 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 123.164 2.576 . . . . 0.73 111.555 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.63 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 70.9 m . . . . . 0 N--CA 1.429 -1.482 0 C-N-CA 118.55 -1.26 . . . . 2.02 113.606 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.799 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 56.1 m . . . . . 0 N--CA 1.441 -0.904 0 CA-C-O 120.814 0.34 . . . . 0.91 111.232 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.911 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 17.0 m -153.0 115.28 4.41 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.225 -0.898 . . . . 2.41 109.304 168.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.659 ' O ' HG21 ' A' ' 104' ' ' ILE . 87.6 mttt 64.27 -40.24 0.24 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 115.006 1.484 . . . . 3.5 115.006 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.663 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER 63.2 -36.55 0.15 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.004 1.322 . . . . 1.74 112.308 -171.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 97' ' ' LYS . 70.9 mmtt 69.54 130.86 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.828 0.851 . . . . 3.53 112.581 172.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.574 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -158.88 -171.38 3.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.847 -0.615 . . . . 1.09 112.397 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.62 31.44 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.419 -0.81 . . . . 2.19 111.092 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.871 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 39.2 p90 -150.43 167.31 13.24 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 108.154 -1.054 . . . . 0.39 108.154 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.1 Cg_exo -64.04 106.52 0.67 Allowed 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 123.597 2.865 . . . . 0.48 113.527 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.979 HG13 ' HB2' ' A' ' 73' ' ' ALA . 2.4 mp -103.43 131.52 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.991 -0.744 . . . . 1.13 108.991 174.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.751 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.5 mmt -109.94 -154.17 0.53 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.118 0.784 . . . . 2.08 113.118 -161.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -69.56 125.22 26.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.123 -0.944 . . . . 1.11 110.496 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.911 ' HE3' ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -64.5 120.55 12.53 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.617 -0.883 . . . . 2.12 108.617 172.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.752 HG13 HG13 ' A' ' 110' ' ' VAL . 9.2 pt -121.39 155.04 25.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.29 -1.004 . . . . 1.19 108.29 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -83.19 69.61 9.94 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.123 -1.066 . . . . 2.16 108.123 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.752 HG13 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.7 90.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.579 -0.737 . . . . 1.1 111.007 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.554 ' OD1' ' HB2' ' A' ' 134' ' ' ALA . 46.5 t30 174.16 172.55 0.19 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.505 -0.924 . . . . 1.98 108.505 166.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.21 -142.49 23.23 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 114.471 0.548 . . . . 0.78 114.471 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -1.52 32.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.49 0.662 . . . . 1.98 110.558 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -95.68 -13.15 24.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.089 -0.959 . . . . 2.1 110.688 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.488 ' HB3' ' H ' ' A' ' 111' ' ' ASN . . . -57.84 149.52 22.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.562 -0.745 . . . . 1.17 111.913 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.824 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 20.2 t-80 -46.99 139.73 6.72 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.118 -0.946 . . . . 0.51 110.131 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.501 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 11.0 Cg_endo -54.18 -35.34 82.21 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.224 2.616 . . . . 0.43 112.437 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.824 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 23.4 tp -61.57 -40.46 94.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.908 -0.587 . . . . 1.69 110.572 175.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.528 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.9 m-85 -75.63 -28.9 58.98 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.224 -0.443 . . . . 1.84 111.009 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.501 ' OE2' ' HA ' ' A' ' 117' ' ' PRO . 40.2 mt-10 -57.6 -39.96 77.99 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.951 -0.7 . . . . 2.37 109.181 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.489 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 79.1 t80 -71.67 -41.74 68.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 1.09 110.519 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.708 ' HE2' HD12 ' A' ' 118' ' ' LEU . 65.6 mtt -66.68 -53.01 38.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.133 -0.485 . . . . 1.06 111.576 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 13.8 mtpt -61.26 -39.63 91.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.541 -0.3 . . . . 1.42 110.958 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -68.58 -32.36 72.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.78 0.324 . . . . 2.63 110.484 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.553 HG22 ' HD2' ' A' ' 150' ' ' PRO . 89.3 m -66.23 -58.75 4.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 1.09 110.979 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.824 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 25.9 ttmt . . . . . 0 C--N 1.325 -0.492 0 C-N-CA 120.509 -0.476 . . . . 2.26 110.521 174.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.554 ' HB2' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 114.813 1.412 . . . . 1.51 114.813 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.862 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 51.0 mt -104.66 87.88 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 113.681 -1.6 . . . . 1.5 110.257 -173.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.7 pttt -110.57 14.98 22.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.477 0.547 . . . . 1.99 112.477 -170.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.862 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -146.7 169.38 19.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.923 0.342 . . . . 1.1 111.923 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.625 ' ND2' ' HB3' ' A' ' 44' ' ' ALA . 1.5 t-20 -51.66 -155.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.535 1.534 . . . . 1.8 113.223 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.903 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 27.4 m-85 -25.43 -59.68 0.07 Allowed 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 125.298 1.439 . . . . 1.68 114.794 -162.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.779 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 19.2 m 42.69 93.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 118.684 0.675 . . . . 1.05 112.738 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.0 p -84.59 150.62 25.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.689 -0.804 . . . . 1.38 110.491 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.47 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 4.5 m-85 -103.75 135.65 44.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.226 -1.027 . . . . 0.53 108.226 167.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.906 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 35.9 tp -82.01 104.85 12.66 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.994 -0.743 . . . . 1.2 108.994 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.677 HG22 HD13 ' A' ' 15' ' ' ILE . 14.6 mm -102.44 121.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.947 -0.76 . . . . 1.05 108.947 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.41 -179.39 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.568 -0.287 . . . . 1.3 110.994 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.634 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.6 mtp180 -56.23 -28.59 58.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.243 0.46 . . . . 4.43 112.243 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -109.77 -4.75 15.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.186 0.517 . . . . 1.18 110.791 -169.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.578 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.09 53.46 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.491 -0.861 . . . . 0.25 114.353 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.469 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 10.3 t -127.7 128.82 23.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 117.382 0.591 . . . . 1.32 110.151 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.553 ' HD2' HG22 ' A' ' 125' ' ' THR . 15.3 Cg_exo -66.26 102.64 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.946 2.431 . . . . 0.46 112.388 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.47 -18.42 8.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.656 -0.702 . . . . 1.09 110.925 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.824 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 77.0 mm-40 -157.07 159.42 37.9 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.682 0.277 . . . . 1.22 110.915 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.476 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 20.1 ttm180 -127.44 96.83 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.01 -0.737 . . . . 2.25 109.01 168.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.906 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 33.9 m-85 -86.42 107.88 18.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.908 -0.775 . . . . 0.38 108.908 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.734 ' HA ' HG22 ' A' ' 140' ' ' THR . 83.5 p -60.6 164.93 6.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.89 -0.411 . . . . 1.49 109.89 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.834 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 42.0 Cg_endo -65.24 -7.6 16.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.032 2.488 . . . . 0.74 112.978 -164.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.95 22.46 38.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.56 111.718 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.04 140.23 29.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 1.14 110.813 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.9 p -91.32 170.13 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.734 -0.667 . . . . 1.64 111.029 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.677 HG13 HD21 ' A' ' 60' ' ' LEU . 74.5 t -53.18 -56.09 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 1.14 110.955 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.575 ' HZ3' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -65.64 -32.05 73.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 3.84 111.461 -175.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.74 -31.78 73.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.121 -0.49 . . . . 1.86 109.922 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.88 HG23 HD23 ' A' ' 39' ' ' LEU . 35.6 mt -83.19 -39.83 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.994 -0.548 . . . . 1.05 110.7 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 54.7 mt-10 -57.79 -35.63 71.08 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.133 0.42 . . . . 0.88 112.133 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.4 pt-20 -61.32 -21.38 63.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.75 111.648 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.548 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtt -104.8 -31.5 9.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.233 -0.44 . . . . 2.11 110.549 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.3 tp -85.58 -42.43 14.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 1.06 112.758 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.652 ' HA ' HD11 ' A' ' 171' ' ' LEU . 60.8 mt -53.94 -46.97 98.38 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.504 0.557 . . . . 1.14 112.504 -173.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.438 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.9 Cg_exo -53.13 -40.16 77.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.809 1.672 . . . . 0.74 112.371 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.6 mt -74.4 -37.05 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 1.35 111.794 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.994 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.8 mt -54.27 -54.07 45.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.539 0.685 . . . . 1.16 109.497 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.7 -59.78 8.77 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.276 -1.329 . . . . 1.52 112.795 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 116.923 0.362 . . . . 2.89 110.857 -179.136 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.825 0.345 . . . . 2.22 110.664 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.3 p -124.33 -179.41 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.596 -0.52 . . . . 1.06 109.596 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.79 HD12 HG22 ' A' ' 144' ' ' ILE . 32.5 pt -68.3 -31.07 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.83 0.348 . . . . 1.08 111.358 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.766 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 29.8 m-85 -72.95 -4.62 33.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.906 0.384 . . . . 0.3 111.594 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.52 -14.22 62.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.83 -0.623 . . . . 1.96 109.366 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.631 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 84.1 m-85 -111.62 142.34 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.373 -0.83 . . . . 0.4 110.701 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -100.18 140.18 34.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.68 -0.489 . . . . 2.77 109.68 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -123.3 159.77 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.378 -0.374 . . . . 1.39 110.804 -171.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.906 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 58.7 mt -97.26 133.34 42.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.531 . . . . 1.33 110.214 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 21.2 t70 -69.78 178.18 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.702 -1.135 . . . . 1.59 109.584 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.658 ' HB3' ' CD ' ' A' ' 97' ' ' LYS . . . -55.43 -25.04 33.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.968 0.413 . . . . 1.14 111.417 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -90.91 -9.82 44.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.206 -0.452 . . . . 2.22 111.111 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.906 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 44.9 m-70 74.51 12.88 3.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.912 0.885 . . . . 0.88 109.994 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.546 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -73.37 150.36 89.39 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 106.126 -1.805 . . . . 3.67 106.126 162.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.23 115.16 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.81 1.007 . . . . 1.19 111.425 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.889 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 87.9 t80 -84.42 122.28 28.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.98 109.825 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.674 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.0 t30 -75.24 82.15 2.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.839 -0.619 . . . . 1.65 109.645 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.737 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.2 pt? -63.06 -29.74 71.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.594 0.711 . . . . 1.08 110.28 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.766 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.6 p -77.31 -0.03 2.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.828 -1.078 . . . . 1.15 112.933 -169.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -78.35 -5.45 52.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.359 -0.608 . . . . 1.94 109.359 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.889 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 77.5 m-70 -98.42 -0.75 42.99 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.38 108.759 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HE2' ' CG2' ' A' ' 31' ' ' VAL . 9.2 ttmm -67.97 132.4 47.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 2.22 109.914 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.46 -0.99 60.06 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.515 -1.034 . . . . 0.36 110.515 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 44.8 m -140.33 138.49 19.12 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.237 -0.653 . . . . 1.58 109.237 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.976 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 43.8 Cg_endo -69.44 154.87 68.42 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.769 1.646 . . . . 0.86 110.893 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.603 ' CB ' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -156.52 148.36 22.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.167 0.508 . . . . 1.63 111.323 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.638 HD22 ' CE1' ' A' ' 69' ' ' PHE . 3.4 mm? -107.12 148.63 28.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.113 -1.069 . . . . 1.69 108.113 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.538 HD12 HG13 ' A' ' 144' ' ' ILE . 69.6 mt -139.55 116.38 10.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.74 -0.467 . . . . 1.05 109.74 -173.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.696 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 16.4 m-85 -101.39 130.31 47.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.602 -0.272 . . . . 0.93 111.313 -172.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.672 ' CB ' HG13 ' A' ' 110' ' ' VAL . 1.1 p30 -87.96 92.04 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.394 -0.965 . . . . 1.97 108.394 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -106.53 150.13 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.453 0.644 . . . . 1.48 112.348 -160.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.31 109.0 5.06 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.2 -1.407 . . . . 1.17 107.2 166.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.002 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -66.76 74.46 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.005 -0.998 . . . . 2.3 112.6 -169.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.74 ' HE3' ' HA ' ' A' ' 98' ' ' PHE . 39.6 ttmt 55.73 57.44 5.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.156 -0.929 . . . . 2.81 111.119 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -160.87 128.14 4.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.108 -0.496 . . . . 1.18 111.288 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.52 -80.9 1.78 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.847 -0.615 . . . . 1.42 113.662 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -131.72 163.18 28.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.423 0.154 . . . . 3.45 110.949 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 p -131.82 -35.69 1.25 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.143 0.423 . . . . 1.94 112.143 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 65.77 0.39 1.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.478 0.711 . . . . 2.51 112.259 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.75 4.97 72.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.666 -0.778 . . . . 0.55 112.259 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.0 86.73 Favored Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.37 -0.692 . . . . 0.39 111.37 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.489 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.3 t80 -61.75 -52.75 62.98 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.941 -0.629 . . . . 1.05 110.254 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.37 -45.97 90.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.765 -0.652 . . . . 2.46 110.668 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 160' ' ' VAL . 30.1 m -57.08 -48.69 77.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.682 -0.69 . . . . 1.06 110.481 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.755 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -61.53 -50.02 74.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 1.03 111.785 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -61.1 -42.98 99.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.173 0.511 . . . . 1.09 111.005 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.8 m -64.67 -47.77 77.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.576 -0.738 . . . . 1.69 111.223 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 90.5 mt -56.52 -52.58 64.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.187 -0.461 . . . . 1.46 111.165 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.665 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 47.3 t80 -46.99 -57.87 4.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 124.435 1.085 . . . . 0.92 110.117 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.34 -38.85 65.61 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.736 -0.665 . . . . 1.88 111.919 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -70.01 -45.14 67.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 2.27 111.301 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.743 ' CD1' HD12 ' A' ' 171' ' ' LEU . 58.6 m-85 -100.02 5.83 45.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.194 0.813 . . . . 0.9 113.194 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.665 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 17.8 mtpp -62.03 -18.67 61.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 2.62 110.073 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 p -61.67 -40.69 95.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.687 -0.688 . . . . 1.59 110.874 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -94.92 10.18 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 1.9 110.599 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.575 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.14 71.66 1.26 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.571 -0.741 . . . . 1.32 112.255 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE1' HD22 ' A' ' 39' ' ' LEU . 59.4 t80 -132.62 142.43 49.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.229 -0.285 . . . . 0.4 110.229 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.603 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.36 152.44 48.16 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.973 0.416 . . . . 1.11 110.622 178.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.755 HG11 ' HB3' ' A' ' 57' ' ' ALA . 25.0 t -122.82 124.66 70.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.864 0.364 . . . . 1.06 110.437 171.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.595 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 16.5 mt -105.68 145.05 31.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.823 -0.806 . . . . 1.23 108.823 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.97 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -132.79 113.46 12.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.133 0.492 . . . . 1.04 111.108 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.639 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.6 m-85 -99.01 113.57 64.74 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.698 -0.683 . . . . 0.45 109.306 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.097 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.29 165.85 6.73 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.562 2.841 . . . . 0.73 111.818 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.438 -1.035 0 CA-C-O 122.604 1.192 . . . . 2.02 113.485 179.363 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.457 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 38.6 m . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 121.683 0.754 . . . . 0.91 110.01 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.53 ' N ' ' HB2' ' A' ' 45' ' ' SER . 10.3 t -148.36 163.49 36.92 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.747 -1.115 . . . . 2.41 108.52 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.658 ' CD ' ' HB3' ' A' ' 23' ' ' ALA . 16.5 pttt -38.85 105.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.883 0.739 . . . . 3.5 111.344 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.74 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 51.5 p90 -58.21 -22.58 52.53 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.589 -0.732 . . . . 1.74 110.92 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? 68.83 142.82 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.168 0 O-C-N 124.282 0.989 . . . . 3.53 110.473 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.45 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . . . -162.26 -160.33 0.66 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.468 -0.493 . . . . 1.09 111.732 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.91 -10.57 44.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 2.19 109.769 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.705 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 51.7 p90 -112.31 166.85 10.11 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 115.173 -0.921 . . . . 0.39 108.934 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.668 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 23.9 Cg_exo -70.61 119.31 6.24 Favored 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 123.712 2.942 . . . . 0.48 113.306 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.97 HG13 ' HB2' ' A' ' 73' ' ' ALA . 3.3 mp -108.21 149.44 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.889 -0.782 . . . . 1.13 108.889 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.639 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.3 mmt -118.49 -157.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.17 0.804 . . . . 2.08 113.17 -164.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.526 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.69 145.5 43.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.929 -1.032 . . . . 1.11 110.359 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.097 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.2 pttt -83.37 137.16 34.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.654 0.74 . . . . 2.12 109.785 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.471 HG13 HG11 ' A' ' 110' ' ' VAL . 5.0 pt -135.35 175.18 11.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.204 -1.362 . . . . 1.19 108.01 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.547 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 22.7 t-20 -88.34 83.96 6.86 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.97 -0.752 . . . . 2.16 108.97 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.672 HG13 ' CB ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -76.08 86.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.455 -1.298 . . . . 1.1 110.157 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 63.7 t30 170.88 179.36 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.86 -1.163 . . . . 1.98 107.86 166.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.75 -146.32 35.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.919 -0.658 . . . . 0.78 113.793 166.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -107.15 1.1 23.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.183 -0.508 . . . . 1.98 111.351 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -103.78 11.8 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.906 0.86 . . . . 2.1 110.065 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -73.88 156.46 37.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 1.17 111.963 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.521 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 35.6 t-80 -57.18 137.69 80.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.07 -0.968 . . . . 0.51 110.5 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.631 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -42.39 -48.78 6.61 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.312 2.675 . . . . 0.43 113.13 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.559 HD22 HG12 ' A' ' 20' ' ' VAL . 13.6 tp -56.01 -41.23 74.58 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.244 -0.435 . . . . 1.69 111.843 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 12.4 m-85 -75.44 -30.71 60.09 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.458 -0.337 . . . . 1.84 110.975 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.518 ' OE1' ' HB3' ' A' ' 115' ' ' ALA . 7.1 mm-40 -59.74 -36.75 77.24 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.141 -0.623 . . . . 2.37 109.417 168.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.4 t80 -67.77 -48.78 65.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 1.09 110.448 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.54 ' HE3' HD13 ' A' ' 118' ' ' LEU . 66.7 mtt -63.08 -53.06 59.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.004 -0.544 . . . . 1.06 111.443 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -60.33 -39.7 88.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 1.42 111.204 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.5 ptmt -71.86 -35.24 69.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.737 0.303 . . . . 2.63 110.801 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.515 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.8 m -70.08 -42.63 72.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.976 -0.556 . . . . 1.09 112.449 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 112.567 0.58 . . . . 2.26 112.567 -173.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 121.112 0.482 . . . . 1.51 111.416 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.788 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 25.9 mt -85.71 110.21 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.373 -0.831 . . . . 1.5 109.769 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -130.08 15.74 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.003 0.43 . . . . 1.99 112.029 -170.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.788 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -153.91 173.87 15.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.215 0.531 . . . . 1.1 111.989 -175.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.463 ' HB3' ' HD1' ' A' ' 139' ' ' PHE . 8.8 m120 -43.16 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.74 1.616 . . . . 1.8 115.196 168.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.772 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 15.4 m-85 -30.79 -58.26 0.21 Allowed 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 112.871 -1.968 . . . . 1.68 113.918 -169.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.812 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 12.5 m 44.95 99.64 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.593 0.961 . . . . 1.05 113.593 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 15.9 p -87.78 151.16 23.1 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.467 -0.771 . . . . 1.38 111.268 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.4 m-85 -103.7 133.62 48.4 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.392 -0.966 . . . . 0.53 108.392 168.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.782 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 25.5 tp -81.36 105.41 12.52 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.133 -0.691 . . . . 1.2 109.133 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.79 HG22 HD12 ' A' ' 15' ' ' ILE . 13.2 mm -105.59 126.91 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.605 -0.725 . . . . 1.05 109.083 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.69 -175.71 4.53 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.912 -0.315 . . . . 1.3 110.614 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.632 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 63.5 mtt180 -63.23 -16.76 61.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.259 0.466 . . . . 4.43 112.259 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -108.09 -10.04 15.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.437 0.637 . . . . 1.18 110.17 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.585 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 95.82 32.31 6.92 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.538 -0.755 . . . . 0.25 112.672 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 72.1 t -111.9 124.09 33.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.871 -0.418 . . . . 1.32 109.871 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.515 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.1 Cg_exo -68.14 118.39 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.44 2.093 . . . . 0.46 111.573 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.467 ' HB ' HD22 ' A' ' 143' ' ' LEU . 32.4 t -98.06 -26.24 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.712 -0.676 . . . . 1.09 110.417 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 27.1 mm-40 -149.83 163.73 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 1.22 111.509 -177.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -131.41 98.19 4.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.439 -0.8 . . . . 2.25 109.071 168.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.782 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 74.1 m-85 -86.95 117.84 25.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.497 -0.557 . . . . 0.38 109.497 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.793 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.0 OUTLIER -63.68 164.3 16.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.665 -0.494 . . . . 1.49 109.665 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.812 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 63.2 Cg_endo -70.65 -6.08 18.23 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.848 2.365 . . . . 0.74 112.495 -167.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.57 5.61 62.47 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.95 -1.023 . . . . 0.56 111.912 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.46 139.11 36.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 1.14 110.139 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.3 m -77.12 163.46 26.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.974 -0.557 . . . . 1.64 111.019 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 34.3 t -53.21 -48.84 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.423 -0.353 . . . . 1.14 110.343 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.424 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.2 tptm -69.79 -28.69 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 3.84 111.034 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.17 -33.84 74.09 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.0 0.429 . . . . 1.86 110.007 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.568 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.0 mt -80.39 -42.21 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.738 -0.665 . . . . 1.05 110.149 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.476 ' O ' HG13 ' A' ' 168' ' ' ILE . 45.2 mt-10 -55.41 -41.63 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.976 -0.556 . . . . 0.88 112.378 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.93 -19.37 60.63 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.241 0.46 . . . . 0.75 112.241 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.708 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -107.2 -17.93 14.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.012 0.435 . . . . 2.11 110.291 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.8 tp -89.98 -39.09 13.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.741 -0.663 . . . . 1.06 111.761 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.659 ' HA ' HD13 ' A' ' 171' ' ' LEU . 80.2 mt -52.48 -47.91 91.81 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.323 0.49 . . . . 1.14 112.323 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.6 Cg_exo -55.43 -27.68 59.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.248 1.966 . . . . 0.74 113.269 175.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.53 -34.52 16.35 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.521 0.201 . . . . 1.35 111.465 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.976 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.5 mt -58.08 -52.56 65.05 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.189 -0.671 . . . . 1.16 109.189 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.81 60.86 2.1 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.717 -1.129 . . . . 1.52 113.189 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.47 0.535 0 C-N-CA 123.426 0.691 . . . . 2.89 112.159 175.34 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.44 0.638 . . . . 2.22 109.743 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 -177.86 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.018 -0.992 . . . . 1.06 108.719 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.729 HD13 HG21 ' A' ' 144' ' ' ILE . 35.5 pt -66.16 -24.67 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.967 0.413 . . . . 1.08 111.312 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.807 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 27.5 m-85 -82.07 1.64 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.047 0.451 . . . . 0.3 110.823 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.86 -16.99 63.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.355 -0.98 . . . . 1.96 108.355 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 70.4 m-85 -110.66 178.92 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.71 -1.132 . . . . 0.4 110.125 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -124.65 144.57 50.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.764 0.316 . . . . 2.77 110.887 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.592 HG23 HD12 ' A' ' 30' ' ' LEU . 74.2 t -114.85 140.89 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.19 -0.459 . . . . 1.39 111.385 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.945 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 65.1 mt -96.71 140.71 30.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.005 -0.739 . . . . 1.33 109.005 169.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -79.07 -169.0 1.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 1.59 109.824 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.496 ' HB1' ' HG3' ' A' ' 97' ' ' LYS . . . -57.31 -22.52 42.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 111.944 0.35 . . . . 1.14 111.944 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.9 t70 -104.74 -2.71 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.69 0.281 . . . . 2.22 111.153 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.945 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.8 m-70 76.57 21.73 1.28 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.628 0.727 . . . . 0.88 109.644 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -83.45 153.67 65.46 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.828 -1.916 . . . . 3.67 105.828 165.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.22 113.83 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.934 1.012 . . . . 1.19 111.997 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.416 ' HB3' HG11 ' A' ' 20' ' ' VAL . 78.5 t80 -84.03 114.6 21.85 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.245 -0.888 . . . . 0.98 109.242 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -67.02 83.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.525 -0.761 . . . . 1.65 109.718 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.807 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -70.54 -33.11 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.236 0.541 . . . . 1.08 110.145 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.718 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -77.57 -0.77 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.427 -0.806 . . . . 1.15 112.843 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.68 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -81.69 -5.61 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.759 0.79 . . . . 1.94 108.936 172.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.642 ' HB3' ' CD2' ' A' ' 38' ' ' LEU . 75.7 m-70 -98.5 3.07 48.16 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.583 -1.19 . . . . 0.38 108.145 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 24.9 ttpt -79.3 136.18 36.95 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.749 -1.114 . . . . 2.22 109.023 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.93 -13.59 52.85 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.254 -1.139 . . . . 0.36 110.254 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 76.3 p -129.8 138.49 33.24 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 109.34 -0.615 . . . . 1.58 109.34 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.938 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 57.7 Cg_endo -74.2 155.46 46.87 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.519 1.479 . . . . 0.86 109.714 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.642 ' CD2' ' HB3' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -159.61 152.51 21.73 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.282 0.563 . . . . 1.63 111.958 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 69' ' ' PHE . 3.6 mm? -107.02 138.44 43.19 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.558 -0.904 . . . . 1.69 108.558 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 70.9 mt -127.58 118.07 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.198 -0.667 . . . . 1.05 109.198 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.82 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.3 m-85 -101.17 123.2 44.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.445 -0.343 . . . . 0.93 111.198 -172.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.71 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -80.52 92.02 5.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.003 -1.11 . . . . 1.97 108.003 169.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.598 HG13 ' HE1' ' A' ' 98' ' ' PHE . 5.8 p -107.99 143.19 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 113.502 0.927 . . . . 1.48 113.502 -160.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.37 101.85 1.3 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.435 -1.32 . . . . 1.17 107.435 166.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.996 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -59.65 87.68 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.973 -1.012 . . . . 2.3 112.882 -170.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 53.38 52.63 13.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.422 -0.808 . . . . 2.81 110.646 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.7 p -164.18 157.01 17.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.797 -0.638 . . . . 1.18 110.83 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.78 -117.2 4.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.932 -0.651 . . . . 1.42 112.717 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.61 166.98 20.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.454 0.645 . . . . 3.45 111.532 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.639 HG23 ' HE1' ' A' ' 139' ' ' PHE . 17.4 p -129.33 107.86 9.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.257 -0.883 . . . . 1.94 109.782 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 27.3 mtpt -83.47 20.07 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 2.51 112.06 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.51 13.87 29.23 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.716 -0.754 . . . . 0.55 111.826 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -40.56 16.05 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.018 -0.61 . . . . 0.39 112.286 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HE1' ' CB ' ' A' ' 100' ' ' ALA . 1.2 t80 -67.9 -48.69 65.31 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.824 0.345 . . . . 1.05 110.177 -176.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.3 -43.89 97.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.9 -0.591 . . . . 2.46 110.902 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.6 m -65.75 -50.9 63.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 1.06 111.142 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.69 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -56.87 -47.59 80.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.202 0.525 . . . . 1.03 110.866 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.452 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 80.2 m -59.74 -51.81 68.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.289 -0.868 . . . . 1.09 111.552 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.4 p -65.95 -39.2 90.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.068 -0.514 . . . . 1.69 111.727 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 85.4 mt -58.73 -51.64 69.09 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 120.503 0.192 . . . . 1.46 111.062 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.761 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 82.9 t80 -53.81 -47.08 71.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.92 109.817 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -73.18 -31.65 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.426 -0.807 . . . . 1.88 111.625 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.84 -36.84 23.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.021 -0.536 . . . . 2.27 111.738 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.659 ' CD1' HD11 ' A' ' 171' ' ' LEU . 58.0 m-85 -114.16 2.05 14.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.499 1.296 . . . . 0.9 114.499 -171.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.633 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 20.4 ptmt -68.71 -16.07 63.71 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.308 -0.957 . . . . 2.62 110.083 175.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 p -59.89 -43.4 94.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.747 -0.66 . . . . 1.59 109.927 171.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -91.36 15.76 11.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 1.9 111.143 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.689 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.46 70.22 1.35 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.999 -0.619 . . . . 1.32 112.452 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 39' ' ' LEU . 54.8 t80 -143.73 139.97 29.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.4 110.537 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.511 HG21 ' HB3' ' A' ' 38' ' ' LEU . 14.9 t -129.39 152.98 48.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.031 0.443 . . . . 1.11 110.077 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.761 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t -113.89 120.75 64.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.387 -0.597 . . . . 1.06 109.387 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.787 ' HB3' ' HE1' ' A' ' 105' ' ' MET . 15.6 mt -107.3 122.13 45.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.892 -0.781 . . . . 1.23 108.892 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.961 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.04 129.71 55.46 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.329 -0.548 . . . . 1.04 110.943 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.475 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.8 m-85 -113.67 108.64 51.41 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.619 -0.719 . . . . 0.45 109.89 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.996 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 33.2 Cg_exo -59.56 156.32 37.35 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 123.505 2.803 . . . . 0.73 111.697 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 114.349 1.24 . . . . 2.02 114.349 -178.313 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.833 ' HB3' ' HG ' ' A' ' 45' ' ' SER . 79.3 m . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 121.787 0.803 . . . . 0.91 110.4 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.764 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 14.0 t -133.58 159.89 39.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.528 -1.215 . . . . 2.41 108.372 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.714 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -58.99 95.7 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.001 0.429 . . . . 3.5 110.149 -175.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.598 ' HE1' HG13 ' A' ' 43' ' ' VAL . 3.8 p90 -54.84 134.83 48.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.059 -1.089 . . . . 1.74 108.059 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -101.64 134.08 45.33 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.548 -0.461 . . . . 3.53 111.011 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.528 ' CB ' ' HE1' ' A' ' 54' ' ' TYR . . . -136.26 -174.97 3.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.337 -0.847 . . . . 1.09 110.939 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.16 16.88 2.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 2.19 110.323 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.696 ' HE1' ' HB1' ' A' ' 73' ' ' ALA . 40.3 p90 -139.36 167.8 17.59 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.594 -0.891 . . . . 0.39 108.594 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.758 ' HB2' ' HE3' ' A' ' 105' ' ' MET . 27.1 Cg_exo -68.6 126.95 14.77 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.683 2.922 . . . . 0.48 113.762 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.961 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -120.92 142.01 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.344 -0.613 . . . . 1.13 109.344 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.787 ' HE1' ' HB3' ' A' ' 72' ' ' LEU . 7.2 mmt -114.01 -154.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.876 0.695 . . . . 2.08 112.876 -164.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.444 ' O ' ' HD2' ' A' ' 75' ' ' PRO . . . -69.77 145.09 52.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.086 -0.961 . . . . 1.11 111.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.764 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 56.4 mttt -73.4 109.79 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.645 -0.872 . . . . 2.12 108.645 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.429 HD11 ' CB ' ' A' ' 116' ' ' HIS . 28.8 pt -121.69 157.57 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.34 -0.985 . . . . 1.19 108.34 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.762 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.2 m120 -66.32 127.02 30.63 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.819 -0.808 . . . . 2.16 108.819 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.625 ' O ' ' HB ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -121.45 88.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 C-N-CA 119.746 -0.781 . . . . 1.1 109.006 167.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.661 ' OD1' ' HB3' ' A' ' 134' ' ' ALA . 16.4 t-20 173.14 179.09 0.09 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.066 -1.087 . . . . 1.98 108.066 168.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 48.29 -137.29 15.23 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.757 0.661 . . . . 0.78 114.59 163.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -104.52 -6.95 20.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.462 -0.869 . . . . 1.98 110.186 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -84.14 -24.52 30.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.292 -0.867 . . . . 2.1 111.449 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.762 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.97 141.49 3.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.058 1.133 . . . . 1.17 114.058 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.882 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 43.8 t-80 -48.75 139.71 11.41 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 114.894 -1.048 . . . . 0.51 110.378 171.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.25 -42.55 46.88 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.899 2.399 . . . . 0.43 112.789 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.882 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 1.3 tm? -54.81 -42.52 71.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.062 -0.517 . . . . 1.69 110.647 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.415 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -76.09 -30.24 58.23 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 119.445 -0.312 . . . . 1.84 111.596 176.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.09 -36.9 73.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.245 -0.582 . . . . 2.37 109.755 170.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 67.6 t80 -69.21 -44.01 72.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 1.09 110.642 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.467 ' HE2' HD21 ' A' ' 118' ' ' LEU . 67.5 mtt -65.67 -51.11 62.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.255 -0.429 . . . . 1.06 110.696 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.564 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 27.8 mtpt -61.96 -40.47 95.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.623 -0.717 . . . . 1.42 111.379 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.7 ptmm? -69.19 -35.92 76.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 2.63 110.615 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 99.9 m -73.94 -46.68 42.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 1.09 111.857 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.508 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 10.4 mmtt . . . . . 0 C--N 1.321 -0.648 0 C-N-CA 120.778 -0.369 . . . . 2.26 111.677 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.661 ' HB3' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 113.203 0.816 . . . . 1.51 113.203 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.872 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 24.4 mm -112.98 84.4 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.054 -0.975 . . . . 1.5 111.454 -166.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -105.69 19.95 19.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.22 0.822 . . . . 1.99 113.22 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.872 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.21 168.95 18.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.873 0.368 . . . . 1.1 111.561 177.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.65 -156.61 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.678 1.591 . . . . 1.8 113.217 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.82 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 35.5 m-85 -27.4 -55.87 0.09 Allowed 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.136 1.374 . . . . 1.68 114.412 -164.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.893 HG23 ' HA ' ' A' ' 155' ' ' SER . 25.0 m 41.58 96.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.444 0.905 . . . . 1.05 113.444 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.674 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 35.1 p -86.48 149.26 25.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.507 -0.746 . . . . 1.38 111.274 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.435 ' O ' HD12 ' A' ' 39' ' ' LEU . 9.5 m-85 -103.09 134.08 47.12 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.598 -0.89 . . . . 0.53 108.598 167.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.906 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 28.5 tp -82.03 105.84 13.46 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 1.2 109.13 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.729 HG21 HD13 ' A' ' 15' ' ' ILE . 11.3 mm -106.08 131.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.312 -0.625 . . . . 1.05 109.312 -175.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -179.17 6.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.997 -0.547 . . . . 1.3 110.83 -176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.713 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mtp180 -64.18 -17.65 63.73 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.115 0.413 . . . . 4.43 112.115 -175.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -105.26 -16.74 14.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.37 0.605 . . . . 1.18 109.664 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.543 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.87 32.66 4.34 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.25 112.735 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.1 t -106.12 126.93 29.36 Favored Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 122.397 -0.472 . . . . 1.32 110.637 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.72 112.17 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.15 2.567 . . . . 0.46 112.22 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.508 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 22.3 t -98.41 -33.42 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.23 -0.441 . . . . 1.09 111.49 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 9.0 mm-40 -152.48 164.37 37.7 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.762 0.315 . . . . 1.22 110.966 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.564 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 18.0 ttm180 -129.37 98.87 5.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 2.25 109.836 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.906 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.4 m-85 -87.01 110.31 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.262 -0.644 . . . . 0.38 109.262 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.893 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.3 p -62.86 167.05 6.47 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.273 -0.64 . . . . 1.49 109.273 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.807 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.6 Cg_endo -70.64 -10.19 27.35 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 122.377 2.051 . . . . 0.74 112.028 -163.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.32 -10.72 84.29 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.402 -1.272 . . . . 0.56 111.178 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.46 137.03 34.78 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.431 -0.581 . . . . 1.14 109.431 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -106.33 -169.56 1.59 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.498 -0.319 . . . . 1.64 111.006 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.535 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 21.4 t -50.4 -59.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.915 -0.584 . . . . 1.14 112.376 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -67.65 -29.86 69.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.67 0.271 . . . . 3.84 110.946 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.13 -38.93 77.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.053 -0.522 . . . . 1.86 109.844 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.534 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 63.5 mt -83.12 -37.45 13.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.416 -0.811 . . . . 1.05 110.967 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.9 mt-10 -57.18 -36.7 71.12 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.551 0.574 . . . . 0.88 112.551 -174.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.508 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.0 pt-20 -58.73 -27.99 65.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.395 . . . . 0.75 111.292 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.606 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -104.78 -16.19 14.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.363 -0.38 . . . . 2.11 110.924 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.591 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.3 tp -91.22 -44.69 9.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 1.06 111.825 -171.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.642 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.7 mt -51.81 -49.23 84.7 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.608 0.596 . . . . 1.14 112.608 -175.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.505 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.2 Cg_exo -54.7 -39.37 89.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.024 1.816 . . . . 0.74 112.6 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.9 mt -74.2 -35.97 63.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.437 -0.347 . . . . 1.35 111.43 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.938 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 13.5 mt -57.12 -54.75 43.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.313 -0.625 . . . . 1.16 109.313 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.98 -62.24 4.74 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.777 -1.101 . . . . 1.52 112.513 171.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 109.482 -0.562 . . . . 2.89 109.482 177.037 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.894 0.378 . . . . 2.22 110.324 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 m -126.09 170.5 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.995 -1.113 . . . . 1.06 107.995 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.589 HD12 HG22 ' A' ' 144' ' ' ILE . 32.5 pt -52.22 -28.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 118.764 0.711 . . . . 1.08 112.902 -173.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.787 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 14.8 m-85 -81.68 5.91 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.997 0.427 . . . . 0.3 111.614 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.86 -19.7 62.61 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.021 -1.104 . . . . 1.96 108.021 171.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' ' 118' ' ' LEU . 49.9 m-85 -106.7 179.32 4.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.425 -1.261 . . . . 0.4 110.531 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.85 148.09 43.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.518 -0.31 . . . . 2.77 110.201 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.572 HG21 HD11 ' A' ' 30' ' ' LEU . 71.7 t -118.19 150.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.054 0.454 . . . . 1.39 111.702 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.737 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 88.8 mt -108.16 143.38 37.02 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.131 -0.486 . . . . 1.33 110.003 173.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.603 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 21.7 t70 -72.97 177.37 4.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.102 -0.954 . . . . 1.59 108.764 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -52.94 -32.85 48.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.337 0.589 . . . . 1.14 110.318 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.641 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 22.5 t70 -79.49 -18.25 52.4 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.353 -0.839 . . . . 2.22 112.029 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.737 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.1 m-70 87.41 6.01 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.853 0.861 . . . . 0.88 111.851 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.603 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 2.8 ptmt -70.77 160.93 80.35 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.905 -1.146 . . . . 3.67 107.905 162.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.3 117.19 3.89 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 121.421 1.414 . . . . 1.19 112.632 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.866 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 89.0 t80 -91.05 119.42 31.19 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.97 -0.752 . . . . 0.98 108.97 170.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.1 t30 -73.81 84.68 1.67 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.525 -0.47 . . . . 1.65 110.002 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.732 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -62.35 -31.55 72.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.466 0.651 . . . . 1.08 110.469 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.6 p -77.2 -0.06 2.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.182 -0.917 . . . . 1.15 113.203 -167.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.8 pt20 -78.91 -5.82 54.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.658 0.742 . . . . 1.94 109.202 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.866 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 92.8 m-70 -97.41 -1.07 45.14 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.908 -1.042 . . . . 0.38 108.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.669 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -77.09 130.99 38.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.987 -1.461 . . . . 2.22 108.975 178.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.535 ' N ' ' HD2' ' A' ' 34' ' ' LYS . . . 109.87 -15.19 31.51 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.042 -0.823 . . . . 0.36 111.042 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.8 m -136.17 155.04 77.7 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.064 -0.717 . . . . 1.58 109.064 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.997 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 73.3 Cg_endo -77.73 154.72 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.004 1.803 . . . . 0.86 111.8 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.542 ' CB ' HG23 ' A' ' 70' ' ' THR . 2.3 pt? -158.96 159.92 35.43 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.248 0.546 . . . . 1.63 111.229 -176.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.739 HD22 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -114.21 155.1 26.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.449 -0.796 . . . . 1.69 109.236 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.603 HG12 ' HB2' ' A' ' 72' ' ' LEU . 84.4 mt -141.29 119.12 8.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.558 -0.534 . . . . 1.05 109.558 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.819 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.7 m-85 -105.59 123.67 48.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.909 -0.316 . . . . 0.93 111.06 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.817 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.6 OUTLIER -78.56 92.25 4.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.829 -0.804 . . . . 1.97 108.829 168.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.589 HG11 ' CE1' ' A' ' 98' ' ' PHE . 2.9 p -108.06 131.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.935 0.717 . . . . 1.48 112.935 -166.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.08 110.71 0.99 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.718 -1.216 . . . . 1.17 107.718 167.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.997 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -70.79 85.93 0.67 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.787 -1.097 . . . . 2.3 113.563 -162.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.641 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 48.8 tptt 71.7 39.56 0.86 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.648 -0.705 . . . . 2.81 110.204 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.2 p -154.23 142.28 20.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.787 -0.642 . . . . 1.18 110.96 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.66 -130.0 10.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.521 -0.847 . . . . 1.42 112.966 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.85 131.71 24.37 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.592 -0.521 . . . . 3.45 109.592 -173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' CE1' ' A' ' 139' ' ' PHE . 72.6 p -83.09 109.69 17.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.627 0.727 . . . . 1.94 109.791 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 1.049 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 26.4 mtpp -79.86 11.56 3.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.363 -0.835 . . . . 2.51 111.2 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.21 28.4 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.64 -0.584 . . . . 0.55 111.64 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.35 -42.62 10.25 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.286 -0.483 . . . . 0.39 112.013 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.692 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 1.4 t80 -70.14 -47.43 61.74 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 1.05 109.835 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.9 mp0 -56.17 -50.77 70.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.867 -1.06 . . . . 2.46 110.397 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.729 HG21 ' HA ' ' A' ' 160' ' ' VAL . 54.9 m -67.48 -47.15 70.88 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.824 -1.08 . . . . 1.06 111.101 -176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.884 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -56.66 -49.51 74.82 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.101 0.477 . . . . 1.03 111.35 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.9 m -58.43 -48.41 80.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.448 -0.796 . . . . 1.09 110.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.9 m -60.77 -46.85 88.86 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.301 -0.863 . . . . 1.69 111.524 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.568 HD13 HD21 ' A' ' 39' ' ' LEU . 62.1 mt -59.05 -50.35 74.4 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.274 -0.421 . . . . 1.46 111.183 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.628 ' HE1' ' HG1' ' A' ' 70' ' ' THR . 15.0 t80 -47.01 -53.63 12.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.057 0.848 . . . . 0.92 110.032 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -73.93 -34.99 64.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.217 -0.901 . . . . 1.88 111.452 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -75.97 -35.77 59.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.007 -0.542 . . . . 2.27 111.255 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.791 ' CD1' HD13 ' A' ' 171' ' ' LEU . 62.7 m-85 -118.15 15.43 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.805 1.039 . . . . 0.9 113.805 -173.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.8 mmmt -59.54 -21.36 60.13 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.686 -0.406 . . . . 2.62 110.388 171.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.87 -41.62 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.84 -0.618 . . . . 1.59 110.35 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' HG3' ' HB3' ' A' ' 171' ' ' LEU . 33.7 mm-40 -76.27 -10.56 59.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.972 -0.558 . . . . 1.9 110.318 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.32 20.73 29.14 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 1.32 110.868 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.562 ' CE1' HD13 ' A' ' 39' ' ' LEU . 88.5 t80 -79.78 136.58 36.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.243 -0.479 . . . . 0.4 110.628 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.628 ' HG1' ' HE1' ' A' ' 61' ' ' TYR . 0.8 OUTLIER -130.82 145.85 52.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.382 -0.599 . . . . 1.11 109.382 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.884 HG11 ' HB2' ' A' ' 57' ' ' ALA . 51.4 t -110.08 109.32 27.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.2 -0.667 . . . . 1.06 109.2 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.603 ' HB2' HG12 ' A' ' 40' ' ' ILE . 23.8 mt -91.65 120.98 32.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.489 -0.93 . . . . 1.23 108.489 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.081 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -108.82 112.92 25.43 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.221 -0.592 . . . . 1.04 110.68 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.524 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.3 m-85 -97.12 110.63 54.95 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.54 -0.755 . . . . 0.45 109.03 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.01 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.91 169.78 3.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.395 2.73 . . . . 0.73 111.365 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 69.7 m . . . . . 0 N--CA 1.437 -1.076 0 N-CA-C 113.889 1.07 . . . . 2.02 113.889 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 121.655 0.741 . . . . 0.91 112.779 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -156.38 119.56 4.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.722 -1.127 . . . . 2.41 109.804 168.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.3 mttp 54.52 100.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.062 0.764 . . . . 3.5 113.062 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.645 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 37.9 p90 -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.776 -0.577 . . . . 1.74 110.688 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 68.15 145.81 0.05 OUTLIER 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.099 0.875 . . . . 3.53 111.145 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -172.69 -173.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.41 . . . . 1.09 112.083 -176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -83.67 -11.88 56.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 2.19 110.155 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.833 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 39.0 p90 -113.34 169.04 6.86 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 115.405 -0.816 . . . . 0.39 109.196 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.826 ' HB2' ' HE2' ' A' ' 105' ' ' MET . 21.2 Cg_exo -71.41 122.12 8.36 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 123.556 2.837 . . . . 0.48 112.999 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.081 HG13 ' HB1' ' A' ' 73' ' ' ALA . 3.5 mp -110.79 139.65 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.909 -0.775 . . . . 1.13 108.909 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.826 ' HE2' ' HB2' ' A' ' 103' ' ' PRO . 10.1 mmt -112.07 -154.74 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.648 0.737 . . . . 2.08 112.909 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.62 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -71.63 133.78 45.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.674 -1.148 . . . . 1.11 110.116 173.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.01 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttt -70.27 126.04 28.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.692 0.758 . . . . 2.12 109.457 171.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.607 HG13 HG12 ' A' ' 110' ' ' VAL . 9.6 pt -121.47 167.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.262 -1.335 . . . . 1.19 107.915 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 34.6 t-20 -85.28 63.97 8.4 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.434 -0.506 . . . . 2.16 109.672 -175.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -64.55 88.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 120.727 -0.389 . . . . 1.1 110.799 -177.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.514 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 56.7 t30 173.05 178.63 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 1.98 108.243 167.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.04 -142.31 31.67 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 114.344 0.497 . . . . 0.78 114.344 165.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -105.84 -1.63 24.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.589 0.709 . . . . 1.98 110.039 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -106.49 2.43 26.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.074 -0.967 . . . . 2.1 111.192 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -62.6 154.58 28.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.728 -0.669 . . . . 1.17 112.242 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.91 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 33.7 t-80 -47.96 138.47 10.06 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.586 -0.734 . . . . 0.51 110.046 172.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.12 -39.16 51.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.138 2.559 . . . . 0.43 112.436 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.91 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -60.45 -39.63 88.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 1.69 111.332 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.473 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.9 m-85 -75.61 -28.89 59.05 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 116.445 -0.343 . . . . 1.84 110.813 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.56 -36.91 74.66 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.867 -0.733 . . . . 2.37 109.426 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.512 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 50.9 t80 -71.77 -45.85 60.29 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.738 -0.385 . . . . 1.09 110.6 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.443 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . 66.5 mtt -61.46 -54.92 37.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.314 -0.403 . . . . 1.06 111.442 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.0 mtpt -62.97 -36.9 85.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 1.42 111.359 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.35 -31.59 67.55 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.843 0.354 . . . . 2.63 110.301 -179.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.527 HG23 ' HD2' ' A' ' 150' ' ' PRO . 97.3 m -73.89 -38.64 64.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 1.09 111.256 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.596 ' HE2' ' O ' ' A' ' 151' ' ' VAL . 32.2 mmtm . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.867 0.365 . . . . 2.26 111.15 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.514 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 112.79 0.663 . . . . 1.51 112.79 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.835 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 49.2 mt -97.76 84.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.942 -1.027 . . . . 1.5 110.742 -171.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -108.61 25.28 11.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.524 0.564 . . . . 1.99 112.524 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.835 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.08 170.14 21.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.281 0.474 . . . . 1.1 112.281 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -52.49 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.48 1.512 . . . . 1.8 113.41 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.819 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 68.5 m-85 -25.89 -59.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.399 0 C-N-CA 125.529 1.532 . . . . 1.68 113.957 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.947 HG23 ' HA ' ' A' ' 155' ' ' SER . 18.0 m 42.43 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.209 0.818 . . . . 1.05 113.209 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.694 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 15.0 p -87.1 151.94 22.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.546 -0.862 . . . . 1.38 111.496 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CB ' HD11 ' A' ' 144' ' ' ILE . 10.1 m-85 -103.78 134.6 46.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.287 -1.005 . . . . 0.53 108.287 164.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.734 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.2 tp -82.08 106.15 13.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.107 -0.701 . . . . 1.2 109.107 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.589 HG22 HD12 ' A' ' 15' ' ' ILE . 16.0 mm -106.42 123.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.021 -0.536 . . . . 1.05 109.736 -171.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -177.41 4.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.374 -0.376 . . . . 1.3 110.595 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 146' ' ' ARG . 51.9 mtt-85 -66.27 -9.58 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.675 0.62 . . . . 4.43 112.675 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -108.0 -21.91 12.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.18 110.066 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.563 ' O ' HG22 ' A' ' 15' ' ' ILE . . . 106.07 31.65 4.05 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.637 -0.792 . . . . 0.25 112.698 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.48 121.29 41.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.891 -0.411 . . . . 1.32 109.891 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.527 ' HD2' HG23 ' A' ' 125' ' ' THR . 44.8 Cg_exo -58.07 116.39 3.2 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.992 2.462 . . . . 0.46 112.223 176.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.596 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 31.8 t -96.07 -25.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.809 -0.632 . . . . 1.09 110.275 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.623 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 9.0 mm-40 -156.29 159.03 38.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.371 -0.377 . . . . 1.22 111.246 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.466 HH11 ' HH2' ' A' ' 137' ' ' TRP . 20.3 ttm180 -120.65 97.02 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.471 -0.566 . . . . 2.25 109.471 168.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.734 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 52.6 m-85 -85.22 110.17 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.277 -0.638 . . . . 0.38 109.277 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.947 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.4 p -63.39 166.25 9.33 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.831 -0.433 . . . . 1.49 109.831 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.049 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 58.7 Cg_endo -72.07 -2.19 11.19 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.371 2.047 . . . . 0.74 113.058 -163.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -96.45 8.74 66.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.631 -0.713 . . . . 0.56 112.317 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.61 140.17 30.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 1.14 110.249 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.492 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 57.3 m -86.76 170.68 11.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.199 -0.455 . . . . 1.64 111.309 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.729 ' HA ' HG21 ' A' ' 56' ' ' THR . 49.0 t -55.41 -51.82 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 1.14 111.584 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 161' ' ' LYS . 20.2 tptt -68.83 -26.84 65.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 3.84 110.622 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.7 m-20 -64.19 -31.81 73.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 1.86 110.27 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.739 HG21 HD22 ' A' ' 39' ' ' LEU . 59.1 mt -83.04 -45.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.902 -0.59 . . . . 1.05 110.529 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -52.68 -39.01 61.51 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.839 0.681 . . . . 0.88 112.839 -176.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -55.52 -31.35 62.01 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.872 0.323 . . . . 0.75 111.872 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.623 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 72.3 mttt -106.32 -9.67 16.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.389 . . . . 2.11 110.976 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' A' ' 171' ' ' LEU . 58.7 tp -91.52 -41.61 10.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 1.06 111.775 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.672 ' HA ' HD11 ' A' ' 171' ' ' LEU . 71.6 mt -50.61 -48.71 81.71 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 112.998 0.74 . . . . 1.14 112.998 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.64 -32.39 90.36 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.099 1.866 . . . . 0.74 112.745 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 151' ' ' VAL . 76.6 mt -80.8 -35.22 33.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.776 -0.193 . . . . 1.35 110.865 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.997 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.2 mt -59.0 -41.48 87.77 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.697 -0.853 . . . . 1.16 108.697 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.34 -81.14 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.21 -1.359 . . . . 1.52 111.129 162.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.762 0.315 . . . . 2.89 110.293 175.504 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.219 0.533 . . . . 2.22 110.563 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.6 p -142.91 172.21 13.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 1.06 110.192 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.671 HD12 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -59.05 -29.64 41.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.418 0.525 . . . . 1.08 112.418 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.794 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 36.5 m-85 -77.33 0.0 23.89 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.861 0.319 . . . . 0.3 111.861 -172.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.7 -23.26 65.27 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.319 -0.993 . . . . 1.96 108.319 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.512 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 53.7 m-85 -102.67 174.61 5.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.731 -1.122 . . . . 0.4 109.792 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -108.56 165.63 11.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.869 0.366 . . . . 2.77 110.658 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.585 HG21 HD13 ' A' ' 30' ' ' LEU . 73.8 t -135.66 151.79 30.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.577 -0.527 . . . . 1.39 109.577 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.842 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 66.8 mt -113.6 148.63 35.85 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.673 -0.492 . . . . 1.33 109.673 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.65 ' CB ' ' HE3' ' A' ' 26' ' ' LYS . 5.8 t0 -78.49 -176.43 4.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.991 -1.114 . . . . 1.59 107.991 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . . . -56.96 -29.92 63.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.462 0.649 . . . . 1.14 110.459 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 5.4 t70 -80.29 -20.01 45.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.324 -0.853 . . . . 2.22 111.981 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.842 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 18.5 m-70 83.77 7.49 0.64 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.779 0.832 . . . . 0.88 111.893 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.65 ' HE3' ' CB ' ' A' ' 22' ' ' ASP . 28.9 pttt -65.09 148.12 98.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 107.282 -1.377 . . . . 3.67 107.282 157.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.536 ' HA ' HD23 ' A' ' 21' ' ' LEU . 19.0 Cg_endo -61.55 116.66 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.241 1.294 . . . . 1.19 112.331 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.916 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 86.3 t80 -80.23 124.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.006 -0.997 . . . . 0.98 110.333 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -68.98 82.78 0.31 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.703 -0.68 . . . . 1.65 109.757 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.794 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -72.45 -31.78 65.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.42 0.629 . . . . 1.08 110.136 -177.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.715 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 p -77.13 -0.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.333 -0.849 . . . . 1.15 112.494 -169.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.7 pt20 -78.84 -9.4 59.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.566 0.698 . . . . 1.94 109.311 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.916 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 75.9 m-70 -91.69 -7.97 48.36 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.156 -1.053 . . . . 0.38 108.156 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 34' ' ' LYS . 21.3 ttpp -70.72 133.68 46.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.53 -1.214 . . . . 2.22 109.354 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.46 -5.35 54.86 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.024 -1.231 . . . . 0.36 110.024 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 15.5 m -140.46 144.29 36.21 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.851 -0.796 . . . . 1.58 108.851 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.04 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 52.6 Cg_endo -73.28 150.55 47.34 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.651 1.567 . . . . 0.86 110.794 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.567 ' HB2' HG21 ' A' ' 70' ' ' THR . 1.8 pt? -153.0 153.51 33.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.324 0.583 . . . . 1.63 111.089 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.75 HD23 HG22 ' A' ' 163' ' ' ILE . 6.7 mp -108.33 152.69 24.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.982 -0.747 . . . . 1.69 108.982 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 88.6 mt -137.29 118.21 17.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.417 -0.586 . . . . 1.05 109.417 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.808 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -100.29 123.15 44.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.459 -0.337 . . . . 0.93 110.532 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.62 ' HB2' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -82.41 90.8 6.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.041 -1.096 . . . . 1.97 108.041 168.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.675 HG12 ' HE2' ' A' ' 98' ' ' PHE . 2.2 p -112.2 132.42 60.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 112.575 0.583 . . . . 1.48 112.575 -163.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -64.52 102.12 0.52 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.938 -1.505 . . . . 1.17 106.938 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.959 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 34.4 t -69.57 90.11 0.55 Allowed 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.432 -0.803 . . . . 2.3 112.236 -165.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt 66.97 49.84 1.1 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.935 -1.03 . . . . 2.81 110.813 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.9 m -135.75 126.43 27.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.719 -0.673 . . . . 1.18 109.761 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.52 -129.91 17.43 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.902 -0.666 . . . . 1.42 112.989 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.98 154.18 19.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.838 0.351 . . . . 3.45 111.044 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.7 p -91.54 -24.49 19.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.317 -0.401 . . . . 1.94 111.49 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 26.3 mtpp 64.04 3.75 1.8 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.644 -0.707 . . . . 2.51 112.069 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.11 -5.01 41.65 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.814 -0.708 . . . . 0.55 112.565 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -35.57 92.14 Favored Glycine 0 CA--C 1.505 -0.585 0 N-CA-C 111.982 -0.447 . . . . 0.39 111.982 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.498 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -67.92 -48.81 64.94 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 110.286 -0.265 . . . . 1.05 110.286 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.44 -52.87 62.16 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.473 0.654 . . . . 2.46 110.167 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.423 ' CG2' HD11 ' A' ' 163' ' ' ILE . 34.7 m -63.11 -47.55 82.35 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.619 -1.173 . . . . 1.06 111.32 -176.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' HB2' HG12 ' A' ' 71' ' ' VAL . . . -61.65 -46.96 87.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.829 0.347 . . . . 1.03 111.401 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.6 m -60.13 -53.68 54.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.778 -0.646 . . . . 1.09 111.393 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 p -62.52 -42.03 99.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 1.69 111.854 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.499 HD11 HD22 ' A' ' 39' ' ' LEU . 93.4 mt -58.92 -52.45 65.68 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 120.514 0.197 . . . . 1.46 111.477 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.695 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 89.4 t80 -54.62 -47.16 73.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.915 -0.584 . . . . 0.92 109.996 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -70.63 -41.03 72.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.533 -0.758 . . . . 1.88 111.394 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.32 -43.59 50.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 2.27 111.647 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.76 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.9 m-85 -102.19 4.5 39.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.728 1.01 . . . . 0.9 113.728 -171.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -58.3 -30.08 66.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 2.62 109.982 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -65.53 -26.4 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 1.59 111.484 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.2 13.16 32.81 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.877 0.37 . . . . 1.9 111.095 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.71 63.42 1.84 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.95 -0.643 . . . . 1.32 112.585 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.524 ' CZ ' HD12 ' A' ' 39' ' ' LEU . 69.0 t80 -132.09 142.09 49.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.552 -0.166 . . . . 0.4 110.552 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.567 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.16 143.29 50.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.129 -0.323 . . . . 1.11 110.129 177.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.695 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 29.3 t -113.27 114.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.993 0.425 . . . . 1.06 110.185 170.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 30.8 mt -100.47 122.44 43.2 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.978 -0.749 . . . . 1.23 108.978 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -106.99 112.84 25.99 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.113 -0.635 . . . . 1.04 110.252 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.545 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-30 -93.9 110.13 45.85 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.106 -1.072 . . . . 0.45 108.106 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.097 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.3 Cg_exo -58.62 169.22 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.81 2.34 . . . . 0.73 110.953 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 27.1 t . . . . . 0 N--CA 1.43 -1.466 0 C-N-CA 119.5 -0.88 . . . . 2.02 111.876 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.441 -0.902 0 CA-C-O 121.565 0.698 . . . . 0.91 111.05 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -149.16 128.69 13.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.562 -1.199 . . . . 2.41 108.029 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -14.07 104.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.775 1.297 . . . . 3.5 113.525 -172.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.675 ' HE2' HG12 ' A' ' 43' ' ' VAL . 34.5 p90 -66.55 -20.74 66.09 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.04 -0.982 . . . . 1.74 111.365 -170.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 67.55 147.61 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 124.041 0.838 . . . . 3.53 111.178 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.435 ' HB1' ' HE1' ' A' ' 54' ' ' TYR . . . -169.93 -154.69 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.105 0.479 . . . . 1.09 112.22 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 -5.74 58.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.559 -0.746 . . . . 2.19 109.884 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.891 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 45.4 p90 -128.28 164.8 35.24 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.182 -0.917 . . . . 0.39 109.135 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 32.4 Cg_exo -66.33 109.03 1.48 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 123.658 2.906 . . . . 0.48 113.701 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.032 HG13 ' HB1' ' A' ' 73' ' ' ALA . 3.6 mp -104.15 128.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.957 -0.757 . . . . 1.13 108.957 172.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.669 ' HA ' ' HE1' ' A' ' 105' ' ' MET . 0.5 OUTLIER -109.49 -148.64 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.852 0.686 . . . . 2.08 112.852 -160.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.741 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -75.54 136.81 40.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.168 -0.924 . . . . 1.11 110.669 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.097 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 15.3 pttp -79.45 128.58 33.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.688 0.756 . . . . 2.12 110.384 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.567 HG13 HG11 ' A' ' 110' ' ' VAL . 3.2 pt -122.77 160.69 25.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.312 -1.313 . . . . 1.19 107.845 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.72 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.4 t-20 -75.93 82.66 2.83 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.187 -1.042 . . . . 2.16 108.187 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.62 HG22 ' HB2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.15 86.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 118.842 -1.143 . . . . 1.1 108.944 177.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 55.8 t30 172.44 178.57 0.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.545 -0.909 . . . . 1.98 108.545 170.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.28 -145.62 17.05 Favored Glycine 0 C--O 1.236 0.23 0 N-CA-C 115.211 0.844 . . . . 0.78 115.211 163.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.46 -15.74 25.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.464 -0.868 . . . . 1.98 110.56 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -94.08 1.28 56.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.617 0.722 . . . . 2.1 110.529 -169.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.18 140.13 45.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.094 -0.957 . . . . 1.17 112.346 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.804 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 45.1 t-80 -50.75 137.25 25.19 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.179 -0.919 . . . . 0.51 110.502 172.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.512 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -45.08 -45.52 14.34 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.89 2.393 . . . . 0.43 112.792 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.804 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 0.8 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.942 -0.572 . . . . 1.69 111.715 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.482 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -75.89 -29.0 58.32 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 119.609 -0.234 . . . . 1.84 111.105 177.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.13 -43.36 78.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.886 -0.783 . . . . 2.37 108.886 168.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.8 t80 -66.63 -45.09 80.2 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.569 0.543 . . . . 1.09 110.652 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.541 ' HE2' HG22 ' A' ' 15' ' ' ILE . 67.1 mtt -63.83 -53.52 49.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.461 -0.336 . . . . 1.06 111.31 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 26.4 mtpt -60.89 -41.59 96.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 1.42 111.002 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.9 ptmt -71.12 -35.39 71.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 2.63 111.108 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.1 m -75.79 -36.5 59.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.924 -0.58 . . . . 1.09 111.189 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 9.5 mmtt . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 112.546 0.573 . . . . 2.26 112.546 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.119 0.485 . . . . 1.51 111.892 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.803 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 44.8 mt -114.95 94.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.488 -0.778 . . . . 1.5 110.568 -171.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -110.56 9.89 23.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.292 0.849 . . . . 1.99 113.292 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.803 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -140.04 168.91 18.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.783 0.66 . . . . 1.1 112.783 -177.047 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.51 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 22.5 m120 -43.67 -156.14 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 126.552 1.941 . . . . 1.8 115.494 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.808 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.2 m-85 -28.02 -55.19 0.11 Allowed 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 113.897 -1.501 . . . . 1.68 113.386 -169.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.821 HG21 ' HA ' ' A' ' 155' ' ' SER . 18.9 m 40.2 96.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.386 0.884 . . . . 1.05 113.386 175.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 7.7 p -85.2 152.7 23.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.789 -0.764 . . . . 1.38 111.129 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 4.9 m-85 -102.61 162.42 12.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.215 -1.402 . . . . 0.53 107.215 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.797 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.5 tp -107.32 105.07 14.85 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.603 -0.888 . . . . 1.2 108.603 177.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.671 HG21 HD12 ' A' ' 15' ' ' ILE . 17.9 mm -103.78 119.8 52.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.844 -0.798 . . . . 1.05 108.844 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.81 179.24 2.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 1.3 110.651 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.65 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -57.99 -20.61 39.65 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.846 0.355 . . . . 4.43 111.619 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.12 -13.8 14.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.113 0.482 . . . . 1.18 110.389 -167.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.533 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.51 32.61 4.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.782 -0.645 . . . . 0.25 113.271 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 59.3 t -109.15 118.93 50.05 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 122.466 -0.432 . . . . 1.32 110.165 175.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HG3' ' HA ' ' A' ' 122' ' ' MET . 14.3 Cg_endo -61.48 112.26 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.46 111.969 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.409 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 26.3 t -94.47 -30.19 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.909 -0.587 . . . . 1.09 111.14 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -154.51 165.13 37.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 1.22 110.916 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.475 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 14.5 ttm180 -134.18 98.5 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 2.25 109.854 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.797 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 9.3 m-85 -85.9 136.65 33.2 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.38 108.006 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.821 ' HA ' HG21 ' A' ' 140' ' ' THR . 25.2 p -79.83 178.72 2.17 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.748 -0.781 . . . . 1.49 109.626 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.75 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 56.6 Cg_endo -67.05 -20.63 50.29 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.616 1.544 . . . . 0.74 110.99 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.13 13.24 45.98 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.618 -1.174 . . . . 0.56 112.17 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.36 139.67 30.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.901 0.381 . . . . 1.14 110.52 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.0 p -90.1 163.93 14.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.163 -0.471 . . . . 1.64 110.882 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.4 t -49.9 -57.61 2.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 O-C-N 123.346 0.404 . . . . 1.14 111.602 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.539 -0.301 . . . . 3.84 111.517 -175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.94 -32.69 74.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.41 0.624 . . . . 1.86 109.651 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.75 HG22 HD23 ' A' ' 39' ' ' LEU . 36.6 mt -82.06 -37.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.549 -0.75 . . . . 1.05 110.049 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 46.9 mt-10 -57.96 -40.64 81.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.88 112.147 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.563 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.0 pt-20 -56.73 -31.35 64.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.651 -0.42 . . . . 0.75 111.551 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.563 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 23.0 mmmt -98.37 -16.95 19.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.104 0.478 . . . . 2.11 110.289 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -92.94 -43.13 9.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.776 -0.647 . . . . 1.06 111.765 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.674 ' HA ' HD11 ' A' ' 171' ' ' LEU . 69.3 mt -51.33 -49.89 79.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.463 0.542 . . . . 1.14 112.463 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 9.9 Cg_endo -54.26 -37.89 88.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.175 1.916 . . . . 0.74 112.532 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 48.2 mt -76.97 -37.18 55.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.778 -0.192 . . . . 1.35 111.462 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 1.04 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 10.1 mt -57.7 -48.38 79.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.819 -0.808 . . . . 1.16 108.819 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.37 -66.91 2.49 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.278 -1.328 . . . . 1.52 112.675 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 N--CA 1.466 0.368 0 C-N-CA 122.481 0.312 . . . . 2.89 110.49 -179.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.342 0.591 . . . . 2.22 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.8 p -130.46 -173.66 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.817 -0.809 . . . . 1.06 108.817 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.741 HD12 HG23 ' A' ' 144' ' ' ILE . 17.7 pt -61.23 -25.8 37.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 1.08 110.877 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.814 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.9 m-85 -83.91 2.34 39.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.3 110.994 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.57 -20.95 63.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.795 -1.187 . . . . 1.96 107.795 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 42.4 m-85 -106.24 178.32 4.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.409 -1.269 . . . . 0.4 109.668 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -124.86 149.19 47.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.43 -0.35 . . . . 2.77 110.321 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 30' ' ' LEU . 77.5 t -114.7 145.56 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.14 0.495 . . . . 1.39 111.785 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.927 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 77.5 mt -101.18 132.38 46.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.741 . . . . 1.33 109.201 171.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.03 -170.33 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.562 . . . . 1.59 109.481 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.9 57.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.619 -0.264 . . . . 1.14 111.624 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -94.36 -4.13 49.1 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.249 -0.282 . . . . 2.22 110.982 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.927 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 20.6 m-70 75.48 26.42 1.14 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.753 0.787 . . . . 0.88 109.532 -177.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -87.82 147.11 40.37 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 105.309 -2.108 . . . . 3.67 105.309 165.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 113.89 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.707 0.931 . . . . 1.19 111.953 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.95 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 80.5 t80 -82.24 116.76 21.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.081 -0.963 . . . . 0.98 109.078 172.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.645 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -66.31 82.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.758 -0.655 . . . . 1.65 109.734 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.814 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -70.53 -34.27 72.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.902 -0.59 . . . . 1.08 110.498 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.71 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.36 -0.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.348 -0.842 . . . . 1.15 112.812 -168.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.645 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 14.9 pt20 -82.88 -6.47 59.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.964 -0.754 . . . . 1.94 108.964 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.95 ' HE2' ' HH ' ' A' ' 28' ' ' TYR . 81.9 m-70 -94.82 -2.69 50.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.803 -1.184 . . . . 0.38 107.803 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -76.67 141.36 40.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.761 -1.108 . . . . 2.22 109.392 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.88 65.85 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 109.761 -1.336 . . . . 0.36 109.761 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.636 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -129.11 143.03 47.21 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.349 -0.926 . . . . 1.58 109.016 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.928 ' HG2' HD23 ' A' ' 171' ' ' LEU . 63.1 Cg_endo -77.72 142.05 19.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.145 1.897 . . . . 0.86 111.133 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.975 HD22 HG21 ' A' ' 70' ' ' THR . 0.2 OUTLIER -139.44 162.84 34.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.218 0.533 . . . . 1.63 110.753 -172.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.688 HD23 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -117.86 149.98 39.95 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.692 -0.855 . . . . 1.69 108.692 168.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -136.28 119.67 23.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.406 -0.59 . . . . 1.05 109.406 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.783 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 25.2 m-85 -103.41 123.61 47.17 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.593 0.235 . . . . 0.93 111.268 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.708 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.7 OUTLIER -81.24 91.79 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.415 -1.328 . . . . 1.97 107.415 167.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.4 p -107.6 140.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.522 0.934 . . . . 1.48 113.522 -159.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.7 101.99 0.23 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.578 -1.192 . . . . 1.17 108.444 167.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.97 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -68.4 87.43 0.3 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.67 -1.15 . . . . 2.3 112.76 -170.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 tttm 78.21 -34.94 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.635 0.774 . . . . 2.81 111.649 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.91 125.69 53.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.649 0.262 . . . . 1.18 110.486 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.89 -136.32 5.42 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.558 -0.83 . . . . 1.42 112.028 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.518 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 29.1 t80 -132.7 156.66 46.6 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.349 -0.612 . . . . 3.45 109.349 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.5 p -119.25 114.7 22.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.338 0.589 . . . . 1.94 110.535 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 18.3 ttmm -100.7 15.78 27.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.5 -0.773 . . . . 2.51 109.822 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.13 18.93 9.35 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.906 -0.664 . . . . 0.55 111.516 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 -52.24 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.316 -0.468 . . . . 0.39 112.536 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.601 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -66.48 -48.69 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.18 0.514 . . . . 1.05 109.945 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.577 ' HG2' ' H ' ' A' ' 56' ' ' THR . 1.6 pm0 -57.83 -53.47 57.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.017 -0.992 . . . . 2.46 110.892 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.577 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 95.0 m -64.14 -42.43 96.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 1.06 111.483 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.576 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -60.71 -49.87 75.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.97 0.414 . . . . 1.03 111.001 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -60.19 -52.39 65.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.6 -0.727 . . . . 1.09 111.353 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -59.84 -47.44 85.71 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.881 -0.599 . . . . 1.69 111.63 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.485 HD11 HD22 ' A' ' 39' ' ' LEU . 77.9 mt -55.32 -50.85 68.53 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.424 0.154 . . . . 1.46 111.326 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.762 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 40.1 t80 -46.78 -56.14 6.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.124 0.89 . . . . 0.92 109.774 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.452 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 90.2 m-20 -74.19 -33.75 63.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.454 -0.794 . . . . 1.88 110.936 -170.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -70.43 -41.2 73.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.227 -0.897 . . . . 2.27 111.052 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.552 ' CD1' HD12 ' A' ' 171' ' ' LEU . 69.0 m-85 -118.14 14.06 13.92 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 114.076 1.139 . . . . 0.9 114.076 -172.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.762 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 34.8 mtmt -56.78 -29.12 62.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.162 0.506 . . . . 2.62 110.156 172.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -59.36 -40.26 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.436 -0.802 . . . . 1.59 111.464 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.07 8.22 27.73 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.698 0.285 . . . . 1.9 110.967 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 83.82 67.9 1.43 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.581 -0.819 . . . . 1.32 111.689 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.527 ' CE1' HD11 ' A' ' 39' ' ' LEU . 73.8 t80 -133.77 135.06 43.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.651 0.262 . . . . 0.4 110.668 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.975 HG21 HD22 ' A' ' 38' ' ' LEU . 4.2 t -131.15 140.81 50.01 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.85 -0.426 . . . . 1.11 109.85 175.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.596 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 39.2 t -104.48 114.17 43.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.603 -0.517 . . . . 1.06 109.603 171.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.709 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 13.8 mt -98.63 121.11 40.16 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.672 -0.862 . . . . 1.23 108.672 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.006 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.67 120.1 41.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.302 -0.559 . . . . 1.04 110.918 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.8 m-85 -105.5 109.24 62.98 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.417 -0.811 . . . . 0.45 109.044 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.97 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 32.0 Cg_exo -60.68 168.72 6.47 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.661 2.907 . . . . 0.73 111.614 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.7 t . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 115.312 1.597 . . . . 2.02 115.312 -178.533 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.683 ' HB3' ' HG ' ' A' ' 45' ' ' SER . 74.2 m . . . . . 0 N--CA 1.441 -0.912 0 CA-C-O 121.941 0.877 . . . . 0.91 110.775 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.86 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 11.5 t -151.66 162.85 40.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.483 -1.69 . . . . 2.41 108.335 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.6 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.12 105.32 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.785 0.678 . . . . 3.5 111.125 177.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.623 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 49.6 p90 -60.61 -23.84 65.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.737 -0.665 . . . . 1.74 111.377 -174.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? 69.75 131.69 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.994 0.808 . . . . 3.53 111.132 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.461 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . . . -155.9 -163.61 1.53 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.097 -0.502 . . . . 1.09 112.191 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.44 -14.82 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 2.19 110.064 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.832 ' HE2' ' HB1' ' A' ' 73' ' ' ALA . 47.0 p90 -115.32 168.11 8.81 Favored Pre-proline 0 N--CA 1.443 -0.802 0 CA-C-N 115.127 -0.942 . . . . 0.39 109.495 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.754 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.6 Cg_exo -71.06 121.53 7.92 Favored 'Trans proline' 0 N--CA 1.478 0.574 0 C-N-CA 123.932 3.088 . . . . 0.48 113.058 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.006 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -114.55 137.13 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.939 -0.763 . . . . 1.13 108.939 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.754 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 7.8 mmt -111.75 -151.63 0.48 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.524 0.678 . . . . 2.08 112.678 -165.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.74 131.97 43.86 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.77 -1.104 . . . . 1.11 110.764 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.86 ' HD3' ' HA ' ' A' ' 96' ' ' THR . 3.6 mtmt -64.95 122.02 16.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.932 -0.766 . . . . 2.12 108.932 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.696 HG13 HG13 ' A' ' 110' ' ' VAL . 10.7 pt -122.17 149.84 25.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.641 -1.244 . . . . 1.19 107.641 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.28 71.31 3.76 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.999 -0.741 . . . . 2.16 108.999 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.696 HG13 HG13 ' A' ' 108' ' ' ILE . 2.0 m -64.69 88.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-O 120.868 0.366 . . . . 1.1 110.854 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' A' ' 134' ' ' ALA . 47.9 t30 173.04 177.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.983 -1.117 . . . . 1.98 107.983 163.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.51 -136.85 21.85 Favored Glycine 0 CA--C 1.511 -0.181 0 C-N-CA 121.307 -0.473 . . . . 0.78 113.675 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.29 -9.17 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.182 0.515 . . . . 1.98 110.369 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -83.09 -4.89 58.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.554 -0.748 . . . . 2.1 110.792 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.8 57.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 1.17 111.817 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.847 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 46.3 t-80 -50.4 137.83 22.12 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.947 -1.024 . . . . 0.51 110.281 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.71 -46.64 14.87 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.785 2.323 . . . . 0.43 112.402 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.847 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 0.4 OUTLIER -57.15 -37.16 71.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.837 -0.62 . . . . 1.69 111.804 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.485 ' HH ' HD21 ' A' ' 42' ' ' ASN . 0.4 OUTLIER -76.13 -30.7 58.28 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 121.076 -0.25 . . . . 1.84 110.945 176.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.05 -31.7 72.9 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 2.37 109.927 171.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 68.0 t80 -70.88 -48.67 52.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 1.09 110.391 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.409 ' HE1' HD12 ' A' ' 40' ' ' ILE . 67.1 mtt -63.77 -51.96 62.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.111 -0.495 . . . . 1.06 111.058 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 35.7 mtpt -58.33 -41.3 84.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 1.42 111.179 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.734 ' HZ3' ' HB2' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -71.12 -30.13 66.12 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.748 0.309 . . . . 2.63 110.614 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.507 HG21 ' HD2' ' A' ' 150' ' ' PRO . 85.2 m -75.27 -38.54 60.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.096 -0.502 . . . . 1.09 111.007 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.799 -0.182 . . . . 2.26 110.743 179.429 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 113.061 0.763 . . . . 1.51 113.061 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.872 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 28.8 mm -82.76 90.39 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.893 -1.049 . . . . 1.5 108.975 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -108.96 -3.2 17.69 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.611 0.597 . . . . 1.99 112.611 -170.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.872 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.24 169.95 14.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.54 0.571 . . . . 1.1 112.54 -172.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 49' ' ' TYR . 10.8 m120 -49.41 -156.87 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.845 1.658 . . . . 1.8 113.111 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.783 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 39.3 m-85 -27.57 -52.51 0.07 Allowed 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 114.74 1.385 . . . . 1.68 114.74 -164.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.884 HG22 ' HA ' ' A' ' 155' ' ' SER . 17.3 m 39.38 102.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.899 1.074 . . . . 1.05 113.899 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.4 p -90.48 155.93 18.56 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.596 -0.842 . . . . 1.38 110.573 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 17.6 m-85 -103.72 161.81 13.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.336 -1.357 . . . . 0.53 107.336 163.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 55.5 tp -108.03 105.85 15.8 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.741 HG23 HD12 ' A' ' 15' ' ' ILE . 16.5 mm -103.82 122.97 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 115.638 -0.71 . . . . 1.05 109.206 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.93 -179.49 5.51 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.67 -0.412 . . . . 1.3 110.478 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -57.27 -21.86 37.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.658 0.614 . . . . 4.43 112.658 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -105.84 -17.33 14.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.297 0.57 . . . . 1.18 109.762 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.535 ' O ' HG21 ' A' ' 15' ' ' ILE . . . 103.71 34.15 3.9 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.345 -0.843 . . . . 0.25 112.581 175.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.84 121.67 42.36 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.791 -0.448 . . . . 1.32 109.791 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.507 ' HD2' HG21 ' A' ' 125' ' ' THR . 31.5 Cg_exo -60.54 109.88 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.733 2.289 . . . . 0.46 112.151 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -91.75 -31.23 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 1.09 110.521 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.555 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.9 mm-40 -149.44 164.93 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.004 -0.544 . . . . 1.22 110.363 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.656 HH11 ' HH2' ' A' ' 137' ' ' TRP . 13.6 ttm180 -132.22 96.65 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.722 -0.844 . . . . 2.25 108.722 168.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.787 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 22.3 m-85 -86.57 108.73 18.71 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.299 -0.63 . . . . 0.38 109.299 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.884 ' HA ' HG22 ' A' ' 140' ' ' THR . 16.4 p -65.2 164.19 25.3 Favored Pre-proline 0 N--CA 1.444 -0.749 0 N-CA-C 109.596 -0.52 . . . . 1.49 109.596 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.793 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 23.5 Cg_endo -61.59 -12.21 23.67 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.986 2.457 . . . . 0.74 113.251 -163.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.71 -0.53 90.16 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.52 -0.764 . . . . 0.56 112.459 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.19 134.67 35.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.894 -0.41 . . . . 1.14 109.894 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.438 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 19.5 m -91.7 176.66 6.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.472 -0.331 . . . . 1.64 110.129 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 38.8 t -51.97 -52.1 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 1.14 111.213 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -64.02 -36.71 84.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 3.84 110.936 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.4 m-20 -57.35 -36.12 70.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.726 -0.67 . . . . 1.86 110.232 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.688 HG21 HD23 ' A' ' 39' ' ' LEU . 74.5 mt -84.24 -43.5 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.342 -0.844 . . . . 1.05 111.413 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 51.3 mt-10 -54.91 -38.53 67.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.493 0.553 . . . . 0.88 112.493 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.0 -18.37 45.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.035 0.383 . . . . 0.75 112.035 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 52.3 mttt -116.64 -10.14 11.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.097 0.475 . . . . 2.11 110.472 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -97.48 -44.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.681 -0.69 . . . . 1.06 111.381 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.64 ' HA ' HD13 ' A' ' 171' ' ' LEU . 69.4 mt -54.09 -49.28 90.83 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.225 0.454 . . . . 1.14 112.225 -175.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 71.8 Cg_exo -51.7 -36.35 61.24 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.187 1.925 . . . . 0.74 112.781 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.02 -36.15 56.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.475 -0.33 . . . . 1.35 111.099 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.928 HD23 ' HG2' ' A' ' 37' ' ' PRO . 12.4 mt -60.13 -49.43 77.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.968 -0.753 . . . . 1.16 108.968 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -52.0 38.62 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 114.462 -1.244 . . . . 1.52 112.536 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 122.726 0.41 . . . . 2.89 110.235 176.778 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 121.359 0.6 . . . . 2.22 112.21 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 p -157.26 -174.68 5.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.334 -0.848 . . . . 1.06 108.91 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 144' ' ' ILE . 18.9 pt -60.61 -25.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.142 0.496 . . . . 1.08 110.647 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.808 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 34.3 m-85 -80.64 3.61 21.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.198 -0.455 . . . . 0.3 111.418 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -73.64 -16.35 61.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.905 -0.776 . . . . 1.96 108.905 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 52.0 m-85 -109.47 159.32 17.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.765 -1.107 . . . . 0.4 110.328 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.14 143.82 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.935 0.398 . . . . 2.77 110.585 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.529 HG23 HD12 ' A' ' 30' ' ' LEU . 69.5 t -115.03 146.48 19.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.802 -0.635 . . . . 1.39 111.114 -178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.825 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 7.1 mp -103.67 145.19 30.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.97 0.414 . . . . 1.33 110.495 170.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.54 -176.52 3.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 1.59 109.101 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.65 -34.43 64.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.002 0.429 . . . . 1.14 110.796 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.1 t70 -82.85 -6.29 59.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 2.22 111.141 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.825 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 8.8 m-70 74.1 21.52 2.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.92 0.867 . . . . 0.88 110.066 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.4 mmpt? -87.25 128.19 56.27 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 106.426 -1.694 . . . . 3.67 106.426 164.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -43.44 115.27 0.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.253 1.968 . . . . 1.19 113.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.525 ' HH ' ' HB3' ' A' ' 103' ' ' PRO . 74.7 t80 -79.32 124.39 28.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.349 -1.296 . . . . 0.98 110.003 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.697 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -72.84 82.93 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.316 -0.624 . . . . 1.65 109.316 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.799 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.47 -32.05 69.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.316 0.579 . . . . 1.08 110.276 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.808 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.1 p -77.04 -0.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.249 -0.887 . . . . 1.15 112.58 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.697 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -82.72 -4.92 58.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.164 -0.68 . . . . 1.94 109.164 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -94.62 -4.08 48.38 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.864 -1.062 . . . . 0.38 108.294 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HE2' ' CD2' ' A' ' 16' ' ' PHE . 38.6 ttmt -71.71 139.8 49.3 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.745 -1.116 . . . . 2.22 109.368 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' C ' ' HB3' ' A' ' 146' ' ' ARG . . . 104.98 -20.32 38.73 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.843 -0.903 . . . . 0.36 110.843 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 m -132.76 144.32 52.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 1.58 108.773 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.911 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -73.36 154.82 51.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.164 1.91 . . . . 0.86 111.262 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.559 ' CB ' HG21 ' A' ' 70' ' ' THR . 2.3 pt? -156.35 151.66 26.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.35 0.595 . . . . 1.63 111.417 -172.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.823 HD22 HG23 ' A' ' 163' ' ' ILE . 6.5 mp -107.99 155.92 19.81 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.982 -0.748 . . . . 1.69 108.982 173.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -141.25 117.53 7.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.549 -0.537 . . . . 1.05 109.549 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.914 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 11.3 m-85 -104.19 123.65 47.7 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.755 -0.378 . . . . 0.93 110.512 -175.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.976 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.4 OUTLIER -82.5 91.97 6.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.271 -1.011 . . . . 1.97 108.271 168.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 75' ' ' PRO . 2.3 p -112.35 130.53 65.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 113.605 0.965 . . . . 1.48 113.605 -160.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -58.9 103.39 0.16 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.248 -1.39 . . . . 1.17 107.248 165.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.039 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -68.72 76.98 0.3 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.878 -1.056 . . . . 2.3 113.423 -163.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 62.2 tttm 71.75 67.55 0.15 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.501 -1.227 . . . . 2.81 111.235 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.6 m -145.4 116.38 7.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.594 -0.73 . . . . 1.18 110.453 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.79 -106.92 1.42 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.758 -0.655 . . . . 1.42 114.03 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.47 155.94 18.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 3.45 112.254 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.5 p -120.31 -21.4 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.643 -0.708 . . . . 1.94 110.631 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.691 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.1 mmmt 67.48 0.33 2.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.58 -0.736 . . . . 2.51 111.378 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 105.71 -0.28 39.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.985 -0.626 . . . . 0.55 111.798 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.73 -38.83 90.13 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.694 -0.563 . . . . 0.39 111.694 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.678 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -69.62 -48.51 59.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.915 -0.402 . . . . 1.05 109.915 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 2.3 mp0 -54.95 -49.05 72.32 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.403 -0.817 . . . . 2.46 110.608 177.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.439 HG21 ' HA ' ' A' ' 160' ' ' VAL . 90.9 m -67.31 -45.45 76.46 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.424 -0.807 . . . . 1.06 110.52 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.797 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -61.62 -49.34 76.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.824 0.345 . . . . 1.03 111.531 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 m -59.74 -46.26 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 1.09 110.852 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.605 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 77.6 m -66.51 -47.75 71.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.613 -0.721 . . . . 1.69 111.033 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -57.21 -48.53 78.55 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.427 0.158 . . . . 1.46 111.427 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.669 ' HE1' ' HG1' ' A' ' 70' ' ' THR . 43.5 t80 -55.43 -53.56 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.92 110.962 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.605 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 2.8 p30 -72.02 -27.6 62.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.23 0.538 . . . . 1.88 110.539 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -78.02 -35.67 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.674 -0.694 . . . . 2.27 110.849 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.722 ' CD1' HD11 ' A' ' 171' ' ' LEU . 70.8 m-85 -118.62 13.03 13.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.66 0.985 . . . . 0.9 113.66 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -63.09 -21.37 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.905 0.383 . . . . 2.62 110.774 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -64.03 -37.11 86.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.644 . . . . 1.59 110.218 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -90.15 3.39 53.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.768 -0.651 . . . . 1.9 110.703 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.32 57.74 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.092 -0.504 . . . . 1.32 113.059 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CE1' HD12 ' A' ' 39' ' ' LEU . 85.8 t80 -72.97 132.35 43.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.835 0.35 . . . . 0.4 111.301 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.669 ' HG1' ' HE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -123.18 135.61 54.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.58 -0.526 . . . . 1.11 109.58 177.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.797 HG11 ' HB3' ' A' ' 57' ' ' ALA . 26.1 t -102.51 111.62 32.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.474 -0.565 . . . . 1.06 109.474 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.875 ' HB3' ' HE1' ' A' ' 105' ' ' MET . 24.4 mt -95.45 121.38 37.06 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.486 -0.931 . . . . 1.23 108.486 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -111.73 112.23 23.77 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.905 -0.718 . . . . 1.04 110.35 177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.767 ' HD2' HD13 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -93.94 111.72 54.17 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.085 -1.08 . . . . 0.45 108.085 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.039 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 23.2 Cg_exo -60.13 170.65 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.186 2.591 . . . . 0.73 111.895 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.2 t . . . . . 0 N--CA 1.429 -1.492 0 CA-C-O 122.13 0.967 . . . . 2.02 113.166 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 55.1 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.805 0.336 . . . . 0.91 111.631 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -146.36 118.97 8.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.095 0.474 . . . . 2.41 110.824 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.793 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 93.8 mttt 66.87 -50.21 0.47 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.87 -1.059 . . . . 3.5 113.471 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.749 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 68.7 -48.78 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.928 0.891 . . . . 1.74 110.659 -170.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.793 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 18.6 mtmt 66.07 146.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.139 0.576 . . . . 3.53 112.192 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.463 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -164.66 -164.03 0.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.702 0.63 . . . . 1.09 112.702 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -79.77 -11.9 59.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.401 -0.818 . . . . 2.19 109.887 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.734 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 42.2 p90 -115.81 166.86 11.27 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.096 -0.957 . . . . 0.39 109.177 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 33.3 Cg_exo -66.02 121.81 9.23 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.37 2.713 . . . . 0.48 112.815 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.915 HG13 ' HB1' ' A' ' 73' ' ' ALA . 1.5 mp -109.51 143.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.466 -0.568 . . . . 1.13 109.466 174.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.875 ' HE1' ' HB3' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -108.92 -160.52 0.72 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.389 0.885 . . . . 2.08 113.389 -165.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.436 ' O ' HG12 ' A' ' 108' ' ' ILE . . . -72.93 131.47 42.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.013 -0.994 . . . . 1.11 110.042 173.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.944 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttt -70.61 115.04 9.31 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.898 0.856 . . . . 2.12 108.752 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.767 HD13 ' HD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -125.54 160.86 31.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.339 -1.726 . . . . 1.19 106.339 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.891 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.0 m120 -65.73 117.54 8.31 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.97 -1.092 . . . . 2.16 109.064 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.608 ' HB ' HD12 ' A' ' 135' ' ' ILE . 1.7 m -116.57 88.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.733 -0.839 . . . . 1.1 108.733 170.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 1.7 t30 173.86 177.32 0.12 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.296 -1.372 . . . . 1.98 107.296 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 42.19 -135.54 3.62 Favored Glycine 0 N--CA 1.46 0.242 0 O-C-N 123.936 0.773 . . . . 0.78 114.739 164.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.47 -11.72 16.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.146 -0.527 . . . . 1.98 110.821 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -81.87 -15.32 54.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.1 111.339 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.891 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.5 137.46 0.82 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.062 1.134 . . . . 1.17 114.062 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.778 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 55.5 t-80 -50.19 140.77 16.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 114.969 -1.014 . . . . 0.51 110.866 173.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.28 -46.92 11.22 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.189 2.593 . . . . 0.43 112.922 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.778 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 20.2 tp -58.05 -36.02 72.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.176 -0.466 . . . . 1.69 111.656 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 15.0 m-85 -75.51 -30.59 59.87 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 116.65 -0.25 . . . . 1.84 110.76 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.435 ' OE2' ' HB1' ' A' ' 115' ' ' ALA . 33.9 mm-40 -64.01 -29.32 70.48 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.068 -0.653 . . . . 2.37 109.721 169.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 86.7 t80 -75.29 -42.02 55.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.277 0.56 . . . . 1.09 110.393 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.606 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 66.8 mtt -69.38 -49.3 56.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 1.06 110.82 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.489 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 38.7 mtpt -60.17 -40.76 91.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 1.42 111.062 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 21.6 ptmt -69.17 -35.72 76.59 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.82 0.343 . . . . 2.63 110.804 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 150' ' ' PRO . 91.1 m -74.23 -44.81 51.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 1.09 110.875 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 42.8 mmtt . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 116.189 -0.46 . . . . 2.26 110.215 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.437 ' C ' HH12 ' A' ' 153' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 112.936 0.717 . . . . 1.51 112.936 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.793 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 38.8 mt -78.5 150.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.768 -1.106 . . . . 1.5 109.475 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -168.57 -1.99 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.597 0.592 . . . . 1.99 112.597 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.793 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -136.82 170.03 16.76 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.332 0.653 . . . . 1.1 111.113 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.46 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 15.7 m120 -43.93 -158.24 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.376 1.47 . . . . 1.8 114.058 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.914 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.6 m-85 -27.76 -57.63 0.11 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 125.018 1.327 . . . . 1.68 114.335 -167.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.976 ' HB ' HD22 ' A' ' 42' ' ' ASN . 10.6 m 42.94 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.111 0.782 . . . . 1.05 113.111 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 25.6 p -86.64 152.11 22.86 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.169 -0.612 . . . . 1.38 110.637 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.9 m-85 -103.76 133.17 49.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.719 -1.215 . . . . 0.53 107.719 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.548 HD21 ' HB ' ' A' ' 151' ' ' VAL . 25.3 tp -81.29 103.63 11.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.741 -0.837 . . . . 1.2 108.741 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.72 HG21 HD11 ' A' ' 15' ' ' ILE . 13.5 mm -104.03 125.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.095 -0.706 . . . . 1.05 109.095 -175.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.4 -179.93 7.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.728 -0.789 . . . . 1.3 110.09 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.414 ' HG3' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -55.27 -23.09 21.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.21 0.529 . . . . 4.43 112.085 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.46 -17.28 18.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.107 -0.701 . . . . 1.18 109.107 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.469 ' O ' HG21 ' A' ' 15' ' ' ILE . . . 100.45 25.19 8.89 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.751 -1.113 . . . . 0.25 112.509 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 65.0 t -106.81 124.54 35.16 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.106 0.453 . . . . 1.32 110.429 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 125' ' ' THR . 34.9 Cg_exo -61.1 111.26 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.332 2.688 . . . . 0.46 112.328 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 143' ' ' LEU . 18.5 t -88.8 -28.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.212 -0.449 . . . . 1.09 110.712 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.511 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 34.3 mm-40 -160.91 164.26 31.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 1.22 110.536 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.792 HH11 ' HH2' ' A' ' 137' ' ' TRP . 14.8 ttm180 -123.0 97.23 5.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.707 -0.479 . . . . 2.25 109.707 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.623 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 84.6 m-85 -82.15 108.59 15.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.531 -0.544 . . . . 0.38 109.531 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.861 ' HA ' HG22 ' A' ' 140' ' ' THR . 3.0 m -62.19 165.21 9.0 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 109.771 -0.455 . . . . 1.49 109.771 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.807 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 44.2 Cg_endo -66.97 -8.21 21.0 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.624 2.216 . . . . 0.74 112.686 -164.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.23 5.56 81.16 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.56 111.865 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.0 133.51 35.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.903 0.382 . . . . 1.14 110.072 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.536 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 51.0 m -86.99 171.44 10.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.134 -0.485 . . . . 1.64 111.342 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.439 ' HA ' HG21 ' A' ' 56' ' ' THR . 99.0 t -52.86 -58.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.828 -0.624 . . . . 1.14 112.356 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.584 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.6 tptm -72.44 -25.33 61.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 3.84 110.597 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.536 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.1 m-20 -61.08 -31.36 71.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.877 -0.602 . . . . 1.86 110.557 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.823 HG23 HD22 ' A' ' 39' ' ' LEU . 43.1 mt -83.17 -42.16 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.002 0.43 . . . . 1.05 110.778 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.584 ' HB2' ' HD2' ' A' ' 161' ' ' LYS . 45.8 mt-10 -56.45 -34.5 66.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.88 112.293 -174.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.425 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.2 pt-20 -53.62 -32.16 50.1 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.725 0.298 . . . . 0.75 111.67 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.425 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 47.5 mmtm -105.26 -14.19 15.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.339 -0.391 . . . . 2.11 111.236 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.609 ' HG ' HD13 ' A' ' 171' ' ' LEU . 65.1 tp -88.57 -42.52 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 1.06 111.735 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.674 ' HA ' HD12 ' A' ' 171' ' ' LEU . 78.5 mt -53.34 -48.56 92.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.418 0.525 . . . . 1.14 112.418 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.509 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.1 Cg_exo -56.32 -26.69 63.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.318 2.012 . . . . 0.74 112.902 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.38 -40.37 16.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 1.35 110.65 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.911 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 16.7 mt -59.18 -48.96 79.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.547 0.689 . . . . 1.16 109.617 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.4 38.83 0.85 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.501 -1.227 . . . . 1.52 113.13 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 171' ' ' LEU . 69.1 m . . . . . 0 N--CA 1.467 0.393 0 C-N-CA 123.56 0.744 . . . . 2.89 112.775 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.587 0.708 . . . . 2.22 109.793 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 p -157.85 175.14 14.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.858 -1.065 . . . . 1.06 108.452 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.785 HD11 HG22 ' A' ' 144' ' ' ILE . 21.9 pt -55.24 -29.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.136 0.421 . . . . 1.08 112.136 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.9 m-85 -75.84 -0.44 21.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.387 0.514 . . . . 0.3 112.387 -172.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.28 -12.2 59.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.505 0.669 . . . . 1.96 109.266 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 72.6 m-85 -108.84 155.54 20.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.228 -0.896 . . . . 0.4 111.085 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.469 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 29.9 tt0 -84.25 143.51 29.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.429 -0.805 . . . . 2.77 110.934 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.548 HG23 HD12 ' A' ' 30' ' ' LEU . 72.5 t -125.45 146.17 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.762 0.315 . . . . 1.39 110.461 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.964 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 90.4 mt -111.59 146.82 36.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.408 -0.36 . . . . 1.33 110.264 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.39 174.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.745 0.653 . . . . 1.59 109.482 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB1' ' HB3' ' A' ' 97' ' ' LYS . . . -53.86 -31.05 48.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.321 0.582 . . . . 1.14 109.959 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.17 4.06 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.35 -0.841 . . . . 2.22 112.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.964 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 30.5 m-70 72.63 26.09 2.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.485 0.66 . . . . 0.88 110.968 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 38.5 mmtt -91.07 128.73 46.51 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 107.03 -1.47 . . . . 3.67 107.03 168.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.47 112.63 0.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.792 1.661 . . . . 1.19 112.476 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.821 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 68.8 t80 -79.39 123.72 27.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.669 -1.15 . . . . 0.98 110.553 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 3.0 t-20 -73.68 81.92 1.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.495 -0.775 . . . . 1.65 109.182 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.773 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.7 pt? -72.12 -32.25 66.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.471 0.653 . . . . 1.08 110.463 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.875 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 8.8 p -77.21 0.5 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.324 -0.853 . . . . 1.15 112.735 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.3 pt20 -82.15 -5.87 58.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.387 0.613 . . . . 1.94 109.564 173.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.821 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 86.7 m-70 -92.54 -1.2 57.11 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.137 -1.06 . . . . 0.38 108.137 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -76.17 141.26 41.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.348 -1.296 . . . . 2.22 109.297 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.92 -8.39 63.3 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.328 -1.109 . . . . 0.36 110.328 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.55 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 20.1 m -140.68 146.08 43.0 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.088 -0.708 . . . . 1.58 109.088 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.037 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.0 Cg_endo -73.5 154.81 50.43 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.765 1.643 . . . . 0.86 111.153 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.585 ' CB ' HG23 ' A' ' 70' ' ' THR . 1.8 pt? -155.09 152.47 29.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.396 0.617 . . . . 1.63 111.372 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.723 HD23 HG22 ' A' ' 163' ' ' ILE . 6.3 mp -107.83 151.48 25.69 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.567 -0.901 . . . . 1.69 108.567 172.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 80.4 mt -140.68 116.72 7.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.553 -0.536 . . . . 1.05 109.553 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.906 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 24.3 m-85 -103.29 123.28 46.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.219 0.325 . . . . 0.93 111.244 -172.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.735 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -79.32 91.56 5.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.783 -0.821 . . . . 1.97 108.783 168.193 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.729 HG11 ' HE2' ' A' ' 98' ' ' PHE . 2.4 p -112.34 133.52 57.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.563 0.949 . . . . 1.48 113.563 -163.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.86 102.62 0.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.726 -1.212 . . . . 1.17 107.726 167.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.985 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 30.1 t -72.08 97.23 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.088 0.773 . . . . 2.3 113.088 -166.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt 73.84 38.19 0.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.743 0.652 . . . . 2.81 111.218 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 m -141.79 157.67 44.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.596 -0.274 . . . . 1.18 110.607 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.2 -118.34 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 O-C-N 123.632 0.583 . . . . 1.42 113.678 171.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -129.21 174.83 9.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.546 0.689 . . . . 3.45 111.782 -174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.658 HG22 ' HE1' ' A' ' 139' ' ' PHE . 7.8 p -133.22 116.72 16.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.058 -0.974 . . . . 1.94 109.616 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.681 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 24.8 mtpp -83.86 17.07 2.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.059 -0.519 . . . . 2.51 111.828 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.3 17.04 21.24 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.878 -0.677 . . . . 0.55 111.89 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.42 -42.85 7.22 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.394 -0.431 . . . . 0.39 112.131 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.566 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -67.12 -44.59 79.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.449 -0.574 . . . . 1.05 109.449 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -55.81 -55.03 37.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.023 -0.99 . . . . 2.46 110.086 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.475 ' CG2' HD13 ' A' ' 163' ' ' ILE . 98.6 m -67.62 -41.45 83.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.941 -1.027 . . . . 1.06 111.284 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.715 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -61.78 -48.2 81.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.859 0.362 . . . . 1.03 110.813 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.6 m -61.29 -49.38 77.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.635 . . . . 1.09 111.043 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 p -64.24 -47.32 80.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.813 -0.63 . . . . 1.69 111.438 -177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.63 HD23 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.59 -45.44 91.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.64 -0.255 . . . . 1.46 111.176 -177.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.807 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 85.4 t80 -53.07 -58.81 5.74 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 123.215 0.322 . . . . 0.92 110.668 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -70.09 -36.18 74.7 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.697 -0.401 . . . . 1.88 111.802 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.01 -39.81 79.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 2.27 111.384 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.723 ' CD1' HD13 ' A' ' 171' ' ' LEU . 73.9 m-85 -108.32 4.95 25.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.9 113.17 -174.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -28.02 66.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 2.62 110.397 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.4 m -65.65 -37.34 86.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.464 . . . . 1.59 111.144 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -88.45 1.44 54.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.92 0.391 . . . . 1.9 111.107 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 88.94 66.0 1.28 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.951 -0.643 . . . . 1.32 112.191 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.623 ' CE1' HD12 ' A' ' 39' ' ' LEU . 71.9 t80 -132.05 140.07 48.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.503 0.192 . . . . 0.4 110.594 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.585 HG23 ' CB ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.27 140.22 52.0 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 120.898 0.38 . . . . 1.11 110.381 177.116 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.807 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 25.4 t -109.74 117.88 55.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.963 0.411 . . . . 1.06 110.521 169.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.648 ' HB3' ' HE1' ' A' ' 105' ' ' MET . 20.3 mt -101.43 137.84 39.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.693 -0.854 . . . . 1.23 108.693 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -122.45 116.34 23.79 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.349 -0.54 . . . . 1.04 110.835 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.613 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -99.12 108.77 51.43 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 108.659 -0.867 . . . . 0.45 108.659 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.096 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.6 Cg_exo -59.3 170.24 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.194 2.596 . . . . 0.73 111.717 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.433 -1.277 0 CA-C-O 121.892 0.853 . . . . 2.02 112.291 -177.194 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 45' ' ' SER . 10.6 m . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.936 0.398 . . . . 0.91 111.6 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 t -154.27 122.09 5.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.101 -0.5 . . . . 2.41 110.964 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.652 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 15.7 ptpt 32.31 84.43 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.867 1.062 . . . . 3.5 113.867 174.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.729 ' HE2' HG11 ' A' ' 43' ' ' VAL . 15.5 p90 -66.77 -25.47 66.5 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.742 -0.599 . . . . 1.74 110.361 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 99' ' ' LYS . 71.3 mmtt 65.78 148.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.081 0.863 . . . . 3.53 111.946 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.433 ' HB2' ' HE1' ' A' ' 54' ' ' TYR . . . -169.39 -164.74 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.736 0.643 . . . . 1.09 112.736 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -69.67 -24.68 63.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.365 -0.834 . . . . 2.19 109.752 173.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.851 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 50.3 p90 -108.9 168.07 8.27 Favored Pre-proline 0 N--CA 1.438 -1.063 0 CA-C-N 114.575 -1.193 . . . . 0.39 109.479 -175.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.839 ' HB2' ' HE3' ' A' ' 105' ' ' MET . 16.4 Cg_exo -73.7 129.37 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.7 2.933 . . . . 0.48 113.186 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.042 HG13 ' HB1' ' A' ' 73' ' ' ALA . 2.9 mp -117.69 138.02 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.336 -0.616 . . . . 1.13 109.336 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.839 ' HE3' ' HB2' ' A' ' 103' ' ' PRO . 8.9 mmt -112.66 -156.59 0.59 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.837 0.827 . . . . 2.08 113.2 -164.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -65.96 137.99 57.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.494 -1.23 . . . . 1.11 110.938 174.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.096 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttp -84.44 127.63 34.12 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.85 0.833 . . . . 2.12 109.458 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -131.66 162.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.983 -1.462 . . . . 1.19 107.769 -176.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 21.5 t-20 -75.81 83.61 2.76 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.857 -0.794 . . . . 2.16 108.857 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.653 HG12 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.26 89.57 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 108.085 -1.08 . . . . 1.1 108.085 173.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 175.02 179.52 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.474 -0.936 . . . . 1.98 108.474 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 47.0 -144.0 5.02 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 124.313 1.008 . . . . 0.78 115.512 156.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.81 -6.96 22.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.152 -1.024 . . . . 1.98 110.331 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -98.29 0.01 44.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.476 -0.784 . . . . 2.1 110.975 -170.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.735 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -50.79 138.89 17.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 1.17 112.888 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.723 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 51.2 t-80 -52.4 138.08 39.7 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.303 -0.862 . . . . 0.51 110.313 172.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.48 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -44.39 -45.08 12.92 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.217 2.611 . . . . 0.43 112.676 -178.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.723 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 2.0 tm? -54.72 -45.61 74.11 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.667 -0.697 . . . . 1.69 111.189 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.5 m-85 -75.56 -29.74 59.47 Favored 'General case' 0 C--O 1.212 -0.885 0 O-C-N 122.295 -0.253 . . . . 1.84 111.451 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 49.8 mt-10 -58.49 -39.42 79.97 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.946 -0.702 . . . . 2.37 109.165 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 88.1 t80 -67.82 -44.0 78.27 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.293 0.371 . . . . 1.09 110.597 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.448 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.3 mtt -65.02 -54.12 35.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.306 -0.406 . . . . 1.06 111.033 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 36.7 mtpt -57.18 -39.94 76.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.735 -0.666 . . . . 1.42 110.877 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.4 ptmt -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.421 -0.354 . . . . 2.63 111.534 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.574 HG23 ' HD2' ' A' ' 150' ' ' PRO . 94.3 m -64.36 -53.8 42.87 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.625 -0.43 . . . . 1.09 110.314 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.673 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.8 ttmt . . . . . 0 C--N 1.323 -0.576 0 N-CA-C 109.847 -0.427 . . . . 2.26 109.847 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 114.027 1.121 . . . . 1.51 114.027 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.852 HG21 ' HZ3' ' A' ' 137' ' ' TRP . 50.4 mt -82.9 156.21 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 113.539 -1.664 . . . . 1.5 108.464 176.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -173.26 10.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.121 0.786 . . . . 1.99 113.121 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.852 ' HZ3' HG21 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.62 171.26 14.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.763 0.425 . . . . 1.1 110.997 -177.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -45.53 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 1.8 113.526 172.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.906 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 47.0 m-85 -27.87 -59.07 0.11 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 114.634 1.346 . . . . 1.68 114.634 -166.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.801 HG21 ' HA ' ' A' ' 155' ' ' SER . 11.6 m 45.11 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.913 0.779 . . . . 1.05 112.954 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.7 p -89.87 150.19 22.32 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.538 -0.865 . . . . 1.38 111.071 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.8 m-85 -102.72 135.84 43.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.895 -1.15 . . . . 0.53 107.895 166.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.947 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 54.9 tp -82.13 105.13 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.015 -0.735 . . . . 1.2 109.015 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.785 HG22 HD11 ' A' ' 15' ' ' ILE . 14.9 mm -102.5 122.59 55.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.558 -0.746 . . . . 1.05 109.04 -173.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.56 179.24 3.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.415 . . . . 1.3 110.355 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.784 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 72.8 mtp180 -62.41 -15.33 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.262 0.467 . . . . 4.43 112.262 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -109.03 -18.29 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.835 -0.541 . . . . 1.18 110.236 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.5 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 112.06 34.07 2.06 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.25 113.27 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 55.0 t -108.41 126.75 28.89 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 117.199 0.5 . . . . 1.32 110.595 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 125' ' ' THR . 11.3 Cg_exo -69.22 97.48 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.073 2.515 . . . . 0.46 112.072 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.95 -20.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.529 . . . . 1.09 111.151 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.673 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 6.0 mm-40 -154.17 162.45 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.998 -0.371 . . . . 1.22 109.998 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -135.3 98.14 3.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.565 -0.531 . . . . 2.25 109.565 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.947 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 16.1 m-85 -88.56 125.06 34.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.801 ' HA ' HG21 ' A' ' 140' ' ' THR . 92.4 p -69.75 171.74 6.71 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.809 -0.811 . . . . 1.49 108.809 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.778 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 37.8 Cg_endo -66.04 -8.89 21.42 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.92 1.747 . . . . 0.74 112.293 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.35 -4.9 83.17 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.231 -0.895 . . . . 0.56 112.108 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.09 113.26 19.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.16 0.505 . . . . 1.14 110.125 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.2 p -82.62 179.92 7.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.677 -0.692 . . . . 1.64 110.804 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.63 HG13 HD23 ' A' ' 60' ' ' LEU . 58.0 t -44.17 -57.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.747 -0.66 . . . . 1.14 111.617 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -58.12 -39.45 78.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.773 -0.648 . . . . 3.84 112.399 -175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.52 -31.1 70.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.472 0.653 . . . . 1.86 110.087 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.723 HG22 HD23 ' A' ' 39' ' ' LEU . 46.0 mt -81.32 -42.52 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.242 -0.89 . . . . 1.05 110.945 177.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 65.3 mt-10 -58.09 -36.32 72.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.43 -0.35 . . . . 0.88 111.902 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.3 pt-20 -63.71 -12.28 33.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.894 0.331 . . . . 0.75 111.894 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.617 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.8 mmtp -116.22 -23.06 8.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.427 . . . . 2.11 110.694 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.8 tp -89.68 -37.16 14.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.398 0.518 . . . . 1.06 112.398 -170.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.639 ' HA ' HD11 ' A' ' 171' ' ' LEU . 68.8 mt -50.75 -48.47 83.16 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 1.14 112.841 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.8 Cg_exo -55.11 -37.07 94.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.924 1.749 . . . . 0.74 112.69 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.3 mt -78.95 -36.93 40.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.688 0.255 . . . . 1.35 111.688 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 1.037 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.9 mt -55.44 -50.69 69.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.586 0.707 . . . . 1.16 109.216 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -48.85 -68.73 1.19 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.11 -1.405 . . . . 1.52 111.78 167.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.784 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 9.3 t . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 120.691 0.282 . . . . 2.89 110.434 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.203 0.525 . . . . 2.22 110.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.6 p -137.25 167.61 21.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.63 -0.714 . . . . 1.06 109.101 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.727 HD13 HG21 ' A' ' 144' ' ' ILE . 18.0 pt -61.57 -29.7 46.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.852 0.358 . . . . 1.08 111.9 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.812 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 72.4 m-85 -76.5 1.52 16.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.264 0.468 . . . . 0.3 112.264 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.39 -17.86 61.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.792 -0.818 . . . . 1.96 108.792 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.582 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 73.9 m-85 -99.73 159.99 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.4 110.6 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -102.21 135.77 43.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 2.77 110.963 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.639 HG23 HD13 ' A' ' 30' ' ' LEU . 89.3 t -114.35 146.63 18.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.294 0.568 . . . . 1.39 111.731 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.967 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 86.3 mt -117.29 153.22 33.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.615 -0.72 . . . . 1.33 110.24 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 176.72 1.4 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.206 -0.906 . . . . 1.59 109.454 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -53.71 -32.04 50.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.299 0.571 . . . . 1.14 110.065 173.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -87.12 -3.91 59.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.62 -0.718 . . . . 2.22 112.281 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.967 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.7 m-70 74.49 27.04 1.43 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.693 0.759 . . . . 0.88 110.296 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -88.56 154.61 50.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.61 -1.626 . . . . 3.67 106.61 167.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.17 113.14 1.31 Allowed 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.047 1.164 . . . . 1.19 112.916 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.459 ' CE2' ' SD ' ' A' ' 105' ' ' MET . 60.3 t80 -89.91 117.53 28.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.411 -0.813 . . . . 0.98 110.722 168.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.556 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.87 84.97 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.587 -0.733 . . . . 1.65 109.512 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.791 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.74 -32.35 67.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.002 0.43 . . . . 1.08 110.58 -176.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.812 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -76.54 -1.37 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 1.15 112.699 -167.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 7.0 pt20 -80.75 -5.71 57.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.418 0.628 . . . . 1.94 109.724 172.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -92.15 1.02 57.46 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.188 -1.041 . . . . 0.38 108.188 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 22.8 ttpp -86.19 132.64 33.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.923 -1.035 . . . . 2.22 109.216 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.2 32.26 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.767 -1.333 . . . . 0.36 109.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 18.1 m -139.84 149.64 59.85 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.389 -0.967 . . . . 1.58 108.389 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.015 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 61.1 Cg_endo -75.41 153.51 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.558 1.505 . . . . 0.86 111.257 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.565 ' CB ' HG21 ' A' ' 70' ' ' THR . 2.2 pt? -154.27 151.07 28.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.297 0.57 . . . . 1.63 111.295 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.754 HD22 HG22 ' A' ' 163' ' ' ILE . 6.4 mp -109.64 154.9 22.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.567 -0.742 . . . . 1.69 109.089 172.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.586 HG21 ' HH ' ' A' ' 119' ' ' TYR . 72.3 mt -140.87 121.56 13.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.75 -0.833 . . . . 1.05 108.75 -176.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 1.051 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -108.41 126.72 53.2 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.882 0.373 . . . . 0.93 111.589 -171.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.658 ' ND2' HD12 ' A' ' 135' ' ' ILE . 0.6 OUTLIER -77.97 93.82 4.5 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.619 -1.252 . . . . 1.97 107.619 170.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.874 HG12 ' HA ' ' A' ' 139' ' ' PHE . 18.0 m -112.65 138.38 42.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 113.44 0.904 . . . . 1.48 113.44 -164.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.8 102.78 2.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.575 -1.639 . . . . 1.17 106.575 163.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.028 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 32.3 t -60.12 94.07 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.69 -0.686 . . . . 2.3 112.202 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 98' ' ' PHE . 24.7 tptp 63.46 19.29 11.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.502 0.668 . . . . 2.81 110.516 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.2 p -135.18 172.62 12.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.706 -0.679 . . . . 1.18 109.846 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.17 -154.58 39.15 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.714 -0.755 . . . . 1.42 112.796 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -110.72 111.9 23.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 3.45 110.235 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 p -77.56 112.86 14.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.5 . . . . 1.94 111.109 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -81.5 14.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 2.51 111.062 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.2 8.38 38.75 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.976 -0.556 . . . . 0.55 111.888 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -39.04 96.73 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 111.987 -0.445 . . . . 0.39 111.987 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CZ ' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -66.71 -47.29 72.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.769 0.319 . . . . 1.05 110.413 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.65 -45.58 92.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.742 -0.466 . . . . 2.46 109.742 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 160' ' ' VAL . 73.2 m -59.74 -50.96 71.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.602 -0.726 . . . . 1.06 111.032 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.903 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.57 -50.25 73.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.164 -0.471 . . . . 1.03 111.372 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m -56.08 -46.77 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.958 0.409 . . . . 1.09 111.252 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.66 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 90.6 m -64.49 -46.5 82.73 Favored 'General case' 0 C--N 1.337 0.036 0 CA-C-N 116.392 -0.367 . . . . 1.69 111.156 -177.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.597 HD12 HD21 ' A' ' 39' ' ' LEU . 71.4 mt -59.72 -49.72 76.63 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 120.722 0.296 . . . . 1.46 110.622 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.649 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 14.8 t80 -50.33 -57.43 7.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.213 -0.903 . . . . 0.92 109.651 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.66 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 2.3 p30 -73.84 -29.07 61.92 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.755 -0.657 . . . . 1.88 111.738 -168.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.669 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 33.2 ttmt -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.641 0.258 . . . . 2.27 111.041 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.765 ' CD1' HD12 ' A' ' 171' ' ' LEU . 70.8 m-85 -116.73 10.43 14.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.892 1.071 . . . . 0.9 113.892 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.649 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 14.7 mtpp -64.02 -20.29 65.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.0 -0.68 . . . . 2.62 109.991 172.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -61.19 -33.27 73.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.766 -0.652 . . . . 1.59 109.887 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.412 HE21 ' HD1' ' A' ' 64' ' ' TYR . 2.0 mp0 -95.31 11.78 31.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.914 -0.584 . . . . 1.9 110.643 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.61 12.38 75.3 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.872 -0.603 . . . . 1.32 113.042 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' PRO . 93.8 t80 -72.03 141.06 49.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.034 0.445 . . . . 0.4 111.302 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.565 HG21 ' CB ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -131.79 144.87 51.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.908 -0.587 . . . . 1.11 109.714 176.579 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.903 HG11 ' HB1' ' A' ' 57' ' ' ALA . 41.4 t -112.26 117.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.605 -0.517 . . . . 1.06 109.605 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.3 mt -100.28 121.11 40.95 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.735 -0.839 . . . . 1.23 108.735 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.066 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -107.99 112.72 25.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.388 -0.525 . . . . 1.04 110.608 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.577 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.1 m-85 -98.46 115.25 65.82 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.039 -0.726 . . . . 0.45 109.039 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.028 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 19.6 Cg_exo -63.28 169.66 9.09 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.107 2.538 . . . . 0.73 111.915 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.433 -1.287 0 C-N-CA 119.519 -0.872 . . . . 2.02 112.165 -178.361 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 45' ' ' SER . 4.6 m . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.364 -0.606 . . . . 0.91 109.364 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.73 HG21 ' HG2' ' A' ' 75' ' ' PRO . 1.8 m -13.98 117.57 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 115.216 1.561 . . . . 2.41 115.216 -140.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 98' ' ' PHE . 6.1 ptmt 171.88 -31.48 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 111.477 -2.601 . . . . 3.5 107.883 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.658 ' HB3' ' HG ' ' A' ' 45' ' ' SER . 0.5 OUTLIER -36.8 109.97 0.11 Allowed 'General case' 0 C--N 1.354 0.779 0 O-C-N 124.972 1.42 . . . . 1.74 111.387 -173.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 97' ' ' LYS . 73.4 mmtt -104.61 143.17 33.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.055 -0.975 . . . . 3.53 110.262 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.472 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . . . -145.15 -170.24 3.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.602 -0.272 . . . . 1.09 110.979 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -75.02 -26.54 59.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.446 0.641 . . . . 2.19 109.496 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.886 ' HE2' ' HB1' ' A' ' 73' ' ' ALA . 44.0 p90 -98.44 159.35 30.78 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 114.933 -1.03 . . . . 0.39 109.544 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 38.8 Cg_exo -67.56 114.18 3.2 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.091 3.194 . . . . 0.48 113.608 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.066 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mp -100.35 131.9 46.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 108.98 -0.748 . . . . 1.13 108.98 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.679 ' HA ' ' HE1' ' A' ' 105' ' ' MET . 0.1 OUTLIER -117.03 -155.58 0.59 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.345 0.869 . . . . 2.08 113.345 -157.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.72 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . . . -68.63 113.47 6.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.979 -1.01 . . . . 1.11 111.177 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.977 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -61.99 139.87 58.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.401 0.62 . . . . 2.12 109.602 171.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.515 HD13 ' CB ' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -150.13 156.59 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.571 -1.27 . . . . 1.19 107.571 -174.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.756 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 24.8 t-20 -67.84 93.99 0.43 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.102 -0.703 . . . . 2.16 109.102 175.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -83.7 82.59 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.278 -0.969 . . . . 1.1 108.793 176.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 32.5 t30 170.68 -177.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.229 -1.026 . . . . 1.98 108.229 170.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 58.92 -141.74 46.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.438 -0.887 . . . . 0.78 114.541 158.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.62 -15.95 16.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.683 0.754 . . . . 1.98 109.671 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.454 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 19.1 m120 -88.46 -5.64 58.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.607 -1.178 . . . . 2.1 110.912 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.37 126.43 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.298 -0.864 . . . . 1.17 112.281 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.828 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 55.1 t-80 -47.47 133.79 10.13 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-O 118.535 -0.745 . . . . 0.51 109.928 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.582 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.6 Cg_endo -42.11 -45.11 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.228 2.619 . . . . 0.43 112.711 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.828 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 20.1 tp -54.77 -51.45 65.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.753 -0.658 . . . . 1.69 111.584 175.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.751 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 22.9 m-85 -69.78 -31.5 69.47 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.403 -0.362 . . . . 1.84 111.201 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.546 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 1.4 mt-10 -55.18 -46.86 75.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.547 -0.909 . . . . 2.37 108.547 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 85.8 t80 -64.6 -49.25 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.665 0.603 . . . . 1.09 110.128 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.65 ' HE3' HD13 ' A' ' 118' ' ' LEU . 64.2 mtt -54.54 -51.58 64.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.123 -0.489 . . . . 1.06 111.722 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.751 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 27.5 mtpt -61.3 -49.33 77.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.868 0.366 . . . . 1.42 110.549 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 16.7 ptpt -70.44 -31.66 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 2.63 111.046 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.523 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.3 m -70.51 -40.58 73.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.429 -0.35 . . . . 1.09 111.78 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.53 . . . . 2.26 112.164 -177.167 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.31 0 CA-C-O 120.832 0.349 . . . . 1.51 111.645 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.815 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 13.6 mt -105.1 105.86 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.537 -0.756 . . . . 1.5 109.659 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -133.01 26.67 4.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.142 0.793 . . . . 1.99 113.142 -172.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.815 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -151.34 170.18 20.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.324 0.583 . . . . 1.1 111.995 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.547 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 2.7 t-20 -49.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 1.8 112.751 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 1.051 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 10.5 m-85 -27.44 -50.99 0.06 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 125.342 1.457 . . . . 1.68 114.794 -167.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.786 HG21 ' HA ' ' A' ' 155' ' ' SER . 12.4 m 37.15 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.763 1.165 . . . . 1.05 113.288 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.637 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.6 p -85.11 150.63 24.72 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.149 -0.621 . . . . 1.38 111.412 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.5 m-85 -103.66 132.2 50.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.955 -1.128 . . . . 0.53 107.955 165.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.57 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 20.7 tp -81.2 106.11 12.93 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.931 -0.766 . . . . 1.2 108.931 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.727 HG21 HD13 ' A' ' 15' ' ' ILE . 18.7 mm -106.17 122.86 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.116 -0.698 . . . . 1.05 109.116 -172.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.41 179.14 3.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.262 -0.426 . . . . 1.3 110.505 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 36' ' ' SER . 61.4 mtt180 -59.25 -21.31 59.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.797 0.666 . . . . 4.43 112.797 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -109.87 -10.08 14.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.151 0.5 . . . . 1.18 110.733 -171.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.552 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 104.16 32.9 4.16 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.737 -0.744 . . . . 0.25 113.375 174.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.3 t -107.22 122.43 41.41 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.695 -0.483 . . . . 1.32 109.695 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.523 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.5 Cg_exo -68.1 118.02 5.33 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.476 2.118 . . . . 0.46 111.178 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.561 ' HB ' HD21 ' A' ' 143' ' ' LEU . 32.6 t -97.22 -30.06 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.928 -0.578 . . . . 1.09 110.632 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -154.83 165.31 37.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 1.22 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.418 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 12.7 ttm180 -132.25 98.61 4.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.698 -0.683 . . . . 2.25 109.358 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.64 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 24.5 m-85 -91.05 108.97 20.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.587 -0.523 . . . . 0.38 109.587 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.786 ' HA ' HG21 ' A' ' 140' ' ' THR . 10.5 p -61.19 163.25 11.04 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.806 -0.442 . . . . 1.49 109.806 175.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.782 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 45.4 Cg_endo -65.46 -7.01 14.77 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.916 2.411 . . . . 0.74 113.4 -162.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 51' ' ' LYS . . . -85.36 -10.66 76.97 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.302 -0.863 . . . . 0.56 111.741 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.41 131.76 43.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 1.14 110.17 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.436 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 48.9 m -81.57 168.96 17.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.79 -0.641 . . . . 1.64 111.12 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' A' ' 56' ' ' THR . 44.8 t -54.44 -51.16 52.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 1.14 110.781 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.488 ' HB2' ' HE3' ' A' ' 161' ' ' LYS . 32.9 ttmt -65.37 -33.65 76.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.553 -0.748 . . . . 3.84 110.868 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.6 m-20 -62.43 -31.77 72.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.349 -0.842 . . . . 1.86 110.263 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.754 HG22 HD22 ' A' ' 39' ' ' LEU . 69.2 mt -82.89 -37.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.987 -0.552 . . . . 1.05 110.908 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.5 mt-10 -57.83 -35.8 71.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.88 112.201 -175.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.99 -32.79 61.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.85 0.357 . . . . 0.75 111.459 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.532 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 47.1 mmtm -100.44 -17.07 17.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 2.11 111.036 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 65.7 tp -88.35 -38.08 15.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.192 -0.458 . . . . 1.06 111.407 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.669 ' HA ' HD13 ' A' ' 171' ' ' LEU . 85.0 mt -50.71 -52.5 55.93 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.835 0.68 . . . . 1.14 112.835 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.6 Cg_endo -55.67 -34.26 89.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.095 1.863 . . . . 0.74 112.673 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.76 -36.0 51.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.569 -0.287 . . . . 1.35 110.84 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 1.015 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.5 mt -56.36 -57.03 14.01 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.07 -0.514 . . . . 1.16 109.781 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -45.21 -61.05 3.74 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.265 -1.334 . . . . 1.52 112.927 172.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 21.9 t . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 109.652 -0.499 . . . . 2.89 109.652 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.327 0.584 . . . . 2.22 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -141.99 177.57 8.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.361 -0.836 . . . . 1.06 108.767 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.841 HD13 HG23 ' A' ' 144' ' ' ILE . 20.7 pt -57.37 -28.67 31.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 1.08 111.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.869 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 33.5 m-85 -78.13 2.68 17.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.3 111.447 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.07 -20.68 64.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.998 -1.112 . . . . 1.96 107.998 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.519 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 61.8 m-85 -111.56 172.36 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.284 -1.326 . . . . 0.4 109.918 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -115.06 161.91 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.75 0.309 . . . . 2.77 110.606 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.522 HG21 HD13 ' A' ' 30' ' ' LEU . 61.2 t -128.52 141.69 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 1.39 111.303 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.908 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 51.0 mt -95.77 132.78 40.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.905 -0.589 . . . . 1.33 109.703 171.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.29 177.75 1.04 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.184 -0.916 . . . . 1.59 109.143 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . . . -51.76 -35.46 43.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.923 0.392 . . . . 1.14 110.748 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -85.82 -3.51 58.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.947 -0.569 . . . . 2.22 111.236 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.908 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.5 m-70 71.97 15.96 5.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.638 0.732 . . . . 0.88 109.521 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -75.55 157.4 84.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 106.726 -1.583 . . . . 3.67 106.726 165.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.63 113.98 2.05 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 120.753 0.969 . . . . 1.19 111.824 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.409 ' HH ' ' CB ' ' A' ' 103' ' ' PRO . 67.9 t80 -90.4 109.12 20.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.36 -0.836 . . . . 0.98 109.324 170.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.643 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.9 t30 -70.93 85.66 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.613 -0.514 . . . . 1.65 109.613 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.869 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -61.6 -29.56 70.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.629 -0.714 . . . . 1.08 111.079 -176.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.82 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 5.4 p -76.12 -0.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.425 -0.807 . . . . 1.15 112.81 -167.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.2 pt20 -80.61 -5.53 56.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.265 0.555 . . . . 1.94 109.921 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -92.98 -5.7 50.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 108.324 -0.991 . . . . 0.38 108.324 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -71.69 141.45 49.85 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.715 -1.13 . . . . 2.22 109.844 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.13 -12.87 55.66 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.895 -1.282 . . . . 0.36 109.895 -172.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.461 ' C ' ' HA ' ' A' ' 146' ' ' ARG . 25.0 m -140.6 148.07 51.68 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 108.572 -0.899 . . . . 1.58 108.572 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.964 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 79.5 Cg_endo -75.35 162.43 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.835 1.69 . . . . 0.86 110.996 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.648 ' CB ' HG23 ' A' ' 70' ' ' THR . 1.8 pt? -159.36 152.69 22.41 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 1.63 110.809 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.668 HD22 HG22 ' A' ' 163' ' ' ILE . 7.2 mp -107.38 148.41 29.12 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.996 -0.742 . . . . 1.69 108.996 173.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 89.0 mt -134.16 119.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.152 -0.684 . . . . 1.05 109.152 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 14.9 m-85 -104.01 130.09 51.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.615 -0.266 . . . . 0.93 111.287 -173.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.729 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -83.79 93.8 8.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.938 -0.764 . . . . 1.97 108.938 167.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.8 m -107.13 140.32 25.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 121.438 -0.789 . . . . 1.48 113.073 -163.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 102.82 4.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.764 -1.569 . . . . 1.17 106.764 164.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.776 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 39.0 t -74.01 94.3 2.35 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.109 0.781 . . . . 2.3 113.109 -163.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 12.7 ttpp 65.11 45.27 3.08 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.7 -1.136 . . . . 2.81 110.733 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.7 p -163.39 151.98 13.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 1.18 110.334 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.96 -124.59 8.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.814 -0.707 . . . . 1.42 113.593 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -107.19 136.89 46.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.351 0.596 . . . . 3.45 112.142 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.551 HG23 ' CE1' ' A' ' 139' ' ' PHE . 55.2 p -116.72 94.03 4.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 1.94 109.585 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.673 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 16.9 ttmm -78.17 41.21 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.283 -0.417 . . . . 2.51 110.908 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.29 85.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.037 -0.602 . . . . 0.55 112.775 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.95 -38.03 84.19 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 112.052 -0.419 . . . . 0.39 112.052 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.601 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.6 t80 -71.74 -50.44 30.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.556 -0.322 . . . . 1.05 110.688 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.35 -44.37 95.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.944 -0.571 . . . . 2.46 110.622 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -52.89 62.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 1.06 110.97 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.663 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -56.7 -49.31 75.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 1.03 111.781 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -56.77 -47.15 80.78 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.967 -0.561 . . . . 1.09 111.169 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.0 m -61.32 -48.89 79.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.627 -0.715 . . . . 1.69 110.988 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.5 mt -58.84 -52.04 67.42 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.244 -0.435 . . . . 1.46 111.738 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.787 ' HE1' ' HG1' ' A' ' 70' ' ' THR . 86.1 t80 -50.86 -52.77 38.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.527 0.517 . . . . 0.92 110.323 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -73.76 -36.65 65.13 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.476 -0.784 . . . . 1.88 111.425 -170.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -74.93 -45.97 38.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.815 -0.629 . . . . 2.27 111.503 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.61 ' CD1' HD12 ' A' ' 171' ' ' LEU . 34.1 m-85 -101.94 -2.84 28.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 114.686 1.365 . . . . 0.9 114.686 -168.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.601 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 13.0 ptmm? -69.18 -15.45 63.4 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.487 -0.885 . . . . 2.62 110.346 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -60.33 -33.2 72.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 1.59 109.979 172.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -101.55 10.24 40.48 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 116.357 -0.383 . . . . 1.9 110.878 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.616 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 90.15 80.61 1.36 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.97 -0.633 . . . . 1.32 112.589 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.601 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 69.9 t80 -151.97 141.89 22.07 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.928 -0.16 . . . . 0.4 110.891 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.787 ' HG1' ' HE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -131.93 149.74 52.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 110.021 -0.362 . . . . 1.11 110.021 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.723 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 49.0 t -117.09 115.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.972 -0.381 . . . . 1.06 109.972 172.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 18.4 mt -102.11 121.95 43.2 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.932 -0.766 . . . . 1.23 108.932 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.961 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -110.9 114.25 27.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.096 0.474 . . . . 1.04 110.656 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.759 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-85 -98.66 112.61 62.98 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 109.075 -0.713 . . . . 0.45 109.075 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.918 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 46.3 Cg_exo -57.89 167.78 3.95 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.278 2.652 . . . . 0.73 112.042 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.435 -1.184 0 C-N-CA 120.027 -0.669 . . . . 2.02 110.911 -178.22 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 108.992 -0.744 . . . . 0.91 108.992 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.3 t -158.96 120.27 3.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.926 -1.034 . . . . 2.41 109.368 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 23' ' ' ALA . 42.7 mttp 45.86 86.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.222 0.823 . . . . 3.5 113.222 172.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.668 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 49.8 p90 -64.58 -20.87 66.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.657 -0.497 . . . . 1.74 109.657 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 66.45 136.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.736 -1.12 . . . . 3.53 111.424 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.487 ' HB2' ' HE1' ' A' ' 54' ' ' TYR . . . -165.06 -178.4 5.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.705 -0.68 . . . . 1.09 110.881 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -88.32 32.84 0.75 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.657 -0.702 . . . . 2.19 110.566 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.769 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.4 p90 -152.0 161.75 28.55 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.114 -1.069 . . . . 0.39 108.114 175.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.9 Cg_exo -64.85 107.94 0.99 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 123.53 2.82 . . . . 0.48 114.189 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.961 HG13 ' HB1' ' A' ' 73' ' ' ALA . 3.3 mp -101.39 131.88 48.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.892 -0.781 . . . . 1.13 108.892 171.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.759 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.7 mmt -110.03 -151.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.924 0.712 . . . . 2.08 112.924 -162.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -75.14 144.58 42.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.391 -0.822 . . . . 1.11 110.778 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.918 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 22.2 pttt -83.45 131.89 35.0 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.659 0.742 . . . . 2.12 109.775 169.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.438 HD13 ' CB ' ' A' ' 116' ' ' HIS . 2.3 pt -136.59 159.22 37.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.78 -1.563 . . . . 1.19 106.78 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.901 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -70.65 95.45 1.1 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.904 -0.718 . . . . 2.16 109.163 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -87.43 83.11 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.262 -0.975 . . . . 1.1 109.065 175.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.0 t-20 171.52 -178.5 0.05 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.367 -0.975 . . . . 1.98 108.367 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 53.2 -147.92 15.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 114.677 0.631 . . . . 0.78 114.677 160.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.42 2.23 28.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.15 -0.525 . . . . 1.98 111.096 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.56 -3.46 36.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.253 -0.43 . . . . 2.1 110.92 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.901 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -46.53 139.3 5.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.189 -0.914 . . . . 1.17 113.34 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.818 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 54.1 t-80 -51.31 137.31 29.81 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.259 -0.882 . . . . 0.51 110.376 171.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.583 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -44.04 -46.5 11.04 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.114 2.542 . . . . 0.43 112.526 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.818 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 20.9 tp -58.63 -41.89 86.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.842 -0.617 . . . . 1.69 111.762 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.506 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 3.7 m-85 -74.5 -29.98 61.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 119.561 -0.257 . . . . 1.84 110.781 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 41.5 mt-10 -56.54 -43.59 80.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.645 -0.872 . . . . 2.37 108.645 169.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.502 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 84.0 t80 -65.96 -46.57 77.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.54 0.525 . . . . 1.09 110.745 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.699 ' HE3' HD13 ' A' ' 118' ' ' LEU . 66.4 mtt -62.72 -51.72 66.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.212 -0.449 . . . . 1.06 111.02 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.566 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 34.7 mtpt -60.75 -45.24 95.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 1.42 110.949 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.4 ptmt -68.69 -33.49 74.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.266 -0.425 . . . . 2.63 111.299 -176.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.469 HG22 ' HD2' ' A' ' 150' ' ' PRO . 93.7 m -74.02 -50.28 20.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.072 -0.513 . . . . 1.09 111.85 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.533 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 6.1 tmtt? . . . . . 0 C--N 1.325 -0.467 0 C-N-CA 120.682 -0.407 . . . . 2.26 111.437 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.784 0.326 . . . . 1.51 110.477 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.83 HG22 ' HZ3' ' A' ' 137' ' ' TRP . 17.6 mt -76.84 161.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.069 -1.086 . . . . 1.5 108.069 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -178.02 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.925 0.784 . . . . 1.99 112.146 -176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.83 ' HZ3' HG22 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.52 165.8 11.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.269 -0.423 . . . . 1.1 112.09 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -48.33 -154.41 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 126.083 1.753 . . . . 1.8 113.817 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.783 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.2 m-85 -28.49 -45.64 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 115.273 1.583 . . . . 1.68 115.273 -163.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.973 HG21 ' HA ' ' A' ' 155' ' ' SER . 15.9 m 30.29 109.89 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.38 1.622 . . . . 1.05 115.38 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.0 p -93.56 156.52 16.68 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.27 0.557 . . . . 1.38 111.09 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.545 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 6.2 m-85 -102.43 166.47 10.53 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.018 -1.475 . . . . 0.53 107.018 163.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.735 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 49.8 tp -112.83 104.77 12.78 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.763 -0.829 . . . . 1.2 108.763 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.841 HG23 HD13 ' A' ' 15' ' ' ILE . 11.9 mm -103.05 125.22 57.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 109.11 -0.7 . . . . 1.05 109.11 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -77.86 -176.35 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.8 -0.36 . . . . 1.3 111.684 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.68 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 76.6 mtp180 -57.41 -24.4 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.626 0.602 . . . . 4.43 112.626 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.52 -12.43 14.69 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.868 -0.733 . . . . 1.18 110.494 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.539 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 109.24 34.35 2.54 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.814 -0.708 . . . . 0.25 113.059 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 57.9 t -107.85 128.33 26.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.859 -0.423 . . . . 1.32 109.859 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.469 ' HD2' HG22 ' A' ' 125' ' ' THR . 4.8 Cg_exo -75.4 112.04 3.44 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.362 2.041 . . . . 0.46 111.24 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.533 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 41.1 t -93.54 -23.94 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 1.09 110.944 -177.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 1.2 mm-40 -156.65 166.11 34.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 1.22 111.042 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.566 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 27.5 ttm180 -131.05 96.55 4.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.905 -0.776 . . . . 2.25 108.905 172.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.784 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 77.3 m-85 -82.42 110.07 17.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.38 109.519 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.973 ' HA ' HG21 ' A' ' 140' ' ' THR . 1.4 m -61.85 168.4 3.61 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.879 -0.415 . . . . 1.49 109.879 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.783 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 36.1 Cg_endo -60.93 -28.16 85.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.629 1.553 . . . . 0.74 111.462 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.49 66.33 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.317 -1.31 . . . . 0.56 112.681 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.64 112.03 6.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.964 0.411 . . . . 1.14 110.045 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.7 m -74.81 174.66 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.895 -0.593 . . . . 1.64 110.828 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.461 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 69.0 t -48.59 -53.37 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.343 -0.389 . . . . 1.14 111.679 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -66.17 -32.13 73.38 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.278 -0.419 . . . . 3.84 111.498 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -63.71 -32.57 74.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.418 -0.586 . . . . 1.86 109.418 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.668 HG22 HD22 ' A' ' 39' ' ' LEU . 63.2 mt -83.68 -39.83 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.322 -0.854 . . . . 1.05 111.12 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.4 mt-10 -51.44 -44.14 62.25 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.234 0.457 . . . . 0.88 112.234 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.9 pt-20 -53.79 -33.57 56.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.123 0.416 . . . . 0.75 112.123 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.784 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtm -102.18 -19.08 15.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.918 0.39 . . . . 2.11 111.007 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.6 tp -84.14 -45.53 12.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 1.06 111.349 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.641 ' HA ' HD13 ' A' ' 171' ' ' LEU . 74.3 mt -53.5 -48.11 94.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.281 0.474 . . . . 1.14 112.281 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.9 Cg_exo -53.54 -37.32 82.64 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.067 1.844 . . . . 0.74 112.7 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.3 mt -78.87 -35.86 43.1 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 111.95 0.352 . . . . 1.35 111.95 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.964 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 11.4 mt -55.51 -54.15 47.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.744 0.783 . . . . 1.16 108.933 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.03 -45.74 94.77 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.211 -1.359 . . . . 1.52 113.539 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-N 117.835 0.817 . . . . 2.89 113.07 -172.467 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 108.516 -0.92 . . . . 2.22 108.516 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.0 p -135.37 178.34 7.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.159 -0.928 . . . . 1.06 109.494 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.681 HD13 HG23 ' A' ' 144' ' ' ILE . 21.4 pt -62.99 -26.42 40.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.241 0.543 . . . . 1.08 110.632 175.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.797 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 45.7 m-85 -76.94 -6.06 51.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.8 -0.637 . . . . 0.3 112.306 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -82.37 7.33 14.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.448 0.642 . . . . 1.96 109.352 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 89.2 m-85 -119.56 169.97 9.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.103 -0.953 . . . . 0.4 110.051 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.7 tt0 -98.01 151.49 20.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.312 -0.404 . . . . 2.77 110.513 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.644 HG13 ' CE2' ' A' ' 74' ' ' PHE . 72.6 t -130.46 136.29 58.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.011 0.434 . . . . 1.39 110.507 172.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.716 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 96.4 mt -101.63 140.42 35.95 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.126 -0.694 . . . . 1.33 109.126 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 -172.72 3.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.238 -0.653 . . . . 1.59 109.238 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.46 66.35 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.779 0.323 . . . . 1.14 111.229 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 20.3 t70 -88.93 -12.16 42.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.192 -0.458 . . . . 2.22 111.191 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 38.7 m-70 82.59 23.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 123.599 0.76 . . . . 0.88 110.399 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -85.43 154.18 59.35 Favored Pre-proline 0 N--CA 1.443 -0.802 0 N-CA-C 105.693 -1.965 . . . . 3.67 105.693 165.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.68 114.38 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.812 0.969 . . . . 1.19 111.904 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.985 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 75.3 t80 -86.74 111.25 20.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.407 -0.815 . . . . 0.98 109.194 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.688 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 57.5 t30 -68.83 86.38 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.216 0.532 . . . . 1.65 109.936 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.797 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -61.38 -35.96 78.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 1.08 111.378 -174.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.561 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 13.5 p -76.54 1.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.003 0.742 . . . . 1.15 113.003 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.5 pt20 -74.73 -5.86 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.174 -0.954 . . . . 1.94 108.997 168.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.985 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 82.1 m-70 -98.42 2.71 48.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.212 -1.033 . . . . 0.38 108.212 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 21.1 ttpt -81.07 142.46 33.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.848 -1.069 . . . . 2.22 109.642 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.06 79.48 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.804 -1.319 . . . . 0.36 109.804 -170.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.636 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 16.3 m -132.54 146.87 63.32 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 114.111 -1.045 . . . . 1.58 108.293 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.849 ' HG2' HD22 ' A' ' 171' ' ' LEU . 1.2 Cg_endo -79.56 149.58 21.29 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.737 1.625 . . . . 0.86 110.238 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.523 ' HB2' HG23 ' A' ' 70' ' ' THR . 2.1 pt? -151.93 149.91 29.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.302 0.572 . . . . 1.63 111.291 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -107.53 154.9 20.71 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.584 -0.895 . . . . 1.69 108.584 172.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.475 HD12 HG13 ' A' ' 144' ' ' ILE . 69.4 mt -141.62 114.82 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.094 -0.706 . . . . 1.05 109.094 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 18.1 m-85 -100.59 124.55 46.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 121.125 -0.23 . . . . 0.93 110.78 -174.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.734 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -80.69 92.7 6.05 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.242 -0.651 . . . . 1.97 109.242 171.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.69 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 m -106.34 145.93 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 114.229 1.196 . . . . 1.48 114.229 -160.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.39 102.22 9.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.603 -1.628 . . . . 1.17 106.603 160.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 95' ' ' CYS . 40.4 t -72.11 85.29 1.02 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 112.563 0.579 . . . . 2.3 112.563 -165.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 17.9 tppt? 75.4 23.31 1.53 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.739 0.78 . . . . 2.81 110.638 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.52 129.33 51.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.238 -0.437 . . . . 1.18 110.548 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 -115.87 4.62 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.862 -0.685 . . . . 1.42 112.7 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -139.63 166.69 23.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.271 0.558 . . . . 3.45 111.868 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 52' ' ' GLY . 40.9 p -131.92 115.07 15.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.663 -0.699 . . . . 1.94 110.372 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.691 ' HD2' ' HA3' ' A' ' 157' ' ' GLY . 28.0 ttmt -79.0 24.61 0.31 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.212 0.53 . . . . 2.51 110.887 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 50' ' ' THR . . . 104.99 13.8 24.39 Favored Glycine 0 C--O 1.224 -0.522 0 CA-C-N 115.881 -0.6 . . . . 0.55 112.38 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.71 -47.43 20.61 Favored Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 121.231 -0.509 . . . . 0.39 112.175 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.665 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.7 t80 -69.67 -47.6 62.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.486 0.184 . . . . 1.05 111.262 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -59.28 -47.11 86.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.069 0.462 . . . . 2.46 110.145 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.5 m -64.31 -45.99 85.51 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.385 -0.825 . . . . 1.06 110.891 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.543 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -57.17 -49.31 76.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.979 0.419 . . . . 1.03 111.07 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.6 m -59.26 -51.3 70.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.615 -0.721 . . . . 1.09 111.147 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 p -63.68 -39.27 93.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 1.69 111.914 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 88.5 mt -62.48 -51.66 66.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.442 0.163 . . . . 1.46 110.996 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.793 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 71.6 t80 -51.96 -48.86 64.12 Favored 'General case' 0 C--O 1.22 -0.45 0 O-C-N 123.752 0.657 . . . . 0.92 109.483 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.12 -43.29 74.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.536 -0.756 . . . . 1.88 111.687 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.61 -44.79 61.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.865 -0.607 . . . . 2.27 111.391 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.752 ' CD1' HD11 ' A' ' 171' ' ' LEU . 70.1 m-85 -100.91 6.3 43.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.402 0.89 . . . . 0.9 113.402 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -60.75 -25.17 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.987 0.422 . . . . 2.62 110.279 171.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -32.76 74.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.777 -0.647 . . . . 1.59 110.69 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -98.65 17.48 19.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.994 0.426 . . . . 1.9 110.703 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 74.78 55.52 5.35 Favored Glycine 0 C--O 1.224 -0.488 0 CA-C-N 115.64 -0.709 . . . . 1.32 112.845 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 39' ' ' LEU . 59.7 t80 -117.15 140.0 50.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.633 0.254 . . . . 0.4 110.781 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.523 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -128.36 138.98 52.61 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 120.907 0.384 . . . . 1.11 110.556 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.793 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 39.4 t -110.91 121.11 63.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.887 0.375 . . . . 1.06 110.242 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.634 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 21.3 mt -102.03 141.62 34.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.901 -0.778 . . . . 1.23 108.901 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.014 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -125.98 124.75 41.43 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.11 0.481 . . . . 1.04 110.222 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.669 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.4 m-85 -108.5 108.3 60.86 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.891 -0.595 . . . . 0.45 109.686 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.622 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 41.7 Cg_exo -58.67 154.97 39.54 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.077 2.518 . . . . 0.73 112.057 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.433 -1.277 0 CA-C-N 115.776 -0.647 . . . . 2.02 110.582 -177.997 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 45' ' ' SER . 21.8 m . . . . . 0 N--CA 1.441 -0.907 0 CA-C-O 121.367 0.603 . . . . 0.91 110.758 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.3 t -157.07 118.47 3.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.135 -0.939 . . . . 2.41 109.313 166.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.612 ' C ' ' H ' ' A' ' 99' ' ' LYS . 27.4 mttm 70.15 -47.02 0.62 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.591 1.33 . . . . 3.5 114.591 173.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.665 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 2.7 p90 58.04 -29.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.414 1.486 . . . . 1.74 111.548 -164.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.612 ' H ' ' C ' ' A' ' 97' ' ' LYS . 6.8 mtmt 71.51 125.47 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.245 1.018 . . . . 3.53 111.739 170.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.553 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . . . -154.02 -170.67 3.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.985 -0.552 . . . . 1.09 112.035 -173.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.04 -6.28 58.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.732 -0.667 . . . . 2.19 110.366 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.807 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 47.9 p90 -115.98 162.23 26.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.62 -0.882 . . . . 0.39 108.62 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 37.8 Cg_exo -66.95 123.39 10.91 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 123.892 3.062 . . . . 0.48 113.675 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.014 HG13 ' HB2' ' A' ' 73' ' ' ALA . 4.0 mp -112.3 148.85 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.291 -0.633 . . . . 1.13 109.291 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.669 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 9.2 mmt -120.36 -154.75 0.59 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.447 0.906 . . . . 2.08 113.447 -164.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 21' ' ' LEU . . . -69.42 154.07 42.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.667 -1.151 . . . . 1.11 111.141 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.561 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 72.0 mttt -80.99 112.5 18.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.271 -0.64 . . . . 2.12 109.271 174.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.9 pt -121.39 149.58 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.224 -1.028 . . . . 1.19 108.224 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.7 t30 -81.74 60.51 4.69 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.831 -0.348 . . . . 2.16 110.384 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -56.38 94.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 116.575 -0.284 . . . . 1.1 110.912 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.786 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER 175.43 178.55 0.16 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 110.207 -0.294 . . . . 1.98 110.207 175.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.91 -123.2 0.15 Allowed Glycine 0 C--N 1.334 0.438 0 O-C-N 125.115 1.509 . . . . 0.78 115.192 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -107.01 -6.09 17.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 1.98 110.662 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -95.19 -6.9 40.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.386 -0.825 . . . . 2.1 112.308 -170.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.557 ' HB2' ' H ' ' A' ' 111' ' ' ASN . . . -57.56 146.38 30.4 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.214 0.82 . . . . 1.17 113.214 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.689 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 26.5 t-80 -50.56 141.06 17.68 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.242 -0.89 . . . . 0.51 109.803 169.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 8.7 Cg_endo -51.08 -37.96 58.78 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.254 2.636 . . . . 0.43 112.523 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.689 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 14.6 tp -54.85 -45.38 74.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.119 0.485 . . . . 1.69 111.074 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.483 ' CG ' HG11 ' A' ' 110' ' ' VAL . 3.3 m-85 -73.95 -28.1 61.33 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 116.079 -0.51 . . . . 1.84 110.974 176.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 39.7 mt-10 -56.23 -38.38 70.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.838 -0.745 . . . . 2.37 109.468 168.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 76.2 t80 -69.95 -47.01 64.04 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.568 -0.453 . . . . 1.09 110.488 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.517 ' HE2' HD12 ' A' ' 118' ' ' LEU . 66.9 mtt -61.48 -55.23 33.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.294 -0.412 . . . . 1.06 111.241 -178.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 27.6 mtpt -58.59 -43.66 89.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 1.42 111.411 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -70.1 -33.91 72.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 2.63 111.077 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.537 HG22 ' HD2' ' A' ' 150' ' ' PRO . 90.2 m -65.65 -46.56 78.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.394 -0.366 . . . . 1.09 111.105 -176.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.609 ' HD3' ' HA ' ' A' ' 152' ' ' GLU . 27.9 tttm . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 2.26 109.95 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.346 0 CA-C-O 120.306 0.098 . . . . 1.51 111.079 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.85 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 30.6 mm -70.13 161.95 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.512 -0.922 . . . . 1.5 108.512 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -177.42 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.748 0.785 . . . . 1.99 110.334 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.85 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -95.64 171.41 8.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.731 -1.122 . . . . 1.1 111.717 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.42 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 18.5 m120 -48.13 -156.57 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.36 -1.746 . . . . 1.8 113.789 170.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 4.5 m-85 -29.32 -57.91 0.15 Allowed 'General case' 0 C--O 1.202 -1.428 0 C-N-CA 125.166 1.387 . . . . 1.68 114.588 -165.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.951 HG22 ' HA ' ' A' ' 155' ' ' SER . 10.0 m 44.48 106.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.309 1.225 . . . . 1.05 114.309 177.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 11.9 p -89.55 149.13 23.01 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.358 -0.839 . . . . 1.38 111.458 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 14.3 m-85 -103.76 133.4 48.81 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.147 -1.057 . . . . 0.53 108.147 163.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.744 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 16.3 tp -82.52 105.26 13.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.44 -0.578 . . . . 1.2 109.44 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.681 HG23 HD13 ' A' ' 15' ' ' ILE . 10.6 mm -105.03 126.97 59.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.409 -0.589 . . . . 1.05 109.409 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.421 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 16.9 p30 -79.57 -175.16 4.64 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.837 -0.345 . . . . 1.3 111.47 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 36' ' ' SER . 91.8 mtt180 -64.54 -12.81 48.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.507 0.558 . . . . 4.43 112.507 -176.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -109.73 -13.46 14.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.41 0.624 . . . . 1.18 109.326 -170.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.408 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 100.52 28.07 7.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.175 -0.921 . . . . 0.25 112.729 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.421 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 61.7 t -110.77 128.0 26.04 Favored Pre-proline 0 C--N 1.317 -0.839 0 O-C-N 122.538 -0.389 . . . . 1.32 110.388 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 125' ' ' THR . 10.6 Cg_exo -68.94 106.09 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.97 2.447 . . . . 0.46 112.174 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.3 t -89.41 -16.33 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 1.09 110.589 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.609 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 5.2 mm-40 -160.73 165.67 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 1.22 110.717 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -137.56 98.28 3.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.94 -0.573 . . . . 2.25 109.531 170.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.744 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.3 m-85 -88.49 113.02 23.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.38 109.745 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.951 ' HA ' HG22 ' A' ' 140' ' ' THR . 3.8 m -64.56 166.14 12.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 109.775 -0.454 . . . . 1.49 109.775 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.809 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 33.8 Cg_endo -65.34 -8.26 18.28 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.695 2.264 . . . . 0.74 113.061 -165.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.691 ' HA3' ' HD2' ' A' ' 51' ' ' LYS . . . -93.24 3.25 72.43 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.433 -0.803 . . . . 0.56 112.882 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.47 139.97 37.46 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.182 -0.303 . . . . 1.14 110.182 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 94.7 p -83.58 171.11 13.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.64 111.034 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.7 t -55.52 -48.27 77.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.684 -0.487 . . . . 1.14 109.684 175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -63.74 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.806 . . . . 3.84 110.9 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.06 -37.73 69.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.95 -0.568 . . . . 1.86 110.313 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.545 HG21 HD21 ' A' ' 39' ' ' LEU . 67.5 mt -82.51 -41.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 1.05 111.399 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 52.0 mt-10 -56.37 -40.02 73.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.147 0.425 . . . . 0.88 112.147 -176.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.462 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 10.0 pt-20 -59.77 -22.71 62.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.821 0.304 . . . . 0.75 111.821 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.698 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.8 mmtp -107.23 -19.88 13.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.104 0.478 . . . . 2.11 110.262 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 171' ' ' LEU . 58.2 tp -84.73 -42.44 15.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 1.06 111.32 -174.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.658 ' HA ' HD12 ' A' ' 171' ' ' LEU . 81.9 mt -53.24 -47.44 95.97 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.16 0.43 . . . . 1.14 112.16 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.531 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.5 Cg_exo -55.29 -23.28 36.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.624 2.216 . . . . 0.74 113.327 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 mt -92.65 -40.31 10.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.634 0.254 . . . . 1.35 110.964 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.849 HD22 ' HG2' ' A' ' 37' ' ' PRO . 10.7 mt -60.39 -48.51 81.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.092 -0.707 . . . . 1.16 109.092 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.92 52.5 2.87 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.699 -1.137 . . . . 1.52 113.057 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 124.991 1.316 . . . . 2.89 113.594 177.078 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.747 0.308 . . . . 2.22 111.138 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.0 p -171.69 -176.96 1.88 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.292 -0.633 . . . . 1.06 109.292 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.748 HD12 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -62.34 -26.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.138 0.494 . . . . 1.08 110.448 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.894 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 44.0 m-85 -79.02 -1.59 36.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.777 -0.647 . . . . 0.3 111.556 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.27 -16.1 61.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.443 -0.947 . . . . 1.96 108.443 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 47.5 m-85 -105.63 177.81 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.579 -1.191 . . . . 0.4 109.658 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -126.13 148.47 49.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.692 0.282 . . . . 2.77 110.722 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 30' ' ' LEU . 70.0 t -117.35 148.17 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 1.39 111.33 -175.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.961 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 92.7 mt -102.82 137.73 40.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 1.33 109.656 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 23' ' ' ALA . 19.7 t70 -72.98 -174.97 1.63 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.035 -0.728 . . . . 1.59 109.035 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.471 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -55.48 -34.15 64.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.042 0.449 . . . . 1.14 111.139 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -93.82 3.03 56.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 2.22 111.186 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.961 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 35.1 m-70 72.91 14.53 4.81 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.276 0.63 . . . . 0.88 110.292 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 10.4 mtmt -66.76 144.34 98.53 Favored Pre-proline 0 CA--C 1.511 -0.519 0 N-CA-C 106.252 -1.759 . . . . 3.67 106.252 163.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.81 113.76 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 CA-C-N 119.809 0.967 . . . . 1.19 111.136 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -87.53 108.84 19.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.375 -0.83 . . . . 0.98 109.124 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.637 ' OD1' HG13 ' A' ' 31' ' ' VAL . 62.6 t30 -66.57 95.59 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.132 -0.692 . . . . 1.65 109.132 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.894 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.88 -30.23 67.63 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.627 -0.715 . . . . 1.08 110.611 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.707 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -76.93 -4.06 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 1.15 112.843 -166.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 27.8 pt20 -79.02 -4.99 52.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.565 0.698 . . . . 1.94 109.396 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.525 ' ND1' HG21 ' A' ' 70' ' ' THR . 84.8 m-70 -97.67 2.38 49.68 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.368 -0.975 . . . . 0.38 108.368 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -78.62 145.6 34.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.111 -0.95 . . . . 2.22 108.951 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.58 87.29 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.904 -1.278 . . . . 0.36 109.904 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -132.27 133.05 23.31 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.64 -0.874 . . . . 1.58 108.64 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.912 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 36.4 Cg_endo -69.56 146.02 60.16 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.305 1.337 . . . . 0.86 109.803 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.554 ' CD2' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -150.77 161.13 43.23 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.495 0.665 . . . . 1.63 111.743 -175.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.764 HD23 HG22 ' A' ' 163' ' ' ILE . 6.5 mp -111.96 154.01 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.977 -1.011 . . . . 1.69 108.671 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 94.5 mt -140.54 115.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.291 -0.633 . . . . 1.05 109.291 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.849 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 34.4 m-85 -99.72 123.4 43.94 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 121.047 -0.261 . . . . 0.93 111.165 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.808 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.7 OUTLIER -80.41 91.56 5.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.197 -1.038 . . . . 1.97 108.197 167.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.4 p -116.11 137.7 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.733 1.012 . . . . 1.48 113.733 -162.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.08 108.85 1.96 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.267 -1.012 . . . . 1.17 108.267 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.932 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 17.8 t -75.68 84.02 2.68 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.278 0.473 . . . . 2.3 112.278 -169.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.657 ' HG3' ' HB2' ' A' ' 98' ' ' PHE . 52.2 mttm 73.15 29.92 1.66 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.18 -0.918 . . . . 2.81 112.328 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -133.04 128.87 37.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.348 -0.612 . . . . 1.18 109.348 174.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.93 -129.39 9.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.441 -0.885 . . . . 1.42 113.387 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.33 161.82 26.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.011 0.91 . . . . 3.45 113.353 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 t -125.22 154.0 42.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.387 -1.279 . . . . 1.94 108.286 168.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 13.2 ttmm -119.08 20.84 12.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.573 0.701 . . . . 2.51 109.345 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.98 16.27 6.87 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 114.846 -1.07 . . . . 0.55 111.584 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.21 -54.25 4.14 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.935 -0.466 . . . . 0.39 111.935 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.654 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.4 t80 -65.92 -45.7 80.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.976 0.417 . . . . 1.05 110.592 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -62.36 -46.63 87.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 2.46 110.541 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.431 ' CG2' HD11 ' A' ' 163' ' ' ILE . 98.5 m -67.75 -41.46 83.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.169 -0.468 . . . . 1.06 110.859 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB3' HG12 ' A' ' 71' ' ' VAL . . . -59.13 -47.78 84.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 1.03 111.235 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 m -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.945 -0.571 . . . . 1.09 111.125 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 p -62.54 -48.38 79.76 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.852 -0.613 . . . . 1.69 111.203 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -46.49 88.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 1.46 111.596 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.724 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 46.3 t80 -50.93 -58.71 5.32 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 123.389 0.43 . . . . 0.92 110.595 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.536 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 91.9 m-20 -73.02 -30.61 63.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.076 0.399 . . . . 1.88 112.076 -173.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.8 -27.26 50.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.211 -0.45 . . . . 2.27 111.329 -174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.792 ' CD1' HD12 ' A' ' 171' ' ' LEU . 65.8 m-85 -122.17 5.2 9.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.687 0.995 . . . . 0.9 113.687 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.724 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 35.3 mtmt -58.79 -28.92 66.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.983 0.421 . . . . 2.62 110.33 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.0 p -61.12 -40.01 92.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.636 -0.711 . . . . 1.59 110.928 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -90.48 12.12 19.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 1.9 110.761 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.49 71.5 1.25 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.79 -0.641 . . . . 1.32 112.133 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 39' ' ' LEU . 74.0 t80 -140.67 141.82 34.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.657 0.265 . . . . 0.4 110.968 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.525 HG21 ' ND1' ' A' ' 33' ' ' HIS . 8.8 t -131.96 142.88 49.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.224 0.535 . . . . 1.11 110.433 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.717 HG12 ' HB3' ' A' ' 57' ' ' ALA . 24.7 t -105.24 119.64 54.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.894 0.378 . . . . 1.06 110.073 170.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.703 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 12.3 mt -104.69 128.06 52.64 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.891 -0.781 . . . . 1.23 108.891 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.986 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -114.52 121.3 43.08 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.309 -0.556 . . . . 1.04 110.878 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.661 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -105.42 108.75 62.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.878 -0.786 . . . . 0.45 108.878 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.96 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 50.9 Cg_exo -56.4 164.76 5.06 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.979 2.453 . . . . 0.73 111.56 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.437 -1.086 0 C-N-CA 119.031 -1.068 . . . . 2.02 113.046 -176.339 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 45' ' ' SER . 12.7 m . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.22 0.534 . . . . 0.91 110.654 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -152.85 118.39 5.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.474 -0.784 . . . . 2.41 109.807 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HG3' ' HE3' ' A' ' 99' ' ' LYS . 15.0 pttm 23.86 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.098 1.359 . . . . 3.5 114.634 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.657 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -57.01 120.18 7.55 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.005 -1.85 . . . . 1.74 106.005 168.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.464 ' HE3' ' HG3' ' A' ' 97' ' ' LYS . 9.3 mptt -79.44 164.44 23.97 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.702 -0.799 . . . . 3.53 111.195 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.497 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -172.67 -175.41 1.3 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.08 0.863 . . . . 1.09 110.969 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.62 0.9 55.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 2.19 110.903 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.789 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 49.9 p90 -121.36 168.4 11.17 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.655 -0.868 . . . . 0.39 108.655 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.692 ' HB2' ' HE2' ' A' ' 105' ' ' MET . 23.6 Cg_exo -69.95 116.92 4.8 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.505 2.803 . . . . 0.48 113.239 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.986 HG13 ' HB1' ' A' ' 73' ' ' ALA . 3.5 mp -109.01 140.22 28.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.934 -0.765 . . . . 1.13 108.934 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.703 ' HE3' ' HB3' ' A' ' 72' ' ' LEU . 8.8 mmt -113.68 -153.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.371 0.605 . . . . 2.08 112.488 -164.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.59 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.76 144.22 45.73 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.036 -0.983 . . . . 1.11 110.477 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.96 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.7 pttp -80.67 127.77 32.86 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.652 -0.87 . . . . 2.12 108.652 169.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.634 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -131.86 169.4 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.049 -1.463 . . . . 1.19 107.049 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.798 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.5 m120 -72.43 118.82 15.81 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.467 -0.938 . . . . 2.16 108.467 172.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -116.97 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 119.453 -0.899 . . . . 1.1 108.914 168.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 13.2 t-20 171.61 178.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.911 -1.144 . . . . 1.98 107.911 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.09 -140.38 12.23 Favored Glycine 0 N--CA 1.448 -0.561 0 O-C-N 123.645 0.59 . . . . 0.78 114.321 163.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -104.84 -2.62 24.51 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.9 -0.65 . . . . 1.98 110.254 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.06 -21.31 26.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.512 -0.767 . . . . 2.1 110.646 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.798 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.05 137.65 0.66 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.213 1.19 . . . . 1.17 114.213 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.787 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 56.6 t-80 -49.79 139.09 16.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.233 -0.894 . . . . 0.51 110.797 172.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -41.87 -49.73 5.43 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.193 2.595 . . . . 0.43 112.938 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.787 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -55.91 -38.32 70.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.102 -0.499 . . . . 1.69 112.138 177.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' A' ' 40' ' ' ILE . 3.5 m-85 -75.97 -30.0 58.46 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 122.35 -0.219 . . . . 1.84 111.003 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.7 mt-10 -57.64 -35.27 70.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.025 -0.731 . . . . 2.37 109.025 169.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.9 t80 -71.38 -48.4 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 1.09 110.309 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.511 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 67.5 mtt -63.09 -53.09 59.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.999 -0.546 . . . . 1.06 111.624 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -56.72 -46.43 81.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.539 . . . . 1.42 111.003 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -67.46 -32.29 73.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 2.63 111.039 -176.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.522 HG23 ' HD2' ' A' ' 150' ' ' PRO . 93.0 m -72.76 -63.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 1.09 111.828 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.604 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 5.4 tmtt? . . . . . 0 C--N 1.324 -0.509 0 C-N-CA 120.924 -0.31 . . . . 2.26 110.843 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.702 0.286 . . . . 1.51 111.164 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.762 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 29.4 mm -76.02 170.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 108.809 -0.811 . . . . 1.5 108.809 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.51 ' H ' HG23 ' A' ' 135' ' ' ILE . 11.9 ptpt 177.47 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.609 0.718 . . . . 1.99 110.52 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.762 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.76 169.76 9.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.071 -0.968 . . . . 1.1 112.261 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -48.91 -155.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.219 1.808 . . . . 1.8 113.959 172.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.849 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 22.8 m-85 -26.7 -58.43 0.09 Allowed 'General case' 0 C--O 1.205 -1.243 0 C-N-CA 125.419 1.488 . . . . 1.68 113.929 -163.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.808 ' HB ' HD22 ' A' ' 42' ' ' ASN . 22.5 m 40.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.33 0.863 . . . . 1.05 113.33 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 18.9 p -85.57 148.38 25.96 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.004 -0.678 . . . . 1.38 110.685 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.511 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 11.6 m-85 -102.34 130.34 49.05 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.036 -1.098 . . . . 0.53 108.036 167.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.781 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.4 tp -80.99 106.17 12.78 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.976 -0.75 . . . . 1.2 108.976 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.748 HG21 HD12 ' A' ' 15' ' ' ILE . 10.1 mm -105.06 128.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.442 -0.947 . . . . 1.05 108.442 -175.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.95 -176.16 3.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.756 0.312 . . . . 1.3 110.884 -174.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.69 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 64.3 mtp180 -68.1 -6.48 23.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 4.43 111.804 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -109.97 -21.13 12.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.501 0.667 . . . . 1.18 109.528 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.514 ' HA2' HG23 ' A' ' 144' ' ' ILE . . . 102.98 32.96 4.49 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.967 -1.015 . . . . 0.25 112.848 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.8 t -111.55 129.0 24.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.523 -0.547 . . . . 1.32 109.523 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.522 ' HD2' HG23 ' A' ' 125' ' ' THR . 15.0 Cg_exo -64.39 109.92 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.376 2.051 . . . . 0.46 111.612 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.604 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 11.4 t -92.55 -22.09 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 1.09 110.351 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.3 mm-40 -153.75 163.99 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.262 0.554 . . . . 1.22 111.276 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.425 ' HD3' ' HH2' ' A' ' 137' ' ' TRP . 26.0 ttm180 -134.02 97.71 3.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.019 -0.991 . . . . 2.25 108.766 172.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.781 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 46.9 m-85 -90.84 113.75 25.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.057 -0.72 . . . . 0.38 109.057 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.767 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.7 m -62.0 173.51 0.87 Allowed Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 110.011 -0.366 . . . . 1.49 110.011 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.699 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 54.0 Cg_endo -64.54 -14.42 44.32 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.693 1.596 . . . . 0.74 111.157 -174.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 51' ' ' LYS . . . -81.54 2.41 82.56 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.466 -1.243 . . . . 0.56 112.132 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.499 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.32 127.39 32.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.816 0.341 . . . . 1.14 110.547 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -178.9 5.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.126 -0.488 . . . . 1.64 110.589 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.423 ' HA ' HG23 ' A' ' 56' ' ' THR . 49.1 t -55.05 -58.87 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 1.14 112.021 -175.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 162' ' ' ASP . 4.0 ptmm? -66.49 -28.32 68.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 3.84 110.988 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 161' ' ' LYS . 62.3 m-20 -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 1.86 110.237 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.764 HG22 HD23 ' A' ' 39' ' ' LEU . 55.1 mt -82.54 -44.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.832 -0.622 . . . . 1.05 110.369 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 168' ' ' ILE . 61.2 mt-10 -56.45 -40.12 74.29 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 112.162 0.43 . . . . 0.88 112.162 -176.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.36 -20.93 47.86 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.012 0.375 . . . . 0.75 112.012 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.631 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 63.1 mmtt -105.4 -25.71 12.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.587 0.232 . . . . 2.11 110.456 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 44.4 tp -85.78 -34.73 21.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 1.06 112.036 -169.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.653 ' HA ' HD13 ' A' ' 171' ' ' LEU . 81.4 mt -50.37 -48.03 81.85 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.271 0.471 . . . . 1.14 112.271 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 75.2 Cg_exo -51.81 -38.49 67.61 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.253 1.969 . . . . 0.74 113.335 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 2.2 mm? -74.07 -42.45 60.17 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 121.076 -0.25 . . . . 1.35 111.036 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.912 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 9.7 mt -57.06 -46.4 82.51 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.2 -0.667 . . . . 1.16 109.2 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -50.8 -73.54 0.37 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.709 -1.132 . . . . 1.52 111.943 168.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 22.9 t . . . . . 0 N--CA 1.467 0.397 0 C-N-CA 122.668 0.387 . . . . 2.89 110.536 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.053 0.454 . . . . 2.22 110.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.8 p -153.2 173.36 15.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 1.06 109.199 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.764 HD13 HG21 ' A' ' 144' ' ' ILE . 25.9 pt -56.0 -32.3 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 1.08 111.583 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.825 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 47.4 m-85 -71.17 -14.31 62.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.3 111.97 -172.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -69.6 -15.02 63.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.312 0.577 . . . . 1.96 109.655 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 86.2 m-85 -103.66 174.13 6.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.342 -0.844 . . . . 0.4 111.528 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 10.5 tt0 -91.74 152.09 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.21 -0.904 . . . . 2.77 110.895 -177.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 93.7 t -138.78 145.45 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.119 0.485 . . . . 1.39 110.413 169.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.892 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 69.3 mt -119.91 148.12 43.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.706 -0.679 . . . . 1.33 109.472 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.634 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 14.5 t70 -78.88 -173.96 3.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.917 -0.771 . . . . 1.59 108.917 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.675 ' HB1' ' HG2' ' A' ' 97' ' ' LYS . . . -52.76 -27.0 15.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.338 0.496 . . . . 1.14 112.338 -172.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.86 25.0 10.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.289 0.477 . . . . 2.22 112.289 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.892 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 46.0 m-70 72.38 9.2 5.82 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 121.658 0.742 . . . . 0.88 110.538 171.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.634 ' HE3' ' HB3' ' A' ' 22' ' ' ASP . 23.9 mtmt -64.25 135.64 96.42 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 106.811 -1.551 . . . . 3.67 106.811 165.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.61 114.17 1.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.208 1.272 . . . . 1.19 112.226 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.475 ' HB3' HG11 ' A' ' 20' ' ' VAL . 46.3 t80 -93.61 110.06 21.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.495 -0.775 . . . . 0.98 111.011 175.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.6 t30 -71.5 93.26 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.136 -0.69 . . . . 1.65 109.136 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.796 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.17 -27.77 65.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.019 -0.537 . . . . 1.08 111.261 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.825 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.7 p -76.73 -1.47 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 113.181 0.808 . . . . 1.15 113.181 -166.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 26.8 pt20 -78.13 -5.39 51.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.319 0.58 . . . . 1.94 109.65 172.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.35 4.58 53.25 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HE3' ' CG2' ' A' ' 31' ' ' VAL . 31.1 ttmt -78.61 146.64 34.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.289 -0.869 . . . . 2.22 110.048 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.23 5.28 89.09 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.043 -1.223 . . . . 0.36 110.043 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.651 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.7 m -141.96 139.13 17.69 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 114.416 -0.892 . . . . 1.58 108.877 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.931 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.7 Cg_endo -72.85 150.55 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.625 1.55 . . . . 0.86 110.805 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.56 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -153.32 151.41 29.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.198 0.523 . . . . 1.63 111.003 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.761 HD21 HG22 ' A' ' 163' ' ' ILE . 6.7 mp -107.25 152.75 23.68 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.735 -0.839 . . . . 1.69 108.735 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 81.0 mt -140.76 114.66 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.974 -0.75 . . . . 1.05 108.974 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.759 ' CD2' ' HB3' ' A' ' 139' ' ' PHE . 21.2 m-85 -102.66 122.99 45.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.336 . . . . 0.93 110.747 -173.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.911 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.3 OUTLIER -80.92 91.78 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.374 -0.973 . . . . 1.97 108.374 168.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.701 ' HB ' ' HA ' ' A' ' 139' ' ' PHE . 2.5 p -110.61 131.99 60.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 113.167 0.803 . . . . 1.48 113.167 -163.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 111.92 2.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.259 -1.385 . . . . 1.17 107.259 167.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.072 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.43 64.33 1.56 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.501 0.926 . . . . 2.3 113.501 -161.128 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.796 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 1.1 tppp? 76.73 52.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.728 1.211 . . . . 2.81 112.503 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -145.91 131.25 18.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.02 -0.733 . . . . 1.18 109.02 170.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.78 -82.77 1.62 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.631 -0.795 . . . . 1.42 113.947 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -137.33 166.51 23.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.87 0.335 . . . . 3.45 111.295 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.7 p -134.65 -41.35 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.199 -0.455 . . . . 1.94 111.745 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.59 ' HD2' ' HG2' ' A' ' 156' ' ' PRO . 27.5 ttmt 71.15 0.56 3.47 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.873 0.869 . . . . 2.51 112.227 175.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.33 39.24 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.71 -0.757 . . . . 0.55 112.829 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.35 74.82 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 111.542 -0.623 . . . . 0.39 111.542 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.978 ' HH ' ' HA ' ' A' ' 100' ' ' ALA . 1.1 t80 -71.42 -56.6 5.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.837 0.351 . . . . 1.05 110.416 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.92 -43.51 91.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.05 -0.523 . . . . 2.46 110.755 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 160' ' ' VAL . 94.0 m -63.63 -49.28 73.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 1.06 111.11 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.877 ' HB3' HG13 ' A' ' 71' ' ' VAL . . . -60.36 -46.13 91.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 1.03 111.719 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.551 HG21 ' HB2' ' A' ' 101' ' ' GLU . 22.6 m -62.24 -47.75 82.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 1.09 111.284 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.2 p -64.0 -41.93 97.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.326 -0.397 . . . . 1.69 111.045 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 82.3 mt -58.21 -52.92 63.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 116.335 -0.393 . . . . 1.46 110.605 175.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.539 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 60.4 t80 -50.41 -56.58 10.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.387 -0.824 . . . . 0.92 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -70.9 -32.12 68.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 1.88 112.145 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.88 -47.08 11.44 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.788 -0.365 . . . . 2.27 111.538 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.722 ' CD1' HD11 ' A' ' 171' ' ' LEU . 63.1 m-85 -96.61 7.44 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.33 0.863 . . . . 0.9 113.33 -170.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -25.11 62.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.417 . . . . 2.62 109.916 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -59.93 -34.78 73.69 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.451 -0.795 . . . . 1.59 111.363 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.55 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -95.85 6.13 49.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.935 0.398 . . . . 1.9 110.897 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.651 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.64 67.22 1.53 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.63 -0.795 . . . . 1.32 111.433 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.593 ' CE1' HD12 ' A' ' 39' ' ' LEU . 80.1 t80 -131.52 136.44 47.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.394 -0.224 . . . . 0.4 110.394 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -128.91 146.73 50.87 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 110.066 -0.346 . . . . 1.11 110.066 178.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.877 HG13 ' HB3' ' A' ' 57' ' ' ALA . 38.4 t -114.08 113.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.801 -0.444 . . . . 1.06 109.801 169.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 27.0 mt -95.79 121.58 37.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.576 -0.898 . . . . 1.23 108.576 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.009 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.07 112.36 24.5 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.064 -0.654 . . . . 1.04 110.573 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.87 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.5 m-85 -96.22 108.16 39.77 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 109.041 -0.726 . . . . 0.45 109.041 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.114 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 32.3 Cg_exo -61.25 171.02 4.44 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.811 3.007 . . . . 0.73 112.114 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 113.875 1.065 . . . . 2.02 113.875 -176.607 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.532 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 97.1 m . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 121.058 0.456 . . . . 0.91 109.854 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.3 m -155.59 119.31 4.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.365 -0.834 . . . . 2.41 109.728 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.68 ' O ' HG22 ' A' ' 104' ' ' ILE . 63.2 mttp 68.84 -44.35 0.52 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 113.699 1.0 . . . . 3.5 113.699 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.796 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 65.67 -32.23 0.16 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.076 0.951 . . . . 1.74 111.077 -168.262 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.786 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 8.3 mmpt? 72.93 127.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.094 0.958 . . . . 3.53 111.892 171.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.978 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . . . -161.07 -173.18 3.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.423 0.63 . . . . 1.09 112.629 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.551 ' HB2' HG21 ' A' ' 58' ' ' THR . 48.6 mt-10 -93.33 9.1 37.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.006 -0.997 . . . . 2.19 111.66 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.781 ' HE1' ' HB1' ' A' ' 73' ' ' ALA . 32.1 p90 -128.71 173.73 5.28 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.575 -0.898 . . . . 0.39 108.575 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 24.0 Cg_exo -70.39 100.25 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.332 0 C-N-CA 123.156 2.57 . . . . 0.48 113.232 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.009 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.8 mp -94.96 133.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.606 -0.887 . . . . 1.13 108.606 173.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.87 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.9 OUTLIER -106.46 -160.02 0.72 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.439 -0.8 . . . . 2.08 111.979 -163.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.55 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.16 132.53 43.36 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.574 -0.739 . . . . 1.11 110.067 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.114 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.7 pttt -69.82 121.52 17.42 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.485 0.66 . . . . 2.12 109.347 172.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.445 HG13 HG12 ' A' ' 110' ' ' VAL . 11.7 pt -120.54 170.96 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.797 -1.092 . . . . 1.19 108.532 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.694 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.8 m120 -78.68 69.46 4.86 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.848 -0.614 . . . . 2.16 110.379 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.618 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -73.09 85.18 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 118.704 -1.198 . . . . 1.1 110.829 -177.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.529 ' OD1' ' HB2' ' A' ' 134' ' ' ALA . 38.1 t30 171.33 178.42 0.06 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.686 -1.227 . . . . 1.98 107.686 160.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.83 -146.86 26.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.82 -0.705 . . . . 0.78 114.687 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.22 -15.02 29.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -0.716 . . . . 1.98 110.672 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.24 -12.92 58.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.755 -0.657 . . . . 2.1 111.376 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -49.29 135.64 16.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.994 0.739 . . . . 1.17 112.994 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.468 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 52.8 t-80 -51.16 131.96 31.71 Favored Pre-proline 0 C--O 1.226 -0.137 0 CA-C-O 118.389 -0.815 . . . . 0.51 109.178 169.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.541 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -38.79 -43.67 2.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.346 2.697 . . . . 0.43 112.924 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.535 HD12 ' HE2' ' A' ' 122' ' ' MET . 30.9 tp -54.22 -47.1 72.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.664 -0.698 . . . . 1.69 112.09 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.451 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.2 m-85 -73.96 -29.04 61.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 119.469 -0.301 . . . . 1.84 111.276 177.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.39 -39.31 72.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.353 -0.939 . . . . 2.37 108.581 168.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 80.4 t80 -68.38 -45.06 73.74 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.181 -0.463 . . . . 1.09 110.635 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.535 ' HE2' HD12 ' A' ' 118' ' ' LEU . 67.1 mtt -65.2 -55.75 16.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.579 -0.282 . . . . 1.06 111.302 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.8 mtpt -57.07 -42.62 80.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 1.42 110.904 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.6 ptmm? -69.82 -37.11 76.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.302 -0.408 . . . . 2.63 110.922 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.482 HG21 ' HD2' ' A' ' 150' ' ' PRO . 92.4 m -64.73 -39.44 93.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 1.09 111.392 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 18.6 ttmm . . . . . 0 C--N 1.328 -0.347 0 N-CA-C 112.716 0.635 . . . . 2.26 112.716 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.529 ' HB2' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 113.709 1.003 . . . . 1.51 113.709 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.773 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.9 mt -93.23 103.14 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.388 -1.278 . . . . 1.5 110.199 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -106.83 0.6 24.14 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.708 0.633 . . . . 1.99 112.708 -167.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.773 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.62 171.86 19.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.157 0.799 . . . . 1.1 113.157 -163.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.59 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 16.3 m120 -46.3 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.096 -1.865 . . . . 1.8 114.103 167.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.759 ' HB3' ' CD2' ' A' ' 41' ' ' TYR . 62.1 m-85 -27.37 -59.06 0.1 Allowed 'General case' 0 C--O 1.204 -1.334 0 C-N-CA 125.158 1.383 . . . . 1.68 113.003 -167.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.92 HG23 ' HA ' ' A' ' 155' ' ' SER . 10.1 m 38.48 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.397 0.888 . . . . 1.05 113.397 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.669 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 12.1 p -85.51 152.93 22.8 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.055 -0.52 . . . . 1.38 111.358 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.404 ' HB2' HD11 ' A' ' 144' ' ' ILE . 12.8 m-85 -103.0 135.23 45.08 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.581 -1.266 . . . . 0.53 107.581 163.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.463 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 25.4 tp -81.12 105.45 12.34 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.625 -0.88 . . . . 1.2 108.625 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.764 HG21 HD13 ' A' ' 15' ' ' ILE . 19.2 mm -101.17 123.78 54.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.478 -0.783 . . . . 1.05 108.973 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -179.8 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 1.3 110.529 -175.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.491 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 52.8 mtt180 -62.61 -13.56 32.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.585 0.587 . . . . 4.43 112.585 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -108.32 -17.58 13.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.201 0.524 . . . . 1.18 110.278 -172.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.531 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.16 34.44 3.96 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.616 -0.72 . . . . 0.25 112.971 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -118.7 123.84 28.83 Favored Pre-proline 0 C--N 1.316 -0.85 0 O-C-N 122.635 -0.332 . . . . 1.32 110.276 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.482 ' HD2' HG21 ' A' ' 125' ' ' THR . 75.5 Cg_exo -53.94 112.98 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.34 2.693 . . . . 0.46 112.97 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.422 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.9 t -92.5 -30.32 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.768 -0.651 . . . . 1.09 110.475 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -155.61 164.07 39.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.36 -0.382 . . . . 1.22 111.027 -177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -127.24 102.15 6.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.495 -0.557 . . . . 2.25 109.495 173.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.588 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 36.8 m-85 -98.5 117.15 32.28 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.105 -0.702 . . . . 0.38 109.105 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.92 ' HA ' HG23 ' A' ' 140' ' ' THR . 53.7 p -69.99 178.22 1.1 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 118.77 0.714 . . . . 1.49 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.721 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.0 Cg_endo -68.24 -14.88 41.58 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.758 1.638 . . . . 0.74 111.122 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.26 13.76 43.58 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.56 112.047 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.55 132.21 40.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.921 0.391 . . . . 1.14 110.611 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.523 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 32.1 m -82.87 164.03 20.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.108 -0.496 . . . . 1.64 110.778 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.434 HG11 ' OE2' ' A' ' 164' ' ' GLU . 28.9 t -52.23 -54.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 1.14 111.791 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 161' ' ' LYS . 25.9 tptt -69.78 -26.16 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 3.84 110.729 -174.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 159' ' ' SER . 21.6 m-20 -67.11 -29.66 69.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 1.86 110.105 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.761 HG22 HD21 ' A' ' 39' ' ' LEU . 62.7 mt -82.7 -40.83 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.354 -0.384 . . . . 1.05 110.541 174.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 48.4 mt-10 -56.07 -35.52 67.07 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.777 0.658 . . . . 0.88 112.777 -176.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.03 -26.38 62.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.75 111.202 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.588 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 48.3 mmtm -105.09 -14.1 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.039 0.447 . . . . 2.11 110.335 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 68.1 tp -95.16 -41.52 9.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 1.06 112.13 -171.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.617 ' HA ' HD12 ' A' ' 171' ' ' LEU . 74.3 mt -51.56 -53.26 52.05 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 112.821 0.674 . . . . 1.14 112.821 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.92 -30.0 84.25 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.946 1.764 . . . . 0.74 112.553 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.45 HD11 HD13 ' A' ' 143' ' ' LEU . 58.7 mt -81.22 -32.51 33.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.612 -0.267 . . . . 1.35 111.147 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.931 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.0 mt -58.57 -50.81 72.43 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.115 -0.698 . . . . 1.16 109.115 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -50.3 -57.28 10.51 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.41 -1.268 . . . . 1.52 112.344 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.491 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 22.9 t . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 109.663 -0.495 . . . . 2.89 109.663 174.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 108.462 -0.94 . . . . 2.22 108.462 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 p -145.81 156.76 43.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.839 -1.073 . . . . 1.06 108.806 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.621 HD12 HG23 ' A' ' 144' ' ' ILE . 16.6 pt -56.32 -22.11 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 113.442 0.904 . . . . 1.08 113.442 -170.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.817 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 69.5 m-85 -83.17 1.04 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.028 0.381 . . . . 0.3 112.028 -172.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.89 -20.71 61.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.776 -0.824 . . . . 1.96 108.776 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 77.3 m-85 -95.38 156.91 16.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.964 -1.016 . . . . 0.4 110.571 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.6 tt0 -101.27 141.87 33.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.906 -0.588 . . . . 2.77 110.189 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.564 HG21 HD11 ' A' ' 30' ' ' LEU . 64.3 t -114.61 150.62 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.785 0.326 . . . . 1.39 110.914 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.805 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 85.2 mt -108.28 133.89 51.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.175 -0.466 . . . . 1.33 110.161 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.98 176.88 2.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.103 -0.953 . . . . 1.59 109.775 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB1' ' HD3' ' A' ' 97' ' ' LYS . . . -51.48 -29.99 18.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.126 0.488 . . . . 1.14 110.847 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 26' ' ' LYS . 22.5 t70 -96.78 1.34 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 2.22 111.649 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.805 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 34.2 m-70 74.94 12.51 3.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.058 0.543 . . . . 0.88 110.825 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 10.7 mmpt? -69.92 146.04 94.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 106.067 -1.827 . . . . 3.67 106.067 165.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.45 113.04 1.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 119.762 0.951 . . . . 1.19 110.985 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.919 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 65.6 t80 -79.28 128.23 33.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.98 110.47 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.646 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.4 t-20 -76.99 81.88 3.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.604 -0.725 . . . . 1.65 109.255 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.817 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.13 -33.8 70.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.42 0.629 . . . . 1.08 110.31 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.705 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.6 p -77.6 -0.86 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.179 -0.919 . . . . 1.15 112.611 -168.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.3 pt20 -82.79 -6.41 59.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.064 -0.717 . . . . 1.94 109.064 173.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.919 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 91.9 m-70 -93.67 -2.3 54.12 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.38 108.398 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -78.12 142.38 38.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.788 -1.096 . . . . 2.22 110.187 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.0 -19.09 25.65 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.36 110.508 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 70.1 m -141.84 139.13 17.84 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.585 -0.894 . . . . 1.58 108.585 177.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.692 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 24.5 Cg_exo -65.35 153.48 78.05 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.738 2.292 . . . . 0.86 112.289 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 70' ' ' THR . 2.3 pt? -154.63 159.25 40.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.302 -0.863 . . . . 1.63 109.766 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 163' ' ' ILE . 6.0 mp -113.69 157.77 21.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.967 -0.382 . . . . 1.69 109.967 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.639 HG12 ' HB2' ' A' ' 72' ' ' LEU . 93.3 mt -141.97 116.46 5.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.715 -0.675 . . . . 1.05 109.621 -176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.908 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.8 m-85 -103.16 123.58 46.96 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.134 -0.226 . . . . 0.93 111.038 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.588 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -79.31 92.89 5.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.354 -0.98 . . . . 1.97 108.354 168.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.6 p -112.95 131.57 64.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 112.95 0.722 . . . . 1.48 112.95 -163.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.61 114.22 1.6 Allowed 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.18 -1.044 . . . . 1.17 108.18 169.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.017 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.62 81.28 2.61 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.366 -1.288 . . . . 2.3 113.191 -162.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 42.8 tptt 72.66 50.6 0.17 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.003 -0.999 . . . . 2.81 109.872 177.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 p -163.16 143.76 9.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.7 -0.682 . . . . 1.18 111.233 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.79 -155.64 35.5 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.82 -0.627 . . . . 1.42 113.258 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -95.32 147.52 23.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.123 0.487 . . . . 3.45 110.612 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 p -88.69 -27.08 21.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.925 -0.579 . . . . 1.94 112.208 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.886 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.2 mtpp 65.8 -4.07 0.66 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.369 0.668 . . . . 2.51 112.069 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.67 0.01 29.06 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.116 -0.564 . . . . 0.55 112.429 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.02 -34.84 77.29 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.373 -0.441 . . . . 0.39 112.294 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.667 ' HH ' ' CB ' ' A' ' 100' ' ' ALA . 1.0 OUTLIER -73.03 -47.57 43.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.722 0.296 . . . . 1.05 110.224 -176.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.685 -0.487 . . . . 2.46 109.685 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.421 ' CG2' HD12 ' A' ' 163' ' ' ILE . 98.8 m -64.03 -48.31 76.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.422 -0.808 . . . . 1.06 110.633 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.905 ' HB1' HG13 ' A' ' 71' ' ' VAL . . . -62.44 -50.54 71.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.362 -0.381 . . . . 1.03 111.606 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.6 m -54.79 -48.91 72.11 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.094 -0.503 . . . . 1.09 111.083 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.5 m -63.69 -45.72 88.73 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.205 -0.452 . . . . 1.69 111.336 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 64.5 mt -60.33 -52.09 66.74 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 111.842 0.312 . . . . 1.46 111.842 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.773 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 59.5 t80 -52.1 -46.68 65.35 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.92 109.422 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -73.31 -37.09 66.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.255 0.55 . . . . 1.88 111.081 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -73.49 -33.33 64.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.343 -0.844 . . . . 2.27 111.74 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.946 ' HB3' HE21 ' A' ' 67' ' ' GLN . 72.3 m-85 -121.88 14.15 10.74 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 114.471 1.286 . . . . 0.9 114.471 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.773 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 21.5 mtmm -57.52 -26.52 61.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.899 -0.72 . . . . 2.62 110.385 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 m -57.16 -41.23 78.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.631 . . . . 1.59 111.708 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.946 HE21 ' HB3' ' A' ' 64' ' ' TYR . 4.6 pp0? -91.89 -4.33 54.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.573 -0.451 . . . . 1.9 111.038 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.23 20.0 7.3 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.823 -0.703 . . . . 1.32 114.069 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.883 ' HB2' ' NE2' ' A' ' 67' ' ' GLN . 75.2 t80 -77.28 137.33 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.037 0.418 . . . . 0.4 111.306 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.585 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 2.4 t -132.01 142.31 49.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.839 -0.801 . . . . 1.11 108.839 173.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.905 HG13 ' HB1' ' A' ' 57' ' ' ALA . 40.8 t -105.56 105.87 19.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.933 -0.765 . . . . 1.06 108.933 169.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.639 ' HB2' HG12 ' A' ' 40' ' ' ILE . 25.6 mt -89.53 120.92 31.26 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.174 -1.047 . . . . 1.23 108.174 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -108.6 112.23 24.47 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.073 -0.651 . . . . 1.04 110.216 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.789 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -95.55 108.05 37.15 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 108.605 -0.887 . . . . 0.45 108.605 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 1.017 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.9 Cg_exo -59.82 168.92 5.04 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.35 2.7 . . . . 0.73 111.397 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 122.625 1.202 . . . . 2.02 113.847 -175.117 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.575 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 60.6 m . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 112.071 0.397 . . . . 0.91 112.071 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 t -149.42 119.65 7.29 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.892 -0.594 . . . . 2.41 110.27 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.524 ' HD3' ' HB1' ' A' ' 23' ' ' ALA . 25.7 pttt 28.44 89.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.764 1.226 . . . . 3.5 114.297 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.731 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -60.79 131.4 50.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.853 -1.165 . . . . 1.74 107.853 170.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 99' ' ' LYS . 11.2 mptt -91.35 147.62 22.91 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.394 -0.523 . . . . 3.53 111.213 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.667 ' CB ' ' HH ' ' A' ' 54' ' ' TYR . . . -158.54 -166.76 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.847 0.717 . . . . 1.09 111.33 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -81.62 -34.1 31.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.373 0.606 . . . . 2.19 110.507 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.764 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 29.4 p90 -84.46 166.74 31.07 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 115.287 -0.87 . . . . 0.39 109.774 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 23.5 Cg_exo -72.1 103.12 1.44 Allowed 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.018 3.145 . . . . 0.48 113.571 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.997 HG13 ' HB2' ' A' ' 73' ' ' ALA . 3.6 mp -94.66 134.25 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.884 -0.784 . . . . 1.13 108.884 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.789 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -109.01 -154.22 0.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 2.08 112.522 -163.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.9 135.55 41.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.218 -0.901 . . . . 1.11 110.23 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.008 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.5 pttp -73.36 125.1 27.07 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.713 0.768 . . . . 2.12 108.997 171.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.487 HG13 HG13 ' A' ' 110' ' ' VAL . 12.1 pt -122.17 174.36 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 106.914 -1.513 . . . . 1.19 106.914 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.835 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 6.7 m120 -83.86 81.17 8.89 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.035 -0.666 . . . . 2.16 109.868 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -79.29 84.12 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 118.468 -1.293 . . . . 1.1 109.085 177.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 56.5 t30 170.35 179.5 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.418 -1.327 . . . . 1.98 107.418 166.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.81 -152.07 23.9 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 115.615 1.006 . . . . 0.78 115.615 160.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.11 -20.9 22.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.148 -1.026 . . . . 1.98 110.695 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -92.94 6.58 47.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.538 -0.755 . . . . 2.1 110.564 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.835 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.09 141.98 38.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.885 -1.052 . . . . 1.17 113.299 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.845 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 35.6 t-80 -54.25 135.25 60.23 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 115.477 -0.783 . . . . 0.51 109.087 167.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.16 -33.29 73.85 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.416 2.744 . . . . 0.43 112.85 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.845 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 1.7 tm? -62.32 -43.21 99.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 1.69 109.941 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.56 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.0 m-85 -75.59 -30.48 59.61 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.449 -0.341 . . . . 1.84 110.851 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.53 -41.15 76.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.89 -0.724 . . . . 2.37 109.206 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 69.7 t80 -65.81 -45.7 81.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.94 0.4 . . . . 1.09 110.442 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.561 ' HE1' ' CD1' ' A' ' 40' ' ' ILE . 67.3 mtt -65.38 -53.29 45.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.144 -0.48 . . . . 1.06 111.806 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.4 mtpt -59.19 -39.21 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 1.42 110.644 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.3 ptmt -74.62 -36.84 62.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 2.63 111.031 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 150' ' ' PRO . 96.0 m -70.55 -43.24 69.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.4 -0.363 . . . . 1.09 111.916 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.9 tmtt? . . . . . 0 C--N 1.324 -0.531 0 C-N-CA 120.422 -0.511 . . . . 2.26 111.484 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.48 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 112.145 0.424 . . . . 1.51 112.145 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.841 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 38.5 mt -103.75 88.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.638 -0.71 . . . . 1.5 110.261 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -117.15 28.15 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.644 0.609 . . . . 1.99 112.644 -173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.841 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.14 169.49 23.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.05 0.452 . . . . 1.1 112.075 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -51.28 -155.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.869 1.668 . . . . 1.8 113.471 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.908 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 53.1 m-85 -24.86 -57.68 0.05 Allowed 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 125.451 1.5 . . . . 1.68 114.212 -165.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.794 HG23 ' HA ' ' A' ' 155' ' ' SER . 23.1 m 38.08 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.275 0.842 . . . . 1.05 113.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 11.9 p -84.34 152.18 24.26 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.094 -0.642 . . . . 1.38 111.532 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.9 m-85 -103.5 134.88 46.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.023 -1.102 . . . . 0.53 108.023 165.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.739 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.2 tp -82.0 104.7 12.55 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.063 -0.717 . . . . 1.2 109.063 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.621 HG23 HD12 ' A' ' 15' ' ' ILE . 18.4 mm -102.8 124.12 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.602 -0.726 . . . . 1.05 109.26 -175.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -78.7 -175.1 4.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.864 -0.334 . . . . 1.3 111.374 -175.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.648 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.8 mtp180 -57.11 -26.01 59.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.831 0.348 . . . . 4.43 111.912 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -108.5 -12.49 15.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.119 0.485 . . . . 1.18 110.829 -168.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.572 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.22 44.65 2.33 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.393 -0.908 . . . . 0.25 113.512 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.445 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.9 t -119.16 127.87 26.25 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.301 -0.629 . . . . 1.32 109.301 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.499 ' HD2' HG22 ' A' ' 125' ' ' THR . 11.5 Cg_exo -68.07 111.68 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.499 2.133 . . . . 0.46 111.383 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.642 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.8 t -94.96 -25.97 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.32 -0.4 . . . . 1.09 110.844 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.511 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 59.2 mm-40 -151.08 164.16 37.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.869 0.366 . . . . 1.22 111.032 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.415 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 23.3 ttm180 -129.98 97.02 4.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.702 -0.851 . . . . 2.25 108.702 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.739 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 49.9 m-85 -88.89 108.66 19.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.461 -0.57 . . . . 0.38 109.461 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.794 ' HA ' HG23 ' A' ' 140' ' ' THR . 88.0 p -63.35 167.3 6.92 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.357 -0.609 . . . . 1.49 109.357 176.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.886 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 9.0 Cg_exo -67.61 -8.99 23.92 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.799 2.333 . . . . 0.74 112.197 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.93 -1.46 89.78 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 114.72 -1.127 . . . . 0.56 111.897 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.58 138.06 31.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.955 0.407 . . . . 1.14 110.43 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.57 172.44 8.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.191 -0.459 . . . . 1.64 110.536 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.408 ' HA ' HG22 ' A' ' 56' ' ' THR . 40.9 t -52.07 -44.88 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 1.14 111.07 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 161' ' ' LYS . 33.1 ttpt -66.41 -38.33 87.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.351 -0.841 . . . . 3.84 110.846 -175.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.64 -32.35 73.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.86 109.962 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.558 HG23 HD21 ' A' ' 39' ' ' LEU . 59.1 mt -82.8 -43.18 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.57 -0.741 . . . . 1.05 111.184 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 33.2 mt-10 -55.54 -36.92 67.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.991 0.737 . . . . 0.88 112.991 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.58 -26.16 65.18 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.761 -0.376 . . . . 0.75 111.637 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 71.5 mmtt -102.06 -17.72 15.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.221 0.534 . . . . 2.11 110.155 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.7 tp -87.64 -49.28 7.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.683 . . . . 1.06 111.946 -172.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 70.1 mt -53.04 -48.09 93.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 112.596 0.591 . . . . 1.14 112.596 -174.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.0 Cg_endo -53.62 -42.65 64.27 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.116 1.877 . . . . 0.74 112.403 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.62 -44.23 82.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.526 -0.306 . . . . 1.35 110.996 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.787 HD23 ' NE2' ' A' ' 67' ' ' GLN . 46.5 mt -55.73 -51.46 67.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.448 0.642 . . . . 1.16 109.671 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.85 -63.05 4.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 114.16 -1.382 . . . . 1.52 113.062 168.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 117.049 0.424 . . . . 2.89 111.086 -179.735 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.234 0.243 0 CA-C-O 121.167 0.508 . . . . 2.22 111.232 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -161.12 -177.86 6.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.574 -0.739 . . . . 1.06 109.301 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.638 HD13 HG23 ' A' ' 144' ' ' ILE . 20.8 pt -60.6 -27.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.741 0.305 . . . . 1.08 111.671 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.8 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 42.4 m-85 -77.73 6.49 7.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.3 111.652 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.89 -9.02 59.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.659 -0.867 . . . . 1.96 108.659 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 80.0 m-85 -116.61 149.8 39.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.824 -1.08 . . . . 0.4 109.811 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -99.98 146.47 26.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.835 0.35 . . . . 2.77 111.01 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -114.13 145.83 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.091 -0.504 . . . . 1.39 110.942 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.992 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 74.9 mt -99.31 134.65 41.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.088 -0.708 . . . . 1.33 109.088 170.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 23' ' ' ALA . 14.1 t70 -70.06 -174.9 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.872 -0.788 . . . . 1.59 108.872 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 1.111 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . -54.33 -29.98 49.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.218 0.532 . . . . 1.14 111.381 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.99 11.65 35.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.012 -0.54 . . . . 2.22 111.76 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.992 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 22.3 m-70 69.46 12.3 8.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.232 0.613 . . . . 0.88 110.593 176.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.78 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.2 mmpt? -75.83 145.85 78.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 106.563 -1.643 . . . . 3.67 106.563 165.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.92 114.52 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.267 1.311 . . . . 1.19 112.314 -173.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.79 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 69.0 t80 -85.83 115.72 23.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.355 -0.838 . . . . 0.98 109.602 172.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -71.39 96.07 1.42 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.654 -0.869 . . . . 1.65 108.654 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.745 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -75.61 -29.64 59.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.722 0.772 . . . . 1.08 109.562 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.8 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 11.7 p -77.5 -0.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.619 -1.173 . . . . 1.15 113.207 -166.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -81.7 -4.57 56.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.399 -0.593 . . . . 1.94 109.399 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.79 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 87.0 m-70 -93.98 4.67 53.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.333 -0.988 . . . . 0.38 108.333 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.549 ' HE3' HG23 ' A' ' 31' ' ' VAL . 36.4 ttmt -82.28 130.48 35.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.99 -1.005 . . . . 2.22 109.138 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.61 58.7 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.158 -1.177 . . . . 0.36 110.158 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 14.3 m -138.23 139.31 25.08 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.587 -0.894 . . . . 1.58 108.587 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.085 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 40.5 Cg_endo -73.94 150.7 44.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.572 1.515 . . . . 0.86 110.41 174.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.601 ' CB ' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -154.4 153.5 31.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.307 0.575 . . . . 1.63 111.62 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.789 HD23 HG23 ' A' ' 163' ' ' ILE . 6.4 mp -108.11 148.82 29.29 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.638 -0.875 . . . . 1.69 108.638 170.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.455 HD12 ' HE2' ' A' ' 122' ' ' MET . 84.5 mt -132.07 119.51 40.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.573 -0.529 . . . . 1.05 109.573 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 26.5 m-85 -101.5 130.4 47.75 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.93 111.399 -172.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.739 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -90.58 93.31 9.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.503 -1.295 . . . . 1.97 107.503 174.012 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.586 HG13 ' HA ' ' A' ' 139' ' ' PHE . 3.5 m -109.01 143.79 18.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 1.48 112.468 -163.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.88 17.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.653 -1.61 . . . . 1.17 106.653 165.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.618 ' OG ' ' HB3' ' A' ' 95' ' ' CYS . 3.2 p -74.02 86.33 1.82 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.844 -0.616 . . . . 2.3 112.294 -165.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 66.18 44.69 2.5 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.208 -0.905 . . . . 2.81 110.385 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.9 p -164.0 133.62 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.567 -0.742 . . . . 1.18 110.81 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.15 -149.04 18.29 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.505 -0.855 . . . . 1.42 113.869 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -96.54 111.3 23.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 122.694 0.398 . . . . 3.45 111.275 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.9 p -66.6 -34.52 78.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.703 0.26 . . . . 1.94 111.703 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 31.1 mtpp 66.32 -3.32 0.84 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.443 0.697 . . . . 2.51 112.536 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 109.38 3.55 30.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.886 -0.673 . . . . 0.55 112.464 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 139' ' ' PHE . . . -72.38 -39.46 57.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.225 -0.512 . . . . 0.39 111.828 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.717 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.5 t80 -69.18 -51.6 36.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.172 -0.307 . . . . 1.05 110.172 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.441 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 1.6 mp0 -51.78 -52.01 52.08 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.37 0.605 . . . . 2.46 110.707 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -64.41 -46.72 82.02 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.899 -1.046 . . . . 1.06 110.88 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.704 ' HB3' HG13 ' A' ' 71' ' ' VAL . . . -58.87 -48.14 82.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.137 -0.483 . . . . 1.03 111.262 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -58.48 -50.27 74.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.703 -0.681 . . . . 1.09 110.419 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.7 m -63.0 -43.28 99.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.263 -0.88 . . . . 1.69 111.597 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.51 HD13 HD22 ' A' ' 39' ' ' LEU . 76.2 mt -61.34 -50.27 73.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.372 0.138 . . . . 1.46 111.372 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.723 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.1 t80 -53.67 -49.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.92 109.83 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -73.02 -31.24 64.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.613 -0.721 . . . . 1.88 111.869 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.34 -45.59 19.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.225 -0.443 . . . . 2.27 111.267 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.634 ' CD1' HD11 ' A' ' 171' ' ' LEU . 69.2 m-85 -104.19 8.03 36.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.592 0.96 . . . . 0.9 113.592 -170.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -25.0 65.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.02 0.438 . . . . 2.62 110.144 170.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.0 t -59.26 -40.14 85.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.497 -0.774 . . . . 1.59 110.727 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.8 14.38 23.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 1.9 111.247 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.632 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.21 59.4 2.74 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 115.916 -0.583 . . . . 1.32 112.651 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CZ ' HD11 ' A' ' 39' ' ' LEU . 67.3 t80 -123.88 139.27 54.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.492 0.187 . . . . 0.4 111.121 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.601 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -127.71 144.49 51.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 120.82 0.343 . . . . 1.11 110.255 177.54 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.723 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 27.2 t -114.05 119.47 61.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 1.06 109.95 169.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.706 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 19.8 mt -103.36 121.57 43.05 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.188 -0.671 . . . . 1.23 109.188 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.972 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -108.02 132.25 53.73 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.364 -0.534 . . . . 1.04 110.431 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.2 m-85 -112.19 108.44 55.03 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-O 121.231 0.538 . . . . 0.45 110.711 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 64.1 Cg_exo -47.85 139.53 19.34 Favored 'Trans proline' 0 CA--C 1.514 -0.476 0 C-N-CA 124.781 3.654 . . . . 0.73 112.136 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.44 -0.936 0 C-N-CA 118.633 -1.227 . . . . 2.02 114.268 -178.93 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.618 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 33.8 m . . . . . 0 N--CA 1.44 -0.953 0 CA-C-O 122.116 0.96 . . . . 0.91 111.26 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.85 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 12.1 t -139.61 156.94 46.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.899 -1.5 . . . . 2.41 107.568 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 1.111 ' HD2' ' HB2' ' A' ' 23' ' ' ALA . 5.7 pttt -39.08 101.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.835 0.71 . . . . 3.5 111.299 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 5.5 p90 -61.95 135.72 57.67 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.133 -1.432 . . . . 1.74 107.133 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -94.12 143.75 26.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.694 -0.802 . . . . 3.53 110.467 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.467 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . . . -145.99 -162.03 1.43 Allowed 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.055 0.847 . . . . 1.09 111.428 -174.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -95.55 -5.37 42.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.625 . . . . 2.19 110.042 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.777 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 39.1 p90 -118.79 170.72 6.12 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.39 108.912 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 23.0 Cg_exo -71.19 125.83 11.78 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 123.599 2.866 . . . . 0.48 113.292 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.972 HG13 ' HB2' ' A' ' 73' ' ' ALA . 3.1 mp -120.9 140.64 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.338 -0.616 . . . . 1.13 109.338 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.706 ' HE2' ' HB3' ' A' ' 72' ' ' LEU . 10.9 mmt -111.1 -151.28 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 2.08 113.717 -163.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -73.73 163.71 27.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.247 -0.888 . . . . 1.11 111.528 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.85 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 82.4 mttt -87.74 112.38 22.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.853 -0.425 . . . . 2.12 109.853 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.7 pt -122.17 164.08 19.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.216 -0.661 . . . . 1.19 109.216 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.59 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 55.4 t-20 -96.43 80.33 3.15 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.692 -0.855 . . . . 2.16 108.692 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 42' ' ' ASN . 1.0 OUTLIER -65.88 91.47 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.132 -0.627 . . . . 1.1 110.298 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' HA ' HD13 ' A' ' 135' ' ' ILE . 0.5 OUTLIER 174.25 172.33 0.2 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.055 -0.35 . . . . 1.98 110.055 172.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 51.15 -133.69 32.95 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 123.944 0.777 . . . . 0.78 114.917 160.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -105.57 3.95 29.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.218 -0.991 . . . . 1.98 109.978 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -106.54 -5.56 18.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.959 -1.018 . . . . 2.1 110.958 -169.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -63.15 147.23 51.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.971 -0.559 . . . . 1.17 112.354 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.84 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 44.7 t-80 -50.36 136.06 23.6 Favored Pre-proline 0 C--O 1.225 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.51 109.412 168.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -49.37 -32.25 25.6 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.693 2.928 . . . . 0.43 113.438 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.84 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 22.4 tp -66.33 -39.5 89.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 1.69 110.901 175.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.74 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 4.5 m-85 -73.98 -31.13 62.85 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 116.433 -0.349 . . . . 1.84 110.283 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -56.22 -42.68 77.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.09 -0.707 . . . . 2.37 109.09 168.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.684 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 90.1 t80 -65.26 -52.6 53.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.979 0.419 . . . . 1.09 111.557 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.48 ' HE3' HD11 ' A' ' 118' ' ' LEU . 55.6 mtt -64.41 -49.17 72.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.558 0.694 . . . . 1.06 110.871 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.74 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 4.6 tmtt? -70.74 -26.62 63.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.805 -1.089 . . . . 1.42 112.075 -174.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.8 ptmt -75.75 -27.59 58.16 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.85 0.357 . . . . 2.63 110.228 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.419 HG21 ' HD2' ' A' ' 150' ' ' PRO . 23.5 m -68.32 -60.43 2.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.703 0.631 . . . . 1.09 112.703 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 151' ' ' VAL . 25.9 tttp . . . . . 0 C--N 1.326 -0.453 0 C-N-CA 119.173 -1.011 . . . . 2.26 113.629 -172.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.441 ' C ' HG13 ' A' ' 135' ' ' ILE . . . . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 120.988 0.423 . . . . 1.51 109.961 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.98 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 1.1 mt 65.84 138.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.708 -1.133 . . . . 1.5 110.151 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.709 ' HZ1' ' HB3' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -178.6 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.582 0.706 . . . . 1.99 110.851 -175.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.98 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.18 170.08 9.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.054 -0.976 . . . . 1.1 111.663 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.572 ' HB3' ' HD1' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -52.56 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.839 1.422 . . . . 1.8 114.839 175.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.601 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 16.3 m-85 -28.42 -34.65 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 127.089 2.156 . . . . 1.68 115.904 -167.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 1.126 HG21 ' HA ' ' A' ' 155' ' ' SER . 8.6 m 13.46 105.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.027 1.491 . . . . 1.05 115.027 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.48 158.85 20.88 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.746 0.784 . . . . 1.38 111.982 -174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.599 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 16.3 m-85 -102.84 169.32 8.67 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.245 -1.391 . . . . 0.53 107.245 162.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.609 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 46.3 tp -116.5 105.94 13.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.753 -0.832 . . . . 1.2 108.753 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.638 HG23 HD13 ' A' ' 15' ' ' ILE . 13.4 mm -108.36 122.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.486 -0.561 . . . . 1.05 109.486 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -178.92 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.893 -0.323 . . . . 1.3 110.549 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.681 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -67.84 -6.6 22.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.184 -0.462 . . . . 4.43 112.164 -174.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.78 -22.29 12.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.491 0.662 . . . . 1.18 109.376 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.492 ' O ' HG22 ' A' ' 15' ' ' ILE . . . 104.42 34.2 3.69 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.877 -1.056 . . . . 0.25 112.67 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 68.5 t -110.55 129.35 24.04 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.93 0.365 . . . . 1.32 110.569 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 149' ' ' VAL . 22.9 Cg_exo -65.21 107.99 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.149 2.566 . . . . 0.46 112.063 176.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.462 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 t -94.81 -12.1 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.136 -0.484 . . . . 1.09 110.893 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.53 167.41 2.24 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.135 0.493 . . . . 1.22 111.815 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.798 ' NH2' HG12 ' A' ' 135' ' ' ILE . 15.2 ttm-85 -134.17 116.4 15.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.06 -0.973 . . . . 2.25 109.788 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.635 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 12.4 m-85 -104.09 134.15 47.82 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 108.393 -0.966 . . . . 0.38 108.393 176.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 1.126 ' HA ' HG21 ' A' ' 140' ' ' THR . 52.7 p -76.33 176.36 3.41 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.114 0.87 . . . . 1.49 109.764 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.825 ' HG3' ' H ' ' A' ' 140' ' ' THR . 7.0 Cg_exo -69.11 -16.61 40.42 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.366 1.377 . . . . 0.74 110.749 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.57 89.4 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.6 -1.182 . . . . 0.56 111.89 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.92 133.48 36.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.564 -0.532 . . . . 1.14 109.564 176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.5 m -78.59 160.02 27.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.855 -0.611 . . . . 1.64 110.657 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 58.1 t -50.04 -50.71 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.729 0.3 . . . . 1.14 110.486 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.745 -0.661 . . . . 3.84 111.779 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -65.81 -31.48 72.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.413 0.625 . . . . 1.86 109.733 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.789 HG23 HD23 ' A' ' 39' ' ' LEU . 54.0 mt -81.38 -41.7 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.527 -0.76 . . . . 1.05 110.189 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 45.0 mt-10 -55.76 -40.81 73.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.88 112.209 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -58.33 -27.62 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.75 111.6 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.535 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.6 mttp -104.28 -12.98 16.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 2.11 110.645 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.2 tp -93.38 -41.99 9.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 1.06 111.534 -174.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.652 ' HA ' HD12 ' A' ' 171' ' ' LEU . 79.5 mt -53.28 -48.97 90.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.489 0.551 . . . . 1.14 112.489 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 40.2 Cg_exo -59.05 -22.72 65.28 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.149 1.899 . . . . 0.74 113.04 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.52 -39.1 14.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.543 0.211 . . . . 1.35 110.734 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 1.085 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.4 mt -56.95 -53.47 57.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 1.16 109.271 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.49 51.75 2.23 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.565 -1.198 . . . . 1.52 113.741 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 123.556 0.742 . . . . 2.89 112.625 175.15 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.091 0.472 . . . . 2.22 110.097 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.0 p -125.17 170.1 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.186 -0.672 . . . . 1.06 109.186 175.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.737 HD12 HG22 ' A' ' 144' ' ' ILE . 32.1 pt -59.91 -27.48 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.021 0.438 . . . . 1.08 111.34 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.892 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 55.4 m-85 -76.56 -1.75 29.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.508 0.559 . . . . 0.3 112.508 -171.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 -17.16 58.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.477 0.656 . . . . 1.96 109.578 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 87.1 m-85 -98.59 175.3 6.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 0.4 110.764 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -110.44 133.83 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 2.77 110.272 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.632 HG12 ' CE2' ' A' ' 74' ' ' PHE . 77.5 t -115.22 149.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.933 0.397 . . . . 1.39 110.927 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.908 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 2.3 mp -114.98 141.1 48.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.927 -0.579 . . . . 1.33 109.87 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.96 175.57 1.16 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.516 -0.765 . . . . 1.59 109.327 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.71 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -47.54 -39.74 17.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.912 0.387 . . . . 1.14 111.685 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.05 8.53 39.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.18 -0.464 . . . . 2.22 112.218 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.908 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 23.0 m-70 72.21 26.08 2.8 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.501 0.667 . . . . 0.88 110.37 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -84.87 132.62 45.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 105.791 -1.929 . . . . 3.67 105.791 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.27 112.63 0.84 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.106 1.204 . . . . 1.19 112.588 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.531 ' HH ' ' HB3' ' A' ' 103' ' ' PRO . 55.7 t80 -86.95 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.014 -0.993 . . . . 0.98 110.515 174.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.572 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.8 t30 -78.32 90.19 4.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.308 -0.627 . . . . 1.65 109.308 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.892 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -65.31 -28.52 69.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 1.08 111.339 -174.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.846 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.0 p -76.46 -1.04 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 113.064 0.764 . . . . 1.15 113.064 -166.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 4.1 pt20 -78.85 -5.05 52.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.304 0.573 . . . . 1.94 109.68 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -99.16 18.3 17.79 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.025 -1.102 . . . . 0.38 108.025 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -96.89 146.35 25.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.33 -1.305 . . . . 2.22 109.464 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.42 -10.62 67.13 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.072 -1.211 . . . . 0.36 110.072 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.592 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 51.1 m -141.75 146.98 43.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.359 -0.978 . . . . 1.58 108.359 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.003 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 72.3 Cg_endo -75.22 159.77 40.2 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.918 1.745 . . . . 0.86 111.404 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.543 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.7 pt? -154.5 151.58 29.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.269 0.557 . . . . 1.63 111.071 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.541 HD23 HG22 ' A' ' 163' ' ' ILE . 6.0 mp -108.07 155.64 20.15 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.618 -0.882 . . . . 1.69 108.618 170.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.606 HG21 ' HH ' ' A' ' 119' ' ' TYR . 86.9 mt -141.03 119.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.415 -0.587 . . . . 1.05 109.415 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 1.003 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 21.0 m-85 -105.77 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.273 0.358 . . . . 0.93 111.435 -172.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.532 HD22 ' HE1' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -77.91 92.81 4.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.575 -1.269 . . . . 1.97 107.575 169.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.407 HG11 ' CE2' ' A' ' 98' ' ' PHE . 2.8 p -113.21 127.54 70.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.425 -0.91 . . . . 1.48 112.634 -167.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.681 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -65.98 101.94 0.74 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.102 -1.444 . . . . 1.17 107.102 168.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.834 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 26.6 t -67.54 92.68 0.32 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.124 -0.944 . . . . 2.3 112.056 -163.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 6.1 mmtm 73.88 31.78 1.17 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.331 0.652 . . . . 2.81 110.866 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -137.24 140.53 41.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 1.18 110.612 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.3 -149.53 29.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.951 -0.642 . . . . 1.42 113.643 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.55 128.03 49.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.055 0.455 . . . . 3.45 111.43 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.622 HG23 ' HE1' ' A' ' 139' ' ' PHE . 3.7 p -71.9 -33.05 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 1.94 111.872 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 28.7 mtpp 64.88 3.96 2.26 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.71 0.633 . . . . 2.51 112.71 173.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.82 45.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.55 112.078 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.04 -31.09 62.22 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.955 -0.458 . . . . 0.39 111.955 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.732 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -76.51 -52.82 9.04 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 120.5 0.191 . . . . 1.05 110.697 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.09 -39.45 92.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.891 0.377 . . . . 2.46 110.677 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 160' ' ' VAL . 95.9 m -66.55 -46.22 76.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 1.06 110.846 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.656 ' HB3' HG13 ' A' ' 71' ' ' VAL . . . -60.63 -46.77 89.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 1.03 110.828 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 62.3 m -58.52 -50.38 73.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.455 -0.793 . . . . 1.09 111.133 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -64.43 -44.31 91.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.303 -0.408 . . . . 1.69 111.578 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 86.4 mt -57.92 -52.4 65.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.68 0.252 . . . . 1.46 111.68 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.754 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.9 t80 -54.42 -49.37 70.11 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 121.202 0.525 . . . . 0.92 109.88 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.02 -34.99 66.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 1.88 111.786 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.12 -47.54 20.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.381 -0.372 . . . . 2.27 111.29 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CD1' HD11 ' A' ' 171' ' ' LEU . 60.8 m-85 -99.34 6.28 46.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.601 0.963 . . . . 0.9 113.601 -171.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -59.41 -28.78 67.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 2.62 110.958 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -63.18 -35.36 80.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.59 111.272 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -94.56 2.93 55.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.971 0.415 . . . . 1.9 111.162 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 90.01 74.1 1.28 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.794 -0.717 . . . . 1.32 112.176 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 74.0 t80 -138.15 140.94 40.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.559 0.219 . . . . 0.4 110.526 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.08 142.55 50.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 120.56 0.219 . . . . 1.11 110.433 178.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.754 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 42.2 t -110.84 115.02 48.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.614 -0.513 . . . . 1.06 109.614 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.608 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 25.1 mt -98.46 121.49 40.46 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.83 -0.804 . . . . 1.23 108.83 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.954 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -108.46 115.95 31.06 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.567 -0.453 . . . . 1.04 110.191 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.75 ' HD2' HD11 ' A' ' 108' ' ' ILE . 3.3 m-85 -97.65 107.59 40.52 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.949 -0.569 . . . . 0.45 109.558 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.834 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 71.2 Cg_exo -51.59 160.04 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.685 2.923 . . . . 0.73 112.486 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.681 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 48.3 m . . . . . 0 N--CA 1.428 -1.554 0 CA-C-N 115.357 -0.838 . . . . 2.02 111.483 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 45' ' ' SER . 31.9 m . . . . . 0 N--CA 1.437 -1.102 0 CA-C-O 121.122 0.487 . . . . 0.91 112.046 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.592 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 3.6 t -152.88 117.55 5.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 2.41 110.836 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.549 ' O ' HG23 ' A' ' 104' ' ' ILE . 79.9 mttt 65.27 -46.37 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.208 1.558 . . . . 3.5 115.208 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.732 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 62.33 -32.72 0.1 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 1.74 110.834 -171.603 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 97' ' ' LYS . 18.7 mtmt 65.35 108.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.211 1.004 . . . . 3.53 113.272 165.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -136.02 -171.84 2.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.749 -1.114 . . . . 1.09 111.487 -174.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.88 26.93 4.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.045 -0.525 . . . . 2.19 110.771 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.756 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 36.0 p90 -142.97 166.06 22.63 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.871 -1.159 . . . . 0.39 107.871 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 39.8 Cg_exo -63.09 122.8 11.16 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.342 2.695 . . . . 0.48 113.297 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.954 HG13 ' HB1' ' A' ' 73' ' ' ALA . 2.4 mp -117.37 142.8 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.513 -0.551 . . . . 1.13 109.513 174.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.71 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 10.3 mmt -116.54 -153.8 0.54 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.288 0.847 . . . . 2.08 113.288 -166.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.72 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . . . -70.47 149.65 46.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.885 -1.052 . . . . 1.11 111.321 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 75' ' ' PRO . 29.3 mttt -82.29 109.77 16.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.026 -1.101 . . . . 2.12 108.026 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.75 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -122.14 162.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 108.736 -0.838 . . . . 1.19 108.736 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 15.9 m120 -78.85 70.02 5.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.872 -0.604 . . . . 2.16 110.95 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -69.68 87.83 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 C-N-CA 118.883 -1.127 . . . . 1.1 108.703 175.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.49 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER 170.97 179.95 0.05 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.845 -1.168 . . . . 1.98 107.845 175.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.35 -143.03 9.88 Favored Glycine 0 CA--C 1.507 -0.412 0 N-CA-C 115.644 1.018 . . . . 0.78 115.644 153.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -105.41 -10.19 17.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.342 -0.929 . . . . 1.98 110.984 -173.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -95.3 -2.15 49.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 2.1 111.949 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -42.65 134.5 3.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.507 0.928 . . . . 1.17 113.507 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.815 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 47.6 t-80 -51.29 140.14 24.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.568 -0.742 . . . . 0.51 110.655 171.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 4.0 Cg_endo -47.69 -46.02 22.22 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.918 2.412 . . . . 0.43 112.813 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.815 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.68 -40.76 69.43 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.987 -0.552 . . . . 1.69 110.641 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.606 ' HH ' HG21 ' A' ' 40' ' ' ILE . 10.1 m-85 -76.7 -28.65 55.95 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.337 -0.392 . . . . 1.84 111.86 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 53.2 mt-10 -55.48 -42.55 74.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.715 -0.846 . . . . 2.37 108.715 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 71.7 t80 -65.03 -49.69 69.17 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 123.585 0.553 . . . . 1.09 110.627 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.494 ' HE1' HD12 ' A' ' 118' ' ' LEU . 64.5 mtt -62.46 -53.06 60.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.743 0.306 . . . . 1.06 111.263 -177.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -56.64 -43.08 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 1.42 111.218 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 16.7 ptmt -73.87 -34.32 64.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.018 0.437 . . . . 2.63 111.244 -176.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.502 HG22 ' HD2' ' A' ' 150' ' ' PRO . 77.5 m -73.88 -44.1 56.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 1.09 111.394 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt . . . . . 0 C--N 1.321 -0.641 0 C-N-CA 120.842 -0.343 . . . . 2.26 111.627 -178.455 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 112.609 0.596 . . . . 1.51 112.609 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.771 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.6 mt -90.13 155.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.315 -0.857 . . . . 1.5 109.612 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -173.99 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.935 0.398 . . . . 1.99 111.829 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.771 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -143.37 169.06 18.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.499 -0.318 . . . . 1.1 111.296 -177.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -154.37 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.656 1.583 . . . . 1.8 113.349 176.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 1.003 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 54.6 m-85 -25.17 -49.91 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 115.216 1.561 . . . . 1.68 115.216 -166.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.816 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 10.6 m 32.2 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.839 1.199 . . . . 1.05 113.59 176.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.621 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.79 149.02 26.03 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.026 -0.67 . . . . 1.38 111.265 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.532 ' HE1' HD22 ' A' ' 42' ' ' ASN . 3.5 m-85 -104.0 133.34 49.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.236 -1.024 . . . . 0.53 108.236 166.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.89 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 34.7 tp -81.56 105.15 12.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.922 -0.77 . . . . 1.2 108.922 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.737 HG22 HD12 ' A' ' 15' ' ' ILE . 15.8 mm -104.8 124.98 59.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 1.05 109.151 -174.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.663 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 12.2 p30 -74.13 -178.12 3.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.766 0.317 . . . . 1.3 111.176 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.654 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.2 mtp180 -65.87 -12.78 57.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.426 0.528 . . . . 4.43 112.426 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -110.61 -14.33 14.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.26 0.552 . . . . 1.18 109.966 -173.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.488 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 106.88 31.03 4.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.388 -0.824 . . . . 0.25 113.034 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.663 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 89.9 t -112.56 129.5 24.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 117.209 0.504 . . . . 1.32 110.225 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.502 ' HD2' HG22 ' A' ' 125' ' ' THR . 7.9 Cg_exo -70.88 118.29 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.627 2.218 . . . . 0.46 111.725 178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.69 -26.07 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 1.09 110.825 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -157.75 165.7 34.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.095 -0.502 . . . . 1.22 110.135 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.563 HH11 ' HH2' ' A' ' 137' ' ' TRP . 18.0 ttm180 -134.97 116.98 15.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.941 -0.392 . . . . 2.25 109.941 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.89 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 3.4 m-85 -101.93 116.63 33.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.992 -0.744 . . . . 0.38 108.992 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.802 ' HA ' HG21 ' A' ' 140' ' ' THR . 97.7 p -64.5 164.8 17.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.494 0.588 . . . . 1.49 109.518 176.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.816 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 35.3 Cg_endo -64.76 -9.04 19.47 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.94 2.427 . . . . 0.74 113.17 -164.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -93.62 24.13 27.28 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.491 -0.777 . . . . 0.56 112.051 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.74 30.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 1.14 110.635 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.2 m -81.54 158.76 24.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.753 -0.658 . . . . 1.64 110.71 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.541 ' HA ' HG21 ' A' ' 56' ' ' THR . 21.5 t -49.56 -50.6 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.388 0.613 . . . . 1.14 109.919 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 161' ' ' LYS . 6.2 ttpp -59.92 -40.43 88.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.656 -1.157 . . . . 3.84 111.038 -177.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -63.52 -30.48 71.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.126 -0.943 . . . . 1.86 110.454 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.541 HG22 HD23 ' A' ' 39' ' ' LEU . 61.4 mt -82.63 -43.6 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.954 -0.566 . . . . 1.05 110.887 175.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.5 mt-10 -56.13 -38.84 71.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.88 112.108 -175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.4 pt-20 -62.33 -19.33 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 0.75 112.058 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -106.32 -17.25 14.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.289 0.566 . . . . 2.11 110.019 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.7 tp -94.11 -44.01 8.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 1.06 111.909 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.652 ' HA ' HD12 ' A' ' 171' ' ' LEU . 63.4 mt -51.79 -47.26 91.02 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.846 0.684 . . . . 1.14 112.846 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.461 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.2 Cg_exo -54.29 -39.59 86.18 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.987 1.792 . . . . 0.74 112.823 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.74 -34.55 58.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.503 -0.317 . . . . 1.35 111.801 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 1.003 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 14.2 mt -54.85 -54.73 38.58 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.463 0.649 . . . . 1.16 109.554 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -56.0 -51.87 52.74 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.221 -1.354 . . . . 1.52 113.266 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 117.409 0.605 . . . . 2.89 111.976 -177.153 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 112.153 -0.379 . . . . 5.87 112.153 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 94.5 mmm -82.65 87.38 6.73 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.253 -0.647 . . . . 5.34 109.253 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.89 84.37 1.34 Allowed Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.937 -0.865 . . . . 1.87 110.937 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 t -77.91 -39.63 42.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.03 0.443 . . . . 2.22 109.937 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.5 p -132.0 -179.47 5.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.905 -0.589 . . . . 1.06 109.899 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.728 HD12 HG21 ' A' ' 144' ' ' ILE . 23.6 pt -65.75 -28.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.073 0.463 . . . . 1.08 111.198 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.809 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 38.3 m-85 -78.81 -1.06 33.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.863 0.363 . . . . 0.3 111.618 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.06 -11.87 60.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.219 -0.66 . . . . 1.96 109.219 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 62.0 m-85 -110.68 160.18 16.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.081 -0.963 . . . . 0.4 109.541 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.31 149.62 27.61 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.216 -0.291 . . . . 2.77 110.216 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.55 HG21 HD12 ' A' ' 30' ' ' LEU . 70.3 t -114.91 147.5 18.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.149 0.499 . . . . 1.39 112.257 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.959 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 75.8 mt -100.92 132.36 46.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.854 -0.612 . . . . 1.33 109.875 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -65.69 177.32 1.27 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.824 -1.08 . . . . 1.59 109.858 176.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.755 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . . . -46.51 -37.57 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.496 0.319 . . . . 1.14 111.743 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.45 21.31 17.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.864 0.32 . . . . 2.22 111.864 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.959 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 39.1 m-70 68.23 16.43 9.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.113 0.565 . . . . 0.88 110.759 172.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.836 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -76.76 146.88 77.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 106.059 -1.83 . . . . 3.67 106.059 167.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.08 113.5 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 120.672 0.915 . . . . 1.19 111.806 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' HH ' ' CB ' ' A' ' 103' ' ' PRO . 68.3 t80 -86.97 117.57 25.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.532 -0.758 . . . . 0.98 110.866 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.46 82.75 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.716 -0.675 . . . . 1.65 109.767 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.809 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.46 -33.09 70.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.445 0.64 . . . . 1.08 110.469 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.762 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.0 p -76.73 -1.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.248 -0.887 . . . . 1.15 112.811 -168.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 2.8 pt20 -81.45 -5.64 58.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 1.94 109.349 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -92.94 -3.79 53.9 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.317 -0.994 . . . . 0.38 108.317 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 34.8 ttpt -74.15 146.45 43.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.879 -1.055 . . . . 2.22 109.827 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.81 -13.67 65.89 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.964 -1.254 . . . . 0.36 109.964 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.647 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 6.0 m -130.91 145.42 57.67 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 114.538 -0.831 . . . . 1.58 108.766 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.976 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -74.84 151.91 40.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.02 1.814 . . . . 0.86 110.664 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.556 ' HB2' HG21 ' A' ' 70' ' ' THR . 2.0 pt? -154.61 154.03 32.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.142 0.496 . . . . 1.63 111.161 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.89 HD23 HG21 ' A' ' 163' ' ' ILE . 6.8 mp -107.47 154.17 21.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.094 -0.706 . . . . 1.69 109.094 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.655 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 85.1 mt -141.0 115.34 5.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.205 -0.665 . . . . 1.05 109.205 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.59 ' HD2' ' HB2' ' A' ' 139' ' ' PHE . 3.9 m-85 -102.04 123.38 45.83 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 121.059 -0.256 . . . . 0.93 111.334 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.791 HD22 ' HB ' ' A' ' 140' ' ' THR . 1.0 OUTLIER -81.88 90.11 6.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.07 -1.085 . . . . 1.97 108.07 167.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 8.3 p -119.1 141.78 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.163 0.801 . . . . 1.48 113.163 -162.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.9 108.98 3.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.926 -1.139 . . . . 1.17 107.926 170.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.995 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 29.8 t -73.88 80.81 1.64 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.857 -0.61 . . . . 2.3 112.216 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 67.25 55.6 0.66 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.935 -1.029 . . . . 2.81 111.348 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -139.05 118.7 13.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.092 -0.504 . . . . 1.18 109.941 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 -93.67 1.24 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.655 -0.783 . . . . 1.42 112.131 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.37 151.91 17.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 3.45 111.301 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 52' ' ' GLY . 69.2 p -119.83 141.96 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.891 -0.781 . . . . 1.94 108.891 169.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 156' ' ' PRO . 33.4 ttmt -77.51 44.12 0.42 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.335 0.588 . . . . 2.51 110.794 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 50' ' ' THR . . . 92.44 28.37 13.07 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.744 -0.662 . . . . 0.55 112.271 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 139' ' ' PHE . . . -80.8 -48.73 6.02 Favored Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.879 -0.676 . . . . 0.39 112.28 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -55.84 -50.69 69.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.79 0.329 . . . . 1.05 110.387 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -60.21 -53.2 60.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.091 -0.504 . . . . 2.46 111.203 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.4 m -57.94 -47.06 84.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 122.728 0.411 . . . . 1.06 110.932 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.689 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -61.66 -49.25 77.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.46 . . . . 1.03 111.195 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -61.03 -47.17 87.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.163 0.506 . . . . 1.09 110.516 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -59.48 -49.8 76.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.362 -0.835 . . . . 1.69 111.172 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.663 HD23 HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -61.13 -44.48 97.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.033 -0.53 . . . . 1.46 110.964 -175.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.798 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 67.8 t80 -53.15 -57.1 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 123.492 0.495 . . . . 0.92 110.476 176.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -68.52 -39.2 81.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.336 -0.393 . . . . 1.88 111.369 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -70.82 -45.18 65.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 2.27 111.66 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.611 ' CD1' HD12 ' A' ' 171' ' ' LEU . 61.2 m-85 -101.53 6.67 42.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.332 0.864 . . . . 0.9 113.332 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -62.33 -19.79 63.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.63 0.252 . . . . 2.62 110.918 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.4 m -66.85 -38.06 85.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 1.59 111.246 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -88.85 4.63 47.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 1.9 110.66 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 82.44 71.61 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.892 -0.671 . . . . 1.32 111.514 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.58 ' CZ ' HD11 ' A' ' 39' ' ' LEU . 76.8 t80 -133.04 138.64 46.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.612 0.244 . . . . 0.4 110.436 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.556 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -126.82 142.91 51.41 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.93 0.395 . . . . 1.11 110.04 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.798 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.6 t -110.77 118.64 57.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 O-C-N 122.188 -0.32 . . . . 1.06 110.27 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.773 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 21.4 mt -105.34 122.92 46.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.91 -0.774 . . . . 1.23 108.91 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.85 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -109.82 112.74 24.96 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.006 -0.677 . . . . 1.04 110.591 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.606 ' CE1' ' HG2' ' A' ' 105' ' ' MET . 1.8 m-85 -93.29 112.59 57.07 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.116 -1.068 . . . . 0.45 108.116 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.024 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.7 Cg_exo -60.03 167.2 7.62 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.025 2.483 . . . . 0.73 111.235 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.0 t -111.64 128.28 56.01 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 119.435 -0.906 . . . . 2.02 111.738 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.516 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 49.8 t30 -86.18 99.1 11.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.396 -1.274 . . . . 3.1 110.896 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.649 ' NE2' ' HB2' ' A' ' 95' ' ' CYS . 0.0 OUTLIER -52.97 -11.55 0.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.903 1.281 . . . . 3.18 113.172 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 77' ' ' ASN . 74.9 m-85 -99.4 7.86 45.12 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.857 0.36 . . . . 4.52 110.556 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 109' ' ' ASN . . . -75.83 -33.45 51.02 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.903 -0.665 . . . . 1.45 112.158 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.09 -41.94 1.93 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.159 -0.543 . . . . 1.43 112.334 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.442 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 3.3 pm0 -131.65 39.94 3.44 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.299 0.481 . . . . 1.43 112.299 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 1.5 mp0 -60.74 132.39 91.51 Favored Pre-proline 0 C--N 1.318 -0.78 0 O-C-N 121.746 -0.596 . . . . 3.06 110.206 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 1.016 ' HG3' HG21 ' A' ' 135' ' ' ILE . 3.4 Cg_exo -12.25 -117.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 1 C-N-CA 126.304 4.669 . . . . 1.61 115.929 -160.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.47 -3.44 56.39 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.526 -1.43 . . . . 1.83 109.526 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -81.54 -0.94 44.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.709 -0.746 . . . . 4.24 112.165 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -25.71 67.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.993 0.368 . . . . 2.47 111.993 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -87.2 -12.12 47.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.99 0.424 . . . . 3.64 110.824 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 91' ' ' LYS . 12.5 tp10 -91.44 -54.89 3.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.984 -0.553 . . . . 2.42 111.122 -175.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.423 HD12 ' SG ' ' A' ' 95' ' ' CYS . 3.2 mt -78.55 35.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.234 0.54 . . . . 2.56 110.573 -174.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 89' ' ' GLU . 48.8 mtmt -96.5 -23.18 16.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.549 0.69 . . . . 4.36 110.294 176.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -115.74 8.24 14.86 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.557 -1.201 . . . . 3.1 109.235 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -133.02 167.56 20.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.585 -1.189 . . . . 2.15 108.929 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.09 120.34 53.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.512 0.672 . . . . 2.13 110.024 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.649 ' HB2' ' NE2' ' A' ' 78' ' ' GLN . 31.1 m -92.64 120.38 33.0 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.865 -0.607 . . . . 0.91 110.453 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.452 ' CG2' ' HE3' ' A' ' 97' ' ' LYS . 28.3 m -153.26 116.57 4.63 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.755 -0.657 . . . . 2.41 109.906 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.755 ' HD2' ' HB3' ' A' ' 23' ' ' ALA . 0.5 OUTLIER 13.27 97.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.824 1.328 . . . . 3.5 114.323 -173.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.672 ' HZ ' ' HZ ' ' A' ' 102' ' ' PHE . 23.7 p90 -64.03 -21.3 66.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.107 -0.497 . . . . 1.74 110.73 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 66.94 150.07 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.998 0.811 . . . . 3.53 111.613 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.446 ' HB2' ' HE1' ' A' ' 54' ' ' TYR . . . -171.29 -165.65 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.589 -0.278 . . . . 1.09 111.483 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -82.77 -4.73 58.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.367 0.603 . . . . 2.19 110.386 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.695 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 53.1 p90 -121.68 163.16 32.64 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.428 -0.953 . . . . 0.39 108.428 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 27.3 Cg_exo -67.71 117.47 4.9 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 123.195 2.597 . . . . 0.48 113.206 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.85 HG13 ' HB2' ' A' ' 73' ' ' ALA . 2.9 mp -105.57 138.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.131 -0.692 . . . . 1.13 109.131 171.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.773 ' HE2' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -103.24 -162.26 0.9 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.319 0.859 . . . . 2.08 113.319 -163.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.16 41.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.158 -0.928 . . . . 1.11 109.948 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.024 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 14.0 pttt -70.25 126.09 28.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.735 -0.786 . . . . 2.12 109.876 172.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 pt -124.64 161.39 28.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.707 -1.133 . . . . 1.19 108.307 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 15.1 t-20 -79.35 88.25 4.98 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.845 -0.798 . . . . 2.16 108.845 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.676 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -74.28 85.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 119.315 -0.954 . . . . 1.1 108.86 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.47 ' O ' ' HB1' ' A' ' 115' ' ' ALA . 9.6 t-20 171.84 -178.88 0.06 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.806 -0.813 . . . . 1.98 108.806 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.96 -142.15 42.18 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 115.116 0.806 . . . . 0.78 115.116 156.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.87 -16.69 15.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.501 -0.85 . . . . 1.98 109.612 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -91.62 1.84 56.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.856 -1.066 . . . . 2.1 110.613 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.675 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -60.89 140.58 57.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.252 -0.885 . . . . 1.17 111.861 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.868 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 33.2 t-80 -50.29 132.48 24.78 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.25 -0.886 . . . . 0.51 108.792 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.21 -33.27 53.9 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.429 2.753 . . . . 0.43 112.457 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.868 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 19.4 tp -62.99 -41.12 99.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 1.69 111.056 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.419 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.7 m-85 -74.83 -30.39 61.37 Favored 'General case' 0 C--O 1.21 -0.99 0 N-CA-C 110.378 -0.23 . . . . 1.84 110.378 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.86 -33.89 70.98 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.058 -0.657 . . . . 2.37 109.868 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.6 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 66.9 t80 -71.69 -52.46 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.357 0.411 . . . . 1.09 110.536 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.578 ' HE1' HD13 ' A' ' 118' ' ' LEU . 66.8 mtt -56.99 -51.91 67.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 1.06 111.333 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.527 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 35.4 mtpt -58.15 -50.62 72.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.817 -0.629 . . . . 1.42 110.652 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.21 -30.2 71.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.664 0.269 . . . . 2.63 111.283 -177.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.54 HG21 ' HD2' ' A' ' 150' ' ' PRO . 87.1 m -72.54 -52.51 15.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.366 -0.379 . . . . 1.09 111.727 -176.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 8.0 mmtt -130.91 99.08 18.47 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 112.869 0.692 . . . . 2.26 112.869 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 6.3 Cg_endo -51.61 -42.31 56.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.609 2.872 . . . . 1.81 112.311 167.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.587 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 100.35 -116.04 5.47 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.496 -0.859 . . . . 2.45 113.37 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.25 0.66 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.293 0.479 . . . . 4.01 112.293 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.433 HD21 ' H ' ' A' ' 130' ' ' LEU . 1.6 pt? -117.34 -171.24 2.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.812 0.339 . . . . 2.97 110.736 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.92 127.66 32.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.131 -0.486 . . . . 3.28 110.538 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 59.9 p 58.96 -172.46 0.11 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.868 0.867 . . . . 4.33 111.859 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 124' ' ' LYS . 31.1 pttt -125.25 47.03 2.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.981 -0.554 . . . . 5.43 112.047 -170.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -109.97 156.96 19.79 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.958 0.409 . . . . 1.51 111.519 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 1.016 HG21 ' HG3' ' A' ' 84' ' ' PRO . 37.6 mt -99.15 106.17 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.787 -0.642 . . . . 1.5 110.423 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 136' ' ' LYS . 9.9 ptpt -131.98 21.29 4.53 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.631 0.604 . . . . 1.99 112.631 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.834 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.2 174.44 15.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.068 0.396 . . . . 1.1 112.068 -175.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.489 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 8.3 m120 -46.66 -161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.422 1.489 . . . . 1.8 114.575 173.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.818 ' CZ ' ' HA ' ' A' ' 156' ' ' PRO . 44.7 p90 -34.37 -46.49 0.27 Allowed 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 113.145 -1.843 . . . . 1.68 115.346 -164.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.793 HG21 ' HA ' ' A' ' 155' ' ' SER . 22.4 m 37.78 94.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.36 0.874 . . . . 1.05 113.36 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.439 ' HB3' ' CE2' ' A' ' 41' ' ' TYR . 13.0 p -85.63 146.64 26.77 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.183 -0.607 . . . . 1.38 110.345 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.7 m-85 -102.17 133.4 47.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.407 -0.961 . . . . 0.53 108.407 169.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.896 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.87 104.66 12.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.095 -0.705 . . . . 1.2 109.095 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.728 HG21 HD12 ' A' ' 15' ' ' ILE . 12.7 mm -102.44 128.51 55.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.086 -0.709 . . . . 1.05 109.086 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.459 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.5 OUTLIER -82.31 -174.59 5.22 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.028 -0.269 . . . . 1.3 111.274 -175.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.469 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 43.9 mtt180 -63.3 -12.51 30.11 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.378 0.51 . . . . 4.43 112.378 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -108.86 -19.24 13.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.374 0.607 . . . . 1.18 109.741 -171.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.503 ' O ' HG22 ' A' ' 15' ' ' ILE . . . 102.37 26.87 7.11 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.199 -0.909 . . . . 0.25 112.36 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.1 t -106.44 126.33 30.7 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.732 -0.47 . . . . 1.32 109.732 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.54 ' HD2' HG21 ' A' ' 125' ' ' THR . 10.5 Cg_exo -67.56 111.35 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.342 2.028 . . . . 0.46 111.361 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.49 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 39.2 t -91.41 -25.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.017 -0.538 . . . . 1.09 110.504 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -152.37 163.6 39.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 1.22 111.226 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.587 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 11.9 ttm180 -131.01 102.62 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.618 -0.719 . . . . 2.25 109.247 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.896 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.9 m-85 -92.22 109.8 21.18 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.267 -0.642 . . . . 0.38 109.267 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.904 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 81.2 p -67.5 -178.65 0.38 Allowed Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.763 -0.458 . . . . 1.49 109.763 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.904 ' HD2' ' HB2' ' A' ' 155' ' ' SER . 30.8 Cg_endo -63.92 10.99 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.138 1.892 . . . . 0.74 113.227 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 155' ' ' SER . . . -99.16 -9.46 51.47 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.06 -0.591 . . . . 0.56 111.877 -177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -96.16 134.7 38.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 1.14 111.067 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.7 m -95.23 -174.02 3.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 1.64 110.265 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.663 HG11 HD23 ' A' ' 60' ' ' LEU . 77.5 t -51.38 -55.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 1.14 111.923 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -72.88 -26.0 61.29 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.606 -0.27 . . . . 3.84 111.126 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -34.45 72.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.644 -0.502 . . . . 1.86 109.644 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.89 HG21 HD23 ' A' ' 39' ' ' LEU . 61.8 mt -82.73 -38.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.608 -0.724 . . . . 1.05 110.762 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.1 mt-10 -56.22 -41.13 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.278 0.474 . . . . 0.88 112.278 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.554 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.9 pt-20 -57.21 -26.65 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.75 111.703 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.583 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.4 mmtp -102.51 -18.45 15.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.841 0.353 . . . . 2.11 110.751 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.688 ' HG ' HD11 ' A' ' 171' ' ' LEU . 60.4 tp -92.31 -45.66 8.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.901 -0.59 . . . . 1.06 112.043 -171.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.643 ' HA ' HD13 ' A' ' 171' ' ' LEU . 66.6 mt -49.73 -49.87 70.59 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 112.999 0.74 . . . . 1.14 112.999 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.9 Cg_exo -55.38 -39.44 91.0 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.116 1.878 . . . . 0.74 112.701 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.0 -40.16 63.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.511 -0.313 . . . . 1.35 110.975 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.976 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 18.6 mt -55.8 -48.4 75.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.296 0.57 . . . . 1.16 109.578 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.82 -69.82 1.05 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.585 -1.188 . . . . 1.52 111.621 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.6 m -161.45 125.31 3.31 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.78 -0.452 . . . . 2.89 109.78 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -90.17 -47.69 7.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.27 0.557 . . . . 3.56 109.769 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.692 ' HG3' ' H ' ' A' ' 176' ' ' LEU . 6.9 ptm180 -120.02 -67.63 0.97 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.259 -0.882 . . . . 8.59 109.869 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.692 ' H ' ' HG3' ' A' ' 175' ' ' ARG . 36.2 mt . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.78 -0.628 . . . . 5.3 109.689 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.477 0 N-CA-C 111.902 -0.479 . . . . 5.87 111.902 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.4 mtm -62.07 105.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.988 0.423 . . . . 5.34 110.182 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.17 52.08 0.85 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.746 -0.942 . . . . 1.87 110.746 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -74.11 -37.58 64.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.066 0.46 . . . . 2.22 110.613 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.5 p -157.53 -174.61 4.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.493 -0.776 . . . . 1.06 109.184 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.78 HD13 HG23 ' A' ' 144' ' ' ILE . 27.9 pt -64.2 -25.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.48 . . . . 1.08 110.649 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.79 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.3 m-85 -81.94 5.55 18.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.3 111.202 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.94 -19.67 60.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.259 -1.015 . . . . 1.96 108.259 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 73.8 m-85 -107.86 175.67 5.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.869 -1.059 . . . . 0.4 111.263 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -112.62 138.8 48.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 2.77 110.382 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.586 HG23 HD11 ' A' ' 30' ' ' LEU . 77.4 t -115.04 144.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.093 0.473 . . . . 1.39 111.514 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.969 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 91.0 mt -104.32 133.23 49.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.545 -0.752 . . . . 1.33 109.546 173.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 23' ' ' ALA . 18.3 t70 -68.53 -176.43 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.672 -0.862 . . . . 1.59 108.672 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -53.96 -35.45 61.79 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.165 0.507 . . . . 1.14 111.624 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -92.96 3.13 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 2.22 111.528 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.969 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 33.6 m-70 74.43 17.59 3.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.414 0.626 . . . . 0.88 109.972 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 12.8 mtmt -69.89 151.85 96.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.149 -1.797 . . . . 3.67 106.149 163.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.98 113.74 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 CA-C-N 120.168 1.096 . . . . 1.19 110.848 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.877 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 65.4 t80 -82.5 120.73 25.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.635 . . . . 0.98 110.232 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.9 t-20 -69.9 85.44 0.5 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.869 -0.605 . . . . 1.65 109.786 176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.79 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -73.4 -32.35 64.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.262 0.553 . . . . 1.08 110.544 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.754 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.3 p -77.19 -0.68 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.522 -0.763 . . . . 1.15 112.686 -168.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.0 pt20 -78.77 -6.62 56.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.574 0.702 . . . . 1.94 109.376 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.877 ' HE2' ' HH ' ' A' ' 28' ' ' TYR . 89.4 m-70 -96.99 3.81 51.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.96 -1.018 . . . . 0.38 108.314 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.529 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 22.1 ttpt -81.2 146.63 30.39 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.723 -1.126 . . . . 2.22 109.298 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.11 -2.1 86.77 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.228 -1.149 . . . . 0.36 110.228 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 13.6 m -140.56 152.31 65.94 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 1.58 108.747 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.961 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 74.3 Cg_endo -82.52 154.78 16.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.826 1.684 . . . . 0.86 111.576 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.644 ' CB ' HG21 ' A' ' 70' ' ' THR . 1.8 pt? -156.98 150.57 24.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.164 0.507 . . . . 1.63 111.749 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.86 151.49 25.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.376 -0.972 . . . . 1.69 108.376 172.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 86.5 mt -140.55 115.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.84 -0.43 . . . . 1.05 109.84 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.754 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 29.8 m-85 -103.02 124.74 49.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.609 0.226 . . . . 0.93 111.609 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.777 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -80.44 93.26 5.98 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.246 -0.65 . . . . 1.97 109.246 167.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.809 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 15.2 m -105.06 150.08 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 114.095 1.146 . . . . 1.48 114.095 -158.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 102.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.683 -1.599 . . . . 1.17 106.683 163.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.607 ' HG ' ' HB3' ' A' ' 95' ' ' CYS . 0.0 OUTLIER -76.07 81.17 2.91 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 113.879 1.066 . . . . 2.3 113.879 -163.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 84.4 tttt 76.18 31.97 0.63 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.558 -0.746 . . . . 2.81 111.488 169.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.652 ' HB3' ' HB3' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -149.28 132.34 16.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.507 -0.477 . . . . 1.18 111.488 178.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -92.69 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.688 -0.687 . . . . 1.42 114.734 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.417 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 66.8 m-85 -110.98 153.77 25.08 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.999 0.37 . . . . 3.45 111.999 -167.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 52' ' ' GLY . 26.9 p -137.24 -38.67 0.61 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.778 0.659 . . . . 1.94 112.778 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 69.47 -12.88 0.41 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.432 0.693 . . . . 2.51 112.791 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 50' ' ' THR . . . 112.01 12.08 14.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.942 -0.647 . . . . 0.55 112.478 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.84 -31.7 61.98 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.156 -0.545 . . . . 0.39 112.051 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.695 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -68.72 -52.05 34.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.534 0.206 . . . . 1.05 110.504 -177.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.95 -47.06 78.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.431 0.634 . . . . 2.46 110.397 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 160' ' ' VAL . 85.5 m -63.03 -47.53 82.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.818 -1.083 . . . . 1.06 110.719 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.82 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -62.16 -50.43 71.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 1.03 111.651 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.654 HG23 ' HG2' ' A' ' 101' ' ' GLU . 24.5 m -56.1 -45.55 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 1.09 110.792 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.674 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 40.7 m -66.57 -45.98 77.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.69 111.31 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 88.5 mt -58.09 -51.38 69.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.538 0.208 . . . . 1.46 111.188 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.498 ' HE1' ' HG1' ' A' ' 70' ' ' THR . 49.7 t80 -52.5 -52.76 52.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.997 0.811 . . . . 0.92 109.785 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.674 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 3.9 p30 -73.93 -33.35 63.91 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.504 -0.478 . . . . 1.88 111.429 -171.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -76.11 -38.17 57.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.277 -0.419 . . . . 2.27 111.309 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.727 ' CD1' HD11 ' A' ' 171' ' ' LEU . 70.9 m-85 -109.07 8.91 26.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.071 0.767 . . . . 0.9 113.071 -174.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -22.53 64.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.861 0.363 . . . . 2.62 110.226 173.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -62.12 -37.93 87.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 1.59 110.785 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.44 5.57 38.23 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.908 0.385 . . . . 1.9 110.923 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.35 25.09 34.46 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.99 -0.624 . . . . 1.32 112.289 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 39' ' ' LEU . 75.7 t80 -85.05 143.72 28.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.775 0.321 . . . . 0.4 110.913 -174.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.644 HG21 ' CB ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -131.03 146.32 52.34 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.062 0.458 . . . . 1.11 110.183 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.82 HG11 ' HB2' ' A' ' 57' ' ' ALA . 37.4 t -116.52 114.71 46.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.19 -0.459 . . . . 1.06 109.84 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.1 mt -100.23 122.78 43.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.103 -0.702 . . . . 1.23 109.103 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.988 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -109.63 116.74 32.3 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.22 -0.592 . . . . 1.04 110.731 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.752 ' HB2' ' HH ' ' A' ' 119' ' ' TYR . 2.8 m-85 -99.11 109.43 54.21 Favored Pre-proline 0 C--N 1.31 -1.134 0 CA-C-N 115.789 -0.641 . . . . 0.45 109.611 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.776 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 75.1 Cg_exo -50.37 160.61 1.48 Allowed 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 124.185 3.256 . . . . 0.73 113.568 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.7 t -114.0 131.28 56.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 122.65 1.214 . . . . 2.02 111.227 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -83.65 75.38 10.06 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.77 -1.567 . . . . 3.1 106.77 170.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 1.023 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -51.33 -11.55 0.12 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.604 1.335 . . . . 3.18 114.604 -168.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -102.71 30.38 4.74 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.62 0.724 . . . . 4.52 109.548 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.04 16.55 32.29 Favored Glycine 0 N--CA 1.454 -0.165 0 CA-C-N 115.971 -0.558 . . . . 1.45 112.847 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.29 -60.05 3.01 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.983 -0.847 . . . . 1.43 110.983 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.668 ' O ' ' HG2' ' A' ' 82' ' ' GLN . 5.0 pm0 -134.75 83.63 2.04 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.068 0.461 . . . . 1.43 111.057 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 1.023 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 77.5 mm-40 -83.83 155.77 64.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 107.999 -1.112 . . . . 3.06 107.999 165.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.95 ' HG3' HG21 ' A' ' 135' ' ' ILE . 16.1 Cg_exo -27.71 -105.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 1 C-N-CA 125.309 4.006 . . . . 1.61 116.655 -168.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.8 0.71 30.37 Favored Glycine 0 C--N 1.31 -0.865 0 N-CA-C 110.172 -1.171 . . . . 1.83 110.172 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -114.58 58.58 0.7 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.555 -0.822 . . . . 4.24 110.516 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -87.83 138.33 31.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.052 -0.522 . . . . 2.47 110.694 -176.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 62.26 16.34 8.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.487 -0.778 . . . . 3.64 111.633 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 31.6 tt0 -65.76 -40.37 91.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.753 0.787 . . . . 2.42 109.416 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.933 HD12 ' HB2' ' A' ' 95' ' ' CYS . 0.8 OUTLIER -55.95 -11.2 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.712 -1.131 . . . . 2.56 113.261 175.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -62.28 -17.48 58.69 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.8 -1.187 . . . . 4.36 111.707 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.65 21.63 3.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.573 -0.739 . . . . 3.1 110.114 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.652 ' HB3' ' HB3' ' A' ' 47' ' ' CYS . 68.0 m-85 -148.92 147.77 29.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.165 -0.925 . . . . 2.15 109.507 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 94' ' ' VAL . 9.9 p -110.71 111.14 34.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 118.969 -1.092 . . . . 2.13 109.5 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.933 ' HB2' HD12 ' A' ' 90' ' ' ILE . 75.8 m -105.18 117.17 33.33 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.481 -0.781 . . . . 0.91 110.111 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -154.56 120.36 5.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.336 -0.847 . . . . 2.41 109.761 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.742 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 7.7 pttt 33.36 77.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.333 1.021 . . . . 3.5 113.271 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.695 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 1.6 p90 -57.9 135.41 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.062 -1.458 . . . . 1.74 107.062 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HE2' ' HG3' ' A' ' 97' ' ' LYS . 70.0 mmtt -102.46 122.88 45.19 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.858 -0.737 . . . . 3.53 112.011 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.681 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . . . -125.11 -162.22 1.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.053 -0.976 . . . . 1.09 110.517 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.654 ' HG2' HG23 ' A' ' 58' ' ' THR . 7.4 pt-20 -90.64 -11.25 40.43 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.068 -0.653 . . . . 2.19 110.129 175.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.775 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.0 p90 -103.15 167.86 9.61 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.225 -0.898 . . . . 0.39 108.889 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.664 ' HB2' ' HE2' ' A' ' 105' ' ' MET . 22.1 Cg_exo -71.95 120.9 7.15 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.749 2.966 . . . . 0.48 113.348 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.988 HG13 ' HB1' ' A' ' 73' ' ' ALA . 3.8 mp -113.71 140.15 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.341 -0.614 . . . . 1.13 109.341 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.664 ' HE2' ' HB2' ' A' ' 103' ' ' PRO . 11.4 mmt -110.79 -151.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.107 0.78 . . . . 2.08 113.107 -164.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -79.64 143.84 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.855 -1.066 . . . . 1.11 110.738 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.776 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 21.4 pttt -78.67 137.74 37.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 2.12 109.995 172.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.44 HD13 ' CE1' ' A' ' 119' ' ' TYR . 3.8 pt -143.66 158.04 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.357 -1.349 . . . . 1.19 107.357 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -73.9 91.45 1.99 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.269 -0.572 . . . . 2.16 109.754 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.6 HG13 ' CB ' ' A' ' 42' ' ' ASN . 1.3 m -82.55 84.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 119.18 -1.008 . . . . 1.1 108.943 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.619 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 20.1 t-20 171.93 179.23 0.07 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.09 -1.078 . . . . 1.98 108.09 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.49 -149.09 19.81 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 116.024 1.17 . . . . 0.78 116.024 153.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 1.5 28.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.886 -1.157 . . . . 1.98 110.029 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.433 ' HB3' ' OD1' ' A' ' 109' ' ' ASN . 35.3 t-20 -108.6 2.83 22.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.917 -1.038 . . . . 2.1 109.559 -171.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.8 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -58.25 139.87 54.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.117 -0.947 . . . . 1.17 112.618 -177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.815 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 38.9 t-80 -48.32 133.52 12.83 Favored Pre-proline 0 C--O 1.226 -0.135 0 N-CA-C 109.012 -0.736 . . . . 0.51 109.012 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 9.2 Cg_endo -53.19 -33.17 63.32 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.37 2.713 . . . . 0.43 112.829 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.815 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 18.2 tp -65.72 -37.0 85.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 1.69 111.042 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.752 ' HH ' ' HB2' ' A' ' 74' ' ' PHE . 8.1 m-85 -75.55 -29.56 59.43 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.572 -0.285 . . . . 1.84 110.668 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 48.6 mt-10 -57.81 -40.2 79.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.883 -0.784 . . . . 2.37 108.883 167.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 77.7 t80 -68.08 -47.76 67.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 1.09 110.53 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.519 ' HE2' HD13 ' A' ' 118' ' ' LEU . 67.0 mtt -62.85 -55.03 29.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.097 -0.501 . . . . 1.06 111.136 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -57.54 -43.15 84.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.201 -0.454 . . . . 1.42 111.474 -176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -69.58 -39.73 77.13 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.479 -0.328 . . . . 2.63 111.009 -176.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 150' ' ' PRO . 52.3 m -69.73 -33.9 73.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.118 -0.492 . . . . 1.09 111.448 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.595 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.3 tmtt? -147.66 101.21 3.72 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.702 -0.399 . . . . 2.26 111.317 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 9.8 Cg_endo -53.53 -23.87 26.7 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.765 2.977 . . . . 1.81 112.26 174.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.592 ' CA ' ' HB3' ' A' ' 153' ' ' ARG . . . 113.24 -159.16 13.83 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.785 -0.721 . . . . 2.45 113.3 171.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.416 HG13 HD23 ' A' ' 130' ' ' LEU . 14.4 pt -66.11 -27.32 40.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.319 0.58 . . . . 4.01 110.703 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.608 ' HG ' HG22 ' A' ' 132' ' ' THR . 2.5 pt? -135.71 155.12 50.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.695 -0.854 . . . . 2.97 108.695 173.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.89 72.22 2.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.166 0.508 . . . . 3.28 111.712 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.608 HG22 ' HG ' ' A' ' 130' ' ' LEU . 15.1 p -76.9 -27.14 54.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.898 -0.592 . . . . 4.33 110.266 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 69.58 -9.76 0.63 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.098 -0.955 . . . . 5.43 111.377 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 132' ' ' THR . . . -163.22 -173.47 3.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.132 0.492 . . . . 1.51 111.327 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.95 HG21 ' HG3' ' A' ' 84' ' ' PRO . 63.8 mt -105.83 110.96 33.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.221 -0.9 . . . . 1.5 110.791 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.55 ' HA ' ' CA ' ' A' ' 84' ' ' PRO . 37.1 pttt -139.06 42.06 2.09 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.407 0.891 . . . . 1.99 113.407 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.801 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -156.4 174.82 14.85 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.458 0.703 . . . . 1.1 110.699 176.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.518 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 17.0 m120 -47.9 -158.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.735 1.214 . . . . 1.8 113.596 167.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.809 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 7.3 m-85 -30.66 -58.71 0.21 Allowed 'General case' 0 C--O 1.204 -1.295 0 C-N-CA 125.416 1.486 . . . . 1.68 114.35 -166.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.779 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 21.5 m 48.51 104.68 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.575 0.954 . . . . 1.05 113.575 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.754 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.9 t -96.35 149.52 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.012 -0.675 . . . . 1.38 111.26 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.2 m-85 -104.48 131.96 51.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.218 -0.66 . . . . 0.53 109.218 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.844 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.1 tp -81.03 106.07 12.74 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.157 -0.683 . . . . 1.2 109.157 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.78 HG23 HD13 ' A' ' 15' ' ' ILE . 12.2 mm -106.36 124.0 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 108.911 -0.774 . . . . 1.05 108.911 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.553 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 39.2 p30 -75.34 -177.72 3.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.135 -0.484 . . . . 1.3 111.404 -175.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 36' ' ' SER . 75.3 mtp180 -70.92 -1.17 11.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 4.43 111.897 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.25 -19.16 12.33 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.597 0.713 . . . . 1.18 109.45 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 103.77 27.76 6.22 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.913 -1.04 . . . . 0.25 112.126 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.466 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 84.2 t -109.62 129.64 23.69 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.651 -0.323 . . . . 1.32 110.411 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 125' ' ' THR . 6.9 Cg_exo -71.86 114.98 4.12 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.719 2.279 . . . . 0.46 111.573 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.595 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.7 t -100.24 -21.61 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.596 . . . . 1.09 110.562 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.0 mm-40 -152.64 164.54 37.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.155 -0.475 . . . . 1.22 110.364 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.592 ' HB3' ' CA ' ' A' ' 128' ' ' GLY . 34.4 ttp85 -139.53 102.32 4.43 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.115 -0.698 . . . . 2.25 109.115 169.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.844 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 14.4 m-85 -90.92 109.24 20.46 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.23 -0.656 . . . . 0.38 109.23 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.777 ' HA ' HG21 ' A' ' 140' ' ' THR . 5.0 p -63.43 164.98 12.65 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 109.153 -0.684 . . . . 1.49 109.153 175.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.779 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 61.0 Cg_endo -68.24 -4.45 12.76 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.65 2.234 . . . . 0.74 112.944 -163.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.83 -10.3 76.11 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.021 -0.991 . . . . 0.56 111.831 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.35 139.5 36.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.461 -0.57 . . . . 1.14 109.461 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.1 m -95.09 178.65 5.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.346 -0.388 . . . . 1.64 111.102 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 62.7 t -54.58 -48.62 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 1.14 110.968 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -29.42 69.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.782 -0.645 . . . . 3.84 110.727 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.32 -34.31 77.1 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.451 -0.795 . . . . 1.86 110.125 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.558 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 53.5 mt -81.26 -41.27 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 1.05 110.74 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 50.8 mt-10 -58.2 -38.83 77.53 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.035 0.383 . . . . 0.88 112.035 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.54 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 11.6 pt-20 -59.93 -18.53 45.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 0.75 111.594 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.607 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.6 mmtp -111.15 -17.76 13.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.078 0.466 . . . . 2.11 110.509 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.588 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.5 tp -92.44 -39.43 11.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.77 -0.65 . . . . 1.06 111.96 -172.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' A' ' 171' ' ' LEU . 76.7 mt -49.96 -51.24 63.14 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.663 0.616 . . . . 1.14 112.663 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.9 Cg_endo -55.71 -38.76 93.95 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.121 1.881 . . . . 0.74 112.246 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.62 -35.74 65.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 1.35 110.969 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.961 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 22.0 mt -57.12 -57.61 11.84 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.368 0.604 . . . . 1.16 109.646 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -50.35 -62.73 4.88 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.286 -1.324 . . . . 1.52 112.201 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t -170.48 121.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 2.89 110.285 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.553 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -93.57 -21.29 19.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.319 0.581 . . . . 3.56 110.371 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -177.67 -42.53 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.376 -1.342 . . . . 8.59 107.376 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.255 1.366 0 CA-C-N 114.014 -1.448 . . . . 5.3 108.466 169.159 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.756 -0.538 . . . . 5.87 111.756 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.5 mtm 62.77 30.99 16.74 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.706 0.402 . . . . 5.34 111.07 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.97 66.27 1.5 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 1.87 112.378 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.4 m -93.79 -29.4 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.413 0.625 . . . . 2.22 110.324 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.0 p -150.29 174.95 12.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 1.06 108.573 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.683 HD13 HG22 ' A' ' 144' ' ' ILE . 24.3 pt -62.28 -27.04 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.913 0.387 . . . . 1.08 111.427 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.866 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 34.7 m-85 -80.34 7.99 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.3 111.125 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.05 -16.28 60.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.231 -1.026 . . . . 1.96 108.231 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 71.9 m-85 -111.73 155.14 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.677 -1.147 . . . . 0.4 111.211 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -100.95 144.31 30.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.529 -0.545 . . . . 2.77 109.529 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.56 ' CG2' ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -125.93 167.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 1.39 110.493 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.974 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 93.6 mt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.292 -0.413 . . . . 1.33 110.245 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.52 -172.9 2.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.177 -0.675 . . . . 1.59 109.177 176.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.704 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . . . -54.0 -30.96 49.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.828 0.347 . . . . 1.14 111.304 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 18.8 t70 -89.56 -16.38 30.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 2.22 111.469 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.974 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 15.3 m-70 83.74 25.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.998 0.919 . . . . 0.88 109.68 -175.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.739 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 mmpt? -84.67 146.51 46.82 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 105.515 -2.032 . . . . 3.67 105.515 164.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.92 113.08 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 119.722 0.936 . . . . 1.19 111.292 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.56 ' HB3' ' CG2' ' A' ' 20' ' ' VAL . 89.3 t80 -79.63 120.86 24.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.542 -0.753 . . . . 0.98 109.816 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.562 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -67.84 84.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.477 -0.783 . . . . 1.65 109.728 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.866 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -72.74 -35.12 67.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.525 0.679 . . . . 1.08 110.142 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.762 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.5 p -76.55 -1.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 1.15 112.919 -167.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.1 pt20 -82.4 -5.1 58.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.303 0.573 . . . . 1.94 109.669 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.407 ' CG ' HG21 ' A' ' 70' ' ' THR . 88.1 m-70 -92.54 -8.55 44.11 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.95 -1.13 . . . . 0.38 107.95 177.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 36.4 ttpt -71.86 133.88 45.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.235 -0.893 . . . . 2.22 109.341 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 -1.25 57.65 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 109.862 -1.295 . . . . 0.36 109.862 -168.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 33.6 m -142.21 124.97 9.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.518 -0.841 . . . . 1.58 108.879 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.816 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 14.6 Cg_endo -59.0 147.86 88.03 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.58 1.52 . . . . 0.86 110.755 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.523 ' HB2' HG23 ' A' ' 70' ' ' THR . 2.0 pt? -150.68 151.29 32.24 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.243 0.544 . . . . 1.63 111.506 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.765 HD23 HG22 ' A' ' 163' ' ' ILE . 7.1 mp -108.51 152.14 25.13 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.69 -0.686 . . . . 1.69 109.266 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.675 HG22 ' HH ' ' A' ' 119' ' ' TYR . 72.6 mt -140.98 118.77 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 110.147 -0.316 . . . . 1.05 110.147 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.823 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 20.6 m-85 -105.11 124.27 49.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.426 0.155 . . . . 0.93 111.324 -173.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.521 ' HB3' HG13 ' A' ' 110' ' ' VAL . 1.3 p30 -81.0 91.67 6.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.841 -1.17 . . . . 1.97 107.841 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.587 HG13 ' HE1' ' A' ' 98' ' ' PHE . 2.4 p -109.05 135.41 48.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 113.288 0.848 . . . . 1.48 113.288 -162.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' HB3' ' HA3' ' A' ' 85' ' ' GLY . . . -60.63 107.89 0.75 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.766 -1.198 . . . . 1.17 107.766 170.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.034 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -71.62 84.67 0.87 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.775 -1.102 . . . . 2.3 113.0 -165.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.0 tmtp? 60.44 53.56 4.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.631 -0.713 . . . . 2.81 110.733 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 p -163.69 136.56 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.757 -0.656 . . . . 1.18 110.43 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.78 -113.57 4.38 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.626 -0.797 . . . . 1.42 112.561 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 169.26 17.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.097 0.475 . . . . 3.45 111.736 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.664 HG21 ' HE1' ' A' ' 139' ' ' PHE . 40.0 p -126.07 139.65 53.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.432 -0.804 . . . . 1.94 109.41 171.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.617 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 27.7 mtpp -106.16 18.87 21.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 2.51 111.09 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.63 13.34 32.7 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.822 -0.704 . . . . 0.55 111.709 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 -43.22 16.53 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.866 -0.494 . . . . 0.39 111.866 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.608 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.2 t80 -68.05 -49.14 63.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 1.05 110.331 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -54.82 -55.14 33.44 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.88 -0.6 . . . . 2.46 110.486 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 160' ' ' VAL . 93.4 m -62.61 -46.96 85.85 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.009 -0.996 . . . . 1.06 111.287 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -59.89 -49.29 78.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.858 0.361 . . . . 1.03 111.152 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.9 m -59.6 -50.58 73.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.721 -0.672 . . . . 1.09 110.749 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 p -65.7 -37.68 87.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 1.69 112.045 -175.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.48 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 84.5 mt -61.55 -52.4 64.62 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 121.158 -0.217 . . . . 1.46 110.951 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.613 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 53.1 t80 -51.89 -51.82 54.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.777 -0.823 . . . . 0.92 108.777 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.47 -30.32 68.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.304 -0.862 . . . . 1.88 112.036 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -86.06 -39.68 16.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.598 0.222 . . . . 2.27 111.598 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.648 ' CD1' HD12 ' A' ' 171' ' ' LEU . 60.5 m-85 -108.35 9.91 27.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.485 1.291 . . . . 0.9 114.485 -170.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 18.3 mtmm -59.34 -26.81 65.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.941 -0.704 . . . . 2.62 110.061 170.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 m -60.5 -30.21 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.593 -0.73 . . . . 1.59 111.627 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -104.44 12.98 32.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 1.9 111.206 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.47 65.58 1.66 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.592 -0.813 . . . . 1.32 112.299 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 65.5 t80 -129.03 137.72 51.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.75 0.31 . . . . 0.4 110.639 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.523 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -129.17 143.06 50.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 120.928 0.394 . . . . 1.11 110.746 177.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.708 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 29.9 t -114.31 120.95 65.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.935 0.398 . . . . 1.06 110.621 171.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.63 ' HB3' ' HE1' ' A' ' 105' ' ' MET . 20.0 mt -105.69 122.87 46.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.297 -0.631 . . . . 1.23 109.297 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.015 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -111.53 116.19 30.45 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.298 -0.561 . . . . 1.04 110.904 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.1 m-85 -100.06 110.04 58.23 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.018 -0.734 . . . . 0.45 109.018 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.034 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 53.2 Cg_exo -54.67 165.81 2.28 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 123.606 2.871 . . . . 0.73 111.421 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 m -123.45 134.68 53.9 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 118.569 -1.252 . . . . 2.02 113.943 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.555 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 22.5 t30 -100.46 88.68 3.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.8 -1.545 . . . . 3.1 109.838 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.977 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 2.1 mp0 -66.0 -15.12 62.73 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.8 0.667 . . . . 3.18 112.8 -172.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -66.83 -9.51 38.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.147 0.499 . . . . 4.52 110.295 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.828 ' HA3' HD22 ' A' ' 109' ' ' ASN . . . -64.02 -27.14 70.91 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.702 -0.681 . . . . 1.45 112.138 175.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 138.11 -80.78 0.28 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.5 -0.857 . . . . 1.43 112.82 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.705 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -100.97 17.86 21.17 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 112.009 0.374 . . . . 1.43 112.009 -174.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.977 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 9.1 mm-40 -60.88 149.52 80.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.552 0.215 . . . . 3.06 110.671 -169.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.712 ' HD3' ' O ' ' A' ' 110' ' ' VAL . 46.3 Cg_endo -71.37 -155.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 122.397 2.065 . . . . 1.61 113.605 -166.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 44' ' ' ALA . . . 68.47 26.71 74.19 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.566 -0.743 . . . . 1.83 112.116 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 66.26 92.24 0.08 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.497 0.665 . . . . 4.24 110.153 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.73 -14.47 8.65 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.008 -0.996 . . . . 2.47 112.251 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -78.81 -23.2 45.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.013 0.435 . . . . 3.64 110.906 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.42 -61.02 2.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.403 0.62 . . . . 2.42 110.391 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 ' SG ' ' A' ' 95' ' ' CYS . 20.5 mt -80.89 43.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 122.081 0.943 . . . . 2.56 111.001 -173.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 91' ' ' LYS . 25.5 mtpp -76.32 -32.24 58.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.569 -0.741 . . . . 4.36 110.563 174.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.98 -10.73 2.64 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.98 -1.009 . . . . 3.1 111.632 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -74.81 173.82 10.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.799 0.333 . . . . 2.15 110.465 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.48 139.2 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 108.201 -1.037 . . . . 2.13 108.201 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 83.9 m -127.73 122.41 32.78 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.109 -0.636 . . . . 0.91 111.388 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -127.39 157.33 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.279 -0.873 . . . . 2.41 109.331 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.704 ' HD2' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -38.97 111.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.135 0.574 . . . . 3.5 111.33 175.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.608 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 46.4 p90 -64.35 -22.07 66.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.872 -0.604 . . . . 1.74 111.794 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 66.66 146.6 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.79 0.681 . . . . 3.53 111.72 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.416 ' CB ' ' HE1' ' A' ' 54' ' ' TYR . . . -166.63 -165.87 0.79 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 1.09 111.371 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.9 1.78 53.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.287 0.565 . . . . 2.19 110.497 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.754 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 51.7 p90 -123.83 165.3 24.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 108.56 -0.904 . . . . 0.39 108.56 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.708 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 29.1 Cg_exo -67.87 120.97 7.97 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.732 2.955 . . . . 0.48 113.256 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.015 HG13 ' HB2' ' A' ' 73' ' ' ALA . 3.2 mp -114.93 140.29 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.22 -0.659 . . . . 1.13 109.22 173.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.63 ' HE1' ' HB3' ' A' ' 72' ' ' LEU . 8.3 mmt -115.37 -150.44 0.46 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.046 0.758 . . . . 2.08 113.046 -165.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.98 135.39 43.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.831 -1.077 . . . . 1.11 110.756 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.872 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttp -74.03 116.9 15.2 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.316 -0.994 . . . . 2.12 108.316 167.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.484 HD12 ' CB ' ' A' ' 116' ' ' HIS . 4.8 pt -122.67 175.99 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.615 -1.175 . . . . 1.19 107.986 -174.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.828 HD22 ' HA3' ' A' ' 80' ' ' GLY . 3.1 m120 -73.33 114.92 12.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.057 -1.09 . . . . 2.16 108.057 169.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.712 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -114.49 83.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 118.992 -1.083 . . . . 1.1 108.913 166.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.705 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 9.3 t-20 170.52 179.41 0.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.428 -0.953 . . . . 1.98 108.428 169.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 59.9 -146.22 45.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.78 113.879 165.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.11 -14.28 15.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.654 0.74 . . . . 1.98 109.475 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.06 -12.19 50.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.962 -1.017 . . . . 2.1 110.866 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.603 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -43.98 149.49 0.32 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.707 1.003 . . . . 1.17 113.707 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.7 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 41.2 t-80 -55.06 133.57 68.15 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 114.847 -1.07 . . . . 0.51 110.507 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -46.86 -47.77 15.64 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.917 2.411 . . . . 0.43 112.788 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.7 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.956 -0.565 . . . . 1.69 111.414 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.675 ' HH ' HG22 ' A' ' 40' ' ' ILE . 2.0 m-85 -75.42 -29.92 59.9 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 122.24 -0.287 . . . . 1.84 111.077 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 8.9 mm-40 -58.0 -42.21 84.73 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.31 -0.556 . . . . 2.37 109.622 168.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 83.9 t80 -61.59 -52.25 65.19 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.923 0.392 . . . . 1.09 110.483 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.507 ' HE1' HD21 ' A' ' 118' ' ' LEU . 66.0 mtt -60.05 -50.04 75.29 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.325 0.583 . . . . 1.06 110.752 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' HZ1' ' HB3' ' A' ' 123' ' ' LYS . 2.9 ttpm? -61.51 -38.21 86.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.729 -1.123 . . . . 1.42 111.396 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 16.2 ptpt -76.57 -35.9 57.92 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.77 0.285 . . . . 2.63 111.77 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.548 HG21 ' HD2' ' A' ' 150' ' ' PRO . 86.4 m -63.47 -42.61 98.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.088 0.471 . . . . 1.09 110.798 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.662 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.0 ttmt -137.02 118.59 11.13 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.327 -0.62 . . . . 2.26 109.327 169.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 126' ' ' LYS . 73.8 Cg_endo -83.29 6.7 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.241 2.627 . . . . 1.81 112.885 -173.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 110.73 -173.06 15.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.985 -0.626 . . . . 2.45 112.342 175.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.0 mm -110.47 -23.71 4.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.41 0.624 . . . . 4.01 109.665 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.605 HD21 ' H ' ' A' ' 130' ' ' LEU . 2.5 pt? -124.77 136.28 53.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.622 -0.717 . . . . 2.97 109.713 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 50.56 57.16 6.92 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.683 0.614 . . . . 3.28 110.471 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.6 p -58.82 119.01 6.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.787 -0.642 . . . . 4.33 112.68 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.6 tttp 177.05 -60.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.507 -1.224 . . . . 5.43 109.696 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -158.36 -168.06 2.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.577 0.954 . . . . 1.51 113.577 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.854 HG21 ' HZ3' ' A' ' 137' ' ' TRP . 23.7 mt -83.24 168.29 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 114.225 -1.352 . . . . 1.5 109.142 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.855 ' HB3' ' HZ3' ' A' ' 136' ' ' LYS . 0.5 OUTLIER 179.02 -35.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.279 0.945 . . . . 1.99 112.873 -176.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.854 ' HZ3' HG21 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.13 171.76 8.25 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.904 0.882 . . . . 1.1 112.201 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 17.6 m120 -44.46 -157.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.407 1.483 . . . . 1.8 114.122 169.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.823 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 31.7 m-85 -28.56 -56.96 0.13 Allowed 'General case' 0 C--O 1.208 -1.111 0 C-N-CA 125.259 1.424 . . . . 1.68 114.323 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.813 HG22 ' HA ' ' A' ' 155' ' ' SER . 7.0 m 42.87 95.73 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.398 0.888 . . . . 1.05 113.398 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.5 p -85.12 152.07 23.66 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.328 -0.549 . . . . 1.38 110.722 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.464 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 6.1 m-85 -103.36 137.71 41.11 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.802 -1.184 . . . . 0.53 107.802 166.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.953 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 44.7 tp -82.58 104.91 13.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.838 -0.801 . . . . 1.2 108.838 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.683 HG22 HD13 ' A' ' 15' ' ' ILE . 16.9 mm -102.69 119.27 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.775 -0.824 . . . . 1.05 108.775 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.523 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.6 OUTLIER -72.12 179.72 3.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.133 0.492 . . . . 1.3 110.292 -176.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -61.83 -12.58 18.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.519 -0.764 . . . . 4.43 112.554 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -111.12 -21.36 11.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 1.18 110.294 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.451 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 110.55 35.56 2.05 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.554 -0.748 . . . . 0.25 112.864 177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 96.0 t -112.08 124.36 32.38 Favored Pre-proline 0 C--N 1.319 -0.75 0 O-C-N 122.584 -0.363 . . . . 1.32 110.361 175.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.548 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -66.9 99.87 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.46 111.761 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.5 t -84.03 -21.19 8.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.581 . . . . 1.09 110.798 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.662 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 mm-40 -159.16 164.55 35.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.786 -0.45 . . . . 1.22 109.786 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.61 HH11 ' HH2' ' A' ' 137' ' ' TRP . 26.2 ttm180 -131.59 97.56 4.26 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.344 -0.614 . . . . 2.25 109.344 171.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.953 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 40.7 m-85 -81.92 111.13 17.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.224 -0.658 . . . . 0.38 109.224 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.813 ' HA ' HG22 ' A' ' 140' ' ' THR . 0.9 OUTLIER -58.72 163.66 5.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.519 -0.549 . . . . 1.49 109.519 174.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.783 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 50.8 Cg_endo -67.69 -7.03 18.21 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.463 2.109 . . . . 0.74 112.06 -169.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -86.1 -0.57 87.05 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.08 -0.963 . . . . 0.56 112.694 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.88 135.36 36.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.942 0.401 . . . . 1.14 110.538 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 172.79 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 1.64 110.62 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.457 ' HA ' HG22 ' A' ' 56' ' ' THR . 31.2 t -50.45 -53.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.532 -0.303 . . . . 1.14 110.829 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.674 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 64.0 tttm -63.41 -35.28 79.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 3.84 111.44 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -54.3 -40.87 68.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.541 0.686 . . . . 1.86 109.485 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.765 HG22 HD23 ' A' ' 39' ' ' LEU . 61.2 mt -82.27 -40.66 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.838 -1.074 . . . . 1.05 111.507 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 41.3 mt-10 -53.14 -42.26 65.91 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.282 0.475 . . . . 0.88 112.282 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.674 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 1.7 pt-20 -69.31 -2.37 10.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.408 0.521 . . . . 0.75 112.408 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.618 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 33.3 mmtm -116.66 -20.83 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.577 . . . . 2.11 109.705 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.555 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.1 tp -93.29 -41.12 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 1.06 111.95 -168.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.644 ' HA ' HD13 ' A' ' 171' ' ' LEU . 77.5 mt -49.86 -50.8 65.86 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.703 0.631 . . . . 1.14 112.703 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.5 Cg_exo -54.24 -36.56 86.6 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.236 1.958 . . . . 0.74 112.835 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -75.99 -37.38 58.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.675 -0.239 . . . . 1.35 110.966 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.816 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.8 mt -59.7 -48.59 81.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.716 0.77 . . . . 1.16 109.033 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -49.29 -65.23 2.86 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 114.241 -1.345 . . . . 1.52 112.42 167.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 p -171.58 126.49 0.62 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.767 0.284 . . . . 2.89 110.658 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -93.86 -18.45 21.97 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.374 0.607 . . . . 3.56 110.39 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.506 ' HG3' ' HG ' ' A' ' 176' ' ' LEU . 18.7 ptp180 177.71 -29.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.839 -1.171 . . . . 8.59 107.839 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.506 ' HG ' ' HG3' ' A' ' 175' ' ' ARG . 90.7 mt . . . . . 0 C--O 1.245 0.843 0 CA-C-N 114.271 -1.331 . . . . 5.3 108.045 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.866 0 N-CA-C 111.602 -0.599 . . . . 5.87 111.602 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.3 tpt -140.85 96.93 3.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.021 0.438 . . . . 5.34 110.203 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.458 ' HA3' ' CE1' ' A' ' 121' ' ' TYR . . . -166.61 -86.16 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.866 -0.606 . . . . 1.87 111.869 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 m 72.46 -54.44 0.69 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.485 0.714 . . . . 2.22 111.848 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 p -151.7 154.93 37.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.417 0.627 . . . . 1.06 110.369 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.622 HD12 HG23 ' A' ' 144' ' ' ILE . 13.8 pt -61.6 -21.46 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.913 -1.039 . . . . 1.08 112.497 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.786 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 62.2 m-85 -77.7 -2.57 36.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.39 0.515 . . . . 0.3 112.39 -171.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -70.47 -17.46 62.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.632 0.73 . . . . 1.96 109.363 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.55 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 79.3 m-85 -100.38 162.6 12.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.191 -0.913 . . . . 0.4 111.477 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 25.9 tt0 -93.97 153.61 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 2.77 110.733 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.504 HG12 ' CE2' ' A' ' 74' ' ' PHE . 75.6 t -133.05 139.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.037 0.446 . . . . 1.39 111.186 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.957 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 95.6 mt -104.96 140.56 38.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.826 -0.805 . . . . 1.33 108.826 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.82 -172.35 1.9 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.268 -0.641 . . . . 1.59 109.268 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -54.36 -33.06 58.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.753 0.311 . . . . 1.14 111.306 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 19.6 t70 -86.85 -11.67 50.14 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.418 -0.355 . . . . 2.22 111.287 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.957 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 42.3 m-70 79.37 22.31 0.57 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.618 0.767 . . . . 0.88 109.745 -176.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.74 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -84.13 146.0 47.37 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 105.857 -1.905 . . . . 3.67 105.857 166.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.89 114.6 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.157 1.238 . . . . 1.19 112.695 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.895 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 64.2 t80 -87.38 116.49 25.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.312 -0.858 . . . . 0.98 110.134 172.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -66.73 93.85 0.27 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.102 -0.703 . . . . 1.65 109.102 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.786 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -77.31 -34.3 55.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.361 0.6 . . . . 1.08 110.454 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.74 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.8 p -76.64 -0.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.271 -0.877 . . . . 1.15 112.296 -168.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.64 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 4.0 pt20 -80.85 -5.24 57.04 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.963 -0.754 . . . . 1.94 108.963 173.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.895 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 88.7 m-70 -101.35 20.64 15.49 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.897 -1.047 . . . . 0.38 108.341 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -96.94 150.95 20.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.462 -1.245 . . . . 2.22 108.742 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 -6.05 81.38 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.636 -0.985 . . . . 0.36 110.636 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.2 m -140.72 141.75 26.0 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.798 -1.186 . . . . 1.58 107.798 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.839 ' HG2' HD22 ' A' ' 171' ' ' LEU . 3.2 Cg_exo -75.99 157.54 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.019 1.813 . . . . 0.86 111.365 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.532 ' HB2' HG23 ' A' ' 70' ' ' THR . 1.8 pt? -154.67 148.61 25.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.249 0.547 . . . . 1.63 111.251 -174.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.617 HD23 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.29 150.7 26.39 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.262 -1.014 . . . . 1.69 108.262 171.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 66.9 mt -139.64 118.7 12.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.623 -0.51 . . . . 1.05 109.623 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.826 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 38.8 m-85 -103.07 124.15 47.99 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 121.154 -0.218 . . . . 0.93 111.359 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.646 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -78.56 92.0 4.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.901 -1.148 . . . . 1.97 107.901 166.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.6 p -108.62 143.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 113.363 0.875 . . . . 1.48 113.363 -161.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.623 ' HA ' ' OG ' ' A' ' 76' ' ' SER . . . -67.04 110.43 3.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.438 -1.319 . . . . 1.17 107.438 170.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.995 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -67.89 81.27 0.2 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.061 -0.972 . . . . 2.3 111.869 -167.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.622 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 14.1 ptpt 46.01 66.37 0.96 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.274 1.43 . . . . 2.81 112.46 -173.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -162.65 138.07 7.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -1.02 . . . . 1.18 110.154 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.13 -140.97 30.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.842 -0.694 . . . . 1.42 113.346 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -84.07 170.09 14.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.075 0.464 . . . . 3.45 111.77 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.15 -28.44 2.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.949 -0.569 . . . . 1.94 111.424 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.859 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.4 mmmt 66.27 3.52 2.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.255 0.622 . . . . 2.51 111.917 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.04 1.9 59.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.818 -0.706 . . . . 0.55 112.28 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.4 81.92 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.468 -0.653 . . . . 0.39 111.468 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.692 ' HE1' ' HB3' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -66.21 -49.34 67.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.203 -0.498 . . . . 1.05 110.185 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.63 -43.51 89.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.505 -0.771 . . . . 2.46 110.119 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 160' ' ' VAL . 55.1 m -57.94 -53.26 60.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.516 -0.765 . . . . 1.06 110.527 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -58.68 -49.48 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.719 -0.673 . . . . 1.03 111.846 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.634 HG22 ' HB2' ' A' ' 101' ' ' GLU . 63.0 m -59.22 -45.39 91.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 1.09 110.754 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.9 m -64.07 -48.44 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.652 -0.704 . . . . 1.69 110.78 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 95.1 mt -56.59 -53.04 62.28 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.803 0.298 . . . . 1.46 111.803 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.636 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 70.9 t80 -53.23 -53.35 52.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.788 -0.642 . . . . 0.92 109.755 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.96 -27.43 60.99 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.371 -0.832 . . . . 1.88 111.815 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.75 -48.34 12.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.839 0.352 . . . . 2.27 111.411 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.677 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.8 m-85 -99.1 6.17 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.258 0.836 . . . . 0.9 113.258 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -57.81 -29.85 65.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.808 0.337 . . . . 2.62 110.316 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -63.57 -32.8 74.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 1.59 111.061 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -96.5 10.78 37.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 1.9 110.689 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 80.66 64.07 1.85 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.945 -0.645 . . . . 1.32 112.19 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.617 ' CE1' HD23 ' A' ' 39' ' ' LEU . 70.6 t80 -129.66 143.85 51.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.727 0.299 . . . . 0.4 110.912 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.532 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.6 146.77 52.37 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.853 0.358 . . . . 1.11 110.416 177.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.742 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 42.5 t -116.52 120.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.96 -0.385 . . . . 1.06 109.96 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 26.7 mt -106.38 123.07 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.654 -0.498 . . . . 1.23 109.654 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.989 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -104.91 131.32 52.56 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.103 0.478 . . . . 1.04 110.266 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.504 ' CE2' HG12 ' A' ' 20' ' ' VAL . 8.2 m-85 -117.27 106.98 46.07 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.219 -0.66 . . . . 0.45 109.219 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.003 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 52.6 Cg_exo -56.69 169.06 1.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.993 3.129 . . . . 0.73 112.04 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.623 ' OG ' ' HA ' ' A' ' 44' ' ' ALA . 3.7 p -114.49 136.5 52.94 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 115.419 1.637 . . . . 2.02 115.419 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.515 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 29.0 m-20 -99.63 73.73 1.83 Allowed 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 113.924 -1.489 . . . . 3.1 109.176 166.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 1.017 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 55.1 mt-30 -64.09 -12.28 37.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.774 -0.648 . . . . 3.18 112.447 -173.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -66.1 -8.86 26.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.147 -0.479 . . . . 4.52 110.845 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.545 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . -60.36 -42.89 99.05 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.099 -0.501 . . . . 1.45 112.735 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.9 -60.82 0.45 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.504 -0.855 . . . . 1.43 112.748 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.681 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.5 pm0 -110.98 9.9 22.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.785 0.293 . . . . 1.43 111.46 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 1.017 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 11.4 mm-40 -63.51 151.28 88.28 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.346 -0.388 . . . . 3.06 110.442 -171.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.857 ' HG3' HG21 ' A' ' 135' ' ' ILE . 10.5 Cg_exo -31.94 150.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 125.272 3.981 . . . . 1.61 116.574 -173.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.33 14.49 66.14 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.313 -1.515 . . . . 1.83 109.313 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.9 m120 69.08 -62.92 0.39 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.135 -1.032 . . . . 4.24 110.737 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 178.0 140.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.5 0.5 . . . . 2.47 110.188 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 65.39 49.82 1.82 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 3.64 112.609 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.577 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 7.5 tp10 -91.76 -12.0 35.12 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.81 -1.182 . . . . 2.42 107.81 165.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.812 HG12 ' SG ' ' A' ' 95' ' ' CYS . 2.2 mt -93.55 21.5 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.235 -0.893 . . . . 2.56 108.868 171.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.654 ' HG3' ' H ' ' A' ' 92' ' ' GLU . 13.3 pttm -53.21 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.682 -0.69 . . . . 4.36 112.192 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.654 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 12.2 pt-20 -93.56 7.65 43.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.038 -0.983 . . . . 3.1 109.53 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 88.2 m-85 -110.97 172.79 6.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.24 -0.891 . . . . 2.15 111.083 -171.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 94' ' ' VAL . 6.6 p -130.9 110.83 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.529 -1.286 . . . . 2.13 107.529 170.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.812 ' SG ' HG12 ' A' ' 90' ' ' ILE . 31.1 m -94.99 117.36 30.0 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 118.989 -1.084 . . . . 0.91 110.218 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.664 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 95.7 m -153.99 128.63 9.33 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.378 -0.828 . . . . 2.41 110.38 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 96' ' ' THR . 44.4 pttt 68.21 -44.73 0.5 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.584 1.328 . . . . 3.5 114.584 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.622 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 62.03 -67.92 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.461 0.573 . . . . 1.74 111.577 -175.314 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.665 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 8.9 mmpt? 71.23 147.68 0.08 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.898 0.879 . . . . 3.53 111.795 173.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.692 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . . . -168.44 -166.66 0.71 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.101 0.477 . . . . 1.09 111.968 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.634 ' HB2' HG22 ' A' ' 58' ' ' THR . 29.0 mm-40 -88.79 27.69 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 2.19 110.547 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.847 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 39.1 p90 -149.6 174.76 3.21 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.153 -1.425 . . . . 0.39 107.153 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.742 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 22.4 Cg_exo -71.1 125.59 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.802 2.334 . . . . 0.48 113.322 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.989 HG13 ' HB2' ' A' ' 73' ' ' ALA . 3.9 mp -124.43 141.49 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.247 -0.649 . . . . 1.13 109.247 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.695 ' HE2' ' HB2' ' A' ' 103' ' ' PRO . 6.4 mmt -115.48 -152.16 0.5 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.542 0.687 . . . . 2.08 112.714 -164.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . . . -73.04 137.26 45.23 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.577 -1.192 . . . . 1.11 110.707 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.003 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 26.7 pttt -73.13 120.97 19.49 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.764 -0.828 . . . . 2.12 108.764 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.497 HD11 ' CB ' ' A' ' 116' ' ' HIS . 5.2 pt -122.53 169.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.795 -1.093 . . . . 1.19 108.343 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.779 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.2 m120 -68.6 121.37 16.29 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.77 -1.196 . . . . 2.16 107.77 169.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.646 HG12 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -119.16 83.57 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 C-N-CA 119.127 -1.029 . . . . 1.1 109.587 170.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.681 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 46.5 t30 170.96 177.97 0.06 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.076 -1.083 . . . . 1.98 108.076 167.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.76 -141.52 35.93 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.955 -0.641 . . . . 0.78 113.779 164.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.23 1.52 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.121 -0.539 . . . . 1.98 110.601 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -87.75 -24.94 23.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.821 -0.627 . . . . 2.1 110.681 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.779 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -44.59 142.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.779 1.029 . . . . 1.17 113.779 -175.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.497 ' CB ' HD11 ' A' ' 108' ' ' ILE . 49.3 t-80 -53.23 136.3 49.84 Favored Pre-proline 0 C--O 1.225 -0.236 0 CA-C-N 114.679 -1.146 . . . . 0.51 110.012 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.55 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.2 Cg_exo -40.95 -45.34 5.03 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.172 2.581 . . . . 0.43 112.845 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.558 HD13 ' HE3' ' A' ' 122' ' ' MET . 30.0 tp -54.02 -51.49 63.82 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.783 -0.644 . . . . 1.69 111.884 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.487 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.5 m-85 -71.28 -30.4 66.22 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 116.517 -0.31 . . . . 1.84 111.0 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 9.6 mm-40 -56.26 -43.3 78.62 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.726 -0.79 . . . . 2.37 109.413 170.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.9 t80 -66.03 -45.03 82.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.614 -0.434 . . . . 1.09 110.508 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.558 ' HE3' HD13 ' A' ' 118' ' ' LEU . 66.9 mtt -60.76 -53.11 61.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.873 0.368 . . . . 1.06 111.236 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 2.5 mtpm? -62.33 -38.24 88.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 1.42 110.838 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 17.1 ptpt -74.82 -27.35 60.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.718 -0.219 . . . . 2.63 110.816 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.542 HG21 ' HD2' ' A' ' 150' ' ' PRO . 59.1 m -65.02 -55.18 20.44 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.945 -0.302 . . . . 1.09 111.068 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.594 ' HG2' ' H ' ' A' ' 128' ' ' GLY . 31.7 ttmt -146.01 135.55 11.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.278 -0.569 . . . . 2.26 111.574 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.615 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 49.4 Cg_endo -74.28 -22.46 16.49 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.245 2.63 . . . . 1.81 110.992 174.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.661 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 101.9 -147.42 17.41 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.264 -0.88 . . . . 2.45 112.835 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 129' ' ' ILE . 4.2 mt -75.67 -26.79 18.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.027 -0.586 . . . . 4.01 110.615 -176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.75 HD21 ' H ' ' A' ' 130' ' ' LEU . 2.2 pt? -96.92 177.47 5.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.52 -0.764 . . . . 2.97 110.517 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.03 -46.69 33.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.484 . . . . 3.28 110.873 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.858 HG21 ' HE2' ' A' ' 136' ' ' LYS . 13.5 m -53.66 122.04 9.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.802 -1.09 . . . . 4.33 111.789 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 127' ' ' PRO . 89.3 mttt -86.63 5.56 35.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.217 -0.901 . . . . 5.43 109.219 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.769 ' H ' HG23 ' A' ' 132' ' ' THR . . . -111.41 159.31 18.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.357 0.873 . . . . 1.51 113.357 -172.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.899 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 26.0 mt -103.19 90.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.845 -1.07 . . . . 1.5 110.79 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.858 ' HE2' HG21 ' A' ' 132' ' ' THR . 36.7 pttt -111.48 -2.38 15.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.451 0.537 . . . . 1.99 112.451 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.899 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -120.41 170.29 9.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.465 0.543 . . . . 1.1 112.465 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 16.3 m120 -47.98 -156.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.901 1.681 . . . . 1.8 113.745 172.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.826 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 33.2 m-85 -27.48 -57.96 0.1 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 125.175 1.39 . . . . 1.68 114.022 -164.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.762 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 24.2 m 42.94 95.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.046 0.758 . . . . 1.05 113.046 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.675 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.3 t -88.33 147.13 24.92 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.997 -0.681 . . . . 1.38 110.786 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.439 ' O ' HD13 ' A' ' 39' ' ' LEU . 5.2 m-85 -102.32 133.99 46.33 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.371 -0.974 . . . . 0.53 108.371 169.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.881 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.35 104.05 11.53 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.001 -0.74 . . . . 1.2 109.001 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.622 HG23 HD12 ' A' ' 15' ' ' ILE . 10.7 mm -104.07 116.86 48.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.92 -0.582 . . . . 1.05 109.737 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' HB2' HD11 ' A' ' 170' ' ' LEU . 6.9 t70 -74.68 169.85 17.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.017 -0.538 . . . . 1.3 109.846 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.867 ' HD3' ' HA ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -60.36 -9.66 3.81 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.329 -0.851 . . . . 4.43 112.09 -168.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.2 8.78 28.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.864 -0.791 . . . . 1.18 108.864 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.522 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 71.57 45.49 45.41 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.25 112.559 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 79.7 t -123.24 123.06 26.69 Favored Pre-proline 0 C--N 1.321 -0.671 0 O-C-N 122.85 -0.206 . . . . 1.32 110.664 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.542 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -68.12 102.75 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.244 2.63 . . . . 0.46 112.417 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.49 ' HB ' HD23 ' A' ' 143' ' ' LEU . 18.8 t -88.49 -15.35 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 1.09 110.806 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.485 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 28.2 mm-40 -168.08 164.54 13.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.094 0.474 . . . . 1.22 111.273 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.661 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 20.3 ttm180 -133.95 99.31 4.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 2.25 109.546 173.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.881 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.5 m-85 -87.25 125.31 34.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.738 -0.838 . . . . 0.38 108.738 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.742 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 95.4 p -69.01 174.29 2.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.617 0.644 . . . . 1.49 109.357 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.859 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 62.8 Cg_endo -68.31 -13.8 38.66 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.062 1.841 . . . . 0.74 111.48 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.13 1.72 79.06 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.835 -1.075 . . . . 0.56 111.699 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.92 133.77 35.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.981 0.42 . . . . 1.14 110.306 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.6 m -90.95 178.52 6.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.109 -0.496 . . . . 1.64 110.221 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.548 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 45.1 t -54.61 -55.9 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 1.14 111.034 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.8 tptp -62.91 -29.23 70.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 3.84 111.265 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.65 -41.12 89.81 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.347 -0.612 . . . . 1.86 109.347 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.693 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.9 mt -82.31 -38.44 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.891 . . . . 1.05 111.344 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 49.0 mt-10 -54.59 -41.86 70.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.297 0.48 . . . . 0.88 112.297 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.1 pt-20 -65.62 -11.78 47.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.444 0.535 . . . . 0.75 112.444 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 73.6 mmtt -109.89 -16.2 13.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.492 . . . . 2.11 110.386 174.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.585 ' HG ' HD12 ' A' ' 171' ' ' LEU . 67.1 tp -95.61 -42.68 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.742 -0.663 . . . . 1.06 111.845 -171.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.632 ' HA ' HD11 ' A' ' 171' ' ' LEU . 80.6 mt -49.79 -51.31 61.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.547 0.573 . . . . 1.14 112.547 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 57.0 Cg_exo -55.09 -30.94 72.94 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.271 1.981 . . . . 0.74 113.154 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 145' ' ' ASP . 64.7 mt -81.73 -34.21 30.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.52 0.2 . . . . 1.35 110.75 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.839 HD22 ' HG2' ' A' ' 37' ' ' PRO . 12.6 mt -64.31 -41.4 96.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.694 0.759 . . . . 1.16 109.245 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.47 12.21 2.72 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 114.411 -1.268 . . . . 1.52 113.278 171.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.867 ' HA ' ' HD3' ' A' ' 146' ' ' ARG . 19.3 t 78.2 130.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.413 1.085 . . . . 2.89 111.562 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.468 ' H ' ' NE ' ' A' ' 146' ' ' ARG . . . -90.09 -32.7 16.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.348 0.499 . . . . 3.56 112.348 -174.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.638 ' HG3' HD11 ' A' ' 176' ' ' LEU . 23.5 ptt180 -144.74 -0.14 0.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.765 0.654 . . . . 8.59 112.765 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.699 HD13 HH12 ' A' ' 146' ' ' ARG . 10.8 mp . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.443 -0.789 . . . . 5.3 110.059 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.833 -0.507 . . . . 5.87 111.833 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 54.9 ttp -98.74 -50.02 4.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.714 0.292 . . . . 5.34 110.683 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.63 90.17 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.375 -0.917 . . . . 1.87 112.923 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -123.3 -35.39 2.97 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.726 -0.842 . . . . 2.22 108.726 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.0 p -145.08 174.85 10.69 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.979 -1.01 . . . . 1.06 108.543 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.677 HD13 HG22 ' A' ' 144' ' ' ILE . 13.0 pt -65.15 -22.92 32.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 1.08 111.203 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.844 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 52.6 m-85 -79.79 -0.28 33.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.195 -0.457 . . . . 0.3 111.951 -172.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.91 -12.37 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.395 0.616 . . . . 1.96 109.52 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 91.2 m-85 -109.9 140.32 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.435 -0.802 . . . . 0.4 110.991 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.99 140.6 33.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.698 -0.683 . . . . 2.77 110.631 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.589 HG22 HD13 ' A' ' 30' ' ' LEU . 70.0 t -114.46 148.74 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.935 0.398 . . . . 1.39 110.914 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.809 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 81.6 mt -111.54 141.62 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 1.33 109.246 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.03 -171.75 2.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.487 -0.561 . . . . 1.59 109.487 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.24 -32.93 57.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.605 -0.27 . . . . 1.14 111.671 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.6 t70 -90.86 -8.33 49.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.597 -0.274 . . . . 2.22 111.402 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.809 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.9 m-70 80.71 22.55 0.39 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.88 110.239 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -81.61 160.68 63.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 105.685 -1.968 . . . . 3.67 105.685 166.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.8 113.67 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 120.093 1.069 . . . . 1.19 111.727 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 1.004 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 58.2 t80 -80.67 130.07 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 0.98 109.969 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.752 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.5 t-20 -80.67 81.99 6.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.07 -0.715 . . . . 1.65 109.07 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.844 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -67.86 -32.38 72.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.198 0.523 . . . . 1.08 110.219 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.701 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.33 -0.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.428 -0.806 . . . . 1.15 112.634 -169.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.752 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.6 pt20 -83.55 -6.04 59.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.609 0.719 . . . . 1.94 109.164 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 1.004 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 87.0 m-70 -91.73 -9.78 42.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.991 -1.114 . . . . 0.38 107.991 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -70.9 137.48 49.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.19 -1.368 . . . . 2.22 109.157 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 -10.56 53.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 109.913 -1.275 . . . . 0.36 109.913 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 49.6 m -141.0 144.78 36.49 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.822 -0.807 . . . . 1.58 108.822 177.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.994 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 60.8 Cg_endo -71.89 155.69 57.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.909 1.739 . . . . 0.86 111.259 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HB2' HG23 ' A' ' 70' ' ' THR . 1.7 pt? -154.19 152.68 30.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.153 0.501 . . . . 1.63 111.217 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.88 HD23 HG23 ' A' ' 163' ' ' ILE . 6.8 mp -108.0 152.5 24.4 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.775 -0.824 . . . . 1.69 108.775 172.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 78.9 mt -140.84 115.48 5.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.542 -0.54 . . . . 1.05 109.542 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.903 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 17.7 m-85 -102.42 123.65 46.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 121.166 -0.213 . . . . 0.93 110.982 -173.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.681 ' HB3' HG12 ' A' ' 110' ' ' VAL . 1.1 p30 -82.23 91.3 6.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.545 -0.909 . . . . 1.97 108.545 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.614 HG12 ' HE2' ' A' ' 98' ' ' PHE . 1.7 p -111.95 125.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 112.455 0.539 . . . . 1.48 112.455 -165.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.63 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.27 107.16 0.45 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.744 -1.576 . . . . 1.17 106.744 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.054 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 3.3 p -76.71 75.67 3.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.28 -1.327 . . . . 2.3 113.483 -156.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 82.6 tttt 92.45 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.627 1.171 . . . . 2.81 111.538 174.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.6 m -141.57 143.26 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.446 -0.343 . . . . 1.18 110.674 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.28 -136.69 19.15 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.031 -0.604 . . . . 1.42 114.222 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.58 111.84 24.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 3.45 111.815 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 p -73.33 -26.7 61.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.981 -0.554 . . . . 1.94 110.648 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.834 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 39.2 mtpt 64.54 3.02 1.77 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.33 -0.85 . . . . 2.51 112.259 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.84 -3.94 34.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.824 -0.703 . . . . 0.55 112.641 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.15 79.83 Favored Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 111.702 -0.559 . . . . 0.39 111.702 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.579 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -69.25 -52.72 24.9 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.073 0.463 . . . . 1.05 110.138 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.29 -41.55 93.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.488 -0.778 . . . . 2.46 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.6 m -68.51 -40.82 80.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.816 -0.629 . . . . 1.06 110.876 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.673 ' HB3' HG12 ' A' ' 71' ' ' VAL . . . -64.98 -49.3 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 1.03 111.283 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -59.18 -48.9 79.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.835 -0.621 . . . . 1.09 111.177 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -63.8 -46.16 86.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.816 -0.629 . . . . 1.69 111.27 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.677 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.78 -46.0 90.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 1.46 111.338 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.671 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 59.0 t80 -53.74 -57.34 11.19 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 123.277 0.361 . . . . 0.92 110.427 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -67.14 -41.57 85.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.291 -0.413 . . . . 1.88 111.555 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.77 -42.79 73.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 2.27 111.717 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.741 ' CD1' HD13 ' A' ' 171' ' ' LEU . 67.7 m-85 -103.9 3.78 34.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.445 0.905 . . . . 0.9 113.445 -172.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -58.48 -29.74 66.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 2.62 110.788 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.6 p -65.32 -38.55 90.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.59 111.237 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -89.24 1.89 55.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.816 0.341 . . . . 1.9 111.255 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 93.08 73.43 1.23 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.701 -0.761 . . . . 1.32 112.006 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.585 ' CE1' HD12 ' A' ' 39' ' ' LEU . 76.7 t80 -143.09 142.13 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.526 0.203 . . . . 0.4 111.06 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.555 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.98 141.45 49.29 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 120.823 0.344 . . . . 1.11 110.207 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.673 HG12 ' HB3' ' A' ' 57' ' ' ALA . 52.9 t -108.01 114.06 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.74 0.305 . . . . 1.06 110.448 168.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 31.2 mt -98.48 122.63 41.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.828 -0.804 . . . . 1.23 108.828 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -109.51 113.42 26.19 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.388 -0.525 . . . . 1.04 110.345 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.751 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.4 m-85 -95.05 108.22 36.9 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.54 -0.911 . . . . 0.45 108.54 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.054 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.2 Cg_exo -59.76 167.67 6.56 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 123.164 2.576 . . . . 0.73 111.555 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.63 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 70.9 m -108.25 138.82 43.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.55 -1.26 . . . . 2.02 113.606 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 79' ' ' PHE . 36.9 t30 -107.77 94.61 5.17 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 112.522 -2.126 . . . . 3.1 110.472 -174.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.677 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -51.95 -9.38 0.09 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.324 1.449 . . . . 3.18 114.683 -176.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 77' ' ' ASN . 64.8 m-85 -89.14 -15.18 34.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.738 0.304 . . . . 4.52 111.8 -166.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.88 -39.05 60.06 Favored Glycine 0 CA--C 1.506 -0.504 0 N-CA-C 110.908 -0.877 . . . . 1.45 110.908 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.96 -85.03 0.24 Allowed Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 120.778 -0.725 . . . . 1.43 112.031 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.717 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -89.22 32.77 0.82 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.798 0.666 . . . . 1.43 112.798 -169.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.677 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -61.09 154.29 62.03 Favored Pre-proline 0 C--N 1.321 -0.658 0 O-C-N 121.982 -0.449 . . . . 3.06 110.719 -177.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.768 ' HG3' HG22 ' A' ' 135' ' ' ILE . 0.5 OUTLIER -29.01 149.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.463 1 C-N-CA 125.476 4.117 . . . . 1.61 116.818 -176.515 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.32 10.77 85.94 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.841 -1.072 . . . . 1.83 110.466 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.22 44.12 25.46 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.182 -0.673 . . . . 4.24 109.182 -173.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HG3' ' HG3' ' A' ' 88' ' ' GLU . 11.4 pt-20 49.36 -175.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.879 1.272 . . . . 2.47 112.026 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' HG3' ' HG3' ' A' ' 87' ' ' GLU . 35.9 mt-10 64.57 3.36 1.9 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.503 -0.771 . . . . 3.64 112.833 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -81.28 -13.79 58.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.682 -0.859 . . . . 2.42 108.682 172.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.66 HG12 ' SG ' ' A' ' 95' ' ' CYS . 21.1 mt -110.78 40.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.473 -1.24 . . . . 2.56 109.657 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 60.2 mtpt -96.38 123.66 40.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.126 -0.943 . . . . 4.36 108.584 171.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 2.7 pt-20 72.95 -37.56 0.39 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.365 1.066 . . . . 3.1 109.502 -170.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 91' ' ' LYS . 41.1 m-85 -74.77 152.53 39.03 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.603 -0.888 . . . . 2.15 108.603 169.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.55 121.59 53.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.193 0.52 . . . . 2.13 109.817 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.799 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 56.1 m -97.03 120.89 38.23 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.054 -0.659 . . . . 0.91 111.232 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.911 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 17.0 m -153.0 115.28 4.41 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.225 -0.898 . . . . 2.41 109.304 168.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.659 ' O ' HG21 ' A' ' 104' ' ' ILE . 87.6 mttt 64.27 -40.24 0.24 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 115.006 1.484 . . . . 3.5 115.006 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.663 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER 63.2 -36.55 0.15 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.004 1.322 . . . . 1.74 112.308 -171.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 97' ' ' LYS . 70.9 mmtt 69.54 130.86 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.828 0.851 . . . . 3.53 112.581 172.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.574 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -158.88 -171.38 3.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.847 -0.615 . . . . 1.09 112.397 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.62 31.44 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.419 -0.81 . . . . 2.19 111.092 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.871 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 39.2 p90 -150.43 167.31 13.24 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 108.154 -1.054 . . . . 0.39 108.154 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.1 Cg_exo -64.04 106.52 0.67 Allowed 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 123.597 2.865 . . . . 0.48 113.527 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.979 HG13 ' HB2' ' A' ' 73' ' ' ALA . 2.4 mp -103.43 131.52 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.991 -0.744 . . . . 1.13 108.991 174.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.751 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.5 mmt -109.94 -154.17 0.53 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.118 0.784 . . . . 2.08 113.118 -161.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -69.56 125.22 26.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.123 -0.944 . . . . 1.11 110.496 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.911 ' HE3' ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -64.5 120.55 12.53 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.617 -0.883 . . . . 2.12 108.617 172.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.752 HG13 HG13 ' A' ' 110' ' ' VAL . 9.2 pt -121.39 155.04 25.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.29 -1.004 . . . . 1.19 108.29 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -83.19 69.61 9.94 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.123 -1.066 . . . . 2.16 108.123 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.752 HG13 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.7 90.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.579 -0.737 . . . . 1.1 111.007 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.717 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 46.5 t30 174.16 172.55 0.19 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.505 -0.924 . . . . 1.98 108.505 166.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.21 -142.49 23.23 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 114.471 0.548 . . . . 0.78 114.471 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -1.52 32.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.49 0.662 . . . . 1.98 110.558 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -95.68 -13.15 24.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.089 -0.959 . . . . 2.1 110.688 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.488 ' HB3' ' H ' ' A' ' 111' ' ' ASN . . . -57.84 149.52 22.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.562 -0.745 . . . . 1.17 111.913 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.824 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 20.2 t-80 -46.99 139.73 6.72 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.118 -0.946 . . . . 0.51 110.131 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.501 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 11.0 Cg_endo -54.18 -35.34 82.21 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.224 2.616 . . . . 0.43 112.437 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.824 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 23.4 tp -61.57 -40.46 94.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.908 -0.587 . . . . 1.69 110.572 175.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.528 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.9 m-85 -75.63 -28.9 58.98 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.224 -0.443 . . . . 1.84 111.009 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.501 ' OE2' ' HA ' ' A' ' 117' ' ' PRO . 40.2 mt-10 -57.6 -39.96 77.99 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.951 -0.7 . . . . 2.37 109.181 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.489 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 79.1 t80 -71.67 -41.74 68.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 1.09 110.519 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.708 ' HE2' HD12 ' A' ' 118' ' ' LEU . 65.6 mtt -66.68 -53.01 38.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.133 -0.485 . . . . 1.06 111.576 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 13.8 mtpt -61.26 -39.63 91.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.541 -0.3 . . . . 1.42 110.958 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -68.58 -32.36 72.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.78 0.324 . . . . 2.63 110.484 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.553 HG22 ' HD2' ' A' ' 150' ' ' PRO . 89.3 m -66.23 -58.75 4.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 1.09 110.979 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.824 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 25.9 ttmt -132.81 128.16 20.66 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 120.509 -0.476 . . . . 2.26 110.521 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.64 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 84.9 Cg_endo -84.99 -162.38 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.526 2.817 . . . . 1.81 111.641 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -84.59 23.76 7.17 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.573 -0.822 . . . . 2.45 111.36 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.1 mt 79.81 -18.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 123.908 0.883 . . . . 4.01 110.408 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.494 HD13 ' HZ1' ' A' ' 136' ' ' LYS . 1.7 pt? -110.54 176.44 5.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.644 . . . . 2.97 110.999 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -51.16 -38.4 51.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.512 0.93 . . . . 3.28 113.512 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.485 HG23 ' HE2' ' A' ' 136' ' ' LYS . 2.3 m -44.49 -47.94 10.07 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.076 0.769 . . . . 4.33 113.076 -169.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 127' ' ' PRO . 69.0 mttm 64.39 -7.62 0.23 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.696 0.623 . . . . 5.43 111.781 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.554 ' HB2' ' OD1' ' A' ' 111' ' ' ASN . . . -105.7 172.41 6.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 114.813 1.412 . . . . 1.51 114.813 -164.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.862 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 51.0 mt -104.66 87.88 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 113.681 -1.6 . . . . 1.5 110.257 -173.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.494 ' HZ1' HD13 ' A' ' 130' ' ' LEU . 29.7 pttt -110.57 14.98 22.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.477 0.547 . . . . 1.99 112.477 -170.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.862 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -146.7 169.38 19.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.923 0.342 . . . . 1.1 111.923 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.625 ' ND2' ' HB3' ' A' ' 44' ' ' ALA . 1.5 t-20 -51.66 -155.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.535 1.534 . . . . 1.8 113.223 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.903 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 27.4 m-85 -25.43 -59.68 0.07 Allowed 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 125.298 1.439 . . . . 1.68 114.794 -162.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.779 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 19.2 m 42.69 93.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 118.684 0.675 . . . . 1.05 112.738 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.0 p -84.59 150.62 25.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.689 -0.804 . . . . 1.38 110.491 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.47 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 4.5 m-85 -103.75 135.65 44.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.226 -1.027 . . . . 0.53 108.226 167.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.906 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 35.9 tp -82.01 104.85 12.66 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.994 -0.743 . . . . 1.2 108.994 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.677 HG22 HD13 ' A' ' 15' ' ' ILE . 14.6 mm -102.44 121.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.947 -0.76 . . . . 1.05 108.947 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.716 ' HB2' ' HB3' ' A' ' 174' ' ' ALA . 0.4 OUTLIER -72.41 -179.39 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.568 -0.287 . . . . 1.3 110.994 -176.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.634 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.6 mtp180 -56.23 -28.59 58.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.243 0.46 . . . . 4.43 112.243 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 175' ' ' ARG . 12.5 t70 -109.77 -4.75 15.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.186 0.517 . . . . 1.18 110.791 -169.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.578 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.09 53.46 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.491 -0.861 . . . . 0.25 114.353 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.554 HG23 HH22 ' A' ' 175' ' ' ARG . 10.3 t -127.7 128.82 23.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 117.382 0.591 . . . . 1.32 110.151 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.553 ' HD2' HG22 ' A' ' 125' ' ' THR . 15.3 Cg_exo -66.26 102.64 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.946 2.431 . . . . 0.46 112.388 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.47 -18.42 8.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.656 -0.702 . . . . 1.09 110.925 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.824 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 77.0 mm-40 -157.07 159.42 37.9 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.682 0.277 . . . . 1.22 110.915 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.64 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 20.1 ttm180 -127.44 96.83 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.01 -0.737 . . . . 2.25 109.01 168.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.906 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 33.9 m-85 -86.42 107.88 18.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.908 -0.775 . . . . 0.38 108.908 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.734 ' HA ' HG22 ' A' ' 140' ' ' THR . 83.5 p -60.6 164.93 6.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.89 -0.411 . . . . 1.49 109.89 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.834 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 42.0 Cg_endo -65.24 -7.6 16.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.032 2.488 . . . . 0.74 112.978 -164.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.95 22.46 38.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.56 111.718 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.04 140.23 29.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 1.14 110.813 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.9 p -91.32 170.13 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.734 -0.667 . . . . 1.64 111.029 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.677 HG13 HD21 ' A' ' 60' ' ' LEU . 74.5 t -53.18 -56.09 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 1.14 110.955 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.575 ' HZ3' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -65.64 -32.05 73.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 3.84 111.461 -175.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.74 -31.78 73.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.121 -0.49 . . . . 1.86 109.922 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.88 HG23 HD23 ' A' ' 39' ' ' LEU . 35.6 mt -83.19 -39.83 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.994 -0.548 . . . . 1.05 110.7 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 54.7 mt-10 -57.79 -35.63 71.08 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.133 0.42 . . . . 0.88 112.133 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.4 pt-20 -61.32 -21.38 63.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.75 111.648 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.548 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtt -104.8 -31.5 9.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.233 -0.44 . . . . 2.11 110.549 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.3 tp -85.58 -42.43 14.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 1.06 112.758 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.652 ' HA ' HD11 ' A' ' 171' ' ' LEU . 60.8 mt -53.94 -46.97 98.38 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.504 0.557 . . . . 1.14 112.504 -173.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.438 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.9 Cg_exo -53.13 -40.16 77.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.809 1.672 . . . . 0.74 112.371 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.6 mt -74.4 -37.05 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 1.35 111.794 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.994 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.8 mt -54.27 -54.07 45.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.539 0.685 . . . . 1.16 109.497 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.7 -59.78 8.77 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.276 -1.329 . . . . 1.52 112.795 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.2 p -167.05 126.03 1.39 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.923 0.362 . . . . 2.89 110.857 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.716 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . . . -94.14 -57.46 2.52 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.103 0.478 . . . . 3.56 111.106 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.554 HH22 HG23 ' A' ' 149' ' ' VAL . 17.9 ptp180 -131.5 4.69 4.31 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.389 -0.967 . . . . 8.59 108.389 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 C--O 1.246 0.87 0 N-CA-C 106.968 -1.493 . . . . 5.3 106.968 -176.775 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.096 -0.401 . . . . 5.87 112.096 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 67.2 mtt -93.16 140.07 29.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.307 -0.257 . . . . 5.34 110.307 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.11 27.84 6.08 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.853 -0.689 . . . . 1.87 111.619 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 m -84.21 -45.33 13.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.825 0.345 . . . . 2.22 110.664 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.3 p -124.33 -179.41 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.596 -0.52 . . . . 1.06 109.596 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.79 HD12 HG22 ' A' ' 144' ' ' ILE . 32.5 pt -68.3 -31.07 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.83 0.348 . . . . 1.08 111.358 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.766 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 29.8 m-85 -72.95 -4.62 33.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.906 0.384 . . . . 0.3 111.594 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.52 -14.22 62.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.83 -0.623 . . . . 1.96 109.366 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.631 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 84.1 m-85 -111.62 142.34 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.373 -0.83 . . . . 0.4 110.701 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -100.18 140.18 34.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.68 -0.489 . . . . 2.77 109.68 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.57 ' CG2' ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -123.3 159.77 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.378 -0.374 . . . . 1.39 110.804 -171.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.906 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 58.7 mt -97.26 133.34 42.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.531 . . . . 1.33 110.214 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 21.2 t70 -69.78 178.18 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.702 -1.135 . . . . 1.59 109.584 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.658 ' HB3' ' CD ' ' A' ' 97' ' ' LYS . . . -55.43 -25.04 33.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.968 0.413 . . . . 1.14 111.417 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -90.91 -9.82 44.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.206 -0.452 . . . . 2.22 111.111 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.906 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 44.9 m-70 74.51 12.88 3.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.912 0.885 . . . . 0.88 109.994 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.546 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -73.37 150.36 89.39 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 106.126 -1.805 . . . . 3.67 106.126 162.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.23 115.16 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.81 1.007 . . . . 1.19 111.425 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.889 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 87.9 t80 -84.42 122.28 28.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.98 109.825 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.674 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.0 t30 -75.24 82.15 2.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.839 -0.619 . . . . 1.65 109.645 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.737 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.2 pt? -63.06 -29.74 71.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.594 0.711 . . . . 1.08 110.28 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.766 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.6 p -77.31 -0.03 2.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.828 -1.078 . . . . 1.15 112.933 -169.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -78.35 -5.45 52.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.359 -0.608 . . . . 1.94 109.359 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.889 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 77.5 m-70 -98.42 -0.75 42.99 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.38 108.759 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HE2' ' CG2' ' A' ' 31' ' ' VAL . 9.2 ttmm -67.97 132.4 47.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 2.22 109.914 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.46 -0.99 60.06 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.515 -1.034 . . . . 0.36 110.515 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 44.8 m -140.33 138.49 19.12 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.237 -0.653 . . . . 1.58 109.237 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.976 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 43.8 Cg_endo -69.44 154.87 68.42 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.769 1.646 . . . . 0.86 110.893 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.603 ' CB ' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -156.52 148.36 22.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.167 0.508 . . . . 1.63 111.323 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.638 HD22 ' CE1' ' A' ' 69' ' ' PHE . 3.4 mm? -107.12 148.63 28.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.113 -1.069 . . . . 1.69 108.113 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.538 HD12 HG13 ' A' ' 144' ' ' ILE . 69.6 mt -139.55 116.38 10.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.74 -0.467 . . . . 1.05 109.74 -173.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.696 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 16.4 m-85 -101.39 130.31 47.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.602 -0.272 . . . . 0.93 111.313 -172.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.672 ' CB ' HG13 ' A' ' 110' ' ' VAL . 1.1 p30 -87.96 92.04 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.394 -0.965 . . . . 1.97 108.394 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -106.53 150.13 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.453 0.644 . . . . 1.48 112.348 -160.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.31 109.0 5.06 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.2 -1.407 . . . . 1.17 107.2 166.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.002 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -66.76 74.46 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.005 -0.998 . . . . 2.3 112.6 -169.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.74 ' HE3' ' HA ' ' A' ' 98' ' ' PHE . 39.6 ttmt 55.73 57.44 5.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.156 -0.929 . . . . 2.81 111.119 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -160.87 128.14 4.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.108 -0.496 . . . . 1.18 111.288 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.52 -80.9 1.78 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.847 -0.615 . . . . 1.42 113.662 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -131.72 163.18 28.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.423 0.154 . . . . 3.45 110.949 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 p -131.82 -35.69 1.25 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.143 0.423 . . . . 1.94 112.143 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 65.77 0.39 1.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.478 0.711 . . . . 2.51 112.259 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.75 4.97 72.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.666 -0.778 . . . . 0.55 112.259 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.0 86.73 Favored Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.37 -0.692 . . . . 0.39 111.37 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.489 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.3 t80 -61.75 -52.75 62.98 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.941 -0.629 . . . . 1.05 110.254 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.37 -45.97 90.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.765 -0.652 . . . . 2.46 110.668 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 160' ' ' VAL . 30.1 m -57.08 -48.69 77.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.682 -0.69 . . . . 1.06 110.481 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.755 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -61.53 -50.02 74.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 1.03 111.785 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -61.1 -42.98 99.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.173 0.511 . . . . 1.09 111.005 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.8 m -64.67 -47.77 77.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.576 -0.738 . . . . 1.69 111.223 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 90.5 mt -56.52 -52.58 64.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.187 -0.461 . . . . 1.46 111.165 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.665 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 47.3 t80 -46.99 -57.87 4.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 124.435 1.085 . . . . 0.92 110.117 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.34 -38.85 65.61 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.736 -0.665 . . . . 1.88 111.919 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -70.01 -45.14 67.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 2.27 111.301 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.743 ' CD1' HD12 ' A' ' 171' ' ' LEU . 58.6 m-85 -100.02 5.83 45.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.194 0.813 . . . . 0.9 113.194 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.665 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 17.8 mtpp -62.03 -18.67 61.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 2.62 110.073 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 p -61.67 -40.69 95.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.687 -0.688 . . . . 1.59 110.874 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -94.92 10.18 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 1.9 110.599 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.575 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.14 71.66 1.26 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.571 -0.741 . . . . 1.32 112.255 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE1' HD22 ' A' ' 39' ' ' LEU . 59.4 t80 -132.62 142.43 49.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.229 -0.285 . . . . 0.4 110.229 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.603 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.36 152.44 48.16 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.973 0.416 . . . . 1.11 110.622 178.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.755 HG11 ' HB3' ' A' ' 57' ' ' ALA . 25.0 t -122.82 124.66 70.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.864 0.364 . . . . 1.06 110.437 171.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.595 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 16.5 mt -105.68 145.05 31.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.823 -0.806 . . . . 1.23 108.823 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.97 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -132.79 113.46 12.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.133 0.492 . . . . 1.04 111.108 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.639 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.6 m-85 -99.01 113.57 64.74 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.698 -0.683 . . . . 0.45 109.306 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.097 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.29 165.85 6.73 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.562 2.841 . . . . 0.73 111.818 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.575 ' HB3' HE22 ' A' ' 78' ' ' GLN . 32.4 t -122.96 137.21 55.01 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 122.604 1.192 . . . . 2.02 113.485 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 79' ' ' PHE . 40.4 t30 -91.12 89.18 7.26 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.164 -1.834 . . . . 3.1 109.139 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.922 ' HB2' HG13 ' A' ' 90' ' ' ILE . 31.3 mm-40 -61.24 -4.16 1.09 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.71 -1.132 . . . . 3.18 112.079 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.428 ' H ' ' C ' ' A' ' 77' ' ' ASN . 26.8 t80 -108.45 30.77 6.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.373 0.606 . . . . 4.52 110.181 -175.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.554 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -97.81 -50.43 1.65 Allowed Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 116.007 -0.542 . . . . 1.45 112.649 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.3 -62.5 0.22 Allowed Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 112.444 -0.263 . . . . 1.43 112.444 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.68 HE22 ' HB3' ' A' ' 114' ' ' ASN . 3.0 pm0 -129.87 41.6 3.4 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 113.257 0.836 . . . . 1.43 113.257 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.73 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 3.9 mp0 -62.74 144.88 96.18 Favored Pre-proline 0 C--N 1.309 -1.188 0 O-C-N 121.834 -0.541 . . . . 3.06 109.95 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.947 ' HG3' HG23 ' A' ' 135' ' ' ILE . 41.4 Cg_exo -20.32 -115.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.418 1 C-N-CA 126.425 4.75 . . . . 1.61 116.346 -165.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.16 -18.7 21.18 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.533 -1.427 . . . . 1.83 109.533 171.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 16.5 m120 -88.5 43.25 1.12 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.736 -0.732 . . . . 4.24 111.828 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.07 135.22 53.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.648 0.261 . . . . 2.47 110.435 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 59.56 28.79 18.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.19 -0.459 . . . . 3.64 111.43 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.681 ' HB3' ' HG3' ' A' ' 78' ' ' GLN . 6.0 tp10 -68.52 -13.31 62.24 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 120.551 0.215 . . . . 2.42 111.045 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.922 HG13 ' HB2' ' A' ' 78' ' ' GLN . 1.0 OUTLIER -87.11 18.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.061 0.458 . . . . 2.56 110.305 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 92' ' ' GLU . 19.4 pttm -59.72 109.99 1.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.47 -0.567 . . . . 4.36 109.47 172.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.555 ' HB3' ' O ' ' A' ' 91' ' ' LYS . 1.1 tp10 74.74 -47.43 0.62 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.712 0.632 . . . . 3.1 110.732 -171.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.55 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 55.8 m-85 -63.6 175.4 1.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.424 0.631 . . . . 2.15 112.237 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 94' ' ' VAL . 3.8 p -132.83 111.92 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.684 -1.228 . . . . 2.13 107.684 172.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.798 ' SG ' HG12 ' A' ' 90' ' ' ILE . 38.6 m -90.43 120.3 31.42 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 118.589 -1.244 . . . . 0.91 110.01 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.53 ' N ' ' HB2' ' A' ' 45' ' ' SER . 10.3 t -148.36 163.49 36.92 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.747 -1.115 . . . . 2.41 108.52 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.658 ' CD ' ' HB3' ' A' ' 23' ' ' ALA . 16.5 pttt -38.85 105.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.883 0.739 . . . . 3.5 111.344 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.74 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 51.5 p90 -58.21 -22.58 52.53 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.589 -0.732 . . . . 1.74 110.92 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? 68.83 142.82 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.168 0 O-C-N 124.282 0.989 . . . . 3.53 110.473 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.45 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . . . -162.26 -160.33 0.66 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.468 -0.493 . . . . 1.09 111.732 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.91 -10.57 44.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 2.19 109.769 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.705 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 51.7 p90 -112.31 166.85 10.11 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 115.173 -0.921 . . . . 0.39 108.934 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.668 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 23.9 Cg_exo -70.61 119.31 6.24 Favored 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 123.712 2.942 . . . . 0.48 113.306 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.97 HG13 ' HB2' ' A' ' 73' ' ' ALA . 3.3 mp -108.21 149.44 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.889 -0.782 . . . . 1.13 108.889 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.639 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 13.3 mmt -118.49 -157.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.17 0.804 . . . . 2.08 113.17 -164.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.526 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.69 145.5 43.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.929 -1.032 . . . . 1.11 110.359 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.097 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.2 pttt -83.37 137.16 34.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.654 0.74 . . . . 2.12 109.785 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.471 HG13 HG11 ' A' ' 110' ' ' VAL . 5.0 pt -135.35 175.18 11.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.204 -1.362 . . . . 1.19 108.01 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.554 HD21 ' HA3' ' A' ' 80' ' ' GLY . 22.7 t-20 -88.34 83.96 6.86 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.97 -0.752 . . . . 2.16 108.97 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.721 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -76.08 86.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.455 -1.298 . . . . 1.1 110.157 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 63.7 t30 170.88 179.36 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.86 -1.163 . . . . 1.98 107.86 166.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.449 ' HA3' ' HG3' ' A' ' 82' ' ' GLN . . . 56.75 -146.32 35.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.919 -0.658 . . . . 0.78 113.793 166.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -107.15 1.1 23.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.183 -0.508 . . . . 1.98 111.351 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.68 ' HB3' HE22 ' A' ' 82' ' ' GLN . 28.7 t-20 -103.78 11.8 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.906 0.86 . . . . 2.1 110.065 -174.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -73.88 156.46 37.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 1.17 111.963 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.521 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 35.6 t-80 -57.18 137.69 80.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.07 -0.968 . . . . 0.51 110.5 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.631 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -42.39 -48.78 6.61 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.312 2.675 . . . . 0.43 113.13 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.559 HD22 HG12 ' A' ' 20' ' ' VAL . 13.6 tp -56.01 -41.23 74.58 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.244 -0.435 . . . . 1.69 111.843 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 12.4 m-85 -75.44 -30.71 60.09 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.458 -0.337 . . . . 1.84 110.975 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.518 ' OE1' ' HB3' ' A' ' 115' ' ' ALA . 7.1 mm-40 -59.74 -36.75 77.24 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.141 -0.623 . . . . 2.37 109.417 168.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.4 t80 -67.77 -48.78 65.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 1.09 110.448 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.54 ' HE3' HD13 ' A' ' 118' ' ' LEU . 66.7 mtt -63.08 -53.06 59.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.004 -0.544 . . . . 1.06 111.443 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -60.33 -39.7 88.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 1.42 111.204 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.5 ptmt -71.86 -35.24 69.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.737 0.303 . . . . 2.63 110.801 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.515 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.8 m -70.08 -42.63 72.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.976 -0.556 . . . . 1.09 112.449 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -135.11 120.78 14.14 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.567 0.58 . . . . 2.26 112.567 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 133' ' ' LYS . 33.7 Cg_endo -67.93 -39.67 10.72 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.805 2.336 . . . . 1.81 111.662 172.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.688 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 103.0 -155.72 18.15 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.932 -0.651 . . . . 2.45 112.795 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 33.0 pt -91.2 21.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 4.01 111.322 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -126.5 -175.05 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.388 -0.369 . . . . 2.97 110.752 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.11 8.11 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 112.485 0.55 . . . . 3.28 112.485 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.4 p -117.67 160.02 21.99 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.15 -0.477 . . . . 4.33 112.095 -170.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.463 ' CB ' ' HA ' ' A' ' 127' ' ' PRO . 19.3 ptpt -93.43 41.8 1.09 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.009 -0.542 . . . . 5.43 111.915 -172.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.28 153.53 37.56 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.273 -0.571 . . . . 1.51 111.416 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.947 HG23 ' HG3' ' A' ' 84' ' ' PRO . 25.9 mt -85.71 110.21 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.373 -0.831 . . . . 1.5 109.769 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -130.08 15.74 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.003 0.43 . . . . 1.99 112.029 -170.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.788 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -153.91 173.87 15.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.215 0.531 . . . . 1.1 111.989 -175.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.463 ' HB3' ' HD1' ' A' ' 139' ' ' PHE . 8.8 m120 -43.16 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.74 1.616 . . . . 1.8 115.196 168.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.772 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 15.4 m-85 -30.79 -58.26 0.21 Allowed 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 112.871 -1.968 . . . . 1.68 113.918 -169.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.812 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 12.5 m 44.95 99.64 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.593 0.961 . . . . 1.05 113.593 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 15.9 p -87.78 151.16 23.1 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.467 -0.771 . . . . 1.38 111.268 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.4 m-85 -103.7 133.62 48.4 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.392 -0.966 . . . . 0.53 108.392 168.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.782 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 25.5 tp -81.36 105.41 12.52 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.133 -0.691 . . . . 1.2 109.133 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.79 HG22 HD12 ' A' ' 15' ' ' ILE . 13.2 mm -105.59 126.91 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.605 -0.725 . . . . 1.05 109.083 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.9 OUTLIER -78.69 -175.71 4.53 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.912 -0.315 . . . . 1.3 110.614 -176.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.632 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 63.5 mtt180 -63.23 -16.76 61.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.259 0.466 . . . . 4.43 112.259 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -108.09 -10.04 15.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.437 0.637 . . . . 1.18 110.17 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.585 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 95.82 32.31 6.92 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.538 -0.755 . . . . 0.25 112.672 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 72.1 t -111.9 124.09 33.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.871 -0.418 . . . . 1.32 109.871 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.515 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.1 Cg_exo -68.14 118.39 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.44 2.093 . . . . 0.46 111.573 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.467 ' HB ' HD22 ' A' ' 143' ' ' LEU . 32.4 t -98.06 -26.24 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.712 -0.676 . . . . 1.09 110.417 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 27.1 mm-40 -149.83 163.73 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 1.22 111.509 -177.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.688 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 19.8 ttm180 -131.41 98.19 4.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.439 -0.8 . . . . 2.25 109.071 168.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.782 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 74.1 m-85 -86.95 117.84 25.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.497 -0.557 . . . . 0.38 109.497 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.793 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.0 OUTLIER -63.68 164.3 16.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.665 -0.494 . . . . 1.49 109.665 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.812 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 63.2 Cg_endo -70.65 -6.08 18.23 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.848 2.365 . . . . 0.74 112.495 -167.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.57 5.61 62.47 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.95 -1.023 . . . . 0.56 111.912 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.46 139.11 36.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 1.14 110.139 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.3 m -77.12 163.46 26.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.974 -0.557 . . . . 1.64 111.019 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 34.3 t -53.21 -48.84 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.423 -0.353 . . . . 1.14 110.343 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.424 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.2 tptm -69.79 -28.69 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 3.84 111.034 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.17 -33.84 74.09 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.0 0.429 . . . . 1.86 110.007 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.568 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.0 mt -80.39 -42.21 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.738 -0.665 . . . . 1.05 110.149 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.476 ' O ' HG13 ' A' ' 168' ' ' ILE . 45.2 mt-10 -55.41 -41.63 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.976 -0.556 . . . . 0.88 112.378 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.93 -19.37 60.63 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.241 0.46 . . . . 0.75 112.241 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.708 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -107.2 -17.93 14.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.012 0.435 . . . . 2.11 110.291 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.8 tp -89.98 -39.09 13.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.741 -0.663 . . . . 1.06 111.761 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.659 ' HA ' HD13 ' A' ' 171' ' ' LEU . 80.2 mt -52.48 -47.91 91.81 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.323 0.49 . . . . 1.14 112.323 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.6 Cg_exo -55.43 -27.68 59.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.248 1.966 . . . . 0.74 113.269 175.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.53 -34.52 16.35 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.521 0.201 . . . . 1.35 111.465 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.976 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.5 mt -58.08 -52.56 65.05 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.189 -0.671 . . . . 1.16 109.189 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.81 60.86 2.1 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.717 -1.129 . . . . 1.52 113.189 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m 69.51 105.2 0.06 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.426 0.691 . . . . 2.89 112.159 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -94.59 -28.6 15.31 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.048 -0.523 . . . . 3.56 112.117 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -112.97 -46.49 3.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 8.59 110.284 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.575 -0.726 . . . . 5.3 110.342 179.881 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.872 0 CA-C-O 120.473 -0.07 . . . . 5.87 112.939 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 66.7 mtt -86.78 108.98 18.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.042 -0.355 . . . . 5.34 110.042 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 121' ' ' TYR . . . -60.23 126.74 42.24 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.805 -0.634 . . . . 1.87 113.279 -174.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.7 m -79.93 -40.93 27.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.44 0.638 . . . . 2.22 109.743 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 -177.86 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.018 -0.992 . . . . 1.06 108.719 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.729 HD13 HG21 ' A' ' 144' ' ' ILE . 35.5 pt -66.16 -24.67 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.967 0.413 . . . . 1.08 111.312 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.807 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 27.5 m-85 -82.07 1.64 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.047 0.451 . . . . 0.3 110.823 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.86 -16.99 63.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.355 -0.98 . . . . 1.96 108.355 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 70.4 m-85 -110.66 178.92 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.71 -1.132 . . . . 0.4 110.125 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -124.65 144.57 50.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.764 0.316 . . . . 2.77 110.887 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.592 HG23 HD12 ' A' ' 30' ' ' LEU . 74.2 t -114.85 140.89 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.19 -0.459 . . . . 1.39 111.385 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.945 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 65.1 mt -96.71 140.71 30.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.005 -0.739 . . . . 1.33 109.005 169.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -79.07 -169.0 1.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 1.59 109.824 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' HB1' ' HG3' ' A' ' 97' ' ' LYS . . . -57.31 -22.52 42.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 111.944 0.35 . . . . 1.14 111.944 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.9 t70 -104.74 -2.71 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.69 0.281 . . . . 2.22 111.153 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.945 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.8 m-70 76.57 21.73 1.28 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.628 0.727 . . . . 0.88 109.644 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -83.45 153.67 65.46 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.828 -1.916 . . . . 3.67 105.828 165.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.22 113.83 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.934 1.012 . . . . 1.19 111.997 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.416 ' HB3' HG11 ' A' ' 20' ' ' VAL . 78.5 t80 -84.03 114.6 21.85 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.245 -0.888 . . . . 0.98 109.242 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -67.02 83.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.525 -0.761 . . . . 1.65 109.718 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.807 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -70.54 -33.11 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.236 0.541 . . . . 1.08 110.145 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.718 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -77.57 -0.77 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.427 -0.806 . . . . 1.15 112.843 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.68 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -81.69 -5.61 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.759 0.79 . . . . 1.94 108.936 172.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.642 ' HB3' ' CD2' ' A' ' 38' ' ' LEU . 75.7 m-70 -98.5 3.07 48.16 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.583 -1.19 . . . . 0.38 108.145 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 24.9 ttpt -79.3 136.18 36.95 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.749 -1.114 . . . . 2.22 109.023 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.93 -13.59 52.85 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.254 -1.139 . . . . 0.36 110.254 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 76.3 p -129.8 138.49 33.24 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 109.34 -0.615 . . . . 1.58 109.34 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.938 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 57.7 Cg_endo -74.2 155.46 46.87 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.519 1.479 . . . . 0.86 109.714 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.642 ' CD2' ' HB3' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -159.61 152.51 21.73 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.282 0.563 . . . . 1.63 111.958 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 69' ' ' PHE . 3.6 mm? -107.02 138.44 43.19 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.558 -0.904 . . . . 1.69 108.558 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 70.9 mt -127.58 118.07 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.198 -0.667 . . . . 1.05 109.198 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.82 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.3 m-85 -101.17 123.2 44.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.445 -0.343 . . . . 0.93 111.198 -172.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.71 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -80.52 92.02 5.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.003 -1.11 . . . . 1.97 108.003 169.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.598 HG13 ' HE1' ' A' ' 98' ' ' PHE . 5.8 p -107.99 143.19 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 113.502 0.927 . . . . 1.48 113.502 -160.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.37 101.85 1.3 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.435 -1.32 . . . . 1.17 107.435 166.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.996 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -59.65 87.68 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.973 -1.012 . . . . 2.3 112.882 -170.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 53.38 52.63 13.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.422 -0.808 . . . . 2.81 110.646 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.7 p -164.18 157.01 17.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.797 -0.638 . . . . 1.18 110.83 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.78 -117.2 4.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.932 -0.651 . . . . 1.42 112.717 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.61 166.98 20.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.454 0.645 . . . . 3.45 111.532 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.639 HG23 ' HE1' ' A' ' 139' ' ' PHE . 17.4 p -129.33 107.86 9.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.257 -0.883 . . . . 1.94 109.782 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 27.3 mtpt -83.47 20.07 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 2.51 112.06 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.51 13.87 29.23 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.716 -0.754 . . . . 0.55 111.826 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -40.56 16.05 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.018 -0.61 . . . . 0.39 112.286 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HE1' ' CB ' ' A' ' 100' ' ' ALA . 1.2 t80 -67.9 -48.69 65.31 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.824 0.345 . . . . 1.05 110.177 -176.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.3 -43.89 97.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.9 -0.591 . . . . 2.46 110.902 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.6 m -65.75 -50.9 63.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 1.06 111.142 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.69 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -56.87 -47.59 80.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.202 0.525 . . . . 1.03 110.866 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.452 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 80.2 m -59.74 -51.81 68.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.289 -0.868 . . . . 1.09 111.552 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.4 p -65.95 -39.2 90.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.068 -0.514 . . . . 1.69 111.727 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 85.4 mt -58.73 -51.64 69.09 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 120.503 0.192 . . . . 1.46 111.062 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.761 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 82.9 t80 -53.81 -47.08 71.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.92 109.817 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -73.18 -31.65 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.426 -0.807 . . . . 1.88 111.625 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.84 -36.84 23.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.021 -0.536 . . . . 2.27 111.738 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.659 ' CD1' HD11 ' A' ' 171' ' ' LEU . 58.0 m-85 -114.16 2.05 14.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.499 1.296 . . . . 0.9 114.499 -171.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.633 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 20.4 ptmt -68.71 -16.07 63.71 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.308 -0.957 . . . . 2.62 110.083 175.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 p -59.89 -43.4 94.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.747 -0.66 . . . . 1.59 109.927 171.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -91.36 15.76 11.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 1.9 111.143 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.689 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.46 70.22 1.35 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.999 -0.619 . . . . 1.32 112.452 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 39' ' ' LEU . 54.8 t80 -143.73 139.97 29.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.4 110.537 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.511 HG21 ' HB3' ' A' ' 38' ' ' LEU . 14.9 t -129.39 152.98 48.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.031 0.443 . . . . 1.11 110.077 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.761 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t -113.89 120.75 64.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.387 -0.597 . . . . 1.06 109.387 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.787 ' HB3' ' HE1' ' A' ' 105' ' ' MET . 15.6 mt -107.3 122.13 45.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.892 -0.781 . . . . 1.23 108.892 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.961 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.04 129.71 55.46 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.329 -0.548 . . . . 1.04 110.943 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.475 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.8 m-85 -113.67 108.64 51.41 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.619 -0.719 . . . . 0.45 109.89 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.996 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 33.2 Cg_exo -59.56 156.32 37.35 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 123.505 2.803 . . . . 0.73 111.697 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.676 ' HB3' HE22 ' A' ' 78' ' ' GLN . 47.6 t -128.3 135.71 49.98 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 114.349 1.24 . . . . 2.02 114.349 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.81 88.41 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 113.556 -1.656 . . . . 3.1 108.785 170.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 1.036 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 32.3 mm-40 -61.19 -13.51 18.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.679 -0.691 . . . . 3.18 112.252 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -72.75 -0.45 13.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.767 0.284 . . . . 4.52 111.767 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.61 ' HA3' HD22 ' A' ' 109' ' ' ASN . . . -60.01 -36.07 89.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.998 -0.62 . . . . 1.45 112.527 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.66 -50.45 0.51 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.658 -0.782 . . . . 1.43 112.537 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.513 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -133.25 13.03 4.22 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.723 -0.391 . . . . 1.43 112.021 -177.316 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 1.036 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 2.5 mm-40 -62.19 151.15 82.29 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 116.012 -0.54 . . . . 3.06 110.717 -168.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.766 ' HG3' HG23 ' A' ' 135' ' ' ILE . 14.9 Cg_exo -24.19 147.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 1 C-N-CA 126.423 4.749 . . . . 1.61 117.691 -167.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . 93.49 32.94 7.4 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.238 -1.346 . . . . 1.83 110.127 -174.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.472 HD21 ' N ' ' A' ' 86' ' ' ASN . 0.9 OUTLIER 72.45 -57.38 0.63 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.363 0.665 . . . . 4.24 109.801 -172.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -173.33 129.6 0.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 2.47 109.882 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 48.0 mt-10 59.04 80.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.151 0.501 . . . . 3.64 112.345 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.815 ' HB3' ' HG3' ' A' ' 78' ' ' GLN . 3.8 tp10 -82.47 -14.14 55.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.121 -0.491 . . . . 2.42 110.123 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.891 HG12 ' SG ' ' A' ' 95' ' ' CYS . 1.3 mt -92.13 38.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.599 -0.273 . . . . 2.56 110.788 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.742 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 29.7 mmmt -68.47 103.64 1.71 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.703 -0.48 . . . . 4.36 109.703 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.742 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 0.4 OUTLIER 65.58 -7.74 0.32 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.947 1.299 . . . . 3.1 111.669 -176.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.487 ' H ' ' C ' ' A' ' 91' ' ' LYS . 85.7 m-85 -77.16 176.58 8.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.36 0.6 . . . . 2.15 110.546 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 94' ' ' VAL . 6.6 p -128.6 111.13 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.059 -1.089 . . . . 2.13 108.059 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.891 ' SG ' HG12 ' A' ' 90' ' ' ILE . 79.3 m -91.63 120.7 32.64 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.35 -0.94 . . . . 0.91 110.4 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.764 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 14.0 t -133.58 159.89 39.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.528 -1.215 . . . . 2.41 108.372 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.714 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -58.99 95.7 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.001 0.429 . . . . 3.5 110.149 -175.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.598 ' HE1' HG13 ' A' ' 43' ' ' VAL . 3.8 p90 -54.84 134.83 48.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.059 -1.089 . . . . 1.74 108.059 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -101.64 134.08 45.33 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.548 -0.461 . . . . 3.53 111.011 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.528 ' CB ' ' HE1' ' A' ' 54' ' ' TYR . . . -136.26 -174.97 3.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.337 -0.847 . . . . 1.09 110.939 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.16 16.88 2.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 2.19 110.323 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.696 ' HE1' ' HB1' ' A' ' 73' ' ' ALA . 40.3 p90 -139.36 167.8 17.59 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.594 -0.891 . . . . 0.39 108.594 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.758 ' HB2' ' HE3' ' A' ' 105' ' ' MET . 27.1 Cg_exo -68.6 126.95 14.77 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.683 2.922 . . . . 0.48 113.762 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.961 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -120.92 142.01 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.344 -0.613 . . . . 1.13 109.344 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.787 ' HE1' ' HB3' ' A' ' 72' ' ' LEU . 7.2 mmt -114.01 -154.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.876 0.695 . . . . 2.08 112.876 -164.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.444 ' O ' ' HD2' ' A' ' 75' ' ' PRO . . . -69.77 145.09 52.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.086 -0.961 . . . . 1.11 111.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.764 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 56.4 mttt -73.4 109.79 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.645 -0.872 . . . . 2.12 108.645 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.429 HD11 ' CB ' ' A' ' 116' ' ' HIS . 28.8 pt -121.69 157.57 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.34 -0.985 . . . . 1.19 108.34 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.762 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.2 m120 -66.32 127.02 30.63 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.819 -0.808 . . . . 2.16 108.819 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.625 ' O ' ' HB ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -121.45 88.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 C-N-CA 119.746 -0.781 . . . . 1.1 109.006 167.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.661 ' OD1' ' HB3' ' A' ' 134' ' ' ALA . 16.4 t-20 173.14 179.09 0.09 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.066 -1.087 . . . . 1.98 108.066 168.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 48.29 -137.29 15.23 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.757 0.661 . . . . 0.78 114.59 163.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -104.52 -6.95 20.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.462 -0.869 . . . . 1.98 110.186 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -84.14 -24.52 30.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.292 -0.867 . . . . 2.1 111.449 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.762 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.97 141.49 3.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.058 1.133 . . . . 1.17 114.058 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.882 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 43.8 t-80 -48.75 139.71 11.41 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 114.894 -1.048 . . . . 0.51 110.378 171.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.25 -42.55 46.88 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.899 2.399 . . . . 0.43 112.789 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.882 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 1.3 tm? -54.81 -42.52 71.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.062 -0.517 . . . . 1.69 110.647 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.415 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -76.09 -30.24 58.23 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 119.445 -0.312 . . . . 1.84 111.596 176.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.09 -36.9 73.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.245 -0.582 . . . . 2.37 109.755 170.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 67.6 t80 -69.21 -44.01 72.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 1.09 110.642 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.467 ' HE2' HD21 ' A' ' 118' ' ' LEU . 67.5 mtt -65.67 -51.11 62.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.255 -0.429 . . . . 1.06 110.696 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.564 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 27.8 mtpt -61.96 -40.47 95.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.623 -0.717 . . . . 1.42 111.379 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.7 ptmm? -69.19 -35.92 76.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 2.63 110.615 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 99.9 m -73.94 -46.68 42.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 1.09 111.857 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 10.4 mmtt -137.17 98.57 10.24 Favored Pre-proline 0 C--N 1.321 -0.648 0 C-N-CA 120.778 -0.369 . . . . 2.26 111.677 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.504 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 44.6 Cg_endo -69.79 -28.09 25.53 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.853 2.369 . . . . 1.81 111.673 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.35 -139.56 14.51 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.859 -0.686 . . . . 2.45 112.243 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 41.2 pt -84.11 -1.38 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.746 0.308 . . . . 4.01 111.571 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.7 pt? -133.12 175.39 9.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.807 0.337 . . . . 2.97 110.626 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 133' ' ' LYS . . . -87.72 -150.92 0.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.531 . . . . 3.28 110.102 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.565 HG21 ' HB1' ' A' ' 134' ' ' ALA . 19.5 m 76.83 -35.5 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.865 0.466 . . . . 4.33 112.095 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 40.0 mttp 65.16 4.41 2.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.709 0.804 . . . . 5.43 111.319 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.661 ' HB3' ' OD1' ' A' ' 111' ' ' ASN . . . -117.49 178.63 4.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.203 0.816 . . . . 1.51 113.203 -165.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.872 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 24.4 mm -112.98 84.4 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.054 -0.975 . . . . 1.5 111.454 -166.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -105.69 19.95 19.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.22 0.822 . . . . 1.99 113.22 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.872 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.21 168.95 18.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.873 0.368 . . . . 1.1 111.561 177.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.65 -156.61 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.678 1.591 . . . . 1.8 113.217 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.82 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 35.5 m-85 -27.4 -55.87 0.09 Allowed 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.136 1.374 . . . . 1.68 114.412 -164.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.893 HG23 ' HA ' ' A' ' 155' ' ' SER . 25.0 m 41.58 96.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.444 0.905 . . . . 1.05 113.444 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.674 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 35.1 p -86.48 149.26 25.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.507 -0.746 . . . . 1.38 111.274 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' O ' HD12 ' A' ' 39' ' ' LEU . 9.5 m-85 -103.09 134.08 47.12 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.598 -0.89 . . . . 0.53 108.598 167.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.906 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 28.5 tp -82.03 105.84 13.46 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 1.2 109.13 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.729 HG21 HD13 ' A' ' 15' ' ' ILE . 11.3 mm -106.08 131.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.312 -0.625 . . . . 1.05 109.312 -175.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -78.64 -179.17 6.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.997 -0.547 . . . . 1.3 110.83 -176.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.713 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mtp180 -64.18 -17.65 63.73 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.115 0.413 . . . . 4.43 112.115 -175.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -105.26 -16.74 14.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.37 0.605 . . . . 1.18 109.664 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.543 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.87 32.66 4.34 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.25 112.735 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.1 t -106.12 126.93 29.36 Favored Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 122.397 -0.472 . . . . 1.32 110.637 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.72 112.17 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.15 2.567 . . . . 0.46 112.22 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.508 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 22.3 t -98.41 -33.42 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.23 -0.441 . . . . 1.09 111.49 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 9.0 mm-40 -152.48 164.37 37.7 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.762 0.315 . . . . 1.22 110.966 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.564 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 18.0 ttm180 -129.37 98.87 5.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 2.25 109.836 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.906 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.4 m-85 -87.01 110.31 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.262 -0.644 . . . . 0.38 109.262 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.893 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.3 p -62.86 167.05 6.47 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.273 -0.64 . . . . 1.49 109.273 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.807 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.6 Cg_endo -70.64 -10.19 27.35 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 122.377 2.051 . . . . 0.74 112.028 -163.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.32 -10.72 84.29 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.402 -1.272 . . . . 0.56 111.178 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.46 137.03 34.78 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.431 -0.581 . . . . 1.14 109.431 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -106.33 -169.56 1.59 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.498 -0.319 . . . . 1.64 111.006 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.535 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 21.4 t -50.4 -59.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.915 -0.584 . . . . 1.14 112.376 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -67.65 -29.86 69.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.67 0.271 . . . . 3.84 110.946 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.13 -38.93 77.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.053 -0.522 . . . . 1.86 109.844 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.534 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 63.5 mt -83.12 -37.45 13.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.416 -0.811 . . . . 1.05 110.967 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.9 mt-10 -57.18 -36.7 71.12 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.551 0.574 . . . . 0.88 112.551 -174.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.508 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.0 pt-20 -58.73 -27.99 65.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.395 . . . . 0.75 111.292 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.606 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -104.78 -16.19 14.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.363 -0.38 . . . . 2.11 110.924 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.591 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.3 tp -91.22 -44.69 9.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 1.06 111.825 -171.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.642 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.7 mt -51.81 -49.23 84.7 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.608 0.596 . . . . 1.14 112.608 -175.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.505 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.2 Cg_exo -54.7 -39.37 89.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.024 1.816 . . . . 0.74 112.6 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.9 mt -74.2 -35.97 63.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.437 -0.347 . . . . 1.35 111.43 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.938 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 13.5 mt -57.12 -54.75 43.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.313 -0.625 . . . . 1.16 109.313 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.98 -62.24 4.74 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.777 -1.101 . . . . 1.52 112.513 171.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -173.18 125.58 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.482 -0.562 . . . . 2.89 109.482 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -90.98 -57.04 2.95 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.906 0.384 . . . . 3.56 110.898 -174.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.57 25.07 1.36 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.971 -0.558 . . . . 8.59 110.66 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 C--O 1.248 1.007 0 O-C-N 123.767 0.667 . . . . 5.3 110.748 -178.179 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.898 0 N-CA-C 112.869 -0.092 . . . . 5.87 112.869 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.2 ptp -159.09 25.01 0.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.243 0.544 . . . . 5.34 110.176 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.71 52.46 7.18 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.334 -0.936 . . . . 1.87 111.004 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -70.85 -64.24 0.94 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 2.22 110.324 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 m -126.09 170.5 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.995 -1.113 . . . . 1.06 107.995 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.589 HD12 HG22 ' A' ' 144' ' ' ILE . 32.5 pt -52.22 -28.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 118.764 0.711 . . . . 1.08 112.902 -173.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.787 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 14.8 m-85 -81.68 5.91 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.997 0.427 . . . . 0.3 111.614 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.86 -19.7 62.61 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.021 -1.104 . . . . 1.96 108.021 171.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' A' ' 118' ' ' LEU . 49.9 m-85 -106.7 179.32 4.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.425 -1.261 . . . . 0.4 110.531 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.85 148.09 43.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.518 -0.31 . . . . 2.77 110.201 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.572 HG21 HD11 ' A' ' 30' ' ' LEU . 71.7 t -118.19 150.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.054 0.454 . . . . 1.39 111.702 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.737 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 88.8 mt -108.16 143.38 37.02 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.131 -0.486 . . . . 1.33 110.003 173.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.603 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 21.7 t70 -72.97 177.37 4.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.102 -0.954 . . . . 1.59 108.764 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -52.94 -32.85 48.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.337 0.589 . . . . 1.14 110.318 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.641 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 22.5 t70 -79.49 -18.25 52.4 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.353 -0.839 . . . . 2.22 112.029 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.737 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.1 m-70 87.41 6.01 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.853 0.861 . . . . 0.88 111.851 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.603 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 2.8 ptmt -70.77 160.93 80.35 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.905 -1.146 . . . . 3.67 107.905 162.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.3 117.19 3.89 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 121.421 1.414 . . . . 1.19 112.632 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.866 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 89.0 t80 -91.05 119.42 31.19 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.97 -0.752 . . . . 0.98 108.97 170.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.1 t30 -73.81 84.68 1.67 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.525 -0.47 . . . . 1.65 110.002 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.732 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -62.35 -31.55 72.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.466 0.651 . . . . 1.08 110.469 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.6 p -77.2 -0.06 2.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.182 -0.917 . . . . 1.15 113.203 -167.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.8 pt20 -78.91 -5.82 54.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.658 0.742 . . . . 1.94 109.202 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.866 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 92.8 m-70 -97.41 -1.07 45.14 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.908 -1.042 . . . . 0.38 108.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.669 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -77.09 130.99 38.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.987 -1.461 . . . . 2.22 108.975 178.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.535 ' N ' ' HD2' ' A' ' 34' ' ' LYS . . . 109.87 -15.19 31.51 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.042 -0.823 . . . . 0.36 111.042 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.8 m -136.17 155.04 77.7 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.064 -0.717 . . . . 1.58 109.064 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.997 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 73.3 Cg_endo -77.73 154.72 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.004 1.803 . . . . 0.86 111.8 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.542 ' CB ' HG23 ' A' ' 70' ' ' THR . 2.3 pt? -158.96 159.92 35.43 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.248 0.546 . . . . 1.63 111.229 -176.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.739 HD22 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -114.21 155.1 26.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.449 -0.796 . . . . 1.69 109.236 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.603 HG12 ' HB2' ' A' ' 72' ' ' LEU . 84.4 mt -141.29 119.12 8.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.558 -0.534 . . . . 1.05 109.558 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.819 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.7 m-85 -105.59 123.67 48.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.909 -0.316 . . . . 0.93 111.06 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.817 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.6 OUTLIER -78.56 92.25 4.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.829 -0.804 . . . . 1.97 108.829 168.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.589 HG11 ' CE1' ' A' ' 98' ' ' PHE . 2.9 p -108.06 131.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.935 0.717 . . . . 1.48 112.935 -166.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.08 110.71 0.99 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.718 -1.216 . . . . 1.17 107.718 167.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.997 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -70.79 85.93 0.67 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.787 -1.097 . . . . 2.3 113.563 -162.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.641 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 48.8 tptt 71.7 39.56 0.86 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.648 -0.705 . . . . 2.81 110.204 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.2 p -154.23 142.28 20.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.787 -0.642 . . . . 1.18 110.96 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.66 -130.0 10.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.521 -0.847 . . . . 1.42 112.966 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.85 131.71 24.37 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.592 -0.521 . . . . 3.45 109.592 -173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' CE1' ' A' ' 139' ' ' PHE . 72.6 p -83.09 109.69 17.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.627 0.727 . . . . 1.94 109.791 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 1.049 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 26.4 mtpp -79.86 11.56 3.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.363 -0.835 . . . . 2.51 111.2 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.21 28.4 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.64 -0.584 . . . . 0.55 111.64 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.35 -42.62 10.25 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.286 -0.483 . . . . 0.39 112.013 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.692 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 1.4 t80 -70.14 -47.43 61.74 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 1.05 109.835 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.9 mp0 -56.17 -50.77 70.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.867 -1.06 . . . . 2.46 110.397 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.729 HG21 ' HA ' ' A' ' 160' ' ' VAL . 54.9 m -67.48 -47.15 70.88 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.824 -1.08 . . . . 1.06 111.101 -176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.884 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -56.66 -49.51 74.82 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.101 0.477 . . . . 1.03 111.35 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.9 m -58.43 -48.41 80.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.448 -0.796 . . . . 1.09 110.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.9 m -60.77 -46.85 88.86 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.301 -0.863 . . . . 1.69 111.524 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.568 HD13 HD21 ' A' ' 39' ' ' LEU . 62.1 mt -59.05 -50.35 74.4 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.274 -0.421 . . . . 1.46 111.183 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.628 ' HE1' ' HG1' ' A' ' 70' ' ' THR . 15.0 t80 -47.01 -53.63 12.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.057 0.848 . . . . 0.92 110.032 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -73.93 -34.99 64.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.217 -0.901 . . . . 1.88 111.452 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -75.97 -35.77 59.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.007 -0.542 . . . . 2.27 111.255 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.791 ' CD1' HD13 ' A' ' 171' ' ' LEU . 62.7 m-85 -118.15 15.43 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.805 1.039 . . . . 0.9 113.805 -173.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.8 mmmt -59.54 -21.36 60.13 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.686 -0.406 . . . . 2.62 110.388 171.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.87 -41.62 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.84 -0.618 . . . . 1.59 110.35 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' HG3' ' HB3' ' A' ' 171' ' ' LEU . 33.7 mm-40 -76.27 -10.56 59.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.972 -0.558 . . . . 1.9 110.318 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.32 20.73 29.14 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 1.32 110.868 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.562 ' CE1' HD13 ' A' ' 39' ' ' LEU . 88.5 t80 -79.78 136.58 36.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.243 -0.479 . . . . 0.4 110.628 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.628 ' HG1' ' HE1' ' A' ' 61' ' ' TYR . 0.8 OUTLIER -130.82 145.85 52.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.382 -0.599 . . . . 1.11 109.382 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.884 HG11 ' HB2' ' A' ' 57' ' ' ALA . 51.4 t -110.08 109.32 27.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.2 -0.667 . . . . 1.06 109.2 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.603 ' HB2' HG12 ' A' ' 40' ' ' ILE . 23.8 mt -91.65 120.98 32.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.489 -0.93 . . . . 1.23 108.489 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.081 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -108.82 112.92 25.43 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.221 -0.592 . . . . 1.04 110.68 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.524 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.3 m-85 -97.12 110.63 54.95 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.54 -0.755 . . . . 0.45 109.03 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.01 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.91 169.78 3.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.395 2.73 . . . . 0.73 111.365 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 69.7 m -111.2 136.34 50.4 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.889 1.07 . . . . 2.02 113.889 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 40.5 t30 -102.19 92.38 4.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 113.943 -1.48 . . . . 3.1 111.352 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.63 ' HA ' ' CG ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -58.57 -12.2 3.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.209 1.004 . . . . 3.18 113.046 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -76.03 -17.85 59.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.449 0.642 . . . . 4.52 109.659 -174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.867 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . -75.89 -36.69 41.04 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.099 -0.955 . . . . 1.45 112.007 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.91 -77.31 0.4 Allowed Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.17 -1.014 . . . . 1.43 112.997 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.788 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -93.06 14.47 17.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.821 1.045 . . . . 1.43 113.821 -165.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.63 ' CG ' ' HA ' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -61.91 159.89 32.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 118.682 0.674 . . . . 3.06 111.782 -172.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.8 ' HG3' HG22 ' A' ' 135' ' ' ILE . 6.0 Cg_exo -34.55 162.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.846 1 C-N-CA 125.342 4.028 . . . . 1.61 117.704 -171.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.33 10.43 85.99 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.325 -1.307 . . . . 1.83 109.899 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.715 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 2.3 t-20 56.95 35.15 26.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.637 -0.781 . . . . 4.24 110.26 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.715 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 9.2 pt-20 56.73 -6.22 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.321 1.448 . . . . 2.47 113.744 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 86' ' ' ASN . 13.2 mm-40 -106.91 13.7 27.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.234 0.54 . . . . 3.64 110.537 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 8.7 tp10 -91.47 -41.45 10.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.819 -0.808 . . . . 2.42 108.819 172.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.555 HD12 ' SG ' ' A' ' 95' ' ' CYS . 18.6 mt -89.56 36.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.051 -0.977 . . . . 2.56 110.321 -177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HD2' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -89.6 5.53 45.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.535 -0.757 . . . . 4.36 111.294 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.431 ' HG2' ' HD2' ' A' ' 91' ' ' LYS . 11.3 pt-20 -160.36 29.77 0.16 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.447 -0.797 . . . . 3.1 109.201 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.424 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 68.4 m-85 -141.43 167.62 21.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.518 -0.765 . . . . 2.15 110.723 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.77 141.31 46.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.751 -1.574 . . . . 2.13 106.751 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.604 ' HB2' HE22 ' A' ' 78' ' ' GLN . 24.9 m -128.79 116.94 20.26 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 118.514 -1.275 . . . . 0.91 112.779 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -156.38 119.56 4.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.722 -1.127 . . . . 2.41 109.804 168.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.3 mttp 54.52 100.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.062 0.764 . . . . 3.5 113.062 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.645 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 37.9 p90 -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.776 -0.577 . . . . 1.74 110.688 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 68.15 145.81 0.05 OUTLIER 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.099 0.875 . . . . 3.53 111.145 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -172.69 -173.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.41 . . . . 1.09 112.083 -176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -83.67 -11.88 56.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 2.19 110.155 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.833 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 39.0 p90 -113.34 169.04 6.86 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 115.405 -0.816 . . . . 0.39 109.196 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.826 ' HB2' ' HE2' ' A' ' 105' ' ' MET . 21.2 Cg_exo -71.41 122.12 8.36 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 123.556 2.837 . . . . 0.48 112.999 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.081 HG13 ' HB1' ' A' ' 73' ' ' ALA . 3.5 mp -110.79 139.65 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.909 -0.775 . . . . 1.13 108.909 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.826 ' HE2' ' HB2' ' A' ' 103' ' ' PRO . 10.1 mmt -112.07 -154.74 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.648 0.737 . . . . 2.08 112.909 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.62 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -71.63 133.78 45.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.674 -1.148 . . . . 1.11 110.116 173.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.01 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttt -70.27 126.04 28.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.692 0.758 . . . . 2.12 109.457 171.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.607 HG13 HG12 ' A' ' 110' ' ' VAL . 9.6 pt -121.47 167.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.262 -1.335 . . . . 1.19 107.915 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.867 ' ND2' ' HA3' ' A' ' 80' ' ' GLY . 34.6 t-20 -85.28 63.97 8.4 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.434 -0.506 . . . . 2.16 109.672 -175.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.788 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -64.55 88.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 120.727 -0.389 . . . . 1.1 110.799 -177.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.788 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 56.7 t30 173.05 178.63 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 1.98 108.243 167.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.04 -142.31 31.67 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 114.344 0.497 . . . . 0.78 114.344 165.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -105.84 -1.63 24.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.589 0.709 . . . . 1.98 110.039 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -106.49 2.43 26.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.074 -0.967 . . . . 2.1 111.192 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -62.6 154.58 28.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.728 -0.669 . . . . 1.17 112.242 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.91 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 33.7 t-80 -47.96 138.47 10.06 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.586 -0.734 . . . . 0.51 110.046 172.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.12 -39.16 51.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.138 2.559 . . . . 0.43 112.436 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.91 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -60.45 -39.63 88.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 1.69 111.332 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.473 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.9 m-85 -75.61 -28.89 59.05 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 116.445 -0.343 . . . . 1.84 110.813 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.56 -36.91 74.66 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.867 -0.733 . . . . 2.37 109.426 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.512 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 50.9 t80 -71.77 -45.85 60.29 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.738 -0.385 . . . . 1.09 110.6 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.443 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . 66.5 mtt -61.46 -54.92 37.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.314 -0.403 . . . . 1.06 111.442 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.0 mtpt -62.97 -36.9 85.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 1.42 111.359 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.35 -31.59 67.55 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.843 0.354 . . . . 2.63 110.301 -179.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.527 HG23 ' HD2' ' A' ' 150' ' ' PRO . 97.3 m -73.89 -38.64 64.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 1.09 111.256 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.596 ' HE2' ' O ' ' A' ' 151' ' ' VAL . 32.2 mmtm -134.35 113.34 12.2 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.867 0.365 . . . . 2.26 111.15 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.68 -54.34 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.186 2.591 . . . . 1.81 113.291 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.69 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . 141.43 -167.74 25.71 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.491 -0.861 . . . . 2.45 112.189 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.0 pt -129.87 17.77 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 112.109 0.411 . . . . 4.01 112.109 -175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.72 76.45 1.25 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.739 0.304 . . . . 2.97 110.823 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 51.46 33.07 9.6 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.364 0.602 . . . . 3.28 110.238 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.69 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 2.3 m -97.04 121.12 38.57 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.411 0.624 . . . . 4.33 111.792 -167.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -122.43 -29.47 4.1 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.077 -0.965 . . . . 5.43 108.659 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.514 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -122.88 176.38 6.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.559 -0.746 . . . . 1.51 112.79 -173.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.835 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 49.2 mt -97.76 84.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.942 -1.027 . . . . 1.5 110.742 -171.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -108.61 25.28 11.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.524 0.564 . . . . 1.99 112.524 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.835 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.08 170.14 21.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.281 0.474 . . . . 1.1 112.281 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -52.49 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.48 1.512 . . . . 1.8 113.41 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.819 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 68.5 m-85 -25.89 -59.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.399 0 C-N-CA 125.529 1.532 . . . . 1.68 113.957 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.947 HG23 ' HA ' ' A' ' 155' ' ' SER . 18.0 m 42.43 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.209 0.818 . . . . 1.05 113.209 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.694 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 15.0 p -87.1 151.94 22.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.546 -0.862 . . . . 1.38 111.496 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CB ' HD11 ' A' ' 144' ' ' ILE . 10.1 m-85 -103.78 134.6 46.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.287 -1.005 . . . . 0.53 108.287 164.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.734 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.2 tp -82.08 106.15 13.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.107 -0.701 . . . . 1.2 109.107 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.589 HG22 HD12 ' A' ' 15' ' ' ILE . 16.0 mm -106.42 123.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.021 -0.536 . . . . 1.05 109.736 -171.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -177.41 4.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.374 -0.376 . . . . 1.3 110.595 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.47 ' HB2' HD11 ' A' ' 176' ' ' LEU . 51.9 mtt-85 -66.27 -9.58 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.675 0.62 . . . . 4.43 112.675 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -108.0 -21.91 12.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.18 110.066 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.563 ' O ' HG22 ' A' ' 15' ' ' ILE . . . 106.07 31.65 4.05 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.637 -0.792 . . . . 0.25 112.698 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.48 121.29 41.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.891 -0.411 . . . . 1.32 109.891 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.527 ' HD2' HG23 ' A' ' 125' ' ' THR . 44.8 Cg_exo -58.07 116.39 3.2 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.992 2.462 . . . . 0.46 112.223 176.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.596 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 31.8 t -96.07 -25.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.809 -0.632 . . . . 1.09 110.275 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.623 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 9.0 mm-40 -156.29 159.03 38.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.371 -0.377 . . . . 1.22 111.246 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.466 HH11 ' HH2' ' A' ' 137' ' ' TRP . 20.3 ttm180 -120.65 97.02 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.471 -0.566 . . . . 2.25 109.471 168.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.734 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 52.6 m-85 -85.22 110.17 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.277 -0.638 . . . . 0.38 109.277 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.947 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.4 p -63.39 166.25 9.33 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.831 -0.433 . . . . 1.49 109.831 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.049 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 58.7 Cg_endo -72.07 -2.19 11.19 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.371 2.047 . . . . 0.74 113.058 -163.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -96.45 8.74 66.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.631 -0.713 . . . . 0.56 112.317 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.61 140.17 30.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 1.14 110.249 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.492 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 57.3 m -86.76 170.68 11.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.199 -0.455 . . . . 1.64 111.309 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.729 ' HA ' HG21 ' A' ' 56' ' ' THR . 49.0 t -55.41 -51.82 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 1.14 111.584 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 161' ' ' LYS . 20.2 tptt -68.83 -26.84 65.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 3.84 110.622 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.7 m-20 -64.19 -31.81 73.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 1.86 110.27 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.739 HG21 HD22 ' A' ' 39' ' ' LEU . 59.1 mt -83.04 -45.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.902 -0.59 . . . . 1.05 110.529 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -52.68 -39.01 61.51 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.839 0.681 . . . . 0.88 112.839 -176.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -55.52 -31.35 62.01 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.872 0.323 . . . . 0.75 111.872 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.623 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 72.3 mttt -106.32 -9.67 16.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.389 . . . . 2.11 110.976 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' A' ' 171' ' ' LEU . 58.7 tp -91.52 -41.61 10.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 1.06 111.775 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.672 ' HA ' HD11 ' A' ' 171' ' ' LEU . 71.6 mt -50.61 -48.71 81.71 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 112.998 0.74 . . . . 1.14 112.998 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.64 -32.39 90.36 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.099 1.866 . . . . 0.74 112.745 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 151' ' ' VAL . 76.6 mt -80.8 -35.22 33.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.776 -0.193 . . . . 1.35 110.865 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.997 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.2 mt -59.0 -41.48 87.77 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.697 -0.853 . . . . 1.16 108.697 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.34 -81.14 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.21 -1.359 . . . . 1.52 111.129 162.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.5 t 179.64 152.68 0.43 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.762 0.315 . . . . 2.89 110.293 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.15 -45.84 7.69 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.773 0.32 . . . . 3.56 110.472 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 175' ' ' ARG . 11.9 ptt-85 -157.95 9.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 8.59 110.435 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 146' ' ' ARG . 6.5 mp . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.485 -0.769 . . . . 5.3 110.17 -173.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 112.101 -0.4 . . . . 5.87 112.101 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.9 ttp -72.92 125.54 27.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.788 0.327 . . . . 5.34 110.503 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.48 51.98 3.33 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.796 -0.716 . . . . 1.87 112.669 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m -85.52 -32.21 22.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.219 0.533 . . . . 2.22 110.563 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.6 p -142.91 172.21 13.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 1.06 110.192 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.671 HD12 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -59.05 -29.64 41.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.418 0.525 . . . . 1.08 112.418 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.794 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 36.5 m-85 -77.33 0.0 23.89 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.861 0.319 . . . . 0.3 111.861 -172.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.7 -23.26 65.27 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.319 -0.993 . . . . 1.96 108.319 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.512 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 53.7 m-85 -102.67 174.61 5.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.731 -1.122 . . . . 0.4 109.792 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -108.56 165.63 11.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.869 0.366 . . . . 2.77 110.658 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.585 HG21 HD13 ' A' ' 30' ' ' LEU . 73.8 t -135.66 151.79 30.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.577 -0.527 . . . . 1.39 109.577 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.842 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 66.8 mt -113.6 148.63 35.85 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.673 -0.492 . . . . 1.33 109.673 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.65 ' CB ' ' HE3' ' A' ' 26' ' ' LYS . 5.8 t0 -78.49 -176.43 4.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.991 -1.114 . . . . 1.59 107.991 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . . . -56.96 -29.92 63.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.462 0.649 . . . . 1.14 110.459 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 5.4 t70 -80.29 -20.01 45.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.324 -0.853 . . . . 2.22 111.981 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.842 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 18.5 m-70 83.77 7.49 0.64 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.779 0.832 . . . . 0.88 111.893 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.65 ' HE3' ' CB ' ' A' ' 22' ' ' ASP . 28.9 pttt -65.09 148.12 98.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 107.282 -1.377 . . . . 3.67 107.282 157.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.536 ' HA ' HD23 ' A' ' 21' ' ' LEU . 19.0 Cg_endo -61.55 116.66 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.241 1.294 . . . . 1.19 112.331 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.916 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 86.3 t80 -80.23 124.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.006 -0.997 . . . . 0.98 110.333 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -68.98 82.78 0.31 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.703 -0.68 . . . . 1.65 109.757 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.794 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -72.45 -31.78 65.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.42 0.629 . . . . 1.08 110.136 -177.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.715 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 p -77.13 -0.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.333 -0.849 . . . . 1.15 112.494 -169.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.7 pt20 -78.84 -9.4 59.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.566 0.698 . . . . 1.94 109.311 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.916 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 75.9 m-70 -91.69 -7.97 48.36 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.156 -1.053 . . . . 0.38 108.156 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 34' ' ' LYS . 21.3 ttpp -70.72 133.68 46.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.53 -1.214 . . . . 2.22 109.354 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.46 -5.35 54.86 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.024 -1.231 . . . . 0.36 110.024 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 15.5 m -140.46 144.29 36.21 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.851 -0.796 . . . . 1.58 108.851 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.04 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 52.6 Cg_endo -73.28 150.55 47.34 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.651 1.567 . . . . 0.86 110.794 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.567 ' HB2' HG21 ' A' ' 70' ' ' THR . 1.8 pt? -153.0 153.51 33.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.324 0.583 . . . . 1.63 111.089 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.75 HD23 HG22 ' A' ' 163' ' ' ILE . 6.7 mp -108.33 152.69 24.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.982 -0.747 . . . . 1.69 108.982 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 88.6 mt -137.29 118.21 17.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.417 -0.586 . . . . 1.05 109.417 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.808 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -100.29 123.15 44.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.459 -0.337 . . . . 0.93 110.532 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.62 ' HB2' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -82.41 90.8 6.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.041 -1.096 . . . . 1.97 108.041 168.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.675 HG12 ' HE2' ' A' ' 98' ' ' PHE . 2.2 p -112.2 132.42 60.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 112.575 0.583 . . . . 1.48 112.575 -163.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -64.52 102.12 0.52 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.938 -1.505 . . . . 1.17 106.938 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.959 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 34.4 t -69.57 90.11 0.55 Allowed 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.432 -0.803 . . . . 2.3 112.236 -165.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt 66.97 49.84 1.1 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.935 -1.03 . . . . 2.81 110.813 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.542 ' SG ' HG23 ' A' ' 90' ' ' ILE . 16.9 m -135.75 126.43 27.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.719 -0.673 . . . . 1.18 109.761 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.546 ' HA3' ' CD ' ' A' ' 89' ' ' GLU . . . 71.52 -129.91 17.43 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.902 -0.666 . . . . 1.42 112.989 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.98 154.18 19.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.838 0.351 . . . . 3.45 111.044 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.7 p -91.54 -24.49 19.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.317 -0.401 . . . . 1.94 111.49 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 26.3 mtpp 64.04 3.75 1.8 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.644 -0.707 . . . . 2.51 112.069 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.11 -5.01 41.65 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.814 -0.708 . . . . 0.55 112.565 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -35.57 92.14 Favored Glycine 0 CA--C 1.505 -0.585 0 N-CA-C 111.982 -0.447 . . . . 0.39 111.982 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.498 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -67.92 -48.81 64.94 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 110.286 -0.265 . . . . 1.05 110.286 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.44 -52.87 62.16 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.473 0.654 . . . . 2.46 110.167 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.423 ' CG2' HD11 ' A' ' 163' ' ' ILE . 34.7 m -63.11 -47.55 82.35 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.619 -1.173 . . . . 1.06 111.32 -176.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' HB2' HG12 ' A' ' 71' ' ' VAL . . . -61.65 -46.96 87.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.829 0.347 . . . . 1.03 111.401 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.6 m -60.13 -53.68 54.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.778 -0.646 . . . . 1.09 111.393 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 p -62.52 -42.03 99.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 1.69 111.854 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.499 HD11 HD22 ' A' ' 39' ' ' LEU . 93.4 mt -58.92 -52.45 65.68 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 120.514 0.197 . . . . 1.46 111.477 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.695 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 89.4 t80 -54.62 -47.16 73.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.915 -0.584 . . . . 0.92 109.996 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -70.63 -41.03 72.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.533 -0.758 . . . . 1.88 111.394 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.32 -43.59 50.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 2.27 111.647 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.76 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.9 m-85 -102.19 4.5 39.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.728 1.01 . . . . 0.9 113.728 -171.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -58.3 -30.08 66.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 2.62 109.982 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -65.53 -26.4 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 1.59 111.484 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.2 13.16 32.81 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.877 0.37 . . . . 1.9 111.095 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.71 63.42 1.84 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.95 -0.643 . . . . 1.32 112.585 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.524 ' CZ ' HD12 ' A' ' 39' ' ' LEU . 69.0 t80 -132.09 142.09 49.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.552 -0.166 . . . . 0.4 110.552 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.567 HG21 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.16 143.29 50.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.129 -0.323 . . . . 1.11 110.129 177.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.695 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 29.3 t -113.27 114.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.993 0.425 . . . . 1.06 110.185 170.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 30.8 mt -100.47 122.44 43.2 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.978 -0.749 . . . . 1.23 108.978 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -106.99 112.84 25.99 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.113 -0.635 . . . . 1.04 110.252 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.545 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-30 -93.9 110.13 45.85 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.106 -1.072 . . . . 0.45 108.106 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.097 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.3 Cg_exo -58.62 169.22 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.81 2.34 . . . . 0.73 110.953 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.576 ' OG ' ' HB3' ' A' ' 83' ' ' GLU . 27.1 t -111.1 129.89 55.78 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.5 -0.88 . . . . 2.02 111.876 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.622 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 56.1 t30 -92.63 98.5 11.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.904 -1.498 . . . . 3.1 111.041 -173.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.873 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -54.36 -9.22 0.27 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.675 1.19 . . . . 3.18 113.462 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 77' ' ' ASN . 86.8 m-85 -93.48 29.96 1.85 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.884 -0.598 . . . . 4.52 111.142 -173.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.553 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . -113.62 -44.94 0.74 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.333 -0.936 . . . . 1.45 112.934 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.9 -42.86 1.27 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.715 -0.755 . . . . 1.43 112.085 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.652 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.2 pm0 -135.96 46.28 2.33 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.155 0.428 . . . . 1.43 112.155 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.873 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.5 mp0 -59.77 148.4 75.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 121.964 -0.46 . . . . 3.06 110.225 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.966 ' HG3' HG21 ' A' ' 135' ' ' ILE . 11.1 Cg_exo -36.96 147.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.971 3.114 . . . . 1.61 114.095 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.57 10.15 86.44 Favored Glycine 0 N--CA 1.44 -1.033 0 N-CA-C 108.981 -1.648 . . . . 1.83 108.981 -168.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.632 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.8 t-20 52.71 47.42 24.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.048 -1.076 . . . . 4.24 111.07 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 3.3 pt-20 66.56 -28.85 0.13 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.09 1.356 . . . . 2.47 112.093 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.697 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 40.7 tt0 -68.7 -26.72 65.42 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.039 0.535 . . . . 3.64 111.893 -170.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.546 ' CD ' ' HA3' ' A' ' 48' ' ' GLY . 3.0 tp10 -76.22 -14.74 60.13 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.242 0.544 . . . . 2.42 110.9 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.542 HG23 ' SG ' ' A' ' 47' ' ' CYS . 1.9 mt -116.93 34.7 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.949 0.404 . . . . 2.56 110.051 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 33.9 mtmm -64.03 -84.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.242 1.02 . . . . 4.36 111.264 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 7.0 pt-20 -77.81 -11.22 59.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.738 -1.574 . . . . 3.1 110.284 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -91.4 158.2 16.65 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.035 -0.984 . . . . 2.15 109.711 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.85 124.27 66.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.172 -0.677 . . . . 2.13 109.172 171.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.623 ' HB2' ' NE2' ' A' ' 78' ' ' GLN . 14.3 m -90.41 120.05 31.2 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.565 0.698 . . . . 0.91 111.05 -174.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -149.16 128.69 13.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.562 -1.199 . . . . 2.41 108.029 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -14.07 104.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.775 1.297 . . . . 3.5 113.525 -172.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.675 ' HE2' HG12 ' A' ' 43' ' ' VAL . 34.5 p90 -66.55 -20.74 66.09 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.04 -0.982 . . . . 1.74 111.365 -170.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 67.55 147.61 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 124.041 0.838 . . . . 3.53 111.178 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.435 ' HB1' ' HE1' ' A' ' 54' ' ' TYR . . . -169.93 -154.69 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.105 0.479 . . . . 1.09 112.22 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 -5.74 58.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.559 -0.746 . . . . 2.19 109.884 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.891 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 45.4 p90 -128.28 164.8 35.24 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.182 -0.917 . . . . 0.39 109.135 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 32.4 Cg_exo -66.33 109.03 1.48 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 123.658 2.906 . . . . 0.48 113.701 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.032 HG13 ' HB1' ' A' ' 73' ' ' ALA . 3.6 mp -104.15 128.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.957 -0.757 . . . . 1.13 108.957 172.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.669 ' HA ' ' HE1' ' A' ' 105' ' ' MET . 0.5 OUTLIER -109.49 -148.64 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.852 0.686 . . . . 2.08 112.852 -160.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.741 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -75.54 136.81 40.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.168 -0.924 . . . . 1.11 110.669 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.097 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 15.3 pttp -79.45 128.58 33.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.688 0.756 . . . . 2.12 110.384 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.567 HG13 HG11 ' A' ' 110' ' ' VAL . 3.2 pt -122.77 160.69 25.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.312 -1.313 . . . . 1.19 107.845 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.72 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.4 t-20 -75.93 82.66 2.83 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.187 -1.042 . . . . 2.16 108.187 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.64 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -74.15 86.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 118.842 -1.143 . . . . 1.1 108.944 177.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.652 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 55.8 t30 172.44 178.57 0.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.545 -0.909 . . . . 1.98 108.545 170.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.28 -145.62 17.05 Favored Glycine 0 C--O 1.236 0.23 0 N-CA-C 115.211 0.844 . . . . 0.78 115.211 163.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.46 -15.74 25.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.464 -0.868 . . . . 1.98 110.56 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -94.08 1.28 56.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.617 0.722 . . . . 2.1 110.529 -169.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.18 140.13 45.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.094 -0.957 . . . . 1.17 112.346 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.804 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 45.1 t-80 -50.75 137.25 25.19 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.179 -0.919 . . . . 0.51 110.502 172.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.512 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -45.08 -45.52 14.34 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.89 2.393 . . . . 0.43 112.792 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.804 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 0.8 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.942 -0.572 . . . . 1.69 111.715 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.482 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -75.89 -29.0 58.32 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 119.609 -0.234 . . . . 1.84 111.105 177.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.13 -43.36 78.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.886 -0.783 . . . . 2.37 108.886 168.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.8 t80 -66.63 -45.09 80.2 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.569 0.543 . . . . 1.09 110.652 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.541 ' HE2' HG22 ' A' ' 15' ' ' ILE . 67.1 mtt -63.83 -53.52 49.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.461 -0.336 . . . . 1.06 111.31 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 26.4 mtpt -60.89 -41.59 96.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 1.42 111.002 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.9 ptmt -71.12 -35.39 71.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 2.63 111.108 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.1 m -75.79 -36.5 59.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.924 -0.58 . . . . 1.09 111.189 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 9.5 mmtt -141.88 100.09 6.05 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 112.546 0.573 . . . . 2.26 112.546 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.624 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 11.8 Cg_endo -56.82 -29.97 83.29 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.251 2.634 . . . . 1.81 111.465 168.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.833 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 92.06 -130.53 10.35 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.912 -0.661 . . . . 2.45 112.974 173.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.1 pt -95.75 10.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.932 0.396 . . . . 4.01 111.254 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.13 -176.3 4.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.242 -0.435 . . . . 2.97 110.563 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.37 -160.76 0.82 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.772 -0.649 . . . . 3.28 110.019 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.9 m 76.12 -38.26 0.33 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.702 0.63 . . . . 4.33 112.702 172.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.624 ' HG2' ' HB3' ' A' ' 127' ' ' PRO . 34.1 mtmm 68.4 1.89 3.1 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.711 0.805 . . . . 5.43 111.02 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 111' ' ' ASN . . . -103.64 174.02 6.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.119 0.485 . . . . 1.51 111.892 -172.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.966 HG21 ' HG3' ' A' ' 84' ' ' PRO . 44.8 mt -114.95 94.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.488 -0.778 . . . . 1.5 110.568 -171.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -110.56 9.89 23.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.292 0.849 . . . . 1.99 113.292 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.855 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -140.04 168.91 18.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.783 0.66 . . . . 1.1 112.783 -177.047 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.51 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 22.5 m120 -43.67 -156.14 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 126.552 1.941 . . . . 1.8 115.494 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.808 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.2 m-85 -28.02 -55.19 0.11 Allowed 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 113.897 -1.501 . . . . 1.68 113.386 -169.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.821 HG21 ' HA ' ' A' ' 155' ' ' SER . 18.9 m 40.2 96.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.386 0.884 . . . . 1.05 113.386 175.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 7.7 p -85.2 152.7 23.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.789 -0.764 . . . . 1.38 111.129 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 4.9 m-85 -102.61 162.42 12.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.215 -1.402 . . . . 0.53 107.215 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.797 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.5 tp -107.32 105.07 14.85 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.603 -0.888 . . . . 1.2 108.603 177.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.671 HG21 HD12 ' A' ' 15' ' ' ILE . 17.9 mm -103.78 119.8 52.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.844 -0.798 . . . . 1.05 108.844 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.848 ' HB2' ' HB3' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -69.81 179.24 2.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 1.3 110.651 -176.106 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.65 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -57.99 -20.61 39.65 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.846 0.355 . . . . 4.43 111.619 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.12 -13.8 14.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.113 0.482 . . . . 1.18 110.389 -167.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.533 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.51 32.61 4.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.782 -0.645 . . . . 0.25 113.271 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 59.3 t -109.15 118.93 50.05 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 122.466 -0.432 . . . . 1.32 110.165 175.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HG3' ' HA ' ' A' ' 122' ' ' MET . 14.3 Cg_endo -61.48 112.26 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.46 111.969 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.409 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 26.3 t -94.47 -30.19 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.909 -0.587 . . . . 1.09 111.14 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -154.51 165.13 37.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 1.22 110.916 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.833 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 14.5 ttm180 -134.18 98.5 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 2.25 109.854 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.797 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 9.3 m-85 -85.9 136.65 33.2 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.38 108.006 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.821 ' HA ' HG21 ' A' ' 140' ' ' THR . 25.2 p -79.83 178.72 2.17 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.748 -0.781 . . . . 1.49 109.626 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.75 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 56.6 Cg_endo -67.05 -20.63 50.29 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.616 1.544 . . . . 0.74 110.99 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.13 13.24 45.98 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.618 -1.174 . . . . 0.56 112.17 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.36 139.67 30.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.901 0.381 . . . . 1.14 110.52 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.0 p -90.1 163.93 14.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.163 -0.471 . . . . 1.64 110.882 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.4 t -49.9 -57.61 2.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 O-C-N 123.346 0.404 . . . . 1.14 111.602 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.539 -0.301 . . . . 3.84 111.517 -175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.94 -32.69 74.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.41 0.624 . . . . 1.86 109.651 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.75 HG22 HD23 ' A' ' 39' ' ' LEU . 36.6 mt -82.06 -37.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.549 -0.75 . . . . 1.05 110.049 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 46.9 mt-10 -57.96 -40.64 81.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.88 112.147 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.563 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.0 pt-20 -56.73 -31.35 64.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.651 -0.42 . . . . 0.75 111.551 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.563 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 23.0 mmmt -98.37 -16.95 19.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.104 0.478 . . . . 2.11 110.289 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -92.94 -43.13 9.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.776 -0.647 . . . . 1.06 111.765 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.674 ' HA ' HD11 ' A' ' 171' ' ' LEU . 69.3 mt -51.33 -49.89 79.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.463 0.542 . . . . 1.14 112.463 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 9.9 Cg_endo -54.26 -37.89 88.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.175 1.916 . . . . 0.74 112.532 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 48.2 mt -76.97 -37.18 55.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.778 -0.192 . . . . 1.35 111.462 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 1.04 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 10.1 mt -57.7 -48.38 79.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.819 -0.808 . . . . 1.16 108.819 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.37 -66.91 2.49 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.278 -1.328 . . . . 1.52 112.675 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 176' ' ' LEU . 45.4 m -159.01 121.22 3.52 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.481 0.312 . . . . 2.89 110.49 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.848 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . . . -92.96 -59.63 2.0 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.335 -0.546 . . . . 3.56 109.99 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -92.18 -55.29 3.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 105.85 -1.907 . . . . 8.59 105.85 159.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 173' ' ' SER . 2.6 tt . . . . . 0 C--O 1.252 1.214 0 CA-C-N 113.436 -1.711 . . . . 5.3 107.439 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.766 -0.134 . . . . 5.87 112.766 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ptm -139.56 -168.33 2.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.988 -0.745 . . . . 5.34 108.988 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.63 -170.86 41.94 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 119.976 -1.107 . . . . 1.87 112.669 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -65.4 -65.26 0.7 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.342 0.591 . . . . 2.22 110.822 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.8 p -130.46 -173.66 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.817 -0.809 . . . . 1.06 108.817 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.741 HD12 HG23 ' A' ' 144' ' ' ILE . 17.7 pt -61.23 -25.8 37.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 1.08 110.877 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.814 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.9 m-85 -83.91 2.34 39.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.3 110.994 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.57 -20.95 63.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.795 -1.187 . . . . 1.96 107.795 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 42.4 m-85 -106.24 178.32 4.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.409 -1.269 . . . . 0.4 109.668 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -124.86 149.19 47.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.43 -0.35 . . . . 2.77 110.321 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 30' ' ' LEU . 77.5 t -114.7 145.56 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.14 0.495 . . . . 1.39 111.785 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.927 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 77.5 mt -101.18 132.38 46.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.741 . . . . 1.33 109.201 171.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.03 -170.33 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.562 . . . . 1.59 109.481 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.9 57.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.619 -0.264 . . . . 1.14 111.624 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -94.36 -4.13 49.1 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.249 -0.282 . . . . 2.22 110.982 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.927 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 20.6 m-70 75.48 26.42 1.14 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.753 0.787 . . . . 0.88 109.532 -177.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -87.82 147.11 40.37 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 105.309 -2.108 . . . . 3.67 105.309 165.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 113.89 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.707 0.931 . . . . 1.19 111.953 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.95 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 80.5 t80 -82.24 116.76 21.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.081 -0.963 . . . . 0.98 109.078 172.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.645 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -66.31 82.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.758 -0.655 . . . . 1.65 109.734 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.814 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -70.53 -34.27 72.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.902 -0.59 . . . . 1.08 110.498 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.71 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.36 -0.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.348 -0.842 . . . . 1.15 112.812 -168.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.645 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 14.9 pt20 -82.88 -6.47 59.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.964 -0.754 . . . . 1.94 108.964 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.95 ' HE2' ' HH ' ' A' ' 28' ' ' TYR . 81.9 m-70 -94.82 -2.69 50.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.803 -1.184 . . . . 0.38 107.803 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -76.67 141.36 40.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.761 -1.108 . . . . 2.22 109.392 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.88 65.85 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 109.761 -1.336 . . . . 0.36 109.761 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.636 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -129.11 143.03 47.21 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.349 -0.926 . . . . 1.58 109.016 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.928 ' HG2' HD23 ' A' ' 171' ' ' LEU . 63.1 Cg_endo -77.72 142.05 19.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.145 1.897 . . . . 0.86 111.133 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.975 HD22 HG21 ' A' ' 70' ' ' THR . 0.2 OUTLIER -139.44 162.84 34.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.218 0.533 . . . . 1.63 110.753 -172.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.688 HD23 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -117.86 149.98 39.95 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.692 -0.855 . . . . 1.69 108.692 168.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -136.28 119.67 23.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.406 -0.59 . . . . 1.05 109.406 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.783 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 25.2 m-85 -103.41 123.61 47.17 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.593 0.235 . . . . 0.93 111.268 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.708 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.7 OUTLIER -81.24 91.79 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.415 -1.328 . . . . 1.97 107.415 167.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.4 p -107.6 140.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.522 0.934 . . . . 1.48 113.522 -159.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.655 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . . . -61.7 101.99 0.23 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.578 -1.192 . . . . 1.17 108.444 167.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.97 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -68.4 87.43 0.3 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.67 -1.15 . . . . 2.3 112.76 -170.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 tttm 78.21 -34.94 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.635 0.774 . . . . 2.81 111.649 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -110.91 125.69 53.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.649 0.262 . . . . 1.18 110.486 177.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.89 -136.32 5.42 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.558 -0.83 . . . . 1.42 112.028 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.518 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 29.1 t80 -132.7 156.66 46.6 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.349 -0.612 . . . . 3.45 109.349 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.5 p -119.25 114.7 22.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.338 0.589 . . . . 1.94 110.535 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 18.3 ttmm -100.7 15.78 27.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.5 -0.773 . . . . 2.51 109.822 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.13 18.93 9.35 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.906 -0.664 . . . . 0.55 111.516 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 -52.24 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.316 -0.468 . . . . 0.39 112.536 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.601 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -66.48 -48.69 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.18 0.514 . . . . 1.05 109.945 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.577 ' HG2' ' H ' ' A' ' 56' ' ' THR . 1.6 pm0 -57.83 -53.47 57.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.017 -0.992 . . . . 2.46 110.892 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.577 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 95.0 m -64.14 -42.43 96.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 1.06 111.483 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.576 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -60.71 -49.87 75.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.97 0.414 . . . . 1.03 111.001 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -60.19 -52.39 65.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.6 -0.727 . . . . 1.09 111.353 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -59.84 -47.44 85.71 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.881 -0.599 . . . . 1.69 111.63 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.485 HD11 HD22 ' A' ' 39' ' ' LEU . 77.9 mt -55.32 -50.85 68.53 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.424 0.154 . . . . 1.46 111.326 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.762 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 40.1 t80 -46.78 -56.14 6.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.124 0.89 . . . . 0.92 109.774 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.452 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 90.2 m-20 -74.19 -33.75 63.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.454 -0.794 . . . . 1.88 110.936 -170.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -70.43 -41.2 73.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.227 -0.897 . . . . 2.27 111.052 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.552 ' CD1' HD12 ' A' ' 171' ' ' LEU . 69.0 m-85 -118.14 14.06 13.92 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 114.076 1.139 . . . . 0.9 114.076 -172.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.762 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 34.8 mtmt -56.78 -29.12 62.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.162 0.506 . . . . 2.62 110.156 172.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -59.36 -40.26 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.436 -0.802 . . . . 1.59 111.464 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.07 8.22 27.73 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.698 0.285 . . . . 1.9 110.967 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 83.82 67.9 1.43 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.581 -0.819 . . . . 1.32 111.689 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.527 ' CE1' HD11 ' A' ' 39' ' ' LEU . 73.8 t80 -133.77 135.06 43.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.651 0.262 . . . . 0.4 110.668 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.975 HG21 HD22 ' A' ' 38' ' ' LEU . 4.2 t -131.15 140.81 50.01 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.85 -0.426 . . . . 1.11 109.85 175.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.596 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 39.2 t -104.48 114.17 43.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.603 -0.517 . . . . 1.06 109.603 171.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.709 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 13.8 mt -98.63 121.11 40.16 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.672 -0.862 . . . . 1.23 108.672 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.006 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.67 120.1 41.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.302 -0.559 . . . . 1.04 110.918 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.8 m-85 -105.5 109.24 62.98 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.417 -0.811 . . . . 0.45 109.044 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.97 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 32.0 Cg_exo -60.68 168.72 6.47 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.661 2.907 . . . . 0.73 111.614 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.7 t -123.12 135.72 54.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 115.312 1.597 . . . . 2.02 115.312 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 8.1 m-20 -70.03 64.01 0.23 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 111.73 -2.486 . . . . 3.1 109.508 168.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.7 HE21 ' HB3' ' A' ' 89' ' ' GLU . 6.9 mt-30 -63.9 -2.72 2.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.375 1.47 . . . . 3.18 113.574 -174.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -107.96 30.08 6.68 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.896 -0.779 . . . . 4.52 108.896 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.471 ' HA3' ' OD1' ' A' ' 109' ' ' ASN . . . -85.39 -57.06 2.28 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.124 -0.944 . . . . 1.45 113.503 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.09 -54.32 0.27 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.036 -0.602 . . . . 1.43 112.157 -174.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.741 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -126.12 15.87 7.86 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 112.547 0.573 . . . . 1.43 112.547 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.64 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -61.39 161.9 16.85 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 120.783 0.325 . . . . 3.06 111.83 -171.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 1.018 ' HG3' HG23 ' A' ' 135' ' ' ILE . 81.5 Cg_exo -51.09 174.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.987 2.458 . . . . 1.61 114.805 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.14 18.21 78.73 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.942 -1.263 . . . . 1.83 109.942 -174.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 19.8 m120 59.62 44.31 14.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.677 -0.762 . . . . 4.24 110.958 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 12.0 pt-20 57.57 142.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.879 1.672 . . . . 2.47 115.183 171.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 68.67 57.69 0.42 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.033 -1.44 . . . . 3.64 111.183 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.7 ' HB3' HE21 ' A' ' 78' ' ' GLN . 11.6 tp10 -93.19 -27.92 16.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.732 0.641 . . . . 2.42 112.732 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.712 HG12 ' SG ' ' A' ' 95' ' ' CYS . 2.1 mt -83.57 50.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.689 0.757 . . . . 2.56 110.761 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 93' ' ' PHE . 11.4 mtmt -78.28 102.33 7.6 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.17 -0.923 . . . . 4.36 109.698 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.63 -26.22 0.19 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.721 0.808 . . . . 3.1 110.562 -177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.535 ' H ' ' C ' ' A' ' 91' ' ' LYS . 42.6 m-85 -69.26 174.22 4.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.608 -0.724 . . . . 2.15 110.845 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 94' ' ' VAL . 4.8 p -128.66 111.01 22.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.013 -0.736 . . . . 2.13 109.013 170.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.712 ' SG ' HG12 ' A' ' 90' ' ' ILE . 74.2 m -95.32 120.99 36.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 118.762 -1.175 . . . . 0.91 110.775 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.86 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 11.5 t -151.66 162.85 40.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.483 -1.69 . . . . 2.41 108.335 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.6 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.12 105.32 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.785 0.678 . . . . 3.5 111.125 177.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.623 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 49.6 p90 -60.61 -23.84 65.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.737 -0.665 . . . . 1.74 111.377 -174.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? 69.75 131.69 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.994 0.808 . . . . 3.53 111.132 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.461 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . . . -155.9 -163.61 1.53 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.097 -0.502 . . . . 1.09 112.191 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.44 -14.82 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 2.19 110.064 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.832 ' HE2' ' HB1' ' A' ' 73' ' ' ALA . 47.0 p90 -115.32 168.11 8.81 Favored Pre-proline 0 N--CA 1.443 -0.802 0 CA-C-N 115.127 -0.942 . . . . 0.39 109.495 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.754 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.6 Cg_exo -71.06 121.53 7.92 Favored 'Trans proline' 0 N--CA 1.478 0.574 0 C-N-CA 123.932 3.088 . . . . 0.48 113.058 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.006 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -114.55 137.13 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.939 -0.763 . . . . 1.13 108.939 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.754 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 7.8 mmt -111.75 -151.63 0.48 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.524 0.678 . . . . 2.08 112.678 -165.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.74 131.97 43.86 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.77 -1.104 . . . . 1.11 110.764 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.86 ' HD3' ' HA ' ' A' ' 96' ' ' THR . 3.6 mtmt -64.95 122.02 16.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.932 -0.766 . . . . 2.12 108.932 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.696 HG13 HG13 ' A' ' 110' ' ' VAL . 10.7 pt -122.17 149.84 25.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.641 -1.244 . . . . 1.19 107.641 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -77.28 71.31 3.76 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.999 -0.741 . . . . 2.16 108.999 -177.127 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.696 HG13 HG13 ' A' ' 108' ' ' ILE . 2.0 m -64.69 88.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-O 120.868 0.366 . . . . 1.1 110.854 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.741 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 47.9 t30 173.04 177.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.983 -1.117 . . . . 1.98 107.983 163.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.51 -136.85 21.85 Favored Glycine 0 CA--C 1.511 -0.181 0 C-N-CA 121.307 -0.473 . . . . 0.78 113.675 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.29 -9.17 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.182 0.515 . . . . 1.98 110.369 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -83.09 -4.89 58.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.554 -0.748 . . . . 2.1 110.792 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.8 57.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 1.17 111.817 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.847 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 46.3 t-80 -50.4 137.83 22.12 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.947 -1.024 . . . . 0.51 110.281 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.71 -46.64 14.87 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.785 2.323 . . . . 0.43 112.402 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.847 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 0.4 OUTLIER -57.15 -37.16 71.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.837 -0.62 . . . . 1.69 111.804 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.485 ' HH ' HD21 ' A' ' 42' ' ' ASN . 0.4 OUTLIER -76.13 -30.7 58.28 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 121.076 -0.25 . . . . 1.84 110.945 176.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.05 -31.7 72.9 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 2.37 109.927 171.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 68.0 t80 -70.88 -48.67 52.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 1.09 110.391 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.409 ' HE1' HD12 ' A' ' 40' ' ' ILE . 67.1 mtt -63.77 -51.96 62.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.111 -0.495 . . . . 1.06 111.058 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 35.7 mtpt -58.33 -41.3 84.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 1.42 111.179 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.734 ' HZ3' ' HB2' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -71.12 -30.13 66.12 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.748 0.309 . . . . 2.63 110.614 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.507 HG21 ' HD2' ' A' ' 150' ' ' PRO . 85.2 m -75.27 -38.54 60.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.096 -0.502 . . . . 1.09 111.007 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -137.77 112.58 9.04 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.799 -0.182 . . . . 2.26 110.743 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.89 -19.83 17.73 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.111 2.541 . . . . 1.81 112.619 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.949 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 138.77 -171.74 23.41 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.598 -0.811 . . . . 2.45 112.91 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 154' ' ' PHE . 21.4 mt -68.56 -33.61 60.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.854 0.835 . . . . 4.01 109.407 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.68 ' H ' HD22 ' A' ' 130' ' ' LEU . 1.8 pt? -112.24 -157.44 0.62 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.078 -1.082 . . . . 2.97 108.078 173.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.43 -87.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.657 -0.497 . . . . 3.28 109.657 175.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.927 HG23 ' HE3' ' A' ' 136' ' ' LYS . 98.9 m 65.75 -62.25 0.24 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.386 0.884 . . . . 4.33 113.386 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 132' ' ' THR . 60.6 tttp 73.56 -47.86 0.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.985 0.914 . . . . 5.43 112.069 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' A' ' 111' ' ' ASN . . . -105.93 157.98 17.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.061 0.763 . . . . 1.51 113.061 -168.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 1.018 HG23 ' HG3' ' A' ' 84' ' ' PRO . 28.8 mm -82.76 90.39 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.893 -1.049 . . . . 1.5 108.975 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.927 ' HE3' HG23 ' A' ' 132' ' ' THR . 17.5 ptpt -108.96 -3.2 17.69 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.611 0.597 . . . . 1.99 112.611 -170.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.872 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.24 169.95 14.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.54 0.571 . . . . 1.1 112.54 -172.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 49' ' ' TYR . 10.8 m120 -49.41 -156.87 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.845 1.658 . . . . 1.8 113.111 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.783 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 39.3 m-85 -27.57 -52.51 0.07 Allowed 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 114.74 1.385 . . . . 1.68 114.74 -164.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.884 HG22 ' HA ' ' A' ' 155' ' ' SER . 17.3 m 39.38 102.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.899 1.074 . . . . 1.05 113.899 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.4 p -90.48 155.93 18.56 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.596 -0.842 . . . . 1.38 110.573 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 17.6 m-85 -103.72 161.81 13.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.336 -1.357 . . . . 0.53 107.336 163.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.787 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 55.5 tp -108.03 105.85 15.8 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.142 -0.688 . . . . 1.2 109.142 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.741 HG23 HD12 ' A' ' 15' ' ' ILE . 16.5 mm -103.82 122.97 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 115.638 -0.71 . . . . 1.05 109.206 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 174' ' ' ALA . 0.4 OUTLIER -76.93 -179.49 5.51 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.67 -0.412 . . . . 1.3 110.478 -177.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -57.27 -21.86 37.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.658 0.614 . . . . 4.43 112.658 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -105.84 -17.33 14.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.297 0.57 . . . . 1.18 109.762 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.535 ' O ' HG21 ' A' ' 15' ' ' ILE . . . 103.71 34.15 3.9 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.345 -0.843 . . . . 0.25 112.581 175.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.84 121.67 42.36 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.791 -0.448 . . . . 1.32 109.791 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.507 ' HD2' HG21 ' A' ' 125' ' ' THR . 31.5 Cg_exo -60.54 109.88 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.733 2.289 . . . . 0.46 112.151 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -91.75 -31.23 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 1.09 110.521 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.555 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.9 mm-40 -149.44 164.93 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.004 -0.544 . . . . 1.22 110.363 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.949 ' HB3' ' HA2' ' A' ' 128' ' ' GLY . 13.6 ttm180 -132.22 96.65 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.722 -0.844 . . . . 2.25 108.722 168.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.787 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 22.3 m-85 -86.57 108.73 18.71 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.299 -0.63 . . . . 0.38 109.299 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.884 ' HA ' HG22 ' A' ' 140' ' ' THR . 16.4 p -65.2 164.19 25.3 Favored Pre-proline 0 N--CA 1.444 -0.749 0 N-CA-C 109.596 -0.52 . . . . 1.49 109.596 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.793 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 23.5 Cg_endo -61.59 -12.21 23.67 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.986 2.457 . . . . 0.74 113.251 -163.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.71 -0.53 90.16 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.52 -0.764 . . . . 0.56 112.459 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.19 134.67 35.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.894 -0.41 . . . . 1.14 109.894 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.438 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 19.5 m -91.7 176.66 6.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.472 -0.331 . . . . 1.64 110.129 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 38.8 t -51.97 -52.1 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 1.14 111.213 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -64.02 -36.71 84.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 3.84 110.936 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.4 m-20 -57.35 -36.12 70.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.726 -0.67 . . . . 1.86 110.232 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.688 HG21 HD23 ' A' ' 39' ' ' LEU . 74.5 mt -84.24 -43.5 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.342 -0.844 . . . . 1.05 111.413 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 51.3 mt-10 -54.91 -38.53 67.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.493 0.553 . . . . 0.88 112.493 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.0 -18.37 45.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.035 0.383 . . . . 0.75 112.035 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 52.3 mttt -116.64 -10.14 11.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.097 0.475 . . . . 2.11 110.472 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -97.48 -44.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.681 -0.69 . . . . 1.06 111.381 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.64 ' HA ' HD13 ' A' ' 171' ' ' LEU . 69.4 mt -54.09 -49.28 90.83 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.225 0.454 . . . . 1.14 112.225 -175.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 71.8 Cg_exo -51.7 -36.35 61.24 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.187 1.925 . . . . 0.74 112.781 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.02 -36.15 56.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.475 -0.33 . . . . 1.35 111.099 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.928 HD23 ' HG2' ' A' ' 37' ' ' PRO . 12.4 mt -60.13 -49.43 77.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.968 -0.753 . . . . 1.16 108.968 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -52.0 38.62 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 114.462 -1.244 . . . . 1.52 112.536 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.3 p 177.83 127.45 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.726 0.41 . . . . 2.89 110.235 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 145' ' ' ASP . . . -82.62 -43.18 17.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.443 0.64 . . . . 3.56 109.711 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 18.8 tpt180 -147.48 -53.62 0.21 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.873 -1.158 . . . . 8.59 107.873 174.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 C--O 1.246 0.906 0 CA-C-N 114.775 -1.102 . . . . 5.3 108.375 171.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.086 -0.406 . . . . 5.87 112.086 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -126.81 18.26 7.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.968 0.413 . . . . 5.34 110.298 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.96 81.78 1.24 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.919 -1.273 . . . . 1.87 109.919 -168.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -44.84 -56.25 4.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.359 0.6 . . . . 2.22 112.21 -174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 p -157.26 -174.68 5.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.334 -0.848 . . . . 1.06 108.91 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.72 HD11 HG21 ' A' ' 144' ' ' ILE . 18.9 pt -60.61 -25.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.142 0.496 . . . . 1.08 110.647 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.808 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 34.3 m-85 -80.64 3.61 21.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.198 -0.455 . . . . 0.3 111.418 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -73.64 -16.35 61.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.905 -0.776 . . . . 1.96 108.905 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 52.0 m-85 -109.47 159.32 17.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.765 -1.107 . . . . 0.4 110.328 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.14 143.82 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.935 0.398 . . . . 2.77 110.585 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.529 HG23 HD12 ' A' ' 30' ' ' LEU . 69.5 t -115.03 146.48 19.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.802 -0.635 . . . . 1.39 111.114 -178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.825 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 7.1 mp -103.67 145.19 30.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.97 0.414 . . . . 1.33 110.495 170.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.54 -176.52 3.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 1.59 109.101 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.65 -34.43 64.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.002 0.429 . . . . 1.14 110.796 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.1 t70 -82.85 -6.29 59.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 2.22 111.141 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.825 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 8.8 m-70 74.1 21.52 2.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.92 0.867 . . . . 0.88 110.066 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.4 mmpt? -87.25 128.19 56.27 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 106.426 -1.694 . . . . 3.67 106.426 164.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -43.44 115.27 0.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.253 1.968 . . . . 1.19 113.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.525 ' HH ' ' HB3' ' A' ' 103' ' ' PRO . 74.7 t80 -79.32 124.39 28.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.349 -1.296 . . . . 0.98 110.003 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.697 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -72.84 82.93 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.316 -0.624 . . . . 1.65 109.316 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.799 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.47 -32.05 69.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.316 0.579 . . . . 1.08 110.276 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.808 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.1 p -77.04 -0.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.249 -0.887 . . . . 1.15 112.58 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.697 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -82.72 -4.92 58.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.164 -0.68 . . . . 1.94 109.164 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -94.62 -4.08 48.38 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.864 -1.062 . . . . 0.38 108.294 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HE2' ' CD2' ' A' ' 16' ' ' PHE . 38.6 ttmt -71.71 139.8 49.3 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.745 -1.116 . . . . 2.22 109.368 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' C ' ' HB3' ' A' ' 146' ' ' ARG . . . 104.98 -20.32 38.73 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.843 -0.903 . . . . 0.36 110.843 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 m -132.76 144.32 52.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 1.58 108.773 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.911 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -73.36 154.82 51.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.164 1.91 . . . . 0.86 111.262 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.559 ' CB ' HG21 ' A' ' 70' ' ' THR . 2.3 pt? -156.35 151.66 26.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.35 0.595 . . . . 1.63 111.417 -172.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.823 HD22 HG23 ' A' ' 163' ' ' ILE . 6.5 mp -107.99 155.92 19.81 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.982 -0.748 . . . . 1.69 108.982 173.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -141.25 117.53 7.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.549 -0.537 . . . . 1.05 109.549 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.914 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 11.3 m-85 -104.19 123.65 47.7 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.755 -0.378 . . . . 0.93 110.512 -175.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.976 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.4 OUTLIER -82.5 91.97 6.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.271 -1.011 . . . . 1.97 108.271 168.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 75' ' ' PRO . 2.3 p -112.35 130.53 65.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 113.605 0.965 . . . . 1.48 113.605 -160.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -58.9 103.39 0.16 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.248 -1.39 . . . . 1.17 107.248 165.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.039 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -68.72 76.98 0.3 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.878 -1.056 . . . . 2.3 113.423 -163.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 62.2 tttm 71.75 67.55 0.15 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.501 -1.227 . . . . 2.81 111.235 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.517 ' SG ' HG21 ' A' ' 90' ' ' ILE . 56.6 m -145.4 116.38 7.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.594 -0.73 . . . . 1.18 110.453 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.79 -106.92 1.42 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.758 -0.655 . . . . 1.42 114.03 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.47 155.94 18.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 3.45 112.254 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.5 p -120.31 -21.4 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.643 -0.708 . . . . 1.94 110.631 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.691 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.1 mmmt 67.48 0.33 2.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.58 -0.736 . . . . 2.51 111.378 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 105.71 -0.28 39.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.985 -0.626 . . . . 0.55 111.798 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.73 -38.83 90.13 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.694 -0.563 . . . . 0.39 111.694 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.678 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -69.62 -48.51 59.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.915 -0.402 . . . . 1.05 109.915 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 2.3 mp0 -54.95 -49.05 72.32 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.403 -0.817 . . . . 2.46 110.608 177.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.439 HG21 ' HA ' ' A' ' 160' ' ' VAL . 90.9 m -67.31 -45.45 76.46 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.424 -0.807 . . . . 1.06 110.52 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.797 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -61.62 -49.34 76.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.824 0.345 . . . . 1.03 111.531 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 m -59.74 -46.26 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 1.09 110.852 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.605 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 77.6 m -66.51 -47.75 71.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.613 -0.721 . . . . 1.69 111.033 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -57.21 -48.53 78.55 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.427 0.158 . . . . 1.46 111.427 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.669 ' HE1' ' HG1' ' A' ' 70' ' ' THR . 43.5 t80 -55.43 -53.56 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.92 110.962 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.605 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 2.8 p30 -72.02 -27.6 62.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.23 0.538 . . . . 1.88 110.539 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -78.02 -35.67 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.674 -0.694 . . . . 2.27 110.849 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.722 ' CD1' HD11 ' A' ' 171' ' ' LEU . 70.8 m-85 -118.62 13.03 13.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.66 0.985 . . . . 0.9 113.66 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -63.09 -21.37 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.905 0.383 . . . . 2.62 110.774 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -64.03 -37.11 86.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.644 . . . . 1.59 110.218 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -90.15 3.39 53.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.768 -0.651 . . . . 1.9 110.703 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.32 57.74 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.092 -0.504 . . . . 1.32 113.059 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CE1' HD12 ' A' ' 39' ' ' LEU . 85.8 t80 -72.97 132.35 43.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.835 0.35 . . . . 0.4 111.301 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.669 ' HG1' ' HE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -123.18 135.61 54.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.58 -0.526 . . . . 1.11 109.58 177.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.797 HG11 ' HB3' ' A' ' 57' ' ' ALA . 26.1 t -102.51 111.62 32.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.474 -0.565 . . . . 1.06 109.474 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.875 ' HB3' ' HE1' ' A' ' 105' ' ' MET . 24.4 mt -95.45 121.38 37.06 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.486 -0.931 . . . . 1.23 108.486 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -111.73 112.23 23.77 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.905 -0.718 . . . . 1.04 110.35 177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.767 ' HD2' HD13 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -93.94 111.72 54.17 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.085 -1.08 . . . . 0.45 108.085 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.039 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 23.2 Cg_exo -60.13 170.65 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.186 2.591 . . . . 0.73 111.895 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.2 t -116.76 133.49 55.94 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.13 0.967 . . . . 2.02 113.166 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.46 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 63.8 t30 -102.65 91.63 4.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.738 -1.573 . . . . 3.1 109.665 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.534 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -56.74 -14.26 3.19 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.793 1.237 . . . . 3.18 113.747 -167.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -73.81 -1.97 21.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.899 0.704 . . . . 4.52 112.899 -171.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.729 ' HA3' HD22 ' A' ' 109' ' ' ASN . . . -87.08 32.75 3.98 Favored Glycine 0 CA--C 1.517 0.173 0 C-N-CA 120.429 -0.891 . . . . 1.45 113.001 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.58 -62.83 3.8 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.552 -0.619 . . . . 1.43 111.552 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.633 ' O ' ' HG2' ' A' ' 82' ' ' GLN . 5.3 pm0 -130.98 101.25 5.53 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 120.914 0.387 . . . . 1.43 110.699 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 78' ' ' GLN . 10.1 mm-40 -95.14 167.32 13.11 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 109.884 -0.414 . . . . 3.06 109.884 161.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.786 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 19.6 Cg_exo -44.61 159.32 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.204 2.603 . . . . 1.61 114.942 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.9 21.76 70.58 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.188 -1.565 . . . . 1.83 109.188 -169.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.473 HD21 ' N ' ' A' ' 86' ' ' ASN . 0.9 OUTLIER 70.54 -64.15 0.38 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.212 -0.994 . . . . 4.24 110.417 -175.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 2.1 pp20? -178.0 -30.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 2.47 110.249 173.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.731 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 37.8 tt0 -74.41 -19.64 60.34 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.741 0.645 . . . . 3.64 112.741 -170.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 8.8 tp10 -57.34 -61.11 2.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.966 0.412 . . . . 2.42 110.504 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.534 ' CG2' ' HG2' ' A' ' 78' ' ' GLN . 3.2 mt -90.79 37.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.242 0.544 . . . . 2.56 110.544 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.731 ' HG3' ' HA ' ' A' ' 88' ' ' GLU . 7.6 mmmm -85.09 -48.99 8.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.968 0.89 . . . . 4.36 110.59 176.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.46 -8.0 45.9 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.153 -1.385 . . . . 3.1 110.105 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CB ' ' HB3' ' A' ' 47' ' ' CYS . 53.2 m-85 -110.61 167.36 10.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.311 -0.858 . . . . 2.15 109.826 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.7 p -128.88 126.06 64.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.239 0.542 . . . . 2.13 109.547 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 55.1 m -102.75 123.98 47.43 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.988 -0.551 . . . . 0.91 111.631 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -146.36 118.97 8.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.095 0.474 . . . . 2.41 110.824 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.793 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 93.8 mttt 66.87 -50.21 0.47 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.87 -1.059 . . . . 3.5 113.471 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.749 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 68.7 -48.78 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.928 0.891 . . . . 1.74 110.659 -170.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.793 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 18.6 mtmt 66.07 146.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.139 0.576 . . . . 3.53 112.192 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.463 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -164.66 -164.03 0.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.702 0.63 . . . . 1.09 112.702 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -79.77 -11.9 59.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.401 -0.818 . . . . 2.19 109.887 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.734 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 42.2 p90 -115.81 166.86 11.27 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.096 -0.957 . . . . 0.39 109.177 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 33.3 Cg_exo -66.02 121.81 9.23 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.37 2.713 . . . . 0.48 112.815 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.915 HG13 ' HB1' ' A' ' 73' ' ' ALA . 1.5 mp -109.51 143.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.466 -0.568 . . . . 1.13 109.466 174.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.875 ' HE1' ' HB3' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -108.92 -160.52 0.72 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.389 0.885 . . . . 2.08 113.389 -165.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.436 ' O ' HG12 ' A' ' 108' ' ' ILE . . . -72.93 131.47 42.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.013 -0.994 . . . . 1.11 110.042 173.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.944 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttt -70.61 115.04 9.31 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.898 0.856 . . . . 2.12 108.752 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.767 HD13 ' HD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -125.54 160.86 31.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.339 -1.726 . . . . 1.19 106.339 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.891 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.0 m120 -65.73 117.54 8.31 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.97 -1.092 . . . . 2.16 109.064 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.639 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 1.7 m -116.57 88.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.733 -0.839 . . . . 1.1 108.733 170.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 1.7 t30 173.86 177.32 0.12 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.296 -1.372 . . . . 1.98 107.296 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 42.19 -135.54 3.62 Favored Glycine 0 N--CA 1.46 0.242 0 O-C-N 123.936 0.773 . . . . 0.78 114.739 164.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.47 -11.72 16.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.146 -0.527 . . . . 1.98 110.821 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -81.87 -15.32 54.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.1 111.339 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.891 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.5 137.46 0.82 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.062 1.134 . . . . 1.17 114.062 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.778 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 55.5 t-80 -50.19 140.77 16.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 114.969 -1.014 . . . . 0.51 110.866 173.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.28 -46.92 11.22 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.189 2.593 . . . . 0.43 112.922 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.778 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 20.2 tp -58.05 -36.02 72.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.176 -0.466 . . . . 1.69 111.656 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 15.0 m-85 -75.51 -30.59 59.87 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 116.65 -0.25 . . . . 1.84 110.76 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.435 ' OE2' ' HB1' ' A' ' 115' ' ' ALA . 33.9 mm-40 -64.01 -29.32 70.48 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.068 -0.653 . . . . 2.37 109.721 169.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 86.7 t80 -75.29 -42.02 55.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.277 0.56 . . . . 1.09 110.393 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.606 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 66.8 mtt -69.38 -49.3 56.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 1.06 110.82 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.489 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 38.7 mtpt -60.17 -40.76 91.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 1.42 111.062 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 21.6 ptmt -69.17 -35.72 76.59 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.82 0.343 . . . . 2.63 110.804 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 150' ' ' PRO . 91.1 m -74.23 -44.81 51.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 1.09 110.875 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 42.8 mmtt -129.47 103.34 17.93 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.189 -0.46 . . . . 2.26 110.215 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.654 ' HB2' ' HB ' ' A' ' 132' ' ' THR . 44.2 Cg_endo -69.05 -19.76 39.06 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.453 2.769 . . . . 1.81 113.435 -174.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.557 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 124.91 -157.38 19.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.648 -0.787 . . . . 2.45 111.881 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.6 -66.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.707 0.254 . . . . 4.01 110.865 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 pp -63.71 -40.11 95.97 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.032 0.444 . . . . 2.97 110.967 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -144.12 101.15 3.67 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.898 -0.779 . . . . 3.28 108.898 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 127' ' ' PRO . 22.4 p -79.78 131.16 35.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.663 -0.699 . . . . 4.33 111.924 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 132' ' ' THR . 16.5 tppt? 155.53 -65.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.996 1.435 . . . . 5.43 109.451 167.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.437 ' C ' HH12 ' A' ' 153' ' ' ARG . . . -147.47 -178.71 6.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.936 0.717 . . . . 1.51 112.936 -168.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.793 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 38.8 mt -78.5 150.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.768 -1.106 . . . . 1.5 109.475 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -168.57 -1.99 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.597 0.592 . . . . 1.99 112.597 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.793 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -136.82 170.03 16.76 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.332 0.653 . . . . 1.1 111.113 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.46 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 15.7 m120 -43.93 -158.24 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.376 1.47 . . . . 1.8 114.058 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.914 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.6 m-85 -27.76 -57.63 0.11 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 125.018 1.327 . . . . 1.68 114.335 -167.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.976 ' HB ' HD22 ' A' ' 42' ' ' ASN . 10.6 m 42.94 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.111 0.782 . . . . 1.05 113.111 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 25.6 p -86.64 152.11 22.86 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.169 -0.612 . . . . 1.38 110.637 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.9 m-85 -103.76 133.17 49.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.719 -1.215 . . . . 0.53 107.719 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.548 HD21 ' HB ' ' A' ' 151' ' ' VAL . 25.3 tp -81.29 103.63 11.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.741 -0.837 . . . . 1.2 108.741 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.72 HG21 HD11 ' A' ' 15' ' ' ILE . 13.5 mm -104.03 125.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.095 -0.706 . . . . 1.05 109.095 -175.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.4 -179.93 7.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.728 -0.789 . . . . 1.3 110.09 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.414 ' HG3' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -55.27 -23.09 21.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.21 0.529 . . . . 4.43 112.085 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.46 -17.28 18.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.107 -0.701 . . . . 1.18 109.107 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.469 ' O ' HG21 ' A' ' 15' ' ' ILE . . . 100.45 25.19 8.89 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.751 -1.113 . . . . 0.25 112.509 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 65.0 t -106.81 124.54 35.16 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.106 0.453 . . . . 1.32 110.429 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 125' ' ' THR . 34.9 Cg_exo -61.1 111.26 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.332 2.688 . . . . 0.46 112.328 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 143' ' ' LEU . 18.5 t -88.8 -28.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.212 -0.449 . . . . 1.09 110.712 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.511 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 34.3 mm-40 -160.91 164.26 31.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 1.22 110.536 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.792 HH11 ' HH2' ' A' ' 137' ' ' TRP . 14.8 ttm180 -123.0 97.23 5.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.707 -0.479 . . . . 2.25 109.707 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.623 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 84.6 m-85 -82.15 108.59 15.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.531 -0.544 . . . . 0.38 109.531 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.861 ' HA ' HG22 ' A' ' 140' ' ' THR . 3.0 m -62.19 165.21 9.0 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 109.771 -0.455 . . . . 1.49 109.771 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.807 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 44.2 Cg_endo -66.97 -8.21 21.0 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.624 2.216 . . . . 0.74 112.686 -164.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.23 5.56 81.16 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.56 111.865 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.0 133.51 35.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.903 0.382 . . . . 1.14 110.072 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.536 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 51.0 m -86.99 171.44 10.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.134 -0.485 . . . . 1.64 111.342 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.439 ' HA ' HG21 ' A' ' 56' ' ' THR . 99.0 t -52.86 -58.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.828 -0.624 . . . . 1.14 112.356 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.584 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.6 tptm -72.44 -25.33 61.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 3.84 110.597 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.536 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.1 m-20 -61.08 -31.36 71.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.877 -0.602 . . . . 1.86 110.557 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.823 HG23 HD22 ' A' ' 39' ' ' LEU . 43.1 mt -83.17 -42.16 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.002 0.43 . . . . 1.05 110.778 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.584 ' HB2' ' HD2' ' A' ' 161' ' ' LYS . 45.8 mt-10 -56.45 -34.5 66.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.88 112.293 -174.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.425 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.2 pt-20 -53.62 -32.16 50.1 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.725 0.298 . . . . 0.75 111.67 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.425 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 47.5 mmtm -105.26 -14.19 15.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.339 -0.391 . . . . 2.11 111.236 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.609 ' HG ' HD13 ' A' ' 171' ' ' LEU . 65.1 tp -88.57 -42.52 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 1.06 111.735 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.674 ' HA ' HD12 ' A' ' 171' ' ' LEU . 78.5 mt -53.34 -48.56 92.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.418 0.525 . . . . 1.14 112.418 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.509 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.1 Cg_exo -56.32 -26.69 63.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.318 2.012 . . . . 0.74 112.902 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.38 -40.37 16.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 1.35 110.65 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.911 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 16.7 mt -59.18 -48.96 79.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.547 0.689 . . . . 1.16 109.617 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.4 38.83 0.85 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.501 -1.227 . . . . 1.52 113.13 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 171' ' ' LEU . 69.1 m 69.07 116.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.56 0.744 . . . . 2.89 112.775 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.01 -17.03 44.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.493 0.663 . . . . 3.56 109.433 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -129.47 -79.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.328 -0.99 . . . . 8.59 108.328 171.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.953 -1.021 . . . . 5.3 108.997 175.792 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.12 -0.392 . . . . 5.87 112.12 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.9 mtt 62.04 63.5 1.09 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.154 0.502 . . . . 5.34 111.307 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.52 53.12 4.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 1.87 113.239 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -95.02 -39.3 10.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.587 0.708 . . . . 2.22 109.793 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 p -157.85 175.14 14.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.858 -1.065 . . . . 1.06 108.452 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.785 HD11 HG22 ' A' ' 144' ' ' ILE . 21.9 pt -55.24 -29.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.136 0.421 . . . . 1.08 112.136 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.9 m-85 -75.84 -0.44 21.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.387 0.514 . . . . 0.3 112.387 -172.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.28 -12.2 59.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.505 0.669 . . . . 1.96 109.266 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 72.6 m-85 -108.84 155.54 20.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.228 -0.896 . . . . 0.4 111.085 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.469 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 29.9 tt0 -84.25 143.51 29.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.429 -0.805 . . . . 2.77 110.934 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.548 HG23 HD12 ' A' ' 30' ' ' LEU . 72.5 t -125.45 146.17 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.762 0.315 . . . . 1.39 110.461 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.964 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 90.4 mt -111.59 146.82 36.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.408 -0.36 . . . . 1.33 110.264 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.39 174.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.745 0.653 . . . . 1.59 109.482 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB1' ' HB3' ' A' ' 97' ' ' LYS . . . -53.86 -31.05 48.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.321 0.582 . . . . 1.14 109.959 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.17 4.06 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.35 -0.841 . . . . 2.22 112.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.964 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 30.5 m-70 72.63 26.09 2.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.485 0.66 . . . . 0.88 110.968 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 38.5 mmtt -91.07 128.73 46.51 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 107.03 -1.47 . . . . 3.67 107.03 168.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.47 112.63 0.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.792 1.661 . . . . 1.19 112.476 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.821 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 68.8 t80 -79.39 123.72 27.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.669 -1.15 . . . . 0.98 110.553 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 3.0 t-20 -73.68 81.92 1.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.495 -0.775 . . . . 1.65 109.182 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.773 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.7 pt? -72.12 -32.25 66.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.471 0.653 . . . . 1.08 110.463 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.875 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 8.8 p -77.21 0.5 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.324 -0.853 . . . . 1.15 112.735 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.3 pt20 -82.15 -5.87 58.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.387 0.613 . . . . 1.94 109.564 173.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.821 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 86.7 m-70 -92.54 -1.2 57.11 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.137 -1.06 . . . . 0.38 108.137 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -76.17 141.26 41.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.348 -1.296 . . . . 2.22 109.297 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.92 -8.39 63.3 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.328 -1.109 . . . . 0.36 110.328 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.55 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 20.1 m -140.68 146.08 43.0 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.088 -0.708 . . . . 1.58 109.088 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.037 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.0 Cg_endo -73.5 154.81 50.43 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.765 1.643 . . . . 0.86 111.153 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.585 ' CB ' HG23 ' A' ' 70' ' ' THR . 1.8 pt? -155.09 152.47 29.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.396 0.617 . . . . 1.63 111.372 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.723 HD23 HG22 ' A' ' 163' ' ' ILE . 6.3 mp -107.83 151.48 25.69 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.567 -0.901 . . . . 1.69 108.567 172.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 80.4 mt -140.68 116.72 7.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.553 -0.536 . . . . 1.05 109.553 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.906 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 24.3 m-85 -103.29 123.28 46.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.219 0.325 . . . . 0.93 111.244 -172.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.735 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -79.32 91.56 5.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.783 -0.821 . . . . 1.97 108.783 168.193 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.729 HG11 ' HE2' ' A' ' 98' ' ' PHE . 2.4 p -112.34 133.52 57.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.563 0.949 . . . . 1.48 113.563 -163.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 90' ' ' ILE . . . -66.86 102.62 0.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.726 -1.212 . . . . 1.17 107.726 167.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.985 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 30.1 t -72.08 97.23 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.088 0.773 . . . . 2.3 113.088 -166.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt 73.84 38.19 0.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.743 0.652 . . . . 2.81 111.218 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 m -141.79 157.67 44.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.596 -0.274 . . . . 1.18 110.607 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.664 ' HA3' ' HG2' ' A' ' 89' ' ' GLU . . . 66.2 -118.34 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 O-C-N 123.632 0.583 . . . . 1.42 113.678 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -129.21 174.83 9.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.546 0.689 . . . . 3.45 111.782 -174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.658 HG22 ' HE1' ' A' ' 139' ' ' PHE . 7.8 p -133.22 116.72 16.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.058 -0.974 . . . . 1.94 109.616 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.681 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 24.8 mtpp -83.86 17.07 2.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.059 -0.519 . . . . 2.51 111.828 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.3 17.04 21.24 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.878 -0.677 . . . . 0.55 111.89 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.42 -42.85 7.22 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.394 -0.431 . . . . 0.39 112.131 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.566 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -67.12 -44.59 79.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.449 -0.574 . . . . 1.05 109.449 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -55.81 -55.03 37.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.023 -0.99 . . . . 2.46 110.086 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.475 ' CG2' HD13 ' A' ' 163' ' ' ILE . 98.6 m -67.62 -41.45 83.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.941 -1.027 . . . . 1.06 111.284 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.715 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -61.78 -48.2 81.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.859 0.362 . . . . 1.03 110.813 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.6 m -61.29 -49.38 77.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.635 . . . . 1.09 111.043 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 p -64.24 -47.32 80.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.813 -0.63 . . . . 1.69 111.438 -177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.63 HD23 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.59 -45.44 91.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.64 -0.255 . . . . 1.46 111.176 -177.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.807 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 85.4 t80 -53.07 -58.81 5.74 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 123.215 0.322 . . . . 0.92 110.668 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -70.09 -36.18 74.7 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.697 -0.401 . . . . 1.88 111.802 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.01 -39.81 79.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 2.27 111.384 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.723 ' CD1' HD13 ' A' ' 171' ' ' LEU . 73.9 m-85 -108.32 4.95 25.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.9 113.17 -174.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -28.02 66.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 2.62 110.397 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.4 m -65.65 -37.34 86.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.464 . . . . 1.59 111.144 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -88.45 1.44 54.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.92 0.391 . . . . 1.9 111.107 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 88.94 66.0 1.28 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.951 -0.643 . . . . 1.32 112.191 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.623 ' CE1' HD12 ' A' ' 39' ' ' LEU . 71.9 t80 -132.05 140.07 48.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.503 0.192 . . . . 0.4 110.594 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.585 HG23 ' CB ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.27 140.22 52.0 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 120.898 0.38 . . . . 1.11 110.381 177.116 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.807 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 25.4 t -109.74 117.88 55.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.963 0.411 . . . . 1.06 110.521 169.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.648 ' HB3' ' HE1' ' A' ' 105' ' ' MET . 20.3 mt -101.43 137.84 39.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.693 -0.854 . . . . 1.23 108.693 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -122.45 116.34 23.79 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.349 -0.54 . . . . 1.04 110.835 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.613 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -99.12 108.77 51.43 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 108.659 -0.867 . . . . 0.45 108.659 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.096 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.6 Cg_exo -59.3 170.24 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.194 2.596 . . . . 0.73 111.717 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 83' ' ' GLU . 46.0 t -115.0 135.79 53.84 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.892 0.853 . . . . 2.02 112.291 -177.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -90.16 104.55 17.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.708 -1.587 . . . . 3.1 109.791 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.838 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -65.13 -14.54 60.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.043 -0.98 . . . . 3.18 111.321 -173.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -86.61 -1.61 57.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.642 -0.708 . . . . 4.52 110.443 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 109' ' ' ASN . . . -71.16 -13.27 72.98 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.848 -0.692 . . . . 1.45 111.579 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.13 -61.55 0.47 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.041 -0.599 . . . . 1.43 112.646 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.536 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.1 pm0 -112.56 20.96 16.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.53 0.567 . . . . 1.43 112.53 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.838 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.5 OUTLIER -61.15 161.21 17.79 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 118.245 0.475 . . . . 3.06 111.296 -170.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.682 ' HG3' HG22 ' A' ' 135' ' ' ILE . 81.6 Cg_exo -51.28 172.52 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.255 2.636 . . . . 1.61 115.631 -168.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.43 13.98 74.33 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.054 -1.618 . . . . 1.83 109.054 -168.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.446 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 13.1 m120 52.78 37.19 23.24 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 114.145 -1.028 . . . . 4.24 111.324 -175.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 4.4 pt-20 61.44 -16.84 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.295 1.438 . . . . 2.47 113.995 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 86' ' ' ASN . 24.6 mt-10 -97.5 8.46 44.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.572 -0.705 . . . . 3.64 112.261 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.664 ' HG2' ' HA3' ' A' ' 48' ' ' GLY . 27.9 tt0 -91.45 -39.42 11.98 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.304 -0.558 . . . . 2.42 109.652 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.598 HD12 ' SG ' ' A' ' 95' ' ' CYS . 5.5 mt -96.88 19.79 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.874 -0.603 . . . . 2.56 110.255 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -76.1 -10.26 59.28 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.53 0.681 . . . . 4.36 110.854 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.79 18.15 5.15 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.079 -0.964 . . . . 3.1 109.639 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.436 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 65.8 m-85 -140.11 170.46 15.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.08 -0.964 . . . . 2.15 109.837 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.91 126.7 67.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.771 -0.455 . . . . 2.13 109.771 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.598 ' SG ' HD12 ' A' ' 90' ' ' ILE . 10.6 m -102.05 120.25 40.12 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.196 -0.456 . . . . 0.91 111.6 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 t -154.27 122.09 5.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.101 -0.5 . . . . 2.41 110.964 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.652 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 15.7 ptpt 32.31 84.43 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.867 1.062 . . . . 3.5 113.867 174.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.729 ' HE2' HG11 ' A' ' 43' ' ' VAL . 15.5 p90 -66.77 -25.47 66.5 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.742 -0.599 . . . . 1.74 110.361 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 99' ' ' LYS . 71.3 mmtt 65.78 148.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.081 0.863 . . . . 3.53 111.946 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.433 ' HB2' ' HE1' ' A' ' 54' ' ' TYR . . . -169.39 -164.74 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.736 0.643 . . . . 1.09 112.736 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -69.67 -24.68 63.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.365 -0.834 . . . . 2.19 109.752 173.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.851 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 50.3 p90 -108.9 168.07 8.27 Favored Pre-proline 0 N--CA 1.438 -1.063 0 CA-C-N 114.575 -1.193 . . . . 0.39 109.479 -175.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.839 ' HB2' ' HE3' ' A' ' 105' ' ' MET . 16.4 Cg_exo -73.7 129.37 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.7 2.933 . . . . 0.48 113.186 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.042 HG13 ' HB1' ' A' ' 73' ' ' ALA . 2.9 mp -117.69 138.02 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.336 -0.616 . . . . 1.13 109.336 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.839 ' HE3' ' HB2' ' A' ' 103' ' ' PRO . 8.9 mmt -112.66 -156.59 0.59 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.837 0.827 . . . . 2.08 113.2 -164.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -65.96 137.99 57.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.494 -1.23 . . . . 1.11 110.938 174.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.096 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttp -84.44 127.63 34.12 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.85 0.833 . . . . 2.12 109.458 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -131.66 162.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.983 -1.462 . . . . 1.19 107.769 -176.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 21.5 t-20 -75.81 83.61 2.76 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.857 -0.794 . . . . 2.16 108.857 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.653 HG12 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.26 89.57 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 108.085 -1.08 . . . . 1.1 108.085 173.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.536 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 1.0 OUTLIER 175.02 179.52 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.474 -0.936 . . . . 1.98 108.474 -178.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 47.0 -144.0 5.02 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 124.313 1.008 . . . . 0.78 115.512 156.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.81 -6.96 22.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.152 -1.024 . . . . 1.98 110.331 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -98.29 0.01 44.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.476 -0.784 . . . . 2.1 110.975 -170.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.735 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -50.79 138.89 17.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 1.17 112.888 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.723 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 51.2 t-80 -52.4 138.08 39.7 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.303 -0.862 . . . . 0.51 110.313 172.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.48 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -44.39 -45.08 12.92 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.217 2.611 . . . . 0.43 112.676 -178.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.723 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 2.0 tm? -54.72 -45.61 74.11 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.667 -0.697 . . . . 1.69 111.189 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.5 m-85 -75.56 -29.74 59.47 Favored 'General case' 0 C--O 1.212 -0.885 0 O-C-N 122.295 -0.253 . . . . 1.84 111.451 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 49.8 mt-10 -58.49 -39.42 79.97 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.946 -0.702 . . . . 2.37 109.165 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 88.1 t80 -67.82 -44.0 78.27 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.293 0.371 . . . . 1.09 110.597 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.448 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.3 mtt -65.02 -54.12 35.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.306 -0.406 . . . . 1.06 111.033 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 36.7 mtpt -57.18 -39.94 76.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.735 -0.666 . . . . 1.42 110.877 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.4 ptmt -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.421 -0.354 . . . . 2.63 111.534 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.574 HG23 ' HD2' ' A' ' 150' ' ' PRO . 94.3 m -64.36 -53.8 42.87 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.625 -0.43 . . . . 1.09 110.314 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.673 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.8 ttmt -127.61 105.76 21.05 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.847 -0.427 . . . . 2.26 109.847 173.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.523 ' HB2' ' H ' ' A' ' 133' ' ' LYS . 32.6 Cg_endo -64.72 -17.85 60.76 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.202 2.601 . . . . 1.81 113.026 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.94 164.81 12.54 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.969 -1.11 . . . . 2.45 112.729 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.1 pt -124.34 20.31 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.418 0.628 . . . . 4.01 110.124 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 131' ' ' ALA . 2.0 pt? -164.94 -41.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 2.97 109.024 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.502 ' N ' ' HG ' ' A' ' 130' ' ' LEU . . . -144.26 122.13 12.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.847 -1.168 . . . . 3.28 107.847 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.2 p -86.36 -179.62 6.71 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.311 0.856 . . . . 4.33 113.311 -169.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' H ' ' HB2' ' A' ' 127' ' ' PRO . 77.9 tttt 78.64 -91.26 0.02 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-N 113.86 -1.518 . . . . 5.43 112.752 173.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -123.09 178.76 4.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 114.027 1.121 . . . . 1.51 114.027 -162.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.852 HG21 ' HZ3' ' A' ' 137' ' ' TRP . 50.4 mt -82.9 156.21 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 113.539 -1.664 . . . . 1.5 108.464 176.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.437 ' HZ1' ' HB3' ' A' ' 131' ' ' ALA . 38.8 pttt -173.26 10.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.121 0.786 . . . . 1.99 113.121 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.852 ' HZ3' HG21 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.62 171.26 14.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.763 0.425 . . . . 1.1 110.997 -177.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -45.53 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 1.8 113.526 172.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.906 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 47.0 m-85 -27.87 -59.07 0.11 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 114.634 1.346 . . . . 1.68 114.634 -166.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.801 HG21 ' HA ' ' A' ' 155' ' ' SER . 11.6 m 45.11 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.913 0.779 . . . . 1.05 112.954 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.7 p -89.87 150.19 22.32 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.538 -0.865 . . . . 1.38 111.071 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.8 m-85 -102.72 135.84 43.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.895 -1.15 . . . . 0.53 107.895 166.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.947 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 54.9 tp -82.13 105.13 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.015 -0.735 . . . . 1.2 109.015 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.785 HG22 HD11 ' A' ' 15' ' ' ILE . 14.9 mm -102.5 122.59 55.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.558 -0.746 . . . . 1.05 109.04 -173.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.56 179.24 3.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.415 . . . . 1.3 110.355 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.784 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 72.8 mtp180 -62.41 -15.33 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.262 0.467 . . . . 4.43 112.262 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -109.03 -18.29 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.835 -0.541 . . . . 1.18 110.236 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.5 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 112.06 34.07 2.06 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.25 113.27 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 55.0 t -108.41 126.75 28.89 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 117.199 0.5 . . . . 1.32 110.595 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 125' ' ' THR . 11.3 Cg_exo -69.22 97.48 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.073 2.515 . . . . 0.46 112.072 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.95 -20.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.529 . . . . 1.09 111.151 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.673 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 6.0 mm-40 -154.17 162.45 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.998 -0.371 . . . . 1.22 109.998 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -135.3 98.14 3.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.565 -0.531 . . . . 2.25 109.565 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.947 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 16.1 m-85 -88.56 125.06 34.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.801 ' HA ' HG21 ' A' ' 140' ' ' THR . 92.4 p -69.75 171.74 6.71 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.809 -0.811 . . . . 1.49 108.809 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.778 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 37.8 Cg_endo -66.04 -8.89 21.42 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.92 1.747 . . . . 0.74 112.293 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.35 -4.9 83.17 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.231 -0.895 . . . . 0.56 112.108 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.09 113.26 19.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.16 0.505 . . . . 1.14 110.125 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.2 p -82.62 179.92 7.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.677 -0.692 . . . . 1.64 110.804 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.63 HG13 HD23 ' A' ' 60' ' ' LEU . 58.0 t -44.17 -57.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.747 -0.66 . . . . 1.14 111.617 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -58.12 -39.45 78.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.773 -0.648 . . . . 3.84 112.399 -175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.52 -31.1 70.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.472 0.653 . . . . 1.86 110.087 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.723 HG22 HD23 ' A' ' 39' ' ' LEU . 46.0 mt -81.32 -42.52 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.242 -0.89 . . . . 1.05 110.945 177.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 65.3 mt-10 -58.09 -36.32 72.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.43 -0.35 . . . . 0.88 111.902 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.3 pt-20 -63.71 -12.28 33.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.894 0.331 . . . . 0.75 111.894 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.617 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.8 mmtp -116.22 -23.06 8.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.427 . . . . 2.11 110.694 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.8 tp -89.68 -37.16 14.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.398 0.518 . . . . 1.06 112.398 -170.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.639 ' HA ' HD11 ' A' ' 171' ' ' LEU . 68.8 mt -50.75 -48.47 83.16 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 1.14 112.841 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.8 Cg_exo -55.11 -37.07 94.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.924 1.749 . . . . 0.74 112.69 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 174' ' ' ALA . 33.3 mt -78.95 -36.93 40.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.688 0.255 . . . . 1.35 111.688 -175.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 1.037 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.9 mt -55.44 -50.69 69.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.586 0.707 . . . . 1.16 109.216 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -48.85 -68.73 1.19 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.11 -1.405 . . . . 1.52 111.78 167.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.784 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 9.3 t 175.9 137.83 0.05 Allowed 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.691 0.282 . . . . 2.89 110.434 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.515 ' HB2' HD23 ' A' ' 170' ' ' LEU . . . -92.2 -31.11 15.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.207 0.527 . . . . 3.56 109.937 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -87.0 -6.28 58.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.417 -0.81 . . . . 8.59 110.581 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.599 ' HB2' ' HG ' ' A' ' 173' ' ' SER . 82.7 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.836 -0.62 . . . . 5.3 109.915 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' H3 ' ' CG ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.792 -0.523 . . . . 5.87 111.792 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -81.62 92.64 6.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.909 -0.404 . . . . 5.34 109.909 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.55 88.19 0.1 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.885 -0.598 . . . . 1.87 112.742 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -107.96 -27.12 10.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 2.22 110.421 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.6 p -137.25 167.61 21.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.63 -0.714 . . . . 1.06 109.101 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.727 HD13 HG21 ' A' ' 144' ' ' ILE . 18.0 pt -61.57 -29.7 46.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.852 0.358 . . . . 1.08 111.9 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.812 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 72.4 m-85 -76.5 1.52 16.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.264 0.468 . . . . 0.3 112.264 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.421 ' CG ' ' H3 ' ' A' ' 10' ' ' GLY . 23.6 t70 -73.39 -17.86 61.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.792 -0.818 . . . . 1.96 108.792 173.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.582 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 73.9 m-85 -99.73 159.99 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.4 110.6 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -102.21 135.77 43.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 2.77 110.963 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.639 HG23 HD13 ' A' ' 30' ' ' LEU . 89.3 t -114.35 146.63 18.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.294 0.568 . . . . 1.39 111.731 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.967 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 86.3 mt -117.29 153.22 33.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.615 -0.72 . . . . 1.33 110.24 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 176.72 1.4 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.206 -0.906 . . . . 1.59 109.454 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -53.71 -32.04 50.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.299 0.571 . . . . 1.14 110.065 173.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -87.12 -3.91 59.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.62 -0.718 . . . . 2.22 112.281 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.967 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.7 m-70 74.49 27.04 1.43 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.693 0.759 . . . . 0.88 110.296 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -88.56 154.61 50.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.61 -1.626 . . . . 3.67 106.61 167.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.17 113.14 1.31 Allowed 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.047 1.164 . . . . 1.19 112.916 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.459 ' CE2' ' SD ' ' A' ' 105' ' ' MET . 60.3 t80 -89.91 117.53 28.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.411 -0.813 . . . . 0.98 110.722 168.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.556 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.87 84.97 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.587 -0.733 . . . . 1.65 109.512 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.791 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.74 -32.35 67.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.002 0.43 . . . . 1.08 110.58 -176.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.812 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -76.54 -1.37 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 1.15 112.699 -167.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 7.0 pt20 -80.75 -5.71 57.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.418 0.628 . . . . 1.94 109.724 172.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -92.15 1.02 57.46 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.188 -1.041 . . . . 0.38 108.188 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 22.8 ttpp -86.19 132.64 33.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.923 -1.035 . . . . 2.22 109.216 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.2 32.26 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.767 -1.333 . . . . 0.36 109.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 18.1 m -139.84 149.64 59.85 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.389 -0.967 . . . . 1.58 108.389 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.015 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 61.1 Cg_endo -75.41 153.51 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.558 1.505 . . . . 0.86 111.257 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.565 ' CB ' HG21 ' A' ' 70' ' ' THR . 2.2 pt? -154.27 151.07 28.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.297 0.57 . . . . 1.63 111.295 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.754 HD22 HG22 ' A' ' 163' ' ' ILE . 6.4 mp -109.64 154.9 22.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.567 -0.742 . . . . 1.69 109.089 172.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.586 HG21 ' HH ' ' A' ' 119' ' ' TYR . 72.3 mt -140.87 121.56 13.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.75 -0.833 . . . . 1.05 108.75 -176.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 1.051 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -108.41 126.72 53.2 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.882 0.373 . . . . 0.93 111.589 -171.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.658 ' ND2' HD12 ' A' ' 135' ' ' ILE . 0.6 OUTLIER -77.97 93.82 4.5 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.619 -1.252 . . . . 1.97 107.619 170.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.874 HG12 ' HA ' ' A' ' 139' ' ' PHE . 18.0 m -112.65 138.38 42.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 113.44 0.904 . . . . 1.48 113.44 -164.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.8 102.78 2.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.575 -1.639 . . . . 1.17 106.575 163.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.028 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 32.3 t -60.12 94.07 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.69 -0.686 . . . . 2.3 112.202 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 98' ' ' PHE . 24.7 tptp 63.46 19.29 11.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.502 0.668 . . . . 2.81 110.516 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.2 p -135.18 172.62 12.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.706 -0.679 . . . . 1.18 109.846 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.17 -154.58 39.15 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.714 -0.755 . . . . 1.42 112.796 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -110.72 111.9 23.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 3.45 110.235 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 p -77.56 112.86 14.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.5 . . . . 1.94 111.109 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -81.5 14.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 2.51 111.062 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.2 8.38 38.75 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.976 -0.556 . . . . 0.55 111.888 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -39.04 96.73 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 111.987 -0.445 . . . . 0.39 111.987 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CZ ' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -66.71 -47.29 72.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.769 0.319 . . . . 1.05 110.413 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.65 -45.58 92.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.742 -0.466 . . . . 2.46 109.742 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 160' ' ' VAL . 73.2 m -59.74 -50.96 71.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.602 -0.726 . . . . 1.06 111.032 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.903 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.57 -50.25 73.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.164 -0.471 . . . . 1.03 111.372 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m -56.08 -46.77 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.958 0.409 . . . . 1.09 111.252 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.66 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 90.6 m -64.49 -46.5 82.73 Favored 'General case' 0 C--N 1.337 0.036 0 CA-C-N 116.392 -0.367 . . . . 1.69 111.156 -177.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.597 HD12 HD21 ' A' ' 39' ' ' LEU . 71.4 mt -59.72 -49.72 76.63 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 120.722 0.296 . . . . 1.46 110.622 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.649 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 14.8 t80 -50.33 -57.43 7.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.213 -0.903 . . . . 0.92 109.651 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.66 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 2.3 p30 -73.84 -29.07 61.92 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.755 -0.657 . . . . 1.88 111.738 -168.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.669 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 33.2 ttmt -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.641 0.258 . . . . 2.27 111.041 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.765 ' CD1' HD12 ' A' ' 171' ' ' LEU . 70.8 m-85 -116.73 10.43 14.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.892 1.071 . . . . 0.9 113.892 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.649 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 14.7 mtpp -64.02 -20.29 65.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.0 -0.68 . . . . 2.62 109.991 172.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -61.19 -33.27 73.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.766 -0.652 . . . . 1.59 109.887 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.412 HE21 ' HD1' ' A' ' 64' ' ' TYR . 2.0 mp0 -95.31 11.78 31.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.914 -0.584 . . . . 1.9 110.643 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.61 12.38 75.3 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.872 -0.603 . . . . 1.32 113.042 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' PRO . 93.8 t80 -72.03 141.06 49.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.034 0.445 . . . . 0.4 111.302 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.565 HG21 ' CB ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -131.79 144.87 51.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.908 -0.587 . . . . 1.11 109.714 176.579 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.903 HG11 ' HB1' ' A' ' 57' ' ' ALA . 41.4 t -112.26 117.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.605 -0.517 . . . . 1.06 109.605 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.3 mt -100.28 121.11 40.95 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.735 -0.839 . . . . 1.23 108.735 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.066 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -107.99 112.72 25.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.388 -0.525 . . . . 1.04 110.608 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.577 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.1 m-85 -98.46 115.25 65.82 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.039 -0.726 . . . . 0.45 109.039 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.028 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 19.6 Cg_exo -63.28 169.66 9.09 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.107 2.538 . . . . 0.73 111.915 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t -128.99 155.4 45.43 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.519 -0.872 . . . . 2.02 112.165 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.686 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -114.83 71.52 0.76 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.248 -1.342 . . . . 3.1 109.087 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.996 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -45.55 -12.5 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.92 1.452 . . . . 3.18 114.92 -173.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -79.12 -7.53 58.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.306 0.574 . . . . 4.52 110.343 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.82 36.91 2.3 Favored Glycine 0 C--N 1.329 0.171 0 CA-C-N 115.975 -0.557 . . . . 1.45 113.735 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.34 -72.98 2.72 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.84 -0.695 . . . . 1.43 112.789 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.682 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.6 pm0 -120.96 30.71 6.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.154 0.798 . . . . 1.43 113.154 -172.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.996 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 6.0 mm-40 -62.34 145.11 94.59 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 119.596 -0.841 . . . . 3.06 110.012 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.691 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 26.8 Cg_endo -70.92 179.02 4.66 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 121.925 1.75 . . . . 1.61 111.892 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.42 ' H ' ' CA ' ' A' ' 137' ' ' TRP . . . 77.7 16.14 80.48 Favored Glycine 0 CA--C 1.498 -0.983 0 N-CA-C 110.095 -1.202 . . . . 1.83 110.095 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 1.0 OUTLIER 71.84 108.18 0.07 Allowed 'General case' 0 C--N 1.333 -0.138 0 O-C-N 125.093 1.113 . . . . 4.24 109.752 -174.105 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 2.3 pm0 -52.72 156.08 2.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.672 -0.695 . . . . 2.47 111.649 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 13.5 mm-40 72.84 21.7 3.28 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.651 -0.704 . . . . 3.64 111.208 -174.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.659 ' HB3' ' HG2' ' A' ' 78' ' ' GLN . 10.1 tp10 -84.14 -11.0 57.31 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 116.109 -0.496 . . . . 2.42 112.155 -175.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.905 HG13 ' HB2' ' A' ' 78' ' ' GLN . 6.6 mt -93.76 -7.09 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.508 -0.745 . . . . 2.56 110.2 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 13.8 mmmm -73.3 8.98 1.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.698 0.629 . . . . 4.36 112.698 -167.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -163.12 24.86 0.09 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.584 -0.895 . . . . 3.1 108.584 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CD2' ' O ' ' A' ' 89' ' ' GLU . 51.9 m-85 -139.65 -178.48 5.43 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.522 -1.217 . . . . 2.15 110.815 -171.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.43 110.86 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.884 -0.784 . . . . 2.13 108.884 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.701 ' SG ' HG12 ' A' ' 90' ' ' ILE . 4.6 m -106.14 -158.13 0.64 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.634 -0.712 . . . . 0.91 109.364 177.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.73 HG21 ' HG2' ' A' ' 75' ' ' PRO . 1.8 m -13.98 117.57 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 115.216 1.561 . . . . 2.41 115.216 -140.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 98' ' ' PHE . 6.1 ptmt 171.88 -31.48 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 111.477 -2.601 . . . . 3.5 107.883 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.658 ' HB3' ' HG ' ' A' ' 45' ' ' SER . 0.5 OUTLIER -36.8 109.97 0.11 Allowed 'General case' 0 C--N 1.354 0.779 0 O-C-N 124.972 1.42 . . . . 1.74 111.387 -173.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 97' ' ' LYS . 73.4 mmtt -104.61 143.17 33.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.055 -0.975 . . . . 3.53 110.262 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.472 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . . . -145.15 -170.24 3.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.602 -0.272 . . . . 1.09 110.979 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -75.02 -26.54 59.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.446 0.641 . . . . 2.19 109.496 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.886 ' HE2' ' HB1' ' A' ' 73' ' ' ALA . 44.0 p90 -98.44 159.35 30.78 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 114.933 -1.03 . . . . 0.39 109.544 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 38.8 Cg_exo -67.56 114.18 3.2 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.091 3.194 . . . . 0.48 113.608 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.066 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mp -100.35 131.9 46.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 108.98 -0.748 . . . . 1.13 108.98 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.679 ' HA ' ' HE1' ' A' ' 105' ' ' MET . 0.1 OUTLIER -117.03 -155.58 0.59 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.345 0.869 . . . . 2.08 113.345 -157.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.72 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . . . -68.63 113.47 6.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.979 -1.01 . . . . 1.11 111.177 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.977 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -61.99 139.87 58.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.401 0.62 . . . . 2.12 109.602 171.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.515 HD13 ' CB ' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -150.13 156.59 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.571 -1.27 . . . . 1.19 107.571 -174.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.756 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 24.8 t-20 -67.84 93.99 0.43 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.102 -0.703 . . . . 2.16 109.102 175.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.602 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -83.7 82.59 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.278 -0.969 . . . . 1.1 108.793 176.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.682 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 32.5 t30 170.68 -177.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.229 -1.026 . . . . 1.98 108.229 170.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 58.92 -141.74 46.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.438 -0.887 . . . . 0.78 114.541 158.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.62 -15.95 16.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.683 0.754 . . . . 1.98 109.671 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.454 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 19.1 m120 -88.46 -5.64 58.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.607 -1.178 . . . . 2.1 110.912 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.37 126.43 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.298 -0.864 . . . . 1.17 112.281 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.828 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 55.1 t-80 -47.47 133.79 10.13 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-O 118.535 -0.745 . . . . 0.51 109.928 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.582 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.6 Cg_endo -42.11 -45.11 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.228 2.619 . . . . 0.43 112.711 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.828 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 20.1 tp -54.77 -51.45 65.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.753 -0.658 . . . . 1.69 111.584 175.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.751 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 22.9 m-85 -69.78 -31.5 69.47 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.403 -0.362 . . . . 1.84 111.201 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.546 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 1.4 mt-10 -55.18 -46.86 75.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.547 -0.909 . . . . 2.37 108.547 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 85.8 t80 -64.6 -49.25 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.665 0.603 . . . . 1.09 110.128 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.65 ' HE3' HD13 ' A' ' 118' ' ' LEU . 64.2 mtt -54.54 -51.58 64.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.123 -0.489 . . . . 1.06 111.722 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.751 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 27.5 mtpt -61.3 -49.33 77.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.868 0.366 . . . . 1.42 110.549 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 16.7 ptpt -70.44 -31.66 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 2.63 111.046 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.523 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.3 m -70.51 -40.58 73.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.429 -0.35 . . . . 1.09 111.78 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD3' ' HD2' ' A' ' 127' ' ' PRO . 10.0 mmtt -144.74 117.79 5.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.53 . . . . 2.26 112.164 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.762 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 54.7 Cg_endo -72.65 -28.06 14.53 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.077 2.518 . . . . 1.81 111.93 174.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.757 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 85.33 -137.08 15.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.916 -0.659 . . . . 2.45 112.856 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.1 pt -80.39 5.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.904 0.383 . . . . 4.01 111.6 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.503 HD12 ' HZ2' ' A' ' 137' ' ' TRP . 2.3 pt? -146.5 128.9 15.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.086 -0.506 . . . . 2.97 109.749 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.0 2.9 13.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.189 0.44 . . . . 3.28 112.189 -175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.464 HG21 ' HE3' ' A' ' 136' ' ' LYS . 21.1 m -58.26 -32.02 67.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.264 -0.425 . . . . 4.33 110.424 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.762 ' HG2' ' HB3' ' A' ' 127' ' ' PRO . 96.8 mttt 67.43 -5.88 0.7 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.34 -0.845 . . . . 5.43 111.531 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 132' ' ' THR . . . -98.64 160.34 14.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.971 -0.559 . . . . 1.51 111.645 -176.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.815 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 13.6 mt -105.1 105.86 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.537 -0.756 . . . . 1.5 109.659 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.464 ' HE3' HG21 ' A' ' 132' ' ' THR . 16.1 ptpt -133.01 26.67 4.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.142 0.793 . . . . 1.99 113.142 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.815 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -151.34 170.18 20.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.324 0.583 . . . . 1.1 111.995 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.547 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 2.7 t-20 -49.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 1.8 112.751 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 1.051 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 10.5 m-85 -27.44 -50.99 0.06 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 125.342 1.457 . . . . 1.68 114.794 -167.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.786 HG21 ' HA ' ' A' ' 155' ' ' SER . 12.4 m 37.15 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.763 1.165 . . . . 1.05 113.288 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.637 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.6 p -85.11 150.63 24.72 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.149 -0.621 . . . . 1.38 111.412 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.5 m-85 -103.66 132.2 50.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.955 -1.128 . . . . 0.53 107.955 165.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.57 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 20.7 tp -81.2 106.11 12.93 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.931 -0.766 . . . . 1.2 108.931 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.727 HG21 HD13 ' A' ' 15' ' ' ILE . 18.7 mm -106.17 122.86 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.116 -0.698 . . . . 1.05 109.116 -172.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.41 179.14 3.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.262 -0.426 . . . . 1.3 110.505 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.434 ' HD2' ' H ' ' A' ' 174' ' ' ALA . 61.4 mtt180 -59.25 -21.31 59.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.797 0.666 . . . . 4.43 112.797 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -109.87 -10.08 14.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.151 0.5 . . . . 1.18 110.733 -171.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.552 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 104.16 32.9 4.16 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.737 -0.744 . . . . 0.25 113.375 174.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.3 t -107.22 122.43 41.41 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.695 -0.483 . . . . 1.32 109.695 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.523 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.5 Cg_exo -68.1 118.02 5.33 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.476 2.118 . . . . 0.46 111.178 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.561 ' HB ' HD21 ' A' ' 143' ' ' LEU . 32.6 t -97.22 -30.06 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.928 -0.578 . . . . 1.09 110.632 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -154.83 165.31 37.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 1.22 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.757 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 12.7 ttm180 -132.25 98.61 4.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.698 -0.683 . . . . 2.25 109.358 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.64 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 24.5 m-85 -91.05 108.97 20.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.587 -0.523 . . . . 0.38 109.587 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.786 ' HA ' HG21 ' A' ' 140' ' ' THR . 10.5 p -61.19 163.25 11.04 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.806 -0.442 . . . . 1.49 109.806 175.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.782 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 45.4 Cg_endo -65.46 -7.01 14.77 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.916 2.411 . . . . 0.74 113.4 -162.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 51' ' ' LYS . . . -85.36 -10.66 76.97 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.302 -0.863 . . . . 0.56 111.741 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.41 131.76 43.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 1.14 110.17 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.436 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 48.9 m -81.57 168.96 17.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.79 -0.641 . . . . 1.64 111.12 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' A' ' 56' ' ' THR . 44.8 t -54.44 -51.16 52.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 1.14 110.781 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.488 ' HE3' ' HB2' ' A' ' 161' ' ' LYS . 32.9 ttmt -65.37 -33.65 76.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.553 -0.748 . . . . 3.84 110.868 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.6 m-20 -62.43 -31.77 72.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.349 -0.842 . . . . 1.86 110.263 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.754 HG22 HD22 ' A' ' 39' ' ' LEU . 69.2 mt -82.89 -37.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.987 -0.552 . . . . 1.05 110.908 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.5 mt-10 -57.83 -35.8 71.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.88 112.201 -175.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.99 -32.79 61.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.85 0.357 . . . . 0.75 111.459 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.532 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 47.1 mmtm -100.44 -17.07 17.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 2.11 111.036 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.6 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 65.7 tp -88.35 -38.08 15.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.192 -0.458 . . . . 1.06 111.407 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.669 ' HA ' HD13 ' A' ' 171' ' ' LEU . 85.0 mt -50.71 -52.5 55.93 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.835 0.68 . . . . 1.14 112.835 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.6 Cg_endo -55.67 -34.26 89.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.095 1.863 . . . . 0.74 112.673 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.76 -36.0 51.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.569 -0.287 . . . . 1.35 110.84 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 1.015 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.5 mt -56.36 -57.03 14.01 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.07 -0.514 . . . . 1.16 109.781 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -45.21 -61.05 3.74 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.265 -1.334 . . . . 1.52 112.927 172.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 21.9 t 177.48 126.06 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.652 -0.499 . . . . 2.89 109.652 175.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.434 ' H ' ' HD2' ' A' ' 146' ' ' ARG . . . -94.4 -40.21 10.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.065 0.459 . . . . 3.56 110.602 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -167.99 -30.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.414 -0.812 . . . . 8.59 108.968 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.299 -0.857 . . . . 5.3 109.595 173.145 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 N-CA-C 111.911 -0.476 . . . . 5.87 111.911 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt -132.83 29.18 4.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.52 0.676 . . . . 5.34 109.606 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.47 42.1 0.12 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.402 -0.817 . . . . 1.87 111.803 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 m -72.48 -59.07 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.327 0.584 . . . . 2.22 109.969 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -141.99 177.57 8.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.361 -0.836 . . . . 1.06 108.767 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.841 HD13 HG23 ' A' ' 144' ' ' ILE . 20.7 pt -57.37 -28.67 31.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 1.08 111.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.869 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 33.5 m-85 -78.13 2.68 17.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.3 111.447 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.07 -20.68 64.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.998 -1.112 . . . . 1.96 107.998 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.519 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 61.8 m-85 -111.56 172.36 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.284 -1.326 . . . . 0.4 109.918 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -115.06 161.91 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.75 0.309 . . . . 2.77 110.606 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.522 HG21 HD13 ' A' ' 30' ' ' LEU . 61.2 t -128.52 141.69 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 1.39 111.303 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.908 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 51.0 mt -95.77 132.78 40.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.905 -0.589 . . . . 1.33 109.703 171.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.29 177.75 1.04 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.184 -0.916 . . . . 1.59 109.143 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . . . -51.76 -35.46 43.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.923 0.392 . . . . 1.14 110.748 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -85.82 -3.51 58.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.947 -0.569 . . . . 2.22 111.236 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.908 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.5 m-70 71.97 15.96 5.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.638 0.732 . . . . 0.88 109.521 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -75.55 157.4 84.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 106.726 -1.583 . . . . 3.67 106.726 165.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.63 113.98 2.05 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 120.753 0.969 . . . . 1.19 111.824 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.409 ' HH ' ' CB ' ' A' ' 103' ' ' PRO . 67.9 t80 -90.4 109.12 20.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.36 -0.836 . . . . 0.98 109.324 170.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.643 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.9 t30 -70.93 85.66 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.613 -0.514 . . . . 1.65 109.613 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.869 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -61.6 -29.56 70.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.629 -0.714 . . . . 1.08 111.079 -176.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.82 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 5.4 p -76.12 -0.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.425 -0.807 . . . . 1.15 112.81 -167.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.2 pt20 -80.61 -5.53 56.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.265 0.555 . . . . 1.94 109.921 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -92.98 -5.7 50.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 108.324 -0.991 . . . . 0.38 108.324 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -71.69 141.45 49.85 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.715 -1.13 . . . . 2.22 109.844 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.13 -12.87 55.66 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.895 -1.282 . . . . 0.36 109.895 -172.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.461 ' C ' ' HA ' ' A' ' 146' ' ' ARG . 25.0 m -140.6 148.07 51.68 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 108.572 -0.899 . . . . 1.58 108.572 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.964 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 79.5 Cg_endo -75.35 162.43 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.835 1.69 . . . . 0.86 110.996 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.648 ' CB ' HG23 ' A' ' 70' ' ' THR . 1.8 pt? -159.36 152.69 22.41 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 1.63 110.809 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.668 HD22 HG22 ' A' ' 163' ' ' ILE . 7.2 mp -107.38 148.41 29.12 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.996 -0.742 . . . . 1.69 108.996 173.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 89.0 mt -134.16 119.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.152 -0.684 . . . . 1.05 109.152 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 14.9 m-85 -104.01 130.09 51.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.615 -0.266 . . . . 0.93 111.287 -173.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.729 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -83.79 93.8 8.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.938 -0.764 . . . . 1.97 108.938 167.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.8 m -107.13 140.32 25.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 121.438 -0.789 . . . . 1.48 113.073 -163.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 102.82 4.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.764 -1.569 . . . . 1.17 106.764 164.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.776 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 39.0 t -74.01 94.3 2.35 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.109 0.781 . . . . 2.3 113.109 -163.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 12.7 ttpp 65.11 45.27 3.08 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.7 -1.136 . . . . 2.81 110.733 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.7 p -163.39 151.98 13.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 1.18 110.334 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA3' ' CD ' ' A' ' 89' ' ' GLU . . . 73.96 -124.59 8.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.814 -0.707 . . . . 1.42 113.593 173.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -107.19 136.89 46.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.351 0.596 . . . . 3.45 112.142 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.551 HG23 ' CE1' ' A' ' 139' ' ' PHE . 55.2 p -116.72 94.03 4.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 1.94 109.585 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.673 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 16.9 ttmm -78.17 41.21 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.283 -0.417 . . . . 2.51 110.908 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.29 85.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.037 -0.602 . . . . 0.55 112.775 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.95 -38.03 84.19 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 112.052 -0.419 . . . . 0.39 112.052 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.601 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.6 t80 -71.74 -50.44 30.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.556 -0.322 . . . . 1.05 110.688 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.35 -44.37 95.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.944 -0.571 . . . . 2.46 110.622 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -52.89 62.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 1.06 110.97 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.663 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -56.7 -49.31 75.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 1.03 111.781 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -56.77 -47.15 80.78 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.967 -0.561 . . . . 1.09 111.169 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.0 m -61.32 -48.89 79.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.627 -0.715 . . . . 1.69 110.988 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.5 mt -58.84 -52.04 67.42 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.244 -0.435 . . . . 1.46 111.738 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.787 ' HE1' ' HG1' ' A' ' 70' ' ' THR . 86.1 t80 -50.86 -52.77 38.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.527 0.517 . . . . 0.92 110.323 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -73.76 -36.65 65.13 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.476 -0.784 . . . . 1.88 111.425 -170.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -74.93 -45.97 38.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.815 -0.629 . . . . 2.27 111.503 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.61 ' CD1' HD12 ' A' ' 171' ' ' LEU . 34.1 m-85 -101.94 -2.84 28.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 114.686 1.365 . . . . 0.9 114.686 -168.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.601 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 13.0 ptmm? -69.18 -15.45 63.4 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.487 -0.885 . . . . 2.62 110.346 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -60.33 -33.2 72.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 1.59 109.979 172.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -101.55 10.24 40.48 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 116.357 -0.383 . . . . 1.9 110.878 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.616 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 90.15 80.61 1.36 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.97 -0.633 . . . . 1.32 112.589 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.601 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 69.9 t80 -151.97 141.89 22.07 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.928 -0.16 . . . . 0.4 110.891 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.787 ' HG1' ' HE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -131.93 149.74 52.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 110.021 -0.362 . . . . 1.11 110.021 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.723 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 49.0 t -117.09 115.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.972 -0.381 . . . . 1.06 109.972 172.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 18.4 mt -102.11 121.95 43.2 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.932 -0.766 . . . . 1.23 108.932 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.961 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -110.9 114.25 27.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.096 0.474 . . . . 1.04 110.656 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.759 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-85 -98.66 112.61 62.98 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 109.075 -0.713 . . . . 0.45 109.075 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.918 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 46.3 Cg_exo -57.89 167.78 3.95 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.278 2.652 . . . . 0.73 112.042 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t -115.4 145.36 42.62 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.027 -0.669 . . . . 2.02 110.911 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.613 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 29.6 t30 -112.22 72.24 0.77 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.541 -1.209 . . . . 3.1 108.987 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.958 ' HB2' HG13 ' A' ' 90' ' ' ILE . 15.5 mp0 -54.28 -13.73 0.96 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.134 -0.939 . . . . 3.18 113.041 -173.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -66.84 -17.61 64.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.896 0.379 . . . . 4.52 110.971 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.54 -27.3 69.43 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.699 -0.682 . . . . 1.45 112.167 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.75 -83.77 0.31 Allowed Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.848 -0.692 . . . . 1.43 111.818 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.736 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.6 pm0 -89.57 24.66 2.22 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.641 0.608 . . . . 1.43 112.641 -174.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.887 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 5.6 mm-40 -60.52 152.25 66.66 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 119.797 -0.761 . . . . 3.06 110.565 -175.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.725 ' HG3' HG23 ' A' ' 135' ' ' ILE . 72.8 Cg_exo -55.04 -177.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.799 2.333 . . . . 1.61 114.043 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.62 22.68 74.67 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.943 -1.263 . . . . 1.83 109.943 -173.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 13.2 m120 63.53 28.04 15.18 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 114.708 -0.746 . . . . 4.24 110.367 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 8.3 pt-20 59.9 161.53 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.521 1.528 . . . . 2.47 113.564 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.529 ' HB3' ' CG ' ' A' ' 91' ' ' LYS . 8.2 mt-10 56.02 37.9 29.35 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.353 -1.294 . . . . 3.64 111.42 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.478 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 3.2 tp10 -80.71 -15.33 56.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.649 -0.705 . . . . 2.42 110.778 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.958 HG13 ' HB2' ' A' ' 78' ' ' GLN . 3.0 mt -101.07 9.6 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 2.56 110.465 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.774 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 14.0 mmmm -65.81 123.9 21.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.409 -0.589 . . . . 4.36 109.409 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.774 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 8.0 pt-20 57.99 16.31 3.67 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.583 1.177 . . . . 3.1 111.552 -174.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -125.93 177.71 6.17 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.368 -0.605 . . . . 2.15 109.368 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.434 HG23 HG21 ' A' ' 96' ' ' THR . 9.1 p -130.26 116.76 37.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.319 -0.623 . . . . 2.13 109.319 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.881 ' SG ' HG12 ' A' ' 90' ' ' ILE . 57.8 m -103.5 111.27 23.65 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 119.008 -1.077 . . . . 0.91 108.992 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 94' ' ' VAL . 3.3 t -158.96 120.27 3.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.926 -1.034 . . . . 2.41 109.368 173.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 23' ' ' ALA . 42.7 mttp 45.86 86.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.222 0.823 . . . . 3.5 113.222 172.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.668 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 49.8 p90 -64.58 -20.87 66.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.657 -0.497 . . . . 1.74 109.657 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 66.45 136.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.736 -1.12 . . . . 3.53 111.424 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.487 ' HB2' ' HE1' ' A' ' 54' ' ' TYR . . . -165.06 -178.4 5.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.705 -0.68 . . . . 1.09 110.881 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -88.32 32.84 0.75 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.657 -0.702 . . . . 2.19 110.566 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.769 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.4 p90 -152.0 161.75 28.55 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.114 -1.069 . . . . 0.39 108.114 175.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.9 Cg_exo -64.85 107.94 0.99 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 123.53 2.82 . . . . 0.48 114.189 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.961 HG13 ' HB1' ' A' ' 73' ' ' ALA . 3.3 mp -101.39 131.88 48.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.892 -0.781 . . . . 1.13 108.892 171.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.759 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.7 mmt -110.03 -151.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.924 0.712 . . . . 2.08 112.924 -162.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -75.14 144.58 42.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.391 -0.822 . . . . 1.11 110.778 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.918 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 22.2 pttt -83.45 131.89 35.0 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.659 0.742 . . . . 2.12 109.775 169.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.438 HD13 ' CB ' ' A' ' 116' ' ' HIS . 2.3 pt -136.59 159.22 37.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.78 -1.563 . . . . 1.19 106.78 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.901 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -70.65 95.45 1.1 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.904 -0.718 . . . . 2.16 109.163 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -87.43 83.11 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.262 -0.975 . . . . 1.1 109.065 175.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.736 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 9.0 t-20 171.52 -178.5 0.05 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.367 -0.975 . . . . 1.98 108.367 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 53.2 -147.92 15.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 114.677 0.631 . . . . 0.78 114.677 160.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.42 2.23 28.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.15 -0.525 . . . . 1.98 111.096 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.56 -3.46 36.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.253 -0.43 . . . . 2.1 110.92 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.901 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -46.53 139.3 5.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.189 -0.914 . . . . 1.17 113.34 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.818 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 54.1 t-80 -51.31 137.31 29.81 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.259 -0.882 . . . . 0.51 110.376 171.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.583 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -44.04 -46.5 11.04 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.114 2.542 . . . . 0.43 112.526 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.818 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 20.9 tp -58.63 -41.89 86.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.842 -0.617 . . . . 1.69 111.762 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.506 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 3.7 m-85 -74.5 -29.98 61.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 119.561 -0.257 . . . . 1.84 110.781 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 41.5 mt-10 -56.54 -43.59 80.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.645 -0.872 . . . . 2.37 108.645 169.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.502 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 84.0 t80 -65.96 -46.57 77.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.54 0.525 . . . . 1.09 110.745 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.699 ' HE3' HD13 ' A' ' 118' ' ' LEU . 66.4 mtt -62.72 -51.72 66.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.212 -0.449 . . . . 1.06 111.02 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.566 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 34.7 mtpt -60.75 -45.24 95.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 1.42 110.949 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.4 ptmt -68.69 -33.49 74.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.266 -0.425 . . . . 2.63 111.299 -176.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.469 HG22 ' HD2' ' A' ' 150' ' ' PRO . 93.7 m -74.02 -50.28 20.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.072 -0.513 . . . . 1.09 111.85 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.533 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 6.1 tmtt? -139.85 104.35 6.86 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.682 -0.407 . . . . 2.26 111.437 -174.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.543 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 26.8 Cg_endo -65.19 -36.33 37.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.902 2.401 . . . . 1.81 111.97 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 92.97 -132.99 11.51 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.742 -0.742 . . . . 2.45 113.557 172.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.34 153.27 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 122.785 0.434 . . . . 4.01 111.057 -172.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 49.75 -163.97 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.221 1.008 . . . . 2.97 112.507 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.2 56.18 3.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.492 0.663 . . . . 3.28 109.885 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.58 HG22 ' HD2' ' A' ' 153' ' ' ARG . 11.3 m -67.76 -64.37 0.87 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.602 -0.726 . . . . 4.33 110.309 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp 63.93 -72.31 0.06 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.914 0.759 . . . . 5.43 110.487 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.91 177.12 4.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.961 -0.563 . . . . 1.51 110.477 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.83 HG22 ' HZ3' ' A' ' 137' ' ' TRP . 17.6 mt -76.84 161.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.069 -1.086 . . . . 1.5 108.069 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -178.02 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.925 0.784 . . . . 1.99 112.146 -176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.83 ' HZ3' HG22 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.52 165.8 11.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.269 -0.423 . . . . 1.1 112.09 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -48.33 -154.41 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 126.083 1.753 . . . . 1.8 113.817 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.783 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.2 m-85 -28.49 -45.64 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 115.273 1.583 . . . . 1.68 115.273 -163.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.973 HG21 ' HA ' ' A' ' 155' ' ' SER . 15.9 m 30.29 109.89 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.38 1.622 . . . . 1.05 115.38 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.0 p -93.56 156.52 16.68 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.27 0.557 . . . . 1.38 111.09 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.545 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 6.2 m-85 -102.43 166.47 10.53 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.018 -1.475 . . . . 0.53 107.018 163.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.735 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 49.8 tp -112.83 104.77 12.78 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.763 -0.829 . . . . 1.2 108.763 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.841 HG23 HD13 ' A' ' 15' ' ' ILE . 11.9 mm -103.05 125.22 57.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 109.11 -0.7 . . . . 1.05 109.11 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.44 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 38.9 p30 -77.86 -176.35 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.8 -0.36 . . . . 1.3 111.684 -175.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.68 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 76.6 mtp180 -57.41 -24.4 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.626 0.602 . . . . 4.43 112.626 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.52 -12.43 14.69 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.868 -0.733 . . . . 1.18 110.494 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.539 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 109.24 34.35 2.54 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.814 -0.708 . . . . 0.25 113.059 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 57.9 t -107.85 128.33 26.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.859 -0.423 . . . . 1.32 109.859 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.469 ' HD2' HG22 ' A' ' 125' ' ' THR . 4.8 Cg_exo -75.4 112.04 3.44 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.362 2.041 . . . . 0.46 111.24 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.533 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 41.1 t -93.54 -23.94 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 1.09 110.944 -177.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 1.2 mm-40 -156.65 166.11 34.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 1.22 111.042 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.58 ' HD2' HG22 ' A' ' 132' ' ' THR . 27.5 ttm180 -131.05 96.55 4.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.905 -0.776 . . . . 2.25 108.905 172.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.784 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 77.3 m-85 -82.42 110.07 17.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.38 109.519 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.973 ' HA ' HG21 ' A' ' 140' ' ' THR . 1.4 m -61.85 168.4 3.61 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.879 -0.415 . . . . 1.49 109.879 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.783 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 36.1 Cg_endo -60.93 -28.16 85.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.629 1.553 . . . . 0.74 111.462 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.49 66.33 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.317 -1.31 . . . . 0.56 112.681 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.64 112.03 6.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.964 0.411 . . . . 1.14 110.045 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.7 m -74.81 174.66 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.895 -0.593 . . . . 1.64 110.828 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 69.0 t -48.59 -53.37 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.343 -0.389 . . . . 1.14 111.679 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -66.17 -32.13 73.38 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.278 -0.419 . . . . 3.84 111.498 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -63.71 -32.57 74.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.418 -0.586 . . . . 1.86 109.418 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.668 HG22 HD22 ' A' ' 39' ' ' LEU . 63.2 mt -83.68 -39.83 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.322 -0.854 . . . . 1.05 111.12 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.4 mt-10 -51.44 -44.14 62.25 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.234 0.457 . . . . 0.88 112.234 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.9 pt-20 -53.79 -33.57 56.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.123 0.416 . . . . 0.75 112.123 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.784 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtm -102.18 -19.08 15.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.918 0.39 . . . . 2.11 111.007 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.6 tp -84.14 -45.53 12.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 1.06 111.349 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.641 ' HA ' HD13 ' A' ' 171' ' ' LEU . 74.3 mt -53.5 -48.11 94.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.281 0.474 . . . . 1.14 112.281 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.9 Cg_exo -53.54 -37.32 82.64 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.067 1.844 . . . . 0.74 112.7 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.3 mt -78.87 -35.86 43.1 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 111.95 0.352 . . . . 1.35 111.95 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.964 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 11.4 mt -55.51 -54.15 47.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.744 0.783 . . . . 1.16 108.933 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.03 -45.74 94.77 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.211 -1.359 . . . . 1.52 113.539 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 p -164.14 125.38 2.24 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.835 0.817 . . . . 2.89 113.07 -172.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.628 ' HB2' ' H ' ' A' ' 146' ' ' ARG . . . -95.01 -58.05 2.26 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.668 0.747 . . . . 3.56 110.009 172.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -136.53 -30.28 0.92 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.575 -1.269 . . . . 8.59 107.575 171.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 C--O 1.251 1.141 0 CA-C-N 114.48 -1.236 . . . . 5.3 107.881 166.541 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.559 -0.616 . . . . 5.87 111.559 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 48.4 ttm -79.97 -33.57 39.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.025 0.441 . . . . 5.34 109.847 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.86 97.54 1.76 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.802 -0.713 . . . . 1.87 112.583 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -93.48 -36.2 12.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.516 -0.92 . . . . 2.22 108.516 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.0 p -135.37 178.34 7.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.159 -0.928 . . . . 1.06 109.494 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.681 HD13 HG23 ' A' ' 144' ' ' ILE . 21.4 pt -62.99 -26.42 40.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.241 0.543 . . . . 1.08 110.632 175.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.797 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 45.7 m-85 -76.94 -6.06 51.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.8 -0.637 . . . . 0.3 112.306 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -82.37 7.33 14.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.448 0.642 . . . . 1.96 109.352 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 89.2 m-85 -119.56 169.97 9.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.103 -0.953 . . . . 0.4 110.051 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.7 tt0 -98.01 151.49 20.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.312 -0.404 . . . . 2.77 110.513 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.644 HG13 ' CE2' ' A' ' 74' ' ' PHE . 72.6 t -130.46 136.29 58.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.011 0.434 . . . . 1.39 110.507 172.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.716 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 96.4 mt -101.63 140.42 35.95 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.126 -0.694 . . . . 1.33 109.126 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 -172.72 3.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.238 -0.653 . . . . 1.59 109.238 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.46 66.35 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.779 0.323 . . . . 1.14 111.229 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 20.3 t70 -88.93 -12.16 42.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.192 -0.458 . . . . 2.22 111.191 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 38.7 m-70 82.59 23.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 123.599 0.76 . . . . 0.88 110.399 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -85.43 154.18 59.35 Favored Pre-proline 0 N--CA 1.443 -0.802 0 N-CA-C 105.693 -1.965 . . . . 3.67 105.693 165.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.68 114.38 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.812 0.969 . . . . 1.19 111.904 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.985 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 75.3 t80 -86.74 111.25 20.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.407 -0.815 . . . . 0.98 109.194 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.688 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 57.5 t30 -68.83 86.38 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.216 0.532 . . . . 1.65 109.936 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.797 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -61.38 -35.96 78.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 1.08 111.378 -174.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.561 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 13.5 p -76.54 1.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.003 0.742 . . . . 1.15 113.003 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.5 pt20 -74.73 -5.86 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.174 -0.954 . . . . 1.94 108.997 168.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.985 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 82.1 m-70 -98.42 2.71 48.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.212 -1.033 . . . . 0.38 108.212 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 21.1 ttpt -81.07 142.46 33.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.848 -1.069 . . . . 2.22 109.642 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.06 79.48 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.804 -1.319 . . . . 0.36 109.804 -170.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.636 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 16.3 m -132.54 146.87 63.32 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 114.111 -1.045 . . . . 1.58 108.293 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.849 ' HG2' HD22 ' A' ' 171' ' ' LEU . 1.2 Cg_endo -79.56 149.58 21.29 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.737 1.625 . . . . 0.86 110.238 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.523 ' HB2' HG23 ' A' ' 70' ' ' THR . 2.1 pt? -151.93 149.91 29.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.302 0.572 . . . . 1.63 111.291 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -107.53 154.9 20.71 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.584 -0.895 . . . . 1.69 108.584 172.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.475 HD12 HG13 ' A' ' 144' ' ' ILE . 69.4 mt -141.62 114.82 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.094 -0.706 . . . . 1.05 109.094 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 18.1 m-85 -100.59 124.55 46.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 121.125 -0.23 . . . . 0.93 110.78 -174.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.734 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -80.69 92.7 6.05 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.242 -0.651 . . . . 1.97 109.242 171.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.69 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 m -106.34 145.93 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 114.229 1.196 . . . . 1.48 114.229 -160.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.39 102.22 9.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.603 -1.628 . . . . 1.17 106.603 160.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 95' ' ' CYS . 40.4 t -72.11 85.29 1.02 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 112.563 0.579 . . . . 2.3 112.563 -165.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 17.9 tppt? 75.4 23.31 1.53 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.739 0.78 . . . . 2.81 110.638 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.52 129.33 51.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.238 -0.437 . . . . 1.18 110.548 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 -115.87 4.62 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.862 -0.685 . . . . 1.42 112.7 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -139.63 166.69 23.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.271 0.558 . . . . 3.45 111.868 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 52' ' ' GLY . 40.9 p -131.92 115.07 15.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.663 -0.699 . . . . 1.94 110.372 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.691 ' HD2' ' HA3' ' A' ' 157' ' ' GLY . 28.0 ttmt -79.0 24.61 0.31 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.212 0.53 . . . . 2.51 110.887 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 50' ' ' THR . . . 104.99 13.8 24.39 Favored Glycine 0 C--O 1.224 -0.522 0 CA-C-N 115.881 -0.6 . . . . 0.55 112.38 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.71 -47.43 20.61 Favored Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 121.231 -0.509 . . . . 0.39 112.175 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.665 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.7 t80 -69.67 -47.6 62.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.486 0.184 . . . . 1.05 111.262 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -59.28 -47.11 86.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.069 0.462 . . . . 2.46 110.145 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.5 m -64.31 -45.99 85.51 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.385 -0.825 . . . . 1.06 110.891 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.543 ' HB2' HG13 ' A' ' 71' ' ' VAL . . . -57.17 -49.31 76.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.979 0.419 . . . . 1.03 111.07 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.6 m -59.26 -51.3 70.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.615 -0.721 . . . . 1.09 111.147 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 p -63.68 -39.27 93.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 1.69 111.914 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 88.5 mt -62.48 -51.66 66.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.442 0.163 . . . . 1.46 110.996 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.793 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 71.6 t80 -51.96 -48.86 64.12 Favored 'General case' 0 C--O 1.22 -0.45 0 O-C-N 123.752 0.657 . . . . 0.92 109.483 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.12 -43.29 74.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.536 -0.756 . . . . 1.88 111.687 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.61 -44.79 61.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.865 -0.607 . . . . 2.27 111.391 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.752 ' CD1' HD11 ' A' ' 171' ' ' LEU . 70.1 m-85 -100.91 6.3 43.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.402 0.89 . . . . 0.9 113.402 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -60.75 -25.17 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.987 0.422 . . . . 2.62 110.279 171.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -32.76 74.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.777 -0.647 . . . . 1.59 110.69 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -98.65 17.48 19.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.994 0.426 . . . . 1.9 110.703 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 74.78 55.52 5.35 Favored Glycine 0 C--O 1.224 -0.488 0 CA-C-N 115.64 -0.709 . . . . 1.32 112.845 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 39' ' ' LEU . 59.7 t80 -117.15 140.0 50.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.633 0.254 . . . . 0.4 110.781 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.523 HG23 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -128.36 138.98 52.61 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 120.907 0.384 . . . . 1.11 110.556 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.793 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 39.4 t -110.91 121.11 63.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.887 0.375 . . . . 1.06 110.242 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.634 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 21.3 mt -102.03 141.62 34.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.901 -0.778 . . . . 1.23 108.901 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.014 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -125.98 124.75 41.43 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.11 0.481 . . . . 1.04 110.222 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.669 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.4 m-85 -108.5 108.3 60.86 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.891 -0.595 . . . . 0.45 109.686 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.622 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 41.7 Cg_exo -58.67 154.97 39.54 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.077 2.518 . . . . 0.73 112.057 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.9 t -127.97 155.66 43.91 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.776 -0.647 . . . . 2.02 110.582 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -116.48 97.49 6.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.15 0.976 . . . . 3.1 109.937 -176.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.821 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 22.0 mp0 -56.4 -5.6 0.22 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.034 1.334 . . . . 3.18 113.894 -175.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.518 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 92.5 m-85 -77.25 -10.92 59.72 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.342 -0.39 . . . . 4.52 111.454 -174.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.33 -56.1 8.13 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.099 -0.572 . . . . 1.45 112.774 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.429 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 154.2 -33.76 0.72 Allowed Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.631 -0.795 . . . . 1.43 113.761 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.727 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -131.0 -6.22 3.93 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.344 1.072 . . . . 1.43 113.04 -174.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.738 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -78.66 150.59 76.16 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 112.826 0.676 . . . . 3.06 112.826 -164.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 36.9 Cg_exo -19.71 131.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.928 1 C-N-CA 126.875 5.05 . . . . 1.61 116.878 -162.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.87 11.74 49.01 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.2 -1.56 . . . . 1.83 109.2 -170.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.8 m120 69.83 -50.06 0.63 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.072 -1.064 . . . . 4.24 111.117 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 175.29 153.31 0.14 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.513 0.508 . . . . 2.47 110.112 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 66.3 2.7 2.48 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.047 1.129 . . . . 3.64 114.047 164.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.463 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 16.2 tt0 -56.92 -30.92 64.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.551 -0.718 . . . . 2.42 111.518 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.821 ' HB ' ' HB2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -69.54 -4.03 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 114.575 1.324 . . . . 2.56 114.575 175.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.416 ' HD3' ' HG2' ' A' ' 88' ' ' GLU . 25.8 pttm -56.84 -21.63 30.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.979 0.733 . . . . 4.36 112.979 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -129.87 21.76 5.41 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.836 -0.62 . . . . 3.1 110.155 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.463 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 86.0 m-85 -141.84 170.91 14.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.32 -0.854 . . . . 2.15 109.774 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 p -129.89 119.0 46.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.093 0.473 . . . . 2.13 109.937 171.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.738 ' HB2' HD12 ' A' ' 90' ' ' ILE . 21.8 m -91.9 114.58 27.16 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.664 -0.814 . . . . 0.91 110.758 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.3 t -157.07 118.47 3.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.135 -0.939 . . . . 2.41 109.313 166.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.612 ' C ' ' H ' ' A' ' 99' ' ' LYS . 27.4 mttm 70.15 -47.02 0.62 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.591 1.33 . . . . 3.5 114.591 173.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.665 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 2.7 p90 58.04 -29.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.414 1.486 . . . . 1.74 111.548 -164.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.612 ' H ' ' C ' ' A' ' 97' ' ' LYS . 6.8 mtmt 71.51 125.47 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.245 1.018 . . . . 3.53 111.739 170.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.553 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . . . -154.02 -170.67 3.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.985 -0.552 . . . . 1.09 112.035 -173.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.04 -6.28 58.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.732 -0.667 . . . . 2.19 110.366 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.807 ' HE1' ' HB3' ' A' ' 73' ' ' ALA . 47.9 p90 -115.98 162.23 26.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.62 -0.882 . . . . 0.39 108.62 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 37.8 Cg_exo -66.95 123.39 10.91 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 123.892 3.062 . . . . 0.48 113.675 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.014 HG13 ' HB2' ' A' ' 73' ' ' ALA . 4.0 mp -112.3 148.85 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.291 -0.633 . . . . 1.13 109.291 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.669 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 9.2 mmt -120.36 -154.75 0.59 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.447 0.906 . . . . 2.08 113.447 -164.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 21' ' ' LEU . . . -69.42 154.07 42.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.667 -1.151 . . . . 1.11 111.141 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.561 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 72.0 mttt -80.99 112.5 18.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.271 -0.64 . . . . 2.12 109.271 174.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.9 pt -121.39 149.58 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.224 -1.028 . . . . 1.19 108.224 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.7 t30 -81.74 60.51 4.69 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.831 -0.348 . . . . 2.16 110.384 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -56.38 94.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 116.575 -0.284 . . . . 1.1 110.912 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.786 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER 175.43 178.55 0.16 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 110.207 -0.294 . . . . 1.98 110.207 175.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.91 -123.2 0.15 Allowed Glycine 0 C--N 1.334 0.438 0 O-C-N 125.115 1.509 . . . . 0.78 115.192 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -107.01 -6.09 17.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 1.98 110.662 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -95.19 -6.9 40.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.386 -0.825 . . . . 2.1 112.308 -170.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.557 ' HB2' ' H ' ' A' ' 111' ' ' ASN . . . -57.56 146.38 30.4 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.214 0.82 . . . . 1.17 113.214 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.689 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 26.5 t-80 -50.56 141.06 17.68 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.242 -0.89 . . . . 0.51 109.803 169.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 8.7 Cg_endo -51.08 -37.96 58.78 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.254 2.636 . . . . 0.43 112.523 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.689 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 14.6 tp -54.85 -45.38 74.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.119 0.485 . . . . 1.69 111.074 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.483 ' CG ' HG11 ' A' ' 110' ' ' VAL . 3.3 m-85 -73.95 -28.1 61.33 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 116.079 -0.51 . . . . 1.84 110.974 176.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 39.7 mt-10 -56.23 -38.38 70.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.838 -0.745 . . . . 2.37 109.468 168.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.536 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 76.2 t80 -69.95 -47.01 64.04 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.568 -0.453 . . . . 1.09 110.488 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.517 ' HE2' HD12 ' A' ' 118' ' ' LEU . 66.9 mtt -61.48 -55.23 33.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.294 -0.412 . . . . 1.06 111.241 -178.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 27.6 mtpt -58.59 -43.66 89.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 1.42 111.411 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -70.1 -33.91 72.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 2.63 111.077 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.537 HG22 ' HD2' ' A' ' 150' ' ' PRO . 90.2 m -65.65 -46.56 78.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.394 -0.366 . . . . 1.09 111.105 -176.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.609 ' HD3' ' HA ' ' A' ' 152' ' ' GLU . 27.9 tttm -143.13 120.09 6.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 2.26 109.95 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.754 ' HB2' ' HB ' ' A' ' 132' ' ' THR . 83.6 Cg_endo -84.32 2.7 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.024 2.483 . . . . 1.81 113.713 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 118.51 177.11 16.83 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.609 -0.805 . . . . 2.45 112.865 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.72 -54.84 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.408 . . . . 4.01 110.251 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.792 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.7 pt? -77.12 -150.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 2.97 110.433 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -44.68 106.19 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.167 0.508 . . . . 3.28 111.534 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.754 ' HB ' ' HB2' ' A' ' 127' ' ' PRO . 32.1 p -89.95 139.67 30.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.496 -0.775 . . . . 4.33 112.624 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -179.0 -71.02 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.424 -0.807 . . . . 5.43 110.102 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -157.72 -169.07 2.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.324 -0.398 . . . . 1.51 111.079 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.85 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 30.6 mm -70.13 161.95 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.512 -0.922 . . . . 1.5 108.512 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -177.42 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.748 0.785 . . . . 1.99 110.334 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.85 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -95.64 171.41 8.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.731 -1.122 . . . . 1.1 111.717 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.42 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 18.5 m120 -48.13 -156.57 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.36 -1.746 . . . . 1.8 113.789 170.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 4.5 m-85 -29.32 -57.91 0.15 Allowed 'General case' 0 C--O 1.202 -1.428 0 C-N-CA 125.166 1.387 . . . . 1.68 114.588 -165.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.951 HG22 ' HA ' ' A' ' 155' ' ' SER . 10.0 m 44.48 106.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.309 1.225 . . . . 1.05 114.309 177.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 11.9 p -89.55 149.13 23.01 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.358 -0.839 . . . . 1.38 111.458 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 14.3 m-85 -103.76 133.4 48.81 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.147 -1.057 . . . . 0.53 108.147 163.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.744 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 16.3 tp -82.52 105.26 13.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.44 -0.578 . . . . 1.2 109.44 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.681 HG23 HD13 ' A' ' 15' ' ' ILE . 10.6 mm -105.03 126.97 59.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.409 -0.589 . . . . 1.05 109.409 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.421 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 16.9 p30 -79.57 -175.16 4.64 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.837 -0.345 . . . . 1.3 111.47 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.588 ' HD2' ' OXT' ' A' ' 176' ' ' LEU . 91.8 mtt180 -64.54 -12.81 48.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.507 0.558 . . . . 4.43 112.507 -176.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -109.73 -13.46 14.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.41 0.624 . . . . 1.18 109.326 -170.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.408 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 100.52 28.07 7.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.175 -0.921 . . . . 0.25 112.729 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.421 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 61.7 t -110.77 128.0 26.04 Favored Pre-proline 0 C--N 1.317 -0.839 0 O-C-N 122.538 -0.389 . . . . 1.32 110.388 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 125' ' ' THR . 10.6 Cg_exo -68.94 106.09 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.97 2.447 . . . . 0.46 112.174 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.3 t -89.41 -16.33 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 1.09 110.589 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.609 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 5.2 mm-40 -160.73 165.67 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 1.22 110.717 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.714 ' HB3' ' HA2' ' A' ' 128' ' ' GLY . 19.6 ttm180 -137.56 98.28 3.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.94 -0.573 . . . . 2.25 109.531 170.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.744 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.3 m-85 -88.49 113.02 23.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.38 109.745 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.951 ' HA ' HG22 ' A' ' 140' ' ' THR . 3.8 m -64.56 166.14 12.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 109.775 -0.454 . . . . 1.49 109.775 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.809 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 33.8 Cg_endo -65.34 -8.26 18.28 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.695 2.264 . . . . 0.74 113.061 -165.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.691 ' HA3' ' HD2' ' A' ' 51' ' ' LYS . . . -93.24 3.25 72.43 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.433 -0.803 . . . . 0.56 112.882 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.47 139.97 37.46 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.182 -0.303 . . . . 1.14 110.182 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 94.7 p -83.58 171.11 13.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.64 111.034 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.7 t -55.52 -48.27 77.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.684 -0.487 . . . . 1.14 109.684 175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -63.74 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.806 . . . . 3.84 110.9 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.06 -37.73 69.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.95 -0.568 . . . . 1.86 110.313 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.545 HG21 HD21 ' A' ' 39' ' ' LEU . 67.5 mt -82.51 -41.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 1.05 111.399 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 52.0 mt-10 -56.37 -40.02 73.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.147 0.425 . . . . 0.88 112.147 -176.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.462 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 10.0 pt-20 -59.77 -22.71 62.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.821 0.304 . . . . 0.75 111.821 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.698 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.8 mmtp -107.23 -19.88 13.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.104 0.478 . . . . 2.11 110.262 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 171' ' ' LEU . 58.2 tp -84.73 -42.44 15.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 1.06 111.32 -174.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.658 ' HA ' HD12 ' A' ' 171' ' ' LEU . 81.9 mt -53.24 -47.44 95.97 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.16 0.43 . . . . 1.14 112.16 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.531 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.5 Cg_exo -55.29 -23.28 36.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.624 2.216 . . . . 0.74 113.327 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 mt -92.65 -40.31 10.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.634 0.254 . . . . 1.35 110.964 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.849 HD22 ' HG2' ' A' ' 37' ' ' PRO . 10.7 mt -60.39 -48.51 81.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.092 -0.707 . . . . 1.16 109.092 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.92 52.5 2.87 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.699 -1.137 . . . . 1.52 113.057 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p 57.24 119.37 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.991 1.316 . . . . 2.89 113.594 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.03 -19.41 21.58 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.235 0.541 . . . . 3.56 110.718 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 179.26 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.954 -1.128 . . . . 8.59 107.954 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.588 ' OXT' ' HD2' ' A' ' 146' ' ' ARG . 60.1 tp . . . . . 0 C--O 1.244 0.808 0 N-CA-C 106.804 -1.554 . . . . 5.3 106.804 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.674 -0.57 . . . . 5.87 111.674 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 mmt -76.37 101.19 5.43 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.369 -0.604 . . . . 5.34 109.369 176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.77 109.4 2.76 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.979 -0.848 . . . . 1.87 110.979 -172.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 m -61.53 -38.09 86.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.747 0.308 . . . . 2.22 111.138 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.0 p -171.69 -176.96 1.88 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.292 -0.633 . . . . 1.06 109.292 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.748 HD12 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -62.34 -26.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.138 0.494 . . . . 1.08 110.448 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.894 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 44.0 m-85 -79.02 -1.59 36.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.777 -0.647 . . . . 0.3 111.556 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.27 -16.1 61.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.443 -0.947 . . . . 1.96 108.443 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 47.5 m-85 -105.63 177.81 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.579 -1.191 . . . . 0.4 109.658 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -126.13 148.47 49.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.692 0.282 . . . . 2.77 110.722 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 30' ' ' LEU . 70.0 t -117.35 148.17 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 1.39 111.33 -175.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.961 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 92.7 mt -102.82 137.73 40.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 1.33 109.656 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 23' ' ' ALA . 19.7 t70 -72.98 -174.97 1.63 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.035 -0.728 . . . . 1.59 109.035 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.471 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -55.48 -34.15 64.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.042 0.449 . . . . 1.14 111.139 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -93.82 3.03 56.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 2.22 111.186 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.961 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 35.1 m-70 72.91 14.53 4.81 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.276 0.63 . . . . 0.88 110.292 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 10.4 mtmt -66.76 144.34 98.53 Favored Pre-proline 0 CA--C 1.511 -0.519 0 N-CA-C 106.252 -1.759 . . . . 3.67 106.252 163.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.81 113.76 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 CA-C-N 119.809 0.967 . . . . 1.19 111.136 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -87.53 108.84 19.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.375 -0.83 . . . . 0.98 109.124 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.637 ' OD1' HG13 ' A' ' 31' ' ' VAL . 62.6 t30 -66.57 95.59 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.132 -0.692 . . . . 1.65 109.132 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.894 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.88 -30.23 67.63 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.627 -0.715 . . . . 1.08 110.611 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.707 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -76.93 -4.06 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 1.15 112.843 -166.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 27.8 pt20 -79.02 -4.99 52.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.565 0.698 . . . . 1.94 109.396 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.525 ' ND1' HG21 ' A' ' 70' ' ' THR . 84.8 m-70 -97.67 2.38 49.68 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.368 -0.975 . . . . 0.38 108.368 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -78.62 145.6 34.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.111 -0.95 . . . . 2.22 108.951 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.58 87.29 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.904 -1.278 . . . . 0.36 109.904 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -132.27 133.05 23.31 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.64 -0.874 . . . . 1.58 108.64 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.912 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 36.4 Cg_endo -69.56 146.02 60.16 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.305 1.337 . . . . 0.86 109.803 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.554 ' CD2' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -150.77 161.13 43.23 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.495 0.665 . . . . 1.63 111.743 -175.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.764 HD23 HG22 ' A' ' 163' ' ' ILE . 6.5 mp -111.96 154.01 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.977 -1.011 . . . . 1.69 108.671 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.66 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 94.5 mt -140.54 115.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.291 -0.633 . . . . 1.05 109.291 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.849 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 34.4 m-85 -99.72 123.4 43.94 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 121.047 -0.261 . . . . 0.93 111.165 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.808 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.7 OUTLIER -80.41 91.56 5.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.197 -1.038 . . . . 1.97 108.197 167.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.4 p -116.11 137.7 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.733 1.012 . . . . 1.48 113.733 -162.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.08 108.85 1.96 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.267 -1.012 . . . . 1.17 108.267 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.932 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 17.8 t -75.68 84.02 2.68 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.278 0.473 . . . . 2.3 112.278 -169.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.657 ' HG3' ' HB2' ' A' ' 98' ' ' PHE . 52.2 mttm 73.15 29.92 1.66 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.18 -0.918 . . . . 2.81 112.328 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -133.04 128.87 37.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.348 -0.612 . . . . 1.18 109.348 174.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.534 ' HA3' ' CD ' ' A' ' 89' ' ' GLU . . . 90.93 -129.39 9.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.441 -0.885 . . . . 1.42 113.387 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.33 161.82 26.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.011 0.91 . . . . 3.45 113.353 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 t -125.22 154.0 42.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.387 -1.279 . . . . 1.94 108.286 168.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 13.2 ttmm -119.08 20.84 12.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.573 0.701 . . . . 2.51 109.345 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.98 16.27 6.87 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 114.846 -1.07 . . . . 0.55 111.584 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.21 -54.25 4.14 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.935 -0.466 . . . . 0.39 111.935 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.654 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.4 t80 -65.92 -45.7 80.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.976 0.417 . . . . 1.05 110.592 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -62.36 -46.63 87.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 2.46 110.541 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.431 ' CG2' HD11 ' A' ' 163' ' ' ILE . 98.5 m -67.75 -41.46 83.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.169 -0.468 . . . . 1.06 110.859 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB3' HG12 ' A' ' 71' ' ' VAL . . . -59.13 -47.78 84.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 1.03 111.235 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 m -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.945 -0.571 . . . . 1.09 111.125 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 p -62.54 -48.38 79.76 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.852 -0.613 . . . . 1.69 111.203 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -46.49 88.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 1.46 111.596 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.724 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 46.3 t80 -50.93 -58.71 5.32 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 123.389 0.43 . . . . 0.92 110.595 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.536 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 91.9 m-20 -73.02 -30.61 63.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.076 0.399 . . . . 1.88 112.076 -173.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.8 -27.26 50.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.211 -0.45 . . . . 2.27 111.329 -174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.792 ' CD1' HD12 ' A' ' 171' ' ' LEU . 65.8 m-85 -122.17 5.2 9.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.687 0.995 . . . . 0.9 113.687 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.724 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 35.3 mtmt -58.79 -28.92 66.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.983 0.421 . . . . 2.62 110.33 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.0 p -61.12 -40.01 92.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.636 -0.711 . . . . 1.59 110.928 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -90.48 12.12 19.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 1.9 110.761 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.49 71.5 1.25 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.79 -0.641 . . . . 1.32 112.133 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 39' ' ' LEU . 74.0 t80 -140.67 141.82 34.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.657 0.265 . . . . 0.4 110.968 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.525 HG21 ' ND1' ' A' ' 33' ' ' HIS . 8.8 t -131.96 142.88 49.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.224 0.535 . . . . 1.11 110.433 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.717 HG12 ' HB3' ' A' ' 57' ' ' ALA . 24.7 t -105.24 119.64 54.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.894 0.378 . . . . 1.06 110.073 170.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.703 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 12.3 mt -104.69 128.06 52.64 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.891 -0.781 . . . . 1.23 108.891 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.986 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -114.52 121.3 43.08 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.309 -0.556 . . . . 1.04 110.878 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.661 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -105.42 108.75 62.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.878 -0.786 . . . . 0.45 108.878 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.96 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 50.9 Cg_exo -56.4 164.76 5.06 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.979 2.453 . . . . 0.73 111.56 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t -121.58 135.82 54.98 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.031 -1.068 . . . . 2.02 113.046 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.616 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 18.2 t30 -91.21 78.09 5.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 112.782 -2.008 . . . . 3.1 109.103 175.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.829 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -60.33 -13.07 10.99 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.604 -0.725 . . . . 3.18 112.217 -176.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -67.48 -15.46 63.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.119 -0.492 . . . . 4.52 110.635 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.708 ' HA3' HD22 ' A' ' 109' ' ' ASN . . . -53.45 -61.62 6.83 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.632 -0.713 . . . . 1.45 113.011 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.96 -52.26 0.18 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.432 -0.89 . . . . 1.43 112.646 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.674 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 4.6 pm0 -127.05 13.53 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.484 0.549 . . . . 1.43 112.484 -175.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.829 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 3.4 mm-40 -61.55 153.57 69.39 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 116.103 -0.498 . . . . 3.06 111.271 -167.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.649 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 7.6 Cg_exo -32.58 159.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.5 1 C-N-CA 125.33 4.02 . . . . 1.61 117.559 -171.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.825 ' HA3' ' HB2' ' A' ' 89' ' ' GLU . . . 81.59 27.77 45.94 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.974 -1.25 . . . . 1.83 109.974 -174.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 20.3 m120 57.64 44.96 19.93 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 114.741 -0.73 . . . . 4.24 110.677 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 8.8 pt-20 59.86 6.65 0.94 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.131 1.373 . . . . 2.47 113.53 173.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.568 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 89.4 mt-10 -134.74 32.74 3.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.673 0.273 . . . . 3.64 111.37 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.825 ' HB2' ' HA3' ' A' ' 85' ' ' GLY . 3.3 tp10 -86.01 -26.59 25.33 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.8 -0.36 . . . . 2.42 111.549 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.601 HG12 ' SG ' ' A' ' 95' ' ' CYS . 37.6 mt -105.3 49.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 122.072 0.939 . . . . 2.56 109.404 173.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.69 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 50.3 mtmt -87.72 117.38 26.52 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.525 -0.916 . . . . 4.36 108.525 168.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 8.8 pt-20 57.05 16.79 3.06 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.3 1.0 . . . . 3.1 111.781 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -114.21 172.46 6.99 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.761 -0.829 . . . . 2.15 108.761 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.7 123.52 54.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.882 0.373 . . . . 2.13 110.517 170.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.601 ' SG ' HG12 ' A' ' 90' ' ' ILE . 12.7 m -100.15 118.65 36.92 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.158 -0.617 . . . . 0.91 110.654 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -152.85 118.39 5.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.474 -0.784 . . . . 2.41 109.807 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HG3' ' HE3' ' A' ' 99' ' ' LYS . 15.0 pttm 23.86 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.098 1.359 . . . . 3.5 114.634 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.657 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -57.01 120.18 7.55 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.005 -1.85 . . . . 1.74 106.005 168.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.464 ' HE3' ' HG3' ' A' ' 97' ' ' LYS . 9.3 mptt -79.44 164.44 23.97 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.702 -0.799 . . . . 3.53 111.195 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.497 ' HB1' HD12 ' A' ' 104' ' ' ILE . . . -172.67 -175.41 1.3 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.08 0.863 . . . . 1.09 110.969 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.62 0.9 55.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 2.19 110.903 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.789 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 49.9 p90 -121.36 168.4 11.17 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.655 -0.868 . . . . 0.39 108.655 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.692 ' HB2' ' HE2' ' A' ' 105' ' ' MET . 23.6 Cg_exo -69.95 116.92 4.8 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.505 2.803 . . . . 0.48 113.239 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.986 HG13 ' HB1' ' A' ' 73' ' ' ALA . 3.5 mp -109.01 140.22 28.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.934 -0.765 . . . . 1.13 108.934 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.703 ' HE3' ' HB3' ' A' ' 72' ' ' LEU . 8.8 mmt -113.68 -153.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.371 0.605 . . . . 2.08 112.488 -164.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.59 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.76 144.22 45.73 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.036 -0.983 . . . . 1.11 110.477 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.96 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.7 pttp -80.67 127.77 32.86 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.652 -0.87 . . . . 2.12 108.652 169.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.634 HD12 ' HD2' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -131.86 169.4 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.049 -1.463 . . . . 1.19 107.049 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.798 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.5 m120 -72.43 118.82 15.81 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.467 -0.938 . . . . 2.16 108.467 172.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -116.97 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 119.453 -0.899 . . . . 1.1 108.914 168.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.674 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 13.2 t-20 171.61 178.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.911 -1.144 . . . . 1.98 107.911 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.09 -140.38 12.23 Favored Glycine 0 N--CA 1.448 -0.561 0 O-C-N 123.645 0.59 . . . . 0.78 114.321 163.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -104.84 -2.62 24.51 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.9 -0.65 . . . . 1.98 110.254 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.06 -21.31 26.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.512 -0.767 . . . . 2.1 110.646 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.798 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.05 137.65 0.66 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.213 1.19 . . . . 1.17 114.213 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.787 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 56.6 t-80 -49.79 139.09 16.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.233 -0.894 . . . . 0.51 110.797 172.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -41.87 -49.73 5.43 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.193 2.595 . . . . 0.43 112.938 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.787 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -55.91 -38.32 70.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.102 -0.499 . . . . 1.69 112.138 177.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' A' ' 40' ' ' ILE . 3.5 m-85 -75.97 -30.0 58.46 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 122.35 -0.219 . . . . 1.84 111.003 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.7 mt-10 -57.64 -35.27 70.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.025 -0.731 . . . . 2.37 109.025 169.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.9 t80 -71.38 -48.4 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 1.09 110.309 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.511 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 67.5 mtt -63.09 -53.09 59.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.999 -0.546 . . . . 1.06 111.624 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -56.72 -46.43 81.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.539 . . . . 1.42 111.003 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -67.46 -32.29 73.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 2.63 111.039 -176.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.522 HG23 ' HD2' ' A' ' 150' ' ' PRO . 93.0 m -72.76 -63.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 1.09 111.828 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.604 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 5.4 tmtt? -125.78 115.62 24.57 Favored Pre-proline 0 C--N 1.324 -0.509 0 C-N-CA 120.924 -0.31 . . . . 2.26 110.843 -173.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 51.4 Cg_endo -71.39 -19.82 28.36 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.824 2.349 . . . . 1.81 112.09 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.683 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 99.42 -139.24 14.33 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.875 -0.678 . . . . 2.45 113.169 174.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.4 mt -79.57 -65.79 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.924 0.392 . . . . 4.01 110.055 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.1 pt? -90.81 144.9 25.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.158 -0.682 . . . . 2.97 109.158 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.9 77.79 0.64 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.18 0.514 . . . . 3.28 110.915 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.609 HG21 ' HG ' ' A' ' 130' ' ' LEU . 2.5 p -79.37 -16.94 55.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.809 -0.632 . . . . 4.33 110.296 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 tptp 68.54 -59.29 0.46 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 124.187 0.929 . . . . 5.43 110.219 -176.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.28 -172.45 2.85 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.716 -0.675 . . . . 1.51 111.164 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.762 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 29.4 mm -76.02 170.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 108.809 -0.811 . . . . 1.5 108.809 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.51 ' H ' HG23 ' A' ' 135' ' ' ILE . 11.9 ptpt 177.47 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.609 0.718 . . . . 1.99 110.52 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.762 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.76 169.76 9.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.071 -0.968 . . . . 1.1 112.261 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -48.91 -155.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.219 1.808 . . . . 1.8 113.959 172.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.849 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 22.8 m-85 -26.7 -58.43 0.09 Allowed 'General case' 0 C--O 1.205 -1.243 0 C-N-CA 125.419 1.488 . . . . 1.68 113.929 -163.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.808 ' HB ' HD22 ' A' ' 42' ' ' ASN . 22.5 m 40.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.33 0.863 . . . . 1.05 113.33 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 18.9 p -85.57 148.38 25.96 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.004 -0.678 . . . . 1.38 110.685 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.511 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 11.6 m-85 -102.34 130.34 49.05 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.036 -1.098 . . . . 0.53 108.036 167.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.781 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.4 tp -80.99 106.17 12.78 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.976 -0.75 . . . . 1.2 108.976 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.748 HG21 HD12 ' A' ' 15' ' ' ILE . 10.1 mm -105.06 128.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.442 -0.947 . . . . 1.05 108.442 -175.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.95 -176.16 3.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.756 0.312 . . . . 1.3 110.884 -174.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.69 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 64.3 mtp180 -68.1 -6.48 23.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 4.43 111.804 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -109.97 -21.13 12.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.501 0.667 . . . . 1.18 109.528 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.514 ' HA2' HG23 ' A' ' 144' ' ' ILE . . . 102.98 32.96 4.49 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.967 -1.015 . . . . 0.25 112.848 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.8 t -111.55 129.0 24.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.523 -0.547 . . . . 1.32 109.523 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.522 ' HD2' HG23 ' A' ' 125' ' ' THR . 15.0 Cg_exo -64.39 109.92 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.376 2.051 . . . . 0.46 111.612 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.604 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 11.4 t -92.55 -22.09 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 1.09 110.351 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.3 mm-40 -153.75 163.99 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.262 0.554 . . . . 1.22 111.276 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.683 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 26.0 ttm180 -134.02 97.71 3.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.019 -0.991 . . . . 2.25 108.766 172.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.781 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 46.9 m-85 -90.84 113.75 25.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.057 -0.72 . . . . 0.38 109.057 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.767 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.7 m -62.0 173.51 0.87 Allowed Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 110.011 -0.366 . . . . 1.49 110.011 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.699 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 54.0 Cg_endo -64.54 -14.42 44.32 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.693 1.596 . . . . 0.74 111.157 -174.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 51' ' ' LYS . . . -81.54 2.41 82.56 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.466 -1.243 . . . . 0.56 112.132 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.499 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.32 127.39 32.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.816 0.341 . . . . 1.14 110.547 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -178.9 5.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.126 -0.488 . . . . 1.64 110.589 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.423 ' HA ' HG23 ' A' ' 56' ' ' THR . 49.1 t -55.05 -58.87 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 1.14 112.021 -175.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 162' ' ' ASP . 4.0 ptmm? -66.49 -28.32 68.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 3.84 110.988 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 161' ' ' LYS . 62.3 m-20 -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 1.86 110.237 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.764 HG22 HD23 ' A' ' 39' ' ' LEU . 55.1 mt -82.54 -44.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.832 -0.622 . . . . 1.05 110.369 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 168' ' ' ILE . 61.2 mt-10 -56.45 -40.12 74.29 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 112.162 0.43 . . . . 0.88 112.162 -176.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.36 -20.93 47.86 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.012 0.375 . . . . 0.75 112.012 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.631 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 63.1 mmtt -105.4 -25.71 12.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.587 0.232 . . . . 2.11 110.456 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 44.4 tp -85.78 -34.73 21.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 1.06 112.036 -169.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.653 ' HA ' HD13 ' A' ' 171' ' ' LEU . 81.4 mt -50.37 -48.03 81.85 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.271 0.471 . . . . 1.14 112.271 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 75.2 Cg_exo -51.81 -38.49 67.61 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.253 1.969 . . . . 0.74 113.335 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 2.2 mm? -74.07 -42.45 60.17 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 121.076 -0.25 . . . . 1.35 111.036 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.912 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 9.7 mt -57.06 -46.4 82.51 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.2 -0.667 . . . . 1.16 109.2 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -50.8 -73.54 0.37 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.709 -1.132 . . . . 1.52 111.943 168.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 22.9 t 175.28 135.56 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.668 0.387 . . . . 2.89 110.536 175.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.596 ' HB3' HD11 ' A' ' 170' ' ' LEU . . . -94.19 -47.59 6.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.832 -0.622 . . . . 3.56 111.52 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -149.29 19.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.172 0.51 . . . . 8.59 110.717 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.3 tp . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.321 -0.847 . . . . 5.3 109.773 -176.388 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.94 0 N-CA-C 112.534 -0.226 . . . . 5.87 112.534 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.1 ttt -111.06 -27.8 8.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.157 0.504 . . . . 5.34 110.15 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.42 25.25 68.56 Favored Glycine 0 C--O 1.227 -0.31 0 CA-C-N 115.648 -0.705 . . . . 1.87 113.191 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -69.27 -45.77 68.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.053 0.454 . . . . 2.22 110.974 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.8 p -153.2 173.36 15.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 1.06 109.199 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.764 HD13 HG21 ' A' ' 144' ' ' ILE . 25.9 pt -56.0 -32.3 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 1.08 111.583 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.825 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 47.4 m-85 -71.17 -14.31 62.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.3 111.97 -172.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -69.6 -15.02 63.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.312 0.577 . . . . 1.96 109.655 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 86.2 m-85 -103.66 174.13 6.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.342 -0.844 . . . . 0.4 111.528 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 10.5 tt0 -91.74 152.09 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.21 -0.904 . . . . 2.77 110.895 -177.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 93.7 t -138.78 145.45 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.119 0.485 . . . . 1.39 110.413 169.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.892 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 69.3 mt -119.91 148.12 43.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.706 -0.679 . . . . 1.33 109.472 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.634 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 14.5 t70 -78.88 -173.96 3.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.917 -0.771 . . . . 1.59 108.917 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.675 ' HB1' ' HG2' ' A' ' 97' ' ' LYS . . . -52.76 -27.0 15.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.338 0.496 . . . . 1.14 112.338 -172.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.86 25.0 10.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.289 0.477 . . . . 2.22 112.289 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.892 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 46.0 m-70 72.38 9.2 5.82 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 121.658 0.742 . . . . 0.88 110.538 171.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.634 ' HE3' ' HB3' ' A' ' 22' ' ' ASP . 23.9 mtmt -64.25 135.64 96.42 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 106.811 -1.551 . . . . 3.67 106.811 165.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.61 114.17 1.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.208 1.272 . . . . 1.19 112.226 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.475 ' CE1' ' HE2' ' A' ' 105' ' ' MET . 46.3 t80 -93.61 110.06 21.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.495 -0.775 . . . . 0.98 111.011 175.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.6 t30 -71.5 93.26 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.136 -0.69 . . . . 1.65 109.136 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.796 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.17 -27.77 65.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.019 -0.537 . . . . 1.08 111.261 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.825 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.7 p -76.73 -1.47 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 113.181 0.808 . . . . 1.15 113.181 -166.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 26.8 pt20 -78.13 -5.39 51.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.319 0.58 . . . . 1.94 109.65 172.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.35 4.58 53.25 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HE3' ' CG2' ' A' ' 31' ' ' VAL . 31.1 ttmt -78.61 146.64 34.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.289 -0.869 . . . . 2.22 110.048 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.23 5.28 89.09 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.043 -1.223 . . . . 0.36 110.043 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.651 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.7 m -141.96 139.13 17.69 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 114.416 -0.892 . . . . 1.58 108.877 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.931 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.7 Cg_endo -72.85 150.55 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.625 1.55 . . . . 0.86 110.805 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.56 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -153.32 151.41 29.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.198 0.523 . . . . 1.63 111.003 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.761 HD21 HG22 ' A' ' 163' ' ' ILE . 6.7 mp -107.25 152.75 23.68 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.735 -0.839 . . . . 1.69 108.735 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 81.0 mt -140.76 114.66 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.974 -0.75 . . . . 1.05 108.974 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.759 ' CD2' ' HB3' ' A' ' 139' ' ' PHE . 21.2 m-85 -102.66 122.99 45.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.336 . . . . 0.93 110.747 -173.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.911 HD22 ' HB ' ' A' ' 140' ' ' THR . 0.3 OUTLIER -80.92 91.78 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.374 -0.973 . . . . 1.97 108.374 168.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.701 ' HB ' ' HA ' ' A' ' 139' ' ' PHE . 2.5 p -110.61 131.99 60.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 113.167 0.803 . . . . 1.48 113.167 -163.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 111.92 2.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.259 -1.385 . . . . 1.17 107.259 167.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.072 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.43 64.33 1.56 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.501 0.926 . . . . 2.3 113.501 -161.128 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.796 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 1.1 tppp? 76.73 52.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.728 1.211 . . . . 2.81 112.503 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -145.91 131.25 18.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.02 -0.733 . . . . 1.18 109.02 170.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.78 -82.77 1.62 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.631 -0.795 . . . . 1.42 113.947 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -137.33 166.51 23.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.87 0.335 . . . . 3.45 111.295 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.7 p -134.65 -41.35 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.199 -0.455 . . . . 1.94 111.745 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.59 ' HD2' ' HG2' ' A' ' 156' ' ' PRO . 27.5 ttmt 71.15 0.56 3.47 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.873 0.869 . . . . 2.51 112.227 175.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.33 39.24 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.71 -0.757 . . . . 0.55 112.829 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.35 74.82 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 111.542 -0.623 . . . . 0.39 111.542 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.978 ' HH ' ' HA ' ' A' ' 100' ' ' ALA . 1.1 t80 -71.42 -56.6 5.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.837 0.351 . . . . 1.05 110.416 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.92 -43.51 91.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.05 -0.523 . . . . 2.46 110.755 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 160' ' ' VAL . 94.0 m -63.63 -49.28 73.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 1.06 111.11 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.877 ' HB3' HG13 ' A' ' 71' ' ' VAL . . . -60.36 -46.13 91.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 1.03 111.719 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.551 HG21 ' HB2' ' A' ' 101' ' ' GLU . 22.6 m -62.24 -47.75 82.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 1.09 111.284 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.2 p -64.0 -41.93 97.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.326 -0.397 . . . . 1.69 111.045 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 82.3 mt -58.21 -52.92 63.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 116.335 -0.393 . . . . 1.46 110.605 175.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.539 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 60.4 t80 -50.41 -56.58 10.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.387 -0.824 . . . . 0.92 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -70.9 -32.12 68.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 1.88 112.145 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.88 -47.08 11.44 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.788 -0.365 . . . . 2.27 111.538 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.722 ' CD1' HD11 ' A' ' 171' ' ' LEU . 63.1 m-85 -96.61 7.44 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.33 0.863 . . . . 0.9 113.33 -170.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -25.11 62.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.417 . . . . 2.62 109.916 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -59.93 -34.78 73.69 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.451 -0.795 . . . . 1.59 111.363 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.55 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -95.85 6.13 49.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.935 0.398 . . . . 1.9 110.897 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.651 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.64 67.22 1.53 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.63 -0.795 . . . . 1.32 111.433 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.593 ' CE1' HD12 ' A' ' 39' ' ' LEU . 80.1 t80 -131.52 136.44 47.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.394 -0.224 . . . . 0.4 110.394 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -128.91 146.73 50.87 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 110.066 -0.346 . . . . 1.11 110.066 178.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.877 HG13 ' HB3' ' A' ' 57' ' ' ALA . 38.4 t -114.08 113.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.801 -0.444 . . . . 1.06 109.801 169.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 27.0 mt -95.79 121.58 37.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.576 -0.898 . . . . 1.23 108.576 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.009 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.07 112.36 24.5 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.064 -0.654 . . . . 1.04 110.573 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.87 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.5 m-85 -96.22 108.16 39.77 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 109.041 -0.726 . . . . 0.45 109.041 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.114 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 32.3 Cg_exo -61.25 171.02 4.44 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.811 3.007 . . . . 0.73 112.114 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.4 t -129.98 135.62 48.5 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.875 1.065 . . . . 2.02 113.875 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 71.1 m-20 -103.69 95.49 6.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.268 -1.333 . . . . 3.1 109.358 169.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.728 ' HB3' ' H ' ' A' ' 88' ' ' GLU . 1.6 mp0 -59.31 -10.72 3.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.915 0.709 . . . . 3.18 112.915 -178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -66.26 -10.51 42.89 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.565 0.346 . . . . 4.52 111.845 -173.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.505 ' HA3' HD22 ' A' ' 109' ' ' ASN . . . -68.12 -35.16 82.91 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.689 -0.767 . . . . 1.45 111.676 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.67 -62.31 0.63 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.916 -0.659 . . . . 1.43 112.732 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.669 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.4 pm0 -103.78 7.43 37.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.387 -0.525 . . . . 1.43 111.892 -172.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.687 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 1.5 mm-40 -59.76 144.87 84.84 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 107.717 -1.216 . . . . 3.06 107.717 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' A' ' 110' ' ' VAL . 8.2 Cg_exo -16.64 145.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 126.722 4.948 . . . . 1.61 116.697 -159.274 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 136' ' ' LYS . . . -46.65 -19.15 0.44 Allowed Glycine 0 N--CA 1.468 0.79 0 CA-C-N 114.228 -1.351 . . . . 1.83 115.367 -164.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.582 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 13.8 m120 -52.8 -28.89 24.6 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.832 0.316 . . . . 4.24 111.267 168.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 18.85 118.04 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 127.25 2.22 . . . . 2.47 115.514 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.754 ' HG2' ' HB3' ' A' ' 91' ' ' LYS . 34.3 tt0 62.08 34.77 16.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.404 -1.271 . . . . 3.64 109.39 -174.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 5.6 tp10 -73.73 -12.77 60.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.388 -0.824 . . . . 2.42 109.253 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.805 HG12 ' SG ' ' A' ' 95' ' ' CYS . 1.6 mt -96.86 23.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.346 -0.843 . . . . 2.56 110.183 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.754 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . 13.4 ptmt -74.76 106.62 6.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.67 -0.493 . . . . 4.36 109.67 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.89 -31.67 0.22 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.579 0.751 . . . . 3.1 110.401 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' A' ' 91' ' ' LYS . 68.3 m-85 -68.44 168.3 13.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.417 -0.586 . . . . 2.15 109.417 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.404 ' O ' HG11 ' A' ' 94' ' ' VAL . 8.5 p -130.23 117.01 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.162 0.506 . . . . 2.13 110.873 174.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.805 ' SG ' HG12 ' A' ' 90' ' ' ILE . 97.1 m -99.62 115.46 29.46 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 120.194 -0.602 . . . . 0.91 109.854 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.3 m -155.59 119.31 4.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.365 -0.834 . . . . 2.41 109.728 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.68 ' O ' HG22 ' A' ' 104' ' ' ILE . 63.2 mttp 68.84 -44.35 0.52 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 113.699 1.0 . . . . 3.5 113.699 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.796 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 65.67 -32.23 0.16 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.076 0.951 . . . . 1.74 111.077 -168.262 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.786 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 8.3 mmpt? 72.93 127.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.094 0.958 . . . . 3.53 111.892 171.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.978 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . . . -161.07 -173.18 3.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.423 0.63 . . . . 1.09 112.629 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.551 ' HB2' HG21 ' A' ' 58' ' ' THR . 48.6 mt-10 -93.33 9.1 37.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.006 -0.997 . . . . 2.19 111.66 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.781 ' HE1' ' HB1' ' A' ' 73' ' ' ALA . 32.1 p90 -128.71 173.73 5.28 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.575 -0.898 . . . . 0.39 108.575 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 24.0 Cg_exo -70.39 100.25 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.332 0 C-N-CA 123.156 2.57 . . . . 0.48 113.232 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.009 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.8 mp -94.96 133.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.606 -0.887 . . . . 1.13 108.606 173.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.87 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.9 OUTLIER -106.46 -160.02 0.72 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.439 -0.8 . . . . 2.08 111.979 -163.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.55 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.16 132.53 43.36 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.574 -0.739 . . . . 1.11 110.067 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.114 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.7 pttt -69.82 121.52 17.42 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.485 0.66 . . . . 2.12 109.347 172.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.445 HG13 HG12 ' A' ' 110' ' ' VAL . 11.7 pt -120.54 170.96 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.797 -1.092 . . . . 1.19 108.532 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.694 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.8 m120 -78.68 69.46 4.86 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.848 -0.614 . . . . 2.16 110.379 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.699 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -73.09 85.18 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 118.704 -1.198 . . . . 1.1 110.829 -177.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.669 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 38.1 t30 171.33 178.42 0.06 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.686 -1.227 . . . . 1.98 107.686 160.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.83 -146.86 26.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.82 -0.705 . . . . 0.78 114.687 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.22 -15.02 29.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -0.716 . . . . 1.98 110.672 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.24 -12.92 58.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.755 -0.657 . . . . 2.1 111.376 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.694 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -49.29 135.64 16.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.994 0.739 . . . . 1.17 112.994 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.468 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 52.8 t-80 -51.16 131.96 31.71 Favored Pre-proline 0 C--O 1.226 -0.137 0 CA-C-O 118.389 -0.815 . . . . 0.51 109.178 169.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.541 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -38.79 -43.67 2.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.346 2.697 . . . . 0.43 112.924 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.535 HD12 ' HE2' ' A' ' 122' ' ' MET . 30.9 tp -54.22 -47.1 72.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.664 -0.698 . . . . 1.69 112.09 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.451 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.2 m-85 -73.96 -29.04 61.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 119.469 -0.301 . . . . 1.84 111.276 177.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.39 -39.31 72.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.353 -0.939 . . . . 2.37 108.581 168.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 80.4 t80 -68.38 -45.06 73.74 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.181 -0.463 . . . . 1.09 110.635 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.535 ' HE2' HD12 ' A' ' 118' ' ' LEU . 67.1 mtt -65.2 -55.75 16.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.579 -0.282 . . . . 1.06 111.302 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.8 mtpt -57.07 -42.62 80.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 1.42 110.904 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.6 ptmm? -69.82 -37.11 76.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.302 -0.408 . . . . 2.63 110.922 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.482 HG21 ' HD2' ' A' ' 150' ' ' PRO . 92.4 m -64.73 -39.44 93.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 1.09 111.392 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 18.6 ttmm -152.57 107.89 2.74 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.716 0.635 . . . . 2.26 112.716 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.508 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 78.3 Cg_endo -81.73 170.0 14.59 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.906 2.404 . . . . 1.81 110.759 166.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.812 ' HA2' HG22 ' A' ' 132' ' ' THR . . . 165.86 151.78 6.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.541 -1.314 . . . . 2.45 113.403 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.738 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 66.6 mt 78.54 123.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 123.908 0.883 . . . . 4.01 112.295 172.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 129' ' ' ILE . 2.7 pp 58.19 -64.99 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.533 1.533 . . . . 2.97 113.481 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.602 ' HB1' ' HE3' ' A' ' 136' ' ' LYS . . . -138.18 101.38 4.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.099 -0.704 . . . . 3.28 109.099 178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.812 HG22 ' HA2' ' A' ' 128' ' ' GLY . 16.6 p -72.18 103.71 3.42 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.34 0.867 . . . . 4.33 113.34 -169.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm 175.18 -53.54 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.394 -0.821 . . . . 5.43 110.657 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.529 ' HB2' ' OD1' ' A' ' 111' ' ' ASN . . . -123.98 179.86 4.68 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.709 1.003 . . . . 1.51 113.709 -160.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.773 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.9 mt -93.23 103.14 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.388 -1.278 . . . . 1.5 110.199 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.602 ' HE3' ' HB1' ' A' ' 131' ' ' ALA . 36.2 mmtt -106.83 0.6 24.14 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.708 0.633 . . . . 1.99 112.708 -167.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.773 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.62 171.86 19.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.157 0.799 . . . . 1.1 113.157 -163.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.59 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 16.3 m120 -46.3 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.096 -1.865 . . . . 1.8 114.103 167.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.759 ' HB3' ' CD2' ' A' ' 41' ' ' TYR . 62.1 m-85 -27.37 -59.06 0.1 Allowed 'General case' 0 C--O 1.204 -1.334 0 C-N-CA 125.158 1.383 . . . . 1.68 113.003 -167.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.92 HG23 ' HA ' ' A' ' 155' ' ' SER . 10.1 m 38.48 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.397 0.888 . . . . 1.05 113.397 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.669 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 12.1 p -85.51 152.93 22.8 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.055 -0.52 . . . . 1.38 111.358 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.404 ' HB2' HD11 ' A' ' 144' ' ' ILE . 12.8 m-85 -103.0 135.23 45.08 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.581 -1.266 . . . . 0.53 107.581 163.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.463 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 25.4 tp -81.12 105.45 12.34 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.625 -0.88 . . . . 1.2 108.625 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.764 HG21 HD13 ' A' ' 15' ' ' ILE . 19.2 mm -101.17 123.78 54.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.478 -0.783 . . . . 1.05 108.973 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 0.8 OUTLIER -75.77 -179.8 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 1.3 110.529 -175.675 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.491 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 52.8 mtt180 -62.61 -13.56 32.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.585 0.587 . . . . 4.43 112.585 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -108.32 -17.58 13.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.201 0.524 . . . . 1.18 110.278 -172.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.531 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.16 34.44 3.96 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.616 -0.72 . . . . 0.25 112.971 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -118.7 123.84 28.83 Favored Pre-proline 0 C--N 1.316 -0.85 0 O-C-N 122.635 -0.332 . . . . 1.32 110.276 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.482 ' HD2' HG21 ' A' ' 125' ' ' THR . 75.5 Cg_exo -53.94 112.98 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.34 2.693 . . . . 0.46 112.97 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.422 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.9 t -92.5 -30.32 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.768 -0.651 . . . . 1.09 110.475 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -155.61 164.07 39.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.36 -0.382 . . . . 1.22 111.027 -177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.508 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 16.7 ttm180 -127.24 102.15 6.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.495 -0.557 . . . . 2.25 109.495 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.588 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 36.8 m-85 -98.5 117.15 32.28 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.105 -0.702 . . . . 0.38 109.105 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.92 ' HA ' HG23 ' A' ' 140' ' ' THR . 53.7 p -69.99 178.22 1.1 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 118.77 0.714 . . . . 1.49 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.721 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.0 Cg_endo -68.24 -14.88 41.58 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.758 1.638 . . . . 0.74 111.122 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.26 13.76 43.58 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.56 112.047 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.55 132.21 40.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.921 0.391 . . . . 1.14 110.611 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.523 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 32.1 m -82.87 164.03 20.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.108 -0.496 . . . . 1.64 110.778 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.434 HG11 ' OE2' ' A' ' 164' ' ' GLU . 28.9 t -52.23 -54.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 1.14 111.791 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 161' ' ' LYS . 25.9 tptt -69.78 -26.16 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 3.84 110.729 -174.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 159' ' ' SER . 21.6 m-20 -67.11 -29.66 69.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 1.86 110.105 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.761 HG22 HD21 ' A' ' 39' ' ' LEU . 62.7 mt -82.7 -40.83 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.354 -0.384 . . . . 1.05 110.541 174.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 48.4 mt-10 -56.07 -35.52 67.07 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.777 0.658 . . . . 0.88 112.777 -176.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.03 -26.38 62.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.75 111.202 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.588 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 48.3 mmtm -105.09 -14.1 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.039 0.447 . . . . 2.11 110.335 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 68.1 tp -95.16 -41.52 9.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 1.06 112.13 -171.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.617 ' HA ' HD12 ' A' ' 171' ' ' LEU . 74.3 mt -51.56 -53.26 52.05 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 112.821 0.674 . . . . 1.14 112.821 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.92 -30.0 84.25 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.946 1.764 . . . . 0.74 112.553 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.45 HD11 HD13 ' A' ' 143' ' ' LEU . 58.7 mt -81.22 -32.51 33.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.612 -0.267 . . . . 1.35 111.147 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.931 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.0 mt -58.57 -50.81 72.43 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.115 -0.698 . . . . 1.16 109.115 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -50.3 -57.28 10.51 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.41 -1.268 . . . . 1.52 112.344 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.491 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 22.9 t 178.06 137.39 0.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.663 -0.495 . . . . 2.89 109.663 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -93.49 -34.34 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.444 0.64 . . . . 3.56 109.925 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -168.28 -34.99 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.684 -1.144 . . . . 8.59 108.107 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 C--O 1.248 0.992 0 CA-C-N 114.652 -1.158 . . . . 5.3 108.811 172.526 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.158 -0.377 . . . . 5.87 112.158 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 48.9 ttp -143.1 51.35 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.569 -0.901 . . . . 5.34 108.569 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.33 73.55 1.1 Allowed Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.068 -0.969 . . . . 1.87 113.528 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -87.78 -29.16 21.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.462 -0.94 . . . . 2.22 108.462 171.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 p -145.81 156.76 43.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.839 -1.073 . . . . 1.06 108.806 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.621 HD12 HG23 ' A' ' 144' ' ' ILE . 16.6 pt -56.32 -22.11 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 113.442 0.904 . . . . 1.08 113.442 -170.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.817 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 69.5 m-85 -83.17 1.04 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.028 0.381 . . . . 0.3 112.028 -172.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.89 -20.71 61.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.776 -0.824 . . . . 1.96 108.776 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 77.3 m-85 -95.38 156.91 16.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.964 -1.016 . . . . 0.4 110.571 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.6 tt0 -101.27 141.87 33.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.906 -0.588 . . . . 2.77 110.189 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.564 HG21 HD11 ' A' ' 30' ' ' LEU . 64.3 t -114.61 150.62 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.785 0.326 . . . . 1.39 110.914 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.805 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 85.2 mt -108.28 133.89 51.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.175 -0.466 . . . . 1.33 110.161 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.98 176.88 2.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.103 -0.953 . . . . 1.59 109.775 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB1' ' HD3' ' A' ' 97' ' ' LYS . . . -51.48 -29.99 18.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.126 0.488 . . . . 1.14 110.847 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 26' ' ' LYS . 22.5 t70 -96.78 1.34 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 2.22 111.649 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.805 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 34.2 m-70 74.94 12.51 3.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.058 0.543 . . . . 0.88 110.825 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 10.7 mmpt? -69.92 146.04 94.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 106.067 -1.827 . . . . 3.67 106.067 165.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.45 113.04 1.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 119.762 0.951 . . . . 1.19 110.985 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.919 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 65.6 t80 -79.28 128.23 33.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.98 110.47 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.646 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.4 t-20 -76.99 81.88 3.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.604 -0.725 . . . . 1.65 109.255 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.817 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.13 -33.8 70.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.42 0.629 . . . . 1.08 110.31 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.705 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.6 p -77.6 -0.86 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.179 -0.919 . . . . 1.15 112.611 -168.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.3 pt20 -82.79 -6.41 59.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.064 -0.717 . . . . 1.94 109.064 173.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.919 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 91.9 m-70 -93.67 -2.3 54.12 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.38 108.398 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -78.12 142.38 38.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.788 -1.096 . . . . 2.22 110.187 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.0 -19.09 25.65 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.36 110.508 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 70.1 m -141.84 139.13 17.84 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.585 -0.894 . . . . 1.58 108.585 177.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.692 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 24.5 Cg_exo -65.35 153.48 78.05 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.738 2.292 . . . . 0.86 112.289 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 70' ' ' THR . 2.3 pt? -154.63 159.25 40.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.302 -0.863 . . . . 1.63 109.766 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 163' ' ' ILE . 6.0 mp -113.69 157.77 21.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.967 -0.382 . . . . 1.69 109.967 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.639 HG12 ' HB2' ' A' ' 72' ' ' LEU . 93.3 mt -141.97 116.46 5.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.715 -0.675 . . . . 1.05 109.621 -176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.908 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.8 m-85 -103.16 123.58 46.96 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.134 -0.226 . . . . 0.93 111.038 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.588 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -79.31 92.89 5.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.354 -0.98 . . . . 1.97 108.354 168.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.6 p -112.95 131.57 64.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 112.95 0.722 . . . . 1.48 112.95 -163.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.573 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -54.61 114.22 1.6 Allowed 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.18 -1.044 . . . . 1.17 108.18 169.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.017 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.62 81.28 2.61 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.366 -1.288 . . . . 2.3 113.191 -162.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 42.8 tptt 72.66 50.6 0.17 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.003 -0.999 . . . . 2.81 109.872 177.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 p -163.16 143.76 9.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.7 -0.682 . . . . 1.18 111.233 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.79 -155.64 35.5 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.82 -0.627 . . . . 1.42 113.258 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -95.32 147.52 23.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.123 0.487 . . . . 3.45 110.612 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 p -88.69 -27.08 21.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.925 -0.579 . . . . 1.94 112.208 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.886 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.2 mtpp 65.8 -4.07 0.66 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.369 0.668 . . . . 2.51 112.069 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.67 0.01 29.06 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.116 -0.564 . . . . 0.55 112.429 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.02 -34.84 77.29 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.373 -0.441 . . . . 0.39 112.294 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.667 ' HH ' ' CB ' ' A' ' 100' ' ' ALA . 1.0 OUTLIER -73.03 -47.57 43.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.722 0.296 . . . . 1.05 110.224 -176.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.685 -0.487 . . . . 2.46 109.685 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.421 ' CG2' HD12 ' A' ' 163' ' ' ILE . 98.8 m -64.03 -48.31 76.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.422 -0.808 . . . . 1.06 110.633 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.905 ' HB1' HG13 ' A' ' 71' ' ' VAL . . . -62.44 -50.54 71.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.362 -0.381 . . . . 1.03 111.606 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.6 m -54.79 -48.91 72.11 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.094 -0.503 . . . . 1.09 111.083 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.5 m -63.69 -45.72 88.73 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.205 -0.452 . . . . 1.69 111.336 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 64.5 mt -60.33 -52.09 66.74 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 111.842 0.312 . . . . 1.46 111.842 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.773 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 59.5 t80 -52.1 -46.68 65.35 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.92 109.422 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -73.31 -37.09 66.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.255 0.55 . . . . 1.88 111.081 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -73.49 -33.33 64.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.343 -0.844 . . . . 2.27 111.74 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.946 ' HB3' HE21 ' A' ' 67' ' ' GLN . 72.3 m-85 -121.88 14.15 10.74 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 114.471 1.286 . . . . 0.9 114.471 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.773 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 21.5 mtmm -57.52 -26.52 61.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.899 -0.72 . . . . 2.62 110.385 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 m -57.16 -41.23 78.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.631 . . . . 1.59 111.708 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.946 HE21 ' HB3' ' A' ' 64' ' ' TYR . 4.6 pp0? -91.89 -4.33 54.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.573 -0.451 . . . . 1.9 111.038 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.23 20.0 7.3 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.823 -0.703 . . . . 1.32 114.069 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.883 ' HB2' ' NE2' ' A' ' 67' ' ' GLN . 75.2 t80 -77.28 137.33 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.037 0.418 . . . . 0.4 111.306 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.585 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 2.4 t -132.01 142.31 49.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.839 -0.801 . . . . 1.11 108.839 173.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.905 HG13 ' HB1' ' A' ' 57' ' ' ALA . 40.8 t -105.56 105.87 19.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.933 -0.765 . . . . 1.06 108.933 169.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.639 ' HB2' HG12 ' A' ' 40' ' ' ILE . 25.6 mt -89.53 120.92 31.26 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.174 -1.047 . . . . 1.23 108.174 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -108.6 112.23 24.47 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.073 -0.651 . . . . 1.04 110.216 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.789 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -95.55 108.05 37.15 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 108.605 -0.887 . . . . 0.45 108.605 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 1.017 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.9 Cg_exo -59.82 168.92 5.04 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.35 2.7 . . . . 0.73 111.397 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.463 ' HB2' HE22 ' A' ' 78' ' ' GLN . 37.4 m -114.41 134.59 54.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.625 1.202 . . . . 2.02 113.847 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.618 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 42.4 t30 -93.04 64.62 3.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.348 -1.751 . . . . 3.1 109.679 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.762 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -53.06 -13.7 0.5 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.351 0.871 . . . . 3.18 113.351 -173.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -70.28 -19.19 63.12 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.341 0.591 . . . . 4.52 110.317 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.803 ' HA3' HD22 ' A' ' 109' ' ' ASN . . . -62.21 -47.92 86.38 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.303 -0.862 . . . . 1.45 112.462 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.71 -58.15 0.6 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.901 -1.142 . . . . 1.43 113.016 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.799 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -93.34 11.81 26.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.421 0.61 . . . . 1.43 112.216 -175.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.762 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 26.3 mm-40 -62.22 149.37 87.21 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 120.422 -0.511 . . . . 3.06 111.95 -172.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.954 ' HG3' HG21 ' A' ' 135' ' ' ILE . 9.1 Cg_exo -36.5 165.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.905 3.736 . . . . 1.61 116.258 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.49 82.13 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.802 -1.319 . . . . 1.83 109.802 -171.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.577 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 2.3 t-20 54.97 30.45 14.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.336 -0.932 . . . . 4.24 110.853 -177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 2.8 pt-20 64.88 -14.19 0.1 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.732 1.213 . . . . 2.47 112.877 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 86' ' ' ASN . 5.8 tp10 -85.2 -15.57 43.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.702 0.287 . . . . 3.64 111.323 -169.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -79.88 -61.51 1.97 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.987 -0.285 . . . . 2.42 110.895 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.799 HG12 ' SG ' ' A' ' 95' ' ' CYS . 3.0 mt -84.82 58.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 122.952 1.358 . . . . 2.56 110.511 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -73.95 -78.02 0.1 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.894 -1.503 . . . . 4.36 110.569 168.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -92.3 19.02 7.46 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.25 -0.886 . . . . 3.1 111.074 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 97.9 m-85 -107.66 168.87 8.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.308 -0.626 . . . . 2.15 109.308 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 p -128.72 151.82 36.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.484 -0.561 . . . . 2.13 109.484 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.799 ' SG ' HG12 ' A' ' 90' ' ' ILE . 60.6 m -138.72 122.81 17.97 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.696 -0.401 . . . . 0.91 112.071 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 t -149.42 119.65 7.29 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.892 -0.594 . . . . 2.41 110.27 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.524 ' HD3' ' HB1' ' A' ' 23' ' ' ALA . 25.7 pttt 28.44 89.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.764 1.226 . . . . 3.5 114.297 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.731 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -60.79 131.4 50.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.853 -1.165 . . . . 1.74 107.853 170.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 99' ' ' LYS . 11.2 mptt -91.35 147.62 22.91 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.394 -0.523 . . . . 3.53 111.213 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.667 ' CB ' ' HH ' ' A' ' 54' ' ' TYR . . . -158.54 -166.76 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.847 0.717 . . . . 1.09 111.33 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -81.62 -34.1 31.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.373 0.606 . . . . 2.19 110.507 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.764 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 29.4 p90 -84.46 166.74 31.07 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 115.287 -0.87 . . . . 0.39 109.774 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 23.5 Cg_exo -72.1 103.12 1.44 Allowed 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.018 3.145 . . . . 0.48 113.571 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.997 HG13 ' HB2' ' A' ' 73' ' ' ALA . 3.6 mp -94.66 134.25 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.884 -0.784 . . . . 1.13 108.884 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.789 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -109.01 -154.22 0.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 2.08 112.522 -163.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.9 135.55 41.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.218 -0.901 . . . . 1.11 110.23 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.008 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.5 pttp -73.36 125.1 27.07 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.713 0.768 . . . . 2.12 108.997 171.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.487 HG13 HG13 ' A' ' 110' ' ' VAL . 12.1 pt -122.17 174.36 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 106.914 -1.513 . . . . 1.19 106.914 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.835 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 6.7 m120 -83.86 81.17 8.89 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.035 -0.666 . . . . 2.16 109.868 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -79.29 84.12 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 118.468 -1.293 . . . . 1.1 109.085 177.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.799 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 56.5 t30 170.35 179.5 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.418 -1.327 . . . . 1.98 107.418 166.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.671 ' HA3' ' HG3' ' A' ' 82' ' ' GLN . . . 56.81 -152.07 23.9 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 115.615 1.006 . . . . 0.78 115.615 160.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.11 -20.9 22.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.148 -1.026 . . . . 1.98 110.695 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -92.94 6.58 47.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.538 -0.755 . . . . 2.1 110.564 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.835 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.09 141.98 38.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.885 -1.052 . . . . 1.17 113.299 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.845 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 35.6 t-80 -54.25 135.25 60.23 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 115.477 -0.783 . . . . 0.51 109.087 167.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.16 -33.29 73.85 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.416 2.744 . . . . 0.43 112.85 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.845 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 1.7 tm? -62.32 -43.21 99.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 1.69 109.941 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.56 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.0 m-85 -75.59 -30.48 59.61 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.449 -0.341 . . . . 1.84 110.851 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.53 -41.15 76.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.89 -0.724 . . . . 2.37 109.206 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 69.7 t80 -65.81 -45.7 81.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.94 0.4 . . . . 1.09 110.442 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.561 ' HE1' ' CD1' ' A' ' 40' ' ' ILE . 67.3 mtt -65.38 -53.29 45.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.144 -0.48 . . . . 1.06 111.806 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.4 mtpt -59.19 -39.21 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 1.42 110.644 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.3 ptmt -74.62 -36.84 62.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 2.63 111.031 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 150' ' ' PRO . 96.0 m -70.55 -43.24 69.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.4 -0.363 . . . . 1.09 111.916 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.9 tmtt? -137.18 100.71 9.46 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.422 -0.511 . . . . 2.26 111.484 -176.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 2.7 Cg_endo -47.53 -52.91 7.23 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.203 3.269 . . . . 1.81 113.463 173.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.93 -154.46 24.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.723 -1.227 . . . . 2.45 113.566 174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.4 mt -73.98 -62.19 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.155 0.502 . . . . 4.01 110.37 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.727 ' H ' HD22 ' A' ' 130' ' ' LEU . 2.1 pt? -87.89 -165.3 1.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.203 -1.036 . . . . 2.97 108.203 172.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -50.76 -56.01 14.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.202 -0.295 . . . . 3.28 110.202 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.515 HG21 ' HD2' ' A' ' 153' ' ' ARG . 6.8 m 63.71 -78.57 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.432 -0.804 . . . . 4.33 112.003 172.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.8 tttm 69.61 -70.02 0.15 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.674 0.79 . . . . 5.43 111.933 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.48 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -109.69 -179.77 3.91 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.145 0.424 . . . . 1.51 112.145 -173.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.954 HG21 ' HG3' ' A' ' 84' ' ' PRO . 38.5 mt -103.75 88.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.638 -0.71 . . . . 1.5 110.261 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -117.15 28.15 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.644 0.609 . . . . 1.99 112.644 -173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.841 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.14 169.49 23.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.05 0.452 . . . . 1.1 112.075 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -51.28 -155.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.869 1.668 . . . . 1.8 113.471 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.908 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 53.1 m-85 -24.86 -57.68 0.05 Allowed 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 125.451 1.5 . . . . 1.68 114.212 -165.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.794 HG23 ' HA ' ' A' ' 155' ' ' SER . 23.1 m 38.08 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.275 0.842 . . . . 1.05 113.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 11.9 p -84.34 152.18 24.26 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.094 -0.642 . . . . 1.38 111.532 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.9 m-85 -103.5 134.88 46.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.023 -1.102 . . . . 0.53 108.023 165.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.739 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.2 tp -82.0 104.7 12.55 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.063 -0.717 . . . . 1.2 109.063 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.621 HG23 HD12 ' A' ' 15' ' ' ILE . 18.4 mm -102.8 124.12 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.602 -0.726 . . . . 1.05 109.26 -175.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.427 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 1.1 p-10 -78.7 -175.1 4.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.864 -0.334 . . . . 1.3 111.374 -175.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.648 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.8 mtp180 -57.11 -26.01 59.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.831 0.348 . . . . 4.43 111.912 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -108.5 -12.49 15.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.119 0.485 . . . . 1.18 110.829 -168.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.572 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.22 44.65 2.33 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.393 -0.908 . . . . 0.25 113.512 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.445 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.9 t -119.16 127.87 26.25 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.301 -0.629 . . . . 1.32 109.301 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.499 ' HD2' HG22 ' A' ' 125' ' ' THR . 11.5 Cg_exo -68.07 111.68 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.499 2.133 . . . . 0.46 111.383 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.642 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.8 t -94.96 -25.97 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.32 -0.4 . . . . 1.09 110.844 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.511 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 59.2 mm-40 -151.08 164.16 37.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.869 0.366 . . . . 1.22 111.032 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.515 ' HD2' HG21 ' A' ' 132' ' ' THR . 23.3 ttm180 -129.98 97.02 4.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.702 -0.851 . . . . 2.25 108.702 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.739 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 49.9 m-85 -88.89 108.66 19.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.461 -0.57 . . . . 0.38 109.461 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.794 ' HA ' HG23 ' A' ' 140' ' ' THR . 88.0 p -63.35 167.3 6.92 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.357 -0.609 . . . . 1.49 109.357 176.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.886 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 9.0 Cg_exo -67.61 -8.99 23.92 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.799 2.333 . . . . 0.74 112.197 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.93 -1.46 89.78 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 114.72 -1.127 . . . . 0.56 111.897 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.58 138.06 31.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.955 0.407 . . . . 1.14 110.43 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.57 172.44 8.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.191 -0.459 . . . . 1.64 110.536 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.408 ' HA ' HG22 ' A' ' 56' ' ' THR . 40.9 t -52.07 -44.88 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 1.14 111.07 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 161' ' ' LYS . 33.1 ttpt -66.41 -38.33 87.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.351 -0.841 . . . . 3.84 110.846 -175.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.64 -32.35 73.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.86 109.962 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.558 HG23 HD21 ' A' ' 39' ' ' LEU . 59.1 mt -82.8 -43.18 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.57 -0.741 . . . . 1.05 111.184 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 33.2 mt-10 -55.54 -36.92 67.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.991 0.737 . . . . 0.88 112.991 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.58 -26.16 65.18 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.761 -0.376 . . . . 0.75 111.637 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 71.5 mmtt -102.06 -17.72 15.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.221 0.534 . . . . 2.11 110.155 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.7 tp -87.64 -49.28 7.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.683 . . . . 1.06 111.946 -172.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 70.1 mt -53.04 -48.09 93.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 112.596 0.591 . . . . 1.14 112.596 -174.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.0 Cg_endo -53.62 -42.65 64.27 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.116 1.877 . . . . 0.74 112.403 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.62 -44.23 82.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.526 -0.306 . . . . 1.35 110.996 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.787 HD23 ' NE2' ' A' ' 67' ' ' GLN . 46.5 mt -55.73 -51.46 67.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.448 0.642 . . . . 1.16 109.671 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.85 -63.05 4.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 114.16 -1.382 . . . . 1.52 113.062 168.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.4 p -169.72 119.84 0.65 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.049 0.424 . . . . 2.89 111.086 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.427 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -94.14 -58.68 2.16 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 121.015 0.436 . . . . 3.56 110.743 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -132.03 11.95 4.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.134 -1.061 . . . . 8.59 108.134 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 C--O 1.251 1.159 0 CA-C-N 113.819 -1.537 . . . . 5.3 107.304 -175.321 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 112.048 -0.421 . . . . 5.87 112.048 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -106.62 -23.87 12.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.97 0.414 . . . . 5.34 110.526 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.97 136.42 2.34 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.947 -0.644 . . . . 1.87 111.975 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 m -56.09 -48.75 75.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.167 0.508 . . . . 2.22 111.232 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -161.12 -177.86 6.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.574 -0.739 . . . . 1.06 109.301 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.638 HD13 HG23 ' A' ' 144' ' ' ILE . 20.8 pt -60.6 -27.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.741 0.305 . . . . 1.08 111.671 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.8 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 42.4 m-85 -77.73 6.49 7.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.3 111.652 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.89 -9.02 59.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.659 -0.867 . . . . 1.96 108.659 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 80.0 m-85 -116.61 149.8 39.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.824 -1.08 . . . . 0.4 109.811 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -99.98 146.47 26.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.835 0.35 . . . . 2.77 111.01 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -114.13 145.83 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.091 -0.504 . . . . 1.39 110.942 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.992 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 74.9 mt -99.31 134.65 41.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.088 -0.708 . . . . 1.33 109.088 170.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 23' ' ' ALA . 14.1 t70 -70.06 -174.9 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.872 -0.788 . . . . 1.59 108.872 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 1.111 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . -54.33 -29.98 49.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.218 0.532 . . . . 1.14 111.381 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.99 11.65 35.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.012 -0.54 . . . . 2.22 111.76 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.992 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 22.3 m-70 69.46 12.3 8.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.232 0.613 . . . . 0.88 110.593 176.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.78 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.2 mmpt? -75.83 145.85 78.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 106.563 -1.643 . . . . 3.67 106.563 165.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.92 114.52 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.267 1.311 . . . . 1.19 112.314 -173.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.79 ' HH ' ' NE2' ' A' ' 33' ' ' HIS . 69.0 t80 -85.83 115.72 23.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.355 -0.838 . . . . 0.98 109.602 172.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -71.39 96.07 1.42 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.654 -0.869 . . . . 1.65 108.654 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.745 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -75.61 -29.64 59.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.722 0.772 . . . . 1.08 109.562 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.8 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 11.7 p -77.5 -0.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.619 -1.173 . . . . 1.15 113.207 -166.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -81.7 -4.57 56.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.399 -0.593 . . . . 1.94 109.399 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.79 ' NE2' ' HH ' ' A' ' 28' ' ' TYR . 87.0 m-70 -93.98 4.67 53.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.333 -0.988 . . . . 0.38 108.333 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.549 ' HE3' HG23 ' A' ' 31' ' ' VAL . 36.4 ttmt -82.28 130.48 35.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.99 -1.005 . . . . 2.22 109.138 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.61 58.7 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.158 -1.177 . . . . 0.36 110.158 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 14.3 m -138.23 139.31 25.08 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.587 -0.894 . . . . 1.58 108.587 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.085 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 40.5 Cg_endo -73.94 150.7 44.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.572 1.515 . . . . 0.86 110.41 174.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.601 ' CB ' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -154.4 153.5 31.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.307 0.575 . . . . 1.63 111.62 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.789 HD23 HG23 ' A' ' 163' ' ' ILE . 6.4 mp -108.11 148.82 29.29 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.638 -0.875 . . . . 1.69 108.638 170.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.455 HD12 ' HE2' ' A' ' 122' ' ' MET . 84.5 mt -132.07 119.51 40.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.573 -0.529 . . . . 1.05 109.573 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 26.5 m-85 -101.5 130.4 47.75 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.93 111.399 -172.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.739 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -90.58 93.31 9.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.503 -1.295 . . . . 1.97 107.503 174.012 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.586 HG13 ' HA ' ' A' ' 139' ' ' PHE . 3.5 m -109.01 143.79 18.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 1.48 112.468 -163.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.88 17.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.653 -1.61 . . . . 1.17 106.653 165.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.618 ' OG ' ' HB3' ' A' ' 95' ' ' CYS . 3.2 p -74.02 86.33 1.82 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.844 -0.616 . . . . 2.3 112.294 -165.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 66.18 44.69 2.5 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.208 -0.905 . . . . 2.81 110.385 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.9 p -164.0 133.62 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.567 -0.742 . . . . 1.18 110.81 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.15 -149.04 18.29 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.505 -0.855 . . . . 1.42 113.869 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -96.54 111.3 23.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 122.694 0.398 . . . . 3.45 111.275 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.9 p -66.6 -34.52 78.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.703 0.26 . . . . 1.94 111.703 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 31.1 mtpp 66.32 -3.32 0.84 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.443 0.697 . . . . 2.51 112.536 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 109.38 3.55 30.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.886 -0.673 . . . . 0.55 112.464 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 139' ' ' PHE . . . -72.38 -39.46 57.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.225 -0.512 . . . . 0.39 111.828 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.717 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.5 t80 -69.18 -51.6 36.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.172 -0.307 . . . . 1.05 110.172 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.441 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 1.6 mp0 -51.78 -52.01 52.08 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.37 0.605 . . . . 2.46 110.707 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -64.41 -46.72 82.02 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.899 -1.046 . . . . 1.06 110.88 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.704 ' HB3' HG13 ' A' ' 71' ' ' VAL . . . -58.87 -48.14 82.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.137 -0.483 . . . . 1.03 111.262 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -58.48 -50.27 74.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.703 -0.681 . . . . 1.09 110.419 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.7 m -63.0 -43.28 99.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.263 -0.88 . . . . 1.69 111.597 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.51 HD13 HD22 ' A' ' 39' ' ' LEU . 76.2 mt -61.34 -50.27 73.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.372 0.138 . . . . 1.46 111.372 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.723 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.1 t80 -53.67 -49.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.92 109.83 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -73.02 -31.24 64.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.613 -0.721 . . . . 1.88 111.869 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.34 -45.59 19.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.225 -0.443 . . . . 2.27 111.267 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.634 ' CD1' HD11 ' A' ' 171' ' ' LEU . 69.2 m-85 -104.19 8.03 36.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.592 0.96 . . . . 0.9 113.592 -170.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -25.0 65.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.02 0.438 . . . . 2.62 110.144 170.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.0 t -59.26 -40.14 85.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.497 -0.774 . . . . 1.59 110.727 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.8 14.38 23.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 1.9 111.247 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.632 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.21 59.4 2.74 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 115.916 -0.583 . . . . 1.32 112.651 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CZ ' HD11 ' A' ' 39' ' ' LEU . 67.3 t80 -123.88 139.27 54.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.492 0.187 . . . . 0.4 111.121 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.601 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -127.71 144.49 51.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 120.82 0.343 . . . . 1.11 110.255 177.54 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.723 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 27.2 t -114.05 119.47 61.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 1.06 109.95 169.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.706 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 19.8 mt -103.36 121.57 43.05 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.188 -0.671 . . . . 1.23 109.188 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.972 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -108.02 132.25 53.73 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.364 -0.534 . . . . 1.04 110.431 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.2 m-85 -112.19 108.44 55.03 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-O 121.231 0.538 . . . . 0.45 110.711 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 64.1 Cg_exo -47.85 139.53 19.34 Favored 'Trans proline' 0 CA--C 1.514 -0.476 0 C-N-CA 124.781 3.654 . . . . 0.73 112.136 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m -122.25 155.13 36.54 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 118.633 -1.227 . . . . 2.02 114.268 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.506 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 88.7 m-20 -106.12 85.86 2.27 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 113.235 -1.802 . . . . 3.1 110.679 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.959 ' HB2' HG13 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -58.61 -4.03 0.37 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.596 0.758 . . . . 3.18 113.0 176.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 77' ' ' ASN . 4.9 t80 -84.61 8.37 17.03 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.233 0.539 . . . . 4.52 109.837 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.527 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . -77.32 -74.12 1.01 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.674 -0.694 . . . . 1.45 114.442 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.43 -41.58 0.24 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.649 -0.786 . . . . 1.43 112.175 -170.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 1.016 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -135.13 14.24 3.55 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.765 -0.256 . . . . 1.43 111.273 176.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.755 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -60.31 151.01 70.2 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 3.06 111.07 -173.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.742 ' HG3' HG22 ' A' ' 135' ' ' ILE . 32.6 Cg_exo -64.22 173.17 5.4 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.599 2.199 . . . . 1.61 112.952 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.56 19.02 57.61 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.899 -1.28 . . . . 1.83 109.899 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.28 65.66 0.49 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.403 -0.898 . . . . 4.24 110.705 -177.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 1.6 pm0 20.08 117.15 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 116.2 1.926 . . . . 2.47 116.2 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 49.1 mm-40 82.43 40.97 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.71 -1.132 . . . . 3.64 111.68 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.699 ' HB3' ' HG2' ' A' ' 78' ' ' GLN . 6.5 tp10 -75.27 -33.47 61.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.877 0.325 . . . . 2.42 111.877 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.959 HG13 ' HB2' ' A' ' 78' ' ' GLN . 2.8 mt -76.27 34.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.415 0.626 . . . . 2.56 111.075 -177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 89' ' ' GLU . 12.5 pttp -78.3 -17.74 56.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.804 0.811 . . . . 4.36 110.725 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.48 18.76 1.19 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.375 -1.284 . . . . 3.1 110.071 -173.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -135.38 174.02 11.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.664 -0.698 . . . . 2.15 110.432 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 94' ' ' VAL . 7.4 p -130.32 111.95 22.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.353 -1.351 . . . . 2.13 107.353 166.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.629 ' SG ' HG12 ' A' ' 90' ' ' ILE . 33.8 m -98.15 120.97 39.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 118.864 -1.135 . . . . 0.91 111.26 -174.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.85 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 12.1 t -139.61 156.94 46.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.899 -1.5 . . . . 2.41 107.568 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 1.111 ' HD2' ' HB2' ' A' ' 23' ' ' ALA . 5.7 pttt -39.08 101.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.835 0.71 . . . . 3.5 111.299 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 5.5 p90 -61.95 135.72 57.67 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.133 -1.432 . . . . 1.74 107.133 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -94.12 143.75 26.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.694 -0.802 . . . . 3.53 110.467 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.467 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . . . -145.99 -162.03 1.43 Allowed 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.055 0.847 . . . . 1.09 111.428 -174.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -95.55 -5.37 42.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.625 . . . . 2.19 110.042 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.777 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 39.1 p90 -118.79 170.72 6.12 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.39 108.912 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 23.0 Cg_exo -71.19 125.83 11.78 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 123.599 2.866 . . . . 0.48 113.292 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.972 HG13 ' HB2' ' A' ' 73' ' ' ALA . 3.1 mp -120.9 140.64 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.338 -0.616 . . . . 1.13 109.338 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.706 ' HE2' ' HB3' ' A' ' 72' ' ' LEU . 10.9 mmt -111.1 -151.28 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 2.08 113.717 -163.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -73.73 163.71 27.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.247 -0.888 . . . . 1.11 111.528 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.85 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 82.4 mttt -87.74 112.38 22.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.853 -0.425 . . . . 2.12 109.853 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.7 pt -122.17 164.08 19.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.216 -0.661 . . . . 1.19 109.216 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.59 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 55.4 t-20 -96.43 80.33 3.15 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.692 -0.855 . . . . 2.16 108.692 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 42' ' ' ASN . 1.0 OUTLIER -65.88 91.47 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.132 -0.627 . . . . 1.1 110.298 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 1.016 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 0.5 OUTLIER 174.25 172.33 0.2 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.055 -0.35 . . . . 1.98 110.055 172.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.571 ' HA3' ' HG3' ' A' ' 82' ' ' GLN . . . 51.15 -133.69 32.95 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 123.944 0.777 . . . . 0.78 114.917 160.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -105.57 3.95 29.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.218 -0.991 . . . . 1.98 109.978 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -106.54 -5.56 18.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.959 -1.018 . . . . 2.1 110.958 -169.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -63.15 147.23 51.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.971 -0.559 . . . . 1.17 112.354 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.84 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 44.7 t-80 -50.36 136.06 23.6 Favored Pre-proline 0 C--O 1.225 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.51 109.412 168.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -49.37 -32.25 25.6 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.693 2.928 . . . . 0.43 113.438 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.84 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 22.4 tp -66.33 -39.5 89.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 1.69 110.901 175.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.74 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 4.5 m-85 -73.98 -31.13 62.85 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 116.433 -0.349 . . . . 1.84 110.283 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -56.22 -42.68 77.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.09 -0.707 . . . . 2.37 109.09 168.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.684 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 90.1 t80 -65.26 -52.6 53.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.979 0.419 . . . . 1.09 111.557 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.48 ' HE3' HD11 ' A' ' 118' ' ' LEU . 55.6 mtt -64.41 -49.17 72.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.558 0.694 . . . . 1.06 110.871 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.74 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 4.6 tmtt? -70.74 -26.62 63.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.805 -1.089 . . . . 1.42 112.075 -174.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.8 ptmt -75.75 -27.59 58.16 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.85 0.357 . . . . 2.63 110.228 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.419 HG21 ' HD2' ' A' ' 150' ' ' PRO . 23.5 m -68.32 -60.43 2.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.703 0.631 . . . . 1.09 112.703 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.789 ' H ' ' HD2' ' A' ' 127' ' ' PRO . 25.9 tttp -122.49 -55.45 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 119.173 -1.011 . . . . 2.26 113.629 -172.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.789 ' HD2' ' H ' ' A' ' 126' ' ' LYS . 90.7 Cg_endo -68.66 176.75 5.52 Favored 'Trans proline' 0 C--N 1.334 -0.235 0 C-N-CA 123.569 2.846 . . . . 1.81 111.961 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 133' ' ' LYS . . . 90.91 -27.17 9.29 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 116.031 -0.531 . . . . 2.45 112.104 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.0 pt -56.22 -22.59 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.387 0.884 . . . . 4.01 113.387 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.5 pt? -122.41 19.75 10.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.562 0.208 . . . . 2.97 111.562 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 70.62 -50.8 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.601 0.563 . . . . 3.28 111.697 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.431 ' HA ' ' CE ' ' A' ' 136' ' ' LYS . 11.4 m -44.24 -56.27 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.745 0.783 . . . . 4.33 111.607 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.764 ' O ' ' HB2' ' A' ' 127' ' ' PRO . 97.8 mttt -81.7 12.45 3.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.918 -1.037 . . . . 5.43 112.169 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.441 ' C ' HG13 ' A' ' 135' ' ' ILE . . . -86.63 24.08 1.52 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.988 0.423 . . . . 1.51 109.961 175.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.98 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 1.1 mt 65.84 138.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.708 -1.133 . . . . 1.5 110.151 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.709 ' HZ1' ' HB3' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -178.6 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.582 0.706 . . . . 1.99 110.851 -175.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.98 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.18 170.08 9.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.054 -0.976 . . . . 1.1 111.663 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.572 ' HB3' ' HD1' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -52.56 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.839 1.422 . . . . 1.8 114.839 175.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.601 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 16.3 m-85 -28.42 -34.65 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 127.089 2.156 . . . . 1.68 115.904 -167.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 1.126 HG21 ' HA ' ' A' ' 155' ' ' SER . 8.6 m 13.46 105.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.027 1.491 . . . . 1.05 115.027 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.48 158.85 20.88 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.746 0.784 . . . . 1.38 111.982 -174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.599 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 16.3 m-85 -102.84 169.32 8.67 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.245 -1.391 . . . . 0.53 107.245 162.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.609 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 46.3 tp -116.5 105.94 13.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.753 -0.832 . . . . 1.2 108.753 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.638 HG23 HD13 ' A' ' 15' ' ' ILE . 13.4 mm -108.36 122.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.486 -0.561 . . . . 1.05 109.486 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -178.92 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.893 -0.323 . . . . 1.3 110.549 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.681 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -67.84 -6.6 22.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.184 -0.462 . . . . 4.43 112.164 -174.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.78 -22.29 12.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.491 0.662 . . . . 1.18 109.376 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.492 ' O ' HG22 ' A' ' 15' ' ' ILE . . . 104.42 34.2 3.69 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.877 -1.056 . . . . 0.25 112.67 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 68.5 t -110.55 129.35 24.04 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.93 0.365 . . . . 1.32 110.569 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 149' ' ' VAL . 22.9 Cg_exo -65.21 107.99 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.149 2.566 . . . . 0.46 112.063 176.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.462 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 t -94.81 -12.1 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.136 -0.484 . . . . 1.09 110.893 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.53 167.41 2.24 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.135 0.493 . . . . 1.22 111.815 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.798 ' NH2' HG12 ' A' ' 135' ' ' ILE . 15.2 ttm-85 -134.17 116.4 15.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.06 -0.973 . . . . 2.25 109.788 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.635 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 12.4 m-85 -104.09 134.15 47.82 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 108.393 -0.966 . . . . 0.38 108.393 176.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 1.126 ' HA ' HG21 ' A' ' 140' ' ' THR . 52.7 p -76.33 176.36 3.41 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.114 0.87 . . . . 1.49 109.764 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.825 ' HG3' ' H ' ' A' ' 140' ' ' THR . 7.0 Cg_exo -69.11 -16.61 40.42 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.366 1.377 . . . . 0.74 110.749 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.57 89.4 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.6 -1.182 . . . . 0.56 111.89 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.92 133.48 36.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.564 -0.532 . . . . 1.14 109.564 176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.5 m -78.59 160.02 27.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.855 -0.611 . . . . 1.64 110.657 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 58.1 t -50.04 -50.71 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.729 0.3 . . . . 1.14 110.486 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.745 -0.661 . . . . 3.84 111.779 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -65.81 -31.48 72.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.413 0.625 . . . . 1.86 109.733 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.789 HG23 HD23 ' A' ' 39' ' ' LEU . 54.0 mt -81.38 -41.7 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.527 -0.76 . . . . 1.05 110.189 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 45.0 mt-10 -55.76 -40.81 73.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.88 112.209 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -58.33 -27.62 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.75 111.6 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.535 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.6 mttp -104.28 -12.98 16.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 2.11 110.645 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.2 tp -93.38 -41.99 9.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 1.06 111.534 -174.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.652 ' HA ' HD12 ' A' ' 171' ' ' LEU . 79.5 mt -53.28 -48.97 90.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.489 0.551 . . . . 1.14 112.489 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 40.2 Cg_exo -59.05 -22.72 65.28 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.149 1.899 . . . . 0.74 113.04 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.52 -39.1 14.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.543 0.211 . . . . 1.35 110.734 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 1.085 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.4 mt -56.95 -53.47 57.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 1.16 109.271 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.49 51.75 2.23 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.565 -1.198 . . . . 1.52 113.741 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m 69.55 112.37 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.556 0.742 . . . . 2.89 112.625 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.02 -57.92 2.49 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.24 0.543 . . . . 3.56 110.343 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.618 ' HG3' HD23 ' A' ' 176' ' ' LEU . 1.5 ptm180 -134.55 -26.64 1.39 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.732 -0.84 . . . . 8.59 108.732 172.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.618 HD23 ' HG3' ' A' ' 175' ' ' ARG . 3.9 mm? . . . . . 0 C--O 1.248 0.982 0 CA-C-N 114.949 -1.023 . . . . 5.3 108.411 168.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 111.734 -0.546 . . . . 5.87 111.734 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 92.9 mmm -136.89 134.65 37.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.923 -0.399 . . . . 5.34 109.923 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.71 46.9 93.56 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.138 -0.553 . . . . 1.87 113.249 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -90.52 -45.57 8.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.091 0.472 . . . . 2.22 110.097 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.0 p -125.17 170.1 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.186 -0.672 . . . . 1.06 109.186 175.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.737 HD12 HG22 ' A' ' 144' ' ' ILE . 32.1 pt -59.91 -27.48 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.021 0.438 . . . . 1.08 111.34 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.892 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 55.4 m-85 -76.56 -1.75 29.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.508 0.559 . . . . 0.3 112.508 -171.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 -17.16 58.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.477 0.656 . . . . 1.96 109.578 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 87.1 m-85 -98.59 175.3 6.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 0.4 110.764 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -110.44 133.83 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 2.77 110.272 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.632 HG12 ' CE2' ' A' ' 74' ' ' PHE . 77.5 t -115.22 149.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.933 0.397 . . . . 1.39 110.927 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.908 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 2.3 mp -114.98 141.1 48.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.927 -0.579 . . . . 1.33 109.87 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.96 175.57 1.16 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.516 -0.765 . . . . 1.59 109.327 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.71 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -47.54 -39.74 17.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.912 0.387 . . . . 1.14 111.685 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.05 8.53 39.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.18 -0.464 . . . . 2.22 112.218 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.908 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 23.0 m-70 72.21 26.08 2.8 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.501 0.667 . . . . 0.88 110.37 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -84.87 132.62 45.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 105.791 -1.929 . . . . 3.67 105.791 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.27 112.63 0.84 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.106 1.204 . . . . 1.19 112.588 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.531 ' HH ' ' HB3' ' A' ' 103' ' ' PRO . 55.7 t80 -86.95 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.014 -0.993 . . . . 0.98 110.515 174.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.572 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.8 t30 -78.32 90.19 4.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.308 -0.627 . . . . 1.65 109.308 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.892 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -65.31 -28.52 69.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 1.08 111.339 -174.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.846 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.0 p -76.46 -1.04 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 113.064 0.764 . . . . 1.15 113.064 -166.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 4.1 pt20 -78.85 -5.05 52.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.304 0.573 . . . . 1.94 109.68 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -99.16 18.3 17.79 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.025 -1.102 . . . . 0.38 108.025 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -96.89 146.35 25.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.33 -1.305 . . . . 2.22 109.464 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.42 -10.62 67.13 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.072 -1.211 . . . . 0.36 110.072 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.592 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 51.1 m -141.75 146.98 43.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.359 -0.978 . . . . 1.58 108.359 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.003 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 72.3 Cg_endo -75.22 159.77 40.2 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.918 1.745 . . . . 0.86 111.404 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.543 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.7 pt? -154.5 151.58 29.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.269 0.557 . . . . 1.63 111.071 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.541 HD23 HG22 ' A' ' 163' ' ' ILE . 6.0 mp -108.07 155.64 20.15 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.618 -0.882 . . . . 1.69 108.618 170.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.606 HG21 ' HH ' ' A' ' 119' ' ' TYR . 86.9 mt -141.03 119.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.415 -0.587 . . . . 1.05 109.415 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 1.003 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 21.0 m-85 -105.77 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.273 0.358 . . . . 0.93 111.435 -172.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.532 HD22 ' HE1' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -77.91 92.81 4.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.575 -1.269 . . . . 1.97 107.575 169.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.407 HG11 ' CE2' ' A' ' 98' ' ' PHE . 2.8 p -113.21 127.54 70.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.425 -0.91 . . . . 1.48 112.634 -167.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.681 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -65.98 101.94 0.74 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.102 -1.444 . . . . 1.17 107.102 168.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.834 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 26.6 t -67.54 92.68 0.32 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.124 -0.944 . . . . 2.3 112.056 -163.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 6.1 mmtm 73.88 31.78 1.17 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.331 0.652 . . . . 2.81 110.866 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -137.24 140.53 41.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 1.18 110.612 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.3 -149.53 29.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.951 -0.642 . . . . 1.42 113.643 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.55 128.03 49.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.055 0.455 . . . . 3.45 111.43 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.622 HG23 ' HE1' ' A' ' 139' ' ' PHE . 3.7 p -71.9 -33.05 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 1.94 111.872 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 28.7 mtpp 64.88 3.96 2.26 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.71 0.633 . . . . 2.51 112.71 173.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.82 45.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.55 112.078 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.04 -31.09 62.22 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.955 -0.458 . . . . 0.39 111.955 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.732 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -76.51 -52.82 9.04 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 120.5 0.191 . . . . 1.05 110.697 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.09 -39.45 92.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.891 0.377 . . . . 2.46 110.677 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 160' ' ' VAL . 95.9 m -66.55 -46.22 76.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 1.06 110.846 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.656 ' HB3' HG13 ' A' ' 71' ' ' VAL . . . -60.63 -46.77 89.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 1.03 110.828 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 62.3 m -58.52 -50.38 73.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.455 -0.793 . . . . 1.09 111.133 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -64.43 -44.31 91.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.303 -0.408 . . . . 1.69 111.578 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 86.4 mt -57.92 -52.4 65.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.68 0.252 . . . . 1.46 111.68 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.754 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.9 t80 -54.42 -49.37 70.11 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 121.202 0.525 . . . . 0.92 109.88 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.02 -34.99 66.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 1.88 111.786 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.12 -47.54 20.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.381 -0.372 . . . . 2.27 111.29 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CD1' HD11 ' A' ' 171' ' ' LEU . 60.8 m-85 -99.34 6.28 46.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.601 0.963 . . . . 0.9 113.601 -171.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -59.41 -28.78 67.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 2.62 110.958 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -63.18 -35.36 80.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.59 111.272 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -94.56 2.93 55.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.971 0.415 . . . . 1.9 111.162 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 90.01 74.1 1.28 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.794 -0.717 . . . . 1.32 112.176 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 74.0 t80 -138.15 140.94 40.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.559 0.219 . . . . 0.4 110.526 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.08 142.55 50.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 120.56 0.219 . . . . 1.11 110.433 178.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.754 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 42.2 t -110.84 115.02 48.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.614 -0.513 . . . . 1.06 109.614 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.608 ' HB3' ' HE2' ' A' ' 105' ' ' MET . 25.1 mt -98.46 121.49 40.46 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.83 -0.804 . . . . 1.23 108.83 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.954 ' HB1' HG13 ' A' ' 104' ' ' ILE . . . -108.46 115.95 31.06 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.567 -0.453 . . . . 1.04 110.191 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.75 ' HD2' HD11 ' A' ' 108' ' ' ILE . 3.3 m-85 -97.65 107.59 40.52 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.949 -0.569 . . . . 0.45 109.558 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.834 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 71.2 Cg_exo -51.59 160.04 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.685 2.923 . . . . 0.73 112.486 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.681 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 48.3 m -112.52 138.59 49.07 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.357 -0.838 . . . . 2.02 111.483 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -106.76 103.28 12.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.17 -0.923 . . . . 3.1 111.191 -173.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.67 ' HA ' ' CD ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -62.45 -10.4 11.51 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.584 1.154 . . . . 3.18 114.04 -172.137 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -71.2 32.35 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 114.455 1.28 . . . . 4.52 114.455 -169.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.64 74.05 1.08 Allowed Glycine 0 CA--C 1.492 -1.363 0 CA-C-O 122.171 0.873 . . . . 1.45 112.471 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 1.042 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -157.83 20.66 0.37 Allowed Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 109.257 -1.537 . . . . 1.43 109.257 174.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 38.08 42.68 0.49 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 125.61 1.418 . . . . 1.43 110.865 -173.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.67 ' CD ' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -62.16 158.07 48.6 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.559 -0.746 . . . . 3.06 112.097 -169.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -18.23 120.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 1 C-N-CA 126.348 4.699 . . . . 1.61 115.701 -174.961 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.98 -2.21 61.55 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.341 -1.503 . . . . 1.83 109.341 -166.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 82' ' ' GLN . 5.4 t-20 56.37 48.74 16.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.432 -0.884 . . . . 4.24 109.572 -175.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 89' ' ' GLU . 9.6 pt-20 50.26 -174.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.896 1.278 . . . . 2.47 111.212 -171.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 43.3 tt0 70.88 -18.49 0.26 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.845 0.458 . . . . 3.64 111.743 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 87' ' ' GLU . 27.3 tt0 -85.85 -22.2 27.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.982 -0.748 . . . . 2.42 108.982 172.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.728 HD11 ' SG ' ' A' ' 95' ' ' CYS . 15.2 mt -106.37 37.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.244 -0.889 . . . . 2.56 110.953 176.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.641 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -92.3 133.22 36.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.824 -0.806 . . . . 4.36 108.824 169.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.641 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 3.8 pt-20 68.03 -19.53 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.213 1.005 . . . . 3.1 111.25 -173.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.547 ' H ' ' C ' ' A' ' 91' ' ' LYS . 72.2 m-85 -90.16 151.27 21.65 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.708 -0.849 . . . . 2.15 108.708 170.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.81 135.85 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.517 -0.92 . . . . 2.13 108.517 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.728 ' SG ' HD11 ' A' ' 90' ' ' ILE . 31.9 m -110.29 122.16 47.01 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.418 -0.913 . . . . 0.91 112.046 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.592 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 3.6 t -152.88 117.55 5.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 2.41 110.836 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.549 ' O ' HG23 ' A' ' 104' ' ' ILE . 79.9 mttt 65.27 -46.37 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.208 1.558 . . . . 3.5 115.208 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.732 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 62.33 -32.72 0.1 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 1.74 110.834 -171.603 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 97' ' ' LYS . 18.7 mtmt 65.35 108.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.211 1.004 . . . . 3.53 113.272 165.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 98' ' ' PHE . . . -136.02 -171.84 2.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.749 -1.114 . . . . 1.09 111.487 -174.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.88 26.93 4.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.045 -0.525 . . . . 2.19 110.771 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.756 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 36.0 p90 -142.97 166.06 22.63 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.871 -1.159 . . . . 0.39 107.871 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 39.8 Cg_exo -63.09 122.8 11.16 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.342 2.695 . . . . 0.48 113.297 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.954 HG13 ' HB1' ' A' ' 73' ' ' ALA . 2.4 mp -117.37 142.8 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.513 -0.551 . . . . 1.13 109.513 174.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.71 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 10.3 mmt -116.54 -153.8 0.54 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.288 0.847 . . . . 2.08 113.288 -166.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.72 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . . . -70.47 149.65 46.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.885 -1.052 . . . . 1.11 111.321 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 75' ' ' PRO . 29.3 mttt -82.29 109.77 16.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.026 -1.101 . . . . 2.12 108.026 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.75 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -122.14 162.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 108.736 -0.838 . . . . 1.19 108.736 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 1.042 HD21 ' HA3' ' A' ' 81' ' ' GLY . 15.9 m120 -78.85 70.02 5.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.872 -0.604 . . . . 2.16 110.95 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.671 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -69.68 87.83 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 C-N-CA 118.883 -1.127 . . . . 1.1 108.703 175.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.495 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 0.7 OUTLIER 170.97 179.95 0.05 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.845 -1.168 . . . . 1.98 107.845 175.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.35 -143.03 9.88 Favored Glycine 0 CA--C 1.507 -0.412 0 N-CA-C 115.644 1.018 . . . . 0.78 115.644 153.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -105.41 -10.19 17.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.342 -0.929 . . . . 1.98 110.984 -173.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -95.3 -2.15 49.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 2.1 111.949 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -42.65 134.5 3.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.507 0.928 . . . . 1.17 113.507 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.815 ' HD1' ' HB3' ' A' ' 118' ' ' LEU . 47.6 t-80 -51.29 140.14 24.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.568 -0.742 . . . . 0.51 110.655 171.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 4.0 Cg_endo -47.69 -46.02 22.22 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.918 2.412 . . . . 0.43 112.813 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.815 ' HB3' ' HD1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.68 -40.76 69.43 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.987 -0.552 . . . . 1.69 110.641 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.606 ' HH ' HG21 ' A' ' 40' ' ' ILE . 10.1 m-85 -76.7 -28.65 55.95 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.337 -0.392 . . . . 1.84 111.86 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 53.2 mt-10 -55.48 -42.55 74.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.715 -0.846 . . . . 2.37 108.715 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 71.7 t80 -65.03 -49.69 69.17 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 123.585 0.553 . . . . 1.09 110.627 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.494 ' HE1' HD12 ' A' ' 118' ' ' LEU . 64.5 mtt -62.46 -53.06 60.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.743 0.306 . . . . 1.06 111.263 -177.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -56.64 -43.08 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 1.42 111.218 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 16.7 ptmt -73.87 -34.32 64.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.018 0.437 . . . . 2.63 111.244 -176.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.502 HG22 ' HD2' ' A' ' 150' ' ' PRO . 77.5 m -73.88 -44.1 56.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 1.09 111.394 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -136.96 102.9 9.09 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.842 -0.343 . . . . 2.26 111.627 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.936 ' HB2' ' HB ' ' A' ' 132' ' ' THR . 60.4 Cg_endo -73.58 -19.73 21.25 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.12 2.546 . . . . 1.81 112.138 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.66 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 83.39 -106.84 2.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.135 -0.555 . . . . 2.45 113.672 172.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.676 HG13 ' HG ' ' A' ' 130' ' ' LEU . 26.8 pt -134.36 -176.62 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.369 0.268 . . . . 4.01 110.857 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.676 ' HG ' HG13 ' A' ' 129' ' ' ILE . 36.2 mt 64.67 -151.75 0.28 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.717 0.636 . . . . 2.97 110.165 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.68 86.29 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.663 -0.866 . . . . 3.28 108.663 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.936 ' HB ' ' HB2' ' A' ' 127' ' ' PRO . 31.9 p -67.08 114.46 5.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.251 -0.886 . . . . 4.33 111.787 -171.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -160.68 -55.24 0.05 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.0 0.428 . . . . 5.43 110.143 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -157.46 -161.77 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.609 0.596 . . . . 1.51 112.609 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.771 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.6 mt -90.13 155.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.315 -0.857 . . . . 1.5 109.612 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -173.99 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.935 0.398 . . . . 1.99 111.829 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.771 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -143.37 169.06 18.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.499 -0.318 . . . . 1.1 111.296 -177.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -154.37 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.656 1.583 . . . . 1.8 113.349 176.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 1.003 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 54.6 m-85 -25.17 -49.91 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 115.216 1.561 . . . . 1.68 115.216 -166.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.816 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 10.6 m 32.2 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.839 1.199 . . . . 1.05 113.59 176.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.621 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.79 149.02 26.03 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.026 -0.67 . . . . 1.38 111.265 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.532 ' HE1' HD22 ' A' ' 42' ' ' ASN . 3.5 m-85 -104.0 133.34 49.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.236 -1.024 . . . . 0.53 108.236 166.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.89 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 34.7 tp -81.56 105.15 12.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.922 -0.77 . . . . 1.2 108.922 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.737 HG22 HD12 ' A' ' 15' ' ' ILE . 15.8 mm -104.8 124.98 59.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 1.05 109.151 -174.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.663 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 12.2 p30 -74.13 -178.12 3.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.766 0.317 . . . . 1.3 111.176 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.654 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.2 mtp180 -65.87 -12.78 57.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.426 0.528 . . . . 4.43 112.426 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.915 ' HB3' HH21 ' A' ' 175' ' ' ARG . 35.1 t0 -110.61 -14.33 14.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.26 0.552 . . . . 1.18 109.966 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.488 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 106.88 31.03 4.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.388 -0.824 . . . . 0.25 113.034 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.663 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 89.9 t -112.56 129.5 24.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 117.209 0.504 . . . . 1.32 110.225 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.502 ' HD2' HG22 ' A' ' 125' ' ' THR . 7.9 Cg_exo -70.88 118.29 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.627 2.218 . . . . 0.46 111.725 178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.69 -26.07 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 1.09 110.825 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -157.75 165.7 34.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.095 -0.502 . . . . 1.22 110.135 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.66 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 18.0 ttm180 -134.97 116.98 15.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.941 -0.392 . . . . 2.25 109.941 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.89 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 3.4 m-85 -101.93 116.63 33.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.992 -0.744 . . . . 0.38 108.992 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.802 ' HA ' HG21 ' A' ' 140' ' ' THR . 97.7 p -64.5 164.8 17.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.494 0.588 . . . . 1.49 109.518 176.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.816 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 35.3 Cg_endo -64.76 -9.04 19.47 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.94 2.427 . . . . 0.74 113.17 -164.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -93.62 24.13 27.28 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.491 -0.777 . . . . 0.56 112.051 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.74 30.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 1.14 110.635 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.2 m -81.54 158.76 24.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.753 -0.658 . . . . 1.64 110.71 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.541 ' HA ' HG21 ' A' ' 56' ' ' THR . 21.5 t -49.56 -50.6 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.388 0.613 . . . . 1.14 109.919 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 161' ' ' LYS . 6.2 ttpp -59.92 -40.43 88.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.656 -1.157 . . . . 3.84 111.038 -177.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -63.52 -30.48 71.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.126 -0.943 . . . . 1.86 110.454 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.541 HG22 HD23 ' A' ' 39' ' ' LEU . 61.4 mt -82.63 -43.6 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.954 -0.566 . . . . 1.05 110.887 175.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.5 mt-10 -56.13 -38.84 71.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.88 112.108 -175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.4 pt-20 -62.33 -19.33 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 0.75 112.058 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -106.32 -17.25 14.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.289 0.566 . . . . 2.11 110.019 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.7 tp -94.11 -44.01 8.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 1.06 111.909 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.652 ' HA ' HD12 ' A' ' 171' ' ' LEU . 63.4 mt -51.79 -47.26 91.02 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.846 0.684 . . . . 1.14 112.846 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.461 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.2 Cg_exo -54.29 -39.59 86.18 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.987 1.792 . . . . 0.74 112.823 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.74 -34.55 58.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.503 -0.317 . . . . 1.35 111.801 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 1.003 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 14.2 mt -54.85 -54.73 38.58 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.463 0.649 . . . . 1.16 109.554 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -56.0 -51.87 52.74 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.221 -1.354 . . . . 1.52 113.266 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 p -165.11 131.2 2.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.409 0.605 . . . . 2.89 111.976 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.572 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -93.99 -29.9 15.0 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.606 0.717 . . . . 3.56 110.118 174.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.915 HH21 ' HB3' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -178.6 -24.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.531 -1.655 . . . . 8.59 106.531 -179.197 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 N--CA 1.442 -0.849 0 CA-C-N 113.448 -1.706 . . . . 5.3 106.682 167.535 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 121.03 0.443 . . . . 1.68 109.937 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.5 p -132.0 -179.47 5.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.905 -0.589 . . . . 0.65 109.899 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.768 HD13 HG21 ' A' ' 144' ' ' ILE . 23.6 pt -65.75 -28.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.073 0.463 . . . . 0.3 111.198 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.816 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 38.3 m-85 -78.81 -1.06 33.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.863 0.363 . . . . 0.27 111.618 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.06 -11.87 60.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.219 -0.66 . . . . 1.96 109.219 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 62.0 m-85 -110.68 160.18 16.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.081 -0.963 . . . . 0.4 109.541 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.31 149.62 27.61 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.216 -0.291 . . . . 2.77 110.216 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.545 HG23 HD13 ' A' ' 30' ' ' LEU . 70.3 t -114.91 147.5 18.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.149 0.499 . . . . 0.74 112.257 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.971 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 75.8 mt -100.92 132.36 46.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.854 -0.612 . . . . 0.72 109.875 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -65.69 177.32 1.27 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.824 -1.08 . . . . 1.59 109.858 176.301 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -46.51 -37.57 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.496 0.319 . . . . 0.52 111.743 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.45 21.31 17.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.864 0.32 . . . . 2.22 111.864 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.971 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 39.1 m-70 68.23 16.43 9.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.113 0.565 . . . . 0.73 110.759 172.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.818 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -76.76 146.88 77.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 106.059 -1.83 . . . . 3.25 106.059 167.379 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.08 113.5 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 120.672 0.915 . . . . 0.86 111.806 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.457 ' HB3' HG12 ' A' ' 20' ' ' VAL . 68.3 t80 -86.97 117.57 25.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.532 -0.758 . . . . 0.28 110.866 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.46 82.75 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.716 -0.675 . . . . 1.65 109.767 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.816 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.46 -33.09 70.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.445 0.64 . . . . 0.25 110.469 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.748 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.0 p -76.73 -1.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.248 -0.887 . . . . 0.41 112.811 -168.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 24.1 pt20 -81.45 -5.64 58.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 1.24 109.349 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -92.94 -3.79 53.9 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.317 -0.994 . . . . 0.38 108.317 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 34.8 ttpt -74.15 146.45 43.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.879 -1.055 . . . . 1.73 109.827 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.81 -13.67 65.89 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.964 -1.254 . . . . 0.36 109.964 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.657 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 6.0 m -130.91 145.42 57.67 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 114.538 -0.831 . . . . 1.14 108.766 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.98 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -74.84 151.91 40.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.02 1.814 . . . . 0.52 110.664 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -154.61 154.03 32.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.142 0.496 . . . . 1.03 111.161 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.86 HD21 HG21 ' A' ' 163' ' ' ILE . 6.8 mp -107.47 154.17 21.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.094 -0.706 . . . . 1.1 109.094 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 85.1 mt -141.0 115.34 5.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.205 -0.665 . . . . 0.2 109.205 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.585 ' HD2' ' HB2' ' A' ' 139' ' ' PHE . 3.9 m-85 -102.04 123.38 45.83 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 121.059 -0.256 . . . . 0.23 111.334 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.775 HD21 ' HB ' ' A' ' 140' ' ' THR . 1.0 OUTLIER -81.88 90.11 6.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.07 -1.085 . . . . 1.28 108.07 167.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 8.3 p -119.1 141.78 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.163 0.801 . . . . 0.88 113.163 -162.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.9 108.98 3.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.926 -1.139 . . . . 0.52 107.926 170.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.983 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 29.8 t -73.88 80.81 1.64 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.857 -0.61 . . . . 1.84 112.216 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 98' ' ' PHE . 37.6 ttmt 67.25 55.6 0.66 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.935 -1.029 . . . . 2.43 111.348 174.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -139.05 118.7 13.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.092 -0.504 . . . . 0.99 109.941 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 -93.67 1.24 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.655 -0.783 . . . . 1.09 112.131 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.37 151.91 17.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 3.16 111.301 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.2 p -119.83 141.96 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.891 -0.781 . . . . 1.94 108.891 169.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 156' ' ' PRO . 33.4 ttmt -77.51 44.12 0.42 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.335 0.588 . . . . 2.03 110.794 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 28.37 13.07 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.744 -0.662 . . . . 0.47 112.271 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 139' ' ' PHE . . . -80.8 -48.73 6.02 Favored Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.879 -0.676 . . . . 0.34 112.28 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -55.84 -50.69 69.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.79 0.329 . . . . 0.57 110.387 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -60.21 -53.2 60.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.091 -0.504 . . . . 2.46 111.203 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.4 m -57.94 -47.06 84.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 122.728 0.411 . . . . 0.33 110.932 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.689 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.66 -49.25 77.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.46 . . . . 0.19 111.195 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -61.03 -47.17 87.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.163 0.506 . . . . 0.3 110.516 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -59.48 -49.8 76.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.362 -0.835 . . . . 1.08 111.172 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -61.13 -44.48 97.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.033 -0.53 . . . . 0.81 110.964 -175.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.788 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 67.8 t80 -53.15 -57.1 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 123.492 0.495 . . . . 0.33 110.476 176.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -68.52 -39.2 81.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.336 -0.393 . . . . 1.76 111.369 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -70.82 -45.18 65.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 1.79 111.66 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.603 ' CD1' HD13 ' A' ' 171' ' ' LEU . 61.2 m-85 -101.53 6.67 42.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.332 0.864 . . . . 0.43 113.332 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -62.33 -19.79 63.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.63 0.252 . . . . 2.11 110.918 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.4 m -66.85 -38.06 85.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 1.2 111.246 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -88.85 4.63 47.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 1.9 110.66 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 82.44 71.61 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.892 -0.671 . . . . 1.32 111.514 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 76.8 t80 -133.04 138.64 46.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.612 0.244 . . . . 0.26 110.436 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -126.82 142.91 51.41 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.93 0.395 . . . . 0.51 110.04 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.788 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.6 t -110.77 118.64 57.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 O-C-N 122.188 -0.32 . . . . 0.24 110.27 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 21.4 mt -105.34 122.92 46.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.91 -0.774 . . . . 0.51 108.91 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.886 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.82 112.74 24.96 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.006 -0.677 . . . . 0.28 110.591 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.609 ' CE1' ' HG2' ' A' ' 105' ' ' MET . 1.8 m-85 -93.29 112.59 57.07 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.116 -1.068 . . . . 0.34 108.116 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.022 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.7 Cg_exo -60.03 167.2 7.62 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.025 2.483 . . . . 0.73 111.235 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.433 -1.275 0 C-N-CA 119.435 -0.906 . . . . 1.54 111.738 -178.129 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 31.1 m . . . . . 0 CA--C 1.506 -0.737 0 CA-C-O 120.9 0.381 . . . . 0.91 110.453 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.459 ' CG2' ' HE3' ' A' ' 97' ' ' LYS . 28.3 m -153.26 116.57 4.63 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.755 -0.657 . . . . 1.92 109.906 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.5 OUTLIER 13.27 97.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.824 1.328 . . . . 3.18 114.323 -173.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.672 ' HZ ' ' HZ ' ' A' ' 102' ' ' PHE . 23.7 p90 -64.03 -21.3 66.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.107 -0.497 . . . . 1.74 110.73 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 66.94 150.07 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.998 0.811 . . . . 3.08 111.613 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . . . -171.29 -165.65 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.589 -0.278 . . . . 0.43 111.483 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -82.77 -4.73 58.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.367 0.603 . . . . 2.19 110.386 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.672 ' HZ ' ' HZ ' ' A' ' 98' ' ' PHE . 53.1 p90 -121.68 163.16 32.64 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.428 -0.953 . . . . 0.24 108.428 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 27.3 Cg_exo -67.71 117.47 4.9 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 123.195 2.597 . . . . 0.31 113.206 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.886 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.9 mp -105.57 138.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.131 -0.692 . . . . 0.37 109.131 171.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.609 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -103.24 -162.26 0.9 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.319 0.859 . . . . 1.47 113.319 -163.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.16 41.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.158 -0.928 . . . . 0.39 109.948 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.022 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 14.0 pttt -70.25 126.09 28.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.735 -0.786 . . . . 1.66 109.876 172.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.415 HG13 HG13 ' A' ' 110' ' ' VAL . 4.9 pt -124.64 161.39 28.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.707 -1.133 . . . . 0.47 108.307 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.67 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 15.1 t-20 -79.35 88.25 4.98 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.845 -0.798 . . . . 2.16 108.845 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.657 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -74.28 85.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 119.315 -0.954 . . . . 0.38 108.86 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 9.6 t-20 171.84 -178.88 0.06 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.806 -0.813 . . . . 1.98 108.806 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.96 -142.15 42.18 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 115.116 0.806 . . . . 0.78 115.116 156.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.87 -16.69 15.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.501 -0.85 . . . . 1.98 109.612 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -91.62 1.84 56.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.856 -1.066 . . . . 2.04 110.613 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -60.89 140.58 57.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.252 -0.885 . . . . 0.48 111.861 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.6 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 33.2 t-80 -50.29 132.48 24.78 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.25 -0.886 . . . . 0.42 108.792 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.21 -33.27 53.9 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.429 2.753 . . . . 0.36 112.457 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.6 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 19.4 tp -62.99 -41.12 99.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 1.1 111.056 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.431 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.7 m-85 -74.83 -30.39 61.37 Favored 'General case' 0 C--O 1.21 -0.99 0 N-CA-C 110.378 -0.23 . . . . 1.49 110.378 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.86 -33.89 70.98 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.058 -0.657 . . . . 2.37 109.868 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.599 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 66.9 t80 -71.69 -52.46 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.357 0.411 . . . . 0.58 110.536 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.582 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.8 mtt -56.99 -51.91 67.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 0.34 111.333 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.533 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 35.4 mtpt -58.15 -50.62 72.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.817 -0.629 . . . . 0.94 110.652 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.21 -30.2 71.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.664 0.269 . . . . 2.13 111.283 -177.106 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.549 HG21 ' HD2' ' A' ' 150' ' ' PRO . 87.1 m -72.54 -52.51 15.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.366 -0.379 . . . . 0.47 111.727 -176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.48 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 8.0 mmtt . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 112.869 0.692 . . . . 1.75 112.869 -171.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.958 0.409 . . . . 0.93 111.519 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.858 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 37.6 mt -99.15 106.17 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.787 -0.642 . . . . 1.05 110.423 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 136' ' ' LYS . 9.9 ptpt -131.98 21.29 4.53 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.631 0.604 . . . . 1.5 112.631 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.858 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.2 174.44 15.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.068 0.396 . . . . 0.87 112.068 -175.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 78.9 m-20 -46.66 -161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.422 1.489 . . . . 1.8 114.575 173.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.812 ' CZ ' ' HA ' ' A' ' 156' ' ' PRO . 44.7 p90 -34.37 -46.49 0.27 Allowed 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 113.145 -1.843 . . . . 1.37 115.346 -164.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.775 ' HB ' HD21 ' A' ' 42' ' ' ASN . 22.4 m 37.78 94.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.36 0.874 . . . . 0.3 113.36 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.0 p -85.63 146.64 26.77 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.183 -0.607 . . . . 0.8 110.345 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.7 m-85 -102.17 133.4 47.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.407 -0.961 . . . . 0.53 108.407 169.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.912 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.87 104.66 12.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.095 -0.705 . . . . 0.51 109.095 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.768 HG21 HD13 ' A' ' 15' ' ' ILE . 12.7 mm -102.44 128.51 55.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.086 -0.709 . . . . 0.2 109.086 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 147' ' ' ASP . 0.5 OUTLIER -82.31 -174.59 5.22 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.028 -0.269 . . . . 1.3 111.274 -175.135 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.464 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 43.9 mtt180 -63.3 -12.51 30.11 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.378 0.51 . . . . 3.78 112.378 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.436 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 21.2 t70 -108.86 -19.24 13.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.374 0.607 . . . . 1.18 109.741 -171.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 102.37 26.87 7.11 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.199 -0.909 . . . . 0.23 112.36 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.1 t -106.44 126.33 30.7 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.732 -0.47 . . . . 0.62 109.732 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' A' ' 125' ' ' THR . 10.5 Cg_exo -67.56 111.35 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.342 2.028 . . . . 0.3 111.361 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.48 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 39.2 t -91.41 -25.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.017 -0.538 . . . . 0.27 110.504 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -152.37 163.6 39.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 1.22 111.226 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.533 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 11.9 ttm180 -131.01 102.62 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.618 -0.719 . . . . 1.75 109.247 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.912 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.9 m-85 -92.22 109.8 21.18 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.267 -0.642 . . . . 0.38 109.267 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.916 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 81.2 p -67.5 -178.65 0.38 Allowed Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.763 -0.458 . . . . 0.99 109.763 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.916 ' HD2' ' HB2' ' A' ' 155' ' ' SER . 30.8 Cg_endo -63.92 10.99 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.138 1.892 . . . . 0.66 113.227 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 155' ' ' SER . . . -99.16 -9.46 51.47 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.06 -0.591 . . . . 0.52 111.877 -177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 154' ' ' PHE . . . -96.16 134.7 38.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 0.43 111.067 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.7 m -95.23 -174.02 3.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 1.25 110.265 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.704 HG13 HD21 ' A' ' 60' ' ' LEU . 77.5 t -51.38 -55.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 0.41 111.923 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -72.88 -26.0 61.29 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.606 -0.27 . . . . 3.44 111.126 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -34.45 72.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.644 -0.502 . . . . 1.86 109.644 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.86 HG21 HD21 ' A' ' 39' ' ' LEU . 61.8 mt -82.73 -38.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.608 -0.724 . . . . 0.21 110.762 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.1 mt-10 -56.22 -41.13 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.278 0.474 . . . . 0.88 112.278 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.575 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.9 pt-20 -57.21 -26.65 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.75 111.703 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.4 mmtp -102.51 -18.45 15.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.841 0.353 . . . . 1.58 110.751 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.664 ' HG ' HD11 ' A' ' 171' ' ' LEU . 60.4 tp -92.31 -45.66 8.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.901 -0.59 . . . . 0.24 112.043 -171.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.716 ' HA ' HD12 ' A' ' 171' ' ' LEU . 66.6 mt -49.73 -49.87 70.59 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 112.999 0.74 . . . . 0.44 112.999 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.9 Cg_exo -55.38 -39.44 91.0 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.116 1.878 . . . . 0.49 112.701 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.0 -40.16 63.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.511 -0.313 . . . . 0.71 110.975 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.98 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 18.6 mt -55.8 -48.4 75.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.296 0.57 . . . . 0.46 109.578 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.82 -69.82 1.05 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.585 -1.188 . . . . 1.52 111.621 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.331 -0.202 0 N-CA-C 109.78 -0.452 . . . . 2.52 109.78 177.234 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.066 0.46 . . . . 1.68 110.613 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.5 p -157.53 -174.61 4.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.493 -0.776 . . . . 0.65 109.184 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.798 HD13 HG21 ' A' ' 144' ' ' ILE . 27.9 pt -64.2 -25.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.48 . . . . 0.3 110.649 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.796 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.3 m-85 -81.94 5.55 18.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.27 111.202 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.94 -19.67 60.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.259 -1.015 . . . . 1.96 108.259 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 73.8 m-85 -107.86 175.67 5.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.869 -1.059 . . . . 0.4 111.263 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -112.62 138.8 48.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 2.77 110.382 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.56 HG23 HD13 ' A' ' 30' ' ' LEU . 77.4 t -115.04 144.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.093 0.473 . . . . 0.74 111.514 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.999 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 91.0 mt -104.32 133.23 49.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.545 -0.752 . . . . 0.72 109.546 173.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.53 -176.43 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.672 -0.862 . . . . 1.59 108.672 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.763 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -53.96 -35.45 61.79 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.165 0.507 . . . . 0.52 111.624 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -92.96 3.13 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 2.22 111.528 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.999 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 33.6 m-70 74.43 17.59 3.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.414 0.626 . . . . 0.73 109.972 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 12.8 mtmt -69.89 151.85 96.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.149 -1.797 . . . . 3.25 106.149 163.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.98 113.74 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 CA-C-N 120.168 1.096 . . . . 0.86 110.848 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.544 ' HB3' HG12 ' A' ' 20' ' ' VAL . 65.4 t80 -82.5 120.73 25.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.635 . . . . 0.28 110.232 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.9 t-20 -69.9 85.44 0.5 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.869 -0.605 . . . . 1.65 109.786 176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.796 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -73.4 -32.35 64.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.262 0.553 . . . . 0.25 110.544 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.737 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.3 p -77.19 -0.68 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.522 -0.763 . . . . 0.41 112.686 -168.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 13.7 pt20 -78.77 -6.62 56.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.574 0.702 . . . . 1.24 109.376 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -96.99 3.81 51.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.96 -1.018 . . . . 0.38 108.314 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 22.1 ttpt -81.2 146.63 30.39 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.723 -1.126 . . . . 1.73 109.298 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.11 -2.1 86.77 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.228 -1.149 . . . . 0.36 110.228 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 13.6 m -140.56 152.31 65.94 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 1.14 108.747 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.99 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 74.3 Cg_endo -82.52 154.78 16.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.826 1.684 . . . . 0.52 111.576 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.671 ' CB ' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -156.98 150.57 24.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.164 0.507 . . . . 1.03 111.749 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.659 HD23 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.86 151.49 25.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.376 -0.972 . . . . 1.1 108.376 172.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 86.5 mt -140.55 115.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.84 -0.43 . . . . 0.2 109.84 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.761 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 29.8 m-85 -103.02 124.74 49.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.609 0.226 . . . . 0.23 111.609 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.607 ' CB ' HG11 ' A' ' 110' ' ' VAL . 1.6 p30 -80.44 93.26 5.98 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.246 -0.65 . . . . 1.28 109.246 167.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.828 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 15.2 m -105.06 150.08 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 114.095 1.146 . . . . 0.88 114.095 -158.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 102.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.683 -1.599 . . . . 0.52 106.683 163.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.497 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -76.07 81.17 2.91 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 113.879 1.066 . . . . 1.84 113.879 -163.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 84.4 tttt 76.18 31.97 0.63 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.558 -0.746 . . . . 2.43 111.488 169.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.28 132.34 16.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.507 -0.477 . . . . 0.99 111.488 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -92.69 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.688 -0.687 . . . . 1.09 114.734 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.438 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 66.8 m-85 -110.98 153.77 25.08 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.999 0.37 . . . . 3.16 111.999 -167.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.9 p -137.24 -38.67 0.61 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.778 0.659 . . . . 1.94 112.778 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 69.47 -12.88 0.41 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.432 0.693 . . . . 2.03 112.791 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.01 12.08 14.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.942 -0.647 . . . . 0.47 112.478 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.84 -31.7 61.98 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.156 -0.545 . . . . 0.34 112.051 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.694 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -68.72 -52.05 34.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.534 0.206 . . . . 0.57 110.504 -177.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.95 -47.06 78.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.431 0.634 . . . . 2.46 110.397 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.48 HG23 ' HA ' ' A' ' 160' ' ' VAL . 85.5 m -63.03 -47.53 82.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.818 -1.083 . . . . 0.33 110.719 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.817 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -62.16 -50.43 71.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.19 111.651 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.67 HG23 ' HG2' ' A' ' 101' ' ' GLU . 24.5 m -56.1 -45.55 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.3 110.792 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.68 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 40.7 m -66.57 -45.98 77.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.08 111.31 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 88.5 mt -58.09 -51.38 69.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.538 0.208 . . . . 0.81 111.188 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.45 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 49.7 t80 -52.5 -52.76 52.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.997 0.811 . . . . 0.33 109.785 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.68 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 3.9 p30 -73.93 -33.35 63.91 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.504 -0.478 . . . . 1.76 111.429 -171.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -76.11 -38.17 57.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.277 -0.419 . . . . 1.79 111.309 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.674 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.9 m-85 -109.07 8.91 26.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.071 0.767 . . . . 0.43 113.071 -174.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -22.53 64.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.861 0.363 . . . . 2.11 110.226 173.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -62.12 -37.93 87.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 1.2 110.785 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.44 5.57 38.23 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.908 0.385 . . . . 1.9 110.923 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.35 25.09 34.46 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.99 -0.624 . . . . 1.32 112.289 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.659 ' CE1' HD23 ' A' ' 39' ' ' LEU . 75.7 t80 -85.05 143.72 28.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.775 0.321 . . . . 0.26 110.913 -174.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.671 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -131.03 146.32 52.34 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.062 0.458 . . . . 0.51 110.183 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.817 HG11 ' HB1' ' A' ' 57' ' ' ALA . 37.4 t -116.52 114.71 46.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.19 -0.459 . . . . 0.24 109.84 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.1 mt -100.23 122.78 43.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.103 -0.702 . . . . 0.51 109.103 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.63 116.74 32.3 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.22 -0.592 . . . . 0.28 110.731 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.8 m-85 -99.11 109.43 54.21 Favored Pre-proline 0 C--N 1.31 -1.134 0 CA-C-N 115.789 -0.641 . . . . 0.34 109.611 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.794 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 75.1 Cg_exo -50.37 160.61 1.48 Allowed 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 124.185 3.256 . . . . 0.73 113.568 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.433 -1.307 0 CA-C-O 122.65 1.214 . . . . 1.54 111.227 171.988 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.437 -1.112 0 CA-C-O 121.184 0.516 . . . . 0.91 110.111 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -154.56 120.36 5.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.336 -0.847 . . . . 1.92 109.761 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.763 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 7.7 pttt 33.36 77.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.333 1.021 . . . . 3.18 113.271 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 1.6 p90 -57.9 135.41 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.062 -1.458 . . . . 1.74 107.062 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.502 ' HE2' ' HG3' ' A' ' 97' ' ' LYS . 70.0 mmtt -102.46 122.88 45.19 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.858 -0.737 . . . . 3.08 112.011 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.5 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . . . -125.11 -162.22 1.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.053 -0.976 . . . . 0.43 110.517 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.67 ' HG2' HG23 ' A' ' 58' ' ' THR . 7.4 pt-20 -90.64 -11.25 40.43 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.068 -0.653 . . . . 2.19 110.129 175.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.747 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.0 p90 -103.15 167.86 9.61 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.225 -0.898 . . . . 0.24 108.889 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.811 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.1 Cg_exo -71.95 120.9 7.15 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.749 2.966 . . . . 0.31 113.348 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.997 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.8 mp -113.71 140.15 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.341 -0.614 . . . . 0.37 109.341 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.811 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 11.4 mmt -110.79 -151.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.107 0.78 . . . . 1.47 113.107 -164.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -79.64 143.84 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.855 -1.066 . . . . 0.39 110.738 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.794 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 21.4 pttt -78.67 137.74 37.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 1.66 109.995 172.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.45 HD11 ' CE1' ' A' ' 119' ' ' TYR . 3.8 pt -143.66 158.04 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.357 -1.349 . . . . 0.47 107.357 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.794 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -73.9 91.45 1.99 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.269 -0.572 . . . . 2.16 109.754 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.607 HG11 ' CB ' ' A' ' 42' ' ' ASN . 1.3 m -82.55 84.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 119.18 -1.008 . . . . 0.38 108.943 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 20.1 t-20 171.93 179.23 0.07 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.09 -1.078 . . . . 1.98 108.09 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.49 -149.09 19.81 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 116.024 1.17 . . . . 0.78 116.024 153.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 1.5 28.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.886 -1.157 . . . . 1.98 110.029 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.44 ' HB3' ' OD1' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -108.6 2.83 22.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.917 -1.038 . . . . 2.04 109.559 -171.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.794 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -58.25 139.87 54.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.117 -0.947 . . . . 0.48 112.618 -177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.601 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 38.9 t-80 -48.32 133.52 12.83 Favored Pre-proline 0 C--O 1.226 -0.135 0 N-CA-C 109.012 -0.736 . . . . 0.42 109.012 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.19 -33.17 63.32 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.37 2.713 . . . . 0.36 112.829 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.601 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 18.2 tp -65.72 -37.0 85.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 1.1 111.042 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.529 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 8.1 m-85 -75.55 -29.56 59.43 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.572 -0.285 . . . . 1.49 110.668 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.81 -40.2 79.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.883 -0.784 . . . . 2.37 108.883 167.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 77.7 t80 -68.08 -47.76 67.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.58 110.53 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.57 ' HE3' HD11 ' A' ' 118' ' ' LEU . 67.0 mtt -62.85 -55.03 29.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.097 -0.501 . . . . 0.34 111.136 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -57.54 -43.15 84.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.201 -0.454 . . . . 0.94 111.474 -176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -69.58 -39.73 77.13 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.479 -0.328 . . . . 2.13 111.009 -176.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.532 HG21 ' HD2' ' A' ' 150' ' ' PRO . 52.3 m -69.73 -33.9 73.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.118 -0.492 . . . . 0.47 111.448 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.595 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.3 tmtt? . . . . . 0 C--N 1.323 -0.557 0 C-N-CA 120.702 -0.399 . . . . 1.75 111.317 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.132 0.492 . . . . 0.93 111.327 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.826 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 63.8 mt -105.83 110.96 33.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.221 -0.9 . . . . 1.05 110.791 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -139.06 42.06 2.09 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.407 0.891 . . . . 1.5 113.407 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.826 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -156.4 174.82 14.85 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.458 0.703 . . . . 0.87 110.699 176.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 17.0 m120 -47.9 -158.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.735 1.214 . . . . 1.8 113.596 167.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.828 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 7.3 m-85 -30.66 -58.71 0.21 Allowed 'General case' 0 C--O 1.204 -1.295 0 C-N-CA 125.416 1.486 . . . . 1.37 114.35 -166.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.798 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 21.5 m 48.51 104.68 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.575 0.954 . . . . 0.3 113.575 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.761 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.9 t -96.35 149.52 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.012 -0.675 . . . . 0.8 111.26 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.2 m-85 -104.48 131.96 51.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.218 -0.66 . . . . 0.53 109.218 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.866 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.1 tp -81.03 106.07 12.74 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.157 -0.683 . . . . 0.51 109.157 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.798 HG21 HD13 ' A' ' 15' ' ' ILE . 12.2 mm -106.36 124.0 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 108.911 -0.774 . . . . 0.2 108.911 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.454 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 39.2 p30 -75.34 -177.72 3.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.135 -0.484 . . . . 1.3 111.404 -175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 36' ' ' SER . 75.3 mtp180 -70.92 -1.17 11.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 3.78 111.897 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.25 -19.16 12.33 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.597 0.713 . . . . 1.18 109.45 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 103.77 27.76 6.22 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.913 -1.04 . . . . 0.23 112.126 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.479 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 84.2 t -109.62 129.64 23.69 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.651 -0.323 . . . . 0.62 110.411 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.532 ' HD2' HG21 ' A' ' 125' ' ' THR . 6.9 Cg_exo -71.86 114.98 4.12 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.719 2.279 . . . . 0.3 111.573 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.595 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.7 t -100.24 -21.61 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.596 . . . . 0.27 110.562 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.0 mm-40 -152.64 164.54 37.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.155 -0.475 . . . . 1.22 110.364 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.439 HH11 ' HG2' ' A' ' 153' ' ' ARG . 34.4 ttp85 -139.53 102.32 4.43 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.115 -0.698 . . . . 1.75 109.115 169.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.866 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 14.4 m-85 -90.92 109.24 20.46 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.23 -0.656 . . . . 0.38 109.23 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.76 ' HA ' HG23 ' A' ' 140' ' ' THR . 5.0 p -63.43 164.98 12.65 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 109.153 -0.684 . . . . 0.99 109.153 175.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.798 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 61.0 Cg_endo -68.24 -4.45 12.76 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.65 2.234 . . . . 0.66 112.944 -163.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.83 -10.3 76.11 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.021 -0.991 . . . . 0.52 111.831 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.35 139.5 36.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.461 -0.57 . . . . 0.43 109.461 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.1 m -95.09 178.65 5.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.346 -0.388 . . . . 1.25 111.102 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 62.7 t -54.58 -48.62 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 0.41 110.968 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -29.42 69.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.782 -0.645 . . . . 3.44 110.727 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.32 -34.31 77.1 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.451 -0.795 . . . . 1.86 110.125 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.569 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 53.5 mt -81.26 -41.27 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 0.21 110.74 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 50.8 mt-10 -58.2 -38.83 77.53 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.035 0.383 . . . . 0.88 112.035 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.566 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 11.6 pt-20 -59.93 -18.53 45.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 0.75 111.594 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.615 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.6 mmtp -111.15 -17.76 13.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.078 0.466 . . . . 1.58 110.509 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.5 tp -92.44 -39.43 11.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.77 -0.65 . . . . 0.24 111.96 -172.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.82 ' HA ' HD12 ' A' ' 171' ' ' LEU . 76.7 mt -49.96 -51.24 63.14 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.663 0.616 . . . . 0.44 112.663 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.9 Cg_endo -55.71 -38.76 93.95 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.121 1.881 . . . . 0.49 112.246 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.62 -35.74 65.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 0.71 110.969 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.99 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 22.0 mt -57.12 -57.61 11.84 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.368 0.604 . . . . 0.46 109.646 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -50.35 -62.73 4.88 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.286 -1.324 . . . . 1.52 112.201 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 2.52 110.285 177.83 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.413 0.625 . . . . 1.68 110.324 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.0 p -150.29 174.95 12.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 0.65 108.573 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.675 HD13 HG21 ' A' ' 144' ' ' ILE . 24.3 pt -62.28 -27.04 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.913 0.387 . . . . 0.3 111.427 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.866 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 34.7 m-85 -80.34 7.99 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.27 111.125 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.05 -16.28 60.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.231 -1.026 . . . . 1.96 108.231 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 71.9 m-85 -111.73 155.14 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.677 -1.147 . . . . 0.4 111.211 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -100.95 144.31 30.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.529 -0.545 . . . . 2.77 109.529 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.574 HG23 ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -125.93 167.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.74 110.493 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.007 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 93.6 mt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.292 -0.413 . . . . 0.72 110.245 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.52 -172.9 2.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.177 -0.675 . . . . 1.59 109.177 176.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.688 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -54.0 -30.96 49.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.828 0.347 . . . . 0.52 111.304 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 18.8 t70 -89.56 -16.38 30.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 2.22 111.469 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 1.007 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 15.3 m-70 83.74 25.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.998 0.919 . . . . 0.73 109.68 -175.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.782 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 mmpt? -84.67 146.51 46.82 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 105.515 -2.032 . . . . 3.25 105.515 164.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.92 113.08 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 119.722 0.936 . . . . 0.86 111.292 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.574 ' HB3' HG23 ' A' ' 20' ' ' VAL . 89.3 t80 -79.63 120.86 24.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.542 -0.753 . . . . 0.28 109.816 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.577 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -67.84 84.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.477 -0.783 . . . . 1.65 109.728 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.866 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -72.74 -35.12 67.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.525 0.679 . . . . 0.25 110.142 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.741 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.5 p -76.55 -1.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 0.41 112.919 -167.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 24.7 pt20 -82.4 -5.1 58.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.303 0.573 . . . . 1.24 109.669 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.419 ' CG ' HG21 ' A' ' 70' ' ' THR . 88.1 m-70 -92.54 -8.55 44.11 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.95 -1.13 . . . . 0.38 107.95 177.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 36.4 ttpt -71.86 133.88 45.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.235 -0.893 . . . . 1.73 109.341 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 -1.25 57.65 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 109.862 -1.295 . . . . 0.36 109.862 -168.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 33.6 m -142.21 124.97 9.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.518 -0.841 . . . . 1.14 108.879 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.84 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 14.6 Cg_endo -59.0 147.86 88.03 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.58 1.52 . . . . 0.52 110.755 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.553 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -150.68 151.29 32.24 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.243 0.544 . . . . 1.03 111.506 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.755 HD21 HG21 ' A' ' 163' ' ' ILE . 7.1 mp -108.51 152.14 25.13 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.69 -0.686 . . . . 1.1 109.266 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 72.6 mt -140.98 118.77 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 110.147 -0.316 . . . . 0.2 110.147 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.832 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 20.6 m-85 -105.11 124.27 49.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.426 0.155 . . . . 0.23 111.324 -173.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.582 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.3 p30 -81.0 91.67 6.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.841 -1.17 . . . . 1.28 107.841 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.592 HG11 ' HE1' ' A' ' 98' ' ' PHE . 2.4 p -109.05 135.41 48.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 113.288 0.848 . . . . 0.88 113.288 -162.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.63 107.89 0.75 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.766 -1.198 . . . . 0.52 107.766 170.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 1.031 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -71.62 84.67 0.87 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.775 -1.102 . . . . 1.84 113.0 -165.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.0 tmtp? 60.44 53.56 4.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.631 -0.713 . . . . 2.43 110.733 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 p -163.69 136.56 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.757 -0.656 . . . . 0.99 110.43 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.78 -113.57 4.38 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.626 -0.797 . . . . 1.09 112.561 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 169.26 17.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.097 0.475 . . . . 3.16 111.736 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.664 HG22 ' HE1' ' A' ' 139' ' ' PHE . 40.0 p -126.07 139.65 53.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.432 -0.804 . . . . 1.94 109.41 171.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 27.7 mtpp -106.16 18.87 21.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 2.03 111.09 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.63 13.34 32.7 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.822 -0.704 . . . . 0.47 111.709 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 -43.22 16.53 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.866 -0.494 . . . . 0.34 111.866 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.606 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.2 t80 -68.05 -49.14 63.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 0.57 110.331 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -54.82 -55.14 33.44 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.88 -0.6 . . . . 2.46 110.486 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 160' ' ' VAL . 93.4 m -62.61 -46.96 85.85 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.009 -0.996 . . . . 0.33 111.287 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.89 -49.29 78.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.858 0.361 . . . . 0.19 111.152 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.9 m -59.6 -50.58 73.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.721 -0.672 . . . . 0.3 110.749 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 p -65.7 -37.68 87.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 1.08 112.045 -175.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 84.5 mt -61.55 -52.4 64.62 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 121.158 -0.217 . . . . 0.81 110.951 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.639 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 53.1 t80 -51.89 -51.82 54.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.777 -0.823 . . . . 0.33 108.777 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.47 -30.32 68.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.304 -0.862 . . . . 1.76 112.036 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -86.06 -39.68 16.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.598 0.222 . . . . 1.79 111.598 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.647 ' CD1' HD13 ' A' ' 171' ' ' LEU . 60.5 m-85 -108.35 9.91 27.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.485 1.291 . . . . 0.43 114.485 -170.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 18.3 mtmm -59.34 -26.81 65.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.941 -0.704 . . . . 2.11 110.061 170.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 m -60.5 -30.21 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.593 -0.73 . . . . 1.2 111.627 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -104.44 12.98 32.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 1.9 111.206 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.47 65.58 1.66 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.592 -0.813 . . . . 1.32 112.299 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 65.5 t80 -129.03 137.72 51.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.75 0.31 . . . . 0.26 110.639 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -129.17 143.06 50.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 120.928 0.394 . . . . 0.51 110.746 177.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.709 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 29.9 t -114.31 120.95 65.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.935 0.398 . . . . 0.24 110.621 171.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 20.0 mt -105.69 122.87 46.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.297 -0.631 . . . . 0.51 109.297 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.057 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -111.53 116.19 30.45 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.298 -0.561 . . . . 0.28 110.904 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.581 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.1 m-85 -100.06 110.04 58.23 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.018 -0.734 . . . . 0.34 109.018 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.031 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 53.2 Cg_exo -54.67 165.81 2.28 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 123.606 2.871 . . . . 0.73 111.421 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.436 -1.14 0 C-N-CA 118.569 -1.252 . . . . 1.54 113.943 -176.451 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.565 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 83.9 m . . . . . 0 N--CA 1.435 -1.217 0 CA-C-O 121.157 0.503 . . . . 0.91 111.388 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -127.39 157.33 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.279 -0.873 . . . . 1.92 109.331 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.688 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -38.97 111.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.135 0.574 . . . . 3.18 111.33 175.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.606 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 46.4 p90 -64.35 -22.07 66.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.872 -0.604 . . . . 1.74 111.794 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 66.66 146.6 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.79 0.681 . . . . 3.08 111.72 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -166.63 -165.87 0.79 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 0.43 111.371 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.9 1.78 53.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.287 0.565 . . . . 2.19 110.497 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.657 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 51.7 p90 -123.83 165.3 24.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 108.56 -0.904 . . . . 0.24 108.56 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.759 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 29.1 Cg_exo -67.87 120.97 7.97 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.732 2.955 . . . . 0.31 113.256 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.057 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mp -114.93 140.29 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.22 -0.659 . . . . 0.37 109.22 173.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.759 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.3 mmt -115.37 -150.44 0.46 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.046 0.758 . . . . 1.47 113.046 -165.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.98 135.39 43.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.831 -1.077 . . . . 0.39 110.756 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.895 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttp -74.03 116.9 15.2 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.316 -0.994 . . . . 1.66 108.316 167.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.488 HD12 ' CB ' ' A' ' 116' ' ' HIS . 4.8 pt -122.67 175.99 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.615 -1.175 . . . . 0.47 107.986 -174.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.1 m120 -73.33 114.92 12.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.057 -1.09 . . . . 2.16 108.057 169.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -114.49 83.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 118.992 -1.083 . . . . 0.38 108.913 166.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.3 t-20 170.52 179.41 0.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.428 -0.953 . . . . 1.98 108.428 169.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 59.9 -146.22 45.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.78 113.879 165.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.11 -14.28 15.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.654 0.74 . . . . 1.98 109.475 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -86.06 -12.19 50.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.962 -1.017 . . . . 2.04 110.866 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -43.98 149.49 0.32 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.707 1.003 . . . . 0.48 113.707 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.509 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 41.2 t-80 -55.06 133.57 68.15 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 114.847 -1.07 . . . . 0.42 110.507 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 2.5 Cg_endo -46.86 -47.77 15.64 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.917 2.411 . . . . 0.36 112.788 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.509 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.956 -0.565 . . . . 1.1 111.414 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.541 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.0 m-85 -75.42 -29.92 59.9 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 122.24 -0.287 . . . . 1.49 111.077 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 8.9 mm-40 -58.0 -42.21 84.73 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.31 -0.556 . . . . 2.37 109.622 168.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 83.9 t80 -61.59 -52.25 65.19 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.923 0.392 . . . . 0.58 110.483 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.476 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 66.0 mtt -60.05 -50.04 75.29 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.325 0.583 . . . . 0.34 110.752 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 119' ' ' TYR . 2.9 ttpm? -61.51 -38.21 86.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.729 -1.123 . . . . 0.94 111.396 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 16.2 ptpt -76.57 -35.9 57.92 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.77 0.285 . . . . 2.13 111.77 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.573 HG21 ' HD2' ' A' ' 150' ' ' PRO . 86.4 m -63.47 -42.61 98.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.088 0.471 . . . . 0.47 110.798 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.685 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.0 ttmt . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 109.327 -0.62 . . . . 1.75 109.327 169.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 113.577 0.954 . . . . 0.93 113.577 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.882 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 23.7 mt -83.24 168.29 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 114.225 -1.352 . . . . 1.05 109.142 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.472 ' NZ ' ' HB3' ' A' ' 136' ' ' LYS . 0.5 OUTLIER 179.02 -35.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.279 0.945 . . . . 1.5 112.873 -176.248 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.882 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.13 171.76 8.25 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.904 0.882 . . . . 0.87 112.201 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.413 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 17.6 m120 -44.46 -157.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.407 1.483 . . . . 1.8 114.122 169.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.832 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 31.7 m-85 -28.56 -56.96 0.13 Allowed 'General case' 0 C--O 1.208 -1.111 0 C-N-CA 125.259 1.424 . . . . 1.37 114.323 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.81 HG23 ' HA ' ' A' ' 155' ' ' SER . 7.0 m 42.87 95.73 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.398 0.888 . . . . 0.3 113.398 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.5 p -85.12 152.07 23.66 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.328 -0.549 . . . . 0.8 110.722 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 6.1 m-85 -103.36 137.71 41.11 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.802 -1.184 . . . . 0.53 107.802 166.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.977 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 44.7 tp -82.58 104.91 13.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.838 -0.801 . . . . 0.51 108.838 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.675 HG21 HD13 ' A' ' 15' ' ' ILE . 16.9 mm -102.69 119.27 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.775 -0.824 . . . . 0.2 108.775 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.12 179.72 3.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.133 0.492 . . . . 1.3 110.292 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -61.83 -12.58 18.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.519 -0.764 . . . . 3.78 112.554 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -111.12 -21.36 11.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 1.18 110.294 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 110.55 35.56 2.05 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.554 -0.748 . . . . 0.23 112.864 177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 96.0 t -112.08 124.36 32.38 Favored Pre-proline 0 C--N 1.319 -0.75 0 O-C-N 122.584 -0.363 . . . . 0.62 110.361 175.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.573 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -66.9 99.87 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.3 111.761 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.5 t -84.03 -21.19 8.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.581 . . . . 0.27 110.798 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.685 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 mm-40 -159.16 164.55 35.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.786 -0.45 . . . . 1.22 109.786 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.625 HH11 ' HH2' ' A' ' 137' ' ' TRP . 26.2 ttm180 -131.59 97.56 4.26 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.344 -0.614 . . . . 1.75 109.344 171.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.977 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 40.7 m-85 -81.92 111.13 17.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.224 -0.658 . . . . 0.38 109.224 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.81 ' HA ' HG23 ' A' ' 140' ' ' THR . 0.9 OUTLIER -58.72 163.66 5.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.519 -0.549 . . . . 0.99 109.519 174.508 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.799 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 50.8 Cg_endo -67.69 -7.03 18.21 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.463 2.109 . . . . 0.66 112.06 -169.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -86.1 -0.57 87.05 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.08 -0.963 . . . . 0.52 112.694 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.88 135.36 36.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.942 0.401 . . . . 0.43 110.538 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 172.79 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 1.25 110.62 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.485 ' HA ' HG23 ' A' ' 56' ' ' THR . 31.2 t -50.45 -53.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.532 -0.303 . . . . 0.41 110.829 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 64.0 tttm -63.41 -35.28 79.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 3.44 111.44 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -54.3 -40.87 68.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.541 0.686 . . . . 1.86 109.485 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.766 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 61.2 mt -82.27 -40.66 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.838 -1.074 . . . . 0.21 111.507 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 41.3 mt-10 -53.14 -42.26 65.91 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.282 0.475 . . . . 0.88 112.282 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 1.7 pt-20 -69.31 -2.37 10.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.408 0.521 . . . . 0.75 112.408 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.614 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 33.3 mmtm -116.66 -20.83 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.577 . . . . 1.58 109.705 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.1 tp -93.29 -41.12 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.24 111.95 -168.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.69 ' HA ' HD12 ' A' ' 171' ' ' LEU . 77.5 mt -49.86 -50.8 65.86 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.703 0.631 . . . . 0.44 112.703 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.5 Cg_exo -54.24 -36.56 86.6 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.236 1.958 . . . . 0.49 112.835 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -75.99 -37.38 58.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.675 -0.239 . . . . 0.71 110.966 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.84 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.8 mt -59.7 -48.59 81.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.716 0.77 . . . . 0.46 109.033 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -49.29 -65.23 2.86 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 114.241 -1.345 . . . . 1.52 112.42 167.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 p . . . . . 0 CA--C 1.533 0.294 0 CA-C-N 116.767 0.284 . . . . 2.52 110.658 178.116 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 111.848 0.314 . . . . 1.68 111.848 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 p -151.7 154.93 37.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.417 0.627 . . . . 0.65 110.369 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 144' ' ' ILE . 13.8 pt -61.6 -21.46 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.913 -1.039 . . . . 0.3 112.497 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.785 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 62.2 m-85 -77.7 -2.57 36.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.39 0.515 . . . . 0.27 112.39 -171.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -70.47 -17.46 62.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.632 0.73 . . . . 1.96 109.363 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 79.3 m-85 -100.38 162.6 12.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.191 -0.913 . . . . 0.4 111.477 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.475 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 25.9 tt0 -93.97 153.61 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 2.77 110.733 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.587 HG12 ' HB3' ' A' ' 28' ' ' TYR . 75.6 t -133.05 139.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.037 0.446 . . . . 0.74 111.186 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.992 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 95.6 mt -104.96 140.56 38.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.826 -0.805 . . . . 0.72 108.826 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.82 -172.35 1.9 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.268 -0.641 . . . . 1.59 109.268 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -54.36 -33.06 58.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.753 0.311 . . . . 0.52 111.306 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 19.6 t70 -86.85 -11.67 50.14 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.418 -0.355 . . . . 2.22 111.287 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.992 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 42.3 m-70 79.37 22.31 0.57 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.618 0.767 . . . . 0.73 109.745 -176.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.761 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -84.13 146.0 47.37 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 105.857 -1.905 . . . . 3.25 105.857 166.234 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.89 114.6 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.157 1.238 . . . . 0.86 112.695 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.587 ' HB3' HG12 ' A' ' 20' ' ' VAL . 64.2 t80 -87.38 116.49 25.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.312 -0.858 . . . . 0.28 110.134 172.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.698 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 54.9 t30 -66.73 93.85 0.27 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.102 -0.703 . . . . 1.65 109.102 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.785 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -77.31 -34.3 55.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.361 0.6 . . . . 0.25 110.454 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.729 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.8 p -76.64 -0.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.271 -0.877 . . . . 0.41 112.296 -168.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.698 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 12.2 pt20 -80.85 -5.24 57.04 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.963 -0.754 . . . . 1.24 108.963 173.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -101.35 20.64 15.49 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.897 -1.047 . . . . 0.38 108.341 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -96.94 150.95 20.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.462 -1.245 . . . . 1.73 108.742 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 -6.05 81.38 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.636 -0.985 . . . . 0.36 110.636 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.578 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.2 m -140.72 141.75 26.0 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.798 -1.186 . . . . 1.14 107.798 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.836 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.2 Cg_exo -75.99 157.54 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.019 1.813 . . . . 0.52 111.365 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.562 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -154.67 148.61 25.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.249 0.547 . . . . 1.03 111.251 -174.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.616 HD23 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.29 150.7 26.39 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.262 -1.014 . . . . 1.1 108.262 171.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 66.9 mt -139.64 118.7 12.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.623 -0.51 . . . . 0.2 109.623 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.841 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 38.8 m-85 -103.07 124.15 47.99 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 121.154 -0.218 . . . . 0.23 111.359 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.709 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -78.56 92.0 4.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.901 -1.148 . . . . 1.28 107.901 166.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.6 p -108.62 143.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 113.363 0.875 . . . . 0.88 113.363 -161.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HA ' ' OG ' ' A' ' 76' ' ' SER . . . -67.04 110.43 3.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.438 -1.319 . . . . 0.52 107.438 170.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.972 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -67.89 81.27 0.2 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.061 -0.972 . . . . 1.84 111.869 -167.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.651 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 14.1 ptpt 46.01 66.37 0.96 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.274 1.43 . . . . 2.43 112.46 -173.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -162.65 138.07 7.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -1.02 . . . . 0.99 110.154 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.13 -140.97 30.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.842 -0.694 . . . . 1.09 113.346 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -84.07 170.09 14.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.075 0.464 . . . . 3.16 111.77 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.15 -28.44 2.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.949 -0.569 . . . . 1.94 111.424 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.876 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.4 mmmt 66.27 3.52 2.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.255 0.622 . . . . 2.03 111.917 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.04 1.9 59.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.818 -0.706 . . . . 0.47 112.28 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.4 81.92 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.468 -0.653 . . . . 0.34 111.468 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.518 ' HE1' ' HB1' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -66.21 -49.34 67.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.203 -0.498 . . . . 0.57 110.185 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.63 -43.51 89.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.505 -0.771 . . . . 2.46 110.119 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 160' ' ' VAL . 55.1 m -57.94 -53.26 60.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.516 -0.765 . . . . 0.33 110.527 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.68 -49.48 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.719 -0.673 . . . . 0.19 111.846 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.647 HG23 ' HB2' ' A' ' 101' ' ' GLU . 63.0 m -59.22 -45.39 91.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 0.3 110.754 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.9 m -64.07 -48.44 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.652 -0.704 . . . . 1.08 110.78 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 95.1 mt -56.59 -53.04 62.28 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.803 0.298 . . . . 0.81 111.803 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.61 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 70.9 t80 -53.23 -53.35 52.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.788 -0.642 . . . . 0.33 109.755 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.96 -27.43 60.99 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.371 -0.832 . . . . 1.76 111.815 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.75 -48.34 12.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.839 0.352 . . . . 1.79 111.411 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.695 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.8 m-85 -99.1 6.17 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.258 0.836 . . . . 0.43 113.258 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -57.81 -29.85 65.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.808 0.337 . . . . 2.11 110.316 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -63.57 -32.8 74.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 1.2 111.061 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -96.5 10.78 37.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 1.9 110.689 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 80.66 64.07 1.85 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.945 -0.645 . . . . 1.32 112.19 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.616 ' CE1' HD23 ' A' ' 39' ' ' LEU . 70.6 t80 -129.66 143.85 51.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.727 0.299 . . . . 0.26 110.912 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.6 146.77 52.37 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.853 0.358 . . . . 0.51 110.416 177.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.738 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 42.5 t -116.52 120.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.96 -0.385 . . . . 0.24 109.96 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 26.7 mt -106.38 123.07 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.654 -0.498 . . . . 0.51 109.654 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.025 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -104.91 131.32 52.56 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.103 0.478 . . . . 0.28 110.266 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 8.2 m-85 -117.27 106.98 46.07 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.219 -0.66 . . . . 0.34 109.219 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.029 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 52.6 Cg_exo -56.69 169.06 1.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.993 3.129 . . . . 0.73 112.04 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' A' ' 44' ' ' ALA . 3.7 p . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 115.419 1.637 . . . . 1.54 115.419 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.52 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 31.1 m . . . . . 0 N--CA 1.44 -0.974 0 CA-C-O 121.096 0.474 . . . . 0.91 110.218 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 95.7 m -153.99 128.63 9.33 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.378 -0.828 . . . . 1.92 110.38 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 96' ' ' THR . 44.4 pttt 68.21 -44.73 0.5 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.584 1.328 . . . . 3.18 114.584 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.651 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 62.03 -67.92 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.461 0.573 . . . . 1.74 111.577 -175.314 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.69 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 8.9 mmpt? 71.23 147.68 0.08 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.898 0.879 . . . . 3.08 111.795 173.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.729 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -168.44 -166.66 0.71 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.101 0.477 . . . . 0.43 111.968 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.647 ' HB2' HG23 ' A' ' 58' ' ' THR . 29.0 mm-40 -88.79 27.69 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 2.19 110.547 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.835 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 39.1 p90 -149.6 174.76 3.21 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.153 -1.425 . . . . 0.24 107.153 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.79 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.4 Cg_exo -71.1 125.59 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.802 2.334 . . . . 0.31 113.322 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.025 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -124.43 141.49 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.247 -0.649 . . . . 0.37 109.247 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.79 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 6.4 mmt -115.48 -152.16 0.5 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.542 0.687 . . . . 1.47 112.714 -164.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -73.04 137.26 45.23 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.577 -1.192 . . . . 0.39 110.707 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.029 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 26.7 pttt -73.13 120.97 19.49 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.764 -0.828 . . . . 1.66 108.764 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.507 HD12 ' CB ' ' A' ' 116' ' ' HIS . 5.2 pt -122.53 169.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.795 -1.093 . . . . 0.47 108.343 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.2 m120 -68.6 121.37 16.29 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.77 -1.196 . . . . 2.16 107.77 169.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.709 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -119.16 83.57 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 C-N-CA 119.127 -1.029 . . . . 0.38 109.587 170.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 46.5 t30 170.96 177.97 0.06 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.076 -1.083 . . . . 1.98 108.076 167.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.76 -141.52 35.93 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.955 -0.641 . . . . 0.78 113.779 164.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.23 1.52 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.121 -0.539 . . . . 1.98 110.601 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -87.75 -24.94 23.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.821 -0.627 . . . . 2.04 110.681 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.775 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -44.59 142.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.779 1.029 . . . . 0.48 113.779 -175.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.507 ' CB ' HD12 ' A' ' 108' ' ' ILE . 49.3 t-80 -53.23 136.3 49.84 Favored Pre-proline 0 C--O 1.225 -0.236 0 CA-C-N 114.679 -1.146 . . . . 0.42 110.012 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.56 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.2 Cg_exo -40.95 -45.34 5.03 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.172 2.581 . . . . 0.36 112.845 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.522 HD11 ' HE3' ' A' ' 122' ' ' MET . 30.0 tp -54.02 -51.49 63.82 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.783 -0.644 . . . . 1.1 111.884 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.5 m-85 -71.28 -30.4 66.22 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 116.517 -0.31 . . . . 1.49 111.0 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.474 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 9.6 mm-40 -56.26 -43.3 78.62 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.726 -0.79 . . . . 2.37 109.413 170.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.9 t80 -66.03 -45.03 82.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.614 -0.434 . . . . 0.58 110.508 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.522 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.9 mtt -60.76 -53.11 61.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.873 0.368 . . . . 0.34 111.236 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 2.5 mtpm? -62.33 -38.24 88.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 0.94 110.838 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 17.1 ptpt -74.82 -27.35 60.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.718 -0.219 . . . . 2.13 110.816 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.537 HG21 ' HD2' ' A' ' 150' ' ' PRO . 59.1 m -65.02 -55.18 20.44 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.945 -0.302 . . . . 0.47 111.068 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.538 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 31.7 ttmt . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.278 -0.569 . . . . 1.75 111.574 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.41 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 113.357 0.873 . . . . 0.93 113.357 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.903 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 26.0 mt -103.19 90.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.845 -1.07 . . . . 1.05 110.79 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -111.48 -2.38 15.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.451 0.537 . . . . 1.5 112.451 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.903 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -120.41 170.29 9.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.465 0.543 . . . . 0.87 112.465 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 16.3 m120 -47.98 -156.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.901 1.681 . . . . 1.8 113.745 172.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.841 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 33.2 m-85 -27.48 -57.96 0.1 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 125.175 1.39 . . . . 1.37 114.022 -164.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.775 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 24.2 m 42.94 95.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.046 0.758 . . . . 0.3 113.046 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.678 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.3 t -88.33 147.13 24.92 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.997 -0.681 . . . . 0.8 110.786 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 39' ' ' LEU . 5.2 m-85 -102.32 133.99 46.33 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.371 -0.974 . . . . 0.53 108.371 169.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.906 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.35 104.05 11.53 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.001 -0.74 . . . . 0.51 109.001 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 15' ' ' ILE . 10.7 mm -104.07 116.86 48.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.92 -0.582 . . . . 0.2 109.737 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.414 ' HB2' HD13 ' A' ' 170' ' ' LEU . 6.9 t70 -74.68 169.85 17.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.017 -0.538 . . . . 1.3 109.846 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.891 ' HD3' ' HA ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -60.36 -9.66 3.81 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.329 -0.851 . . . . 3.78 112.09 -168.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.2 8.78 28.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.864 -0.791 . . . . 1.18 108.864 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.519 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 71.57 45.49 45.41 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.23 112.559 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 79.7 t -123.24 123.06 26.69 Favored Pre-proline 0 C--N 1.321 -0.671 0 O-C-N 122.85 -0.206 . . . . 0.62 110.664 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.537 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -68.12 102.75 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.244 2.63 . . . . 0.3 112.417 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.51 ' HB ' HD23 ' A' ' 143' ' ' LEU . 18.8 t -88.49 -15.35 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 0.27 110.806 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.538 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 28.2 mm-40 -168.08 164.54 13.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.094 0.474 . . . . 1.22 111.273 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -133.95 99.31 4.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 1.75 109.546 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.906 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.5 m-85 -87.25 125.31 34.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.738 -0.838 . . . . 0.38 108.738 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.765 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 95.4 p -69.01 174.29 2.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.617 0.644 . . . . 0.99 109.357 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.876 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 62.8 Cg_endo -68.31 -13.8 38.66 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.062 1.841 . . . . 0.66 111.48 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.13 1.72 79.06 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.835 -1.075 . . . . 0.52 111.699 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.92 133.77 35.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.981 0.42 . . . . 0.43 110.306 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.6 m -90.95 178.52 6.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.109 -0.496 . . . . 1.25 110.221 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.557 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 45.1 t -54.61 -55.9 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 0.41 111.034 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.8 tptp -62.91 -29.23 70.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 3.44 111.265 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.65 -41.12 89.81 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.347 -0.612 . . . . 1.86 109.347 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.706 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.9 mt -82.31 -38.44 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.891 . . . . 0.21 111.344 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 49.0 mt-10 -54.59 -41.86 70.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.297 0.48 . . . . 0.88 112.297 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.1 pt-20 -65.62 -11.78 47.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.444 0.535 . . . . 0.75 112.444 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.726 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 73.6 mmtt -109.89 -16.2 13.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.492 . . . . 1.58 110.386 174.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.566 ' HG ' HD11 ' A' ' 171' ' ' LEU . 67.1 tp -95.61 -42.68 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.742 -0.663 . . . . 0.24 111.845 -171.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.729 ' HA ' HD12 ' A' ' 171' ' ' LEU . 80.6 mt -49.79 -51.31 61.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.547 0.573 . . . . 0.44 112.547 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 57.0 Cg_exo -55.09 -30.94 72.94 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.271 1.981 . . . . 0.49 113.154 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.414 HD13 ' HB2' ' A' ' 145' ' ' ASP . 64.7 mt -81.73 -34.21 30.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.52 0.2 . . . . 0.71 110.75 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.836 HD23 ' HG2' ' A' ' 37' ' ' PRO . 12.6 mt -64.31 -41.4 96.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.694 0.759 . . . . 0.46 109.245 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.47 12.21 2.72 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 114.411 -1.268 . . . . 1.52 113.278 171.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.891 ' HA ' ' HD3' ' A' ' 146' ' ' ARG . 19.3 t . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 124.413 1.085 . . . . 2.52 111.562 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 108.726 -0.842 . . . . 1.68 108.726 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.0 p -145.08 174.85 10.69 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.979 -1.01 . . . . 0.65 108.543 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.702 HD13 HG21 ' A' ' 144' ' ' ILE . 13.0 pt -65.15 -22.92 32.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 0.3 111.203 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.841 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 52.6 m-85 -79.79 -0.28 33.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.195 -0.457 . . . . 0.27 111.951 -172.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.91 -12.37 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.395 0.616 . . . . 1.96 109.52 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 91.2 m-85 -109.9 140.32 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.435 -0.802 . . . . 0.4 110.991 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.99 140.6 33.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.698 -0.683 . . . . 2.77 110.631 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.573 HG23 HD13 ' A' ' 30' ' ' LEU . 70.0 t -114.46 148.74 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.935 0.398 . . . . 0.74 110.914 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.835 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 81.6 mt -111.54 141.62 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 0.72 109.246 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.03 -171.75 2.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.487 -0.561 . . . . 1.59 109.487 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.24 -32.93 57.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.605 -0.27 . . . . 0.52 111.671 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.6 t70 -90.86 -8.33 49.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.597 -0.274 . . . . 2.22 111.402 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.835 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.9 m-70 80.71 22.55 0.39 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.73 110.239 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -81.61 160.68 63.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 105.685 -1.968 . . . . 3.25 105.685 166.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.8 113.67 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 120.093 1.069 . . . . 0.86 111.727 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.515 ' HB3' HG12 ' A' ' 20' ' ' VAL . 58.2 t80 -80.67 130.07 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 0.28 109.969 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.757 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 54.1 t30 -80.67 81.99 6.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.07 -0.715 . . . . 1.65 109.07 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.841 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -67.86 -32.38 72.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.198 0.523 . . . . 0.25 110.219 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.679 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.33 -0.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.428 -0.806 . . . . 0.41 112.634 -169.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.757 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.4 pt20 -83.55 -6.04 59.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.609 0.719 . . . . 1.24 109.164 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -91.73 -9.78 42.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.991 -1.114 . . . . 0.38 107.991 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -70.9 137.48 49.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.19 -1.368 . . . . 1.73 109.157 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 -10.56 53.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 109.913 -1.275 . . . . 0.36 109.913 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 49.6 m -141.0 144.78 36.49 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.822 -0.807 . . . . 1.14 108.822 177.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.024 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 60.8 Cg_endo -71.89 155.69 57.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.909 1.739 . . . . 0.52 111.259 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.603 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.7 pt? -154.19 152.68 30.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.153 0.501 . . . . 1.03 111.217 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 163' ' ' ILE . 6.8 mp -108.0 152.5 24.4 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.775 -0.824 . . . . 1.1 108.775 172.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 78.9 mt -140.84 115.48 5.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.542 -0.54 . . . . 0.2 109.542 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.909 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 17.7 m-85 -102.42 123.65 46.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 121.166 -0.213 . . . . 0.23 110.982 -173.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.734 ' HB2' HG21 ' A' ' 110' ' ' VAL . 1.1 p30 -82.23 91.3 6.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.545 -0.909 . . . . 1.28 108.545 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.605 HG11 ' HE2' ' A' ' 98' ' ' PHE . 1.7 p -111.95 125.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 112.455 0.539 . . . . 0.88 112.455 -165.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.27 107.16 0.45 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.744 -1.576 . . . . 0.52 106.744 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 1.071 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 3.3 p -76.71 75.67 3.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.28 -1.327 . . . . 1.84 113.483 -156.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 82.6 tttt 92.45 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.627 1.171 . . . . 2.43 111.538 174.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.6 m -141.57 143.26 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.446 -0.343 . . . . 0.99 110.674 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.28 -136.69 19.15 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.031 -0.604 . . . . 1.09 114.222 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.58 111.84 24.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 3.16 111.815 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 p -73.33 -26.7 61.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.981 -0.554 . . . . 1.94 110.648 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.86 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 39.2 mtpt 64.54 3.02 1.77 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.33 -0.85 . . . . 2.03 112.259 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.84 -3.94 34.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.824 -0.703 . . . . 0.47 112.641 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.15 79.83 Favored Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 111.702 -0.559 . . . . 0.34 111.702 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.576 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -69.25 -52.72 24.9 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.073 0.463 . . . . 0.57 110.138 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.29 -41.55 93.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.488 -0.778 . . . . 2.46 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.6 m -68.51 -40.82 80.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.816 -0.629 . . . . 0.33 110.876 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -64.98 -49.3 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.19 111.283 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -59.18 -48.9 79.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.835 -0.621 . . . . 0.3 111.177 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -63.8 -46.16 86.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.816 -0.629 . . . . 1.08 111.27 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.686 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.78 -46.0 90.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.81 111.338 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.656 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 59.0 t80 -53.74 -57.34 11.19 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 123.277 0.361 . . . . 0.33 110.427 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -67.14 -41.57 85.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.291 -0.413 . . . . 1.76 111.555 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.77 -42.79 73.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 1.79 111.717 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.686 ' CD1' HD13 ' A' ' 171' ' ' LEU . 67.7 m-85 -103.9 3.78 34.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.445 0.905 . . . . 0.43 113.445 -172.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -58.48 -29.74 66.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 2.11 110.788 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.6 p -65.32 -38.55 90.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.2 111.237 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -89.24 1.89 55.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.816 0.341 . . . . 1.9 111.255 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.508 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 93.08 73.43 1.23 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.701 -0.761 . . . . 1.32 112.006 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.601 ' CE1' HD13 ' A' ' 39' ' ' LEU . 76.7 t80 -143.09 142.13 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.526 0.203 . . . . 0.26 111.06 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.98 141.45 49.29 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 120.823 0.344 . . . . 0.51 110.207 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.661 HG11 ' HB1' ' A' ' 57' ' ' ALA . 52.9 t -108.01 114.06 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.74 0.305 . . . . 0.24 110.448 168.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 31.2 mt -98.48 122.63 41.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.828 -0.804 . . . . 0.51 108.828 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.51 113.42 26.19 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.388 -0.525 . . . . 0.28 110.345 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.76 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.4 m-85 -95.05 108.22 36.9 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.54 -0.911 . . . . 0.34 108.54 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.071 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.2 Cg_exo -59.76 167.67 6.56 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 123.164 2.576 . . . . 0.73 111.555 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 70.9 m . . . . . 0 N--CA 1.429 -1.482 0 C-N-CA 118.55 -1.26 . . . . 1.54 113.606 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.821 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 56.1 m . . . . . 0 N--CA 1.441 -0.904 0 CA-C-O 120.814 0.34 . . . . 0.91 111.232 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.947 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 17.0 m -153.0 115.28 4.41 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.225 -0.898 . . . . 1.92 109.304 168.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.662 ' O ' HG21 ' A' ' 104' ' ' ILE . 87.6 mttt 64.27 -40.24 0.24 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 115.006 1.484 . . . . 3.18 115.006 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.695 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER 63.2 -36.55 0.15 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.004 1.322 . . . . 1.74 112.308 -171.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 97' ' ' LYS . 70.9 mmtt 69.54 130.86 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.828 0.851 . . . . 3.08 112.581 172.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.69 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -158.88 -171.38 3.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.847 -0.615 . . . . 0.43 112.397 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.62 31.44 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.419 -0.81 . . . . 2.19 111.092 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.877 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 39.2 p90 -150.43 167.31 13.24 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 108.154 -1.054 . . . . 0.24 108.154 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.1 Cg_exo -64.04 106.52 0.67 Allowed 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 123.597 2.865 . . . . 0.31 113.527 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.979 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.4 mp -103.43 131.52 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.991 -0.744 . . . . 0.37 108.991 174.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.5 mmt -109.94 -154.17 0.53 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.118 0.784 . . . . 1.47 113.118 -161.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -69.56 125.22 26.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.123 -0.944 . . . . 0.39 110.496 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.947 ' HE3' ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -64.5 120.55 12.53 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.617 -0.883 . . . . 1.66 108.617 172.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.754 HG13 HG13 ' A' ' 110' ' ' VAL . 9.2 pt -121.39 155.04 25.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.29 -1.004 . . . . 0.47 108.29 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -83.19 69.61 9.94 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.123 -1.066 . . . . 2.16 108.123 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.7 90.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.38 111.007 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.581 ' H ' ' HB2' ' A' ' 115' ' ' ALA . 46.5 t30 174.16 172.55 0.19 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.505 -0.924 . . . . 1.98 108.505 166.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.21 -142.49 23.23 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 114.471 0.548 . . . . 0.78 114.471 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -1.52 32.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.49 0.662 . . . . 1.98 110.558 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -95.68 -13.15 24.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.089 -0.959 . . . . 2.04 110.688 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.581 ' HB2' ' H ' ' A' ' 111' ' ' ASN . . . -57.84 149.52 22.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.562 -0.745 . . . . 0.48 111.913 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.553 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 20.2 t-80 -46.99 139.73 6.72 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.118 -0.946 . . . . 0.42 110.131 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.476 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 11.0 Cg_endo -54.18 -35.34 82.21 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.224 2.616 . . . . 0.36 112.437 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.562 HD11 ' HE3' ' A' ' 122' ' ' MET . 23.4 tp -61.57 -40.46 94.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.908 -0.587 . . . . 1.1 110.572 175.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.9 m-85 -75.63 -28.9 58.98 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.224 -0.443 . . . . 1.49 111.009 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' A' ' 117' ' ' PRO . 40.2 mt-10 -57.6 -39.96 77.99 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.951 -0.7 . . . . 2.37 109.181 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.501 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 79.1 t80 -71.67 -41.74 68.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 0.58 110.519 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.562 ' HE3' HD11 ' A' ' 118' ' ' LEU . 65.6 mtt -66.68 -53.01 38.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.133 -0.485 . . . . 0.34 111.576 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 13.8 mtpt -61.26 -39.63 91.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.541 -0.3 . . . . 0.94 110.958 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -68.58 -32.36 72.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.78 0.324 . . . . 2.13 110.484 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.556 HG21 ' HD2' ' A' ' 150' ' ' PRO . 89.3 m -66.23 -58.75 4.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 0.47 110.979 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.866 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 25.9 ttmt . . . . . 0 C--N 1.325 -0.492 0 C-N-CA 120.509 -0.476 . . . . 1.75 110.521 174.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.553 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 114.813 1.412 . . . . 0.93 114.813 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.873 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 51.0 mt -104.66 87.88 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 113.681 -1.6 . . . . 1.05 110.257 -173.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.7 pttt -110.57 14.98 22.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.477 0.547 . . . . 1.5 112.477 -170.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.873 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -146.7 169.38 19.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.923 0.342 . . . . 0.87 111.923 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.613 ' ND2' ' HB3' ' A' ' 44' ' ' ALA . 1.5 t-20 -51.66 -155.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.535 1.534 . . . . 1.8 113.223 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.909 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 27.4 m-85 -25.43 -59.68 0.07 Allowed 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 125.298 1.439 . . . . 1.37 114.794 -162.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.796 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 19.2 m 42.69 93.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 118.684 0.675 . . . . 0.3 112.738 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.0 p -84.59 150.62 25.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.689 -0.804 . . . . 0.8 110.491 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 4.5 m-85 -103.75 135.65 44.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.226 -1.027 . . . . 0.53 108.226 167.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.911 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 35.9 tp -82.01 104.85 12.66 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.994 -0.743 . . . . 0.51 108.994 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 15' ' ' ILE . 14.6 mm -102.44 121.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.947 -0.76 . . . . 0.2 108.947 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.41 -179.39 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.568 -0.287 . . . . 1.3 110.994 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.661 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.6 mtp180 -56.23 -28.59 58.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.243 0.46 . . . . 3.78 112.243 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -109.77 -4.75 15.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.186 0.517 . . . . 1.18 110.791 -169.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.581 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.09 53.46 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.491 -0.861 . . . . 0.23 114.353 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 10.3 t -127.7 128.82 23.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 117.382 0.591 . . . . 0.62 110.151 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.556 ' HD2' HG21 ' A' ' 125' ' ' THR . 15.3 Cg_exo -66.26 102.64 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.946 2.431 . . . . 0.3 112.388 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.47 -18.42 8.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.656 -0.702 . . . . 0.27 110.925 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.866 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 77.0 mm-40 -157.07 159.42 37.9 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.682 0.277 . . . . 1.22 110.915 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.459 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 20.1 ttm180 -127.44 96.83 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.01 -0.737 . . . . 1.75 109.01 168.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.911 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 33.9 m-85 -86.42 107.88 18.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.908 -0.775 . . . . 0.38 108.908 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.701 ' HA ' HG23 ' A' ' 140' ' ' THR . 83.5 p -60.6 164.93 6.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.89 -0.411 . . . . 0.99 109.89 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.86 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 42.0 Cg_endo -65.24 -7.6 16.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.032 2.488 . . . . 0.66 112.978 -164.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.95 22.46 38.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.52 111.718 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.04 140.23 29.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 0.43 110.813 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.9 p -91.32 170.13 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.734 -0.667 . . . . 1.25 111.029 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.686 HG13 HD21 ' A' ' 60' ' ' LEU . 74.5 t -53.18 -56.09 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.41 110.955 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.424 ' NZ ' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -65.64 -32.05 73.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 3.44 111.461 -175.088 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.74 -31.78 73.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.121 -0.49 . . . . 1.86 109.922 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.887 HG21 HD21 ' A' ' 39' ' ' LEU . 35.6 mt -83.19 -39.83 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.994 -0.548 . . . . 0.21 110.7 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 54.7 mt-10 -57.79 -35.63 71.08 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.133 0.42 . . . . 0.88 112.133 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.519 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.4 pt-20 -61.32 -21.38 63.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.75 111.648 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.547 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtt -104.8 -31.5 9.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.233 -0.44 . . . . 1.58 110.549 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.3 tp -85.58 -42.43 14.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.24 112.758 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.806 ' HA ' HD12 ' A' ' 171' ' ' LEU . 60.8 mt -53.94 -46.97 98.38 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.504 0.557 . . . . 0.44 112.504 -173.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.9 Cg_exo -53.13 -40.16 77.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.809 1.672 . . . . 0.49 112.371 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.6 mt -74.4 -37.05 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.71 111.794 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.024 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.8 mt -54.27 -54.07 45.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.539 0.685 . . . . 0.46 109.497 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.7 -59.78 8.77 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.276 -1.329 . . . . 1.52 112.795 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 116.923 0.362 . . . . 2.52 110.857 -179.136 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.825 0.345 . . . . 1.68 110.664 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.3 p -124.33 -179.41 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.596 -0.52 . . . . 0.65 109.596 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.833 HD13 HG21 ' A' ' 144' ' ' ILE . 32.5 pt -68.3 -31.07 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.83 0.348 . . . . 0.3 111.358 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 29.8 m-85 -72.95 -4.62 33.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.906 0.384 . . . . 0.27 111.594 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.52 -14.22 62.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.83 -0.623 . . . . 1.96 109.366 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.645 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 84.1 m-85 -111.62 142.34 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.373 -0.83 . . . . 0.4 110.701 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -100.18 140.18 34.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.68 -0.489 . . . . 2.77 109.68 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.577 ' CG2' ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -123.3 159.77 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.378 -0.374 . . . . 0.74 110.804 -171.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.907 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 58.7 mt -97.26 133.34 42.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.531 . . . . 0.72 110.214 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 21.2 t70 -69.78 178.18 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.702 -1.135 . . . . 1.59 109.584 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.674 ' HB1' ' CD ' ' A' ' 97' ' ' LYS . . . -55.43 -25.04 33.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.968 0.413 . . . . 0.52 111.417 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -90.91 -9.82 44.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.206 -0.452 . . . . 2.22 111.111 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.907 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 44.9 m-70 74.51 12.88 3.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.912 0.885 . . . . 0.73 109.994 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -73.37 150.36 89.39 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 106.126 -1.805 . . . . 3.25 106.126 162.493 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.23 115.16 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.81 1.007 . . . . 0.86 111.425 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.577 ' HB3' ' CG2' ' A' ' 20' ' ' VAL . 87.9 t80 -84.42 122.28 28.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.28 109.825 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.671 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.0 t30 -75.24 82.15 2.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.839 -0.619 . . . . 1.65 109.645 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.738 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.2 pt? -63.06 -29.74 71.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.594 0.711 . . . . 0.25 110.28 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.75 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.6 p -77.31 -0.03 2.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.828 -1.078 . . . . 0.41 112.933 -169.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.671 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 29.3 pt20 -78.35 -5.45 52.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.359 -0.608 . . . . 1.24 109.359 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CG ' HG21 ' A' ' 70' ' ' THR . 77.5 m-70 -98.42 -0.75 42.99 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.38 108.759 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HE2' ' CG2' ' A' ' 31' ' ' VAL . 9.2 ttmm -67.97 132.4 47.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 1.73 109.914 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.46 -0.99 60.06 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.515 -1.034 . . . . 0.36 110.515 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 44.8 m -140.33 138.49 19.12 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.237 -0.653 . . . . 1.14 109.237 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.003 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 43.8 Cg_endo -69.44 154.87 68.42 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.769 1.646 . . . . 0.52 110.893 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.624 ' CB ' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -156.52 148.36 22.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.167 0.508 . . . . 1.03 111.323 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 141' ' ' SER . 3.4 mm? -107.12 148.63 28.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.113 -1.069 . . . . 1.1 108.113 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.541 HD12 HG13 ' A' ' 144' ' ' ILE . 69.6 mt -139.55 116.38 10.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.74 -0.467 . . . . 0.2 109.74 -173.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.707 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 16.4 m-85 -101.39 130.31 47.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.602 -0.272 . . . . 0.23 111.313 -172.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.673 ' CB ' HG11 ' A' ' 110' ' ' VAL . 1.1 p30 -87.96 92.04 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.394 -0.965 . . . . 1.28 108.394 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -106.53 150.13 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.453 0.644 . . . . 0.88 112.348 -160.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.31 109.0 5.06 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.2 -1.407 . . . . 0.52 107.2 166.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.986 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -66.76 74.46 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.005 -0.998 . . . . 1.84 112.6 -169.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.781 ' HE3' ' HA ' ' A' ' 98' ' ' PHE . 39.6 ttmt 55.73 57.44 5.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.156 -0.929 . . . . 2.43 111.119 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -160.87 128.14 4.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.108 -0.496 . . . . 0.99 111.288 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.52 -80.9 1.78 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.847 -0.615 . . . . 1.09 113.662 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -131.72 163.18 28.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.423 0.154 . . . . 3.16 110.949 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 p -131.82 -35.69 1.25 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.143 0.423 . . . . 1.94 112.143 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 65.77 0.39 1.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.478 0.711 . . . . 2.03 112.259 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.75 4.97 72.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.666 -0.778 . . . . 0.47 112.259 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.0 86.73 Favored Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.37 -0.692 . . . . 0.34 111.37 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.493 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.3 t80 -61.75 -52.75 62.98 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.941 -0.629 . . . . 0.57 110.254 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.37 -45.97 90.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.765 -0.652 . . . . 2.46 110.668 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 160' ' ' VAL . 30.1 m -57.08 -48.69 77.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.682 -0.69 . . . . 0.33 110.481 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.761 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.53 -50.02 74.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 0.19 111.785 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -61.1 -42.98 99.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.173 0.511 . . . . 0.3 111.005 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.8 m -64.67 -47.77 77.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.576 -0.738 . . . . 1.08 111.223 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 90.5 mt -56.52 -52.58 64.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.187 -0.461 . . . . 0.81 111.165 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.656 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 47.3 t80 -46.99 -57.87 4.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 124.435 1.085 . . . . 0.33 110.117 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.34 -38.85 65.61 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.736 -0.665 . . . . 1.76 111.919 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -70.01 -45.14 67.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 1.79 111.301 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.711 ' CD1' HD13 ' A' ' 171' ' ' LEU . 58.6 m-85 -100.02 5.83 45.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.194 0.813 . . . . 0.43 113.194 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 17.8 mtpp -62.03 -18.67 61.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 2.11 110.073 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 p -61.67 -40.69 95.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.687 -0.688 . . . . 1.2 110.874 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -94.92 10.18 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 1.9 110.599 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.577 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.14 71.66 1.26 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.571 -0.741 . . . . 1.32 112.255 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE1' HD23 ' A' ' 39' ' ' LEU . 59.4 t80 -132.62 142.43 49.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.229 -0.285 . . . . 0.26 110.229 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.624 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.36 152.44 48.16 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.973 0.416 . . . . 0.51 110.622 178.169 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.761 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.0 t -122.82 124.66 70.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.864 0.364 . . . . 0.24 110.437 171.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.494 HD22 ' HE3' ' A' ' 105' ' ' MET . 16.5 mt -105.68 145.05 31.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.823 -0.806 . . . . 0.51 108.823 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -132.79 113.46 12.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.133 0.492 . . . . 0.28 111.108 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.657 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.6 m-85 -99.01 113.57 64.74 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.698 -0.683 . . . . 0.34 109.306 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.075 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.29 165.85 6.73 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.562 2.841 . . . . 0.73 111.818 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.438 -1.035 0 CA-C-O 122.604 1.192 . . . . 1.54 113.485 179.363 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 38.6 m . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 121.683 0.754 . . . . 0.91 110.01 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.546 ' N ' ' HB2' ' A' ' 45' ' ' SER . 10.3 t -148.36 163.49 36.92 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.747 -1.115 . . . . 1.92 108.52 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.674 ' CD ' ' HB1' ' A' ' 23' ' ' ALA . 16.5 pttt -38.85 105.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.883 0.739 . . . . 3.18 111.344 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.781 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 51.5 p90 -58.21 -22.58 52.53 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.589 -0.732 . . . . 1.74 110.92 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? 68.83 142.82 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.168 0 O-C-N 124.282 0.989 . . . . 3.08 110.473 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.478 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -162.26 -160.33 0.66 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.468 -0.493 . . . . 0.43 111.732 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.91 -10.57 44.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 2.19 109.769 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.604 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 51.7 p90 -112.31 166.85 10.11 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 115.173 -0.921 . . . . 0.24 108.934 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.769 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.9 Cg_exo -70.61 119.31 6.24 Favored 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 123.712 2.942 . . . . 0.31 113.306 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.969 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.3 mp -108.21 149.44 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.889 -0.782 . . . . 0.37 108.889 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.769 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 13.3 mmt -118.49 -157.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.17 0.804 . . . . 1.47 113.17 -164.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.69 145.5 43.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.929 -1.032 . . . . 0.39 110.359 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.075 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.2 pttt -83.37 137.16 34.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.654 0.74 . . . . 1.66 109.785 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.488 HG13 HG13 ' A' ' 110' ' ' VAL . 5.0 pt -135.35 175.18 11.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.204 -1.362 . . . . 0.47 108.01 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 22.7 t-20 -88.34 83.96 6.86 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.97 -0.752 . . . . 2.16 108.97 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.673 HG11 ' CB ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -76.08 86.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.455 -1.298 . . . . 0.38 110.157 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 63.7 t30 170.88 179.36 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.86 -1.163 . . . . 1.98 107.86 166.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.75 -146.32 35.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.919 -0.658 . . . . 0.78 113.793 166.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -107.15 1.1 23.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.183 -0.508 . . . . 1.98 111.351 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -103.78 11.8 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.906 0.86 . . . . 2.04 110.065 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.536 ' HB3' ' OE1' ' A' ' 120' ' ' GLU . . . -73.88 156.46 37.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 0.48 111.963 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 20' ' ' VAL . 35.6 t-80 -57.18 137.69 80.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.07 -0.968 . . . . 0.42 110.5 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -42.39 -48.78 6.61 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.312 2.675 . . . . 0.36 113.13 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.568 HD22 ' CG1' ' A' ' 20' ' ' VAL . 13.6 tp -56.01 -41.23 74.58 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.244 -0.435 . . . . 1.1 111.843 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.601 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 12.4 m-85 -75.44 -30.71 60.09 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.458 -0.337 . . . . 1.49 110.975 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.536 ' OE1' ' HB3' ' A' ' 115' ' ' ALA . 7.1 mm-40 -59.74 -36.75 77.24 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.141 -0.623 . . . . 2.37 109.417 168.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.4 t80 -67.77 -48.78 65.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 0.58 110.448 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.546 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.7 mtt -63.08 -53.06 59.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.004 -0.544 . . . . 0.34 111.443 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -60.33 -39.7 88.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 0.94 111.204 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.5 ptmt -71.86 -35.24 69.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.737 0.303 . . . . 2.13 110.801 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.512 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.8 m -70.08 -42.63 72.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.976 -0.556 . . . . 0.47 112.449 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 112.567 0.58 . . . . 1.75 112.567 -173.946 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 121.112 0.482 . . . . 0.93 111.416 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.809 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 25.9 mt -85.71 110.21 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.373 -0.831 . . . . 1.05 109.769 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -130.08 15.74 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.003 0.43 . . . . 1.5 112.029 -170.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.809 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -153.91 173.87 15.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.215 0.531 . . . . 0.87 111.989 -175.131 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.486 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 8.8 m120 -43.16 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.74 1.616 . . . . 1.8 115.196 168.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.784 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 15.4 m-85 -30.79 -58.26 0.21 Allowed 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 112.871 -1.968 . . . . 1.37 113.918 -169.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.817 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 12.5 m 44.95 99.64 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.593 0.961 . . . . 0.3 113.593 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.7 ' HB2' HD12 ' A' ' 39' ' ' LEU . 15.9 p -87.78 151.16 23.1 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.467 -0.771 . . . . 0.8 111.268 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.4 m-85 -103.7 133.62 48.4 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.392 -0.966 . . . . 0.53 108.392 168.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.806 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 25.5 tp -81.36 105.41 12.52 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.133 -0.691 . . . . 0.51 109.133 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 15' ' ' ILE . 13.2 mm -105.59 126.91 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.605 -0.725 . . . . 0.2 109.083 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.69 -175.71 4.53 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.912 -0.315 . . . . 1.3 110.614 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.649 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 63.5 mtt180 -63.23 -16.76 61.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.259 0.466 . . . . 3.78 112.259 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -108.09 -10.04 15.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.437 0.637 . . . . 1.18 110.17 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.587 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 95.82 32.31 6.92 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.538 -0.755 . . . . 0.23 112.672 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 72.1 t -111.9 124.09 33.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.871 -0.418 . . . . 0.62 109.871 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.512 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.1 Cg_exo -68.14 118.39 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.44 2.093 . . . . 0.3 111.573 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.471 ' HB ' HD23 ' A' ' 143' ' ' LEU . 32.4 t -98.06 -26.24 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.712 -0.676 . . . . 0.27 110.417 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 27.1 mm-40 -149.83 163.73 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 1.22 111.509 -177.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -131.41 98.19 4.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.439 -0.8 . . . . 1.75 109.071 168.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.806 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 74.1 m-85 -86.95 117.84 25.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.497 -0.557 . . . . 0.38 109.497 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.799 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.0 OUTLIER -63.68 164.3 16.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.665 -0.494 . . . . 0.99 109.665 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.817 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 63.2 Cg_endo -70.65 -6.08 18.23 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.848 2.365 . . . . 0.66 112.495 -167.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.57 5.61 62.47 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.95 -1.023 . . . . 0.52 111.912 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.46 139.11 36.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.43 110.139 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.3 m -77.12 163.46 26.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.974 -0.557 . . . . 1.25 111.019 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 34.3 t -53.21 -48.84 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.423 -0.353 . . . . 0.41 110.343 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.449 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.2 tptm -69.79 -28.69 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 3.44 111.034 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.17 -33.84 74.09 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.0 0.429 . . . . 1.86 110.007 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.58 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.0 mt -80.39 -42.21 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.738 -0.665 . . . . 0.21 110.149 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 168' ' ' ILE . 45.2 mt-10 -55.41 -41.63 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.976 -0.556 . . . . 0.88 112.378 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.93 -19.37 60.63 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.241 0.46 . . . . 0.75 112.241 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -107.2 -17.93 14.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.012 0.435 . . . . 1.58 110.291 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.8 tp -89.98 -39.09 13.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.741 -0.663 . . . . 0.24 111.761 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.763 ' HA ' HD12 ' A' ' 171' ' ' LEU . 80.2 mt -52.48 -47.91 91.81 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.323 0.49 . . . . 0.44 112.323 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.508 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.6 Cg_exo -55.43 -27.68 59.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.248 1.966 . . . . 0.49 113.269 175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.53 -34.52 16.35 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.521 0.201 . . . . 0.71 111.465 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.003 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.5 mt -58.08 -52.56 65.05 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.189 -0.671 . . . . 0.46 109.189 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.81 60.86 2.1 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.717 -1.129 . . . . 1.52 113.189 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.47 0.535 0 C-N-CA 123.426 0.691 . . . . 2.52 112.159 175.34 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.44 0.638 . . . . 1.68 109.743 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 -177.86 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.018 -0.992 . . . . 0.65 108.719 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 144' ' ' ILE . 35.5 pt -66.16 -24.67 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.967 0.413 . . . . 0.3 111.312 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.806 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 27.5 m-85 -82.07 1.64 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.047 0.451 . . . . 0.27 110.823 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.86 -16.99 63.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.355 -0.98 . . . . 1.96 108.355 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 70.4 m-85 -110.66 178.92 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.71 -1.132 . . . . 0.4 110.125 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -124.65 144.57 50.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.764 0.316 . . . . 2.77 110.887 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.607 HG23 HD13 ' A' ' 30' ' ' LEU . 74.2 t -114.85 140.89 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.19 -0.459 . . . . 0.74 111.385 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.967 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 65.1 mt -96.71 140.71 30.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.005 -0.739 . . . . 0.72 109.005 169.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -79.07 -169.0 1.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 1.59 109.824 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB1' ' HG3' ' A' ' 97' ' ' LYS . . . -57.31 -22.52 42.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 111.944 0.35 . . . . 0.52 111.944 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.9 t70 -104.74 -2.71 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.69 0.281 . . . . 2.22 111.153 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.967 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.8 m-70 76.57 21.73 1.28 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.628 0.727 . . . . 0.73 109.644 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -83.45 153.67 65.46 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.828 -1.916 . . . . 3.25 105.828 165.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.22 113.83 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.934 1.012 . . . . 0.86 111.997 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.545 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 78.5 t80 -84.03 114.6 21.85 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.245 -0.888 . . . . 0.28 109.242 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.691 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -67.02 83.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.525 -0.761 . . . . 1.65 109.718 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.806 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -70.54 -33.11 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.236 0.541 . . . . 0.25 110.145 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.703 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -77.57 -0.77 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.427 -0.806 . . . . 0.41 112.843 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -81.69 -5.61 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.759 0.79 . . . . 1.24 108.936 172.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.664 ' HB3' ' CD2' ' A' ' 38' ' ' LEU . 75.7 m-70 -98.5 3.07 48.16 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.583 -1.19 . . . . 0.38 108.145 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 24.9 ttpt -79.3 136.18 36.95 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.749 -1.114 . . . . 1.73 109.023 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.93 -13.59 52.85 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.254 -1.139 . . . . 0.36 110.254 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 76.3 p -129.8 138.49 33.24 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 109.34 -0.615 . . . . 1.14 109.34 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.964 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 57.7 Cg_endo -74.2 155.46 46.87 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.519 1.479 . . . . 0.52 109.714 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.818 HD12 ' HB ' ' A' ' 144' ' ' ILE . 0.8 OUTLIER -159.61 152.51 21.73 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.282 0.563 . . . . 1.03 111.958 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 141' ' ' SER . 3.6 mm? -107.02 138.44 43.19 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.558 -0.904 . . . . 1.1 108.558 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 70.9 mt -127.58 118.07 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.198 -0.667 . . . . 0.2 109.198 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.834 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.3 m-85 -101.17 123.2 44.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.445 -0.343 . . . . 0.23 111.198 -172.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.721 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -80.52 92.02 5.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.003 -1.11 . . . . 1.28 108.003 169.152 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.625 HG11 ' HE1' ' A' ' 98' ' ' PHE . 5.8 p -107.99 143.19 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 113.502 0.927 . . . . 0.88 113.502 -160.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.37 101.85 1.3 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.435 -1.32 . . . . 0.52 107.435 166.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 1.005 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -59.65 87.68 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.973 -1.012 . . . . 1.84 112.882 -170.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 53.38 52.63 13.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.422 -0.808 . . . . 2.43 110.646 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.7 p -164.18 157.01 17.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.797 -0.638 . . . . 0.99 110.83 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.78 -117.2 4.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.932 -0.651 . . . . 1.09 112.717 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.61 166.98 20.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.454 0.645 . . . . 3.16 111.532 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.643 HG22 ' HE1' ' A' ' 139' ' ' PHE . 17.4 p -129.33 107.86 9.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.257 -0.883 . . . . 1.94 109.782 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 27.3 mtpt -83.47 20.07 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 2.03 112.06 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.51 13.87 29.23 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.716 -0.754 . . . . 0.47 111.826 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -40.56 16.05 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.018 -0.61 . . . . 0.34 112.286 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.2 t80 -67.9 -48.69 65.31 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.824 0.345 . . . . 0.57 110.177 -176.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.3 -43.89 97.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.9 -0.591 . . . . 2.46 110.902 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.6 m -65.75 -50.9 63.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.33 111.142 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.87 -47.59 80.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.202 0.525 . . . . 0.19 110.866 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.443 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 80.2 m -59.74 -51.81 68.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.289 -0.868 . . . . 0.3 111.552 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.4 p -65.95 -39.2 90.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.068 -0.514 . . . . 1.08 111.727 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.465 HD11 HD12 ' A' ' 163' ' ' ILE . 85.4 mt -58.73 -51.64 69.09 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 120.503 0.192 . . . . 0.81 111.062 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.735 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 82.9 t80 -53.81 -47.08 71.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.33 109.817 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -73.18 -31.65 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.426 -0.807 . . . . 1.76 111.625 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.84 -36.84 23.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.021 -0.536 . . . . 1.79 111.738 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.645 ' CD1' HD13 ' A' ' 171' ' ' LEU . 58.0 m-85 -114.16 2.05 14.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.499 1.296 . . . . 0.43 114.499 -171.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.693 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 20.4 ptmt -68.71 -16.07 63.71 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.308 -0.957 . . . . 2.11 110.083 175.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 p -59.89 -43.4 94.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.747 -0.66 . . . . 1.2 109.927 171.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -91.36 15.76 11.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 1.9 111.143 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.692 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.46 70.22 1.35 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.999 -0.619 . . . . 1.32 112.452 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.693 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 54.8 t80 -143.73 139.97 29.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.26 110.537 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.607 ' HG1' ' HE1' ' A' ' 61' ' ' TYR . 14.9 t -129.39 152.98 48.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.031 0.443 . . . . 0.51 110.077 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.735 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t -113.89 120.75 64.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.387 -0.597 . . . . 0.24 109.387 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.592 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 15.6 mt -107.3 122.13 45.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.892 -0.781 . . . . 0.51 108.892 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.04 129.71 55.46 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.329 -0.548 . . . . 0.28 110.943 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.484 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.8 m-85 -113.67 108.64 51.41 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.619 -0.719 . . . . 0.34 109.89 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.005 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 33.2 Cg_exo -59.56 156.32 37.35 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 123.505 2.803 . . . . 0.73 111.697 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 114.349 1.24 . . . . 1.54 114.349 -178.313 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.438 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 79.3 m . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 121.787 0.803 . . . . 0.91 110.4 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.767 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 14.0 t -133.58 159.89 39.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.528 -1.215 . . . . 1.92 108.372 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.775 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -58.99 95.7 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.001 0.429 . . . . 3.18 110.149 -175.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.625 ' HE1' HG11 ' A' ' 43' ' ' VAL . 3.8 p90 -54.84 134.83 48.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.059 -1.089 . . . . 1.74 108.059 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -101.64 134.08 45.33 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.548 -0.461 . . . . 3.08 111.011 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.516 ' CB ' ' HE1' ' A' ' 54' ' ' TYR . . . -136.26 -174.97 3.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.337 -0.847 . . . . 0.43 110.939 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.16 16.88 2.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 2.19 110.323 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.591 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 40.3 p90 -139.36 167.8 17.59 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.594 -0.891 . . . . 0.24 108.594 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.916 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 27.1 Cg_exo -68.6 126.95 14.77 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.683 2.922 . . . . 0.31 113.762 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.032 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -120.92 142.01 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.344 -0.613 . . . . 0.37 109.344 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.916 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 7.2 mmt -114.01 -154.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.876 0.695 . . . . 1.47 112.876 -164.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.448 ' O ' ' HD2' ' A' ' 75' ' ' PRO . . . -69.77 145.09 52.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.086 -0.961 . . . . 0.39 111.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 56.4 mttt -73.4 109.79 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.645 -0.872 . . . . 1.66 108.645 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.432 HD12 ' CB ' ' A' ' 116' ' ' HIS . 28.8 pt -121.69 157.57 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.34 -0.985 . . . . 0.47 108.34 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.2 m120 -66.32 127.02 30.63 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.819 -0.808 . . . . 2.16 108.819 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.626 ' O ' ' HB ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -121.45 88.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 C-N-CA 119.746 -0.781 . . . . 0.38 109.006 167.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.694 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 16.4 t-20 173.14 179.09 0.09 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.066 -1.087 . . . . 1.98 108.066 168.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 48.29 -137.29 15.23 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.757 0.661 . . . . 0.78 114.59 163.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -104.52 -6.95 20.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.462 -0.869 . . . . 1.98 110.186 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -84.14 -24.52 30.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.292 -0.867 . . . . 2.04 111.449 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.97 141.49 3.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.058 1.133 . . . . 0.48 114.058 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.65 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 43.8 t-80 -48.75 139.71 11.41 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 114.894 -1.048 . . . . 0.42 110.378 171.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.25 -42.55 46.88 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.899 2.399 . . . . 0.36 112.789 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.65 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.3 tm? -54.81 -42.52 71.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.062 -0.517 . . . . 1.1 110.647 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.415 ' OH ' HG22 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -76.09 -30.24 58.23 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 119.445 -0.312 . . . . 1.49 111.596 176.314 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.09 -36.9 73.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.245 -0.582 . . . . 2.37 109.755 170.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 67.6 t80 -69.21 -44.01 72.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 0.58 110.642 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.4 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.5 mtt -65.67 -51.11 62.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.255 -0.429 . . . . 0.34 110.696 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.566 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 27.8 mtpt -61.96 -40.47 95.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.623 -0.717 . . . . 0.94 111.379 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.7 ptmm? -69.19 -35.92 76.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 2.13 110.615 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 99.9 m -73.94 -46.68 42.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 0.47 111.857 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.509 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 10.4 mmtt . . . . . 0 C--N 1.321 -0.648 0 C-N-CA 120.778 -0.369 . . . . 1.75 111.677 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.694 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 113.203 0.816 . . . . 0.93 113.203 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.878 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 24.4 mm -112.98 84.4 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.054 -0.975 . . . . 1.05 111.454 -166.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -105.69 19.95 19.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.22 0.822 . . . . 1.5 113.22 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.878 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.21 168.95 18.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.873 0.368 . . . . 0.87 111.561 177.379 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -50.65 -156.61 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.678 1.591 . . . . 1.8 113.217 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.834 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 35.5 m-85 -27.4 -55.87 0.09 Allowed 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.136 1.374 . . . . 1.37 114.412 -164.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.873 HG23 ' HA ' ' A' ' 155' ' ' SER . 25.0 m 41.58 96.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.444 0.905 . . . . 0.3 113.444 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.7 ' HB2' HD12 ' A' ' 39' ' ' LEU . 35.1 p -86.48 149.26 25.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.507 -0.746 . . . . 0.8 111.274 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.431 ' O ' HD13 ' A' ' 39' ' ' LEU . 9.5 m-85 -103.09 134.08 47.12 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.598 -0.89 . . . . 0.53 108.598 167.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.925 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 28.5 tp -82.03 105.84 13.46 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 0.51 109.13 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.818 ' HB ' HD12 ' A' ' 38' ' ' LEU . 11.3 mm -106.08 131.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.312 -0.625 . . . . 0.2 109.312 -175.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -78.64 -179.17 6.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.997 -0.547 . . . . 1.3 110.83 -176.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.716 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mtp180 -64.18 -17.65 63.73 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.115 0.413 . . . . 3.78 112.115 -175.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.451 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 13.7 t70 -105.26 -16.74 14.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.37 0.605 . . . . 1.18 109.664 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.541 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.87 32.66 4.34 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.23 112.735 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.1 t -106.12 126.93 29.36 Favored Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 122.397 -0.472 . . . . 0.62 110.637 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.72 112.17 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.15 2.567 . . . . 0.3 112.22 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.498 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 22.3 t -98.41 -33.42 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.23 -0.441 . . . . 0.27 111.49 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 9.0 mm-40 -152.48 164.37 37.7 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.762 0.315 . . . . 1.22 110.966 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.566 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 18.0 ttm180 -129.37 98.87 5.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 1.75 109.836 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.925 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.4 m-85 -87.01 110.31 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.262 -0.644 . . . . 0.38 109.262 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.873 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.3 p -62.86 167.05 6.47 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.273 -0.64 . . . . 0.99 109.273 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.808 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.6 Cg_endo -70.64 -10.19 27.35 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 122.377 2.051 . . . . 0.66 112.028 -163.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.32 -10.72 84.29 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.402 -1.272 . . . . 0.52 111.178 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.46 137.03 34.78 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.431 -0.581 . . . . 0.43 109.431 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -106.33 -169.56 1.59 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.498 -0.319 . . . . 1.25 111.006 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 21.4 t -50.4 -59.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.915 -0.584 . . . . 0.41 112.376 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -67.65 -29.86 69.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.67 0.271 . . . . 3.44 110.946 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.13 -38.93 77.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.053 -0.522 . . . . 1.86 109.844 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.545 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 63.5 mt -83.12 -37.45 13.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.416 -0.811 . . . . 0.21 110.967 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.9 mt-10 -57.18 -36.7 71.12 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.551 0.574 . . . . 0.88 112.551 -174.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.528 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.0 pt-20 -58.73 -27.99 65.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.395 . . . . 0.75 111.292 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.595 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -104.78 -16.19 14.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.363 -0.38 . . . . 1.58 110.924 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.3 tp -91.22 -44.69 9.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.24 111.825 -171.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.738 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.7 mt -51.81 -49.23 84.7 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.608 0.596 . . . . 0.44 112.608 -175.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.2 Cg_exo -54.7 -39.37 89.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.024 1.816 . . . . 0.49 112.6 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.9 mt -74.2 -35.97 63.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.437 -0.347 . . . . 0.71 111.43 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.964 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 13.5 mt -57.12 -54.75 43.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.313 -0.625 . . . . 0.46 109.313 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.98 -62.24 4.74 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.777 -1.101 . . . . 1.52 112.513 171.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 109.482 -0.562 . . . . 2.52 109.482 177.037 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.894 0.378 . . . . 1.68 110.324 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 m -126.09 170.5 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.995 -1.113 . . . . 0.65 107.995 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.634 HD13 HG21 ' A' ' 144' ' ' ILE . 32.5 pt -52.22 -28.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 118.764 0.711 . . . . 0.3 112.902 -173.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.763 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 14.8 m-85 -81.68 5.91 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.997 0.427 . . . . 0.27 111.614 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.86 -19.7 62.61 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.021 -1.104 . . . . 1.96 108.021 171.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 49.9 m-85 -106.7 179.32 4.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.425 -1.261 . . . . 0.4 110.531 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.85 148.09 43.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.518 -0.31 . . . . 2.77 110.201 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 30' ' ' LEU . 71.7 t -118.19 150.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.054 0.454 . . . . 0.74 111.702 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.747 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 88.8 mt -108.16 143.38 37.02 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.131 -0.486 . . . . 0.72 110.003 173.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.637 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 21.7 t70 -72.97 177.37 4.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.102 -0.954 . . . . 1.59 108.764 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -52.94 -32.85 48.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.337 0.589 . . . . 0.52 110.318 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 22.5 t70 -79.49 -18.25 52.4 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.353 -0.839 . . . . 2.22 112.029 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.747 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.1 m-70 87.41 6.01 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.853 0.861 . . . . 0.73 111.851 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 2.8 ptmt -70.77 160.93 80.35 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.905 -1.146 . . . . 3.25 107.905 162.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.3 117.19 3.89 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 121.421 1.414 . . . . 0.86 112.632 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.538 ' HB3' HG12 ' A' ' 20' ' ' VAL . 89.0 t80 -91.05 119.42 31.19 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.97 -0.752 . . . . 0.28 108.97 170.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.1 t30 -73.81 84.68 1.67 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.525 -0.47 . . . . 1.65 110.002 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.729 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -62.35 -31.55 72.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.466 0.651 . . . . 0.25 110.469 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.763 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.6 p -77.2 -0.06 2.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.182 -0.917 . . . . 0.41 113.203 -167.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.9 pt20 -78.91 -5.82 54.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.658 0.742 . . . . 1.24 109.202 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.556 ' HB3' HD13 ' A' ' 38' ' ' LEU . 92.8 m-70 -97.41 -1.07 45.14 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.908 -1.042 . . . . 0.38 108.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.681 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -77.09 130.99 38.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.987 -1.461 . . . . 1.73 108.975 178.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' N ' ' HD2' ' A' ' 34' ' ' LYS . . . 109.87 -15.19 31.51 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.042 -0.823 . . . . 0.36 111.042 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.8 m -136.17 155.04 77.7 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.064 -0.717 . . . . 1.14 109.064 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.0 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 73.3 Cg_endo -77.73 154.72 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.004 1.803 . . . . 0.52 111.8 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.62 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.3 pt? -158.96 159.92 35.43 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.248 0.546 . . . . 1.03 111.229 -176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -114.21 155.1 26.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.449 -0.796 . . . . 1.1 109.236 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 72' ' ' LEU . 84.4 mt -141.29 119.12 8.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.558 -0.534 . . . . 0.2 109.558 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.833 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.7 m-85 -105.59 123.67 48.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.909 -0.316 . . . . 0.23 111.06 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.663 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -78.56 92.25 4.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.829 -0.804 . . . . 1.28 108.829 168.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.585 HG11 ' CE1' ' A' ' 98' ' ' PHE . 2.9 p -108.06 131.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.935 0.717 . . . . 0.88 112.935 -166.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.08 110.71 0.99 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.718 -1.216 . . . . 0.52 107.718 167.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.979 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -70.79 85.93 0.67 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.787 -1.097 . . . . 1.84 113.563 -162.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 48.8 tptt 71.7 39.56 0.86 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.648 -0.705 . . . . 2.43 110.204 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.2 p -154.23 142.28 20.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.787 -0.642 . . . . 0.99 110.96 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.66 -130.0 10.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.521 -0.847 . . . . 1.09 112.966 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.85 131.71 24.37 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.592 -0.521 . . . . 3.16 109.592 -173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.447 HG22 ' CE1' ' A' ' 139' ' ' PHE . 72.6 p -83.09 109.69 17.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.627 0.727 . . . . 1.94 109.791 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 1.069 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 26.4 mtpp -79.86 11.56 3.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.363 -0.835 . . . . 2.03 111.2 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.21 28.4 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.64 -0.584 . . . . 0.47 111.64 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.35 -42.62 10.25 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.286 -0.483 . . . . 0.34 112.013 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 1.4 t80 -70.14 -47.43 61.74 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 0.57 109.835 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 53.9 mp0 -56.17 -50.77 70.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.867 -1.06 . . . . 2.46 110.397 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.712 HG23 ' HA ' ' A' ' 160' ' ' VAL . 54.9 m -67.48 -47.15 70.88 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.824 -1.08 . . . . 0.33 111.101 -176.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.872 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.66 -49.51 74.82 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.19 111.35 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.9 m -58.43 -48.41 80.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.448 -0.796 . . . . 0.3 110.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.9 m -60.77 -46.85 88.86 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.301 -0.863 . . . . 1.08 111.524 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.584 HD13 HD22 ' A' ' 39' ' ' LEU . 62.1 mt -59.05 -50.35 74.4 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.274 -0.421 . . . . 0.81 111.183 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.528 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 15.0 t80 -47.01 -53.63 12.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.057 0.848 . . . . 0.33 110.032 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -73.93 -34.99 64.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.217 -0.901 . . . . 1.76 111.452 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -75.97 -35.77 59.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.007 -0.542 . . . . 1.79 111.255 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.812 ' CD1' HD13 ' A' ' 171' ' ' LEU . 62.7 m-85 -118.15 15.43 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.805 1.039 . . . . 0.43 113.805 -173.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.8 mmmt -59.54 -21.36 60.13 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.686 -0.406 . . . . 2.11 110.388 171.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.87 -41.62 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.84 -0.618 . . . . 1.2 110.35 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.517 ' HG3' ' HB3' ' A' ' 171' ' ' LEU . 33.7 mm-40 -76.27 -10.56 59.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.972 -0.558 . . . . 1.9 110.318 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.32 20.73 29.14 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 1.32 110.868 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CE1' HD13 ' A' ' 39' ' ' LEU . 88.5 t80 -79.78 136.58 36.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.243 -0.479 . . . . 0.26 110.628 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -130.82 145.85 52.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.382 -0.599 . . . . 0.51 109.382 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.872 HG11 ' HB1' ' A' ' 57' ' ' ALA . 51.4 t -110.08 109.32 27.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.2 -0.667 . . . . 0.24 109.2 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.612 ' HB2' HG12 ' A' ' 40' ' ' ILE . 23.8 mt -91.65 120.98 32.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.489 -0.93 . . . . 0.51 108.489 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.073 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.82 112.92 25.43 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.221 -0.592 . . . . 0.28 110.68 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.3 m-85 -97.12 110.63 54.95 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.54 -0.755 . . . . 0.34 109.03 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.01 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.91 169.78 3.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.395 2.73 . . . . 0.73 111.365 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 69.7 m . . . . . 0 N--CA 1.437 -1.076 0 N-CA-C 113.889 1.07 . . . . 1.54 113.889 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.415 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 24.9 m . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 121.655 0.741 . . . . 0.91 112.779 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -156.38 119.56 4.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.722 -1.127 . . . . 1.92 109.804 168.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.3 mttp 54.52 100.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.062 0.764 . . . . 3.18 113.062 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.658 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 37.9 p90 -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.776 -0.577 . . . . 1.74 110.688 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 68.15 145.81 0.05 OUTLIER 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.099 0.875 . . . . 3.08 111.145 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.619 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -172.69 -173.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.41 . . . . 0.43 112.083 -176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -83.67 -11.88 56.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 2.19 110.155 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.814 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 39.0 p90 -113.34 169.04 6.86 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 115.405 -0.816 . . . . 0.24 109.196 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.918 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 21.2 Cg_exo -71.41 122.12 8.36 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 123.556 2.837 . . . . 0.31 112.999 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.073 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.5 mp -110.79 139.65 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.909 -0.775 . . . . 0.37 108.909 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.918 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 10.1 mmt -112.07 -154.74 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.648 0.737 . . . . 1.47 112.909 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -71.63 133.78 45.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.674 -1.148 . . . . 0.39 110.116 173.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.01 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttt -70.27 126.04 28.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.692 0.758 . . . . 1.66 109.457 171.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.613 HG13 HG13 ' A' ' 110' ' ' VAL . 9.6 pt -121.47 167.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.262 -1.335 . . . . 0.47 107.915 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 34.6 t-20 -85.28 63.97 8.4 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.434 -0.506 . . . . 2.16 109.672 -175.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -64.55 88.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 120.727 -0.389 . . . . 0.38 110.799 -177.113 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.576 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 56.7 t30 173.05 178.63 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 1.98 108.243 167.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.04 -142.31 31.67 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 114.344 0.497 . . . . 0.78 114.344 165.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -105.84 -1.63 24.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.589 0.709 . . . . 1.98 110.039 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -106.49 2.43 26.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.074 -0.967 . . . . 2.04 111.192 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -62.6 154.58 28.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.728 -0.669 . . . . 0.48 112.242 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.681 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 33.7 t-80 -47.96 138.47 10.06 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.586 -0.734 . . . . 0.42 110.046 172.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.12 -39.16 51.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.138 2.559 . . . . 0.36 112.436 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.681 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -60.45 -39.63 88.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 1.1 111.332 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.635 ' HE2' HD21 ' A' ' 42' ' ' ASN . 1.9 m-85 -75.61 -28.89 59.05 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 116.445 -0.343 . . . . 1.49 110.813 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.56 -36.91 74.66 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.867 -0.733 . . . . 2.37 109.426 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 50.9 t80 -71.77 -45.85 60.29 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.738 -0.385 . . . . 0.58 110.6 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.49 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . 66.5 mtt -61.46 -54.92 37.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.314 -0.403 . . . . 0.34 111.442 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.0 mtpt -62.97 -36.9 85.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.94 111.359 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.35 -31.59 67.55 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.843 0.354 . . . . 2.13 110.301 -179.167 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.514 HG21 ' HD2' ' A' ' 150' ' ' PRO . 97.3 m -73.89 -38.64 64.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.47 111.256 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 151' ' ' VAL . 32.2 mmtm . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.867 0.365 . . . . 1.75 111.15 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 112.79 0.663 . . . . 0.93 112.79 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.854 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 49.2 mt -97.76 84.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.942 -1.027 . . . . 1.05 110.742 -171.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -108.61 25.28 11.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.524 0.564 . . . . 1.5 112.524 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.854 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.08 170.14 21.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.281 0.474 . . . . 0.87 112.281 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 44' ' ' ALA . 16.2 m120 -52.49 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.48 1.512 . . . . 1.8 113.41 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.833 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 68.5 m-85 -25.89 -59.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.399 0 C-N-CA 125.529 1.532 . . . . 1.37 113.957 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.913 HG23 ' HA ' ' A' ' 155' ' ' SER . 18.0 m 42.43 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.209 0.818 . . . . 0.3 113.209 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.696 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 15.0 p -87.1 151.94 22.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.546 -0.862 . . . . 0.8 111.496 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -103.78 134.6 46.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.287 -1.005 . . . . 0.53 108.287 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.701 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.2 tp -82.08 106.15 13.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.107 -0.701 . . . . 0.51 109.107 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.634 HG21 HD13 ' A' ' 15' ' ' ILE . 16.0 mm -106.42 123.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.021 -0.536 . . . . 0.2 109.736 -171.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -177.41 4.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.374 -0.376 . . . . 1.3 110.595 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 146' ' ' ARG . 51.9 mtt-85 -66.27 -9.58 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.675 0.62 . . . . 3.78 112.675 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -108.0 -21.91 12.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.18 110.066 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 106.07 31.65 4.05 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.637 -0.792 . . . . 0.23 112.698 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.48 121.29 41.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.891 -0.411 . . . . 0.62 109.891 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.514 ' HD2' HG21 ' A' ' 125' ' ' THR . 44.8 Cg_exo -58.07 116.39 3.2 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.992 2.462 . . . . 0.3 112.223 176.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.609 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 31.8 t -96.07 -25.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.809 -0.632 . . . . 0.27 110.275 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.65 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 9.0 mm-40 -156.29 159.03 38.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.371 -0.377 . . . . 1.22 111.246 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.489 HH11 ' HH2' ' A' ' 137' ' ' TRP . 20.3 ttm180 -120.65 97.02 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.471 -0.566 . . . . 1.75 109.471 168.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.701 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 52.6 m-85 -85.22 110.17 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.277 -0.638 . . . . 0.38 109.277 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.913 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.4 p -63.39 166.25 9.33 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.831 -0.433 . . . . 0.99 109.831 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.069 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 58.7 Cg_endo -72.07 -2.19 11.19 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.371 2.047 . . . . 0.66 113.058 -163.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -96.45 8.74 66.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.631 -0.713 . . . . 0.52 112.317 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.61 140.17 30.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 0.43 110.249 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.488 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 57.3 m -86.76 170.68 11.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.199 -0.455 . . . . 1.25 111.309 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.712 ' HA ' HG23 ' A' ' 56' ' ' THR . 49.0 t -55.41 -51.82 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 0.41 111.584 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 161' ' ' LYS . 20.2 tptt -68.83 -26.84 65.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 3.44 110.622 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.488 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.7 m-20 -64.19 -31.81 73.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 1.86 110.27 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.757 HG21 HD21 ' A' ' 39' ' ' LEU . 59.1 mt -83.04 -45.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.902 -0.59 . . . . 0.21 110.529 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -52.68 -39.01 61.51 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.839 0.681 . . . . 0.88 112.839 -176.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -55.52 -31.35 62.01 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.872 0.323 . . . . 0.75 111.872 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.65 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 72.3 mttt -106.32 -9.67 16.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.389 . . . . 1.58 110.976 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 58.7 tp -91.52 -41.61 10.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 0.24 111.775 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.757 ' HA ' HD12 ' A' ' 171' ' ' LEU . 71.6 mt -50.61 -48.71 81.71 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 112.998 0.74 . . . . 0.44 112.998 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.491 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.64 -32.39 90.36 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.099 1.866 . . . . 0.49 112.745 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 151' ' ' VAL . 76.6 mt -80.8 -35.22 33.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.776 -0.193 . . . . 0.71 110.865 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.0 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.2 mt -59.0 -41.48 87.77 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.697 -0.853 . . . . 0.46 108.697 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.34 -81.14 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.21 -1.359 . . . . 1.52 111.129 162.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.762 0.315 . . . . 2.52 110.293 175.504 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.219 0.533 . . . . 1.68 110.563 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.6 p -142.91 172.21 13.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.65 110.192 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.68 HD13 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -59.05 -29.64 41.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.418 0.525 . . . . 0.3 112.418 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.79 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 36.5 m-85 -77.33 0.0 23.89 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.861 0.319 . . . . 0.27 111.861 -172.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.7 -23.26 65.27 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.319 -0.993 . . . . 1.96 108.319 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 53.7 m-85 -102.67 174.61 5.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.731 -1.122 . . . . 0.4 109.792 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -108.56 165.63 11.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.869 0.366 . . . . 2.77 110.658 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.579 HG23 HD13 ' A' ' 30' ' ' LEU . 73.8 t -135.66 151.79 30.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.577 -0.527 . . . . 0.74 109.577 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.869 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 66.8 mt -113.6 148.63 35.85 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.673 -0.492 . . . . 0.72 109.673 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.653 ' CB ' ' HE3' ' A' ' 26' ' ' LYS . 5.8 t0 -78.49 -176.43 4.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.991 -1.114 . . . . 1.59 107.991 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -56.96 -29.92 63.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.462 0.649 . . . . 0.52 110.459 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 5.4 t70 -80.29 -20.01 45.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.324 -0.853 . . . . 2.22 111.981 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.869 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 18.5 m-70 83.77 7.49 0.64 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.779 0.832 . . . . 0.73 111.893 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.653 ' HE3' ' CB ' ' A' ' 22' ' ' ASP . 28.9 pttt -65.09 148.12 98.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 107.282 -1.377 . . . . 3.25 107.282 157.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 21' ' ' LEU . 19.0 Cg_endo -61.55 116.66 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.241 1.294 . . . . 0.86 112.331 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.463 ' HB3' HG12 ' A' ' 20' ' ' VAL . 86.3 t80 -80.23 124.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.006 -0.997 . . . . 0.28 110.333 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.627 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -68.98 82.78 0.31 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.703 -0.68 . . . . 1.65 109.757 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.79 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -72.45 -31.78 65.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.42 0.629 . . . . 0.25 110.136 -177.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.692 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 p -77.13 -0.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.333 -0.849 . . . . 0.41 112.494 -169.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.7 pt20 -78.84 -9.4 59.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.566 0.698 . . . . 1.24 109.311 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -91.69 -7.97 48.36 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.156 -1.053 . . . . 0.38 108.156 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 21.3 ttpp -70.72 133.68 46.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.53 -1.214 . . . . 1.73 109.354 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.46 -5.35 54.86 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.024 -1.231 . . . . 0.36 110.024 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 15.5 m -140.46 144.29 36.21 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.851 -0.796 . . . . 1.14 108.851 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.063 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 52.6 Cg_endo -73.28 150.55 47.34 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.651 1.567 . . . . 0.52 110.794 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.608 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -153.0 153.51 33.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.324 0.583 . . . . 1.03 111.089 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.779 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -108.33 152.69 24.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.982 -0.747 . . . . 1.1 108.982 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 88.6 mt -137.29 118.21 17.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.417 -0.586 . . . . 0.2 109.417 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.825 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -100.29 123.15 44.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.459 -0.337 . . . . 0.23 110.532 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.65 ' HB2' HG21 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -82.41 90.8 6.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.041 -1.096 . . . . 1.28 108.041 168.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.663 HG11 ' HE2' ' A' ' 98' ' ' PHE . 2.2 p -112.2 132.42 60.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 112.575 0.583 . . . . 0.88 112.575 -163.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -64.52 102.12 0.52 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.938 -1.505 . . . . 0.52 106.938 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.983 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 34.4 t -69.57 90.11 0.55 Allowed 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.432 -0.803 . . . . 1.84 112.236 -165.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt 66.97 49.84 1.1 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.935 -1.03 . . . . 2.43 110.813 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.9 m -135.75 126.43 27.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.719 -0.673 . . . . 0.99 109.761 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.52 -129.91 17.43 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.902 -0.666 . . . . 1.09 112.989 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.98 154.18 19.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.838 0.351 . . . . 3.16 111.044 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.7 p -91.54 -24.49 19.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.317 -0.401 . . . . 1.94 111.49 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 26.3 mtpp 64.04 3.75 1.8 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.644 -0.707 . . . . 2.03 112.069 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.11 -5.01 41.65 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.814 -0.708 . . . . 0.47 112.565 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -35.57 92.14 Favored Glycine 0 CA--C 1.505 -0.585 0 N-CA-C 111.982 -0.447 . . . . 0.34 111.982 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.509 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -67.92 -48.81 64.94 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 110.286 -0.265 . . . . 0.57 110.286 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.44 -52.87 62.16 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.473 0.654 . . . . 2.46 110.167 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 160' ' ' VAL . 34.7 m -63.11 -47.55 82.35 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.619 -1.173 . . . . 0.33 111.32 -176.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.65 -46.96 87.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.829 0.347 . . . . 0.19 111.401 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.6 m -60.13 -53.68 54.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.778 -0.646 . . . . 0.3 111.393 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 p -62.52 -42.03 99.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 1.08 111.854 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.503 HD13 HD22 ' A' ' 39' ' ' LEU . 93.4 mt -58.92 -52.45 65.68 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 120.514 0.197 . . . . 0.81 111.477 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.691 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 89.4 t80 -54.62 -47.16 73.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.915 -0.584 . . . . 0.33 109.996 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -70.63 -41.03 72.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.533 -0.758 . . . . 1.76 111.394 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.32 -43.59 50.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 1.79 111.647 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.9 m-85 -102.19 4.5 39.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.728 1.01 . . . . 0.43 113.728 -171.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -58.3 -30.08 66.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 2.11 109.982 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -65.53 -26.4 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 1.2 111.484 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.2 13.16 32.81 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.877 0.37 . . . . 1.9 111.095 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.71 63.42 1.84 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.95 -0.643 . . . . 1.32 112.585 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.535 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 69.0 t80 -132.09 142.09 49.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.552 -0.166 . . . . 0.26 110.552 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.608 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.16 143.29 50.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.129 -0.323 . . . . 0.51 110.129 177.567 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.691 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 29.3 t -113.27 114.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.993 0.425 . . . . 0.24 110.185 170.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 30.8 mt -100.47 122.44 43.2 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.978 -0.749 . . . . 0.51 108.978 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -106.99 112.84 25.99 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.113 -0.635 . . . . 0.28 110.252 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-30 -93.9 110.13 45.85 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.106 -1.072 . . . . 0.34 108.106 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.087 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.3 Cg_exo -58.62 169.22 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.81 2.34 . . . . 0.73 110.953 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 27.1 t . . . . . 0 N--CA 1.43 -1.466 0 C-N-CA 119.5 -0.88 . . . . 1.54 111.876 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.441 -0.902 0 CA-C-O 121.565 0.698 . . . . 0.91 111.05 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -149.16 128.69 13.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.562 -1.199 . . . . 1.92 108.029 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -14.07 104.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.775 1.297 . . . . 3.18 113.525 -172.542 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.663 ' HE2' HG11 ' A' ' 43' ' ' VAL . 34.5 p90 -66.55 -20.74 66.09 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.04 -0.982 . . . . 1.74 111.365 -170.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 67.55 147.61 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 124.041 0.838 . . . . 3.08 111.178 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.45 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -169.93 -154.69 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.105 0.479 . . . . 0.43 112.22 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 -5.74 58.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.559 -0.746 . . . . 2.19 109.884 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.789 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 45.4 p90 -128.28 164.8 35.24 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.182 -0.917 . . . . 0.24 109.135 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 32.4 Cg_exo -66.33 109.03 1.48 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 123.658 2.906 . . . . 0.31 113.701 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mp -104.15 128.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.957 -0.757 . . . . 0.37 108.957 172.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.581 ' HE2' ' HA ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -109.49 -148.64 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.852 0.686 . . . . 1.47 112.852 -160.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.754 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -75.54 136.81 40.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.168 -0.924 . . . . 0.39 110.669 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.087 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 15.3 pttp -79.45 128.58 33.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.688 0.756 . . . . 1.66 110.384 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.569 HG13 HG13 ' A' ' 110' ' ' VAL . 3.2 pt -122.77 160.69 25.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.312 -1.313 . . . . 0.47 107.845 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.708 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.4 t-20 -75.93 82.66 2.83 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.187 -1.042 . . . . 2.16 108.187 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.15 86.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 118.842 -1.143 . . . . 0.38 108.944 177.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 55.8 t30 172.44 178.57 0.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.545 -0.909 . . . . 1.98 108.545 170.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.28 -145.62 17.05 Favored Glycine 0 C--O 1.236 0.23 0 N-CA-C 115.211 0.844 . . . . 0.78 115.211 163.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.46 -15.74 25.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.464 -0.868 . . . . 1.98 110.56 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -94.08 1.28 56.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.617 0.722 . . . . 2.04 110.529 -169.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.18 140.13 45.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.094 -0.957 . . . . 0.48 112.346 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.552 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 45.1 t-80 -50.75 137.25 25.19 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.179 -0.919 . . . . 0.42 110.502 172.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.516 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -45.08 -45.52 14.34 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.89 2.393 . . . . 0.36 112.792 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.552 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.8 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.942 -0.572 . . . . 1.1 111.715 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -75.89 -29.0 58.32 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 119.609 -0.234 . . . . 1.49 111.105 177.23 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.13 -43.36 78.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.886 -0.783 . . . . 2.37 108.886 168.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.8 t80 -66.63 -45.09 80.2 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.569 0.543 . . . . 0.58 110.652 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.508 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 67.1 mtt -63.83 -53.52 49.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.461 -0.336 . . . . 0.34 111.31 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.47 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 26.4 mtpt -60.89 -41.59 96.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.94 111.002 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.9 ptmt -71.12 -35.39 71.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 2.13 111.108 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.1 m -75.79 -36.5 59.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.924 -0.58 . . . . 0.47 111.189 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 112.546 0.573 . . . . 1.75 112.546 -176.804 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.119 0.485 . . . . 0.93 111.892 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.823 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 44.8 mt -114.95 94.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.488 -0.778 . . . . 1.05 110.568 -171.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -110.56 9.89 23.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.292 0.849 . . . . 1.5 113.292 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.823 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -140.04 168.91 18.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.783 0.66 . . . . 0.87 112.783 -177.047 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 22.5 m120 -43.67 -156.14 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 126.552 1.941 . . . . 1.8 115.494 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.825 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.2 m-85 -28.02 -55.19 0.11 Allowed 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 113.897 -1.501 . . . . 1.37 113.386 -169.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.818 HG23 ' HA ' ' A' ' 155' ' ' SER . 18.9 m 40.2 96.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.386 0.884 . . . . 0.3 113.386 175.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 7.7 p -85.2 152.7 23.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.789 -0.764 . . . . 0.8 111.129 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 4.9 m-85 -102.61 162.42 12.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.215 -1.402 . . . . 0.53 107.215 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.833 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.5 tp -107.32 105.07 14.85 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.603 -0.888 . . . . 0.51 108.603 177.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.68 HG21 HD13 ' A' ' 15' ' ' ILE . 17.9 mm -103.78 119.8 52.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.844 -0.798 . . . . 0.2 108.844 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -69.81 179.24 2.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 1.3 110.651 -176.106 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.654 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -57.99 -20.61 39.65 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.846 0.355 . . . . 3.78 111.619 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.442 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 1.0 OUTLIER -109.12 -13.8 14.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.113 0.482 . . . . 1.18 110.389 -167.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.532 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.51 32.61 4.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.782 -0.645 . . . . 0.23 113.271 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 59.3 t -109.15 118.93 50.05 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 122.466 -0.432 . . . . 0.62 110.165 175.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.445 ' HG3' ' HA ' ' A' ' 122' ' ' MET . 14.3 Cg_endo -61.48 112.26 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.3 111.969 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.3 t -94.47 -30.19 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.909 -0.587 . . . . 0.27 111.14 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -154.51 165.13 37.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 1.22 110.916 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.47 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 14.5 ttm180 -134.18 98.5 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 1.75 109.854 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.833 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 9.3 m-85 -85.9 136.65 33.2 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.38 108.006 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.818 ' HA ' HG23 ' A' ' 140' ' ' THR . 25.2 p -79.83 178.72 2.17 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.748 -0.781 . . . . 0.99 109.626 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.767 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 56.6 Cg_endo -67.05 -20.63 50.29 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.616 1.544 . . . . 0.66 110.99 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.13 13.24 45.98 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.618 -1.174 . . . . 0.52 112.17 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.36 139.67 30.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.901 0.381 . . . . 0.43 110.52 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.0 p -90.1 163.93 14.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.163 -0.471 . . . . 1.25 110.882 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.4 t -49.9 -57.61 2.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 O-C-N 123.346 0.404 . . . . 0.41 111.602 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 164' ' ' GLU . 18.7 ptpt -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.539 -0.301 . . . . 3.44 111.517 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.94 -32.69 74.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.41 0.624 . . . . 1.86 109.651 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.779 HG21 HD21 ' A' ' 39' ' ' LEU . 36.6 mt -82.06 -37.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.549 -0.75 . . . . 0.21 110.049 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 46.9 mt-10 -57.96 -40.64 81.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.88 112.147 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.581 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.0 pt-20 -56.73 -31.35 64.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.651 -0.42 . . . . 0.75 111.551 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.581 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 23.0 mmmt -98.37 -16.95 19.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.104 0.478 . . . . 1.58 110.289 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.595 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -92.94 -43.13 9.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.776 -0.647 . . . . 0.24 111.765 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.835 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.3 mt -51.33 -49.89 79.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.463 0.542 . . . . 0.44 112.463 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 9.9 Cg_endo -54.26 -37.89 88.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.175 1.916 . . . . 0.49 112.532 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 48.2 mt -76.97 -37.18 55.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.778 -0.192 . . . . 0.71 111.462 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.063 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 10.1 mt -57.7 -48.38 79.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.819 -0.808 . . . . 0.46 108.819 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.37 -66.91 2.49 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.278 -1.328 . . . . 1.52 112.675 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 N--CA 1.466 0.368 0 C-N-CA 122.481 0.312 . . . . 2.52 110.49 -179.581 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.342 0.591 . . . . 1.68 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.8 p -130.46 -173.66 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.817 -0.809 . . . . 0.65 108.817 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 144' ' ' ILE . 17.7 pt -61.23 -25.8 37.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 0.3 110.877 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.809 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.9 m-85 -83.91 2.34 39.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.27 110.994 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.57 -20.95 63.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.795 -1.187 . . . . 1.96 107.795 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 42.4 m-85 -106.24 178.32 4.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.409 -1.269 . . . . 0.4 109.668 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -124.86 149.19 47.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.43 -0.35 . . . . 2.77 110.321 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.62 HG23 HD13 ' A' ' 30' ' ' LEU . 77.5 t -114.7 145.56 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.14 0.495 . . . . 0.74 111.785 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.952 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 77.5 mt -101.18 132.38 46.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.741 . . . . 0.72 109.201 171.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.03 -170.33 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.562 . . . . 1.59 109.481 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.9 57.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.619 -0.264 . . . . 0.52 111.624 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -94.36 -4.13 49.1 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.249 -0.282 . . . . 2.22 110.982 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.952 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 20.6 m-70 75.48 26.42 1.14 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.753 0.787 . . . . 0.73 109.532 -177.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.634 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -87.82 147.11 40.37 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 105.309 -2.108 . . . . 3.25 105.309 165.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 113.89 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.707 0.931 . . . . 0.86 111.953 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.446 ' HB3' HG12 ' A' ' 20' ' ' VAL . 80.5 t80 -82.24 116.76 21.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.081 -0.963 . . . . 0.28 109.078 172.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.657 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -66.31 82.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.758 -0.655 . . . . 1.65 109.734 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.809 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -70.53 -34.27 72.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.902 -0.59 . . . . 0.25 110.498 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.686 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.36 -0.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.348 -0.842 . . . . 0.41 112.812 -168.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 14.9 pt20 -82.88 -6.47 59.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.964 -0.754 . . . . 1.24 108.964 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.468 ' O ' HD21 ' A' ' 38' ' ' LEU . 81.9 m-70 -94.82 -2.69 50.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.803 -1.184 . . . . 0.38 107.803 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -76.67 141.36 40.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.761 -1.108 . . . . 1.73 109.392 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.88 65.85 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 109.761 -1.336 . . . . 0.36 109.761 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.646 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -129.11 143.03 47.21 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.349 -0.926 . . . . 1.14 109.016 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.979 ' HG2' HD23 ' A' ' 171' ' ' LEU . 63.1 Cg_endo -77.72 142.05 19.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.145 1.897 . . . . 0.52 111.133 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.041 HD22 HG22 ' A' ' 70' ' ' THR . 0.2 OUTLIER -139.44 162.84 34.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.218 0.533 . . . . 1.03 110.753 -172.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.691 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -117.86 149.98 39.95 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.692 -0.855 . . . . 1.1 108.692 168.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -136.28 119.67 23.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.406 -0.59 . . . . 0.2 109.406 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.796 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 25.2 m-85 -103.41 123.61 47.17 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.593 0.235 . . . . 0.23 111.268 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.73 ' HB2' HG21 ' A' ' 110' ' ' VAL . 0.7 OUTLIER -81.24 91.79 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.415 -1.328 . . . . 1.28 107.415 167.255 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.4 p -107.6 140.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.522 0.934 . . . . 0.88 113.522 -159.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.7 101.99 0.23 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.578 -1.192 . . . . 0.52 108.444 167.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.971 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -68.4 87.43 0.3 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.67 -1.15 . . . . 1.84 112.76 -170.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 tttm 78.21 -34.94 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.635 0.774 . . . . 2.43 111.649 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.91 125.69 53.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.649 0.262 . . . . 0.99 110.486 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.89 -136.32 5.42 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.558 -0.83 . . . . 1.09 112.028 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.529 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 29.1 t80 -132.7 156.66 46.6 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.349 -0.612 . . . . 3.16 109.349 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.5 p -119.25 114.7 22.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.338 0.589 . . . . 1.94 110.535 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 18.3 ttmm -100.7 15.78 27.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.5 -0.773 . . . . 2.03 109.822 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.13 18.93 9.35 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.906 -0.664 . . . . 0.47 111.516 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 -52.24 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.316 -0.468 . . . . 0.34 112.536 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.607 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -66.48 -48.69 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.18 0.514 . . . . 0.57 109.945 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.544 ' HG2' ' H ' ' A' ' 56' ' ' THR . 1.6 pm0 -57.83 -53.47 57.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.017 -0.992 . . . . 2.46 110.892 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.544 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 95.0 m -64.14 -42.43 96.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 0.33 111.483 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.71 -49.87 75.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.97 0.414 . . . . 0.19 111.001 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -60.19 -52.39 65.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.6 -0.727 . . . . 0.3 111.353 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -59.84 -47.44 85.71 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.881 -0.599 . . . . 1.08 111.63 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 39' ' ' LEU . 77.9 mt -55.32 -50.85 68.53 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.424 0.154 . . . . 0.81 111.326 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.77 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 40.1 t80 -46.78 -56.14 6.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.124 0.89 . . . . 0.33 109.774 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 90.2 m-20 -74.19 -33.75 63.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.454 -0.794 . . . . 1.76 110.936 -170.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -70.43 -41.2 73.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.227 -0.897 . . . . 1.79 111.052 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.552 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.0 m-85 -118.14 14.06 13.92 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 114.076 1.139 . . . . 0.43 114.076 -172.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.77 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 34.8 mtmt -56.78 -29.12 62.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.162 0.506 . . . . 2.11 110.156 172.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -59.36 -40.26 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.436 -0.802 . . . . 1.2 111.464 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.07 8.22 27.73 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.698 0.285 . . . . 1.9 110.967 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 83.82 67.9 1.43 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.581 -0.819 . . . . 1.32 111.689 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 39' ' ' LEU . 73.8 t80 -133.77 135.06 43.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.651 0.262 . . . . 0.26 110.668 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 1.041 HG22 HD22 ' A' ' 38' ' ' LEU . 4.2 t -131.15 140.81 50.01 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.85 -0.426 . . . . 0.51 109.85 175.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.603 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 39.2 t -104.48 114.17 43.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.603 -0.517 . . . . 0.24 109.603 171.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.618 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 13.8 mt -98.63 121.11 40.16 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.672 -0.862 . . . . 0.51 108.672 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.017 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.67 120.1 41.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.302 -0.559 . . . . 0.28 110.918 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.467 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.8 m-85 -105.5 109.24 62.98 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.417 -0.811 . . . . 0.34 109.044 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.971 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 32.0 Cg_exo -60.68 168.72 6.47 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.661 2.907 . . . . 0.73 111.614 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.7 t . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 115.312 1.597 . . . . 1.54 115.312 -178.533 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 45' ' ' SER . 74.2 m . . . . . 0 N--CA 1.441 -0.912 0 CA-C-O 121.941 0.877 . . . . 0.91 110.775 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.871 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 11.5 t -151.66 162.85 40.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.483 -1.69 . . . . 1.92 108.335 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.669 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.12 105.32 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.785 0.678 . . . . 3.18 111.125 177.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.607 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 49.6 p90 -60.61 -23.84 65.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.737 -0.665 . . . . 1.74 111.377 -174.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? 69.75 131.69 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.994 0.808 . . . . 3.08 111.132 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -155.9 -163.61 1.53 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.097 -0.502 . . . . 0.43 112.191 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.44 -14.82 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 2.19 110.064 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.733 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 47.0 p90 -115.32 168.11 8.81 Favored Pre-proline 0 N--CA 1.443 -0.802 0 CA-C-N 115.127 -0.942 . . . . 0.24 109.495 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.878 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.6 Cg_exo -71.06 121.53 7.92 Favored 'Trans proline' 0 N--CA 1.478 0.574 0 C-N-CA 123.932 3.088 . . . . 0.31 113.058 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.017 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -114.55 137.13 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.939 -0.763 . . . . 0.37 108.939 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.878 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 7.8 mmt -111.75 -151.63 0.48 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.524 0.678 . . . . 1.47 112.678 -165.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.74 131.97 43.86 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.77 -1.104 . . . . 0.39 110.764 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.871 ' HD3' ' HA ' ' A' ' 96' ' ' THR . 3.6 mtmt -64.95 122.02 16.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.932 -0.766 . . . . 1.66 108.932 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.727 HG13 HG13 ' A' ' 110' ' ' VAL . 10.7 pt -122.17 149.84 25.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.641 -1.244 . . . . 0.47 107.641 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -77.28 71.31 3.76 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.999 -0.741 . . . . 2.16 108.999 -177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.73 HG21 ' HB2' ' A' ' 42' ' ' ASN . 2.0 m -64.69 88.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-O 120.868 0.366 . . . . 0.38 110.854 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.605 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 47.9 t30 173.04 177.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.983 -1.117 . . . . 1.98 107.983 163.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.51 -136.85 21.85 Favored Glycine 0 CA--C 1.511 -0.181 0 C-N-CA 121.307 -0.473 . . . . 0.78 113.675 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.29 -9.17 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.182 0.515 . . . . 1.98 110.369 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -83.09 -4.89 58.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.554 -0.748 . . . . 2.04 110.792 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.8 57.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 0.48 111.817 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.638 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 46.3 t-80 -50.4 137.83 22.12 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.947 -1.024 . . . . 0.42 110.281 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.71 -46.64 14.87 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.785 2.323 . . . . 0.36 112.402 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.638 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.4 OUTLIER -57.15 -37.16 71.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.837 -0.62 . . . . 1.1 111.804 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -30.7 58.28 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 121.076 -0.25 . . . . 1.49 110.945 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.05 -31.7 72.9 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 2.37 109.927 171.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 68.0 t80 -70.88 -48.67 52.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 0.58 110.391 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 67.1 mtt -63.77 -51.96 62.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.111 -0.495 . . . . 0.34 111.058 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -58.33 -41.3 84.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 0.94 111.179 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.12 -30.13 66.12 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.748 0.309 . . . . 2.13 110.614 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.503 HG21 ' HD2' ' A' ' 150' ' ' PRO . 85.2 m -75.27 -38.54 60.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.096 -0.502 . . . . 0.47 111.007 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 35.7 mmtm . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.799 -0.182 . . . . 1.75 110.743 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.605 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 113.061 0.763 . . . . 0.93 113.061 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.882 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 28.8 mm -82.76 90.39 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.893 -1.049 . . . . 1.05 108.975 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -108.96 -3.2 17.69 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.611 0.597 . . . . 1.5 112.611 -170.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.882 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.24 169.95 14.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.54 0.571 . . . . 0.87 112.54 -172.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 49' ' ' TYR . 10.8 m120 -49.41 -156.87 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.845 1.658 . . . . 1.8 113.111 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.796 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 39.3 m-85 -27.57 -52.51 0.07 Allowed 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 114.74 1.385 . . . . 1.37 114.74 -164.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.872 HG23 ' HA ' ' A' ' 155' ' ' SER . 17.3 m 39.38 102.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.899 1.074 . . . . 0.3 113.899 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.692 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.4 p -90.48 155.93 18.56 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.596 -0.842 . . . . 0.8 110.573 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 17.6 m-85 -103.72 161.81 13.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.336 -1.357 . . . . 0.53 107.336 163.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.806 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 55.5 tp -108.03 105.85 15.8 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.142 -0.688 . . . . 0.51 109.142 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.75 HG21 HD13 ' A' ' 15' ' ' ILE . 16.5 mm -103.82 122.97 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 115.638 -0.71 . . . . 0.2 109.206 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.93 -179.49 5.51 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.67 -0.412 . . . . 1.3 110.478 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.414 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 91.5 mtt180 -57.27 -21.86 37.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.658 0.614 . . . . 3.78 112.658 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -105.84 -17.33 14.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.297 0.57 . . . . 1.18 109.762 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 103.71 34.15 3.9 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.345 -0.843 . . . . 0.23 112.581 175.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.84 121.67 42.36 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.791 -0.448 . . . . 0.62 109.791 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.503 ' HD2' HG21 ' A' ' 125' ' ' THR . 31.5 Cg_exo -60.54 109.88 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.733 2.289 . . . . 0.3 112.151 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -91.75 -31.23 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 0.27 110.521 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.573 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.9 mm-40 -149.44 164.93 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.004 -0.544 . . . . 1.22 110.363 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.673 HH11 ' HH2' ' A' ' 137' ' ' TRP . 13.6 ttm180 -132.22 96.65 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.722 -0.844 . . . . 1.75 108.722 168.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.806 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 22.3 m-85 -86.57 108.73 18.71 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.299 -0.63 . . . . 0.38 109.299 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.872 ' HA ' HG23 ' A' ' 140' ' ' THR . 16.4 p -65.2 164.19 25.3 Favored Pre-proline 0 N--CA 1.444 -0.749 0 N-CA-C 109.596 -0.52 . . . . 0.99 109.596 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.815 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 23.5 Cg_endo -61.59 -12.21 23.67 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.986 2.457 . . . . 0.66 113.251 -163.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.71 -0.53 90.16 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.52 -0.764 . . . . 0.52 112.459 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.19 134.67 35.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.894 -0.41 . . . . 0.43 109.894 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 19.5 m -91.7 176.66 6.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.472 -0.331 . . . . 1.25 110.129 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.413 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 38.8 t -51.97 -52.1 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 0.41 111.213 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -64.02 -36.71 84.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 3.44 110.936 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.4 m-20 -57.35 -36.12 70.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.726 -0.67 . . . . 1.86 110.232 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.691 HG21 HD21 ' A' ' 39' ' ' LEU . 74.5 mt -84.24 -43.5 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.342 -0.844 . . . . 0.21 111.413 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 51.3 mt-10 -54.91 -38.53 67.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.493 0.553 . . . . 0.88 112.493 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.0 -18.37 45.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.035 0.383 . . . . 0.75 112.035 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.573 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 52.3 mttt -116.64 -10.14 11.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.097 0.475 . . . . 1.58 110.472 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -97.48 -44.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.681 -0.69 . . . . 0.24 111.381 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.4 mt -54.09 -49.28 90.83 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.225 0.454 . . . . 0.44 112.225 -175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 71.8 Cg_exo -51.7 -36.35 61.24 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.187 1.925 . . . . 0.49 112.781 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.02 -36.15 56.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.475 -0.33 . . . . 0.71 111.099 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.979 HD23 ' HG2' ' A' ' 37' ' ' PRO . 12.4 mt -60.13 -49.43 77.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.968 -0.753 . . . . 0.46 108.968 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -52.0 38.62 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 114.462 -1.244 . . . . 1.52 112.536 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 122.726 0.41 . . . . 2.52 110.235 176.778 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 121.359 0.6 . . . . 1.68 112.21 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 p -157.26 -174.68 5.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.334 -0.848 . . . . 0.65 108.91 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.727 HD13 HG21 ' A' ' 144' ' ' ILE . 18.9 pt -60.61 -25.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.142 0.496 . . . . 0.3 110.647 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.797 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 34.3 m-85 -80.64 3.61 21.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.198 -0.455 . . . . 0.27 111.418 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -73.64 -16.35 61.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.905 -0.776 . . . . 1.96 108.905 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 52.0 m-85 -109.47 159.32 17.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.765 -1.107 . . . . 0.4 110.328 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.14 143.82 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.935 0.398 . . . . 2.77 110.585 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG23 HD13 ' A' ' 30' ' ' LEU . 69.5 t -115.03 146.48 19.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.802 -0.635 . . . . 0.74 111.114 -178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.843 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 7.1 mp -103.67 145.19 30.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.97 0.414 . . . . 0.72 110.495 170.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.54 -176.52 3.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 1.59 109.101 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' ' HE2' ' A' ' 97' ' ' LYS . . . -55.65 -34.43 64.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.002 0.429 . . . . 0.52 110.796 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.1 t70 -82.85 -6.29 59.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 2.22 111.141 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.843 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 8.8 m-70 74.1 21.52 2.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.92 0.867 . . . . 0.73 110.066 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.4 mmpt? -87.25 128.19 56.27 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 106.426 -1.694 . . . . 3.25 106.426 164.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -43.44 115.27 0.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.253 1.968 . . . . 0.86 113.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.491 ' HB3' HG12 ' A' ' 20' ' ' VAL . 74.7 t80 -79.32 124.39 28.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.349 -1.296 . . . . 0.28 110.003 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.701 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 56.1 t30 -72.84 82.93 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.316 -0.624 . . . . 1.65 109.316 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.797 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.47 -32.05 69.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.316 0.579 . . . . 0.25 110.276 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.795 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.1 p -77.04 -0.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.249 -0.887 . . . . 0.41 112.58 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 11.6 pt20 -82.72 -4.92 58.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.164 -0.68 . . . . 1.24 109.164 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.414 ' HB3' HD13 ' A' ' 38' ' ' LEU . 89.8 m-70 -94.62 -4.08 48.38 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.864 -1.062 . . . . 0.38 108.294 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HE2' ' CD2' ' A' ' 16' ' ' PHE . 38.6 ttmt -71.71 139.8 49.3 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.745 -1.116 . . . . 1.73 109.368 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' HB3' ' A' ' 146' ' ' ARG . . . 104.98 -20.32 38.73 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.843 -0.903 . . . . 0.36 110.843 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 m -132.76 144.32 52.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 1.14 108.773 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -73.36 154.82 51.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.164 1.91 . . . . 0.52 111.262 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.653 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.3 pt? -156.35 151.66 26.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.35 0.595 . . . . 1.03 111.417 -172.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.841 HD21 HG21 ' A' ' 163' ' ' ILE . 6.5 mp -107.99 155.92 19.81 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.982 -0.748 . . . . 1.1 108.982 173.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -141.25 117.53 7.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.549 -0.537 . . . . 0.2 109.549 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.924 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 11.3 m-85 -104.19 123.65 47.7 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.755 -0.378 . . . . 0.23 110.512 -175.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.654 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 7.8 p30 -82.5 91.97 6.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.271 -1.011 . . . . 1.28 108.271 168.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 75' ' ' PRO . 2.3 p -112.35 130.53 65.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 113.605 0.965 . . . . 0.88 113.605 -160.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -58.9 103.39 0.16 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.248 -1.39 . . . . 0.52 107.248 165.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 1.056 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -68.72 76.98 0.3 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.878 -1.056 . . . . 1.84 113.423 -163.128 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.824 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 62.2 tttm 71.75 67.55 0.15 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.501 -1.227 . . . . 2.43 111.235 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.6 m -145.4 116.38 7.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.594 -0.73 . . . . 0.99 110.453 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.79 -106.92 1.42 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.758 -0.655 . . . . 1.09 114.03 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.47 155.94 18.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 3.16 112.254 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.5 p -120.31 -21.4 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.643 -0.708 . . . . 1.94 110.631 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.1 mmmt 67.48 0.33 2.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.58 -0.736 . . . . 2.03 111.378 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 105.71 -0.28 39.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.985 -0.626 . . . . 0.47 111.798 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.73 -38.83 90.13 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.694 -0.563 . . . . 0.34 111.694 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.63 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -69.62 -48.51 59.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.915 -0.402 . . . . 0.57 109.915 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 2.3 mp0 -54.95 -49.05 72.32 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.403 -0.817 . . . . 2.46 110.608 177.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 160' ' ' VAL . 90.9 m -67.31 -45.45 76.46 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.424 -0.807 . . . . 0.33 110.52 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.797 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.62 -49.34 76.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.824 0.345 . . . . 0.19 111.531 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 m -59.74 -46.26 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.3 110.852 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.47 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 77.6 m -66.51 -47.75 71.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.613 -0.721 . . . . 1.08 111.033 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -57.21 -48.53 78.55 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.427 0.158 . . . . 0.81 111.427 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 70' ' ' THR . 43.5 t80 -55.43 -53.56 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.33 110.962 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 59' ' ' THR . 0.3 OUTLIER -72.02 -27.6 62.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.23 0.538 . . . . 1.76 110.539 -174.051 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -78.02 -35.67 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.674 -0.694 . . . . 1.79 110.849 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.712 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.8 m-85 -118.62 13.03 13.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.66 0.985 . . . . 0.43 113.66 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -63.09 -21.37 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.905 0.383 . . . . 2.11 110.774 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -64.03 -37.11 86.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.644 . . . . 1.2 110.218 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -90.15 3.39 53.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.768 -0.651 . . . . 1.9 110.703 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.32 57.74 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.092 -0.504 . . . . 1.32 113.059 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.656 ' CE1' HD13 ' A' ' 39' ' ' LEU . 85.8 t80 -72.97 132.35 43.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.835 0.35 . . . . 0.26 111.301 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -123.18 135.61 54.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.58 -0.526 . . . . 0.51 109.58 177.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.797 HG11 ' HB1' ' A' ' 57' ' ' ALA . 26.1 t -102.51 111.62 32.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.474 -0.565 . . . . 0.24 109.474 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 24.4 mt -95.45 121.38 37.06 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.486 -0.931 . . . . 0.51 108.486 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.88 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -111.73 112.23 23.77 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.905 -0.718 . . . . 0.28 110.35 177.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.79 ' HD2' HD11 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -93.94 111.72 54.17 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.085 -1.08 . . . . 0.34 108.085 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.056 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 23.2 Cg_exo -60.13 170.65 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.186 2.591 . . . . 0.73 111.895 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.2 t . . . . . 0 N--CA 1.429 -1.492 0 CA-C-O 122.13 0.967 . . . . 1.54 113.166 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.64 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 55.1 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.805 0.336 . . . . 0.91 111.631 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -146.36 118.97 8.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.095 0.474 . . . . 1.92 110.824 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.83 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 93.8 mttt 66.87 -50.21 0.47 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.87 -1.059 . . . . 3.18 113.471 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.824 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 68.7 -48.78 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.928 0.891 . . . . 1.74 110.659 -170.598 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.83 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 18.6 mtmt 66.07 146.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.139 0.576 . . . . 3.08 112.192 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.464 ' HB2' ' HE1' ' A' ' 98' ' ' PHE . . . -164.66 -164.03 0.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.702 0.63 . . . . 0.43 112.702 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -79.77 -11.9 59.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.401 -0.818 . . . . 2.19 109.887 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.623 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 42.2 p90 -115.81 166.86 11.27 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.096 -0.957 . . . . 0.24 109.177 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 33.3 Cg_exo -66.02 121.81 9.23 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.37 2.713 . . . . 0.31 112.815 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.88 HG13 ' HB3' ' A' ' 73' ' ' ALA . 1.5 mp -109.51 143.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.466 -0.568 . . . . 0.37 109.466 174.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.692 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -108.92 -160.52 0.72 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.389 0.885 . . . . 1.47 113.389 -165.123 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 108' ' ' ILE . . . -72.93 131.47 42.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.013 -0.994 . . . . 0.39 110.042 173.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.925 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttt -70.61 115.04 9.31 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.898 0.856 . . . . 1.66 108.752 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.79 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -125.54 160.86 31.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.339 -1.726 . . . . 0.47 106.339 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.894 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.0 m120 -65.73 117.54 8.31 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.97 -1.092 . . . . 2.16 109.064 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' A' ' 135' ' ' ILE . 1.7 m -116.57 88.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.733 -0.839 . . . . 0.38 108.733 170.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 1.7 t30 173.86 177.32 0.12 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.296 -1.372 . . . . 1.98 107.296 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 42.19 -135.54 3.62 Favored Glycine 0 N--CA 1.46 0.242 0 O-C-N 123.936 0.773 . . . . 0.78 114.739 164.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.47 -11.72 16.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.146 -0.527 . . . . 1.98 110.821 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -81.87 -15.32 54.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.04 111.339 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.894 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.5 137.46 0.82 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.062 1.134 . . . . 0.48 114.062 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.59 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 55.5 t-80 -50.19 140.77 16.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 114.969 -1.014 . . . . 0.42 110.866 173.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.28 -46.92 11.22 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.189 2.593 . . . . 0.36 112.922 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.59 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 20.2 tp -58.05 -36.02 72.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.176 -0.466 . . . . 1.1 111.656 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 15.0 m-85 -75.51 -30.59 59.87 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 116.65 -0.25 . . . . 1.49 110.76 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 115' ' ' ALA . 33.9 mm-40 -64.01 -29.32 70.48 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.068 -0.653 . . . . 2.37 109.721 169.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 86.7 t80 -75.29 -42.02 55.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.277 0.56 . . . . 0.58 110.393 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.622 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 66.8 mtt -69.38 -49.3 56.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 0.34 110.82 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 38.7 mtpt -60.17 -40.76 91.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.94 111.062 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 21.6 ptmt -69.17 -35.72 76.59 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.82 0.343 . . . . 2.13 110.804 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 150' ' ' PRO . 91.1 m -74.23 -44.81 51.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.47 110.875 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 42.8 mmtt . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 116.189 -0.46 . . . . 1.75 110.215 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.449 ' C ' HH12 ' A' ' 153' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 112.936 0.717 . . . . 0.93 112.936 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.828 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 38.8 mt -78.5 150.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.768 -1.106 . . . . 1.05 109.475 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -168.57 -1.99 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.597 0.592 . . . . 1.5 112.597 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.828 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -136.82 170.03 16.76 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.332 0.653 . . . . 0.87 111.113 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.465 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 15.7 m120 -43.93 -158.24 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.376 1.47 . . . . 1.8 114.058 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.924 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.6 m-85 -27.76 -57.63 0.11 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 125.018 1.327 . . . . 1.37 114.335 -167.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.852 HG23 ' HA ' ' A' ' 155' ' ' SER . 10.6 m 42.94 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.111 0.782 . . . . 0.3 113.111 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 25.6 p -86.64 152.11 22.86 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.169 -0.612 . . . . 0.8 110.637 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.622 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.9 m-85 -103.76 133.17 49.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.719 -1.215 . . . . 0.53 107.719 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 151' ' ' VAL . 25.3 tp -81.29 103.63 11.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.741 -0.837 . . . . 0.51 108.741 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.727 HG21 HD13 ' A' ' 15' ' ' ILE . 13.5 mm -104.03 125.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.095 -0.706 . . . . 0.2 109.095 -175.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.4 -179.93 7.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.728 -0.789 . . . . 1.3 110.09 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.432 ' HG3' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -55.27 -23.09 21.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.21 0.529 . . . . 3.78 112.085 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.46 -17.28 18.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.107 -0.701 . . . . 1.18 109.107 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 100.45 25.19 8.89 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.751 -1.113 . . . . 0.23 112.509 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 65.0 t -106.81 124.54 35.16 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.106 0.453 . . . . 0.62 110.429 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 125' ' ' THR . 34.9 Cg_exo -61.1 111.26 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.332 2.688 . . . . 0.3 112.328 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.551 ' HB ' HD23 ' A' ' 143' ' ' LEU . 18.5 t -88.8 -28.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.212 -0.449 . . . . 0.27 110.712 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.521 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 34.3 mm-40 -160.91 164.26 31.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 1.22 110.536 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.803 HH11 ' HH2' ' A' ' 137' ' ' TRP . 14.8 ttm180 -123.0 97.23 5.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.707 -0.479 . . . . 1.75 109.707 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.637 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 84.6 m-85 -82.15 108.59 15.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.531 -0.544 . . . . 0.38 109.531 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.852 ' HA ' HG23 ' A' ' 140' ' ' THR . 3.0 m -62.19 165.21 9.0 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 109.771 -0.455 . . . . 0.99 109.771 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.814 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 44.2 Cg_endo -66.97 -8.21 21.0 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.624 2.216 . . . . 0.66 112.686 -164.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.23 5.56 81.16 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.52 111.865 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.0 133.51 35.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.903 0.382 . . . . 0.43 110.072 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.546 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 51.0 m -86.99 171.44 10.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.134 -0.485 . . . . 1.25 111.342 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.465 ' HA ' HG23 ' A' ' 56' ' ' THR . 99.0 t -52.86 -58.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.828 -0.624 . . . . 0.41 112.356 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.6 tptm -72.44 -25.33 61.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 3.44 110.597 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.1 m-20 -61.08 -31.36 71.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.877 -0.602 . . . . 1.86 110.557 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.841 HG21 HD21 ' A' ' 39' ' ' LEU . 43.1 mt -83.17 -42.16 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.002 0.43 . . . . 0.21 110.778 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.603 ' HB2' ' HD2' ' A' ' 161' ' ' LYS . 45.8 mt-10 -56.45 -34.5 66.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.88 112.293 -174.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.434 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.2 pt-20 -53.62 -32.16 50.1 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.725 0.298 . . . . 0.75 111.67 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 47.5 mmtm -105.26 -14.19 15.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.339 -0.391 . . . . 1.58 111.236 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 171' ' ' LEU . 65.1 tp -88.57 -42.52 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 0.24 111.735 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.744 ' HA ' HD12 ' A' ' 171' ' ' LEU . 78.5 mt -53.34 -48.56 92.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.418 0.525 . . . . 0.44 112.418 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.525 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.1 Cg_exo -56.32 -26.69 63.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.318 2.012 . . . . 0.49 112.902 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.38 -40.37 16.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.71 110.65 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.955 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 16.7 mt -59.18 -48.96 79.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.547 0.689 . . . . 0.46 109.617 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.4 38.83 0.85 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.501 -1.227 . . . . 1.52 113.13 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 171' ' ' LEU . 69.1 m . . . . . 0 N--CA 1.467 0.393 0 C-N-CA 123.56 0.744 . . . . 2.52 112.775 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.587 0.708 . . . . 1.68 109.793 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 p -157.85 175.14 14.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.858 -1.065 . . . . 0.65 108.452 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.806 HD13 HG21 ' A' ' 144' ' ' ILE . 21.9 pt -55.24 -29.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.136 0.421 . . . . 0.3 112.136 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.865 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.9 m-85 -75.84 -0.44 21.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.387 0.514 . . . . 0.27 112.387 -172.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.28 -12.2 59.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.505 0.669 . . . . 1.96 109.266 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 72.6 m-85 -108.84 155.54 20.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.228 -0.896 . . . . 0.4 111.085 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 29.9 tt0 -84.25 143.51 29.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.429 -0.805 . . . . 2.77 110.934 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 28' ' ' TYR . 72.5 t -125.45 146.17 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.762 0.315 . . . . 0.74 110.461 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.975 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 90.4 mt -111.59 146.82 36.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.408 -0.36 . . . . 0.72 110.264 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.39 174.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.745 0.653 . . . . 1.59 109.482 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 97' ' ' LYS . . . -53.86 -31.05 48.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.321 0.582 . . . . 0.52 109.959 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.17 4.06 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.35 -0.841 . . . . 2.22 112.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.975 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 30.5 m-70 72.63 26.09 2.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.485 0.66 . . . . 0.73 110.968 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 38.5 mmtt -91.07 128.73 46.51 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 107.03 -1.47 . . . . 3.25 107.03 168.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.47 112.63 0.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.792 1.661 . . . . 0.86 112.476 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HB3' HG12 ' A' ' 20' ' ' VAL . 68.8 t80 -79.39 123.72 27.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.669 -1.15 . . . . 0.28 110.553 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.632 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 3.0 t-20 -73.68 81.92 1.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.495 -0.775 . . . . 1.65 109.182 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.777 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.7 pt? -72.12 -32.25 66.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.471 0.653 . . . . 0.25 110.463 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.865 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 8.8 p -77.21 0.5 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.324 -0.853 . . . . 0.41 112.735 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.3 pt20 -82.15 -5.87 58.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.387 0.613 . . . . 1.24 109.564 173.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -92.54 -1.2 57.11 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.137 -1.06 . . . . 0.38 108.137 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -76.17 141.26 41.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.348 -1.296 . . . . 1.73 109.297 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.92 -8.39 63.3 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.328 -1.109 . . . . 0.36 110.328 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 20.1 m -140.68 146.08 43.0 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.088 -0.708 . . . . 1.14 109.088 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.056 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.0 Cg_endo -73.5 154.81 50.43 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.765 1.643 . . . . 0.52 111.153 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.614 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -155.09 152.47 29.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.396 0.617 . . . . 1.03 111.372 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.742 HD21 HG21 ' A' ' 163' ' ' ILE . 6.3 mp -107.83 151.48 25.69 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.567 -0.901 . . . . 1.1 108.567 172.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 80.4 mt -140.68 116.72 7.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.553 -0.536 . . . . 0.2 109.553 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.922 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 24.3 m-85 -103.29 123.28 46.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.219 0.325 . . . . 0.23 111.244 -172.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.697 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.6 p30 -79.32 91.56 5.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.783 -0.821 . . . . 1.28 108.783 168.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.713 HG11 ' HE2' ' A' ' 98' ' ' PHE . 2.4 p -112.34 133.52 57.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.563 0.949 . . . . 0.88 113.563 -163.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.86 102.62 0.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.726 -1.212 . . . . 0.52 107.726 167.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.976 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 30.1 t -72.08 97.23 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.088 0.773 . . . . 1.84 113.088 -166.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt 73.84 38.19 0.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.743 0.652 . . . . 2.43 111.218 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 m -141.79 157.67 44.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.596 -0.274 . . . . 0.99 110.607 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.2 -118.34 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 O-C-N 123.632 0.583 . . . . 1.09 113.678 171.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -129.21 174.83 9.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.546 0.689 . . . . 3.16 111.782 -174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.661 HG22 ' HE1' ' A' ' 139' ' ' PHE . 7.8 p -133.22 116.72 16.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.058 -0.974 . . . . 1.94 109.616 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.703 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 24.8 mtpp -83.86 17.07 2.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.059 -0.519 . . . . 2.03 111.828 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.3 17.04 21.24 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.878 -0.677 . . . . 0.47 111.89 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.42 -42.85 7.22 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.394 -0.431 . . . . 0.34 112.131 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.555 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -67.12 -44.59 79.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.449 -0.574 . . . . 0.57 109.449 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 23.6 mp0 -55.81 -55.03 37.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.023 -0.99 . . . . 2.46 110.086 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.515 ' CG2' HD12 ' A' ' 163' ' ' ILE . 98.6 m -67.62 -41.45 83.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.941 -1.027 . . . . 0.33 111.284 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.724 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.78 -48.2 81.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.859 0.362 . . . . 0.19 110.813 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.6 m -61.29 -49.38 77.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.635 . . . . 0.3 111.043 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 p -64.24 -47.32 80.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.813 -0.63 . . . . 1.08 111.438 -177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.642 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.59 -45.44 91.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.64 -0.255 . . . . 0.81 111.176 -177.463 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.814 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 85.4 t80 -53.07 -58.81 5.74 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 123.215 0.322 . . . . 0.33 110.668 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -70.09 -36.18 74.7 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.697 -0.401 . . . . 1.76 111.802 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.01 -39.81 79.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 1.79 111.384 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.727 ' CD1' HD13 ' A' ' 171' ' ' LEU . 73.9 m-85 -108.32 4.95 25.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.43 113.17 -174.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -59.03 -28.02 66.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 2.11 110.397 173.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.4 m -65.65 -37.34 86.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.464 . . . . 1.2 111.144 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -88.45 1.44 54.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.92 0.391 . . . . 1.9 111.107 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 88.94 66.0 1.28 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.951 -0.643 . . . . 1.32 112.191 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 39' ' ' LEU . 71.9 t80 -132.05 140.07 48.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.503 0.192 . . . . 0.26 110.594 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.27 140.22 52.0 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 120.898 0.38 . . . . 0.51 110.381 177.116 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.814 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 25.4 t -109.74 117.88 55.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.963 0.411 . . . . 0.24 110.521 169.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 20.3 mt -101.43 137.84 39.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.693 -0.854 . . . . 0.51 108.693 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.056 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -122.45 116.34 23.79 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.349 -0.54 . . . . 0.28 110.835 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.629 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -99.12 108.77 51.43 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 108.659 -0.867 . . . . 0.34 108.659 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.129 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.6 Cg_exo -59.3 170.24 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.194 2.596 . . . . 0.73 111.717 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.433 -1.277 0 CA-C-O 121.892 0.853 . . . . 1.54 112.291 -177.194 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 45' ' ' SER . 10.6 m . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.936 0.398 . . . . 0.91 111.6 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 t -154.27 122.09 5.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.101 -0.5 . . . . 1.92 110.964 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.707 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 15.7 ptpt 32.31 84.43 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.867 1.062 . . . . 3.18 113.867 174.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.713 ' HE2' HG11 ' A' ' 43' ' ' VAL . 15.5 p90 -66.77 -25.47 66.5 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.742 -0.599 . . . . 1.74 110.361 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 99' ' ' LYS . 71.3 mmtt 65.78 148.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.081 0.863 . . . . 3.08 111.946 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -169.39 -164.74 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.736 0.643 . . . . 0.43 112.736 -174.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -69.67 -24.68 63.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.365 -0.834 . . . . 2.19 109.752 173.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.794 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 50.3 p90 -108.9 168.07 8.27 Favored Pre-proline 0 N--CA 1.438 -1.063 0 CA-C-N 114.575 -1.193 . . . . 0.24 109.479 -175.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 1.008 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 16.4 Cg_exo -73.7 129.37 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.7 2.933 . . . . 0.31 113.186 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.056 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.9 mp -117.69 138.02 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.336 -0.616 . . . . 0.37 109.336 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 1.008 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.9 mmt -112.66 -156.59 0.59 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.837 0.827 . . . . 1.47 113.2 -164.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.796 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -65.96 137.99 57.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.494 -1.23 . . . . 0.39 110.938 174.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.129 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttp -84.44 127.63 34.12 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.85 0.833 . . . . 1.66 109.458 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -131.66 162.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.983 -1.462 . . . . 0.47 107.769 -176.51 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.721 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 21.5 t-20 -75.81 83.61 2.76 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.857 -0.794 . . . . 2.16 108.857 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.697 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.26 89.57 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 108.085 -1.08 . . . . 0.38 108.085 173.232 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 175.02 179.52 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.474 -0.936 . . . . 1.98 108.474 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 47.0 -144.0 5.02 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 124.313 1.008 . . . . 0.78 115.512 156.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 11.5 pt-20 -102.81 -6.96 22.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.152 -1.024 . . . . 1.98 110.331 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -98.29 0.01 44.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.476 -0.784 . . . . 2.04 110.975 -170.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -50.79 138.89 17.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 0.48 112.888 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.46 ' HE1' ' O ' ' A' ' 19' ' ' GLU . 51.2 t-80 -52.4 138.08 39.7 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.303 -0.862 . . . . 0.42 110.313 172.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -44.39 -45.08 12.92 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.217 2.611 . . . . 0.36 112.676 -178.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.444 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 2.0 tm? -54.72 -45.61 74.11 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.667 -0.697 . . . . 1.1 111.189 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.479 ' HE1' HD21 ' A' ' 42' ' ' ASN . 2.5 m-85 -75.56 -29.74 59.47 Favored 'General case' 0 C--O 1.212 -0.885 0 O-C-N 122.295 -0.253 . . . . 1.49 111.451 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 49.8 mt-10 -58.49 -39.42 79.97 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.946 -0.702 . . . . 2.37 109.165 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 88.1 t80 -67.82 -44.0 78.27 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.293 0.371 . . . . 0.58 110.597 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.456 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.3 mtt -65.02 -54.12 35.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.306 -0.406 . . . . 0.34 111.033 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 36.7 mtpt -57.18 -39.94 76.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.735 -0.666 . . . . 0.94 110.877 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.4 ptmt -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.421 -0.354 . . . . 2.13 111.534 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.58 HG21 ' HD2' ' A' ' 150' ' ' PRO . 94.3 m -64.36 -53.8 42.87 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.625 -0.43 . . . . 0.47 110.314 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.698 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.8 ttmt . . . . . 0 C--N 1.323 -0.576 0 N-CA-C 109.847 -0.427 . . . . 1.75 109.847 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 114.027 1.121 . . . . 0.93 114.027 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.872 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 50.4 mt -82.9 156.21 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 113.539 -1.664 . . . . 1.05 108.464 176.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -173.26 10.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.121 0.786 . . . . 1.5 113.121 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.872 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.62 171.26 14.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.763 0.425 . . . . 0.87 110.997 -177.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.433 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 86.6 m-20 -45.53 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 1.8 113.526 172.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.922 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 47.0 m-85 -27.87 -59.07 0.11 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 114.634 1.346 . . . . 1.37 114.634 -166.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.79 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 11.6 m 45.11 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.913 0.779 . . . . 0.3 112.954 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.7 p -89.87 150.19 22.32 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.538 -0.865 . . . . 0.8 111.071 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.8 m-85 -102.72 135.84 43.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.895 -1.15 . . . . 0.53 107.895 166.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.972 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 54.9 tp -82.13 105.13 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.015 -0.735 . . . . 0.51 109.015 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 15' ' ' ILE . 14.9 mm -102.5 122.59 55.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.558 -0.746 . . . . 0.2 109.04 -173.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.56 179.24 3.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.415 . . . . 1.3 110.355 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.82 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 72.8 mtp180 -62.41 -15.33 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.262 0.467 . . . . 3.78 112.262 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -109.03 -18.29 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.835 -0.541 . . . . 1.18 110.236 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.499 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 112.06 34.07 2.06 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.23 113.27 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 55.0 t -108.41 126.75 28.89 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 117.199 0.5 . . . . 0.62 110.595 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.58 ' HD2' HG21 ' A' ' 125' ' ' THR . 11.3 Cg_exo -69.22 97.48 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.073 2.515 . . . . 0.3 112.072 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.95 -20.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.529 . . . . 0.27 111.151 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.698 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 6.0 mm-40 -154.17 162.45 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.998 -0.371 . . . . 1.22 109.998 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -135.3 98.14 3.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.565 -0.531 . . . . 1.75 109.565 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.972 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 16.1 m-85 -88.56 125.06 34.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.772 ' HA ' HG23 ' A' ' 140' ' ' THR . 92.4 p -69.75 171.74 6.71 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.809 -0.811 . . . . 0.99 108.809 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.79 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 37.8 Cg_endo -66.04 -8.89 21.42 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.92 1.747 . . . . 0.66 112.293 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.35 -4.9 83.17 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.231 -0.895 . . . . 0.52 112.108 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.09 113.26 19.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.16 0.505 . . . . 0.43 110.125 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.2 p -82.62 179.92 7.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.677 -0.692 . . . . 1.25 110.804 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.642 HG13 HD21 ' A' ' 60' ' ' LEU . 58.0 t -44.17 -57.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.747 -0.66 . . . . 0.41 111.617 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -58.12 -39.45 78.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.773 -0.648 . . . . 3.44 112.399 -175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.52 -31.1 70.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.472 0.653 . . . . 1.86 110.087 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.742 HG21 HD21 ' A' ' 39' ' ' LEU . 46.0 mt -81.32 -42.52 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.242 -0.89 . . . . 0.21 110.945 177.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 65.3 mt-10 -58.09 -36.32 72.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.43 -0.35 . . . . 0.88 111.902 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.3 pt-20 -63.71 -12.28 33.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.894 0.331 . . . . 0.75 111.894 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.624 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.8 mmtp -116.22 -23.06 8.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.427 . . . . 1.58 110.694 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.8 tp -89.68 -37.16 14.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.398 0.518 . . . . 0.24 112.398 -170.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.666 ' HA ' HD12 ' A' ' 171' ' ' LEU . 68.8 mt -50.75 -48.47 83.16 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 0.44 112.841 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.8 Cg_exo -55.11 -37.07 94.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.924 1.749 . . . . 0.49 112.69 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.3 mt -78.95 -36.93 40.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.688 0.255 . . . . 0.71 111.688 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.056 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.9 mt -55.44 -50.69 69.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.586 0.707 . . . . 0.46 109.216 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -48.85 -68.73 1.19 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.11 -1.405 . . . . 1.52 111.78 167.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.82 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 9.3 t . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 120.691 0.282 . . . . 2.52 110.434 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.203 0.525 . . . . 1.68 110.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.6 p -137.25 167.61 21.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.63 -0.714 . . . . 0.65 109.101 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.715 HD13 HG21 ' A' ' 144' ' ' ILE . 18.0 pt -61.57 -29.7 46.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.852 0.358 . . . . 0.3 111.9 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.795 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 72.4 m-85 -76.5 1.52 16.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.264 0.468 . . . . 0.27 112.264 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.39 -17.86 61.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.792 -0.818 . . . . 1.96 108.792 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 73.9 m-85 -99.73 159.99 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.4 110.6 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -102.21 135.77 43.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 2.77 110.963 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.605 HG23 HD13 ' A' ' 30' ' ' LEU . 89.3 t -114.35 146.63 18.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.294 0.568 . . . . 0.74 111.731 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 86.3 mt -117.29 153.22 33.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.615 -0.72 . . . . 0.72 110.24 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 176.72 1.4 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.206 -0.906 . . . . 1.59 109.454 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -53.71 -32.04 50.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.299 0.571 . . . . 0.52 110.065 173.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 1.7 m-20 -87.12 -3.91 59.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.62 -0.718 . . . . 2.22 112.281 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.97 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.7 m-70 74.49 27.04 1.43 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.693 0.759 . . . . 0.73 110.296 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -88.56 154.61 50.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.61 -1.626 . . . . 3.25 106.61 167.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.17 113.14 1.31 Allowed 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.047 1.164 . . . . 0.86 112.916 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.505 ' HB3' HG12 ' A' ' 20' ' ' VAL . 60.3 t80 -89.91 117.53 28.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.411 -0.813 . . . . 0.28 110.722 168.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.573 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.87 84.97 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.587 -0.733 . . . . 1.65 109.512 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.786 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.74 -32.35 67.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.002 0.43 . . . . 0.25 110.58 -176.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.795 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -76.54 -1.37 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 0.41 112.699 -167.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 7.0 pt20 -80.75 -5.71 57.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.418 0.628 . . . . 1.24 109.724 172.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.425 ' HB3' HD13 ' A' ' 38' ' ' LEU . 81.9 m-70 -92.15 1.02 57.46 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.188 -1.041 . . . . 0.38 108.188 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 22.8 ttpp -86.19 132.64 33.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.923 -1.035 . . . . 1.73 109.216 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.2 32.26 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.767 -1.333 . . . . 0.36 109.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 18.1 m -139.84 149.64 59.85 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.389 -0.967 . . . . 1.14 108.389 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.04 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 61.1 Cg_endo -75.41 153.51 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.558 1.505 . . . . 0.52 111.257 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.679 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.2 pt? -154.27 151.07 28.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.297 0.57 . . . . 1.03 111.295 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.791 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -109.64 154.9 22.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.567 -0.742 . . . . 1.1 109.089 172.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 72.3 mt -140.87 121.56 13.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.75 -0.833 . . . . 0.2 108.75 -176.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.06 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -108.41 126.72 53.2 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.882 0.373 . . . . 0.23 111.589 -171.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.669 ' ND2' HD13 ' A' ' 135' ' ' ILE . 0.6 OUTLIER -77.97 93.82 4.5 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.619 -1.252 . . . . 1.28 107.619 170.365 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.792 HG12 ' HA ' ' A' ' 139' ' ' PHE . 18.0 m -112.65 138.38 42.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 113.44 0.904 . . . . 0.88 113.44 -164.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.8 102.78 2.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.575 -1.639 . . . . 0.52 106.575 163.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 1.039 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 32.3 t -60.12 94.07 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.69 -0.686 . . . . 1.84 112.202 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 98' ' ' PHE . 24.7 tptp 63.46 19.29 11.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.502 0.668 . . . . 2.43 110.516 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.2 p -135.18 172.62 12.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.706 -0.679 . . . . 0.99 109.846 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.17 -154.58 39.15 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.714 -0.755 . . . . 1.09 112.796 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -110.72 111.9 23.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 3.16 110.235 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.408 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 1.5 p -77.56 112.86 14.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.5 . . . . 1.94 111.109 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.434 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -81.5 14.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 2.03 111.062 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.2 8.38 38.75 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.976 -0.556 . . . . 0.47 111.888 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -39.04 96.73 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 111.987 -0.445 . . . . 0.34 111.987 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.518 ' CZ ' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -66.71 -47.29 72.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.769 0.319 . . . . 0.57 110.413 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.65 -45.58 92.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.742 -0.466 . . . . 2.46 109.742 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.662 ' HA ' HG22 ' A' ' 160' ' ' VAL . 73.2 m -59.74 -50.96 71.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.602 -0.726 . . . . 0.33 111.032 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.891 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.57 -50.25 73.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.164 -0.471 . . . . 0.19 111.372 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m -56.08 -46.77 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.958 0.409 . . . . 0.3 111.252 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.517 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 90.6 m -64.49 -46.5 82.73 Favored 'General case' 0 C--N 1.337 0.036 0 CA-C-N 116.392 -0.367 . . . . 1.08 111.156 -177.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 39' ' ' LEU . 71.4 mt -59.72 -49.72 76.63 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 120.722 0.296 . . . . 0.81 110.622 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.668 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 14.8 t80 -50.33 -57.43 7.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.213 -0.903 . . . . 0.33 109.651 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 59' ' ' THR . 0.4 OUTLIER -73.84 -29.07 61.92 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.755 -0.657 . . . . 1.76 111.738 -168.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.679 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 33.2 ttmt -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.641 0.258 . . . . 1.79 111.041 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.679 ' CE2' ' HD2' ' A' ' 63' ' ' LYS . 70.8 m-85 -116.73 10.43 14.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.892 1.071 . . . . 0.43 113.892 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 14.7 mtpp -64.02 -20.29 65.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.0 -0.68 . . . . 2.11 109.991 172.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -61.19 -33.27 73.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.766 -0.652 . . . . 1.2 109.887 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.467 HE21 ' HD1' ' A' ' 64' ' ' TYR . 2.0 mp0 -95.31 11.78 31.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.914 -0.584 . . . . 1.9 110.643 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.61 12.38 75.3 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.872 -0.603 . . . . 1.32 113.042 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 37' ' ' PRO . 93.8 t80 -72.03 141.06 49.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.034 0.445 . . . . 0.26 111.302 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -131.79 144.87 51.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.908 -0.587 . . . . 0.51 109.714 176.579 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.891 HG11 ' HB1' ' A' ' 57' ' ' ALA . 41.4 t -112.26 117.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.605 -0.517 . . . . 0.24 109.605 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.3 mt -100.28 121.11 40.95 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.735 -0.839 . . . . 0.51 108.735 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.033 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -107.99 112.72 25.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.388 -0.525 . . . . 0.28 110.608 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.1 m-85 -98.46 115.25 65.82 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.039 -0.726 . . . . 0.34 109.039 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.039 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 19.6 Cg_exo -63.28 169.66 9.09 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.107 2.538 . . . . 0.73 111.915 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.433 -1.287 0 C-N-CA 119.519 -0.872 . . . . 1.54 112.165 -178.361 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 45' ' ' SER . 4.6 m . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.364 -0.606 . . . . 0.91 109.364 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.745 HG23 ' HG2' ' A' ' 75' ' ' PRO . 1.8 m -13.98 117.57 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 115.216 1.561 . . . . 1.92 115.216 -140.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 6.1 ptmt 171.88 -31.48 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 111.477 -2.601 . . . . 3.18 107.883 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.562 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -36.8 109.97 0.11 Allowed 'General case' 0 C--N 1.354 0.779 0 O-C-N 124.972 1.42 . . . . 1.74 111.387 -173.362 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 97' ' ' LYS . 73.4 mmtt -104.61 143.17 33.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.055 -0.975 . . . . 3.08 110.262 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -145.15 -170.24 3.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.602 -0.272 . . . . 0.43 110.979 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -75.02 -26.54 59.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.446 0.641 . . . . 2.19 109.496 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.878 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 44.0 p90 -98.44 159.35 30.78 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 114.933 -1.03 . . . . 0.24 109.544 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 38.8 Cg_exo -67.56 114.18 3.2 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.091 3.194 . . . . 0.31 113.608 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.033 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mp -100.35 131.9 46.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 108.98 -0.748 . . . . 0.37 108.98 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.647 ' HE2' ' HA ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -117.03 -155.58 0.59 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.345 0.869 . . . . 1.47 113.345 -157.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -68.63 113.47 6.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.979 -1.01 . . . . 0.39 111.177 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.007 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -61.99 139.87 58.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.401 0.62 . . . . 1.66 109.602 171.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.539 HD12 ' CB ' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -150.13 156.59 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.571 -1.27 . . . . 0.47 107.571 -174.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.762 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 24.8 t-20 -67.84 93.99 0.43 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.102 -0.703 . . . . 2.16 109.102 175.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -83.7 82.59 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.278 -0.969 . . . . 0.38 108.793 176.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 32.5 t30 170.68 -177.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.229 -1.026 . . . . 1.98 108.229 170.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 58.92 -141.74 46.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.438 -0.887 . . . . 0.78 114.541 158.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.62 -15.95 16.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.683 0.754 . . . . 1.98 109.671 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.469 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 19.1 m120 -88.46 -5.64 58.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.607 -1.178 . . . . 2.04 110.912 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.762 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.37 126.43 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.298 -0.864 . . . . 0.48 112.281 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.561 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 55.1 t-80 -47.47 133.79 10.13 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-O 118.535 -0.745 . . . . 0.42 109.928 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.601 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.6 Cg_endo -42.11 -45.11 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.228 2.619 . . . . 0.36 112.711 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.561 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 20.1 tp -54.77 -51.45 65.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.753 -0.658 . . . . 1.1 111.584 175.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.746 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 22.9 m-85 -69.78 -31.5 69.47 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.403 -0.362 . . . . 1.49 111.201 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.55 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 1.4 mt-10 -55.18 -46.86 75.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.547 -0.909 . . . . 2.37 108.547 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 85.8 t80 -64.6 -49.25 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.665 0.603 . . . . 0.58 110.128 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.584 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 64.2 mtt -54.54 -51.58 64.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.123 -0.489 . . . . 0.34 111.722 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.746 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 27.5 mtpt -61.3 -49.33 77.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.868 0.366 . . . . 0.94 110.549 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 16.7 ptpt -70.44 -31.66 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 2.13 111.046 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.549 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.3 m -70.51 -40.58 73.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.429 -0.35 . . . . 0.47 111.78 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 10.0 mmtt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.53 . . . . 1.75 112.164 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.31 0 CA-C-O 120.832 0.349 . . . . 0.93 111.645 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.831 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 13.6 mt -105.1 105.86 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.537 -0.756 . . . . 1.05 109.659 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -133.01 26.67 4.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.142 0.793 . . . . 1.5 113.142 -172.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.831 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -151.34 170.18 20.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.324 0.583 . . . . 0.87 111.995 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 2.7 t-20 -49.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 1.8 112.751 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 1.06 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 10.5 m-85 -27.44 -50.99 0.06 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 125.342 1.457 . . . . 1.37 114.794 -167.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.795 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 12.4 m 37.15 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.763 1.165 . . . . 0.3 113.288 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.6 p -85.11 150.63 24.72 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.149 -0.621 . . . . 0.8 111.412 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.5 m-85 -103.66 132.2 50.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.955 -1.128 . . . . 0.53 107.955 165.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.608 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 20.7 tp -81.2 106.11 12.93 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.931 -0.766 . . . . 0.51 108.931 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.715 HG21 HD13 ' A' ' 15' ' ' ILE . 18.7 mm -106.17 122.86 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.116 -0.698 . . . . 0.2 109.116 -172.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.41 179.14 3.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.262 -0.426 . . . . 1.3 110.505 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 36' ' ' SER . 61.4 mtt180 -59.25 -21.31 59.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.797 0.666 . . . . 3.78 112.797 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -109.87 -10.08 14.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.151 0.5 . . . . 1.18 110.733 -171.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.553 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 104.16 32.9 4.16 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.737 -0.744 . . . . 0.23 113.375 174.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.3 t -107.22 122.43 41.41 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.695 -0.483 . . . . 0.62 109.695 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.5 Cg_exo -68.1 118.02 5.33 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.476 2.118 . . . . 0.3 111.178 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.57 ' HB ' HD23 ' A' ' 143' ' ' LEU . 32.6 t -97.22 -30.06 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.928 -0.578 . . . . 0.27 110.632 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -154.83 165.31 37.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 1.22 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -132.25 98.61 4.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.698 -0.683 . . . . 1.75 109.358 174.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.652 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 24.5 m-85 -91.05 108.97 20.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.587 -0.523 . . . . 0.38 109.587 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.748 ' HA ' HG23 ' A' ' 140' ' ' THR . 10.5 p -61.19 163.25 11.04 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.806 -0.442 . . . . 0.99 109.806 175.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.795 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 45.4 Cg_endo -65.46 -7.01 14.77 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.916 2.411 . . . . 0.66 113.4 -162.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 51' ' ' LYS . . . -85.36 -10.66 76.97 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.302 -0.863 . . . . 0.52 111.741 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -71.41 131.76 43.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.43 110.17 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.439 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 48.9 m -81.57 168.96 17.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.79 -0.641 . . . . 1.25 111.12 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.662 HG22 ' HA ' ' A' ' 56' ' ' THR . 44.8 t -54.44 -51.16 52.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.41 110.781 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.495 ' HB2' ' HE3' ' A' ' 161' ' ' LYS . 32.9 ttmt -65.37 -33.65 76.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.553 -0.748 . . . . 3.44 110.868 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.6 m-20 -62.43 -31.77 72.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.349 -0.842 . . . . 1.86 110.263 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.791 HG21 HD21 ' A' ' 39' ' ' LEU . 69.2 mt -82.89 -37.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.987 -0.552 . . . . 0.21 110.908 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.5 mt-10 -57.83 -35.8 71.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.88 112.201 -175.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.99 -32.79 61.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.85 0.357 . . . . 0.75 111.459 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.533 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 47.1 mmtm -100.44 -17.07 17.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 1.58 111.036 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 65.7 tp -88.35 -38.08 15.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.192 -0.458 . . . . 0.24 111.407 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.841 ' HA ' HD12 ' A' ' 171' ' ' LEU . 85.0 mt -50.71 -52.5 55.93 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.835 0.68 . . . . 0.44 112.835 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.6 Cg_endo -55.67 -34.26 89.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.095 1.863 . . . . 0.49 112.673 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.76 -36.0 51.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.569 -0.287 . . . . 0.71 110.84 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.04 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.5 mt -56.36 -57.03 14.01 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.07 -0.514 . . . . 0.46 109.781 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -45.21 -61.05 3.74 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.265 -1.334 . . . . 1.52 112.927 172.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 21.9 t . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 109.652 -0.499 . . . . 2.52 109.652 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.327 0.584 . . . . 1.68 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -141.99 177.57 8.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.361 -0.836 . . . . 0.65 108.767 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.851 HD13 HG21 ' A' ' 144' ' ' ILE . 20.7 pt -57.37 -28.67 31.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 0.3 111.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.876 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 33.5 m-85 -78.13 2.68 17.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.27 111.447 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.07 -20.68 64.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.998 -1.112 . . . . 1.96 107.998 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 61.8 m-85 -111.56 172.36 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.284 -1.326 . . . . 0.4 109.918 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -115.06 161.91 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.75 0.309 . . . . 2.77 110.606 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.487 HG23 HD13 ' A' ' 30' ' ' LEU . 61.2 t -128.52 141.69 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.74 111.303 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.931 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 51.0 mt -95.77 132.78 40.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.905 -0.589 . . . . 0.72 109.703 171.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.29 177.75 1.04 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.184 -0.916 . . . . 1.59 109.143 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.474 ' O ' ' HE3' ' A' ' 97' ' ' LYS . . . -51.76 -35.46 43.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.923 0.392 . . . . 0.52 110.748 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -85.82 -3.51 58.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.947 -0.569 . . . . 2.22 111.236 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.931 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.5 m-70 71.97 15.96 5.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.638 0.732 . . . . 0.73 109.521 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -75.55 157.4 84.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 106.726 -1.583 . . . . 3.25 106.726 165.361 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.63 113.98 2.05 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 120.753 0.969 . . . . 0.86 111.824 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.428 ' HB3' HG12 ' A' ' 20' ' ' VAL . 67.9 t80 -90.4 109.12 20.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.36 -0.836 . . . . 0.28 109.324 170.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.9 t30 -70.93 85.66 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.613 -0.514 . . . . 1.65 109.613 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.876 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -61.6 -29.56 70.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.629 -0.714 . . . . 0.25 111.079 -176.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.809 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 5.4 p -76.12 -0.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.425 -0.807 . . . . 0.41 112.81 -167.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.2 pt20 -80.61 -5.53 56.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.265 0.555 . . . . 1.24 109.921 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.401 ' CG ' HG21 ' A' ' 70' ' ' THR . 83.4 m-70 -92.98 -5.7 50.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 108.324 -0.991 . . . . 0.38 108.324 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HZ3' ' HD2' ' A' ' 16' ' ' PHE . 16.6 ttmm -71.69 141.45 49.85 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.715 -1.13 . . . . 1.73 109.844 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.13 -12.87 55.66 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.895 -1.282 . . . . 0.36 109.895 -172.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.462 ' C ' ' HA ' ' A' ' 146' ' ' ARG . 25.0 m -140.6 148.07 51.68 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 108.572 -0.899 . . . . 1.14 108.572 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.985 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 79.5 Cg_endo -75.35 162.43 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.835 1.69 . . . . 0.52 110.996 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.684 ' CB ' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -159.36 152.69 22.41 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 1.03 110.809 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.634 HD21 HG21 ' A' ' 163' ' ' ILE . 7.2 mp -107.38 148.41 29.12 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.996 -0.742 . . . . 1.1 108.996 173.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 89.0 mt -134.16 119.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.152 -0.684 . . . . 0.2 109.152 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 14.9 m-85 -104.01 130.09 51.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.615 -0.266 . . . . 0.23 111.287 -173.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.716 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.5 p30 -83.79 93.8 8.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.938 -0.764 . . . . 1.28 108.938 167.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.8 m -107.13 140.32 25.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 121.438 -0.789 . . . . 0.88 113.073 -163.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 102.82 4.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.764 -1.569 . . . . 0.52 106.764 164.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.776 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 39.0 t -74.01 94.3 2.35 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.109 0.781 . . . . 1.84 113.109 -163.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 12.7 ttpp 65.11 45.27 3.08 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.7 -1.136 . . . . 2.43 110.733 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.7 p -163.39 151.98 13.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 0.99 110.334 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.96 -124.59 8.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.814 -0.707 . . . . 1.09 113.593 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -107.19 136.89 46.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.351 0.596 . . . . 3.16 112.142 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.561 HG22 ' CE1' ' A' ' 139' ' ' PHE . 55.2 p -116.72 94.03 4.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 1.94 109.585 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 16.9 ttmm -78.17 41.21 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.283 -0.417 . . . . 2.03 110.908 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.29 85.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.037 -0.602 . . . . 0.47 112.775 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.95 -38.03 84.19 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 112.052 -0.419 . . . . 0.34 112.052 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.599 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.6 t80 -71.74 -50.44 30.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.556 -0.322 . . . . 0.57 110.688 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.35 -44.37 95.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.944 -0.571 . . . . 2.46 110.622 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -52.89 62.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 0.33 110.97 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.66 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.7 -49.31 75.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.19 111.781 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -56.77 -47.15 80.78 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.967 -0.561 . . . . 0.3 111.169 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.0 m -61.32 -48.89 79.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.627 -0.715 . . . . 1.08 110.988 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 163' ' ' ILE . 51.5 mt -58.84 -52.04 67.42 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.244 -0.435 . . . . 0.81 111.738 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 86.1 t80 -50.86 -52.77 38.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.527 0.517 . . . . 0.33 110.323 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -73.76 -36.65 65.13 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.476 -0.784 . . . . 1.76 111.425 -170.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -74.93 -45.97 38.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.815 -0.629 . . . . 1.79 111.503 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.558 ' CD1' HD13 ' A' ' 171' ' ' LEU . 34.1 m-85 -101.94 -2.84 28.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 114.686 1.365 . . . . 0.43 114.686 -168.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.635 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 13.0 ptmm? -69.18 -15.45 63.4 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.487 -0.885 . . . . 2.11 110.346 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -60.33 -33.2 72.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 1.2 109.979 172.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -101.55 10.24 40.48 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 116.357 -0.383 . . . . 1.9 110.878 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.612 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 90.15 80.61 1.36 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.97 -0.633 . . . . 1.32 112.589 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.635 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 69.9 t80 -151.97 141.89 22.07 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.928 -0.16 . . . . 0.26 110.891 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.684 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -131.93 149.74 52.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 110.021 -0.362 . . . . 0.51 110.021 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.682 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 49.0 t -117.09 115.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.972 -0.381 . . . . 0.24 109.972 172.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 18.4 mt -102.11 121.95 43.2 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.932 -0.766 . . . . 0.51 108.932 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.995 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -110.9 114.25 27.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.096 0.474 . . . . 0.28 110.656 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.769 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-85 -98.66 112.61 62.98 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 109.075 -0.713 . . . . 0.34 109.075 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.908 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 46.3 Cg_exo -57.89 167.78 3.95 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.278 2.652 . . . . 0.73 112.042 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.435 -1.184 0 C-N-CA 120.027 -0.669 . . . . 1.54 110.911 -178.22 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 108.992 -0.744 . . . . 0.91 108.992 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.3 t -158.96 120.27 3.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.926 -1.034 . . . . 1.92 109.368 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 23' ' ' ALA . 42.7 mttp 45.86 86.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.222 0.823 . . . . 3.18 113.222 172.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.704 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 49.8 p90 -64.58 -20.87 66.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.657 -0.497 . . . . 1.74 109.657 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 66.45 136.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.736 -1.12 . . . . 3.08 111.424 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -165.06 -178.4 5.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.705 -0.68 . . . . 0.43 110.881 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -88.32 32.84 0.75 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.657 -0.702 . . . . 2.19 110.566 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.688 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.4 p90 -152.0 161.75 28.55 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.114 -1.069 . . . . 0.24 108.114 175.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.9 Cg_exo -64.85 107.94 0.99 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 123.53 2.82 . . . . 0.31 114.189 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.995 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.3 mp -101.39 131.88 48.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.892 -0.781 . . . . 0.37 108.892 171.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.769 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.7 mmt -110.03 -151.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.924 0.712 . . . . 1.47 112.924 -162.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.495 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -75.14 144.58 42.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.391 -0.822 . . . . 0.39 110.778 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.908 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 22.2 pttt -83.45 131.89 35.0 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.659 0.742 . . . . 1.66 109.775 169.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' A' ' 116' ' ' HIS . 2.3 pt -136.59 159.22 37.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.78 -1.563 . . . . 0.47 106.78 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.908 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -70.65 95.45 1.1 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.904 -0.718 . . . . 2.16 109.163 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.716 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -87.43 83.11 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.262 -0.975 . . . . 0.38 109.065 175.213 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.0 t-20 171.52 -178.5 0.05 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.367 -0.975 . . . . 1.98 108.367 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 53.2 -147.92 15.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 114.677 0.631 . . . . 0.78 114.677 160.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.42 2.23 28.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.15 -0.525 . . . . 1.98 111.096 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -98.56 -3.46 36.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.253 -0.43 . . . . 2.04 110.92 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.908 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -46.53 139.3 5.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.189 -0.914 . . . . 0.48 113.34 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.606 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 54.1 t-80 -51.31 137.31 29.81 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.259 -0.882 . . . . 0.42 110.376 171.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.565 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -44.04 -46.5 11.04 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.114 2.542 . . . . 0.36 112.526 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.657 HD11 ' HE3' ' A' ' 122' ' ' MET . 20.9 tp -58.63 -41.89 86.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.842 -0.617 . . . . 1.1 111.762 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.487 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 3.7 m-85 -74.5 -29.98 61.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 119.561 -0.257 . . . . 1.49 110.781 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 41.5 mt-10 -56.54 -43.59 80.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.645 -0.872 . . . . 2.37 108.645 169.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 84.0 t80 -65.96 -46.57 77.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.54 0.525 . . . . 0.58 110.745 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.657 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.4 mtt -62.72 -51.72 66.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.212 -0.449 . . . . 0.34 111.02 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.563 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 34.7 mtpt -60.75 -45.24 95.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.94 110.949 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.4 ptmt -68.69 -33.49 74.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.266 -0.425 . . . . 2.13 111.299 -176.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.48 HG21 ' HD2' ' A' ' 150' ' ' PRO . 93.7 m -74.02 -50.28 20.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.072 -0.513 . . . . 0.47 111.85 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 6.1 tmtt? . . . . . 0 C--N 1.325 -0.467 0 C-N-CA 120.682 -0.407 . . . . 1.75 111.437 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.784 0.326 . . . . 0.93 110.477 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.861 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 17.6 mt -76.84 161.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.069 -1.086 . . . . 1.05 108.069 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -178.02 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.925 0.784 . . . . 1.5 112.146 -176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.861 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.52 165.8 11.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.269 -0.423 . . . . 0.87 112.09 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -48.33 -154.41 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 126.083 1.753 . . . . 1.8 113.817 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.815 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.2 m-85 -28.49 -45.64 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 115.273 1.583 . . . . 1.37 115.273 -163.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.96 HG23 ' HA ' ' A' ' 155' ' ' SER . 15.9 m 30.29 109.89 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.38 1.622 . . . . 0.3 115.38 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.0 p -93.56 156.52 16.68 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.27 0.557 . . . . 0.8 111.09 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 6.2 m-85 -102.43 166.47 10.53 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.018 -1.475 . . . . 0.53 107.018 163.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.758 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 49.8 tp -112.83 104.77 12.78 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.763 -0.829 . . . . 0.51 108.763 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.851 HG21 HD13 ' A' ' 15' ' ' ILE . 11.9 mm -103.05 125.22 57.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 109.11 -0.7 . . . . 0.2 109.11 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -77.86 -176.35 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.8 -0.36 . . . . 1.3 111.684 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.694 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 76.6 mtp180 -57.41 -24.4 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.626 0.602 . . . . 3.78 112.626 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.52 -12.43 14.69 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.868 -0.733 . . . . 1.18 110.494 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.542 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 109.24 34.35 2.54 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.814 -0.708 . . . . 0.23 113.059 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 57.9 t -107.85 128.33 26.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.859 -0.423 . . . . 0.62 109.859 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.48 ' HD2' HG21 ' A' ' 125' ' ' THR . 4.8 Cg_exo -75.4 112.04 3.44 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.362 2.041 . . . . 0.3 111.24 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.524 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 41.1 t -93.54 -23.94 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.27 110.944 -177.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 1.2 mm-40 -156.65 166.11 34.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 1.22 111.042 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.563 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 27.5 ttm180 -131.05 96.55 4.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.905 -0.776 . . . . 1.75 108.905 172.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.758 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 77.3 m-85 -82.42 110.07 17.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.38 109.519 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.96 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.4 m -61.85 168.4 3.61 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.879 -0.415 . . . . 0.99 109.879 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.807 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 36.1 Cg_endo -60.93 -28.16 85.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.629 1.553 . . . . 0.66 111.462 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.49 66.33 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.317 -1.31 . . . . 0.52 112.681 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.64 112.03 6.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.964 0.411 . . . . 0.43 110.045 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.7 m -74.81 174.66 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.895 -0.593 . . . . 1.25 110.828 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 69.0 t -48.59 -53.37 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.343 -0.389 . . . . 0.41 111.679 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -66.17 -32.13 73.38 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.278 -0.419 . . . . 3.44 111.498 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -63.71 -32.57 74.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.418 -0.586 . . . . 1.86 109.418 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.634 HG21 HD21 ' A' ' 39' ' ' LEU . 63.2 mt -83.68 -39.83 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.322 -0.854 . . . . 0.21 111.12 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.4 mt-10 -51.44 -44.14 62.25 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.234 0.457 . . . . 0.88 112.234 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.9 pt-20 -53.79 -33.57 56.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.123 0.416 . . . . 0.75 112.123 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.751 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtm -102.18 -19.08 15.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.918 0.39 . . . . 1.58 111.007 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.6 tp -84.14 -45.53 12.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 0.24 111.349 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.76 ' HA ' HD12 ' A' ' 171' ' ' LEU . 74.3 mt -53.5 -48.11 94.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.281 0.474 . . . . 0.44 112.281 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.9 Cg_exo -53.54 -37.32 82.64 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.067 1.844 . . . . 0.49 112.7 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.3 mt -78.87 -35.86 43.1 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 111.95 0.352 . . . . 0.71 111.95 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.985 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 11.4 mt -55.51 -54.15 47.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.744 0.783 . . . . 0.46 108.933 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.03 -45.74 94.77 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.211 -1.359 . . . . 1.52 113.539 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-N 117.835 0.817 . . . . 2.52 113.07 -172.467 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 108.516 -0.92 . . . . 1.68 108.516 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.0 p -135.37 178.34 7.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.159 -0.928 . . . . 0.65 109.494 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.71 HD13 HG21 ' A' ' 144' ' ' ILE . 21.4 pt -62.99 -26.42 40.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.241 0.543 . . . . 0.3 110.632 175.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.793 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 45.7 m-85 -76.94 -6.06 51.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.8 -0.637 . . . . 0.27 112.306 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -82.37 7.33 14.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.448 0.642 . . . . 1.96 109.352 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 89.2 m-85 -119.56 169.97 9.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.103 -0.953 . . . . 0.4 110.051 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.7 tt0 -98.01 151.49 20.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.312 -0.404 . . . . 2.77 110.513 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 28' ' ' TYR . 72.6 t -130.46 136.29 58.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.011 0.434 . . . . 0.74 110.507 172.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.729 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 96.4 mt -101.63 140.42 35.95 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.126 -0.694 . . . . 0.72 109.126 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 -172.72 3.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.238 -0.653 . . . . 1.59 109.238 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.46 66.35 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.779 0.323 . . . . 0.52 111.229 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 20.3 t70 -88.93 -12.16 42.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.192 -0.458 . . . . 2.22 111.191 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.729 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 38.7 m-70 82.59 23.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 123.599 0.76 . . . . 0.73 110.399 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -85.43 154.18 59.35 Favored Pre-proline 0 N--CA 1.443 -0.802 0 N-CA-C 105.693 -1.965 . . . . 3.25 105.693 165.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.68 114.38 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.812 0.969 . . . . 0.86 111.904 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.578 ' HB3' HG12 ' A' ' 20' ' ' VAL . 75.3 t80 -86.74 111.25 20.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.407 -0.815 . . . . 0.28 109.194 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.703 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 57.5 t30 -68.83 86.38 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.216 0.532 . . . . 1.65 109.936 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.793 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -61.38 -35.96 78.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 0.25 111.378 -174.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 13.5 p -76.54 1.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.003 0.742 . . . . 0.41 113.003 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.703 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.5 pt20 -74.73 -5.86 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.174 -0.954 . . . . 1.24 108.997 168.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -98.42 2.71 48.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.212 -1.033 . . . . 0.38 108.212 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 21.1 ttpt -81.07 142.46 33.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.848 -1.069 . . . . 1.73 109.642 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.06 79.48 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.804 -1.319 . . . . 0.36 109.804 -170.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.645 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 16.3 m -132.54 146.87 63.32 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 114.111 -1.045 . . . . 1.14 108.293 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.859 ' HG2' HD23 ' A' ' 171' ' ' LEU . 1.2 Cg_endo -79.56 149.58 21.29 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.737 1.625 . . . . 0.52 110.238 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.1 pt? -151.93 149.91 29.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.302 0.572 . . . . 1.03 111.291 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -107.53 154.9 20.71 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.584 -0.895 . . . . 1.1 108.584 172.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.487 HD12 HG13 ' A' ' 144' ' ' ILE . 69.4 mt -141.62 114.82 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.094 -0.706 . . . . 0.2 109.094 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 18.1 m-85 -100.59 124.55 46.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 121.125 -0.23 . . . . 0.23 110.78 -174.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.4 p30 -80.69 92.7 6.05 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.242 -0.651 . . . . 1.28 109.242 171.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.711 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 m -106.34 145.93 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 114.229 1.196 . . . . 0.88 114.229 -160.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.39 102.22 9.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.603 -1.628 . . . . 0.52 106.603 160.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 95' ' ' CYS . 40.4 t -72.11 85.29 1.02 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 112.563 0.579 . . . . 1.84 112.563 -165.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 17.9 tppt? 75.4 23.31 1.53 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.739 0.78 . . . . 2.43 110.638 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.52 129.33 51.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.238 -0.437 . . . . 0.99 110.548 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 -115.87 4.62 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.862 -0.685 . . . . 1.09 112.7 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -139.63 166.69 23.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.271 0.558 . . . . 3.16 111.868 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.9 p -131.92 115.07 15.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.663 -0.699 . . . . 1.94 110.372 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.721 ' HD2' ' HA3' ' A' ' 157' ' ' GLY . 28.0 ttmt -79.0 24.61 0.31 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.212 0.53 . . . . 2.03 110.887 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.99 13.8 24.39 Favored Glycine 0 C--O 1.224 -0.522 0 CA-C-N 115.881 -0.6 . . . . 0.47 112.38 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.71 -47.43 20.61 Favored Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 121.231 -0.509 . . . . 0.34 112.175 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.649 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.7 t80 -69.67 -47.6 62.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.486 0.184 . . . . 0.57 111.262 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -59.28 -47.11 86.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.069 0.462 . . . . 2.46 110.145 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.5 m -64.31 -45.99 85.51 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.385 -0.825 . . . . 0.33 110.891 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.547 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.17 -49.31 76.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.979 0.419 . . . . 0.19 111.07 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.6 m -59.26 -51.3 70.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.615 -0.721 . . . . 0.3 111.147 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 p -63.68 -39.27 93.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 1.08 111.914 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.495 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 88.5 mt -62.48 -51.66 66.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.442 0.163 . . . . 0.81 110.996 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.836 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 71.6 t80 -51.96 -48.86 64.12 Favored 'General case' 0 C--O 1.22 -0.45 0 O-C-N 123.752 0.657 . . . . 0.33 109.483 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.12 -43.29 74.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.536 -0.756 . . . . 1.76 111.687 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.61 -44.79 61.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.865 -0.607 . . . . 1.79 111.391 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.749 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.1 m-85 -100.91 6.3 43.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.402 0.89 . . . . 0.43 113.402 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 65' ' ' LYS . 7.5 mmmt -60.75 -25.17 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.987 0.422 . . . . 2.11 110.279 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -32.76 74.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.777 -0.647 . . . . 1.2 110.69 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -98.65 17.48 19.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.994 0.426 . . . . 1.9 110.703 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.645 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 74.78 55.52 5.35 Favored Glycine 0 C--O 1.224 -0.488 0 CA-C-N 115.64 -0.709 . . . . 1.32 112.845 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 59.7 t80 -117.15 140.0 50.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.633 0.254 . . . . 0.26 110.781 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -128.36 138.98 52.61 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 120.907 0.384 . . . . 0.51 110.556 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.836 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 39.4 t -110.91 121.11 63.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.887 0.375 . . . . 0.24 110.242 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' HE3' ' A' ' 105' ' ' MET . 21.3 mt -102.03 141.62 34.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.901 -0.778 . . . . 0.51 108.901 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.015 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -125.98 124.75 41.43 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.11 0.481 . . . . 0.28 110.222 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.676 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.4 m-85 -108.5 108.3 60.86 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.891 -0.595 . . . . 0.34 109.686 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.611 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 41.7 Cg_exo -58.67 154.97 39.54 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.077 2.518 . . . . 0.73 112.057 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.433 -1.277 0 CA-C-N 115.776 -0.647 . . . . 1.54 110.582 -177.997 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 45' ' ' SER . 21.8 m . . . . . 0 N--CA 1.441 -0.907 0 CA-C-O 121.367 0.603 . . . . 0.91 110.758 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.409 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 8.3 t -157.07 118.47 3.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.135 -0.939 . . . . 1.92 109.313 166.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HA ' HG21 ' A' ' 104' ' ' ILE . 27.4 mttm 70.15 -47.02 0.62 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.591 1.33 . . . . 3.18 114.591 173.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.649 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 2.7 p90 58.04 -29.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.414 1.486 . . . . 1.74 111.548 -164.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.601 ' H ' ' C ' ' A' ' 97' ' ' LYS . 6.8 mtmt 71.51 125.47 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.245 1.018 . . . . 3.08 111.739 170.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.547 ' HB2' ' HE1' ' A' ' 98' ' ' PHE . . . -154.02 -170.67 3.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.985 -0.552 . . . . 0.43 112.035 -173.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.04 -6.28 58.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.732 -0.667 . . . . 2.19 110.366 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.709 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 47.9 p90 -115.98 162.23 26.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.62 -0.882 . . . . 0.24 108.62 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.794 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 37.8 Cg_exo -66.95 123.39 10.91 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 123.892 3.062 . . . . 0.31 113.675 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.015 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -112.3 148.85 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.291 -0.633 . . . . 0.37 109.291 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.794 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 9.2 mmt -120.36 -154.75 0.59 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.447 0.906 . . . . 1.47 113.447 -164.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.462 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -69.42 154.07 42.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.667 -1.151 . . . . 0.39 111.141 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.598 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 72.0 mttt -80.99 112.5 18.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.271 -0.64 . . . . 1.66 109.271 174.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.41 HG13 HG13 ' A' ' 110' ' ' VAL . 30.9 pt -121.39 149.58 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.224 -1.028 . . . . 0.47 108.224 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.6 t-20 -81.74 60.51 4.69 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.831 -0.348 . . . . 2.16 110.384 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -56.38 94.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 116.575 -0.284 . . . . 0.38 110.912 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.818 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER 175.43 178.55 0.16 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 110.207 -0.294 . . . . 1.98 110.207 175.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.91 -123.2 0.15 Allowed Glycine 0 C--N 1.334 0.438 0 O-C-N 125.115 1.509 . . . . 0.78 115.192 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -107.01 -6.09 17.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 1.98 110.662 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -95.19 -6.9 40.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.386 -0.825 . . . . 2.04 112.308 -170.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB2' ' H ' ' A' ' 111' ' ' ASN . . . -57.56 146.38 30.4 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.214 0.82 . . . . 0.48 113.214 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.476 ' HE1' ' O ' ' A' ' 19' ' ' GLU . 26.5 t-80 -50.56 141.06 17.68 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.242 -0.89 . . . . 0.42 109.803 169.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 8.7 Cg_endo -51.08 -37.96 58.78 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.254 2.636 . . . . 0.36 112.523 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.523 HD11 ' HE3' ' A' ' 122' ' ' MET . 14.6 tp -54.85 -45.38 74.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.119 0.485 . . . . 1.1 111.074 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.489 ' CG ' HG12 ' A' ' 110' ' ' VAL . 3.3 m-85 -73.95 -28.1 61.33 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 116.079 -0.51 . . . . 1.49 110.974 176.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 39.7 mt-10 -56.23 -38.38 70.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.838 -0.745 . . . . 2.37 109.468 168.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 76.2 t80 -69.95 -47.01 64.04 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.568 -0.453 . . . . 0.58 110.488 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.523 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.9 mtt -61.48 -55.23 33.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.294 -0.412 . . . . 0.34 111.241 -178.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 27.6 mtpt -58.59 -43.66 89.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.94 111.411 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 15.0 ptmm? -70.1 -33.91 72.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 2.13 111.077 -176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.576 HG21 ' HD2' ' A' ' 150' ' ' PRO . 90.2 m -65.65 -46.56 78.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.394 -0.366 . . . . 0.47 111.105 -176.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.631 ' HD3' ' HA ' ' A' ' 152' ' ' GLU . 27.9 tttm . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 1.75 109.95 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.346 0 CA-C-O 120.306 0.098 . . . . 0.93 111.079 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.868 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 30.6 mm -70.13 161.95 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.512 -0.922 . . . . 1.05 108.512 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -177.42 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.748 0.785 . . . . 1.5 110.334 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.868 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -95.64 171.41 8.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.731 -1.122 . . . . 0.87 111.717 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.424 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 89.5 m-20 -48.13 -156.57 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.36 -1.746 . . . . 1.8 113.789 170.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 4.5 m-85 -29.32 -57.91 0.15 Allowed 'General case' 0 C--O 1.202 -1.428 0 C-N-CA 125.166 1.387 . . . . 1.37 114.588 -165.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.938 HG23 ' HA ' ' A' ' 155' ' ' SER . 10.0 m 44.48 106.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.309 1.225 . . . . 0.3 114.309 177.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 11.9 p -89.55 149.13 23.01 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.358 -0.839 . . . . 0.8 111.458 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 14.3 m-85 -103.76 133.4 48.81 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.147 -1.057 . . . . 0.53 108.147 163.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.794 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 16.3 tp -82.52 105.26 13.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.44 -0.578 . . . . 0.51 109.44 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.71 HG21 HD13 ' A' ' 15' ' ' ILE . 10.6 mm -105.03 126.97 59.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.409 -0.589 . . . . 0.2 109.409 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 16.9 p30 -79.57 -175.16 4.64 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.837 -0.345 . . . . 1.3 111.47 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 36' ' ' SER . 91.8 mtt180 -64.54 -12.81 48.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.507 0.558 . . . . 3.78 112.507 -176.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -109.73 -13.46 14.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.41 0.624 . . . . 1.18 109.326 -170.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.407 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 100.52 28.07 7.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.175 -0.921 . . . . 0.23 112.729 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.431 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 61.7 t -110.77 128.0 26.04 Favored Pre-proline 0 C--N 1.317 -0.839 0 O-C-N 122.538 -0.389 . . . . 0.62 110.388 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.576 ' HD2' HG21 ' A' ' 125' ' ' THR . 10.6 Cg_exo -68.94 106.09 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.97 2.447 . . . . 0.3 112.174 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.3 t -89.41 -16.33 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 0.27 110.589 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.631 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 5.2 mm-40 -160.73 165.67 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 1.22 110.717 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -137.56 98.28 3.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.94 -0.573 . . . . 1.75 109.531 170.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.794 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.3 m-85 -88.49 113.02 23.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.38 109.745 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.938 ' HA ' HG23 ' A' ' 140' ' ' THR . 3.8 m -64.56 166.14 12.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 109.775 -0.454 . . . . 0.99 109.775 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.822 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 33.8 Cg_endo -65.34 -8.26 18.28 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.695 2.264 . . . . 0.66 113.061 -165.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.721 ' HA3' ' HD2' ' A' ' 51' ' ' LYS . . . -93.24 3.25 72.43 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.433 -0.803 . . . . 0.52 112.882 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.47 139.97 37.46 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.182 -0.303 . . . . 0.43 110.182 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 94.7 p -83.58 171.11 13.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.25 111.034 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.7 t -55.52 -48.27 77.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.684 -0.487 . . . . 0.41 109.684 175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -63.74 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.806 . . . . 3.44 110.9 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.06 -37.73 69.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.95 -0.568 . . . . 1.86 110.313 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.553 HG21 HD21 ' A' ' 39' ' ' LEU . 67.5 mt -82.51 -41.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 0.21 111.399 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 52.0 mt-10 -56.37 -40.02 73.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.147 0.425 . . . . 0.88 112.147 -176.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 10.0 pt-20 -59.77 -22.71 62.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.821 0.304 . . . . 0.75 111.821 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.7 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.8 mmtp -107.23 -19.88 13.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.104 0.478 . . . . 1.58 110.262 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.658 ' HG ' HD11 ' A' ' 171' ' ' LEU . 58.2 tp -84.73 -42.44 15.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.24 111.32 -174.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.693 ' HA ' HD12 ' A' ' 171' ' ' LEU . 81.9 mt -53.24 -47.44 95.97 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.16 0.43 . . . . 0.44 112.16 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.5 Cg_exo -55.29 -23.28 36.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.624 2.216 . . . . 0.49 113.327 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 mt -92.65 -40.31 10.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.634 0.254 . . . . 0.71 110.964 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.859 HD23 ' HG2' ' A' ' 37' ' ' PRO . 10.7 mt -60.39 -48.51 81.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.092 -0.707 . . . . 0.46 109.092 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.92 52.5 2.87 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.699 -1.137 . . . . 1.52 113.057 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 124.991 1.316 . . . . 2.52 113.594 177.078 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.747 0.308 . . . . 1.68 111.138 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.0 p -171.69 -176.96 1.88 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.292 -0.633 . . . . 0.65 109.292 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.764 HD13 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -62.34 -26.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.138 0.494 . . . . 0.3 110.448 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.899 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 44.0 m-85 -79.02 -1.59 36.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.777 -0.647 . . . . 0.27 111.556 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.27 -16.1 61.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.443 -0.947 . . . . 1.96 108.443 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 47.5 m-85 -105.63 177.81 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.579 -1.191 . . . . 0.4 109.658 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -126.13 148.47 49.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.692 0.282 . . . . 2.77 110.722 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG23 HD13 ' A' ' 30' ' ' LEU . 70.0 t -117.35 148.17 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.74 111.33 -175.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 92.7 mt -102.82 137.73 40.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 0.72 109.656 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 23' ' ' ALA . 19.7 t70 -72.98 -174.97 1.63 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.035 -0.728 . . . . 1.59 109.035 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.424 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -55.48 -34.15 64.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.042 0.449 . . . . 0.52 111.139 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 27.5 m-20 -93.82 3.03 56.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 2.22 111.186 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.97 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 35.1 m-70 72.91 14.53 4.81 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.276 0.63 . . . . 0.73 110.292 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 10.4 mtmt -66.76 144.34 98.53 Favored Pre-proline 0 CA--C 1.511 -0.519 0 N-CA-C 106.252 -1.759 . . . . 3.25 106.252 163.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.81 113.76 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 CA-C-N 119.809 0.967 . . . . 0.86 111.136 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.423 ' HB3' HG12 ' A' ' 20' ' ' VAL . 69.2 t80 -87.53 108.84 19.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.375 -0.83 . . . . 0.28 109.124 172.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.65 ' OD1' HG12 ' A' ' 31' ' ' VAL . 62.6 t30 -66.57 95.59 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.132 -0.692 . . . . 1.65 109.132 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.899 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.88 -30.23 67.63 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.627 -0.715 . . . . 0.25 110.611 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.687 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -76.93 -4.06 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 0.41 112.843 -166.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 27.8 pt20 -79.02 -4.99 52.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.565 0.698 . . . . 1.24 109.396 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.531 ' ND1' HG21 ' A' ' 70' ' ' THR . 84.8 m-70 -97.67 2.38 49.68 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.368 -0.975 . . . . 0.38 108.368 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -78.62 145.6 34.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.111 -0.95 . . . . 1.73 108.951 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.58 87.29 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.904 -1.278 . . . . 0.36 109.904 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -132.27 133.05 23.31 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.64 -0.874 . . . . 1.14 108.64 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.934 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 36.4 Cg_endo -69.56 146.02 60.16 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.305 1.337 . . . . 0.52 109.803 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.566 ' CD2' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -150.77 161.13 43.23 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.495 0.665 . . . . 1.03 111.743 -175.701 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.794 HD21 HG21 ' A' ' 163' ' ' ILE . 6.5 mp -111.96 154.01 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.977 -1.011 . . . . 1.1 108.671 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 94.5 mt -140.54 115.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.291 -0.633 . . . . 0.2 109.291 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.862 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 34.4 m-85 -99.72 123.4 43.94 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 121.047 -0.261 . . . . 0.23 111.165 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.714 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -80.41 91.56 5.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.197 -1.038 . . . . 1.28 108.197 167.171 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.4 p -116.11 137.7 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.733 1.012 . . . . 0.88 113.733 -162.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.08 108.85 1.96 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.267 -1.012 . . . . 0.52 108.267 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.962 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 17.8 t -75.68 84.02 2.68 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.278 0.473 . . . . 1.84 112.278 -169.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.696 ' HG3' ' HB2' ' A' ' 98' ' ' PHE . 52.2 mttm 73.15 29.92 1.66 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.18 -0.918 . . . . 2.43 112.328 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -133.04 128.87 37.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.348 -0.612 . . . . 0.99 109.348 174.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.93 -129.39 9.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.441 -0.885 . . . . 1.09 113.387 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.33 161.82 26.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.011 0.91 . . . . 3.16 113.353 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 t -125.22 154.0 42.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.387 -1.279 . . . . 1.94 108.286 168.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -119.08 20.84 12.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.573 0.701 . . . . 2.03 109.345 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.98 16.27 6.87 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 114.846 -1.07 . . . . 0.47 111.584 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.21 -54.25 4.14 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.935 -0.466 . . . . 0.34 111.935 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.654 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.4 t80 -65.92 -45.7 80.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.976 0.417 . . . . 0.57 110.592 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -62.36 -46.63 87.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 2.46 110.541 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.465 ' CG2' HD12 ' A' ' 163' ' ' ILE . 98.5 m -67.75 -41.46 83.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.169 -0.468 . . . . 0.33 110.859 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.728 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.13 -47.78 84.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.19 111.235 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 m -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.945 -0.571 . . . . 0.3 111.125 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 p -62.54 -48.38 79.76 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.852 -0.613 . . . . 1.08 111.203 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.05 -46.49 88.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 0.81 111.596 -177.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.725 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 46.3 t80 -50.93 -58.71 5.32 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 123.389 0.43 . . . . 0.33 110.595 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.571 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 91.9 m-20 -73.02 -30.61 63.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.076 0.399 . . . . 1.76 112.076 -173.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.8 -27.26 50.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.211 -0.45 . . . . 1.79 111.329 -174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.774 ' CD1' HD13 ' A' ' 171' ' ' LEU . 65.8 m-85 -122.17 5.2 9.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.687 0.995 . . . . 0.43 113.687 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 35.3 mtmt -58.79 -28.92 66.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.983 0.421 . . . . 2.11 110.33 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.0 p -61.12 -40.01 92.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.636 -0.711 . . . . 1.2 110.928 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -90.48 12.12 19.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 1.9 110.761 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.673 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.49 71.5 1.25 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.79 -0.641 . . . . 1.32 112.133 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CE1' HD13 ' A' ' 39' ' ' LEU . 74.0 t80 -140.67 141.82 34.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.657 0.265 . . . . 0.26 110.968 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.531 HG21 ' ND1' ' A' ' 33' ' ' HIS . 8.8 t -131.96 142.88 49.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.224 0.535 . . . . 0.51 110.433 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.728 HG11 ' HB1' ' A' ' 57' ' ' ALA . 24.7 t -105.24 119.64 54.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.894 0.378 . . . . 0.24 110.073 170.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.663 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 12.3 mt -104.69 128.06 52.64 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.891 -0.781 . . . . 0.51 108.891 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -114.52 121.3 43.08 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.309 -0.556 . . . . 0.28 110.878 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.672 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -105.42 108.75 62.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.878 -0.786 . . . . 0.34 108.878 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.962 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 50.9 Cg_exo -56.4 164.76 5.06 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.979 2.453 . . . . 0.73 111.56 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.437 -1.086 0 C-N-CA 119.031 -1.068 . . . . 1.54 113.046 -176.339 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 45' ' ' SER . 12.7 m . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.22 0.534 . . . . 0.91 110.654 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -152.85 118.39 5.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.474 -0.784 . . . . 1.92 109.807 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HG3' ' HE3' ' A' ' 99' ' ' LYS . 15.0 pttm 23.86 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.098 1.359 . . . . 3.18 114.634 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.696 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -57.01 120.18 7.55 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.005 -1.85 . . . . 1.74 106.005 168.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HE3' ' HG3' ' A' ' 97' ' ' LYS . 9.3 mptt -79.44 164.44 23.97 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.702 -0.799 . . . . 3.08 111.195 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.621 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -172.67 -175.41 1.3 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.08 0.863 . . . . 0.43 110.969 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.62 0.9 55.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 2.19 110.903 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.685 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 49.9 p90 -121.36 168.4 11.17 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.655 -0.868 . . . . 0.24 108.655 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.914 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.6 Cg_exo -69.95 116.92 4.8 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.505 2.803 . . . . 0.31 113.239 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.969 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.5 mp -109.01 140.22 28.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.934 -0.765 . . . . 0.37 108.934 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.914 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.8 mmt -113.68 -153.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.371 0.605 . . . . 1.47 112.488 -164.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.603 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.76 144.22 45.73 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.036 -0.983 . . . . 0.39 110.477 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.942 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.7 pttp -80.67 127.77 32.86 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.652 -0.87 . . . . 1.66 108.652 169.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.626 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -131.86 169.4 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.049 -1.463 . . . . 0.47 107.049 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.802 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.5 m120 -72.43 118.82 15.81 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.467 -0.938 . . . . 2.16 108.467 172.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.714 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -116.97 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 119.453 -0.899 . . . . 0.38 108.914 168.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 13.2 t-20 171.61 178.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.911 -1.144 . . . . 1.98 107.911 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.09 -140.38 12.23 Favored Glycine 0 N--CA 1.448 -0.561 0 O-C-N 123.645 0.59 . . . . 0.78 114.321 163.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -104.84 -2.62 24.51 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.9 -0.65 . . . . 1.98 110.254 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.06 -21.31 26.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.512 -0.767 . . . . 2.04 110.646 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.802 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.05 137.65 0.66 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.213 1.19 . . . . 0.48 114.213 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.585 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 56.6 t-80 -49.79 139.09 16.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.233 -0.894 . . . . 0.42 110.797 172.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -41.87 -49.73 5.43 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.193 2.595 . . . . 0.36 112.938 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.585 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -55.91 -38.32 70.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.102 -0.499 . . . . 1.1 112.138 177.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.519 ' HE1' HD21 ' A' ' 42' ' ' ASN . 3.5 m-85 -75.97 -30.0 58.46 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 122.35 -0.219 . . . . 1.49 111.003 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.7 mt-10 -57.64 -35.27 70.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.025 -0.731 . . . . 2.37 109.025 169.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.9 t80 -71.38 -48.4 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.58 110.309 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.529 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 67.5 mtt -63.09 -53.09 59.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.999 -0.546 . . . . 0.34 111.624 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -56.72 -46.43 81.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.539 . . . . 0.94 111.003 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -67.46 -32.29 73.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 2.13 111.039 -176.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.526 HG21 ' HD2' ' A' ' 150' ' ' PRO . 93.0 m -72.76 -63.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 0.47 111.828 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.597 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 5.4 tmtt? . . . . . 0 C--N 1.324 -0.509 0 C-N-CA 120.924 -0.31 . . . . 1.75 110.843 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.702 0.286 . . . . 0.93 111.164 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.79 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 29.4 mm -76.02 170.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 108.809 -0.811 . . . . 1.05 108.809 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 135' ' ' ILE . 11.9 ptpt 177.47 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.609 0.718 . . . . 1.5 110.52 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.79 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.76 169.76 9.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.071 -0.968 . . . . 0.87 112.261 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.4 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 22.0 m120 -48.91 -155.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.219 1.808 . . . . 1.8 113.959 172.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.862 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 22.8 m-85 -26.7 -58.43 0.09 Allowed 'General case' 0 C--O 1.205 -1.243 0 C-N-CA 125.419 1.488 . . . . 1.37 113.929 -163.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 155' ' ' SER . 22.5 m 40.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.33 0.863 . . . . 0.3 113.33 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 18.9 p -85.57 148.38 25.96 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.004 -0.678 . . . . 0.8 110.685 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 11.6 m-85 -102.34 130.34 49.05 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.036 -1.098 . . . . 0.53 108.036 167.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.802 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.4 tp -80.99 106.17 12.78 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.976 -0.75 . . . . 0.51 108.976 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.764 HG21 HD13 ' A' ' 15' ' ' ILE . 10.1 mm -105.06 128.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.442 -0.947 . . . . 0.2 108.442 -175.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.446 ' HB2' HD12 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -76.95 -176.16 3.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.756 0.312 . . . . 1.3 110.884 -174.387 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.704 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 64.3 mtp180 -68.1 -6.48 23.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 3.78 111.804 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -109.97 -21.13 12.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.501 0.667 . . . . 1.18 109.528 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.513 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 102.98 32.96 4.49 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.967 -1.015 . . . . 0.23 112.848 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.8 t -111.55 129.0 24.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.523 -0.547 . . . . 0.62 109.523 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.526 ' HD2' HG21 ' A' ' 125' ' ' THR . 15.0 Cg_exo -64.39 109.92 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.376 2.051 . . . . 0.3 111.612 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.597 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 11.4 t -92.55 -22.09 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 0.27 110.351 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.3 mm-40 -153.75 163.99 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.262 0.554 . . . . 1.22 111.276 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.445 ' HD3' ' HH2' ' A' ' 137' ' ' TRP . 26.0 ttm180 -134.02 97.71 3.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.019 -0.991 . . . . 1.75 108.766 172.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.802 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 46.9 m-85 -90.84 113.75 25.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.057 -0.72 . . . . 0.38 109.057 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.741 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.7 m -62.0 173.51 0.87 Allowed Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 110.011 -0.366 . . . . 0.99 110.011 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.723 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 54.0 Cg_endo -64.54 -14.42 44.32 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.693 1.596 . . . . 0.66 111.157 -174.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.54 2.41 82.56 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.466 -1.243 . . . . 0.52 112.132 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.32 127.39 32.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.816 0.341 . . . . 0.43 110.547 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -178.9 5.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.126 -0.488 . . . . 1.25 110.589 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.439 ' HA ' HG23 ' A' ' 56' ' ' THR . 49.1 t -55.05 -58.87 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.41 112.021 -175.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 162' ' ' ASP . 4.0 ptmm? -66.49 -28.32 68.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 3.44 110.988 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 161' ' ' LYS . 62.3 m-20 -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 1.86 110.237 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.794 HG21 HD21 ' A' ' 39' ' ' LEU . 55.1 mt -82.54 -44.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.832 -0.622 . . . . 0.21 110.369 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.5 ' O ' HG13 ' A' ' 168' ' ' ILE . 61.2 mt-10 -56.45 -40.12 74.29 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 112.162 0.43 . . . . 0.88 112.162 -176.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.36 -20.93 47.86 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.012 0.375 . . . . 0.75 112.012 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.637 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 63.1 mmtt -105.4 -25.71 12.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.587 0.232 . . . . 1.58 110.456 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 44.4 tp -85.78 -34.73 21.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.24 112.036 -169.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.719 ' HA ' HD12 ' A' ' 171' ' ' LEU . 81.4 mt -50.37 -48.03 81.85 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.271 0.471 . . . . 0.44 112.271 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 75.2 Cg_exo -51.81 -38.49 67.61 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.253 1.969 . . . . 0.49 113.335 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 2.2 mm? -74.07 -42.45 60.17 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 121.076 -0.25 . . . . 0.71 111.036 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.934 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 9.7 mt -57.06 -46.4 82.51 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.2 -0.667 . . . . 0.46 109.2 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -50.8 -73.54 0.37 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.709 -1.132 . . . . 1.52 111.943 168.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 22.9 t . . . . . 0 N--CA 1.467 0.397 0 C-N-CA 122.668 0.387 . . . . 2.52 110.536 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.053 0.454 . . . . 1.68 110.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.8 p -153.2 173.36 15.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 0.65 109.199 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.792 HD13 HG21 ' A' ' 144' ' ' ILE . 25.9 pt -56.0 -32.3 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.3 111.583 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.809 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 47.4 m-85 -71.17 -14.31 62.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.27 111.97 -172.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -69.6 -15.02 63.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.312 0.577 . . . . 1.96 109.655 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 86.2 m-85 -103.66 174.13 6.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.342 -0.844 . . . . 0.4 111.528 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 10.5 tt0 -91.74 152.09 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.21 -0.904 . . . . 2.77 110.895 -177.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.609 HG12 ' HB3' ' A' ' 28' ' ' TYR . 93.7 t -138.78 145.45 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.119 0.485 . . . . 0.74 110.413 169.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.924 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 69.3 mt -119.91 148.12 43.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.706 -0.679 . . . . 0.72 109.472 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.66 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 14.5 t70 -78.88 -173.96 3.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.917 -0.771 . . . . 1.59 108.917 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.675 ' HB1' ' HG2' ' A' ' 97' ' ' LYS . . . -52.76 -27.0 15.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.338 0.496 . . . . 0.52 112.338 -172.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.86 25.0 10.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.289 0.477 . . . . 2.22 112.289 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.924 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 46.0 m-70 72.38 9.2 5.82 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 121.658 0.742 . . . . 0.73 110.538 171.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.66 ' HE3' ' HB3' ' A' ' 22' ' ' ASP . 23.9 mtmt -64.25 135.64 96.42 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 106.811 -1.551 . . . . 3.25 106.811 165.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.61 114.17 1.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.208 1.272 . . . . 0.86 112.226 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.609 ' HB3' HG12 ' A' ' 20' ' ' VAL . 46.3 t80 -93.61 110.06 21.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.495 -0.775 . . . . 0.28 111.011 175.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.556 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.6 t30 -71.5 93.26 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.136 -0.69 . . . . 1.65 109.136 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.794 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.17 -27.77 65.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.019 -0.537 . . . . 0.25 111.261 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.809 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.7 p -76.73 -1.47 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 113.181 0.808 . . . . 0.41 113.181 -166.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 26.8 pt20 -78.13 -5.39 51.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.319 0.58 . . . . 1.24 109.65 172.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.35 4.58 53.25 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HE3' ' CG2' ' A' ' 31' ' ' VAL . 31.1 ttmt -78.61 146.64 34.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.289 -0.869 . . . . 1.73 110.048 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.23 5.28 89.09 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.043 -1.223 . . . . 0.36 110.043 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.659 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.7 m -141.96 139.13 17.69 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 114.416 -0.892 . . . . 1.14 108.877 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.953 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.7 Cg_endo -72.85 150.55 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.625 1.55 . . . . 0.52 110.805 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.67 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -153.32 151.41 29.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.198 0.523 . . . . 1.03 111.003 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.771 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -107.25 152.75 23.68 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.735 -0.839 . . . . 1.1 108.735 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 81.0 mt -140.76 114.66 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.974 -0.75 . . . . 0.2 108.974 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.778 ' CD2' ' HB3' ' A' ' 139' ' ' PHE . 21.2 m-85 -102.66 122.99 45.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.336 . . . . 0.23 110.747 -173.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.683 ' HB3' HG11 ' A' ' 110' ' ' VAL . 5.4 p30 -80.92 91.78 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.374 -0.973 . . . . 1.28 108.374 168.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 139' ' ' PHE . 2.5 p -110.61 131.99 60.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 113.167 0.803 . . . . 0.88 113.167 -163.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 111.92 2.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.259 -1.385 . . . . 0.52 107.259 167.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 1.068 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.43 64.33 1.56 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.501 0.926 . . . . 1.84 113.501 -161.128 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.858 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 1.1 tppp? 76.73 52.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.728 1.211 . . . . 2.43 112.503 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -145.91 131.25 18.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.02 -0.733 . . . . 0.99 109.02 170.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.78 -82.77 1.62 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.631 -0.795 . . . . 1.09 113.947 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -137.33 166.51 23.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.87 0.335 . . . . 3.16 111.295 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.7 p -134.65 -41.35 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.199 -0.455 . . . . 1.94 111.745 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.586 ' HD2' ' HG2' ' A' ' 156' ' ' PRO . 27.5 ttmt 71.15 0.56 3.47 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.873 0.869 . . . . 2.03 112.227 175.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.33 39.24 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.71 -0.757 . . . . 0.47 112.829 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.35 74.82 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 111.542 -0.623 . . . . 0.34 111.542 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 1.1 t80 -71.42 -56.6 5.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.837 0.351 . . . . 0.57 110.416 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.92 -43.51 91.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.05 -0.523 . . . . 2.46 110.755 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' HA ' ' A' ' 160' ' ' VAL . 94.0 m -63.63 -49.28 73.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.33 111.11 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.36 -46.13 91.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 0.19 111.719 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.565 HG23 ' HB2' ' A' ' 101' ' ' GLU . 22.6 m -62.24 -47.75 82.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 0.3 111.284 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.2 p -64.0 -41.93 97.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.326 -0.397 . . . . 1.08 111.045 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.516 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 82.3 mt -58.21 -52.92 63.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 116.335 -0.393 . . . . 0.81 110.605 175.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.533 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 60.4 t80 -50.41 -56.58 10.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.387 -0.824 . . . . 0.33 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -70.9 -32.12 68.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 1.76 112.145 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.88 -47.08 11.44 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.788 -0.365 . . . . 1.79 111.538 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.699 ' CD1' HD13 ' A' ' 171' ' ' LEU . 63.1 m-85 -96.61 7.44 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.33 0.863 . . . . 0.43 113.33 -170.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -25.11 62.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.417 . . . . 2.11 109.916 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -59.93 -34.78 73.69 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.451 -0.795 . . . . 1.2 111.363 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -95.85 6.13 49.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.935 0.398 . . . . 1.9 110.897 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.64 67.22 1.53 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.63 -0.795 . . . . 1.32 111.433 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CE1' HD13 ' A' ' 39' ' ' LEU . 80.1 t80 -131.52 136.44 47.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.394 -0.224 . . . . 0.26 110.394 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.67 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -128.91 146.73 50.87 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 110.066 -0.346 . . . . 0.51 110.066 178.613 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.846 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.4 t -114.08 113.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.801 -0.444 . . . . 0.24 109.801 169.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 27.0 mt -95.79 121.58 37.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.576 -0.898 . . . . 0.51 108.576 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.07 112.36 24.5 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.064 -0.654 . . . . 0.28 110.573 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.878 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.5 m-85 -96.22 108.16 39.77 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 109.041 -0.726 . . . . 0.34 109.041 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 1.078 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 32.3 Cg_exo -61.25 171.02 4.44 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.811 3.007 . . . . 0.73 112.114 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 113.875 1.065 . . . . 1.54 113.875 -176.607 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.559 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 97.1 m . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 121.058 0.456 . . . . 0.91 109.854 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.3 m -155.59 119.31 4.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.365 -0.834 . . . . 1.92 109.728 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.687 ' O ' HG21 ' A' ' 104' ' ' ILE . 63.2 mttp 68.84 -44.35 0.52 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 113.699 1.0 . . . . 3.18 113.699 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.858 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 65.67 -32.23 0.16 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.076 0.951 . . . . 1.74 111.077 -168.262 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.812 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 8.3 mmpt? 72.93 127.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.094 0.958 . . . . 3.08 111.892 171.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.862 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -161.07 -173.18 3.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.423 0.63 . . . . 0.43 112.629 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HB2' HG23 ' A' ' 58' ' ' THR . 48.6 mt-10 -93.33 9.1 37.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.006 -0.997 . . . . 2.19 111.66 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.738 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 32.1 p90 -128.71 173.73 5.28 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.575 -0.898 . . . . 0.24 108.575 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 24.0 Cg_exo -70.39 100.25 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.332 0 C-N-CA 123.156 2.57 . . . . 0.31 113.232 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.032 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.8 mp -94.96 133.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.606 -0.887 . . . . 0.37 108.606 173.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.878 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.9 OUTLIER -106.46 -160.02 0.72 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.439 -0.8 . . . . 1.47 111.979 -163.804 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.562 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.16 132.53 43.36 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.574 -0.739 . . . . 0.39 110.067 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.078 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.7 pttt -69.82 121.52 17.42 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.485 0.66 . . . . 1.66 109.347 172.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.455 HG13 HG13 ' A' ' 110' ' ' VAL . 11.7 pt -120.54 170.96 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.797 -1.092 . . . . 0.47 108.532 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.8 m120 -78.68 69.46 4.86 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.848 -0.614 . . . . 2.16 110.379 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.683 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -73.09 85.18 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 118.704 -1.198 . . . . 0.38 110.829 -177.674 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.543 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 38.1 t30 171.33 178.42 0.06 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.686 -1.227 . . . . 1.98 107.686 160.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.83 -146.86 26.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.82 -0.705 . . . . 0.78 114.687 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.22 -15.02 29.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -0.716 . . . . 1.98 110.672 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.24 -12.92 58.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.755 -0.657 . . . . 2.04 111.376 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -49.29 135.64 16.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.994 0.739 . . . . 0.48 112.994 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -51.16 131.96 31.71 Favored Pre-proline 0 C--O 1.226 -0.137 0 CA-C-O 118.389 -0.815 . . . . 0.42 109.178 169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.55 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -38.79 -43.67 2.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.346 2.697 . . . . 0.36 112.924 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.559 HD11 ' HE3' ' A' ' 122' ' ' MET . 30.9 tp -54.22 -47.1 72.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.664 -0.698 . . . . 1.1 112.09 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.496 ' HE2' HD21 ' A' ' 42' ' ' ASN . 2.2 m-85 -73.96 -29.04 61.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 119.469 -0.301 . . . . 1.49 111.276 177.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.39 -39.31 72.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.353 -0.939 . . . . 2.37 108.581 168.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 80.4 t80 -68.38 -45.06 73.74 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.181 -0.463 . . . . 0.58 110.635 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.559 ' HE3' HD11 ' A' ' 118' ' ' LEU . 67.1 mtt -65.2 -55.75 16.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.579 -0.282 . . . . 0.34 111.302 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.8 mtpt -57.07 -42.62 80.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.94 110.904 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.6 ptmm? -69.82 -37.11 76.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.302 -0.408 . . . . 2.13 110.922 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 150' ' ' PRO . 92.4 m -64.73 -39.44 93.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.47 111.392 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 18.6 ttmm . . . . . 0 C--N 1.328 -0.347 0 N-CA-C 112.716 0.635 . . . . 1.75 112.716 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.543 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 113.709 1.003 . . . . 0.93 113.709 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.805 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.9 mt -93.23 103.14 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.388 -1.278 . . . . 1.05 110.199 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -106.83 0.6 24.14 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.708 0.633 . . . . 1.5 112.708 -167.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.805 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.62 171.86 19.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.157 0.799 . . . . 0.87 113.157 -163.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.609 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 16.3 m120 -46.3 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.096 -1.865 . . . . 1.8 114.103 167.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.778 ' HB3' ' CD2' ' A' ' 41' ' ' TYR . 62.1 m-85 -27.37 -59.06 0.1 Allowed 'General case' 0 C--O 1.204 -1.334 0 C-N-CA 125.158 1.383 . . . . 1.37 113.003 -167.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.909 HG23 ' HA ' ' A' ' 155' ' ' SER . 10.1 m 38.48 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.397 0.888 . . . . 0.3 113.397 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.685 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 12.1 p -85.51 152.93 22.8 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.055 -0.52 . . . . 0.8 111.358 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -103.0 135.23 45.08 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.581 -1.266 . . . . 0.53 107.581 163.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 170' ' ' LEU . 25.4 tp -81.12 105.45 12.34 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.625 -0.88 . . . . 0.51 108.625 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.792 HG21 HD13 ' A' ' 15' ' ' ILE . 19.2 mm -101.17 123.78 54.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.478 -0.783 . . . . 0.2 108.973 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -179.8 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 1.3 110.529 -175.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 52.8 mtt180 -62.61 -13.56 32.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.585 0.587 . . . . 3.78 112.585 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -108.32 -17.58 13.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.201 0.524 . . . . 1.18 110.278 -172.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.533 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.16 34.44 3.96 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.616 -0.72 . . . . 0.23 112.971 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -118.7 123.84 28.83 Favored Pre-proline 0 C--N 1.316 -0.85 0 O-C-N 122.635 -0.332 . . . . 0.62 110.276 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' ' 125' ' ' THR . 75.5 Cg_exo -53.94 112.98 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.34 2.693 . . . . 0.3 112.97 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.417 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.9 t -92.5 -30.32 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.768 -0.651 . . . . 0.27 110.475 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.404 ' HA ' ' CD ' ' A' ' 126' ' ' LYS . 61.3 mm-40 -155.61 164.07 39.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.36 -0.382 . . . . 1.22 111.027 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -127.24 102.15 6.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.495 -0.557 . . . . 1.75 109.495 173.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.604 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 36.8 m-85 -98.5 117.15 32.28 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.105 -0.702 . . . . 0.38 109.105 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.909 ' HA ' HG23 ' A' ' 140' ' ' THR . 53.7 p -69.99 178.22 1.1 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 118.77 0.714 . . . . 0.99 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.745 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.0 Cg_endo -68.24 -14.88 41.58 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.758 1.638 . . . . 0.66 111.122 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.26 13.76 43.58 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.52 112.047 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.55 132.21 40.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.921 0.391 . . . . 0.43 110.611 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.524 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 32.1 m -82.87 164.03 20.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.108 -0.496 . . . . 1.25 110.778 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.457 ' HA ' HG23 ' A' ' 56' ' ' THR . 28.9 t -52.23 -54.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.41 111.791 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 161' ' ' LYS . 25.9 tptt -69.78 -26.16 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 3.44 110.729 -174.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 159' ' ' SER . 21.6 m-20 -67.11 -29.66 69.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 1.86 110.105 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 39' ' ' LEU . 62.7 mt -82.7 -40.83 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.354 -0.384 . . . . 0.21 110.541 174.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 48.4 mt-10 -56.07 -35.52 67.07 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.777 0.658 . . . . 0.88 112.777 -176.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.3 pt-20 -58.03 -26.38 62.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.75 111.202 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.604 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 48.3 mmtm -105.09 -14.1 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.039 0.447 . . . . 1.58 110.335 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.661 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 68.1 tp -95.16 -41.52 9.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 0.24 112.13 -171.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.76 ' HA ' HD12 ' A' ' 171' ' ' LEU . 74.3 mt -51.56 -53.26 52.05 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 112.821 0.674 . . . . 0.44 112.821 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.92 -30.0 84.25 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.946 1.764 . . . . 0.49 112.553 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 143' ' ' LEU . 58.7 mt -81.22 -32.51 33.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.612 -0.267 . . . . 0.71 111.147 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.953 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.0 mt -58.57 -50.81 72.43 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.115 -0.698 . . . . 0.46 109.115 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -50.3 -57.28 10.51 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.41 -1.268 . . . . 1.52 112.344 169.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.488 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 22.9 t . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 109.663 -0.495 . . . . 2.52 109.663 174.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 108.462 -0.94 . . . . 1.68 108.462 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 p -145.81 156.76 43.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.839 -1.073 . . . . 0.65 108.806 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 144' ' ' ILE . 16.6 pt -56.32 -22.11 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 113.442 0.904 . . . . 0.3 113.442 -170.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.81 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 69.5 m-85 -83.17 1.04 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.028 0.381 . . . . 0.27 112.028 -172.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.89 -20.71 61.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.776 -0.824 . . . . 1.96 108.776 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 77.3 m-85 -95.38 156.91 16.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.964 -1.016 . . . . 0.4 110.571 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.6 tt0 -101.27 141.87 33.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.906 -0.588 . . . . 2.77 110.189 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.509 HG23 HD13 ' A' ' 30' ' ' LEU . 64.3 t -114.61 150.62 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.785 0.326 . . . . 0.74 110.914 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.826 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 85.2 mt -108.28 133.89 51.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.175 -0.466 . . . . 0.72 110.161 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.98 176.88 2.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.103 -0.953 . . . . 1.59 109.775 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.561 ' HB1' ' HD3' ' A' ' 97' ' ' LYS . . . -51.48 -29.99 18.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.126 0.488 . . . . 0.52 110.847 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' A' ' 26' ' ' LYS . 22.5 t70 -96.78 1.34 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 2.22 111.649 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.826 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 46.9 m80 74.94 12.51 3.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.058 0.543 . . . . 0.73 110.825 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 10.7 mmpt? -69.92 146.04 94.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 106.067 -1.827 . . . . 3.25 106.067 165.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.45 113.04 1.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 119.762 0.951 . . . . 0.86 110.985 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.451 ' HB3' HG12 ' A' ' 20' ' ' VAL . 65.6 t80 -79.28 128.23 33.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.28 110.47 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.659 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 62.4 t30 -76.99 81.88 3.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.604 -0.725 . . . . 1.65 109.255 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.81 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.13 -33.8 70.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.42 0.629 . . . . 0.25 110.31 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.684 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.6 p -77.6 -0.86 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.179 -0.919 . . . . 0.41 112.611 -168.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.3 pt20 -82.79 -6.41 59.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.064 -0.717 . . . . 1.24 109.064 173.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.528 ' HB3' HD13 ' A' ' 38' ' ' LEU . 91.9 m-70 -93.67 -2.3 54.12 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.38 108.398 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -78.12 142.38 38.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.788 -1.096 . . . . 1.73 110.187 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.0 -19.09 25.65 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.36 110.508 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 70.1 m -141.84 139.13 17.84 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.585 -0.894 . . . . 1.14 108.585 177.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.694 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 24.5 Cg_exo -65.35 153.48 78.05 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.738 2.292 . . . . 0.52 112.289 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' A' ' 33' ' ' HIS . 2.3 pt? -154.63 159.25 40.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.302 -0.863 . . . . 1.03 109.766 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -113.69 157.77 21.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.967 -0.382 . . . . 1.1 109.967 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 72' ' ' LEU . 93.3 mt -141.97 116.46 5.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.715 -0.675 . . . . 0.2 109.621 -176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.929 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.8 m-85 -103.16 123.58 46.96 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.134 -0.226 . . . . 0.23 111.038 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.614 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -79.31 92.89 5.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.354 -0.98 . . . . 1.28 108.354 168.089 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.6 p -112.95 131.57 64.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 112.95 0.722 . . . . 0.88 112.95 -163.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.61 114.22 1.6 Allowed 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.18 -1.044 . . . . 0.52 108.18 169.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.995 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.62 81.28 2.61 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.366 -1.288 . . . . 1.84 113.191 -162.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 42.8 tptt 72.66 50.6 0.17 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.003 -0.999 . . . . 2.43 109.872 177.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 p -163.16 143.76 9.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.7 -0.682 . . . . 0.99 111.233 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.79 -155.64 35.5 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.82 -0.627 . . . . 1.09 113.258 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -95.32 147.52 23.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.123 0.487 . . . . 3.16 110.612 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 p -88.69 -27.08 21.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.925 -0.579 . . . . 1.94 112.208 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.911 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.2 mtpp 65.8 -4.07 0.66 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.369 0.668 . . . . 2.03 112.069 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.67 0.01 29.06 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.116 -0.564 . . . . 0.47 112.429 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.02 -34.84 77.29 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.373 -0.441 . . . . 0.34 112.294 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.628 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -73.03 -47.57 43.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.722 0.296 . . . . 0.57 110.224 -176.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.685 -0.487 . . . . 2.46 109.685 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 160' ' ' VAL . 98.8 m -64.03 -48.31 76.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.422 -0.808 . . . . 0.33 110.633 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.903 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -62.44 -50.54 71.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.362 -0.381 . . . . 0.19 111.606 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.6 m -54.79 -48.91 72.11 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.3 111.083 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.5 m -63.69 -45.72 88.73 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.205 -0.452 . . . . 1.08 111.336 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 64.5 mt -60.33 -52.09 66.74 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 111.842 0.312 . . . . 0.81 111.842 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.78 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 59.5 t80 -52.1 -46.68 65.35 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.33 109.422 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -73.31 -37.09 66.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.255 0.55 . . . . 1.76 111.081 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -73.49 -33.33 64.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.343 -0.844 . . . . 1.79 111.74 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.619 ' CD1' HD13 ' A' ' 171' ' ' LEU . 72.3 m-85 -121.88 14.15 10.74 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 114.471 1.286 . . . . 0.43 114.471 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.78 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 21.5 mtmm -57.52 -26.52 61.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.899 -0.72 . . . . 2.11 110.385 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 m -57.16 -41.23 78.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.631 . . . . 1.2 111.708 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.751 ' OE1' ' HB2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -91.89 -4.33 54.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.573 -0.451 . . . . 1.9 111.038 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.23 20.0 7.3 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.823 -0.703 . . . . 1.32 114.069 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.751 ' HB2' ' OE1' ' A' ' 67' ' ' GLN . 75.2 t80 -77.28 137.33 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.037 0.418 . . . . 0.26 111.306 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 2.4 t -132.01 142.31 49.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.839 -0.801 . . . . 0.51 108.839 173.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.903 HG11 ' HB1' ' A' ' 57' ' ' ALA . 40.8 t -105.56 105.87 19.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.933 -0.765 . . . . 0.24 108.933 169.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.654 ' HB2' HG12 ' A' ' 40' ' ' ILE . 25.6 mt -89.53 120.92 31.26 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.174 -1.047 . . . . 0.51 108.174 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.062 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.6 112.23 24.47 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.073 -0.651 . . . . 0.28 110.216 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.795 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -95.55 108.05 37.15 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 108.605 -0.887 . . . . 0.34 108.605 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.995 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.9 Cg_exo -59.82 168.92 5.04 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.35 2.7 . . . . 0.73 111.397 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 122.625 1.202 . . . . 1.54 113.847 -175.117 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.599 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 60.6 m . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 112.071 0.397 . . . . 0.91 112.071 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 t -149.42 119.65 7.29 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.892 -0.594 . . . . 1.92 110.27 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HD3' ' HB1' ' A' ' 23' ' ' ALA . 25.7 pttt 28.44 89.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.764 1.226 . . . . 3.18 114.297 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.743 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -60.79 131.4 50.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.853 -1.165 . . . . 1.74 107.853 170.149 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.435 ' N ' ' HD2' ' A' ' 99' ' ' LYS . 11.2 mptt -91.35 147.62 22.91 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.394 -0.523 . . . . 3.08 111.213 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -158.54 -166.76 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.847 0.717 . . . . 0.43 111.33 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -81.62 -34.1 31.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.373 0.606 . . . . 2.19 110.507 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.743 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 29.4 p90 -84.46 166.74 31.07 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 115.287 -0.87 . . . . 0.24 109.774 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 23.5 Cg_exo -72.1 103.12 1.44 Allowed 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.018 3.145 . . . . 0.31 113.571 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.062 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mp -94.66 134.25 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.884 -0.784 . . . . 0.37 108.884 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.795 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -109.01 -154.22 0.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 1.47 112.522 -163.159 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.9 135.55 41.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.218 -0.901 . . . . 0.39 110.23 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.981 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.5 pttp -73.36 125.1 27.07 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.713 0.768 . . . . 1.66 108.997 171.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.499 HG13 HG13 ' A' ' 110' ' ' VAL . 12.1 pt -122.17 174.36 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 106.914 -1.513 . . . . 0.47 106.914 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.828 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 6.7 m120 -83.86 81.17 8.89 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.035 -0.666 . . . . 2.16 109.868 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -79.29 84.12 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 118.468 -1.293 . . . . 0.38 109.085 177.773 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 56.5 t30 170.35 179.5 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.418 -1.327 . . . . 1.98 107.418 166.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.81 -152.07 23.9 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 115.615 1.006 . . . . 0.78 115.615 160.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.11 -20.9 22.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.148 -1.026 . . . . 1.98 110.695 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -92.94 6.58 47.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.538 -0.755 . . . . 2.04 110.564 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.828 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.09 141.98 38.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.885 -1.052 . . . . 0.48 113.299 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.598 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 35.6 t-80 -54.25 135.25 60.23 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 115.477 -0.783 . . . . 0.42 109.087 167.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.16 -33.29 73.85 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.416 2.744 . . . . 0.36 112.85 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.598 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.7 tm? -62.32 -43.21 99.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 1.1 109.941 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.544 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.0 m-85 -75.59 -30.48 59.61 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.449 -0.341 . . . . 1.49 110.851 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.53 -41.15 76.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.89 -0.724 . . . . 2.37 109.206 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 69.7 t80 -65.81 -45.7 81.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.94 0.4 . . . . 0.58 110.442 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.504 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.3 mtt -65.38 -53.29 45.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.144 -0.48 . . . . 0.34 111.806 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.4 mtpt -59.19 -39.21 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.94 110.644 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.3 ptmt -74.62 -36.84 62.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 2.13 111.031 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.499 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.0 m -70.55 -43.24 69.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.4 -0.363 . . . . 0.47 111.916 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.634 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.9 tmtt? . . . . . 0 C--N 1.324 -0.531 0 C-N-CA 120.422 -0.511 . . . . 1.75 111.484 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.507 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 112.145 0.424 . . . . 0.93 112.145 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.849 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 38.5 mt -103.75 88.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.638 -0.71 . . . . 1.05 110.261 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -117.15 28.15 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.644 0.609 . . . . 1.5 112.644 -173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.849 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.14 169.49 23.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.05 0.452 . . . . 0.87 112.075 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -51.28 -155.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.869 1.668 . . . . 1.8 113.471 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.929 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 53.1 m-85 -24.86 -57.68 0.05 Allowed 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 125.451 1.5 . . . . 1.37 114.212 -165.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.772 HG23 ' HA ' ' A' ' 155' ' ' SER . 23.1 m 38.08 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.275 0.842 . . . . 0.3 113.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.635 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 11.9 p -84.34 152.18 24.26 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.094 -0.642 . . . . 0.8 111.532 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.9 m-85 -103.5 134.88 46.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.023 -1.102 . . . . 0.53 108.023 165.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.771 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.2 tp -82.0 104.7 12.55 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.063 -0.717 . . . . 0.51 109.063 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 15' ' ' ILE . 18.4 mm -102.8 124.12 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.602 -0.726 . . . . 0.2 109.26 -175.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -78.7 -175.1 4.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.864 -0.334 . . . . 1.3 111.374 -175.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.618 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.8 mtp180 -57.11 -26.01 59.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.831 0.348 . . . . 3.78 111.912 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -108.5 -12.49 15.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.119 0.485 . . . . 1.18 110.829 -168.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.568 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.22 44.65 2.33 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.393 -0.908 . . . . 0.23 113.512 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.9 t -119.16 127.87 26.25 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.301 -0.629 . . . . 0.62 109.301 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.499 ' HD2' HG21 ' A' ' 125' ' ' THR . 11.5 Cg_exo -68.07 111.68 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.499 2.133 . . . . 0.3 111.383 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.634 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.8 t -94.96 -25.97 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.32 -0.4 . . . . 0.27 110.844 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.508 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 59.2 mm-40 -151.08 164.16 37.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.869 0.366 . . . . 1.22 111.032 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.41 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 23.3 ttm180 -129.98 97.02 4.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.702 -0.851 . . . . 1.75 108.702 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.771 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 49.9 m-85 -88.89 108.66 19.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.461 -0.57 . . . . 0.38 109.461 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.772 ' HA ' HG23 ' A' ' 140' ' ' THR . 88.0 p -63.35 167.3 6.92 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.357 -0.609 . . . . 0.99 109.357 176.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.911 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 9.0 Cg_exo -67.61 -8.99 23.92 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.799 2.333 . . . . 0.66 112.197 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.93 -1.46 89.78 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 114.72 -1.127 . . . . 0.52 111.897 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.58 138.06 31.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.955 0.407 . . . . 0.43 110.43 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.57 172.44 8.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.191 -0.459 . . . . 1.25 110.536 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.437 ' HA ' HG23 ' A' ' 56' ' ' THR . 40.9 t -52.07 -44.88 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 0.41 111.07 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 161' ' ' LYS . 33.1 ttpt -66.41 -38.33 87.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.351 -0.841 . . . . 3.44 110.846 -175.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.64 -32.35 73.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.86 109.962 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 39' ' ' LEU . 59.1 mt -82.8 -43.18 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.21 111.184 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 33.2 mt-10 -55.54 -36.92 67.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.991 0.737 . . . . 0.88 112.991 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.58 -26.16 65.18 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.761 -0.376 . . . . 0.75 111.637 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.448 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 71.5 mmtt -102.06 -17.72 15.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.221 0.534 . . . . 1.58 110.155 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.641 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.7 tp -87.64 -49.28 7.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.683 . . . . 0.24 111.946 -172.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 70.1 mt -53.04 -48.09 93.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 112.596 0.591 . . . . 0.44 112.596 -174.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.0 Cg_endo -53.62 -42.65 64.27 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.116 1.877 . . . . 0.49 112.403 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.62 -44.23 82.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.526 -0.306 . . . . 0.71 110.996 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.694 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 46.5 mt -55.73 -51.46 67.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.448 0.642 . . . . 0.46 109.671 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.85 -63.05 4.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 114.16 -1.382 . . . . 1.52 113.062 168.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 117.049 0.424 . . . . 2.52 111.086 -179.735 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.234 0.243 0 CA-C-O 121.167 0.508 . . . . 1.68 111.232 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -161.12 -177.86 6.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.574 -0.739 . . . . 0.65 109.301 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.666 HD13 HG21 ' A' ' 144' ' ' ILE . 20.8 pt -60.6 -27.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.741 0.305 . . . . 0.3 111.671 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.783 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 42.4 m-85 -77.73 6.49 7.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.27 111.652 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.89 -9.02 59.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.659 -0.867 . . . . 1.96 108.659 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 80.0 m-85 -116.61 149.8 39.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.824 -1.08 . . . . 0.4 109.811 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -99.98 146.47 26.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.835 0.35 . . . . 2.77 111.01 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -114.13 145.83 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.74 110.942 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.019 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 74.9 mt -99.31 134.65 41.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.088 -0.708 . . . . 0.72 109.088 170.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.06 -174.9 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.872 -0.788 . . . . 1.59 108.872 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 1.098 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -54.33 -29.98 49.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.218 0.532 . . . . 0.52 111.381 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.99 11.65 35.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.012 -0.54 . . . . 2.22 111.76 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 1.019 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 22.3 m-70 69.46 12.3 8.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.232 0.613 . . . . 0.73 110.593 176.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.792 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.2 mmpt? -75.83 145.85 78.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 106.563 -1.643 . . . . 3.25 106.563 165.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.92 114.52 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.267 1.311 . . . . 0.86 112.314 -173.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -85.83 115.72 23.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.355 -0.838 . . . . 0.28 109.602 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -71.39 96.07 1.42 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.654 -0.869 . . . . 1.65 108.654 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.75 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -75.61 -29.64 59.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.722 0.772 . . . . 0.25 109.562 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.783 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 11.7 p -77.5 -0.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.619 -1.173 . . . . 0.41 113.207 -166.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -81.7 -4.57 56.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.399 -0.593 . . . . 1.24 109.399 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -93.98 4.67 53.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.333 -0.988 . . . . 0.38 108.333 177.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.619 ' HE3' HG23 ' A' ' 31' ' ' VAL . 36.4 ttmt -82.28 130.48 35.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.99 -1.005 . . . . 1.73 109.138 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.61 58.7 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.158 -1.177 . . . . 0.36 110.158 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 14.3 m -138.23 139.31 25.08 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.587 -0.894 . . . . 1.14 108.587 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.097 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 40.5 Cg_endo -73.94 150.7 44.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.572 1.515 . . . . 0.52 110.41 174.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.625 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -154.4 153.5 31.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.307 0.575 . . . . 1.03 111.62 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -108.11 148.82 29.29 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.638 -0.875 . . . . 1.1 108.638 170.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 84.5 mt -132.07 119.51 40.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.573 -0.529 . . . . 0.2 109.573 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 26.5 m-85 -101.5 130.4 47.75 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.23 111.399 -172.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.735 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -90.58 93.31 9.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.503 -1.295 . . . . 1.28 107.503 174.012 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 139' ' ' PHE . 3.5 m -109.01 143.79 18.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 0.88 112.468 -163.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.88 17.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.653 -1.61 . . . . 0.52 106.653 165.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.665 ' OG ' ' HB3' ' A' ' 95' ' ' CYS . 3.2 p -74.02 86.33 1.82 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.844 -0.616 . . . . 1.84 112.294 -165.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 66.18 44.69 2.5 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.208 -0.905 . . . . 2.43 110.385 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.9 p -164.0 133.62 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.567 -0.742 . . . . 0.99 110.81 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.15 -149.04 18.29 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.505 -0.855 . . . . 1.09 113.869 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -96.54 111.3 23.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 122.694 0.398 . . . . 3.16 111.275 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.9 p -66.6 -34.52 78.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.703 0.26 . . . . 1.94 111.703 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.8 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 31.1 mtpp 66.32 -3.32 0.84 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.443 0.697 . . . . 2.03 112.536 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.446 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 109.38 3.55 30.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.886 -0.673 . . . . 0.47 112.464 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 139' ' ' PHE . . . -72.38 -39.46 57.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.225 -0.512 . . . . 0.34 111.828 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.737 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.5 t80 -69.18 -51.6 36.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.172 -0.307 . . . . 0.57 110.172 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.446 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 1.6 mp0 -51.78 -52.01 52.08 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.37 0.605 . . . . 2.46 110.707 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -64.41 -46.72 82.02 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.899 -1.046 . . . . 0.33 110.88 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.87 -48.14 82.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.137 -0.483 . . . . 0.19 111.262 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -58.48 -50.27 74.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.703 -0.681 . . . . 0.3 110.419 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.7 m -63.0 -43.28 99.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.263 -0.88 . . . . 1.08 111.597 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.522 HD13 HD22 ' A' ' 39' ' ' LEU . 76.2 mt -61.34 -50.27 73.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.372 0.138 . . . . 0.81 111.372 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.727 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.1 t80 -53.67 -49.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.33 109.83 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -73.02 -31.24 64.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.613 -0.721 . . . . 1.76 111.869 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.34 -45.59 19.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.225 -0.443 . . . . 1.79 111.267 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.625 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.2 m-85 -104.19 8.03 36.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.592 0.96 . . . . 0.43 113.592 -170.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -25.0 65.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.02 0.438 . . . . 2.11 110.144 170.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.0 t -59.26 -40.14 85.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.497 -0.774 . . . . 1.2 110.727 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -95.8 14.38 23.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 1.9 111.247 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.625 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.21 59.4 2.74 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 115.916 -0.583 . . . . 1.32 112.651 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 67.3 t80 -123.88 139.27 54.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.492 0.187 . . . . 0.26 111.121 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -127.71 144.49 51.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 120.82 0.343 . . . . 0.51 110.255 177.54 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.727 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 27.2 t -114.05 119.47 61.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 0.24 109.95 169.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.523 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 19.8 mt -103.36 121.57 43.05 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.188 -0.671 . . . . 0.51 109.188 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.012 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.02 132.25 53.73 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.364 -0.534 . . . . 0.28 110.431 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.2 m-85 -112.19 108.44 55.03 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-O 121.231 0.538 . . . . 0.34 110.711 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.601 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 64.1 Cg_exo -47.85 139.53 19.34 Favored 'Trans proline' 0 CA--C 1.514 -0.476 0 C-N-CA 124.781 3.654 . . . . 0.73 112.136 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 15.7 m . . . . . 0 N--CA 1.44 -0.936 0 C-N-CA 118.633 -1.227 . . . . 1.54 114.268 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.665 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 33.8 m . . . . . 0 N--CA 1.44 -0.953 0 CA-C-O 122.116 0.96 . . . . 0.91 111.26 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.856 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 12.1 t -139.61 156.94 46.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.899 -1.5 . . . . 1.92 107.568 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 1.098 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 5.7 pttt -39.08 101.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.835 0.71 . . . . 3.18 111.299 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.737 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 5.5 p90 -61.95 135.72 57.67 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.133 -1.432 . . . . 1.74 107.133 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -94.12 143.75 26.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.694 -0.802 . . . . 3.08 110.467 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.436 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -145.99 -162.03 1.43 Allowed 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.055 0.847 . . . . 0.43 111.428 -174.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -95.55 -5.37 42.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.625 . . . . 2.19 110.042 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.718 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 39.1 p90 -118.79 170.72 6.12 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.24 108.912 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.0 Cg_exo -71.19 125.83 11.78 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 123.599 2.866 . . . . 0.31 113.292 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.012 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.1 mp -120.9 140.64 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.338 -0.616 . . . . 0.37 109.338 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.735 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 10.9 mmt -111.1 -151.28 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 1.47 113.717 -163.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -73.73 163.71 27.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.247 -0.888 . . . . 0.39 111.528 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.856 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 82.4 mttt -87.74 112.38 22.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.853 -0.425 . . . . 1.66 109.853 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' SER . 14.7 pt -122.17 164.08 19.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.216 -0.661 . . . . 0.47 109.216 177.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 55.4 t-20 -96.43 80.33 3.15 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.692 -0.855 . . . . 2.16 108.692 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 42' ' ' ASN . 1.0 OUTLIER -65.88 91.47 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.132 -0.627 . . . . 0.38 110.298 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.471 ' HA ' HD12 ' A' ' 135' ' ' ILE . 0.5 OUTLIER 174.25 172.33 0.2 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.055 -0.35 . . . . 1.98 110.055 172.543 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 51.15 -133.69 32.95 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 123.944 0.777 . . . . 0.78 114.917 160.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -105.57 3.95 29.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.218 -0.991 . . . . 1.98 109.978 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.54 -5.56 18.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.959 -1.018 . . . . 2.04 110.958 -169.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -63.15 147.23 51.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.971 -0.559 . . . . 0.48 112.354 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.541 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 44.7 t-80 -50.36 136.06 23.6 Favored Pre-proline 0 C--O 1.225 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.42 109.412 168.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 6.0 Cg_endo -49.37 -32.25 25.6 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.693 2.928 . . . . 0.36 113.438 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.554 HD11 ' HE3' ' A' ' 122' ' ' MET . 22.4 tp -66.33 -39.5 89.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 1.1 110.901 175.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.749 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 4.5 m-85 -73.98 -31.13 62.85 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 116.433 -0.349 . . . . 1.49 110.283 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 117' ' ' PRO . 34.2 mm-40 -56.22 -42.68 77.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.09 -0.707 . . . . 2.37 109.09 168.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.694 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 90.1 t80 -65.26 -52.6 53.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.979 0.419 . . . . 0.58 111.557 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.554 ' HE3' HD11 ' A' ' 118' ' ' LEU . 55.6 mtt -64.41 -49.17 72.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.558 0.694 . . . . 0.34 110.871 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.749 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 4.6 tmtt? -70.74 -26.62 63.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.805 -1.089 . . . . 0.94 112.075 -174.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.8 ptmt -75.75 -27.59 58.16 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.85 0.357 . . . . 2.13 110.228 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.42 HG21 ' HD2' ' A' ' 150' ' ' PRO . 23.5 m -68.32 -60.43 2.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.703 0.631 . . . . 0.47 112.703 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 151' ' ' VAL . 25.9 tttp . . . . . 0 C--N 1.326 -0.453 0 C-N-CA 119.173 -1.011 . . . . 1.75 113.629 -172.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.456 ' C ' HG13 ' A' ' 135' ' ' ILE . . . . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 120.988 0.423 . . . . 0.93 109.961 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.976 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 1.1 mt 65.84 138.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.708 -1.133 . . . . 1.05 110.151 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -178.6 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.582 0.706 . . . . 1.5 110.851 -175.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.976 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.18 170.08 9.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.054 -0.976 . . . . 0.87 111.663 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.573 ' HB3' ' HD1' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -52.56 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.839 1.422 . . . . 1.8 114.839 175.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.616 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 16.3 m-85 -28.42 -34.65 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 127.089 2.156 . . . . 1.37 115.904 -167.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . 1.086 HG23 ' HA ' ' A' ' 155' ' ' SER . 8.6 m 13.46 105.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.027 1.491 . . . . 0.3 115.027 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.48 158.85 20.88 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.746 0.784 . . . . 0.8 111.982 -174.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.616 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 16.3 m-85 -102.84 169.32 8.67 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.245 -1.391 . . . . 0.53 107.245 162.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.624 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 46.3 tp -116.5 105.94 13.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.753 -0.832 . . . . 0.51 108.753 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.666 HG21 HD13 ' A' ' 15' ' ' ILE . 13.4 mm -108.36 122.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.486 -0.561 . . . . 0.2 109.486 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -178.92 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.893 -0.323 . . . . 1.3 110.549 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.677 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -67.84 -6.6 22.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.184 -0.462 . . . . 3.78 112.164 -174.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.78 -22.29 12.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.491 0.662 . . . . 1.18 109.376 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 104.42 34.2 3.69 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.877 -1.056 . . . . 0.23 112.67 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 68.5 t -110.55 129.35 24.04 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.93 0.365 . . . . 0.62 110.569 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 149' ' ' VAL . 22.9 Cg_exo -65.21 107.99 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.149 2.566 . . . . 0.3 112.063 176.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 t -94.81 -12.1 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.136 -0.484 . . . . 0.27 110.893 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -177.53 167.41 2.24 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.135 0.493 . . . . 1.22 111.815 -179.404 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.805 ' NH2' HG12 ' A' ' 135' ' ' ILE . 15.2 ttm-85 -134.17 116.4 15.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.06 -0.973 . . . . 1.75 109.788 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 12.4 m-85 -104.09 134.15 47.82 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 108.393 -0.966 . . . . 0.38 108.393 176.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' SER . . . . . 1.086 ' HA ' HG23 ' A' ' 140' ' ' THR . 52.7 p -76.33 176.36 3.41 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.114 0.87 . . . . 0.99 109.764 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.876 ' HG3' ' H ' ' A' ' 140' ' ' THR . 7.0 Cg_exo -69.11 -16.61 40.42 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.366 1.377 . . . . 0.66 110.749 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.57 89.4 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.6 -1.182 . . . . 0.52 111.89 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.92 133.48 36.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.564 -0.532 . . . . 0.43 109.564 176.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.5 m -78.59 160.02 27.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.855 -0.611 . . . . 1.25 110.657 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 58.1 t -50.04 -50.71 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.729 0.3 . . . . 0.41 110.486 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.745 -0.661 . . . . 3.44 111.779 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -65.81 -31.48 72.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.413 0.625 . . . . 1.86 109.733 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.827 HG21 HD21 ' A' ' 39' ' ' LEU . 54.0 mt -81.38 -41.7 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.527 -0.76 . . . . 0.21 110.189 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 45.0 mt-10 -55.76 -40.81 73.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.88 112.209 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.409 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 4.6 pt-20 -58.33 -27.62 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.75 111.6 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.538 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.6 mttp -104.28 -12.98 16.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 1.58 110.645 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.2 tp -93.38 -41.99 9.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 0.24 111.534 -174.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.72 ' HA ' HD12 ' A' ' 171' ' ' LEU . 79.5 mt -53.28 -48.97 90.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.489 0.551 . . . . 0.44 112.489 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 40.2 Cg_exo -59.05 -22.72 65.28 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.149 1.899 . . . . 0.49 113.04 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.52 -39.1 14.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.543 0.211 . . . . 0.71 110.734 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.097 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.4 mt -56.95 -53.47 57.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 0.46 109.271 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.49 51.75 2.23 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.565 -1.198 . . . . 1.52 113.741 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 123.556 0.742 . . . . 2.52 112.625 175.15 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.091 0.472 . . . . 1.68 110.097 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.0 p -125.17 170.1 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.186 -0.672 . . . . 0.65 109.186 175.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.737 HD13 HG21 ' A' ' 144' ' ' ILE . 32.1 pt -59.91 -27.48 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.021 0.438 . . . . 0.3 111.34 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.902 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 55.4 m-85 -76.56 -1.75 29.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.508 0.559 . . . . 0.27 112.508 -171.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 -17.16 58.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.477 0.656 . . . . 1.96 109.578 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 87.1 m-85 -98.59 175.3 6.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 0.4 110.764 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -110.44 133.83 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 2.77 110.272 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 28' ' ' TYR . 77.5 t -115.22 149.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.933 0.397 . . . . 0.74 110.927 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.904 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 2.3 mp -114.98 141.1 48.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.927 -0.579 . . . . 0.72 109.87 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.96 175.57 1.16 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.516 -0.765 . . . . 1.59 109.327 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -47.54 -39.74 17.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.912 0.387 . . . . 0.52 111.685 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.05 8.53 39.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.18 -0.464 . . . . 2.22 112.218 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.904 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 23.0 m-70 72.21 26.08 2.8 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.501 0.667 . . . . 0.73 110.37 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -84.87 132.62 45.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 105.791 -1.929 . . . . 3.25 105.791 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.27 112.63 0.84 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.106 1.204 . . . . 0.86 112.588 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' HB3' HG12 ' A' ' 20' ' ' VAL . 55.7 t80 -86.95 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.014 -0.993 . . . . 0.28 110.515 174.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.8 t30 -78.32 90.19 4.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.308 -0.627 . . . . 1.65 109.308 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.902 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -65.31 -28.52 69.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 0.25 111.339 -174.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.836 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.0 p -76.46 -1.04 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 113.064 0.764 . . . . 0.41 113.064 -166.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 11.3 pt20 -78.85 -5.05 52.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.304 0.573 . . . . 1.24 109.68 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -99.16 18.3 17.79 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.025 -1.102 . . . . 0.38 108.025 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -96.89 146.35 25.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.33 -1.305 . . . . 1.73 109.464 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.42 -10.62 67.13 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.072 -1.211 . . . . 0.36 110.072 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.596 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 51.1 m -141.75 146.98 43.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.359 -0.978 . . . . 1.14 108.359 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.002 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 72.3 Cg_endo -75.22 159.77 40.2 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.918 1.745 . . . . 0.52 111.404 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.7 pt? -154.5 151.58 29.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.269 0.557 . . . . 1.03 111.071 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.546 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -108.07 155.64 20.15 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.618 -0.882 . . . . 1.1 108.618 170.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 86.9 mt -141.03 119.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.415 -0.587 . . . . 0.2 109.415 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 1.003 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 21.0 m-85 -105.77 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.273 0.358 . . . . 0.23 111.435 -172.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.509 ' ND2' ' HE1' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -77.91 92.81 4.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.575 -1.269 . . . . 1.28 107.575 169.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.8 p -113.21 127.54 70.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.425 -0.91 . . . . 0.88 112.634 -167.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -65.98 101.94 0.74 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.102 -1.444 . . . . 0.52 107.102 168.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.822 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 26.6 t -67.54 92.68 0.32 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.124 -0.944 . . . . 1.84 112.056 -163.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.611 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 6.1 mmtm 73.88 31.78 1.17 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.331 0.652 . . . . 2.43 110.866 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -137.24 140.53 41.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 0.99 110.612 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.3 -149.53 29.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.951 -0.642 . . . . 1.09 113.643 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.55 128.03 49.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.055 0.455 . . . . 3.16 111.43 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.629 HG22 ' HE1' ' A' ' 139' ' ' PHE . 3.7 p -71.9 -33.05 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 1.94 111.872 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 28.7 mtpp 64.88 3.96 2.26 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.71 0.633 . . . . 2.03 112.71 173.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.82 45.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.47 112.078 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.04 -31.09 62.22 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.955 -0.458 . . . . 0.34 111.955 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.734 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -76.51 -52.82 9.04 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 120.5 0.191 . . . . 0.57 110.697 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.09 -39.45 92.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.891 0.377 . . . . 2.46 110.677 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.567 HG23 ' HA ' ' A' ' 160' ' ' VAL . 95.9 m -66.55 -46.22 76.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.33 110.846 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.665 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.63 -46.77 89.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.19 110.828 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 62.3 m -58.52 -50.38 73.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.455 -0.793 . . . . 0.3 111.133 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -64.43 -44.31 91.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.303 -0.408 . . . . 1.08 111.578 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 86.4 mt -57.92 -52.4 65.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.68 0.252 . . . . 0.81 111.68 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.743 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.9 t80 -54.42 -49.37 70.11 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 121.202 0.525 . . . . 0.33 109.88 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.02 -34.99 66.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 1.76 111.786 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.12 -47.54 20.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.381 -0.372 . . . . 1.79 111.29 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.673 ' CD1' HD13 ' A' ' 171' ' ' LEU . 60.8 m-85 -99.34 6.28 46.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.601 0.963 . . . . 0.43 113.601 -171.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -59.41 -28.78 67.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 2.11 110.958 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -63.18 -35.36 80.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.2 111.272 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -94.56 2.93 55.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.971 0.415 . . . . 1.9 111.162 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 90.01 74.1 1.28 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.794 -0.717 . . . . 1.32 112.176 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 74.0 t80 -138.15 140.94 40.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.559 0.219 . . . . 0.26 110.526 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.08 142.55 50.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 120.56 0.219 . . . . 0.51 110.433 178.258 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.743 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 42.2 t -110.84 115.02 48.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.614 -0.513 . . . . 0.24 109.614 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.684 HD22 ' HE3' ' A' ' 105' ' ' MET . 25.1 mt -98.46 121.49 40.46 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.83 -0.804 . . . . 0.51 108.83 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.958 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.46 115.95 31.06 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.567 -0.453 . . . . 0.28 110.191 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.749 ' HD2' HD11 ' A' ' 108' ' ' ILE . 3.3 m-85 -97.65 107.59 40.52 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.949 -0.569 . . . . 0.34 109.558 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.822 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 71.2 Cg_exo -51.59 160.04 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.685 2.923 . . . . 0.73 112.486 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.68 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 48.3 m . . . . . 0 N--CA 1.428 -1.554 0 CA-C-N 115.357 -0.838 . . . . 1.54 111.483 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 45' ' ' SER . 31.9 m . . . . . 0 N--CA 1.437 -1.102 0 CA-C-O 121.122 0.487 . . . . 0.91 112.046 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.604 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 3.6 t -152.88 117.55 5.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 1.92 110.836 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.609 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 79.9 mttt 65.27 -46.37 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.208 1.558 . . . . 3.18 115.208 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.734 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 62.33 -32.72 0.1 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 1.74 110.834 -171.603 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.609 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 18.7 mtmt 65.35 108.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.211 1.004 . . . . 3.08 113.272 165.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -136.02 -171.84 2.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.749 -1.114 . . . . 0.43 111.487 -174.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.88 26.93 4.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.045 -0.525 . . . . 2.19 110.771 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.654 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 36.0 p90 -142.97 166.06 22.63 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.871 -1.159 . . . . 0.24 107.871 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 39.8 Cg_exo -63.09 122.8 11.16 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.342 2.695 . . . . 0.31 113.297 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.958 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.4 mp -117.37 142.8 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.513 -0.551 . . . . 0.37 109.513 174.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.712 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 10.3 mmt -116.54 -153.8 0.54 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.288 0.847 . . . . 1.47 113.288 -166.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.728 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -70.47 149.65 46.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.885 -1.052 . . . . 0.39 111.321 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 75' ' ' PRO . 29.3 mttt -82.29 109.77 16.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.026 -1.101 . . . . 1.66 108.026 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.749 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -122.14 162.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 108.736 -0.838 . . . . 0.47 108.736 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.715 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 15.9 m120 -78.85 70.02 5.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.872 -0.604 . . . . 2.16 110.95 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.576 ' HB ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -69.68 87.83 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 C-N-CA 118.883 -1.127 . . . . 0.38 108.703 175.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.526 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER 170.97 179.95 0.05 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.845 -1.168 . . . . 1.98 107.845 175.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.35 -143.03 9.88 Favored Glycine 0 CA--C 1.507 -0.412 0 N-CA-C 115.644 1.018 . . . . 0.78 115.644 153.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -105.41 -10.19 17.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.342 -0.929 . . . . 1.98 110.984 -173.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -95.3 -2.15 49.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 2.04 111.949 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -42.65 134.5 3.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.507 0.928 . . . . 0.48 113.507 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.599 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 47.6 t-80 -51.29 140.14 24.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.568 -0.742 . . . . 0.42 110.655 171.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 4.0 Cg_endo -47.69 -46.02 22.22 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.918 2.412 . . . . 0.36 112.813 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.599 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.68 -40.76 69.43 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.987 -0.552 . . . . 1.1 110.641 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.509 ' HE1' ' ND2' ' A' ' 42' ' ' ASN . 10.1 m-85 -76.7 -28.65 55.95 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.337 -0.392 . . . . 1.49 111.86 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 53.2 mt-10 -55.48 -42.55 74.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.715 -0.846 . . . . 2.37 108.715 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 71.7 t80 -65.03 -49.69 69.17 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 123.585 0.553 . . . . 0.58 110.627 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.429 ' CE ' HD11 ' A' ' 118' ' ' LEU . 64.5 mtt -62.46 -53.06 60.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.743 0.306 . . . . 0.34 111.263 -177.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -56.64 -43.08 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.94 111.218 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 16.7 ptmt -73.87 -34.32 64.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.018 0.437 . . . . 2.13 111.244 -176.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 150' ' ' PRO . 77.5 m -73.88 -44.1 56.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 0.47 111.394 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt . . . . . 0 C--N 1.321 -0.641 0 C-N-CA 120.842 -0.343 . . . . 1.75 111.627 -178.455 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 112.609 0.596 . . . . 0.93 112.609 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.799 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.6 mt -90.13 155.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.315 -0.857 . . . . 1.05 109.612 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -173.99 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.935 0.398 . . . . 1.5 111.829 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.799 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -143.37 169.06 18.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.499 -0.318 . . . . 0.87 111.296 -177.089 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -154.37 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.656 1.583 . . . . 1.8 113.349 176.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 1.003 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 54.6 m-85 -25.17 -49.91 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 115.216 1.561 . . . . 1.37 115.216 -166.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.835 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 10.6 m 32.2 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.839 1.199 . . . . 0.3 113.59 176.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.79 149.02 26.03 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.026 -0.67 . . . . 0.8 111.265 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -104.0 133.34 49.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.236 -1.024 . . . . 0.53 108.236 166.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.931 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 34.7 tp -81.56 105.15 12.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.922 -0.77 . . . . 0.51 108.922 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.737 HG21 HD13 ' A' ' 15' ' ' ILE . 15.8 mm -104.8 124.98 59.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 0.2 109.151 -174.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.673 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 12.2 p30 -74.13 -178.12 3.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.766 0.317 . . . . 1.3 111.176 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.638 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.2 mtp180 -65.87 -12.78 57.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.426 0.528 . . . . 3.78 112.426 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -110.61 -14.33 14.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.26 0.552 . . . . 1.18 109.966 -173.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.486 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 106.88 31.03 4.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.388 -0.824 . . . . 0.23 113.034 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.673 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 89.9 t -112.56 129.5 24.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 117.209 0.504 . . . . 0.62 110.225 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 125' ' ' THR . 7.9 Cg_exo -70.88 118.29 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.627 2.218 . . . . 0.3 111.725 178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.69 -26.07 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 0.27 110.825 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -157.75 165.7 34.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.095 -0.502 . . . . 1.22 110.135 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.585 HH11 ' HH2' ' A' ' 137' ' ' TRP . 18.0 ttm180 -134.97 116.98 15.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.941 -0.392 . . . . 1.75 109.941 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.931 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 3.4 m-85 -101.93 116.63 33.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.992 -0.744 . . . . 0.38 108.992 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.789 ' HA ' HG23 ' A' ' 140' ' ' THR . 97.7 p -64.5 164.8 17.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.494 0.588 . . . . 0.99 109.518 176.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.835 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 35.3 Cg_endo -64.76 -9.04 19.47 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.94 2.427 . . . . 0.66 113.17 -164.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -93.62 24.13 27.28 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.491 -0.777 . . . . 0.52 112.051 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.74 30.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.43 110.635 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.2 m -81.54 158.76 24.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.71 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 56' ' ' THR . 21.5 t -49.56 -50.6 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.388 0.613 . . . . 0.41 109.919 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 6.2 ttpp -59.92 -40.43 88.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.656 -1.157 . . . . 3.44 111.038 -177.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -63.52 -30.48 71.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.126 -0.943 . . . . 1.86 110.454 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.546 HG21 HD21 ' A' ' 39' ' ' LEU . 61.4 mt -82.63 -43.6 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.954 -0.566 . . . . 0.21 110.887 175.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.5 mt-10 -56.13 -38.84 71.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.88 112.108 -175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.4 pt-20 -62.33 -19.33 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 0.75 112.058 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -106.32 -17.25 14.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.289 0.566 . . . . 1.58 110.019 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.7 tp -94.11 -44.01 8.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 0.24 111.909 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.778 ' HA ' HD12 ' A' ' 171' ' ' LEU . 63.4 mt -51.79 -47.26 91.02 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.846 0.684 . . . . 0.44 112.846 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.2 Cg_exo -54.29 -39.59 86.18 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.987 1.792 . . . . 0.49 112.823 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.74 -34.55 58.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.503 -0.317 . . . . 0.71 111.801 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.002 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 14.2 mt -54.85 -54.73 38.58 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.463 0.649 . . . . 0.46 109.554 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -56.0 -51.87 52.74 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.221 -1.354 . . . . 1.52 113.266 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 117.409 0.605 . . . . 2.52 111.976 -177.153 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 112.153 -0.379 . . . . 5.51 112.153 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 94.5 mmm -82.65 87.38 6.73 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.253 -0.647 . . . . 5.05 109.253 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.89 84.37 1.34 Allowed Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.937 -0.865 . . . . 1.37 110.937 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 t -77.91 -39.63 42.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.03 0.443 . . . . 1.68 109.937 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.5 p -132.0 -179.47 5.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.905 -0.589 . . . . 0.65 109.899 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.768 HD13 HG21 ' A' ' 144' ' ' ILE . 23.6 pt -65.75 -28.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.073 0.463 . . . . 0.3 111.198 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.816 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 38.3 m-85 -78.81 -1.06 33.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.863 0.363 . . . . 0.27 111.618 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.06 -11.87 60.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.219 -0.66 . . . . 1.96 109.219 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 62.0 m-85 -110.68 160.18 16.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.081 -0.963 . . . . 0.4 109.541 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.31 149.62 27.61 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.216 -0.291 . . . . 2.77 110.216 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.545 HG23 HD13 ' A' ' 30' ' ' LEU . 70.3 t -114.91 147.5 18.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.149 0.499 . . . . 0.74 112.257 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.971 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 75.8 mt -100.92 132.36 46.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.854 -0.612 . . . . 0.72 109.875 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -65.69 177.32 1.27 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.824 -1.08 . . . . 1.59 109.858 176.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -46.51 -37.57 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.496 0.319 . . . . 0.52 111.743 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.45 21.31 17.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.864 0.32 . . . . 2.22 111.864 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.971 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 39.1 m-70 68.23 16.43 9.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.113 0.565 . . . . 0.73 110.759 172.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.818 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -76.76 146.88 77.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 106.059 -1.83 . . . . 3.25 106.059 167.379 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.08 113.5 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 120.672 0.915 . . . . 0.86 111.806 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.457 ' HB3' HG12 ' A' ' 20' ' ' VAL . 68.3 t80 -86.97 117.57 25.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.532 -0.758 . . . . 0.28 110.866 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.46 82.75 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.716 -0.675 . . . . 1.65 109.767 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.816 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.46 -33.09 70.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.445 0.64 . . . . 0.25 110.469 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.748 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.0 p -76.73 -1.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.248 -0.887 . . . . 0.41 112.811 -168.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 24.1 pt20 -81.45 -5.64 58.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 1.24 109.349 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -92.94 -3.79 53.9 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.317 -0.994 . . . . 0.38 108.317 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 34.8 ttpt -74.15 146.45 43.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.879 -1.055 . . . . 1.73 109.827 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.81 -13.67 65.89 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.964 -1.254 . . . . 0.36 109.964 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.657 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 6.0 m -130.91 145.42 57.67 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 114.538 -0.831 . . . . 1.14 108.766 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.98 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -74.84 151.91 40.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.02 1.814 . . . . 0.52 110.664 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -154.61 154.03 32.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.142 0.496 . . . . 1.03 111.161 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.86 HD21 HG21 ' A' ' 163' ' ' ILE . 6.8 mp -107.47 154.17 21.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.094 -0.706 . . . . 1.1 109.094 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 85.1 mt -141.0 115.34 5.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.205 -0.665 . . . . 0.2 109.205 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' HD2' ' HB2' ' A' ' 139' ' ' PHE . 3.9 m-85 -102.04 123.38 45.83 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 121.059 -0.256 . . . . 0.23 111.334 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.775 HD21 ' HB ' ' A' ' 140' ' ' THR . 1.0 OUTLIER -81.88 90.11 6.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.07 -1.085 . . . . 1.28 108.07 167.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 8.3 p -119.1 141.78 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.163 0.801 . . . . 0.88 113.163 -162.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.9 108.98 3.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.926 -1.139 . . . . 0.52 107.926 170.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.983 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 29.8 t -73.88 80.81 1.64 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.857 -0.61 . . . . 1.84 112.216 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 98' ' ' PHE . 37.6 ttmt 67.25 55.6 0.66 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.935 -1.029 . . . . 2.43 111.348 174.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -139.05 118.7 13.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.092 -0.504 . . . . 0.99 109.941 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 -93.67 1.24 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.655 -0.783 . . . . 1.09 112.131 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.37 151.91 17.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 3.16 111.301 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.2 p -119.83 141.96 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.891 -0.781 . . . . 1.94 108.891 169.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 156' ' ' PRO . 33.4 ttmt -77.51 44.12 0.42 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.335 0.588 . . . . 2.03 110.794 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 28.37 13.07 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.744 -0.662 . . . . 0.47 112.271 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 139' ' ' PHE . . . -80.8 -48.73 6.02 Favored Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.879 -0.676 . . . . 0.34 112.28 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -55.84 -50.69 69.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.79 0.329 . . . . 0.57 110.387 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -60.21 -53.2 60.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.091 -0.504 . . . . 2.46 111.203 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.4 m -57.94 -47.06 84.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 122.728 0.411 . . . . 0.33 110.932 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.689 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.66 -49.25 77.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.46 . . . . 0.19 111.195 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -61.03 -47.17 87.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.163 0.506 . . . . 0.3 110.516 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -59.48 -49.8 76.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.362 -0.835 . . . . 1.08 111.172 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -61.13 -44.48 97.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.033 -0.53 . . . . 0.81 110.964 -175.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.788 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 67.8 t80 -53.15 -57.1 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 123.492 0.495 . . . . 0.33 110.476 176.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -68.52 -39.2 81.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.336 -0.393 . . . . 1.76 111.369 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -70.82 -45.18 65.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 1.79 111.66 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.603 ' CD1' HD13 ' A' ' 171' ' ' LEU . 61.2 m-85 -101.53 6.67 42.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.332 0.864 . . . . 0.43 113.332 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -62.33 -19.79 63.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.63 0.252 . . . . 2.11 110.918 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.4 m -66.85 -38.06 85.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 1.2 111.246 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -88.85 4.63 47.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 1.9 110.66 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 82.44 71.61 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.892 -0.671 . . . . 1.32 111.514 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 76.8 t80 -133.04 138.64 46.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.612 0.244 . . . . 0.26 110.436 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -126.82 142.91 51.41 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.93 0.395 . . . . 0.51 110.04 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.788 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.6 t -110.77 118.64 57.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 O-C-N 122.188 -0.32 . . . . 0.24 110.27 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 21.4 mt -105.34 122.92 46.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.91 -0.774 . . . . 0.51 108.91 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.886 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.82 112.74 24.96 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.006 -0.677 . . . . 0.28 110.591 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.609 ' CE1' ' HG2' ' A' ' 105' ' ' MET . 1.8 m-85 -93.29 112.59 57.07 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.116 -1.068 . . . . 0.34 108.116 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.022 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.7 Cg_exo -60.03 167.2 7.62 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.025 2.483 . . . . 0.73 111.235 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.0 t -111.64 128.28 56.01 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 119.435 -0.906 . . . . 1.54 111.738 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 49.8 t30 -86.18 99.1 11.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.396 -1.274 . . . . 2.52 110.896 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.519 ' CD ' ' H ' ' A' ' 78' ' ' GLN . 3.8 pm0 -52.97 -11.55 0.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.903 1.281 . . . . 3.18 113.172 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.4 7.86 45.12 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.857 0.36 . . . . 3.8 110.556 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' A' ' 109' ' ' ASN . . . -75.83 -33.45 51.02 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.903 -0.665 . . . . 1.45 112.158 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.09 -41.94 1.93 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.159 -0.543 . . . . 1.43 112.334 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 3.3 pm0 -131.65 39.94 3.44 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.299 0.481 . . . . 1.43 112.299 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 1.5 mp0 -60.74 132.39 91.51 Favored Pre-proline 0 C--N 1.318 -0.78 0 O-C-N 121.746 -0.596 . . . . 3.06 110.206 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 1.032 ' HG3' HG22 ' A' ' 135' ' ' ILE . 3.4 Cg_exo -12.25 -117.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 1 C-N-CA 126.304 4.669 . . . . 1.61 115.929 -160.225 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.47 -3.44 56.39 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.526 -1.43 . . . . 1.39 109.526 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -81.54 -0.94 44.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.709 -0.746 . . . . 3.69 112.165 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -65.82 -25.71 67.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.993 0.368 . . . . 2.47 111.993 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -87.2 -12.12 47.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.99 0.424 . . . . 3.64 110.824 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -91.44 -54.89 3.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.984 -0.553 . . . . 2.42 111.122 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.404 HD13 ' SG ' ' A' ' 95' ' ' CYS . 3.2 mt -78.55 35.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.234 0.54 . . . . 2.05 110.573 -174.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -96.5 -23.18 16.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.549 0.69 . . . . 4.0 110.294 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -115.74 8.24 14.86 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.557 -1.201 . . . . 3.1 109.235 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -133.02 167.56 20.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.585 -1.189 . . . . 1.91 108.929 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.09 120.34 53.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.512 0.672 . . . . 1.65 110.024 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.508 ' HB2' ' OE1' ' A' ' 78' ' ' GLN . 31.1 m -92.64 120.38 33.0 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.865 -0.607 . . . . 0.91 110.453 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.459 ' CG2' ' HE3' ' A' ' 97' ' ' LYS . 28.3 m -153.26 116.57 4.63 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.755 -0.657 . . . . 1.92 109.906 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.5 OUTLIER 13.27 97.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.824 1.328 . . . . 3.18 114.323 -173.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.672 ' HZ ' ' HZ ' ' A' ' 102' ' ' PHE . 23.7 p90 -64.03 -21.3 66.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.107 -0.497 . . . . 1.74 110.73 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 66.94 150.07 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.998 0.811 . . . . 3.08 111.613 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . . . -171.29 -165.65 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.589 -0.278 . . . . 0.43 111.483 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -82.77 -4.73 58.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.367 0.603 . . . . 2.19 110.386 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.672 ' HZ ' ' HZ ' ' A' ' 98' ' ' PHE . 53.1 p90 -121.68 163.16 32.64 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.428 -0.953 . . . . 0.24 108.428 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 27.3 Cg_exo -67.71 117.47 4.9 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 123.195 2.597 . . . . 0.31 113.206 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.886 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.9 mp -105.57 138.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.131 -0.692 . . . . 0.37 109.131 171.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.609 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -103.24 -162.26 0.9 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.319 0.859 . . . . 1.47 113.319 -163.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.16 41.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.158 -0.928 . . . . 0.39 109.948 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.022 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 14.0 pttt -70.25 126.09 28.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.735 -0.786 . . . . 1.66 109.876 172.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.415 HG13 HG13 ' A' ' 110' ' ' VAL . 4.9 pt -124.64 161.39 28.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.707 -1.133 . . . . 0.47 108.307 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.67 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 15.1 t-20 -79.35 88.25 4.98 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.845 -0.798 . . . . 2.16 108.845 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.686 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -74.28 85.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 119.315 -0.954 . . . . 0.38 108.86 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.507 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 9.6 t-20 171.84 -178.88 0.06 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.806 -0.813 . . . . 1.98 108.806 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.96 -142.15 42.18 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 115.116 0.806 . . . . 0.78 115.116 156.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.87 -16.69 15.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.501 -0.85 . . . . 1.98 109.612 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -91.62 1.84 56.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.856 -1.066 . . . . 2.04 110.613 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -60.89 140.58 57.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.252 -0.885 . . . . 0.48 111.861 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.6 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 33.2 t-80 -50.29 132.48 24.78 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.25 -0.886 . . . . 0.42 108.792 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.21 -33.27 53.9 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.429 2.753 . . . . 0.36 112.457 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.6 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 19.4 tp -62.99 -41.12 99.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 1.1 111.056 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.431 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.7 m-85 -74.83 -30.39 61.37 Favored 'General case' 0 C--O 1.21 -0.99 0 N-CA-C 110.378 -0.23 . . . . 1.49 110.378 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.86 -33.89 70.98 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.058 -0.657 . . . . 2.37 109.868 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.599 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 66.9 t80 -71.69 -52.46 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.357 0.411 . . . . 0.58 110.536 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.582 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.8 mtt -56.99 -51.91 67.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 0.34 111.333 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.533 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 35.4 mtpt -58.15 -50.62 72.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.817 -0.629 . . . . 0.94 110.652 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.21 -30.2 71.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.664 0.269 . . . . 2.13 111.283 -177.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.549 HG21 ' HD2' ' A' ' 150' ' ' PRO . 87.1 m -72.54 -52.51 15.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.366 -0.379 . . . . 0.47 111.727 -176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 8.0 mmtt -130.91 99.08 18.47 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 112.869 0.692 . . . . 1.75 112.869 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 6.3 Cg_endo -51.61 -42.31 56.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.609 2.872 . . . . 1.76 112.311 167.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.606 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 100.35 -116.04 5.47 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.496 -0.859 . . . . 2.37 113.37 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.25 0.66 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.293 0.479 . . . . 3.56 112.293 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.6 pt? -117.34 -171.24 2.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.812 0.339 . . . . 2.76 110.736 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.92 127.66 32.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.131 -0.486 . . . . 2.84 110.538 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 59.9 p 58.96 -172.46 0.11 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.868 0.867 . . . . 3.9 111.859 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.519 ' HD2' ' HA ' ' A' ' 124' ' ' LYS . 31.1 pttt -125.25 47.03 2.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.981 -0.554 . . . . 5.13 112.047 -170.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -109.97 156.96 19.79 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.958 0.409 . . . . 0.93 111.519 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 1.032 HG22 ' HG3' ' A' ' 84' ' ' PRO . 37.6 mt -99.15 106.17 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.787 -0.642 . . . . 1.05 110.423 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 136' ' ' LYS . 9.9 ptpt -131.98 21.29 4.53 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.631 0.604 . . . . 1.5 112.631 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.858 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.2 174.44 15.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.068 0.396 . . . . 0.87 112.068 -175.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 78.9 m-20 -46.66 -161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.422 1.489 . . . . 1.8 114.575 173.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.812 ' CZ ' ' HA ' ' A' ' 156' ' ' PRO . 44.7 p90 -34.37 -46.49 0.27 Allowed 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 113.145 -1.843 . . . . 1.37 115.346 -164.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.775 ' HB ' HD21 ' A' ' 42' ' ' ASN . 22.4 m 37.78 94.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.36 0.874 . . . . 0.3 113.36 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.0 p -85.63 146.64 26.77 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.183 -0.607 . . . . 0.8 110.345 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.7 m-85 -102.17 133.4 47.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.407 -0.961 . . . . 0.53 108.407 169.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.912 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.87 104.66 12.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.095 -0.705 . . . . 0.51 109.095 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.768 HG21 HD13 ' A' ' 15' ' ' ILE . 12.7 mm -102.44 128.51 55.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.086 -0.709 . . . . 0.2 109.086 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 0.5 OUTLIER -82.31 -174.59 5.22 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.028 -0.269 . . . . 1.3 111.274 -175.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.464 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 43.9 mtt180 -63.3 -12.51 30.11 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.378 0.51 . . . . 3.78 112.378 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.436 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 21.2 t70 -108.86 -19.24 13.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.374 0.607 . . . . 1.18 109.741 -171.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 102.37 26.87 7.11 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.199 -0.909 . . . . 0.23 112.36 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.1 t -106.44 126.33 30.7 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.732 -0.47 . . . . 0.62 109.732 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' A' ' 125' ' ' THR . 10.5 Cg_exo -67.56 111.35 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.342 2.028 . . . . 0.3 111.361 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.48 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 39.2 t -91.41 -25.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.017 -0.538 . . . . 0.27 110.504 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -152.37 163.6 39.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 1.22 111.226 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.606 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 11.9 ttm180 -131.01 102.62 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.618 -0.719 . . . . 1.75 109.247 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.912 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.9 m-85 -92.22 109.8 21.18 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.267 -0.642 . . . . 0.38 109.267 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.916 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 81.2 p -67.5 -178.65 0.38 Allowed Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.763 -0.458 . . . . 0.99 109.763 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.916 ' HD2' ' HB2' ' A' ' 155' ' ' SER . 30.8 Cg_endo -63.92 10.99 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.138 1.892 . . . . 0.66 113.227 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 155' ' ' SER . . . -99.16 -9.46 51.47 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.06 -0.591 . . . . 0.52 111.877 -177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 154' ' ' PHE . . . -96.16 134.7 38.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 0.43 111.067 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.7 m -95.23 -174.02 3.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 1.25 110.265 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.704 HG13 HD21 ' A' ' 60' ' ' LEU . 77.5 t -51.38 -55.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 0.41 111.923 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -72.88 -26.0 61.29 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.606 -0.27 . . . . 3.44 111.126 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -34.45 72.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.644 -0.502 . . . . 1.86 109.644 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.86 HG21 HD21 ' A' ' 39' ' ' LEU . 61.8 mt -82.73 -38.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.608 -0.724 . . . . 0.21 110.762 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.1 mt-10 -56.22 -41.13 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.278 0.474 . . . . 0.88 112.278 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.575 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.9 pt-20 -57.21 -26.65 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.75 111.703 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.4 mmtp -102.51 -18.45 15.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.841 0.353 . . . . 1.58 110.751 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.664 ' HG ' HD11 ' A' ' 171' ' ' LEU . 60.4 tp -92.31 -45.66 8.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.901 -0.59 . . . . 0.24 112.043 -171.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.716 ' HA ' HD12 ' A' ' 171' ' ' LEU . 66.6 mt -49.73 -49.87 70.59 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 112.999 0.74 . . . . 0.44 112.999 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.9 Cg_exo -55.38 -39.44 91.0 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.116 1.878 . . . . 0.49 112.701 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.0 -40.16 63.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.511 -0.313 . . . . 0.71 110.975 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.98 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 18.6 mt -55.8 -48.4 75.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.296 0.57 . . . . 0.46 109.578 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.82 -69.82 1.05 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.585 -1.188 . . . . 1.52 111.621 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.6 m -161.45 125.31 3.31 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.78 -0.452 . . . . 2.52 109.78 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.453 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -90.17 -47.69 7.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.27 0.557 . . . . 3.56 109.769 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.701 ' HG3' ' H ' ' A' ' 176' ' ' LEU . 6.9 ptm180 -120.02 -67.63 0.97 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.259 -0.882 . . . . 7.86 109.869 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.701 ' H ' ' HG3' ' A' ' 175' ' ' ARG . 36.2 mt . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.78 -0.628 . . . . 4.81 109.689 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.477 0 N-CA-C 111.902 -0.479 . . . . 5.51 111.902 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.4 mtm -62.07 105.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.988 0.423 . . . . 5.05 110.182 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.17 52.08 0.85 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.746 -0.942 . . . . 1.37 110.746 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -74.11 -37.58 64.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.066 0.46 . . . . 1.68 110.613 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.5 p -157.53 -174.61 4.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.493 -0.776 . . . . 0.65 109.184 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.798 HD13 HG21 ' A' ' 144' ' ' ILE . 27.9 pt -64.2 -25.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.48 . . . . 0.3 110.649 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.796 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.3 m-85 -81.94 5.55 18.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.27 111.202 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.94 -19.67 60.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.259 -1.015 . . . . 1.96 108.259 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 73.8 m-85 -107.86 175.67 5.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.869 -1.059 . . . . 0.4 111.263 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -112.62 138.8 48.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 2.77 110.382 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.56 HG23 HD13 ' A' ' 30' ' ' LEU . 77.4 t -115.04 144.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.093 0.473 . . . . 0.74 111.514 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.999 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 91.0 mt -104.32 133.23 49.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.545 -0.752 . . . . 0.72 109.546 173.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.53 -176.43 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.672 -0.862 . . . . 1.59 108.672 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.763 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -53.96 -35.45 61.79 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.165 0.507 . . . . 0.52 111.624 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -92.96 3.13 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 2.22 111.528 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.999 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 33.6 m-70 74.43 17.59 3.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.414 0.626 . . . . 0.73 109.972 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 12.8 mtmt -69.89 151.85 96.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.149 -1.797 . . . . 3.25 106.149 163.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.98 113.74 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 CA-C-N 120.168 1.096 . . . . 0.86 110.848 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.544 ' HB3' HG12 ' A' ' 20' ' ' VAL . 65.4 t80 -82.5 120.73 25.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.635 . . . . 0.28 110.232 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.9 t-20 -69.9 85.44 0.5 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.869 -0.605 . . . . 1.65 109.786 176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.796 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -73.4 -32.35 64.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.262 0.553 . . . . 0.25 110.544 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.737 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.3 p -77.19 -0.68 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.522 -0.763 . . . . 0.41 112.686 -168.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 13.7 pt20 -78.77 -6.62 56.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.574 0.702 . . . . 1.24 109.376 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -96.99 3.81 51.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.96 -1.018 . . . . 0.38 108.314 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 22.1 ttpt -81.2 146.63 30.39 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.723 -1.126 . . . . 1.73 109.298 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.11 -2.1 86.77 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.228 -1.149 . . . . 0.36 110.228 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 13.6 m -140.56 152.31 65.94 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 1.14 108.747 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.99 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 74.3 Cg_endo -82.52 154.78 16.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.826 1.684 . . . . 0.52 111.576 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.671 ' CB ' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -156.98 150.57 24.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.164 0.507 . . . . 1.03 111.749 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.659 HD23 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.86 151.49 25.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.376 -0.972 . . . . 1.1 108.376 172.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 86.5 mt -140.55 115.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.84 -0.43 . . . . 0.2 109.84 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.761 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 29.8 m-85 -103.02 124.74 49.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.609 0.226 . . . . 0.23 111.609 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.607 ' CB ' HG11 ' A' ' 110' ' ' VAL . 1.6 p30 -80.44 93.26 5.98 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.246 -0.65 . . . . 1.28 109.246 167.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.828 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 15.2 m -105.06 150.08 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 114.095 1.146 . . . . 0.88 114.095 -158.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 102.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.683 -1.599 . . . . 0.52 106.683 163.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.497 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -76.07 81.17 2.91 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 113.879 1.066 . . . . 1.84 113.879 -163.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 84.4 tttt 76.18 31.97 0.63 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.558 -0.746 . . . . 2.43 111.488 169.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -149.28 132.34 16.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.507 -0.477 . . . . 0.99 111.488 178.229 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -92.69 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.688 -0.687 . . . . 1.09 114.734 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.438 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 66.8 m-85 -110.98 153.77 25.08 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.999 0.37 . . . . 3.16 111.999 -167.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.9 p -137.24 -38.67 0.61 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.778 0.659 . . . . 1.94 112.778 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 69.47 -12.88 0.41 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.432 0.693 . . . . 2.03 112.791 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.01 12.08 14.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.942 -0.647 . . . . 0.47 112.478 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.84 -31.7 61.98 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.156 -0.545 . . . . 0.34 112.051 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.694 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -68.72 -52.05 34.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.534 0.206 . . . . 0.57 110.504 -177.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.95 -47.06 78.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.431 0.634 . . . . 2.46 110.397 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.48 HG23 ' HA ' ' A' ' 160' ' ' VAL . 85.5 m -63.03 -47.53 82.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.818 -1.083 . . . . 0.33 110.719 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.817 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -62.16 -50.43 71.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.19 111.651 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.67 HG23 ' HG2' ' A' ' 101' ' ' GLU . 24.5 m -56.1 -45.55 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.3 110.792 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.68 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 40.7 m -66.57 -45.98 77.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.08 111.31 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 88.5 mt -58.09 -51.38 69.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.538 0.208 . . . . 0.81 111.188 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.45 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 49.7 t80 -52.5 -52.76 52.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.997 0.811 . . . . 0.33 109.785 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.68 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 3.9 p30 -73.93 -33.35 63.91 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.504 -0.478 . . . . 1.76 111.429 -171.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -76.11 -38.17 57.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.277 -0.419 . . . . 1.79 111.309 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.674 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.9 m-85 -109.07 8.91 26.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.071 0.767 . . . . 0.43 113.071 -174.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -22.53 64.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.861 0.363 . . . . 2.11 110.226 173.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -62.12 -37.93 87.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 1.2 110.785 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.44 5.57 38.23 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.908 0.385 . . . . 1.9 110.923 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.35 25.09 34.46 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.99 -0.624 . . . . 1.32 112.289 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.659 ' CE1' HD23 ' A' ' 39' ' ' LEU . 75.7 t80 -85.05 143.72 28.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.775 0.321 . . . . 0.26 110.913 -174.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.671 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -131.03 146.32 52.34 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.062 0.458 . . . . 0.51 110.183 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.817 HG11 ' HB1' ' A' ' 57' ' ' ALA . 37.4 t -116.52 114.71 46.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.19 -0.459 . . . . 0.24 109.84 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.1 mt -100.23 122.78 43.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.103 -0.702 . . . . 0.51 109.103 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.63 116.74 32.3 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.22 -0.592 . . . . 0.28 110.731 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.8 m-85 -99.11 109.43 54.21 Favored Pre-proline 0 C--N 1.31 -1.134 0 CA-C-N 115.789 -0.641 . . . . 0.34 109.611 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.794 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 75.1 Cg_exo -50.37 160.61 1.48 Allowed 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 124.185 3.256 . . . . 0.73 113.568 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.7 t -114.0 131.28 56.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 122.65 1.214 . . . . 1.54 111.227 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -83.65 75.38 10.06 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.77 -1.567 . . . . 2.52 106.77 170.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 1.004 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -51.33 -11.55 0.12 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.604 1.335 . . . . 3.18 114.604 -168.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -102.71 30.38 4.74 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.62 0.724 . . . . 3.8 109.548 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.04 16.55 32.29 Favored Glycine 0 N--CA 1.454 -0.165 0 CA-C-N 115.971 -0.558 . . . . 1.45 112.847 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.29 -60.05 3.01 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.983 -0.847 . . . . 1.43 110.983 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.651 ' O ' ' HG2' ' A' ' 82' ' ' GLN . 5.0 pm0 -134.75 83.63 2.04 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.068 0.461 . . . . 1.43 111.057 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 1.004 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 77.5 mm-40 -83.83 155.77 64.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 107.999 -1.112 . . . . 3.06 107.999 165.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.97 ' HG3' HG22 ' A' ' 135' ' ' ILE . 16.1 Cg_exo -27.71 -105.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 1 C-N-CA 125.309 4.006 . . . . 1.61 116.655 -168.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 84' ' ' PRO . . . -109.8 0.71 30.37 Favored Glycine 0 C--N 1.31 -0.865 0 N-CA-C 110.172 -1.171 . . . . 1.39 110.172 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -114.58 58.58 0.7 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.555 -0.822 . . . . 3.69 110.516 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -87.83 138.33 31.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.052 -0.522 . . . . 2.47 110.694 -176.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 62.26 16.34 8.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.487 -0.778 . . . . 3.64 111.633 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 31.6 tt0 -65.76 -40.37 91.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.753 0.787 . . . . 2.42 109.416 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 95' ' ' CYS . 0.8 OUTLIER -55.95 -11.2 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.712 -1.131 . . . . 2.05 113.261 175.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -62.28 -17.48 58.69 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.8 -1.187 . . . . 4.0 111.707 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.65 21.63 3.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.573 -0.739 . . . . 3.1 110.114 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.646 ' HB3' ' HB3' ' A' ' 47' ' ' CYS . 68.0 m-85 -148.92 147.77 29.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.165 -0.925 . . . . 1.91 109.507 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 94' ' ' VAL . 9.9 p -110.71 111.14 34.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 118.969 -1.092 . . . . 1.65 109.5 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.941 ' HB2' HD11 ' A' ' 90' ' ' ILE . 75.8 m -105.18 117.17 33.33 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.481 -0.781 . . . . 0.91 110.111 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -154.56 120.36 5.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.336 -0.847 . . . . 1.92 109.761 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.763 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 7.7 pttt 33.36 77.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.333 1.021 . . . . 3.18 113.271 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 1.6 p90 -57.9 135.41 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.062 -1.458 . . . . 1.74 107.062 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.502 ' HE2' ' HG3' ' A' ' 97' ' ' LYS . 70.0 mmtt -102.46 122.88 45.19 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.858 -0.737 . . . . 3.08 112.011 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.5 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . . . -125.11 -162.22 1.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.053 -0.976 . . . . 0.43 110.517 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.67 ' HG2' HG23 ' A' ' 58' ' ' THR . 7.4 pt-20 -90.64 -11.25 40.43 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.068 -0.653 . . . . 2.19 110.129 175.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.747 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.0 p90 -103.15 167.86 9.61 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.225 -0.898 . . . . 0.24 108.889 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.811 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.1 Cg_exo -71.95 120.9 7.15 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.749 2.966 . . . . 0.31 113.348 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.997 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.8 mp -113.71 140.15 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.341 -0.614 . . . . 0.37 109.341 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.811 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 11.4 mmt -110.79 -151.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.107 0.78 . . . . 1.47 113.107 -164.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -79.64 143.84 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.855 -1.066 . . . . 0.39 110.738 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.794 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 21.4 pttt -78.67 137.74 37.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 1.66 109.995 172.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.45 HD11 ' CE1' ' A' ' 119' ' ' TYR . 3.8 pt -143.66 158.04 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.357 -1.349 . . . . 0.47 107.357 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.794 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -73.9 91.45 1.99 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.269 -0.572 . . . . 2.16 109.754 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.607 HG11 ' CB ' ' A' ' 42' ' ' ASN . 1.3 m -82.55 84.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 119.18 -1.008 . . . . 0.38 108.943 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.63 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 20.1 t-20 171.93 179.23 0.07 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.09 -1.078 . . . . 1.98 108.09 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.49 -149.09 19.81 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 116.024 1.17 . . . . 0.78 116.024 153.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 1.5 28.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.886 -1.157 . . . . 1.98 110.029 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.44 ' HB3' ' OD1' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -108.6 2.83 22.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.917 -1.038 . . . . 2.04 109.559 -171.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.794 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -58.25 139.87 54.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.117 -0.947 . . . . 0.48 112.618 -177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.601 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 38.9 t-80 -48.32 133.52 12.83 Favored Pre-proline 0 C--O 1.226 -0.135 0 N-CA-C 109.012 -0.736 . . . . 0.42 109.012 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.19 -33.17 63.32 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.37 2.713 . . . . 0.36 112.829 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.601 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 18.2 tp -65.72 -37.0 85.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 1.1 111.042 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.529 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 8.1 m-85 -75.55 -29.56 59.43 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.572 -0.285 . . . . 1.49 110.668 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.81 -40.2 79.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.883 -0.784 . . . . 2.37 108.883 167.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 77.7 t80 -68.08 -47.76 67.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.58 110.53 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.57 ' HE3' HD11 ' A' ' 118' ' ' LEU . 67.0 mtt -62.85 -55.03 29.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.097 -0.501 . . . . 0.34 111.136 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -57.54 -43.15 84.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.201 -0.454 . . . . 0.94 111.474 -176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -69.58 -39.73 77.13 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.479 -0.328 . . . . 2.13 111.009 -176.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.532 HG21 ' HD2' ' A' ' 150' ' ' PRO . 52.3 m -69.73 -33.9 73.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.118 -0.492 . . . . 0.47 111.448 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.595 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.3 tmtt? -147.66 101.21 3.72 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.702 -0.399 . . . . 1.75 111.317 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.526 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 9.8 Cg_endo -53.53 -23.87 26.7 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.765 2.977 . . . . 1.76 112.26 174.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.607 ' CA ' ' HB3' ' A' ' 153' ' ' ARG . . . 113.24 -159.16 13.83 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.785 -0.721 . . . . 2.37 113.3 171.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.442 HG13 HD23 ' A' ' 130' ' ' LEU . 14.4 pt -66.11 -27.32 40.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.319 0.58 . . . . 3.56 110.703 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.611 ' HG ' HG23 ' A' ' 132' ' ' THR . 2.5 pt? -135.71 155.12 50.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.695 -0.854 . . . . 2.76 108.695 173.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.89 72.22 2.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.166 0.508 . . . . 2.84 111.712 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.611 HG23 ' HG ' ' A' ' 130' ' ' LEU . 15.1 p -76.9 -27.14 54.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.898 -0.592 . . . . 3.9 110.266 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 69.58 -9.76 0.63 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.098 -0.955 . . . . 5.13 111.377 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 132' ' ' THR . . . -163.22 -173.47 3.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.132 0.492 . . . . 0.93 111.327 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.97 HG22 ' HG3' ' A' ' 84' ' ' PRO . 63.8 mt -105.83 110.96 33.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.221 -0.9 . . . . 1.05 110.791 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.573 ' HA ' ' CA ' ' A' ' 84' ' ' PRO . 37.1 pttt -139.06 42.06 2.09 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.407 0.891 . . . . 1.5 113.407 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.826 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -156.4 174.82 14.85 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.458 0.703 . . . . 0.87 110.699 176.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 17.0 m120 -47.9 -158.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.735 1.214 . . . . 1.8 113.596 167.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.828 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 7.3 m-85 -30.66 -58.71 0.21 Allowed 'General case' 0 C--O 1.204 -1.295 0 C-N-CA 125.416 1.486 . . . . 1.37 114.35 -166.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.798 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 21.5 m 48.51 104.68 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.575 0.954 . . . . 0.3 113.575 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.761 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.9 t -96.35 149.52 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.012 -0.675 . . . . 0.8 111.26 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.2 m-85 -104.48 131.96 51.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.218 -0.66 . . . . 0.53 109.218 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.866 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.1 tp -81.03 106.07 12.74 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.157 -0.683 . . . . 0.51 109.157 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.798 HG21 HD13 ' A' ' 15' ' ' ILE . 12.2 mm -106.36 124.0 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 108.911 -0.774 . . . . 0.2 108.911 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.57 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 39.2 p30 -75.34 -177.72 3.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.135 -0.484 . . . . 1.3 111.404 -175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 36' ' ' SER . 75.3 mtp180 -70.92 -1.17 11.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 3.78 111.897 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.25 -19.16 12.33 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.597 0.713 . . . . 1.18 109.45 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 103.77 27.76 6.22 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.913 -1.04 . . . . 0.23 112.126 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.479 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 84.2 t -109.62 129.64 23.69 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.651 -0.323 . . . . 0.62 110.411 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.532 ' HD2' HG21 ' A' ' 125' ' ' THR . 6.9 Cg_exo -71.86 114.98 4.12 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.719 2.279 . . . . 0.3 111.573 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.595 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.7 t -100.24 -21.61 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.596 . . . . 0.27 110.562 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.0 mm-40 -152.64 164.54 37.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.155 -0.475 . . . . 1.22 110.364 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.607 ' HB3' ' CA ' ' A' ' 128' ' ' GLY . 34.4 ttp85 -139.53 102.32 4.43 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.115 -0.698 . . . . 1.75 109.115 169.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.866 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 14.4 m-85 -90.92 109.24 20.46 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.23 -0.656 . . . . 0.38 109.23 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.76 ' HA ' HG23 ' A' ' 140' ' ' THR . 5.0 p -63.43 164.98 12.65 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 109.153 -0.684 . . . . 0.99 109.153 175.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.798 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 61.0 Cg_endo -68.24 -4.45 12.76 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.65 2.234 . . . . 0.66 112.944 -163.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.83 -10.3 76.11 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.021 -0.991 . . . . 0.52 111.831 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.35 139.5 36.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.461 -0.57 . . . . 0.43 109.461 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.1 m -95.09 178.65 5.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.346 -0.388 . . . . 1.25 111.102 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 62.7 t -54.58 -48.62 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 0.41 110.968 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -29.42 69.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.782 -0.645 . . . . 3.44 110.727 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.32 -34.31 77.1 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.451 -0.795 . . . . 1.86 110.125 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.569 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 53.5 mt -81.26 -41.27 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 0.21 110.74 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 50.8 mt-10 -58.2 -38.83 77.53 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.035 0.383 . . . . 0.88 112.035 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.566 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 11.6 pt-20 -59.93 -18.53 45.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 0.75 111.594 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.615 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.6 mmtp -111.15 -17.76 13.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.078 0.466 . . . . 1.58 110.509 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.5 tp -92.44 -39.43 11.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.77 -0.65 . . . . 0.24 111.96 -172.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.82 ' HA ' HD12 ' A' ' 171' ' ' LEU . 76.7 mt -49.96 -51.24 63.14 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.663 0.616 . . . . 0.44 112.663 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.9 Cg_endo -55.71 -38.76 93.95 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.121 1.881 . . . . 0.49 112.246 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.62 -35.74 65.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 0.71 110.969 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.99 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 22.0 mt -57.12 -57.61 11.84 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.368 0.604 . . . . 0.46 109.646 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -50.35 -62.73 4.88 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.286 -1.324 . . . . 1.52 112.201 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t -170.48 121.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 2.52 110.285 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.57 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -93.57 -21.29 19.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.319 0.581 . . . . 3.56 110.371 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -177.67 -42.53 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.376 -1.342 . . . . 7.86 107.376 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.255 1.366 0 CA-C-N 114.014 -1.448 . . . . 4.81 108.466 169.159 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.664 ' N ' ' HG ' ' A' ' 13' ' ' SER . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.756 -0.538 . . . . 5.51 111.756 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.5 mtm 62.77 30.99 16.74 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.706 0.402 . . . . 5.05 111.07 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.97 66.27 1.5 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 1.37 112.378 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.664 ' HG ' ' N ' ' A' ' 10' ' ' GLY . 20.4 m -93.79 -29.4 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.413 0.625 . . . . 1.68 110.324 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.0 p -150.29 174.95 12.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 0.65 108.573 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.675 HD13 HG21 ' A' ' 144' ' ' ILE . 24.3 pt -62.28 -27.04 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.913 0.387 . . . . 0.3 111.427 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.866 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 34.7 m-85 -80.34 7.99 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.27 111.125 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.05 -16.28 60.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.231 -1.026 . . . . 1.96 108.231 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 71.9 m-85 -111.73 155.14 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.677 -1.147 . . . . 0.4 111.211 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -100.95 144.31 30.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.529 -0.545 . . . . 2.77 109.529 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.574 HG23 ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -125.93 167.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.74 110.493 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.007 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 93.6 mt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.292 -0.413 . . . . 0.72 110.245 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.52 -172.9 2.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.177 -0.675 . . . . 1.59 109.177 176.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.688 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -54.0 -30.96 49.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.828 0.347 . . . . 0.52 111.304 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 18.8 t70 -89.56 -16.38 30.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 2.22 111.469 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 1.007 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 15.3 m-70 83.74 25.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.998 0.919 . . . . 0.73 109.68 -175.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.782 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 mmpt? -84.67 146.51 46.82 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 105.515 -2.032 . . . . 3.25 105.515 164.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.92 113.08 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 119.722 0.936 . . . . 0.86 111.292 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.574 ' HB3' HG23 ' A' ' 20' ' ' VAL . 89.3 t80 -79.63 120.86 24.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.542 -0.753 . . . . 0.28 109.816 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.577 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -67.84 84.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.477 -0.783 . . . . 1.65 109.728 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.866 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -72.74 -35.12 67.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.525 0.679 . . . . 0.25 110.142 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.741 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.5 p -76.55 -1.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 0.41 112.919 -167.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 24.7 pt20 -82.4 -5.1 58.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.303 0.573 . . . . 1.24 109.669 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.419 ' CG ' HG21 ' A' ' 70' ' ' THR . 88.1 m-70 -92.54 -8.55 44.11 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.95 -1.13 . . . . 0.38 107.95 177.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 36.4 ttpt -71.86 133.88 45.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.235 -0.893 . . . . 1.73 109.341 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 -1.25 57.65 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 109.862 -1.295 . . . . 0.36 109.862 -168.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 33.6 m -142.21 124.97 9.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.518 -0.841 . . . . 1.14 108.879 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.84 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 14.6 Cg_endo -59.0 147.86 88.03 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.58 1.52 . . . . 0.52 110.755 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.553 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -150.68 151.29 32.24 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.243 0.544 . . . . 1.03 111.506 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.755 HD21 HG21 ' A' ' 163' ' ' ILE . 7.1 mp -108.51 152.14 25.13 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.69 -0.686 . . . . 1.1 109.266 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 72.6 mt -140.98 118.77 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 110.147 -0.316 . . . . 0.2 110.147 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.832 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 20.6 m-85 -105.11 124.27 49.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.426 0.155 . . . . 0.23 111.324 -173.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.582 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.3 p30 -81.0 91.67 6.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.841 -1.17 . . . . 1.28 107.841 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.592 HG11 ' HE1' ' A' ' 98' ' ' PHE . 2.4 p -109.05 135.41 48.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 113.288 0.848 . . . . 0.88 113.288 -162.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.484 ' HB2' ' HA3' ' A' ' 85' ' ' GLY . . . -60.63 107.89 0.75 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.766 -1.198 . . . . 0.52 107.766 170.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 1.031 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -71.62 84.67 0.87 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.775 -1.102 . . . . 1.84 113.0 -165.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.0 tmtp? 60.44 53.56 4.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.631 -0.713 . . . . 2.43 110.733 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 p -163.69 136.56 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.757 -0.656 . . . . 0.99 110.43 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.78 -113.57 4.38 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.626 -0.797 . . . . 1.09 112.561 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 169.26 17.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.097 0.475 . . . . 3.16 111.736 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.664 HG22 ' HE1' ' A' ' 139' ' ' PHE . 40.0 p -126.07 139.65 53.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.432 -0.804 . . . . 1.94 109.41 171.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 27.7 mtpp -106.16 18.87 21.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 2.03 111.09 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.63 13.34 32.7 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.822 -0.704 . . . . 0.47 111.709 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 -43.22 16.53 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.866 -0.494 . . . . 0.34 111.866 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.606 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.2 t80 -68.05 -49.14 63.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 0.57 110.331 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -54.82 -55.14 33.44 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.88 -0.6 . . . . 2.46 110.486 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 160' ' ' VAL . 93.4 m -62.61 -46.96 85.85 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.009 -0.996 . . . . 0.33 111.287 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.89 -49.29 78.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.858 0.361 . . . . 0.19 111.152 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.9 m -59.6 -50.58 73.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.721 -0.672 . . . . 0.3 110.749 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 p -65.7 -37.68 87.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 1.08 112.045 -175.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 84.5 mt -61.55 -52.4 64.62 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 121.158 -0.217 . . . . 0.81 110.951 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.639 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 53.1 t80 -51.89 -51.82 54.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.777 -0.823 . . . . 0.33 108.777 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.47 -30.32 68.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.304 -0.862 . . . . 1.76 112.036 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -86.06 -39.68 16.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.598 0.222 . . . . 1.79 111.598 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.647 ' CD1' HD13 ' A' ' 171' ' ' LEU . 60.5 m-85 -108.35 9.91 27.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.485 1.291 . . . . 0.43 114.485 -170.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 18.3 mtmm -59.34 -26.81 65.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.941 -0.704 . . . . 2.11 110.061 170.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 m -60.5 -30.21 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.593 -0.73 . . . . 1.2 111.627 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -104.44 12.98 32.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 1.9 111.206 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.47 65.58 1.66 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.592 -0.813 . . . . 1.32 112.299 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 65.5 t80 -129.03 137.72 51.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.75 0.31 . . . . 0.26 110.639 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -129.17 143.06 50.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 120.928 0.394 . . . . 0.51 110.746 177.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.709 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 29.9 t -114.31 120.95 65.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.935 0.398 . . . . 0.24 110.621 171.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 20.0 mt -105.69 122.87 46.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.297 -0.631 . . . . 0.51 109.297 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.057 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -111.53 116.19 30.45 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.298 -0.561 . . . . 0.28 110.904 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.581 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.1 m-85 -100.06 110.04 58.23 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.018 -0.734 . . . . 0.34 109.018 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.031 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 53.2 Cg_exo -54.67 165.81 2.28 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 123.606 2.871 . . . . 0.73 111.421 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 m -123.45 134.68 53.9 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 118.569 -1.252 . . . . 1.54 113.943 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 22.5 t30 -100.46 88.68 3.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.8 -1.545 . . . . 2.52 109.838 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.963 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 2.1 mp0 -66.0 -15.12 62.73 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.8 0.667 . . . . 3.18 112.8 -172.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -66.83 -9.51 38.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.147 0.499 . . . . 3.8 110.295 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA3' ' OD1' ' A' ' 109' ' ' ASN . . . -64.02 -27.14 70.91 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.702 -0.681 . . . . 1.45 112.138 175.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 138.11 -80.78 0.28 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.5 -0.857 . . . . 1.43 112.82 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.742 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -100.97 17.86 21.17 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 112.009 0.374 . . . . 1.43 112.009 -174.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.963 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 9.1 mm-40 -60.88 149.52 80.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.552 0.215 . . . . 3.06 110.671 -169.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.739 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 46.3 Cg_endo -71.37 -155.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 122.397 2.065 . . . . 1.61 113.605 -166.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 44' ' ' ALA . . . 68.47 26.71 74.19 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.566 -0.743 . . . . 1.39 112.116 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 66.26 92.24 0.08 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.497 0.665 . . . . 3.69 110.153 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.73 -14.47 8.65 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.008 -0.996 . . . . 2.47 112.251 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -78.81 -23.2 45.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.013 0.435 . . . . 3.64 110.906 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.42 -61.02 2.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.403 0.62 . . . . 2.42 110.391 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.414 HD13 ' SG ' ' A' ' 95' ' ' CYS . 20.5 mt -80.89 43.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 122.081 0.943 . . . . 2.05 111.001 -173.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 91' ' ' LYS . 25.5 mtpp -76.32 -32.24 58.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.569 -0.741 . . . . 4.0 110.563 174.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.98 -10.73 2.64 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.98 -1.009 . . . . 3.1 111.632 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -74.81 173.82 10.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.799 0.333 . . . . 1.91 110.465 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.48 139.2 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 108.201 -1.037 . . . . 1.65 108.201 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.565 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 83.9 m -127.73 122.41 32.78 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.109 -0.636 . . . . 0.91 111.388 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -127.39 157.33 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.279 -0.873 . . . . 1.92 109.331 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.688 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -38.97 111.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.135 0.574 . . . . 3.18 111.33 175.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.606 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 46.4 p90 -64.35 -22.07 66.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.872 -0.604 . . . . 1.74 111.794 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 66.66 146.6 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.79 0.681 . . . . 3.08 111.72 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -166.63 -165.87 0.79 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 0.43 111.371 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.9 1.78 53.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.287 0.565 . . . . 2.19 110.497 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.657 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 51.7 p90 -123.83 165.3 24.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 108.56 -0.904 . . . . 0.24 108.56 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.759 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 29.1 Cg_exo -67.87 120.97 7.97 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.732 2.955 . . . . 0.31 113.256 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.057 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mp -114.93 140.29 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.22 -0.659 . . . . 0.37 109.22 173.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.759 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.3 mmt -115.37 -150.44 0.46 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.046 0.758 . . . . 1.47 113.046 -165.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.98 135.39 43.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.831 -1.077 . . . . 0.39 110.756 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.895 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttp -74.03 116.9 15.2 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.316 -0.994 . . . . 1.66 108.316 167.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.488 HD12 ' CB ' ' A' ' 116' ' ' HIS . 4.8 pt -122.67 175.99 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.615 -1.175 . . . . 0.47 107.986 -174.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 6.6 m-80 -73.33 114.92 12.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.057 -1.09 . . . . 2.16 108.057 169.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.715 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -114.49 83.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 118.992 -1.083 . . . . 0.38 108.913 166.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.742 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 9.3 t-20 170.52 179.41 0.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.428 -0.953 . . . . 1.98 108.428 169.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 59.9 -146.22 45.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.78 113.879 165.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.11 -14.28 15.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.654 0.74 . . . . 1.98 109.475 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -86.06 -12.19 50.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.962 -1.017 . . . . 2.04 110.866 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -43.98 149.49 0.32 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.707 1.003 . . . . 0.48 113.707 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.509 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 41.2 t-80 -55.06 133.57 68.15 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 114.847 -1.07 . . . . 0.42 110.507 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 2.5 Cg_endo -46.86 -47.77 15.64 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.917 2.411 . . . . 0.36 112.788 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.509 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.956 -0.565 . . . . 1.1 111.414 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.541 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.0 m-85 -75.42 -29.92 59.9 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 122.24 -0.287 . . . . 1.49 111.077 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 8.9 mm-40 -58.0 -42.21 84.73 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.31 -0.556 . . . . 2.37 109.622 168.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 83.9 t80 -61.59 -52.25 65.19 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.923 0.392 . . . . 0.58 110.483 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.476 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 66.0 mtt -60.05 -50.04 75.29 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.325 0.583 . . . . 0.34 110.752 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 119' ' ' TYR . 2.9 ttpm? -61.51 -38.21 86.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.729 -1.123 . . . . 0.94 111.396 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 16.2 ptpt -76.57 -35.9 57.92 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.77 0.285 . . . . 2.13 111.77 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.573 HG21 ' HD2' ' A' ' 150' ' ' PRO . 86.4 m -63.47 -42.61 98.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.088 0.471 . . . . 0.47 110.798 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.685 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.0 ttmt -137.02 118.59 11.13 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.327 -0.62 . . . . 1.75 109.327 169.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.466 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 73.8 Cg_endo -83.29 6.7 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.241 2.627 . . . . 1.76 112.885 -173.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 110.73 -173.06 15.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.985 -0.626 . . . . 2.37 112.342 175.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.0 mm -110.47 -23.71 4.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.41 0.624 . . . . 3.56 109.665 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.5 pt? -124.77 136.28 53.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.622 -0.717 . . . . 2.76 109.713 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 50.56 57.16 6.92 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.683 0.614 . . . . 2.84 110.471 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.6 p -58.82 119.01 6.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.787 -0.642 . . . . 3.9 112.68 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.6 tttp 177.05 -60.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.507 -1.224 . . . . 5.13 109.696 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -158.36 -168.06 2.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.577 0.954 . . . . 0.93 113.577 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.882 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 23.7 mt -83.24 168.29 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 114.225 -1.352 . . . . 1.05 109.142 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.472 ' NZ ' ' HB3' ' A' ' 136' ' ' LYS . 0.5 OUTLIER 179.02 -35.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.279 0.945 . . . . 1.5 112.873 -176.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.882 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.13 171.76 8.25 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.904 0.882 . . . . 0.87 112.201 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.437 ' ND2' ' HA2' ' A' ' 85' ' ' GLY . 17.6 m120 -44.46 -157.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.407 1.483 . . . . 1.8 114.122 169.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.832 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 31.7 m-85 -28.56 -56.96 0.13 Allowed 'General case' 0 C--O 1.208 -1.111 0 C-N-CA 125.259 1.424 . . . . 1.37 114.323 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.81 HG23 ' HA ' ' A' ' 155' ' ' SER . 7.0 m 42.87 95.73 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.398 0.888 . . . . 0.3 113.398 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.5 p -85.12 152.07 23.66 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.328 -0.549 . . . . 0.8 110.722 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 6.1 m-85 -103.36 137.71 41.11 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.802 -1.184 . . . . 0.53 107.802 166.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.977 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 44.7 tp -82.58 104.91 13.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.838 -0.801 . . . . 0.51 108.838 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.675 HG21 HD13 ' A' ' 15' ' ' ILE . 16.9 mm -102.69 119.27 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.775 -0.824 . . . . 0.2 108.775 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.524 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.6 OUTLIER -72.12 179.72 3.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.133 0.492 . . . . 1.3 110.292 -176.441 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -61.83 -12.58 18.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.519 -0.764 . . . . 3.78 112.554 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -111.12 -21.36 11.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 1.18 110.294 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 110.55 35.56 2.05 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.554 -0.748 . . . . 0.23 112.864 177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 96.0 t -112.08 124.36 32.38 Favored Pre-proline 0 C--N 1.319 -0.75 0 O-C-N 122.584 -0.363 . . . . 0.62 110.361 175.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.573 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -66.9 99.87 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.3 111.761 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.5 t -84.03 -21.19 8.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.581 . . . . 0.27 110.798 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.685 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 mm-40 -159.16 164.55 35.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.786 -0.45 . . . . 1.22 109.786 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.625 HH11 ' HH2' ' A' ' 137' ' ' TRP . 26.2 ttm180 -131.59 97.56 4.26 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.344 -0.614 . . . . 1.75 109.344 171.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.977 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 40.7 m-85 -81.92 111.13 17.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.224 -0.658 . . . . 0.38 109.224 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.81 ' HA ' HG23 ' A' ' 140' ' ' THR . 0.9 OUTLIER -58.72 163.66 5.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.519 -0.549 . . . . 0.99 109.519 174.508 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.799 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 50.8 Cg_endo -67.69 -7.03 18.21 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.463 2.109 . . . . 0.66 112.06 -169.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -86.1 -0.57 87.05 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.08 -0.963 . . . . 0.52 112.694 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.88 135.36 36.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.942 0.401 . . . . 0.43 110.538 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 172.79 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 1.25 110.62 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.485 ' HA ' HG23 ' A' ' 56' ' ' THR . 31.2 t -50.45 -53.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.532 -0.303 . . . . 0.41 110.829 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 64.0 tttm -63.41 -35.28 79.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 3.44 111.44 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -54.3 -40.87 68.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.541 0.686 . . . . 1.86 109.485 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.766 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 61.2 mt -82.27 -40.66 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.838 -1.074 . . . . 0.21 111.507 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 41.3 mt-10 -53.14 -42.26 65.91 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.282 0.475 . . . . 0.88 112.282 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 1.7 pt-20 -69.31 -2.37 10.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.408 0.521 . . . . 0.75 112.408 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.614 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 33.3 mmtm -116.66 -20.83 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.577 . . . . 1.58 109.705 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.1 tp -93.29 -41.12 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.24 111.95 -168.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.69 ' HA ' HD12 ' A' ' 171' ' ' LEU . 77.5 mt -49.86 -50.8 65.86 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.703 0.631 . . . . 0.44 112.703 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.5 Cg_exo -54.24 -36.56 86.6 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.236 1.958 . . . . 0.49 112.835 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -75.99 -37.38 58.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.675 -0.239 . . . . 0.71 110.966 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.84 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.8 mt -59.7 -48.59 81.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.716 0.77 . . . . 0.46 109.033 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -49.29 -65.23 2.86 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 114.241 -1.345 . . . . 1.52 112.42 167.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 p -171.58 126.49 0.62 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.767 0.284 . . . . 2.52 110.658 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -93.86 -18.45 21.97 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.374 0.607 . . . . 3.56 110.39 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.529 ' HG3' ' HG ' ' A' ' 176' ' ' LEU . 18.7 ptp180 177.71 -29.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.839 -1.171 . . . . 7.86 107.839 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.529 ' HG ' ' HG3' ' A' ' 175' ' ' ARG . 90.7 mt . . . . . 0 C--O 1.245 0.843 0 CA-C-N 114.271 -1.331 . . . . 4.81 108.045 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.866 0 N-CA-C 111.602 -0.599 . . . . 5.51 111.602 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.3 tpt -140.85 96.93 3.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.021 0.438 . . . . 5.05 110.203 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 121' ' ' TYR . . . -166.61 -86.16 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.866 -0.606 . . . . 1.37 111.869 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 m 72.46 -54.44 0.69 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.485 0.714 . . . . 1.68 111.848 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 p -151.7 154.93 37.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.417 0.627 . . . . 0.65 110.369 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 144' ' ' ILE . 13.8 pt -61.6 -21.46 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.913 -1.039 . . . . 0.3 112.497 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.785 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 62.2 m-85 -77.7 -2.57 36.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.39 0.515 . . . . 0.27 112.39 -171.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -70.47 -17.46 62.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.632 0.73 . . . . 1.96 109.363 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 79.3 m-85 -100.38 162.6 12.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.191 -0.913 . . . . 0.4 111.477 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.475 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 25.9 tt0 -93.97 153.61 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 2.77 110.733 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.587 HG12 ' HB3' ' A' ' 28' ' ' TYR . 75.6 t -133.05 139.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.037 0.446 . . . . 0.74 111.186 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.992 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 95.6 mt -104.96 140.56 38.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.826 -0.805 . . . . 0.72 108.826 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.82 -172.35 1.9 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.268 -0.641 . . . . 1.59 109.268 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -54.36 -33.06 58.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.753 0.311 . . . . 0.52 111.306 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 19.6 t70 -86.85 -11.67 50.14 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.418 -0.355 . . . . 2.22 111.287 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.992 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 42.3 m-70 79.37 22.31 0.57 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.618 0.767 . . . . 0.73 109.745 -176.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.761 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -84.13 146.0 47.37 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 105.857 -1.905 . . . . 3.25 105.857 166.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.89 114.6 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.157 1.238 . . . . 0.86 112.695 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.587 ' HB3' HG12 ' A' ' 20' ' ' VAL . 64.2 t80 -87.38 116.49 25.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.312 -0.858 . . . . 0.28 110.134 172.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.698 ' ND2' ' HB3' ' A' ' 32' ' ' GLN . 54.9 t30 -66.73 93.85 0.27 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.102 -0.703 . . . . 1.65 109.102 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.785 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -77.31 -34.3 55.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.361 0.6 . . . . 0.25 110.454 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.729 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.8 p -76.64 -0.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.271 -0.877 . . . . 0.41 112.296 -168.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.698 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 12.2 pt20 -80.85 -5.24 57.04 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.963 -0.754 . . . . 1.24 108.963 173.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -101.35 20.64 15.49 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.897 -1.047 . . . . 0.38 108.341 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -96.94 150.95 20.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.462 -1.245 . . . . 1.73 108.742 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 -6.05 81.38 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.636 -0.985 . . . . 0.36 110.636 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.578 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.2 m -140.72 141.75 26.0 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.798 -1.186 . . . . 1.14 107.798 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.836 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.2 Cg_exo -75.99 157.54 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.019 1.813 . . . . 0.52 111.365 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.562 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -154.67 148.61 25.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.249 0.547 . . . . 1.03 111.251 -174.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.616 HD23 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.29 150.7 26.39 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.262 -1.014 . . . . 1.1 108.262 171.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 66.9 mt -139.64 118.7 12.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.623 -0.51 . . . . 0.2 109.623 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.841 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 38.8 m-85 -103.07 124.15 47.99 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 121.154 -0.218 . . . . 0.23 111.359 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.709 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -78.56 92.0 4.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.901 -1.148 . . . . 1.28 107.901 166.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.6 p -108.62 143.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 113.363 0.875 . . . . 0.88 113.363 -161.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HA ' ' OG ' ' A' ' 76' ' ' SER . . . -67.04 110.43 3.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.438 -1.319 . . . . 0.52 107.438 170.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.972 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -67.89 81.27 0.2 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.061 -0.972 . . . . 1.84 111.869 -167.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.651 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 14.1 ptpt 46.01 66.37 0.96 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.274 1.43 . . . . 2.43 112.46 -173.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -162.65 138.07 7.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -1.02 . . . . 0.99 110.154 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.13 -140.97 30.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.842 -0.694 . . . . 1.09 113.346 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -84.07 170.09 14.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.075 0.464 . . . . 3.16 111.77 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.15 -28.44 2.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.949 -0.569 . . . . 1.94 111.424 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.876 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.4 mmmt 66.27 3.52 2.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.255 0.622 . . . . 2.03 111.917 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.04 1.9 59.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.818 -0.706 . . . . 0.47 112.28 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.4 81.92 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.468 -0.653 . . . . 0.34 111.468 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.518 ' HE1' ' HB1' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -66.21 -49.34 67.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.203 -0.498 . . . . 0.57 110.185 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.63 -43.51 89.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.505 -0.771 . . . . 2.46 110.119 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 160' ' ' VAL . 55.1 m -57.94 -53.26 60.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.516 -0.765 . . . . 0.33 110.527 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.68 -49.48 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.719 -0.673 . . . . 0.19 111.846 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.647 HG23 ' HB2' ' A' ' 101' ' ' GLU . 63.0 m -59.22 -45.39 91.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 0.3 110.754 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.9 m -64.07 -48.44 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.652 -0.704 . . . . 1.08 110.78 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 95.1 mt -56.59 -53.04 62.28 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.803 0.298 . . . . 0.81 111.803 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.61 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 70.9 t80 -53.23 -53.35 52.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.788 -0.642 . . . . 0.33 109.755 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.96 -27.43 60.99 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.371 -0.832 . . . . 1.76 111.815 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.75 -48.34 12.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.839 0.352 . . . . 1.79 111.411 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.695 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.8 m-85 -99.1 6.17 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.258 0.836 . . . . 0.43 113.258 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -57.81 -29.85 65.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.808 0.337 . . . . 2.11 110.316 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -63.57 -32.8 74.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 1.2 111.061 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -96.5 10.78 37.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 1.9 110.689 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 80.66 64.07 1.85 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.945 -0.645 . . . . 1.32 112.19 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.616 ' CE1' HD23 ' A' ' 39' ' ' LEU . 70.6 t80 -129.66 143.85 51.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.727 0.299 . . . . 0.26 110.912 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.6 146.77 52.37 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.853 0.358 . . . . 0.51 110.416 177.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.738 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 42.5 t -116.52 120.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.96 -0.385 . . . . 0.24 109.96 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 26.7 mt -106.38 123.07 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.654 -0.498 . . . . 0.51 109.654 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.025 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -104.91 131.32 52.56 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.103 0.478 . . . . 0.28 110.266 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 8.2 m-85 -117.27 106.98 46.07 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.219 -0.66 . . . . 0.34 109.219 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.029 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 52.6 Cg_exo -56.69 169.06 1.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.993 3.129 . . . . 0.73 112.04 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' A' ' 44' ' ' ALA . 3.7 p -114.49 136.5 52.94 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 115.419 1.637 . . . . 1.54 115.419 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.527 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 29.0 m-20 -99.63 73.73 1.83 Allowed 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 113.924 -1.489 . . . . 2.52 109.176 166.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 1.047 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 55.1 mt-30 -64.09 -12.28 37.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.774 -0.648 . . . . 3.18 112.447 -173.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -66.1 -8.86 26.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.147 -0.479 . . . . 3.8 110.845 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' HA3' ' OD1' ' A' ' 109' ' ' ASN . . . -60.36 -42.89 99.05 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.099 -0.501 . . . . 1.45 112.735 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.9 -60.82 0.45 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.504 -0.855 . . . . 1.43 112.748 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.688 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -110.98 9.9 22.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.785 0.293 . . . . 1.43 111.46 -176.389 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 1.047 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 11.4 mm-40 -63.51 151.28 88.28 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.346 -0.388 . . . . 3.06 110.442 -171.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.885 ' HG3' HG22 ' A' ' 135' ' ' ILE . 10.5 Cg_exo -31.94 150.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 125.272 3.981 . . . . 1.61 116.574 -173.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.33 14.49 66.14 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.313 -1.515 . . . . 1.39 109.313 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 69.08 -62.92 0.39 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.135 -1.032 . . . . 3.69 110.737 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 178.0 140.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.5 0.5 . . . . 2.47 110.188 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 65.39 49.82 1.82 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 3.64 112.609 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.595 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 7.5 tp10 -91.76 -12.0 35.12 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.81 -1.182 . . . . 2.42 107.81 165.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.812 HG12 ' SG ' ' A' ' 95' ' ' CYS . 2.2 mt -93.55 21.5 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.235 -0.893 . . . . 2.05 108.868 171.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.676 ' HG3' ' H ' ' A' ' 92' ' ' GLU . 13.3 pttm -53.21 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.682 -0.69 . . . . 4.0 112.192 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.676 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 12.2 pt-20 -93.56 7.65 43.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.038 -0.983 . . . . 3.1 109.53 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.449 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 88.2 m-85 -110.97 172.79 6.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.24 -0.891 . . . . 1.91 111.083 -171.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 94' ' ' VAL . 6.6 p -130.9 110.83 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.529 -1.286 . . . . 1.65 107.529 170.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.812 ' SG ' HG12 ' A' ' 90' ' ' ILE . 31.1 m -94.99 117.36 30.0 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 118.989 -1.084 . . . . 0.91 110.218 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 95.7 m -153.99 128.63 9.33 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.378 -0.828 . . . . 1.92 110.38 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 96' ' ' THR . 44.4 pttt 68.21 -44.73 0.5 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.584 1.328 . . . . 3.18 114.584 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.651 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 62.03 -67.92 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.461 0.573 . . . . 1.74 111.577 -175.314 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.69 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 8.9 mmpt? 71.23 147.68 0.08 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.898 0.879 . . . . 3.08 111.795 173.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.729 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -168.44 -166.66 0.71 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.101 0.477 . . . . 0.43 111.968 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.647 ' HB2' HG23 ' A' ' 58' ' ' THR . 29.0 mm-40 -88.79 27.69 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 2.19 110.547 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.835 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 39.1 p90 -149.6 174.76 3.21 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.153 -1.425 . . . . 0.24 107.153 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.79 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.4 Cg_exo -71.1 125.59 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.802 2.334 . . . . 0.31 113.322 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.025 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -124.43 141.49 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.247 -0.649 . . . . 0.37 109.247 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.79 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 6.4 mmt -115.48 -152.16 0.5 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.542 0.687 . . . . 1.47 112.714 -164.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -73.04 137.26 45.23 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.577 -1.192 . . . . 0.39 110.707 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.029 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 26.7 pttt -73.13 120.97 19.49 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.764 -0.828 . . . . 1.66 108.764 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.507 HD12 ' CB ' ' A' ' 116' ' ' HIS . 5.2 pt -122.53 169.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.795 -1.093 . . . . 0.47 108.343 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 12.5 m-80 -68.6 121.37 16.29 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.77 -1.196 . . . . 2.16 107.77 169.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.709 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -119.16 83.57 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 C-N-CA 119.127 -1.029 . . . . 0.38 109.587 170.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.688 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 46.5 t30 170.96 177.97 0.06 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.076 -1.083 . . . . 1.98 108.076 167.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.76 -141.52 35.93 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.955 -0.641 . . . . 0.78 113.779 164.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.23 1.52 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.121 -0.539 . . . . 1.98 110.601 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -87.75 -24.94 23.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.821 -0.627 . . . . 2.04 110.681 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.775 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -44.59 142.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.779 1.029 . . . . 0.48 113.779 -175.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.507 ' CB ' HD12 ' A' ' 108' ' ' ILE . 49.3 t-80 -53.23 136.3 49.84 Favored Pre-proline 0 C--O 1.225 -0.236 0 CA-C-N 114.679 -1.146 . . . . 0.42 110.012 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.56 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.2 Cg_exo -40.95 -45.34 5.03 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.172 2.581 . . . . 0.36 112.845 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.522 HD11 ' HE3' ' A' ' 122' ' ' MET . 30.0 tp -54.02 -51.49 63.82 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.783 -0.644 . . . . 1.1 111.884 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.5 m-85 -71.28 -30.4 66.22 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 116.517 -0.31 . . . . 1.49 111.0 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.474 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 9.6 mm-40 -56.26 -43.3 78.62 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.726 -0.79 . . . . 2.37 109.413 170.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.9 t80 -66.03 -45.03 82.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.614 -0.434 . . . . 0.58 110.508 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.522 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.9 mtt -60.76 -53.11 61.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.873 0.368 . . . . 0.34 111.236 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 2.5 mtpm? -62.33 -38.24 88.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 0.94 110.838 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 17.1 ptpt -74.82 -27.35 60.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.718 -0.219 . . . . 2.13 110.816 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.537 HG21 ' HD2' ' A' ' 150' ' ' PRO . 59.1 m -65.02 -55.18 20.44 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.945 -0.302 . . . . 0.47 111.068 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.69 ' HG2' ' H ' ' A' ' 128' ' ' GLY . 31.7 ttmt -146.01 135.55 11.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.278 -0.569 . . . . 1.75 111.574 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.646 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 49.4 Cg_endo -74.28 -22.46 16.49 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.245 2.63 . . . . 1.76 110.992 174.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.694 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 101.9 -147.42 17.41 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.264 -0.88 . . . . 2.37 112.835 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.67 -26.79 18.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.027 -0.586 . . . . 3.56 110.615 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.831 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.2 pt? -96.92 177.47 5.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.52 -0.764 . . . . 2.76 110.517 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.03 -46.69 33.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.484 . . . . 2.84 110.873 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.858 HG21 ' HE2' ' A' ' 136' ' ' LYS . 13.5 m -53.66 122.04 9.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.802 -1.09 . . . . 3.9 111.789 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.646 ' HG2' ' HB3' ' A' ' 127' ' ' PRO . 89.3 mttt -86.63 5.56 35.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.217 -0.901 . . . . 5.13 109.219 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.85 ' H ' HG22 ' A' ' 132' ' ' THR . . . -111.41 159.31 18.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.357 0.873 . . . . 0.93 113.357 -172.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.903 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 26.0 mt -103.19 90.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.845 -1.07 . . . . 1.05 110.79 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.858 ' HE2' HG21 ' A' ' 132' ' ' THR . 36.7 pttt -111.48 -2.38 15.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.451 0.537 . . . . 1.5 112.451 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.903 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -120.41 170.29 9.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.465 0.543 . . . . 0.87 112.465 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 16.3 m120 -47.98 -156.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.901 1.681 . . . . 1.8 113.745 172.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.841 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 33.2 m-85 -27.48 -57.96 0.1 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 125.175 1.39 . . . . 1.37 114.022 -164.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.775 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 24.2 m 42.94 95.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.046 0.758 . . . . 0.3 113.046 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.678 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.3 t -88.33 147.13 24.92 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.997 -0.681 . . . . 0.8 110.786 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 39' ' ' LEU . 5.2 m-85 -102.32 133.99 46.33 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.371 -0.974 . . . . 0.53 108.371 169.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.906 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.35 104.05 11.53 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.001 -0.74 . . . . 0.51 109.001 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 15' ' ' ILE . 10.7 mm -104.07 116.86 48.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.92 -0.582 . . . . 0.2 109.737 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' HB2' HD13 ' A' ' 170' ' ' LEU . 6.9 t70 -74.68 169.85 17.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.017 -0.538 . . . . 1.3 109.846 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.891 ' HD3' ' HA ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -60.36 -9.66 3.81 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.329 -0.851 . . . . 3.78 112.09 -168.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.2 8.78 28.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.864 -0.791 . . . . 1.18 108.864 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.519 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 71.57 45.49 45.41 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.23 112.559 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 79.7 t -123.24 123.06 26.69 Favored Pre-proline 0 C--N 1.321 -0.671 0 O-C-N 122.85 -0.206 . . . . 0.62 110.664 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.537 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -68.12 102.75 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.244 2.63 . . . . 0.3 112.417 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.51 ' HB ' HD23 ' A' ' 143' ' ' LEU . 18.8 t -88.49 -15.35 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 0.27 110.806 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.538 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 28.2 mm-40 -168.08 164.54 13.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.094 0.474 . . . . 1.22 111.273 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.694 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 20.3 ttm180 -133.95 99.31 4.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 1.75 109.546 173.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.906 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.5 m-85 -87.25 125.31 34.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.738 -0.838 . . . . 0.38 108.738 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.765 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 95.4 p -69.01 174.29 2.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.617 0.644 . . . . 0.99 109.357 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.876 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 62.8 Cg_endo -68.31 -13.8 38.66 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.062 1.841 . . . . 0.66 111.48 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.13 1.72 79.06 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.835 -1.075 . . . . 0.52 111.699 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.92 133.77 35.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.981 0.42 . . . . 0.43 110.306 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.6 m -90.95 178.52 6.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.109 -0.496 . . . . 1.25 110.221 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.557 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 45.1 t -54.61 -55.9 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 0.41 111.034 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.8 tptp -62.91 -29.23 70.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 3.44 111.265 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.65 -41.12 89.81 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.347 -0.612 . . . . 1.86 109.347 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.706 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.9 mt -82.31 -38.44 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.891 . . . . 0.21 111.344 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 49.0 mt-10 -54.59 -41.86 70.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.297 0.48 . . . . 0.88 112.297 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.1 pt-20 -65.62 -11.78 47.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.444 0.535 . . . . 0.75 112.444 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.726 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 73.6 mmtt -109.89 -16.2 13.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.492 . . . . 1.58 110.386 174.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.566 ' HG ' HD11 ' A' ' 171' ' ' LEU . 67.1 tp -95.61 -42.68 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.742 -0.663 . . . . 0.24 111.845 -171.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.729 ' HA ' HD12 ' A' ' 171' ' ' LEU . 80.6 mt -49.79 -51.31 61.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.547 0.573 . . . . 0.44 112.547 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 57.0 Cg_exo -55.09 -30.94 72.94 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.271 1.981 . . . . 0.49 113.154 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.414 HD13 ' HB2' ' A' ' 145' ' ' ASP . 64.7 mt -81.73 -34.21 30.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.52 0.2 . . . . 0.71 110.75 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.836 HD23 ' HG2' ' A' ' 37' ' ' PRO . 12.6 mt -64.31 -41.4 96.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.694 0.759 . . . . 0.46 109.245 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.47 12.21 2.72 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 114.411 -1.268 . . . . 1.52 113.278 171.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.891 ' HA ' ' HD3' ' A' ' 146' ' ' ARG . 19.3 t 78.2 130.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.413 1.085 . . . . 2.52 111.562 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.491 ' H ' ' NE ' ' A' ' 146' ' ' ARG . . . -90.09 -32.7 16.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.348 0.499 . . . . 3.56 112.348 -174.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.662 ' HG3' HD12 ' A' ' 176' ' ' LEU . 23.5 ptt180 -144.74 -0.14 0.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.765 0.654 . . . . 7.86 112.765 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.73 HD13 HH12 ' A' ' 146' ' ' ARG . 10.8 mp . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.443 -0.789 . . . . 4.81 110.059 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.833 -0.507 . . . . 5.51 111.833 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 54.9 ttp -98.74 -50.02 4.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.714 0.292 . . . . 5.05 110.683 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.63 90.17 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.375 -0.917 . . . . 1.37 112.923 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -123.3 -35.39 2.97 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.726 -0.842 . . . . 1.68 108.726 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.0 p -145.08 174.85 10.69 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.979 -1.01 . . . . 0.65 108.543 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.702 HD13 HG21 ' A' ' 144' ' ' ILE . 13.0 pt -65.15 -22.92 32.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 0.3 111.203 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.841 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 52.6 m-85 -79.79 -0.28 33.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.195 -0.457 . . . . 0.27 111.951 -172.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.91 -12.37 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.395 0.616 . . . . 1.96 109.52 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 91.2 m-85 -109.9 140.32 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.435 -0.802 . . . . 0.4 110.991 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.99 140.6 33.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.698 -0.683 . . . . 2.77 110.631 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.573 HG23 HD13 ' A' ' 30' ' ' LEU . 70.0 t -114.46 148.74 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.935 0.398 . . . . 0.74 110.914 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.835 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 81.6 mt -111.54 141.62 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 0.72 109.246 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.03 -171.75 2.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.487 -0.561 . . . . 1.59 109.487 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.24 -32.93 57.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.605 -0.27 . . . . 0.52 111.671 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.6 t70 -90.86 -8.33 49.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.597 -0.274 . . . . 2.22 111.402 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.835 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.9 m-70 80.71 22.55 0.39 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.73 110.239 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -81.61 160.68 63.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 105.685 -1.968 . . . . 3.25 105.685 166.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.8 113.67 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 120.093 1.069 . . . . 0.86 111.727 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.515 ' HB3' HG12 ' A' ' 20' ' ' VAL . 58.2 t80 -80.67 130.07 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 0.28 109.969 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.757 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 54.1 t30 -80.67 81.99 6.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.07 -0.715 . . . . 1.65 109.07 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.841 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -67.86 -32.38 72.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.198 0.523 . . . . 0.25 110.219 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.679 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.33 -0.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.428 -0.806 . . . . 0.41 112.634 -169.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.757 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 28.4 pt20 -83.55 -6.04 59.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.609 0.719 . . . . 1.24 109.164 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -91.73 -9.78 42.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.991 -1.114 . . . . 0.38 107.991 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -70.9 137.48 49.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.19 -1.368 . . . . 1.73 109.157 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 -10.56 53.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 109.913 -1.275 . . . . 0.36 109.913 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 49.6 m -141.0 144.78 36.49 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.822 -0.807 . . . . 1.14 108.822 177.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.024 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 60.8 Cg_endo -71.89 155.69 57.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.909 1.739 . . . . 0.52 111.259 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.603 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.7 pt? -154.19 152.68 30.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.153 0.501 . . . . 1.03 111.217 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 163' ' ' ILE . 6.8 mp -108.0 152.5 24.4 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.775 -0.824 . . . . 1.1 108.775 172.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 78.9 mt -140.84 115.48 5.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.542 -0.54 . . . . 0.2 109.542 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.909 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 17.7 m-85 -102.42 123.65 46.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 121.166 -0.213 . . . . 0.23 110.982 -173.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.734 ' HB2' HG21 ' A' ' 110' ' ' VAL . 1.1 p30 -82.23 91.3 6.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.545 -0.909 . . . . 1.28 108.545 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.605 HG11 ' HE2' ' A' ' 98' ' ' PHE . 1.7 p -111.95 125.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 112.455 0.539 . . . . 0.88 112.455 -165.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.27 107.16 0.45 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.744 -1.576 . . . . 0.52 106.744 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 1.071 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 3.3 p -76.71 75.67 3.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.28 -1.327 . . . . 1.84 113.483 -156.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 82.6 tttt 92.45 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.627 1.171 . . . . 2.43 111.538 174.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.6 m -141.57 143.26 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.446 -0.343 . . . . 0.99 110.674 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.28 -136.69 19.15 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.031 -0.604 . . . . 1.09 114.222 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.58 111.84 24.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 3.16 111.815 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 p -73.33 -26.7 61.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.981 -0.554 . . . . 1.94 110.648 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.86 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 39.2 mtpt 64.54 3.02 1.77 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.33 -0.85 . . . . 2.03 112.259 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.84 -3.94 34.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.824 -0.703 . . . . 0.47 112.641 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.15 79.83 Favored Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 111.702 -0.559 . . . . 0.34 111.702 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.576 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -69.25 -52.72 24.9 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.073 0.463 . . . . 0.57 110.138 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.29 -41.55 93.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.488 -0.778 . . . . 2.46 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.6 m -68.51 -40.82 80.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.816 -0.629 . . . . 0.33 110.876 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -64.98 -49.3 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.19 111.283 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -59.18 -48.9 79.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.835 -0.621 . . . . 0.3 111.177 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -63.8 -46.16 86.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.816 -0.629 . . . . 1.08 111.27 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.686 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.78 -46.0 90.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.81 111.338 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.656 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 59.0 t80 -53.74 -57.34 11.19 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 123.277 0.361 . . . . 0.33 110.427 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -67.14 -41.57 85.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.291 -0.413 . . . . 1.76 111.555 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.77 -42.79 73.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 1.79 111.717 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.686 ' CD1' HD13 ' A' ' 171' ' ' LEU . 67.7 m-85 -103.9 3.78 34.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.445 0.905 . . . . 0.43 113.445 -172.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -58.48 -29.74 66.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 2.11 110.788 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.6 p -65.32 -38.55 90.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.2 111.237 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -89.24 1.89 55.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.816 0.341 . . . . 1.9 111.255 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.508 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 93.08 73.43 1.23 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.701 -0.761 . . . . 1.32 112.006 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.601 ' CE1' HD13 ' A' ' 39' ' ' LEU . 76.7 t80 -143.09 142.13 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.526 0.203 . . . . 0.26 111.06 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.98 141.45 49.29 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 120.823 0.344 . . . . 0.51 110.207 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.661 HG11 ' HB1' ' A' ' 57' ' ' ALA . 52.9 t -108.01 114.06 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.74 0.305 . . . . 0.24 110.448 168.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 31.2 mt -98.48 122.63 41.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.828 -0.804 . . . . 0.51 108.828 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.51 113.42 26.19 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.388 -0.525 . . . . 0.28 110.345 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.76 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.4 m-85 -95.05 108.22 36.9 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.54 -0.911 . . . . 0.34 108.54 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.071 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.2 Cg_exo -59.76 167.67 6.56 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 123.164 2.576 . . . . 0.73 111.555 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 70.9 m -108.25 138.82 43.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.55 -1.26 . . . . 1.54 113.606 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.407 ' OD1' ' HD2' ' A' ' 79' ' ' PHE . 36.9 t30 -107.77 94.61 5.17 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 112.522 -2.126 . . . . 2.52 110.472 -174.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.707 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 2.6 pm0 -51.95 -9.38 0.09 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.324 1.449 . . . . 3.18 114.683 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.407 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 64.8 m-85 -89.14 -15.18 34.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.738 0.304 . . . . 3.8 111.8 -166.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.88 -39.05 60.06 Favored Glycine 0 CA--C 1.506 -0.504 0 N-CA-C 110.908 -0.877 . . . . 1.45 110.908 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.96 -85.03 0.24 Allowed Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 120.778 -0.725 . . . . 1.43 112.031 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.748 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -89.22 32.77 0.82 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.798 0.666 . . . . 1.43 112.798 -169.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.707 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -61.09 154.29 62.03 Favored Pre-proline 0 C--N 1.321 -0.658 0 O-C-N 121.982 -0.449 . . . . 3.06 110.719 -177.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.764 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -29.01 149.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.463 1 C-N-CA 125.476 4.117 . . . . 1.61 116.818 -176.515 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.32 10.77 85.94 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.841 -1.072 . . . . 1.39 110.466 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.22 44.12 25.46 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.182 -0.673 . . . . 3.69 109.182 -173.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 88' ' ' GLU . 11.4 pt-20 49.36 -175.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.879 1.272 . . . . 2.47 112.026 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 87' ' ' GLU . 35.9 mt-10 64.57 3.36 1.9 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.503 -0.771 . . . . 3.64 112.833 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -81.28 -13.79 58.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.682 -0.859 . . . . 2.42 108.682 172.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.649 HG12 ' SG ' ' A' ' 95' ' ' CYS . 21.1 mt -110.78 40.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.473 -1.24 . . . . 2.05 109.657 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 60.2 mtpt -96.38 123.66 40.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.126 -0.943 . . . . 4.0 108.584 171.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 2.7 pt-20 72.95 -37.56 0.39 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.365 1.066 . . . . 3.1 109.502 -170.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.473 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 41.1 m-85 -74.77 152.53 39.03 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.603 -0.888 . . . . 1.91 108.603 169.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.55 121.59 53.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.193 0.52 . . . . 1.65 109.817 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.821 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 56.1 m -97.03 120.89 38.23 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.054 -0.659 . . . . 0.91 111.232 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.947 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 17.0 m -153.0 115.28 4.41 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.225 -0.898 . . . . 1.92 109.304 168.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.662 ' O ' HG21 ' A' ' 104' ' ' ILE . 87.6 mttt 64.27 -40.24 0.24 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 115.006 1.484 . . . . 3.18 115.006 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.695 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER 63.2 -36.55 0.15 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.004 1.322 . . . . 1.74 112.308 -171.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 97' ' ' LYS . 70.9 mmtt 69.54 130.86 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.828 0.851 . . . . 3.08 112.581 172.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.69 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -158.88 -171.38 3.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.847 -0.615 . . . . 0.43 112.397 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.62 31.44 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.419 -0.81 . . . . 2.19 111.092 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.877 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 39.2 p90 -150.43 167.31 13.24 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 108.154 -1.054 . . . . 0.24 108.154 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.1 Cg_exo -64.04 106.52 0.67 Allowed 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 123.597 2.865 . . . . 0.31 113.527 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.979 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.4 mp -103.43 131.52 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.991 -0.744 . . . . 0.37 108.991 174.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.5 mmt -109.94 -154.17 0.53 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.118 0.784 . . . . 1.47 113.118 -161.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -69.56 125.22 26.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.123 -0.944 . . . . 0.39 110.496 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.947 ' HE3' ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -64.5 120.55 12.53 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.617 -0.883 . . . . 1.66 108.617 172.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.754 HG13 HG13 ' A' ' 110' ' ' VAL . 9.2 pt -121.39 155.04 25.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.29 -1.004 . . . . 0.47 108.29 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -83.19 69.61 9.94 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.123 -1.066 . . . . 2.16 108.123 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.7 90.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.38 111.007 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.748 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 46.5 t30 174.16 172.55 0.19 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.505 -0.924 . . . . 1.98 108.505 166.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.49 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 52.21 -142.49 23.23 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 114.471 0.548 . . . . 0.78 114.471 168.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -1.52 32.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.49 0.662 . . . . 1.98 110.558 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -95.68 -13.15 24.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.089 -0.959 . . . . 2.04 110.688 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.581 ' HB2' ' H ' ' A' ' 111' ' ' ASN . . . -57.84 149.52 22.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.562 -0.745 . . . . 0.48 111.913 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.553 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 20.2 t-80 -46.99 139.73 6.72 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.118 -0.946 . . . . 0.42 110.131 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.476 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 11.0 Cg_endo -54.18 -35.34 82.21 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.224 2.616 . . . . 0.36 112.437 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.562 HD11 ' HE3' ' A' ' 122' ' ' MET . 23.4 tp -61.57 -40.46 94.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.908 -0.587 . . . . 1.1 110.572 175.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.9 m-85 -75.63 -28.9 58.98 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.224 -0.443 . . . . 1.49 111.009 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' A' ' 117' ' ' PRO . 40.2 mt-10 -57.6 -39.96 77.99 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.951 -0.7 . . . . 2.37 109.181 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.501 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 79.1 t80 -71.67 -41.74 68.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 0.58 110.519 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.562 ' HE3' HD11 ' A' ' 118' ' ' LEU . 65.6 mtt -66.68 -53.01 38.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.133 -0.485 . . . . 0.34 111.576 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 13.8 mtpt -61.26 -39.63 91.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.541 -0.3 . . . . 0.94 110.958 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -68.58 -32.36 72.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.78 0.324 . . . . 2.13 110.484 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.556 HG21 ' HD2' ' A' ' 150' ' ' PRO . 89.3 m -66.23 -58.75 4.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 0.47 110.979 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.866 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 25.9 ttmt -132.81 128.16 20.66 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 120.509 -0.476 . . . . 1.75 110.521 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.651 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 84.9 Cg_endo -84.99 -162.38 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.526 2.817 . . . . 1.76 111.641 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -84.59 23.76 7.17 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.573 -0.822 . . . . 2.37 111.36 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.1 mt 79.81 -18.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 123.908 0.883 . . . . 3.56 110.408 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.7 pt? -110.54 176.44 5.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.644 . . . . 2.76 110.999 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -51.16 -38.4 51.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.512 0.93 . . . . 2.84 113.512 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.524 HG22 ' HB3' ' A' ' 134' ' ' ALA . 2.3 m -44.49 -47.94 10.07 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.076 0.769 . . . . 3.9 113.076 -169.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.575 ' HA ' ' CB ' ' A' ' 127' ' ' PRO . 69.0 mttm 64.39 -7.62 0.23 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.696 0.623 . . . . 5.13 111.781 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.553 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -105.7 172.41 6.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 114.813 1.412 . . . . 0.93 114.813 -164.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.873 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 51.0 mt -104.66 87.88 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 113.681 -1.6 . . . . 1.05 110.257 -173.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.484 ' HE2' HG21 ' A' ' 132' ' ' THR . 29.7 pttt -110.57 14.98 22.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.477 0.547 . . . . 1.5 112.477 -170.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.873 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -146.7 169.38 19.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.923 0.342 . . . . 0.87 111.923 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.613 ' ND2' ' HB3' ' A' ' 44' ' ' ALA . 1.5 t-20 -51.66 -155.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.535 1.534 . . . . 1.8 113.223 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.909 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 27.4 m-85 -25.43 -59.68 0.07 Allowed 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 125.298 1.439 . . . . 1.37 114.794 -162.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.796 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 19.2 m 42.69 93.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 118.684 0.675 . . . . 0.3 112.738 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.0 p -84.59 150.62 25.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.689 -0.804 . . . . 0.8 110.491 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 4.5 m-85 -103.75 135.65 44.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.226 -1.027 . . . . 0.53 108.226 167.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.911 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 35.9 tp -82.01 104.85 12.66 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.994 -0.743 . . . . 0.51 108.994 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 15' ' ' ILE . 14.6 mm -102.44 121.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.947 -0.76 . . . . 0.2 108.947 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.694 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.4 OUTLIER -72.41 -179.39 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.568 -0.287 . . . . 1.3 110.994 -176.165 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.661 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.6 mtp180 -56.23 -28.59 58.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.243 0.46 . . . . 3.78 112.243 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 175' ' ' ARG . 12.5 t70 -109.77 -4.75 15.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.186 0.517 . . . . 1.18 110.791 -169.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.581 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.09 53.46 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.491 -0.861 . . . . 0.23 114.353 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.556 HG23 HH22 ' A' ' 175' ' ' ARG . 10.3 t -127.7 128.82 23.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 117.382 0.591 . . . . 0.62 110.151 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.556 ' HD2' HG21 ' A' ' 125' ' ' THR . 15.3 Cg_exo -66.26 102.64 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.946 2.431 . . . . 0.3 112.388 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.47 -18.42 8.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.656 -0.702 . . . . 0.27 110.925 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.866 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 77.0 mm-40 -157.07 159.42 37.9 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.682 0.277 . . . . 1.22 110.915 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.651 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 20.1 ttm180 -127.44 96.83 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.01 -0.737 . . . . 1.75 109.01 168.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.911 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 33.9 m-85 -86.42 107.88 18.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.908 -0.775 . . . . 0.38 108.908 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.701 ' HA ' HG23 ' A' ' 140' ' ' THR . 83.5 p -60.6 164.93 6.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.89 -0.411 . . . . 0.99 109.89 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.86 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 42.0 Cg_endo -65.24 -7.6 16.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.032 2.488 . . . . 0.66 112.978 -164.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.95 22.46 38.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.52 111.718 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.04 140.23 29.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 0.43 110.813 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.9 p -91.32 170.13 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.734 -0.667 . . . . 1.25 111.029 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.686 HG13 HD21 ' A' ' 60' ' ' LEU . 74.5 t -53.18 -56.09 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.41 110.955 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.424 ' NZ ' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -65.64 -32.05 73.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 3.44 111.461 -175.088 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.74 -31.78 73.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.121 -0.49 . . . . 1.86 109.922 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.887 HG21 HD21 ' A' ' 39' ' ' LEU . 35.6 mt -83.19 -39.83 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.994 -0.548 . . . . 0.21 110.7 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 54.7 mt-10 -57.79 -35.63 71.08 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.133 0.42 . . . . 0.88 112.133 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.519 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.4 pt-20 -61.32 -21.38 63.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.75 111.648 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.547 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtt -104.8 -31.5 9.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.233 -0.44 . . . . 1.58 110.549 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.3 tp -85.58 -42.43 14.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.24 112.758 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.806 ' HA ' HD12 ' A' ' 171' ' ' LEU . 60.8 mt -53.94 -46.97 98.38 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.504 0.557 . . . . 0.44 112.504 -173.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.9 Cg_exo -53.13 -40.16 77.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.809 1.672 . . . . 0.49 112.371 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.6 mt -74.4 -37.05 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.71 111.794 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.024 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.8 mt -54.27 -54.07 45.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.539 0.685 . . . . 0.46 109.497 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.7 -59.78 8.77 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.276 -1.329 . . . . 1.52 112.795 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.2 p -167.05 126.03 1.39 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.923 0.362 . . . . 2.52 110.857 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.694 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -94.14 -57.46 2.52 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.103 0.478 . . . . 3.56 111.106 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 147' ' ' ASP . 17.9 ptp180 -131.5 4.69 4.31 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.389 -0.967 . . . . 7.86 108.389 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 C--O 1.246 0.87 0 N-CA-C 106.968 -1.493 . . . . 4.81 106.968 -176.775 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.096 -0.401 . . . . 5.51 112.096 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 67.2 mtt -93.16 140.07 29.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.307 -0.257 . . . . 5.05 110.307 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.11 27.84 6.08 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.853 -0.689 . . . . 1.37 111.619 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 m -84.21 -45.33 13.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.825 0.345 . . . . 1.68 110.664 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.3 p -124.33 -179.41 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.596 -0.52 . . . . 0.65 109.596 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.833 HD13 HG21 ' A' ' 144' ' ' ILE . 32.5 pt -68.3 -31.07 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.83 0.348 . . . . 0.3 111.358 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 29.8 m-85 -72.95 -4.62 33.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.906 0.384 . . . . 0.27 111.594 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.52 -14.22 62.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.83 -0.623 . . . . 1.96 109.366 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.645 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 84.1 m-85 -111.62 142.34 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.373 -0.83 . . . . 0.4 110.701 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -100.18 140.18 34.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.68 -0.489 . . . . 2.77 109.68 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.577 ' CG2' ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -123.3 159.77 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.378 -0.374 . . . . 0.74 110.804 -171.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.907 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 58.7 mt -97.26 133.34 42.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.531 . . . . 0.72 110.214 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 21.2 t70 -69.78 178.18 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.702 -1.135 . . . . 1.59 109.584 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.674 ' HB1' ' CD ' ' A' ' 97' ' ' LYS . . . -55.43 -25.04 33.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.968 0.413 . . . . 0.52 111.417 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -90.91 -9.82 44.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.206 -0.452 . . . . 2.22 111.111 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.907 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 44.9 m-70 74.51 12.88 3.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.912 0.885 . . . . 0.73 109.994 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -73.37 150.36 89.39 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 106.126 -1.805 . . . . 3.25 106.126 162.493 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.23 115.16 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.81 1.007 . . . . 0.86 111.425 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.577 ' HB3' ' CG2' ' A' ' 20' ' ' VAL . 87.9 t80 -84.42 122.28 28.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.28 109.825 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.671 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.0 t30 -75.24 82.15 2.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.839 -0.619 . . . . 1.65 109.645 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.738 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.2 pt? -63.06 -29.74 71.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.594 0.711 . . . . 0.25 110.28 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.75 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.6 p -77.31 -0.03 2.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.828 -1.078 . . . . 0.41 112.933 -169.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.671 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 29.3 pt20 -78.35 -5.45 52.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.359 -0.608 . . . . 1.24 109.359 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CG ' HG21 ' A' ' 70' ' ' THR . 77.5 m-70 -98.42 -0.75 42.99 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.38 108.759 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HE2' ' CG2' ' A' ' 31' ' ' VAL . 9.2 ttmm -67.97 132.4 47.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 1.73 109.914 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.46 -0.99 60.06 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.515 -1.034 . . . . 0.36 110.515 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 44.8 m -140.33 138.49 19.12 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.237 -0.653 . . . . 1.14 109.237 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.003 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 43.8 Cg_endo -69.44 154.87 68.42 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.769 1.646 . . . . 0.52 110.893 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.624 ' CB ' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -156.52 148.36 22.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.167 0.508 . . . . 1.03 111.323 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 141' ' ' SER . 3.4 mm? -107.12 148.63 28.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.113 -1.069 . . . . 1.1 108.113 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.541 HD12 HG13 ' A' ' 144' ' ' ILE . 69.6 mt -139.55 116.38 10.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.74 -0.467 . . . . 0.2 109.74 -173.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.707 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 16.4 m-85 -101.39 130.31 47.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.602 -0.272 . . . . 0.23 111.313 -172.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.673 ' CB ' HG11 ' A' ' 110' ' ' VAL . 1.1 p30 -87.96 92.04 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.394 -0.965 . . . . 1.28 108.394 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -106.53 150.13 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.453 0.644 . . . . 0.88 112.348 -160.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.31 109.0 5.06 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.2 -1.407 . . . . 0.52 107.2 166.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.986 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -66.76 74.46 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.005 -0.998 . . . . 1.84 112.6 -169.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.781 ' HE3' ' HA ' ' A' ' 98' ' ' PHE . 39.6 ttmt 55.73 57.44 5.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.156 -0.929 . . . . 2.43 111.119 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -160.87 128.14 4.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.108 -0.496 . . . . 0.99 111.288 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.52 -80.9 1.78 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.847 -0.615 . . . . 1.09 113.662 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -131.72 163.18 28.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.423 0.154 . . . . 3.16 110.949 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 p -131.82 -35.69 1.25 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.143 0.423 . . . . 1.94 112.143 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 65.77 0.39 1.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.478 0.711 . . . . 2.03 112.259 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.75 4.97 72.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.666 -0.778 . . . . 0.47 112.259 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.0 86.73 Favored Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.37 -0.692 . . . . 0.34 111.37 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.493 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.3 t80 -61.75 -52.75 62.98 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.941 -0.629 . . . . 0.57 110.254 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.37 -45.97 90.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.765 -0.652 . . . . 2.46 110.668 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 160' ' ' VAL . 30.1 m -57.08 -48.69 77.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.682 -0.69 . . . . 0.33 110.481 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.761 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.53 -50.02 74.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 0.19 111.785 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -61.1 -42.98 99.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.173 0.511 . . . . 0.3 111.005 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.8 m -64.67 -47.77 77.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.576 -0.738 . . . . 1.08 111.223 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 90.5 mt -56.52 -52.58 64.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.187 -0.461 . . . . 0.81 111.165 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.656 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 47.3 t80 -46.99 -57.87 4.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 124.435 1.085 . . . . 0.33 110.117 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.34 -38.85 65.61 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.736 -0.665 . . . . 1.76 111.919 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -70.01 -45.14 67.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 1.79 111.301 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.711 ' CD1' HD13 ' A' ' 171' ' ' LEU . 58.6 m-85 -100.02 5.83 45.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.194 0.813 . . . . 0.43 113.194 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 17.8 mtpp -62.03 -18.67 61.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 2.11 110.073 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 p -61.67 -40.69 95.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.687 -0.688 . . . . 1.2 110.874 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -94.92 10.18 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 1.9 110.599 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.577 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.14 71.66 1.26 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.571 -0.741 . . . . 1.32 112.255 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE1' HD23 ' A' ' 39' ' ' LEU . 59.4 t80 -132.62 142.43 49.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.229 -0.285 . . . . 0.26 110.229 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.624 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.36 152.44 48.16 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.973 0.416 . . . . 0.51 110.622 178.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.761 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.0 t -122.82 124.66 70.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.864 0.364 . . . . 0.24 110.437 171.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.494 HD22 ' HE3' ' A' ' 105' ' ' MET . 16.5 mt -105.68 145.05 31.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.823 -0.806 . . . . 0.51 108.823 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -132.79 113.46 12.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.133 0.492 . . . . 0.28 111.108 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.657 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.6 m-85 -99.01 113.57 64.74 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.698 -0.683 . . . . 0.34 109.306 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.075 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.29 165.85 6.73 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.562 2.841 . . . . 0.73 111.818 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.4 t -122.96 137.21 55.01 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 122.604 1.192 . . . . 1.54 113.485 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 40.4 t30 -91.12 89.18 7.26 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.164 -1.834 . . . . 2.52 109.139 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.938 ' HB2' HG13 ' A' ' 90' ' ' ILE . 5.3 mm100 -61.24 -4.16 1.09 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.71 -1.132 . . . . 3.18 112.079 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -108.45 30.77 6.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.373 0.606 . . . . 3.8 110.181 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.81 -50.43 1.65 Allowed Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 116.007 -0.542 . . . . 1.45 112.649 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.3 -62.5 0.22 Allowed Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 112.444 -0.263 . . . . 1.43 112.444 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.467 ' HG3' ' HA3' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -129.87 41.6 3.4 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 113.257 0.836 . . . . 1.43 113.257 -173.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.75 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 3.9 mp0 -62.74 144.88 96.18 Favored Pre-proline 0 C--N 1.309 -1.188 0 O-C-N 121.834 -0.541 . . . . 3.06 109.95 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.935 ' HG3' HG22 ' A' ' 135' ' ' ILE . 41.4 Cg_exo -20.32 -115.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.418 1 C-N-CA 126.425 4.75 . . . . 1.61 116.346 -165.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.16 -18.7 21.18 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.533 -1.427 . . . . 1.39 109.533 171.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 16.5 m120 -88.5 43.25 1.12 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.736 -0.732 . . . . 3.69 111.828 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.07 135.22 53.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.648 0.261 . . . . 2.47 110.435 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 59.56 28.79 18.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.19 -0.459 . . . . 3.64 111.43 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.705 ' HB3' ' HG3' ' A' ' 78' ' ' GLN . 6.0 tp10 -68.52 -13.31 62.24 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 120.551 0.215 . . . . 2.42 111.045 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.938 HG13 ' HB2' ' A' ' 78' ' ' GLN . 1.0 OUTLIER -87.11 18.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.061 0.458 . . . . 2.05 110.305 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 92' ' ' GLU . 19.4 pttm -59.72 109.99 1.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.47 -0.567 . . . . 4.0 109.47 172.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.551 ' HB3' ' O ' ' A' ' 91' ' ' LYS . 1.1 tp10 74.74 -47.43 0.62 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.712 0.632 . . . . 3.1 110.732 -171.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 55.8 m-85 -63.6 175.4 1.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.424 0.631 . . . . 1.91 112.237 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.8 p -132.83 111.92 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.684 -1.228 . . . . 1.65 107.684 172.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.788 ' SG ' HG12 ' A' ' 90' ' ' ILE . 38.6 m -90.43 120.3 31.42 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 118.589 -1.244 . . . . 0.91 110.01 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.546 ' N ' ' HB2' ' A' ' 45' ' ' SER . 10.3 t -148.36 163.49 36.92 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.747 -1.115 . . . . 1.92 108.52 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.674 ' CD ' ' HB1' ' A' ' 23' ' ' ALA . 16.5 pttt -38.85 105.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.883 0.739 . . . . 3.18 111.344 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.781 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 51.5 p90 -58.21 -22.58 52.53 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.589 -0.732 . . . . 1.74 110.92 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? 68.83 142.82 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.168 0 O-C-N 124.282 0.989 . . . . 3.08 110.473 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.478 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -162.26 -160.33 0.66 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.468 -0.493 . . . . 0.43 111.732 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.91 -10.57 44.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 2.19 109.769 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.604 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 51.7 p90 -112.31 166.85 10.11 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 115.173 -0.921 . . . . 0.24 108.934 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.769 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.9 Cg_exo -70.61 119.31 6.24 Favored 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 123.712 2.942 . . . . 0.31 113.306 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.969 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.3 mp -108.21 149.44 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.889 -0.782 . . . . 0.37 108.889 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.769 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 13.3 mmt -118.49 -157.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.17 0.804 . . . . 1.47 113.17 -164.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.69 145.5 43.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.929 -1.032 . . . . 0.39 110.359 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.075 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.2 pttt -83.37 137.16 34.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.654 0.74 . . . . 1.66 109.785 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.488 HG13 HG13 ' A' ' 110' ' ' VAL . 5.0 pt -135.35 175.18 11.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.204 -1.362 . . . . 0.47 108.01 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.3 t30 -88.34 83.96 6.86 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.97 -0.752 . . . . 2.16 108.97 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.732 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -76.08 86.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.455 -1.298 . . . . 0.38 110.157 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 63.7 t30 170.88 179.36 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.86 -1.163 . . . . 1.98 107.86 166.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 82' ' ' GLN . . . 56.75 -146.32 35.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.919 -0.658 . . . . 0.78 113.793 166.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -107.15 1.1 23.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.183 -0.508 . . . . 1.98 111.351 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.433 ' HB3' ' OE1' ' A' ' 82' ' ' GLN . 28.7 t-20 -103.78 11.8 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.906 0.86 . . . . 2.04 110.065 -174.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.536 ' HB3' ' OE1' ' A' ' 120' ' ' GLU . . . -73.88 156.46 37.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 0.48 111.963 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 20' ' ' VAL . 35.6 t-80 -57.18 137.69 80.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.07 -0.968 . . . . 0.42 110.5 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -42.39 -48.78 6.61 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.312 2.675 . . . . 0.36 113.13 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.568 HD22 ' CG1' ' A' ' 20' ' ' VAL . 13.6 tp -56.01 -41.23 74.58 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.244 -0.435 . . . . 1.1 111.843 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.601 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 12.4 m-85 -75.44 -30.71 60.09 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.458 -0.337 . . . . 1.49 110.975 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.536 ' OE1' ' HB3' ' A' ' 115' ' ' ALA . 7.1 mm-40 -59.74 -36.75 77.24 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.141 -0.623 . . . . 2.37 109.417 168.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.4 t80 -67.77 -48.78 65.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 0.58 110.448 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.546 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.7 mtt -63.08 -53.06 59.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.004 -0.544 . . . . 0.34 111.443 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -60.33 -39.7 88.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 0.94 111.204 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.5 ptmt -71.86 -35.24 69.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.737 0.303 . . . . 2.13 110.801 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.512 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.8 m -70.08 -42.63 72.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.976 -0.556 . . . . 0.47 112.449 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 21.9 mmtm -135.11 120.78 14.14 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.567 0.58 . . . . 1.75 112.567 -173.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 33.7 Cg_endo -67.93 -39.67 10.72 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.805 2.336 . . . . 1.76 111.662 172.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.721 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 103.0 -155.72 18.15 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.932 -0.651 . . . . 2.37 112.795 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 33.0 pt -91.2 21.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 3.56 111.322 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -126.5 -175.05 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.388 -0.369 . . . . 2.76 110.752 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.11 8.11 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 112.485 0.55 . . . . 2.84 112.485 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.4 p -117.67 160.02 21.99 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.15 -0.477 . . . . 3.9 112.095 -170.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 127' ' ' PRO . 19.3 ptpt -93.43 41.8 1.09 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.009 -0.542 . . . . 5.13 111.915 -172.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.28 153.53 37.56 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.273 -0.571 . . . . 0.93 111.416 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.935 HG22 ' HG3' ' A' ' 84' ' ' PRO . 25.9 mt -85.71 110.21 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.373 -0.831 . . . . 1.05 109.769 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -130.08 15.74 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.003 0.43 . . . . 1.5 112.029 -170.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.809 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -153.91 173.87 15.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.215 0.531 . . . . 0.87 111.989 -175.131 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.486 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 8.8 m120 -43.16 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.74 1.616 . . . . 1.8 115.196 168.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.784 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 15.4 m-85 -30.79 -58.26 0.21 Allowed 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 112.871 -1.968 . . . . 1.37 113.918 -169.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.817 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 12.5 m 44.95 99.64 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.593 0.961 . . . . 0.3 113.593 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.7 ' HB2' HD12 ' A' ' 39' ' ' LEU . 15.9 p -87.78 151.16 23.1 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.467 -0.771 . . . . 0.8 111.268 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.4 m-85 -103.7 133.62 48.4 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.392 -0.966 . . . . 0.53 108.392 168.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.806 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 25.5 tp -81.36 105.41 12.52 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.133 -0.691 . . . . 0.51 109.133 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 15' ' ' ILE . 13.2 mm -105.59 126.91 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.605 -0.725 . . . . 0.2 109.083 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.9 OUTLIER -78.69 -175.71 4.53 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.912 -0.315 . . . . 1.3 110.614 -176.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.649 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 63.5 mtt180 -63.23 -16.76 61.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.259 0.466 . . . . 3.78 112.259 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -108.09 -10.04 15.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.437 0.637 . . . . 1.18 110.17 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.587 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 95.82 32.31 6.92 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.538 -0.755 . . . . 0.23 112.672 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 72.1 t -111.9 124.09 33.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.871 -0.418 . . . . 0.62 109.871 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.512 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.1 Cg_exo -68.14 118.39 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.44 2.093 . . . . 0.3 111.573 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.471 ' HB ' HD23 ' A' ' 143' ' ' LEU . 32.4 t -98.06 -26.24 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.712 -0.676 . . . . 0.27 110.417 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 27.1 mm-40 -149.83 163.73 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 1.22 111.509 -177.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.721 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 19.8 ttm180 -131.41 98.19 4.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.439 -0.8 . . . . 1.75 109.071 168.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.806 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 74.1 m-85 -86.95 117.84 25.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.497 -0.557 . . . . 0.38 109.497 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.799 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.0 OUTLIER -63.68 164.3 16.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.665 -0.494 . . . . 0.99 109.665 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.817 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 63.2 Cg_endo -70.65 -6.08 18.23 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.848 2.365 . . . . 0.66 112.495 -167.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.57 5.61 62.47 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.95 -1.023 . . . . 0.52 111.912 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.46 139.11 36.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.43 110.139 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.3 m -77.12 163.46 26.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.974 -0.557 . . . . 1.25 111.019 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 34.3 t -53.21 -48.84 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.423 -0.353 . . . . 0.41 110.343 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.449 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.2 tptm -69.79 -28.69 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 3.44 111.034 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.17 -33.84 74.09 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.0 0.429 . . . . 1.86 110.007 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.58 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.0 mt -80.39 -42.21 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.738 -0.665 . . . . 0.21 110.149 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 168' ' ' ILE . 45.2 mt-10 -55.41 -41.63 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.976 -0.556 . . . . 0.88 112.378 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.93 -19.37 60.63 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.241 0.46 . . . . 0.75 112.241 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -107.2 -17.93 14.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.012 0.435 . . . . 1.58 110.291 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.8 tp -89.98 -39.09 13.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.741 -0.663 . . . . 0.24 111.761 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.763 ' HA ' HD12 ' A' ' 171' ' ' LEU . 80.2 mt -52.48 -47.91 91.81 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.323 0.49 . . . . 0.44 112.323 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.508 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.6 Cg_exo -55.43 -27.68 59.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.248 1.966 . . . . 0.49 113.269 175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.53 -34.52 16.35 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.521 0.201 . . . . 0.71 111.465 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.003 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.5 mt -58.08 -52.56 65.05 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.189 -0.671 . . . . 0.46 109.189 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.81 60.86 2.1 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.717 -1.129 . . . . 1.52 113.189 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m 69.51 105.2 0.06 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.426 0.691 . . . . 2.52 112.159 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -94.59 -28.6 15.31 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.048 -0.523 . . . . 3.56 112.117 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -112.97 -46.49 3.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 7.86 110.284 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.575 -0.726 . . . . 4.81 110.342 179.881 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.872 0 CA-C-O 120.473 -0.07 . . . . 5.51 112.939 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 66.7 mtt -86.78 108.98 18.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.042 -0.355 . . . . 5.05 110.042 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 121' ' ' TYR . . . -60.23 126.74 42.24 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.805 -0.634 . . . . 1.37 113.279 -174.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.7 m -79.93 -40.93 27.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.44 0.638 . . . . 1.68 109.743 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 -177.86 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.018 -0.992 . . . . 0.65 108.719 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 144' ' ' ILE . 35.5 pt -66.16 -24.67 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.967 0.413 . . . . 0.3 111.312 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.806 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 27.5 m-85 -82.07 1.64 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.047 0.451 . . . . 0.27 110.823 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.86 -16.99 63.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.355 -0.98 . . . . 1.96 108.355 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 70.4 m-85 -110.66 178.92 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.71 -1.132 . . . . 0.4 110.125 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -124.65 144.57 50.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.764 0.316 . . . . 2.77 110.887 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.607 HG23 HD13 ' A' ' 30' ' ' LEU . 74.2 t -114.85 140.89 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.19 -0.459 . . . . 0.74 111.385 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.967 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 65.1 mt -96.71 140.71 30.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.005 -0.739 . . . . 0.72 109.005 169.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -79.07 -169.0 1.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 1.59 109.824 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB1' ' HG3' ' A' ' 97' ' ' LYS . . . -57.31 -22.52 42.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 111.944 0.35 . . . . 0.52 111.944 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.9 t70 -104.74 -2.71 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.69 0.281 . . . . 2.22 111.153 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.967 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.8 m-70 76.57 21.73 1.28 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.628 0.727 . . . . 0.73 109.644 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -83.45 153.67 65.46 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.828 -1.916 . . . . 3.25 105.828 165.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.22 113.83 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.934 1.012 . . . . 0.86 111.997 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.545 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 78.5 t80 -84.03 114.6 21.85 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.245 -0.888 . . . . 0.28 109.242 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.691 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -67.02 83.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.525 -0.761 . . . . 1.65 109.718 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.806 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -70.54 -33.11 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.236 0.541 . . . . 0.25 110.145 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.703 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -77.57 -0.77 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.427 -0.806 . . . . 0.41 112.843 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -81.69 -5.61 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.759 0.79 . . . . 1.24 108.936 172.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.664 ' HB3' ' CD2' ' A' ' 38' ' ' LEU . 75.7 m-70 -98.5 3.07 48.16 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.583 -1.19 . . . . 0.38 108.145 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 24.9 ttpt -79.3 136.18 36.95 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.749 -1.114 . . . . 1.73 109.023 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.93 -13.59 52.85 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.254 -1.139 . . . . 0.36 110.254 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 76.3 p -129.8 138.49 33.24 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 109.34 -0.615 . . . . 1.14 109.34 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.964 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 57.7 Cg_endo -74.2 155.46 46.87 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.519 1.479 . . . . 0.52 109.714 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.818 HD12 ' HB ' ' A' ' 144' ' ' ILE . 0.8 OUTLIER -159.61 152.51 21.73 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.282 0.563 . . . . 1.03 111.958 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 141' ' ' SER . 3.6 mm? -107.02 138.44 43.19 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.558 -0.904 . . . . 1.1 108.558 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 70.9 mt -127.58 118.07 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.198 -0.667 . . . . 0.2 109.198 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.834 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.3 m-85 -101.17 123.2 44.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.445 -0.343 . . . . 0.23 111.198 -172.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.721 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -80.52 92.02 5.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.003 -1.11 . . . . 1.28 108.003 169.152 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.625 HG11 ' HE1' ' A' ' 98' ' ' PHE . 5.8 p -107.99 143.19 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 113.502 0.927 . . . . 0.88 113.502 -160.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.37 101.85 1.3 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.435 -1.32 . . . . 0.52 107.435 166.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 1.005 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -59.65 87.68 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.973 -1.012 . . . . 1.84 112.882 -170.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 53.38 52.63 13.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.422 -0.808 . . . . 2.43 110.646 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.7 p -164.18 157.01 17.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.797 -0.638 . . . . 0.99 110.83 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA3' ' CG ' ' A' ' 89' ' ' GLU . . . 80.78 -117.2 4.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.932 -0.651 . . . . 1.09 112.717 176.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.61 166.98 20.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.454 0.645 . . . . 3.16 111.532 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.643 HG22 ' HE1' ' A' ' 139' ' ' PHE . 17.4 p -129.33 107.86 9.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.257 -0.883 . . . . 1.94 109.782 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 27.3 mtpt -83.47 20.07 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 2.03 112.06 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.51 13.87 29.23 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.716 -0.754 . . . . 0.47 111.826 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -40.56 16.05 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.018 -0.61 . . . . 0.34 112.286 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.2 t80 -67.9 -48.69 65.31 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.824 0.345 . . . . 0.57 110.177 -176.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.3 -43.89 97.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.9 -0.591 . . . . 2.46 110.902 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.6 m -65.75 -50.9 63.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.33 111.142 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.87 -47.59 80.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.202 0.525 . . . . 0.19 110.866 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.443 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 80.2 m -59.74 -51.81 68.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.289 -0.868 . . . . 0.3 111.552 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.4 p -65.95 -39.2 90.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.068 -0.514 . . . . 1.08 111.727 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.465 HD11 HD12 ' A' ' 163' ' ' ILE . 85.4 mt -58.73 -51.64 69.09 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 120.503 0.192 . . . . 0.81 111.062 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.735 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 82.9 t80 -53.81 -47.08 71.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.33 109.817 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -73.18 -31.65 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.426 -0.807 . . . . 1.76 111.625 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.84 -36.84 23.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.021 -0.536 . . . . 1.79 111.738 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.645 ' CD1' HD13 ' A' ' 171' ' ' LEU . 58.0 m-85 -114.16 2.05 14.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.499 1.296 . . . . 0.43 114.499 -171.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.693 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 20.4 ptmt -68.71 -16.07 63.71 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.308 -0.957 . . . . 2.11 110.083 175.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 p -59.89 -43.4 94.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.747 -0.66 . . . . 1.2 109.927 171.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -91.36 15.76 11.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 1.9 111.143 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.692 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.46 70.22 1.35 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.999 -0.619 . . . . 1.32 112.452 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.693 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 54.8 t80 -143.73 139.97 29.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.26 110.537 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.607 ' HG1' ' HE1' ' A' ' 61' ' ' TYR . 14.9 t -129.39 152.98 48.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.031 0.443 . . . . 0.51 110.077 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.735 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t -113.89 120.75 64.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.387 -0.597 . . . . 0.24 109.387 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.592 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 15.6 mt -107.3 122.13 45.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.892 -0.781 . . . . 0.51 108.892 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.04 129.71 55.46 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.329 -0.548 . . . . 0.28 110.943 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.484 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.8 m-85 -113.67 108.64 51.41 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.619 -0.719 . . . . 0.34 109.89 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.005 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 33.2 Cg_exo -59.56 156.32 37.35 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 123.505 2.803 . . . . 0.73 111.697 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.681 ' HB3' HE22 ' A' ' 78' ' ' GLN . 47.6 t -128.3 135.71 49.98 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 114.349 1.24 . . . . 1.54 114.349 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -86.81 88.41 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 113.556 -1.656 . . . . 2.52 108.785 170.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 1.019 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 32.3 mm-40 -61.19 -13.51 18.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.679 -0.691 . . . . 3.18 112.252 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -72.75 -0.45 13.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.767 0.284 . . . . 3.8 111.767 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.428 ' HA3' ' OD1' ' A' ' 109' ' ' ASN . . . -60.01 -36.07 89.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.998 -0.62 . . . . 1.45 112.527 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.66 -50.45 0.51 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.658 -0.782 . . . . 1.43 112.537 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.505 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -133.25 13.03 4.22 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.723 -0.391 . . . . 1.43 112.021 -177.316 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 1.019 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 2.5 mm-40 -62.19 151.15 82.29 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 116.012 -0.54 . . . . 3.06 110.717 -168.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.751 ' HG3' HG22 ' A' ' 135' ' ' ILE . 14.9 Cg_exo -24.19 147.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 1 C-N-CA 126.423 4.749 . . . . 1.61 117.691 -167.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . 93.49 32.94 7.4 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.238 -1.346 . . . . 1.39 110.127 -174.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 4.3 m-20 72.45 -57.38 0.63 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.363 0.665 . . . . 3.69 109.801 -172.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -173.33 129.6 0.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 2.47 109.882 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 48.0 mt-10 59.04 80.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.151 0.501 . . . . 3.64 112.345 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.841 ' HB3' ' HG3' ' A' ' 78' ' ' GLN . 3.8 tp10 -82.47 -14.14 55.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.121 -0.491 . . . . 2.42 110.123 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.885 HG12 ' SG ' ' A' ' 95' ' ' CYS . 1.3 mt -92.13 38.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.599 -0.273 . . . . 2.05 110.788 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.744 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 29.7 mmmt -68.47 103.64 1.71 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.703 -0.48 . . . . 4.0 109.703 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.744 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 0.4 OUTLIER 65.58 -7.74 0.32 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.947 1.299 . . . . 3.1 111.669 -176.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.456 ' H ' ' C ' ' A' ' 91' ' ' LYS . 85.7 m-85 -77.16 176.58 8.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.36 0.6 . . . . 1.91 110.546 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 94' ' ' VAL . 6.6 p -128.6 111.13 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.059 -1.089 . . . . 1.65 108.059 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.885 ' SG ' HG12 ' A' ' 90' ' ' ILE . 79.3 m -91.63 120.7 32.64 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.35 -0.94 . . . . 0.91 110.4 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.767 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 14.0 t -133.58 159.89 39.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.528 -1.215 . . . . 1.92 108.372 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.775 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -58.99 95.7 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.001 0.429 . . . . 3.18 110.149 -175.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.625 ' HE1' HG11 ' A' ' 43' ' ' VAL . 3.8 p90 -54.84 134.83 48.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.059 -1.089 . . . . 1.74 108.059 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -101.64 134.08 45.33 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.548 -0.461 . . . . 3.08 111.011 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.516 ' CB ' ' HE1' ' A' ' 54' ' ' TYR . . . -136.26 -174.97 3.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.337 -0.847 . . . . 0.43 110.939 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.16 16.88 2.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 2.19 110.323 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.591 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 40.3 p90 -139.36 167.8 17.59 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.594 -0.891 . . . . 0.24 108.594 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.916 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 27.1 Cg_exo -68.6 126.95 14.77 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.683 2.922 . . . . 0.31 113.762 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.032 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -120.92 142.01 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.344 -0.613 . . . . 0.37 109.344 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.916 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 7.2 mmt -114.01 -154.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.876 0.695 . . . . 1.47 112.876 -164.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.448 ' O ' ' HD2' ' A' ' 75' ' ' PRO . . . -69.77 145.09 52.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.086 -0.961 . . . . 0.39 111.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 56.4 mttt -73.4 109.79 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.645 -0.872 . . . . 1.66 108.645 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.432 HD12 ' CB ' ' A' ' 116' ' ' HIS . 28.8 pt -121.69 157.57 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.34 -0.985 . . . . 0.47 108.34 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 11.7 m-80 -66.32 127.02 30.63 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.819 -0.808 . . . . 2.16 108.819 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.626 ' O ' ' HB ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -121.45 88.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 C-N-CA 119.746 -0.781 . . . . 0.38 109.006 167.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.694 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 16.4 t-20 173.14 179.09 0.09 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.066 -1.087 . . . . 1.98 108.066 168.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 48.29 -137.29 15.23 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.757 0.661 . . . . 0.78 114.59 163.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -104.52 -6.95 20.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.462 -0.869 . . . . 1.98 110.186 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -84.14 -24.52 30.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.292 -0.867 . . . . 2.04 111.449 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.97 141.49 3.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.058 1.133 . . . . 0.48 114.058 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.65 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 43.8 t-80 -48.75 139.71 11.41 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 114.894 -1.048 . . . . 0.42 110.378 171.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.25 -42.55 46.88 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.899 2.399 . . . . 0.36 112.789 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.65 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.3 tm? -54.81 -42.52 71.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.062 -0.517 . . . . 1.1 110.647 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.415 ' OH ' HG22 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -76.09 -30.24 58.23 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 119.445 -0.312 . . . . 1.49 111.596 176.314 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.09 -36.9 73.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.245 -0.582 . . . . 2.37 109.755 170.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 67.6 t80 -69.21 -44.01 72.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 0.58 110.642 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.4 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.5 mtt -65.67 -51.11 62.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.255 -0.429 . . . . 0.34 110.696 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.566 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 27.8 mtpt -61.96 -40.47 95.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.623 -0.717 . . . . 0.94 111.379 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.7 ptmm? -69.19 -35.92 76.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 2.13 110.615 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 99.9 m -73.94 -46.68 42.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 0.47 111.857 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.509 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 10.4 mmtt -137.17 98.57 10.24 Favored Pre-proline 0 C--N 1.321 -0.648 0 C-N-CA 120.778 -0.369 . . . . 1.75 111.677 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.524 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 44.6 Cg_endo -69.79 -28.09 25.53 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.853 2.369 . . . . 1.76 111.673 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.35 -139.56 14.51 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.859 -0.686 . . . . 2.37 112.243 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 41.2 pt -84.11 -1.38 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.746 0.308 . . . . 3.56 111.571 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.7 pt? -133.12 175.39 9.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.807 0.337 . . . . 2.76 110.626 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -87.72 -150.92 0.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.531 . . . . 2.84 110.102 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.644 HG22 ' HB3' ' A' ' 134' ' ' ALA . 19.5 m 76.83 -35.5 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.865 0.466 . . . . 3.9 112.095 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 40.0 mttp 65.16 4.41 2.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.709 0.804 . . . . 5.13 111.319 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.694 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -117.49 178.63 4.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.203 0.816 . . . . 0.93 113.203 -165.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.878 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 24.4 mm -112.98 84.4 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.054 -0.975 . . . . 1.05 111.454 -166.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -105.69 19.95 19.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.22 0.822 . . . . 1.5 113.22 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.878 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.21 168.95 18.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.873 0.368 . . . . 0.87 111.561 177.379 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.65 -156.61 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.678 1.591 . . . . 1.8 113.217 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.834 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 35.5 m-85 -27.4 -55.87 0.09 Allowed 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.136 1.374 . . . . 1.37 114.412 -164.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.873 HG23 ' HA ' ' A' ' 155' ' ' SER . 25.0 m 41.58 96.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.444 0.905 . . . . 0.3 113.444 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.7 ' HB2' HD12 ' A' ' 39' ' ' LEU . 35.1 p -86.48 149.26 25.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.507 -0.746 . . . . 0.8 111.274 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.431 ' O ' HD13 ' A' ' 39' ' ' LEU . 9.5 m-85 -103.09 134.08 47.12 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.598 -0.89 . . . . 0.53 108.598 167.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.925 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 28.5 tp -82.03 105.84 13.46 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 0.51 109.13 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.818 ' HB ' HD12 ' A' ' 38' ' ' LEU . 11.3 mm -106.08 131.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.312 -0.625 . . . . 0.2 109.312 -175.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -78.64 -179.17 6.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.997 -0.547 . . . . 1.3 110.83 -176.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.716 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mtp180 -64.18 -17.65 63.73 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.115 0.413 . . . . 3.78 112.115 -175.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.451 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 13.7 t70 -105.26 -16.74 14.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.37 0.605 . . . . 1.18 109.664 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.541 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.87 32.66 4.34 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.23 112.735 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.1 t -106.12 126.93 29.36 Favored Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 122.397 -0.472 . . . . 0.62 110.637 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.72 112.17 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.15 2.567 . . . . 0.3 112.22 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.498 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 22.3 t -98.41 -33.42 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.23 -0.441 . . . . 0.27 111.49 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 9.0 mm-40 -152.48 164.37 37.7 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.762 0.315 . . . . 1.22 110.966 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.566 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 18.0 ttm180 -129.37 98.87 5.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 1.75 109.836 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.925 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.4 m-85 -87.01 110.31 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.262 -0.644 . . . . 0.38 109.262 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.873 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.3 p -62.86 167.05 6.47 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.273 -0.64 . . . . 0.99 109.273 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.808 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.6 Cg_endo -70.64 -10.19 27.35 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 122.377 2.051 . . . . 0.66 112.028 -163.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.32 -10.72 84.29 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.402 -1.272 . . . . 0.52 111.178 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.46 137.03 34.78 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.431 -0.581 . . . . 0.43 109.431 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -106.33 -169.56 1.59 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.498 -0.319 . . . . 1.25 111.006 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 21.4 t -50.4 -59.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.915 -0.584 . . . . 0.41 112.376 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -67.65 -29.86 69.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.67 0.271 . . . . 3.44 110.946 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.13 -38.93 77.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.053 -0.522 . . . . 1.86 109.844 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.545 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 63.5 mt -83.12 -37.45 13.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.416 -0.811 . . . . 0.21 110.967 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.9 mt-10 -57.18 -36.7 71.12 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.551 0.574 . . . . 0.88 112.551 -174.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.528 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.0 pt-20 -58.73 -27.99 65.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.395 . . . . 0.75 111.292 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.595 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -104.78 -16.19 14.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.363 -0.38 . . . . 1.58 110.924 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.3 tp -91.22 -44.69 9.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.24 111.825 -171.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.738 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.7 mt -51.81 -49.23 84.7 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.608 0.596 . . . . 0.44 112.608 -175.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.2 Cg_exo -54.7 -39.37 89.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.024 1.816 . . . . 0.49 112.6 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.9 mt -74.2 -35.97 63.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.437 -0.347 . . . . 0.71 111.43 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.964 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 13.5 mt -57.12 -54.75 43.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.313 -0.625 . . . . 0.46 109.313 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.98 -62.24 4.74 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.777 -1.101 . . . . 1.52 112.513 171.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -173.18 125.58 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.482 -0.562 . . . . 2.52 109.482 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -90.98 -57.04 2.95 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.906 0.384 . . . . 3.56 110.898 -174.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.57 25.07 1.36 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.971 -0.558 . . . . 7.86 110.66 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 C--O 1.248 1.007 0 O-C-N 123.767 0.667 . . . . 4.81 110.748 -178.179 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.898 0 N-CA-C 112.869 -0.092 . . . . 5.51 112.869 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.2 ptp -159.09 25.01 0.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.243 0.544 . . . . 5.05 110.176 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.71 52.46 7.18 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.334 -0.936 . . . . 1.37 111.004 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -70.85 -64.24 0.94 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 1.68 110.324 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 m -126.09 170.5 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.995 -1.113 . . . . 0.65 107.995 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.634 HD13 HG21 ' A' ' 144' ' ' ILE . 32.5 pt -52.22 -28.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 118.764 0.711 . . . . 0.3 112.902 -173.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.763 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 14.8 m-85 -81.68 5.91 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.997 0.427 . . . . 0.27 111.614 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.86 -19.7 62.61 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.021 -1.104 . . . . 1.96 108.021 171.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 49.9 m-85 -106.7 179.32 4.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.425 -1.261 . . . . 0.4 110.531 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.85 148.09 43.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.518 -0.31 . . . . 2.77 110.201 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 30' ' ' LEU . 71.7 t -118.19 150.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.054 0.454 . . . . 0.74 111.702 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.747 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 88.8 mt -108.16 143.38 37.02 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.131 -0.486 . . . . 0.72 110.003 173.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.637 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 21.7 t70 -72.97 177.37 4.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.102 -0.954 . . . . 1.59 108.764 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -52.94 -32.85 48.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.337 0.589 . . . . 0.52 110.318 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 22.5 t70 -79.49 -18.25 52.4 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.353 -0.839 . . . . 2.22 112.029 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.747 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.1 m-70 87.41 6.01 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.853 0.861 . . . . 0.73 111.851 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 2.8 ptmt -70.77 160.93 80.35 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.905 -1.146 . . . . 3.25 107.905 162.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.3 117.19 3.89 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 121.421 1.414 . . . . 0.86 112.632 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.538 ' HB3' HG12 ' A' ' 20' ' ' VAL . 89.0 t80 -91.05 119.42 31.19 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.97 -0.752 . . . . 0.28 108.97 170.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.1 t30 -73.81 84.68 1.67 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.525 -0.47 . . . . 1.65 110.002 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.729 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -62.35 -31.55 72.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.466 0.651 . . . . 0.25 110.469 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.763 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.6 p -77.2 -0.06 2.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.182 -0.917 . . . . 0.41 113.203 -167.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.9 pt20 -78.91 -5.82 54.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.658 0.742 . . . . 1.24 109.202 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.556 ' HB3' HD13 ' A' ' 38' ' ' LEU . 92.8 m-70 -97.41 -1.07 45.14 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.908 -1.042 . . . . 0.38 108.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.681 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -77.09 130.99 38.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.987 -1.461 . . . . 1.73 108.975 178.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' N ' ' HD2' ' A' ' 34' ' ' LYS . . . 109.87 -15.19 31.51 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.042 -0.823 . . . . 0.36 111.042 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.8 m -136.17 155.04 77.7 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.064 -0.717 . . . . 1.14 109.064 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.0 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 73.3 Cg_endo -77.73 154.72 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.004 1.803 . . . . 0.52 111.8 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.62 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.3 pt? -158.96 159.92 35.43 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.248 0.546 . . . . 1.03 111.229 -176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -114.21 155.1 26.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.449 -0.796 . . . . 1.1 109.236 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 72' ' ' LEU . 84.4 mt -141.29 119.12 8.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.558 -0.534 . . . . 0.2 109.558 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.833 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.7 m-85 -105.59 123.67 48.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.909 -0.316 . . . . 0.23 111.06 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.663 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -78.56 92.25 4.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.829 -0.804 . . . . 1.28 108.829 168.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.585 HG11 ' CE1' ' A' ' 98' ' ' PHE . 2.9 p -108.06 131.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.935 0.717 . . . . 0.88 112.935 -166.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.08 110.71 0.99 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.718 -1.216 . . . . 0.52 107.718 167.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.979 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -70.79 85.93 0.67 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.787 -1.097 . . . . 1.84 113.563 -162.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 48.8 tptt 71.7 39.56 0.86 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.648 -0.705 . . . . 2.43 110.204 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.2 p -154.23 142.28 20.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.787 -0.642 . . . . 0.99 110.96 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.66 -130.0 10.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.521 -0.847 . . . . 1.09 112.966 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.85 131.71 24.37 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.592 -0.521 . . . . 3.16 109.592 -173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.447 HG22 ' CE1' ' A' ' 139' ' ' PHE . 72.6 p -83.09 109.69 17.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.627 0.727 . . . . 1.94 109.791 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 1.069 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 26.4 mtpp -79.86 11.56 3.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.363 -0.835 . . . . 2.03 111.2 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.21 28.4 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.64 -0.584 . . . . 0.47 111.64 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.35 -42.62 10.25 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.286 -0.483 . . . . 0.34 112.013 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 1.4 t80 -70.14 -47.43 61.74 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 0.57 109.835 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 53.9 mp0 -56.17 -50.77 70.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.867 -1.06 . . . . 2.46 110.397 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.712 HG23 ' HA ' ' A' ' 160' ' ' VAL . 54.9 m -67.48 -47.15 70.88 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.824 -1.08 . . . . 0.33 111.101 -176.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.872 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.66 -49.51 74.82 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.19 111.35 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.9 m -58.43 -48.41 80.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.448 -0.796 . . . . 0.3 110.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.9 m -60.77 -46.85 88.86 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.301 -0.863 . . . . 1.08 111.524 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.584 HD13 HD22 ' A' ' 39' ' ' LEU . 62.1 mt -59.05 -50.35 74.4 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.274 -0.421 . . . . 0.81 111.183 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.528 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 15.0 t80 -47.01 -53.63 12.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.057 0.848 . . . . 0.33 110.032 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -73.93 -34.99 64.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.217 -0.901 . . . . 1.76 111.452 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -75.97 -35.77 59.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.007 -0.542 . . . . 1.79 111.255 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.812 ' CD1' HD13 ' A' ' 171' ' ' LEU . 62.7 m-85 -118.15 15.43 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.805 1.039 . . . . 0.43 113.805 -173.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.8 mmmt -59.54 -21.36 60.13 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.686 -0.406 . . . . 2.11 110.388 171.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.87 -41.62 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.84 -0.618 . . . . 1.2 110.35 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.517 ' HG3' ' HB3' ' A' ' 171' ' ' LEU . 33.7 mm-40 -76.27 -10.56 59.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.972 -0.558 . . . . 1.9 110.318 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.32 20.73 29.14 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 1.32 110.868 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CE1' HD13 ' A' ' 39' ' ' LEU . 88.5 t80 -79.78 136.58 36.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.243 -0.479 . . . . 0.26 110.628 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -130.82 145.85 52.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.382 -0.599 . . . . 0.51 109.382 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.872 HG11 ' HB1' ' A' ' 57' ' ' ALA . 51.4 t -110.08 109.32 27.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.2 -0.667 . . . . 0.24 109.2 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.612 ' HB2' HG12 ' A' ' 40' ' ' ILE . 23.8 mt -91.65 120.98 32.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.489 -0.93 . . . . 0.51 108.489 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.073 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.82 112.92 25.43 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.221 -0.592 . . . . 0.28 110.68 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.3 m-85 -97.12 110.63 54.95 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.54 -0.755 . . . . 0.34 109.03 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.01 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.91 169.78 3.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.395 2.73 . . . . 0.73 111.365 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 69.7 m -111.2 136.34 50.4 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.889 1.07 . . . . 1.54 113.889 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 40.5 t30 -102.19 92.38 4.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 113.943 -1.48 . . . . 2.52 111.352 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.644 ' HA ' ' CG ' ' A' ' 83' ' ' GLU . 2.7 pm0 -58.57 -12.2 3.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.209 1.004 . . . . 3.18 113.046 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -76.03 -17.85 59.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.449 0.642 . . . . 3.8 109.659 -174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.866 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . -75.89 -36.69 41.04 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.099 -0.955 . . . . 1.45 112.007 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.91 -77.31 0.4 Allowed Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.17 -1.014 . . . . 1.43 112.997 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.807 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -93.06 14.47 17.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.821 1.045 . . . . 1.43 113.821 -165.333 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.644 ' CG ' ' HA ' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -61.91 159.89 32.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 118.682 0.674 . . . . 3.06 111.782 -172.026 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.817 ' HG3' HG22 ' A' ' 135' ' ' ILE . 6.0 Cg_exo -34.55 162.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.846 1 C-N-CA 125.342 4.028 . . . . 1.61 117.704 -171.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.33 10.43 85.99 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.325 -1.307 . . . . 1.39 109.899 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.728 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 63.5 t30 56.95 35.15 26.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.637 -0.781 . . . . 3.69 110.26 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.728 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 9.2 pt-20 56.73 -6.22 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.321 1.448 . . . . 2.47 113.744 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 86' ' ' ASN . 13.2 mm-40 -106.91 13.7 27.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.234 0.54 . . . . 3.64 110.537 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.427 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 8.7 tp10 -91.47 -41.45 10.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.819 -0.808 . . . . 2.42 108.819 172.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.567 HD13 ' SG ' ' A' ' 95' ' ' CYS . 18.6 mt -89.56 36.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.051 -0.977 . . . . 2.05 110.321 -177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' HD2' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -89.6 5.53 45.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.535 -0.757 . . . . 4.0 111.294 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' HG2' ' HD2' ' A' ' 91' ' ' LYS . 11.3 pt-20 -160.36 29.77 0.16 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.447 -0.797 . . . . 3.1 109.201 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 68.4 m-85 -141.43 167.62 21.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.518 -0.765 . . . . 1.91 110.723 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.77 141.31 46.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.751 -1.574 . . . . 1.65 106.751 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.567 ' SG ' HD13 ' A' ' 90' ' ' ILE . 24.9 m -128.79 116.94 20.26 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 118.514 -1.275 . . . . 0.91 112.779 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -156.38 119.56 4.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.722 -1.127 . . . . 1.92 109.804 168.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.3 mttp 54.52 100.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.062 0.764 . . . . 3.18 113.062 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.658 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 37.9 p90 -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.776 -0.577 . . . . 1.74 110.688 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 68.15 145.81 0.05 OUTLIER 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.099 0.875 . . . . 3.08 111.145 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.619 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -172.69 -173.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.41 . . . . 0.43 112.083 -176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -83.67 -11.88 56.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 2.19 110.155 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.814 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 39.0 p90 -113.34 169.04 6.86 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 115.405 -0.816 . . . . 0.24 109.196 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.918 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 21.2 Cg_exo -71.41 122.12 8.36 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 123.556 2.837 . . . . 0.31 112.999 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.073 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.5 mp -110.79 139.65 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.909 -0.775 . . . . 0.37 108.909 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.918 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 10.1 mmt -112.07 -154.74 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.648 0.737 . . . . 1.47 112.909 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -71.63 133.78 45.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.674 -1.148 . . . . 0.39 110.116 173.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.01 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttt -70.27 126.04 28.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.692 0.758 . . . . 1.66 109.457 171.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.613 HG13 HG13 ' A' ' 110' ' ' VAL . 9.6 pt -121.47 167.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.262 -1.335 . . . . 0.47 107.915 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.866 ' ND2' ' HA3' ' A' ' 80' ' ' GLY . 34.6 t-20 -85.28 63.97 8.4 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.434 -0.506 . . . . 2.16 109.672 -175.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.793 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -64.55 88.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 120.727 -0.389 . . . . 0.38 110.799 -177.113 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.807 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 56.7 t30 173.05 178.63 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 1.98 108.243 167.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.04 -142.31 31.67 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 114.344 0.497 . . . . 0.78 114.344 165.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -105.84 -1.63 24.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.589 0.709 . . . . 1.98 110.039 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -106.49 2.43 26.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.074 -0.967 . . . . 2.04 111.192 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -62.6 154.58 28.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.728 -0.669 . . . . 0.48 112.242 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.681 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 33.7 t-80 -47.96 138.47 10.06 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.586 -0.734 . . . . 0.42 110.046 172.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.12 -39.16 51.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.138 2.559 . . . . 0.36 112.436 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.681 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -60.45 -39.63 88.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 1.1 111.332 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.635 ' HE2' HD21 ' A' ' 42' ' ' ASN . 1.9 m-85 -75.61 -28.89 59.05 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 116.445 -0.343 . . . . 1.49 110.813 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.56 -36.91 74.66 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.867 -0.733 . . . . 2.37 109.426 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 50.9 t80 -71.77 -45.85 60.29 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.738 -0.385 . . . . 0.58 110.6 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.49 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . 66.5 mtt -61.46 -54.92 37.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.314 -0.403 . . . . 0.34 111.442 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.0 mtpt -62.97 -36.9 85.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.94 111.359 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.35 -31.59 67.55 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.843 0.354 . . . . 2.13 110.301 -179.167 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.514 HG21 ' HD2' ' A' ' 150' ' ' PRO . 97.3 m -73.89 -38.64 64.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.47 111.256 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 151' ' ' VAL . 32.2 mmtm -134.35 113.34 12.2 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.867 0.365 . . . . 1.75 111.15 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.68 -54.34 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.186 2.591 . . . . 1.76 113.291 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.69 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . 141.43 -167.74 25.71 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.491 -0.861 . . . . 2.37 112.189 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.0 pt -129.87 17.77 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 112.109 0.411 . . . . 3.56 112.109 -175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.72 76.45 1.25 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.739 0.304 . . . . 2.76 110.823 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 51.46 33.07 9.6 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.364 0.602 . . . . 2.84 110.238 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.69 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 2.3 m -97.04 121.12 38.57 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.411 0.624 . . . . 3.9 111.792 -167.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -122.43 -29.47 4.1 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.077 -0.965 . . . . 5.13 108.659 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -122.88 176.38 6.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.559 -0.746 . . . . 0.93 112.79 -173.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.854 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 49.2 mt -97.76 84.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.942 -1.027 . . . . 1.05 110.742 -171.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -108.61 25.28 11.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.524 0.564 . . . . 1.5 112.524 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.854 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.08 170.14 21.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.281 0.474 . . . . 0.87 112.281 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 44' ' ' ALA . 16.2 m120 -52.49 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.48 1.512 . . . . 1.8 113.41 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.833 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 68.5 m-85 -25.89 -59.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.399 0 C-N-CA 125.529 1.532 . . . . 1.37 113.957 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.913 HG23 ' HA ' ' A' ' 155' ' ' SER . 18.0 m 42.43 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.209 0.818 . . . . 0.3 113.209 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.696 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 15.0 p -87.1 151.94 22.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.546 -0.862 . . . . 0.8 111.496 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -103.78 134.6 46.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.287 -1.005 . . . . 0.53 108.287 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.701 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.2 tp -82.08 106.15 13.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.107 -0.701 . . . . 0.51 109.107 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.634 HG21 HD13 ' A' ' 15' ' ' ILE . 16.0 mm -106.42 123.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.021 -0.536 . . . . 0.2 109.736 -171.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -177.41 4.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.374 -0.376 . . . . 1.3 110.595 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.506 ' HB2' HD13 ' A' ' 176' ' ' LEU . 51.9 mtt-85 -66.27 -9.58 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.675 0.62 . . . . 3.78 112.675 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -108.0 -21.91 12.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.18 110.066 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 106.07 31.65 4.05 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.637 -0.792 . . . . 0.23 112.698 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.48 121.29 41.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.891 -0.411 . . . . 0.62 109.891 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.514 ' HD2' HG21 ' A' ' 125' ' ' THR . 44.8 Cg_exo -58.07 116.39 3.2 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.992 2.462 . . . . 0.3 112.223 176.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.609 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 31.8 t -96.07 -25.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.809 -0.632 . . . . 0.27 110.275 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.65 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 9.0 mm-40 -156.29 159.03 38.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.371 -0.377 . . . . 1.22 111.246 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.489 HH11 ' HH2' ' A' ' 137' ' ' TRP . 20.3 ttm180 -120.65 97.02 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.471 -0.566 . . . . 1.75 109.471 168.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.701 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 52.6 m-85 -85.22 110.17 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.277 -0.638 . . . . 0.38 109.277 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.913 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.4 p -63.39 166.25 9.33 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.831 -0.433 . . . . 0.99 109.831 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.069 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 58.7 Cg_endo -72.07 -2.19 11.19 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.371 2.047 . . . . 0.66 113.058 -163.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -96.45 8.74 66.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.631 -0.713 . . . . 0.52 112.317 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.61 140.17 30.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 0.43 110.249 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.488 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 57.3 m -86.76 170.68 11.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.199 -0.455 . . . . 1.25 111.309 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.712 ' HA ' HG23 ' A' ' 56' ' ' THR . 49.0 t -55.41 -51.82 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 0.41 111.584 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 161' ' ' LYS . 20.2 tptt -68.83 -26.84 65.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 3.44 110.622 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.488 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.7 m-20 -64.19 -31.81 73.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 1.86 110.27 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.757 HG21 HD21 ' A' ' 39' ' ' LEU . 59.1 mt -83.04 -45.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.902 -0.59 . . . . 0.21 110.529 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -52.68 -39.01 61.51 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.839 0.681 . . . . 0.88 112.839 -176.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -55.52 -31.35 62.01 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.872 0.323 . . . . 0.75 111.872 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.65 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 72.3 mttt -106.32 -9.67 16.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.389 . . . . 1.58 110.976 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 58.7 tp -91.52 -41.61 10.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 0.24 111.775 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.757 ' HA ' HD12 ' A' ' 171' ' ' LEU . 71.6 mt -50.61 -48.71 81.71 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 112.998 0.74 . . . . 0.44 112.998 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.491 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.64 -32.39 90.36 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.099 1.866 . . . . 0.49 112.745 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 151' ' ' VAL . 76.6 mt -80.8 -35.22 33.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.776 -0.193 . . . . 0.71 110.865 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.0 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.2 mt -59.0 -41.48 87.77 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.697 -0.853 . . . . 0.46 108.697 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.34 -81.14 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.21 -1.359 . . . . 1.52 111.129 162.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.5 t 179.64 152.68 0.43 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.762 0.315 . . . . 2.52 110.293 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.15 -45.84 7.69 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.773 0.32 . . . . 3.56 110.472 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 175' ' ' ARG . 11.9 ptt-85 -157.95 9.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 7.86 110.435 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 146' ' ' ARG . 6.5 mp . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.485 -0.769 . . . . 4.81 110.17 -173.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 112.101 -0.4 . . . . 5.51 112.101 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.9 ttp -72.92 125.54 27.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.788 0.327 . . . . 5.05 110.503 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.48 51.98 3.33 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.796 -0.716 . . . . 1.37 112.669 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m -85.52 -32.21 22.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.219 0.533 . . . . 1.68 110.563 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.6 p -142.91 172.21 13.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.65 110.192 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.68 HD13 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -59.05 -29.64 41.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.418 0.525 . . . . 0.3 112.418 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.79 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 36.5 m-85 -77.33 0.0 23.89 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.861 0.319 . . . . 0.27 111.861 -172.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.7 -23.26 65.27 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.319 -0.993 . . . . 1.96 108.319 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 53.7 m-85 -102.67 174.61 5.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.731 -1.122 . . . . 0.4 109.792 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -108.56 165.63 11.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.869 0.366 . . . . 2.77 110.658 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.579 HG23 HD13 ' A' ' 30' ' ' LEU . 73.8 t -135.66 151.79 30.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.577 -0.527 . . . . 0.74 109.577 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.869 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 66.8 mt -113.6 148.63 35.85 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.673 -0.492 . . . . 0.72 109.673 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.653 ' CB ' ' HE3' ' A' ' 26' ' ' LYS . 5.8 t0 -78.49 -176.43 4.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.991 -1.114 . . . . 1.59 107.991 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -56.96 -29.92 63.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.462 0.649 . . . . 0.52 110.459 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 5.4 t70 -80.29 -20.01 45.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.324 -0.853 . . . . 2.22 111.981 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.869 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 18.5 m-70 83.77 7.49 0.64 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.779 0.832 . . . . 0.73 111.893 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.653 ' HE3' ' CB ' ' A' ' 22' ' ' ASP . 28.9 pttt -65.09 148.12 98.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 107.282 -1.377 . . . . 3.25 107.282 157.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 21' ' ' LEU . 19.0 Cg_endo -61.55 116.66 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.241 1.294 . . . . 0.86 112.331 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.463 ' HB3' HG12 ' A' ' 20' ' ' VAL . 86.3 t80 -80.23 124.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.006 -0.997 . . . . 0.28 110.333 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.627 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -68.98 82.78 0.31 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.703 -0.68 . . . . 1.65 109.757 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.79 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -72.45 -31.78 65.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.42 0.629 . . . . 0.25 110.136 -177.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.692 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 p -77.13 -0.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.333 -0.849 . . . . 0.41 112.494 -169.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.7 pt20 -78.84 -9.4 59.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.566 0.698 . . . . 1.24 109.311 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -91.69 -7.97 48.36 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.156 -1.053 . . . . 0.38 108.156 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 21.3 ttpp -70.72 133.68 46.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.53 -1.214 . . . . 1.73 109.354 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.46 -5.35 54.86 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.024 -1.231 . . . . 0.36 110.024 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 15.5 m -140.46 144.29 36.21 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.851 -0.796 . . . . 1.14 108.851 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.063 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 52.6 Cg_endo -73.28 150.55 47.34 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.651 1.567 . . . . 0.52 110.794 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.608 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -153.0 153.51 33.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.324 0.583 . . . . 1.03 111.089 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.779 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -108.33 152.69 24.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.982 -0.747 . . . . 1.1 108.982 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 88.6 mt -137.29 118.21 17.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.417 -0.586 . . . . 0.2 109.417 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.825 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -100.29 123.15 44.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.459 -0.337 . . . . 0.23 110.532 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.65 ' HB2' HG21 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -82.41 90.8 6.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.041 -1.096 . . . . 1.28 108.041 168.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.663 HG11 ' HE2' ' A' ' 98' ' ' PHE . 2.2 p -112.2 132.42 60.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 112.575 0.583 . . . . 0.88 112.575 -163.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -64.52 102.12 0.52 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.938 -1.505 . . . . 0.52 106.938 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.983 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 34.4 t -69.57 90.11 0.55 Allowed 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.432 -0.803 . . . . 1.84 112.236 -165.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt 66.97 49.84 1.1 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.935 -1.03 . . . . 2.43 110.813 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.557 ' SG ' HG23 ' A' ' 90' ' ' ILE . 16.9 m -135.75 126.43 27.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.719 -0.673 . . . . 0.99 109.761 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.558 ' HA3' ' CD ' ' A' ' 89' ' ' GLU . . . 71.52 -129.91 17.43 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.902 -0.666 . . . . 1.09 112.989 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.98 154.18 19.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.838 0.351 . . . . 3.16 111.044 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.7 p -91.54 -24.49 19.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.317 -0.401 . . . . 1.94 111.49 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 26.3 mtpp 64.04 3.75 1.8 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.644 -0.707 . . . . 2.03 112.069 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.11 -5.01 41.65 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.814 -0.708 . . . . 0.47 112.565 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -35.57 92.14 Favored Glycine 0 CA--C 1.505 -0.585 0 N-CA-C 111.982 -0.447 . . . . 0.34 111.982 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.509 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -67.92 -48.81 64.94 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 110.286 -0.265 . . . . 0.57 110.286 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.44 -52.87 62.16 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.473 0.654 . . . . 2.46 110.167 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 160' ' ' VAL . 34.7 m -63.11 -47.55 82.35 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.619 -1.173 . . . . 0.33 111.32 -176.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.65 -46.96 87.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.829 0.347 . . . . 0.19 111.401 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.6 m -60.13 -53.68 54.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.778 -0.646 . . . . 0.3 111.393 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 p -62.52 -42.03 99.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 1.08 111.854 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.503 HD13 HD22 ' A' ' 39' ' ' LEU . 93.4 mt -58.92 -52.45 65.68 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 120.514 0.197 . . . . 0.81 111.477 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.691 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 89.4 t80 -54.62 -47.16 73.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.915 -0.584 . . . . 0.33 109.996 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -70.63 -41.03 72.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.533 -0.758 . . . . 1.76 111.394 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.32 -43.59 50.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 1.79 111.647 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.9 m-85 -102.19 4.5 39.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.728 1.01 . . . . 0.43 113.728 -171.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -58.3 -30.08 66.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 2.11 109.982 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -65.53 -26.4 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 1.2 111.484 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.2 13.16 32.81 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.877 0.37 . . . . 1.9 111.095 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.71 63.42 1.84 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.95 -0.643 . . . . 1.32 112.585 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.535 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 69.0 t80 -132.09 142.09 49.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.552 -0.166 . . . . 0.26 110.552 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.608 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.16 143.29 50.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.129 -0.323 . . . . 0.51 110.129 177.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.691 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 29.3 t -113.27 114.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.993 0.425 . . . . 0.24 110.185 170.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 30.8 mt -100.47 122.44 43.2 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.978 -0.749 . . . . 0.51 108.978 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -106.99 112.84 25.99 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.113 -0.635 . . . . 0.28 110.252 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-30 -93.9 110.13 45.85 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.106 -1.072 . . . . 0.34 108.106 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.087 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.3 Cg_exo -58.62 169.22 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.81 2.34 . . . . 0.73 110.953 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.589 ' OG ' ' HB3' ' A' ' 83' ' ' GLU . 27.1 t -111.1 129.89 55.78 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.5 -0.88 . . . . 1.54 111.876 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.629 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 56.1 t30 -92.63 98.5 11.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.904 -1.498 . . . . 2.52 111.041 -173.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.87 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.0 pm0 -54.36 -9.22 0.27 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.675 1.19 . . . . 3.18 113.462 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -93.48 29.96 1.85 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.884 -0.598 . . . . 3.8 111.142 -173.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA3' ' OD1' ' A' ' 109' ' ' ASN . . . -113.62 -44.94 0.74 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.333 -0.936 . . . . 1.45 112.934 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.9 -42.86 1.27 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.715 -0.755 . . . . 1.43 112.085 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.658 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -135.96 46.28 2.33 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.155 0.428 . . . . 1.43 112.155 -177.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.87 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.5 mp0 -59.77 148.4 75.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 121.964 -0.46 . . . . 3.06 110.225 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.972 ' HG3' HG22 ' A' ' 135' ' ' ILE . 11.1 Cg_exo -36.96 147.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.971 3.114 . . . . 1.61 114.095 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.57 10.15 86.44 Favored Glycine 0 N--CA 1.44 -1.033 0 N-CA-C 108.981 -1.648 . . . . 1.39 108.981 -168.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.635 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 51.5 t30 52.71 47.42 24.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.048 -1.076 . . . . 3.69 111.07 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 3.3 pt-20 66.56 -28.85 0.13 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.09 1.356 . . . . 2.47 112.093 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.694 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 40.7 tt0 -68.7 -26.72 65.42 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.039 0.535 . . . . 3.64 111.893 -170.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' CD ' ' HA3' ' A' ' 48' ' ' GLY . 3.0 tp10 -76.22 -14.74 60.13 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.242 0.544 . . . . 2.42 110.9 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.557 HG23 ' SG ' ' A' ' 47' ' ' CYS . 1.9 mt -116.93 34.7 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.949 0.404 . . . . 2.05 110.051 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.694 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 33.9 mtmm -64.03 -84.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.242 1.02 . . . . 4.0 111.264 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 7.0 pt-20 -77.81 -11.22 59.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.738 -1.574 . . . . 3.1 110.284 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -91.4 158.2 16.65 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.035 -0.984 . . . . 1.91 109.711 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.85 124.27 66.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.172 -0.677 . . . . 1.65 109.172 171.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.493 ' HB2' ' OE1' ' A' ' 78' ' ' GLN . 14.3 m -90.41 120.05 31.2 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.565 0.698 . . . . 0.91 111.05 -174.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -149.16 128.69 13.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.562 -1.199 . . . . 1.92 108.029 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -14.07 104.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.775 1.297 . . . . 3.18 113.525 -172.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.663 ' HE2' HG11 ' A' ' 43' ' ' VAL . 34.5 p90 -66.55 -20.74 66.09 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.04 -0.982 . . . . 1.74 111.365 -170.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 67.55 147.61 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 124.041 0.838 . . . . 3.08 111.178 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.45 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -169.93 -154.69 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.105 0.479 . . . . 0.43 112.22 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 -5.74 58.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.559 -0.746 . . . . 2.19 109.884 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.789 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 45.4 p90 -128.28 164.8 35.24 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.182 -0.917 . . . . 0.24 109.135 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 32.4 Cg_exo -66.33 109.03 1.48 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 123.658 2.906 . . . . 0.31 113.701 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mp -104.15 128.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.957 -0.757 . . . . 0.37 108.957 172.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.581 ' HE2' ' HA ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -109.49 -148.64 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.852 0.686 . . . . 1.47 112.852 -160.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.754 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -75.54 136.81 40.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.168 -0.924 . . . . 0.39 110.669 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.087 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 15.3 pttp -79.45 128.58 33.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.688 0.756 . . . . 1.66 110.384 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.569 HG13 HG13 ' A' ' 110' ' ' VAL . 3.2 pt -122.77 160.69 25.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.312 -1.313 . . . . 0.47 107.845 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.708 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 5.0 t30 -75.93 82.66 2.83 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.187 -1.042 . . . . 2.16 108.187 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.15 86.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 118.842 -1.143 . . . . 0.38 108.944 177.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.658 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 55.8 t30 172.44 178.57 0.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.545 -0.909 . . . . 1.98 108.545 170.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.28 -145.62 17.05 Favored Glycine 0 C--O 1.236 0.23 0 N-CA-C 115.211 0.844 . . . . 0.78 115.211 163.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.46 -15.74 25.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.464 -0.868 . . . . 1.98 110.56 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -94.08 1.28 56.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.617 0.722 . . . . 2.04 110.529 -169.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.18 140.13 45.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.094 -0.957 . . . . 0.48 112.346 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.552 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 45.1 t-80 -50.75 137.25 25.19 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.179 -0.919 . . . . 0.42 110.502 172.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.516 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -45.08 -45.52 14.34 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.89 2.393 . . . . 0.36 112.792 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.552 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.8 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.942 -0.572 . . . . 1.1 111.715 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -75.89 -29.0 58.32 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 119.609 -0.234 . . . . 1.49 111.105 177.23 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.13 -43.36 78.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.886 -0.783 . . . . 2.37 108.886 168.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.8 t80 -66.63 -45.09 80.2 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.569 0.543 . . . . 0.58 110.652 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.508 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 67.1 mtt -63.83 -53.52 49.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.461 -0.336 . . . . 0.34 111.31 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.47 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 26.4 mtpt -60.89 -41.59 96.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.94 111.002 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.9 ptmt -71.12 -35.39 71.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 2.13 111.108 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.1 m -75.79 -36.5 59.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.924 -0.58 . . . . 0.47 111.189 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 9.5 mmtt -141.88 100.09 6.05 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 112.546 0.573 . . . . 1.75 112.546 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.636 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 11.8 Cg_endo -56.82 -29.97 83.29 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.251 2.634 . . . . 1.76 111.465 168.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.858 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 92.06 -130.53 10.35 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.912 -0.661 . . . . 2.37 112.974 173.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.1 pt -95.75 10.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.932 0.396 . . . . 3.56 111.254 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.13 -176.3 4.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.242 -0.435 . . . . 2.76 110.563 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.37 -160.76 0.82 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.772 -0.649 . . . . 2.84 110.019 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.9 m 76.12 -38.26 0.33 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.702 0.63 . . . . 3.9 112.702 172.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.636 ' HG2' ' HB3' ' A' ' 127' ' ' PRO . 34.1 mtmm 68.4 1.89 3.1 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.711 0.805 . . . . 5.13 111.02 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -103.64 174.02 6.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.119 0.485 . . . . 0.93 111.892 -172.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.972 HG22 ' HG3' ' A' ' 84' ' ' PRO . 44.8 mt -114.95 94.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.488 -0.778 . . . . 1.05 110.568 -171.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -110.56 9.89 23.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.292 0.849 . . . . 1.5 113.292 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.874 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -140.04 168.91 18.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.783 0.66 . . . . 0.87 112.783 -177.047 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 22.5 m120 -43.67 -156.14 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 126.552 1.941 . . . . 1.8 115.494 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.825 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.2 m-85 -28.02 -55.19 0.11 Allowed 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 113.897 -1.501 . . . . 1.37 113.386 -169.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.818 HG23 ' HA ' ' A' ' 155' ' ' SER . 18.9 m 40.2 96.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.386 0.884 . . . . 0.3 113.386 175.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 7.7 p -85.2 152.7 23.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.789 -0.764 . . . . 0.8 111.129 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 4.9 m-85 -102.61 162.42 12.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.215 -1.402 . . . . 0.53 107.215 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.833 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.5 tp -107.32 105.07 14.85 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.603 -0.888 . . . . 0.51 108.603 177.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.68 HG21 HD13 ' A' ' 15' ' ' ILE . 17.9 mm -103.78 119.8 52.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.844 -0.798 . . . . 0.2 108.844 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.864 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -69.81 179.24 2.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 1.3 110.651 -176.106 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.654 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -57.99 -20.61 39.65 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.846 0.355 . . . . 3.78 111.619 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.442 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 1.0 OUTLIER -109.12 -13.8 14.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.113 0.482 . . . . 1.18 110.389 -167.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.532 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.51 32.61 4.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.782 -0.645 . . . . 0.23 113.271 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 59.3 t -109.15 118.93 50.05 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 122.466 -0.432 . . . . 0.62 110.165 175.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.445 ' HG3' ' HA ' ' A' ' 122' ' ' MET . 14.3 Cg_endo -61.48 112.26 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.3 111.969 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.3 t -94.47 -30.19 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.909 -0.587 . . . . 0.27 111.14 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -154.51 165.13 37.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 1.22 110.916 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.858 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 14.5 ttm180 -134.18 98.5 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 1.75 109.854 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.833 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 9.3 m-85 -85.9 136.65 33.2 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.38 108.006 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.818 ' HA ' HG23 ' A' ' 140' ' ' THR . 25.2 p -79.83 178.72 2.17 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.748 -0.781 . . . . 0.99 109.626 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.767 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 56.6 Cg_endo -67.05 -20.63 50.29 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.616 1.544 . . . . 0.66 110.99 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.13 13.24 45.98 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.618 -1.174 . . . . 0.52 112.17 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.36 139.67 30.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.901 0.381 . . . . 0.43 110.52 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.0 p -90.1 163.93 14.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.163 -0.471 . . . . 1.25 110.882 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.4 t -49.9 -57.61 2.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 O-C-N 123.346 0.404 . . . . 0.41 111.602 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 164' ' ' GLU . 18.7 ptpt -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.539 -0.301 . . . . 3.44 111.517 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.94 -32.69 74.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.41 0.624 . . . . 1.86 109.651 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.779 HG21 HD21 ' A' ' 39' ' ' LEU . 36.6 mt -82.06 -37.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.549 -0.75 . . . . 0.21 110.049 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 46.9 mt-10 -57.96 -40.64 81.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.88 112.147 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.581 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.0 pt-20 -56.73 -31.35 64.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.651 -0.42 . . . . 0.75 111.551 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.581 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 23.0 mmmt -98.37 -16.95 19.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.104 0.478 . . . . 1.58 110.289 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.595 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -92.94 -43.13 9.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.776 -0.647 . . . . 0.24 111.765 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.835 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.3 mt -51.33 -49.89 79.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.463 0.542 . . . . 0.44 112.463 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 9.9 Cg_endo -54.26 -37.89 88.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.175 1.916 . . . . 0.49 112.532 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 48.2 mt -76.97 -37.18 55.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.778 -0.192 . . . . 0.71 111.462 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.063 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 10.1 mt -57.7 -48.38 79.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.819 -0.808 . . . . 0.46 108.819 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.37 -66.91 2.49 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.278 -1.328 . . . . 1.52 112.675 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 176' ' ' LEU . 45.4 m -159.01 121.22 3.52 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.481 0.312 . . . . 2.52 110.49 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.864 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -92.96 -59.63 2.0 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.335 -0.546 . . . . 3.56 109.99 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -92.18 -55.29 3.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 105.85 -1.907 . . . . 7.86 105.85 159.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 173' ' ' SER . 2.6 tt . . . . . 0 C--O 1.252 1.214 0 CA-C-N 113.436 -1.711 . . . . 4.81 107.439 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.766 -0.134 . . . . 5.51 112.766 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ptm -139.56 -168.33 2.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.988 -0.745 . . . . 5.05 108.988 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.63 -170.86 41.94 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 119.976 -1.107 . . . . 1.37 112.669 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -65.4 -65.26 0.7 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.342 0.591 . . . . 1.68 110.822 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.8 p -130.46 -173.66 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.817 -0.809 . . . . 0.65 108.817 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 144' ' ' ILE . 17.7 pt -61.23 -25.8 37.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 0.3 110.877 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.809 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.9 m-85 -83.91 2.34 39.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.27 110.994 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.57 -20.95 63.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.795 -1.187 . . . . 1.96 107.795 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 42.4 m-85 -106.24 178.32 4.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.409 -1.269 . . . . 0.4 109.668 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -124.86 149.19 47.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.43 -0.35 . . . . 2.77 110.321 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG23 HD13 ' A' ' 30' ' ' LEU . 77.5 t -114.7 145.56 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.14 0.495 . . . . 0.74 111.785 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.952 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 77.5 mt -101.18 132.38 46.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.741 . . . . 0.72 109.201 171.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.03 -170.33 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.562 . . . . 1.59 109.481 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.9 57.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.619 -0.264 . . . . 0.52 111.624 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -94.36 -4.13 49.1 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.249 -0.282 . . . . 2.22 110.982 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.952 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 20.6 m-70 75.48 26.42 1.14 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.753 0.787 . . . . 0.73 109.532 -177.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.634 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -87.82 147.11 40.37 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 105.309 -2.108 . . . . 3.25 105.309 165.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 113.89 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.707 0.931 . . . . 0.86 111.953 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.446 ' HB3' HG12 ' A' ' 20' ' ' VAL . 80.5 t80 -82.24 116.76 21.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.081 -0.963 . . . . 0.28 109.078 172.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.657 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -66.31 82.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.758 -0.655 . . . . 1.65 109.734 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.809 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -70.53 -34.27 72.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.902 -0.59 . . . . 0.25 110.498 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.686 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.36 -0.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.348 -0.842 . . . . 0.41 112.812 -168.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 14.9 pt20 -82.88 -6.47 59.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.964 -0.754 . . . . 1.24 108.964 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.468 ' O ' HD21 ' A' ' 38' ' ' LEU . 81.9 m-70 -94.82 -2.69 50.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.803 -1.184 . . . . 0.38 107.803 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -76.67 141.36 40.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.761 -1.108 . . . . 1.73 109.392 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.88 65.85 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 109.761 -1.336 . . . . 0.36 109.761 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.646 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -129.11 143.03 47.21 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.349 -0.926 . . . . 1.14 109.016 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.979 ' HG2' HD23 ' A' ' 171' ' ' LEU . 63.1 Cg_endo -77.72 142.05 19.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.145 1.897 . . . . 0.52 111.133 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.041 HD22 HG22 ' A' ' 70' ' ' THR . 0.2 OUTLIER -139.44 162.84 34.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.218 0.533 . . . . 1.03 110.753 -172.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.691 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -117.86 149.98 39.95 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.692 -0.855 . . . . 1.1 108.692 168.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -136.28 119.67 23.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.406 -0.59 . . . . 0.2 109.406 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.796 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 25.2 m-85 -103.41 123.61 47.17 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.593 0.235 . . . . 0.23 111.268 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.73 ' HB2' HG21 ' A' ' 110' ' ' VAL . 0.7 OUTLIER -81.24 91.79 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.415 -1.328 . . . . 1.28 107.415 167.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.4 p -107.6 140.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.522 0.934 . . . . 0.88 113.522 -159.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.663 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . . . -61.7 101.99 0.23 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.578 -1.192 . . . . 0.52 108.444 167.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.971 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -68.4 87.43 0.3 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.67 -1.15 . . . . 1.84 112.76 -170.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 tttm 78.21 -34.94 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.635 0.774 . . . . 2.43 111.649 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -110.91 125.69 53.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.649 0.262 . . . . 0.99 110.486 177.103 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.89 -136.32 5.42 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.558 -0.83 . . . . 1.09 112.028 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.529 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 29.1 t80 -132.7 156.66 46.6 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.349 -0.612 . . . . 3.16 109.349 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.5 p -119.25 114.7 22.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.338 0.589 . . . . 1.94 110.535 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 18.3 ttmm -100.7 15.78 27.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.5 -0.773 . . . . 2.03 109.822 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.13 18.93 9.35 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.906 -0.664 . . . . 0.47 111.516 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 -52.24 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.316 -0.468 . . . . 0.34 112.536 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.607 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -66.48 -48.69 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.18 0.514 . . . . 0.57 109.945 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.544 ' HG2' ' H ' ' A' ' 56' ' ' THR . 1.6 pm0 -57.83 -53.47 57.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.017 -0.992 . . . . 2.46 110.892 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.544 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 95.0 m -64.14 -42.43 96.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 0.33 111.483 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.71 -49.87 75.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.97 0.414 . . . . 0.19 111.001 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -60.19 -52.39 65.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.6 -0.727 . . . . 0.3 111.353 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -59.84 -47.44 85.71 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.881 -0.599 . . . . 1.08 111.63 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 39' ' ' LEU . 77.9 mt -55.32 -50.85 68.53 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.424 0.154 . . . . 0.81 111.326 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.77 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 40.1 t80 -46.78 -56.14 6.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.124 0.89 . . . . 0.33 109.774 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 90.2 m-20 -74.19 -33.75 63.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.454 -0.794 . . . . 1.76 110.936 -170.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -70.43 -41.2 73.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.227 -0.897 . . . . 1.79 111.052 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.552 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.0 m-85 -118.14 14.06 13.92 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 114.076 1.139 . . . . 0.43 114.076 -172.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.77 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 34.8 mtmt -56.78 -29.12 62.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.162 0.506 . . . . 2.11 110.156 172.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -59.36 -40.26 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.436 -0.802 . . . . 1.2 111.464 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.07 8.22 27.73 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.698 0.285 . . . . 1.9 110.967 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 83.82 67.9 1.43 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.581 -0.819 . . . . 1.32 111.689 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 39' ' ' LEU . 73.8 t80 -133.77 135.06 43.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.651 0.262 . . . . 0.26 110.668 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 1.041 HG22 HD22 ' A' ' 38' ' ' LEU . 4.2 t -131.15 140.81 50.01 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.85 -0.426 . . . . 0.51 109.85 175.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.603 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 39.2 t -104.48 114.17 43.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.603 -0.517 . . . . 0.24 109.603 171.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.618 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 13.8 mt -98.63 121.11 40.16 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.672 -0.862 . . . . 0.51 108.672 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.017 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.67 120.1 41.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.302 -0.559 . . . . 0.28 110.918 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.8 m-85 -105.5 109.24 62.98 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.417 -0.811 . . . . 0.34 109.044 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.971 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 32.0 Cg_exo -60.68 168.72 6.47 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.661 2.907 . . . . 0.73 111.614 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.7 t -123.12 135.72 54.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 115.312 1.597 . . . . 1.54 115.312 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.668 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 8.1 m-20 -70.03 64.01 0.23 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 111.73 -2.486 . . . . 2.52 109.508 168.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.71 HE21 ' HB3' ' A' ' 89' ' ' GLU . 6.9 mt-30 -63.9 -2.72 2.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.375 1.47 . . . . 3.18 113.574 -174.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -107.96 30.08 6.68 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.896 -0.779 . . . . 3.8 108.896 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . -85.39 -57.06 2.28 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.124 -0.944 . . . . 1.45 113.503 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.09 -54.32 0.27 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.036 -0.602 . . . . 1.43 112.157 -174.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.759 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -126.12 15.87 7.86 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 112.547 0.573 . . . . 1.43 112.547 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.668 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -61.39 161.9 16.85 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 120.783 0.325 . . . . 3.06 111.83 -171.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 1.036 ' HG3' HG22 ' A' ' 135' ' ' ILE . 81.5 Cg_exo -51.09 174.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.987 2.458 . . . . 1.61 114.805 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.14 18.21 78.73 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.942 -1.263 . . . . 1.39 109.942 -174.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 19.8 m120 59.62 44.31 14.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.677 -0.762 . . . . 3.69 110.958 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.507 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 12.0 pt-20 57.57 142.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.879 1.672 . . . . 2.47 115.183 171.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 68.67 57.69 0.42 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.033 -1.44 . . . . 3.64 111.183 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.71 ' HB3' HE21 ' A' ' 78' ' ' GLN . 11.6 tp10 -93.19 -27.92 16.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.732 0.641 . . . . 2.42 112.732 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.711 HG12 ' SG ' ' A' ' 95' ' ' CYS . 2.1 mt -83.57 50.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.689 0.757 . . . . 2.05 110.761 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 93' ' ' PHE . 11.4 mtmt -78.28 102.33 7.6 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.17 -0.923 . . . . 4.0 109.698 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.63 -26.22 0.19 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.721 0.808 . . . . 3.1 110.562 -177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 91' ' ' LYS . 42.6 m-85 -69.26 174.22 4.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.608 -0.724 . . . . 1.91 110.845 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 94' ' ' VAL . 4.8 p -128.66 111.01 22.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.013 -0.736 . . . . 1.65 109.013 170.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.711 ' SG ' HG12 ' A' ' 90' ' ' ILE . 74.2 m -95.32 120.99 36.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 118.762 -1.175 . . . . 0.91 110.775 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.871 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 11.5 t -151.66 162.85 40.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.483 -1.69 . . . . 1.92 108.335 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.669 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.12 105.32 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.785 0.678 . . . . 3.18 111.125 177.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.607 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 49.6 p90 -60.61 -23.84 65.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.737 -0.665 . . . . 1.74 111.377 -174.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? 69.75 131.69 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.994 0.808 . . . . 3.08 111.132 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -155.9 -163.61 1.53 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.097 -0.502 . . . . 0.43 112.191 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.44 -14.82 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 2.19 110.064 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.733 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 47.0 p90 -115.32 168.11 8.81 Favored Pre-proline 0 N--CA 1.443 -0.802 0 CA-C-N 115.127 -0.942 . . . . 0.24 109.495 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.878 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.6 Cg_exo -71.06 121.53 7.92 Favored 'Trans proline' 0 N--CA 1.478 0.574 0 C-N-CA 123.932 3.088 . . . . 0.31 113.058 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.017 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -114.55 137.13 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.939 -0.763 . . . . 0.37 108.939 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.878 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 7.8 mmt -111.75 -151.63 0.48 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.524 0.678 . . . . 1.47 112.678 -165.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.74 131.97 43.86 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.77 -1.104 . . . . 0.39 110.764 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.871 ' HD3' ' HA ' ' A' ' 96' ' ' THR . 3.6 mtmt -64.95 122.02 16.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.932 -0.766 . . . . 1.66 108.932 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.727 HG13 HG13 ' A' ' 110' ' ' VAL . 10.7 pt -122.17 149.84 25.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.641 -1.244 . . . . 0.47 107.641 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.63 ' ND2' ' HA3' ' A' ' 80' ' ' GLY . 29.7 t-20 -77.28 71.31 3.76 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.999 -0.741 . . . . 2.16 108.999 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.73 HG21 ' HB2' ' A' ' 42' ' ' ASN . 2.0 m -64.69 88.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-O 120.868 0.366 . . . . 0.38 110.854 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.759 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 47.9 t30 173.04 177.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.983 -1.117 . . . . 1.98 107.983 163.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.431 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 49.51 -136.85 21.85 Favored Glycine 0 CA--C 1.511 -0.181 0 C-N-CA 121.307 -0.473 . . . . 0.78 113.675 168.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.29 -9.17 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.182 0.515 . . . . 1.98 110.369 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -83.09 -4.89 58.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.554 -0.748 . . . . 2.04 110.792 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.8 57.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 0.48 111.817 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.638 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 46.3 t-80 -50.4 137.83 22.12 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.947 -1.024 . . . . 0.42 110.281 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.71 -46.64 14.87 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.785 2.323 . . . . 0.36 112.402 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.638 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.4 OUTLIER -57.15 -37.16 71.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.837 -0.62 . . . . 1.1 111.804 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -30.7 58.28 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 121.076 -0.25 . . . . 1.49 110.945 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.05 -31.7 72.9 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 2.37 109.927 171.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 68.0 t80 -70.88 -48.67 52.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 0.58 110.391 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 67.1 mtt -63.77 -51.96 62.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.111 -0.495 . . . . 0.34 111.058 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -58.33 -41.3 84.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 0.94 111.179 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.12 -30.13 66.12 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.748 0.309 . . . . 2.13 110.614 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.503 HG21 ' HD2' ' A' ' 150' ' ' PRO . 85.2 m -75.27 -38.54 60.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.096 -0.502 . . . . 0.47 111.007 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 35.7 mmtm -137.77 112.58 9.04 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.799 -0.182 . . . . 1.75 110.743 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.89 -19.83 17.73 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.111 2.541 . . . . 1.76 112.619 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.964 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 138.77 -171.74 23.41 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.598 -0.811 . . . . 2.37 112.91 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.565 HD11 ' HA ' ' A' ' 154' ' ' PHE . 21.4 mt -68.56 -33.61 60.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.854 0.835 . . . . 3.56 109.407 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.752 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.8 pt? -112.24 -157.44 0.62 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.078 -1.082 . . . . 2.76 108.078 173.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.43 -87.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.657 -0.497 . . . . 2.84 109.657 175.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.968 HG23 ' HE3' ' A' ' 136' ' ' LYS . 98.9 m 65.75 -62.25 0.24 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.386 0.884 . . . . 3.9 113.386 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 132' ' ' THR . 60.6 tttp 73.56 -47.86 0.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.985 0.914 . . . . 5.13 112.069 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.605 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -105.93 157.98 17.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.061 0.763 . . . . 0.93 113.061 -168.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 1.036 HG22 ' HG3' ' A' ' 84' ' ' PRO . 28.8 mm -82.76 90.39 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.893 -1.049 . . . . 1.05 108.975 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.968 ' HE3' HG23 ' A' ' 132' ' ' THR . 17.5 ptpt -108.96 -3.2 17.69 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.611 0.597 . . . . 1.5 112.611 -170.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.882 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.24 169.95 14.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.54 0.571 . . . . 0.87 112.54 -172.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 49' ' ' TYR . 10.8 m120 -49.41 -156.87 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.845 1.658 . . . . 1.8 113.111 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.796 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 39.3 m-85 -27.57 -52.51 0.07 Allowed 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 114.74 1.385 . . . . 1.37 114.74 -164.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.872 HG23 ' HA ' ' A' ' 155' ' ' SER . 17.3 m 39.38 102.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.899 1.074 . . . . 0.3 113.899 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.692 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.4 p -90.48 155.93 18.56 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.596 -0.842 . . . . 0.8 110.573 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 17.6 m-85 -103.72 161.81 13.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.336 -1.357 . . . . 0.53 107.336 163.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.806 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 55.5 tp -108.03 105.85 15.8 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.142 -0.688 . . . . 0.51 109.142 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.75 HG21 HD13 ' A' ' 15' ' ' ILE . 16.5 mm -103.82 122.97 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 115.638 -0.71 . . . . 0.2 109.206 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.463 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.4 OUTLIER -76.93 -179.49 5.51 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.67 -0.412 . . . . 1.3 110.478 -177.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.414 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 91.5 mtt180 -57.27 -21.86 37.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.658 0.614 . . . . 3.78 112.658 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -105.84 -17.33 14.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.297 0.57 . . . . 1.18 109.762 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 103.71 34.15 3.9 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.345 -0.843 . . . . 0.23 112.581 175.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.84 121.67 42.36 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.791 -0.448 . . . . 0.62 109.791 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.503 ' HD2' HG21 ' A' ' 125' ' ' THR . 31.5 Cg_exo -60.54 109.88 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.733 2.289 . . . . 0.3 112.151 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -91.75 -31.23 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 0.27 110.521 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.573 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.9 mm-40 -149.44 164.93 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.004 -0.544 . . . . 1.22 110.363 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.964 ' HB3' ' HA2' ' A' ' 128' ' ' GLY . 13.6 ttm180 -132.22 96.65 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.722 -0.844 . . . . 1.75 108.722 168.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.806 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 22.3 m-85 -86.57 108.73 18.71 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.299 -0.63 . . . . 0.38 109.299 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.872 ' HA ' HG23 ' A' ' 140' ' ' THR . 16.4 p -65.2 164.19 25.3 Favored Pre-proline 0 N--CA 1.444 -0.749 0 N-CA-C 109.596 -0.52 . . . . 0.99 109.596 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.815 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 23.5 Cg_endo -61.59 -12.21 23.67 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.986 2.457 . . . . 0.66 113.251 -163.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.71 -0.53 90.16 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.52 -0.764 . . . . 0.52 112.459 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.19 134.67 35.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.894 -0.41 . . . . 0.43 109.894 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 19.5 m -91.7 176.66 6.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.472 -0.331 . . . . 1.25 110.129 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.413 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 38.8 t -51.97 -52.1 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 0.41 111.213 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -64.02 -36.71 84.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 3.44 110.936 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.4 m-20 -57.35 -36.12 70.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.726 -0.67 . . . . 1.86 110.232 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.691 HG21 HD21 ' A' ' 39' ' ' LEU . 74.5 mt -84.24 -43.5 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.342 -0.844 . . . . 0.21 111.413 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 51.3 mt-10 -54.91 -38.53 67.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.493 0.553 . . . . 0.88 112.493 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.0 -18.37 45.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.035 0.383 . . . . 0.75 112.035 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.573 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 52.3 mttt -116.64 -10.14 11.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.097 0.475 . . . . 1.58 110.472 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -97.48 -44.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.681 -0.69 . . . . 0.24 111.381 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.4 mt -54.09 -49.28 90.83 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.225 0.454 . . . . 0.44 112.225 -175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 71.8 Cg_exo -51.7 -36.35 61.24 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.187 1.925 . . . . 0.49 112.781 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.02 -36.15 56.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.475 -0.33 . . . . 0.71 111.099 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.979 HD23 ' HG2' ' A' ' 37' ' ' PRO . 12.4 mt -60.13 -49.43 77.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.968 -0.753 . . . . 0.46 108.968 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -52.0 38.62 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 114.462 -1.244 . . . . 1.52 112.536 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.3 p 177.83 127.45 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.726 0.41 . . . . 2.52 110.235 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -82.62 -43.18 17.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.443 0.64 . . . . 3.56 109.711 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 175' ' ' ARG . 18.8 tpt180 -147.48 -53.62 0.21 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.873 -1.158 . . . . 7.86 107.873 174.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 C--O 1.246 0.906 0 CA-C-N 114.775 -1.102 . . . . 4.81 108.375 171.87 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.086 -0.406 . . . . 5.51 112.086 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -126.81 18.26 7.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.968 0.413 . . . . 5.05 110.298 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.96 81.78 1.24 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.919 -1.273 . . . . 1.37 109.919 -168.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -44.84 -56.25 4.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.359 0.6 . . . . 1.68 112.21 -174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 p -157.26 -174.68 5.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.334 -0.848 . . . . 0.65 108.91 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.727 HD13 HG21 ' A' ' 144' ' ' ILE . 18.9 pt -60.61 -25.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.142 0.496 . . . . 0.3 110.647 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.797 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 34.3 m-85 -80.64 3.61 21.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.198 -0.455 . . . . 0.27 111.418 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -73.64 -16.35 61.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.905 -0.776 . . . . 1.96 108.905 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 52.0 m-85 -109.47 159.32 17.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.765 -1.107 . . . . 0.4 110.328 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.14 143.82 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.935 0.398 . . . . 2.77 110.585 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG23 HD13 ' A' ' 30' ' ' LEU . 69.5 t -115.03 146.48 19.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.802 -0.635 . . . . 0.74 111.114 -178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.843 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 7.1 mp -103.67 145.19 30.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.97 0.414 . . . . 0.72 110.495 170.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.54 -176.52 3.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 1.59 109.101 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' ' HE2' ' A' ' 97' ' ' LYS . . . -55.65 -34.43 64.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.002 0.429 . . . . 0.52 110.796 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.1 t70 -82.85 -6.29 59.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 2.22 111.141 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.843 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 8.8 m-70 74.1 21.52 2.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.92 0.867 . . . . 0.73 110.066 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.4 mmpt? -87.25 128.19 56.27 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 106.426 -1.694 . . . . 3.25 106.426 164.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -43.44 115.27 0.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.253 1.968 . . . . 0.86 113.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.491 ' HB3' HG12 ' A' ' 20' ' ' VAL . 74.7 t80 -79.32 124.39 28.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.349 -1.296 . . . . 0.28 110.003 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.701 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 56.1 t30 -72.84 82.93 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.316 -0.624 . . . . 1.65 109.316 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.797 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.47 -32.05 69.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.316 0.579 . . . . 0.25 110.276 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.795 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.1 p -77.04 -0.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.249 -0.887 . . . . 0.41 112.58 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 11.6 pt20 -82.72 -4.92 58.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.164 -0.68 . . . . 1.24 109.164 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.414 ' HB3' HD13 ' A' ' 38' ' ' LEU . 89.8 m-70 -94.62 -4.08 48.38 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.864 -1.062 . . . . 0.38 108.294 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HE2' ' CD2' ' A' ' 16' ' ' PHE . 38.6 ttmt -71.71 139.8 49.3 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.745 -1.116 . . . . 1.73 109.368 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' HB3' ' A' ' 146' ' ' ARG . . . 104.98 -20.32 38.73 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.843 -0.903 . . . . 0.36 110.843 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 m -132.76 144.32 52.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 1.14 108.773 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -73.36 154.82 51.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.164 1.91 . . . . 0.52 111.262 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.653 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.3 pt? -156.35 151.66 26.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.35 0.595 . . . . 1.03 111.417 -172.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.841 HD21 HG21 ' A' ' 163' ' ' ILE . 6.5 mp -107.99 155.92 19.81 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.982 -0.748 . . . . 1.1 108.982 173.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -141.25 117.53 7.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.549 -0.537 . . . . 0.2 109.549 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.924 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 11.3 m-85 -104.19 123.65 47.7 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.755 -0.378 . . . . 0.23 110.512 -175.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.654 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 7.8 p30 -82.5 91.97 6.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.271 -1.011 . . . . 1.28 108.271 168.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 75' ' ' PRO . 2.3 p -112.35 130.53 65.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 113.605 0.965 . . . . 0.88 113.605 -160.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -58.9 103.39 0.16 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.248 -1.39 . . . . 0.52 107.248 165.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 1.056 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -68.72 76.98 0.3 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.878 -1.056 . . . . 1.84 113.423 -163.128 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.824 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 62.2 tttm 71.75 67.55 0.15 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.501 -1.227 . . . . 2.43 111.235 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.512 ' SG ' HG23 ' A' ' 90' ' ' ILE . 56.6 m -145.4 116.38 7.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.594 -0.73 . . . . 0.99 110.453 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.79 -106.92 1.42 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.758 -0.655 . . . . 1.09 114.03 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.47 155.94 18.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 3.16 112.254 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.5 p -120.31 -21.4 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.643 -0.708 . . . . 1.94 110.631 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.1 mmmt 67.48 0.33 2.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.58 -0.736 . . . . 2.03 111.378 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 105.71 -0.28 39.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.985 -0.626 . . . . 0.47 111.798 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.73 -38.83 90.13 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.694 -0.563 . . . . 0.34 111.694 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.63 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -69.62 -48.51 59.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.915 -0.402 . . . . 0.57 109.915 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 2.3 mp0 -54.95 -49.05 72.32 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.403 -0.817 . . . . 2.46 110.608 177.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 160' ' ' VAL . 90.9 m -67.31 -45.45 76.46 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.424 -0.807 . . . . 0.33 110.52 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.797 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.62 -49.34 76.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.824 0.345 . . . . 0.19 111.531 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 m -59.74 -46.26 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.3 110.852 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.47 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 77.6 m -66.51 -47.75 71.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.613 -0.721 . . . . 1.08 111.033 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -57.21 -48.53 78.55 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.427 0.158 . . . . 0.81 111.427 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 70' ' ' THR . 43.5 t80 -55.43 -53.56 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.33 110.962 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 59' ' ' THR . 0.3 OUTLIER -72.02 -27.6 62.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.23 0.538 . . . . 1.76 110.539 -174.051 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -78.02 -35.67 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.674 -0.694 . . . . 1.79 110.849 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.712 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.8 m-85 -118.62 13.03 13.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.66 0.985 . . . . 0.43 113.66 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -63.09 -21.37 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.905 0.383 . . . . 2.11 110.774 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -64.03 -37.11 86.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.644 . . . . 1.2 110.218 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -90.15 3.39 53.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.768 -0.651 . . . . 1.9 110.703 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.32 57.74 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.092 -0.504 . . . . 1.32 113.059 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.656 ' CE1' HD13 ' A' ' 39' ' ' LEU . 85.8 t80 -72.97 132.35 43.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.835 0.35 . . . . 0.26 111.301 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -123.18 135.61 54.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.58 -0.526 . . . . 0.51 109.58 177.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.797 HG11 ' HB1' ' A' ' 57' ' ' ALA . 26.1 t -102.51 111.62 32.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.474 -0.565 . . . . 0.24 109.474 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 24.4 mt -95.45 121.38 37.06 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.486 -0.931 . . . . 0.51 108.486 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.88 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -111.73 112.23 23.77 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.905 -0.718 . . . . 0.28 110.35 177.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.79 ' HD2' HD11 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -93.94 111.72 54.17 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.085 -1.08 . . . . 0.34 108.085 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.056 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 23.2 Cg_exo -60.13 170.65 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.186 2.591 . . . . 0.73 111.895 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.2 t -116.76 133.49 55.94 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.13 0.967 . . . . 1.54 113.166 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.483 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 63.8 t30 -102.65 91.63 4.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.738 -1.573 . . . . 2.52 109.665 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.608 ' CD ' ' H ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -56.74 -14.26 3.19 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.793 1.237 . . . . 3.18 113.747 -167.302 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -73.81 -1.97 21.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.899 0.704 . . . . 3.8 112.899 -171.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.483 ' HA3' ' OD1' ' A' ' 109' ' ' ASN . . . -87.08 32.75 3.98 Favored Glycine 0 CA--C 1.517 0.173 0 C-N-CA 120.429 -0.891 . . . . 1.45 113.001 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.58 -62.83 3.8 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.552 -0.619 . . . . 1.43 111.552 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' A' ' 82' ' ' GLN . 5.3 pm0 -130.98 101.25 5.53 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 120.914 0.387 . . . . 1.43 110.699 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 78' ' ' GLN . 10.1 mm-40 -95.14 167.32 13.11 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 109.884 -0.414 . . . . 3.06 109.884 161.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.813 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 19.6 Cg_exo -44.61 159.32 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.204 2.603 . . . . 1.61 114.942 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.9 21.76 70.58 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.188 -1.565 . . . . 1.39 109.188 -169.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 70.54 -64.15 0.38 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.212 -0.994 . . . . 3.69 110.417 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 2.1 pp20? -178.0 -30.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 2.47 110.249 173.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.766 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 37.8 tt0 -74.41 -19.64 60.34 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.741 0.645 . . . . 3.64 112.741 -170.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 8.8 tp10 -57.34 -61.11 2.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.966 0.412 . . . . 2.42 110.504 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.552 ' CG2' ' HG2' ' A' ' 78' ' ' GLN . 3.2 mt -90.79 37.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.242 0.544 . . . . 2.05 110.544 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.766 ' HG3' ' HA ' ' A' ' 88' ' ' GLU . 7.6 mmmm -85.09 -48.99 8.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.968 0.89 . . . . 4.0 110.59 176.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.46 -8.0 45.9 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.153 -1.385 . . . . 3.1 110.105 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.426 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 53.2 m-85 -110.61 167.36 10.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.311 -0.858 . . . . 1.91 109.826 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.7 p -128.88 126.06 64.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.239 0.542 . . . . 1.65 109.547 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.64 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 55.1 m -102.75 123.98 47.43 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.988 -0.551 . . . . 0.91 111.631 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -146.36 118.97 8.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.095 0.474 . . . . 1.92 110.824 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.83 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 93.8 mttt 66.87 -50.21 0.47 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.87 -1.059 . . . . 3.18 113.471 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.824 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 68.7 -48.78 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.928 0.891 . . . . 1.74 110.659 -170.598 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.83 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 18.6 mtmt 66.07 146.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.139 0.576 . . . . 3.08 112.192 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.464 ' HB2' ' HE1' ' A' ' 98' ' ' PHE . . . -164.66 -164.03 0.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.702 0.63 . . . . 0.43 112.702 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -79.77 -11.9 59.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.401 -0.818 . . . . 2.19 109.887 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.623 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 42.2 p90 -115.81 166.86 11.27 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.096 -0.957 . . . . 0.24 109.177 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 33.3 Cg_exo -66.02 121.81 9.23 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.37 2.713 . . . . 0.31 112.815 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.88 HG13 ' HB3' ' A' ' 73' ' ' ALA . 1.5 mp -109.51 143.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.466 -0.568 . . . . 0.37 109.466 174.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.692 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -108.92 -160.52 0.72 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.389 0.885 . . . . 1.47 113.389 -165.123 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 108' ' ' ILE . . . -72.93 131.47 42.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.013 -0.994 . . . . 0.39 110.042 173.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.925 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttt -70.61 115.04 9.31 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.898 0.856 . . . . 1.66 108.752 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.79 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -125.54 160.86 31.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.339 -1.726 . . . . 0.47 106.339 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.894 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.6 m-80 -65.73 117.54 8.31 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.97 -1.092 . . . . 2.16 109.064 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' A' ' 135' ' ' ILE . 1.7 m -116.57 88.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.733 -0.839 . . . . 0.38 108.733 170.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 1.7 t30 173.86 177.32 0.12 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.296 -1.372 . . . . 1.98 107.296 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.476 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 42.19 -135.54 3.62 Favored Glycine 0 N--CA 1.46 0.242 0 O-C-N 123.936 0.773 . . . . 0.78 114.739 164.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.47 -11.72 16.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.146 -0.527 . . . . 1.98 110.821 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.87 -15.32 54.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.04 111.339 -172.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.894 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.5 137.46 0.82 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.062 1.134 . . . . 0.48 114.062 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.59 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 55.5 t-80 -50.19 140.77 16.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 114.969 -1.014 . . . . 0.42 110.866 173.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.28 -46.92 11.22 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.189 2.593 . . . . 0.36 112.922 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.59 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 20.2 tp -58.05 -36.02 72.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.176 -0.466 . . . . 1.1 111.656 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 15.0 m-85 -75.51 -30.59 59.87 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 116.65 -0.25 . . . . 1.49 110.76 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 115' ' ' ALA . 33.9 mm-40 -64.01 -29.32 70.48 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.068 -0.653 . . . . 2.37 109.721 169.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 86.7 t80 -75.29 -42.02 55.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.277 0.56 . . . . 0.58 110.393 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.622 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 66.8 mtt -69.38 -49.3 56.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 0.34 110.82 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 38.7 mtpt -60.17 -40.76 91.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.94 111.062 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 21.6 ptmt -69.17 -35.72 76.59 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.82 0.343 . . . . 2.13 110.804 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 150' ' ' PRO . 91.1 m -74.23 -44.81 51.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.47 110.875 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 42.8 mmtt -129.47 103.34 17.93 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.189 -0.46 . . . . 1.75 110.215 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.694 ' HB2' ' HB ' ' A' ' 132' ' ' THR . 44.2 Cg_endo -69.05 -19.76 39.06 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.453 2.769 . . . . 1.76 113.435 -174.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 124.91 -157.38 19.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.648 -0.787 . . . . 2.37 111.881 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.6 -66.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.707 0.254 . . . . 3.56 110.865 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 pp -63.71 -40.11 95.97 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.032 0.444 . . . . 2.76 110.967 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -144.12 101.15 3.67 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.898 -0.779 . . . . 2.84 108.898 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 127' ' ' PRO . 22.4 p -79.78 131.16 35.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.663 -0.699 . . . . 3.9 111.924 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 132' ' ' THR . 16.5 tppt? 155.53 -65.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.996 1.435 . . . . 5.13 109.451 167.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.449 ' C ' HH12 ' A' ' 153' ' ' ARG . . . -147.47 -178.71 6.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.936 0.717 . . . . 0.93 112.936 -168.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.828 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 38.8 mt -78.5 150.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.768 -1.106 . . . . 1.05 109.475 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -168.57 -1.99 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.597 0.592 . . . . 1.5 112.597 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.828 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -136.82 170.03 16.76 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.332 0.653 . . . . 0.87 111.113 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.465 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 15.7 m120 -43.93 -158.24 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.376 1.47 . . . . 1.8 114.058 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.924 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.6 m-85 -27.76 -57.63 0.11 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 125.018 1.327 . . . . 1.37 114.335 -167.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.852 HG23 ' HA ' ' A' ' 155' ' ' SER . 10.6 m 42.94 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.111 0.782 . . . . 0.3 113.111 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 25.6 p -86.64 152.11 22.86 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.169 -0.612 . . . . 0.8 110.637 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.622 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.9 m-85 -103.76 133.17 49.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.719 -1.215 . . . . 0.53 107.719 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 151' ' ' VAL . 25.3 tp -81.29 103.63 11.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.741 -0.837 . . . . 0.51 108.741 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.727 HG21 HD13 ' A' ' 15' ' ' ILE . 13.5 mm -104.03 125.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.095 -0.706 . . . . 0.2 109.095 -175.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.4 -179.93 7.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.728 -0.789 . . . . 1.3 110.09 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.432 ' HG3' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -55.27 -23.09 21.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.21 0.529 . . . . 3.78 112.085 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.46 -17.28 18.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.107 -0.701 . . . . 1.18 109.107 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 100.45 25.19 8.89 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.751 -1.113 . . . . 0.23 112.509 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 65.0 t -106.81 124.54 35.16 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.106 0.453 . . . . 0.62 110.429 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 125' ' ' THR . 34.9 Cg_exo -61.1 111.26 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.332 2.688 . . . . 0.3 112.328 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.551 ' HB ' HD23 ' A' ' 143' ' ' LEU . 18.5 t -88.8 -28.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.212 -0.449 . . . . 0.27 110.712 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.521 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 34.3 mm-40 -160.91 164.26 31.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 1.22 110.536 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.803 HH11 ' HH2' ' A' ' 137' ' ' TRP . 14.8 ttm180 -123.0 97.23 5.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.707 -0.479 . . . . 1.75 109.707 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.637 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 84.6 m-85 -82.15 108.59 15.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.531 -0.544 . . . . 0.38 109.531 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.852 ' HA ' HG23 ' A' ' 140' ' ' THR . 3.0 m -62.19 165.21 9.0 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 109.771 -0.455 . . . . 0.99 109.771 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.814 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 44.2 Cg_endo -66.97 -8.21 21.0 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.624 2.216 . . . . 0.66 112.686 -164.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.23 5.56 81.16 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.52 111.865 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.0 133.51 35.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.903 0.382 . . . . 0.43 110.072 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.546 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 51.0 m -86.99 171.44 10.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.134 -0.485 . . . . 1.25 111.342 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.465 ' HA ' HG23 ' A' ' 56' ' ' THR . 99.0 t -52.86 -58.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.828 -0.624 . . . . 0.41 112.356 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.6 tptm -72.44 -25.33 61.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 3.44 110.597 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.1 m-20 -61.08 -31.36 71.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.877 -0.602 . . . . 1.86 110.557 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.841 HG21 HD21 ' A' ' 39' ' ' LEU . 43.1 mt -83.17 -42.16 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.002 0.43 . . . . 0.21 110.778 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.603 ' HB2' ' HD2' ' A' ' 161' ' ' LYS . 45.8 mt-10 -56.45 -34.5 66.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.88 112.293 -174.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.434 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.2 pt-20 -53.62 -32.16 50.1 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.725 0.298 . . . . 0.75 111.67 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 47.5 mmtm -105.26 -14.19 15.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.339 -0.391 . . . . 1.58 111.236 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 171' ' ' LEU . 65.1 tp -88.57 -42.52 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 0.24 111.735 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.744 ' HA ' HD12 ' A' ' 171' ' ' LEU . 78.5 mt -53.34 -48.56 92.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.418 0.525 . . . . 0.44 112.418 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.525 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.1 Cg_exo -56.32 -26.69 63.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.318 2.012 . . . . 0.49 112.902 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.38 -40.37 16.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.71 110.65 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.955 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 16.7 mt -59.18 -48.96 79.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.547 0.689 . . . . 0.46 109.617 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.4 38.83 0.85 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.501 -1.227 . . . . 1.52 113.13 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 171' ' ' LEU . 69.1 m 69.07 116.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.56 0.744 . . . . 2.52 112.775 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.01 -17.03 44.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.493 0.663 . . . . 3.56 109.433 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -129.47 -79.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.328 -0.99 . . . . 7.86 108.328 171.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.953 -1.021 . . . . 4.81 108.997 175.792 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.741 ' N ' ' HG ' ' A' ' 13' ' ' SER . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.12 -0.392 . . . . 5.51 112.12 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.9 mtt 62.04 63.5 1.09 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.154 0.502 . . . . 5.05 111.307 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.52 53.12 4.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 1.37 113.239 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.741 ' HG ' ' N ' ' A' ' 10' ' ' GLY . 9.1 m -95.02 -39.3 10.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.587 0.708 . . . . 1.68 109.793 175.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 p -157.85 175.14 14.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.858 -1.065 . . . . 0.65 108.452 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.806 HD13 HG21 ' A' ' 144' ' ' ILE . 21.9 pt -55.24 -29.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.136 0.421 . . . . 0.3 112.136 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.865 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.9 m-85 -75.84 -0.44 21.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.387 0.514 . . . . 0.27 112.387 -172.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.28 -12.2 59.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.505 0.669 . . . . 1.96 109.266 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 72.6 m-85 -108.84 155.54 20.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.228 -0.896 . . . . 0.4 111.085 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 29.9 tt0 -84.25 143.51 29.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.429 -0.805 . . . . 2.77 110.934 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 28' ' ' TYR . 72.5 t -125.45 146.17 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.762 0.315 . . . . 0.74 110.461 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.975 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 90.4 mt -111.59 146.82 36.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.408 -0.36 . . . . 0.72 110.264 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.39 174.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.745 0.653 . . . . 1.59 109.482 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 97' ' ' LYS . . . -53.86 -31.05 48.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.321 0.582 . . . . 0.52 109.959 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.17 4.06 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.35 -0.841 . . . . 2.22 112.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.975 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 30.5 m-70 72.63 26.09 2.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.485 0.66 . . . . 0.73 110.968 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 38.5 mmtt -91.07 128.73 46.51 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 107.03 -1.47 . . . . 3.25 107.03 168.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.47 112.63 0.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.792 1.661 . . . . 0.86 112.476 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HB3' HG12 ' A' ' 20' ' ' VAL . 68.8 t80 -79.39 123.72 27.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.669 -1.15 . . . . 0.28 110.553 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.632 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 3.0 t-20 -73.68 81.92 1.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.495 -0.775 . . . . 1.65 109.182 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.777 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.7 pt? -72.12 -32.25 66.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.471 0.653 . . . . 0.25 110.463 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.865 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 8.8 p -77.21 0.5 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.324 -0.853 . . . . 0.41 112.735 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.3 pt20 -82.15 -5.87 58.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.387 0.613 . . . . 1.24 109.564 173.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -92.54 -1.2 57.11 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.137 -1.06 . . . . 0.38 108.137 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -76.17 141.26 41.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.348 -1.296 . . . . 1.73 109.297 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.92 -8.39 63.3 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.328 -1.109 . . . . 0.36 110.328 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 20.1 m -140.68 146.08 43.0 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.088 -0.708 . . . . 1.14 109.088 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.056 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.0 Cg_endo -73.5 154.81 50.43 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.765 1.643 . . . . 0.52 111.153 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.614 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -155.09 152.47 29.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.396 0.617 . . . . 1.03 111.372 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.742 HD21 HG21 ' A' ' 163' ' ' ILE . 6.3 mp -107.83 151.48 25.69 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.567 -0.901 . . . . 1.1 108.567 172.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 80.4 mt -140.68 116.72 7.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.553 -0.536 . . . . 0.2 109.553 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.922 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 24.3 m-85 -103.29 123.28 46.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.219 0.325 . . . . 0.23 111.244 -172.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.697 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.6 p30 -79.32 91.56 5.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.783 -0.821 . . . . 1.28 108.783 168.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.713 HG11 ' HE2' ' A' ' 98' ' ' PHE . 2.4 p -112.34 133.52 57.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.563 0.949 . . . . 0.88 113.563 -163.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.86 102.62 0.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.726 -1.212 . . . . 0.52 107.726 167.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.976 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 30.1 t -72.08 97.23 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.088 0.773 . . . . 1.84 113.088 -166.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt 73.84 38.19 0.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.743 0.652 . . . . 2.43 111.218 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 m -141.79 157.67 44.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.596 -0.274 . . . . 0.99 110.607 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.69 ' HA3' ' HG2' ' A' ' 89' ' ' GLU . . . 66.2 -118.34 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 O-C-N 123.632 0.583 . . . . 1.09 113.678 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -129.21 174.83 9.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.546 0.689 . . . . 3.16 111.782 -174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.661 HG22 ' HE1' ' A' ' 139' ' ' PHE . 7.8 p -133.22 116.72 16.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.058 -0.974 . . . . 1.94 109.616 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.703 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 24.8 mtpp -83.86 17.07 2.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.059 -0.519 . . . . 2.03 111.828 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.3 17.04 21.24 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.878 -0.677 . . . . 0.47 111.89 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.42 -42.85 7.22 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.394 -0.431 . . . . 0.34 112.131 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.555 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -67.12 -44.59 79.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.449 -0.574 . . . . 0.57 109.449 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 23.6 mp0 -55.81 -55.03 37.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.023 -0.99 . . . . 2.46 110.086 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.515 ' CG2' HD12 ' A' ' 163' ' ' ILE . 98.6 m -67.62 -41.45 83.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.941 -1.027 . . . . 0.33 111.284 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.724 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.78 -48.2 81.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.859 0.362 . . . . 0.19 110.813 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.6 m -61.29 -49.38 77.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.635 . . . . 0.3 111.043 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 p -64.24 -47.32 80.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.813 -0.63 . . . . 1.08 111.438 -177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.642 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.59 -45.44 91.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.64 -0.255 . . . . 0.81 111.176 -177.463 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.814 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 85.4 t80 -53.07 -58.81 5.74 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 123.215 0.322 . . . . 0.33 110.668 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -70.09 -36.18 74.7 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.697 -0.401 . . . . 1.76 111.802 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.01 -39.81 79.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 1.79 111.384 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.727 ' CD1' HD13 ' A' ' 171' ' ' LEU . 73.9 m-85 -108.32 4.95 25.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.43 113.17 -174.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -59.03 -28.02 66.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 2.11 110.397 173.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.4 m -65.65 -37.34 86.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.464 . . . . 1.2 111.144 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -88.45 1.44 54.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.92 0.391 . . . . 1.9 111.107 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 88.94 66.0 1.28 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.951 -0.643 . . . . 1.32 112.191 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 39' ' ' LEU . 71.9 t80 -132.05 140.07 48.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.503 0.192 . . . . 0.26 110.594 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.27 140.22 52.0 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 120.898 0.38 . . . . 0.51 110.381 177.116 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.814 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 25.4 t -109.74 117.88 55.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.963 0.411 . . . . 0.24 110.521 169.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 20.3 mt -101.43 137.84 39.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.693 -0.854 . . . . 0.51 108.693 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.056 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -122.45 116.34 23.79 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.349 -0.54 . . . . 0.28 110.835 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.629 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -99.12 108.77 51.43 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 108.659 -0.867 . . . . 0.34 108.659 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.129 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.6 Cg_exo -59.3 170.24 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.194 2.596 . . . . 0.73 111.717 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 83' ' ' GLU . 46.0 t -115.0 135.79 53.84 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.892 0.853 . . . . 1.54 112.291 -177.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -90.16 104.55 17.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.708 -1.587 . . . . 2.52 109.791 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.855 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -65.13 -14.54 60.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.043 -0.98 . . . . 3.18 111.321 -173.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -86.61 -1.61 57.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.642 -0.708 . . . . 3.8 110.443 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 109' ' ' ASN . . . -71.16 -13.27 72.98 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.848 -0.692 . . . . 1.45 111.579 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.13 -61.55 0.47 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.041 -0.599 . . . . 1.43 112.646 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.564 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.1 pm0 -112.56 20.96 16.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.53 0.567 . . . . 1.43 112.53 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.855 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.5 OUTLIER -61.15 161.21 17.79 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 118.245 0.475 . . . . 3.06 111.296 -170.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.728 ' HG3' HG22 ' A' ' 135' ' ' ILE . 81.6 Cg_exo -51.28 172.52 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.255 2.636 . . . . 1.61 115.631 -168.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.43 13.98 74.33 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.054 -1.618 . . . . 1.39 109.054 -168.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 89.8 m-20 52.78 37.19 23.24 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 114.145 -1.028 . . . . 3.69 111.324 -175.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 4.4 pt-20 61.44 -16.84 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.295 1.438 . . . . 2.47 113.995 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -97.5 8.46 44.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.572 -0.705 . . . . 3.64 112.261 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.69 ' HG2' ' HA3' ' A' ' 48' ' ' GLY . 27.9 tt0 -91.45 -39.42 11.98 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.304 -0.558 . . . . 2.42 109.652 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.607 HD13 ' SG ' ' A' ' 95' ' ' CYS . 5.5 mt -96.88 19.79 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.874 -0.603 . . . . 2.05 110.255 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -76.1 -10.26 59.28 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.53 0.681 . . . . 4.0 110.854 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.79 18.15 5.15 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.079 -0.964 . . . . 3.1 109.639 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 65.8 m-85 -140.11 170.46 15.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.08 -0.964 . . . . 1.91 109.837 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.91 126.7 67.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.771 -0.455 . . . . 1.65 109.771 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.607 ' SG ' HD13 ' A' ' 90' ' ' ILE . 10.6 m -102.05 120.25 40.12 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.196 -0.456 . . . . 0.91 111.6 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 t -154.27 122.09 5.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.101 -0.5 . . . . 1.92 110.964 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.707 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 15.7 ptpt 32.31 84.43 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.867 1.062 . . . . 3.18 113.867 174.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.713 ' HE2' HG11 ' A' ' 43' ' ' VAL . 15.5 p90 -66.77 -25.47 66.5 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.742 -0.599 . . . . 1.74 110.361 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 99' ' ' LYS . 71.3 mmtt 65.78 148.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.081 0.863 . . . . 3.08 111.946 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -169.39 -164.74 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.736 0.643 . . . . 0.43 112.736 -174.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -69.67 -24.68 63.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.365 -0.834 . . . . 2.19 109.752 173.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.794 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 50.3 p90 -108.9 168.07 8.27 Favored Pre-proline 0 N--CA 1.438 -1.063 0 CA-C-N 114.575 -1.193 . . . . 0.24 109.479 -175.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 1.008 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 16.4 Cg_exo -73.7 129.37 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.7 2.933 . . . . 0.31 113.186 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.056 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.9 mp -117.69 138.02 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.336 -0.616 . . . . 0.37 109.336 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 1.008 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.9 mmt -112.66 -156.59 0.59 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.837 0.827 . . . . 1.47 113.2 -164.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.796 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -65.96 137.99 57.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.494 -1.23 . . . . 0.39 110.938 174.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.129 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttp -84.44 127.63 34.12 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.85 0.833 . . . . 1.66 109.458 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -131.66 162.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.983 -1.462 . . . . 0.47 107.769 -176.51 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.721 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 21.5 t-20 -75.81 83.61 2.76 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.857 -0.794 . . . . 2.16 108.857 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.697 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.26 89.57 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 108.085 -1.08 . . . . 0.38 108.085 173.232 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.564 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 1.0 OUTLIER 175.02 179.52 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.474 -0.936 . . . . 1.98 108.474 -178.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 47.0 -144.0 5.02 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 124.313 1.008 . . . . 0.78 115.512 156.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 11.5 pt-20 -102.81 -6.96 22.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.152 -1.024 . . . . 1.98 110.331 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -98.29 0.01 44.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.476 -0.784 . . . . 2.04 110.975 -170.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -50.79 138.89 17.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 0.48 112.888 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.46 ' HE1' ' O ' ' A' ' 19' ' ' GLU . 51.2 t-80 -52.4 138.08 39.7 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.303 -0.862 . . . . 0.42 110.313 172.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -44.39 -45.08 12.92 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.217 2.611 . . . . 0.36 112.676 -178.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.444 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 2.0 tm? -54.72 -45.61 74.11 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.667 -0.697 . . . . 1.1 111.189 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.479 ' HE1' HD21 ' A' ' 42' ' ' ASN . 2.5 m-85 -75.56 -29.74 59.47 Favored 'General case' 0 C--O 1.212 -0.885 0 O-C-N 122.295 -0.253 . . . . 1.49 111.451 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 49.8 mt-10 -58.49 -39.42 79.97 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.946 -0.702 . . . . 2.37 109.165 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 88.1 t80 -67.82 -44.0 78.27 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.293 0.371 . . . . 0.58 110.597 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.456 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.3 mtt -65.02 -54.12 35.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.306 -0.406 . . . . 0.34 111.033 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 36.7 mtpt -57.18 -39.94 76.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.735 -0.666 . . . . 0.94 110.877 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.4 ptmt -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.421 -0.354 . . . . 2.13 111.534 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.58 HG21 ' HD2' ' A' ' 150' ' ' PRO . 94.3 m -64.36 -53.8 42.87 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.625 -0.43 . . . . 0.47 110.314 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.698 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.8 ttmt -127.61 105.76 21.05 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.847 -0.427 . . . . 1.75 109.847 173.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.549 ' HB2' ' H ' ' A' ' 133' ' ' LYS . 32.6 Cg_endo -64.72 -17.85 60.76 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.202 2.601 . . . . 1.76 113.026 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.94 164.81 12.54 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.969 -1.11 . . . . 2.37 112.729 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.1 pt -124.34 20.31 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.418 0.628 . . . . 3.56 110.124 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 131' ' ' ALA . 2.0 pt? -164.94 -41.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 2.76 109.024 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.53 ' N ' ' HG ' ' A' ' 130' ' ' LEU . . . -144.26 122.13 12.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.847 -1.168 . . . . 2.84 107.847 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.2 p -86.36 -179.62 6.71 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.311 0.856 . . . . 3.9 113.311 -169.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.549 ' H ' ' HB2' ' A' ' 127' ' ' PRO . 77.9 tttt 78.64 -91.26 0.02 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-N 113.86 -1.518 . . . . 5.13 112.752 173.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -123.09 178.76 4.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 114.027 1.121 . . . . 0.93 114.027 -162.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.872 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 50.4 mt -82.9 156.21 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 113.539 -1.664 . . . . 1.05 108.464 176.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -173.26 10.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.121 0.786 . . . . 1.5 113.121 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.872 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.62 171.26 14.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.763 0.425 . . . . 0.87 110.997 -177.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.433 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 17.6 m120 -45.53 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 1.8 113.526 172.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.922 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 47.0 m-85 -27.87 -59.07 0.11 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 114.634 1.346 . . . . 1.37 114.634 -166.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.79 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 11.6 m 45.11 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.913 0.779 . . . . 0.3 112.954 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.7 p -89.87 150.19 22.32 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.538 -0.865 . . . . 0.8 111.071 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.8 m-85 -102.72 135.84 43.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.895 -1.15 . . . . 0.53 107.895 166.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.972 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 54.9 tp -82.13 105.13 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.015 -0.735 . . . . 0.51 109.015 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 15' ' ' ILE . 14.9 mm -102.5 122.59 55.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.558 -0.746 . . . . 0.2 109.04 -173.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.56 179.24 3.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.415 . . . . 1.3 110.355 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.82 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 72.8 mtp180 -62.41 -15.33 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.262 0.467 . . . . 3.78 112.262 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -109.03 -18.29 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.835 -0.541 . . . . 1.18 110.236 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.499 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 112.06 34.07 2.06 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.23 113.27 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 55.0 t -108.41 126.75 28.89 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 117.199 0.5 . . . . 0.62 110.595 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.58 ' HD2' HG21 ' A' ' 125' ' ' THR . 11.3 Cg_exo -69.22 97.48 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.073 2.515 . . . . 0.3 112.072 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.95 -20.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.529 . . . . 0.27 111.151 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.698 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 6.0 mm-40 -154.17 162.45 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.998 -0.371 . . . . 1.22 109.998 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -135.3 98.14 3.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.565 -0.531 . . . . 1.75 109.565 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.972 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 16.1 m-85 -88.56 125.06 34.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.772 ' HA ' HG23 ' A' ' 140' ' ' THR . 92.4 p -69.75 171.74 6.71 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.809 -0.811 . . . . 0.99 108.809 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.79 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 37.8 Cg_endo -66.04 -8.89 21.42 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.92 1.747 . . . . 0.66 112.293 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.35 -4.9 83.17 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.231 -0.895 . . . . 0.52 112.108 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.09 113.26 19.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.16 0.505 . . . . 0.43 110.125 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.2 p -82.62 179.92 7.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.677 -0.692 . . . . 1.25 110.804 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.642 HG13 HD21 ' A' ' 60' ' ' LEU . 58.0 t -44.17 -57.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.747 -0.66 . . . . 0.41 111.617 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -58.12 -39.45 78.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.773 -0.648 . . . . 3.44 112.399 -175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.52 -31.1 70.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.472 0.653 . . . . 1.86 110.087 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.742 HG21 HD21 ' A' ' 39' ' ' LEU . 46.0 mt -81.32 -42.52 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.242 -0.89 . . . . 0.21 110.945 177.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 65.3 mt-10 -58.09 -36.32 72.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.43 -0.35 . . . . 0.88 111.902 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.3 pt-20 -63.71 -12.28 33.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.894 0.331 . . . . 0.75 111.894 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.624 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.8 mmtp -116.22 -23.06 8.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.427 . . . . 1.58 110.694 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.8 tp -89.68 -37.16 14.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.398 0.518 . . . . 0.24 112.398 -170.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.666 ' HA ' HD12 ' A' ' 171' ' ' LEU . 68.8 mt -50.75 -48.47 83.16 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 0.44 112.841 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.8 Cg_exo -55.11 -37.07 94.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.924 1.749 . . . . 0.49 112.69 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.598 HD22 ' HB2' ' A' ' 174' ' ' ALA . 33.3 mt -78.95 -36.93 40.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.688 0.255 . . . . 0.71 111.688 -175.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.056 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.9 mt -55.44 -50.69 69.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.586 0.707 . . . . 0.46 109.216 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -48.85 -68.73 1.19 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.11 -1.405 . . . . 1.52 111.78 167.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.82 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 9.3 t 175.9 137.83 0.05 Allowed 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.691 0.282 . . . . 2.52 110.434 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.598 ' HB2' HD22 ' A' ' 170' ' ' LEU . . . -92.2 -31.11 15.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.207 0.527 . . . . 3.56 109.937 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -87.0 -6.28 58.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.417 -0.81 . . . . 7.86 110.581 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 173' ' ' SER . 82.7 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.836 -0.62 . . . . 4.81 109.915 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.792 -0.523 . . . . 5.51 111.792 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -81.62 92.64 6.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.909 -0.404 . . . . 5.05 109.909 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.55 88.19 0.1 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.885 -0.598 . . . . 1.37 112.742 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -107.96 -27.12 10.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 1.68 110.421 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.6 p -137.25 167.61 21.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.63 -0.714 . . . . 0.65 109.101 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.715 HD13 HG21 ' A' ' 144' ' ' ILE . 18.0 pt -61.57 -29.7 46.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.852 0.358 . . . . 0.3 111.9 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.795 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 72.4 m-85 -76.5 1.52 16.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.264 0.468 . . . . 0.27 112.264 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.39 -17.86 61.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.792 -0.818 . . . . 1.96 108.792 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 73.9 m-85 -99.73 159.99 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.4 110.6 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -102.21 135.77 43.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 2.77 110.963 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.605 HG23 HD13 ' A' ' 30' ' ' LEU . 89.3 t -114.35 146.63 18.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.294 0.568 . . . . 0.74 111.731 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 86.3 mt -117.29 153.22 33.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.615 -0.72 . . . . 0.72 110.24 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 176.72 1.4 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.206 -0.906 . . . . 1.59 109.454 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -53.71 -32.04 50.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.299 0.571 . . . . 0.52 110.065 173.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 1.7 m-20 -87.12 -3.91 59.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.62 -0.718 . . . . 2.22 112.281 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.97 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.7 m-70 74.49 27.04 1.43 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.693 0.759 . . . . 0.73 110.296 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -88.56 154.61 50.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.61 -1.626 . . . . 3.25 106.61 167.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.17 113.14 1.31 Allowed 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.047 1.164 . . . . 0.86 112.916 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.505 ' HB3' HG12 ' A' ' 20' ' ' VAL . 60.3 t80 -89.91 117.53 28.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.411 -0.813 . . . . 0.28 110.722 168.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.573 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.87 84.97 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.587 -0.733 . . . . 1.65 109.512 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.786 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.74 -32.35 67.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.002 0.43 . . . . 0.25 110.58 -176.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.795 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -76.54 -1.37 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 0.41 112.699 -167.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 7.0 pt20 -80.75 -5.71 57.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.418 0.628 . . . . 1.24 109.724 172.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.425 ' HB3' HD13 ' A' ' 38' ' ' LEU . 81.9 m-70 -92.15 1.02 57.46 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.188 -1.041 . . . . 0.38 108.188 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 22.8 ttpp -86.19 132.64 33.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.923 -1.035 . . . . 1.73 109.216 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.2 32.26 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.767 -1.333 . . . . 0.36 109.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 18.1 m -139.84 149.64 59.85 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.389 -0.967 . . . . 1.14 108.389 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.04 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 61.1 Cg_endo -75.41 153.51 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.558 1.505 . . . . 0.52 111.257 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.679 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.2 pt? -154.27 151.07 28.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.297 0.57 . . . . 1.03 111.295 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.791 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -109.64 154.9 22.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.567 -0.742 . . . . 1.1 109.089 172.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 72.3 mt -140.87 121.56 13.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.75 -0.833 . . . . 0.2 108.75 -176.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.06 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -108.41 126.72 53.2 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.882 0.373 . . . . 0.23 111.589 -171.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.669 ' ND2' HD13 ' A' ' 135' ' ' ILE . 0.6 OUTLIER -77.97 93.82 4.5 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.619 -1.252 . . . . 1.28 107.619 170.365 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.792 HG12 ' HA ' ' A' ' 139' ' ' PHE . 18.0 m -112.65 138.38 42.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 113.44 0.904 . . . . 0.88 113.44 -164.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.8 102.78 2.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.575 -1.639 . . . . 0.52 106.575 163.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 1.039 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 32.3 t -60.12 94.07 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.69 -0.686 . . . . 1.84 112.202 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 98' ' ' PHE . 24.7 tptp 63.46 19.29 11.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.502 0.668 . . . . 2.43 110.516 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 93' ' ' PHE . 24.2 p -135.18 172.62 12.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.706 -0.679 . . . . 0.99 109.846 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.17 -154.58 39.15 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.714 -0.755 . . . . 1.09 112.796 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -110.72 111.9 23.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 3.16 110.235 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.408 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 1.5 p -77.56 112.86 14.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.5 . . . . 1.94 111.109 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.434 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -81.5 14.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 2.03 111.062 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.2 8.38 38.75 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.976 -0.556 . . . . 0.47 111.888 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -39.04 96.73 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 111.987 -0.445 . . . . 0.34 111.987 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.518 ' CZ ' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -66.71 -47.29 72.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.769 0.319 . . . . 0.57 110.413 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.65 -45.58 92.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.742 -0.466 . . . . 2.46 109.742 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.662 ' HA ' HG22 ' A' ' 160' ' ' VAL . 73.2 m -59.74 -50.96 71.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.602 -0.726 . . . . 0.33 111.032 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.891 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.57 -50.25 73.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.164 -0.471 . . . . 0.19 111.372 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m -56.08 -46.77 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.958 0.409 . . . . 0.3 111.252 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.517 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 90.6 m -64.49 -46.5 82.73 Favored 'General case' 0 C--N 1.337 0.036 0 CA-C-N 116.392 -0.367 . . . . 1.08 111.156 -177.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 39' ' ' LEU . 71.4 mt -59.72 -49.72 76.63 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 120.722 0.296 . . . . 0.81 110.622 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.668 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 14.8 t80 -50.33 -57.43 7.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.213 -0.903 . . . . 0.33 109.651 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 59' ' ' THR . 0.4 OUTLIER -73.84 -29.07 61.92 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.755 -0.657 . . . . 1.76 111.738 -168.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.679 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 33.2 ttmt -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.641 0.258 . . . . 1.79 111.041 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.679 ' CE2' ' HD2' ' A' ' 63' ' ' LYS . 70.8 m-85 -116.73 10.43 14.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.892 1.071 . . . . 0.43 113.892 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 14.7 mtpp -64.02 -20.29 65.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.0 -0.68 . . . . 2.11 109.991 172.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -61.19 -33.27 73.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.766 -0.652 . . . . 1.2 109.887 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.467 HE21 ' HD1' ' A' ' 64' ' ' TYR . 2.0 mp0 -95.31 11.78 31.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.914 -0.584 . . . . 1.9 110.643 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.61 12.38 75.3 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.872 -0.603 . . . . 1.32 113.042 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 37' ' ' PRO . 93.8 t80 -72.03 141.06 49.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.034 0.445 . . . . 0.26 111.302 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -131.79 144.87 51.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.908 -0.587 . . . . 0.51 109.714 176.579 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.891 HG11 ' HB1' ' A' ' 57' ' ' ALA . 41.4 t -112.26 117.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.605 -0.517 . . . . 0.24 109.605 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.3 mt -100.28 121.11 40.95 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.735 -0.839 . . . . 0.51 108.735 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.033 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -107.99 112.72 25.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.388 -0.525 . . . . 0.28 110.608 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.1 m-85 -98.46 115.25 65.82 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.039 -0.726 . . . . 0.34 109.039 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.039 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 19.6 Cg_exo -63.28 169.66 9.09 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.107 2.538 . . . . 0.73 111.915 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t -128.99 155.4 45.43 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.519 -0.872 . . . . 1.54 112.165 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.705 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -114.83 71.52 0.76 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.248 -1.342 . . . . 2.52 109.087 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.986 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -45.55 -12.5 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.92 1.452 . . . . 3.18 114.92 -173.417 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -79.12 -7.53 58.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.306 0.574 . . . . 3.8 110.343 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.82 36.91 2.3 Favored Glycine 0 C--N 1.329 0.171 0 CA-C-N 115.975 -0.557 . . . . 1.45 113.735 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.34 -72.98 2.72 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.84 -0.695 . . . . 1.43 112.789 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.71 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.6 pm0 -120.96 30.71 6.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.154 0.798 . . . . 1.43 113.154 -172.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.986 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 6.0 mm-40 -62.34 145.11 94.59 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 119.596 -0.841 . . . . 3.06 110.012 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.714 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 26.8 Cg_endo -70.92 179.02 4.66 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 121.925 1.75 . . . . 1.61 111.892 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.489 ' H ' ' CA ' ' A' ' 137' ' ' TRP . . . 77.7 16.14 80.48 Favored Glycine 0 CA--C 1.498 -0.983 0 N-CA-C 110.095 -1.202 . . . . 1.39 110.095 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 1.0 OUTLIER 71.84 108.18 0.07 Allowed 'General case' 0 C--N 1.333 -0.138 0 O-C-N 125.093 1.113 . . . . 3.69 109.752 -174.105 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 2.3 pm0 -52.72 156.08 2.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.672 -0.695 . . . . 2.47 111.649 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 13.5 mm-40 72.84 21.7 3.28 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.651 -0.704 . . . . 3.64 111.208 -174.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.667 ' HB3' ' HG2' ' A' ' 78' ' ' GLN . 10.1 tp10 -84.14 -11.0 57.31 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 116.109 -0.496 . . . . 2.42 112.155 -175.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.912 HG13 ' HB2' ' A' ' 78' ' ' GLN . 6.6 mt -93.76 -7.09 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.508 -0.745 . . . . 2.05 110.2 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -73.3 8.98 1.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.698 0.629 . . . . 4.0 112.698 -167.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.4 ' HG3' ' CD2' ' A' ' 93' ' ' PHE . 10.7 pt-20 -163.12 24.86 0.09 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.584 -0.895 . . . . 3.1 108.584 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CD2' ' O ' ' A' ' 89' ' ' GLU . 51.9 m-85 -139.65 -178.48 5.43 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.522 -1.217 . . . . 1.91 110.815 -171.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.416 HG12 ' HD2' ' A' ' 97' ' ' LYS . 62.3 t -128.43 110.86 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.884 -0.784 . . . . 1.65 108.884 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.698 ' SG ' HG12 ' A' ' 90' ' ' ILE . 4.6 m -106.14 -158.13 0.64 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.634 -0.712 . . . . 0.91 109.364 177.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.745 HG23 ' HG2' ' A' ' 75' ' ' PRO . 1.8 m -13.98 117.57 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 115.216 1.561 . . . . 1.92 115.216 -140.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 6.1 ptmt 171.88 -31.48 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 111.477 -2.601 . . . . 3.18 107.883 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.562 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -36.8 109.97 0.11 Allowed 'General case' 0 C--N 1.354 0.779 0 O-C-N 124.972 1.42 . . . . 1.74 111.387 -173.362 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 97' ' ' LYS . 73.4 mmtt -104.61 143.17 33.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.055 -0.975 . . . . 3.08 110.262 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -145.15 -170.24 3.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.602 -0.272 . . . . 0.43 110.979 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -75.02 -26.54 59.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.446 0.641 . . . . 2.19 109.496 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.878 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 44.0 p90 -98.44 159.35 30.78 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 114.933 -1.03 . . . . 0.24 109.544 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 38.8 Cg_exo -67.56 114.18 3.2 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.091 3.194 . . . . 0.31 113.608 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.033 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mp -100.35 131.9 46.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 108.98 -0.748 . . . . 0.37 108.98 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.647 ' HE2' ' HA ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -117.03 -155.58 0.59 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.345 0.869 . . . . 1.47 113.345 -157.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -68.63 113.47 6.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.979 -1.01 . . . . 0.39 111.177 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.007 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -61.99 139.87 58.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.401 0.62 . . . . 1.66 109.602 171.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.539 HD12 ' CB ' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -150.13 156.59 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.571 -1.27 . . . . 0.47 107.571 -174.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.762 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 24.8 t-20 -67.84 93.99 0.43 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.102 -0.703 . . . . 2.16 109.102 175.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.596 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -83.7 82.59 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.278 -0.969 . . . . 0.38 108.793 176.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.71 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 32.5 t30 170.68 -177.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.229 -1.026 . . . . 1.98 108.229 170.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 58.92 -141.74 46.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.438 -0.887 . . . . 0.78 114.541 158.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.62 -15.95 16.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.683 0.754 . . . . 1.98 109.671 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.469 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 19.1 m120 -88.46 -5.64 58.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.607 -1.178 . . . . 2.04 110.912 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.762 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.37 126.43 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.298 -0.864 . . . . 0.48 112.281 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.561 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 55.1 t-80 -47.47 133.79 10.13 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-O 118.535 -0.745 . . . . 0.42 109.928 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.601 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.6 Cg_endo -42.11 -45.11 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.228 2.619 . . . . 0.36 112.711 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.561 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 20.1 tp -54.77 -51.45 65.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.753 -0.658 . . . . 1.1 111.584 175.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.746 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 22.9 m-85 -69.78 -31.5 69.47 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.403 -0.362 . . . . 1.49 111.201 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.55 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 1.4 mt-10 -55.18 -46.86 75.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.547 -0.909 . . . . 2.37 108.547 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 85.8 t80 -64.6 -49.25 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.665 0.603 . . . . 0.58 110.128 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.584 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 64.2 mtt -54.54 -51.58 64.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.123 -0.489 . . . . 0.34 111.722 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.746 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 27.5 mtpt -61.3 -49.33 77.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.868 0.366 . . . . 0.94 110.549 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 16.7 ptpt -70.44 -31.66 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 2.13 111.046 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.549 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.3 m -70.51 -40.58 73.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.429 -0.35 . . . . 0.47 111.78 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.465 ' HD3' ' HD2' ' A' ' 127' ' ' PRO . 10.0 mmtt -144.74 117.79 5.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.53 . . . . 1.75 112.164 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.789 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 54.7 Cg_endo -72.65 -28.06 14.53 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.077 2.518 . . . . 1.76 111.93 174.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.775 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 85.33 -137.08 15.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.916 -0.659 . . . . 2.37 112.856 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.1 pt -80.39 5.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.904 0.383 . . . . 3.56 111.6 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.51 HD11 ' HZ2' ' A' ' 137' ' ' TRP . 2.3 pt? -146.5 128.9 15.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.086 -0.506 . . . . 2.76 109.749 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.0 2.9 13.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.189 0.44 . . . . 2.84 112.189 -175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.497 HG21 ' HE3' ' A' ' 136' ' ' LYS . 21.1 m -58.26 -32.02 67.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.264 -0.425 . . . . 3.9 110.424 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.789 ' HG2' ' HB3' ' A' ' 127' ' ' PRO . 96.8 mttt 67.43 -5.88 0.7 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.34 -0.845 . . . . 5.13 111.531 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 132' ' ' THR . . . -98.64 160.34 14.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.971 -0.559 . . . . 0.93 111.645 -176.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.831 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 13.6 mt -105.1 105.86 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.537 -0.756 . . . . 1.05 109.659 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.497 ' HE3' HG21 ' A' ' 132' ' ' THR . 16.1 ptpt -133.01 26.67 4.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.142 0.793 . . . . 1.5 113.142 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.831 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -151.34 170.18 20.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.324 0.583 . . . . 0.87 111.995 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 2.7 t-20 -49.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 1.8 112.751 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 1.06 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 10.5 m-85 -27.44 -50.99 0.06 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 125.342 1.457 . . . . 1.37 114.794 -167.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.795 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 12.4 m 37.15 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.763 1.165 . . . . 0.3 113.288 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.6 p -85.11 150.63 24.72 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.149 -0.621 . . . . 0.8 111.412 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.5 m-85 -103.66 132.2 50.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.955 -1.128 . . . . 0.53 107.955 165.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.608 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 20.7 tp -81.2 106.11 12.93 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.931 -0.766 . . . . 0.51 108.931 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.715 HG21 HD13 ' A' ' 15' ' ' ILE . 18.7 mm -106.17 122.86 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.116 -0.698 . . . . 0.2 109.116 -172.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.41 179.14 3.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.262 -0.426 . . . . 1.3 110.505 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.435 ' HD2' ' H ' ' A' ' 174' ' ' ALA . 61.4 mtt180 -59.25 -21.31 59.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.797 0.666 . . . . 3.78 112.797 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -109.87 -10.08 14.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.151 0.5 . . . . 1.18 110.733 -171.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.553 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 104.16 32.9 4.16 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.737 -0.744 . . . . 0.23 113.375 174.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.3 t -107.22 122.43 41.41 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.695 -0.483 . . . . 0.62 109.695 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.5 Cg_exo -68.1 118.02 5.33 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.476 2.118 . . . . 0.3 111.178 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.57 ' HB ' HD23 ' A' ' 143' ' ' LEU . 32.6 t -97.22 -30.06 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.928 -0.578 . . . . 0.27 110.632 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -154.83 165.31 37.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 1.22 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.775 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 12.7 ttm180 -132.25 98.61 4.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.698 -0.683 . . . . 1.75 109.358 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.652 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 24.5 m-85 -91.05 108.97 20.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.587 -0.523 . . . . 0.38 109.587 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.748 ' HA ' HG23 ' A' ' 140' ' ' THR . 10.5 p -61.19 163.25 11.04 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.806 -0.442 . . . . 0.99 109.806 175.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.795 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 45.4 Cg_endo -65.46 -7.01 14.77 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.916 2.411 . . . . 0.66 113.4 -162.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 51' ' ' LYS . . . -85.36 -10.66 76.97 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.302 -0.863 . . . . 0.52 111.741 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -71.41 131.76 43.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.43 110.17 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.439 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 48.9 m -81.57 168.96 17.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.79 -0.641 . . . . 1.25 111.12 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.662 HG22 ' HA ' ' A' ' 56' ' ' THR . 44.8 t -54.44 -51.16 52.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.41 110.781 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 161' ' ' LYS . 32.9 ttmt -65.37 -33.65 76.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.553 -0.748 . . . . 3.44 110.868 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.6 m-20 -62.43 -31.77 72.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.349 -0.842 . . . . 1.86 110.263 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.791 HG21 HD21 ' A' ' 39' ' ' LEU . 69.2 mt -82.89 -37.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.987 -0.552 . . . . 0.21 110.908 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.5 mt-10 -57.83 -35.8 71.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.88 112.201 -175.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.99 -32.79 61.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.85 0.357 . . . . 0.75 111.459 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.533 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 47.1 mmtm -100.44 -17.07 17.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 1.58 111.036 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 65.7 tp -88.35 -38.08 15.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.192 -0.458 . . . . 0.24 111.407 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.841 ' HA ' HD12 ' A' ' 171' ' ' LEU . 85.0 mt -50.71 -52.5 55.93 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.835 0.68 . . . . 0.44 112.835 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.6 Cg_endo -55.67 -34.26 89.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.095 1.863 . . . . 0.49 112.673 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.76 -36.0 51.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.569 -0.287 . . . . 0.71 110.84 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.04 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.5 mt -56.36 -57.03 14.01 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.07 -0.514 . . . . 0.46 109.781 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -45.21 -61.05 3.74 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.265 -1.334 . . . . 1.52 112.927 172.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 21.9 t 177.48 126.06 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.652 -0.499 . . . . 2.52 109.652 175.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.435 ' H ' ' HD2' ' A' ' 146' ' ' ARG . . . -94.4 -40.21 10.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.065 0.459 . . . . 3.56 110.602 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -167.99 -30.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.414 -0.812 . . . . 7.86 108.968 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.299 -0.857 . . . . 4.81 109.595 173.145 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 N-CA-C 111.911 -0.476 . . . . 5.51 111.911 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt -132.83 29.18 4.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.52 0.676 . . . . 5.05 109.606 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.47 42.1 0.12 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.402 -0.817 . . . . 1.37 111.803 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 m -72.48 -59.07 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.327 0.584 . . . . 1.68 109.969 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -141.99 177.57 8.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.361 -0.836 . . . . 0.65 108.767 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.851 HD13 HG21 ' A' ' 144' ' ' ILE . 20.7 pt -57.37 -28.67 31.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 0.3 111.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.876 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 33.5 m-85 -78.13 2.68 17.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.27 111.447 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.07 -20.68 64.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.998 -1.112 . . . . 1.96 107.998 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 61.8 m-85 -111.56 172.36 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.284 -1.326 . . . . 0.4 109.918 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -115.06 161.91 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.75 0.309 . . . . 2.77 110.606 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.487 HG23 HD13 ' A' ' 30' ' ' LEU . 61.2 t -128.52 141.69 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.74 111.303 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.931 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 51.0 mt -95.77 132.78 40.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.905 -0.589 . . . . 0.72 109.703 171.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.29 177.75 1.04 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.184 -0.916 . . . . 1.59 109.143 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.474 ' O ' ' HE3' ' A' ' 97' ' ' LYS . . . -51.76 -35.46 43.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.923 0.392 . . . . 0.52 110.748 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -85.82 -3.51 58.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.947 -0.569 . . . . 2.22 111.236 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.931 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.5 m-70 71.97 15.96 5.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.638 0.732 . . . . 0.73 109.521 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -75.55 157.4 84.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 106.726 -1.583 . . . . 3.25 106.726 165.361 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.63 113.98 2.05 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 120.753 0.969 . . . . 0.86 111.824 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.428 ' HB3' HG12 ' A' ' 20' ' ' VAL . 67.9 t80 -90.4 109.12 20.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.36 -0.836 . . . . 0.28 109.324 170.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.9 t30 -70.93 85.66 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.613 -0.514 . . . . 1.65 109.613 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.876 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -61.6 -29.56 70.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.629 -0.714 . . . . 0.25 111.079 -176.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.809 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 5.4 p -76.12 -0.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.425 -0.807 . . . . 0.41 112.81 -167.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.2 pt20 -80.61 -5.53 56.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.265 0.555 . . . . 1.24 109.921 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.401 ' CG ' HG21 ' A' ' 70' ' ' THR . 83.4 m-70 -92.98 -5.7 50.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 108.324 -0.991 . . . . 0.38 108.324 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HZ3' ' HD2' ' A' ' 16' ' ' PHE . 16.6 ttmm -71.69 141.45 49.85 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.715 -1.13 . . . . 1.73 109.844 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.13 -12.87 55.66 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.895 -1.282 . . . . 0.36 109.895 -172.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.462 ' C ' ' HA ' ' A' ' 146' ' ' ARG . 25.0 m -140.6 148.07 51.68 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 108.572 -0.899 . . . . 1.14 108.572 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.985 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 79.5 Cg_endo -75.35 162.43 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.835 1.69 . . . . 0.52 110.996 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.684 ' CB ' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -159.36 152.69 22.41 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 1.03 110.809 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.634 HD21 HG21 ' A' ' 163' ' ' ILE . 7.2 mp -107.38 148.41 29.12 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.996 -0.742 . . . . 1.1 108.996 173.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 89.0 mt -134.16 119.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.152 -0.684 . . . . 0.2 109.152 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 14.9 m-85 -104.01 130.09 51.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.615 -0.266 . . . . 0.23 111.287 -173.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.716 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.5 p30 -83.79 93.8 8.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.938 -0.764 . . . . 1.28 108.938 167.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.8 m -107.13 140.32 25.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 121.438 -0.789 . . . . 0.88 113.073 -163.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 102.82 4.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.764 -1.569 . . . . 0.52 106.764 164.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.776 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 39.0 t -74.01 94.3 2.35 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.109 0.781 . . . . 1.84 113.109 -163.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 12.7 ttpp 65.11 45.27 3.08 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.7 -1.136 . . . . 2.43 110.733 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.7 p -163.39 151.98 13.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 0.99 110.334 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.493 ' HA3' ' CD ' ' A' ' 89' ' ' GLU . . . 73.96 -124.59 8.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.814 -0.707 . . . . 1.09 113.593 173.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -107.19 136.89 46.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.351 0.596 . . . . 3.16 112.142 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.561 HG22 ' CE1' ' A' ' 139' ' ' PHE . 55.2 p -116.72 94.03 4.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 1.94 109.585 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 16.9 ttmm -78.17 41.21 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.283 -0.417 . . . . 2.03 110.908 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.29 85.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.037 -0.602 . . . . 0.47 112.775 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.95 -38.03 84.19 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 112.052 -0.419 . . . . 0.34 112.052 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.599 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.6 t80 -71.74 -50.44 30.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.556 -0.322 . . . . 0.57 110.688 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.35 -44.37 95.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.944 -0.571 . . . . 2.46 110.622 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -52.89 62.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 0.33 110.97 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.66 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.7 -49.31 75.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.19 111.781 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -56.77 -47.15 80.78 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.967 -0.561 . . . . 0.3 111.169 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.0 m -61.32 -48.89 79.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.627 -0.715 . . . . 1.08 110.988 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 163' ' ' ILE . 51.5 mt -58.84 -52.04 67.42 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.244 -0.435 . . . . 0.81 111.738 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 86.1 t80 -50.86 -52.77 38.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.527 0.517 . . . . 0.33 110.323 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -73.76 -36.65 65.13 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.476 -0.784 . . . . 1.76 111.425 -170.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -74.93 -45.97 38.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.815 -0.629 . . . . 1.79 111.503 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.558 ' CD1' HD13 ' A' ' 171' ' ' LEU . 34.1 m-85 -101.94 -2.84 28.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 114.686 1.365 . . . . 0.43 114.686 -168.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.635 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 13.0 ptmm? -69.18 -15.45 63.4 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.487 -0.885 . . . . 2.11 110.346 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -60.33 -33.2 72.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 1.2 109.979 172.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -101.55 10.24 40.48 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 116.357 -0.383 . . . . 1.9 110.878 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.612 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 90.15 80.61 1.36 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.97 -0.633 . . . . 1.32 112.589 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.635 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 69.9 t80 -151.97 141.89 22.07 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.928 -0.16 . . . . 0.26 110.891 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.684 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -131.93 149.74 52.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 110.021 -0.362 . . . . 0.51 110.021 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.682 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 49.0 t -117.09 115.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.972 -0.381 . . . . 0.24 109.972 172.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 18.4 mt -102.11 121.95 43.2 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.932 -0.766 . . . . 0.51 108.932 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.995 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -110.9 114.25 27.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.096 0.474 . . . . 0.28 110.656 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.769 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-85 -98.66 112.61 62.98 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 109.075 -0.713 . . . . 0.34 109.075 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.908 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 46.3 Cg_exo -57.89 167.78 3.95 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.278 2.652 . . . . 0.73 112.042 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t -115.4 145.36 42.62 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.027 -0.669 . . . . 1.54 110.911 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.63 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 29.6 t30 -112.22 72.24 0.77 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.541 -1.209 . . . . 2.52 108.987 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.947 ' HB2' HG13 ' A' ' 90' ' ' ILE . 15.5 mp0 -54.28 -13.73 0.96 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.134 -0.939 . . . . 3.18 113.041 -173.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -66.84 -17.61 64.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.896 0.379 . . . . 3.8 110.971 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.54 -27.3 69.43 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.699 -0.682 . . . . 1.45 112.167 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.75 -83.77 0.31 Allowed Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.848 -0.692 . . . . 1.43 111.818 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.757 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.6 pm0 -89.57 24.66 2.22 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.641 0.608 . . . . 1.43 112.641 -174.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.875 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 5.6 mm-40 -60.52 152.25 66.66 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 119.797 -0.761 . . . . 3.06 110.565 -175.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.769 ' HG3' HG22 ' A' ' 135' ' ' ILE . 72.8 Cg_exo -55.04 -177.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.799 2.333 . . . . 1.61 114.043 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.62 22.68 74.67 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.943 -1.263 . . . . 1.39 109.943 -173.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.534 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 79.9 m-20 63.53 28.04 15.18 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 114.708 -0.746 . . . . 3.69 110.367 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 8.3 pt-20 59.9 161.53 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.521 1.528 . . . . 2.47 113.564 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.529 ' HB3' ' CG ' ' A' ' 91' ' ' LYS . 8.2 mt-10 56.02 37.9 29.35 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.353 -1.294 . . . . 3.64 111.42 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.493 ' CD ' ' HA3' ' A' ' 48' ' ' GLY . 3.2 tp10 -80.71 -15.33 56.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.649 -0.705 . . . . 2.42 110.778 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.947 HG13 ' HB2' ' A' ' 78' ' ' GLN . 3.0 mt -101.07 9.6 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 2.05 110.465 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.779 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 14.0 mmmm -65.81 123.9 21.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.409 -0.589 . . . . 4.0 109.409 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.779 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 8.0 pt-20 57.99 16.31 3.67 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.583 1.177 . . . . 3.1 111.552 -174.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -125.93 177.71 6.17 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.368 -0.605 . . . . 1.91 109.368 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.437 HG22 HG22 ' A' ' 96' ' ' THR . 9.1 p -130.26 116.76 37.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.319 -0.623 . . . . 1.65 109.319 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.882 ' SG ' HG12 ' A' ' 90' ' ' ILE . 57.8 m -103.5 111.27 23.65 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 119.008 -1.077 . . . . 0.91 108.992 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.437 HG22 HG22 ' A' ' 94' ' ' VAL . 3.3 t -158.96 120.27 3.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.926 -1.034 . . . . 1.92 109.368 173.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 23' ' ' ALA . 42.7 mttp 45.86 86.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.222 0.823 . . . . 3.18 113.222 172.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.704 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 49.8 p90 -64.58 -20.87 66.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.657 -0.497 . . . . 1.74 109.657 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 66.45 136.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.736 -1.12 . . . . 3.08 111.424 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -165.06 -178.4 5.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.705 -0.68 . . . . 0.43 110.881 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -88.32 32.84 0.75 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.657 -0.702 . . . . 2.19 110.566 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.688 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.4 p90 -152.0 161.75 28.55 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.114 -1.069 . . . . 0.24 108.114 175.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.9 Cg_exo -64.85 107.94 0.99 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 123.53 2.82 . . . . 0.31 114.189 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.995 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.3 mp -101.39 131.88 48.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.892 -0.781 . . . . 0.37 108.892 171.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.769 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.7 mmt -110.03 -151.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.924 0.712 . . . . 1.47 112.924 -162.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.495 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -75.14 144.58 42.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.391 -0.822 . . . . 0.39 110.778 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.908 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 22.2 pttt -83.45 131.89 35.0 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.659 0.742 . . . . 1.66 109.775 169.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' A' ' 116' ' ' HIS . 2.3 pt -136.59 159.22 37.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.78 -1.563 . . . . 0.47 106.78 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.908 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -70.65 95.45 1.1 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.904 -0.718 . . . . 2.16 109.163 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.716 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -87.43 83.11 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.262 -0.975 . . . . 0.38 109.065 175.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.757 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 9.0 t-20 171.52 -178.5 0.05 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.367 -0.975 . . . . 1.98 108.367 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 53.2 -147.92 15.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 114.677 0.631 . . . . 0.78 114.677 160.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.42 2.23 28.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.15 -0.525 . . . . 1.98 111.096 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -98.56 -3.46 36.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.253 -0.43 . . . . 2.04 110.92 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.908 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -46.53 139.3 5.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.189 -0.914 . . . . 0.48 113.34 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.606 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 54.1 t-80 -51.31 137.31 29.81 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.259 -0.882 . . . . 0.42 110.376 171.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.565 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -44.04 -46.5 11.04 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.114 2.542 . . . . 0.36 112.526 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.657 HD11 ' HE3' ' A' ' 122' ' ' MET . 20.9 tp -58.63 -41.89 86.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.842 -0.617 . . . . 1.1 111.762 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.487 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 3.7 m-85 -74.5 -29.98 61.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 119.561 -0.257 . . . . 1.49 110.781 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 41.5 mt-10 -56.54 -43.59 80.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.645 -0.872 . . . . 2.37 108.645 169.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 84.0 t80 -65.96 -46.57 77.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.54 0.525 . . . . 0.58 110.745 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.657 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.4 mtt -62.72 -51.72 66.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.212 -0.449 . . . . 0.34 111.02 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.563 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 34.7 mtpt -60.75 -45.24 95.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.94 110.949 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.4 ptmt -68.69 -33.49 74.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.266 -0.425 . . . . 2.13 111.299 -176.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.48 HG21 ' HD2' ' A' ' 150' ' ' PRO . 93.7 m -74.02 -50.28 20.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.072 -0.513 . . . . 0.47 111.85 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 6.1 tmtt? -139.85 104.35 6.86 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.682 -0.407 . . . . 1.75 111.437 -174.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.571 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 26.8 Cg_endo -65.19 -36.33 37.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.902 2.401 . . . . 1.76 111.97 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 92.97 -132.99 11.51 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.742 -0.742 . . . . 2.37 113.557 172.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.34 153.27 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 122.785 0.434 . . . . 3.56 111.057 -172.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 49.75 -163.97 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.221 1.008 . . . . 2.76 112.507 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.2 56.18 3.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.492 0.663 . . . . 2.84 109.885 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.601 HG21 ' HD2' ' A' ' 153' ' ' ARG . 11.3 m -67.76 -64.37 0.87 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.602 -0.726 . . . . 3.9 110.309 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp 63.93 -72.31 0.06 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.914 0.759 . . . . 5.13 110.487 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.91 177.12 4.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.961 -0.563 . . . . 0.93 110.477 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.861 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 17.6 mt -76.84 161.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.069 -1.086 . . . . 1.05 108.069 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -178.02 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.925 0.784 . . . . 1.5 112.146 -176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.861 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.52 165.8 11.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.269 -0.423 . . . . 0.87 112.09 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -48.33 -154.41 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 126.083 1.753 . . . . 1.8 113.817 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.815 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.2 m-85 -28.49 -45.64 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 115.273 1.583 . . . . 1.37 115.273 -163.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.96 HG23 ' HA ' ' A' ' 155' ' ' SER . 15.9 m 30.29 109.89 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.38 1.622 . . . . 0.3 115.38 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.0 p -93.56 156.52 16.68 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.27 0.557 . . . . 0.8 111.09 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 6.2 m-85 -102.43 166.47 10.53 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.018 -1.475 . . . . 0.53 107.018 163.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.758 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 49.8 tp -112.83 104.77 12.78 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.763 -0.829 . . . . 0.51 108.763 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.851 HG21 HD13 ' A' ' 15' ' ' ILE . 11.9 mm -103.05 125.22 57.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 109.11 -0.7 . . . . 0.2 109.11 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 38.9 p30 -77.86 -176.35 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.8 -0.36 . . . . 1.3 111.684 -175.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.694 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 76.6 mtp180 -57.41 -24.4 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.626 0.602 . . . . 3.78 112.626 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.52 -12.43 14.69 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.868 -0.733 . . . . 1.18 110.494 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.542 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 109.24 34.35 2.54 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.814 -0.708 . . . . 0.23 113.059 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 57.9 t -107.85 128.33 26.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.859 -0.423 . . . . 0.62 109.859 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.48 ' HD2' HG21 ' A' ' 125' ' ' THR . 4.8 Cg_exo -75.4 112.04 3.44 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.362 2.041 . . . . 0.3 111.24 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.524 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 41.1 t -93.54 -23.94 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.27 110.944 -177.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 1.2 mm-40 -156.65 166.11 34.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 1.22 111.042 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.601 ' HD2' HG21 ' A' ' 132' ' ' THR . 27.5 ttm180 -131.05 96.55 4.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.905 -0.776 . . . . 1.75 108.905 172.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.758 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 77.3 m-85 -82.42 110.07 17.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.38 109.519 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.96 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.4 m -61.85 168.4 3.61 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.879 -0.415 . . . . 0.99 109.879 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.807 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 36.1 Cg_endo -60.93 -28.16 85.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.629 1.553 . . . . 0.66 111.462 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.49 66.33 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.317 -1.31 . . . . 0.52 112.681 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.64 112.03 6.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.964 0.411 . . . . 0.43 110.045 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.7 m -74.81 174.66 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.895 -0.593 . . . . 1.25 110.828 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 69.0 t -48.59 -53.37 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.343 -0.389 . . . . 0.41 111.679 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -66.17 -32.13 73.38 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.278 -0.419 . . . . 3.44 111.498 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -63.71 -32.57 74.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.418 -0.586 . . . . 1.86 109.418 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.634 HG21 HD21 ' A' ' 39' ' ' LEU . 63.2 mt -83.68 -39.83 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.322 -0.854 . . . . 0.21 111.12 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.4 mt-10 -51.44 -44.14 62.25 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.234 0.457 . . . . 0.88 112.234 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.9 pt-20 -53.79 -33.57 56.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.123 0.416 . . . . 0.75 112.123 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.751 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtm -102.18 -19.08 15.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.918 0.39 . . . . 1.58 111.007 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.6 tp -84.14 -45.53 12.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 0.24 111.349 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.76 ' HA ' HD12 ' A' ' 171' ' ' LEU . 74.3 mt -53.5 -48.11 94.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.281 0.474 . . . . 0.44 112.281 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.9 Cg_exo -53.54 -37.32 82.64 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.067 1.844 . . . . 0.49 112.7 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.3 mt -78.87 -35.86 43.1 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 111.95 0.352 . . . . 0.71 111.95 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.985 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 11.4 mt -55.51 -54.15 47.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.744 0.783 . . . . 0.46 108.933 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.03 -45.74 94.77 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.211 -1.359 . . . . 1.52 113.539 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 p -164.14 125.38 2.24 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.835 0.817 . . . . 2.52 113.07 -172.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.689 ' HB2' ' H ' ' A' ' 146' ' ' ARG . . . -95.01 -58.05 2.26 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.668 0.747 . . . . 3.56 110.009 172.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -136.53 -30.28 0.92 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.575 -1.269 . . . . 7.86 107.575 171.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 C--O 1.251 1.141 0 CA-C-N 114.48 -1.236 . . . . 4.81 107.881 166.541 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.559 -0.616 . . . . 5.51 111.559 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 48.4 ttm -79.97 -33.57 39.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.025 0.441 . . . . 5.05 109.847 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.86 97.54 1.76 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.802 -0.713 . . . . 1.37 112.583 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -93.48 -36.2 12.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.516 -0.92 . . . . 1.68 108.516 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.0 p -135.37 178.34 7.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.159 -0.928 . . . . 0.65 109.494 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.71 HD13 HG21 ' A' ' 144' ' ' ILE . 21.4 pt -62.99 -26.42 40.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.241 0.543 . . . . 0.3 110.632 175.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.793 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 45.7 m-85 -76.94 -6.06 51.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.8 -0.637 . . . . 0.27 112.306 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -82.37 7.33 14.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.448 0.642 . . . . 1.96 109.352 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 89.2 m-85 -119.56 169.97 9.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.103 -0.953 . . . . 0.4 110.051 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.7 tt0 -98.01 151.49 20.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.312 -0.404 . . . . 2.77 110.513 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 28' ' ' TYR . 72.6 t -130.46 136.29 58.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.011 0.434 . . . . 0.74 110.507 172.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.729 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 96.4 mt -101.63 140.42 35.95 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.126 -0.694 . . . . 0.72 109.126 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 -172.72 3.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.238 -0.653 . . . . 1.59 109.238 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.46 66.35 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.779 0.323 . . . . 0.52 111.229 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 20.3 t70 -88.93 -12.16 42.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.192 -0.458 . . . . 2.22 111.191 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.729 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 38.7 m-70 82.59 23.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 123.599 0.76 . . . . 0.73 110.399 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -85.43 154.18 59.35 Favored Pre-proline 0 N--CA 1.443 -0.802 0 N-CA-C 105.693 -1.965 . . . . 3.25 105.693 165.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.68 114.38 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.812 0.969 . . . . 0.86 111.904 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.578 ' HB3' HG12 ' A' ' 20' ' ' VAL . 75.3 t80 -86.74 111.25 20.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.407 -0.815 . . . . 0.28 109.194 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.703 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 57.5 t30 -68.83 86.38 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.216 0.532 . . . . 1.65 109.936 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.793 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -61.38 -35.96 78.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 0.25 111.378 -174.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 13.5 p -76.54 1.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.003 0.742 . . . . 0.41 113.003 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.703 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.5 pt20 -74.73 -5.86 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.174 -0.954 . . . . 1.24 108.997 168.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -98.42 2.71 48.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.212 -1.033 . . . . 0.38 108.212 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 21.1 ttpt -81.07 142.46 33.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.848 -1.069 . . . . 1.73 109.642 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.06 79.48 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.804 -1.319 . . . . 0.36 109.804 -170.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.645 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 16.3 m -132.54 146.87 63.32 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 114.111 -1.045 . . . . 1.14 108.293 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.859 ' HG2' HD23 ' A' ' 171' ' ' LEU . 1.2 Cg_endo -79.56 149.58 21.29 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.737 1.625 . . . . 0.52 110.238 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.1 pt? -151.93 149.91 29.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.302 0.572 . . . . 1.03 111.291 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -107.53 154.9 20.71 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.584 -0.895 . . . . 1.1 108.584 172.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.487 HD12 HG13 ' A' ' 144' ' ' ILE . 69.4 mt -141.62 114.82 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.094 -0.706 . . . . 0.2 109.094 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 18.1 m-85 -100.59 124.55 46.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 121.125 -0.23 . . . . 0.23 110.78 -174.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.4 p30 -80.69 92.7 6.05 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.242 -0.651 . . . . 1.28 109.242 171.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.711 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 m -106.34 145.93 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 114.229 1.196 . . . . 0.88 114.229 -160.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.39 102.22 9.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.603 -1.628 . . . . 0.52 106.603 160.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 95' ' ' CYS . 40.4 t -72.11 85.29 1.02 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 112.563 0.579 . . . . 1.84 112.563 -165.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 17.9 tppt? 75.4 23.31 1.53 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.739 0.78 . . . . 2.43 110.638 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.52 129.33 51.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.238 -0.437 . . . . 0.99 110.548 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 -115.87 4.62 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.862 -0.685 . . . . 1.09 112.7 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -139.63 166.69 23.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.271 0.558 . . . . 3.16 111.868 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.9 p -131.92 115.07 15.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.663 -0.699 . . . . 1.94 110.372 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.721 ' HD2' ' HA3' ' A' ' 157' ' ' GLY . 28.0 ttmt -79.0 24.61 0.31 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.212 0.53 . . . . 2.03 110.887 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.99 13.8 24.39 Favored Glycine 0 C--O 1.224 -0.522 0 CA-C-N 115.881 -0.6 . . . . 0.47 112.38 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.71 -47.43 20.61 Favored Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 121.231 -0.509 . . . . 0.34 112.175 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.649 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.7 t80 -69.67 -47.6 62.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.486 0.184 . . . . 0.57 111.262 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -59.28 -47.11 86.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.069 0.462 . . . . 2.46 110.145 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.5 m -64.31 -45.99 85.51 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.385 -0.825 . . . . 0.33 110.891 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.547 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.17 -49.31 76.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.979 0.419 . . . . 0.19 111.07 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.6 m -59.26 -51.3 70.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.615 -0.721 . . . . 0.3 111.147 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 p -63.68 -39.27 93.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 1.08 111.914 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.495 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 88.5 mt -62.48 -51.66 66.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.442 0.163 . . . . 0.81 110.996 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.836 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 71.6 t80 -51.96 -48.86 64.12 Favored 'General case' 0 C--O 1.22 -0.45 0 O-C-N 123.752 0.657 . . . . 0.33 109.483 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.12 -43.29 74.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.536 -0.756 . . . . 1.76 111.687 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.61 -44.79 61.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.865 -0.607 . . . . 1.79 111.391 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.749 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.1 m-85 -100.91 6.3 43.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.402 0.89 . . . . 0.43 113.402 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 65' ' ' LYS . 7.5 mmmt -60.75 -25.17 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.987 0.422 . . . . 2.11 110.279 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -32.76 74.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.777 -0.647 . . . . 1.2 110.69 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -98.65 17.48 19.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.994 0.426 . . . . 1.9 110.703 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.645 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 74.78 55.52 5.35 Favored Glycine 0 C--O 1.224 -0.488 0 CA-C-N 115.64 -0.709 . . . . 1.32 112.845 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 59.7 t80 -117.15 140.0 50.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.633 0.254 . . . . 0.26 110.781 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -128.36 138.98 52.61 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 120.907 0.384 . . . . 0.51 110.556 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.836 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 39.4 t -110.91 121.11 63.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.887 0.375 . . . . 0.24 110.242 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' HE3' ' A' ' 105' ' ' MET . 21.3 mt -102.03 141.62 34.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.901 -0.778 . . . . 0.51 108.901 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.015 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -125.98 124.75 41.43 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.11 0.481 . . . . 0.28 110.222 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.676 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.4 m-85 -108.5 108.3 60.86 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.891 -0.595 . . . . 0.34 109.686 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.611 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 41.7 Cg_exo -58.67 154.97 39.54 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.077 2.518 . . . . 0.73 112.057 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.9 t -127.97 155.66 43.91 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.776 -0.647 . . . . 1.54 110.582 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -116.48 97.49 6.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.15 0.976 . . . . 2.52 109.937 -176.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.856 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 22.0 mp0 -56.4 -5.6 0.22 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.034 1.334 . . . . 3.18 113.894 -175.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.516 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 92.5 m-85 -77.25 -10.92 59.72 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.342 -0.39 . . . . 3.8 111.454 -174.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.33 -56.1 8.13 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.099 -0.572 . . . . 1.45 112.774 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.428 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 154.2 -33.76 0.72 Allowed Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.631 -0.795 . . . . 1.43 113.761 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.729 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -131.0 -6.22 3.93 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.344 1.072 . . . . 1.43 113.04 -174.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.828 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -78.66 150.59 76.16 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 112.826 0.676 . . . . 3.06 112.826 -164.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 36.9 Cg_exo -19.71 131.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.928 1 C-N-CA 126.875 5.05 . . . . 1.61 116.878 -162.222 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.87 11.74 49.01 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.2 -1.56 . . . . 1.39 109.2 -170.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 69.83 -50.06 0.63 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.072 -1.064 . . . . 3.69 111.117 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 175.29 153.31 0.14 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.513 0.508 . . . . 2.47 110.112 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 66.3 2.7 2.48 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.047 1.129 . . . . 3.64 114.047 164.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 16.2 tt0 -56.92 -30.92 64.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.551 -0.718 . . . . 2.42 111.518 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.856 ' HB ' ' HB2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -69.54 -4.03 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 114.575 1.324 . . . . 2.05 114.575 175.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HD3' ' HG2' ' A' ' 88' ' ' GLU . 25.8 pttm -56.84 -21.63 30.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.979 0.733 . . . . 4.0 112.979 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -129.87 21.76 5.41 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.836 -0.62 . . . . 3.1 110.155 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.465 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 86.0 m-85 -141.84 170.91 14.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.32 -0.854 . . . . 1.91 109.774 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 p -129.89 119.0 46.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.093 0.473 . . . . 1.65 109.937 171.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.719 ' HB2' HD11 ' A' ' 90' ' ' ILE . 21.8 m -91.9 114.58 27.16 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.664 -0.814 . . . . 0.91 110.758 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.409 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 8.3 t -157.07 118.47 3.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.135 -0.939 . . . . 1.92 109.313 166.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HA ' HG21 ' A' ' 104' ' ' ILE . 27.4 mttm 70.15 -47.02 0.62 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.591 1.33 . . . . 3.18 114.591 173.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.649 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 2.7 p90 58.04 -29.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.414 1.486 . . . . 1.74 111.548 -164.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.601 ' H ' ' C ' ' A' ' 97' ' ' LYS . 6.8 mtmt 71.51 125.47 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.245 1.018 . . . . 3.08 111.739 170.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.547 ' HB2' ' HE1' ' A' ' 98' ' ' PHE . . . -154.02 -170.67 3.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.985 -0.552 . . . . 0.43 112.035 -173.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.04 -6.28 58.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.732 -0.667 . . . . 2.19 110.366 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.709 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 47.9 p90 -115.98 162.23 26.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.62 -0.882 . . . . 0.24 108.62 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.794 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 37.8 Cg_exo -66.95 123.39 10.91 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 123.892 3.062 . . . . 0.31 113.675 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.015 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -112.3 148.85 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.291 -0.633 . . . . 0.37 109.291 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.794 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 9.2 mmt -120.36 -154.75 0.59 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.447 0.906 . . . . 1.47 113.447 -164.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.462 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -69.42 154.07 42.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.667 -1.151 . . . . 0.39 111.141 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.598 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 72.0 mttt -80.99 112.5 18.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.271 -0.64 . . . . 1.66 109.271 174.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.41 HG13 HG13 ' A' ' 110' ' ' VAL . 30.9 pt -121.39 149.58 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.224 -1.028 . . . . 0.47 108.224 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.7 t30 -81.74 60.51 4.69 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.831 -0.348 . . . . 2.16 110.384 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -56.38 94.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 116.575 -0.284 . . . . 0.38 110.912 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.818 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER 175.43 178.55 0.16 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 110.207 -0.294 . . . . 1.98 110.207 175.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.91 -123.2 0.15 Allowed Glycine 0 C--N 1.334 0.438 0 O-C-N 125.115 1.509 . . . . 0.78 115.192 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -107.01 -6.09 17.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 1.98 110.662 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -95.19 -6.9 40.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.386 -0.825 . . . . 2.04 112.308 -170.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB2' ' H ' ' A' ' 111' ' ' ASN . . . -57.56 146.38 30.4 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.214 0.82 . . . . 0.48 113.214 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.476 ' HE1' ' O ' ' A' ' 19' ' ' GLU . 26.5 t-80 -50.56 141.06 17.68 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.242 -0.89 . . . . 0.42 109.803 169.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 8.7 Cg_endo -51.08 -37.96 58.78 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.254 2.636 . . . . 0.36 112.523 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.523 HD11 ' HE3' ' A' ' 122' ' ' MET . 14.6 tp -54.85 -45.38 74.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.119 0.485 . . . . 1.1 111.074 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.489 ' CG ' HG12 ' A' ' 110' ' ' VAL . 3.3 m-85 -73.95 -28.1 61.33 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 116.079 -0.51 . . . . 1.49 110.974 176.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 39.7 mt-10 -56.23 -38.38 70.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.838 -0.745 . . . . 2.37 109.468 168.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 76.2 t80 -69.95 -47.01 64.04 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.568 -0.453 . . . . 0.58 110.488 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.523 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.9 mtt -61.48 -55.23 33.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.294 -0.412 . . . . 0.34 111.241 -178.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 27.6 mtpt -58.59 -43.66 89.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.94 111.411 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 15.0 ptmm? -70.1 -33.91 72.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 2.13 111.077 -176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.576 HG21 ' HD2' ' A' ' 150' ' ' PRO . 90.2 m -65.65 -46.56 78.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.394 -0.366 . . . . 0.47 111.105 -176.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.631 ' HD3' ' HA ' ' A' ' 152' ' ' GLU . 27.9 tttm -143.13 120.09 6.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 1.75 109.95 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.772 ' HB2' ' HB ' ' A' ' 132' ' ' THR . 83.6 Cg_endo -84.32 2.7 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.024 2.483 . . . . 1.76 113.713 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.731 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 118.51 177.11 16.83 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.609 -0.805 . . . . 2.37 112.865 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.72 -54.84 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.408 . . . . 3.56 110.251 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.857 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.7 pt? -77.12 -150.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 2.76 110.433 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -44.68 106.19 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.167 0.508 . . . . 2.84 111.534 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.772 ' HB ' ' HB2' ' A' ' 127' ' ' PRO . 32.1 p -89.95 139.67 30.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.496 -0.775 . . . . 3.9 112.624 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -179.0 -71.02 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.424 -0.807 . . . . 5.13 110.102 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -157.72 -169.07 2.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.324 -0.398 . . . . 0.93 111.079 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.868 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 30.6 mm -70.13 161.95 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.512 -0.922 . . . . 1.05 108.512 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -177.42 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.748 0.785 . . . . 1.5 110.334 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.868 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -95.64 171.41 8.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.731 -1.122 . . . . 0.87 111.717 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.424 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 18.5 m120 -48.13 -156.57 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.36 -1.746 . . . . 1.8 113.789 170.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 4.5 m-85 -29.32 -57.91 0.15 Allowed 'General case' 0 C--O 1.202 -1.428 0 C-N-CA 125.166 1.387 . . . . 1.37 114.588 -165.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.938 HG23 ' HA ' ' A' ' 155' ' ' SER . 10.0 m 44.48 106.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.309 1.225 . . . . 0.3 114.309 177.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 11.9 p -89.55 149.13 23.01 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.358 -0.839 . . . . 0.8 111.458 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 14.3 m-85 -103.76 133.4 48.81 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.147 -1.057 . . . . 0.53 108.147 163.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.794 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 16.3 tp -82.52 105.26 13.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.44 -0.578 . . . . 0.51 109.44 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.71 HG21 HD13 ' A' ' 15' ' ' ILE . 10.6 mm -105.03 126.97 59.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.409 -0.589 . . . . 0.2 109.409 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 16.9 p30 -79.57 -175.16 4.64 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.837 -0.345 . . . . 1.3 111.47 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.607 ' HD2' ' OXT' ' A' ' 176' ' ' LEU . 91.8 mtt180 -64.54 -12.81 48.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.507 0.558 . . . . 3.78 112.507 -176.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -109.73 -13.46 14.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.41 0.624 . . . . 1.18 109.326 -170.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.407 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 100.52 28.07 7.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.175 -0.921 . . . . 0.23 112.729 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.431 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 61.7 t -110.77 128.0 26.04 Favored Pre-proline 0 C--N 1.317 -0.839 0 O-C-N 122.538 -0.389 . . . . 0.62 110.388 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.576 ' HD2' HG21 ' A' ' 125' ' ' THR . 10.6 Cg_exo -68.94 106.09 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.97 2.447 . . . . 0.3 112.174 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.3 t -89.41 -16.33 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 0.27 110.589 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.631 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 5.2 mm-40 -160.73 165.67 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 1.22 110.717 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.731 ' HB3' ' HA2' ' A' ' 128' ' ' GLY . 19.6 ttm180 -137.56 98.28 3.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.94 -0.573 . . . . 1.75 109.531 170.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.794 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.3 m-85 -88.49 113.02 23.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.38 109.745 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.938 ' HA ' HG23 ' A' ' 140' ' ' THR . 3.8 m -64.56 166.14 12.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 109.775 -0.454 . . . . 0.99 109.775 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.822 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 33.8 Cg_endo -65.34 -8.26 18.28 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.695 2.264 . . . . 0.66 113.061 -165.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.721 ' HA3' ' HD2' ' A' ' 51' ' ' LYS . . . -93.24 3.25 72.43 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.433 -0.803 . . . . 0.52 112.882 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.47 139.97 37.46 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.182 -0.303 . . . . 0.43 110.182 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 94.7 p -83.58 171.11 13.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.25 111.034 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.7 t -55.52 -48.27 77.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.684 -0.487 . . . . 0.41 109.684 175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -63.74 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.806 . . . . 3.44 110.9 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.06 -37.73 69.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.95 -0.568 . . . . 1.86 110.313 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.553 HG21 HD21 ' A' ' 39' ' ' LEU . 67.5 mt -82.51 -41.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 0.21 111.399 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 52.0 mt-10 -56.37 -40.02 73.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.147 0.425 . . . . 0.88 112.147 -176.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 10.0 pt-20 -59.77 -22.71 62.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.821 0.304 . . . . 0.75 111.821 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.7 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.8 mmtp -107.23 -19.88 13.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.104 0.478 . . . . 1.58 110.262 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.658 ' HG ' HD11 ' A' ' 171' ' ' LEU . 58.2 tp -84.73 -42.44 15.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.24 111.32 -174.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.693 ' HA ' HD12 ' A' ' 171' ' ' LEU . 81.9 mt -53.24 -47.44 95.97 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.16 0.43 . . . . 0.44 112.16 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.5 Cg_exo -55.29 -23.28 36.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.624 2.216 . . . . 0.49 113.327 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 mt -92.65 -40.31 10.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.634 0.254 . . . . 0.71 110.964 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.859 HD23 ' HG2' ' A' ' 37' ' ' PRO . 10.7 mt -60.39 -48.51 81.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.092 -0.707 . . . . 0.46 109.092 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.92 52.5 2.87 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.699 -1.137 . . . . 1.52 113.057 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p 57.24 119.37 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.991 1.316 . . . . 2.52 113.594 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.03 -19.41 21.58 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.235 0.541 . . . . 3.56 110.718 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 175' ' ' ARG . 6.8 ptp85 179.26 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.954 -1.128 . . . . 7.86 107.954 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.607 ' OXT' ' HD2' ' A' ' 146' ' ' ARG . 60.1 tp . . . . . 0 C--O 1.244 0.808 0 N-CA-C 106.804 -1.554 . . . . 4.81 106.804 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.674 -0.57 . . . . 5.51 111.674 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 mmt -76.37 101.19 5.43 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.369 -0.604 . . . . 5.05 109.369 176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.77 109.4 2.76 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.979 -0.848 . . . . 1.37 110.979 -172.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 m -61.53 -38.09 86.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.747 0.308 . . . . 1.68 111.138 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.0 p -171.69 -176.96 1.88 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.292 -0.633 . . . . 0.65 109.292 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.764 HD13 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -62.34 -26.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.138 0.494 . . . . 0.3 110.448 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.899 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 44.0 m-85 -79.02 -1.59 36.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.777 -0.647 . . . . 0.27 111.556 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.27 -16.1 61.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.443 -0.947 . . . . 1.96 108.443 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 47.5 m-85 -105.63 177.81 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.579 -1.191 . . . . 0.4 109.658 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -126.13 148.47 49.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.692 0.282 . . . . 2.77 110.722 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG23 HD13 ' A' ' 30' ' ' LEU . 70.0 t -117.35 148.17 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.74 111.33 -175.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 92.7 mt -102.82 137.73 40.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 0.72 109.656 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 23' ' ' ALA . 19.7 t70 -72.98 -174.97 1.63 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.035 -0.728 . . . . 1.59 109.035 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.424 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -55.48 -34.15 64.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.042 0.449 . . . . 0.52 111.139 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 27.5 m-20 -93.82 3.03 56.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 2.22 111.186 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.97 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 35.1 m-70 72.91 14.53 4.81 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.276 0.63 . . . . 0.73 110.292 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 10.4 mtmt -66.76 144.34 98.53 Favored Pre-proline 0 CA--C 1.511 -0.519 0 N-CA-C 106.252 -1.759 . . . . 3.25 106.252 163.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.81 113.76 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 CA-C-N 119.809 0.967 . . . . 0.86 111.136 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.423 ' HB3' HG12 ' A' ' 20' ' ' VAL . 69.2 t80 -87.53 108.84 19.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.375 -0.83 . . . . 0.28 109.124 172.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.65 ' OD1' HG12 ' A' ' 31' ' ' VAL . 62.6 t30 -66.57 95.59 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.132 -0.692 . . . . 1.65 109.132 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.899 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.88 -30.23 67.63 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.627 -0.715 . . . . 0.25 110.611 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.687 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -76.93 -4.06 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 0.41 112.843 -166.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 27.8 pt20 -79.02 -4.99 52.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.565 0.698 . . . . 1.24 109.396 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.531 ' ND1' HG21 ' A' ' 70' ' ' THR . 84.8 m-70 -97.67 2.38 49.68 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.368 -0.975 . . . . 0.38 108.368 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -78.62 145.6 34.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.111 -0.95 . . . . 1.73 108.951 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.58 87.29 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.904 -1.278 . . . . 0.36 109.904 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -132.27 133.05 23.31 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.64 -0.874 . . . . 1.14 108.64 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.934 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 36.4 Cg_endo -69.56 146.02 60.16 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.305 1.337 . . . . 0.52 109.803 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.566 ' CD2' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -150.77 161.13 43.23 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.495 0.665 . . . . 1.03 111.743 -175.701 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.794 HD21 HG21 ' A' ' 163' ' ' ILE . 6.5 mp -111.96 154.01 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.977 -1.011 . . . . 1.1 108.671 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 94.5 mt -140.54 115.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.291 -0.633 . . . . 0.2 109.291 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.862 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 34.4 m-85 -99.72 123.4 43.94 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 121.047 -0.261 . . . . 0.23 111.165 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.714 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -80.41 91.56 5.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.197 -1.038 . . . . 1.28 108.197 167.171 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.4 p -116.11 137.7 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.733 1.012 . . . . 0.88 113.733 -162.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.08 108.85 1.96 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.267 -1.012 . . . . 0.52 108.267 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.962 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 17.8 t -75.68 84.02 2.68 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.278 0.473 . . . . 1.84 112.278 -169.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.696 ' HG3' ' HB2' ' A' ' 98' ' ' PHE . 52.2 mttm 73.15 29.92 1.66 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.18 -0.918 . . . . 2.43 112.328 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -133.04 128.87 37.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.348 -0.612 . . . . 0.99 109.348 174.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.549 ' HA3' ' CD ' ' A' ' 89' ' ' GLU . . . 90.93 -129.39 9.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.441 -0.885 . . . . 1.09 113.387 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.33 161.82 26.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.011 0.91 . . . . 3.16 113.353 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 t -125.22 154.0 42.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.387 -1.279 . . . . 1.94 108.286 168.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -119.08 20.84 12.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.573 0.701 . . . . 2.03 109.345 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.98 16.27 6.87 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 114.846 -1.07 . . . . 0.47 111.584 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.21 -54.25 4.14 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.935 -0.466 . . . . 0.34 111.935 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.654 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.4 t80 -65.92 -45.7 80.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.976 0.417 . . . . 0.57 110.592 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -62.36 -46.63 87.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 2.46 110.541 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.465 ' CG2' HD12 ' A' ' 163' ' ' ILE . 98.5 m -67.75 -41.46 83.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.169 -0.468 . . . . 0.33 110.859 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.728 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.13 -47.78 84.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.19 111.235 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 m -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.945 -0.571 . . . . 0.3 111.125 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 p -62.54 -48.38 79.76 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.852 -0.613 . . . . 1.08 111.203 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.05 -46.49 88.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 0.81 111.596 -177.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.725 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 46.3 t80 -50.93 -58.71 5.32 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 123.389 0.43 . . . . 0.33 110.595 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.571 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 91.9 m-20 -73.02 -30.61 63.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.076 0.399 . . . . 1.76 112.076 -173.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.8 -27.26 50.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.211 -0.45 . . . . 1.79 111.329 -174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.774 ' CD1' HD13 ' A' ' 171' ' ' LEU . 65.8 m-85 -122.17 5.2 9.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.687 0.995 . . . . 0.43 113.687 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 35.3 mtmt -58.79 -28.92 66.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.983 0.421 . . . . 2.11 110.33 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.0 p -61.12 -40.01 92.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.636 -0.711 . . . . 1.2 110.928 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -90.48 12.12 19.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 1.9 110.761 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.673 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.49 71.5 1.25 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.79 -0.641 . . . . 1.32 112.133 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CE1' HD13 ' A' ' 39' ' ' LEU . 74.0 t80 -140.67 141.82 34.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.657 0.265 . . . . 0.26 110.968 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.531 HG21 ' ND1' ' A' ' 33' ' ' HIS . 8.8 t -131.96 142.88 49.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.224 0.535 . . . . 0.51 110.433 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.728 HG11 ' HB1' ' A' ' 57' ' ' ALA . 24.7 t -105.24 119.64 54.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.894 0.378 . . . . 0.24 110.073 170.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.663 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 12.3 mt -104.69 128.06 52.64 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.891 -0.781 . . . . 0.51 108.891 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -114.52 121.3 43.08 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.309 -0.556 . . . . 0.28 110.878 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.672 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -105.42 108.75 62.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.878 -0.786 . . . . 0.34 108.878 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.962 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 50.9 Cg_exo -56.4 164.76 5.06 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.979 2.453 . . . . 0.73 111.56 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.41 ' HB3' HE22 ' A' ' 78' ' ' GLN . 37.5 t -121.58 135.82 54.98 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.031 -1.068 . . . . 1.54 113.046 -176.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.64 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 18.2 t30 -91.21 78.09 5.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 112.782 -2.008 . . . . 2.52 109.103 175.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.823 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 8.9 mp0 -60.33 -13.07 10.99 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.604 -0.725 . . . . 3.18 112.217 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -67.48 -15.46 63.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.119 -0.492 . . . . 3.8 110.635 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.469 ' HA3' ' OD1' ' A' ' 109' ' ' ASN . . . -53.45 -61.62 6.83 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.632 -0.713 . . . . 1.45 113.011 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.96 -52.26 0.18 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.432 -0.89 . . . . 1.43 112.646 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.676 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 4.6 pm0 -127.05 13.53 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.484 0.549 . . . . 1.43 112.484 -175.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.823 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 3.4 mm-40 -61.55 153.57 69.39 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 116.103 -0.498 . . . . 3.06 111.271 -167.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.646 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 7.6 Cg_exo -32.58 159.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.5 1 C-N-CA 125.33 4.02 . . . . 1.61 117.559 -171.065 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.818 ' HA3' ' HB2' ' A' ' 89' ' ' GLU . . . 81.59 27.77 45.94 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.974 -1.25 . . . . 1.39 109.974 -174.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.657 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 20.3 m120 57.64 44.96 19.93 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 114.741 -0.73 . . . . 3.69 110.677 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 8.8 pt-20 59.86 6.65 0.94 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.131 1.373 . . . . 2.47 113.53 173.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.57 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 89.4 mt-10 -134.74 32.74 3.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.673 0.273 . . . . 3.64 111.37 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.818 ' HB2' ' HA3' ' A' ' 85' ' ' GLY . 3.3 tp10 -86.01 -26.59 25.33 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.8 -0.36 . . . . 2.42 111.549 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.599 HG12 ' SG ' ' A' ' 95' ' ' CYS . 37.6 mt -105.3 49.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 122.072 0.939 . . . . 2.05 109.404 173.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.695 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 50.3 mtmt -87.72 117.38 26.52 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.525 -0.916 . . . . 4.0 108.525 168.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 8.8 pt-20 57.05 16.79 3.06 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.3 1.0 . . . . 3.1 111.781 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -114.21 172.46 6.99 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.761 -0.829 . . . . 1.91 108.761 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.7 123.52 54.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.882 0.373 . . . . 1.65 110.517 170.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' A' ' 90' ' ' ILE . 12.7 m -100.15 118.65 36.92 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.158 -0.617 . . . . 0.91 110.654 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -152.85 118.39 5.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.474 -0.784 . . . . 1.92 109.807 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HG3' ' HE3' ' A' ' 99' ' ' LYS . 15.0 pttm 23.86 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.098 1.359 . . . . 3.18 114.634 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.696 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -57.01 120.18 7.55 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.005 -1.85 . . . . 1.74 106.005 168.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HE3' ' HG3' ' A' ' 97' ' ' LYS . 9.3 mptt -79.44 164.44 23.97 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.702 -0.799 . . . . 3.08 111.195 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.621 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -172.67 -175.41 1.3 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.08 0.863 . . . . 0.43 110.969 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.62 0.9 55.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 2.19 110.903 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.685 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 49.9 p90 -121.36 168.4 11.17 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.655 -0.868 . . . . 0.24 108.655 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.914 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.6 Cg_exo -69.95 116.92 4.8 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.505 2.803 . . . . 0.31 113.239 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.969 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.5 mp -109.01 140.22 28.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.934 -0.765 . . . . 0.37 108.934 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.914 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.8 mmt -113.68 -153.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.371 0.605 . . . . 1.47 112.488 -164.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.603 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.76 144.22 45.73 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.036 -0.983 . . . . 0.39 110.477 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.942 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.7 pttp -80.67 127.77 32.86 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.652 -0.87 . . . . 1.66 108.652 169.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.626 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -131.86 169.4 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.049 -1.463 . . . . 0.47 107.049 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.802 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 32.2 m-80 -72.43 118.82 15.81 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.467 -0.938 . . . . 2.16 108.467 172.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.714 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -116.97 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 119.453 -0.899 . . . . 0.38 108.914 168.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.676 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 13.2 t-20 171.61 178.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.911 -1.144 . . . . 1.98 107.911 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.09 -140.38 12.23 Favored Glycine 0 N--CA 1.448 -0.561 0 O-C-N 123.645 0.59 . . . . 0.78 114.321 163.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -104.84 -2.62 24.51 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.9 -0.65 . . . . 1.98 110.254 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.06 -21.31 26.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.512 -0.767 . . . . 2.04 110.646 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.802 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.05 137.65 0.66 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.213 1.19 . . . . 0.48 114.213 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.585 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 56.6 t-80 -49.79 139.09 16.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.233 -0.894 . . . . 0.42 110.797 172.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -41.87 -49.73 5.43 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.193 2.595 . . . . 0.36 112.938 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.585 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -55.91 -38.32 70.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.102 -0.499 . . . . 1.1 112.138 177.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.519 ' HE1' HD21 ' A' ' 42' ' ' ASN . 3.5 m-85 -75.97 -30.0 58.46 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 122.35 -0.219 . . . . 1.49 111.003 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.7 mt-10 -57.64 -35.27 70.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.025 -0.731 . . . . 2.37 109.025 169.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.9 t80 -71.38 -48.4 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.58 110.309 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.529 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 67.5 mtt -63.09 -53.09 59.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.999 -0.546 . . . . 0.34 111.624 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -56.72 -46.43 81.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.539 . . . . 0.94 111.003 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -67.46 -32.29 73.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 2.13 111.039 -176.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.526 HG21 ' HD2' ' A' ' 150' ' ' PRO . 93.0 m -72.76 -63.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 0.47 111.828 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.597 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 5.4 tmtt? -125.78 115.62 24.57 Favored Pre-proline 0 C--N 1.324 -0.509 0 C-N-CA 120.924 -0.31 . . . . 1.75 110.843 -173.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.462 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 51.4 Cg_endo -71.39 -19.82 28.36 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.824 2.349 . . . . 1.76 112.09 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.713 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 99.42 -139.24 14.33 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.875 -0.678 . . . . 2.37 113.169 174.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.4 mt -79.57 -65.79 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.924 0.392 . . . . 3.56 110.055 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.1 pt? -90.81 144.9 25.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.158 -0.682 . . . . 2.76 109.158 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.9 77.79 0.64 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.18 0.514 . . . . 2.84 110.915 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.605 HG23 ' HG ' ' A' ' 130' ' ' LEU . 2.5 p -79.37 -16.94 55.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.809 -0.632 . . . . 3.9 110.296 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 tptp 68.54 -59.29 0.46 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 124.187 0.929 . . . . 5.13 110.219 -176.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.28 -172.45 2.85 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.716 -0.675 . . . . 0.93 111.164 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.79 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 29.4 mm -76.02 170.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 108.809 -0.811 . . . . 1.05 108.809 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 135' ' ' ILE . 11.9 ptpt 177.47 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.609 0.718 . . . . 1.5 110.52 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.79 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.76 169.76 9.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.071 -0.968 . . . . 0.87 112.261 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.4 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 22.0 m120 -48.91 -155.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.219 1.808 . . . . 1.8 113.959 172.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.862 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 22.8 m-85 -26.7 -58.43 0.09 Allowed 'General case' 0 C--O 1.205 -1.243 0 C-N-CA 125.419 1.488 . . . . 1.37 113.929 -163.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 155' ' ' SER . 22.5 m 40.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.33 0.863 . . . . 0.3 113.33 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 18.9 p -85.57 148.38 25.96 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.004 -0.678 . . . . 0.8 110.685 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 11.6 m-85 -102.34 130.34 49.05 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.036 -1.098 . . . . 0.53 108.036 167.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.802 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.4 tp -80.99 106.17 12.78 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.976 -0.75 . . . . 0.51 108.976 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.764 HG21 HD13 ' A' ' 15' ' ' ILE . 10.1 mm -105.06 128.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.442 -0.947 . . . . 0.2 108.442 -175.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.446 ' HB2' HD12 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -76.95 -176.16 3.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.756 0.312 . . . . 1.3 110.884 -174.387 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.704 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 64.3 mtp180 -68.1 -6.48 23.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 3.78 111.804 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -109.97 -21.13 12.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.501 0.667 . . . . 1.18 109.528 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.513 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 102.98 32.96 4.49 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.967 -1.015 . . . . 0.23 112.848 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.8 t -111.55 129.0 24.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.523 -0.547 . . . . 0.62 109.523 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.526 ' HD2' HG21 ' A' ' 125' ' ' THR . 15.0 Cg_exo -64.39 109.92 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.376 2.051 . . . . 0.3 111.612 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.597 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 11.4 t -92.55 -22.09 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 0.27 110.351 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.3 mm-40 -153.75 163.99 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.262 0.554 . . . . 1.22 111.276 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.713 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 26.0 ttm180 -134.02 97.71 3.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.019 -0.991 . . . . 1.75 108.766 172.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.802 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 46.9 m-85 -90.84 113.75 25.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.057 -0.72 . . . . 0.38 109.057 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.741 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.7 m -62.0 173.51 0.87 Allowed Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 110.011 -0.366 . . . . 0.99 110.011 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.723 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 54.0 Cg_endo -64.54 -14.42 44.32 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.693 1.596 . . . . 0.66 111.157 -174.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.54 2.41 82.56 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.466 -1.243 . . . . 0.52 112.132 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.32 127.39 32.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.816 0.341 . . . . 0.43 110.547 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -178.9 5.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.126 -0.488 . . . . 1.25 110.589 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.439 ' HA ' HG23 ' A' ' 56' ' ' THR . 49.1 t -55.05 -58.87 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.41 112.021 -175.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 162' ' ' ASP . 4.0 ptmm? -66.49 -28.32 68.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 3.44 110.988 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 161' ' ' LYS . 62.3 m-20 -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 1.86 110.237 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.794 HG21 HD21 ' A' ' 39' ' ' LEU . 55.1 mt -82.54 -44.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.832 -0.622 . . . . 0.21 110.369 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.5 ' O ' HG13 ' A' ' 168' ' ' ILE . 61.2 mt-10 -56.45 -40.12 74.29 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 112.162 0.43 . . . . 0.88 112.162 -176.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.36 -20.93 47.86 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.012 0.375 . . . . 0.75 112.012 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.637 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 63.1 mmtt -105.4 -25.71 12.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.587 0.232 . . . . 1.58 110.456 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 44.4 tp -85.78 -34.73 21.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.24 112.036 -169.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.719 ' HA ' HD12 ' A' ' 171' ' ' LEU . 81.4 mt -50.37 -48.03 81.85 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.271 0.471 . . . . 0.44 112.271 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 75.2 Cg_exo -51.81 -38.49 67.61 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.253 1.969 . . . . 0.49 113.335 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 2.2 mm? -74.07 -42.45 60.17 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 121.076 -0.25 . . . . 0.71 111.036 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.934 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 9.7 mt -57.06 -46.4 82.51 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.2 -0.667 . . . . 0.46 109.2 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -50.8 -73.54 0.37 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.709 -1.132 . . . . 1.52 111.943 168.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 22.9 t 175.28 135.56 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.668 0.387 . . . . 2.52 110.536 175.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.629 ' HB2' HD12 ' A' ' 170' ' ' LEU . . . -94.19 -47.59 6.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.832 -0.622 . . . . 3.56 111.52 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -149.29 19.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.172 0.51 . . . . 7.86 110.717 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.3 tp . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.321 -0.847 . . . . 4.81 109.773 -176.388 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.94 0 N-CA-C 112.534 -0.226 . . . . 5.51 112.534 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.1 ttt -111.06 -27.8 8.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.157 0.504 . . . . 5.05 110.15 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.42 25.25 68.56 Favored Glycine 0 C--O 1.227 -0.31 0 CA-C-N 115.648 -0.705 . . . . 1.37 113.191 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -69.27 -45.77 68.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.053 0.454 . . . . 1.68 110.974 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.8 p -153.2 173.36 15.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 0.65 109.199 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.792 HD13 HG21 ' A' ' 144' ' ' ILE . 25.9 pt -56.0 -32.3 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.3 111.583 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.809 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 47.4 m-85 -71.17 -14.31 62.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.27 111.97 -172.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -69.6 -15.02 63.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.312 0.577 . . . . 1.96 109.655 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 86.2 m-85 -103.66 174.13 6.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.342 -0.844 . . . . 0.4 111.528 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 10.5 tt0 -91.74 152.09 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.21 -0.904 . . . . 2.77 110.895 -177.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.609 HG12 ' HB3' ' A' ' 28' ' ' TYR . 93.7 t -138.78 145.45 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.119 0.485 . . . . 0.74 110.413 169.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.924 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 69.3 mt -119.91 148.12 43.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.706 -0.679 . . . . 0.72 109.472 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.66 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 14.5 t70 -78.88 -173.96 3.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.917 -0.771 . . . . 1.59 108.917 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.675 ' HB1' ' HG2' ' A' ' 97' ' ' LYS . . . -52.76 -27.0 15.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.338 0.496 . . . . 0.52 112.338 -172.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.86 25.0 10.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.289 0.477 . . . . 2.22 112.289 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.924 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 46.0 m-70 72.38 9.2 5.82 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 121.658 0.742 . . . . 0.73 110.538 171.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.66 ' HE3' ' HB3' ' A' ' 22' ' ' ASP . 23.9 mtmt -64.25 135.64 96.42 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 106.811 -1.551 . . . . 3.25 106.811 165.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.61 114.17 1.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.208 1.272 . . . . 0.86 112.226 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.609 ' HB3' HG12 ' A' ' 20' ' ' VAL . 46.3 t80 -93.61 110.06 21.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.495 -0.775 . . . . 0.28 111.011 175.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.556 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.6 t30 -71.5 93.26 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.136 -0.69 . . . . 1.65 109.136 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.794 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.17 -27.77 65.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.019 -0.537 . . . . 0.25 111.261 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.809 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.7 p -76.73 -1.47 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 113.181 0.808 . . . . 0.41 113.181 -166.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 26.8 pt20 -78.13 -5.39 51.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.319 0.58 . . . . 1.24 109.65 172.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.35 4.58 53.25 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HE3' ' CG2' ' A' ' 31' ' ' VAL . 31.1 ttmt -78.61 146.64 34.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.289 -0.869 . . . . 1.73 110.048 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.23 5.28 89.09 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.043 -1.223 . . . . 0.36 110.043 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.659 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.7 m -141.96 139.13 17.69 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 114.416 -0.892 . . . . 1.14 108.877 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.953 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.7 Cg_endo -72.85 150.55 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.625 1.55 . . . . 0.52 110.805 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.67 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -153.32 151.41 29.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.198 0.523 . . . . 1.03 111.003 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.771 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -107.25 152.75 23.68 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.735 -0.839 . . . . 1.1 108.735 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 81.0 mt -140.76 114.66 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.974 -0.75 . . . . 0.2 108.974 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.778 ' CD2' ' HB3' ' A' ' 139' ' ' PHE . 21.2 m-85 -102.66 122.99 45.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.336 . . . . 0.23 110.747 -173.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.683 ' HB3' HG11 ' A' ' 110' ' ' VAL . 5.4 p30 -80.92 91.78 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.374 -0.973 . . . . 1.28 108.374 168.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 139' ' ' PHE . 2.5 p -110.61 131.99 60.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 113.167 0.803 . . . . 0.88 113.167 -163.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 111.92 2.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.259 -1.385 . . . . 0.52 107.259 167.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 1.068 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.43 64.33 1.56 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.501 0.926 . . . . 1.84 113.501 -161.128 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.858 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 1.1 tppp? 76.73 52.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.728 1.211 . . . . 2.43 112.503 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -145.91 131.25 18.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.02 -0.733 . . . . 0.99 109.02 170.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.78 -82.77 1.62 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.631 -0.795 . . . . 1.09 113.947 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -137.33 166.51 23.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.87 0.335 . . . . 3.16 111.295 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.7 p -134.65 -41.35 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.199 -0.455 . . . . 1.94 111.745 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.586 ' HD2' ' HG2' ' A' ' 156' ' ' PRO . 27.5 ttmt 71.15 0.56 3.47 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.873 0.869 . . . . 2.03 112.227 175.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.33 39.24 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.71 -0.757 . . . . 0.47 112.829 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.35 74.82 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 111.542 -0.623 . . . . 0.34 111.542 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 1.1 t80 -71.42 -56.6 5.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.837 0.351 . . . . 0.57 110.416 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.92 -43.51 91.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.05 -0.523 . . . . 2.46 110.755 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' HA ' ' A' ' 160' ' ' VAL . 94.0 m -63.63 -49.28 73.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.33 111.11 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.36 -46.13 91.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 0.19 111.719 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.565 HG23 ' HB2' ' A' ' 101' ' ' GLU . 22.6 m -62.24 -47.75 82.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 0.3 111.284 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.2 p -64.0 -41.93 97.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.326 -0.397 . . . . 1.08 111.045 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.516 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 82.3 mt -58.21 -52.92 63.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 116.335 -0.393 . . . . 0.81 110.605 175.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.533 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 60.4 t80 -50.41 -56.58 10.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.387 -0.824 . . . . 0.33 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -70.9 -32.12 68.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 1.76 112.145 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.88 -47.08 11.44 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.788 -0.365 . . . . 1.79 111.538 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.699 ' CD1' HD13 ' A' ' 171' ' ' LEU . 63.1 m-85 -96.61 7.44 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.33 0.863 . . . . 0.43 113.33 -170.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -25.11 62.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.417 . . . . 2.11 109.916 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -59.93 -34.78 73.69 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.451 -0.795 . . . . 1.2 111.363 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -95.85 6.13 49.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.935 0.398 . . . . 1.9 110.897 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.64 67.22 1.53 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.63 -0.795 . . . . 1.32 111.433 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CE1' HD13 ' A' ' 39' ' ' LEU . 80.1 t80 -131.52 136.44 47.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.394 -0.224 . . . . 0.26 110.394 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.67 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -128.91 146.73 50.87 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 110.066 -0.346 . . . . 0.51 110.066 178.613 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.846 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.4 t -114.08 113.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.801 -0.444 . . . . 0.24 109.801 169.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 27.0 mt -95.79 121.58 37.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.576 -0.898 . . . . 0.51 108.576 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.07 112.36 24.5 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.064 -0.654 . . . . 0.28 110.573 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.878 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.5 m-85 -96.22 108.16 39.77 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 109.041 -0.726 . . . . 0.34 109.041 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.078 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 32.3 Cg_exo -61.25 171.02 4.44 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.811 3.007 . . . . 0.73 112.114 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.4 t -129.98 135.62 48.5 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.875 1.065 . . . . 1.54 113.875 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.516 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 71.1 m-20 -103.69 95.49 6.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.268 -1.333 . . . . 2.52 109.358 169.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.794 ' HB3' ' H ' ' A' ' 88' ' ' GLU . 1.6 mp0 -59.31 -10.72 3.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.915 0.709 . . . . 3.18 112.915 -178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -66.26 -10.51 42.89 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.565 0.346 . . . . 3.8 111.845 -173.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.12 -35.16 82.91 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.689 -0.767 . . . . 1.45 111.676 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.67 -62.31 0.63 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.916 -0.659 . . . . 1.43 112.732 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.673 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.4 pm0 -103.78 7.43 37.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.387 -0.525 . . . . 1.43 111.892 -172.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.696 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 1.5 mm-40 -59.76 144.87 84.84 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 107.717 -1.216 . . . . 3.06 107.717 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.711 ' HD3' ' O ' ' A' ' 110' ' ' VAL . 8.2 Cg_exo -16.64 145.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 126.722 4.948 . . . . 1.61 116.697 -159.274 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 136' ' ' LYS . . . -46.65 -19.15 0.44 Allowed Glycine 0 N--CA 1.468 0.79 0 CA-C-N 114.228 -1.351 . . . . 1.39 115.367 -164.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 13.8 m120 -52.8 -28.89 24.6 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.832 0.316 . . . . 3.69 111.267 168.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 11.3 pt-20 18.85 118.04 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 127.25 2.22 . . . . 2.47 115.514 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.794 ' H ' ' HB3' ' A' ' 78' ' ' GLN . 34.3 tt0 62.08 34.77 16.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.404 -1.271 . . . . 3.64 109.39 -174.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 5.6 tp10 -73.73 -12.77 60.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.388 -0.824 . . . . 2.42 109.253 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.803 HG12 ' SG ' ' A' ' 95' ' ' CYS . 1.6 mt -96.86 23.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.346 -0.843 . . . . 2.05 110.183 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.769 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . 13.4 ptmt -74.76 106.62 6.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.67 -0.493 . . . . 4.0 109.67 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.89 -31.67 0.22 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.579 0.751 . . . . 3.1 110.401 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 68.3 m-85 -68.44 168.3 13.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.417 -0.586 . . . . 1.91 109.417 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.23 117.01 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.162 0.506 . . . . 1.65 110.873 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.803 ' SG ' HG12 ' A' ' 90' ' ' ILE . 97.1 m -99.62 115.46 29.46 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 120.194 -0.602 . . . . 0.91 109.854 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.3 m -155.59 119.31 4.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.365 -0.834 . . . . 1.92 109.728 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.687 ' O ' HG21 ' A' ' 104' ' ' ILE . 63.2 mttp 68.84 -44.35 0.52 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 113.699 1.0 . . . . 3.18 113.699 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.858 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 65.67 -32.23 0.16 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.076 0.951 . . . . 1.74 111.077 -168.262 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.812 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 8.3 mmpt? 72.93 127.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.094 0.958 . . . . 3.08 111.892 171.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.862 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -161.07 -173.18 3.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.423 0.63 . . . . 0.43 112.629 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HB2' HG23 ' A' ' 58' ' ' THR . 48.6 mt-10 -93.33 9.1 37.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.006 -0.997 . . . . 2.19 111.66 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.738 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 32.1 p90 -128.71 173.73 5.28 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.575 -0.898 . . . . 0.24 108.575 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 24.0 Cg_exo -70.39 100.25 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.332 0 C-N-CA 123.156 2.57 . . . . 0.31 113.232 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.032 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.8 mp -94.96 133.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.606 -0.887 . . . . 0.37 108.606 173.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.878 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.9 OUTLIER -106.46 -160.02 0.72 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.439 -0.8 . . . . 1.47 111.979 -163.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.562 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.16 132.53 43.36 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.574 -0.739 . . . . 0.39 110.067 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.078 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.7 pttt -69.82 121.52 17.42 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.485 0.66 . . . . 1.66 109.347 172.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.455 HG13 HG13 ' A' ' 110' ' ' VAL . 11.7 pt -120.54 170.96 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.797 -1.092 . . . . 0.47 108.532 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 9.8 m-80 -78.68 69.46 4.86 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.848 -0.614 . . . . 2.16 110.379 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.711 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -73.09 85.18 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 118.704 -1.198 . . . . 0.38 110.829 -177.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.673 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 38.1 t30 171.33 178.42 0.06 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.686 -1.227 . . . . 1.98 107.686 160.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.83 -146.86 26.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.82 -0.705 . . . . 0.78 114.687 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.22 -15.02 29.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -0.716 . . . . 1.98 110.672 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.24 -12.92 58.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.755 -0.657 . . . . 2.04 111.376 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -49.29 135.64 16.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.994 0.739 . . . . 0.48 112.994 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -51.16 131.96 31.71 Favored Pre-proline 0 C--O 1.226 -0.137 0 CA-C-O 118.389 -0.815 . . . . 0.42 109.178 169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.55 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -38.79 -43.67 2.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.346 2.697 . . . . 0.36 112.924 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.559 HD11 ' HE3' ' A' ' 122' ' ' MET . 30.9 tp -54.22 -47.1 72.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.664 -0.698 . . . . 1.1 112.09 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.496 ' HE2' HD21 ' A' ' 42' ' ' ASN . 2.2 m-85 -73.96 -29.04 61.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 119.469 -0.301 . . . . 1.49 111.276 177.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.39 -39.31 72.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.353 -0.939 . . . . 2.37 108.581 168.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 80.4 t80 -68.38 -45.06 73.74 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.181 -0.463 . . . . 0.58 110.635 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.559 ' HE3' HD11 ' A' ' 118' ' ' LEU . 67.1 mtt -65.2 -55.75 16.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.579 -0.282 . . . . 0.34 111.302 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.8 mtpt -57.07 -42.62 80.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.94 110.904 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.6 ptmm? -69.82 -37.11 76.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.302 -0.408 . . . . 2.13 110.922 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 150' ' ' PRO . 92.4 m -64.73 -39.44 93.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.47 111.392 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 18.6 ttmm -152.57 107.89 2.74 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.716 0.635 . . . . 1.75 112.716 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 153' ' ' ARG . 78.3 Cg_endo -81.73 170.0 14.59 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.906 2.404 . . . . 1.76 110.759 166.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.802 ' HA2' HG22 ' A' ' 132' ' ' THR . . . 165.86 151.78 6.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.541 -1.314 . . . . 2.37 113.403 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.751 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 66.6 mt 78.54 123.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 123.908 0.883 . . . . 3.56 112.295 172.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 129' ' ' ILE . 2.7 pp 58.19 -64.99 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.533 1.533 . . . . 2.76 113.481 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.588 ' HB3' ' HE3' ' A' ' 136' ' ' LYS . . . -138.18 101.38 4.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.099 -0.704 . . . . 2.84 109.099 178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.802 HG22 ' HA2' ' A' ' 128' ' ' GLY . 16.6 p -72.18 103.71 3.42 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.34 0.867 . . . . 3.9 113.34 -169.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 127' ' ' PRO . 20.4 ttmm 175.18 -53.54 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.394 -0.821 . . . . 5.13 110.657 169.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.543 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -123.98 179.86 4.68 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.709 1.003 . . . . 0.93 113.709 -160.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.805 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.9 mt -93.23 103.14 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.388 -1.278 . . . . 1.05 110.199 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.588 ' HE3' ' HB3' ' A' ' 131' ' ' ALA . 36.2 mmtt -106.83 0.6 24.14 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.708 0.633 . . . . 1.5 112.708 -167.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.805 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.62 171.86 19.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.157 0.799 . . . . 0.87 113.157 -163.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.609 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 16.3 m120 -46.3 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.096 -1.865 . . . . 1.8 114.103 167.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.778 ' HB3' ' CD2' ' A' ' 41' ' ' TYR . 62.1 m-85 -27.37 -59.06 0.1 Allowed 'General case' 0 C--O 1.204 -1.334 0 C-N-CA 125.158 1.383 . . . . 1.37 113.003 -167.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.909 HG23 ' HA ' ' A' ' 155' ' ' SER . 10.1 m 38.48 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.397 0.888 . . . . 0.3 113.397 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.685 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 12.1 p -85.51 152.93 22.8 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.055 -0.52 . . . . 0.8 111.358 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -103.0 135.23 45.08 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.581 -1.266 . . . . 0.53 107.581 163.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 170' ' ' LEU . 25.4 tp -81.12 105.45 12.34 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.625 -0.88 . . . . 0.51 108.625 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.792 HG21 HD13 ' A' ' 15' ' ' ILE . 19.2 mm -101.17 123.78 54.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.478 -0.783 . . . . 0.2 108.973 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 0.8 OUTLIER -75.77 -179.8 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 1.3 110.529 -175.675 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 52.8 mtt180 -62.61 -13.56 32.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.585 0.587 . . . . 3.78 112.585 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -108.32 -17.58 13.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.201 0.524 . . . . 1.18 110.278 -172.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.533 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.16 34.44 3.96 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.616 -0.72 . . . . 0.23 112.971 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -118.7 123.84 28.83 Favored Pre-proline 0 C--N 1.316 -0.85 0 O-C-N 122.635 -0.332 . . . . 0.62 110.276 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' ' 125' ' ' THR . 75.5 Cg_exo -53.94 112.98 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.34 2.693 . . . . 0.3 112.97 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.417 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.9 t -92.5 -30.32 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.768 -0.651 . . . . 0.27 110.475 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' HA ' ' CD ' ' A' ' 126' ' ' LYS . 61.3 mm-40 -155.61 164.07 39.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.36 -0.382 . . . . 1.22 111.027 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.494 ' CZ ' ' HA ' ' A' ' 127' ' ' PRO . 16.7 ttm180 -127.24 102.15 6.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.495 -0.557 . . . . 1.75 109.495 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.604 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 36.8 m-85 -98.5 117.15 32.28 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.105 -0.702 . . . . 0.38 109.105 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.909 ' HA ' HG23 ' A' ' 140' ' ' THR . 53.7 p -69.99 178.22 1.1 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 118.77 0.714 . . . . 0.99 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.745 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.0 Cg_endo -68.24 -14.88 41.58 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.758 1.638 . . . . 0.66 111.122 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.26 13.76 43.58 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.52 112.047 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.55 132.21 40.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.921 0.391 . . . . 0.43 110.611 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.524 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 32.1 m -82.87 164.03 20.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.108 -0.496 . . . . 1.25 110.778 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.457 ' HA ' HG23 ' A' ' 56' ' ' THR . 28.9 t -52.23 -54.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.41 111.791 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 161' ' ' LYS . 25.9 tptt -69.78 -26.16 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 3.44 110.729 -174.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 159' ' ' SER . 21.6 m-20 -67.11 -29.66 69.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 1.86 110.105 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 39' ' ' LEU . 62.7 mt -82.7 -40.83 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.354 -0.384 . . . . 0.21 110.541 174.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 48.4 mt-10 -56.07 -35.52 67.07 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.777 0.658 . . . . 0.88 112.777 -176.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.3 pt-20 -58.03 -26.38 62.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.75 111.202 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.604 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 48.3 mmtm -105.09 -14.1 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.039 0.447 . . . . 1.58 110.335 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.661 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 68.1 tp -95.16 -41.52 9.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 0.24 112.13 -171.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.76 ' HA ' HD12 ' A' ' 171' ' ' LEU . 74.3 mt -51.56 -53.26 52.05 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 112.821 0.674 . . . . 0.44 112.821 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.92 -30.0 84.25 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.946 1.764 . . . . 0.49 112.553 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 143' ' ' LEU . 58.7 mt -81.22 -32.51 33.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.612 -0.267 . . . . 0.71 111.147 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.953 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.0 mt -58.57 -50.81 72.43 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.115 -0.698 . . . . 0.46 109.115 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -50.3 -57.28 10.51 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.41 -1.268 . . . . 1.52 112.344 169.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.488 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 22.9 t 178.06 137.39 0.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.663 -0.495 . . . . 2.52 109.663 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.506 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -93.49 -34.34 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.444 0.64 . . . . 3.56 109.925 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -168.28 -34.99 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.684 -1.144 . . . . 7.86 108.107 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 C--O 1.248 0.992 0 CA-C-N 114.652 -1.158 . . . . 4.81 108.811 172.526 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.158 -0.377 . . . . 5.51 112.158 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 48.9 ttp -143.1 51.35 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.569 -0.901 . . . . 5.05 108.569 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.33 73.55 1.1 Allowed Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.068 -0.969 . . . . 1.37 113.528 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -87.78 -29.16 21.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.462 -0.94 . . . . 1.68 108.462 171.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 p -145.81 156.76 43.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.839 -1.073 . . . . 0.65 108.806 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 144' ' ' ILE . 16.6 pt -56.32 -22.11 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 113.442 0.904 . . . . 0.3 113.442 -170.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.81 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 69.5 m-85 -83.17 1.04 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.028 0.381 . . . . 0.27 112.028 -172.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.89 -20.71 61.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.776 -0.824 . . . . 1.96 108.776 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 77.3 m-85 -95.38 156.91 16.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.964 -1.016 . . . . 0.4 110.571 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.6 tt0 -101.27 141.87 33.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.906 -0.588 . . . . 2.77 110.189 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.509 HG23 HD13 ' A' ' 30' ' ' LEU . 64.3 t -114.61 150.62 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.785 0.326 . . . . 0.74 110.914 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.826 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 85.2 mt -108.28 133.89 51.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.175 -0.466 . . . . 0.72 110.161 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.98 176.88 2.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.103 -0.953 . . . . 1.59 109.775 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.561 ' HB1' ' HD3' ' A' ' 97' ' ' LYS . . . -51.48 -29.99 18.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.126 0.488 . . . . 0.52 110.847 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' A' ' 26' ' ' LYS . 22.5 t70 -96.78 1.34 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 2.22 111.649 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.826 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 46.9 m80 74.94 12.51 3.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.058 0.543 . . . . 0.73 110.825 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 10.7 mmpt? -69.92 146.04 94.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 106.067 -1.827 . . . . 3.25 106.067 165.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.45 113.04 1.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 119.762 0.951 . . . . 0.86 110.985 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.451 ' HB3' HG12 ' A' ' 20' ' ' VAL . 65.6 t80 -79.28 128.23 33.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.28 110.47 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.659 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 62.4 t30 -76.99 81.88 3.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.604 -0.725 . . . . 1.65 109.255 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.81 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.13 -33.8 70.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.42 0.629 . . . . 0.25 110.31 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.684 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.6 p -77.6 -0.86 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.179 -0.919 . . . . 0.41 112.611 -168.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.3 pt20 -82.79 -6.41 59.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.064 -0.717 . . . . 1.24 109.064 173.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.528 ' HB3' HD13 ' A' ' 38' ' ' LEU . 91.9 m-70 -93.67 -2.3 54.12 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.38 108.398 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -78.12 142.38 38.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.788 -1.096 . . . . 1.73 110.187 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.0 -19.09 25.65 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.36 110.508 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 70.1 m -141.84 139.13 17.84 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.585 -0.894 . . . . 1.14 108.585 177.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.694 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 24.5 Cg_exo -65.35 153.48 78.05 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.738 2.292 . . . . 0.52 112.289 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' A' ' 33' ' ' HIS . 2.3 pt? -154.63 159.25 40.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.302 -0.863 . . . . 1.03 109.766 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -113.69 157.77 21.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.967 -0.382 . . . . 1.1 109.967 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 72' ' ' LEU . 93.3 mt -141.97 116.46 5.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.715 -0.675 . . . . 0.2 109.621 -176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.929 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.8 m-85 -103.16 123.58 46.96 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.134 -0.226 . . . . 0.23 111.038 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.614 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -79.31 92.89 5.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.354 -0.98 . . . . 1.28 108.354 168.089 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.6 p -112.95 131.57 64.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 112.95 0.722 . . . . 0.88 112.95 -163.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 90' ' ' ILE . . . -54.61 114.22 1.6 Allowed 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.18 -1.044 . . . . 0.52 108.18 169.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.995 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.62 81.28 2.61 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.366 -1.288 . . . . 1.84 113.191 -162.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 42.8 tptt 72.66 50.6 0.17 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.003 -0.999 . . . . 2.43 109.872 177.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 p -163.16 143.76 9.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.7 -0.682 . . . . 0.99 111.233 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.79 -155.64 35.5 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.82 -0.627 . . . . 1.09 113.258 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -95.32 147.52 23.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.123 0.487 . . . . 3.16 110.612 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 p -88.69 -27.08 21.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.925 -0.579 . . . . 1.94 112.208 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.911 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.2 mtpp 65.8 -4.07 0.66 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.369 0.668 . . . . 2.03 112.069 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.67 0.01 29.06 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.116 -0.564 . . . . 0.47 112.429 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.02 -34.84 77.29 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.373 -0.441 . . . . 0.34 112.294 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.628 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -73.03 -47.57 43.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.722 0.296 . . . . 0.57 110.224 -176.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.685 -0.487 . . . . 2.46 109.685 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 160' ' ' VAL . 98.8 m -64.03 -48.31 76.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.422 -0.808 . . . . 0.33 110.633 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.903 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -62.44 -50.54 71.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.362 -0.381 . . . . 0.19 111.606 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.6 m -54.79 -48.91 72.11 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.3 111.083 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.5 m -63.69 -45.72 88.73 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.205 -0.452 . . . . 1.08 111.336 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 64.5 mt -60.33 -52.09 66.74 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 111.842 0.312 . . . . 0.81 111.842 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.78 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 59.5 t80 -52.1 -46.68 65.35 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.33 109.422 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -73.31 -37.09 66.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.255 0.55 . . . . 1.76 111.081 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -73.49 -33.33 64.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.343 -0.844 . . . . 1.79 111.74 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.619 ' CD1' HD13 ' A' ' 171' ' ' LEU . 72.3 m-85 -121.88 14.15 10.74 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 114.471 1.286 . . . . 0.43 114.471 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.78 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 21.5 mtmm -57.52 -26.52 61.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.899 -0.72 . . . . 2.11 110.385 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 m -57.16 -41.23 78.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.631 . . . . 1.2 111.708 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.751 ' OE1' ' HB2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -91.89 -4.33 54.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.573 -0.451 . . . . 1.9 111.038 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.23 20.0 7.3 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.823 -0.703 . . . . 1.32 114.069 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.751 ' HB2' ' OE1' ' A' ' 67' ' ' GLN . 75.2 t80 -77.28 137.33 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.037 0.418 . . . . 0.26 111.306 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 2.4 t -132.01 142.31 49.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.839 -0.801 . . . . 0.51 108.839 173.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.903 HG11 ' HB1' ' A' ' 57' ' ' ALA . 40.8 t -105.56 105.87 19.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.933 -0.765 . . . . 0.24 108.933 169.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.654 ' HB2' HG12 ' A' ' 40' ' ' ILE . 25.6 mt -89.53 120.92 31.26 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.174 -1.047 . . . . 0.51 108.174 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.062 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.6 112.23 24.47 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.073 -0.651 . . . . 0.28 110.216 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.795 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -95.55 108.05 37.15 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 108.605 -0.887 . . . . 0.34 108.605 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.995 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.9 Cg_exo -59.82 168.92 5.04 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.35 2.7 . . . . 0.73 111.397 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.412 ' CB ' HE22 ' A' ' 78' ' ' GLN . 37.4 m -114.41 134.59 54.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.625 1.202 . . . . 1.54 113.847 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.635 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 3.0 t-20 -93.04 64.62 3.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.348 -1.751 . . . . 2.52 109.679 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.759 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 9.2 mp0 -53.06 -13.7 0.5 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.351 0.871 . . . . 3.18 113.351 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -70.28 -19.19 63.12 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.341 0.591 . . . . 3.8 110.317 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.21 -47.92 86.38 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.303 -0.862 . . . . 1.45 112.462 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.71 -58.15 0.6 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.901 -1.142 . . . . 1.43 113.016 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.825 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -93.34 11.81 26.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.421 0.61 . . . . 1.43 112.216 -175.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.759 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 26.3 mm-40 -62.22 149.37 87.21 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 120.422 -0.511 . . . . 3.06 111.95 -172.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.987 ' HG3' HG22 ' A' ' 135' ' ' ILE . 9.1 Cg_exo -36.5 165.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.905 3.736 . . . . 1.61 116.258 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.49 82.13 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.802 -1.319 . . . . 1.39 109.802 -171.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.581 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 64.5 t30 54.97 30.45 14.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.336 -0.932 . . . . 3.69 110.853 -177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 2.8 pt-20 64.88 -14.19 0.1 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.732 1.213 . . . . 2.47 112.877 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -85.2 -15.57 43.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.702 0.287 . . . . 3.64 111.323 -169.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -79.88 -61.51 1.97 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.987 -0.285 . . . . 2.42 110.895 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.797 HG12 ' SG ' ' A' ' 95' ' ' CYS . 3.0 mt -84.82 58.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 122.952 1.358 . . . . 2.05 110.511 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 91' ' ' LYS . 25.8 mmmt -73.95 -78.02 0.1 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.894 -1.503 . . . . 4.0 110.569 168.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -92.3 19.02 7.46 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.25 -0.886 . . . . 3.1 111.074 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 97.9 m-85 -107.66 168.87 8.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.308 -0.626 . . . . 1.91 109.308 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 p -128.72 151.82 36.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.484 -0.561 . . . . 1.65 109.484 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.797 ' SG ' HG12 ' A' ' 90' ' ' ILE . 60.6 m -138.72 122.81 17.97 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.696 -0.401 . . . . 0.91 112.071 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 t -149.42 119.65 7.29 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.892 -0.594 . . . . 1.92 110.27 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HD3' ' HB1' ' A' ' 23' ' ' ALA . 25.7 pttt 28.44 89.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.764 1.226 . . . . 3.18 114.297 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.743 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -60.79 131.4 50.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.853 -1.165 . . . . 1.74 107.853 170.149 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.435 ' N ' ' HD2' ' A' ' 99' ' ' LYS . 11.2 mptt -91.35 147.62 22.91 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.394 -0.523 . . . . 3.08 111.213 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -158.54 -166.76 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.847 0.717 . . . . 0.43 111.33 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -81.62 -34.1 31.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.373 0.606 . . . . 2.19 110.507 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.743 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 29.4 p90 -84.46 166.74 31.07 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 115.287 -0.87 . . . . 0.24 109.774 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 23.5 Cg_exo -72.1 103.12 1.44 Allowed 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.018 3.145 . . . . 0.31 113.571 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.062 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mp -94.66 134.25 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.884 -0.784 . . . . 0.37 108.884 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.795 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -109.01 -154.22 0.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 1.47 112.522 -163.159 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.9 135.55 41.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.218 -0.901 . . . . 0.39 110.23 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.981 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.5 pttp -73.36 125.1 27.07 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.713 0.768 . . . . 1.66 108.997 171.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.499 HG13 HG13 ' A' ' 110' ' ' VAL . 12.1 pt -122.17 174.36 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 106.914 -1.513 . . . . 0.47 106.914 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.828 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 22.5 m-80 -83.86 81.17 8.89 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.035 -0.666 . . . . 2.16 109.868 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -79.29 84.12 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 118.468 -1.293 . . . . 0.38 109.085 177.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.825 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 56.5 t30 170.35 179.5 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.418 -1.327 . . . . 1.98 107.418 166.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.68 ' HA3' ' HG3' ' A' ' 82' ' ' GLN . . . 56.81 -152.07 23.9 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 115.615 1.006 . . . . 0.78 115.615 160.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.11 -20.9 22.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.148 -1.026 . . . . 1.98 110.695 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -92.94 6.58 47.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.538 -0.755 . . . . 2.04 110.564 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.828 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.09 141.98 38.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.885 -1.052 . . . . 0.48 113.299 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.598 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 35.6 t-80 -54.25 135.25 60.23 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 115.477 -0.783 . . . . 0.42 109.087 167.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.16 -33.29 73.85 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.416 2.744 . . . . 0.36 112.85 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.598 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.7 tm? -62.32 -43.21 99.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 1.1 109.941 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.544 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.0 m-85 -75.59 -30.48 59.61 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.449 -0.341 . . . . 1.49 110.851 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.53 -41.15 76.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.89 -0.724 . . . . 2.37 109.206 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 69.7 t80 -65.81 -45.7 81.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.94 0.4 . . . . 0.58 110.442 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.504 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.3 mtt -65.38 -53.29 45.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.144 -0.48 . . . . 0.34 111.806 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.4 mtpt -59.19 -39.21 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.94 110.644 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.3 ptmt -74.62 -36.84 62.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 2.13 111.031 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.499 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.0 m -70.55 -43.24 69.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.4 -0.363 . . . . 0.47 111.916 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.634 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.9 tmtt? -137.18 100.71 9.46 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.422 -0.511 . . . . 1.75 111.484 -176.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 2.7 Cg_endo -47.53 -52.91 7.23 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.203 3.269 . . . . 1.76 113.463 173.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.93 -154.46 24.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.723 -1.227 . . . . 2.37 113.566 174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.4 mt -73.98 -62.19 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.155 0.502 . . . . 3.56 110.37 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.814 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.1 pt? -87.89 -165.3 1.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.203 -1.036 . . . . 2.76 108.203 172.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -50.76 -56.01 14.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.202 -0.295 . . . . 2.84 110.202 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.531 HG21 ' HD2' ' A' ' 153' ' ' ARG . 6.8 m 63.71 -78.57 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.432 -0.804 . . . . 3.9 112.003 172.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.8 tttm 69.61 -70.02 0.15 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.674 0.79 . . . . 5.13 111.933 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.507 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -109.69 -179.77 3.91 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.145 0.424 . . . . 0.93 112.145 -173.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.987 HG22 ' HG3' ' A' ' 84' ' ' PRO . 38.5 mt -103.75 88.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.638 -0.71 . . . . 1.05 110.261 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -117.15 28.15 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.644 0.609 . . . . 1.5 112.644 -173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.849 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.14 169.49 23.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.05 0.452 . . . . 0.87 112.075 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -51.28 -155.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.869 1.668 . . . . 1.8 113.471 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.929 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 53.1 m-85 -24.86 -57.68 0.05 Allowed 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 125.451 1.5 . . . . 1.37 114.212 -165.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.772 HG23 ' HA ' ' A' ' 155' ' ' SER . 23.1 m 38.08 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.275 0.842 . . . . 0.3 113.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.635 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 11.9 p -84.34 152.18 24.26 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.094 -0.642 . . . . 0.8 111.532 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.9 m-85 -103.5 134.88 46.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.023 -1.102 . . . . 0.53 108.023 165.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.771 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.2 tp -82.0 104.7 12.55 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.063 -0.717 . . . . 0.51 109.063 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 15' ' ' ILE . 18.4 mm -102.8 124.12 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.602 -0.726 . . . . 0.2 109.26 -175.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 1.1 p-10 -78.7 -175.1 4.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.864 -0.334 . . . . 1.3 111.374 -175.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.618 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.8 mtp180 -57.11 -26.01 59.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.831 0.348 . . . . 3.78 111.912 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -108.5 -12.49 15.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.119 0.485 . . . . 1.18 110.829 -168.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.568 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.22 44.65 2.33 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.393 -0.908 . . . . 0.23 113.512 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.9 t -119.16 127.87 26.25 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.301 -0.629 . . . . 0.62 109.301 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.499 ' HD2' HG21 ' A' ' 125' ' ' THR . 11.5 Cg_exo -68.07 111.68 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.499 2.133 . . . . 0.3 111.383 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.634 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.8 t -94.96 -25.97 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.32 -0.4 . . . . 0.27 110.844 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.508 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 59.2 mm-40 -151.08 164.16 37.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.869 0.366 . . . . 1.22 111.032 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.531 ' HD2' HG21 ' A' ' 132' ' ' THR . 23.3 ttm180 -129.98 97.02 4.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.702 -0.851 . . . . 1.75 108.702 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.771 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 49.9 m-85 -88.89 108.66 19.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.461 -0.57 . . . . 0.38 109.461 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.772 ' HA ' HG23 ' A' ' 140' ' ' THR . 88.0 p -63.35 167.3 6.92 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.357 -0.609 . . . . 0.99 109.357 176.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.911 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 9.0 Cg_exo -67.61 -8.99 23.92 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.799 2.333 . . . . 0.66 112.197 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.93 -1.46 89.78 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 114.72 -1.127 . . . . 0.52 111.897 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.58 138.06 31.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.955 0.407 . . . . 0.43 110.43 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.57 172.44 8.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.191 -0.459 . . . . 1.25 110.536 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.437 ' HA ' HG23 ' A' ' 56' ' ' THR . 40.9 t -52.07 -44.88 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 0.41 111.07 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 161' ' ' LYS . 33.1 ttpt -66.41 -38.33 87.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.351 -0.841 . . . . 3.44 110.846 -175.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.64 -32.35 73.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.86 109.962 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 39' ' ' LEU . 59.1 mt -82.8 -43.18 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.21 111.184 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 33.2 mt-10 -55.54 -36.92 67.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.991 0.737 . . . . 0.88 112.991 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.58 -26.16 65.18 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.761 -0.376 . . . . 0.75 111.637 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.448 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 71.5 mmtt -102.06 -17.72 15.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.221 0.534 . . . . 1.58 110.155 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.641 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.7 tp -87.64 -49.28 7.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.683 . . . . 0.24 111.946 -172.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 70.1 mt -53.04 -48.09 93.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 112.596 0.591 . . . . 0.44 112.596 -174.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.0 Cg_endo -53.62 -42.65 64.27 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.116 1.877 . . . . 0.49 112.403 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.62 -44.23 82.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.526 -0.306 . . . . 0.71 110.996 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.694 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 46.5 mt -55.73 -51.46 67.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.448 0.642 . . . . 0.46 109.671 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.85 -63.05 4.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 114.16 -1.382 . . . . 1.52 113.062 168.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.4 p -169.72 119.84 0.65 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.049 0.424 . . . . 2.52 111.086 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -94.14 -58.68 2.16 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 121.015 0.436 . . . . 3.56 110.743 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -132.03 11.95 4.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.134 -1.061 . . . . 7.86 108.134 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 C--O 1.251 1.159 0 CA-C-N 113.819 -1.537 . . . . 4.81 107.304 -175.321 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 112.048 -0.421 . . . . 5.51 112.048 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -106.62 -23.87 12.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.97 0.414 . . . . 5.05 110.526 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.97 136.42 2.34 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.947 -0.644 . . . . 1.37 111.975 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 m -56.09 -48.75 75.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.167 0.508 . . . . 1.68 111.232 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -161.12 -177.86 6.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.574 -0.739 . . . . 0.65 109.301 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.666 HD13 HG21 ' A' ' 144' ' ' ILE . 20.8 pt -60.6 -27.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.741 0.305 . . . . 0.3 111.671 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.783 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 42.4 m-85 -77.73 6.49 7.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.27 111.652 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.89 -9.02 59.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.659 -0.867 . . . . 1.96 108.659 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 80.0 m-85 -116.61 149.8 39.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.824 -1.08 . . . . 0.4 109.811 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -99.98 146.47 26.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.835 0.35 . . . . 2.77 111.01 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -114.13 145.83 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.74 110.942 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.019 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 74.9 mt -99.31 134.65 41.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.088 -0.708 . . . . 0.72 109.088 170.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.06 -174.9 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.872 -0.788 . . . . 1.59 108.872 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 1.098 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -54.33 -29.98 49.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.218 0.532 . . . . 0.52 111.381 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.99 11.65 35.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.012 -0.54 . . . . 2.22 111.76 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 1.019 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 22.3 m-70 69.46 12.3 8.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.232 0.613 . . . . 0.73 110.593 176.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.792 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.2 mmpt? -75.83 145.85 78.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 106.563 -1.643 . . . . 3.25 106.563 165.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.92 114.52 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.267 1.311 . . . . 0.86 112.314 -173.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -85.83 115.72 23.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.355 -0.838 . . . . 0.28 109.602 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -71.39 96.07 1.42 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.654 -0.869 . . . . 1.65 108.654 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.75 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -75.61 -29.64 59.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.722 0.772 . . . . 0.25 109.562 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.783 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 11.7 p -77.5 -0.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.619 -1.173 . . . . 0.41 113.207 -166.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -81.7 -4.57 56.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.399 -0.593 . . . . 1.24 109.399 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -93.98 4.67 53.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.333 -0.988 . . . . 0.38 108.333 177.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.619 ' HE3' HG23 ' A' ' 31' ' ' VAL . 36.4 ttmt -82.28 130.48 35.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.99 -1.005 . . . . 1.73 109.138 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.61 58.7 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.158 -1.177 . . . . 0.36 110.158 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 14.3 m -138.23 139.31 25.08 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.587 -0.894 . . . . 1.14 108.587 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.097 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 40.5 Cg_endo -73.94 150.7 44.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.572 1.515 . . . . 0.52 110.41 174.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.625 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -154.4 153.5 31.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.307 0.575 . . . . 1.03 111.62 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -108.11 148.82 29.29 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.638 -0.875 . . . . 1.1 108.638 170.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 84.5 mt -132.07 119.51 40.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.573 -0.529 . . . . 0.2 109.573 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 26.5 m-85 -101.5 130.4 47.75 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.23 111.399 -172.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.735 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -90.58 93.31 9.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.503 -1.295 . . . . 1.28 107.503 174.012 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 139' ' ' PHE . 3.5 m -109.01 143.79 18.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 0.88 112.468 -163.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.88 17.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.653 -1.61 . . . . 0.52 106.653 165.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.665 ' OG ' ' HB3' ' A' ' 95' ' ' CYS . 3.2 p -74.02 86.33 1.82 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.844 -0.616 . . . . 1.84 112.294 -165.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 66.18 44.69 2.5 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.208 -0.905 . . . . 2.43 110.385 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.9 p -164.0 133.62 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.567 -0.742 . . . . 0.99 110.81 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.15 -149.04 18.29 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.505 -0.855 . . . . 1.09 113.869 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -96.54 111.3 23.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 122.694 0.398 . . . . 3.16 111.275 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.9 p -66.6 -34.52 78.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.703 0.26 . . . . 1.94 111.703 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.8 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 31.1 mtpp 66.32 -3.32 0.84 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.443 0.697 . . . . 2.03 112.536 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.446 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 109.38 3.55 30.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.886 -0.673 . . . . 0.47 112.464 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 139' ' ' PHE . . . -72.38 -39.46 57.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.225 -0.512 . . . . 0.34 111.828 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.737 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.5 t80 -69.18 -51.6 36.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.172 -0.307 . . . . 0.57 110.172 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.446 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 1.6 mp0 -51.78 -52.01 52.08 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.37 0.605 . . . . 2.46 110.707 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -64.41 -46.72 82.02 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.899 -1.046 . . . . 0.33 110.88 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.87 -48.14 82.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.137 -0.483 . . . . 0.19 111.262 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -58.48 -50.27 74.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.703 -0.681 . . . . 0.3 110.419 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.7 m -63.0 -43.28 99.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.263 -0.88 . . . . 1.08 111.597 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.522 HD13 HD22 ' A' ' 39' ' ' LEU . 76.2 mt -61.34 -50.27 73.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.372 0.138 . . . . 0.81 111.372 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.727 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.1 t80 -53.67 -49.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.33 109.83 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -73.02 -31.24 64.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.613 -0.721 . . . . 1.76 111.869 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.34 -45.59 19.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.225 -0.443 . . . . 1.79 111.267 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.625 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.2 m-85 -104.19 8.03 36.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.592 0.96 . . . . 0.43 113.592 -170.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -25.0 65.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.02 0.438 . . . . 2.11 110.144 170.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.0 t -59.26 -40.14 85.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.497 -0.774 . . . . 1.2 110.727 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -95.8 14.38 23.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 1.9 111.247 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.625 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.21 59.4 2.74 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 115.916 -0.583 . . . . 1.32 112.651 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 67.3 t80 -123.88 139.27 54.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.492 0.187 . . . . 0.26 111.121 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -127.71 144.49 51.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 120.82 0.343 . . . . 0.51 110.255 177.54 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.727 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 27.2 t -114.05 119.47 61.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 0.24 109.95 169.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.523 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 19.8 mt -103.36 121.57 43.05 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.188 -0.671 . . . . 0.51 109.188 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.012 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.02 132.25 53.73 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.364 -0.534 . . . . 0.28 110.431 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.2 m-85 -112.19 108.44 55.03 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-O 121.231 0.538 . . . . 0.34 110.711 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.601 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 64.1 Cg_exo -47.85 139.53 19.34 Favored 'Trans proline' 0 CA--C 1.514 -0.476 0 C-N-CA 124.781 3.654 . . . . 0.73 112.136 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 15.7 m -122.25 155.13 36.54 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 118.633 -1.227 . . . . 1.54 114.268 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.527 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 88.7 m-20 -106.12 85.86 2.27 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 113.235 -1.802 . . . . 2.52 110.679 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.98 ' HB2' HG13 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -58.61 -4.03 0.37 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.596 0.758 . . . . 3.18 113.0 176.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -84.61 8.37 17.03 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.233 0.539 . . . . 3.8 109.837 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.536 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . -77.32 -74.12 1.01 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.674 -0.694 . . . . 1.45 114.442 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.43 -41.58 0.24 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.649 -0.786 . . . . 1.43 112.175 -170.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.095 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -135.13 14.24 3.55 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.765 -0.256 . . . . 1.43 111.273 176.105 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.729 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -60.31 151.01 70.2 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 3.06 111.07 -173.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.759 ' HG3' HG22 ' A' ' 135' ' ' ILE . 32.6 Cg_exo -64.22 173.17 5.4 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.599 2.199 . . . . 1.61 112.952 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.56 19.02 57.61 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.899 -1.28 . . . . 1.39 109.899 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.28 65.66 0.49 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.403 -0.898 . . . . 3.69 110.705 -177.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 1.6 pm0 20.08 117.15 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 116.2 1.926 . . . . 2.47 116.2 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 49.1 mm-40 82.43 40.97 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.71 -1.132 . . . . 3.64 111.68 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.703 ' HB3' ' HG2' ' A' ' 78' ' ' GLN . 6.5 tp10 -75.27 -33.47 61.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.877 0.325 . . . . 2.42 111.877 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.98 HG13 ' HB2' ' A' ' 78' ' ' GLN . 2.8 mt -76.27 34.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.415 0.626 . . . . 2.05 111.075 -177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 89' ' ' GLU . 12.5 pttp -78.3 -17.74 56.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.804 0.811 . . . . 4.0 110.725 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.48 18.76 1.19 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.375 -1.284 . . . . 3.1 110.071 -173.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -135.38 174.02 11.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.664 -0.698 . . . . 1.91 110.432 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 94' ' ' VAL . 7.4 p -130.32 111.95 22.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.353 -1.351 . . . . 1.65 107.353 166.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.665 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 33.8 m -98.15 120.97 39.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 118.864 -1.135 . . . . 0.91 111.26 -174.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.856 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 12.1 t -139.61 156.94 46.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.899 -1.5 . . . . 1.92 107.568 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 1.098 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 5.7 pttt -39.08 101.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.835 0.71 . . . . 3.18 111.299 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.737 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 5.5 p90 -61.95 135.72 57.67 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.133 -1.432 . . . . 1.74 107.133 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -94.12 143.75 26.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.694 -0.802 . . . . 3.08 110.467 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.436 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -145.99 -162.03 1.43 Allowed 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.055 0.847 . . . . 0.43 111.428 -174.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -95.55 -5.37 42.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.625 . . . . 2.19 110.042 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.718 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 39.1 p90 -118.79 170.72 6.12 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.24 108.912 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.0 Cg_exo -71.19 125.83 11.78 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 123.599 2.866 . . . . 0.31 113.292 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.012 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.1 mp -120.9 140.64 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.338 -0.616 . . . . 0.37 109.338 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.735 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 10.9 mmt -111.1 -151.28 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 1.47 113.717 -163.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -73.73 163.71 27.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.247 -0.888 . . . . 0.39 111.528 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.856 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 82.4 mttt -87.74 112.38 22.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.853 -0.425 . . . . 1.66 109.853 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' SER . 14.7 pt -122.17 164.08 19.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.216 -0.661 . . . . 0.47 109.216 177.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 55.4 t-20 -96.43 80.33 3.15 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.692 -0.855 . . . . 2.16 108.692 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 42' ' ' ASN . 1.0 OUTLIER -65.88 91.47 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.132 -0.627 . . . . 0.38 110.298 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 1.095 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 0.5 OUTLIER 174.25 172.33 0.2 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.055 -0.35 . . . . 1.98 110.055 172.543 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.581 ' HA3' ' HG3' ' A' ' 82' ' ' GLN . . . 51.15 -133.69 32.95 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 123.944 0.777 . . . . 0.78 114.917 160.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -105.57 3.95 29.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.218 -0.991 . . . . 1.98 109.978 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.54 -5.56 18.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.959 -1.018 . . . . 2.04 110.958 -169.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -63.15 147.23 51.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.971 -0.559 . . . . 0.48 112.354 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.541 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 44.7 t-80 -50.36 136.06 23.6 Favored Pre-proline 0 C--O 1.225 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.42 109.412 168.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 6.0 Cg_endo -49.37 -32.25 25.6 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.693 2.928 . . . . 0.36 113.438 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.554 HD11 ' HE3' ' A' ' 122' ' ' MET . 22.4 tp -66.33 -39.5 89.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 1.1 110.901 175.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.749 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 4.5 m-85 -73.98 -31.13 62.85 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 116.433 -0.349 . . . . 1.49 110.283 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 117' ' ' PRO . 34.2 mm-40 -56.22 -42.68 77.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.09 -0.707 . . . . 2.37 109.09 168.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.694 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 90.1 t80 -65.26 -52.6 53.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.979 0.419 . . . . 0.58 111.557 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.554 ' HE3' HD11 ' A' ' 118' ' ' LEU . 55.6 mtt -64.41 -49.17 72.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.558 0.694 . . . . 0.34 110.871 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.79 ' HA ' ' HG2' ' A' ' 127' ' ' PRO . 4.6 tmtt? -70.74 -26.62 63.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.805 -1.089 . . . . 0.94 112.075 -174.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.8 ptmt -75.75 -27.59 58.16 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.85 0.357 . . . . 2.13 110.228 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.42 HG21 ' HD2' ' A' ' 150' ' ' PRO . 23.5 m -68.32 -60.43 2.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.703 0.631 . . . . 0.47 112.703 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.85 ' H ' ' HD2' ' A' ' 127' ' ' PRO . 25.9 tttp -122.49 -55.45 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 119.173 -1.011 . . . . 1.75 113.629 -172.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.85 ' HD2' ' H ' ' A' ' 126' ' ' LYS . 90.7 Cg_endo -68.66 176.75 5.52 Favored 'Trans proline' 0 C--N 1.334 -0.235 0 C-N-CA 123.569 2.846 . . . . 1.76 111.961 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' A' ' 133' ' ' LYS . . . 90.91 -27.17 9.29 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 116.031 -0.531 . . . . 2.37 112.104 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.0 pt -56.22 -22.59 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.387 0.884 . . . . 3.56 113.387 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.567 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.5 pt? -122.41 19.75 10.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.562 0.208 . . . . 2.76 111.562 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 70.62 -50.8 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.601 0.563 . . . . 2.84 111.697 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.461 ' HA ' ' CE ' ' A' ' 136' ' ' LYS . 11.4 m -44.24 -56.27 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.745 0.783 . . . . 3.9 111.607 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.764 ' O ' ' HB2' ' A' ' 127' ' ' PRO . 97.8 mttt -81.7 12.45 3.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.918 -1.037 . . . . 5.13 112.169 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.456 ' C ' HG13 ' A' ' 135' ' ' ILE . . . -86.63 24.08 1.52 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.988 0.423 . . . . 0.93 109.961 175.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.976 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 1.1 mt 65.84 138.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.708 -1.133 . . . . 1.05 110.151 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.461 ' CE ' ' HA ' ' A' ' 132' ' ' THR . 0.2 OUTLIER -178.6 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.582 0.706 . . . . 1.5 110.851 -175.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.976 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.18 170.08 9.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.054 -0.976 . . . . 0.87 111.663 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.573 ' HB3' ' HD1' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -52.56 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.839 1.422 . . . . 1.8 114.839 175.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.616 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 16.3 m-85 -28.42 -34.65 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 127.089 2.156 . . . . 1.37 115.904 -167.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . 1.086 HG23 ' HA ' ' A' ' 155' ' ' SER . 8.6 m 13.46 105.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.027 1.491 . . . . 0.3 115.027 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.48 158.85 20.88 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.746 0.784 . . . . 0.8 111.982 -174.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.616 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 16.3 m-85 -102.84 169.32 8.67 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.245 -1.391 . . . . 0.53 107.245 162.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.624 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 46.3 tp -116.5 105.94 13.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.753 -0.832 . . . . 0.51 108.753 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.666 HG21 HD13 ' A' ' 15' ' ' ILE . 13.4 mm -108.36 122.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.486 -0.561 . . . . 0.2 109.486 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -178.92 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.893 -0.323 . . . . 1.3 110.549 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.677 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -67.84 -6.6 22.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.184 -0.462 . . . . 3.78 112.164 -174.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.78 -22.29 12.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.491 0.662 . . . . 1.18 109.376 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 104.42 34.2 3.69 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.877 -1.056 . . . . 0.23 112.67 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 68.5 t -110.55 129.35 24.04 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.93 0.365 . . . . 0.62 110.569 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 149' ' ' VAL . 22.9 Cg_exo -65.21 107.99 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.149 2.566 . . . . 0.3 112.063 176.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 t -94.81 -12.1 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.136 -0.484 . . . . 0.27 110.893 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -177.53 167.41 2.24 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.135 0.493 . . . . 1.22 111.815 -179.404 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.805 ' NH2' HG12 ' A' ' 135' ' ' ILE . 15.2 ttm-85 -134.17 116.4 15.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.06 -0.973 . . . . 1.75 109.788 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 12.4 m-85 -104.09 134.15 47.82 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 108.393 -0.966 . . . . 0.38 108.393 176.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . 1.086 ' HA ' HG23 ' A' ' 140' ' ' THR . 52.7 p -76.33 176.36 3.41 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.114 0.87 . . . . 0.99 109.764 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.876 ' HG3' ' H ' ' A' ' 140' ' ' THR . 7.0 Cg_exo -69.11 -16.61 40.42 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.366 1.377 . . . . 0.66 110.749 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.57 89.4 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.6 -1.182 . . . . 0.52 111.89 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.92 133.48 36.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.564 -0.532 . . . . 0.43 109.564 176.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.5 m -78.59 160.02 27.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.855 -0.611 . . . . 1.25 110.657 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 58.1 t -50.04 -50.71 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.729 0.3 . . . . 0.41 110.486 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.745 -0.661 . . . . 3.44 111.779 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -65.81 -31.48 72.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.413 0.625 . . . . 1.86 109.733 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.827 HG21 HD21 ' A' ' 39' ' ' LEU . 54.0 mt -81.38 -41.7 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.527 -0.76 . . . . 0.21 110.189 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 45.0 mt-10 -55.76 -40.81 73.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.88 112.209 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.409 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 4.6 pt-20 -58.33 -27.62 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.75 111.6 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.538 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.6 mttp -104.28 -12.98 16.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 1.58 110.645 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.2 tp -93.38 -41.99 9.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 0.24 111.534 -174.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.72 ' HA ' HD12 ' A' ' 171' ' ' LEU . 79.5 mt -53.28 -48.97 90.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.489 0.551 . . . . 0.44 112.489 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 40.2 Cg_exo -59.05 -22.72 65.28 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.149 1.899 . . . . 0.49 113.04 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.52 -39.1 14.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.543 0.211 . . . . 0.71 110.734 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.097 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.4 mt -56.95 -53.47 57.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 0.46 109.271 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.49 51.75 2.23 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.565 -1.198 . . . . 1.52 113.741 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m 69.55 112.37 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.556 0.742 . . . . 2.52 112.625 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.02 -57.92 2.49 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.24 0.543 . . . . 3.56 110.343 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.645 ' HG3' HD22 ' A' ' 176' ' ' LEU . 1.5 ptm180 -134.55 -26.64 1.39 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.732 -0.84 . . . . 7.86 108.732 172.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.645 HD22 ' HG3' ' A' ' 175' ' ' ARG . 3.9 mm? . . . . . 0 C--O 1.248 0.982 0 CA-C-N 114.949 -1.023 . . . . 4.81 108.411 168.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 111.734 -0.546 . . . . 5.51 111.734 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 92.9 mmm -136.89 134.65 37.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.923 -0.399 . . . . 5.05 109.923 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.71 46.9 93.56 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.138 -0.553 . . . . 1.37 113.249 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -90.52 -45.57 8.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.091 0.472 . . . . 1.68 110.097 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.0 p -125.17 170.1 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.186 -0.672 . . . . 0.65 109.186 175.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.737 HD13 HG21 ' A' ' 144' ' ' ILE . 32.1 pt -59.91 -27.48 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.021 0.438 . . . . 0.3 111.34 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.902 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 55.4 m-85 -76.56 -1.75 29.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.508 0.559 . . . . 0.27 112.508 -171.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 -17.16 58.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.477 0.656 . . . . 1.96 109.578 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 87.1 m-85 -98.59 175.3 6.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 0.4 110.764 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -110.44 133.83 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 2.77 110.272 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 28' ' ' TYR . 77.5 t -115.22 149.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.933 0.397 . . . . 0.74 110.927 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.904 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 2.3 mp -114.98 141.1 48.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.927 -0.579 . . . . 0.72 109.87 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.96 175.57 1.16 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.516 -0.765 . . . . 1.59 109.327 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -47.54 -39.74 17.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.912 0.387 . . . . 0.52 111.685 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.05 8.53 39.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.18 -0.464 . . . . 2.22 112.218 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.904 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 23.0 m-70 72.21 26.08 2.8 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.501 0.667 . . . . 0.73 110.37 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -84.87 132.62 45.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 105.791 -1.929 . . . . 3.25 105.791 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.27 112.63 0.84 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.106 1.204 . . . . 0.86 112.588 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' HB3' HG12 ' A' ' 20' ' ' VAL . 55.7 t80 -86.95 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.014 -0.993 . . . . 0.28 110.515 174.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.8 t30 -78.32 90.19 4.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.308 -0.627 . . . . 1.65 109.308 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.902 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -65.31 -28.52 69.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 0.25 111.339 -174.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.836 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.0 p -76.46 -1.04 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 113.064 0.764 . . . . 0.41 113.064 -166.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 11.3 pt20 -78.85 -5.05 52.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.304 0.573 . . . . 1.24 109.68 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -99.16 18.3 17.79 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.025 -1.102 . . . . 0.38 108.025 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -96.89 146.35 25.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.33 -1.305 . . . . 1.73 109.464 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.42 -10.62 67.13 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.072 -1.211 . . . . 0.36 110.072 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.596 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 51.1 m -141.75 146.98 43.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.359 -0.978 . . . . 1.14 108.359 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.002 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 72.3 Cg_endo -75.22 159.77 40.2 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.918 1.745 . . . . 0.52 111.404 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.7 pt? -154.5 151.58 29.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.269 0.557 . . . . 1.03 111.071 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.546 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -108.07 155.64 20.15 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.618 -0.882 . . . . 1.1 108.618 170.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 86.9 mt -141.03 119.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.415 -0.587 . . . . 0.2 109.415 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.003 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 21.0 m-85 -105.77 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.273 0.358 . . . . 0.23 111.435 -172.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.509 ' ND2' ' HE1' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -77.91 92.81 4.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.575 -1.269 . . . . 1.28 107.575 169.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.8 p -113.21 127.54 70.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.425 -0.91 . . . . 0.88 112.634 -167.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -65.98 101.94 0.74 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.102 -1.444 . . . . 0.52 107.102 168.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.822 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 26.6 t -67.54 92.68 0.32 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.124 -0.944 . . . . 1.84 112.056 -163.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.611 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 6.1 mmtm 73.88 31.78 1.17 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.331 0.652 . . . . 2.43 110.866 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -137.24 140.53 41.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 0.99 110.612 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.3 -149.53 29.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.951 -0.642 . . . . 1.09 113.643 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.55 128.03 49.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.055 0.455 . . . . 3.16 111.43 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.629 HG22 ' HE1' ' A' ' 139' ' ' PHE . 3.7 p -71.9 -33.05 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 1.94 111.872 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 28.7 mtpp 64.88 3.96 2.26 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.71 0.633 . . . . 2.03 112.71 173.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.82 45.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.47 112.078 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.04 -31.09 62.22 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.955 -0.458 . . . . 0.34 111.955 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.734 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -76.51 -52.82 9.04 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 120.5 0.191 . . . . 0.57 110.697 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.09 -39.45 92.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.891 0.377 . . . . 2.46 110.677 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.567 HG23 ' HA ' ' A' ' 160' ' ' VAL . 95.9 m -66.55 -46.22 76.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.33 110.846 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.665 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.63 -46.77 89.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.19 110.828 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 62.3 m -58.52 -50.38 73.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.455 -0.793 . . . . 0.3 111.133 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -64.43 -44.31 91.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.303 -0.408 . . . . 1.08 111.578 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 86.4 mt -57.92 -52.4 65.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.68 0.252 . . . . 0.81 111.68 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.743 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.9 t80 -54.42 -49.37 70.11 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 121.202 0.525 . . . . 0.33 109.88 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.02 -34.99 66.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 1.76 111.786 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.12 -47.54 20.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.381 -0.372 . . . . 1.79 111.29 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.673 ' CD1' HD13 ' A' ' 171' ' ' LEU . 60.8 m-85 -99.34 6.28 46.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.601 0.963 . . . . 0.43 113.601 -171.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -59.41 -28.78 67.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 2.11 110.958 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -63.18 -35.36 80.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.2 111.272 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -94.56 2.93 55.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.971 0.415 . . . . 1.9 111.162 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 90.01 74.1 1.28 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.794 -0.717 . . . . 1.32 112.176 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 74.0 t80 -138.15 140.94 40.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.559 0.219 . . . . 0.26 110.526 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.08 142.55 50.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 120.56 0.219 . . . . 0.51 110.433 178.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.743 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 42.2 t -110.84 115.02 48.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.614 -0.513 . . . . 0.24 109.614 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.684 HD22 ' HE3' ' A' ' 105' ' ' MET . 25.1 mt -98.46 121.49 40.46 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.83 -0.804 . . . . 0.51 108.83 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.958 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.46 115.95 31.06 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.567 -0.453 . . . . 0.28 110.191 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.749 ' HD2' HD11 ' A' ' 108' ' ' ILE . 3.3 m-85 -97.65 107.59 40.52 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.949 -0.569 . . . . 0.34 109.558 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.822 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 71.2 Cg_exo -51.59 160.04 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.685 2.923 . . . . 0.73 112.486 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.68 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 48.3 m -112.52 138.59 49.07 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.357 -0.838 . . . . 1.54 111.483 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -106.76 103.28 12.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.17 -0.923 . . . . 2.52 111.191 -173.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.679 ' HA ' ' CD ' ' A' ' 83' ' ' GLU . 3.5 pm0 -62.45 -10.4 11.51 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.584 1.154 . . . . 3.18 114.04 -172.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -71.2 32.35 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 114.455 1.28 . . . . 3.8 114.455 -169.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.64 74.05 1.08 Allowed Glycine 0 CA--C 1.492 -1.363 0 CA-C-O 122.171 0.873 . . . . 1.45 112.471 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 82' ' ' GLN . . . -157.83 20.66 0.37 Allowed Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 109.257 -1.537 . . . . 1.43 109.257 174.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.654 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 0.2 OUTLIER 38.08 42.68 0.49 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 125.61 1.418 . . . . 1.43 110.865 -173.437 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.679 ' CD ' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -62.16 158.07 48.6 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.559 -0.746 . . . . 3.06 112.097 -169.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.691 ' HD3' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -18.23 120.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 1 C-N-CA 126.348 4.699 . . . . 1.61 115.701 -174.961 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.98 -2.21 61.55 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.341 -1.503 . . . . 1.39 109.341 -166.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 82' ' ' GLN . 5.4 t-20 56.37 48.74 16.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.432 -0.884 . . . . 3.69 109.572 -175.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.412 ' HB3' ' OE2' ' A' ' 83' ' ' GLU . 9.6 pt-20 50.26 -174.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.896 1.278 . . . . 2.47 111.212 -171.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 43.3 tt0 70.88 -18.49 0.26 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.845 0.458 . . . . 3.64 111.743 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 87' ' ' GLU . 27.3 tt0 -85.85 -22.2 27.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.982 -0.748 . . . . 2.42 108.982 172.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.733 HD13 ' SG ' ' A' ' 95' ' ' CYS . 15.2 mt -106.37 37.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.244 -0.889 . . . . 2.05 110.953 176.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -92.3 133.22 36.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.824 -0.806 . . . . 4.0 108.824 169.029 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 3.8 pt-20 68.03 -19.53 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.213 1.005 . . . . 3.1 111.25 -173.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 91' ' ' LYS . 72.2 m-85 -90.16 151.27 21.65 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.708 -0.849 . . . . 1.91 108.708 170.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.81 135.85 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.517 -0.92 . . . . 1.65 108.517 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.733 ' SG ' HD13 ' A' ' 90' ' ' ILE . 31.9 m -110.29 122.16 47.01 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.418 -0.913 . . . . 0.91 112.046 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.604 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 3.6 t -152.88 117.55 5.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 1.92 110.836 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.609 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 79.9 mttt 65.27 -46.37 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.208 1.558 . . . . 3.18 115.208 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.734 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 62.33 -32.72 0.1 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 1.74 110.834 -171.603 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.609 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 18.7 mtmt 65.35 108.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.211 1.004 . . . . 3.08 113.272 165.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -136.02 -171.84 2.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.749 -1.114 . . . . 0.43 111.487 -174.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.88 26.93 4.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.045 -0.525 . . . . 2.19 110.771 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.654 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 36.0 p90 -142.97 166.06 22.63 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.871 -1.159 . . . . 0.24 107.871 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 39.8 Cg_exo -63.09 122.8 11.16 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.342 2.695 . . . . 0.31 113.297 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.958 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.4 mp -117.37 142.8 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.513 -0.551 . . . . 0.37 109.513 174.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.712 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 10.3 mmt -116.54 -153.8 0.54 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.288 0.847 . . . . 1.47 113.288 -166.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.728 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -70.47 149.65 46.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.885 -1.052 . . . . 0.39 111.321 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 75' ' ' PRO . 29.3 mttt -82.29 109.77 16.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.026 -1.101 . . . . 1.66 108.026 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.749 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -122.14 162.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 108.736 -0.838 . . . . 0.47 108.736 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.715 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 28.2 m-80 -78.85 70.02 5.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.872 -0.604 . . . . 2.16 110.95 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.691 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -69.68 87.83 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 C-N-CA 118.883 -1.127 . . . . 0.38 108.703 175.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.571 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 0.7 OUTLIER 170.97 179.95 0.05 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.845 -1.168 . . . . 1.98 107.845 175.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.35 -143.03 9.88 Favored Glycine 0 CA--C 1.507 -0.412 0 N-CA-C 115.644 1.018 . . . . 0.78 115.644 153.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -105.41 -10.19 17.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.342 -0.929 . . . . 1.98 110.984 -173.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -95.3 -2.15 49.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 2.04 111.949 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -42.65 134.5 3.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.507 0.928 . . . . 0.48 113.507 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.599 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 47.6 t-80 -51.29 140.14 24.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.568 -0.742 . . . . 0.42 110.655 171.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 4.0 Cg_endo -47.69 -46.02 22.22 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.918 2.412 . . . . 0.36 112.813 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.599 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.68 -40.76 69.43 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.987 -0.552 . . . . 1.1 110.641 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.509 ' HE1' ' ND2' ' A' ' 42' ' ' ASN . 10.1 m-85 -76.7 -28.65 55.95 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.337 -0.392 . . . . 1.49 111.86 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 53.2 mt-10 -55.48 -42.55 74.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.715 -0.846 . . . . 2.37 108.715 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 71.7 t80 -65.03 -49.69 69.17 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 123.585 0.553 . . . . 0.58 110.627 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.429 ' CE ' HD11 ' A' ' 118' ' ' LEU . 64.5 mtt -62.46 -53.06 60.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.743 0.306 . . . . 0.34 111.263 -177.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -56.64 -43.08 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.94 111.218 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 16.7 ptmt -73.87 -34.32 64.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.018 0.437 . . . . 2.13 111.244 -176.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 150' ' ' PRO . 77.5 m -73.88 -44.1 56.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 0.47 111.394 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 26.9 mmtt -136.96 102.9 9.09 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.842 -0.343 . . . . 1.75 111.627 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.969 ' HB2' ' HB ' ' A' ' 132' ' ' THR . 60.4 Cg_endo -73.58 -19.73 21.25 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.12 2.546 . . . . 1.76 112.138 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.669 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 83.39 -106.84 2.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.135 -0.555 . . . . 2.37 113.672 172.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.678 HG13 ' HG ' ' A' ' 130' ' ' LEU . 26.8 pt -134.36 -176.62 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.369 0.268 . . . . 3.56 110.857 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.678 ' HG ' HG13 ' A' ' 129' ' ' ILE . 36.2 mt 64.67 -151.75 0.28 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.717 0.636 . . . . 2.76 110.165 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.68 86.29 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.663 -0.866 . . . . 2.84 108.663 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.969 ' HB ' ' HB2' ' A' ' 127' ' ' PRO . 31.9 p -67.08 114.46 5.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.251 -0.886 . . . . 3.9 111.787 -171.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -160.68 -55.24 0.05 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.0 0.428 . . . . 5.13 110.143 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -157.46 -161.77 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.609 0.596 . . . . 0.93 112.609 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.799 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.6 mt -90.13 155.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.315 -0.857 . . . . 1.05 109.612 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -173.99 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.935 0.398 . . . . 1.5 111.829 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.799 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -143.37 169.06 18.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.499 -0.318 . . . . 0.87 111.296 -177.089 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -154.37 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.656 1.583 . . . . 1.8 113.349 176.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 1.003 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 54.6 m-85 -25.17 -49.91 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 115.216 1.561 . . . . 1.37 115.216 -166.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.835 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 10.6 m 32.2 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.839 1.199 . . . . 0.3 113.59 176.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.79 149.02 26.03 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.026 -0.67 . . . . 0.8 111.265 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -104.0 133.34 49.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.236 -1.024 . . . . 0.53 108.236 166.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.931 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 34.7 tp -81.56 105.15 12.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.922 -0.77 . . . . 0.51 108.922 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.737 HG21 HD13 ' A' ' 15' ' ' ILE . 15.8 mm -104.8 124.98 59.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 0.2 109.151 -174.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.673 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 12.2 p30 -74.13 -178.12 3.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.766 0.317 . . . . 1.3 111.176 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.638 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.2 mtp180 -65.87 -12.78 57.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.426 0.528 . . . . 3.78 112.426 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.948 ' HB3' HH21 ' A' ' 175' ' ' ARG . 35.1 t0 -110.61 -14.33 14.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.26 0.552 . . . . 1.18 109.966 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.486 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 106.88 31.03 4.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.388 -0.824 . . . . 0.23 113.034 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.673 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 89.9 t -112.56 129.5 24.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 117.209 0.504 . . . . 0.62 110.225 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 125' ' ' THR . 7.9 Cg_exo -70.88 118.29 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.627 2.218 . . . . 0.3 111.725 178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.69 -26.07 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 0.27 110.825 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -157.75 165.7 34.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.095 -0.502 . . . . 1.22 110.135 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.669 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 18.0 ttm180 -134.97 116.98 15.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.941 -0.392 . . . . 1.75 109.941 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.931 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 3.4 m-85 -101.93 116.63 33.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.992 -0.744 . . . . 0.38 108.992 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.789 ' HA ' HG23 ' A' ' 140' ' ' THR . 97.7 p -64.5 164.8 17.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.494 0.588 . . . . 0.99 109.518 176.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.835 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 35.3 Cg_endo -64.76 -9.04 19.47 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.94 2.427 . . . . 0.66 113.17 -164.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -93.62 24.13 27.28 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.491 -0.777 . . . . 0.52 112.051 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.74 30.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.43 110.635 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.2 m -81.54 158.76 24.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.71 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 56' ' ' THR . 21.5 t -49.56 -50.6 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.388 0.613 . . . . 0.41 109.919 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 6.2 ttpp -59.92 -40.43 88.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.656 -1.157 . . . . 3.44 111.038 -177.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -63.52 -30.48 71.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.126 -0.943 . . . . 1.86 110.454 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.546 HG21 HD21 ' A' ' 39' ' ' LEU . 61.4 mt -82.63 -43.6 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.954 -0.566 . . . . 0.21 110.887 175.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.5 mt-10 -56.13 -38.84 71.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.88 112.108 -175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.4 pt-20 -62.33 -19.33 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 0.75 112.058 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -106.32 -17.25 14.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.289 0.566 . . . . 1.58 110.019 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.7 tp -94.11 -44.01 8.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 0.24 111.909 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.778 ' HA ' HD12 ' A' ' 171' ' ' LEU . 63.4 mt -51.79 -47.26 91.02 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.846 0.684 . . . . 0.44 112.846 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.2 Cg_exo -54.29 -39.59 86.18 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.987 1.792 . . . . 0.49 112.823 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.74 -34.55 58.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.503 -0.317 . . . . 0.71 111.801 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.002 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 14.2 mt -54.85 -54.73 38.58 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.463 0.649 . . . . 0.46 109.554 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -56.0 -51.87 52.74 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.221 -1.354 . . . . 1.52 113.266 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 p -165.11 131.2 2.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.409 0.605 . . . . 2.52 111.976 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.582 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -93.99 -29.9 15.0 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.606 0.717 . . . . 3.56 110.118 174.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.948 HH21 ' HB3' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -178.6 -24.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.531 -1.655 . . . . 7.86 106.531 -179.197 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 N--CA 1.442 -0.849 0 CA-C-N 113.448 -1.706 . . . . 4.81 106.682 167.535 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 121.03 0.443 . . . . 1.6799999999999999 109.937 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.5 p -132.0 -179.47 5.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.905 -0.589 . . . . 0.65000000000000002 109.899 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.768 HD13 HG21 ' A' ' 144' ' ' ILE . 23.6 pt -65.75 -28.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.073 0.463 . . . . 0.29999999999999999 111.198 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.816 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 38.3 m-85 -78.81 -1.06 33.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.863 0.363 . . . . 0.27000000000000002 111.618 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.06 -11.87 60.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.219 -0.66 . . . . 1.96 109.219 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 62.0 m-85 -110.68 160.18 16.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.081 -0.963 . . . . 0.40000000000000002 109.541 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.31 149.62 27.61 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.216 -0.291 . . . . 2.77 110.216 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.545 HG23 HD13 ' A' ' 30' ' ' LEU . 70.3 t -114.91 147.5 18.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.149 0.499 . . . . 0.73999999999999999 112.257 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.971 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 75.8 mt -100.92 132.36 46.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.854 -0.612 . . . . 0.71999999999999997 109.875 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -65.69 177.32 1.27 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.824 -1.08 . . . . 1.5900000000000001 109.858 176.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -46.51 -37.57 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.496 0.319 . . . . 0.52000000000000002 111.743 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.45 21.31 17.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.864 0.32 . . . . 2.2200000000000002 111.864 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.971 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 39.1 m-70 68.23 16.43 9.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.113 0.565 . . . . 0.72999999999999998 110.759 172.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.818 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -76.76 146.88 77.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 106.059 -1.83 . . . . 3.25 106.059 167.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.08 113.5 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 120.672 0.915 . . . . 0.85999999999999999 111.806 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.457 ' HB3' HG12 ' A' ' 20' ' ' VAL . 68.3 t80 -86.97 117.57 25.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.532 -0.758 . . . . 0.28000000000000003 110.866 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.46 82.75 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.716 -0.675 . . . . 1.6499999999999999 109.767 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.816 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.46 -33.09 70.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.445 0.64 . . . . 0.25 110.469 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.748 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.0 p -76.73 -1.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.248 -0.887 . . . . 0.40999999999999998 112.811 -168.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 2.8 pt20 -81.45 -5.64 58.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 1.24 109.349 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -92.94 -3.79 53.9 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.317 -0.994 . . . . 0.38 108.317 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 34.8 ttpt -74.15 146.45 43.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.879 -1.055 . . . . 1.73 109.827 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.81 -13.67 65.89 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.964 -1.254 . . . . 0.35999999999999999 109.964 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.657 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 6.0 m -130.91 145.42 57.67 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 114.538 -0.831 . . . . 1.1399999999999999 108.766 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.98 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -74.84 151.91 40.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.02 1.814 . . . . 0.52000000000000002 110.664 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -154.61 154.03 32.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.142 0.496 . . . . 1.03 111.161 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.86 HD21 HG21 ' A' ' 163' ' ' ILE . 6.8 mp -107.47 154.17 21.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.094 -0.706 . . . . 1.1000000000000001 109.094 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 85.1 mt -141.0 115.34 5.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.205 -0.665 . . . . 0.20000000000000001 109.205 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.585 ' HD2' ' HB2' ' A' ' 139' ' ' PHE . 3.9 m-85 -102.04 123.38 45.83 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 121.059 -0.256 . . . . 0.23000000000000001 111.334 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.775 HD21 ' HB ' ' A' ' 140' ' ' THR . 1.0 OUTLIER -81.88 90.11 6.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.07 -1.085 . . . . 1.28 108.07 167.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 8.3 p -119.1 141.78 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.163 0.801 . . . . 0.88 113.163 -162.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.9 108.98 3.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.926 -1.139 . . . . 0.52000000000000002 107.926 170.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.983 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 29.8 t -73.88 80.81 1.64 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.857 -0.61 . . . . 1.8400000000000001 112.216 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 98' ' ' PHE . 37.6 ttmt 67.25 55.6 0.66 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.935 -1.029 . . . . 2.4300000000000002 111.348 174.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -139.05 118.7 13.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.092 -0.504 . . . . 0.98999999999999999 109.941 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 -93.67 1.24 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.655 -0.783 . . . . 1.0900000000000001 112.131 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.37 151.91 17.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 3.1600000000000001 111.301 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.2 p -119.83 141.96 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.891 -0.781 . . . . 1.9399999999999999 108.891 169.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 156' ' ' PRO . 33.4 ttmt -77.51 44.12 0.42 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.335 0.588 . . . . 2.0299999999999998 110.794 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 28.37 13.07 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.744 -0.662 . . . . 0.46999999999999997 112.271 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 139' ' ' PHE . . . -80.8 -48.73 6.02 Favored Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.879 -0.676 . . . . 0.34000000000000002 112.28 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -55.84 -50.69 69.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.79 0.329 . . . . 0.56999999999999995 110.387 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -60.21 -53.2 60.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.091 -0.504 . . . . 2.46 111.203 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.4 m -57.94 -47.06 84.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 122.728 0.411 . . . . 0.33000000000000002 110.932 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.689 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.66 -49.25 77.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.46 . . . . 0.19 111.195 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -61.03 -47.17 87.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.163 0.506 . . . . 0.29999999999999999 110.516 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -59.48 -49.8 76.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.362 -0.835 . . . . 1.0800000000000001 111.172 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -61.13 -44.48 97.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.033 -0.53 . . . . 0.81000000000000005 110.964 -175.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.788 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 67.8 t80 -53.15 -57.1 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 123.492 0.495 . . . . 0.33000000000000002 110.476 176.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -68.52 -39.2 81.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.336 -0.393 . . . . 1.76 111.369 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -70.82 -45.18 65.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 1.79 111.66 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.603 ' CD1' HD13 ' A' ' 171' ' ' LEU . 61.2 m-85 -101.53 6.67 42.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.332 0.864 . . . . 0.42999999999999999 113.332 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -62.33 -19.79 63.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.63 0.252 . . . . 2.1099999999999999 110.918 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.4 m -66.85 -38.06 85.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 1.2 111.246 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -88.85 4.63 47.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 1.8999999999999999 110.66 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 82.44 71.61 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.892 -0.671 . . . . 1.3200000000000001 111.514 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 76.8 t80 -133.04 138.64 46.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.612 0.244 . . . . 0.26000000000000001 110.436 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -126.82 142.91 51.41 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.93 0.395 . . . . 0.51000000000000001 110.04 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.788 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.6 t -110.77 118.64 57.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 O-C-N 122.188 -0.32 . . . . 0.23999999999999999 110.27 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 21.4 mt -105.34 122.92 46.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.91 -0.774 . . . . 0.51000000000000001 108.91 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.886 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.82 112.74 24.96 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.006 -0.677 . . . . 0.28000000000000003 110.591 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.609 ' CE1' ' HG2' ' A' ' 105' ' ' MET . 1.8 m-85 -93.29 112.59 57.07 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.116 -1.068 . . . . 0.34000000000000002 108.116 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.022 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.7 Cg_exo -60.03 167.2 7.62 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.025 2.483 . . . . 0.72999999999999998 111.235 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.433 -1.275 0 C-N-CA 119.435 -0.906 . . . . 1.54 111.738 -178.129 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 31.1 m . . . . . 0 CA--C 1.506 -0.737 0 CA-C-O 120.9 0.381 . . . . 0.91000000000000003 110.453 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.459 ' CG2' ' HE3' ' A' ' 97' ' ' LYS . 28.3 m -153.26 116.57 4.63 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.755 -0.657 . . . . 1.9199999999999999 109.906 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.5 OUTLIER 13.27 97.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.824 1.328 . . . . 3.1800000000000002 114.323 -173.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.672 ' HZ ' ' HZ ' ' A' ' 102' ' ' PHE . 23.7 p90 -64.03 -21.3 66.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.107 -0.497 . . . . 1.74 110.73 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 66.94 150.07 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.998 0.811 . . . . 3.0800000000000001 111.613 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . . . -171.29 -165.65 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.589 -0.278 . . . . 0.42999999999999999 111.483 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -82.77 -4.73 58.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.367 0.603 . . . . 2.1899999999999999 110.386 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.672 ' HZ ' ' HZ ' ' A' ' 98' ' ' PHE . 53.1 p90 -121.68 163.16 32.64 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.428 -0.953 . . . . 0.23999999999999999 108.428 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 27.3 Cg_exo -67.71 117.47 4.9 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 123.195 2.597 . . . . 0.31 113.206 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.886 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.9 mp -105.57 138.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.131 -0.692 . . . . 0.37 109.131 171.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.609 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -103.24 -162.26 0.9 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.319 0.859 . . . . 1.47 113.319 -163.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.16 41.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.158 -0.928 . . . . 0.39000000000000001 109.948 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.022 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 14.0 pttt -70.25 126.09 28.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.735 -0.786 . . . . 1.6599999999999999 109.876 172.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.415 HG13 HG13 ' A' ' 110' ' ' VAL . 4.9 pt -124.64 161.39 28.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.707 -1.133 . . . . 0.46999999999999997 108.307 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.67 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 15.1 t-20 -79.35 88.25 4.98 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.845 -0.798 . . . . 2.1600000000000001 108.845 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.657 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -74.28 85.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 119.315 -0.954 . . . . 0.38 108.86 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 9.6 t-20 171.84 -178.88 0.06 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.806 -0.813 . . . . 1.98 108.806 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.96 -142.15 42.18 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 115.116 0.806 . . . . 0.78000000000000003 115.116 156.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.87 -16.69 15.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.501 -0.85 . . . . 1.98 109.612 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -91.62 1.84 56.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.856 -1.066 . . . . 2.04 110.613 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -60.89 140.58 57.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.252 -0.885 . . . . 0.47999999999999998 111.861 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.6 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 33.2 t-80 -50.29 132.48 24.78 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.25 -0.886 . . . . 0.41999999999999998 108.792 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.21 -33.27 53.9 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.429 2.753 . . . . 0.35999999999999999 112.457 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.6 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 19.4 tp -62.99 -41.12 99.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 1.1000000000000001 111.056 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.431 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.7 m-85 -74.83 -30.39 61.37 Favored 'General case' 0 C--O 1.21 -0.99 0 N-CA-C 110.378 -0.23 . . . . 1.49 110.378 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.86 -33.89 70.98 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.058 -0.657 . . . . 2.3700000000000001 109.868 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.599 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 66.9 t80 -71.69 -52.46 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.357 0.411 . . . . 0.57999999999999996 110.536 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.582 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.8 mtt -56.99 -51.91 67.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 0.34000000000000002 111.333 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.533 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 35.4 mtpt -58.15 -50.62 72.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.817 -0.629 . . . . 0.93999999999999995 110.652 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.21 -30.2 71.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.664 0.269 . . . . 2.1299999999999999 111.283 -177.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.549 HG21 ' HD2' ' A' ' 150' ' ' PRO . 87.1 m -72.54 -52.51 15.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.366 -0.379 . . . . 0.46999999999999997 111.727 -176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.48 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 8.0 mmtt . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 112.869 0.692 . . . . 1.75 112.869 -171.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.958 0.409 . . . . 0.93000000000000005 111.519 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.858 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 37.6 mt -99.15 106.17 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.787 -0.642 . . . . 1.05 110.423 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 136' ' ' LYS . 9.9 ptpt -131.98 21.29 4.53 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.631 0.604 . . . . 1.5 112.631 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.858 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.2 174.44 15.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.068 0.396 . . . . 0.87 112.068 -175.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 8.3 m120 -46.66 -161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.422 1.489 . . . . 1.8 114.575 173.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.812 ' CZ ' ' HA ' ' A' ' 156' ' ' PRO . 44.7 p90 -34.37 -46.49 0.27 Allowed 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 113.145 -1.843 . . . . 1.3700000000000001 115.346 -164.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.775 ' HB ' HD21 ' A' ' 42' ' ' ASN . 22.4 m 37.78 94.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.36 0.874 . . . . 0.29999999999999999 113.36 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.0 p -85.63 146.64 26.77 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.183 -0.607 . . . . 0.80000000000000004 110.345 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.7 m-85 -102.17 133.4 47.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.407 -0.961 . . . . 0.53000000000000003 108.407 169.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.912 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.87 104.66 12.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.095 -0.705 . . . . 0.51000000000000001 109.095 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.768 HG21 HD13 ' A' ' 15' ' ' ILE . 12.7 mm -102.44 128.51 55.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.086 -0.709 . . . . 0.20000000000000001 109.086 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 147' ' ' ASP . 0.5 OUTLIER -82.31 -174.59 5.22 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.028 -0.269 . . . . 1.3 111.274 -175.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.464 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 43.9 mtt180 -63.3 -12.51 30.11 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.378 0.51 . . . . 3.7799999999999998 112.378 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.436 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 21.2 t70 -108.86 -19.24 13.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.374 0.607 . . . . 1.1799999999999999 109.741 -171.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 102.37 26.87 7.11 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.199 -0.909 . . . . 0.23000000000000001 112.36 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.1 t -106.44 126.33 30.7 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.732 -0.47 . . . . 0.62 109.732 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' A' ' 125' ' ' THR . 10.5 Cg_exo -67.56 111.35 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.342 2.028 . . . . 0.29999999999999999 111.361 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.48 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 39.2 t -91.41 -25.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.017 -0.538 . . . . 0.27000000000000002 110.504 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -152.37 163.6 39.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 1.22 111.226 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.533 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 11.9 ttm180 -131.01 102.62 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.618 -0.719 . . . . 1.75 109.247 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.912 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.9 m-85 -92.22 109.8 21.18 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.267 -0.642 . . . . 0.38 109.267 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.916 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 81.2 p -67.5 -178.65 0.38 Allowed Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.763 -0.458 . . . . 0.98999999999999999 109.763 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.916 ' HD2' ' HB2' ' A' ' 155' ' ' SER . 30.8 Cg_endo -63.92 10.99 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.138 1.892 . . . . 0.66000000000000003 113.227 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 155' ' ' SER . . . -99.16 -9.46 51.47 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.06 -0.591 . . . . 0.52000000000000002 111.877 -177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 154' ' ' PHE . . . -96.16 134.7 38.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 0.42999999999999999 111.067 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.7 m -95.23 -174.02 3.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 1.25 110.265 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.704 HG13 HD21 ' A' ' 60' ' ' LEU . 77.5 t -51.38 -55.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 0.40999999999999998 111.923 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -72.88 -26.0 61.29 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.606 -0.27 . . . . 3.4399999999999999 111.126 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -34.45 72.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.644 -0.502 . . . . 1.8600000000000001 109.644 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.86 HG21 HD21 ' A' ' 39' ' ' LEU . 61.8 mt -82.73 -38.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.608 -0.724 . . . . 0.20999999999999999 110.762 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.1 mt-10 -56.22 -41.13 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.278 0.474 . . . . 0.88 112.278 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.575 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.9 pt-20 -57.21 -26.65 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.75 111.703 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.4 mmtp -102.51 -18.45 15.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.841 0.353 . . . . 1.5800000000000001 110.751 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.664 ' HG ' HD11 ' A' ' 171' ' ' LEU . 60.4 tp -92.31 -45.66 8.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.901 -0.59 . . . . 0.23999999999999999 112.043 -171.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.716 ' HA ' HD12 ' A' ' 171' ' ' LEU . 66.6 mt -49.73 -49.87 70.59 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 112.999 0.74 . . . . 0.44 112.999 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.9 Cg_exo -55.38 -39.44 91.0 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.116 1.878 . . . . 0.48999999999999999 112.701 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.0 -40.16 63.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.511 -0.313 . . . . 0.70999999999999996 110.975 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.98 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 18.6 mt -55.8 -48.4 75.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.296 0.57 . . . . 0.46000000000000002 109.578 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.82 -69.82 1.05 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.585 -1.188 . . . . 1.52 111.621 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.331 -0.202 0 N-CA-C 109.78 -0.452 . . . . 2.52 109.78 177.234 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.066 0.46 . . . . 1.6799999999999999 110.613 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.5 p -157.53 -174.61 4.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.493 -0.776 . . . . 0.65000000000000002 109.184 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.798 HD13 HG21 ' A' ' 144' ' ' ILE . 27.9 pt -64.2 -25.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.48 . . . . 0.29999999999999999 110.649 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.796 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.3 m-85 -81.94 5.55 18.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.27000000000000002 111.202 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.94 -19.67 60.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.259 -1.015 . . . . 1.96 108.259 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 73.8 m-85 -107.86 175.67 5.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.869 -1.059 . . . . 0.40000000000000002 111.263 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -112.62 138.8 48.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 2.77 110.382 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.56 HG23 HD13 ' A' ' 30' ' ' LEU . 77.4 t -115.04 144.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.093 0.473 . . . . 0.73999999999999999 111.514 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.999 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 91.0 mt -104.32 133.23 49.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.545 -0.752 . . . . 0.71999999999999997 109.546 173.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.53 -176.43 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.672 -0.862 . . . . 1.5900000000000001 108.672 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.763 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -53.96 -35.45 61.79 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.165 0.507 . . . . 0.52000000000000002 111.624 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -92.96 3.13 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 2.2200000000000002 111.528 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.999 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 33.6 m-70 74.43 17.59 3.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.414 0.626 . . . . 0.72999999999999998 109.972 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 12.8 mtmt -69.89 151.85 96.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.149 -1.797 . . . . 3.25 106.149 163.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.98 113.74 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 CA-C-N 120.168 1.096 . . . . 0.85999999999999999 110.848 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.544 ' HB3' HG12 ' A' ' 20' ' ' VAL . 65.4 t80 -82.5 120.73 25.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.635 . . . . 0.28000000000000003 110.232 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.9 t-20 -69.9 85.44 0.5 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.869 -0.605 . . . . 1.6499999999999999 109.786 176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.796 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -73.4 -32.35 64.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.262 0.553 . . . . 0.25 110.544 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.737 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.3 p -77.19 -0.68 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.522 -0.763 . . . . 0.40999999999999998 112.686 -168.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.0 pt20 -78.77 -6.62 56.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.574 0.702 . . . . 1.24 109.376 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -96.99 3.81 51.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.96 -1.018 . . . . 0.38 108.314 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 22.1 ttpt -81.2 146.63 30.39 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.723 -1.126 . . . . 1.73 109.298 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.11 -2.1 86.77 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.228 -1.149 . . . . 0.35999999999999999 110.228 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 13.6 m -140.56 152.31 65.94 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 1.1399999999999999 108.747 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.99 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 74.3 Cg_endo -82.52 154.78 16.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.826 1.684 . . . . 0.52000000000000002 111.576 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.671 ' CB ' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -156.98 150.57 24.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.164 0.507 . . . . 1.03 111.749 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.659 HD23 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.86 151.49 25.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.376 -0.972 . . . . 1.1000000000000001 108.376 172.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 86.5 mt -140.55 115.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.84 -0.43 . . . . 0.20000000000000001 109.84 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.761 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 29.8 m-85 -103.02 124.74 49.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.609 0.226 . . . . 0.23000000000000001 111.609 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.793 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -80.44 93.26 5.98 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.246 -0.65 . . . . 1.28 109.246 167.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.828 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 15.2 m -105.06 150.08 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 114.095 1.146 . . . . 0.88 114.095 -158.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 102.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.683 -1.599 . . . . 0.52000000000000002 106.683 163.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.497 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -76.07 81.17 2.91 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 113.879 1.066 . . . . 1.8400000000000001 113.879 -163.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 84.4 tttt 76.18 31.97 0.63 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.558 -0.746 . . . . 2.4300000000000002 111.488 169.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.28 132.34 16.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.507 -0.477 . . . . 0.98999999999999999 111.488 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -92.69 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.688 -0.687 . . . . 1.0900000000000001 114.734 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.438 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 66.8 m-85 -110.98 153.77 25.08 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.999 0.37 . . . . 3.1600000000000001 111.999 -167.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.9 p -137.24 -38.67 0.61 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.778 0.659 . . . . 1.9399999999999999 112.778 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 69.47 -12.88 0.41 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.432 0.693 . . . . 2.0299999999999998 112.791 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.01 12.08 14.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.942 -0.647 . . . . 0.46999999999999997 112.478 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.84 -31.7 61.98 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.156 -0.545 . . . . 0.34000000000000002 112.051 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.694 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -68.72 -52.05 34.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.534 0.206 . . . . 0.56999999999999995 110.504 -177.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.95 -47.06 78.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.431 0.634 . . . . 2.46 110.397 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.48 HG23 ' HA ' ' A' ' 160' ' ' VAL . 85.5 m -63.03 -47.53 82.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.818 -1.083 . . . . 0.33000000000000002 110.719 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.817 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -62.16 -50.43 71.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.19 111.651 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.67 HG23 ' HG2' ' A' ' 101' ' ' GLU . 24.5 m -56.1 -45.55 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.29999999999999999 110.792 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.68 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 40.7 m -66.57 -45.98 77.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.0800000000000001 111.31 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 88.5 mt -58.09 -51.38 69.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.538 0.208 . . . . 0.81000000000000005 111.188 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.45 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 49.7 t80 -52.5 -52.76 52.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.997 0.811 . . . . 0.33000000000000002 109.785 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.68 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 3.9 p30 -73.93 -33.35 63.91 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.504 -0.478 . . . . 1.76 111.429 -171.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -76.11 -38.17 57.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.277 -0.419 . . . . 1.79 111.309 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.674 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.9 m-85 -109.07 8.91 26.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.071 0.767 . . . . 0.42999999999999999 113.071 -174.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -22.53 64.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.861 0.363 . . . . 2.1099999999999999 110.226 173.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -62.12 -37.93 87.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 1.2 110.785 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.44 5.57 38.23 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.908 0.385 . . . . 1.8999999999999999 110.923 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.35 25.09 34.46 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.99 -0.624 . . . . 1.3200000000000001 112.289 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.659 ' CE1' HD23 ' A' ' 39' ' ' LEU . 75.7 t80 -85.05 143.72 28.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.775 0.321 . . . . 0.26000000000000001 110.913 -174.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.671 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -131.03 146.32 52.34 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.062 0.458 . . . . 0.51000000000000001 110.183 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.817 HG11 ' HB1' ' A' ' 57' ' ' ALA . 37.4 t -116.52 114.71 46.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.19 -0.459 . . . . 0.23999999999999999 109.84 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.1 mt -100.23 122.78 43.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.103 -0.702 . . . . 0.51000000000000001 109.103 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.63 116.74 32.3 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.22 -0.592 . . . . 0.28000000000000003 110.731 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.8 m-85 -99.11 109.43 54.21 Favored Pre-proline 0 C--N 1.31 -1.134 0 CA-C-N 115.789 -0.641 . . . . 0.34000000000000002 109.611 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.794 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 75.1 Cg_exo -50.37 160.61 1.48 Allowed 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 124.185 3.256 . . . . 0.72999999999999998 113.568 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.433 -1.307 0 CA-C-O 122.65 1.214 . . . . 1.54 111.227 171.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.437 -1.112 0 CA-C-O 121.184 0.516 . . . . 0.91000000000000003 110.111 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -154.56 120.36 5.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.336 -0.847 . . . . 1.9199999999999999 109.761 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.763 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 7.7 pttt 33.36 77.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.333 1.021 . . . . 3.1800000000000002 113.271 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 1.6 p90 -57.9 135.41 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.062 -1.458 . . . . 1.74 107.062 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.502 ' HE2' ' HG3' ' A' ' 97' ' ' LYS . 70.0 mmtt -102.46 122.88 45.19 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.858 -0.737 . . . . 3.0800000000000001 112.011 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.5 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . . . -125.11 -162.22 1.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.053 -0.976 . . . . 0.42999999999999999 110.517 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.67 ' HG2' HG23 ' A' ' 58' ' ' THR . 7.4 pt-20 -90.64 -11.25 40.43 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.068 -0.653 . . . . 2.1899999999999999 110.129 175.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.747 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.0 p90 -103.15 167.86 9.61 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.225 -0.898 . . . . 0.23999999999999999 108.889 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.811 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.1 Cg_exo -71.95 120.9 7.15 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.749 2.966 . . . . 0.31 113.348 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.997 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.8 mp -113.71 140.15 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.341 -0.614 . . . . 0.37 109.341 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.811 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 11.4 mmt -110.79 -151.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.107 0.78 . . . . 1.47 113.107 -164.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -79.64 143.84 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.855 -1.066 . . . . 0.39000000000000001 110.738 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.794 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 21.4 pttt -78.67 137.74 37.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 1.6599999999999999 109.995 172.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.45 HD11 ' CE1' ' A' ' 119' ' ' TYR . 3.8 pt -143.66 158.04 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.357 -1.349 . . . . 0.46999999999999997 107.357 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.794 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -73.9 91.45 1.99 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.269 -0.572 . . . . 2.1600000000000001 109.754 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.607 HG11 ' CB ' ' A' ' 42' ' ' ASN . 1.3 m -82.55 84.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 119.18 -1.008 . . . . 0.38 108.943 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 20.1 t-20 171.93 179.23 0.07 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.09 -1.078 . . . . 1.98 108.09 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.49 -149.09 19.81 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 116.024 1.17 . . . . 0.78000000000000003 116.024 153.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 1.5 28.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.886 -1.157 . . . . 1.98 110.029 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.44 ' HB3' ' OD1' ' A' ' 109' ' ' ASN . 35.3 t-20 -108.6 2.83 22.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.917 -1.038 . . . . 2.04 109.559 -171.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.794 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -58.25 139.87 54.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.117 -0.947 . . . . 0.47999999999999998 112.618 -177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.601 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 38.9 t-80 -48.32 133.52 12.83 Favored Pre-proline 0 C--O 1.226 -0.135 0 N-CA-C 109.012 -0.736 . . . . 0.41999999999999998 109.012 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.19 -33.17 63.32 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.37 2.713 . . . . 0.35999999999999999 112.829 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.601 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 18.2 tp -65.72 -37.0 85.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 1.1000000000000001 111.042 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.529 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 8.1 m-85 -75.55 -29.56 59.43 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.572 -0.285 . . . . 1.49 110.668 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.81 -40.2 79.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.883 -0.784 . . . . 2.3700000000000001 108.883 167.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 77.7 t80 -68.08 -47.76 67.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.57999999999999996 110.53 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.57 ' HE3' HD11 ' A' ' 118' ' ' LEU . 67.0 mtt -62.85 -55.03 29.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.097 -0.501 . . . . 0.34000000000000002 111.136 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -57.54 -43.15 84.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.201 -0.454 . . . . 0.93999999999999995 111.474 -176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -69.58 -39.73 77.13 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.479 -0.328 . . . . 2.1299999999999999 111.009 -176.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.532 HG21 ' HD2' ' A' ' 150' ' ' PRO . 52.3 m -69.73 -33.9 73.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.118 -0.492 . . . . 0.46999999999999997 111.448 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.595 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.3 tmtt? . . . . . 0 C--N 1.323 -0.557 0 C-N-CA 120.702 -0.399 . . . . 1.75 111.317 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.132 0.492 . . . . 0.93000000000000005 111.327 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.826 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 63.8 mt -105.83 110.96 33.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.221 -0.9 . . . . 1.05 110.791 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -139.06 42.06 2.09 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.407 0.891 . . . . 1.5 113.407 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.826 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -156.4 174.82 14.85 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.458 0.703 . . . . 0.87 110.699 176.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 17.0 m120 -47.9 -158.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.735 1.214 . . . . 1.8 113.596 167.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.828 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 7.3 m-85 -30.66 -58.71 0.21 Allowed 'General case' 0 C--O 1.204 -1.295 0 C-N-CA 125.416 1.486 . . . . 1.3700000000000001 114.35 -166.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.798 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 21.5 m 48.51 104.68 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.575 0.954 . . . . 0.29999999999999999 113.575 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.761 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.9 t -96.35 149.52 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.012 -0.675 . . . . 0.80000000000000004 111.26 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.2 m-85 -104.48 131.96 51.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.218 -0.66 . . . . 0.53000000000000003 109.218 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.866 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.1 tp -81.03 106.07 12.74 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.157 -0.683 . . . . 0.51000000000000001 109.157 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.798 HG21 HD13 ' A' ' 15' ' ' ILE . 12.2 mm -106.36 124.0 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 108.911 -0.774 . . . . 0.20000000000000001 108.911 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.454 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 39.2 p30 -75.34 -177.72 3.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.135 -0.484 . . . . 1.3 111.404 -175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 36' ' ' SER . 75.3 mtp180 -70.92 -1.17 11.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 3.7799999999999998 111.897 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.25 -19.16 12.33 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.597 0.713 . . . . 1.1799999999999999 109.45 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 103.77 27.76 6.22 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.913 -1.04 . . . . 0.23000000000000001 112.126 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.479 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 84.2 t -109.62 129.64 23.69 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.651 -0.323 . . . . 0.62 110.411 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.532 ' HD2' HG21 ' A' ' 125' ' ' THR . 6.9 Cg_exo -71.86 114.98 4.12 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.719 2.279 . . . . 0.29999999999999999 111.573 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.595 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.7 t -100.24 -21.61 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.596 . . . . 0.27000000000000002 110.562 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.0 mm-40 -152.64 164.54 37.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.155 -0.475 . . . . 1.22 110.364 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 153' ' ' ARG . 34.4 ttp85 -139.53 102.32 4.43 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.115 -0.698 . . . . 1.75 109.115 169.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.866 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 14.4 m-85 -90.92 109.24 20.46 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.23 -0.656 . . . . 0.38 109.23 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.76 ' HA ' HG23 ' A' ' 140' ' ' THR . 5.0 p -63.43 164.98 12.65 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 109.153 -0.684 . . . . 0.98999999999999999 109.153 175.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.798 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 61.0 Cg_endo -68.24 -4.45 12.76 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.65 2.234 . . . . 0.66000000000000003 112.944 -163.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.83 -10.3 76.11 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.021 -0.991 . . . . 0.52000000000000002 111.831 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.35 139.5 36.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.461 -0.57 . . . . 0.42999999999999999 109.461 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.1 m -95.09 178.65 5.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.346 -0.388 . . . . 1.25 111.102 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 62.7 t -54.58 -48.62 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 0.40999999999999998 110.968 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -29.42 69.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.782 -0.645 . . . . 3.4399999999999999 110.727 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.32 -34.31 77.1 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.451 -0.795 . . . . 1.8600000000000001 110.125 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.569 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 53.5 mt -81.26 -41.27 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.74 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 50.8 mt-10 -58.2 -38.83 77.53 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.035 0.383 . . . . 0.88 112.035 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.566 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 11.6 pt-20 -59.93 -18.53 45.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 0.75 111.594 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.615 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.6 mmtp -111.15 -17.76 13.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.078 0.466 . . . . 1.5800000000000001 110.509 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.5 tp -92.44 -39.43 11.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.77 -0.65 . . . . 0.23999999999999999 111.96 -172.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.82 ' HA ' HD12 ' A' ' 171' ' ' LEU . 76.7 mt -49.96 -51.24 63.14 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.663 0.616 . . . . 0.44 112.663 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.9 Cg_endo -55.71 -38.76 93.95 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.121 1.881 . . . . 0.48999999999999999 112.246 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.62 -35.74 65.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 0.70999999999999996 110.969 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.99 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 22.0 mt -57.12 -57.61 11.84 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.368 0.604 . . . . 0.46000000000000002 109.646 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -50.35 -62.73 4.88 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.286 -1.324 . . . . 1.52 112.201 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 2.52 110.285 177.83 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.413 0.625 . . . . 1.6799999999999999 110.324 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.0 p -150.29 174.95 12.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 0.65000000000000002 108.573 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.675 HD13 HG21 ' A' ' 144' ' ' ILE . 24.3 pt -62.28 -27.04 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.913 0.387 . . . . 0.29999999999999999 111.427 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.866 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 34.7 m-85 -80.34 7.99 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.27000000000000002 111.125 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.05 -16.28 60.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.231 -1.026 . . . . 1.96 108.231 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 71.9 m-85 -111.73 155.14 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.677 -1.147 . . . . 0.40000000000000002 111.211 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -100.95 144.31 30.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.529 -0.545 . . . . 2.77 109.529 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.574 HG23 ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -125.93 167.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.73999999999999999 110.493 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.007 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 93.6 mt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.292 -0.413 . . . . 0.71999999999999997 110.245 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.52 -172.9 2.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.177 -0.675 . . . . 1.5900000000000001 109.177 176.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.688 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -54.0 -30.96 49.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.828 0.347 . . . . 0.52000000000000002 111.304 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 18.8 t70 -89.56 -16.38 30.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 2.2200000000000002 111.469 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 1.007 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 15.3 m-70 83.74 25.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.998 0.919 . . . . 0.72999999999999998 109.68 -175.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.782 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 mmpt? -84.67 146.51 46.82 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 105.515 -2.032 . . . . 3.25 105.515 164.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.92 113.08 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 119.722 0.936 . . . . 0.85999999999999999 111.292 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.574 ' HB3' HG23 ' A' ' 20' ' ' VAL . 89.3 t80 -79.63 120.86 24.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.542 -0.753 . . . . 0.28000000000000003 109.816 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.577 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -67.84 84.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.477 -0.783 . . . . 1.6499999999999999 109.728 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.866 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -72.74 -35.12 67.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.525 0.679 . . . . 0.25 110.142 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.741 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.5 p -76.55 -1.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 0.40999999999999998 112.919 -167.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.1 pt20 -82.4 -5.1 58.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.303 0.573 . . . . 1.24 109.669 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.419 ' CG ' HG21 ' A' ' 70' ' ' THR . 88.1 m-70 -92.54 -8.55 44.11 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.95 -1.13 . . . . 0.38 107.95 177.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 36.4 ttpt -71.86 133.88 45.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.235 -0.893 . . . . 1.73 109.341 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 -1.25 57.65 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 109.862 -1.295 . . . . 0.35999999999999999 109.862 -168.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 33.6 m -142.21 124.97 9.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.518 -0.841 . . . . 1.1399999999999999 108.879 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.84 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 14.6 Cg_endo -59.0 147.86 88.03 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.58 1.52 . . . . 0.52000000000000002 110.755 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.553 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -150.68 151.29 32.24 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.243 0.544 . . . . 1.03 111.506 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.755 HD21 HG21 ' A' ' 163' ' ' ILE . 7.1 mp -108.51 152.14 25.13 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.69 -0.686 . . . . 1.1000000000000001 109.266 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 72.6 mt -140.98 118.77 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 110.147 -0.316 . . . . 0.20000000000000001 110.147 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.832 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 20.6 m-85 -105.11 124.27 49.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.426 0.155 . . . . 0.23000000000000001 111.324 -173.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.582 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.3 p30 -81.0 91.67 6.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.841 -1.17 . . . . 1.28 107.841 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.592 HG11 ' HE1' ' A' ' 98' ' ' PHE . 2.4 p -109.05 135.41 48.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 113.288 0.848 . . . . 0.88 113.288 -162.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.63 107.89 0.75 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.766 -1.198 . . . . 0.52000000000000002 107.766 170.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 1.031 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -71.62 84.67 0.87 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.775 -1.102 . . . . 1.8400000000000001 113.0 -165.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.0 tmtp? 60.44 53.56 4.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.631 -0.713 . . . . 2.4300000000000002 110.733 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 p -163.69 136.56 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.757 -0.656 . . . . 0.98999999999999999 110.43 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.78 -113.57 4.38 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.626 -0.797 . . . . 1.0900000000000001 112.561 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 169.26 17.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.097 0.475 . . . . 3.1600000000000001 111.736 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.664 HG22 ' HE1' ' A' ' 139' ' ' PHE . 40.0 p -126.07 139.65 53.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.432 -0.804 . . . . 1.9399999999999999 109.41 171.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 27.7 mtpp -106.16 18.87 21.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 2.0299999999999998 111.09 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.63 13.34 32.7 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.822 -0.704 . . . . 0.46999999999999997 111.709 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 -43.22 16.53 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.866 -0.494 . . . . 0.34000000000000002 111.866 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.606 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.2 t80 -68.05 -49.14 63.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 0.56999999999999995 110.331 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -54.82 -55.14 33.44 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.88 -0.6 . . . . 2.46 110.486 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 160' ' ' VAL . 93.4 m -62.61 -46.96 85.85 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.009 -0.996 . . . . 0.33000000000000002 111.287 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.89 -49.29 78.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.858 0.361 . . . . 0.19 111.152 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.9 m -59.6 -50.58 73.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.721 -0.672 . . . . 0.29999999999999999 110.749 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 p -65.7 -37.68 87.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 1.0800000000000001 112.045 -175.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 84.5 mt -61.55 -52.4 64.62 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 121.158 -0.217 . . . . 0.81000000000000005 110.951 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.639 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 53.1 t80 -51.89 -51.82 54.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.777 -0.823 . . . . 0.33000000000000002 108.777 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.47 -30.32 68.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.304 -0.862 . . . . 1.76 112.036 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -86.06 -39.68 16.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.598 0.222 . . . . 1.79 111.598 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.647 ' CD1' HD13 ' A' ' 171' ' ' LEU . 60.5 m-85 -108.35 9.91 27.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.485 1.291 . . . . 0.42999999999999999 114.485 -170.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 18.3 mtmm -59.34 -26.81 65.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.941 -0.704 . . . . 2.1099999999999999 110.061 170.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 m -60.5 -30.21 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.593 -0.73 . . . . 1.2 111.627 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -104.44 12.98 32.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 1.8999999999999999 111.206 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.47 65.58 1.66 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.592 -0.813 . . . . 1.3200000000000001 112.299 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 65.5 t80 -129.03 137.72 51.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.75 0.31 . . . . 0.26000000000000001 110.639 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -129.17 143.06 50.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 120.928 0.394 . . . . 0.51000000000000001 110.746 177.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.709 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 29.9 t -114.31 120.95 65.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.935 0.398 . . . . 0.23999999999999999 110.621 171.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 20.0 mt -105.69 122.87 46.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.297 -0.631 . . . . 0.51000000000000001 109.297 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.057 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -111.53 116.19 30.45 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.298 -0.561 . . . . 0.28000000000000003 110.904 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.581 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.1 m-85 -100.06 110.04 58.23 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.018 -0.734 . . . . 0.34000000000000002 109.018 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.031 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 53.2 Cg_exo -54.67 165.81 2.28 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 123.606 2.871 . . . . 0.72999999999999998 111.421 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.436 -1.14 0 C-N-CA 118.569 -1.252 . . . . 1.54 113.943 -176.451 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.565 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 83.9 m . . . . . 0 N--CA 1.435 -1.217 0 CA-C-O 121.157 0.503 . . . . 0.91000000000000003 111.388 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -127.39 157.33 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.279 -0.873 . . . . 1.9199999999999999 109.331 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.688 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -38.97 111.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.135 0.574 . . . . 3.1800000000000002 111.33 175.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.606 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 46.4 p90 -64.35 -22.07 66.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.872 -0.604 . . . . 1.74 111.794 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 66.66 146.6 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.79 0.681 . . . . 3.0800000000000001 111.72 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -166.63 -165.87 0.79 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 0.42999999999999999 111.371 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.9 1.78 53.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.287 0.565 . . . . 2.1899999999999999 110.497 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.657 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 51.7 p90 -123.83 165.3 24.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 108.56 -0.904 . . . . 0.23999999999999999 108.56 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.759 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 29.1 Cg_exo -67.87 120.97 7.97 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.732 2.955 . . . . 0.31 113.256 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.057 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mp -114.93 140.29 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.22 -0.659 . . . . 0.37 109.22 173.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.759 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.3 mmt -115.37 -150.44 0.46 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.046 0.758 . . . . 1.47 113.046 -165.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.98 135.39 43.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.831 -1.077 . . . . 0.39000000000000001 110.756 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.895 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttp -74.03 116.9 15.2 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.316 -0.994 . . . . 1.6599999999999999 108.316 167.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.488 HD12 ' CB ' ' A' ' 116' ' ' HIS . 4.8 pt -122.67 175.99 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.615 -1.175 . . . . 0.46999999999999997 107.986 -174.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.1 m120 -73.33 114.92 12.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.057 -1.09 . . . . 2.1600000000000001 108.057 169.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -114.49 83.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 118.992 -1.083 . . . . 0.38 108.913 166.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.3 t-20 170.52 179.41 0.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.428 -0.953 . . . . 1.98 108.428 169.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 59.9 -146.22 45.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.78000000000000003 113.879 165.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.11 -14.28 15.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.654 0.74 . . . . 1.98 109.475 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.06 -12.19 50.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.962 -1.017 . . . . 2.04 110.866 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -43.98 149.49 0.32 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.707 1.003 . . . . 0.47999999999999998 113.707 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.509 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 41.2 t-80 -55.06 133.57 68.15 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 114.847 -1.07 . . . . 0.41999999999999998 110.507 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 2.5 Cg_endo -46.86 -47.77 15.64 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.917 2.411 . . . . 0.35999999999999999 112.788 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.509 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.956 -0.565 . . . . 1.1000000000000001 111.414 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.541 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.0 m-85 -75.42 -29.92 59.9 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 122.24 -0.287 . . . . 1.49 111.077 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 8.9 mm-40 -58.0 -42.21 84.73 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.31 -0.556 . . . . 2.3700000000000001 109.622 168.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 83.9 t80 -61.59 -52.25 65.19 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.923 0.392 . . . . 0.57999999999999996 110.483 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.476 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 66.0 mtt -60.05 -50.04 75.29 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.325 0.583 . . . . 0.34000000000000002 110.752 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 119' ' ' TYR . 2.9 ttpm? -61.51 -38.21 86.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.729 -1.123 . . . . 0.93999999999999995 111.396 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 16.2 ptpt -76.57 -35.9 57.92 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.77 0.285 . . . . 2.1299999999999999 111.77 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.573 HG21 ' HD2' ' A' ' 150' ' ' PRO . 86.4 m -63.47 -42.61 98.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.088 0.471 . . . . 0.46999999999999997 110.798 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.685 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.0 ttmt . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 109.327 -0.62 . . . . 1.75 109.327 169.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 113.577 0.954 . . . . 0.93000000000000005 113.577 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.882 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 23.7 mt -83.24 168.29 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 114.225 -1.352 . . . . 1.05 109.142 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER 179.02 -35.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.279 0.945 . . . . 1.5 112.873 -176.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.882 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.13 171.76 8.25 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.904 0.882 . . . . 0.87 112.201 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.413 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 17.6 m120 -44.46 -157.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.407 1.483 . . . . 1.8 114.122 169.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.832 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 31.7 m-85 -28.56 -56.96 0.13 Allowed 'General case' 0 C--O 1.208 -1.111 0 C-N-CA 125.259 1.424 . . . . 1.3700000000000001 114.323 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.81 HG23 ' HA ' ' A' ' 155' ' ' SER . 7.0 m 42.87 95.73 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.398 0.888 . . . . 0.29999999999999999 113.398 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.5 p -85.12 152.07 23.66 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.328 -0.549 . . . . 0.80000000000000004 110.722 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 6.1 m-85 -103.36 137.71 41.11 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.802 -1.184 . . . . 0.53000000000000003 107.802 166.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.977 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 44.7 tp -82.58 104.91 13.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.838 -0.801 . . . . 0.51000000000000001 108.838 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.675 HG21 HD13 ' A' ' 15' ' ' ILE . 16.9 mm -102.69 119.27 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.775 -0.824 . . . . 0.20000000000000001 108.775 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.12 179.72 3.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.133 0.492 . . . . 1.3 110.292 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -61.83 -12.58 18.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.519 -0.764 . . . . 3.7799999999999998 112.554 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -111.12 -21.36 11.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 1.1799999999999999 110.294 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 110.55 35.56 2.05 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.554 -0.748 . . . . 0.23000000000000001 112.864 177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 96.0 t -112.08 124.36 32.38 Favored Pre-proline 0 C--N 1.319 -0.75 0 O-C-N 122.584 -0.363 . . . . 0.62 110.361 175.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.573 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -66.9 99.87 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.29999999999999999 111.761 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.5 t -84.03 -21.19 8.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.581 . . . . 0.27000000000000002 110.798 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.685 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 mm-40 -159.16 164.55 35.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.786 -0.45 . . . . 1.22 109.786 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.625 HH11 ' HH2' ' A' ' 137' ' ' TRP . 26.2 ttm180 -131.59 97.56 4.26 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.344 -0.614 . . . . 1.75 109.344 171.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.977 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 40.7 m-85 -81.92 111.13 17.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.224 -0.658 . . . . 0.38 109.224 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.81 ' HA ' HG23 ' A' ' 140' ' ' THR . 0.9 OUTLIER -58.72 163.66 5.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.519 -0.549 . . . . 0.98999999999999999 109.519 174.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.799 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 50.8 Cg_endo -67.69 -7.03 18.21 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.463 2.109 . . . . 0.66000000000000003 112.06 -169.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -86.1 -0.57 87.05 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.08 -0.963 . . . . 0.52000000000000002 112.694 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.88 135.36 36.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.942 0.401 . . . . 0.42999999999999999 110.538 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 172.79 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 1.25 110.62 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.485 ' HA ' HG23 ' A' ' 56' ' ' THR . 31.2 t -50.45 -53.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.532 -0.303 . . . . 0.40999999999999998 110.829 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 64.0 tttm -63.41 -35.28 79.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 3.4399999999999999 111.44 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -54.3 -40.87 68.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.541 0.686 . . . . 1.8600000000000001 109.485 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.766 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 61.2 mt -82.27 -40.66 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.838 -1.074 . . . . 0.20999999999999999 111.507 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 41.3 mt-10 -53.14 -42.26 65.91 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.282 0.475 . . . . 0.88 112.282 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 1.7 pt-20 -69.31 -2.37 10.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.408 0.521 . . . . 0.75 112.408 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.614 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 33.3 mmtm -116.66 -20.83 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.577 . . . . 1.5800000000000001 109.705 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.1 tp -93.29 -41.12 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.23999999999999999 111.95 -168.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.69 ' HA ' HD12 ' A' ' 171' ' ' LEU . 77.5 mt -49.86 -50.8 65.86 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.703 0.631 . . . . 0.44 112.703 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.5 Cg_exo -54.24 -36.56 86.6 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.236 1.958 . . . . 0.48999999999999999 112.835 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -75.99 -37.38 58.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.675 -0.239 . . . . 0.70999999999999996 110.966 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.84 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.8 mt -59.7 -48.59 81.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.716 0.77 . . . . 0.46000000000000002 109.033 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -49.29 -65.23 2.86 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 114.241 -1.345 . . . . 1.52 112.42 167.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 p . . . . . 0 CA--C 1.533 0.294 0 CA-C-N 116.767 0.284 . . . . 2.52 110.658 178.116 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 111.848 0.314 . . . . 1.6799999999999999 111.848 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 p -151.7 154.93 37.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.417 0.627 . . . . 0.65000000000000002 110.369 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 144' ' ' ILE . 13.8 pt -61.6 -21.46 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.913 -1.039 . . . . 0.29999999999999999 112.497 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.785 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 62.2 m-85 -77.7 -2.57 36.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.39 0.515 . . . . 0.27000000000000002 112.39 -171.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -70.47 -17.46 62.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.632 0.73 . . . . 1.96 109.363 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 79.3 m-85 -100.38 162.6 12.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.191 -0.913 . . . . 0.40000000000000002 111.477 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.475 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 25.9 tt0 -93.97 153.61 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 2.77 110.733 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.587 HG12 ' HB3' ' A' ' 28' ' ' TYR . 75.6 t -133.05 139.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.037 0.446 . . . . 0.73999999999999999 111.186 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.992 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 95.6 mt -104.96 140.56 38.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.826 -0.805 . . . . 0.71999999999999997 108.826 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.82 -172.35 1.9 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.268 -0.641 . . . . 1.5900000000000001 109.268 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -54.36 -33.06 58.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.753 0.311 . . . . 0.52000000000000002 111.306 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 19.6 t70 -86.85 -11.67 50.14 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.418 -0.355 . . . . 2.2200000000000002 111.287 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.992 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 42.3 m-70 79.37 22.31 0.57 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.618 0.767 . . . . 0.72999999999999998 109.745 -176.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.761 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -84.13 146.0 47.37 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 105.857 -1.905 . . . . 3.25 105.857 166.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.89 114.6 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.157 1.238 . . . . 0.85999999999999999 112.695 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.587 ' HB3' HG12 ' A' ' 20' ' ' VAL . 64.2 t80 -87.38 116.49 25.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.312 -0.858 . . . . 0.28000000000000003 110.134 172.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.642 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -66.73 93.85 0.27 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.102 -0.703 . . . . 1.6499999999999999 109.102 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.785 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -77.31 -34.3 55.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.361 0.6 . . . . 0.25 110.454 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.729 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.8 p -76.64 -0.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.271 -0.877 . . . . 0.40999999999999998 112.296 -168.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.642 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 4.0 pt20 -80.85 -5.24 57.04 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.963 -0.754 . . . . 1.24 108.963 173.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -101.35 20.64 15.49 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.897 -1.047 . . . . 0.38 108.341 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -96.94 150.95 20.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.462 -1.245 . . . . 1.73 108.742 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 -6.05 81.38 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.636 -0.985 . . . . 0.35999999999999999 110.636 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.578 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.2 m -140.72 141.75 26.0 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.798 -1.186 . . . . 1.1399999999999999 107.798 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.836 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.2 Cg_exo -75.99 157.54 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.019 1.813 . . . . 0.52000000000000002 111.365 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.562 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -154.67 148.61 25.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.249 0.547 . . . . 1.03 111.251 -174.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.616 HD23 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.29 150.7 26.39 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.262 -1.014 . . . . 1.1000000000000001 108.262 171.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 66.9 mt -139.64 118.7 12.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.623 -0.51 . . . . 0.20000000000000001 109.623 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.841 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 38.8 m-85 -103.07 124.15 47.99 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 121.154 -0.218 . . . . 0.23000000000000001 111.359 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.709 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -78.56 92.0 4.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.901 -1.148 . . . . 1.28 107.901 166.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.6 p -108.62 143.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 113.363 0.875 . . . . 0.88 113.363 -161.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HA ' ' OG ' ' A' ' 76' ' ' SER . . . -67.04 110.43 3.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.438 -1.319 . . . . 0.52000000000000002 107.438 170.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.972 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -67.89 81.27 0.2 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.061 -0.972 . . . . 1.8400000000000001 111.869 -167.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.651 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 14.1 ptpt 46.01 66.37 0.96 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.274 1.43 . . . . 2.4300000000000002 112.46 -173.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -162.65 138.07 7.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -1.02 . . . . 0.98999999999999999 110.154 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.13 -140.97 30.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.842 -0.694 . . . . 1.0900000000000001 113.346 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -84.07 170.09 14.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.075 0.464 . . . . 3.1600000000000001 111.77 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.15 -28.44 2.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.949 -0.569 . . . . 1.9399999999999999 111.424 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.876 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.4 mmmt 66.27 3.52 2.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.255 0.622 . . . . 2.0299999999999998 111.917 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.04 1.9 59.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.818 -0.706 . . . . 0.46999999999999997 112.28 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.4 81.92 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.468 -0.653 . . . . 0.34000000000000002 111.468 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.518 ' HE1' ' HB1' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -66.21 -49.34 67.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.203 -0.498 . . . . 0.56999999999999995 110.185 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.63 -43.51 89.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.505 -0.771 . . . . 2.46 110.119 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 160' ' ' VAL . 55.1 m -57.94 -53.26 60.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.516 -0.765 . . . . 0.33000000000000002 110.527 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.68 -49.48 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.719 -0.673 . . . . 0.19 111.846 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.647 HG23 ' HB2' ' A' ' 101' ' ' GLU . 63.0 m -59.22 -45.39 91.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 0.29999999999999999 110.754 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.9 m -64.07 -48.44 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.652 -0.704 . . . . 1.0800000000000001 110.78 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 95.1 mt -56.59 -53.04 62.28 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.803 0.298 . . . . 0.81000000000000005 111.803 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.61 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 70.9 t80 -53.23 -53.35 52.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.788 -0.642 . . . . 0.33000000000000002 109.755 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.96 -27.43 60.99 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.371 -0.832 . . . . 1.76 111.815 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.75 -48.34 12.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.839 0.352 . . . . 1.79 111.411 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.695 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.8 m-85 -99.1 6.17 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.258 0.836 . . . . 0.42999999999999999 113.258 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -57.81 -29.85 65.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.808 0.337 . . . . 2.1099999999999999 110.316 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -63.57 -32.8 74.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 1.2 111.061 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -96.5 10.78 37.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 1.8999999999999999 110.689 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 80.66 64.07 1.85 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.945 -0.645 . . . . 1.3200000000000001 112.19 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.616 ' CE1' HD23 ' A' ' 39' ' ' LEU . 70.6 t80 -129.66 143.85 51.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.727 0.299 . . . . 0.26000000000000001 110.912 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.6 146.77 52.37 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.853 0.358 . . . . 0.51000000000000001 110.416 177.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.738 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 42.5 t -116.52 120.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.96 -0.385 . . . . 0.23999999999999999 109.96 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 26.7 mt -106.38 123.07 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.654 -0.498 . . . . 0.51000000000000001 109.654 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.025 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -104.91 131.32 52.56 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.103 0.478 . . . . 0.28000000000000003 110.266 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 8.2 m-85 -117.27 106.98 46.07 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.219 -0.66 . . . . 0.34000000000000002 109.219 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.029 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 52.6 Cg_exo -56.69 169.06 1.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.993 3.129 . . . . 0.72999999999999998 112.04 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' A' ' 44' ' ' ALA . 3.7 p . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 115.419 1.637 . . . . 1.54 115.419 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.52 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 31.1 m . . . . . 0 N--CA 1.44 -0.974 0 CA-C-O 121.096 0.474 . . . . 0.91000000000000003 110.218 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 95.7 m -153.99 128.63 9.33 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.378 -0.828 . . . . 1.9199999999999999 110.38 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 96' ' ' THR . 44.4 pttt 68.21 -44.73 0.5 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.584 1.328 . . . . 3.1800000000000002 114.584 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.651 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 62.03 -67.92 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.461 0.573 . . . . 1.74 111.577 -175.314 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.69 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 8.9 mmpt? 71.23 147.68 0.08 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.898 0.879 . . . . 3.0800000000000001 111.795 173.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.729 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -168.44 -166.66 0.71 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.101 0.477 . . . . 0.42999999999999999 111.968 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.647 ' HB2' HG23 ' A' ' 58' ' ' THR . 29.0 mm-40 -88.79 27.69 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 2.1899999999999999 110.547 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.835 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 39.1 p90 -149.6 174.76 3.21 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.153 -1.425 . . . . 0.23999999999999999 107.153 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.79 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.4 Cg_exo -71.1 125.59 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.802 2.334 . . . . 0.31 113.322 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.025 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -124.43 141.49 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.247 -0.649 . . . . 0.37 109.247 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.79 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 6.4 mmt -115.48 -152.16 0.5 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.542 0.687 . . . . 1.47 112.714 -164.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -73.04 137.26 45.23 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.577 -1.192 . . . . 0.39000000000000001 110.707 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.029 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 26.7 pttt -73.13 120.97 19.49 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.764 -0.828 . . . . 1.6599999999999999 108.764 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.507 HD12 ' CB ' ' A' ' 116' ' ' HIS . 5.2 pt -122.53 169.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.795 -1.093 . . . . 0.46999999999999997 108.343 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.2 m120 -68.6 121.37 16.29 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.77 -1.196 . . . . 2.1600000000000001 107.77 169.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.709 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -119.16 83.57 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 C-N-CA 119.127 -1.029 . . . . 0.38 109.587 170.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 46.5 t30 170.96 177.97 0.06 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.076 -1.083 . . . . 1.98 108.076 167.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.76 -141.52 35.93 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.955 -0.641 . . . . 0.78000000000000003 113.779 164.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.23 1.52 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.121 -0.539 . . . . 1.98 110.601 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -87.75 -24.94 23.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.821 -0.627 . . . . 2.04 110.681 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.775 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -44.59 142.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.779 1.029 . . . . 0.47999999999999998 113.779 -175.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.507 ' CB ' HD12 ' A' ' 108' ' ' ILE . 49.3 t-80 -53.23 136.3 49.84 Favored Pre-proline 0 C--O 1.225 -0.236 0 CA-C-N 114.679 -1.146 . . . . 0.41999999999999998 110.012 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.56 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.2 Cg_exo -40.95 -45.34 5.03 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.172 2.581 . . . . 0.35999999999999999 112.845 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.522 HD11 ' HE3' ' A' ' 122' ' ' MET . 30.0 tp -54.02 -51.49 63.82 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.783 -0.644 . . . . 1.1000000000000001 111.884 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.5 m-85 -71.28 -30.4 66.22 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 116.517 -0.31 . . . . 1.49 111.0 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.474 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 9.6 mm-40 -56.26 -43.3 78.62 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.726 -0.79 . . . . 2.3700000000000001 109.413 170.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.9 t80 -66.03 -45.03 82.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.614 -0.434 . . . . 0.57999999999999996 110.508 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.522 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.9 mtt -60.76 -53.11 61.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.873 0.368 . . . . 0.34000000000000002 111.236 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 2.5 mtpm? -62.33 -38.24 88.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 0.93999999999999995 110.838 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 17.1 ptpt -74.82 -27.35 60.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.718 -0.219 . . . . 2.1299999999999999 110.816 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.537 HG21 ' HD2' ' A' ' 150' ' ' PRO . 59.1 m -65.02 -55.18 20.44 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.945 -0.302 . . . . 0.46999999999999997 111.068 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.538 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 31.7 ttmt . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.278 -0.569 . . . . 1.75 111.574 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.41 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 113.357 0.873 . . . . 0.93000000000000005 113.357 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.903 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 26.0 mt -103.19 90.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.845 -1.07 . . . . 1.05 110.79 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -111.48 -2.38 15.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.451 0.537 . . . . 1.5 112.451 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.903 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -120.41 170.29 9.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.465 0.543 . . . . 0.87 112.465 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 16.3 m120 -47.98 -156.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.901 1.681 . . . . 1.8 113.745 172.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.841 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 33.2 m-85 -27.48 -57.96 0.1 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 125.175 1.39 . . . . 1.3700000000000001 114.022 -164.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.775 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 24.2 m 42.94 95.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.046 0.758 . . . . 0.29999999999999999 113.046 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.678 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.3 t -88.33 147.13 24.92 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.997 -0.681 . . . . 0.80000000000000004 110.786 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 39' ' ' LEU . 5.2 m-85 -102.32 133.99 46.33 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.371 -0.974 . . . . 0.53000000000000003 108.371 169.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.906 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.35 104.05 11.53 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.001 -0.74 . . . . 0.51000000000000001 109.001 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 15' ' ' ILE . 10.7 mm -104.07 116.86 48.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.92 -0.582 . . . . 0.20000000000000001 109.737 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.414 ' HB2' HD13 ' A' ' 170' ' ' LEU . 6.9 t70 -74.68 169.85 17.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.017 -0.538 . . . . 1.3 109.846 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.891 ' HD3' ' HA ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -60.36 -9.66 3.81 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.329 -0.851 . . . . 3.7799999999999998 112.09 -168.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.2 8.78 28.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.864 -0.791 . . . . 1.1799999999999999 108.864 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.519 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 71.57 45.49 45.41 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.23000000000000001 112.559 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 79.7 t -123.24 123.06 26.69 Favored Pre-proline 0 C--N 1.321 -0.671 0 O-C-N 122.85 -0.206 . . . . 0.62 110.664 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.537 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -68.12 102.75 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.244 2.63 . . . . 0.29999999999999999 112.417 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.51 ' HB ' HD23 ' A' ' 143' ' ' LEU . 18.8 t -88.49 -15.35 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 0.27000000000000002 110.806 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.538 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 28.2 mm-40 -168.08 164.54 13.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.094 0.474 . . . . 1.22 111.273 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -133.95 99.31 4.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 1.75 109.546 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.906 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.5 m-85 -87.25 125.31 34.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.738 -0.838 . . . . 0.38 108.738 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.765 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 95.4 p -69.01 174.29 2.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.617 0.644 . . . . 0.98999999999999999 109.357 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.876 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 62.8 Cg_endo -68.31 -13.8 38.66 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.062 1.841 . . . . 0.66000000000000003 111.48 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.13 1.72 79.06 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.835 -1.075 . . . . 0.52000000000000002 111.699 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.92 133.77 35.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.981 0.42 . . . . 0.42999999999999999 110.306 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.6 m -90.95 178.52 6.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.109 -0.496 . . . . 1.25 110.221 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.557 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 45.1 t -54.61 -55.9 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 0.40999999999999998 111.034 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.8 tptp -62.91 -29.23 70.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 3.4399999999999999 111.265 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.65 -41.12 89.81 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.347 -0.612 . . . . 1.8600000000000001 109.347 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.706 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.9 mt -82.31 -38.44 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.891 . . . . 0.20999999999999999 111.344 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 49.0 mt-10 -54.59 -41.86 70.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.297 0.48 . . . . 0.88 112.297 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.1 pt-20 -65.62 -11.78 47.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.444 0.535 . . . . 0.75 112.444 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.726 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 73.6 mmtt -109.89 -16.2 13.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.492 . . . . 1.5800000000000001 110.386 174.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.566 ' HG ' HD11 ' A' ' 171' ' ' LEU . 67.1 tp -95.61 -42.68 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.742 -0.663 . . . . 0.23999999999999999 111.845 -171.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.729 ' HA ' HD12 ' A' ' 171' ' ' LEU . 80.6 mt -49.79 -51.31 61.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.547 0.573 . . . . 0.44 112.547 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 57.0 Cg_exo -55.09 -30.94 72.94 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.271 1.981 . . . . 0.48999999999999999 113.154 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.414 HD13 ' HB2' ' A' ' 145' ' ' ASP . 64.7 mt -81.73 -34.21 30.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.52 0.2 . . . . 0.70999999999999996 110.75 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.836 HD23 ' HG2' ' A' ' 37' ' ' PRO . 12.6 mt -64.31 -41.4 96.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.694 0.759 . . . . 0.46000000000000002 109.245 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.47 12.21 2.72 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 114.411 -1.268 . . . . 1.52 113.278 171.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.891 ' HA ' ' HD3' ' A' ' 146' ' ' ARG . 19.3 t . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 124.413 1.085 . . . . 2.52 111.562 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 108.726 -0.842 . . . . 1.6799999999999999 108.726 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.0 p -145.08 174.85 10.69 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.979 -1.01 . . . . 0.65000000000000002 108.543 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.702 HD13 HG21 ' A' ' 144' ' ' ILE . 13.0 pt -65.15 -22.92 32.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 0.29999999999999999 111.203 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.841 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 52.6 m-85 -79.79 -0.28 33.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.195 -0.457 . . . . 0.27000000000000002 111.951 -172.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.91 -12.37 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.395 0.616 . . . . 1.96 109.52 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 91.2 m-85 -109.9 140.32 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.435 -0.802 . . . . 0.40000000000000002 110.991 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.99 140.6 33.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.698 -0.683 . . . . 2.77 110.631 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.573 HG23 HD13 ' A' ' 30' ' ' LEU . 70.0 t -114.46 148.74 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.935 0.398 . . . . 0.73999999999999999 110.914 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.835 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 81.6 mt -111.54 141.62 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 0.71999999999999997 109.246 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.03 -171.75 2.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.487 -0.561 . . . . 1.5900000000000001 109.487 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.24 -32.93 57.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.605 -0.27 . . . . 0.52000000000000002 111.671 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.6 t70 -90.86 -8.33 49.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.597 -0.274 . . . . 2.2200000000000002 111.402 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.835 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.9 m-70 80.71 22.55 0.39 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.72999999999999998 110.239 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -81.61 160.68 63.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 105.685 -1.968 . . . . 3.25 105.685 166.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.8 113.67 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 120.093 1.069 . . . . 0.85999999999999999 111.727 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.515 ' HB3' HG12 ' A' ' 20' ' ' VAL . 58.2 t80 -80.67 130.07 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 0.28000000000000003 109.969 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.757 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.5 t-20 -80.67 81.99 6.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.07 -0.715 . . . . 1.6499999999999999 109.07 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.841 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -67.86 -32.38 72.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.198 0.523 . . . . 0.25 110.219 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.679 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.33 -0.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.428 -0.806 . . . . 0.40999999999999998 112.634 -169.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.757 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.6 pt20 -83.55 -6.04 59.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.609 0.719 . . . . 1.24 109.164 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -91.73 -9.78 42.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.991 -1.114 . . . . 0.38 107.991 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -70.9 137.48 49.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.19 -1.368 . . . . 1.73 109.157 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 -10.56 53.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 109.913 -1.275 . . . . 0.35999999999999999 109.913 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 49.6 m -141.0 144.78 36.49 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.822 -0.807 . . . . 1.1399999999999999 108.822 177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.024 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 60.8 Cg_endo -71.89 155.69 57.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.909 1.739 . . . . 0.52000000000000002 111.259 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.603 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.7 pt? -154.19 152.68 30.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.153 0.501 . . . . 1.03 111.217 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 163' ' ' ILE . 6.8 mp -108.0 152.5 24.4 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.775 -0.824 . . . . 1.1000000000000001 108.775 172.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 78.9 mt -140.84 115.48 5.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.542 -0.54 . . . . 0.20000000000000001 109.542 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.909 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 17.7 m-85 -102.42 123.65 46.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 121.166 -0.213 . . . . 0.23000000000000001 110.982 -173.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.734 ' HB2' HG21 ' A' ' 110' ' ' VAL . 1.1 p30 -82.23 91.3 6.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.545 -0.909 . . . . 1.28 108.545 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.605 HG11 ' HE2' ' A' ' 98' ' ' PHE . 1.7 p -111.95 125.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 112.455 0.539 . . . . 0.88 112.455 -165.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.27 107.16 0.45 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.744 -1.576 . . . . 0.52000000000000002 106.744 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 1.071 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 3.3 p -76.71 75.67 3.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.28 -1.327 . . . . 1.8400000000000001 113.483 -156.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 82.6 tttt 92.45 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.627 1.171 . . . . 2.4300000000000002 111.538 174.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.6 m -141.57 143.26 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.446 -0.343 . . . . 0.98999999999999999 110.674 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.28 -136.69 19.15 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.031 -0.604 . . . . 1.0900000000000001 114.222 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.58 111.84 24.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 3.1600000000000001 111.815 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 p -73.33 -26.7 61.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.981 -0.554 . . . . 1.9399999999999999 110.648 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.86 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 39.2 mtpt 64.54 3.02 1.77 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.33 -0.85 . . . . 2.0299999999999998 112.259 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.84 -3.94 34.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.824 -0.703 . . . . 0.46999999999999997 112.641 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.15 79.83 Favored Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 111.702 -0.559 . . . . 0.34000000000000002 111.702 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.576 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -69.25 -52.72 24.9 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.073 0.463 . . . . 0.56999999999999995 110.138 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.29 -41.55 93.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.488 -0.778 . . . . 2.46 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.6 m -68.51 -40.82 80.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.816 -0.629 . . . . 0.33000000000000002 110.876 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -64.98 -49.3 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.19 111.283 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -59.18 -48.9 79.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.835 -0.621 . . . . 0.29999999999999999 111.177 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -63.8 -46.16 86.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.816 -0.629 . . . . 1.0800000000000001 111.27 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.686 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.78 -46.0 90.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.81000000000000005 111.338 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.656 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 59.0 t80 -53.74 -57.34 11.19 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 123.277 0.361 . . . . 0.33000000000000002 110.427 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -67.14 -41.57 85.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.291 -0.413 . . . . 1.76 111.555 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.77 -42.79 73.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 1.79 111.717 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.686 ' CD1' HD13 ' A' ' 171' ' ' LEU . 67.7 m-85 -103.9 3.78 34.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.445 0.905 . . . . 0.42999999999999999 113.445 -172.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -58.48 -29.74 66.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 2.1099999999999999 110.788 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.6 p -65.32 -38.55 90.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.2 111.237 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -89.24 1.89 55.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.816 0.341 . . . . 1.8999999999999999 111.255 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.508 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 93.08 73.43 1.23 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.701 -0.761 . . . . 1.3200000000000001 112.006 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.601 ' CE1' HD13 ' A' ' 39' ' ' LEU . 76.7 t80 -143.09 142.13 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.526 0.203 . . . . 0.26000000000000001 111.06 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.98 141.45 49.29 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 120.823 0.344 . . . . 0.51000000000000001 110.207 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.661 HG11 ' HB1' ' A' ' 57' ' ' ALA . 52.9 t -108.01 114.06 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.74 0.305 . . . . 0.23999999999999999 110.448 168.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 31.2 mt -98.48 122.63 41.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.828 -0.804 . . . . 0.51000000000000001 108.828 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.51 113.42 26.19 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.388 -0.525 . . . . 0.28000000000000003 110.345 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.76 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.4 m-85 -95.05 108.22 36.9 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.54 -0.911 . . . . 0.34000000000000002 108.54 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.071 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.2 Cg_exo -59.76 167.67 6.56 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 123.164 2.576 . . . . 0.72999999999999998 111.555 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 70.9 m . . . . . 0 N--CA 1.429 -1.482 0 C-N-CA 118.55 -1.26 . . . . 1.54 113.606 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.821 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 56.1 m . . . . . 0 N--CA 1.441 -0.904 0 CA-C-O 120.814 0.34 . . . . 0.91000000000000003 111.232 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.947 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 17.0 m -153.0 115.28 4.41 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.225 -0.898 . . . . 1.9199999999999999 109.304 168.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.662 ' O ' HG21 ' A' ' 104' ' ' ILE . 87.6 mttt 64.27 -40.24 0.24 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 115.006 1.484 . . . . 3.1800000000000002 115.006 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.695 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER 63.2 -36.55 0.15 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.004 1.322 . . . . 1.74 112.308 -171.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 97' ' ' LYS . 70.9 mmtt 69.54 130.86 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.828 0.851 . . . . 3.0800000000000001 112.581 172.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.69 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -158.88 -171.38 3.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.847 -0.615 . . . . 0.42999999999999999 112.397 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.62 31.44 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.419 -0.81 . . . . 2.1899999999999999 111.092 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.877 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 39.2 p90 -150.43 167.31 13.24 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 108.154 -1.054 . . . . 0.23999999999999999 108.154 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.1 Cg_exo -64.04 106.52 0.67 Allowed 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 123.597 2.865 . . . . 0.31 113.527 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.979 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.4 mp -103.43 131.52 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.991 -0.744 . . . . 0.37 108.991 174.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.5 mmt -109.94 -154.17 0.53 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.118 0.784 . . . . 1.47 113.118 -161.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -69.56 125.22 26.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.123 -0.944 . . . . 0.39000000000000001 110.496 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.947 ' HE3' ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -64.5 120.55 12.53 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.617 -0.883 . . . . 1.6599999999999999 108.617 172.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.754 HG13 HG13 ' A' ' 110' ' ' VAL . 9.2 pt -121.39 155.04 25.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.29 -1.004 . . . . 0.46999999999999997 108.29 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -83.19 69.61 9.94 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.123 -1.066 . . . . 2.1600000000000001 108.123 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.7 90.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.38 111.007 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.581 ' H ' ' HB2' ' A' ' 115' ' ' ALA . 46.5 t30 174.16 172.55 0.19 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.505 -0.924 . . . . 1.98 108.505 166.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.21 -142.49 23.23 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 114.471 0.548 . . . . 0.78000000000000003 114.471 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -1.52 32.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.49 0.662 . . . . 1.98 110.558 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -95.68 -13.15 24.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.089 -0.959 . . . . 2.04 110.688 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.581 ' HB2' ' H ' ' A' ' 111' ' ' ASN . . . -57.84 149.52 22.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.562 -0.745 . . . . 0.47999999999999998 111.913 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.553 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 20.2 t-80 -46.99 139.73 6.72 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.118 -0.946 . . . . 0.41999999999999998 110.131 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.476 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 11.0 Cg_endo -54.18 -35.34 82.21 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.224 2.616 . . . . 0.35999999999999999 112.437 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.562 HD11 ' HE3' ' A' ' 122' ' ' MET . 23.4 tp -61.57 -40.46 94.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.908 -0.587 . . . . 1.1000000000000001 110.572 175.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.9 m-85 -75.63 -28.9 58.98 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.224 -0.443 . . . . 1.49 111.009 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' A' ' 117' ' ' PRO . 40.2 mt-10 -57.6 -39.96 77.99 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.951 -0.7 . . . . 2.3700000000000001 109.181 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.501 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 79.1 t80 -71.67 -41.74 68.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 0.57999999999999996 110.519 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.562 ' HE3' HD11 ' A' ' 118' ' ' LEU . 65.6 mtt -66.68 -53.01 38.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.133 -0.485 . . . . 0.34000000000000002 111.576 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 13.8 mtpt -61.26 -39.63 91.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.541 -0.3 . . . . 0.93999999999999995 110.958 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -68.58 -32.36 72.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.78 0.324 . . . . 2.1299999999999999 110.484 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.556 HG21 ' HD2' ' A' ' 150' ' ' PRO . 89.3 m -66.23 -58.75 4.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 0.46999999999999997 110.979 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.866 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 25.9 ttmt . . . . . 0 C--N 1.325 -0.492 0 C-N-CA 120.509 -0.476 . . . . 1.75 110.521 174.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.553 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 114.813 1.412 . . . . 0.93000000000000005 114.813 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.873 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 51.0 mt -104.66 87.88 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 113.681 -1.6 . . . . 1.05 110.257 -173.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.7 pttt -110.57 14.98 22.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.477 0.547 . . . . 1.5 112.477 -170.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.873 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -146.7 169.38 19.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.923 0.342 . . . . 0.87 111.923 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.613 ' ND2' ' HB3' ' A' ' 44' ' ' ALA . 1.5 t-20 -51.66 -155.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.535 1.534 . . . . 1.8 113.223 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.909 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 27.4 m-85 -25.43 -59.68 0.07 Allowed 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 125.298 1.439 . . . . 1.3700000000000001 114.794 -162.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.796 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 19.2 m 42.69 93.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 118.684 0.675 . . . . 0.29999999999999999 112.738 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.0 p -84.59 150.62 25.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.689 -0.804 . . . . 0.80000000000000004 110.491 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 4.5 m-85 -103.75 135.65 44.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.226 -1.027 . . . . 0.53000000000000003 108.226 167.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.911 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 35.9 tp -82.01 104.85 12.66 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.994 -0.743 . . . . 0.51000000000000001 108.994 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 15' ' ' ILE . 14.6 mm -102.44 121.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.947 -0.76 . . . . 0.20000000000000001 108.947 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.41 -179.39 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.568 -0.287 . . . . 1.3 110.994 -176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.661 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.6 mtp180 -56.23 -28.59 58.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.243 0.46 . . . . 3.7799999999999998 112.243 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -109.77 -4.75 15.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.186 0.517 . . . . 1.1799999999999999 110.791 -169.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.581 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.09 53.46 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.491 -0.861 . . . . 0.23000000000000001 114.353 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 10.3 t -127.7 128.82 23.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 117.382 0.591 . . . . 0.62 110.151 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.556 ' HD2' HG21 ' A' ' 125' ' ' THR . 15.3 Cg_exo -66.26 102.64 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.946 2.431 . . . . 0.29999999999999999 112.388 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.47 -18.42 8.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.656 -0.702 . . . . 0.27000000000000002 110.925 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.866 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 77.0 mm-40 -157.07 159.42 37.9 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.682 0.277 . . . . 1.22 110.915 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.459 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 20.1 ttm180 -127.44 96.83 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.01 -0.737 . . . . 1.75 109.01 168.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.911 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 33.9 m-85 -86.42 107.88 18.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.908 -0.775 . . . . 0.38 108.908 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.701 ' HA ' HG23 ' A' ' 140' ' ' THR . 83.5 p -60.6 164.93 6.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.89 -0.411 . . . . 0.98999999999999999 109.89 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.86 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 42.0 Cg_endo -65.24 -7.6 16.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.032 2.488 . . . . 0.66000000000000003 112.978 -164.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.95 22.46 38.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.52000000000000002 111.718 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.04 140.23 29.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 0.42999999999999999 110.813 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.9 p -91.32 170.13 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.734 -0.667 . . . . 1.25 111.029 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.686 HG13 HD21 ' A' ' 60' ' ' LEU . 74.5 t -53.18 -56.09 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.40999999999999998 110.955 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.424 ' NZ ' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -65.64 -32.05 73.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 3.4399999999999999 111.461 -175.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.74 -31.78 73.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.121 -0.49 . . . . 1.8600000000000001 109.922 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.887 HG21 HD21 ' A' ' 39' ' ' LEU . 35.6 mt -83.19 -39.83 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.994 -0.548 . . . . 0.20999999999999999 110.7 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 54.7 mt-10 -57.79 -35.63 71.08 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.133 0.42 . . . . 0.88 112.133 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.519 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.4 pt-20 -61.32 -21.38 63.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.75 111.648 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.547 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtt -104.8 -31.5 9.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.233 -0.44 . . . . 1.5800000000000001 110.549 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.3 tp -85.58 -42.43 14.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.23999999999999999 112.758 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.806 ' HA ' HD12 ' A' ' 171' ' ' LEU . 60.8 mt -53.94 -46.97 98.38 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.504 0.557 . . . . 0.44 112.504 -173.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.9 Cg_exo -53.13 -40.16 77.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.809 1.672 . . . . 0.48999999999999999 112.371 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.6 mt -74.4 -37.05 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.70999999999999996 111.794 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.024 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.8 mt -54.27 -54.07 45.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.539 0.685 . . . . 0.46000000000000002 109.497 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.7 -59.78 8.77 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.276 -1.329 . . . . 1.52 112.795 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 116.923 0.362 . . . . 2.52 110.857 -179.136 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.825 0.345 . . . . 1.6799999999999999 110.664 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.3 p -124.33 -179.41 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.596 -0.52 . . . . 0.65000000000000002 109.596 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.833 HD13 HG21 ' A' ' 144' ' ' ILE . 32.5 pt -68.3 -31.07 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.83 0.348 . . . . 0.29999999999999999 111.358 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 29.8 m-85 -72.95 -4.62 33.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.906 0.384 . . . . 0.27000000000000002 111.594 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.52 -14.22 62.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.83 -0.623 . . . . 1.96 109.366 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.645 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 84.1 m-85 -111.62 142.34 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.373 -0.83 . . . . 0.40000000000000002 110.701 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -100.18 140.18 34.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.68 -0.489 . . . . 2.77 109.68 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.577 ' CG2' ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -123.3 159.77 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.378 -0.374 . . . . 0.73999999999999999 110.804 -171.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.907 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 58.7 mt -97.26 133.34 42.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.531 . . . . 0.71999999999999997 110.214 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 21.2 t70 -69.78 178.18 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.702 -1.135 . . . . 1.5900000000000001 109.584 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.674 ' HB1' ' CD ' ' A' ' 97' ' ' LYS . . . -55.43 -25.04 33.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.968 0.413 . . . . 0.52000000000000002 111.417 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -90.91 -9.82 44.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.206 -0.452 . . . . 2.2200000000000002 111.111 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.907 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 44.9 m-70 74.51 12.88 3.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.912 0.885 . . . . 0.72999999999999998 109.994 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -73.37 150.36 89.39 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 106.126 -1.805 . . . . 3.25 106.126 162.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.23 115.16 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.81 1.007 . . . . 0.85999999999999999 111.425 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.577 ' HB3' ' CG2' ' A' ' 20' ' ' VAL . 87.9 t80 -84.42 122.28 28.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.28000000000000003 109.825 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.671 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.0 t30 -75.24 82.15 2.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.839 -0.619 . . . . 1.6499999999999999 109.645 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.738 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.2 pt? -63.06 -29.74 71.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.594 0.711 . . . . 0.25 110.28 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.75 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.6 p -77.31 -0.03 2.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.828 -1.078 . . . . 0.40999999999999998 112.933 -169.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.671 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -78.35 -5.45 52.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.359 -0.608 . . . . 1.24 109.359 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CG ' HG21 ' A' ' 70' ' ' THR . 77.5 m-70 -98.42 -0.75 42.99 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.38 108.759 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HE2' ' CG2' ' A' ' 31' ' ' VAL . 9.2 ttmm -67.97 132.4 47.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 1.73 109.914 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.46 -0.99 60.06 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.515 -1.034 . . . . 0.35999999999999999 110.515 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 44.8 m -140.33 138.49 19.12 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.237 -0.653 . . . . 1.1399999999999999 109.237 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.003 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 43.8 Cg_endo -69.44 154.87 68.42 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.769 1.646 . . . . 0.52000000000000002 110.893 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.624 ' CB ' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -156.52 148.36 22.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.167 0.508 . . . . 1.03 111.323 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 141' ' ' SER . 3.4 mm? -107.12 148.63 28.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.113 -1.069 . . . . 1.1000000000000001 108.113 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.541 HD12 HG13 ' A' ' 144' ' ' ILE . 69.6 mt -139.55 116.38 10.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.74 -0.467 . . . . 0.20000000000000001 109.74 -173.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.707 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 16.4 m-85 -101.39 130.31 47.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.602 -0.272 . . . . 0.23000000000000001 111.313 -172.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.673 ' CB ' HG11 ' A' ' 110' ' ' VAL . 1.1 p30 -87.96 92.04 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.394 -0.965 . . . . 1.28 108.394 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -106.53 150.13 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.453 0.644 . . . . 0.88 112.348 -160.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.31 109.0 5.06 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.2 -1.407 . . . . 0.52000000000000002 107.2 166.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.986 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -66.76 74.46 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.005 -0.998 . . . . 1.8400000000000001 112.6 -169.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.781 ' HE3' ' HA ' ' A' ' 98' ' ' PHE . 39.6 ttmt 55.73 57.44 5.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.156 -0.929 . . . . 2.4300000000000002 111.119 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -160.87 128.14 4.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.108 -0.496 . . . . 0.98999999999999999 111.288 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.52 -80.9 1.78 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.847 -0.615 . . . . 1.0900000000000001 113.662 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -131.72 163.18 28.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.423 0.154 . . . . 3.1600000000000001 110.949 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 p -131.82 -35.69 1.25 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.143 0.423 . . . . 1.9399999999999999 112.143 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 65.77 0.39 1.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.478 0.711 . . . . 2.0299999999999998 112.259 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.75 4.97 72.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.666 -0.778 . . . . 0.46999999999999997 112.259 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.0 86.73 Favored Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.37 -0.692 . . . . 0.34000000000000002 111.37 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.493 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.3 t80 -61.75 -52.75 62.98 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.941 -0.629 . . . . 0.56999999999999995 110.254 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.37 -45.97 90.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.765 -0.652 . . . . 2.46 110.668 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 160' ' ' VAL . 30.1 m -57.08 -48.69 77.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.682 -0.69 . . . . 0.33000000000000002 110.481 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.761 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.53 -50.02 74.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 0.19 111.785 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -61.1 -42.98 99.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.173 0.511 . . . . 0.29999999999999999 111.005 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.8 m -64.67 -47.77 77.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.576 -0.738 . . . . 1.0800000000000001 111.223 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 90.5 mt -56.52 -52.58 64.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.187 -0.461 . . . . 0.81000000000000005 111.165 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.656 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 47.3 t80 -46.99 -57.87 4.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 124.435 1.085 . . . . 0.33000000000000002 110.117 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.34 -38.85 65.61 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.736 -0.665 . . . . 1.76 111.919 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -70.01 -45.14 67.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 1.79 111.301 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.711 ' CD1' HD13 ' A' ' 171' ' ' LEU . 58.6 m-85 -100.02 5.83 45.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.194 0.813 . . . . 0.42999999999999999 113.194 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 17.8 mtpp -62.03 -18.67 61.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 2.1099999999999999 110.073 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 p -61.67 -40.69 95.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.687 -0.688 . . . . 1.2 110.874 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -94.92 10.18 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 1.8999999999999999 110.599 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.577 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.14 71.66 1.26 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.571 -0.741 . . . . 1.3200000000000001 112.255 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE1' HD23 ' A' ' 39' ' ' LEU . 59.4 t80 -132.62 142.43 49.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.229 -0.285 . . . . 0.26000000000000001 110.229 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.624 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.36 152.44 48.16 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.973 0.416 . . . . 0.51000000000000001 110.622 178.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.761 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.0 t -122.82 124.66 70.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.864 0.364 . . . . 0.23999999999999999 110.437 171.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.494 HD22 ' HE3' ' A' ' 105' ' ' MET . 16.5 mt -105.68 145.05 31.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.823 -0.806 . . . . 0.51000000000000001 108.823 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -132.79 113.46 12.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.133 0.492 . . . . 0.28000000000000003 111.108 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.657 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.6 m-85 -99.01 113.57 64.74 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.698 -0.683 . . . . 0.34000000000000002 109.306 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.075 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.29 165.85 6.73 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.562 2.841 . . . . 0.72999999999999998 111.818 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.438 -1.035 0 CA-C-O 122.604 1.192 . . . . 1.54 113.485 179.363 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 38.6 m . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 121.683 0.754 . . . . 0.91000000000000003 110.01 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.546 ' N ' ' HB2' ' A' ' 45' ' ' SER . 10.3 t -148.36 163.49 36.92 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.747 -1.115 . . . . 1.9199999999999999 108.52 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.674 ' CD ' ' HB1' ' A' ' 23' ' ' ALA . 16.5 pttt -38.85 105.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.883 0.739 . . . . 3.1800000000000002 111.344 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.781 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 51.5 p90 -58.21 -22.58 52.53 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.589 -0.732 . . . . 1.74 110.92 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? 68.83 142.82 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.168 0 O-C-N 124.282 0.989 . . . . 3.0800000000000001 110.473 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.478 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -162.26 -160.33 0.66 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.468 -0.493 . . . . 0.42999999999999999 111.732 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.91 -10.57 44.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 2.1899999999999999 109.769 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.604 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 51.7 p90 -112.31 166.85 10.11 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 115.173 -0.921 . . . . 0.23999999999999999 108.934 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.769 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.9 Cg_exo -70.61 119.31 6.24 Favored 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 123.712 2.942 . . . . 0.31 113.306 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.969 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.3 mp -108.21 149.44 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.889 -0.782 . . . . 0.37 108.889 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.769 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 13.3 mmt -118.49 -157.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.17 0.804 . . . . 1.47 113.17 -164.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.69 145.5 43.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.929 -1.032 . . . . 0.39000000000000001 110.359 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.075 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.2 pttt -83.37 137.16 34.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.654 0.74 . . . . 1.6599999999999999 109.785 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.488 HG13 HG13 ' A' ' 110' ' ' VAL . 5.0 pt -135.35 175.18 11.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.204 -1.362 . . . . 0.46999999999999997 108.01 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 22.7 t-20 -88.34 83.96 6.86 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.97 -0.752 . . . . 2.1600000000000001 108.97 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.673 HG11 ' CB ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -76.08 86.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.455 -1.298 . . . . 0.38 110.157 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 63.7 t30 170.88 179.36 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.86 -1.163 . . . . 1.98 107.86 166.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.75 -146.32 35.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.919 -0.658 . . . . 0.78000000000000003 113.793 166.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -107.15 1.1 23.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.183 -0.508 . . . . 1.98 111.351 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -103.78 11.8 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.906 0.86 . . . . 2.04 110.065 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.536 ' HB3' ' OE1' ' A' ' 120' ' ' GLU . . . -73.88 156.46 37.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 0.47999999999999998 111.963 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 20' ' ' VAL . 35.6 t-80 -57.18 137.69 80.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.07 -0.968 . . . . 0.41999999999999998 110.5 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -42.39 -48.78 6.61 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.312 2.675 . . . . 0.35999999999999999 113.13 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.568 HD22 ' CG1' ' A' ' 20' ' ' VAL . 13.6 tp -56.01 -41.23 74.58 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.244 -0.435 . . . . 1.1000000000000001 111.843 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.601 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 12.4 m-85 -75.44 -30.71 60.09 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.458 -0.337 . . . . 1.49 110.975 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.536 ' OE1' ' HB3' ' A' ' 115' ' ' ALA . 7.1 mm-40 -59.74 -36.75 77.24 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.141 -0.623 . . . . 2.3700000000000001 109.417 168.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.4 t80 -67.77 -48.78 65.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 0.57999999999999996 110.448 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.546 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.7 mtt -63.08 -53.06 59.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.004 -0.544 . . . . 0.34000000000000002 111.443 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -60.33 -39.7 88.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 0.93999999999999995 111.204 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.5 ptmt -71.86 -35.24 69.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.737 0.303 . . . . 2.1299999999999999 110.801 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.512 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.8 m -70.08 -42.63 72.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.976 -0.556 . . . . 0.46999999999999997 112.449 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 112.567 0.58 . . . . 1.75 112.567 -173.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 121.112 0.482 . . . . 0.93000000000000005 111.416 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.809 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 25.9 mt -85.71 110.21 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.373 -0.831 . . . . 1.05 109.769 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -130.08 15.74 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.003 0.43 . . . . 1.5 112.029 -170.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.809 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -153.91 173.87 15.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.215 0.531 . . . . 0.87 111.989 -175.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.486 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 8.8 m120 -43.16 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.74 1.616 . . . . 1.8 115.196 168.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.784 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 15.4 m-85 -30.79 -58.26 0.21 Allowed 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 112.871 -1.968 . . . . 1.3700000000000001 113.918 -169.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.817 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 12.5 m 44.95 99.64 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.593 0.961 . . . . 0.29999999999999999 113.593 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.7 ' HB2' HD12 ' A' ' 39' ' ' LEU . 15.9 p -87.78 151.16 23.1 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.467 -0.771 . . . . 0.80000000000000004 111.268 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.4 m-85 -103.7 133.62 48.4 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.392 -0.966 . . . . 0.53000000000000003 108.392 168.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.806 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 25.5 tp -81.36 105.41 12.52 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.133 -0.691 . . . . 0.51000000000000001 109.133 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 15' ' ' ILE . 13.2 mm -105.59 126.91 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.605 -0.725 . . . . 0.20000000000000001 109.083 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.69 -175.71 4.53 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.912 -0.315 . . . . 1.3 110.614 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.649 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 63.5 mtt180 -63.23 -16.76 61.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.259 0.466 . . . . 3.7799999999999998 112.259 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -108.09 -10.04 15.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.437 0.637 . . . . 1.1799999999999999 110.17 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.587 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 95.82 32.31 6.92 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.538 -0.755 . . . . 0.23000000000000001 112.672 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 72.1 t -111.9 124.09 33.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.871 -0.418 . . . . 0.62 109.871 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.512 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.1 Cg_exo -68.14 118.39 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.44 2.093 . . . . 0.29999999999999999 111.573 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.471 ' HB ' HD23 ' A' ' 143' ' ' LEU . 32.4 t -98.06 -26.24 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.712 -0.676 . . . . 0.27000000000000002 110.417 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 27.1 mm-40 -149.83 163.73 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 1.22 111.509 -177.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -131.41 98.19 4.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.439 -0.8 . . . . 1.75 109.071 168.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.806 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 74.1 m-85 -86.95 117.84 25.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.497 -0.557 . . . . 0.38 109.497 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.799 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.0 OUTLIER -63.68 164.3 16.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.665 -0.494 . . . . 0.98999999999999999 109.665 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.817 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 63.2 Cg_endo -70.65 -6.08 18.23 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.848 2.365 . . . . 0.66000000000000003 112.495 -167.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.57 5.61 62.47 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.95 -1.023 . . . . 0.52000000000000002 111.912 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.46 139.11 36.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.42999999999999999 110.139 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.3 m -77.12 163.46 26.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.974 -0.557 . . . . 1.25 111.019 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 34.3 t -53.21 -48.84 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.423 -0.353 . . . . 0.40999999999999998 110.343 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.449 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.2 tptm -69.79 -28.69 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 3.4399999999999999 111.034 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.17 -33.84 74.09 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.0 0.429 . . . . 1.8600000000000001 110.007 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.58 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.0 mt -80.39 -42.21 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.738 -0.665 . . . . 0.20999999999999999 110.149 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 168' ' ' ILE . 45.2 mt-10 -55.41 -41.63 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.976 -0.556 . . . . 0.88 112.378 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.93 -19.37 60.63 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.241 0.46 . . . . 0.75 112.241 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -107.2 -17.93 14.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.012 0.435 . . . . 1.5800000000000001 110.291 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.8 tp -89.98 -39.09 13.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.741 -0.663 . . . . 0.23999999999999999 111.761 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.763 ' HA ' HD12 ' A' ' 171' ' ' LEU . 80.2 mt -52.48 -47.91 91.81 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.323 0.49 . . . . 0.44 112.323 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.508 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.6 Cg_exo -55.43 -27.68 59.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.248 1.966 . . . . 0.48999999999999999 113.269 175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.53 -34.52 16.35 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.521 0.201 . . . . 0.70999999999999996 111.465 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.003 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.5 mt -58.08 -52.56 65.05 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.189 -0.671 . . . . 0.46000000000000002 109.189 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.81 60.86 2.1 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.717 -1.129 . . . . 1.52 113.189 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.47 0.535 0 C-N-CA 123.426 0.691 . . . . 2.52 112.159 175.34 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.44 0.638 . . . . 1.6799999999999999 109.743 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 -177.86 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.018 -0.992 . . . . 0.65000000000000002 108.719 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 144' ' ' ILE . 35.5 pt -66.16 -24.67 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.967 0.413 . . . . 0.29999999999999999 111.312 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.806 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 27.5 m-85 -82.07 1.64 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.047 0.451 . . . . 0.27000000000000002 110.823 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.86 -16.99 63.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.355 -0.98 . . . . 1.96 108.355 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 70.4 m-85 -110.66 178.92 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.71 -1.132 . . . . 0.40000000000000002 110.125 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -124.65 144.57 50.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.764 0.316 . . . . 2.77 110.887 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.607 HG23 HD13 ' A' ' 30' ' ' LEU . 74.2 t -114.85 140.89 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.19 -0.459 . . . . 0.73999999999999999 111.385 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.967 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 65.1 mt -96.71 140.71 30.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.005 -0.739 . . . . 0.71999999999999997 109.005 169.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -79.07 -169.0 1.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 1.5900000000000001 109.824 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB1' ' HG3' ' A' ' 97' ' ' LYS . . . -57.31 -22.52 42.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 111.944 0.35 . . . . 0.52000000000000002 111.944 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.9 t70 -104.74 -2.71 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.69 0.281 . . . . 2.2200000000000002 111.153 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.967 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.8 m-70 76.57 21.73 1.28 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.628 0.727 . . . . 0.72999999999999998 109.644 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -83.45 153.67 65.46 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.828 -1.916 . . . . 3.25 105.828 165.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.22 113.83 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.934 1.012 . . . . 0.85999999999999999 111.997 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.545 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 78.5 t80 -84.03 114.6 21.85 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.245 -0.888 . . . . 0.28000000000000003 109.242 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.691 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -67.02 83.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.525 -0.761 . . . . 1.6499999999999999 109.718 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.806 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -70.54 -33.11 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.236 0.541 . . . . 0.25 110.145 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.703 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -77.57 -0.77 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.427 -0.806 . . . . 0.40999999999999998 112.843 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -81.69 -5.61 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.759 0.79 . . . . 1.24 108.936 172.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.664 ' HB3' ' CD2' ' A' ' 38' ' ' LEU . 75.7 m-70 -98.5 3.07 48.16 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.583 -1.19 . . . . 0.38 108.145 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 24.9 ttpt -79.3 136.18 36.95 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.749 -1.114 . . . . 1.73 109.023 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.93 -13.59 52.85 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.254 -1.139 . . . . 0.35999999999999999 110.254 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 76.3 p -129.8 138.49 33.24 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 109.34 -0.615 . . . . 1.1399999999999999 109.34 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.964 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 57.7 Cg_endo -74.2 155.46 46.87 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.519 1.479 . . . . 0.52000000000000002 109.714 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.818 HD12 ' HB ' ' A' ' 144' ' ' ILE . 0.8 OUTLIER -159.61 152.51 21.73 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.282 0.563 . . . . 1.03 111.958 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 141' ' ' SER . 3.6 mm? -107.02 138.44 43.19 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.558 -0.904 . . . . 1.1000000000000001 108.558 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 70.9 mt -127.58 118.07 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.198 -0.667 . . . . 0.20000000000000001 109.198 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.834 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.3 m-85 -101.17 123.2 44.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.445 -0.343 . . . . 0.23000000000000001 111.198 -172.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.721 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -80.52 92.02 5.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.003 -1.11 . . . . 1.28 108.003 169.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.625 HG11 ' HE1' ' A' ' 98' ' ' PHE . 5.8 p -107.99 143.19 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 113.502 0.927 . . . . 0.88 113.502 -160.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.37 101.85 1.3 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.435 -1.32 . . . . 0.52000000000000002 107.435 166.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 1.005 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -59.65 87.68 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.973 -1.012 . . . . 1.8400000000000001 112.882 -170.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 53.38 52.63 13.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.422 -0.808 . . . . 2.4300000000000002 110.646 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.7 p -164.18 157.01 17.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.797 -0.638 . . . . 0.98999999999999999 110.83 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.78 -117.2 4.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.932 -0.651 . . . . 1.0900000000000001 112.717 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.61 166.98 20.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.454 0.645 . . . . 3.1600000000000001 111.532 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.643 HG22 ' HE1' ' A' ' 139' ' ' PHE . 17.4 p -129.33 107.86 9.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.257 -0.883 . . . . 1.9399999999999999 109.782 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 27.3 mtpt -83.47 20.07 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 2.0299999999999998 112.06 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.51 13.87 29.23 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.716 -0.754 . . . . 0.46999999999999997 111.826 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -40.56 16.05 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.018 -0.61 . . . . 0.34000000000000002 112.286 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.2 t80 -67.9 -48.69 65.31 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.824 0.345 . . . . 0.56999999999999995 110.177 -176.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.3 -43.89 97.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.9 -0.591 . . . . 2.46 110.902 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.6 m -65.75 -50.9 63.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.33000000000000002 111.142 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.87 -47.59 80.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.202 0.525 . . . . 0.19 110.866 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.443 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 80.2 m -59.74 -51.81 68.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.289 -0.868 . . . . 0.29999999999999999 111.552 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.4 p -65.95 -39.2 90.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.068 -0.514 . . . . 1.0800000000000001 111.727 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.465 HD11 HD12 ' A' ' 163' ' ' ILE . 85.4 mt -58.73 -51.64 69.09 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 120.503 0.192 . . . . 0.81000000000000005 111.062 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.735 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 82.9 t80 -53.81 -47.08 71.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.33000000000000002 109.817 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -73.18 -31.65 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.426 -0.807 . . . . 1.76 111.625 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.84 -36.84 23.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.021 -0.536 . . . . 1.79 111.738 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.645 ' CD1' HD13 ' A' ' 171' ' ' LEU . 58.0 m-85 -114.16 2.05 14.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.499 1.296 . . . . 0.42999999999999999 114.499 -171.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.693 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 20.4 ptmt -68.71 -16.07 63.71 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.308 -0.957 . . . . 2.1099999999999999 110.083 175.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 p -59.89 -43.4 94.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.747 -0.66 . . . . 1.2 109.927 171.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -91.36 15.76 11.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 1.8999999999999999 111.143 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.692 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.46 70.22 1.35 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.999 -0.619 . . . . 1.3200000000000001 112.452 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.693 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 54.8 t80 -143.73 139.97 29.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.26000000000000001 110.537 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.607 ' HG1' ' HE1' ' A' ' 61' ' ' TYR . 14.9 t -129.39 152.98 48.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.031 0.443 . . . . 0.51000000000000001 110.077 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.735 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t -113.89 120.75 64.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.387 -0.597 . . . . 0.23999999999999999 109.387 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.592 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 15.6 mt -107.3 122.13 45.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.892 -0.781 . . . . 0.51000000000000001 108.892 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.04 129.71 55.46 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.329 -0.548 . . . . 0.28000000000000003 110.943 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.484 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.8 m-85 -113.67 108.64 51.41 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.619 -0.719 . . . . 0.34000000000000002 109.89 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.005 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 33.2 Cg_exo -59.56 156.32 37.35 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 123.505 2.803 . . . . 0.72999999999999998 111.697 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 114.349 1.24 . . . . 1.54 114.349 -178.313 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.438 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 79.3 m . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 121.787 0.803 . . . . 0.91000000000000003 110.4 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.767 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 14.0 t -133.58 159.89 39.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.528 -1.215 . . . . 1.9199999999999999 108.372 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.775 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -58.99 95.7 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.001 0.429 . . . . 3.1800000000000002 110.149 -175.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.625 ' HE1' HG11 ' A' ' 43' ' ' VAL . 3.8 p90 -54.84 134.83 48.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.059 -1.089 . . . . 1.74 108.059 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -101.64 134.08 45.33 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.548 -0.461 . . . . 3.0800000000000001 111.011 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.516 ' CB ' ' HE1' ' A' ' 54' ' ' TYR . . . -136.26 -174.97 3.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.337 -0.847 . . . . 0.42999999999999999 110.939 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.16 16.88 2.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 2.1899999999999999 110.323 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.591 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 40.3 p90 -139.36 167.8 17.59 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.594 -0.891 . . . . 0.23999999999999999 108.594 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.916 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 27.1 Cg_exo -68.6 126.95 14.77 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.683 2.922 . . . . 0.31 113.762 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.032 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -120.92 142.01 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.344 -0.613 . . . . 0.37 109.344 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.916 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 7.2 mmt -114.01 -154.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.876 0.695 . . . . 1.47 112.876 -164.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.448 ' O ' ' HD2' ' A' ' 75' ' ' PRO . . . -69.77 145.09 52.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.086 -0.961 . . . . 0.39000000000000001 111.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 56.4 mttt -73.4 109.79 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.645 -0.872 . . . . 1.6599999999999999 108.645 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.432 HD12 ' CB ' ' A' ' 116' ' ' HIS . 28.8 pt -121.69 157.57 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.34 -0.985 . . . . 0.46999999999999997 108.34 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.2 m120 -66.32 127.02 30.63 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.819 -0.808 . . . . 2.1600000000000001 108.819 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.626 ' O ' ' HB ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -121.45 88.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 C-N-CA 119.746 -0.781 . . . . 0.38 109.006 167.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.694 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 16.4 t-20 173.14 179.09 0.09 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.066 -1.087 . . . . 1.98 108.066 168.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 48.29 -137.29 15.23 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.757 0.661 . . . . 0.78000000000000003 114.59 163.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -104.52 -6.95 20.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.462 -0.869 . . . . 1.98 110.186 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -84.14 -24.52 30.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.292 -0.867 . . . . 2.04 111.449 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.97 141.49 3.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.058 1.133 . . . . 0.47999999999999998 114.058 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.65 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 43.8 t-80 -48.75 139.71 11.41 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 114.894 -1.048 . . . . 0.41999999999999998 110.378 171.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.25 -42.55 46.88 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.899 2.399 . . . . 0.35999999999999999 112.789 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.65 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.3 tm? -54.81 -42.52 71.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.062 -0.517 . . . . 1.1000000000000001 110.647 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.415 ' OH ' HG22 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -76.09 -30.24 58.23 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 119.445 -0.312 . . . . 1.49 111.596 176.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.09 -36.9 73.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.245 -0.582 . . . . 2.3700000000000001 109.755 170.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 67.6 t80 -69.21 -44.01 72.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 0.57999999999999996 110.642 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.4 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.5 mtt -65.67 -51.11 62.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.255 -0.429 . . . . 0.34000000000000002 110.696 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.566 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 27.8 mtpt -61.96 -40.47 95.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.623 -0.717 . . . . 0.93999999999999995 111.379 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.7 ptmm? -69.19 -35.92 76.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 2.1299999999999999 110.615 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 99.9 m -73.94 -46.68 42.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 0.46999999999999997 111.857 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.509 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 10.4 mmtt . . . . . 0 C--N 1.321 -0.648 0 C-N-CA 120.778 -0.369 . . . . 1.75 111.677 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.694 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 113.203 0.816 . . . . 0.93000000000000005 113.203 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.878 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 24.4 mm -112.98 84.4 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.054 -0.975 . . . . 1.05 111.454 -166.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -105.69 19.95 19.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.22 0.822 . . . . 1.5 113.22 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.878 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.21 168.95 18.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.873 0.368 . . . . 0.87 111.561 177.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.65 -156.61 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.678 1.591 . . . . 1.8 113.217 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.834 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 35.5 m-85 -27.4 -55.87 0.09 Allowed 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.136 1.374 . . . . 1.3700000000000001 114.412 -164.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.873 HG23 ' HA ' ' A' ' 155' ' ' SER . 25.0 m 41.58 96.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.444 0.905 . . . . 0.29999999999999999 113.444 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.7 ' HB2' HD12 ' A' ' 39' ' ' LEU . 35.1 p -86.48 149.26 25.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.507 -0.746 . . . . 0.80000000000000004 111.274 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.431 ' O ' HD13 ' A' ' 39' ' ' LEU . 9.5 m-85 -103.09 134.08 47.12 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.598 -0.89 . . . . 0.53000000000000003 108.598 167.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.925 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 28.5 tp -82.03 105.84 13.46 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 0.51000000000000001 109.13 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.818 ' HB ' HD12 ' A' ' 38' ' ' LEU . 11.3 mm -106.08 131.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.312 -0.625 . . . . 0.20000000000000001 109.312 -175.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -78.64 -179.17 6.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.997 -0.547 . . . . 1.3 110.83 -176.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.716 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mtp180 -64.18 -17.65 63.73 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.115 0.413 . . . . 3.7799999999999998 112.115 -175.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.451 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 13.7 t70 -105.26 -16.74 14.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.37 0.605 . . . . 1.1799999999999999 109.664 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.541 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.87 32.66 4.34 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.23000000000000001 112.735 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.1 t -106.12 126.93 29.36 Favored Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 122.397 -0.472 . . . . 0.62 110.637 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.72 112.17 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.15 2.567 . . . . 0.29999999999999999 112.22 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.498 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 22.3 t -98.41 -33.42 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.23 -0.441 . . . . 0.27000000000000002 111.49 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 9.0 mm-40 -152.48 164.37 37.7 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.762 0.315 . . . . 1.22 110.966 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.566 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 18.0 ttm180 -129.37 98.87 5.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 1.75 109.836 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.925 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.4 m-85 -87.01 110.31 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.262 -0.644 . . . . 0.38 109.262 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.873 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.3 p -62.86 167.05 6.47 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.273 -0.64 . . . . 0.98999999999999999 109.273 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.808 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.6 Cg_endo -70.64 -10.19 27.35 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 122.377 2.051 . . . . 0.66000000000000003 112.028 -163.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.32 -10.72 84.29 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.402 -1.272 . . . . 0.52000000000000002 111.178 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.46 137.03 34.78 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.431 -0.581 . . . . 0.42999999999999999 109.431 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -106.33 -169.56 1.59 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.498 -0.319 . . . . 1.25 111.006 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 21.4 t -50.4 -59.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.915 -0.584 . . . . 0.40999999999999998 112.376 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -67.65 -29.86 69.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.67 0.271 . . . . 3.4399999999999999 110.946 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.13 -38.93 77.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.053 -0.522 . . . . 1.8600000000000001 109.844 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.545 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 63.5 mt -83.12 -37.45 13.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.416 -0.811 . . . . 0.20999999999999999 110.967 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.9 mt-10 -57.18 -36.7 71.12 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.551 0.574 . . . . 0.88 112.551 -174.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.528 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.0 pt-20 -58.73 -27.99 65.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.395 . . . . 0.75 111.292 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.595 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -104.78 -16.19 14.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.363 -0.38 . . . . 1.5800000000000001 110.924 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.3 tp -91.22 -44.69 9.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.23999999999999999 111.825 -171.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.738 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.7 mt -51.81 -49.23 84.7 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.608 0.596 . . . . 0.44 112.608 -175.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.2 Cg_exo -54.7 -39.37 89.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.024 1.816 . . . . 0.48999999999999999 112.6 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.9 mt -74.2 -35.97 63.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.437 -0.347 . . . . 0.70999999999999996 111.43 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.964 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 13.5 mt -57.12 -54.75 43.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.313 -0.625 . . . . 0.46000000000000002 109.313 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.98 -62.24 4.74 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.777 -1.101 . . . . 1.52 112.513 171.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 109.482 -0.562 . . . . 2.52 109.482 177.037 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.894 0.378 . . . . 1.6799999999999999 110.324 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 m -126.09 170.5 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.995 -1.113 . . . . 0.65000000000000002 107.995 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.634 HD13 HG21 ' A' ' 144' ' ' ILE . 32.5 pt -52.22 -28.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 118.764 0.711 . . . . 0.29999999999999999 112.902 -173.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.763 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 14.8 m-85 -81.68 5.91 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.997 0.427 . . . . 0.27000000000000002 111.614 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.86 -19.7 62.61 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.021 -1.104 . . . . 1.96 108.021 171.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 49.9 m-85 -106.7 179.32 4.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.425 -1.261 . . . . 0.40000000000000002 110.531 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.85 148.09 43.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.518 -0.31 . . . . 2.77 110.201 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 30' ' ' LEU . 71.7 t -118.19 150.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.054 0.454 . . . . 0.73999999999999999 111.702 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.747 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 88.8 mt -108.16 143.38 37.02 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.131 -0.486 . . . . 0.71999999999999997 110.003 173.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.637 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 21.7 t70 -72.97 177.37 4.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.102 -0.954 . . . . 1.5900000000000001 108.764 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -52.94 -32.85 48.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.337 0.589 . . . . 0.52000000000000002 110.318 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 22.5 t70 -79.49 -18.25 52.4 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.353 -0.839 . . . . 2.2200000000000002 112.029 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.747 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.1 m-70 87.41 6.01 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.853 0.861 . . . . 0.72999999999999998 111.851 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 2.8 ptmt -70.77 160.93 80.35 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.905 -1.146 . . . . 3.25 107.905 162.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.3 117.19 3.89 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 121.421 1.414 . . . . 0.85999999999999999 112.632 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.538 ' HB3' HG12 ' A' ' 20' ' ' VAL . 89.0 t80 -91.05 119.42 31.19 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.97 -0.752 . . . . 0.28000000000000003 108.97 170.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.1 t30 -73.81 84.68 1.67 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.525 -0.47 . . . . 1.6499999999999999 110.002 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.729 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -62.35 -31.55 72.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.466 0.651 . . . . 0.25 110.469 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.763 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.6 p -77.2 -0.06 2.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.182 -0.917 . . . . 0.40999999999999998 113.203 -167.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.8 pt20 -78.91 -5.82 54.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.658 0.742 . . . . 1.24 109.202 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.556 ' HB3' HD13 ' A' ' 38' ' ' LEU . 92.8 m-70 -97.41 -1.07 45.14 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.908 -1.042 . . . . 0.38 108.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.681 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -77.09 130.99 38.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.987 -1.461 . . . . 1.73 108.975 178.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' N ' ' HD2' ' A' ' 34' ' ' LYS . . . 109.87 -15.19 31.51 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.042 -0.823 . . . . 0.35999999999999999 111.042 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.8 m -136.17 155.04 77.7 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.064 -0.717 . . . . 1.1399999999999999 109.064 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.0 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 73.3 Cg_endo -77.73 154.72 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.004 1.803 . . . . 0.52000000000000002 111.8 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.62 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.3 pt? -158.96 159.92 35.43 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.248 0.546 . . . . 1.03 111.229 -176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -114.21 155.1 26.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.449 -0.796 . . . . 1.1000000000000001 109.236 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 72' ' ' LEU . 84.4 mt -141.29 119.12 8.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.558 -0.534 . . . . 0.20000000000000001 109.558 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.833 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.7 m-85 -105.59 123.67 48.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.909 -0.316 . . . . 0.23000000000000001 111.06 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.861 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.6 OUTLIER -78.56 92.25 4.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.829 -0.804 . . . . 1.28 108.829 168.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.585 HG11 ' CE1' ' A' ' 98' ' ' PHE . 2.9 p -108.06 131.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.935 0.717 . . . . 0.88 112.935 -166.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.08 110.71 0.99 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.718 -1.216 . . . . 0.52000000000000002 107.718 167.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.979 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -70.79 85.93 0.67 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.787 -1.097 . . . . 1.8400000000000001 113.563 -162.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 48.8 tptt 71.7 39.56 0.86 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.648 -0.705 . . . . 2.4300000000000002 110.204 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.2 p -154.23 142.28 20.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.787 -0.642 . . . . 0.98999999999999999 110.96 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.66 -130.0 10.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.521 -0.847 . . . . 1.0900000000000001 112.966 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.85 131.71 24.37 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.592 -0.521 . . . . 3.1600000000000001 109.592 -173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.447 HG22 ' CE1' ' A' ' 139' ' ' PHE . 72.6 p -83.09 109.69 17.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.627 0.727 . . . . 1.9399999999999999 109.791 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 1.069 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 26.4 mtpp -79.86 11.56 3.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.363 -0.835 . . . . 2.0299999999999998 111.2 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.21 28.4 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.64 -0.584 . . . . 0.46999999999999997 111.64 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.35 -42.62 10.25 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.286 -0.483 . . . . 0.34000000000000002 112.013 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 1.4 t80 -70.14 -47.43 61.74 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 0.56999999999999995 109.835 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 53.9 mp0 -56.17 -50.77 70.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.867 -1.06 . . . . 2.46 110.397 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.712 HG23 ' HA ' ' A' ' 160' ' ' VAL . 54.9 m -67.48 -47.15 70.88 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.824 -1.08 . . . . 0.33000000000000002 111.101 -176.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.872 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.66 -49.51 74.82 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.19 111.35 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.9 m -58.43 -48.41 80.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.448 -0.796 . . . . 0.29999999999999999 110.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.9 m -60.77 -46.85 88.86 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.301 -0.863 . . . . 1.0800000000000001 111.524 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.584 HD13 HD22 ' A' ' 39' ' ' LEU . 62.1 mt -59.05 -50.35 74.4 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.274 -0.421 . . . . 0.81000000000000005 111.183 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.528 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 15.0 t80 -47.01 -53.63 12.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.057 0.848 . . . . 0.33000000000000002 110.032 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -73.93 -34.99 64.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.217 -0.901 . . . . 1.76 111.452 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -75.97 -35.77 59.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.007 -0.542 . . . . 1.79 111.255 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.812 ' CD1' HD13 ' A' ' 171' ' ' LEU . 62.7 m-85 -118.15 15.43 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.805 1.039 . . . . 0.42999999999999999 113.805 -173.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.8 mmmt -59.54 -21.36 60.13 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.686 -0.406 . . . . 2.1099999999999999 110.388 171.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.87 -41.62 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.84 -0.618 . . . . 1.2 110.35 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.517 ' HG3' ' HB3' ' A' ' 171' ' ' LEU . 33.7 mm-40 -76.27 -10.56 59.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.972 -0.558 . . . . 1.8999999999999999 110.318 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.32 20.73 29.14 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 1.3200000000000001 110.868 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CE1' HD13 ' A' ' 39' ' ' LEU . 88.5 t80 -79.78 136.58 36.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.243 -0.479 . . . . 0.26000000000000001 110.628 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -130.82 145.85 52.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.382 -0.599 . . . . 0.51000000000000001 109.382 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.872 HG11 ' HB1' ' A' ' 57' ' ' ALA . 51.4 t -110.08 109.32 27.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.2 -0.667 . . . . 0.23999999999999999 109.2 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.612 ' HB2' HG12 ' A' ' 40' ' ' ILE . 23.8 mt -91.65 120.98 32.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.489 -0.93 . . . . 0.51000000000000001 108.489 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.073 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.82 112.92 25.43 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.221 -0.592 . . . . 0.28000000000000003 110.68 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.3 m-85 -97.12 110.63 54.95 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.54 -0.755 . . . . 0.34000000000000002 109.03 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.01 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.91 169.78 3.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.395 2.73 . . . . 0.72999999999999998 111.365 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 69.7 m . . . . . 0 N--CA 1.437 -1.076 0 N-CA-C 113.889 1.07 . . . . 1.54 113.889 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.415 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 24.9 m . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 121.655 0.741 . . . . 0.91000000000000003 112.779 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -156.38 119.56 4.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.722 -1.127 . . . . 1.9199999999999999 109.804 168.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.3 mttp 54.52 100.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.062 0.764 . . . . 3.1800000000000002 113.062 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.658 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 37.9 p90 -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.776 -0.577 . . . . 1.74 110.688 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 68.15 145.81 0.05 OUTLIER 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.099 0.875 . . . . 3.0800000000000001 111.145 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.619 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -172.69 -173.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.41 . . . . 0.42999999999999999 112.083 -176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -83.67 -11.88 56.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 2.1899999999999999 110.155 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.814 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 39.0 p90 -113.34 169.04 6.86 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 115.405 -0.816 . . . . 0.23999999999999999 109.196 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.918 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 21.2 Cg_exo -71.41 122.12 8.36 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 123.556 2.837 . . . . 0.31 112.999 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.073 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.5 mp -110.79 139.65 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.909 -0.775 . . . . 0.37 108.909 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.918 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 10.1 mmt -112.07 -154.74 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.648 0.737 . . . . 1.47 112.909 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -71.63 133.78 45.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.674 -1.148 . . . . 0.39000000000000001 110.116 173.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.01 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttt -70.27 126.04 28.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.692 0.758 . . . . 1.6599999999999999 109.457 171.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.613 HG13 HG13 ' A' ' 110' ' ' VAL . 9.6 pt -121.47 167.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.262 -1.335 . . . . 0.46999999999999997 107.915 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 34.6 t-20 -85.28 63.97 8.4 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.434 -0.506 . . . . 2.1600000000000001 109.672 -175.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -64.55 88.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 120.727 -0.389 . . . . 0.38 110.799 -177.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.576 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 56.7 t30 173.05 178.63 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 1.98 108.243 167.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.04 -142.31 31.67 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 114.344 0.497 . . . . 0.78000000000000003 114.344 165.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -105.84 -1.63 24.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.589 0.709 . . . . 1.98 110.039 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -106.49 2.43 26.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.074 -0.967 . . . . 2.04 111.192 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -62.6 154.58 28.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.728 -0.669 . . . . 0.47999999999999998 112.242 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.681 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 33.7 t-80 -47.96 138.47 10.06 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.586 -0.734 . . . . 0.41999999999999998 110.046 172.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.12 -39.16 51.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.138 2.559 . . . . 0.35999999999999999 112.436 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.681 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -60.45 -39.63 88.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 1.1000000000000001 111.332 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.454 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.9 m-85 -75.61 -28.89 59.05 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 116.445 -0.343 . . . . 1.49 110.813 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.56 -36.91 74.66 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.867 -0.733 . . . . 2.3700000000000001 109.426 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 50.9 t80 -71.77 -45.85 60.29 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.738 -0.385 . . . . 0.57999999999999996 110.6 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.49 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . 66.5 mtt -61.46 -54.92 37.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.314 -0.403 . . . . 0.34000000000000002 111.442 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.0 mtpt -62.97 -36.9 85.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.93999999999999995 111.359 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.35 -31.59 67.55 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.843 0.354 . . . . 2.1299999999999999 110.301 -179.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.514 HG21 ' HD2' ' A' ' 150' ' ' PRO . 97.3 m -73.89 -38.64 64.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.46999999999999997 111.256 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 151' ' ' VAL . 32.2 mmtm . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.867 0.365 . . . . 1.75 111.15 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 112.79 0.663 . . . . 0.93000000000000005 112.79 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.854 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 49.2 mt -97.76 84.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.942 -1.027 . . . . 1.05 110.742 -171.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -108.61 25.28 11.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.524 0.564 . . . . 1.5 112.524 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.854 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.08 170.14 21.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.281 0.474 . . . . 0.87 112.281 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 44' ' ' ALA . 16.2 m120 -52.49 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.48 1.512 . . . . 1.8 113.41 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.833 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 68.5 m-85 -25.89 -59.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.399 0 C-N-CA 125.529 1.532 . . . . 1.3700000000000001 113.957 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.913 HG23 ' HA ' ' A' ' 155' ' ' SER . 18.0 m 42.43 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.209 0.818 . . . . 0.29999999999999999 113.209 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.696 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 15.0 p -87.1 151.94 22.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.546 -0.862 . . . . 0.80000000000000004 111.496 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -103.78 134.6 46.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.287 -1.005 . . . . 0.53000000000000003 108.287 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.701 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.2 tp -82.08 106.15 13.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.107 -0.701 . . . . 0.51000000000000001 109.107 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.634 HG21 HD13 ' A' ' 15' ' ' ILE . 16.0 mm -106.42 123.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.021 -0.536 . . . . 0.20000000000000001 109.736 -171.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -177.41 4.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.374 -0.376 . . . . 1.3 110.595 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 146' ' ' ARG . 51.9 mtt-85 -66.27 -9.58 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.675 0.62 . . . . 3.7799999999999998 112.675 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -108.0 -21.91 12.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.1799999999999999 110.066 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 106.07 31.65 4.05 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.637 -0.792 . . . . 0.23000000000000001 112.698 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.48 121.29 41.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.891 -0.411 . . . . 0.62 109.891 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.514 ' HD2' HG21 ' A' ' 125' ' ' THR . 44.8 Cg_exo -58.07 116.39 3.2 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.992 2.462 . . . . 0.29999999999999999 112.223 176.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.609 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 31.8 t -96.07 -25.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.809 -0.632 . . . . 0.27000000000000002 110.275 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.65 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 9.0 mm-40 -156.29 159.03 38.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.371 -0.377 . . . . 1.22 111.246 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.489 HH11 ' HH2' ' A' ' 137' ' ' TRP . 20.3 ttm180 -120.65 97.02 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.471 -0.566 . . . . 1.75 109.471 168.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.701 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 52.6 m-85 -85.22 110.17 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.277 -0.638 . . . . 0.38 109.277 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.913 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.4 p -63.39 166.25 9.33 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.831 -0.433 . . . . 0.98999999999999999 109.831 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.069 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 58.7 Cg_endo -72.07 -2.19 11.19 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.371 2.047 . . . . 0.66000000000000003 113.058 -163.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -96.45 8.74 66.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.631 -0.713 . . . . 0.52000000000000002 112.317 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.61 140.17 30.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 0.42999999999999999 110.249 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.488 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 57.3 m -86.76 170.68 11.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.199 -0.455 . . . . 1.25 111.309 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.712 ' HA ' HG23 ' A' ' 56' ' ' THR . 49.0 t -55.41 -51.82 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 0.40999999999999998 111.584 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 161' ' ' LYS . 20.2 tptt -68.83 -26.84 65.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 3.4399999999999999 110.622 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.488 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.7 m-20 -64.19 -31.81 73.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 1.8600000000000001 110.27 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.757 HG21 HD21 ' A' ' 39' ' ' LEU . 59.1 mt -83.04 -45.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.902 -0.59 . . . . 0.20999999999999999 110.529 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -52.68 -39.01 61.51 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.839 0.681 . . . . 0.88 112.839 -176.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -55.52 -31.35 62.01 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.872 0.323 . . . . 0.75 111.872 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.65 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 72.3 mttt -106.32 -9.67 16.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.389 . . . . 1.5800000000000001 110.976 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 58.7 tp -91.52 -41.61 10.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 0.23999999999999999 111.775 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.757 ' HA ' HD12 ' A' ' 171' ' ' LEU . 71.6 mt -50.61 -48.71 81.71 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 112.998 0.74 . . . . 0.44 112.998 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.491 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.64 -32.39 90.36 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.099 1.866 . . . . 0.48999999999999999 112.745 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 151' ' ' VAL . 76.6 mt -80.8 -35.22 33.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.776 -0.193 . . . . 0.70999999999999996 110.865 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.0 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.2 mt -59.0 -41.48 87.77 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.697 -0.853 . . . . 0.46000000000000002 108.697 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.34 -81.14 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.21 -1.359 . . . . 1.52 111.129 162.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.762 0.315 . . . . 2.52 110.293 175.504 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.219 0.533 . . . . 1.6799999999999999 110.563 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.6 p -142.91 172.21 13.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.65000000000000002 110.192 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.68 HD13 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -59.05 -29.64 41.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.418 0.525 . . . . 0.29999999999999999 112.418 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.79 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 36.5 m-85 -77.33 0.0 23.89 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.861 0.319 . . . . 0.27000000000000002 111.861 -172.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.7 -23.26 65.27 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.319 -0.993 . . . . 1.96 108.319 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 53.7 m-85 -102.67 174.61 5.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.731 -1.122 . . . . 0.40000000000000002 109.792 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -108.56 165.63 11.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.869 0.366 . . . . 2.77 110.658 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.579 HG23 HD13 ' A' ' 30' ' ' LEU . 73.8 t -135.66 151.79 30.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.577 -0.527 . . . . 0.73999999999999999 109.577 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.869 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 66.8 mt -113.6 148.63 35.85 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.673 -0.492 . . . . 0.71999999999999997 109.673 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.653 ' CB ' ' HE3' ' A' ' 26' ' ' LYS . 5.8 t0 -78.49 -176.43 4.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.991 -1.114 . . . . 1.5900000000000001 107.991 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -56.96 -29.92 63.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.462 0.649 . . . . 0.52000000000000002 110.459 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 5.4 t70 -80.29 -20.01 45.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.324 -0.853 . . . . 2.2200000000000002 111.981 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.869 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 18.5 m-70 83.77 7.49 0.64 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.779 0.832 . . . . 0.72999999999999998 111.893 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.653 ' HE3' ' CB ' ' A' ' 22' ' ' ASP . 28.9 pttt -65.09 148.12 98.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 107.282 -1.377 . . . . 3.25 107.282 157.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 21' ' ' LEU . 19.0 Cg_endo -61.55 116.66 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.241 1.294 . . . . 0.85999999999999999 112.331 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.463 ' HB3' HG12 ' A' ' 20' ' ' VAL . 86.3 t80 -80.23 124.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.006 -0.997 . . . . 0.28000000000000003 110.333 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.627 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -68.98 82.78 0.31 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.703 -0.68 . . . . 1.6499999999999999 109.757 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.79 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -72.45 -31.78 65.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.42 0.629 . . . . 0.25 110.136 -177.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.692 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 p -77.13 -0.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.333 -0.849 . . . . 0.40999999999999998 112.494 -169.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.7 pt20 -78.84 -9.4 59.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.566 0.698 . . . . 1.24 109.311 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -91.69 -7.97 48.36 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.156 -1.053 . . . . 0.38 108.156 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 21.3 ttpp -70.72 133.68 46.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.53 -1.214 . . . . 1.73 109.354 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.46 -5.35 54.86 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.024 -1.231 . . . . 0.35999999999999999 110.024 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 15.5 m -140.46 144.29 36.21 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.851 -0.796 . . . . 1.1399999999999999 108.851 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.063 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 52.6 Cg_endo -73.28 150.55 47.34 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.651 1.567 . . . . 0.52000000000000002 110.794 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.608 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -153.0 153.51 33.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.324 0.583 . . . . 1.03 111.089 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.779 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -108.33 152.69 24.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.982 -0.747 . . . . 1.1000000000000001 108.982 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 88.6 mt -137.29 118.21 17.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.417 -0.586 . . . . 0.20000000000000001 109.417 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.825 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -100.29 123.15 44.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.459 -0.337 . . . . 0.23000000000000001 110.532 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.65 ' HB2' HG21 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -82.41 90.8 6.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.041 -1.096 . . . . 1.28 108.041 168.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.663 HG11 ' HE2' ' A' ' 98' ' ' PHE . 2.2 p -112.2 132.42 60.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 112.575 0.583 . . . . 0.88 112.575 -163.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -64.52 102.12 0.52 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.938 -1.505 . . . . 0.52000000000000002 106.938 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.983 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 34.4 t -69.57 90.11 0.55 Allowed 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.432 -0.803 . . . . 1.8400000000000001 112.236 -165.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt 66.97 49.84 1.1 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.935 -1.03 . . . . 2.4300000000000002 110.813 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.9 m -135.75 126.43 27.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.719 -0.673 . . . . 0.98999999999999999 109.761 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.52 -129.91 17.43 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.902 -0.666 . . . . 1.0900000000000001 112.989 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.98 154.18 19.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.838 0.351 . . . . 3.1600000000000001 111.044 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.7 p -91.54 -24.49 19.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.317 -0.401 . . . . 1.9399999999999999 111.49 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 26.3 mtpp 64.04 3.75 1.8 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.644 -0.707 . . . . 2.0299999999999998 112.069 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.11 -5.01 41.65 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.814 -0.708 . . . . 0.46999999999999997 112.565 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -35.57 92.14 Favored Glycine 0 CA--C 1.505 -0.585 0 N-CA-C 111.982 -0.447 . . . . 0.34000000000000002 111.982 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.509 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -67.92 -48.81 64.94 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 110.286 -0.265 . . . . 0.56999999999999995 110.286 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.44 -52.87 62.16 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.473 0.654 . . . . 2.46 110.167 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 160' ' ' VAL . 34.7 m -63.11 -47.55 82.35 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.619 -1.173 . . . . 0.33000000000000002 111.32 -176.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.65 -46.96 87.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.829 0.347 . . . . 0.19 111.401 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.6 m -60.13 -53.68 54.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.778 -0.646 . . . . 0.29999999999999999 111.393 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 p -62.52 -42.03 99.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 1.0800000000000001 111.854 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.503 HD13 HD22 ' A' ' 39' ' ' LEU . 93.4 mt -58.92 -52.45 65.68 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 120.514 0.197 . . . . 0.81000000000000005 111.477 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.691 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 89.4 t80 -54.62 -47.16 73.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.915 -0.584 . . . . 0.33000000000000002 109.996 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -70.63 -41.03 72.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.533 -0.758 . . . . 1.76 111.394 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.32 -43.59 50.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 1.79 111.647 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.9 m-85 -102.19 4.5 39.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.728 1.01 . . . . 0.42999999999999999 113.728 -171.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -58.3 -30.08 66.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 2.1099999999999999 109.982 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -65.53 -26.4 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 1.2 111.484 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.2 13.16 32.81 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.877 0.37 . . . . 1.8999999999999999 111.095 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.71 63.42 1.84 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.95 -0.643 . . . . 1.3200000000000001 112.585 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.535 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 69.0 t80 -132.09 142.09 49.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.552 -0.166 . . . . 0.26000000000000001 110.552 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.608 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.16 143.29 50.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.129 -0.323 . . . . 0.51000000000000001 110.129 177.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.691 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 29.3 t -113.27 114.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.993 0.425 . . . . 0.23999999999999999 110.185 170.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 30.8 mt -100.47 122.44 43.2 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.978 -0.749 . . . . 0.51000000000000001 108.978 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -106.99 112.84 25.99 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.113 -0.635 . . . . 0.28000000000000003 110.252 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-30 -93.9 110.13 45.85 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.106 -1.072 . . . . 0.34000000000000002 108.106 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.087 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.3 Cg_exo -58.62 169.22 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.81 2.34 . . . . 0.72999999999999998 110.953 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 27.1 t . . . . . 0 N--CA 1.43 -1.466 0 C-N-CA 119.5 -0.88 . . . . 1.54 111.876 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.441 -0.902 0 CA-C-O 121.565 0.698 . . . . 0.91000000000000003 111.05 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -149.16 128.69 13.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.562 -1.199 . . . . 1.9199999999999999 108.029 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -14.07 104.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.775 1.297 . . . . 3.1800000000000002 113.525 -172.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.663 ' HE2' HG11 ' A' ' 43' ' ' VAL . 34.5 p90 -66.55 -20.74 66.09 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.04 -0.982 . . . . 1.74 111.365 -170.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 67.55 147.61 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 124.041 0.838 . . . . 3.0800000000000001 111.178 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.45 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -169.93 -154.69 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.105 0.479 . . . . 0.42999999999999999 112.22 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 -5.74 58.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.559 -0.746 . . . . 2.1899999999999999 109.884 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.789 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 45.4 p90 -128.28 164.8 35.24 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.182 -0.917 . . . . 0.23999999999999999 109.135 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 32.4 Cg_exo -66.33 109.03 1.48 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 123.658 2.906 . . . . 0.31 113.701 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mp -104.15 128.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.957 -0.757 . . . . 0.37 108.957 172.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.581 ' HE2' ' HA ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -109.49 -148.64 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.852 0.686 . . . . 1.47 112.852 -160.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.754 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -75.54 136.81 40.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.168 -0.924 . . . . 0.39000000000000001 110.669 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.087 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 15.3 pttp -79.45 128.58 33.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.688 0.756 . . . . 1.6599999999999999 110.384 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.569 HG13 HG13 ' A' ' 110' ' ' VAL . 3.2 pt -122.77 160.69 25.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.312 -1.313 . . . . 0.46999999999999997 107.845 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.708 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.4 t-20 -75.93 82.66 2.83 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.187 -1.042 . . . . 2.1600000000000001 108.187 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.15 86.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 118.842 -1.143 . . . . 0.38 108.944 177.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 55.8 t30 172.44 178.57 0.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.545 -0.909 . . . . 1.98 108.545 170.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.28 -145.62 17.05 Favored Glycine 0 C--O 1.236 0.23 0 N-CA-C 115.211 0.844 . . . . 0.78000000000000003 115.211 163.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.46 -15.74 25.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.464 -0.868 . . . . 1.98 110.56 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -94.08 1.28 56.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.617 0.722 . . . . 2.04 110.529 -169.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.18 140.13 45.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.094 -0.957 . . . . 0.47999999999999998 112.346 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.552 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 45.1 t-80 -50.75 137.25 25.19 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.179 -0.919 . . . . 0.41999999999999998 110.502 172.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.516 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -45.08 -45.52 14.34 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.89 2.393 . . . . 0.35999999999999999 112.792 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.552 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.8 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.942 -0.572 . . . . 1.1000000000000001 111.715 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -75.89 -29.0 58.32 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 119.609 -0.234 . . . . 1.49 111.105 177.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.13 -43.36 78.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.886 -0.783 . . . . 2.3700000000000001 108.886 168.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.8 t80 -66.63 -45.09 80.2 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.569 0.543 . . . . 0.57999999999999996 110.652 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.508 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 67.1 mtt -63.83 -53.52 49.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.461 -0.336 . . . . 0.34000000000000002 111.31 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.47 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 26.4 mtpt -60.89 -41.59 96.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.93999999999999995 111.002 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.9 ptmt -71.12 -35.39 71.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 2.1299999999999999 111.108 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.1 m -75.79 -36.5 59.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.924 -0.58 . . . . 0.46999999999999997 111.189 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 112.546 0.573 . . . . 1.75 112.546 -176.804 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.119 0.485 . . . . 0.93000000000000005 111.892 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.823 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 44.8 mt -114.95 94.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.488 -0.778 . . . . 1.05 110.568 -171.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -110.56 9.89 23.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.292 0.849 . . . . 1.5 113.292 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.823 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -140.04 168.91 18.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.783 0.66 . . . . 0.87 112.783 -177.047 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 22.5 m120 -43.67 -156.14 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 126.552 1.941 . . . . 1.8 115.494 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.825 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.2 m-85 -28.02 -55.19 0.11 Allowed 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 113.897 -1.501 . . . . 1.3700000000000001 113.386 -169.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.818 HG23 ' HA ' ' A' ' 155' ' ' SER . 18.9 m 40.2 96.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.386 0.884 . . . . 0.29999999999999999 113.386 175.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 7.7 p -85.2 152.7 23.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.789 -0.764 . . . . 0.80000000000000004 111.129 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 4.9 m-85 -102.61 162.42 12.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.215 -1.402 . . . . 0.53000000000000003 107.215 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.833 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.5 tp -107.32 105.07 14.85 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.603 -0.888 . . . . 0.51000000000000001 108.603 177.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.68 HG21 HD13 ' A' ' 15' ' ' ILE . 17.9 mm -103.78 119.8 52.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.844 -0.798 . . . . 0.20000000000000001 108.844 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -69.81 179.24 2.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 1.3 110.651 -176.106 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.654 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -57.99 -20.61 39.65 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.846 0.355 . . . . 3.7799999999999998 111.619 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.442 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 1.0 OUTLIER -109.12 -13.8 14.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.113 0.482 . . . . 1.1799999999999999 110.389 -167.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.532 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.51 32.61 4.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.782 -0.645 . . . . 0.23000000000000001 113.271 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 59.3 t -109.15 118.93 50.05 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 122.466 -0.432 . . . . 0.62 110.165 175.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.445 ' HG3' ' HA ' ' A' ' 122' ' ' MET . 14.3 Cg_endo -61.48 112.26 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.29999999999999999 111.969 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.3 t -94.47 -30.19 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.909 -0.587 . . . . 0.27000000000000002 111.14 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -154.51 165.13 37.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 1.22 110.916 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.47 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 14.5 ttm180 -134.18 98.5 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 1.75 109.854 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.833 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 9.3 m-85 -85.9 136.65 33.2 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.38 108.006 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.818 ' HA ' HG23 ' A' ' 140' ' ' THR . 25.2 p -79.83 178.72 2.17 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.748 -0.781 . . . . 0.98999999999999999 109.626 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.767 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 56.6 Cg_endo -67.05 -20.63 50.29 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.616 1.544 . . . . 0.66000000000000003 110.99 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.13 13.24 45.98 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.618 -1.174 . . . . 0.52000000000000002 112.17 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.36 139.67 30.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.901 0.381 . . . . 0.42999999999999999 110.52 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.0 p -90.1 163.93 14.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.163 -0.471 . . . . 1.25 110.882 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.4 t -49.9 -57.61 2.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 O-C-N 123.346 0.404 . . . . 0.40999999999999998 111.602 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 164' ' ' GLU . 18.7 ptpt -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.539 -0.301 . . . . 3.4399999999999999 111.517 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.94 -32.69 74.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.41 0.624 . . . . 1.8600000000000001 109.651 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.779 HG21 HD21 ' A' ' 39' ' ' LEU . 36.6 mt -82.06 -37.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.549 -0.75 . . . . 0.20999999999999999 110.049 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 46.9 mt-10 -57.96 -40.64 81.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.88 112.147 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.581 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.0 pt-20 -56.73 -31.35 64.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.651 -0.42 . . . . 0.75 111.551 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.581 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 23.0 mmmt -98.37 -16.95 19.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.104 0.478 . . . . 1.5800000000000001 110.289 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.595 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -92.94 -43.13 9.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.776 -0.647 . . . . 0.23999999999999999 111.765 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.835 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.3 mt -51.33 -49.89 79.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.463 0.542 . . . . 0.44 112.463 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 9.9 Cg_endo -54.26 -37.89 88.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.175 1.916 . . . . 0.48999999999999999 112.532 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 48.2 mt -76.97 -37.18 55.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.778 -0.192 . . . . 0.70999999999999996 111.462 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.063 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 10.1 mt -57.7 -48.38 79.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.819 -0.808 . . . . 0.46000000000000002 108.819 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.37 -66.91 2.49 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.278 -1.328 . . . . 1.52 112.675 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 N--CA 1.466 0.368 0 C-N-CA 122.481 0.312 . . . . 2.52 110.49 -179.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.342 0.591 . . . . 1.6799999999999999 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.8 p -130.46 -173.66 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.817 -0.809 . . . . 0.65000000000000002 108.817 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 144' ' ' ILE . 17.7 pt -61.23 -25.8 37.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 0.29999999999999999 110.877 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.809 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.9 m-85 -83.91 2.34 39.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.27000000000000002 110.994 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.57 -20.95 63.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.795 -1.187 . . . . 1.96 107.795 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 42.4 m-85 -106.24 178.32 4.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.409 -1.269 . . . . 0.40000000000000002 109.668 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -124.86 149.19 47.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.43 -0.35 . . . . 2.77 110.321 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.62 HG23 HD13 ' A' ' 30' ' ' LEU . 77.5 t -114.7 145.56 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.14 0.495 . . . . 0.73999999999999999 111.785 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.952 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 77.5 mt -101.18 132.38 46.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.741 . . . . 0.71999999999999997 109.201 171.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.03 -170.33 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.562 . . . . 1.5900000000000001 109.481 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.9 57.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.619 -0.264 . . . . 0.52000000000000002 111.624 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -94.36 -4.13 49.1 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.249 -0.282 . . . . 2.2200000000000002 110.982 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.952 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 20.6 m-70 75.48 26.42 1.14 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.753 0.787 . . . . 0.72999999999999998 109.532 -177.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.634 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -87.82 147.11 40.37 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 105.309 -2.108 . . . . 3.25 105.309 165.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 113.89 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.707 0.931 . . . . 0.85999999999999999 111.953 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.446 ' HB3' HG12 ' A' ' 20' ' ' VAL . 80.5 t80 -82.24 116.76 21.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.081 -0.963 . . . . 0.28000000000000003 109.078 172.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.657 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -66.31 82.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.758 -0.655 . . . . 1.6499999999999999 109.734 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.809 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -70.53 -34.27 72.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.902 -0.59 . . . . 0.25 110.498 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.686 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.36 -0.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.348 -0.842 . . . . 0.40999999999999998 112.812 -168.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 14.9 pt20 -82.88 -6.47 59.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.964 -0.754 . . . . 1.24 108.964 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.468 ' O ' HD21 ' A' ' 38' ' ' LEU . 81.9 m-70 -94.82 -2.69 50.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.803 -1.184 . . . . 0.38 107.803 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -76.67 141.36 40.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.761 -1.108 . . . . 1.73 109.392 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.88 65.85 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 109.761 -1.336 . . . . 0.35999999999999999 109.761 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.646 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -129.11 143.03 47.21 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.349 -0.926 . . . . 1.1399999999999999 109.016 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.979 ' HG2' HD23 ' A' ' 171' ' ' LEU . 63.1 Cg_endo -77.72 142.05 19.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.145 1.897 . . . . 0.52000000000000002 111.133 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.041 HD22 HG22 ' A' ' 70' ' ' THR . 0.2 OUTLIER -139.44 162.84 34.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.218 0.533 . . . . 1.03 110.753 -172.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.691 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -117.86 149.98 39.95 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.692 -0.855 . . . . 1.1000000000000001 108.692 168.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -136.28 119.67 23.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.406 -0.59 . . . . 0.20000000000000001 109.406 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.796 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 25.2 m-85 -103.41 123.61 47.17 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.593 0.235 . . . . 0.23000000000000001 111.268 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.73 ' HB2' HG21 ' A' ' 110' ' ' VAL . 0.7 OUTLIER -81.24 91.79 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.415 -1.328 . . . . 1.28 107.415 167.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.4 p -107.6 140.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.522 0.934 . . . . 0.88 113.522 -159.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.7 101.99 0.23 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.578 -1.192 . . . . 0.52000000000000002 108.444 167.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.971 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -68.4 87.43 0.3 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.67 -1.15 . . . . 1.8400000000000001 112.76 -170.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 tttm 78.21 -34.94 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.635 0.774 . . . . 2.4300000000000002 111.649 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.91 125.69 53.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.649 0.262 . . . . 0.98999999999999999 110.486 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.89 -136.32 5.42 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.558 -0.83 . . . . 1.0900000000000001 112.028 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.529 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 29.1 t80 -132.7 156.66 46.6 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.349 -0.612 . . . . 3.1600000000000001 109.349 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.5 p -119.25 114.7 22.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.338 0.589 . . . . 1.9399999999999999 110.535 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 18.3 ttmm -100.7 15.78 27.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.5 -0.773 . . . . 2.0299999999999998 109.822 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.13 18.93 9.35 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.906 -0.664 . . . . 0.46999999999999997 111.516 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 -52.24 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.316 -0.468 . . . . 0.34000000000000002 112.536 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.607 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -66.48 -48.69 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.18 0.514 . . . . 0.56999999999999995 109.945 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.544 ' HG2' ' H ' ' A' ' 56' ' ' THR . 1.6 pm0 -57.83 -53.47 57.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.017 -0.992 . . . . 2.46 110.892 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.544 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 95.0 m -64.14 -42.43 96.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 0.33000000000000002 111.483 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.71 -49.87 75.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.97 0.414 . . . . 0.19 111.001 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -60.19 -52.39 65.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.6 -0.727 . . . . 0.29999999999999999 111.353 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -59.84 -47.44 85.71 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.881 -0.599 . . . . 1.0800000000000001 111.63 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 39' ' ' LEU . 77.9 mt -55.32 -50.85 68.53 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.424 0.154 . . . . 0.81000000000000005 111.326 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.77 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 40.1 t80 -46.78 -56.14 6.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.124 0.89 . . . . 0.33000000000000002 109.774 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 90.2 m-20 -74.19 -33.75 63.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.454 -0.794 . . . . 1.76 110.936 -170.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -70.43 -41.2 73.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.227 -0.897 . . . . 1.79 111.052 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.552 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.0 m-85 -118.14 14.06 13.92 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 114.076 1.139 . . . . 0.42999999999999999 114.076 -172.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.77 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 34.8 mtmt -56.78 -29.12 62.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.162 0.506 . . . . 2.1099999999999999 110.156 172.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -59.36 -40.26 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.436 -0.802 . . . . 1.2 111.464 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.07 8.22 27.73 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.698 0.285 . . . . 1.8999999999999999 110.967 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 83.82 67.9 1.43 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.581 -0.819 . . . . 1.3200000000000001 111.689 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 39' ' ' LEU . 73.8 t80 -133.77 135.06 43.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.651 0.262 . . . . 0.26000000000000001 110.668 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 1.041 HG22 HD22 ' A' ' 38' ' ' LEU . 4.2 t -131.15 140.81 50.01 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.85 -0.426 . . . . 0.51000000000000001 109.85 175.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.603 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 39.2 t -104.48 114.17 43.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.603 -0.517 . . . . 0.23999999999999999 109.603 171.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.618 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 13.8 mt -98.63 121.11 40.16 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.672 -0.862 . . . . 0.51000000000000001 108.672 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.017 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.67 120.1 41.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.302 -0.559 . . . . 0.28000000000000003 110.918 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.467 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.8 m-85 -105.5 109.24 62.98 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.417 -0.811 . . . . 0.34000000000000002 109.044 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.971 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 32.0 Cg_exo -60.68 168.72 6.47 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.661 2.907 . . . . 0.72999999999999998 111.614 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.7 t . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 115.312 1.597 . . . . 1.54 115.312 -178.533 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 45' ' ' SER . 74.2 m . . . . . 0 N--CA 1.441 -0.912 0 CA-C-O 121.941 0.877 . . . . 0.91000000000000003 110.775 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.871 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 11.5 t -151.66 162.85 40.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.483 -1.69 . . . . 1.9199999999999999 108.335 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.669 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.12 105.32 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.785 0.678 . . . . 3.1800000000000002 111.125 177.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.607 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 49.6 p90 -60.61 -23.84 65.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.737 -0.665 . . . . 1.74 111.377 -174.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? 69.75 131.69 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.994 0.808 . . . . 3.0800000000000001 111.132 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -155.9 -163.61 1.53 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.097 -0.502 . . . . 0.42999999999999999 112.191 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.44 -14.82 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 2.1899999999999999 110.064 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.733 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 47.0 p90 -115.32 168.11 8.81 Favored Pre-proline 0 N--CA 1.443 -0.802 0 CA-C-N 115.127 -0.942 . . . . 0.23999999999999999 109.495 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.878 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.6 Cg_exo -71.06 121.53 7.92 Favored 'Trans proline' 0 N--CA 1.478 0.574 0 C-N-CA 123.932 3.088 . . . . 0.31 113.058 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.017 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -114.55 137.13 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.939 -0.763 . . . . 0.37 108.939 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.878 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 7.8 mmt -111.75 -151.63 0.48 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.524 0.678 . . . . 1.47 112.678 -165.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.74 131.97 43.86 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.77 -1.104 . . . . 0.39000000000000001 110.764 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.871 ' HD3' ' HA ' ' A' ' 96' ' ' THR . 3.6 mtmt -64.95 122.02 16.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.932 -0.766 . . . . 1.6599999999999999 108.932 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.727 HG13 HG13 ' A' ' 110' ' ' VAL . 10.7 pt -122.17 149.84 25.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.641 -1.244 . . . . 0.46999999999999997 107.641 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.28 71.31 3.76 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.999 -0.741 . . . . 2.1600000000000001 108.999 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.73 HG21 ' HB2' ' A' ' 42' ' ' ASN . 2.0 m -64.69 88.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-O 120.868 0.366 . . . . 0.38 110.854 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.605 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 47.9 t30 173.04 177.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.983 -1.117 . . . . 1.98 107.983 163.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.51 -136.85 21.85 Favored Glycine 0 CA--C 1.511 -0.181 0 C-N-CA 121.307 -0.473 . . . . 0.78000000000000003 113.675 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.29 -9.17 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.182 0.515 . . . . 1.98 110.369 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -83.09 -4.89 58.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.554 -0.748 . . . . 2.04 110.792 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.8 57.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 0.47999999999999998 111.817 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.638 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 46.3 t-80 -50.4 137.83 22.12 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.947 -1.024 . . . . 0.41999999999999998 110.281 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.71 -46.64 14.87 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.785 2.323 . . . . 0.35999999999999999 112.402 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.638 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.4 OUTLIER -57.15 -37.16 71.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.837 -0.62 . . . . 1.1000000000000001 111.804 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -30.7 58.28 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 121.076 -0.25 . . . . 1.49 110.945 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.05 -31.7 72.9 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 2.3700000000000001 109.927 171.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 68.0 t80 -70.88 -48.67 52.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 0.57999999999999996 110.391 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 67.1 mtt -63.77 -51.96 62.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.111 -0.495 . . . . 0.34000000000000002 111.058 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -58.33 -41.3 84.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 0.93999999999999995 111.179 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.12 -30.13 66.12 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.748 0.309 . . . . 2.1299999999999999 110.614 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.503 HG21 ' HD2' ' A' ' 150' ' ' PRO . 85.2 m -75.27 -38.54 60.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.096 -0.502 . . . . 0.46999999999999997 111.007 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 35.7 mmtm . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.799 -0.182 . . . . 1.75 110.743 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.605 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 113.061 0.763 . . . . 0.93000000000000005 113.061 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.882 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 28.8 mm -82.76 90.39 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.893 -1.049 . . . . 1.05 108.975 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -108.96 -3.2 17.69 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.611 0.597 . . . . 1.5 112.611 -170.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.882 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.24 169.95 14.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.54 0.571 . . . . 0.87 112.54 -172.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 49' ' ' TYR . 10.8 m120 -49.41 -156.87 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.845 1.658 . . . . 1.8 113.111 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.796 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 39.3 m-85 -27.57 -52.51 0.07 Allowed 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 114.74 1.385 . . . . 1.3700000000000001 114.74 -164.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.872 HG23 ' HA ' ' A' ' 155' ' ' SER . 17.3 m 39.38 102.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.899 1.074 . . . . 0.29999999999999999 113.899 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.692 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.4 p -90.48 155.93 18.56 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.596 -0.842 . . . . 0.80000000000000004 110.573 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 17.6 m-85 -103.72 161.81 13.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.336 -1.357 . . . . 0.53000000000000003 107.336 163.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.806 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 55.5 tp -108.03 105.85 15.8 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.142 -0.688 . . . . 0.51000000000000001 109.142 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.75 HG21 HD13 ' A' ' 15' ' ' ILE . 16.5 mm -103.82 122.97 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 115.638 -0.71 . . . . 0.20000000000000001 109.206 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.93 -179.49 5.51 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.67 -0.412 . . . . 1.3 110.478 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.414 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 91.5 mtt180 -57.27 -21.86 37.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.658 0.614 . . . . 3.7799999999999998 112.658 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -105.84 -17.33 14.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.297 0.57 . . . . 1.1799999999999999 109.762 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 103.71 34.15 3.9 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.345 -0.843 . . . . 0.23000000000000001 112.581 175.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.84 121.67 42.36 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.791 -0.448 . . . . 0.62 109.791 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.503 ' HD2' HG21 ' A' ' 125' ' ' THR . 31.5 Cg_exo -60.54 109.88 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.733 2.289 . . . . 0.29999999999999999 112.151 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -91.75 -31.23 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 0.27000000000000002 110.521 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.573 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.9 mm-40 -149.44 164.93 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.004 -0.544 . . . . 1.22 110.363 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.673 HH11 ' HH2' ' A' ' 137' ' ' TRP . 13.6 ttm180 -132.22 96.65 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.722 -0.844 . . . . 1.75 108.722 168.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.806 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 22.3 m-85 -86.57 108.73 18.71 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.299 -0.63 . . . . 0.38 109.299 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.872 ' HA ' HG23 ' A' ' 140' ' ' THR . 16.4 p -65.2 164.19 25.3 Favored Pre-proline 0 N--CA 1.444 -0.749 0 N-CA-C 109.596 -0.52 . . . . 0.98999999999999999 109.596 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.815 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 23.5 Cg_endo -61.59 -12.21 23.67 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.986 2.457 . . . . 0.66000000000000003 113.251 -163.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.71 -0.53 90.16 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.52 -0.764 . . . . 0.52000000000000002 112.459 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.19 134.67 35.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.894 -0.41 . . . . 0.42999999999999999 109.894 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 19.5 m -91.7 176.66 6.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.472 -0.331 . . . . 1.25 110.129 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.413 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 38.8 t -51.97 -52.1 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 0.40999999999999998 111.213 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -64.02 -36.71 84.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 3.4399999999999999 110.936 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.4 m-20 -57.35 -36.12 70.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.726 -0.67 . . . . 1.8600000000000001 110.232 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.691 HG21 HD21 ' A' ' 39' ' ' LEU . 74.5 mt -84.24 -43.5 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.342 -0.844 . . . . 0.20999999999999999 111.413 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 51.3 mt-10 -54.91 -38.53 67.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.493 0.553 . . . . 0.88 112.493 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.0 -18.37 45.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.035 0.383 . . . . 0.75 112.035 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.573 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 52.3 mttt -116.64 -10.14 11.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.097 0.475 . . . . 1.5800000000000001 110.472 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -97.48 -44.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.681 -0.69 . . . . 0.23999999999999999 111.381 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.4 mt -54.09 -49.28 90.83 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.225 0.454 . . . . 0.44 112.225 -175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 71.8 Cg_exo -51.7 -36.35 61.24 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.187 1.925 . . . . 0.48999999999999999 112.781 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.02 -36.15 56.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.475 -0.33 . . . . 0.70999999999999996 111.099 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.979 HD23 ' HG2' ' A' ' 37' ' ' PRO . 12.4 mt -60.13 -49.43 77.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.968 -0.753 . . . . 0.46000000000000002 108.968 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -52.0 38.62 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 114.462 -1.244 . . . . 1.52 112.536 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 122.726 0.41 . . . . 2.52 110.235 176.778 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 121.359 0.6 . . . . 1.6799999999999999 112.21 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 p -157.26 -174.68 5.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.334 -0.848 . . . . 0.65000000000000002 108.91 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.727 HD13 HG21 ' A' ' 144' ' ' ILE . 18.9 pt -60.61 -25.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.142 0.496 . . . . 0.29999999999999999 110.647 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.797 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 34.3 m-85 -80.64 3.61 21.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.198 -0.455 . . . . 0.27000000000000002 111.418 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -73.64 -16.35 61.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.905 -0.776 . . . . 1.96 108.905 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 52.0 m-85 -109.47 159.32 17.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.765 -1.107 . . . . 0.40000000000000002 110.328 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.14 143.82 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.935 0.398 . . . . 2.77 110.585 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG23 HD13 ' A' ' 30' ' ' LEU . 69.5 t -115.03 146.48 19.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.802 -0.635 . . . . 0.73999999999999999 111.114 -178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.843 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 7.1 mp -103.67 145.19 30.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.97 0.414 . . . . 0.71999999999999997 110.495 170.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.54 -176.52 3.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 1.5900000000000001 109.101 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' ' HE2' ' A' ' 97' ' ' LYS . . . -55.65 -34.43 64.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.002 0.429 . . . . 0.52000000000000002 110.796 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.1 t70 -82.85 -6.29 59.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 2.2200000000000002 111.141 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.843 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 8.8 m-70 74.1 21.52 2.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.92 0.867 . . . . 0.72999999999999998 110.066 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.4 mmpt? -87.25 128.19 56.27 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 106.426 -1.694 . . . . 3.25 106.426 164.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -43.44 115.27 0.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.253 1.968 . . . . 0.85999999999999999 113.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.491 ' HB3' HG12 ' A' ' 20' ' ' VAL . 74.7 t80 -79.32 124.39 28.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.349 -1.296 . . . . 0.28000000000000003 110.003 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.701 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -72.84 82.93 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.316 -0.624 . . . . 1.6499999999999999 109.316 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.797 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.47 -32.05 69.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.316 0.579 . . . . 0.25 110.276 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.795 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.1 p -77.04 -0.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.249 -0.887 . . . . 0.40999999999999998 112.58 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -82.72 -4.92 58.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.164 -0.68 . . . . 1.24 109.164 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.414 ' HB3' HD13 ' A' ' 38' ' ' LEU . 89.8 m-70 -94.62 -4.08 48.38 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.864 -1.062 . . . . 0.38 108.294 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HE2' ' CD2' ' A' ' 16' ' ' PHE . 38.6 ttmt -71.71 139.8 49.3 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.745 -1.116 . . . . 1.73 109.368 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' HB3' ' A' ' 146' ' ' ARG . . . 104.98 -20.32 38.73 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.843 -0.903 . . . . 0.35999999999999999 110.843 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 m -132.76 144.32 52.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 1.1399999999999999 108.773 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -73.36 154.82 51.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.164 1.91 . . . . 0.52000000000000002 111.262 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.653 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.3 pt? -156.35 151.66 26.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.35 0.595 . . . . 1.03 111.417 -172.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.841 HD21 HG21 ' A' ' 163' ' ' ILE . 6.5 mp -107.99 155.92 19.81 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.982 -0.748 . . . . 1.1000000000000001 108.982 173.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -141.25 117.53 7.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.549 -0.537 . . . . 0.20000000000000001 109.549 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.924 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 11.3 m-85 -104.19 123.65 47.7 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.755 -0.378 . . . . 0.23000000000000001 110.512 -175.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 1.013 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.4 OUTLIER -82.5 91.97 6.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.271 -1.011 . . . . 1.28 108.271 168.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 75' ' ' PRO . 2.3 p -112.35 130.53 65.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 113.605 0.965 . . . . 0.88 113.605 -160.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -58.9 103.39 0.16 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.248 -1.39 . . . . 0.52000000000000002 107.248 165.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 1.056 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -68.72 76.98 0.3 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.878 -1.056 . . . . 1.8400000000000001 113.423 -163.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.824 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 62.2 tttm 71.75 67.55 0.15 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.501 -1.227 . . . . 2.4300000000000002 111.235 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.6 m -145.4 116.38 7.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.594 -0.73 . . . . 0.98999999999999999 110.453 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.79 -106.92 1.42 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.758 -0.655 . . . . 1.0900000000000001 114.03 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.47 155.94 18.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 3.1600000000000001 112.254 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.5 p -120.31 -21.4 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.643 -0.708 . . . . 1.9399999999999999 110.631 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.1 mmmt 67.48 0.33 2.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.58 -0.736 . . . . 2.0299999999999998 111.378 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 105.71 -0.28 39.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.985 -0.626 . . . . 0.46999999999999997 111.798 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.73 -38.83 90.13 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.694 -0.563 . . . . 0.34000000000000002 111.694 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.63 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -69.62 -48.51 59.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.915 -0.402 . . . . 0.56999999999999995 109.915 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 2.3 mp0 -54.95 -49.05 72.32 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.403 -0.817 . . . . 2.46 110.608 177.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 160' ' ' VAL . 90.9 m -67.31 -45.45 76.46 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.424 -0.807 . . . . 0.33000000000000002 110.52 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.797 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.62 -49.34 76.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.824 0.345 . . . . 0.19 111.531 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 m -59.74 -46.26 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.29999999999999999 110.852 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.612 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 77.6 m -66.51 -47.75 71.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.613 -0.721 . . . . 1.0800000000000001 111.033 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -57.21 -48.53 78.55 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.427 0.158 . . . . 0.81000000000000005 111.427 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 70' ' ' THR . 43.5 t80 -55.43 -53.56 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.33000000000000002 110.962 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.612 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 2.8 p30 -72.02 -27.6 62.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.23 0.538 . . . . 1.76 110.539 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -78.02 -35.67 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.674 -0.694 . . . . 1.79 110.849 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.712 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.8 m-85 -118.62 13.03 13.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.66 0.985 . . . . 0.42999999999999999 113.66 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -63.09 -21.37 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.905 0.383 . . . . 2.1099999999999999 110.774 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -64.03 -37.11 86.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.644 . . . . 1.2 110.218 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -90.15 3.39 53.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.768 -0.651 . . . . 1.8999999999999999 110.703 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.32 57.74 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.092 -0.504 . . . . 1.3200000000000001 113.059 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.656 ' CE1' HD13 ' A' ' 39' ' ' LEU . 85.8 t80 -72.97 132.35 43.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.835 0.35 . . . . 0.26000000000000001 111.301 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -123.18 135.61 54.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.58 -0.526 . . . . 0.51000000000000001 109.58 177.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.797 HG11 ' HB1' ' A' ' 57' ' ' ALA . 26.1 t -102.51 111.62 32.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.474 -0.565 . . . . 0.23999999999999999 109.474 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 24.4 mt -95.45 121.38 37.06 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.486 -0.931 . . . . 0.51000000000000001 108.486 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.88 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -111.73 112.23 23.77 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.905 -0.718 . . . . 0.28000000000000003 110.35 177.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.79 ' HD2' HD11 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -93.94 111.72 54.17 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.085 -1.08 . . . . 0.34000000000000002 108.085 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.056 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 23.2 Cg_exo -60.13 170.65 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.186 2.591 . . . . 0.72999999999999998 111.895 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.2 t . . . . . 0 N--CA 1.429 -1.492 0 CA-C-O 122.13 0.967 . . . . 1.54 113.166 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.64 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 55.1 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.805 0.336 . . . . 0.91000000000000003 111.631 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -146.36 118.97 8.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.095 0.474 . . . . 1.9199999999999999 110.824 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.83 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 93.8 mttt 66.87 -50.21 0.47 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.87 -1.059 . . . . 3.1800000000000002 113.471 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.824 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 68.7 -48.78 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.928 0.891 . . . . 1.74 110.659 -170.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.83 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 18.6 mtmt 66.07 146.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.139 0.576 . . . . 3.0800000000000001 112.192 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.464 ' HB2' ' HE1' ' A' ' 98' ' ' PHE . . . -164.66 -164.03 0.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.702 0.63 . . . . 0.42999999999999999 112.702 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -79.77 -11.9 59.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.401 -0.818 . . . . 2.1899999999999999 109.887 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.623 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 42.2 p90 -115.81 166.86 11.27 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.096 -0.957 . . . . 0.23999999999999999 109.177 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 33.3 Cg_exo -66.02 121.81 9.23 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.37 2.713 . . . . 0.31 112.815 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.88 HG13 ' HB3' ' A' ' 73' ' ' ALA . 1.5 mp -109.51 143.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.466 -0.568 . . . . 0.37 109.466 174.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.692 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -108.92 -160.52 0.72 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.389 0.885 . . . . 1.47 113.389 -165.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 108' ' ' ILE . . . -72.93 131.47 42.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.013 -0.994 . . . . 0.39000000000000001 110.042 173.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.925 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttt -70.61 115.04 9.31 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.898 0.856 . . . . 1.6599999999999999 108.752 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.79 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -125.54 160.86 31.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.339 -1.726 . . . . 0.46999999999999997 106.339 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.894 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.0 m120 -65.73 117.54 8.31 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.97 -1.092 . . . . 2.1600000000000001 109.064 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' A' ' 135' ' ' ILE . 1.7 m -116.57 88.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.733 -0.839 . . . . 0.38 108.733 170.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 1.7 t30 173.86 177.32 0.12 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.296 -1.372 . . . . 1.98 107.296 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 42.19 -135.54 3.62 Favored Glycine 0 N--CA 1.46 0.242 0 O-C-N 123.936 0.773 . . . . 0.78000000000000003 114.739 164.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.47 -11.72 16.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.146 -0.527 . . . . 1.98 110.821 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -81.87 -15.32 54.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.04 111.339 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.894 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.5 137.46 0.82 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.062 1.134 . . . . 0.47999999999999998 114.062 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.59 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 55.5 t-80 -50.19 140.77 16.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 114.969 -1.014 . . . . 0.41999999999999998 110.866 173.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.28 -46.92 11.22 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.189 2.593 . . . . 0.35999999999999999 112.922 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.59 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 20.2 tp -58.05 -36.02 72.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.176 -0.466 . . . . 1.1000000000000001 111.656 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 15.0 m-85 -75.51 -30.59 59.87 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 116.65 -0.25 . . . . 1.49 110.76 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 115' ' ' ALA . 33.9 mm-40 -64.01 -29.32 70.48 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.068 -0.653 . . . . 2.3700000000000001 109.721 169.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 86.7 t80 -75.29 -42.02 55.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.277 0.56 . . . . 0.57999999999999996 110.393 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.622 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 66.8 mtt -69.38 -49.3 56.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 0.34000000000000002 110.82 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 38.7 mtpt -60.17 -40.76 91.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.93999999999999995 111.062 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 21.6 ptmt -69.17 -35.72 76.59 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.82 0.343 . . . . 2.1299999999999999 110.804 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 150' ' ' PRO . 91.1 m -74.23 -44.81 51.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.46999999999999997 110.875 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 42.8 mmtt . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 116.189 -0.46 . . . . 1.75 110.215 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.449 ' C ' HH12 ' A' ' 153' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 112.936 0.717 . . . . 0.93000000000000005 112.936 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.828 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 38.8 mt -78.5 150.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.768 -1.106 . . . . 1.05 109.475 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -168.57 -1.99 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.597 0.592 . . . . 1.5 112.597 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.828 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -136.82 170.03 16.76 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.332 0.653 . . . . 0.87 111.113 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.465 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 15.7 m120 -43.93 -158.24 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.376 1.47 . . . . 1.8 114.058 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.924 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.6 m-85 -27.76 -57.63 0.11 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 125.018 1.327 . . . . 1.3700000000000001 114.335 -167.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 1.013 ' HB ' HD21 ' A' ' 42' ' ' ASN . 10.6 m 42.94 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.111 0.782 . . . . 0.29999999999999999 113.111 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 25.6 p -86.64 152.11 22.86 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.169 -0.612 . . . . 0.80000000000000004 110.637 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.622 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.9 m-85 -103.76 133.17 49.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.719 -1.215 . . . . 0.53000000000000003 107.719 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 151' ' ' VAL . 25.3 tp -81.29 103.63 11.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.741 -0.837 . . . . 0.51000000000000001 108.741 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.727 HG21 HD13 ' A' ' 15' ' ' ILE . 13.5 mm -104.03 125.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.095 -0.706 . . . . 0.20000000000000001 109.095 -175.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.4 -179.93 7.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.728 -0.789 . . . . 1.3 110.09 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.432 ' HG3' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -55.27 -23.09 21.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.21 0.529 . . . . 3.7799999999999998 112.085 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.46 -17.28 18.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.107 -0.701 . . . . 1.1799999999999999 109.107 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 100.45 25.19 8.89 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.751 -1.113 . . . . 0.23000000000000001 112.509 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 65.0 t -106.81 124.54 35.16 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.106 0.453 . . . . 0.62 110.429 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 125' ' ' THR . 34.9 Cg_exo -61.1 111.26 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.332 2.688 . . . . 0.29999999999999999 112.328 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.551 ' HB ' HD23 ' A' ' 143' ' ' LEU . 18.5 t -88.8 -28.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.212 -0.449 . . . . 0.27000000000000002 110.712 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.521 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 34.3 mm-40 -160.91 164.26 31.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 1.22 110.536 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.803 HH11 ' HH2' ' A' ' 137' ' ' TRP . 14.8 ttm180 -123.0 97.23 5.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.707 -0.479 . . . . 1.75 109.707 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.637 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 84.6 m-85 -82.15 108.59 15.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.531 -0.544 . . . . 0.38 109.531 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.852 ' HA ' HG23 ' A' ' 140' ' ' THR . 3.0 m -62.19 165.21 9.0 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 109.771 -0.455 . . . . 0.98999999999999999 109.771 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.814 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 44.2 Cg_endo -66.97 -8.21 21.0 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.624 2.216 . . . . 0.66000000000000003 112.686 -164.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.23 5.56 81.16 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.52000000000000002 111.865 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.0 133.51 35.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.903 0.382 . . . . 0.42999999999999999 110.072 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.546 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 51.0 m -86.99 171.44 10.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.134 -0.485 . . . . 1.25 111.342 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.465 ' HA ' HG23 ' A' ' 56' ' ' THR . 99.0 t -52.86 -58.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.828 -0.624 . . . . 0.40999999999999998 112.356 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.6 tptm -72.44 -25.33 61.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 3.4399999999999999 110.597 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.1 m-20 -61.08 -31.36 71.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.877 -0.602 . . . . 1.8600000000000001 110.557 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.841 HG21 HD21 ' A' ' 39' ' ' LEU . 43.1 mt -83.17 -42.16 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.002 0.43 . . . . 0.20999999999999999 110.778 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.603 ' HB2' ' HD2' ' A' ' 161' ' ' LYS . 45.8 mt-10 -56.45 -34.5 66.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.88 112.293 -174.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.434 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.2 pt-20 -53.62 -32.16 50.1 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.725 0.298 . . . . 0.75 111.67 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 47.5 mmtm -105.26 -14.19 15.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.339 -0.391 . . . . 1.5800000000000001 111.236 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 171' ' ' LEU . 65.1 tp -88.57 -42.52 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 0.23999999999999999 111.735 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.744 ' HA ' HD12 ' A' ' 171' ' ' LEU . 78.5 mt -53.34 -48.56 92.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.418 0.525 . . . . 0.44 112.418 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.525 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.1 Cg_exo -56.32 -26.69 63.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.318 2.012 . . . . 0.48999999999999999 112.902 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.38 -40.37 16.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.70999999999999996 110.65 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.955 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 16.7 mt -59.18 -48.96 79.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.547 0.689 . . . . 0.46000000000000002 109.617 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.4 38.83 0.85 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.501 -1.227 . . . . 1.52 113.13 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 171' ' ' LEU . 69.1 m . . . . . 0 N--CA 1.467 0.393 0 C-N-CA 123.56 0.744 . . . . 2.52 112.775 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.587 0.708 . . . . 1.6799999999999999 109.793 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 p -157.85 175.14 14.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.858 -1.065 . . . . 0.65000000000000002 108.452 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.806 HD13 HG21 ' A' ' 144' ' ' ILE . 21.9 pt -55.24 -29.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.136 0.421 . . . . 0.29999999999999999 112.136 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.865 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.9 m-85 -75.84 -0.44 21.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.387 0.514 . . . . 0.27000000000000002 112.387 -172.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.28 -12.2 59.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.505 0.669 . . . . 1.96 109.266 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 72.6 m-85 -108.84 155.54 20.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.228 -0.896 . . . . 0.40000000000000002 111.085 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 29.9 tt0 -84.25 143.51 29.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.429 -0.805 . . . . 2.77 110.934 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 28' ' ' TYR . 72.5 t -125.45 146.17 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.762 0.315 . . . . 0.73999999999999999 110.461 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.975 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 90.4 mt -111.59 146.82 36.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.408 -0.36 . . . . 0.71999999999999997 110.264 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.39 174.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.745 0.653 . . . . 1.5900000000000001 109.482 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 97' ' ' LYS . . . -53.86 -31.05 48.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.321 0.582 . . . . 0.52000000000000002 109.959 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.17 4.06 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.35 -0.841 . . . . 2.2200000000000002 112.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.975 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 30.5 m-70 72.63 26.09 2.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.485 0.66 . . . . 0.72999999999999998 110.968 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 38.5 mmtt -91.07 128.73 46.51 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 107.03 -1.47 . . . . 3.25 107.03 168.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.47 112.63 0.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.792 1.661 . . . . 0.85999999999999999 112.476 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HB3' HG12 ' A' ' 20' ' ' VAL . 68.8 t80 -79.39 123.72 27.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.669 -1.15 . . . . 0.28000000000000003 110.553 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.632 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 3.0 t-20 -73.68 81.92 1.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.495 -0.775 . . . . 1.6499999999999999 109.182 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.777 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.7 pt? -72.12 -32.25 66.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.471 0.653 . . . . 0.25 110.463 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.865 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 8.8 p -77.21 0.5 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.324 -0.853 . . . . 0.40999999999999998 112.735 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.3 pt20 -82.15 -5.87 58.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.387 0.613 . . . . 1.24 109.564 173.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -92.54 -1.2 57.11 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.137 -1.06 . . . . 0.38 108.137 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -76.17 141.26 41.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.348 -1.296 . . . . 1.73 109.297 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.92 -8.39 63.3 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.328 -1.109 . . . . 0.35999999999999999 110.328 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 20.1 m -140.68 146.08 43.0 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.088 -0.708 . . . . 1.1399999999999999 109.088 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.056 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.0 Cg_endo -73.5 154.81 50.43 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.765 1.643 . . . . 0.52000000000000002 111.153 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.614 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -155.09 152.47 29.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.396 0.617 . . . . 1.03 111.372 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.742 HD21 HG21 ' A' ' 163' ' ' ILE . 6.3 mp -107.83 151.48 25.69 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.567 -0.901 . . . . 1.1000000000000001 108.567 172.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 80.4 mt -140.68 116.72 7.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.553 -0.536 . . . . 0.20000000000000001 109.553 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.922 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 24.3 m-85 -103.29 123.28 46.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.219 0.325 . . . . 0.23000000000000001 111.244 -172.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.728 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -79.32 91.56 5.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.783 -0.821 . . . . 1.28 108.783 168.193 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.713 HG11 ' HE2' ' A' ' 98' ' ' PHE . 2.4 p -112.34 133.52 57.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.563 0.949 . . . . 0.88 113.563 -163.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.86 102.62 0.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.726 -1.212 . . . . 0.52000000000000002 107.726 167.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.976 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 30.1 t -72.08 97.23 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.088 0.773 . . . . 1.8400000000000001 113.088 -166.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt 73.84 38.19 0.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.743 0.652 . . . . 2.4300000000000002 111.218 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 m -141.79 157.67 44.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.596 -0.274 . . . . 0.98999999999999999 110.607 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.2 -118.34 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 O-C-N 123.632 0.583 . . . . 1.0900000000000001 113.678 171.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -129.21 174.83 9.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.546 0.689 . . . . 3.1600000000000001 111.782 -174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.661 HG22 ' HE1' ' A' ' 139' ' ' PHE . 7.8 p -133.22 116.72 16.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.058 -0.974 . . . . 1.9399999999999999 109.616 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.703 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 24.8 mtpp -83.86 17.07 2.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.059 -0.519 . . . . 2.0299999999999998 111.828 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.3 17.04 21.24 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.878 -0.677 . . . . 0.46999999999999997 111.89 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.42 -42.85 7.22 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.394 -0.431 . . . . 0.34000000000000002 112.131 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.555 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -67.12 -44.59 79.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.449 -0.574 . . . . 0.56999999999999995 109.449 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 23.6 mp0 -55.81 -55.03 37.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.023 -0.99 . . . . 2.46 110.086 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.515 ' CG2' HD12 ' A' ' 163' ' ' ILE . 98.6 m -67.62 -41.45 83.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.941 -1.027 . . . . 0.33000000000000002 111.284 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.724 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.78 -48.2 81.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.859 0.362 . . . . 0.19 110.813 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.6 m -61.29 -49.38 77.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.635 . . . . 0.29999999999999999 111.043 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 p -64.24 -47.32 80.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.813 -0.63 . . . . 1.0800000000000001 111.438 -177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.642 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.59 -45.44 91.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.64 -0.255 . . . . 0.81000000000000005 111.176 -177.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.814 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 85.4 t80 -53.07 -58.81 5.74 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 123.215 0.322 . . . . 0.33000000000000002 110.668 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -70.09 -36.18 74.7 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.697 -0.401 . . . . 1.76 111.802 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.01 -39.81 79.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 1.79 111.384 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.727 ' CD1' HD13 ' A' ' 171' ' ' LEU . 73.9 m-85 -108.32 4.95 25.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.42999999999999999 113.17 -174.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -59.03 -28.02 66.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 2.1099999999999999 110.397 173.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.4 m -65.65 -37.34 86.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.464 . . . . 1.2 111.144 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -88.45 1.44 54.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.92 0.391 . . . . 1.8999999999999999 111.107 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 88.94 66.0 1.28 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.951 -0.643 . . . . 1.3200000000000001 112.191 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 39' ' ' LEU . 71.9 t80 -132.05 140.07 48.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.503 0.192 . . . . 0.26000000000000001 110.594 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.27 140.22 52.0 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 120.898 0.38 . . . . 0.51000000000000001 110.381 177.116 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.814 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 25.4 t -109.74 117.88 55.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.963 0.411 . . . . 0.23999999999999999 110.521 169.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 20.3 mt -101.43 137.84 39.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.693 -0.854 . . . . 0.51000000000000001 108.693 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.056 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -122.45 116.34 23.79 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.349 -0.54 . . . . 0.28000000000000003 110.835 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.629 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -99.12 108.77 51.43 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 108.659 -0.867 . . . . 0.34000000000000002 108.659 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.129 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.6 Cg_exo -59.3 170.24 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.194 2.596 . . . . 0.72999999999999998 111.717 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.433 -1.277 0 CA-C-O 121.892 0.853 . . . . 1.54 112.291 -177.194 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 45' ' ' SER . 10.6 m . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.936 0.398 . . . . 0.91000000000000003 111.6 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 t -154.27 122.09 5.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.101 -0.5 . . . . 1.9199999999999999 110.964 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.707 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 15.7 ptpt 32.31 84.43 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.867 1.062 . . . . 3.1800000000000002 113.867 174.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.713 ' HE2' HG11 ' A' ' 43' ' ' VAL . 15.5 p90 -66.77 -25.47 66.5 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.742 -0.599 . . . . 1.74 110.361 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 99' ' ' LYS . 71.3 mmtt 65.78 148.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.081 0.863 . . . . 3.0800000000000001 111.946 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -169.39 -164.74 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.736 0.643 . . . . 0.42999999999999999 112.736 -174.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -69.67 -24.68 63.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.365 -0.834 . . . . 2.1899999999999999 109.752 173.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.794 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 50.3 p90 -108.9 168.07 8.27 Favored Pre-proline 0 N--CA 1.438 -1.063 0 CA-C-N 114.575 -1.193 . . . . 0.23999999999999999 109.479 -175.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 1.008 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 16.4 Cg_exo -73.7 129.37 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.7 2.933 . . . . 0.31 113.186 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.056 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.9 mp -117.69 138.02 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.336 -0.616 . . . . 0.37 109.336 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 1.008 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.9 mmt -112.66 -156.59 0.59 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.837 0.827 . . . . 1.47 113.2 -164.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.796 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -65.96 137.99 57.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.494 -1.23 . . . . 0.39000000000000001 110.938 174.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.129 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttp -84.44 127.63 34.12 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.85 0.833 . . . . 1.6599999999999999 109.458 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -131.66 162.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.983 -1.462 . . . . 0.46999999999999997 107.769 -176.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.721 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 21.5 t-20 -75.81 83.61 2.76 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.857 -0.794 . . . . 2.1600000000000001 108.857 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.697 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.26 89.57 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 108.085 -1.08 . . . . 0.38 108.085 173.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 175.02 179.52 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.474 -0.936 . . . . 1.98 108.474 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 47.0 -144.0 5.02 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 124.313 1.008 . . . . 0.78000000000000003 115.512 156.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 11.5 pt-20 -102.81 -6.96 22.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.152 -1.024 . . . . 1.98 110.331 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -98.29 0.01 44.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.476 -0.784 . . . . 2.04 110.975 -170.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -50.79 138.89 17.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 0.47999999999999998 112.888 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.46 ' HE1' ' O ' ' A' ' 19' ' ' GLU . 51.2 t-80 -52.4 138.08 39.7 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.303 -0.862 . . . . 0.41999999999999998 110.313 172.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -44.39 -45.08 12.92 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.217 2.611 . . . . 0.35999999999999999 112.676 -178.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.444 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 2.0 tm? -54.72 -45.61 74.11 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.667 -0.697 . . . . 1.1000000000000001 111.189 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.468 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.5 m-85 -75.56 -29.74 59.47 Favored 'General case' 0 C--O 1.212 -0.885 0 O-C-N 122.295 -0.253 . . . . 1.49 111.451 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 49.8 mt-10 -58.49 -39.42 79.97 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.946 -0.702 . . . . 2.3700000000000001 109.165 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 88.1 t80 -67.82 -44.0 78.27 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.293 0.371 . . . . 0.57999999999999996 110.597 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.456 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.3 mtt -65.02 -54.12 35.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.306 -0.406 . . . . 0.34000000000000002 111.033 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 36.7 mtpt -57.18 -39.94 76.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.735 -0.666 . . . . 0.93999999999999995 110.877 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.4 ptmt -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.421 -0.354 . . . . 2.1299999999999999 111.534 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.58 HG21 ' HD2' ' A' ' 150' ' ' PRO . 94.3 m -64.36 -53.8 42.87 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.625 -0.43 . . . . 0.46999999999999997 110.314 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.698 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.8 ttmt . . . . . 0 C--N 1.323 -0.576 0 N-CA-C 109.847 -0.427 . . . . 1.75 109.847 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 114.027 1.121 . . . . 0.93000000000000005 114.027 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.872 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 50.4 mt -82.9 156.21 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 113.539 -1.664 . . . . 1.05 108.464 176.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -173.26 10.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.121 0.786 . . . . 1.5 113.121 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.872 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.62 171.26 14.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.763 0.425 . . . . 0.87 110.997 -177.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.433 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 17.6 m120 -45.53 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 1.8 113.526 172.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.922 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 47.0 m-85 -27.87 -59.07 0.11 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 114.634 1.346 . . . . 1.3700000000000001 114.634 -166.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.79 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 11.6 m 45.11 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.913 0.779 . . . . 0.29999999999999999 112.954 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.7 p -89.87 150.19 22.32 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.538 -0.865 . . . . 0.80000000000000004 111.071 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.8 m-85 -102.72 135.84 43.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.895 -1.15 . . . . 0.53000000000000003 107.895 166.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.972 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 54.9 tp -82.13 105.13 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.015 -0.735 . . . . 0.51000000000000001 109.015 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 15' ' ' ILE . 14.9 mm -102.5 122.59 55.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.558 -0.746 . . . . 0.20000000000000001 109.04 -173.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.56 179.24 3.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.415 . . . . 1.3 110.355 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.82 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 72.8 mtp180 -62.41 -15.33 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.262 0.467 . . . . 3.7799999999999998 112.262 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -109.03 -18.29 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.835 -0.541 . . . . 1.1799999999999999 110.236 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.499 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 112.06 34.07 2.06 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.23000000000000001 113.27 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 55.0 t -108.41 126.75 28.89 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 117.199 0.5 . . . . 0.62 110.595 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.58 ' HD2' HG21 ' A' ' 125' ' ' THR . 11.3 Cg_exo -69.22 97.48 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.073 2.515 . . . . 0.29999999999999999 112.072 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.95 -20.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.529 . . . . 0.27000000000000002 111.151 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.698 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 6.0 mm-40 -154.17 162.45 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.998 -0.371 . . . . 1.22 109.998 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -135.3 98.14 3.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.565 -0.531 . . . . 1.75 109.565 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.972 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 16.1 m-85 -88.56 125.06 34.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.772 ' HA ' HG23 ' A' ' 140' ' ' THR . 92.4 p -69.75 171.74 6.71 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.809 -0.811 . . . . 0.98999999999999999 108.809 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.79 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 37.8 Cg_endo -66.04 -8.89 21.42 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.92 1.747 . . . . 0.66000000000000003 112.293 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.35 -4.9 83.17 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.231 -0.895 . . . . 0.52000000000000002 112.108 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.09 113.26 19.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.16 0.505 . . . . 0.42999999999999999 110.125 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.2 p -82.62 179.92 7.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.677 -0.692 . . . . 1.25 110.804 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.642 HG13 HD21 ' A' ' 60' ' ' LEU . 58.0 t -44.17 -57.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.747 -0.66 . . . . 0.40999999999999998 111.617 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -58.12 -39.45 78.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.773 -0.648 . . . . 3.4399999999999999 112.399 -175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.52 -31.1 70.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.472 0.653 . . . . 1.8600000000000001 110.087 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.742 HG21 HD21 ' A' ' 39' ' ' LEU . 46.0 mt -81.32 -42.52 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.242 -0.89 . . . . 0.20999999999999999 110.945 177.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 65.3 mt-10 -58.09 -36.32 72.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.43 -0.35 . . . . 0.88 111.902 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.3 pt-20 -63.71 -12.28 33.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.894 0.331 . . . . 0.75 111.894 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.624 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.8 mmtp -116.22 -23.06 8.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.427 . . . . 1.5800000000000001 110.694 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.8 tp -89.68 -37.16 14.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.398 0.518 . . . . 0.23999999999999999 112.398 -170.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.666 ' HA ' HD12 ' A' ' 171' ' ' LEU . 68.8 mt -50.75 -48.47 83.16 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 0.44 112.841 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.8 Cg_exo -55.11 -37.07 94.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.924 1.749 . . . . 0.48999999999999999 112.69 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.3 mt -78.95 -36.93 40.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.688 0.255 . . . . 0.70999999999999996 111.688 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.056 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.9 mt -55.44 -50.69 69.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.586 0.707 . . . . 0.46000000000000002 109.216 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -48.85 -68.73 1.19 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.11 -1.405 . . . . 1.52 111.78 167.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.82 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 9.3 t . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 120.691 0.282 . . . . 2.52 110.434 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.203 0.525 . . . . 1.6799999999999999 110.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.6 p -137.25 167.61 21.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.63 -0.714 . . . . 0.65000000000000002 109.101 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.715 HD13 HG21 ' A' ' 144' ' ' ILE . 18.0 pt -61.57 -29.7 46.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.852 0.358 . . . . 0.29999999999999999 111.9 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.795 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 72.4 m-85 -76.5 1.52 16.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.264 0.468 . . . . 0.27000000000000002 112.264 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.39 -17.86 61.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.792 -0.818 . . . . 1.96 108.792 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 73.9 m-85 -99.73 159.99 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.40000000000000002 110.6 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -102.21 135.77 43.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 2.77 110.963 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.605 HG23 HD13 ' A' ' 30' ' ' LEU . 89.3 t -114.35 146.63 18.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.294 0.568 . . . . 0.73999999999999999 111.731 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 86.3 mt -117.29 153.22 33.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.615 -0.72 . . . . 0.71999999999999997 110.24 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 176.72 1.4 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.206 -0.906 . . . . 1.5900000000000001 109.454 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -53.71 -32.04 50.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.299 0.571 . . . . 0.52000000000000002 110.065 173.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 1.7 m-20 -87.12 -3.91 59.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.62 -0.718 . . . . 2.2200000000000002 112.281 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.97 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.7 m-70 74.49 27.04 1.43 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.693 0.759 . . . . 0.72999999999999998 110.296 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -88.56 154.61 50.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.61 -1.626 . . . . 3.25 106.61 167.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.17 113.14 1.31 Allowed 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.047 1.164 . . . . 0.85999999999999999 112.916 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.505 ' HB3' HG12 ' A' ' 20' ' ' VAL . 60.3 t80 -89.91 117.53 28.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.411 -0.813 . . . . 0.28000000000000003 110.722 168.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.573 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.87 84.97 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.587 -0.733 . . . . 1.6499999999999999 109.512 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.786 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.74 -32.35 67.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.002 0.43 . . . . 0.25 110.58 -176.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.795 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -76.54 -1.37 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 0.40999999999999998 112.699 -167.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 7.0 pt20 -80.75 -5.71 57.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.418 0.628 . . . . 1.24 109.724 172.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.425 ' HB3' HD13 ' A' ' 38' ' ' LEU . 81.9 m-70 -92.15 1.02 57.46 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.188 -1.041 . . . . 0.38 108.188 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 22.8 ttpp -86.19 132.64 33.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.923 -1.035 . . . . 1.73 109.216 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.2 32.26 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.767 -1.333 . . . . 0.35999999999999999 109.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 18.1 m -139.84 149.64 59.85 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.389 -0.967 . . . . 1.1399999999999999 108.389 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.04 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 61.1 Cg_endo -75.41 153.51 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.558 1.505 . . . . 0.52000000000000002 111.257 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.679 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.2 pt? -154.27 151.07 28.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.297 0.57 . . . . 1.03 111.295 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.791 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -109.64 154.9 22.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.567 -0.742 . . . . 1.1000000000000001 109.089 172.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 72.3 mt -140.87 121.56 13.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.75 -0.833 . . . . 0.20000000000000001 108.75 -176.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.06 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -108.41 126.72 53.2 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.882 0.373 . . . . 0.23000000000000001 111.589 -171.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.669 ' ND2' HD13 ' A' ' 135' ' ' ILE . 0.6 OUTLIER -77.97 93.82 4.5 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.619 -1.252 . . . . 1.28 107.619 170.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.792 HG12 ' HA ' ' A' ' 139' ' ' PHE . 18.0 m -112.65 138.38 42.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 113.44 0.904 . . . . 0.88 113.44 -164.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.8 102.78 2.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.575 -1.639 . . . . 0.52000000000000002 106.575 163.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 1.039 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 32.3 t -60.12 94.07 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.69 -0.686 . . . . 1.8400000000000001 112.202 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 98' ' ' PHE . 24.7 tptp 63.46 19.29 11.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.502 0.668 . . . . 2.4300000000000002 110.516 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.2 p -135.18 172.62 12.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.706 -0.679 . . . . 0.98999999999999999 109.846 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.17 -154.58 39.15 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.714 -0.755 . . . . 1.0900000000000001 112.796 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -110.72 111.9 23.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 3.1600000000000001 110.235 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.408 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 1.5 p -77.56 112.86 14.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.5 . . . . 1.9399999999999999 111.109 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.434 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -81.5 14.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 2.0299999999999998 111.062 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.2 8.38 38.75 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.976 -0.556 . . . . 0.46999999999999997 111.888 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -39.04 96.73 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 111.987 -0.445 . . . . 0.34000000000000002 111.987 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.518 ' CZ ' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -66.71 -47.29 72.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.769 0.319 . . . . 0.56999999999999995 110.413 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.65 -45.58 92.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.742 -0.466 . . . . 2.46 109.742 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.662 ' HA ' HG22 ' A' ' 160' ' ' VAL . 73.2 m -59.74 -50.96 71.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.602 -0.726 . . . . 0.33000000000000002 111.032 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.891 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.57 -50.25 73.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.164 -0.471 . . . . 0.19 111.372 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m -56.08 -46.77 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.958 0.409 . . . . 0.29999999999999999 111.252 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.661 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 90.6 m -64.49 -46.5 82.73 Favored 'General case' 0 C--N 1.337 0.036 0 CA-C-N 116.392 -0.367 . . . . 1.0800000000000001 111.156 -177.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 39' ' ' LEU . 71.4 mt -59.72 -49.72 76.63 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 120.722 0.296 . . . . 0.81000000000000005 110.622 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.668 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 14.8 t80 -50.33 -57.43 7.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.213 -0.903 . . . . 0.33000000000000002 109.651 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 2.3 p30 -73.84 -29.07 61.92 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.755 -0.657 . . . . 1.76 111.738 -168.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.679 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 33.2 ttmt -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.641 0.258 . . . . 1.79 111.041 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.679 ' CE2' ' HD2' ' A' ' 63' ' ' LYS . 70.8 m-85 -116.73 10.43 14.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.892 1.071 . . . . 0.42999999999999999 113.892 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 14.7 mtpp -64.02 -20.29 65.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.0 -0.68 . . . . 2.1099999999999999 109.991 172.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -61.19 -33.27 73.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.766 -0.652 . . . . 1.2 109.887 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.467 HE21 ' HD1' ' A' ' 64' ' ' TYR . 2.0 mp0 -95.31 11.78 31.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.914 -0.584 . . . . 1.8999999999999999 110.643 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.61 12.38 75.3 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.872 -0.603 . . . . 1.3200000000000001 113.042 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 37' ' ' PRO . 93.8 t80 -72.03 141.06 49.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.034 0.445 . . . . 0.26000000000000001 111.302 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -131.79 144.87 51.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.908 -0.587 . . . . 0.51000000000000001 109.714 176.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.891 HG11 ' HB1' ' A' ' 57' ' ' ALA . 41.4 t -112.26 117.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.605 -0.517 . . . . 0.23999999999999999 109.605 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.3 mt -100.28 121.11 40.95 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.735 -0.839 . . . . 0.51000000000000001 108.735 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.033 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -107.99 112.72 25.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.388 -0.525 . . . . 0.28000000000000003 110.608 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.1 m-85 -98.46 115.25 65.82 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.039 -0.726 . . . . 0.34000000000000002 109.039 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.039 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 19.6 Cg_exo -63.28 169.66 9.09 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.107 2.538 . . . . 0.72999999999999998 111.915 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.433 -1.287 0 C-N-CA 119.519 -0.872 . . . . 1.54 112.165 -178.361 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 45' ' ' SER . 4.6 m . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.364 -0.606 . . . . 0.91000000000000003 109.364 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.745 HG23 ' HG2' ' A' ' 75' ' ' PRO . 1.8 m -13.98 117.57 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 115.216 1.561 . . . . 1.9199999999999999 115.216 -140.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 6.1 ptmt 171.88 -31.48 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 111.477 -2.601 . . . . 3.1800000000000002 107.883 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.562 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -36.8 109.97 0.11 Allowed 'General case' 0 C--N 1.354 0.779 0 O-C-N 124.972 1.42 . . . . 1.74 111.387 -173.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 97' ' ' LYS . 73.4 mmtt -104.61 143.17 33.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.055 -0.975 . . . . 3.0800000000000001 110.262 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -145.15 -170.24 3.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.602 -0.272 . . . . 0.42999999999999999 110.979 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -75.02 -26.54 59.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.446 0.641 . . . . 2.1899999999999999 109.496 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.878 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 44.0 p90 -98.44 159.35 30.78 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 114.933 -1.03 . . . . 0.23999999999999999 109.544 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 38.8 Cg_exo -67.56 114.18 3.2 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.091 3.194 . . . . 0.31 113.608 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.033 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mp -100.35 131.9 46.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 108.98 -0.748 . . . . 0.37 108.98 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.647 ' HE2' ' HA ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -117.03 -155.58 0.59 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.345 0.869 . . . . 1.47 113.345 -157.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -68.63 113.47 6.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.979 -1.01 . . . . 0.39000000000000001 111.177 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.007 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -61.99 139.87 58.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.401 0.62 . . . . 1.6599999999999999 109.602 171.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.539 HD12 ' CB ' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -150.13 156.59 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.571 -1.27 . . . . 0.46999999999999997 107.571 -174.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.762 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 24.8 t-20 -67.84 93.99 0.43 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.102 -0.703 . . . . 2.1600000000000001 109.102 175.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -83.7 82.59 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.278 -0.969 . . . . 0.38 108.793 176.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 32.5 t30 170.68 -177.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.229 -1.026 . . . . 1.98 108.229 170.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 58.92 -141.74 46.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.438 -0.887 . . . . 0.78000000000000003 114.541 158.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.62 -15.95 16.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.683 0.754 . . . . 1.98 109.671 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.469 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 19.1 m120 -88.46 -5.64 58.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.607 -1.178 . . . . 2.04 110.912 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.762 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.37 126.43 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.298 -0.864 . . . . 0.47999999999999998 112.281 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.561 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 55.1 t-80 -47.47 133.79 10.13 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-O 118.535 -0.745 . . . . 0.41999999999999998 109.928 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.601 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.6 Cg_endo -42.11 -45.11 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.228 2.619 . . . . 0.35999999999999999 112.711 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.561 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 20.1 tp -54.77 -51.45 65.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.753 -0.658 . . . . 1.1000000000000001 111.584 175.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.746 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 22.9 m-85 -69.78 -31.5 69.47 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.403 -0.362 . . . . 1.49 111.201 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.55 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 1.4 mt-10 -55.18 -46.86 75.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.547 -0.909 . . . . 2.3700000000000001 108.547 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 85.8 t80 -64.6 -49.25 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.665 0.603 . . . . 0.57999999999999996 110.128 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.584 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 64.2 mtt -54.54 -51.58 64.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.123 -0.489 . . . . 0.34000000000000002 111.722 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.746 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 27.5 mtpt -61.3 -49.33 77.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.868 0.366 . . . . 0.93999999999999995 110.549 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 16.7 ptpt -70.44 -31.66 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 2.1299999999999999 111.046 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.549 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.3 m -70.51 -40.58 73.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.429 -0.35 . . . . 0.46999999999999997 111.78 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 10.0 mmtt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.53 . . . . 1.75 112.164 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.31 0 CA-C-O 120.832 0.349 . . . . 0.93000000000000005 111.645 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.831 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 13.6 mt -105.1 105.86 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.537 -0.756 . . . . 1.05 109.659 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -133.01 26.67 4.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.142 0.793 . . . . 1.5 113.142 -172.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.831 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -151.34 170.18 20.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.324 0.583 . . . . 0.87 111.995 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 2.7 t-20 -49.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 1.8 112.751 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 1.06 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 10.5 m-85 -27.44 -50.99 0.06 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 125.342 1.457 . . . . 1.3700000000000001 114.794 -167.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.795 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 12.4 m 37.15 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.763 1.165 . . . . 0.29999999999999999 113.288 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.6 p -85.11 150.63 24.72 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.149 -0.621 . . . . 0.80000000000000004 111.412 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.5 m-85 -103.66 132.2 50.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.955 -1.128 . . . . 0.53000000000000003 107.955 165.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.608 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 20.7 tp -81.2 106.11 12.93 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.931 -0.766 . . . . 0.51000000000000001 108.931 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.715 HG21 HD13 ' A' ' 15' ' ' ILE . 18.7 mm -106.17 122.86 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.116 -0.698 . . . . 0.20000000000000001 109.116 -172.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.41 179.14 3.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.262 -0.426 . . . . 1.3 110.505 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 36' ' ' SER . 61.4 mtt180 -59.25 -21.31 59.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.797 0.666 . . . . 3.7799999999999998 112.797 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -109.87 -10.08 14.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.151 0.5 . . . . 1.1799999999999999 110.733 -171.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.553 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 104.16 32.9 4.16 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.737 -0.744 . . . . 0.23000000000000001 113.375 174.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.3 t -107.22 122.43 41.41 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.695 -0.483 . . . . 0.62 109.695 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.5 Cg_exo -68.1 118.02 5.33 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.476 2.118 . . . . 0.29999999999999999 111.178 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.57 ' HB ' HD23 ' A' ' 143' ' ' LEU . 32.6 t -97.22 -30.06 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.928 -0.578 . . . . 0.27000000000000002 110.632 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -154.83 165.31 37.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 1.22 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -132.25 98.61 4.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.698 -0.683 . . . . 1.75 109.358 174.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.652 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 24.5 m-85 -91.05 108.97 20.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.587 -0.523 . . . . 0.38 109.587 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.748 ' HA ' HG23 ' A' ' 140' ' ' THR . 10.5 p -61.19 163.25 11.04 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.806 -0.442 . . . . 0.98999999999999999 109.806 175.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.795 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 45.4 Cg_endo -65.46 -7.01 14.77 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.916 2.411 . . . . 0.66000000000000003 113.4 -162.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 51' ' ' LYS . . . -85.36 -10.66 76.97 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.302 -0.863 . . . . 0.52000000000000002 111.741 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -71.41 131.76 43.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.42999999999999999 110.17 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.439 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 48.9 m -81.57 168.96 17.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.79 -0.641 . . . . 1.25 111.12 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.662 HG22 ' HA ' ' A' ' 56' ' ' THR . 44.8 t -54.44 -51.16 52.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.40999999999999998 110.781 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 161' ' ' LYS . 32.9 ttmt -65.37 -33.65 76.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.553 -0.748 . . . . 3.4399999999999999 110.868 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.6 m-20 -62.43 -31.77 72.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.349 -0.842 . . . . 1.8600000000000001 110.263 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.791 HG21 HD21 ' A' ' 39' ' ' LEU . 69.2 mt -82.89 -37.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.987 -0.552 . . . . 0.20999999999999999 110.908 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.5 mt-10 -57.83 -35.8 71.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.88 112.201 -175.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.99 -32.79 61.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.85 0.357 . . . . 0.75 111.459 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.533 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 47.1 mmtm -100.44 -17.07 17.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 1.5800000000000001 111.036 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 65.7 tp -88.35 -38.08 15.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.192 -0.458 . . . . 0.23999999999999999 111.407 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.841 ' HA ' HD12 ' A' ' 171' ' ' LEU . 85.0 mt -50.71 -52.5 55.93 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.835 0.68 . . . . 0.44 112.835 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.6 Cg_endo -55.67 -34.26 89.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.095 1.863 . . . . 0.48999999999999999 112.673 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.76 -36.0 51.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.569 -0.287 . . . . 0.70999999999999996 110.84 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.04 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.5 mt -56.36 -57.03 14.01 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.07 -0.514 . . . . 0.46000000000000002 109.781 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -45.21 -61.05 3.74 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.265 -1.334 . . . . 1.52 112.927 172.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 21.9 t . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 109.652 -0.499 . . . . 2.52 109.652 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.327 0.584 . . . . 1.6799999999999999 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -141.99 177.57 8.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.361 -0.836 . . . . 0.65000000000000002 108.767 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.851 HD13 HG21 ' A' ' 144' ' ' ILE . 20.7 pt -57.37 -28.67 31.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 0.29999999999999999 111.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.876 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 33.5 m-85 -78.13 2.68 17.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.27000000000000002 111.447 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.07 -20.68 64.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.998 -1.112 . . . . 1.96 107.998 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 61.8 m-85 -111.56 172.36 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.284 -1.326 . . . . 0.40000000000000002 109.918 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -115.06 161.91 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.75 0.309 . . . . 2.77 110.606 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.487 HG23 HD13 ' A' ' 30' ' ' LEU . 61.2 t -128.52 141.69 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.73999999999999999 111.303 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.931 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 51.0 mt -95.77 132.78 40.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.905 -0.589 . . . . 0.71999999999999997 109.703 171.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.29 177.75 1.04 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.184 -0.916 . . . . 1.5900000000000001 109.143 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.474 ' O ' ' HE3' ' A' ' 97' ' ' LYS . . . -51.76 -35.46 43.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.923 0.392 . . . . 0.52000000000000002 110.748 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -85.82 -3.51 58.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.947 -0.569 . . . . 2.2200000000000002 111.236 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.931 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.5 m-70 71.97 15.96 5.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.638 0.732 . . . . 0.72999999999999998 109.521 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -75.55 157.4 84.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 106.726 -1.583 . . . . 3.25 106.726 165.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.63 113.98 2.05 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 120.753 0.969 . . . . 0.85999999999999999 111.824 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.428 ' HB3' HG12 ' A' ' 20' ' ' VAL . 67.9 t80 -90.4 109.12 20.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.36 -0.836 . . . . 0.28000000000000003 109.324 170.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.9 t30 -70.93 85.66 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.613 -0.514 . . . . 1.6499999999999999 109.613 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.876 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -61.6 -29.56 70.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.629 -0.714 . . . . 0.25 111.079 -176.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.809 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 5.4 p -76.12 -0.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.425 -0.807 . . . . 0.40999999999999998 112.81 -167.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.2 pt20 -80.61 -5.53 56.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.265 0.555 . . . . 1.24 109.921 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.401 ' CG ' HG21 ' A' ' 70' ' ' THR . 83.4 m-70 -92.98 -5.7 50.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 108.324 -0.991 . . . . 0.38 108.324 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HZ3' ' HD2' ' A' ' 16' ' ' PHE . 16.6 ttmm -71.69 141.45 49.85 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.715 -1.13 . . . . 1.73 109.844 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.13 -12.87 55.66 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.895 -1.282 . . . . 0.35999999999999999 109.895 -172.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.462 ' C ' ' HA ' ' A' ' 146' ' ' ARG . 25.0 m -140.6 148.07 51.68 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 108.572 -0.899 . . . . 1.1399999999999999 108.572 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.985 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 79.5 Cg_endo -75.35 162.43 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.835 1.69 . . . . 0.52000000000000002 110.996 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.684 ' CB ' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -159.36 152.69 22.41 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 1.03 110.809 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.634 HD21 HG21 ' A' ' 163' ' ' ILE . 7.2 mp -107.38 148.41 29.12 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.996 -0.742 . . . . 1.1000000000000001 108.996 173.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 89.0 mt -134.16 119.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.152 -0.684 . . . . 0.20000000000000001 109.152 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 14.9 m-85 -104.01 130.09 51.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.615 -0.266 . . . . 0.23000000000000001 111.287 -173.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.737 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -83.79 93.8 8.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.938 -0.764 . . . . 1.28 108.938 167.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.8 m -107.13 140.32 25.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 121.438 -0.789 . . . . 0.88 113.073 -163.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 102.82 4.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.764 -1.569 . . . . 0.52000000000000002 106.764 164.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.776 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 39.0 t -74.01 94.3 2.35 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.109 0.781 . . . . 1.8400000000000001 113.109 -163.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 12.7 ttpp 65.11 45.27 3.08 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.7 -1.136 . . . . 2.4300000000000002 110.733 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.7 p -163.39 151.98 13.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 0.98999999999999999 110.334 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.96 -124.59 8.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.814 -0.707 . . . . 1.0900000000000001 113.593 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -107.19 136.89 46.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.351 0.596 . . . . 3.1600000000000001 112.142 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.561 HG22 ' CE1' ' A' ' 139' ' ' PHE . 55.2 p -116.72 94.03 4.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 1.9399999999999999 109.585 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 16.9 ttmm -78.17 41.21 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.283 -0.417 . . . . 2.0299999999999998 110.908 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.29 85.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.037 -0.602 . . . . 0.46999999999999997 112.775 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.95 -38.03 84.19 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 112.052 -0.419 . . . . 0.34000000000000002 112.052 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.599 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.6 t80 -71.74 -50.44 30.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.556 -0.322 . . . . 0.56999999999999995 110.688 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.35 -44.37 95.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.944 -0.571 . . . . 2.46 110.622 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -52.89 62.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 0.33000000000000002 110.97 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.66 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.7 -49.31 75.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.19 111.781 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -56.77 -47.15 80.78 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.967 -0.561 . . . . 0.29999999999999999 111.169 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.0 m -61.32 -48.89 79.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.627 -0.715 . . . . 1.0800000000000001 110.988 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 163' ' ' ILE . 51.5 mt -58.84 -52.04 67.42 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.244 -0.435 . . . . 0.81000000000000005 111.738 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 86.1 t80 -50.86 -52.77 38.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.527 0.517 . . . . 0.33000000000000002 110.323 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -73.76 -36.65 65.13 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.476 -0.784 . . . . 1.76 111.425 -170.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -74.93 -45.97 38.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.815 -0.629 . . . . 1.79 111.503 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.558 ' CD1' HD13 ' A' ' 171' ' ' LEU . 34.1 m-85 -101.94 -2.84 28.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 114.686 1.365 . . . . 0.42999999999999999 114.686 -168.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.635 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 13.0 ptmm? -69.18 -15.45 63.4 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.487 -0.885 . . . . 2.1099999999999999 110.346 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -60.33 -33.2 72.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 1.2 109.979 172.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -101.55 10.24 40.48 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 116.357 -0.383 . . . . 1.8999999999999999 110.878 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.612 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 90.15 80.61 1.36 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.97 -0.633 . . . . 1.3200000000000001 112.589 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.635 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 69.9 t80 -151.97 141.89 22.07 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.928 -0.16 . . . . 0.26000000000000001 110.891 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.684 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -131.93 149.74 52.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 110.021 -0.362 . . . . 0.51000000000000001 110.021 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.682 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 49.0 t -117.09 115.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.972 -0.381 . . . . 0.23999999999999999 109.972 172.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 18.4 mt -102.11 121.95 43.2 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.932 -0.766 . . . . 0.51000000000000001 108.932 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.995 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -110.9 114.25 27.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.096 0.474 . . . . 0.28000000000000003 110.656 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.769 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-85 -98.66 112.61 62.98 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 109.075 -0.713 . . . . 0.34000000000000002 109.075 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.908 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 46.3 Cg_exo -57.89 167.78 3.95 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.278 2.652 . . . . 0.72999999999999998 112.042 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.435 -1.184 0 C-N-CA 120.027 -0.669 . . . . 1.54 110.911 -178.22 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 108.992 -0.744 . . . . 0.91000000000000003 108.992 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.3 t -158.96 120.27 3.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.926 -1.034 . . . . 1.9199999999999999 109.368 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 23' ' ' ALA . 42.7 mttp 45.86 86.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.222 0.823 . . . . 3.1800000000000002 113.222 172.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.704 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 49.8 p90 -64.58 -20.87 66.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.657 -0.497 . . . . 1.74 109.657 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 66.45 136.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.736 -1.12 . . . . 3.0800000000000001 111.424 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -165.06 -178.4 5.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.705 -0.68 . . . . 0.42999999999999999 110.881 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -88.32 32.84 0.75 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.657 -0.702 . . . . 2.1899999999999999 110.566 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.688 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.4 p90 -152.0 161.75 28.55 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.114 -1.069 . . . . 0.23999999999999999 108.114 175.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.9 Cg_exo -64.85 107.94 0.99 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 123.53 2.82 . . . . 0.31 114.189 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.995 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.3 mp -101.39 131.88 48.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.892 -0.781 . . . . 0.37 108.892 171.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.769 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.7 mmt -110.03 -151.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.924 0.712 . . . . 1.47 112.924 -162.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.495 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -75.14 144.58 42.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.391 -0.822 . . . . 0.39000000000000001 110.778 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.908 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 22.2 pttt -83.45 131.89 35.0 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.659 0.742 . . . . 1.6599999999999999 109.775 169.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' A' ' 116' ' ' HIS . 2.3 pt -136.59 159.22 37.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.78 -1.563 . . . . 0.46999999999999997 106.78 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.908 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -70.65 95.45 1.1 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.904 -0.718 . . . . 2.1600000000000001 109.163 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.716 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -87.43 83.11 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.262 -0.975 . . . . 0.38 109.065 175.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.0 t-20 171.52 -178.5 0.05 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.367 -0.975 . . . . 1.98 108.367 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 53.2 -147.92 15.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 114.677 0.631 . . . . 0.78000000000000003 114.677 160.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.42 2.23 28.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.15 -0.525 . . . . 1.98 111.096 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.56 -3.46 36.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.253 -0.43 . . . . 2.04 110.92 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.908 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -46.53 139.3 5.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.189 -0.914 . . . . 0.47999999999999998 113.34 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.606 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 54.1 t-80 -51.31 137.31 29.81 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.259 -0.882 . . . . 0.41999999999999998 110.376 171.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.565 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -44.04 -46.5 11.04 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.114 2.542 . . . . 0.35999999999999999 112.526 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.657 HD11 ' HE3' ' A' ' 122' ' ' MET . 20.9 tp -58.63 -41.89 86.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.842 -0.617 . . . . 1.1000000000000001 111.762 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.487 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 3.7 m-85 -74.5 -29.98 61.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 119.561 -0.257 . . . . 1.49 110.781 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 41.5 mt-10 -56.54 -43.59 80.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.645 -0.872 . . . . 2.3700000000000001 108.645 169.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 84.0 t80 -65.96 -46.57 77.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.54 0.525 . . . . 0.57999999999999996 110.745 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.657 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.4 mtt -62.72 -51.72 66.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.212 -0.449 . . . . 0.34000000000000002 111.02 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.563 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 34.7 mtpt -60.75 -45.24 95.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.93999999999999995 110.949 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.4 ptmt -68.69 -33.49 74.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.266 -0.425 . . . . 2.1299999999999999 111.299 -176.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.48 HG21 ' HD2' ' A' ' 150' ' ' PRO . 93.7 m -74.02 -50.28 20.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.072 -0.513 . . . . 0.46999999999999997 111.85 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 6.1 tmtt? . . . . . 0 C--N 1.325 -0.467 0 C-N-CA 120.682 -0.407 . . . . 1.75 111.437 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.784 0.326 . . . . 0.93000000000000005 110.477 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.861 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 17.6 mt -76.84 161.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.069 -1.086 . . . . 1.05 108.069 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -178.02 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.925 0.784 . . . . 1.5 112.146 -176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.861 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.52 165.8 11.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.269 -0.423 . . . . 0.87 112.09 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -48.33 -154.41 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 126.083 1.753 . . . . 1.8 113.817 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.815 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.2 m-85 -28.49 -45.64 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 115.273 1.583 . . . . 1.3700000000000001 115.273 -163.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.96 HG23 ' HA ' ' A' ' 155' ' ' SER . 15.9 m 30.29 109.89 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.38 1.622 . . . . 0.29999999999999999 115.38 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.0 p -93.56 156.52 16.68 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.27 0.557 . . . . 0.80000000000000004 111.09 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 6.2 m-85 -102.43 166.47 10.53 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.018 -1.475 . . . . 0.53000000000000003 107.018 163.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.758 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 49.8 tp -112.83 104.77 12.78 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.763 -0.829 . . . . 0.51000000000000001 108.763 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.851 HG21 HD13 ' A' ' 15' ' ' ILE . 11.9 mm -103.05 125.22 57.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 109.11 -0.7 . . . . 0.20000000000000001 109.11 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -77.86 -176.35 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.8 -0.36 . . . . 1.3 111.684 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.694 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 76.6 mtp180 -57.41 -24.4 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.626 0.602 . . . . 3.7799999999999998 112.626 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.52 -12.43 14.69 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.868 -0.733 . . . . 1.1799999999999999 110.494 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.542 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 109.24 34.35 2.54 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.814 -0.708 . . . . 0.23000000000000001 113.059 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 57.9 t -107.85 128.33 26.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.859 -0.423 . . . . 0.62 109.859 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.48 ' HD2' HG21 ' A' ' 125' ' ' THR . 4.8 Cg_exo -75.4 112.04 3.44 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.362 2.041 . . . . 0.29999999999999999 111.24 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.524 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 41.1 t -93.54 -23.94 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.27000000000000002 110.944 -177.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 1.2 mm-40 -156.65 166.11 34.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 1.22 111.042 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.563 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 27.5 ttm180 -131.05 96.55 4.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.905 -0.776 . . . . 1.75 108.905 172.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.758 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 77.3 m-85 -82.42 110.07 17.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.38 109.519 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.96 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.4 m -61.85 168.4 3.61 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.879 -0.415 . . . . 0.98999999999999999 109.879 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.807 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 36.1 Cg_endo -60.93 -28.16 85.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.629 1.553 . . . . 0.66000000000000003 111.462 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.49 66.33 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.317 -1.31 . . . . 0.52000000000000002 112.681 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.64 112.03 6.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 110.045 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.7 m -74.81 174.66 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.895 -0.593 . . . . 1.25 110.828 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 69.0 t -48.59 -53.37 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.343 -0.389 . . . . 0.40999999999999998 111.679 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -66.17 -32.13 73.38 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.278 -0.419 . . . . 3.4399999999999999 111.498 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -63.71 -32.57 74.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.418 -0.586 . . . . 1.8600000000000001 109.418 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.634 HG21 HD21 ' A' ' 39' ' ' LEU . 63.2 mt -83.68 -39.83 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.322 -0.854 . . . . 0.20999999999999999 111.12 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.4 mt-10 -51.44 -44.14 62.25 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.234 0.457 . . . . 0.88 112.234 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.9 pt-20 -53.79 -33.57 56.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.123 0.416 . . . . 0.75 112.123 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.751 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtm -102.18 -19.08 15.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.918 0.39 . . . . 1.5800000000000001 111.007 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.6 tp -84.14 -45.53 12.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 0.23999999999999999 111.349 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.76 ' HA ' HD12 ' A' ' 171' ' ' LEU . 74.3 mt -53.5 -48.11 94.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.281 0.474 . . . . 0.44 112.281 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.9 Cg_exo -53.54 -37.32 82.64 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.067 1.844 . . . . 0.48999999999999999 112.7 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.3 mt -78.87 -35.86 43.1 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 111.95 0.352 . . . . 0.70999999999999996 111.95 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.985 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 11.4 mt -55.51 -54.15 47.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.744 0.783 . . . . 0.46000000000000002 108.933 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.03 -45.74 94.77 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.211 -1.359 . . . . 1.52 113.539 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 CA--C 1.535 0.373 0 CA-C-N 117.835 0.817 . . . . 2.52 113.07 -172.467 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 108.516 -0.92 . . . . 1.6799999999999999 108.516 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.0 p -135.37 178.34 7.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.159 -0.928 . . . . 0.65000000000000002 109.494 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.71 HD13 HG21 ' A' ' 144' ' ' ILE . 21.4 pt -62.99 -26.42 40.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.241 0.543 . . . . 0.29999999999999999 110.632 175.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.793 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 45.7 m-85 -76.94 -6.06 51.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.8 -0.637 . . . . 0.27000000000000002 112.306 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -82.37 7.33 14.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.448 0.642 . . . . 1.96 109.352 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 89.2 m-85 -119.56 169.97 9.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.103 -0.953 . . . . 0.40000000000000002 110.051 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.7 tt0 -98.01 151.49 20.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.312 -0.404 . . . . 2.77 110.513 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 28' ' ' TYR . 72.6 t -130.46 136.29 58.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.011 0.434 . . . . 0.73999999999999999 110.507 172.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.729 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 96.4 mt -101.63 140.42 35.95 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.126 -0.694 . . . . 0.71999999999999997 109.126 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 -172.72 3.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.238 -0.653 . . . . 1.5900000000000001 109.238 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.46 66.35 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.779 0.323 . . . . 0.52000000000000002 111.229 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 20.3 t70 -88.93 -12.16 42.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.192 -0.458 . . . . 2.2200000000000002 111.191 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.729 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 38.7 m-70 82.59 23.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 123.599 0.76 . . . . 0.72999999999999998 110.399 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -85.43 154.18 59.35 Favored Pre-proline 0 N--CA 1.443 -0.802 0 N-CA-C 105.693 -1.965 . . . . 3.25 105.693 165.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.68 114.38 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.812 0.969 . . . . 0.85999999999999999 111.904 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.578 ' HB3' HG12 ' A' ' 20' ' ' VAL . 75.3 t80 -86.74 111.25 20.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.407 -0.815 . . . . 0.28000000000000003 109.194 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.703 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 57.5 t30 -68.83 86.38 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.216 0.532 . . . . 1.6499999999999999 109.936 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.793 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -61.38 -35.96 78.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 0.25 111.378 -174.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 13.5 p -76.54 1.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.003 0.742 . . . . 0.40999999999999998 113.003 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.703 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.5 pt20 -74.73 -5.86 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.174 -0.954 . . . . 1.24 108.997 168.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -98.42 2.71 48.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.212 -1.033 . . . . 0.38 108.212 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 21.1 ttpt -81.07 142.46 33.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.848 -1.069 . . . . 1.73 109.642 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.06 79.48 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.804 -1.319 . . . . 0.35999999999999999 109.804 -170.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.645 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 16.3 m -132.54 146.87 63.32 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 114.111 -1.045 . . . . 1.1399999999999999 108.293 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.859 ' HG2' HD23 ' A' ' 171' ' ' LEU . 1.2 Cg_endo -79.56 149.58 21.29 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.737 1.625 . . . . 0.52000000000000002 110.238 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.1 pt? -151.93 149.91 29.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.302 0.572 . . . . 1.03 111.291 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -107.53 154.9 20.71 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.584 -0.895 . . . . 1.1000000000000001 108.584 172.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.487 HD12 HG13 ' A' ' 144' ' ' ILE . 69.4 mt -141.62 114.82 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.094 -0.706 . . . . 0.20000000000000001 109.094 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 18.1 m-85 -100.59 124.55 46.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 121.125 -0.23 . . . . 0.23000000000000001 110.78 -174.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.748 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -80.69 92.7 6.05 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.242 -0.651 . . . . 1.28 109.242 171.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.711 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 m -106.34 145.93 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 114.229 1.196 . . . . 0.88 114.229 -160.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.39 102.22 9.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.603 -1.628 . . . . 0.52000000000000002 106.603 160.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 95' ' ' CYS . 40.4 t -72.11 85.29 1.02 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 112.563 0.579 . . . . 1.8400000000000001 112.563 -165.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 17.9 tppt? 75.4 23.31 1.53 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.739 0.78 . . . . 2.4300000000000002 110.638 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.52 129.33 51.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.238 -0.437 . . . . 0.98999999999999999 110.548 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 -115.87 4.62 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.862 -0.685 . . . . 1.0900000000000001 112.7 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -139.63 166.69 23.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.271 0.558 . . . . 3.1600000000000001 111.868 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.9 p -131.92 115.07 15.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.663 -0.699 . . . . 1.9399999999999999 110.372 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.721 ' HD2' ' HA3' ' A' ' 157' ' ' GLY . 28.0 ttmt -79.0 24.61 0.31 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.212 0.53 . . . . 2.0299999999999998 110.887 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.99 13.8 24.39 Favored Glycine 0 C--O 1.224 -0.522 0 CA-C-N 115.881 -0.6 . . . . 0.46999999999999997 112.38 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.71 -47.43 20.61 Favored Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 121.231 -0.509 . . . . 0.34000000000000002 112.175 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.649 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.7 t80 -69.67 -47.6 62.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.486 0.184 . . . . 0.56999999999999995 111.262 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -59.28 -47.11 86.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.069 0.462 . . . . 2.46 110.145 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.5 m -64.31 -45.99 85.51 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.385 -0.825 . . . . 0.33000000000000002 110.891 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.547 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.17 -49.31 76.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.979 0.419 . . . . 0.19 111.07 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.6 m -59.26 -51.3 70.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.615 -0.721 . . . . 0.29999999999999999 111.147 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 p -63.68 -39.27 93.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 1.0800000000000001 111.914 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.495 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 88.5 mt -62.48 -51.66 66.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.442 0.163 . . . . 0.81000000000000005 110.996 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.836 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 71.6 t80 -51.96 -48.86 64.12 Favored 'General case' 0 C--O 1.22 -0.45 0 O-C-N 123.752 0.657 . . . . 0.33000000000000002 109.483 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.12 -43.29 74.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.536 -0.756 . . . . 1.76 111.687 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.61 -44.79 61.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.865 -0.607 . . . . 1.79 111.391 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.749 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.1 m-85 -100.91 6.3 43.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.402 0.89 . . . . 0.42999999999999999 113.402 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 65' ' ' LYS . 7.5 mmmt -60.75 -25.17 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.987 0.422 . . . . 2.1099999999999999 110.279 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -32.76 74.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.777 -0.647 . . . . 1.2 110.69 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -98.65 17.48 19.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.994 0.426 . . . . 1.8999999999999999 110.703 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.645 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 74.78 55.52 5.35 Favored Glycine 0 C--O 1.224 -0.488 0 CA-C-N 115.64 -0.709 . . . . 1.3200000000000001 112.845 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 59.7 t80 -117.15 140.0 50.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.633 0.254 . . . . 0.26000000000000001 110.781 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -128.36 138.98 52.61 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 120.907 0.384 . . . . 0.51000000000000001 110.556 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.836 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 39.4 t -110.91 121.11 63.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.887 0.375 . . . . 0.23999999999999999 110.242 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' HE3' ' A' ' 105' ' ' MET . 21.3 mt -102.03 141.62 34.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.901 -0.778 . . . . 0.51000000000000001 108.901 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.015 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -125.98 124.75 41.43 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.11 0.481 . . . . 0.28000000000000003 110.222 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.676 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.4 m-85 -108.5 108.3 60.86 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.891 -0.595 . . . . 0.34000000000000002 109.686 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.611 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 41.7 Cg_exo -58.67 154.97 39.54 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.077 2.518 . . . . 0.72999999999999998 112.057 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.433 -1.277 0 CA-C-N 115.776 -0.647 . . . . 1.54 110.582 -177.997 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 45' ' ' SER . 21.8 m . . . . . 0 N--CA 1.441 -0.907 0 CA-C-O 121.367 0.603 . . . . 0.91000000000000003 110.758 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.409 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 8.3 t -157.07 118.47 3.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.135 -0.939 . . . . 1.9199999999999999 109.313 166.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HA ' HG21 ' A' ' 104' ' ' ILE . 27.4 mttm 70.15 -47.02 0.62 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.591 1.33 . . . . 3.1800000000000002 114.591 173.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.649 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 2.7 p90 58.04 -29.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.414 1.486 . . . . 1.74 111.548 -164.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.601 ' H ' ' C ' ' A' ' 97' ' ' LYS . 6.8 mtmt 71.51 125.47 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.245 1.018 . . . . 3.0800000000000001 111.739 170.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.547 ' HB2' ' HE1' ' A' ' 98' ' ' PHE . . . -154.02 -170.67 3.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.985 -0.552 . . . . 0.42999999999999999 112.035 -173.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.04 -6.28 58.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.732 -0.667 . . . . 2.1899999999999999 110.366 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.709 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 47.9 p90 -115.98 162.23 26.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.62 -0.882 . . . . 0.23999999999999999 108.62 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.794 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 37.8 Cg_exo -66.95 123.39 10.91 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 123.892 3.062 . . . . 0.31 113.675 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.015 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -112.3 148.85 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.291 -0.633 . . . . 0.37 109.291 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.794 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 9.2 mmt -120.36 -154.75 0.59 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.447 0.906 . . . . 1.47 113.447 -164.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.462 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -69.42 154.07 42.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.667 -1.151 . . . . 0.39000000000000001 111.141 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.598 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 72.0 mttt -80.99 112.5 18.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.271 -0.64 . . . . 1.6599999999999999 109.271 174.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.41 HG13 HG13 ' A' ' 110' ' ' VAL . 30.9 pt -121.39 149.58 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.224 -1.028 . . . . 0.46999999999999997 108.224 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.7 t30 -81.74 60.51 4.69 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.831 -0.348 . . . . 2.1600000000000001 110.384 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -56.38 94.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 116.575 -0.284 . . . . 0.38 110.912 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.818 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER 175.43 178.55 0.16 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 110.207 -0.294 . . . . 1.98 110.207 175.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.91 -123.2 0.15 Allowed Glycine 0 C--N 1.334 0.438 0 O-C-N 125.115 1.509 . . . . 0.78000000000000003 115.192 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -107.01 -6.09 17.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 1.98 110.662 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -95.19 -6.9 40.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.386 -0.825 . . . . 2.04 112.308 -170.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB2' ' H ' ' A' ' 111' ' ' ASN . . . -57.56 146.38 30.4 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.214 0.82 . . . . 0.47999999999999998 113.214 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.476 ' HE1' ' O ' ' A' ' 19' ' ' GLU . 26.5 t-80 -50.56 141.06 17.68 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.242 -0.89 . . . . 0.41999999999999998 109.803 169.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 8.7 Cg_endo -51.08 -37.96 58.78 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.254 2.636 . . . . 0.35999999999999999 112.523 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.523 HD11 ' HE3' ' A' ' 122' ' ' MET . 14.6 tp -54.85 -45.38 74.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.119 0.485 . . . . 1.1000000000000001 111.074 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.489 ' CG ' HG12 ' A' ' 110' ' ' VAL . 3.3 m-85 -73.95 -28.1 61.33 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 116.079 -0.51 . . . . 1.49 110.974 176.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 39.7 mt-10 -56.23 -38.38 70.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.838 -0.745 . . . . 2.3700000000000001 109.468 168.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 76.2 t80 -69.95 -47.01 64.04 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.568 -0.453 . . . . 0.57999999999999996 110.488 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.523 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.9 mtt -61.48 -55.23 33.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.294 -0.412 . . . . 0.34000000000000002 111.241 -178.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 27.6 mtpt -58.59 -43.66 89.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.93999999999999995 111.411 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 15.0 ptmm? -70.1 -33.91 72.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 2.1299999999999999 111.077 -176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.576 HG21 ' HD2' ' A' ' 150' ' ' PRO . 90.2 m -65.65 -46.56 78.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.394 -0.366 . . . . 0.46999999999999997 111.105 -176.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.631 ' HD3' ' HA ' ' A' ' 152' ' ' GLU . 27.9 tttm . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 1.75 109.95 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.346 0 CA-C-O 120.306 0.098 . . . . 0.93000000000000005 111.079 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.868 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 30.6 mm -70.13 161.95 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.512 -0.922 . . . . 1.05 108.512 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -177.42 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.748 0.785 . . . . 1.5 110.334 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.868 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -95.64 171.41 8.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.731 -1.122 . . . . 0.87 111.717 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.424 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 18.5 m120 -48.13 -156.57 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.36 -1.746 . . . . 1.8 113.789 170.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 4.5 m-85 -29.32 -57.91 0.15 Allowed 'General case' 0 C--O 1.202 -1.428 0 C-N-CA 125.166 1.387 . . . . 1.3700000000000001 114.588 -165.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.938 HG23 ' HA ' ' A' ' 155' ' ' SER . 10.0 m 44.48 106.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.309 1.225 . . . . 0.29999999999999999 114.309 177.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 11.9 p -89.55 149.13 23.01 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.358 -0.839 . . . . 0.80000000000000004 111.458 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 14.3 m-85 -103.76 133.4 48.81 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.147 -1.057 . . . . 0.53000000000000003 108.147 163.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.794 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 16.3 tp -82.52 105.26 13.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.44 -0.578 . . . . 0.51000000000000001 109.44 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.71 HG21 HD13 ' A' ' 15' ' ' ILE . 10.6 mm -105.03 126.97 59.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.409 -0.589 . . . . 0.20000000000000001 109.409 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 16.9 p30 -79.57 -175.16 4.64 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.837 -0.345 . . . . 1.3 111.47 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 36' ' ' SER . 91.8 mtt180 -64.54 -12.81 48.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.507 0.558 . . . . 3.7799999999999998 112.507 -176.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -109.73 -13.46 14.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.41 0.624 . . . . 1.1799999999999999 109.326 -170.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.407 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 100.52 28.07 7.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.175 -0.921 . . . . 0.23000000000000001 112.729 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.431 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 61.7 t -110.77 128.0 26.04 Favored Pre-proline 0 C--N 1.317 -0.839 0 O-C-N 122.538 -0.389 . . . . 0.62 110.388 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.576 ' HD2' HG21 ' A' ' 125' ' ' THR . 10.6 Cg_exo -68.94 106.09 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.97 2.447 . . . . 0.29999999999999999 112.174 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.3 t -89.41 -16.33 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 0.27000000000000002 110.589 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.631 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 5.2 mm-40 -160.73 165.67 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 1.22 110.717 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -137.56 98.28 3.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.94 -0.573 . . . . 1.75 109.531 170.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.794 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.3 m-85 -88.49 113.02 23.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.38 109.745 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.938 ' HA ' HG23 ' A' ' 140' ' ' THR . 3.8 m -64.56 166.14 12.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 109.775 -0.454 . . . . 0.98999999999999999 109.775 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.822 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 33.8 Cg_endo -65.34 -8.26 18.28 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.695 2.264 . . . . 0.66000000000000003 113.061 -165.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.721 ' HA3' ' HD2' ' A' ' 51' ' ' LYS . . . -93.24 3.25 72.43 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.433 -0.803 . . . . 0.52000000000000002 112.882 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.47 139.97 37.46 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.182 -0.303 . . . . 0.42999999999999999 110.182 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 94.7 p -83.58 171.11 13.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.25 111.034 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.7 t -55.52 -48.27 77.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.684 -0.487 . . . . 0.40999999999999998 109.684 175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -63.74 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.806 . . . . 3.4399999999999999 110.9 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.06 -37.73 69.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.95 -0.568 . . . . 1.8600000000000001 110.313 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.553 HG21 HD21 ' A' ' 39' ' ' LEU . 67.5 mt -82.51 -41.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 0.20999999999999999 111.399 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 52.0 mt-10 -56.37 -40.02 73.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.147 0.425 . . . . 0.88 112.147 -176.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 10.0 pt-20 -59.77 -22.71 62.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.821 0.304 . . . . 0.75 111.821 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.7 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.8 mmtp -107.23 -19.88 13.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.104 0.478 . . . . 1.5800000000000001 110.262 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.658 ' HG ' HD11 ' A' ' 171' ' ' LEU . 58.2 tp -84.73 -42.44 15.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.23999999999999999 111.32 -174.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.693 ' HA ' HD12 ' A' ' 171' ' ' LEU . 81.9 mt -53.24 -47.44 95.97 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.16 0.43 . . . . 0.44 112.16 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.5 Cg_exo -55.29 -23.28 36.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.624 2.216 . . . . 0.48999999999999999 113.327 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 mt -92.65 -40.31 10.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.634 0.254 . . . . 0.70999999999999996 110.964 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.859 HD23 ' HG2' ' A' ' 37' ' ' PRO . 10.7 mt -60.39 -48.51 81.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.092 -0.707 . . . . 0.46000000000000002 109.092 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.92 52.5 2.87 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.699 -1.137 . . . . 1.52 113.057 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 124.991 1.316 . . . . 2.52 113.594 177.078 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.747 0.308 . . . . 1.6799999999999999 111.138 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.0 p -171.69 -176.96 1.88 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.292 -0.633 . . . . 0.65000000000000002 109.292 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.764 HD13 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -62.34 -26.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.138 0.494 . . . . 0.29999999999999999 110.448 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.899 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 44.0 m-85 -79.02 -1.59 36.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.777 -0.647 . . . . 0.27000000000000002 111.556 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.27 -16.1 61.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.443 -0.947 . . . . 1.96 108.443 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 47.5 m-85 -105.63 177.81 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.579 -1.191 . . . . 0.40000000000000002 109.658 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -126.13 148.47 49.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.692 0.282 . . . . 2.77 110.722 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG23 HD13 ' A' ' 30' ' ' LEU . 70.0 t -117.35 148.17 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.73999999999999999 111.33 -175.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 92.7 mt -102.82 137.73 40.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 0.71999999999999997 109.656 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 23' ' ' ALA . 19.7 t70 -72.98 -174.97 1.63 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.035 -0.728 . . . . 1.5900000000000001 109.035 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.424 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -55.48 -34.15 64.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.042 0.449 . . . . 0.52000000000000002 111.139 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 27.5 m-20 -93.82 3.03 56.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 2.2200000000000002 111.186 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.97 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 35.1 m-70 72.91 14.53 4.81 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.276 0.63 . . . . 0.72999999999999998 110.292 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 10.4 mtmt -66.76 144.34 98.53 Favored Pre-proline 0 CA--C 1.511 -0.519 0 N-CA-C 106.252 -1.759 . . . . 3.25 106.252 163.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.81 113.76 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 CA-C-N 119.809 0.967 . . . . 0.85999999999999999 111.136 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.423 ' HB3' HG12 ' A' ' 20' ' ' VAL . 69.2 t80 -87.53 108.84 19.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.375 -0.83 . . . . 0.28000000000000003 109.124 172.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.65 ' OD1' HG12 ' A' ' 31' ' ' VAL . 62.6 t30 -66.57 95.59 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.132 -0.692 . . . . 1.6499999999999999 109.132 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.899 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.88 -30.23 67.63 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.627 -0.715 . . . . 0.25 110.611 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.687 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -76.93 -4.06 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 0.40999999999999998 112.843 -166.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 27.8 pt20 -79.02 -4.99 52.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.565 0.698 . . . . 1.24 109.396 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.531 ' ND1' HG21 ' A' ' 70' ' ' THR . 84.8 m-70 -97.67 2.38 49.68 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.368 -0.975 . . . . 0.38 108.368 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -78.62 145.6 34.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.111 -0.95 . . . . 1.73 108.951 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.58 87.29 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.904 -1.278 . . . . 0.35999999999999999 109.904 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -132.27 133.05 23.31 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.64 -0.874 . . . . 1.1399999999999999 108.64 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.934 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 36.4 Cg_endo -69.56 146.02 60.16 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.305 1.337 . . . . 0.52000000000000002 109.803 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.566 ' CD2' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -150.77 161.13 43.23 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.495 0.665 . . . . 1.03 111.743 -175.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.794 HD21 HG21 ' A' ' 163' ' ' ILE . 6.5 mp -111.96 154.01 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.977 -1.011 . . . . 1.1000000000000001 108.671 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 94.5 mt -140.54 115.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.291 -0.633 . . . . 0.20000000000000001 109.291 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.862 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 34.4 m-85 -99.72 123.4 43.94 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 121.047 -0.261 . . . . 0.23000000000000001 111.165 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.821 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.7 OUTLIER -80.41 91.56 5.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.197 -1.038 . . . . 1.28 108.197 167.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.4 p -116.11 137.7 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.733 1.012 . . . . 0.88 113.733 -162.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.08 108.85 1.96 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.267 -1.012 . . . . 0.52000000000000002 108.267 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.962 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 17.8 t -75.68 84.02 2.68 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.278 0.473 . . . . 1.8400000000000001 112.278 -169.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.696 ' HG3' ' HB2' ' A' ' 98' ' ' PHE . 52.2 mttm 73.15 29.92 1.66 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.18 -0.918 . . . . 2.4300000000000002 112.328 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -133.04 128.87 37.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.348 -0.612 . . . . 0.98999999999999999 109.348 174.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.93 -129.39 9.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.441 -0.885 . . . . 1.0900000000000001 113.387 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.33 161.82 26.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.011 0.91 . . . . 3.1600000000000001 113.353 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 t -125.22 154.0 42.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.387 -1.279 . . . . 1.9399999999999999 108.286 168.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -119.08 20.84 12.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.573 0.701 . . . . 2.0299999999999998 109.345 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.98 16.27 6.87 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 114.846 -1.07 . . . . 0.46999999999999997 111.584 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.21 -54.25 4.14 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.935 -0.466 . . . . 0.34000000000000002 111.935 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.654 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.4 t80 -65.92 -45.7 80.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.976 0.417 . . . . 0.56999999999999995 110.592 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -62.36 -46.63 87.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 2.46 110.541 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.465 ' CG2' HD12 ' A' ' 163' ' ' ILE . 98.5 m -67.75 -41.46 83.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.169 -0.468 . . . . 0.33000000000000002 110.859 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.728 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.13 -47.78 84.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.19 111.235 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 m -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.945 -0.571 . . . . 0.29999999999999999 111.125 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 p -62.54 -48.38 79.76 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.852 -0.613 . . . . 1.0800000000000001 111.203 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.05 -46.49 88.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 0.81000000000000005 111.596 -177.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.725 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 46.3 t80 -50.93 -58.71 5.32 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 123.389 0.43 . . . . 0.33000000000000002 110.595 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.571 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 91.9 m-20 -73.02 -30.61 63.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.076 0.399 . . . . 1.76 112.076 -173.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.8 -27.26 50.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.211 -0.45 . . . . 1.79 111.329 -174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.774 ' CD1' HD13 ' A' ' 171' ' ' LEU . 65.8 m-85 -122.17 5.2 9.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.687 0.995 . . . . 0.42999999999999999 113.687 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 35.3 mtmt -58.79 -28.92 66.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.983 0.421 . . . . 2.1099999999999999 110.33 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.0 p -61.12 -40.01 92.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.636 -0.711 . . . . 1.2 110.928 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -90.48 12.12 19.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 1.8999999999999999 110.761 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.673 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.49 71.5 1.25 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.79 -0.641 . . . . 1.3200000000000001 112.133 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CE1' HD13 ' A' ' 39' ' ' LEU . 74.0 t80 -140.67 141.82 34.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.657 0.265 . . . . 0.26000000000000001 110.968 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.531 HG21 ' ND1' ' A' ' 33' ' ' HIS . 8.8 t -131.96 142.88 49.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.224 0.535 . . . . 0.51000000000000001 110.433 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.728 HG11 ' HB1' ' A' ' 57' ' ' ALA . 24.7 t -105.24 119.64 54.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.894 0.378 . . . . 0.23999999999999999 110.073 170.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.663 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 12.3 mt -104.69 128.06 52.64 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.891 -0.781 . . . . 0.51000000000000001 108.891 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -114.52 121.3 43.08 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.309 -0.556 . . . . 0.28000000000000003 110.878 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.672 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -105.42 108.75 62.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.878 -0.786 . . . . 0.34000000000000002 108.878 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.962 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 50.9 Cg_exo -56.4 164.76 5.06 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.979 2.453 . . . . 0.72999999999999998 111.56 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.437 -1.086 0 C-N-CA 119.031 -1.068 . . . . 1.54 113.046 -176.339 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 45' ' ' SER . 12.7 m . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.22 0.534 . . . . 0.91000000000000003 110.654 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -152.85 118.39 5.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.474 -0.784 . . . . 1.9199999999999999 109.807 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HG3' ' HE3' ' A' ' 99' ' ' LYS . 15.0 pttm 23.86 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.098 1.359 . . . . 3.1800000000000002 114.634 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.696 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -57.01 120.18 7.55 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.005 -1.85 . . . . 1.74 106.005 168.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HE3' ' HG3' ' A' ' 97' ' ' LYS . 9.3 mptt -79.44 164.44 23.97 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.702 -0.799 . . . . 3.0800000000000001 111.195 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.621 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -172.67 -175.41 1.3 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.08 0.863 . . . . 0.42999999999999999 110.969 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.62 0.9 55.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 2.1899999999999999 110.903 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.685 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 49.9 p90 -121.36 168.4 11.17 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.655 -0.868 . . . . 0.23999999999999999 108.655 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.914 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.6 Cg_exo -69.95 116.92 4.8 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.505 2.803 . . . . 0.31 113.239 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.969 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.5 mp -109.01 140.22 28.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.934 -0.765 . . . . 0.37 108.934 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.914 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.8 mmt -113.68 -153.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.371 0.605 . . . . 1.47 112.488 -164.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.603 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.76 144.22 45.73 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.036 -0.983 . . . . 0.39000000000000001 110.477 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.942 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.7 pttp -80.67 127.77 32.86 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.652 -0.87 . . . . 1.6599999999999999 108.652 169.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.626 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -131.86 169.4 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.049 -1.463 . . . . 0.46999999999999997 107.049 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.802 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.5 m120 -72.43 118.82 15.81 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.467 -0.938 . . . . 2.1600000000000001 108.467 172.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.714 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -116.97 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 119.453 -0.899 . . . . 0.38 108.914 168.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 13.2 t-20 171.61 178.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.911 -1.144 . . . . 1.98 107.911 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.09 -140.38 12.23 Favored Glycine 0 N--CA 1.448 -0.561 0 O-C-N 123.645 0.59 . . . . 0.78000000000000003 114.321 163.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -104.84 -2.62 24.51 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.9 -0.65 . . . . 1.98 110.254 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.06 -21.31 26.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.512 -0.767 . . . . 2.04 110.646 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.802 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.05 137.65 0.66 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.213 1.19 . . . . 0.47999999999999998 114.213 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.585 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 56.6 t-80 -49.79 139.09 16.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.233 -0.894 . . . . 0.41999999999999998 110.797 172.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -41.87 -49.73 5.43 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.193 2.595 . . . . 0.35999999999999999 112.938 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.585 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -55.91 -38.32 70.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.102 -0.499 . . . . 1.1000000000000001 112.138 177.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.431 ' OH ' HG22 ' A' ' 40' ' ' ILE . 3.5 m-85 -75.97 -30.0 58.46 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 122.35 -0.219 . . . . 1.49 111.003 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.7 mt-10 -57.64 -35.27 70.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.025 -0.731 . . . . 2.3700000000000001 109.025 169.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.9 t80 -71.38 -48.4 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.57999999999999996 110.309 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.529 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 67.5 mtt -63.09 -53.09 59.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.999 -0.546 . . . . 0.34000000000000002 111.624 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -56.72 -46.43 81.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.539 . . . . 0.93999999999999995 111.003 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -67.46 -32.29 73.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 2.1299999999999999 111.039 -176.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.526 HG21 ' HD2' ' A' ' 150' ' ' PRO . 93.0 m -72.76 -63.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 0.46999999999999997 111.828 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.597 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 5.4 tmtt? . . . . . 0 C--N 1.324 -0.509 0 C-N-CA 120.924 -0.31 . . . . 1.75 110.843 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.702 0.286 . . . . 0.93000000000000005 111.164 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.79 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 29.4 mm -76.02 170.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 108.809 -0.811 . . . . 1.05 108.809 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 135' ' ' ILE . 11.9 ptpt 177.47 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.609 0.718 . . . . 1.5 110.52 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.79 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.76 169.76 9.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.071 -0.968 . . . . 0.87 112.261 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.4 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 22.0 m120 -48.91 -155.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.219 1.808 . . . . 1.8 113.959 172.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.862 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 22.8 m-85 -26.7 -58.43 0.09 Allowed 'General case' 0 C--O 1.205 -1.243 0 C-N-CA 125.419 1.488 . . . . 1.3700000000000001 113.929 -163.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.821 ' HB ' HD21 ' A' ' 42' ' ' ASN . 22.5 m 40.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.33 0.863 . . . . 0.29999999999999999 113.33 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 18.9 p -85.57 148.38 25.96 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.004 -0.678 . . . . 0.80000000000000004 110.685 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 11.6 m-85 -102.34 130.34 49.05 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.036 -1.098 . . . . 0.53000000000000003 108.036 167.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.802 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.4 tp -80.99 106.17 12.78 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.976 -0.75 . . . . 0.51000000000000001 108.976 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.764 HG21 HD13 ' A' ' 15' ' ' ILE . 10.1 mm -105.06 128.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.442 -0.947 . . . . 0.20000000000000001 108.442 -175.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.446 ' HB2' HD12 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -76.95 -176.16 3.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.756 0.312 . . . . 1.3 110.884 -174.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.704 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 64.3 mtp180 -68.1 -6.48 23.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 3.7799999999999998 111.804 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -109.97 -21.13 12.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.501 0.667 . . . . 1.1799999999999999 109.528 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.513 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 102.98 32.96 4.49 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.967 -1.015 . . . . 0.23000000000000001 112.848 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.8 t -111.55 129.0 24.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.523 -0.547 . . . . 0.62 109.523 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.526 ' HD2' HG21 ' A' ' 125' ' ' THR . 15.0 Cg_exo -64.39 109.92 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.376 2.051 . . . . 0.29999999999999999 111.612 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.597 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 11.4 t -92.55 -22.09 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 0.27000000000000002 110.351 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.3 mm-40 -153.75 163.99 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.262 0.554 . . . . 1.22 111.276 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.445 ' HD3' ' HH2' ' A' ' 137' ' ' TRP . 26.0 ttm180 -134.02 97.71 3.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.019 -0.991 . . . . 1.75 108.766 172.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.802 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 46.9 m-85 -90.84 113.75 25.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.057 -0.72 . . . . 0.38 109.057 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.741 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.7 m -62.0 173.51 0.87 Allowed Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 110.011 -0.366 . . . . 0.98999999999999999 110.011 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.723 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 54.0 Cg_endo -64.54 -14.42 44.32 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.693 1.596 . . . . 0.66000000000000003 111.157 -174.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.54 2.41 82.56 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.466 -1.243 . . . . 0.52000000000000002 112.132 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.32 127.39 32.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.816 0.341 . . . . 0.42999999999999999 110.547 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -178.9 5.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.126 -0.488 . . . . 1.25 110.589 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.439 ' HA ' HG23 ' A' ' 56' ' ' THR . 49.1 t -55.05 -58.87 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.40999999999999998 112.021 -175.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 162' ' ' ASP . 4.0 ptmm? -66.49 -28.32 68.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 3.4399999999999999 110.988 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 161' ' ' LYS . 62.3 m-20 -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 1.8600000000000001 110.237 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.794 HG21 HD21 ' A' ' 39' ' ' LEU . 55.1 mt -82.54 -44.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.832 -0.622 . . . . 0.20999999999999999 110.369 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.5 ' O ' HG13 ' A' ' 168' ' ' ILE . 61.2 mt-10 -56.45 -40.12 74.29 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 112.162 0.43 . . . . 0.88 112.162 -176.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.36 -20.93 47.86 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.012 0.375 . . . . 0.75 112.012 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.637 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 63.1 mmtt -105.4 -25.71 12.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.587 0.232 . . . . 1.5800000000000001 110.456 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 44.4 tp -85.78 -34.73 21.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.23999999999999999 112.036 -169.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.719 ' HA ' HD12 ' A' ' 171' ' ' LEU . 81.4 mt -50.37 -48.03 81.85 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.271 0.471 . . . . 0.44 112.271 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 75.2 Cg_exo -51.81 -38.49 67.61 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.253 1.969 . . . . 0.48999999999999999 113.335 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 2.2 mm? -74.07 -42.45 60.17 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 121.076 -0.25 . . . . 0.70999999999999996 111.036 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.934 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 9.7 mt -57.06 -46.4 82.51 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.2 -0.667 . . . . 0.46000000000000002 109.2 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -50.8 -73.54 0.37 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.709 -1.132 . . . . 1.52 111.943 168.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 22.9 t . . . . . 0 N--CA 1.467 0.397 0 C-N-CA 122.668 0.387 . . . . 2.52 110.536 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.053 0.454 . . . . 1.6799999999999999 110.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.8 p -153.2 173.36 15.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 0.65000000000000002 109.199 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.792 HD13 HG21 ' A' ' 144' ' ' ILE . 25.9 pt -56.0 -32.3 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.29999999999999999 111.583 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.809 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 47.4 m-85 -71.17 -14.31 62.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.27000000000000002 111.97 -172.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -69.6 -15.02 63.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.312 0.577 . . . . 1.96 109.655 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 86.2 m-85 -103.66 174.13 6.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.342 -0.844 . . . . 0.40000000000000002 111.528 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 10.5 tt0 -91.74 152.09 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.21 -0.904 . . . . 2.77 110.895 -177.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.609 HG12 ' HB3' ' A' ' 28' ' ' TYR . 93.7 t -138.78 145.45 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.119 0.485 . . . . 0.73999999999999999 110.413 169.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.924 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 69.3 mt -119.91 148.12 43.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.706 -0.679 . . . . 0.71999999999999997 109.472 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.66 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 14.5 t70 -78.88 -173.96 3.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.917 -0.771 . . . . 1.5900000000000001 108.917 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.675 ' HB1' ' HG2' ' A' ' 97' ' ' LYS . . . -52.76 -27.0 15.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.338 0.496 . . . . 0.52000000000000002 112.338 -172.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.86 25.0 10.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.289 0.477 . . . . 2.2200000000000002 112.289 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.924 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 46.0 m-70 72.38 9.2 5.82 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 121.658 0.742 . . . . 0.72999999999999998 110.538 171.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.66 ' HE3' ' HB3' ' A' ' 22' ' ' ASP . 23.9 mtmt -64.25 135.64 96.42 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 106.811 -1.551 . . . . 3.25 106.811 165.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.61 114.17 1.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.208 1.272 . . . . 0.85999999999999999 112.226 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.609 ' HB3' HG12 ' A' ' 20' ' ' VAL . 46.3 t80 -93.61 110.06 21.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.495 -0.775 . . . . 0.28000000000000003 111.011 175.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.556 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.6 t30 -71.5 93.26 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.136 -0.69 . . . . 1.6499999999999999 109.136 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.794 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.17 -27.77 65.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.019 -0.537 . . . . 0.25 111.261 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.809 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.7 p -76.73 -1.47 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 113.181 0.808 . . . . 0.40999999999999998 113.181 -166.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 26.8 pt20 -78.13 -5.39 51.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.319 0.58 . . . . 1.24 109.65 172.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.35 4.58 53.25 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HE3' ' CG2' ' A' ' 31' ' ' VAL . 31.1 ttmt -78.61 146.64 34.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.289 -0.869 . . . . 1.73 110.048 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.23 5.28 89.09 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.043 -1.223 . . . . 0.35999999999999999 110.043 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.659 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.7 m -141.96 139.13 17.69 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 114.416 -0.892 . . . . 1.1399999999999999 108.877 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.953 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.7 Cg_endo -72.85 150.55 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.625 1.55 . . . . 0.52000000000000002 110.805 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.67 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -153.32 151.41 29.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.198 0.523 . . . . 1.03 111.003 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.771 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -107.25 152.75 23.68 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.735 -0.839 . . . . 1.1000000000000001 108.735 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 81.0 mt -140.76 114.66 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.974 -0.75 . . . . 0.20000000000000001 108.974 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.778 ' CD2' ' HB3' ' A' ' 139' ' ' PHE . 21.2 m-85 -102.66 122.99 45.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.336 . . . . 0.23000000000000001 110.747 -173.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.942 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.3 OUTLIER -80.92 91.78 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.374 -0.973 . . . . 1.28 108.374 168.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 139' ' ' PHE . 2.5 p -110.61 131.99 60.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 113.167 0.803 . . . . 0.88 113.167 -163.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 111.92 2.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.259 -1.385 . . . . 0.52000000000000002 107.259 167.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 1.068 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.43 64.33 1.56 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.501 0.926 . . . . 1.8400000000000001 113.501 -161.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.858 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 1.1 tppp? 76.73 52.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.728 1.211 . . . . 2.4300000000000002 112.503 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -145.91 131.25 18.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.02 -0.733 . . . . 0.98999999999999999 109.02 170.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.78 -82.77 1.62 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.631 -0.795 . . . . 1.0900000000000001 113.947 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -137.33 166.51 23.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.87 0.335 . . . . 3.1600000000000001 111.295 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.7 p -134.65 -41.35 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.199 -0.455 . . . . 1.9399999999999999 111.745 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.586 ' HD2' ' HG2' ' A' ' 156' ' ' PRO . 27.5 ttmt 71.15 0.56 3.47 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.873 0.869 . . . . 2.0299999999999998 112.227 175.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.33 39.24 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.71 -0.757 . . . . 0.46999999999999997 112.829 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.35 74.82 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 111.542 -0.623 . . . . 0.34000000000000002 111.542 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 1.1 t80 -71.42 -56.6 5.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.837 0.351 . . . . 0.56999999999999995 110.416 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.92 -43.51 91.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.05 -0.523 . . . . 2.46 110.755 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' HA ' ' A' ' 160' ' ' VAL . 94.0 m -63.63 -49.28 73.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.33000000000000002 111.11 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.36 -46.13 91.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 0.19 111.719 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.565 HG23 ' HB2' ' A' ' 101' ' ' GLU . 22.6 m -62.24 -47.75 82.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 0.29999999999999999 111.284 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.2 p -64.0 -41.93 97.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.326 -0.397 . . . . 1.0800000000000001 111.045 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.516 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 82.3 mt -58.21 -52.92 63.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 116.335 -0.393 . . . . 0.81000000000000005 110.605 175.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.533 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 60.4 t80 -50.41 -56.58 10.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.387 -0.824 . . . . 0.33000000000000002 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -70.9 -32.12 68.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 1.76 112.145 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.88 -47.08 11.44 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.788 -0.365 . . . . 1.79 111.538 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.699 ' CD1' HD13 ' A' ' 171' ' ' LEU . 63.1 m-85 -96.61 7.44 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.33 0.863 . . . . 0.42999999999999999 113.33 -170.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -25.11 62.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.417 . . . . 2.1099999999999999 109.916 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -59.93 -34.78 73.69 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.451 -0.795 . . . . 1.2 111.363 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.576 ' N ' HE21 ' A' ' 67' ' ' GLN . 0.0 OUTLIER -95.85 6.13 49.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.935 0.398 . . . . 1.8999999999999999 110.897 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.64 67.22 1.53 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.63 -0.795 . . . . 1.3200000000000001 111.433 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CE1' HD13 ' A' ' 39' ' ' LEU . 80.1 t80 -131.52 136.44 47.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.394 -0.224 . . . . 0.26000000000000001 110.394 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.67 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -128.91 146.73 50.87 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 110.066 -0.346 . . . . 0.51000000000000001 110.066 178.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.846 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.4 t -114.08 113.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.801 -0.444 . . . . 0.23999999999999999 109.801 169.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 27.0 mt -95.79 121.58 37.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.576 -0.898 . . . . 0.51000000000000001 108.576 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.07 112.36 24.5 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.064 -0.654 . . . . 0.28000000000000003 110.573 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.878 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.5 m-85 -96.22 108.16 39.77 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 109.041 -0.726 . . . . 0.34000000000000002 109.041 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 1.078 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 32.3 Cg_exo -61.25 171.02 4.44 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.811 3.007 . . . . 0.72999999999999998 112.114 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 113.875 1.065 . . . . 1.54 113.875 -176.607 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.559 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 97.1 m . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 121.058 0.456 . . . . 0.91000000000000003 109.854 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.3 m -155.59 119.31 4.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.365 -0.834 . . . . 1.9199999999999999 109.728 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.687 ' O ' HG21 ' A' ' 104' ' ' ILE . 63.2 mttp 68.84 -44.35 0.52 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 113.699 1.0 . . . . 3.1800000000000002 113.699 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.858 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 65.67 -32.23 0.16 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.076 0.951 . . . . 1.74 111.077 -168.262 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.812 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 8.3 mmpt? 72.93 127.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.094 0.958 . . . . 3.0800000000000001 111.892 171.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.862 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -161.07 -173.18 3.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.423 0.63 . . . . 0.42999999999999999 112.629 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HB2' HG23 ' A' ' 58' ' ' THR . 48.6 mt-10 -93.33 9.1 37.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.006 -0.997 . . . . 2.1899999999999999 111.66 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.738 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 32.1 p90 -128.71 173.73 5.28 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.575 -0.898 . . . . 0.23999999999999999 108.575 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 24.0 Cg_exo -70.39 100.25 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.332 0 C-N-CA 123.156 2.57 . . . . 0.31 113.232 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.032 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.8 mp -94.96 133.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.606 -0.887 . . . . 0.37 108.606 173.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.878 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.9 OUTLIER -106.46 -160.02 0.72 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.439 -0.8 . . . . 1.47 111.979 -163.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.562 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.16 132.53 43.36 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.574 -0.739 . . . . 0.39000000000000001 110.067 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.078 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.7 pttt -69.82 121.52 17.42 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.485 0.66 . . . . 1.6599999999999999 109.347 172.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.455 HG13 HG13 ' A' ' 110' ' ' VAL . 11.7 pt -120.54 170.96 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.797 -1.092 . . . . 0.46999999999999997 108.532 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.8 m120 -78.68 69.46 4.86 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.848 -0.614 . . . . 2.1600000000000001 110.379 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.683 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -73.09 85.18 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 118.704 -1.198 . . . . 0.38 110.829 -177.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.543 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 38.1 t30 171.33 178.42 0.06 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.686 -1.227 . . . . 1.98 107.686 160.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.83 -146.86 26.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.82 -0.705 . . . . 0.78000000000000003 114.687 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.22 -15.02 29.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -0.716 . . . . 1.98 110.672 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.24 -12.92 58.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.755 -0.657 . . . . 2.04 111.376 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -49.29 135.64 16.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.994 0.739 . . . . 0.47999999999999998 112.994 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -51.16 131.96 31.71 Favored Pre-proline 0 C--O 1.226 -0.137 0 CA-C-O 118.389 -0.815 . . . . 0.41999999999999998 109.178 169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.55 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -38.79 -43.67 2.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.346 2.697 . . . . 0.35999999999999999 112.924 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.559 HD11 ' HE3' ' A' ' 122' ' ' MET . 30.9 tp -54.22 -47.1 72.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.664 -0.698 . . . . 1.1000000000000001 112.09 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.436 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.2 m-85 -73.96 -29.04 61.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 119.469 -0.301 . . . . 1.49 111.276 177.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.39 -39.31 72.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.353 -0.939 . . . . 2.3700000000000001 108.581 168.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 80.4 t80 -68.38 -45.06 73.74 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.181 -0.463 . . . . 0.57999999999999996 110.635 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.559 ' HE3' HD11 ' A' ' 118' ' ' LEU . 67.1 mtt -65.2 -55.75 16.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.579 -0.282 . . . . 0.34000000000000002 111.302 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.8 mtpt -57.07 -42.62 80.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.93999999999999995 110.904 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.6 ptmm? -69.82 -37.11 76.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.302 -0.408 . . . . 2.1299999999999999 110.922 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 150' ' ' PRO . 92.4 m -64.73 -39.44 93.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.46999999999999997 111.392 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 18.6 ttmm . . . . . 0 C--N 1.328 -0.347 0 N-CA-C 112.716 0.635 . . . . 1.75 112.716 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.543 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 113.709 1.003 . . . . 0.93000000000000005 113.709 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.805 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.9 mt -93.23 103.14 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.388 -1.278 . . . . 1.05 110.199 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -106.83 0.6 24.14 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.708 0.633 . . . . 1.5 112.708 -167.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.805 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.62 171.86 19.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.157 0.799 . . . . 0.87 113.157 -163.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.609 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 16.3 m120 -46.3 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.096 -1.865 . . . . 1.8 114.103 167.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.778 ' HB3' ' CD2' ' A' ' 41' ' ' TYR . 62.1 m-85 -27.37 -59.06 0.1 Allowed 'General case' 0 C--O 1.204 -1.334 0 C-N-CA 125.158 1.383 . . . . 1.3700000000000001 113.003 -167.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.942 ' HB ' HD21 ' A' ' 42' ' ' ASN . 10.1 m 38.48 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.397 0.888 . . . . 0.29999999999999999 113.397 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.685 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 12.1 p -85.51 152.93 22.8 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.055 -0.52 . . . . 0.80000000000000004 111.358 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -103.0 135.23 45.08 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.581 -1.266 . . . . 0.53000000000000003 107.581 163.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 170' ' ' LEU . 25.4 tp -81.12 105.45 12.34 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.625 -0.88 . . . . 0.51000000000000001 108.625 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.792 HG21 HD13 ' A' ' 15' ' ' ILE . 19.2 mm -101.17 123.78 54.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.478 -0.783 . . . . 0.20000000000000001 108.973 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -179.8 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 1.3 110.529 -175.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 52.8 mtt180 -62.61 -13.56 32.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.585 0.587 . . . . 3.7799999999999998 112.585 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -108.32 -17.58 13.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.201 0.524 . . . . 1.1799999999999999 110.278 -172.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.533 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.16 34.44 3.96 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.616 -0.72 . . . . 0.23000000000000001 112.971 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -118.7 123.84 28.83 Favored Pre-proline 0 C--N 1.316 -0.85 0 O-C-N 122.635 -0.332 . . . . 0.62 110.276 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' ' 125' ' ' THR . 75.5 Cg_exo -53.94 112.98 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.34 2.693 . . . . 0.29999999999999999 112.97 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.417 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.9 t -92.5 -30.32 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.768 -0.651 . . . . 0.27000000000000002 110.475 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.404 ' HA ' ' CD ' ' A' ' 126' ' ' LYS . 61.3 mm-40 -155.61 164.07 39.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.36 -0.382 . . . . 1.22 111.027 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -127.24 102.15 6.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.495 -0.557 . . . . 1.75 109.495 173.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.604 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 36.8 m-85 -98.5 117.15 32.28 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.105 -0.702 . . . . 0.38 109.105 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.909 ' HA ' HG23 ' A' ' 140' ' ' THR . 53.7 p -69.99 178.22 1.1 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 118.77 0.714 . . . . 0.98999999999999999 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.745 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.0 Cg_endo -68.24 -14.88 41.58 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.758 1.638 . . . . 0.66000000000000003 111.122 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.26 13.76 43.58 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.52000000000000002 112.047 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.55 132.21 40.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.921 0.391 . . . . 0.42999999999999999 110.611 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.524 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 32.1 m -82.87 164.03 20.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.108 -0.496 . . . . 1.25 110.778 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.457 ' HA ' HG23 ' A' ' 56' ' ' THR . 28.9 t -52.23 -54.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.40999999999999998 111.791 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 161' ' ' LYS . 25.9 tptt -69.78 -26.16 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 3.4399999999999999 110.729 -174.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 159' ' ' SER . 21.6 m-20 -67.11 -29.66 69.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 1.8600000000000001 110.105 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 39' ' ' LEU . 62.7 mt -82.7 -40.83 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.354 -0.384 . . . . 0.20999999999999999 110.541 174.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 48.4 mt-10 -56.07 -35.52 67.07 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.777 0.658 . . . . 0.88 112.777 -176.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.3 pt-20 -58.03 -26.38 62.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.75 111.202 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.604 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 48.3 mmtm -105.09 -14.1 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.039 0.447 . . . . 1.5800000000000001 110.335 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.661 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 68.1 tp -95.16 -41.52 9.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 0.23999999999999999 112.13 -171.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.76 ' HA ' HD12 ' A' ' 171' ' ' LEU . 74.3 mt -51.56 -53.26 52.05 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 112.821 0.674 . . . . 0.44 112.821 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.92 -30.0 84.25 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.946 1.764 . . . . 0.48999999999999999 112.553 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 143' ' ' LEU . 58.7 mt -81.22 -32.51 33.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.612 -0.267 . . . . 0.70999999999999996 111.147 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.953 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.0 mt -58.57 -50.81 72.43 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.115 -0.698 . . . . 0.46000000000000002 109.115 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -50.3 -57.28 10.51 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.41 -1.268 . . . . 1.52 112.344 169.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.488 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 22.9 t . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 109.663 -0.495 . . . . 2.52 109.663 174.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 108.462 -0.94 . . . . 1.6799999999999999 108.462 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 p -145.81 156.76 43.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.839 -1.073 . . . . 0.65000000000000002 108.806 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 144' ' ' ILE . 16.6 pt -56.32 -22.11 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 113.442 0.904 . . . . 0.29999999999999999 113.442 -170.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.81 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 69.5 m-85 -83.17 1.04 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.028 0.381 . . . . 0.27000000000000002 112.028 -172.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.89 -20.71 61.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.776 -0.824 . . . . 1.96 108.776 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 77.3 m-85 -95.38 156.91 16.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.964 -1.016 . . . . 0.40000000000000002 110.571 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.6 tt0 -101.27 141.87 33.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.906 -0.588 . . . . 2.77 110.189 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.509 HG23 HD13 ' A' ' 30' ' ' LEU . 64.3 t -114.61 150.62 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.785 0.326 . . . . 0.73999999999999999 110.914 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.826 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 85.2 mt -108.28 133.89 51.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.175 -0.466 . . . . 0.71999999999999997 110.161 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.98 176.88 2.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.103 -0.953 . . . . 1.5900000000000001 109.775 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.561 ' HB1' ' HD3' ' A' ' 97' ' ' LYS . . . -51.48 -29.99 18.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.126 0.488 . . . . 0.52000000000000002 110.847 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' A' ' 26' ' ' LYS . 22.5 t70 -96.78 1.34 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 2.2200000000000002 111.649 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.826 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 34.2 m-70 74.94 12.51 3.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.058 0.543 . . . . 0.72999999999999998 110.825 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 10.7 mmpt? -69.92 146.04 94.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 106.067 -1.827 . . . . 3.25 106.067 165.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.45 113.04 1.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 119.762 0.951 . . . . 0.85999999999999999 110.985 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.451 ' HB3' HG12 ' A' ' 20' ' ' VAL . 65.6 t80 -79.28 128.23 33.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.28000000000000003 110.47 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.659 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.4 t-20 -76.99 81.88 3.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.604 -0.725 . . . . 1.6499999999999999 109.255 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.81 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.13 -33.8 70.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.42 0.629 . . . . 0.25 110.31 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.684 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.6 p -77.6 -0.86 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.179 -0.919 . . . . 0.40999999999999998 112.611 -168.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.3 pt20 -82.79 -6.41 59.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.064 -0.717 . . . . 1.24 109.064 173.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.528 ' HB3' HD13 ' A' ' 38' ' ' LEU . 91.9 m-70 -93.67 -2.3 54.12 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.38 108.398 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -78.12 142.38 38.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.788 -1.096 . . . . 1.73 110.187 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.0 -19.09 25.65 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.35999999999999999 110.508 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 70.1 m -141.84 139.13 17.84 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.585 -0.894 . . . . 1.1399999999999999 108.585 177.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.694 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 24.5 Cg_exo -65.35 153.48 78.05 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.738 2.292 . . . . 0.52000000000000002 112.289 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' A' ' 33' ' ' HIS . 2.3 pt? -154.63 159.25 40.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.302 -0.863 . . . . 1.03 109.766 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -113.69 157.77 21.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.967 -0.382 . . . . 1.1000000000000001 109.967 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 72' ' ' LEU . 93.3 mt -141.97 116.46 5.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.715 -0.675 . . . . 0.20000000000000001 109.621 -176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.929 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.8 m-85 -103.16 123.58 46.96 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.134 -0.226 . . . . 0.23000000000000001 111.038 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.614 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -79.31 92.89 5.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.354 -0.98 . . . . 1.28 108.354 168.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.6 p -112.95 131.57 64.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 112.95 0.722 . . . . 0.88 112.95 -163.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.61 114.22 1.6 Allowed 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.18 -1.044 . . . . 0.52000000000000002 108.18 169.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.995 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.62 81.28 2.61 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.366 -1.288 . . . . 1.8400000000000001 113.191 -162.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 42.8 tptt 72.66 50.6 0.17 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.003 -0.999 . . . . 2.4300000000000002 109.872 177.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 p -163.16 143.76 9.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.7 -0.682 . . . . 0.98999999999999999 111.233 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.79 -155.64 35.5 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.82 -0.627 . . . . 1.0900000000000001 113.258 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -95.32 147.52 23.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.123 0.487 . . . . 3.1600000000000001 110.612 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 p -88.69 -27.08 21.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.925 -0.579 . . . . 1.9399999999999999 112.208 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.911 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.2 mtpp 65.8 -4.07 0.66 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.369 0.668 . . . . 2.0299999999999998 112.069 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.67 0.01 29.06 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.116 -0.564 . . . . 0.46999999999999997 112.429 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.02 -34.84 77.29 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.373 -0.441 . . . . 0.34000000000000002 112.294 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.628 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -73.03 -47.57 43.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.722 0.296 . . . . 0.56999999999999995 110.224 -176.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.685 -0.487 . . . . 2.46 109.685 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 160' ' ' VAL . 98.8 m -64.03 -48.31 76.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.422 -0.808 . . . . 0.33000000000000002 110.633 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.903 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -62.44 -50.54 71.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.362 -0.381 . . . . 0.19 111.606 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.6 m -54.79 -48.91 72.11 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.29999999999999999 111.083 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.5 m -63.69 -45.72 88.73 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.205 -0.452 . . . . 1.0800000000000001 111.336 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 64.5 mt -60.33 -52.09 66.74 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 111.842 0.312 . . . . 0.81000000000000005 111.842 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.78 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 59.5 t80 -52.1 -46.68 65.35 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.33000000000000002 109.422 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -73.31 -37.09 66.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.255 0.55 . . . . 1.76 111.081 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -73.49 -33.33 64.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.343 -0.844 . . . . 1.79 111.74 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.005 ' HB3' HE21 ' A' ' 67' ' ' GLN . 72.3 m-85 -121.88 14.15 10.74 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 114.471 1.286 . . . . 0.42999999999999999 114.471 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.78 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 21.5 mtmm -57.52 -26.52 61.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.899 -0.72 . . . . 2.1099999999999999 110.385 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 m -57.16 -41.23 78.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.631 . . . . 1.2 111.708 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 1.005 HE21 ' HB3' ' A' ' 64' ' ' TYR . 4.6 pp0? -91.89 -4.33 54.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.573 -0.451 . . . . 1.8999999999999999 111.038 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.23 20.0 7.3 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.823 -0.703 . . . . 1.3200000000000001 114.069 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.901 ' HB2' ' NE2' ' A' ' 67' ' ' GLN . 75.2 t80 -77.28 137.33 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.037 0.418 . . . . 0.26000000000000001 111.306 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 2.4 t -132.01 142.31 49.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.839 -0.801 . . . . 0.51000000000000001 108.839 173.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.903 HG11 ' HB1' ' A' ' 57' ' ' ALA . 40.8 t -105.56 105.87 19.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.933 -0.765 . . . . 0.23999999999999999 108.933 169.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.654 ' HB2' HG12 ' A' ' 40' ' ' ILE . 25.6 mt -89.53 120.92 31.26 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.174 -1.047 . . . . 0.51000000000000001 108.174 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.062 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.6 112.23 24.47 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.073 -0.651 . . . . 0.28000000000000003 110.216 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.795 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -95.55 108.05 37.15 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 108.605 -0.887 . . . . 0.34000000000000002 108.605 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.995 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.9 Cg_exo -59.82 168.92 5.04 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.35 2.7 . . . . 0.72999999999999998 111.397 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 122.625 1.202 . . . . 1.54 113.847 -175.117 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.599 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 60.6 m . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 112.071 0.397 . . . . 0.91000000000000003 112.071 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 t -149.42 119.65 7.29 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.892 -0.594 . . . . 1.9199999999999999 110.27 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HD3' ' HB1' ' A' ' 23' ' ' ALA . 25.7 pttt 28.44 89.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.764 1.226 . . . . 3.1800000000000002 114.297 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.743 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -60.79 131.4 50.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.853 -1.165 . . . . 1.74 107.853 170.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 99' ' ' LYS . 11.2 mptt -91.35 147.62 22.91 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.394 -0.523 . . . . 3.0800000000000001 111.213 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -158.54 -166.76 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.847 0.717 . . . . 0.42999999999999999 111.33 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -81.62 -34.1 31.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.373 0.606 . . . . 2.1899999999999999 110.507 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.743 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 29.4 p90 -84.46 166.74 31.07 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 115.287 -0.87 . . . . 0.23999999999999999 109.774 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 23.5 Cg_exo -72.1 103.12 1.44 Allowed 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.018 3.145 . . . . 0.31 113.571 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.062 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mp -94.66 134.25 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.884 -0.784 . . . . 0.37 108.884 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.795 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -109.01 -154.22 0.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 1.47 112.522 -163.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.9 135.55 41.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.218 -0.901 . . . . 0.39000000000000001 110.23 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.981 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.5 pttp -73.36 125.1 27.07 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.713 0.768 . . . . 1.6599999999999999 108.997 171.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.499 HG13 HG13 ' A' ' 110' ' ' VAL . 12.1 pt -122.17 174.36 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 106.914 -1.513 . . . . 0.46999999999999997 106.914 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.828 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 6.7 m120 -83.86 81.17 8.89 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.035 -0.666 . . . . 2.1600000000000001 109.868 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -79.29 84.12 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 118.468 -1.293 . . . . 0.38 109.085 177.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 56.5 t30 170.35 179.5 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.418 -1.327 . . . . 1.98 107.418 166.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.81 -152.07 23.9 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 115.615 1.006 . . . . 0.78000000000000003 115.615 160.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.11 -20.9 22.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.148 -1.026 . . . . 1.98 110.695 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -92.94 6.58 47.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.538 -0.755 . . . . 2.04 110.564 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.828 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.09 141.98 38.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.885 -1.052 . . . . 0.47999999999999998 113.299 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.598 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 35.6 t-80 -54.25 135.25 60.23 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 115.477 -0.783 . . . . 0.41999999999999998 109.087 167.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.16 -33.29 73.85 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.416 2.744 . . . . 0.35999999999999999 112.85 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.598 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.7 tm? -62.32 -43.21 99.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 1.1000000000000001 109.941 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.544 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.0 m-85 -75.59 -30.48 59.61 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.449 -0.341 . . . . 1.49 110.851 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.53 -41.15 76.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.89 -0.724 . . . . 2.3700000000000001 109.206 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 69.7 t80 -65.81 -45.7 81.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.94 0.4 . . . . 0.57999999999999996 110.442 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.504 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.3 mtt -65.38 -53.29 45.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.144 -0.48 . . . . 0.34000000000000002 111.806 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.4 mtpt -59.19 -39.21 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.93999999999999995 110.644 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.3 ptmt -74.62 -36.84 62.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 2.1299999999999999 111.031 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.499 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.0 m -70.55 -43.24 69.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.4 -0.363 . . . . 0.46999999999999997 111.916 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.634 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.9 tmtt? . . . . . 0 C--N 1.324 -0.531 0 C-N-CA 120.422 -0.511 . . . . 1.75 111.484 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.507 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 112.145 0.424 . . . . 0.93000000000000005 112.145 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.849 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 38.5 mt -103.75 88.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.638 -0.71 . . . . 1.05 110.261 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -117.15 28.15 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.644 0.609 . . . . 1.5 112.644 -173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.849 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.14 169.49 23.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.05 0.452 . . . . 0.87 112.075 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -51.28 -155.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.869 1.668 . . . . 1.8 113.471 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.929 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 53.1 m-85 -24.86 -57.68 0.05 Allowed 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 125.451 1.5 . . . . 1.3700000000000001 114.212 -165.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.772 HG23 ' HA ' ' A' ' 155' ' ' SER . 23.1 m 38.08 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.275 0.842 . . . . 0.29999999999999999 113.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.635 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 11.9 p -84.34 152.18 24.26 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.094 -0.642 . . . . 0.80000000000000004 111.532 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.9 m-85 -103.5 134.88 46.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.023 -1.102 . . . . 0.53000000000000003 108.023 165.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.771 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.2 tp -82.0 104.7 12.55 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.063 -0.717 . . . . 0.51000000000000001 109.063 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 15' ' ' ILE . 18.4 mm -102.8 124.12 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.602 -0.726 . . . . 0.20000000000000001 109.26 -175.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -78.7 -175.1 4.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.864 -0.334 . . . . 1.3 111.374 -175.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.618 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.8 mtp180 -57.11 -26.01 59.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.831 0.348 . . . . 3.7799999999999998 111.912 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -108.5 -12.49 15.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.119 0.485 . . . . 1.1799999999999999 110.829 -168.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.568 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.22 44.65 2.33 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.393 -0.908 . . . . 0.23000000000000001 113.512 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.9 t -119.16 127.87 26.25 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.301 -0.629 . . . . 0.62 109.301 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.499 ' HD2' HG21 ' A' ' 125' ' ' THR . 11.5 Cg_exo -68.07 111.68 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.499 2.133 . . . . 0.29999999999999999 111.383 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.634 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.8 t -94.96 -25.97 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.32 -0.4 . . . . 0.27000000000000002 110.844 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.508 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 59.2 mm-40 -151.08 164.16 37.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.869 0.366 . . . . 1.22 111.032 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.41 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 23.3 ttm180 -129.98 97.02 4.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.702 -0.851 . . . . 1.75 108.702 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.771 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 49.9 m-85 -88.89 108.66 19.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.461 -0.57 . . . . 0.38 109.461 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.772 ' HA ' HG23 ' A' ' 140' ' ' THR . 88.0 p -63.35 167.3 6.92 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.357 -0.609 . . . . 0.98999999999999999 109.357 176.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.911 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 9.0 Cg_exo -67.61 -8.99 23.92 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.799 2.333 . . . . 0.66000000000000003 112.197 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.93 -1.46 89.78 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 114.72 -1.127 . . . . 0.52000000000000002 111.897 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.58 138.06 31.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.955 0.407 . . . . 0.42999999999999999 110.43 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.57 172.44 8.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.191 -0.459 . . . . 1.25 110.536 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.437 ' HA ' HG23 ' A' ' 56' ' ' THR . 40.9 t -52.07 -44.88 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 0.40999999999999998 111.07 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 161' ' ' LYS . 33.1 ttpt -66.41 -38.33 87.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.351 -0.841 . . . . 3.4399999999999999 110.846 -175.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.64 -32.35 73.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.8600000000000001 109.962 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 39' ' ' LEU . 59.1 mt -82.8 -43.18 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.20999999999999999 111.184 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 33.2 mt-10 -55.54 -36.92 67.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.991 0.737 . . . . 0.88 112.991 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.58 -26.16 65.18 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.761 -0.376 . . . . 0.75 111.637 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.448 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 71.5 mmtt -102.06 -17.72 15.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.221 0.534 . . . . 1.5800000000000001 110.155 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.641 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.7 tp -87.64 -49.28 7.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.683 . . . . 0.23999999999999999 111.946 -172.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 70.1 mt -53.04 -48.09 93.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 112.596 0.591 . . . . 0.44 112.596 -174.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.0 Cg_endo -53.62 -42.65 64.27 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.116 1.877 . . . . 0.48999999999999999 112.403 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.62 -44.23 82.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.526 -0.306 . . . . 0.70999999999999996 110.996 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.827 HD22 ' NE2' ' A' ' 67' ' ' GLN . 46.5 mt -55.73 -51.46 67.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.448 0.642 . . . . 0.46000000000000002 109.671 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.85 -63.05 4.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 114.16 -1.382 . . . . 1.52 113.062 168.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 117.049 0.424 . . . . 2.52 111.086 -179.735 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.234 0.243 0 CA-C-O 121.167 0.508 . . . . 1.6799999999999999 111.232 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -161.12 -177.86 6.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.574 -0.739 . . . . 0.65000000000000002 109.301 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.666 HD13 HG21 ' A' ' 144' ' ' ILE . 20.8 pt -60.6 -27.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.741 0.305 . . . . 0.29999999999999999 111.671 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.783 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 42.4 m-85 -77.73 6.49 7.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.27000000000000002 111.652 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.89 -9.02 59.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.659 -0.867 . . . . 1.96 108.659 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 80.0 m-85 -116.61 149.8 39.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.824 -1.08 . . . . 0.40000000000000002 109.811 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -99.98 146.47 26.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.835 0.35 . . . . 2.77 111.01 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -114.13 145.83 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.73999999999999999 110.942 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.019 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 74.9 mt -99.31 134.65 41.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.088 -0.708 . . . . 0.71999999999999997 109.088 170.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.06 -174.9 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.872 -0.788 . . . . 1.5900000000000001 108.872 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 1.098 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -54.33 -29.98 49.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.218 0.532 . . . . 0.52000000000000002 111.381 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.99 11.65 35.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.012 -0.54 . . . . 2.2200000000000002 111.76 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 1.019 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 22.3 m-70 69.46 12.3 8.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.232 0.613 . . . . 0.72999999999999998 110.593 176.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.792 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.2 mmpt? -75.83 145.85 78.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 106.563 -1.643 . . . . 3.25 106.563 165.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.92 114.52 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.267 1.311 . . . . 0.85999999999999999 112.314 -173.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -85.83 115.72 23.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.355 -0.838 . . . . 0.28000000000000003 109.602 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -71.39 96.07 1.42 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.654 -0.869 . . . . 1.6499999999999999 108.654 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.75 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -75.61 -29.64 59.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.722 0.772 . . . . 0.25 109.562 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.783 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 11.7 p -77.5 -0.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.619 -1.173 . . . . 0.40999999999999998 113.207 -166.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -81.7 -4.57 56.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.399 -0.593 . . . . 1.24 109.399 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -93.98 4.67 53.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.333 -0.988 . . . . 0.38 108.333 177.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.619 ' HE3' HG23 ' A' ' 31' ' ' VAL . 36.4 ttmt -82.28 130.48 35.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.99 -1.005 . . . . 1.73 109.138 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.61 58.7 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.158 -1.177 . . . . 0.35999999999999999 110.158 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 14.3 m -138.23 139.31 25.08 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.587 -0.894 . . . . 1.1399999999999999 108.587 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.097 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 40.5 Cg_endo -73.94 150.7 44.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.572 1.515 . . . . 0.52000000000000002 110.41 174.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.625 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -154.4 153.5 31.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.307 0.575 . . . . 1.03 111.62 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -108.11 148.82 29.29 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.638 -0.875 . . . . 1.1000000000000001 108.638 170.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 84.5 mt -132.07 119.51 40.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.573 -0.529 . . . . 0.20000000000000001 109.573 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 26.5 m-85 -101.5 130.4 47.75 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.23000000000000001 111.399 -172.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.735 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -90.58 93.31 9.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.503 -1.295 . . . . 1.28 107.503 174.012 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 139' ' ' PHE . 3.5 m -109.01 143.79 18.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 0.88 112.468 -163.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.88 17.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.653 -1.61 . . . . 0.52000000000000002 106.653 165.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.665 ' OG ' ' HB3' ' A' ' 95' ' ' CYS . 3.2 p -74.02 86.33 1.82 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.844 -0.616 . . . . 1.8400000000000001 112.294 -165.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 66.18 44.69 2.5 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.208 -0.905 . . . . 2.4300000000000002 110.385 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.9 p -164.0 133.62 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.567 -0.742 . . . . 0.98999999999999999 110.81 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.15 -149.04 18.29 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.505 -0.855 . . . . 1.0900000000000001 113.869 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -96.54 111.3 23.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 122.694 0.398 . . . . 3.1600000000000001 111.275 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.9 p -66.6 -34.52 78.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.703 0.26 . . . . 1.9399999999999999 111.703 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.8 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 31.1 mtpp 66.32 -3.32 0.84 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.443 0.697 . . . . 2.0299999999999998 112.536 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.446 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 109.38 3.55 30.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.886 -0.673 . . . . 0.46999999999999997 112.464 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 139' ' ' PHE . . . -72.38 -39.46 57.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.225 -0.512 . . . . 0.34000000000000002 111.828 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.737 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.5 t80 -69.18 -51.6 36.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.172 -0.307 . . . . 0.56999999999999995 110.172 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.446 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 1.6 mp0 -51.78 -52.01 52.08 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.37 0.605 . . . . 2.46 110.707 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -64.41 -46.72 82.02 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.899 -1.046 . . . . 0.33000000000000002 110.88 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.87 -48.14 82.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.137 -0.483 . . . . 0.19 111.262 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -58.48 -50.27 74.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.703 -0.681 . . . . 0.29999999999999999 110.419 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.7 m -63.0 -43.28 99.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.263 -0.88 . . . . 1.0800000000000001 111.597 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.522 HD13 HD22 ' A' ' 39' ' ' LEU . 76.2 mt -61.34 -50.27 73.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.372 0.138 . . . . 0.81000000000000005 111.372 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.727 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.1 t80 -53.67 -49.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.33000000000000002 109.83 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -73.02 -31.24 64.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.613 -0.721 . . . . 1.76 111.869 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.34 -45.59 19.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.225 -0.443 . . . . 1.79 111.267 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.625 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.2 m-85 -104.19 8.03 36.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.592 0.96 . . . . 0.42999999999999999 113.592 -170.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -25.0 65.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.02 0.438 . . . . 2.1099999999999999 110.144 170.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.0 t -59.26 -40.14 85.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.497 -0.774 . . . . 1.2 110.727 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.8 14.38 23.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 1.8999999999999999 111.247 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.625 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.21 59.4 2.74 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 115.916 -0.583 . . . . 1.3200000000000001 112.651 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 67.3 t80 -123.88 139.27 54.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.492 0.187 . . . . 0.26000000000000001 111.121 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -127.71 144.49 51.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 120.82 0.343 . . . . 0.51000000000000001 110.255 177.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.727 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 27.2 t -114.05 119.47 61.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 0.23999999999999999 109.95 169.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.523 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 19.8 mt -103.36 121.57 43.05 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.188 -0.671 . . . . 0.51000000000000001 109.188 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.012 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.02 132.25 53.73 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.364 -0.534 . . . . 0.28000000000000003 110.431 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.2 m-85 -112.19 108.44 55.03 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-O 121.231 0.538 . . . . 0.34000000000000002 110.711 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.601 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 64.1 Cg_exo -47.85 139.53 19.34 Favored 'Trans proline' 0 CA--C 1.514 -0.476 0 C-N-CA 124.781 3.654 . . . . 0.72999999999999998 112.136 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 15.7 m . . . . . 0 N--CA 1.44 -0.936 0 C-N-CA 118.633 -1.227 . . . . 1.54 114.268 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.665 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 33.8 m . . . . . 0 N--CA 1.44 -0.953 0 CA-C-O 122.116 0.96 . . . . 0.91000000000000003 111.26 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.856 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 12.1 t -139.61 156.94 46.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.899 -1.5 . . . . 1.9199999999999999 107.568 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 1.098 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 5.7 pttt -39.08 101.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.835 0.71 . . . . 3.1800000000000002 111.299 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.737 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 5.5 p90 -61.95 135.72 57.67 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.133 -1.432 . . . . 1.74 107.133 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -94.12 143.75 26.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.694 -0.802 . . . . 3.0800000000000001 110.467 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.436 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -145.99 -162.03 1.43 Allowed 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.055 0.847 . . . . 0.42999999999999999 111.428 -174.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -95.55 -5.37 42.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.625 . . . . 2.1899999999999999 110.042 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.718 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 39.1 p90 -118.79 170.72 6.12 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.23999999999999999 108.912 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.0 Cg_exo -71.19 125.83 11.78 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 123.599 2.866 . . . . 0.31 113.292 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.012 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.1 mp -120.9 140.64 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.338 -0.616 . . . . 0.37 109.338 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.735 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 10.9 mmt -111.1 -151.28 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 1.47 113.717 -163.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -73.73 163.71 27.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.247 -0.888 . . . . 0.39000000000000001 111.528 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.856 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 82.4 mttt -87.74 112.38 22.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.853 -0.425 . . . . 1.6599999999999999 109.853 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' SER . 14.7 pt -122.17 164.08 19.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.216 -0.661 . . . . 0.46999999999999997 109.216 177.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 55.4 t-20 -96.43 80.33 3.15 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.692 -0.855 . . . . 2.1600000000000001 108.692 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 42' ' ' ASN . 1.0 OUTLIER -65.88 91.47 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.132 -0.627 . . . . 0.38 110.298 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.471 ' HA ' HD12 ' A' ' 135' ' ' ILE . 0.5 OUTLIER 174.25 172.33 0.2 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.055 -0.35 . . . . 1.98 110.055 172.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 51.15 -133.69 32.95 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 123.944 0.777 . . . . 0.78000000000000003 114.917 160.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -105.57 3.95 29.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.218 -0.991 . . . . 1.98 109.978 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -106.54 -5.56 18.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.959 -1.018 . . . . 2.04 110.958 -169.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -63.15 147.23 51.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.971 -0.559 . . . . 0.47999999999999998 112.354 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.541 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 44.7 t-80 -50.36 136.06 23.6 Favored Pre-proline 0 C--O 1.225 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.41999999999999998 109.412 168.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 6.0 Cg_endo -49.37 -32.25 25.6 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.693 2.928 . . . . 0.35999999999999999 113.438 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.554 HD11 ' HE3' ' A' ' 122' ' ' MET . 22.4 tp -66.33 -39.5 89.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 1.1000000000000001 110.901 175.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.749 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 4.5 m-85 -73.98 -31.13 62.85 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 116.433 -0.349 . . . . 1.49 110.283 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 117' ' ' PRO . 34.2 mm-40 -56.22 -42.68 77.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.09 -0.707 . . . . 2.3700000000000001 109.09 168.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.694 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 90.1 t80 -65.26 -52.6 53.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.979 0.419 . . . . 0.57999999999999996 111.557 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.554 ' HE3' HD11 ' A' ' 118' ' ' LEU . 55.6 mtt -64.41 -49.17 72.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.558 0.694 . . . . 0.34000000000000002 110.871 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.749 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 4.6 tmtt? -70.74 -26.62 63.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.805 -1.089 . . . . 0.93999999999999995 112.075 -174.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.8 ptmt -75.75 -27.59 58.16 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.85 0.357 . . . . 2.1299999999999999 110.228 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.42 HG21 ' HD2' ' A' ' 150' ' ' PRO . 23.5 m -68.32 -60.43 2.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.703 0.631 . . . . 0.46999999999999997 112.703 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 151' ' ' VAL . 25.9 tttp . . . . . 0 C--N 1.326 -0.453 0 C-N-CA 119.173 -1.011 . . . . 1.75 113.629 -172.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.456 ' C ' HG13 ' A' ' 135' ' ' ILE . . . . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 120.988 0.423 . . . . 0.93000000000000005 109.961 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.976 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 1.1 mt 65.84 138.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.708 -1.133 . . . . 1.05 110.151 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -178.6 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.582 0.706 . . . . 1.5 110.851 -175.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.976 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.18 170.08 9.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.054 -0.976 . . . . 0.87 111.663 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.573 ' HB3' ' HD1' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -52.56 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.839 1.422 . . . . 1.8 114.839 175.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.616 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 16.3 m-85 -28.42 -34.65 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 127.089 2.156 . . . . 1.3700000000000001 115.904 -167.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 1.086 HG23 ' HA ' ' A' ' 155' ' ' SER . 8.6 m 13.46 105.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.027 1.491 . . . . 0.29999999999999999 115.027 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.48 158.85 20.88 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.746 0.784 . . . . 0.80000000000000004 111.982 -174.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.616 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 16.3 m-85 -102.84 169.32 8.67 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.245 -1.391 . . . . 0.53000000000000003 107.245 162.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.624 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 46.3 tp -116.5 105.94 13.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.753 -0.832 . . . . 0.51000000000000001 108.753 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.666 HG21 HD13 ' A' ' 15' ' ' ILE . 13.4 mm -108.36 122.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.486 -0.561 . . . . 0.20000000000000001 109.486 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -178.92 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.893 -0.323 . . . . 1.3 110.549 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.677 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -67.84 -6.6 22.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.184 -0.462 . . . . 3.7799999999999998 112.164 -174.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.78 -22.29 12.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.491 0.662 . . . . 1.1799999999999999 109.376 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 104.42 34.2 3.69 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.877 -1.056 . . . . 0.23000000000000001 112.67 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 68.5 t -110.55 129.35 24.04 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.93 0.365 . . . . 0.62 110.569 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 149' ' ' VAL . 22.9 Cg_exo -65.21 107.99 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.149 2.566 . . . . 0.29999999999999999 112.063 176.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 t -94.81 -12.1 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.136 -0.484 . . . . 0.27000000000000002 110.893 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -177.53 167.41 2.24 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.135 0.493 . . . . 1.22 111.815 -179.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.805 ' NH2' HG12 ' A' ' 135' ' ' ILE . 15.2 ttm-85 -134.17 116.4 15.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.06 -0.973 . . . . 1.75 109.788 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 12.4 m-85 -104.09 134.15 47.82 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 108.393 -0.966 . . . . 0.38 108.393 176.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 1.086 ' HA ' HG23 ' A' ' 140' ' ' THR . 52.7 p -76.33 176.36 3.41 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.114 0.87 . . . . 0.98999999999999999 109.764 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.876 ' HG3' ' H ' ' A' ' 140' ' ' THR . 7.0 Cg_exo -69.11 -16.61 40.42 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.366 1.377 . . . . 0.66000000000000003 110.749 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.57 89.4 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.6 -1.182 . . . . 0.52000000000000002 111.89 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.92 133.48 36.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.564 -0.532 . . . . 0.42999999999999999 109.564 176.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.5 m -78.59 160.02 27.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.855 -0.611 . . . . 1.25 110.657 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 58.1 t -50.04 -50.71 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.729 0.3 . . . . 0.40999999999999998 110.486 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.745 -0.661 . . . . 3.4399999999999999 111.779 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -65.81 -31.48 72.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.413 0.625 . . . . 1.8600000000000001 109.733 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.827 HG21 HD21 ' A' ' 39' ' ' LEU . 54.0 mt -81.38 -41.7 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.527 -0.76 . . . . 0.20999999999999999 110.189 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 45.0 mt-10 -55.76 -40.81 73.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.88 112.209 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.409 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 4.6 pt-20 -58.33 -27.62 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.75 111.6 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.538 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.6 mttp -104.28 -12.98 16.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 1.5800000000000001 110.645 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.2 tp -93.38 -41.99 9.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 0.23999999999999999 111.534 -174.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.72 ' HA ' HD12 ' A' ' 171' ' ' LEU . 79.5 mt -53.28 -48.97 90.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.489 0.551 . . . . 0.44 112.489 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 40.2 Cg_exo -59.05 -22.72 65.28 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.149 1.899 . . . . 0.48999999999999999 113.04 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.52 -39.1 14.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.543 0.211 . . . . 0.70999999999999996 110.734 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.097 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.4 mt -56.95 -53.47 57.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 0.46000000000000002 109.271 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.49 51.75 2.23 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.565 -1.198 . . . . 1.52 113.741 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 123.556 0.742 . . . . 2.52 112.625 175.15 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.091 0.472 . . . . 1.6799999999999999 110.097 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.0 p -125.17 170.1 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.186 -0.672 . . . . 0.65000000000000002 109.186 175.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.737 HD13 HG21 ' A' ' 144' ' ' ILE . 32.1 pt -59.91 -27.48 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.021 0.438 . . . . 0.29999999999999999 111.34 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.902 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 55.4 m-85 -76.56 -1.75 29.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.508 0.559 . . . . 0.27000000000000002 112.508 -171.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 -17.16 58.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.477 0.656 . . . . 1.96 109.578 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 87.1 m-85 -98.59 175.3 6.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 0.40000000000000002 110.764 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -110.44 133.83 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 2.77 110.272 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 28' ' ' TYR . 77.5 t -115.22 149.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.933 0.397 . . . . 0.73999999999999999 110.927 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.904 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 2.3 mp -114.98 141.1 48.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.927 -0.579 . . . . 0.71999999999999997 109.87 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.96 175.57 1.16 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.516 -0.765 . . . . 1.5900000000000001 109.327 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -47.54 -39.74 17.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.912 0.387 . . . . 0.52000000000000002 111.685 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.05 8.53 39.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.18 -0.464 . . . . 2.2200000000000002 112.218 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.904 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 23.0 m-70 72.21 26.08 2.8 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.501 0.667 . . . . 0.72999999999999998 110.37 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -84.87 132.62 45.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 105.791 -1.929 . . . . 3.25 105.791 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.27 112.63 0.84 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.106 1.204 . . . . 0.85999999999999999 112.588 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' HB3' HG12 ' A' ' 20' ' ' VAL . 55.7 t80 -86.95 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.014 -0.993 . . . . 0.28000000000000003 110.515 174.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.8 t30 -78.32 90.19 4.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.308 -0.627 . . . . 1.6499999999999999 109.308 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.902 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -65.31 -28.52 69.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 0.25 111.339 -174.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.836 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.0 p -76.46 -1.04 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 113.064 0.764 . . . . 0.40999999999999998 113.064 -166.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 4.1 pt20 -78.85 -5.05 52.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.304 0.573 . . . . 1.24 109.68 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -99.16 18.3 17.79 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.025 -1.102 . . . . 0.38 108.025 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -96.89 146.35 25.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.33 -1.305 . . . . 1.73 109.464 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.42 -10.62 67.13 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.072 -1.211 . . . . 0.35999999999999999 110.072 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.596 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 51.1 m -141.75 146.98 43.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.359 -0.978 . . . . 1.1399999999999999 108.359 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.002 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 72.3 Cg_endo -75.22 159.77 40.2 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.918 1.745 . . . . 0.52000000000000002 111.404 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.7 pt? -154.5 151.58 29.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.269 0.557 . . . . 1.03 111.071 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.546 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -108.07 155.64 20.15 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.618 -0.882 . . . . 1.1000000000000001 108.618 170.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 86.9 mt -141.03 119.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.415 -0.587 . . . . 0.20000000000000001 109.415 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 1.003 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 21.0 m-85 -105.77 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.273 0.358 . . . . 0.23000000000000001 111.435 -172.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.569 HD21 ' HE1' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -77.91 92.81 4.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.575 -1.269 . . . . 1.28 107.575 169.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.8 p -113.21 127.54 70.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.425 -0.91 . . . . 0.88 112.634 -167.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -65.98 101.94 0.74 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.102 -1.444 . . . . 0.52000000000000002 107.102 168.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.822 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 26.6 t -67.54 92.68 0.32 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.124 -0.944 . . . . 1.8400000000000001 112.056 -163.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.611 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 6.1 mmtm 73.88 31.78 1.17 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.331 0.652 . . . . 2.4300000000000002 110.866 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -137.24 140.53 41.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 0.98999999999999999 110.612 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.3 -149.53 29.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.951 -0.642 . . . . 1.0900000000000001 113.643 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.55 128.03 49.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.055 0.455 . . . . 3.1600000000000001 111.43 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.629 HG22 ' HE1' ' A' ' 139' ' ' PHE . 3.7 p -71.9 -33.05 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 1.9399999999999999 111.872 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 28.7 mtpp 64.88 3.96 2.26 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.71 0.633 . . . . 2.0299999999999998 112.71 173.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.82 45.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.46999999999999997 112.078 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.04 -31.09 62.22 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.955 -0.458 . . . . 0.34000000000000002 111.955 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.734 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -76.51 -52.82 9.04 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 120.5 0.191 . . . . 0.56999999999999995 110.697 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.09 -39.45 92.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.891 0.377 . . . . 2.46 110.677 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.567 HG23 ' HA ' ' A' ' 160' ' ' VAL . 95.9 m -66.55 -46.22 76.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.33000000000000002 110.846 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.665 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.63 -46.77 89.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.19 110.828 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 62.3 m -58.52 -50.38 73.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.455 -0.793 . . . . 0.29999999999999999 111.133 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -64.43 -44.31 91.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.303 -0.408 . . . . 1.0800000000000001 111.578 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 86.4 mt -57.92 -52.4 65.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.68 0.252 . . . . 0.81000000000000005 111.68 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.743 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.9 t80 -54.42 -49.37 70.11 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 121.202 0.525 . . . . 0.33000000000000002 109.88 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.02 -34.99 66.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 1.76 111.786 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.12 -47.54 20.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.381 -0.372 . . . . 1.79 111.29 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.673 ' CD1' HD13 ' A' ' 171' ' ' LEU . 60.8 m-85 -99.34 6.28 46.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.601 0.963 . . . . 0.42999999999999999 113.601 -171.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -59.41 -28.78 67.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 2.1099999999999999 110.958 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -63.18 -35.36 80.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.2 111.272 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -94.56 2.93 55.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.971 0.415 . . . . 1.8999999999999999 111.162 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 90.01 74.1 1.28 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.794 -0.717 . . . . 1.3200000000000001 112.176 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 74.0 t80 -138.15 140.94 40.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.559 0.219 . . . . 0.26000000000000001 110.526 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.08 142.55 50.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 120.56 0.219 . . . . 0.51000000000000001 110.433 178.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.743 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 42.2 t -110.84 115.02 48.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.614 -0.513 . . . . 0.23999999999999999 109.614 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.684 HD22 ' HE3' ' A' ' 105' ' ' MET . 25.1 mt -98.46 121.49 40.46 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.83 -0.804 . . . . 0.51000000000000001 108.83 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.958 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.46 115.95 31.06 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.567 -0.453 . . . . 0.28000000000000003 110.191 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.749 ' HD2' HD11 ' A' ' 108' ' ' ILE . 3.3 m-85 -97.65 107.59 40.52 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.949 -0.569 . . . . 0.34000000000000002 109.558 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.822 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 71.2 Cg_exo -51.59 160.04 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.685 2.923 . . . . 0.72999999999999998 112.486 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.68 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 48.3 m . . . . . 0 N--CA 1.428 -1.554 0 CA-C-N 115.357 -0.838 . . . . 1.54 111.483 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 45' ' ' SER . 31.9 m . . . . . 0 N--CA 1.437 -1.102 0 CA-C-O 121.122 0.487 . . . . 0.91000000000000003 112.046 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.604 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 3.6 t -152.88 117.55 5.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 1.9199999999999999 110.836 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.609 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 79.9 mttt 65.27 -46.37 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.208 1.558 . . . . 3.1800000000000002 115.208 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.734 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 62.33 -32.72 0.1 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 1.74 110.834 -171.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.609 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 18.7 mtmt 65.35 108.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.211 1.004 . . . . 3.0800000000000001 113.272 165.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -136.02 -171.84 2.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.749 -1.114 . . . . 0.42999999999999999 111.487 -174.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.88 26.93 4.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.045 -0.525 . . . . 2.1899999999999999 110.771 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.654 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 36.0 p90 -142.97 166.06 22.63 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.871 -1.159 . . . . 0.23999999999999999 107.871 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 39.8 Cg_exo -63.09 122.8 11.16 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.342 2.695 . . . . 0.31 113.297 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.958 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.4 mp -117.37 142.8 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.513 -0.551 . . . . 0.37 109.513 174.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.712 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 10.3 mmt -116.54 -153.8 0.54 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.288 0.847 . . . . 1.47 113.288 -166.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.728 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -70.47 149.65 46.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.885 -1.052 . . . . 0.39000000000000001 111.321 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 75' ' ' PRO . 29.3 mttt -82.29 109.77 16.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.026 -1.101 . . . . 1.6599999999999999 108.026 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.749 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -122.14 162.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 108.736 -0.838 . . . . 0.46999999999999997 108.736 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.715 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 15.9 m120 -78.85 70.02 5.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.872 -0.604 . . . . 2.1600000000000001 110.95 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.576 ' HB ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -69.68 87.83 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 C-N-CA 118.883 -1.127 . . . . 0.38 108.703 175.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.526 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER 170.97 179.95 0.05 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.845 -1.168 . . . . 1.98 107.845 175.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.35 -143.03 9.88 Favored Glycine 0 CA--C 1.507 -0.412 0 N-CA-C 115.644 1.018 . . . . 0.78000000000000003 115.644 153.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -105.41 -10.19 17.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.342 -0.929 . . . . 1.98 110.984 -173.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -95.3 -2.15 49.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 2.04 111.949 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -42.65 134.5 3.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.507 0.928 . . . . 0.47999999999999998 113.507 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.599 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 47.6 t-80 -51.29 140.14 24.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.568 -0.742 . . . . 0.41999999999999998 110.655 171.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 4.0 Cg_endo -47.69 -46.02 22.22 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.918 2.412 . . . . 0.35999999999999999 112.813 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.599 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.68 -40.76 69.43 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.987 -0.552 . . . . 1.1000000000000001 110.641 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.427 ' CD2' HD12 ' A' ' 108' ' ' ILE . 10.1 m-85 -76.7 -28.65 55.95 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.337 -0.392 . . . . 1.49 111.86 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 53.2 mt-10 -55.48 -42.55 74.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.715 -0.846 . . . . 2.3700000000000001 108.715 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 71.7 t80 -65.03 -49.69 69.17 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 123.585 0.553 . . . . 0.57999999999999996 110.627 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.429 ' CE ' HD11 ' A' ' 118' ' ' LEU . 64.5 mtt -62.46 -53.06 60.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.743 0.306 . . . . 0.34000000000000002 111.263 -177.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -56.64 -43.08 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.93999999999999995 111.218 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 16.7 ptmt -73.87 -34.32 64.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.018 0.437 . . . . 2.1299999999999999 111.244 -176.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 150' ' ' PRO . 77.5 m -73.88 -44.1 56.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 0.46999999999999997 111.394 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt . . . . . 0 C--N 1.321 -0.641 0 C-N-CA 120.842 -0.343 . . . . 1.75 111.627 -178.455 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 112.609 0.596 . . . . 0.93000000000000005 112.609 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.799 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.6 mt -90.13 155.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.315 -0.857 . . . . 1.05 109.612 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -173.99 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.935 0.398 . . . . 1.5 111.829 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.799 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -143.37 169.06 18.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.499 -0.318 . . . . 0.87 111.296 -177.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -154.37 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.656 1.583 . . . . 1.8 113.349 176.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 1.003 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 54.6 m-85 -25.17 -49.91 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 115.216 1.561 . . . . 1.3700000000000001 115.216 -166.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.835 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 10.6 m 32.2 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.839 1.199 . . . . 0.29999999999999999 113.59 176.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.79 149.02 26.03 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.026 -0.67 . . . . 0.80000000000000004 111.265 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.569 ' HE1' HD21 ' A' ' 42' ' ' ASN . 3.5 m-85 -104.0 133.34 49.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.236 -1.024 . . . . 0.53000000000000003 108.236 166.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.931 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 34.7 tp -81.56 105.15 12.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.922 -0.77 . . . . 0.51000000000000001 108.922 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.737 HG21 HD13 ' A' ' 15' ' ' ILE . 15.8 mm -104.8 124.98 59.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 0.20000000000000001 109.151 -174.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.673 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 12.2 p30 -74.13 -178.12 3.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.766 0.317 . . . . 1.3 111.176 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.638 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.2 mtp180 -65.87 -12.78 57.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.426 0.528 . . . . 3.7799999999999998 112.426 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -110.61 -14.33 14.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.26 0.552 . . . . 1.1799999999999999 109.966 -173.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.486 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 106.88 31.03 4.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.388 -0.824 . . . . 0.23000000000000001 113.034 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.673 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 89.9 t -112.56 129.5 24.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 117.209 0.504 . . . . 0.62 110.225 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 125' ' ' THR . 7.9 Cg_exo -70.88 118.29 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.627 2.218 . . . . 0.29999999999999999 111.725 178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.69 -26.07 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 0.27000000000000002 110.825 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -157.75 165.7 34.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.095 -0.502 . . . . 1.22 110.135 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.585 HH11 ' HH2' ' A' ' 137' ' ' TRP . 18.0 ttm180 -134.97 116.98 15.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.941 -0.392 . . . . 1.75 109.941 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.931 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 3.4 m-85 -101.93 116.63 33.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.992 -0.744 . . . . 0.38 108.992 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.789 ' HA ' HG23 ' A' ' 140' ' ' THR . 97.7 p -64.5 164.8 17.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.494 0.588 . . . . 0.98999999999999999 109.518 176.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.835 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 35.3 Cg_endo -64.76 -9.04 19.47 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.94 2.427 . . . . 0.66000000000000003 113.17 -164.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -93.62 24.13 27.28 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.491 -0.777 . . . . 0.52000000000000002 112.051 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.74 30.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.42999999999999999 110.635 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.2 m -81.54 158.76 24.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.71 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 56' ' ' THR . 21.5 t -49.56 -50.6 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.388 0.613 . . . . 0.40999999999999998 109.919 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 6.2 ttpp -59.92 -40.43 88.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.656 -1.157 . . . . 3.4399999999999999 111.038 -177.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -63.52 -30.48 71.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.126 -0.943 . . . . 1.8600000000000001 110.454 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.546 HG21 HD21 ' A' ' 39' ' ' LEU . 61.4 mt -82.63 -43.6 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.954 -0.566 . . . . 0.20999999999999999 110.887 175.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.5 mt-10 -56.13 -38.84 71.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.88 112.108 -175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.4 pt-20 -62.33 -19.33 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 0.75 112.058 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -106.32 -17.25 14.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.289 0.566 . . . . 1.5800000000000001 110.019 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.7 tp -94.11 -44.01 8.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 0.23999999999999999 111.909 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.778 ' HA ' HD12 ' A' ' 171' ' ' LEU . 63.4 mt -51.79 -47.26 91.02 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.846 0.684 . . . . 0.44 112.846 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.2 Cg_exo -54.29 -39.59 86.18 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.987 1.792 . . . . 0.48999999999999999 112.823 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.74 -34.55 58.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.503 -0.317 . . . . 0.70999999999999996 111.801 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.002 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 14.2 mt -54.85 -54.73 38.58 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.463 0.649 . . . . 0.46000000000000002 109.554 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -56.0 -51.87 52.74 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.221 -1.354 . . . . 1.52 113.266 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 117.409 0.605 . . . . 2.52 111.976 -177.153 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 112.153 -0.379 . . . . 5.5099999999999998 112.153 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 94.5 mmm -82.65 87.38 6.73 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.253 -0.647 . . . . 5.0499999999999998 109.253 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.89 84.37 1.34 Allowed Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.937 -0.865 . . . . 1.3700000000000001 110.937 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 t -77.91 -39.63 42.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.03 0.443 . . . . 1.6799999999999999 109.937 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 92.5 p -132.0 -179.47 5.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.905 -0.589 . . . . 0.65000000000000002 109.899 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.768 HD13 HG21 ' A' ' 144' ' ' ILE . 23.6 pt -65.75 -28.93 45.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.073 0.463 . . . . 0.29999999999999999 111.198 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.816 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 38.3 m-85 -78.81 -1.06 33.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.863 0.363 . . . . 0.27000000000000002 111.618 -172.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.06 -11.87 60.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.219 -0.66 . . . . 1.96 109.219 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 62.0 m-85 -110.68 160.18 16.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.081 -0.963 . . . . 0.40000000000000002 109.541 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.31 149.62 27.61 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.216 -0.291 . . . . 2.77 110.216 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.545 HG23 HD13 ' A' ' 30' ' ' LEU . 70.3 t -114.91 147.5 18.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.149 0.499 . . . . 0.73999999999999999 112.257 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.971 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 75.8 mt -100.92 132.36 46.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.854 -0.612 . . . . 0.71999999999999997 109.875 171.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -65.69 177.32 1.27 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.824 -1.08 . . . . 1.5900000000000001 109.858 176.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -46.51 -37.57 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.496 0.319 . . . . 0.52000000000000002 111.743 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.45 21.31 17.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.864 0.32 . . . . 2.2200000000000002 111.864 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.971 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 39.1 m-70 68.23 16.43 9.36 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.113 0.565 . . . . 0.72999999999999998 110.759 172.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.818 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -76.76 146.88 77.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 106.059 -1.83 . . . . 3.25 106.059 167.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.08 113.5 1.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 120.672 0.915 . . . . 0.85999999999999999 111.806 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.457 ' HB3' HG12 ' A' ' 20' ' ' VAL . 68.3 t80 -86.97 117.57 25.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.532 -0.758 . . . . 0.28000000000000003 110.866 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.46 82.75 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.716 -0.675 . . . . 1.6499999999999999 109.767 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.816 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.46 -33.09 70.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.445 0.64 . . . . 0.25 110.469 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.748 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.0 p -76.73 -1.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.248 -0.887 . . . . 0.40999999999999998 112.811 -168.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 2.8 pt20 -81.45 -5.64 58.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 1.24 109.349 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -92.94 -3.79 53.9 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.317 -0.994 . . . . 0.38 108.317 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 34.8 ttpt -74.15 146.45 43.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.879 -1.055 . . . . 1.73 109.827 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.81 -13.67 65.89 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.964 -1.254 . . . . 0.35999999999999999 109.964 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.657 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 6.0 m -130.91 145.42 57.67 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 114.538 -0.831 . . . . 1.1399999999999999 108.766 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.98 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -74.84 151.91 40.96 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.02 1.814 . . . . 0.52000000000000002 110.664 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.629 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -154.61 154.03 32.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.142 0.496 . . . . 1.03 111.161 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.86 HD21 HG21 ' A' ' 163' ' ' ILE . 6.8 mp -107.47 154.17 21.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.094 -0.706 . . . . 1.1000000000000001 109.094 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 85.1 mt -141.0 115.34 5.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.205 -0.665 . . . . 0.20000000000000001 109.205 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' HD2' ' HB2' ' A' ' 139' ' ' PHE . 3.9 m-85 -102.04 123.38 45.83 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 121.059 -0.256 . . . . 0.23000000000000001 111.334 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.775 HD21 ' HB ' ' A' ' 140' ' ' THR . 1.0 OUTLIER -81.88 90.11 6.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.07 -1.085 . . . . 1.28 108.07 167.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 8.3 p -119.1 141.78 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.163 0.801 . . . . 0.88 113.163 -162.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.9 108.98 3.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.926 -1.139 . . . . 0.52000000000000002 107.926 170.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.983 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 29.8 t -73.88 80.81 1.64 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.857 -0.61 . . . . 1.8400000000000001 112.216 -170.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 98' ' ' PHE . 37.6 ttmt 67.25 55.6 0.66 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.935 -1.029 . . . . 2.4300000000000002 111.348 174.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -139.05 118.7 13.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.092 -0.504 . . . . 0.98999999999999999 109.941 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.47 -93.67 1.24 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.655 -0.783 . . . . 1.0900000000000001 112.131 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.37 151.91 17.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 3.1600000000000001 111.301 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.2 p -119.83 141.96 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.891 -0.781 . . . . 1.9399999999999999 108.891 169.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 156' ' ' PRO . 33.4 ttmt -77.51 44.12 0.42 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.335 0.588 . . . . 2.0299999999999998 110.794 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 28.37 13.07 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.744 -0.662 . . . . 0.46999999999999997 112.271 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 139' ' ' PHE . . . -80.8 -48.73 6.02 Favored Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.879 -0.676 . . . . 0.34000000000000002 112.28 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -55.84 -50.69 69.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.79 0.329 . . . . 0.56999999999999995 110.387 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -60.21 -53.2 60.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.091 -0.504 . . . . 2.46 111.203 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.4 m -57.94 -47.06 84.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 122.728 0.411 . . . . 0.33000000000000002 110.932 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.689 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.66 -49.25 77.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.46 . . . . 0.19 111.195 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 m -61.03 -47.17 87.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.163 0.506 . . . . 0.29999999999999999 110.516 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -59.48 -49.8 76.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.362 -0.835 . . . . 1.0800000000000001 111.172 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -61.13 -44.48 97.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.033 -0.53 . . . . 0.81000000000000005 110.964 -175.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.788 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 67.8 t80 -53.15 -57.1 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 123.492 0.495 . . . . 0.33000000000000002 110.476 176.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -68.52 -39.2 81.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.336 -0.393 . . . . 1.76 111.369 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -70.82 -45.18 65.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 1.79 111.66 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.603 ' CD1' HD13 ' A' ' 171' ' ' LEU . 61.2 m-85 -101.53 6.67 42.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.332 0.864 . . . . 0.42999999999999999 113.332 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -62.33 -19.79 63.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.63 0.252 . . . . 2.1099999999999999 110.918 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.4 m -66.85 -38.06 85.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 1.2 111.246 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -88.85 4.63 47.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 1.8999999999999999 110.66 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 82.44 71.61 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.892 -0.671 . . . . 1.3200000000000001 111.514 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 76.8 t80 -133.04 138.64 46.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.612 0.244 . . . . 0.26000000000000001 110.436 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -126.82 142.91 51.41 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.93 0.395 . . . . 0.51000000000000001 110.04 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.788 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.6 t -110.77 118.64 57.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 O-C-N 122.188 -0.32 . . . . 0.23999999999999999 110.27 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 21.4 mt -105.34 122.92 46.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.91 -0.774 . . . . 0.51000000000000001 108.91 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.886 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.82 112.74 24.96 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.006 -0.677 . . . . 0.28000000000000003 110.591 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.609 ' CE1' ' HG2' ' A' ' 105' ' ' MET . 1.8 m-85 -93.29 112.59 57.07 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.116 -1.068 . . . . 0.34000000000000002 108.116 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.022 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.7 Cg_exo -60.03 167.2 7.62 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.025 2.483 . . . . 0.72999999999999998 111.235 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.0 t -111.64 128.28 56.01 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 119.435 -0.906 . . . . 1.54 111.738 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 49.8 t30 -86.18 99.1 11.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.396 -1.274 . . . . 2.52 110.896 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.673 HE22 ' HB2' ' A' ' 95' ' ' CYS . 0.0 OUTLIER -52.97 -11.55 0.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.903 1.281 . . . . 3.1800000000000002 113.172 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.4 7.86 45.12 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.857 0.36 . . . . 3.7999999999999998 110.556 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.542 ' HA3' ' HB2' ' A' ' 109' ' ' ASN . . . -75.83 -33.45 51.02 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.903 -0.665 . . . . 1.45 112.158 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.09 -41.94 1.93 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.159 -0.543 . . . . 1.4299999999999999 112.334 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 3.3 pm0 -131.65 39.94 3.44 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.299 0.481 . . . . 1.4299999999999999 112.299 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 1.5 mp0 -60.74 132.39 91.51 Favored Pre-proline 0 C--N 1.318 -0.78 0 O-C-N 121.746 -0.596 . . . . 3.0600000000000001 110.206 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 1.032 ' HG3' HG22 ' A' ' 135' ' ' ILE . 3.4 Cg_exo -12.25 -117.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 1 C-N-CA 126.304 4.669 . . . . 1.6100000000000001 115.929 -160.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.47 -3.44 56.39 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.526 -1.43 . . . . 1.3899999999999999 109.526 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -81.54 -0.94 44.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.709 -0.746 . . . . 3.6899999999999999 112.165 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -65.82 -25.71 67.35 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.993 0.368 . . . . 2.4700000000000002 111.993 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -87.2 -12.12 47.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.99 0.424 . . . . 3.6400000000000001 110.824 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -91.44 -54.89 3.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.984 -0.553 . . . . 2.4199999999999999 111.122 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.404 HD13 ' SG ' ' A' ' 95' ' ' CYS . 3.2 mt -78.55 35.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.234 0.54 . . . . 2.0499999999999998 110.573 -174.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -96.5 -23.18 16.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.549 0.69 . . . . 4.0 110.294 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -115.74 8.24 14.86 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.557 -1.201 . . . . 3.1000000000000001 109.235 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -133.02 167.56 20.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.585 -1.189 . . . . 1.9099999999999999 108.929 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.09 120.34 53.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.512 0.672 . . . . 1.6499999999999999 110.024 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.673 ' HB2' HE22 ' A' ' 78' ' ' GLN . 31.1 m -92.64 120.38 33.0 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.865 -0.607 . . . . 0.91000000000000003 110.453 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.459 ' CG2' ' HE3' ' A' ' 97' ' ' LYS . 28.3 m -153.26 116.57 4.63 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.755 -0.657 . . . . 1.9199999999999999 109.906 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.5 OUTLIER 13.27 97.26 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 O-C-N 124.824 1.328 . . . . 3.1800000000000002 114.323 -173.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.672 ' HZ ' ' HZ ' ' A' ' 102' ' ' PHE . 23.7 p90 -64.03 -21.3 66.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.107 -0.497 . . . . 1.74 110.73 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 66.94 150.07 0.06 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.998 0.811 . . . . 3.0800000000000001 111.613 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . . . -171.29 -165.65 0.41 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.589 -0.278 . . . . 0.42999999999999999 111.483 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -82.77 -4.73 58.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.367 0.603 . . . . 2.1899999999999999 110.386 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.672 ' HZ ' ' HZ ' ' A' ' 98' ' ' PHE . 53.1 p90 -121.68 163.16 32.64 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 108.428 -0.953 . . . . 0.23999999999999999 108.428 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 27.3 Cg_exo -67.71 117.47 4.9 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 123.195 2.597 . . . . 0.31 113.206 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.886 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.9 mp -105.57 138.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.131 -0.692 . . . . 0.37 109.131 171.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.609 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -103.24 -162.26 0.9 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.319 0.859 . . . . 1.47 113.319 -163.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.16 41.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.158 -0.928 . . . . 0.39000000000000001 109.948 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.022 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 14.0 pttt -70.25 126.09 28.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 119.735 -0.786 . . . . 1.6599999999999999 109.876 172.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.415 HG13 HG13 ' A' ' 110' ' ' VAL . 4.9 pt -124.64 161.39 28.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.707 -1.133 . . . . 0.46999999999999997 108.307 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.67 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 15.1 t-20 -79.35 88.25 4.98 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.845 -0.798 . . . . 2.1600000000000001 108.845 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.686 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.4 OUTLIER -74.28 85.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 119.315 -0.954 . . . . 0.38 108.86 176.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.507 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 9.6 t-20 171.84 -178.88 0.06 Allowed 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.806 -0.813 . . . . 1.98 108.806 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 56.96 -142.15 42.18 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 115.116 0.806 . . . . 0.78000000000000003 115.116 156.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.87 -16.69 15.3 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.501 -0.85 . . . . 1.98 109.612 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -91.62 1.84 56.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.856 -1.066 . . . . 2.04 110.613 -168.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -60.89 140.58 57.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.252 -0.885 . . . . 0.47999999999999998 111.861 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.6 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 33.2 t-80 -50.29 132.48 24.78 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.25 -0.886 . . . . 0.41999999999999998 108.792 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.21 -33.27 53.9 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.429 2.753 . . . . 0.35999999999999999 112.457 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.6 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 19.4 tp -62.99 -41.12 99.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.098 -0.501 . . . . 1.1000000000000001 111.056 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.431 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.7 m-85 -74.83 -30.39 61.37 Favored 'General case' 0 C--O 1.21 -0.99 0 N-CA-C 110.378 -0.23 . . . . 1.49 110.378 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.86 -33.89 70.98 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.058 -0.657 . . . . 2.3700000000000001 109.868 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.599 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 66.9 t80 -71.69 -52.46 17.69 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.357 0.411 . . . . 0.57999999999999996 110.536 174.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.582 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.8 mtt -56.99 -51.91 67.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 0.34000000000000002 111.333 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.533 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 35.4 mtpt -58.15 -50.62 72.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.817 -0.629 . . . . 0.93999999999999995 110.652 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.21 -30.2 71.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.664 0.269 . . . . 2.1299999999999999 111.283 -177.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.549 HG21 ' HD2' ' A' ' 150' ' ' PRO . 87.1 m -72.54 -52.51 15.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.366 -0.379 . . . . 0.46999999999999997 111.727 -176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 8.0 mmtt -130.91 99.08 18.47 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 112.869 0.692 . . . . 1.75 112.869 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 6.3 Cg_endo -51.61 -42.31 56.85 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.609 2.872 . . . . 1.76 112.311 167.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.606 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 100.35 -116.04 5.47 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.496 -0.859 . . . . 2.3700000000000001 113.37 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.25 0.66 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.293 0.479 . . . . 3.5600000000000001 112.293 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.6 pt? -117.34 -171.24 2.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.812 0.339 . . . . 2.7599999999999998 110.736 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.92 127.66 32.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.131 -0.486 . . . . 2.8399999999999999 110.538 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 59.9 p 58.96 -172.46 0.11 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.868 0.867 . . . . 3.8999999999999999 111.859 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.519 ' HD2' ' HA ' ' A' ' 124' ' ' LYS . 31.1 pttt -125.25 47.03 2.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.981 -0.554 . . . . 5.1299999999999999 112.047 -170.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -109.97 156.96 19.79 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.958 0.409 . . . . 0.93000000000000005 111.519 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 1.032 HG22 ' HG3' ' A' ' 84' ' ' PRO . 37.6 mt -99.15 106.17 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.787 -0.642 . . . . 1.05 110.423 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 136' ' ' LYS . 9.9 ptpt -131.98 21.29 4.53 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.631 0.604 . . . . 1.5 112.631 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.858 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.2 174.44 15.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.068 0.396 . . . . 0.87 112.068 -175.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 8.3 m120 -46.66 -161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.422 1.489 . . . . 1.8 114.575 173.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.812 ' CZ ' ' HA ' ' A' ' 156' ' ' PRO . 44.7 p90 -34.37 -46.49 0.27 Allowed 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 113.145 -1.843 . . . . 1.3700000000000001 115.346 -164.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.775 ' HB ' HD21 ' A' ' 42' ' ' ASN . 22.4 m 37.78 94.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.36 0.874 . . . . 0.29999999999999999 113.36 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.0 p -85.63 146.64 26.77 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.183 -0.607 . . . . 0.80000000000000004 110.345 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.7 m-85 -102.17 133.4 47.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.407 -0.961 . . . . 0.53000000000000003 108.407 169.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.912 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.87 104.66 12.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.095 -0.705 . . . . 0.51000000000000001 109.095 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.768 HG21 HD13 ' A' ' 15' ' ' ILE . 12.7 mm -102.44 128.51 55.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.086 -0.709 . . . . 0.20000000000000001 109.086 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 0.5 OUTLIER -82.31 -174.59 5.22 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.028 -0.269 . . . . 1.3 111.274 -175.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.464 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 43.9 mtt180 -63.3 -12.51 30.11 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.378 0.51 . . . . 3.7799999999999998 112.378 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.436 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 21.2 t70 -108.86 -19.24 13.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.374 0.607 . . . . 1.1799999999999999 109.741 -171.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 102.37 26.87 7.11 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.199 -0.909 . . . . 0.23000000000000001 112.36 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.1 t -106.44 126.33 30.7 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.732 -0.47 . . . . 0.62 109.732 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' A' ' 125' ' ' THR . 10.5 Cg_exo -67.56 111.35 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.342 2.028 . . . . 0.29999999999999999 111.361 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.48 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 39.2 t -91.41 -25.94 5.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.017 -0.538 . . . . 0.27000000000000002 110.504 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -152.37 163.6 39.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 1.22 111.226 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.606 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 11.9 ttm180 -131.01 102.62 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.618 -0.719 . . . . 1.75 109.247 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.912 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.9 m-85 -92.22 109.8 21.18 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.267 -0.642 . . . . 0.38 109.267 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.916 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 81.2 p -67.5 -178.65 0.38 Allowed Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.763 -0.458 . . . . 0.98999999999999999 109.763 177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.916 ' HD2' ' HB2' ' A' ' 155' ' ' SER . 30.8 Cg_endo -63.92 10.99 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.138 1.892 . . . . 0.66000000000000003 113.227 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 155' ' ' SER . . . -99.16 -9.46 51.47 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.06 -0.591 . . . . 0.52000000000000002 111.877 -177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 154' ' ' PHE . . . -96.16 134.7 38.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.798 0.332 . . . . 0.42999999999999999 111.067 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.7 m -95.23 -174.02 3.1 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.021 -0.536 . . . . 1.25 110.265 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.704 HG13 HD21 ' A' ' 60' ' ' LEU . 77.5 t -51.38 -55.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 0.40999999999999998 111.923 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -72.88 -26.0 61.29 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.606 -0.27 . . . . 3.4399999999999999 111.126 -173.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -34.45 72.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.644 -0.502 . . . . 1.8600000000000001 109.644 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.86 HG21 HD21 ' A' ' 39' ' ' LEU . 61.8 mt -82.73 -38.36 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.608 -0.724 . . . . 0.20999999999999999 110.762 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.1 mt-10 -56.22 -41.13 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.278 0.474 . . . . 0.88 112.278 -174.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.575 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.9 pt-20 -57.21 -26.65 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.75 111.703 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.4 mmtp -102.51 -18.45 15.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.841 0.353 . . . . 1.5800000000000001 110.751 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.664 ' HG ' HD11 ' A' ' 171' ' ' LEU . 60.4 tp -92.31 -45.66 8.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.901 -0.59 . . . . 0.23999999999999999 112.043 -171.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.716 ' HA ' HD12 ' A' ' 171' ' ' LEU . 66.6 mt -49.73 -49.87 70.59 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 112.999 0.74 . . . . 0.44 112.999 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.9 Cg_exo -55.38 -39.44 91.0 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.116 1.878 . . . . 0.48999999999999999 112.701 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.0 -40.16 63.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.511 -0.313 . . . . 0.70999999999999996 110.975 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.98 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 18.6 mt -55.8 -48.4 75.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.296 0.57 . . . . 0.46000000000000002 109.578 177.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.82 -69.82 1.05 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.585 -1.188 . . . . 1.52 111.621 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.6 m -161.45 125.31 3.31 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.78 -0.452 . . . . 2.52 109.78 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.453 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -90.17 -47.69 7.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.27 0.557 . . . . 3.5600000000000001 109.769 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.701 ' HG3' ' H ' ' A' ' 176' ' ' LEU . 6.9 ptm180 -120.02 -67.63 0.97 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.259 -0.882 . . . . 7.8600000000000003 109.869 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.701 ' H ' ' HG3' ' A' ' 175' ' ' ARG . 36.2 mt . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.78 -0.628 . . . . 4.8099999999999996 109.689 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.477 0 N-CA-C 111.902 -0.479 . . . . 5.5099999999999998 111.902 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.4 mtm -62.07 105.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.988 0.423 . . . . 5.0499999999999998 110.182 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.17 52.08 0.85 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.746 -0.942 . . . . 1.3700000000000001 110.746 -173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -74.11 -37.58 64.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.066 0.46 . . . . 1.6799999999999999 110.613 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.5 p -157.53 -174.61 4.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.493 -0.776 . . . . 0.65000000000000002 109.184 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.798 HD13 HG21 ' A' ' 144' ' ' ILE . 27.9 pt -64.2 -25.35 37.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.48 . . . . 0.29999999999999999 110.649 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.796 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.3 m-85 -81.94 5.55 18.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.27000000000000002 111.202 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -73.94 -19.67 60.61 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.259 -1.015 . . . . 1.96 108.259 174.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 73.8 m-85 -107.86 175.67 5.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.869 -1.059 . . . . 0.40000000000000002 111.263 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -112.62 138.8 48.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 2.77 110.382 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.56 HG23 HD13 ' A' ' 30' ' ' LEU . 77.4 t -115.04 144.6 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.093 0.473 . . . . 0.73999999999999999 111.514 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.999 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 91.0 mt -104.32 133.23 49.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.545 -0.752 . . . . 0.71999999999999997 109.546 173.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.53 -176.43 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.672 -0.862 . . . . 1.5900000000000001 108.672 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.763 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -53.96 -35.45 61.79 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.165 0.507 . . . . 0.52000000000000002 111.624 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -92.96 3.13 56.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 2.2200000000000002 111.528 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.999 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 33.6 m-70 74.43 17.59 3.1 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.414 0.626 . . . . 0.72999999999999998 109.972 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 12.8 mtmt -69.89 151.85 96.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.149 -1.797 . . . . 3.25 106.149 163.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.98 113.74 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 CA-C-N 120.168 1.096 . . . . 0.85999999999999999 110.848 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.544 ' HB3' HG12 ' A' ' 20' ' ' VAL . 65.4 t80 -82.5 120.73 25.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.635 . . . . 0.28000000000000003 110.232 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.9 t-20 -69.9 85.44 0.5 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.869 -0.605 . . . . 1.6499999999999999 109.786 176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.796 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -73.4 -32.35 64.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.262 0.553 . . . . 0.25 110.544 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.737 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.3 p -77.19 -0.68 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.522 -0.763 . . . . 0.40999999999999998 112.686 -168.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.0 pt20 -78.77 -6.62 56.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.574 0.702 . . . . 1.24 109.376 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -96.99 3.81 51.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.96 -1.018 . . . . 0.38 108.314 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 22.1 ttpt -81.2 146.63 30.39 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.723 -1.126 . . . . 1.73 109.298 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.11 -2.1 86.77 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.228 -1.149 . . . . 0.35999999999999999 110.228 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 13.6 m -140.56 152.31 65.94 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 1.1399999999999999 108.747 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.99 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 74.3 Cg_endo -82.52 154.78 16.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.826 1.684 . . . . 0.52000000000000002 111.576 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.671 ' CB ' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -156.98 150.57 24.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.164 0.507 . . . . 1.03 111.749 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.659 HD23 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.86 151.49 25.69 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.376 -0.972 . . . . 1.1000000000000001 108.376 172.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 86.5 mt -140.55 115.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.84 -0.43 . . . . 0.20000000000000001 109.84 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.761 ' CE2' ' HB2' ' A' ' 141' ' ' SER . 29.8 m-85 -103.02 124.74 49.09 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 111.609 0.226 . . . . 0.23000000000000001 111.609 -173.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.793 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -80.44 93.26 5.98 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.246 -0.65 . . . . 1.28 109.246 167.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.828 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 15.2 m -105.06 150.08 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 114.095 1.146 . . . . 0.88 114.095 -158.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 102.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.683 -1.599 . . . . 0.52000000000000002 106.683 163.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.497 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -76.07 81.17 2.91 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 113.879 1.066 . . . . 1.8400000000000001 113.879 -163.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 84.4 tttt 76.18 31.97 0.63 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.558 -0.746 . . . . 2.4300000000000002 111.488 169.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -149.28 132.34 16.27 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.507 -0.477 . . . . 0.98999999999999999 111.488 178.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.31 -92.69 0.97 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.688 -0.687 . . . . 1.0900000000000001 114.734 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.438 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 66.8 m-85 -110.98 153.77 25.08 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.999 0.37 . . . . 3.1600000000000001 111.999 -167.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.9 p -137.24 -38.67 0.61 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.778 0.659 . . . . 1.9399999999999999 112.778 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 69.47 -12.88 0.41 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.432 0.693 . . . . 2.0299999999999998 112.791 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.01 12.08 14.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.942 -0.647 . . . . 0.46999999999999997 112.478 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.84 -31.7 61.98 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.156 -0.545 . . . . 0.34000000000000002 112.051 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.694 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -68.72 -52.05 34.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.534 0.206 . . . . 0.56999999999999995 110.504 -177.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.95 -47.06 78.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.431 0.634 . . . . 2.46 110.397 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.48 HG23 ' HA ' ' A' ' 160' ' ' VAL . 85.5 m -63.03 -47.53 82.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.818 -1.083 . . . . 0.33000000000000002 110.719 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.817 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -62.16 -50.43 71.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.19 111.651 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.67 HG23 ' HG2' ' A' ' 101' ' ' GLU . 24.5 m -56.1 -45.55 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 0.29999999999999999 110.792 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.68 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 40.7 m -66.57 -45.98 77.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 1.0800000000000001 111.31 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 88.5 mt -58.09 -51.38 69.92 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.538 0.208 . . . . 0.81000000000000005 111.188 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.45 ' CD1' ' HA ' ' A' ' 70' ' ' THR . 49.7 t80 -52.5 -52.76 52.85 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.997 0.811 . . . . 0.33000000000000002 109.785 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.68 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 3.9 p30 -73.93 -33.35 63.91 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.504 -0.478 . . . . 1.76 111.429 -171.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -76.11 -38.17 57.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.277 -0.419 . . . . 1.79 111.309 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.674 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.9 m-85 -109.07 8.91 26.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.071 0.767 . . . . 0.42999999999999999 113.071 -174.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -22.53 64.12 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.861 0.363 . . . . 2.1099999999999999 110.226 173.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -62.12 -37.93 87.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 1.2 110.785 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.44 5.57 38.23 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.908 0.385 . . . . 1.8999999999999999 110.923 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.35 25.09 34.46 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.99 -0.624 . . . . 1.3200000000000001 112.289 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.659 ' CE1' HD23 ' A' ' 39' ' ' LEU . 75.7 t80 -85.05 143.72 28.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.775 0.321 . . . . 0.26000000000000001 110.913 -174.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.671 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -131.03 146.32 52.34 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.062 0.458 . . . . 0.51000000000000001 110.183 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.817 HG11 ' HB1' ' A' ' 57' ' ' ALA . 37.4 t -116.52 114.71 46.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.19 -0.459 . . . . 0.23999999999999999 109.84 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.1 mt -100.23 122.78 43.58 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.103 -0.702 . . . . 0.51000000000000001 109.103 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.63 116.74 32.3 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.22 -0.592 . . . . 0.28000000000000003 110.731 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.8 m-85 -99.11 109.43 54.21 Favored Pre-proline 0 C--N 1.31 -1.134 0 CA-C-N 115.789 -0.641 . . . . 0.34000000000000002 109.611 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.794 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 75.1 Cg_exo -50.37 160.61 1.48 Allowed 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 124.185 3.256 . . . . 0.72999999999999998 113.568 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.7 t -114.0 131.28 56.4 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 122.65 1.214 . . . . 1.54 111.227 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -83.65 75.38 10.06 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.77 -1.567 . . . . 2.52 106.77 170.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 1.004 ' HA ' ' HG3' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -51.33 -11.55 0.12 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.604 1.335 . . . . 3.1800000000000002 114.604 -168.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -102.71 30.38 4.74 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.62 0.724 . . . . 3.7999999999999998 109.548 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.04 16.55 32.29 Favored Glycine 0 N--CA 1.454 -0.165 0 CA-C-N 115.971 -0.558 . . . . 1.45 112.847 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.29 -60.05 3.01 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.983 -0.847 . . . . 1.4299999999999999 110.983 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.651 ' HG2' ' O ' ' A' ' 82' ' ' GLN . 5.0 pm0 -134.75 83.63 2.04 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.068 0.461 . . . . 1.4299999999999999 111.057 173.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 1.004 ' HG3' ' HA ' ' A' ' 78' ' ' GLN . 77.5 mm-40 -83.83 155.77 64.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 107.999 -1.112 . . . . 3.0600000000000001 107.999 165.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.97 ' HG3' HG22 ' A' ' 135' ' ' ILE . 16.1 Cg_exo -27.71 -105.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 1 C-N-CA 125.309 4.006 . . . . 1.6100000000000001 116.655 -168.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 84' ' ' PRO . . . -109.8 0.71 30.37 Favored Glycine 0 C--N 1.31 -0.865 0 N-CA-C 110.172 -1.171 . . . . 1.3899999999999999 110.172 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -114.58 58.58 0.7 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.555 -0.822 . . . . 3.6899999999999999 110.516 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -87.83 138.33 31.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.052 -0.522 . . . . 2.4700000000000002 110.694 -176.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 62.26 16.34 8.35 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.487 -0.778 . . . . 3.6400000000000001 111.633 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 31.6 tt0 -65.76 -40.37 91.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.753 0.787 . . . . 2.4199999999999999 109.416 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 95' ' ' CYS . 0.8 OUTLIER -55.95 -11.2 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.712 -1.131 . . . . 2.0499999999999998 113.261 175.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -62.28 -17.48 58.69 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.8 -1.187 . . . . 4.0 111.707 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.65 21.63 3.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.573 -0.739 . . . . 3.1000000000000001 110.114 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.646 ' HB3' ' HB3' ' A' ' 47' ' ' CYS . 68.0 m-85 -148.92 147.77 29.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.165 -0.925 . . . . 1.9099999999999999 109.507 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 94' ' ' VAL . 9.9 p -110.71 111.14 34.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 118.969 -1.092 . . . . 1.6499999999999999 109.5 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.941 ' HB2' HD11 ' A' ' 90' ' ' ILE . 75.8 m -105.18 117.17 33.33 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.481 -0.781 . . . . 0.91000000000000003 110.111 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -154.56 120.36 5.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.336 -0.847 . . . . 1.9199999999999999 109.761 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.763 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 7.7 pttt 33.36 77.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.333 1.021 . . . . 3.1800000000000002 113.271 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.694 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 1.6 p90 -57.9 135.41 56.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.062 -1.458 . . . . 1.74 107.062 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.502 ' HE2' ' HG3' ' A' ' 97' ' ' LYS . 70.0 mmtt -102.46 122.88 45.19 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.858 -0.737 . . . . 3.0800000000000001 112.011 -170.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.5 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . . . -125.11 -162.22 1.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.053 -0.976 . . . . 0.42999999999999999 110.517 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.67 ' HG2' HG23 ' A' ' 58' ' ' THR . 7.4 pt-20 -90.64 -11.25 40.43 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.068 -0.653 . . . . 2.1899999999999999 110.129 175.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.747 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.0 p90 -103.15 167.86 9.61 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-N 115.225 -0.898 . . . . 0.23999999999999999 108.889 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.811 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.1 Cg_exo -71.95 120.9 7.15 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.749 2.966 . . . . 0.31 113.348 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.997 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.8 mp -113.71 140.15 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.341 -0.614 . . . . 0.37 109.341 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.811 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 11.4 mmt -110.79 -151.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.107 0.78 . . . . 1.47 113.107 -164.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -79.64 143.84 34.31 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.855 -1.066 . . . . 0.39000000000000001 110.738 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.794 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 21.4 pttt -78.67 137.74 37.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.044 0.449 . . . . 1.6599999999999999 109.995 172.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.45 HD11 ' CE1' ' A' ' 119' ' ' TYR . 3.8 pt -143.66 158.04 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.357 -1.349 . . . . 0.46999999999999997 107.357 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.794 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -73.9 91.45 1.99 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.269 -0.572 . . . . 2.1600000000000001 109.754 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.607 HG11 ' CB ' ' A' ' 42' ' ' ASN . 1.3 m -82.55 84.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 119.18 -1.008 . . . . 0.38 108.943 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.63 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 20.1 t-20 171.93 179.23 0.07 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.09 -1.078 . . . . 1.98 108.09 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.49 -149.09 19.81 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 116.024 1.17 . . . . 0.78000000000000003 116.024 153.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 1.5 28.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.886 -1.157 . . . . 1.98 110.029 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.44 ' HB3' ' OD1' ' A' ' 109' ' ' ASN . 35.3 t-20 -108.6 2.83 22.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.917 -1.038 . . . . 2.04 109.559 -171.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.794 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -58.25 139.87 54.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.117 -0.947 . . . . 0.47999999999999998 112.618 -177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.601 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 38.9 t-80 -48.32 133.52 12.83 Favored Pre-proline 0 C--O 1.226 -0.135 0 N-CA-C 109.012 -0.736 . . . . 0.41999999999999998 109.012 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.19 -33.17 63.32 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.37 2.713 . . . . 0.35999999999999999 112.829 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.601 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 18.2 tp -65.72 -37.0 85.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 1.1000000000000001 111.042 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.529 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 8.1 m-85 -75.55 -29.56 59.43 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.572 -0.285 . . . . 1.49 110.668 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.81 -40.2 79.37 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.883 -0.784 . . . . 2.3700000000000001 108.883 167.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 77.7 t80 -68.08 -47.76 67.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.57999999999999996 110.53 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.57 ' HE3' HD11 ' A' ' 118' ' ' LEU . 67.0 mtt -62.85 -55.03 29.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.097 -0.501 . . . . 0.34000000000000002 111.136 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -57.54 -43.15 84.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.201 -0.454 . . . . 0.93999999999999995 111.474 -176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -69.58 -39.73 77.13 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.479 -0.328 . . . . 2.1299999999999999 111.009 -176.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.532 HG21 ' HD2' ' A' ' 150' ' ' PRO . 52.3 m -69.73 -33.9 73.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.118 -0.492 . . . . 0.46999999999999997 111.448 -173.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.595 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.3 tmtt? -147.66 101.21 3.72 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.702 -0.399 . . . . 1.75 111.317 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.526 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 9.8 Cg_endo -53.53 -23.87 26.7 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.765 2.977 . . . . 1.76 112.26 174.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.607 ' CA ' ' HB3' ' A' ' 153' ' ' ARG . . . 113.24 -159.16 13.83 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.785 -0.721 . . . . 2.3700000000000001 113.3 171.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.442 HG13 HD23 ' A' ' 130' ' ' LEU . 14.4 pt -66.11 -27.32 40.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.319 0.58 . . . . 3.5600000000000001 110.703 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.611 ' HG ' HG23 ' A' ' 132' ' ' THR . 2.5 pt? -135.71 155.12 50.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.695 -0.854 . . . . 2.7599999999999998 108.695 173.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.89 72.22 2.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.166 0.508 . . . . 2.8399999999999999 111.712 -175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.611 HG23 ' HG ' ' A' ' 130' ' ' LEU . 15.1 p -76.9 -27.14 54.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.898 -0.592 . . . . 3.8999999999999999 110.266 175.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 69.58 -9.76 0.63 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.098 -0.955 . . . . 5.1299999999999999 111.377 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 132' ' ' THR . . . -163.22 -173.47 3.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.132 0.492 . . . . 0.93000000000000005 111.327 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.97 HG22 ' HG3' ' A' ' 84' ' ' PRO . 63.8 mt -105.83 110.96 33.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.221 -0.9 . . . . 1.05 110.791 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.573 ' HA ' ' CA ' ' A' ' 84' ' ' PRO . 37.1 pttt -139.06 42.06 2.09 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.407 0.891 . . . . 1.5 113.407 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.826 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -156.4 174.82 14.85 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.458 0.703 . . . . 0.87 110.699 176.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 17.0 m120 -47.9 -158.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.735 1.214 . . . . 1.8 113.596 167.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.828 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 7.3 m-85 -30.66 -58.71 0.21 Allowed 'General case' 0 C--O 1.204 -1.295 0 C-N-CA 125.416 1.486 . . . . 1.3700000000000001 114.35 -166.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.798 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 21.5 m 48.51 104.68 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.575 0.954 . . . . 0.29999999999999999 113.575 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.761 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.9 t -96.35 149.52 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.012 -0.675 . . . . 0.80000000000000004 111.26 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.2 m-85 -104.48 131.96 51.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.218 -0.66 . . . . 0.53000000000000003 109.218 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.866 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.1 tp -81.03 106.07 12.74 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.157 -0.683 . . . . 0.51000000000000001 109.157 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.798 HG21 HD13 ' A' ' 15' ' ' ILE . 12.2 mm -106.36 124.0 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 108.911 -0.774 . . . . 0.20000000000000001 108.911 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.57 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 39.2 p30 -75.34 -177.72 3.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.135 -0.484 . . . . 1.3 111.404 -175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 36' ' ' SER . 75.3 mtp180 -70.92 -1.17 11.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 3.7799999999999998 111.897 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -112.25 -19.16 12.33 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.597 0.713 . . . . 1.1799999999999999 109.45 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 103.77 27.76 6.22 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 114.913 -1.04 . . . . 0.23000000000000001 112.126 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.479 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 84.2 t -109.62 129.64 23.69 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.651 -0.323 . . . . 0.62 110.411 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.532 ' HD2' HG21 ' A' ' 125' ' ' THR . 6.9 Cg_exo -71.86 114.98 4.12 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.719 2.279 . . . . 0.29999999999999999 111.573 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.595 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.7 t -100.24 -21.61 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.89 -0.596 . . . . 0.27000000000000002 110.562 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.0 mm-40 -152.64 164.54 37.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.155 -0.475 . . . . 1.22 110.364 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.607 ' HB3' ' CA ' ' A' ' 128' ' ' GLY . 34.4 ttp85 -139.53 102.32 4.43 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.115 -0.698 . . . . 1.75 109.115 169.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.866 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 14.4 m-85 -90.92 109.24 20.46 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.23 -0.656 . . . . 0.38 109.23 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.76 ' HA ' HG23 ' A' ' 140' ' ' THR . 5.0 p -63.43 164.98 12.65 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 109.153 -0.684 . . . . 0.98999999999999999 109.153 175.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.798 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 61.0 Cg_endo -68.24 -4.45 12.76 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.65 2.234 . . . . 0.66000000000000003 112.944 -163.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.83 -10.3 76.11 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.021 -0.991 . . . . 0.52000000000000002 111.831 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.35 139.5 36.54 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.461 -0.57 . . . . 0.42999999999999999 109.461 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.1 m -95.09 178.65 5.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.346 -0.388 . . . . 1.25 111.102 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 62.7 t -54.58 -48.62 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.998 0.428 . . . . 0.40999999999999998 110.968 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.92 -29.42 69.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.782 -0.645 . . . . 3.4399999999999999 110.727 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.32 -34.31 77.1 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.451 -0.795 . . . . 1.8600000000000001 110.125 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.569 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 53.5 mt -81.26 -41.27 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.74 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 50.8 mt-10 -58.2 -38.83 77.53 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.035 0.383 . . . . 0.88 112.035 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.566 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 11.6 pt-20 -59.93 -18.53 45.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 0.75 111.594 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.615 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.6 mmtp -111.15 -17.76 13.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.078 0.466 . . . . 1.5800000000000001 110.509 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.5 tp -92.44 -39.43 11.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.77 -0.65 . . . . 0.23999999999999999 111.96 -172.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.82 ' HA ' HD12 ' A' ' 171' ' ' LEU . 76.7 mt -49.96 -51.24 63.14 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.663 0.616 . . . . 0.44 112.663 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.9 Cg_endo -55.71 -38.76 93.95 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.121 1.881 . . . . 0.48999999999999999 112.246 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 33.1 mt -73.62 -35.74 65.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.467 -0.333 . . . . 0.70999999999999996 110.969 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.99 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 22.0 mt -57.12 -57.61 11.84 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.368 0.604 . . . . 0.46000000000000002 109.646 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -50.35 -62.73 4.88 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.286 -1.324 . . . . 1.52 112.201 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t -170.48 121.96 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 2.52 110.285 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.57 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -93.57 -21.29 19.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.319 0.581 . . . . 3.5600000000000001 110.371 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -177.67 -42.53 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.376 -1.342 . . . . 7.8600000000000003 107.376 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.255 1.366 0 CA-C-N 114.014 -1.448 . . . . 4.8099999999999996 108.466 169.159 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.664 ' N ' ' HG ' ' A' ' 13' ' ' SER . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.756 -0.538 . . . . 5.5099999999999998 111.756 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.5 mtm 62.77 30.99 16.74 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.706 0.402 . . . . 5.0499999999999998 111.07 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.97 66.27 1.5 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 1.3700000000000001 112.378 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.664 ' HG ' ' N ' ' A' ' 10' ' ' GLY . 20.4 m -93.79 -29.4 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.413 0.625 . . . . 1.6799999999999999 110.324 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.0 p -150.29 174.95 12.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 0.65000000000000002 108.573 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.675 HD13 HG21 ' A' ' 144' ' ' ILE . 24.3 pt -62.28 -27.04 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.913 0.387 . . . . 0.29999999999999999 111.427 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.866 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 34.7 m-85 -80.34 7.99 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.27000000000000002 111.125 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.05 -16.28 60.6 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.231 -1.026 . . . . 1.96 108.231 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 71.9 m-85 -111.73 155.14 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.677 -1.147 . . . . 0.40000000000000002 111.211 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -100.95 144.31 30.04 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.529 -0.545 . . . . 2.77 109.529 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.574 HG23 ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -125.93 167.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.73999999999999999 110.493 -178.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.007 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 93.6 mt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.292 -0.413 . . . . 0.71999999999999997 110.245 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.52 -172.9 2.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.177 -0.675 . . . . 1.5900000000000001 109.177 176.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.688 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -54.0 -30.96 49.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.828 0.347 . . . . 0.52000000000000002 111.304 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 18.8 t70 -89.56 -16.38 30.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 2.2200000000000002 111.469 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 1.007 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 15.3 m-70 83.74 25.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.998 0.919 . . . . 0.72999999999999998 109.68 -175.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.782 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 mmpt? -84.67 146.51 46.82 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 105.515 -2.032 . . . . 3.25 105.515 164.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.92 113.08 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 119.722 0.936 . . . . 0.85999999999999999 111.292 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.574 ' HB3' HG23 ' A' ' 20' ' ' VAL . 89.3 t80 -79.63 120.86 24.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.542 -0.753 . . . . 0.28000000000000003 109.816 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.577 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -67.84 84.12 0.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.477 -0.783 . . . . 1.6499999999999999 109.728 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.866 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -72.74 -35.12 67.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.525 0.679 . . . . 0.25 110.142 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.741 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.5 p -76.55 -1.07 3.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.991 -1.004 . . . . 0.40999999999999998 112.919 -167.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.1 pt20 -82.4 -5.1 58.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.303 0.573 . . . . 1.24 109.669 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.419 ' CG ' HG21 ' A' ' 70' ' ' THR . 88.1 m-70 -92.54 -8.55 44.11 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.95 -1.13 . . . . 0.38 107.95 177.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 36.4 ttpt -71.86 133.88 45.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.235 -0.893 . . . . 1.73 109.341 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 -1.25 57.65 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 109.862 -1.295 . . . . 0.35999999999999999 109.862 -168.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 33.6 m -142.21 124.97 9.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.518 -0.841 . . . . 1.1399999999999999 108.879 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.84 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 14.6 Cg_endo -59.0 147.86 88.03 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.58 1.52 . . . . 0.52000000000000002 110.755 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.553 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -150.68 151.29 32.24 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.243 0.544 . . . . 1.03 111.506 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.755 HD21 HG21 ' A' ' 163' ' ' ILE . 7.1 mp -108.51 152.14 25.13 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.69 -0.686 . . . . 1.1000000000000001 109.266 171.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 72.6 mt -140.98 118.77 9.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 110.147 -0.316 . . . . 0.20000000000000001 110.147 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.832 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 20.6 m-85 -105.11 124.27 49.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.426 0.155 . . . . 0.23000000000000001 111.324 -173.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.582 ' HB3' HG11 ' A' ' 110' ' ' VAL . 1.3 p30 -81.0 91.67 6.09 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.841 -1.17 . . . . 1.28 107.841 167.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.592 HG11 ' HE1' ' A' ' 98' ' ' PHE . 2.4 p -109.05 135.41 48.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 113.288 0.848 . . . . 0.88 113.288 -162.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.484 ' HB2' ' HA3' ' A' ' 85' ' ' GLY . . . -60.63 107.89 0.75 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.766 -1.198 . . . . 0.52000000000000002 107.766 170.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 1.031 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -71.62 84.67 0.87 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.775 -1.102 . . . . 1.8400000000000001 113.0 -165.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.0 tmtp? 60.44 53.56 4.18 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.631 -0.713 . . . . 2.4300000000000002 110.733 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 p -163.69 136.56 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.757 -0.656 . . . . 0.98999999999999999 110.43 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.78 -113.57 4.38 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.626 -0.797 . . . . 1.0900000000000001 112.561 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -135.56 169.26 17.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.097 0.475 . . . . 3.1600000000000001 111.736 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.664 HG22 ' HE1' ' A' ' 139' ' ' PHE . 40.0 p -126.07 139.65 53.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.432 -0.804 . . . . 1.9399999999999999 109.41 171.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 27.7 mtpp -106.16 18.87 21.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 2.0299999999999998 111.09 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.63 13.34 32.7 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.822 -0.704 . . . . 0.46999999999999997 111.709 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 -43.22 16.53 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.866 -0.494 . . . . 0.34000000000000002 111.866 -175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.606 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.2 t80 -68.05 -49.14 63.19 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 120.668 0.27 . . . . 0.56999999999999995 110.331 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -54.82 -55.14 33.44 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.88 -0.6 . . . . 2.46 110.486 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 160' ' ' VAL . 93.4 m -62.61 -46.96 85.85 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.009 -0.996 . . . . 0.33000000000000002 111.287 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.89 -49.29 78.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.858 0.361 . . . . 0.19 111.152 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.9 m -59.6 -50.58 73.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.721 -0.672 . . . . 0.29999999999999999 110.749 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.0 p -65.7 -37.68 87.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 1.0800000000000001 112.045 -175.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 84.5 mt -61.55 -52.4 64.62 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 121.158 -0.217 . . . . 0.81000000000000005 110.951 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.639 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 53.1 t80 -51.89 -51.82 54.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.777 -0.823 . . . . 0.33000000000000002 108.777 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.47 -30.32 68.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.304 -0.862 . . . . 1.76 112.036 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -86.06 -39.68 16.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.598 0.222 . . . . 1.79 111.598 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.647 ' CD1' HD13 ' A' ' 171' ' ' LEU . 60.5 m-85 -108.35 9.91 27.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 114.485 1.291 . . . . 0.42999999999999999 114.485 -170.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 18.3 mtmm -59.34 -26.81 65.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.941 -0.704 . . . . 2.1099999999999999 110.061 170.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 m -60.5 -30.21 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.593 -0.73 . . . . 1.2 111.627 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -104.44 12.98 32.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.984 0.421 . . . . 1.8999999999999999 111.206 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.47 65.58 1.66 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.592 -0.813 . . . . 1.3200000000000001 112.299 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 65.5 t80 -129.03 137.72 51.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.75 0.31 . . . . 0.26000000000000001 110.639 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -129.17 143.06 50.73 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 120.928 0.394 . . . . 0.51000000000000001 110.746 177.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.709 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 29.9 t -114.31 120.95 65.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.935 0.398 . . . . 0.23999999999999999 110.621 171.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 20.0 mt -105.69 122.87 46.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.297 -0.631 . . . . 0.51000000000000001 109.297 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.057 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -111.53 116.19 30.45 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.298 -0.561 . . . . 0.28000000000000003 110.904 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.581 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.1 m-85 -100.06 110.04 58.23 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.018 -0.734 . . . . 0.34000000000000002 109.018 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.031 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 53.2 Cg_exo -54.67 165.81 2.28 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 123.606 2.871 . . . . 0.72999999999999998 111.421 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.1 m -123.45 134.68 53.9 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 118.569 -1.252 . . . . 1.54 113.943 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.575 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 22.5 t30 -100.46 88.68 3.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.8 -1.545 . . . . 2.52 109.838 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.963 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 2.1 mp0 -66.0 -15.12 62.73 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.8 0.667 . . . . 3.1800000000000002 112.8 -172.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -66.83 -9.51 38.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.147 0.499 . . . . 3.7999999999999998 110.295 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.855 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -64.02 -27.14 70.91 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.702 -0.681 . . . . 1.45 112.138 175.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 138.11 -80.78 0.28 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.5 -0.857 . . . . 1.4299999999999999 112.82 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.742 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -100.97 17.86 21.17 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 112.009 0.374 . . . . 1.4299999999999999 112.009 -174.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.963 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 9.1 mm-40 -60.88 149.52 80.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.552 0.215 . . . . 3.0600000000000001 110.671 -169.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.739 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 46.3 Cg_endo -71.37 -155.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 122.397 2.065 . . . . 1.6100000000000001 113.605 -166.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 44' ' ' ALA . . . 68.47 26.71 74.19 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.566 -0.743 . . . . 1.3899999999999999 112.116 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 66.26 92.24 0.08 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.497 0.665 . . . . 3.6899999999999999 110.153 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.73 -14.47 8.65 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.008 -0.996 . . . . 2.4700000000000002 112.251 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -78.81 -23.2 45.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.013 0.435 . . . . 3.6400000000000001 110.906 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.42 -61.02 2.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.403 0.62 . . . . 2.4199999999999999 110.391 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.414 HD13 ' SG ' ' A' ' 95' ' ' CYS . 20.5 mt -80.89 43.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 122.081 0.943 . . . . 2.0499999999999998 111.001 -173.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' HB3' ' HE3' ' A' ' 91' ' ' LYS . 25.5 mtpp -76.32 -32.24 58.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.569 -0.741 . . . . 4.0 110.563 174.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.98 -10.73 2.64 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.98 -1.009 . . . . 3.1000000000000001 111.632 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -74.81 173.82 10.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.799 0.333 . . . . 1.9099999999999999 110.465 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.7 m -126.48 139.2 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 108.201 -1.037 . . . . 1.6499999999999999 108.201 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.565 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 83.9 m -127.73 122.41 32.78 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.109 -0.636 . . . . 0.91000000000000003 111.388 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -127.39 157.33 40.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.279 -0.873 . . . . 1.9199999999999999 109.331 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.688 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -38.97 111.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.135 0.574 . . . . 3.1800000000000002 111.33 175.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.606 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 46.4 p90 -64.35 -22.07 66.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.872 -0.604 . . . . 1.74 111.794 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp 66.66 146.6 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.79 0.681 . . . . 3.0800000000000001 111.72 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.452 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -166.63 -165.87 0.79 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.327 -0.397 . . . . 0.42999999999999999 111.371 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.9 1.78 53.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.287 0.565 . . . . 2.1899999999999999 110.497 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.657 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 51.7 p90 -123.83 165.3 24.24 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 108.56 -0.904 . . . . 0.23999999999999999 108.56 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.759 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 29.1 Cg_exo -67.87 120.97 7.97 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.732 2.955 . . . . 0.31 113.256 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.057 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mp -114.93 140.29 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.22 -0.659 . . . . 0.37 109.22 173.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.759 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.3 mmt -115.37 -150.44 0.46 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.046 0.758 . . . . 1.47 113.046 -165.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.98 135.39 43.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.831 -1.077 . . . . 0.39000000000000001 110.756 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.895 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttp -74.03 116.9 15.2 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.316 -0.994 . . . . 1.6599999999999999 108.316 167.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.488 HD12 ' CB ' ' A' ' 116' ' ' HIS . 4.8 pt -122.67 175.99 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 114.615 -1.175 . . . . 0.46999999999999997 107.986 -174.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.855 HD21 ' HA3' ' A' ' 80' ' ' GLY . 3.1 m120 -73.33 114.92 12.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.057 -1.09 . . . . 2.1600000000000001 108.057 169.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.715 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -114.49 83.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 118.992 -1.083 . . . . 0.38 108.913 166.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.742 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 9.3 t-20 170.52 179.41 0.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.428 -0.953 . . . . 1.98 108.428 169.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 59.9 -146.22 45.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.78000000000000003 113.879 165.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -105.11 -14.28 15.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.654 0.74 . . . . 1.98 109.475 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.06 -12.19 50.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.962 -1.017 . . . . 2.04 110.866 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -43.98 149.49 0.32 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.707 1.003 . . . . 0.47999999999999998 113.707 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.509 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 41.2 t-80 -55.06 133.57 68.15 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 114.847 -1.07 . . . . 0.41999999999999998 110.507 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 2.5 Cg_endo -46.86 -47.77 15.64 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.917 2.411 . . . . 0.35999999999999999 112.788 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.509 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.79 -43.26 72.7 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.956 -0.565 . . . . 1.1000000000000001 111.414 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.541 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.0 m-85 -75.42 -29.92 59.9 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 122.24 -0.287 . . . . 1.49 111.077 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 8.9 mm-40 -58.0 -42.21 84.73 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.31 -0.556 . . . . 2.3700000000000001 109.622 168.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 83.9 t80 -61.59 -52.25 65.19 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 120.923 0.392 . . . . 0.57999999999999996 110.483 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.476 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 66.0 mtt -60.05 -50.04 75.29 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.325 0.583 . . . . 0.34000000000000002 110.752 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 119' ' ' TYR . 2.9 ttpm? -61.51 -38.21 86.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.729 -1.123 . . . . 0.93999999999999995 111.396 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 16.2 ptpt -76.57 -35.9 57.92 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.77 0.285 . . . . 2.1299999999999999 111.77 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.573 HG21 ' HD2' ' A' ' 150' ' ' PRO . 86.4 m -63.47 -42.61 98.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.088 0.471 . . . . 0.46999999999999997 110.798 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.685 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.0 ttmt -137.02 118.59 11.13 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.327 -0.62 . . . . 1.75 109.327 169.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.466 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 73.8 Cg_endo -83.29 6.7 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.241 2.627 . . . . 1.76 112.885 -173.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 110.73 -173.06 15.78 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.985 -0.626 . . . . 2.3700000000000001 112.342 175.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.0 mm -110.47 -23.71 4.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.41 0.624 . . . . 3.5600000000000001 109.665 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.5 pt? -124.77 136.28 53.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.622 -0.717 . . . . 2.7599999999999998 109.713 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 50.56 57.16 6.92 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.683 0.614 . . . . 2.8399999999999999 110.471 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.6 p -58.82 119.01 6.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.787 -0.642 . . . . 3.8999999999999999 112.68 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.6 tttp 177.05 -60.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.507 -1.224 . . . . 5.1299999999999999 109.696 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -158.36 -168.06 2.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.577 0.954 . . . . 0.93000000000000005 113.577 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.882 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 23.7 mt -83.24 168.29 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 114.225 -1.352 . . . . 1.05 109.142 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HB3' ' NZ ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER 179.02 -35.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.279 0.945 . . . . 1.5 112.873 -176.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.882 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.13 171.76 8.25 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.904 0.882 . . . . 0.87 112.201 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.437 ' ND2' ' HA2' ' A' ' 85' ' ' GLY . 17.6 m120 -44.46 -157.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.407 1.483 . . . . 1.8 114.122 169.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.832 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 31.7 m-85 -28.56 -56.96 0.13 Allowed 'General case' 0 C--O 1.208 -1.111 0 C-N-CA 125.259 1.424 . . . . 1.3700000000000001 114.323 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.81 HG23 ' HA ' ' A' ' 155' ' ' SER . 7.0 m 42.87 95.73 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.398 0.888 . . . . 0.29999999999999999 113.398 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.5 p -85.12 152.07 23.66 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.328 -0.549 . . . . 0.80000000000000004 110.722 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 6.1 m-85 -103.36 137.71 41.11 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.802 -1.184 . . . . 0.53000000000000003 107.802 166.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.977 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 44.7 tp -82.58 104.91 13.2 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.838 -0.801 . . . . 0.51000000000000001 108.838 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.675 HG21 HD13 ' A' ' 15' ' ' ILE . 16.9 mm -102.69 119.27 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.775 -0.824 . . . . 0.20000000000000001 108.775 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.524 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.6 OUTLIER -72.12 179.72 3.19 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.133 0.492 . . . . 1.3 110.292 -176.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -61.83 -12.58 18.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.519 -0.764 . . . . 3.7799999999999998 112.554 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -111.12 -21.36 11.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 1.1799999999999999 110.294 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 110.55 35.56 2.05 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.554 -0.748 . . . . 0.23000000000000001 112.864 177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 96.0 t -112.08 124.36 32.38 Favored Pre-proline 0 C--N 1.319 -0.75 0 O-C-N 122.584 -0.363 . . . . 0.62 110.361 175.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.573 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -66.9 99.87 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.29999999999999999 111.761 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.5 t -84.03 -21.19 8.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.581 . . . . 0.27000000000000002 110.798 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.685 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 mm-40 -159.16 164.55 35.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.786 -0.45 . . . . 1.22 109.786 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.625 HH11 ' HH2' ' A' ' 137' ' ' TRP . 26.2 ttm180 -131.59 97.56 4.26 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.344 -0.614 . . . . 1.75 109.344 171.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.977 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 40.7 m-85 -81.92 111.13 17.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.224 -0.658 . . . . 0.38 109.224 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.81 ' HA ' HG23 ' A' ' 140' ' ' THR . 0.9 OUTLIER -58.72 163.66 5.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.519 -0.549 . . . . 0.98999999999999999 109.519 174.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.799 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 50.8 Cg_endo -67.69 -7.03 18.21 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.463 2.109 . . . . 0.66000000000000003 112.06 -169.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -86.1 -0.57 87.05 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.08 -0.963 . . . . 0.52000000000000002 112.694 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.88 135.36 36.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.942 0.401 . . . . 0.42999999999999999 110.538 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 172.79 9.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 1.25 110.62 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.485 ' HA ' HG23 ' A' ' 56' ' ' THR . 31.2 t -50.45 -53.86 10.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.532 -0.303 . . . . 0.40999999999999998 110.829 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 64.0 tttm -63.41 -35.28 79.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 3.4399999999999999 111.44 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -54.3 -40.87 68.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.541 0.686 . . . . 1.8600000000000001 109.485 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.766 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 61.2 mt -82.27 -40.66 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.838 -1.074 . . . . 0.20999999999999999 111.507 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 41.3 mt-10 -53.14 -42.26 65.91 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.282 0.475 . . . . 0.88 112.282 -176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 1.7 pt-20 -69.31 -2.37 10.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.408 0.521 . . . . 0.75 112.408 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.614 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 33.3 mmtm -116.66 -20.83 9.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.577 . . . . 1.5800000000000001 109.705 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.1 tp -93.29 -41.12 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.23999999999999999 111.95 -168.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.69 ' HA ' HD12 ' A' ' 171' ' ' LEU . 77.5 mt -49.86 -50.8 65.86 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.703 0.631 . . . . 0.44 112.703 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.5 Cg_exo -54.24 -36.56 86.6 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.236 1.958 . . . . 0.48999999999999999 112.835 176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.6 mt -75.99 -37.38 58.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.675 -0.239 . . . . 0.70999999999999996 110.966 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.84 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.8 mt -59.7 -48.59 81.08 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.716 0.77 . . . . 0.46000000000000002 109.033 175.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -49.29 -65.23 2.86 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 114.241 -1.345 . . . . 1.52 112.42 167.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.4 p -171.58 126.49 0.62 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.767 0.284 . . . . 2.52 110.658 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -93.86 -18.45 21.97 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.374 0.607 . . . . 3.5600000000000001 110.39 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.529 ' HG3' ' HG ' ' A' ' 176' ' ' LEU . 18.7 ptp180 177.71 -29.44 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.839 -1.171 . . . . 7.8600000000000003 107.839 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.529 ' HG ' ' HG3' ' A' ' 175' ' ' ARG . 90.7 mt . . . . . 0 C--O 1.245 0.843 0 CA-C-N 114.271 -1.331 . . . . 4.8099999999999996 108.045 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.866 0 N-CA-C 111.602 -0.599 . . . . 5.5099999999999998 111.602 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.3 tpt -140.85 96.93 3.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.021 0.438 . . . . 5.0499999999999998 110.203 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 121' ' ' TYR . . . -166.61 -86.16 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.866 -0.606 . . . . 1.3700000000000001 111.869 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 m 72.46 -54.44 0.69 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.485 0.714 . . . . 1.6799999999999999 111.848 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 p -151.7 154.93 37.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.417 0.627 . . . . 0.65000000000000002 110.369 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 144' ' ' ILE . 13.8 pt -61.6 -21.46 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.913 -1.039 . . . . 0.29999999999999999 112.497 -175.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.785 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 62.2 m-85 -77.7 -2.57 36.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.39 0.515 . . . . 0.27000000000000002 112.39 -171.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -70.47 -17.46 62.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.632 0.73 . . . . 1.96 109.363 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 79.3 m-85 -100.38 162.6 12.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.191 -0.913 . . . . 0.40000000000000002 111.477 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.475 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 25.9 tt0 -93.97 153.61 18.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 2.77 110.733 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.587 HG12 ' HB3' ' A' ' 28' ' ' TYR . 75.6 t -133.05 139.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.037 0.446 . . . . 0.73999999999999999 111.186 173.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.992 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 95.6 mt -104.96 140.56 38.0 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.826 -0.805 . . . . 0.71999999999999997 108.826 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.82 -172.35 1.9 Allowed 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.268 -0.641 . . . . 1.5900000000000001 109.268 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -54.36 -33.06 58.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.753 0.311 . . . . 0.52000000000000002 111.306 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 19.6 t70 -86.85 -11.67 50.14 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.418 -0.355 . . . . 2.2200000000000002 111.287 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.992 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 42.3 m-70 79.37 22.31 0.57 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.618 0.767 . . . . 0.72999999999999998 109.745 -176.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.761 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -84.13 146.0 47.37 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 105.857 -1.905 . . . . 3.25 105.857 166.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.89 114.6 1.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.157 1.238 . . . . 0.85999999999999999 112.695 -173.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.587 ' HB3' HG12 ' A' ' 20' ' ' VAL . 64.2 t80 -87.38 116.49 25.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.312 -0.858 . . . . 0.28000000000000003 110.134 172.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.642 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -66.73 93.85 0.27 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.102 -0.703 . . . . 1.6499999999999999 109.102 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.785 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -77.31 -34.3 55.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.361 0.6 . . . . 0.25 110.454 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.729 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.8 p -76.64 -0.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.271 -0.877 . . . . 0.40999999999999998 112.296 -168.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.642 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 4.0 pt20 -80.85 -5.24 57.04 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.963 -0.754 . . . . 1.24 108.963 173.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -101.35 20.64 15.49 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.897 -1.047 . . . . 0.38 108.341 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -96.94 150.95 20.18 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.462 -1.245 . . . . 1.73 108.742 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 -6.05 81.38 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.636 -0.985 . . . . 0.35999999999999999 110.636 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.578 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.2 m -140.72 141.75 26.0 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.798 -1.186 . . . . 1.1399999999999999 107.798 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.836 ' HG2' HD23 ' A' ' 171' ' ' LEU . 3.2 Cg_exo -75.99 157.54 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.019 1.813 . . . . 0.52000000000000002 111.365 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.562 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -154.67 148.61 25.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.249 0.547 . . . . 1.03 111.251 -174.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.616 HD23 ' CE1' ' A' ' 69' ' ' PHE . 3.8 mm? -107.29 150.7 26.39 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.262 -1.014 . . . . 1.1000000000000001 108.262 171.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 66.9 mt -139.64 118.7 12.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.623 -0.51 . . . . 0.20000000000000001 109.623 -174.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.841 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 38.8 m-85 -103.07 124.15 47.99 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 121.154 -0.218 . . . . 0.23000000000000001 111.359 -174.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.709 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -78.56 92.0 4.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.901 -1.148 . . . . 1.28 107.901 166.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.6 p -108.62 143.42 18.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 113.363 0.875 . . . . 0.88 113.363 -161.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HA ' ' OG ' ' A' ' 76' ' ' SER . . . -67.04 110.43 3.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.438 -1.319 . . . . 0.52000000000000002 107.438 170.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.972 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -67.89 81.27 0.2 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.061 -0.972 . . . . 1.8400000000000001 111.869 -167.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.651 ' HB3' ' HA ' ' A' ' 98' ' ' PHE . 14.1 ptpt 46.01 66.37 0.96 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.274 1.43 . . . . 2.4300000000000002 112.46 -173.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -162.65 138.07 7.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -1.02 . . . . 0.98999999999999999 110.154 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.13 -140.97 30.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.842 -0.694 . . . . 1.0900000000000001 113.346 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -84.07 170.09 14.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.075 0.464 . . . . 3.1600000000000001 111.77 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -130.15 -28.44 2.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.949 -0.569 . . . . 1.9399999999999999 111.424 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.876 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.4 mmmt 66.27 3.52 2.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.255 0.622 . . . . 2.0299999999999998 111.917 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.04 1.9 59.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.818 -0.706 . . . . 0.46999999999999997 112.28 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -32.4 81.92 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.468 -0.653 . . . . 0.34000000000000002 111.468 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.518 ' HE1' ' HB1' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -66.21 -49.34 67.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.203 -0.498 . . . . 0.56999999999999995 110.185 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.63 -43.51 89.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.505 -0.771 . . . . 2.46 110.119 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 160' ' ' VAL . 55.1 m -57.94 -53.26 60.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.516 -0.765 . . . . 0.33000000000000002 110.527 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.68 -49.48 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.719 -0.673 . . . . 0.19 111.846 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.647 HG23 ' HB2' ' A' ' 101' ' ' GLU . 63.0 m -59.22 -45.39 91.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.891 -0.595 . . . . 0.29999999999999999 110.754 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.9 m -64.07 -48.44 76.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.652 -0.704 . . . . 1.0800000000000001 110.78 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 95.1 mt -56.59 -53.04 62.28 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.803 0.298 . . . . 0.81000000000000005 111.803 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.61 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 70.9 t80 -53.23 -53.35 52.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.788 -0.642 . . . . 0.33000000000000002 109.755 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -73.96 -27.43 60.99 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.371 -0.832 . . . . 1.76 111.815 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.75 -48.34 12.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.839 0.352 . . . . 1.79 111.411 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.695 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.8 m-85 -99.1 6.17 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.258 0.836 . . . . 0.42999999999999999 113.258 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -57.81 -29.85 65.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.808 0.337 . . . . 2.1099999999999999 110.316 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -63.57 -32.8 74.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 1.2 111.061 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -96.5 10.78 37.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 1.8999999999999999 110.689 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 80.66 64.07 1.85 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.945 -0.645 . . . . 1.3200000000000001 112.19 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.616 ' CE1' HD23 ' A' ' 39' ' ' LEU . 70.6 t80 -129.66 143.85 51.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.727 0.299 . . . . 0.26000000000000001 110.912 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.6 146.77 52.37 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 120.853 0.358 . . . . 0.51000000000000001 110.416 177.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.738 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 42.5 t -116.52 120.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.96 -0.385 . . . . 0.23999999999999999 109.96 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 26.7 mt -106.38 123.07 47.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.654 -0.498 . . . . 0.51000000000000001 109.654 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.025 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -104.91 131.32 52.56 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.103 0.478 . . . . 0.28000000000000003 110.266 175.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 8.2 m-85 -117.27 106.98 46.07 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.219 -0.66 . . . . 0.34000000000000002 109.219 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.029 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 52.6 Cg_exo -56.69 169.06 1.93 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.993 3.129 . . . . 0.72999999999999998 112.04 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' A' ' 44' ' ' ALA . 3.7 p -114.49 136.5 52.94 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 115.419 1.637 . . . . 1.54 115.419 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.527 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 29.0 m-20 -99.63 73.73 1.83 Allowed 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 113.924 -1.489 . . . . 2.52 109.176 166.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 1.047 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 55.1 mt-30 -64.09 -12.28 37.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.774 -0.648 . . . . 3.1800000000000002 112.447 -173.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -66.1 -8.86 26.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.147 -0.479 . . . . 3.7999999999999998 110.845 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.605 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -60.36 -42.89 99.05 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.099 -0.501 . . . . 1.45 112.735 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.9 -60.82 0.45 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.504 -0.855 . . . . 1.4299999999999999 112.748 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.688 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.5 pm0 -110.98 9.9 22.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.785 0.293 . . . . 1.4299999999999999 111.46 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 1.047 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 11.4 mm-40 -63.51 151.28 88.28 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.346 -0.388 . . . . 3.0600000000000001 110.442 -171.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.885 ' HG3' HG22 ' A' ' 135' ' ' ILE . 10.5 Cg_exo -31.94 150.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 125.272 3.981 . . . . 1.6100000000000001 116.574 -173.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.33 14.49 66.14 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.313 -1.515 . . . . 1.3899999999999999 109.313 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.9 m120 69.08 -62.92 0.39 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.135 -1.032 . . . . 3.6899999999999999 110.737 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 178.0 140.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.5 0.5 . . . . 2.4700000000000002 110.188 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 65.39 49.82 1.82 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 3.6400000000000001 112.609 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.595 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 7.5 tp10 -91.76 -12.0 35.12 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.81 -1.182 . . . . 2.4199999999999999 107.81 165.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.812 HG12 ' SG ' ' A' ' 95' ' ' CYS . 2.2 mt -93.55 21.5 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.235 -0.893 . . . . 2.0499999999999998 108.868 171.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.676 ' HG3' ' H ' ' A' ' 92' ' ' GLU . 13.3 pttm -53.21 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.682 -0.69 . . . . 4.0 112.192 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.676 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 12.2 pt-20 -93.56 7.65 43.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.038 -0.983 . . . . 3.1000000000000001 109.53 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.449 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 88.2 m-85 -110.97 172.79 6.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.24 -0.891 . . . . 1.9099999999999999 111.083 -171.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 94' ' ' VAL . 6.6 p -130.9 110.83 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.529 -1.286 . . . . 1.6499999999999999 107.529 170.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.812 ' SG ' HG12 ' A' ' 90' ' ' ILE . 31.1 m -94.99 117.36 30.0 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 118.989 -1.084 . . . . 0.91000000000000003 110.218 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 95.7 m -153.99 128.63 9.33 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.378 -0.828 . . . . 1.9199999999999999 110.38 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 96' ' ' THR . 44.4 pttt 68.21 -44.73 0.5 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.584 1.328 . . . . 3.1800000000000002 114.584 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.651 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 62.03 -67.92 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.461 0.573 . . . . 1.74 111.577 -175.314 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.69 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 8.9 mmpt? 71.23 147.68 0.08 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.898 0.879 . . . . 3.0800000000000001 111.795 173.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.729 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -168.44 -166.66 0.71 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.101 0.477 . . . . 0.42999999999999999 111.968 -172.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.647 ' HB2' HG23 ' A' ' 58' ' ' THR . 29.0 mm-40 -88.79 27.69 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.299 -0.864 . . . . 2.1899999999999999 110.547 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.835 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 39.1 p90 -149.6 174.76 3.21 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 107.153 -1.425 . . . . 0.23999999999999999 107.153 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.79 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.4 Cg_exo -71.1 125.59 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.802 2.334 . . . . 0.31 113.322 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.025 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -124.43 141.49 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.247 -0.649 . . . . 0.37 109.247 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.79 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 6.4 mmt -115.48 -152.16 0.5 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.542 0.687 . . . . 1.47 112.714 -164.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -73.04 137.26 45.23 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.577 -1.192 . . . . 0.39000000000000001 110.707 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.029 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 26.7 pttt -73.13 120.97 19.49 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.764 -0.828 . . . . 1.6599999999999999 108.764 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.507 HD12 ' CB ' ' A' ' 116' ' ' HIS . 5.2 pt -122.53 169.36 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.795 -1.093 . . . . 0.46999999999999997 108.343 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.2 m120 -68.6 121.37 16.29 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.77 -1.196 . . . . 2.1600000000000001 107.77 169.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.709 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -119.16 83.57 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 C-N-CA 119.127 -1.029 . . . . 0.38 109.587 170.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.688 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 46.5 t30 170.96 177.97 0.06 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.076 -1.083 . . . . 1.98 108.076 167.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.76 -141.52 35.93 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.955 -0.641 . . . . 0.78000000000000003 113.779 164.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.23 1.52 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.121 -0.539 . . . . 1.98 110.601 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -87.75 -24.94 23.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.821 -0.627 . . . . 2.04 110.681 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.775 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -44.59 142.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.779 1.029 . . . . 0.47999999999999998 113.779 -175.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.507 ' CB ' HD12 ' A' ' 108' ' ' ILE . 49.3 t-80 -53.23 136.3 49.84 Favored Pre-proline 0 C--O 1.225 -0.236 0 CA-C-N 114.679 -1.146 . . . . 0.41999999999999998 110.012 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.56 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 3.2 Cg_exo -40.95 -45.34 5.03 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.172 2.581 . . . . 0.35999999999999999 112.845 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.522 HD11 ' HE3' ' A' ' 122' ' ' MET . 30.0 tp -54.02 -51.49 63.82 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.783 -0.644 . . . . 1.1000000000000001 111.884 176.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.5 m-85 -71.28 -30.4 66.22 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-N 116.517 -0.31 . . . . 1.49 111.0 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.474 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 9.6 mm-40 -56.26 -43.3 78.62 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.726 -0.79 . . . . 2.3700000000000001 109.413 170.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.9 t80 -66.03 -45.03 82.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.614 -0.434 . . . . 0.57999999999999996 110.508 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.522 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.9 mtt -60.76 -53.11 61.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.873 0.368 . . . . 0.34000000000000002 111.236 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 2.5 mtpm? -62.33 -38.24 88.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.799 -0.637 . . . . 0.93999999999999995 110.838 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 17.1 ptpt -74.82 -27.35 60.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.718 -0.219 . . . . 2.1299999999999999 110.816 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.537 HG21 ' HD2' ' A' ' 150' ' ' PRO . 59.1 m -65.02 -55.18 20.44 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.945 -0.302 . . . . 0.46999999999999997 111.068 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.69 ' HG2' ' H ' ' A' ' 128' ' ' GLY . 31.7 ttmt -146.01 135.55 11.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.278 -0.569 . . . . 1.75 111.574 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.646 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 49.4 Cg_endo -74.28 -22.46 16.49 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.245 2.63 . . . . 1.76 110.992 174.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.694 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 101.9 -147.42 17.41 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.264 -0.88 . . . . 2.3700000000000001 112.835 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.67 -26.79 18.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.027 -0.586 . . . . 3.5600000000000001 110.615 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.831 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.2 pt? -96.92 177.47 5.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.52 -0.764 . . . . 2.7599999999999998 110.517 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.03 -46.69 33.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.484 . . . . 2.8399999999999999 110.873 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.858 HG21 ' HE2' ' A' ' 136' ' ' LYS . 13.5 m -53.66 122.04 9.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.802 -1.09 . . . . 3.8999999999999999 111.789 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.646 ' HG2' ' HB3' ' A' ' 127' ' ' PRO . 89.3 mttt -86.63 5.56 35.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.217 -0.901 . . . . 5.1299999999999999 109.219 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.85 ' H ' HG22 ' A' ' 132' ' ' THR . . . -111.41 159.31 18.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.357 0.873 . . . . 0.93000000000000005 113.357 -172.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.903 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 26.0 mt -103.19 90.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.845 -1.07 . . . . 1.05 110.79 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.858 ' HE2' HG21 ' A' ' 132' ' ' THR . 36.7 pttt -111.48 -2.38 15.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.451 0.537 . . . . 1.5 112.451 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.903 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -120.41 170.29 9.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.465 0.543 . . . . 0.87 112.465 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 16.3 m120 -47.98 -156.77 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.901 1.681 . . . . 1.8 113.745 172.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.841 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 33.2 m-85 -27.48 -57.96 0.1 Allowed 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 125.175 1.39 . . . . 1.3700000000000001 114.022 -164.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.775 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 24.2 m 42.94 95.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.046 0.758 . . . . 0.29999999999999999 113.046 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.678 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.3 t -88.33 147.13 24.92 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.997 -0.681 . . . . 0.80000000000000004 110.786 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 39' ' ' LEU . 5.2 m-85 -102.32 133.99 46.33 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.371 -0.974 . . . . 0.53000000000000003 108.371 169.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.906 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.9 tp -81.35 104.05 11.53 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.001 -0.74 . . . . 0.51000000000000001 109.001 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 15' ' ' ILE . 10.7 mm -104.07 116.86 48.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.92 -0.582 . . . . 0.20000000000000001 109.737 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' HB2' HD13 ' A' ' 170' ' ' LEU . 6.9 t70 -74.68 169.85 17.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.017 -0.538 . . . . 1.3 109.846 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.891 ' HD3' ' HA ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -60.36 -9.66 3.81 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.329 -0.851 . . . . 3.7799999999999998 112.09 -168.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.2 8.78 28.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.864 -0.791 . . . . 1.1799999999999999 108.864 -172.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.519 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 71.57 45.49 45.41 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.23000000000000001 112.559 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 79.7 t -123.24 123.06 26.69 Favored Pre-proline 0 C--N 1.321 -0.671 0 O-C-N 122.85 -0.206 . . . . 0.62 110.664 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.537 ' HD2' HG21 ' A' ' 125' ' ' THR . 16.0 Cg_exo -68.12 102.75 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.244 2.63 . . . . 0.29999999999999999 112.417 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.51 ' HB ' HD23 ' A' ' 143' ' ' LEU . 18.8 t -88.49 -15.35 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.822 -0.626 . . . . 0.27000000000000002 110.806 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.538 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 28.2 mm-40 -168.08 164.54 13.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.094 0.474 . . . . 1.22 111.273 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.694 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 20.3 ttm180 -133.95 99.31 4.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 1.75 109.546 173.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.906 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 23.5 m-85 -87.25 125.31 34.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.738 -0.838 . . . . 0.38 108.738 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.765 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 95.4 p -69.01 174.29 2.91 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.617 0.644 . . . . 0.98999999999999999 109.357 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.876 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 62.8 Cg_endo -68.31 -13.8 38.66 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.062 1.841 . . . . 0.66000000000000003 111.48 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -80.13 1.72 79.06 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.835 -1.075 . . . . 0.52000000000000002 111.699 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.92 133.77 35.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.981 0.42 . . . . 0.42999999999999999 110.306 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.6 m -90.95 178.52 6.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.109 -0.496 . . . . 1.25 110.221 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.557 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 45.1 t -54.61 -55.9 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 0.40999999999999998 111.034 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 25.8 tptp -62.91 -29.23 70.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 3.4399999999999999 111.265 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.65 -41.12 89.81 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.347 -0.612 . . . . 1.8600000000000001 109.347 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.706 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.9 mt -82.31 -38.44 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.891 . . . . 0.20999999999999999 111.344 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 49.0 mt-10 -54.59 -41.86 70.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.297 0.48 . . . . 0.88 112.297 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.1 pt-20 -65.62 -11.78 47.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.444 0.535 . . . . 0.75 112.444 -175.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.726 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 73.6 mmtt -109.89 -16.2 13.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.492 . . . . 1.5800000000000001 110.386 174.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.566 ' HG ' HD11 ' A' ' 171' ' ' LEU . 67.1 tp -95.61 -42.68 8.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.742 -0.663 . . . . 0.23999999999999999 111.845 -171.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.729 ' HA ' HD12 ' A' ' 171' ' ' LEU . 80.6 mt -49.79 -51.31 61.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.547 0.573 . . . . 0.44 112.547 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 57.0 Cg_exo -55.09 -30.94 72.94 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.271 1.981 . . . . 0.48999999999999999 113.154 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.414 HD13 ' HB2' ' A' ' 145' ' ' ASP . 64.7 mt -81.73 -34.21 30.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.52 0.2 . . . . 0.70999999999999996 110.75 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.836 HD23 ' HG2' ' A' ' 37' ' ' PRO . 12.6 mt -64.31 -41.4 96.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.694 0.759 . . . . 0.46000000000000002 109.245 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.47 12.21 2.72 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 114.411 -1.268 . . . . 1.52 113.278 171.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.891 ' HA ' ' HD3' ' A' ' 146' ' ' ARG . 19.3 t 78.2 130.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.413 1.085 . . . . 2.52 111.562 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.491 ' H ' ' NE ' ' A' ' 146' ' ' ARG . . . -90.09 -32.7 16.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.348 0.499 . . . . 3.5600000000000001 112.348 -174.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.662 ' HG3' HD12 ' A' ' 176' ' ' LEU . 23.5 ptt180 -144.74 -0.14 0.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.765 0.654 . . . . 7.8600000000000003 112.765 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.73 HD13 HH12 ' A' ' 146' ' ' ARG . 10.8 mp . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.443 -0.789 . . . . 4.8099999999999996 110.059 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.833 -0.507 . . . . 5.5099999999999998 111.833 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 54.9 ttp -98.74 -50.02 4.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.714 0.292 . . . . 5.0499999999999998 110.683 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.63 90.17 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.375 -0.917 . . . . 1.3700000000000001 112.923 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -123.3 -35.39 2.97 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.726 -0.842 . . . . 1.6799999999999999 108.726 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.0 p -145.08 174.85 10.69 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.979 -1.01 . . . . 0.65000000000000002 108.543 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.702 HD13 HG21 ' A' ' 144' ' ' ILE . 13.0 pt -65.15 -22.92 32.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 0.29999999999999999 111.203 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.841 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 52.6 m-85 -79.79 -0.28 33.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.195 -0.457 . . . . 0.27000000000000002 111.951 -172.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.91 -12.37 60.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.395 0.616 . . . . 1.96 109.52 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 91.2 m-85 -109.9 140.32 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.435 -0.802 . . . . 0.40000000000000002 110.991 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.99 140.6 33.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.698 -0.683 . . . . 2.77 110.631 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.573 HG23 HD13 ' A' ' 30' ' ' LEU . 70.0 t -114.46 148.74 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.935 0.398 . . . . 0.73999999999999999 110.914 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.835 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 81.6 mt -111.54 141.62 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.631 -0.713 . . . . 0.71999999999999997 109.246 176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.03 -171.75 2.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.487 -0.561 . . . . 1.5900000000000001 109.487 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.24 -32.93 57.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.605 -0.27 . . . . 0.52000000000000002 111.671 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.6 t70 -90.86 -8.33 49.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.597 -0.274 . . . . 2.2200000000000002 111.402 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.835 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.9 m-70 80.71 22.55 0.39 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.72999999999999998 110.239 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -81.61 160.68 63.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 N-CA-C 105.685 -1.968 . . . . 3.25 105.685 166.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.8 113.67 2.85 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 120.093 1.069 . . . . 0.85999999999999999 111.727 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.515 ' HB3' HG12 ' A' ' 20' ' ' VAL . 58.2 t80 -80.67 130.07 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 0.28000000000000003 109.969 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.757 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.5 t-20 -80.67 81.99 6.78 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.07 -0.715 . . . . 1.6499999999999999 109.07 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.841 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -67.86 -32.38 72.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.198 0.523 . . . . 0.25 110.219 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.679 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.33 -0.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.428 -0.806 . . . . 0.40999999999999998 112.634 -169.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.757 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.6 pt20 -83.55 -6.04 59.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.609 0.719 . . . . 1.24 109.164 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -91.73 -9.78 42.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.991 -1.114 . . . . 0.38 107.991 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -70.9 137.48 49.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.19 -1.368 . . . . 1.73 109.157 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.47 -10.56 53.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 109.913 -1.275 . . . . 0.35999999999999999 109.913 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 49.6 m -141.0 144.78 36.49 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.822 -0.807 . . . . 1.1399999999999999 108.822 177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.024 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 60.8 Cg_endo -71.89 155.69 57.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.909 1.739 . . . . 0.52000000000000002 111.259 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.603 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.7 pt? -154.19 152.68 30.64 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.153 0.501 . . . . 1.03 111.217 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 163' ' ' ILE . 6.8 mp -108.0 152.5 24.4 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.775 -0.824 . . . . 1.1000000000000001 108.775 172.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 78.9 mt -140.84 115.48 5.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.542 -0.54 . . . . 0.20000000000000001 109.542 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.909 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 17.7 m-85 -102.42 123.65 46.58 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 121.166 -0.213 . . . . 0.23000000000000001 110.982 -173.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.734 ' HB2' HG21 ' A' ' 110' ' ' VAL . 1.1 p30 -82.23 91.3 6.71 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.545 -0.909 . . . . 1.28 108.545 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.605 HG11 ' HE2' ' A' ' 98' ' ' PHE . 1.7 p -111.95 125.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 112.455 0.539 . . . . 0.88 112.455 -165.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.27 107.16 0.45 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.744 -1.576 . . . . 0.52000000000000002 106.744 168.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 1.071 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 3.3 p -76.71 75.67 3.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.28 -1.327 . . . . 1.8400000000000001 113.483 -156.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 82.6 tttt 92.45 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.627 1.171 . . . . 2.4300000000000002 111.538 174.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.6 m -141.57 143.26 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.446 -0.343 . . . . 0.98999999999999999 110.674 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.28 -136.69 19.15 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.031 -0.604 . . . . 1.0900000000000001 114.222 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.58 111.84 24.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 3.1600000000000001 111.815 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 p -73.33 -26.7 61.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.981 -0.554 . . . . 1.9399999999999999 110.648 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.86 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 39.2 mtpt 64.54 3.02 1.77 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.33 -0.85 . . . . 2.0299999999999998 112.259 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.84 -3.94 34.09 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.824 -0.703 . . . . 0.46999999999999997 112.641 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -31.15 79.83 Favored Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 111.702 -0.559 . . . . 0.34000000000000002 111.702 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.576 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -69.25 -52.72 24.9 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.073 0.463 . . . . 0.56999999999999995 110.138 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -60.29 -41.55 93.62 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.488 -0.778 . . . . 2.46 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.6 m -68.51 -40.82 80.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.816 -0.629 . . . . 0.33000000000000002 110.876 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -64.98 -49.3 70.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.19 111.283 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.1 m -59.18 -48.9 79.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.835 -0.621 . . . . 0.29999999999999999 111.177 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -63.8 -46.16 86.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.816 -0.629 . . . . 1.0800000000000001 111.27 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.686 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.78 -46.0 90.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.81000000000000005 111.338 -176.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.656 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 59.0 t80 -53.74 -57.34 11.19 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 123.277 0.361 . . . . 0.33000000000000002 110.427 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -67.14 -41.57 85.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.291 -0.413 . . . . 1.76 111.555 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -69.77 -42.79 73.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 1.79 111.717 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.686 ' CD1' HD13 ' A' ' 171' ' ' LEU . 67.7 m-85 -103.9 3.78 34.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.445 0.905 . . . . 0.42999999999999999 113.445 -172.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -58.48 -29.74 66.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.788 0.328 . . . . 2.1099999999999999 110.788 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.6 p -65.32 -38.55 90.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.2 111.237 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -89.24 1.89 55.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.816 0.341 . . . . 1.8999999999999999 111.255 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.508 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 93.08 73.43 1.23 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.701 -0.761 . . . . 1.3200000000000001 112.006 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.601 ' CE1' HD13 ' A' ' 39' ' ' LEU . 76.7 t80 -143.09 142.13 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.526 0.203 . . . . 0.26000000000000001 111.06 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.98 141.45 49.29 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 120.823 0.344 . . . . 0.51000000000000001 110.207 176.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.661 HG11 ' HB1' ' A' ' 57' ' ' ALA . 52.9 t -108.01 114.06 45.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.74 0.305 . . . . 0.23999999999999999 110.448 168.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 31.2 mt -98.48 122.63 41.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.828 -0.804 . . . . 0.51000000000000001 108.828 175.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.979 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.51 113.42 26.19 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.388 -0.525 . . . . 0.28000000000000003 110.345 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.76 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.4 m-85 -95.05 108.22 36.9 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.54 -0.911 . . . . 0.34000000000000002 108.54 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.071 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.2 Cg_exo -59.76 167.67 6.56 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 123.164 2.576 . . . . 0.72999999999999998 111.555 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 70.9 m -108.25 138.82 43.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.55 -1.26 . . . . 1.54 113.606 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.407 ' OD1' ' HD2' ' A' ' 79' ' ' PHE . 36.9 t30 -107.77 94.61 5.17 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 112.522 -2.126 . . . . 2.52 110.472 -174.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.713 ' NE2' ' H ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -51.95 -9.38 0.09 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.324 1.449 . . . . 3.1800000000000002 114.683 -176.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.407 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 64.8 m-85 -89.14 -15.18 34.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.738 0.304 . . . . 3.7999999999999998 111.8 -166.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.88 -39.05 60.06 Favored Glycine 0 CA--C 1.506 -0.504 0 N-CA-C 110.908 -0.877 . . . . 1.45 110.908 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.96 -85.03 0.24 Allowed Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 120.778 -0.725 . . . . 1.4299999999999999 112.031 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.748 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -89.22 32.77 0.82 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.798 0.666 . . . . 1.4299999999999999 112.798 -169.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.707 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -61.09 154.29 62.03 Favored Pre-proline 0 C--N 1.321 -0.658 0 O-C-N 121.982 -0.449 . . . . 3.0600000000000001 110.719 -177.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.764 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -29.01 149.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.463 1 C-N-CA 125.476 4.117 . . . . 1.6100000000000001 116.818 -176.515 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.32 10.77 85.94 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.841 -1.072 . . . . 1.3899999999999999 110.466 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.22 44.12 25.46 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.182 -0.673 . . . . 3.6899999999999999 109.182 -173.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 88' ' ' GLU . 11.4 pt-20 49.36 -175.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.879 1.272 . . . . 2.4700000000000002 112.026 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 87' ' ' GLU . 35.9 mt-10 64.57 3.36 1.9 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.503 -0.771 . . . . 3.6400000000000001 112.833 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -81.28 -13.79 58.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.682 -0.859 . . . . 2.4199999999999999 108.682 172.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.649 HG12 ' SG ' ' A' ' 95' ' ' CYS . 21.1 mt -110.78 40.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.473 -1.24 . . . . 2.0499999999999998 109.657 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 60.2 mtpt -96.38 123.66 40.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.126 -0.943 . . . . 4.0 108.584 171.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 2.7 pt-20 72.95 -37.56 0.39 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.365 1.066 . . . . 3.1000000000000001 109.502 -170.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.473 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 41.1 m-85 -74.77 152.53 39.03 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.603 -0.888 . . . . 1.9099999999999999 108.603 169.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.55 121.59 53.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.193 0.52 . . . . 1.6499999999999999 109.817 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.821 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 56.1 m -97.03 120.89 38.23 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.054 -0.659 . . . . 0.91000000000000003 111.232 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.947 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 17.0 m -153.0 115.28 4.41 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.225 -0.898 . . . . 1.9199999999999999 109.304 168.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.662 ' O ' HG21 ' A' ' 104' ' ' ILE . 87.6 mttt 64.27 -40.24 0.24 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 115.006 1.484 . . . . 3.1800000000000002 115.006 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.695 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER 63.2 -36.55 0.15 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.004 1.322 . . . . 1.74 112.308 -171.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 97' ' ' LYS . 70.9 mmtt 69.54 130.86 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.828 0.851 . . . . 3.0800000000000001 112.581 172.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.69 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -158.88 -171.38 3.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.847 -0.615 . . . . 0.42999999999999999 112.397 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -94.62 31.44 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.419 -0.81 . . . . 2.1899999999999999 111.092 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.877 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 39.2 p90 -150.43 167.31 13.24 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 108.154 -1.054 . . . . 0.23999999999999999 108.154 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.1 Cg_exo -64.04 106.52 0.67 Allowed 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 123.597 2.865 . . . . 0.31 113.527 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.979 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.4 mp -103.43 131.52 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.991 -0.744 . . . . 0.37 108.991 174.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.76 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.5 mmt -109.94 -154.17 0.53 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.118 0.784 . . . . 1.47 113.118 -161.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -69.56 125.22 26.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.123 -0.944 . . . . 0.39000000000000001 110.496 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.947 ' HE3' ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -64.5 120.55 12.53 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.617 -0.883 . . . . 1.6599999999999999 108.617 172.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.754 HG13 HG13 ' A' ' 110' ' ' VAL . 9.2 pt -121.39 155.04 25.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.29 -1.004 . . . . 0.46999999999999997 108.29 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.431 ' ND2' HE21 ' A' ' 82' ' ' GLN . 2.2 t30 -83.19 69.61 9.94 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.123 -1.066 . . . . 2.1600000000000001 108.123 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.7 90.65 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.38 111.007 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.748 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 46.5 t30 174.16 172.55 0.19 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.505 -0.924 . . . . 1.98 108.505 166.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.21 -142.49 23.23 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 114.471 0.548 . . . . 0.78000000000000003 114.471 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -1.52 32.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.49 0.662 . . . . 1.98 110.558 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -95.68 -13.15 24.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.089 -0.959 . . . . 2.04 110.688 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.581 ' HB2' ' H ' ' A' ' 111' ' ' ASN . . . -57.84 149.52 22.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.562 -0.745 . . . . 0.47999999999999998 111.913 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.553 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 20.2 t-80 -46.99 139.73 6.72 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.118 -0.946 . . . . 0.41999999999999998 110.131 171.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.476 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 11.0 Cg_endo -54.18 -35.34 82.21 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.224 2.616 . . . . 0.35999999999999999 112.437 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.562 HD11 ' HE3' ' A' ' 122' ' ' MET . 23.4 tp -61.57 -40.46 94.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.908 -0.587 . . . . 1.1000000000000001 110.572 175.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.9 m-85 -75.63 -28.9 58.98 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.224 -0.443 . . . . 1.49 111.009 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' A' ' 117' ' ' PRO . 40.2 mt-10 -57.6 -39.96 77.99 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.951 -0.7 . . . . 2.3700000000000001 109.181 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.501 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 79.1 t80 -71.67 -41.74 68.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 0.57999999999999996 110.519 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.562 ' HE3' HD11 ' A' ' 118' ' ' LEU . 65.6 mtt -66.68 -53.01 38.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.133 -0.485 . . . . 0.34000000000000002 111.576 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 13.8 mtpt -61.26 -39.63 91.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.541 -0.3 . . . . 0.93999999999999995 110.958 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -68.58 -32.36 72.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.78 0.324 . . . . 2.1299999999999999 110.484 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.556 HG21 ' HD2' ' A' ' 150' ' ' PRO . 89.3 m -66.23 -58.75 4.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 0.46999999999999997 110.979 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.866 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 25.9 ttmt -132.81 128.16 20.66 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 120.509 -0.476 . . . . 1.75 110.521 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.651 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 84.9 Cg_endo -84.99 -162.38 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.526 2.817 . . . . 1.76 111.641 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -84.59 23.76 7.17 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.573 -0.822 . . . . 2.3700000000000001 111.36 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.1 mt 79.81 -18.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 123.908 0.883 . . . . 3.5600000000000001 110.408 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.7 pt? -110.54 176.44 5.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.782 -0.644 . . . . 2.7599999999999998 110.999 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -51.16 -38.4 51.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.512 0.93 . . . . 2.8399999999999999 113.512 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.524 HG22 ' HB3' ' A' ' 134' ' ' ALA . 2.3 m -44.49 -47.94 10.07 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.076 0.769 . . . . 3.8999999999999999 113.076 -169.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.575 ' HA ' ' CB ' ' A' ' 127' ' ' PRO . 69.0 mttm 64.39 -7.62 0.23 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.696 0.623 . . . . 5.1299999999999999 111.781 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.553 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -105.7 172.41 6.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 114.813 1.412 . . . . 0.93000000000000005 114.813 -164.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.873 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 51.0 mt -104.66 87.88 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 113.681 -1.6 . . . . 1.05 110.257 -173.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.484 ' HE2' HG21 ' A' ' 132' ' ' THR . 29.7 pttt -110.57 14.98 22.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.477 0.547 . . . . 1.5 112.477 -170.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.873 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -146.7 169.38 19.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.923 0.342 . . . . 0.87 111.923 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.613 ' ND2' ' HB3' ' A' ' 44' ' ' ALA . 1.5 t-20 -51.66 -155.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.535 1.534 . . . . 1.8 113.223 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.909 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 27.4 m-85 -25.43 -59.68 0.07 Allowed 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 125.298 1.439 . . . . 1.3700000000000001 114.794 -162.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.796 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 19.2 m 42.69 93.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 118.684 0.675 . . . . 0.29999999999999999 112.738 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.0 p -84.59 150.62 25.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.689 -0.804 . . . . 0.80000000000000004 110.491 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 4.5 m-85 -103.75 135.65 44.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.226 -1.027 . . . . 0.53000000000000003 108.226 167.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.911 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 35.9 tp -82.01 104.85 12.66 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.994 -0.743 . . . . 0.51000000000000001 108.994 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 15' ' ' ILE . 14.6 mm -102.44 121.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.947 -0.76 . . . . 0.20000000000000001 108.947 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.694 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.4 OUTLIER -72.41 -179.39 2.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.568 -0.287 . . . . 1.3 110.994 -176.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.661 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.6 mtp180 -56.23 -28.59 58.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.243 0.46 . . . . 3.7799999999999998 112.243 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 175' ' ' ARG . 12.5 t70 -109.77 -4.75 15.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.186 0.517 . . . . 1.1799999999999999 110.791 -169.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.581 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.09 53.46 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.491 -0.861 . . . . 0.23000000000000001 114.353 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.556 HG23 HH22 ' A' ' 175' ' ' ARG . 10.3 t -127.7 128.82 23.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 117.382 0.591 . . . . 0.62 110.151 170.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.556 ' HD2' HG21 ' A' ' 125' ' ' THR . 15.3 Cg_exo -66.26 102.64 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.946 2.431 . . . . 0.29999999999999999 112.388 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.47 -18.42 8.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.656 -0.702 . . . . 0.27000000000000002 110.925 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.866 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 77.0 mm-40 -157.07 159.42 37.9 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.682 0.277 . . . . 1.22 110.915 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.651 ' NH2' ' HA ' ' A' ' 127' ' ' PRO . 20.1 ttm180 -127.44 96.83 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.01 -0.737 . . . . 1.75 109.01 168.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.911 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 33.9 m-85 -86.42 107.88 18.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.908 -0.775 . . . . 0.38 108.908 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.701 ' HA ' HG23 ' A' ' 140' ' ' THR . 83.5 p -60.6 164.93 6.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.89 -0.411 . . . . 0.98999999999999999 109.89 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.86 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 42.0 Cg_endo -65.24 -7.6 16.15 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.032 2.488 . . . . 0.66000000000000003 112.978 -164.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.95 22.46 38.13 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.52000000000000002 111.718 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -93.04 140.23 29.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 0.42999999999999999 110.813 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 11.9 p -91.32 170.13 10.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.734 -0.667 . . . . 1.25 111.029 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.686 HG13 HD21 ' A' ' 60' ' ' LEU . 74.5 t -53.18 -56.09 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.40999999999999998 110.955 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.424 ' NZ ' ' HB2' ' A' ' 161' ' ' LYS . 0.1 OUTLIER -65.64 -32.05 73.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 3.4399999999999999 111.461 -175.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.74 -31.78 73.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.121 -0.49 . . . . 1.8600000000000001 109.922 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.887 HG21 HD21 ' A' ' 39' ' ' LEU . 35.6 mt -83.19 -39.83 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.994 -0.548 . . . . 0.20999999999999999 110.7 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 54.7 mt-10 -57.79 -35.63 71.08 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.133 0.42 . . . . 0.88 112.133 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.519 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.4 pt-20 -61.32 -21.38 63.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.75 111.648 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.547 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtt -104.8 -31.5 9.28 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.233 -0.44 . . . . 1.5800000000000001 110.549 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.3 tp -85.58 -42.43 14.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.748 -0.66 . . . . 0.23999999999999999 112.758 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.806 ' HA ' HD12 ' A' ' 171' ' ' LEU . 60.8 mt -53.94 -46.97 98.38 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.504 0.557 . . . . 0.44 112.504 -173.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 74.9 Cg_exo -53.13 -40.16 77.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.809 1.672 . . . . 0.48999999999999999 112.371 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.6 mt -74.4 -37.05 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.70999999999999996 111.794 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.024 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.8 mt -54.27 -54.07 45.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.539 0.685 . . . . 0.46000000000000002 109.497 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.7 -59.78 8.77 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 114.276 -1.329 . . . . 1.52 112.795 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.2 p -167.05 126.03 1.39 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.923 0.362 . . . . 2.52 110.857 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.694 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -94.14 -57.46 2.52 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.103 0.478 . . . . 3.5600000000000001 111.106 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 147' ' ' ASP . 17.9 ptp180 -131.5 4.69 4.31 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.389 -0.967 . . . . 7.8600000000000003 108.389 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 C--O 1.246 0.87 0 N-CA-C 106.968 -1.493 . . . . 4.8099999999999996 106.968 -176.775 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.096 -0.401 . . . . 5.5099999999999998 112.096 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 67.2 mtt -93.16 140.07 29.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.307 -0.257 . . . . 5.0499999999999998 110.307 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.11 27.84 6.08 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.853 -0.689 . . . . 1.3700000000000001 111.619 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.2 m -84.21 -45.33 13.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.825 0.345 . . . . 1.6799999999999999 110.664 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.3 p -124.33 -179.41 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.596 -0.52 . . . . 0.65000000000000002 109.596 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.833 HD13 HG21 ' A' ' 144' ' ' ILE . 32.5 pt -68.3 -31.07 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.83 0.348 . . . . 0.29999999999999999 111.358 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 29.8 m-85 -72.95 -4.62 33.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.906 0.384 . . . . 0.27000000000000002 111.594 -173.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.52 -14.22 62.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.83 -0.623 . . . . 1.96 109.366 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.645 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 84.1 m-85 -111.62 142.34 44.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.373 -0.83 . . . . 0.40000000000000002 110.701 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -100.18 140.18 34.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.68 -0.489 . . . . 2.77 109.68 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.577 ' CG2' ' HB3' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -123.3 159.77 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.378 -0.374 . . . . 0.73999999999999999 110.804 -171.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.907 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 58.7 mt -97.26 133.34 42.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.531 . . . . 0.71999999999999997 110.214 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 21.2 t70 -69.78 178.18 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.702 -1.135 . . . . 1.5900000000000001 109.584 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.674 ' HB1' ' CD ' ' A' ' 97' ' ' LYS . . . -55.43 -25.04 33.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.968 0.413 . . . . 0.52000000000000002 111.417 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -90.91 -9.82 44.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.206 -0.452 . . . . 2.2200000000000002 111.111 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.907 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 44.9 m-70 74.51 12.88 3.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.912 0.885 . . . . 0.72999999999999998 109.994 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -73.37 150.36 89.39 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 106.126 -1.805 . . . . 3.25 106.126 162.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.23 115.16 2.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.81 1.007 . . . . 0.85999999999999999 111.425 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.577 ' HB3' ' CG2' ' A' ' 20' ' ' VAL . 87.9 t80 -84.42 122.28 28.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.785 -0.643 . . . . 0.28000000000000003 109.825 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.671 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.0 t30 -75.24 82.15 2.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.839 -0.619 . . . . 1.6499999999999999 109.645 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.738 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.2 pt? -63.06 -29.74 71.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.594 0.711 . . . . 0.25 110.28 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.75 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 7.6 p -77.31 -0.03 2.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.828 -1.078 . . . . 0.40999999999999998 112.933 -169.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.671 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -78.35 -5.45 52.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.359 -0.608 . . . . 1.24 109.359 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CG ' HG21 ' A' ' 70' ' ' THR . 77.5 m-70 -98.42 -0.75 42.99 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.38 108.759 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HE2' ' CG2' ' A' ' 31' ' ' VAL . 9.2 ttmm -67.97 132.4 47.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 1.73 109.914 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.46 -0.99 60.06 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.515 -1.034 . . . . 0.35999999999999999 110.515 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 44.8 m -140.33 138.49 19.12 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.237 -0.653 . . . . 1.1399999999999999 109.237 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.003 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 43.8 Cg_endo -69.44 154.87 68.42 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.769 1.646 . . . . 0.52000000000000002 110.893 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.624 ' CB ' HG22 ' A' ' 70' ' ' THR . 2.0 pt? -156.52 148.36 22.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.167 0.508 . . . . 1.03 111.323 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 141' ' ' SER . 3.4 mm? -107.12 148.63 28.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.113 -1.069 . . . . 1.1000000000000001 108.113 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.541 HD12 HG13 ' A' ' 144' ' ' ILE . 69.6 mt -139.55 116.38 10.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 109.74 -0.467 . . . . 0.20000000000000001 109.74 -173.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.707 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 16.4 m-85 -101.39 130.31 47.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.602 -0.272 . . . . 0.23000000000000001 111.313 -172.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.673 ' CB ' HG11 ' A' ' 110' ' ' VAL . 1.1 p30 -87.96 92.04 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.394 -0.965 . . . . 1.28 108.394 166.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -106.53 150.13 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.453 0.644 . . . . 0.88 112.348 -160.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.31 109.0 5.06 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.2 -1.407 . . . . 0.52000000000000002 107.2 166.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.986 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -66.76 74.46 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.005 -0.998 . . . . 1.8400000000000001 112.6 -169.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.781 ' HE3' ' HA ' ' A' ' 98' ' ' PHE . 39.6 ttmt 55.73 57.44 5.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.156 -0.929 . . . . 2.4300000000000002 111.119 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.5 p -160.87 128.14 4.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.108 -0.496 . . . . 0.98999999999999999 111.288 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.52 -80.9 1.78 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.847 -0.615 . . . . 1.0900000000000001 113.662 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -131.72 163.18 28.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.423 0.154 . . . . 3.1600000000000001 110.949 -172.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.5 p -131.82 -35.69 1.25 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.143 0.423 . . . . 1.9399999999999999 112.143 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.0 mmmt 65.77 0.39 1.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.478 0.711 . . . . 2.0299999999999998 112.259 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.75 4.97 72.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.666 -0.778 . . . . 0.46999999999999997 112.259 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.0 86.73 Favored Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.37 -0.692 . . . . 0.34000000000000002 111.37 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.493 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.3 t80 -61.75 -52.75 62.98 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.941 -0.629 . . . . 0.56999999999999995 110.254 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.37 -45.97 90.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.765 -0.652 . . . . 2.46 110.668 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 160' ' ' VAL . 30.1 m -57.08 -48.69 77.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.682 -0.69 . . . . 0.33000000000000002 110.481 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.761 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.53 -50.02 74.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.798 -0.637 . . . . 0.19 111.785 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -61.1 -42.98 99.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.173 0.511 . . . . 0.29999999999999999 111.005 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.8 m -64.67 -47.77 77.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.576 -0.738 . . . . 1.0800000000000001 111.223 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 90.5 mt -56.52 -52.58 64.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.187 -0.461 . . . . 0.81000000000000005 111.165 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.656 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 47.3 t80 -46.99 -57.87 4.56 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 124.435 1.085 . . . . 0.33000000000000002 110.117 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.34 -38.85 65.61 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.736 -0.665 . . . . 1.76 111.919 -170.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -70.01 -45.14 67.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 1.79 111.301 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.711 ' CD1' HD13 ' A' ' 171' ' ' LEU . 58.6 m-85 -100.02 5.83 45.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.194 0.813 . . . . 0.42999999999999999 113.194 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 17.8 mtpp -62.03 -18.67 61.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 2.1099999999999999 110.073 170.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 p -61.67 -40.69 95.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.687 -0.688 . . . . 1.2 110.874 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -94.92 10.18 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 1.8999999999999999 110.599 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.577 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.14 71.66 1.26 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.571 -0.741 . . . . 1.3200000000000001 112.255 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE1' HD23 ' A' ' 39' ' ' LEU . 59.4 t80 -132.62 142.43 49.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.229 -0.285 . . . . 0.26000000000000001 110.229 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.624 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.36 152.44 48.16 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 120.973 0.416 . . . . 0.51000000000000001 110.622 178.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.761 HG11 ' HB1' ' A' ' 57' ' ' ALA . 25.0 t -122.82 124.66 70.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.864 0.364 . . . . 0.23999999999999999 110.437 171.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.494 HD22 ' HE3' ' A' ' 105' ' ' MET . 16.5 mt -105.68 145.05 31.57 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.823 -0.806 . . . . 0.51000000000000001 108.823 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -132.79 113.46 12.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.133 0.492 . . . . 0.28000000000000003 111.108 176.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.657 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.6 m-85 -99.01 113.57 64.74 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.698 -0.683 . . . . 0.34000000000000002 109.306 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.075 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.29 165.85 6.73 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.562 2.841 . . . . 0.72999999999999998 111.818 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.596 ' HB3' HE22 ' A' ' 78' ' ' GLN . 32.4 t -122.96 137.21 55.01 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 122.604 1.192 . . . . 1.54 113.485 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 40.4 t30 -91.12 89.18 7.26 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.164 -1.834 . . . . 2.52 109.139 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.938 ' HB2' HG13 ' A' ' 90' ' ' ILE . 31.3 mm-40 -61.24 -4.16 1.09 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.71 -1.132 . . . . 3.1800000000000002 112.079 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -108.45 30.77 6.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.373 0.606 . . . . 3.7999999999999998 110.181 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.587 ' HA3' HD22 ' A' ' 109' ' ' ASN . . . -97.81 -50.43 1.65 Allowed Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 116.007 -0.542 . . . . 1.45 112.649 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.3 -62.5 0.22 Allowed Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 112.444 -0.263 . . . . 1.4299999999999999 112.444 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.733 HE22 ' HB3' ' A' ' 114' ' ' ASN . 3.0 pm0 -129.87 41.6 3.4 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 113.257 0.836 . . . . 1.4299999999999999 113.257 -173.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.75 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 3.9 mp0 -62.74 144.88 96.18 Favored Pre-proline 0 C--N 1.309 -1.188 0 O-C-N 121.834 -0.541 . . . . 3.0600000000000001 109.95 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.935 ' HG3' HG22 ' A' ' 135' ' ' ILE . 41.4 Cg_exo -20.32 -115.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.418 1 C-N-CA 126.425 4.75 . . . . 1.6100000000000001 116.346 -165.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.16 -18.7 21.18 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.533 -1.427 . . . . 1.3899999999999999 109.533 171.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 16.5 m120 -88.5 43.25 1.12 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.736 -0.732 . . . . 3.6899999999999999 111.828 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.07 135.22 53.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.648 0.261 . . . . 2.4700000000000002 110.435 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 59.56 28.79 18.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.19 -0.459 . . . . 3.6400000000000001 111.43 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.705 ' HB3' ' HG3' ' A' ' 78' ' ' GLN . 6.0 tp10 -68.52 -13.31 62.24 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 120.551 0.215 . . . . 2.4199999999999999 111.045 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.938 HG13 ' HB2' ' A' ' 78' ' ' GLN . 1.0 OUTLIER -87.11 18.49 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.061 0.458 . . . . 2.0499999999999998 110.305 -179.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 92' ' ' GLU . 19.4 pttm -59.72 109.99 1.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.47 -0.567 . . . . 4.0 109.47 172.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.551 ' HB3' ' O ' ' A' ' 91' ' ' LYS . 1.1 tp10 74.74 -47.43 0.62 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.712 0.632 . . . . 3.1000000000000001 110.732 -171.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 55.8 m-85 -63.6 175.4 1.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.424 0.631 . . . . 1.9099999999999999 112.237 -175.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.8 p -132.83 111.92 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.684 -1.228 . . . . 1.6499999999999999 107.684 172.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.788 ' SG ' HG12 ' A' ' 90' ' ' ILE . 38.6 m -90.43 120.3 31.42 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 118.589 -1.244 . . . . 0.91000000000000003 110.01 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.546 ' N ' ' HB2' ' A' ' 45' ' ' SER . 10.3 t -148.36 163.49 36.92 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.747 -1.115 . . . . 1.9199999999999999 108.52 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.674 ' CD ' ' HB1' ' A' ' 23' ' ' ALA . 16.5 pttt -38.85 105.77 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.883 0.739 . . . . 3.1800000000000002 111.344 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.781 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 51.5 p90 -58.21 -22.58 52.53 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.589 -0.732 . . . . 1.74 110.92 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? 68.83 142.82 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.168 0 O-C-N 124.282 0.989 . . . . 3.0800000000000001 110.473 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.478 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -162.26 -160.33 0.66 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.468 -0.493 . . . . 0.42999999999999999 111.732 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.91 -10.57 44.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 2.1899999999999999 109.769 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.604 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 51.7 p90 -112.31 166.85 10.11 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-N 115.173 -0.921 . . . . 0.23999999999999999 108.934 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.769 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.9 Cg_exo -70.61 119.31 6.24 Favored 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 123.712 2.942 . . . . 0.31 113.306 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.969 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.3 mp -108.21 149.44 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.889 -0.782 . . . . 0.37 108.889 173.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.769 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 13.3 mmt -118.49 -157.72 0.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.17 0.804 . . . . 1.47 113.17 -164.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.69 145.5 43.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.929 -1.032 . . . . 0.39000000000000001 110.359 175.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.075 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.2 pttt -83.37 137.16 34.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.654 0.74 . . . . 1.6599999999999999 109.785 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.488 HG13 HG13 ' A' ' 110' ' ' VAL . 5.0 pt -135.35 175.18 11.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.204 -1.362 . . . . 0.46999999999999997 108.01 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.587 HD22 ' HA3' ' A' ' 80' ' ' GLY . 22.7 t-20 -88.34 83.96 6.86 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.97 -0.752 . . . . 2.1600000000000001 108.97 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.732 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -76.08 86.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 118.455 -1.298 . . . . 0.38 110.157 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 63.7 t30 170.88 179.36 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.86 -1.163 . . . . 1.98 107.86 166.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 82' ' ' GLN . . . 56.75 -146.32 35.07 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.919 -0.658 . . . . 0.78000000000000003 113.793 166.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -107.15 1.1 23.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.183 -0.508 . . . . 1.98 111.351 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.733 ' HB3' HE22 ' A' ' 82' ' ' GLN . 28.7 t-20 -103.78 11.8 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.906 0.86 . . . . 2.04 110.065 -174.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.536 ' HB3' ' OE1' ' A' ' 120' ' ' GLU . . . -73.88 156.46 37.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 0.47999999999999998 111.963 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 20' ' ' VAL . 35.6 t-80 -57.18 137.69 80.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.07 -0.968 . . . . 0.41999999999999998 110.5 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -42.39 -48.78 6.61 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.312 2.675 . . . . 0.35999999999999999 113.13 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.568 HD22 ' CG1' ' A' ' 20' ' ' VAL . 13.6 tp -56.01 -41.23 74.58 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.244 -0.435 . . . . 1.1000000000000001 111.843 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.601 ' CE2' ' HB3' ' A' ' 42' ' ' ASN . 12.4 m-85 -75.44 -30.71 60.09 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.458 -0.337 . . . . 1.49 110.975 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.536 ' OE1' ' HB3' ' A' ' 115' ' ' ALA . 7.1 mm-40 -59.74 -36.75 77.24 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.141 -0.623 . . . . 2.3700000000000001 109.417 168.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.4 t80 -67.77 -48.78 65.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 0.57999999999999996 110.448 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.546 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.7 mtt -63.08 -53.06 59.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.004 -0.544 . . . . 0.34000000000000002 111.443 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -60.33 -39.7 88.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 0.93999999999999995 111.204 -174.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.5 ptmt -71.86 -35.24 69.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.737 0.303 . . . . 2.1299999999999999 110.801 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.512 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.8 m -70.08 -42.63 72.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.976 -0.556 . . . . 0.46999999999999997 112.449 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 21.9 mmtm -135.11 120.78 14.14 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.567 0.58 . . . . 1.75 112.567 -173.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 33.7 Cg_endo -67.93 -39.67 10.72 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.805 2.336 . . . . 1.76 111.662 172.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.721 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 103.0 -155.72 18.15 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.932 -0.651 . . . . 2.3700000000000001 112.795 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 33.0 pt -91.2 21.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.827 0.346 . . . . 3.5600000000000001 111.322 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -126.5 -175.05 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.388 -0.369 . . . . 2.7599999999999998 110.752 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.11 8.11 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 112.485 0.55 . . . . 2.8399999999999999 112.485 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.4 p -117.67 160.02 21.99 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.15 -0.477 . . . . 3.8999999999999999 112.095 -170.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 127' ' ' PRO . 19.3 ptpt -93.43 41.8 1.09 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.009 -0.542 . . . . 5.1299999999999999 111.915 -172.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.28 153.53 37.56 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.273 -0.571 . . . . 0.93000000000000005 111.416 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.935 HG22 ' HG3' ' A' ' 84' ' ' PRO . 25.9 mt -85.71 110.21 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.373 -0.831 . . . . 1.05 109.769 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -130.08 15.74 5.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.003 0.43 . . . . 1.5 112.029 -170.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.809 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -153.91 173.87 15.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.215 0.531 . . . . 0.87 111.989 -175.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.486 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 8.8 m120 -43.16 -158.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.74 1.616 . . . . 1.8 115.196 168.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.784 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 15.4 m-85 -30.79 -58.26 0.21 Allowed 'General case' 0 C--O 1.202 -1.432 0 CA-C-N 112.871 -1.968 . . . . 1.3700000000000001 113.918 -169.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.817 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 12.5 m 44.95 99.64 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.593 0.961 . . . . 0.29999999999999999 113.593 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.7 ' HB2' HD12 ' A' ' 39' ' ' LEU . 15.9 p -87.78 151.16 23.1 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.467 -0.771 . . . . 0.80000000000000004 111.268 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 9.4 m-85 -103.7 133.62 48.4 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.392 -0.966 . . . . 0.53000000000000003 108.392 168.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.806 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 25.5 tp -81.36 105.41 12.52 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.133 -0.691 . . . . 0.51000000000000001 109.133 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 15' ' ' ILE . 13.2 mm -105.59 126.91 60.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.605 -0.725 . . . . 0.20000000000000001 109.083 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.9 OUTLIER -78.69 -175.71 4.53 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.912 -0.315 . . . . 1.3 110.614 -176.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.649 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 63.5 mtt180 -63.23 -16.76 61.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.259 0.466 . . . . 3.7799999999999998 112.259 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -108.09 -10.04 15.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.437 0.637 . . . . 1.1799999999999999 110.17 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.587 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 95.82 32.31 6.92 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.538 -0.755 . . . . 0.23000000000000001 112.672 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 72.1 t -111.9 124.09 33.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.871 -0.418 . . . . 0.62 109.871 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.512 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.1 Cg_exo -68.14 118.39 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.44 2.093 . . . . 0.29999999999999999 111.573 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.471 ' HB ' HD23 ' A' ' 143' ' ' LEU . 32.4 t -98.06 -26.24 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.712 -0.676 . . . . 0.27000000000000002 110.417 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 27.1 mm-40 -149.83 163.73 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 1.22 111.509 -177.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.721 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 19.8 ttm180 -131.41 98.19 4.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.439 -0.8 . . . . 1.75 109.071 168.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.806 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 74.1 m-85 -86.95 117.84 25.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.497 -0.557 . . . . 0.38 109.497 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.799 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.0 OUTLIER -63.68 164.3 16.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.665 -0.494 . . . . 0.98999999999999999 109.665 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.817 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 63.2 Cg_endo -70.65 -6.08 18.23 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.848 2.365 . . . . 0.66000000000000003 112.495 -167.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.57 5.61 62.47 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.95 -1.023 . . . . 0.52000000000000002 111.912 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.46 139.11 36.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.42999999999999999 110.139 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.3 m -77.12 163.46 26.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.974 -0.557 . . . . 1.25 111.019 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 34.3 t -53.21 -48.84 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.423 -0.353 . . . . 0.40999999999999998 110.343 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.449 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.2 tptm -69.79 -28.69 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 3.4399999999999999 111.034 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.17 -33.84 74.09 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.0 0.429 . . . . 1.8600000000000001 110.007 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.58 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 52.0 mt -80.39 -42.21 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.738 -0.665 . . . . 0.20999999999999999 110.149 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 168' ' ' ILE . 45.2 mt-10 -55.41 -41.63 73.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.976 -0.556 . . . . 0.88 112.378 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.93 -19.37 60.63 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.241 0.46 . . . . 0.75 112.241 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -107.2 -17.93 14.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.012 0.435 . . . . 1.5800000000000001 110.291 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.8 tp -89.98 -39.09 13.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.741 -0.663 . . . . 0.23999999999999999 111.761 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.763 ' HA ' HD12 ' A' ' 171' ' ' LEU . 80.2 mt -52.48 -47.91 91.81 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.323 0.49 . . . . 0.44 112.323 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.508 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.6 Cg_exo -55.43 -27.68 59.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.248 1.966 . . . . 0.48999999999999999 113.269 175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.53 -34.52 16.35 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.521 0.201 . . . . 0.70999999999999996 111.465 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.003 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 12.5 mt -58.08 -52.56 65.05 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.189 -0.671 . . . . 0.46000000000000002 109.189 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.81 60.86 2.1 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.717 -1.129 . . . . 1.52 113.189 175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m 69.51 105.2 0.06 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.426 0.691 . . . . 2.52 112.159 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -94.59 -28.6 15.31 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 116.048 -0.523 . . . . 3.5600000000000001 112.117 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -112.97 -46.49 3.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 7.8600000000000003 110.284 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.575 -0.726 . . . . 4.8099999999999996 110.342 179.881 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.872 0 CA-C-O 120.473 -0.07 . . . . 5.5099999999999998 112.939 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 66.7 mtt -86.78 108.98 18.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.042 -0.355 . . . . 5.0499999999999998 110.042 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 121' ' ' TYR . . . -60.23 126.74 42.24 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.805 -0.634 . . . . 1.3700000000000001 113.279 -174.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.7 m -79.93 -40.93 27.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.44 0.638 . . . . 1.6799999999999999 109.743 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 -177.86 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.018 -0.992 . . . . 0.65000000000000002 108.719 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 144' ' ' ILE . 35.5 pt -66.16 -24.67 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.967 0.413 . . . . 0.29999999999999999 111.312 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.806 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 27.5 m-85 -82.07 1.64 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.047 0.451 . . . . 0.27000000000000002 110.823 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -69.86 -16.99 63.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.355 -0.98 . . . . 1.96 108.355 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 70.4 m-85 -110.66 178.92 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.71 -1.132 . . . . 0.40000000000000002 110.125 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -124.65 144.57 50.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.764 0.316 . . . . 2.77 110.887 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.607 HG23 HD13 ' A' ' 30' ' ' LEU . 74.2 t -114.85 140.89 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.19 -0.459 . . . . 0.73999999999999999 111.385 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.967 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 65.1 mt -96.71 140.71 30.9 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.005 -0.739 . . . . 0.71999999999999997 109.005 169.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -79.07 -169.0 1.65 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.824 -0.436 . . . . 1.5900000000000001 109.824 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB1' ' HG3' ' A' ' 97' ' ' LYS . . . -57.31 -22.52 42.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 111.944 0.35 . . . . 0.52000000000000002 111.944 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 23.9 t70 -104.74 -2.71 24.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.69 0.281 . . . . 2.2200000000000002 111.153 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.967 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.8 m-70 76.57 21.73 1.28 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.628 0.727 . . . . 0.72999999999999998 109.644 -177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -83.45 153.67 65.46 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 105.828 -1.916 . . . . 3.25 105.828 165.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.22 113.83 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.934 1.012 . . . . 0.85999999999999999 111.997 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.545 ' HH ' ' HE2' ' A' ' 33' ' ' HIS . 78.5 t80 -84.03 114.6 21.85 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.245 -0.888 . . . . 0.28000000000000003 109.242 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.691 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -67.02 83.04 0.12 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.525 -0.761 . . . . 1.6499999999999999 109.718 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.806 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.0 pt? -70.54 -33.11 70.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.236 0.541 . . . . 0.25 110.145 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.703 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -77.57 -0.77 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.427 -0.806 . . . . 0.40999999999999998 112.843 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.4 pt20 -81.69 -5.61 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.759 0.79 . . . . 1.24 108.936 172.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.664 ' HB3' ' CD2' ' A' ' 38' ' ' LEU . 75.7 m-70 -98.5 3.07 48.16 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.583 -1.19 . . . . 0.38 108.145 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 24.9 ttpt -79.3 136.18 36.95 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.749 -1.114 . . . . 1.73 109.023 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.93 -13.59 52.85 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.254 -1.139 . . . . 0.35999999999999999 110.254 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 76.3 p -129.8 138.49 33.24 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 109.34 -0.615 . . . . 1.1399999999999999 109.34 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.964 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 57.7 Cg_endo -74.2 155.46 46.87 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.519 1.479 . . . . 0.52000000000000002 109.714 176.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.818 HD12 ' HB ' ' A' ' 144' ' ' ILE . 0.8 OUTLIER -159.61 152.51 21.73 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.282 0.563 . . . . 1.03 111.958 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 141' ' ' SER . 3.6 mm? -107.02 138.44 43.19 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.558 -0.904 . . . . 1.1000000000000001 108.558 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 70.9 mt -127.58 118.07 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.198 -0.667 . . . . 0.20000000000000001 109.198 -174.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.834 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.3 m-85 -101.17 123.2 44.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.445 -0.343 . . . . 0.23000000000000001 111.198 -172.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.721 ' OD1' ' HB ' ' A' ' 140' ' ' THR . 0.5 OUTLIER -80.52 92.02 5.85 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.003 -1.11 . . . . 1.28 108.003 169.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.625 HG11 ' HE1' ' A' ' 98' ' ' PHE . 5.8 p -107.99 143.19 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 113.502 0.927 . . . . 0.88 113.502 -160.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.37 101.85 1.3 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.435 -1.32 . . . . 0.52000000000000002 107.435 166.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 1.005 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -59.65 87.68 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.973 -1.012 . . . . 1.8400000000000001 112.882 -170.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 53.38 52.63 13.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.422 -0.808 . . . . 2.4300000000000002 110.646 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.7 p -164.18 157.01 17.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.797 -0.638 . . . . 0.98999999999999999 110.83 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA3' ' CG ' ' A' ' 89' ' ' GLU . . . 80.78 -117.2 4.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.932 -0.651 . . . . 1.0900000000000001 112.717 176.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.61 166.98 20.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.454 0.645 . . . . 3.1600000000000001 111.532 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.643 HG22 ' HE1' ' A' ' 139' ' ' PHE . 17.4 p -129.33 107.86 9.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.257 -0.883 . . . . 1.9399999999999999 109.782 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 27.3 mtpt -83.47 20.07 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 2.0299999999999998 112.06 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.51 13.87 29.23 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.716 -0.754 . . . . 0.46999999999999997 111.826 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.14 -40.56 16.05 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 121.018 -0.61 . . . . 0.34000000000000002 112.286 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.527 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.2 t80 -67.9 -48.69 65.31 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.824 0.345 . . . . 0.56999999999999995 110.177 -176.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.3 -43.89 97.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.9 -0.591 . . . . 2.46 110.902 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 79.6 m -65.75 -50.9 63.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.33000000000000002 111.142 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.87 -47.59 80.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.202 0.525 . . . . 0.19 110.866 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.443 ' HA ' ' HD2' ' A' ' 102' ' ' PHE . 80.2 m -59.74 -51.81 68.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.289 -0.868 . . . . 0.29999999999999999 111.552 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.4 p -65.95 -39.2 90.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.068 -0.514 . . . . 1.0800000000000001 111.727 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.465 HD11 HD12 ' A' ' 163' ' ' ILE . 85.4 mt -58.73 -51.64 69.09 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 120.503 0.192 . . . . 0.81000000000000005 111.062 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.735 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 82.9 t80 -53.81 -47.08 71.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.877 -0.601 . . . . 0.33000000000000002 109.817 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -73.18 -31.65 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.426 -0.807 . . . . 1.76 111.625 -173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.84 -36.84 23.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.021 -0.536 . . . . 1.79 111.738 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.645 ' CD1' HD13 ' A' ' 171' ' ' LEU . 58.0 m-85 -114.16 2.05 14.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.499 1.296 . . . . 0.42999999999999999 114.499 -171.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.693 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 20.4 ptmt -68.71 -16.07 63.71 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.308 -0.957 . . . . 2.1099999999999999 110.083 175.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 p -59.89 -43.4 94.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.747 -0.66 . . . . 1.2 109.927 171.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -91.36 15.76 11.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 1.8999999999999999 111.143 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.692 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 80.46 70.22 1.35 Allowed Glycine 0 C--O 1.224 -0.527 0 C-N-CA 120.999 -0.619 . . . . 1.3200000000000001 112.452 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.693 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 54.8 t80 -143.73 139.97 29.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.26000000000000001 110.537 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.607 ' HG1' ' HE1' ' A' ' 61' ' ' TYR . 14.9 t -129.39 152.98 48.35 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.031 0.443 . . . . 0.51000000000000001 110.077 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.735 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t -113.89 120.75 64.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.387 -0.597 . . . . 0.23999999999999999 109.387 171.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.592 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 15.6 mt -107.3 122.13 45.94 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.892 -0.781 . . . . 0.51000000000000001 108.892 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.04 129.71 55.46 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.329 -0.548 . . . . 0.28000000000000003 110.943 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.484 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.8 m-85 -113.67 108.64 51.41 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.619 -0.719 . . . . 0.34000000000000002 109.89 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.005 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 33.2 Cg_exo -59.56 156.32 37.35 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 123.505 2.803 . . . . 0.72999999999999998 111.697 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.681 ' HB3' HE22 ' A' ' 78' ' ' GLN . 47.6 t -128.3 135.71 49.98 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 114.349 1.24 . . . . 1.54 114.349 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.81 88.41 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 113.556 -1.656 . . . . 2.52 108.785 170.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 1.019 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 32.3 mm-40 -61.19 -13.51 18.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.679 -0.691 . . . . 3.1800000000000002 112.252 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -72.75 -0.45 13.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.767 0.284 . . . . 3.7999999999999998 111.767 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.672 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -60.01 -36.07 89.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.998 -0.62 . . . . 1.45 112.527 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.66 -50.45 0.51 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.658 -0.782 . . . . 1.4299999999999999 112.537 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.505 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -133.25 13.03 4.22 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.723 -0.391 . . . . 1.4299999999999999 112.021 -177.316 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 1.019 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 2.5 mm-40 -62.19 151.15 82.29 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 116.012 -0.54 . . . . 3.0600000000000001 110.717 -168.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.751 ' HG3' HG22 ' A' ' 135' ' ' ILE . 14.9 Cg_exo -24.19 147.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 1 C-N-CA 126.423 4.749 . . . . 1.6100000000000001 117.691 -167.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 86' ' ' ASN . . . 93.49 32.94 7.4 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.238 -1.346 . . . . 1.3899999999999999 110.127 -174.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.477 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.9 OUTLIER 72.45 -57.38 0.63 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.363 0.665 . . . . 3.6899999999999999 109.801 -172.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -173.33 129.6 0.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 2.4700000000000002 109.882 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 48.0 mt-10 59.04 80.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.151 0.501 . . . . 3.6400000000000001 112.345 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.841 ' HB3' ' HG3' ' A' ' 78' ' ' GLN . 3.8 tp10 -82.47 -14.14 55.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.121 -0.491 . . . . 2.4199999999999999 110.123 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.885 HG12 ' SG ' ' A' ' 95' ' ' CYS . 1.3 mt -92.13 38.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.599 -0.273 . . . . 2.0499999999999998 110.788 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.744 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 29.7 mmmt -68.47 103.64 1.71 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.703 -0.48 . . . . 4.0 109.703 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.744 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 0.4 OUTLIER 65.58 -7.74 0.32 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.947 1.299 . . . . 3.1000000000000001 111.669 -176.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.456 ' H ' ' C ' ' A' ' 91' ' ' LYS . 85.7 m-85 -77.16 176.58 8.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.36 0.6 . . . . 1.9099999999999999 110.546 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 94' ' ' VAL . 6.6 p -128.6 111.13 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.059 -1.089 . . . . 1.6499999999999999 108.059 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.885 ' SG ' HG12 ' A' ' 90' ' ' ILE . 79.3 m -91.63 120.7 32.64 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.35 -0.94 . . . . 0.91000000000000003 110.4 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.767 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 14.0 t -133.58 159.89 39.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.528 -1.215 . . . . 1.9199999999999999 108.372 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.775 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -58.99 95.7 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.001 0.429 . . . . 3.1800000000000002 110.149 -175.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.625 ' HE1' HG11 ' A' ' 43' ' ' VAL . 3.8 p90 -54.84 134.83 48.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.059 -1.089 . . . . 1.74 108.059 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -101.64 134.08 45.33 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.548 -0.461 . . . . 3.0800000000000001 111.011 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.516 ' CB ' ' HE1' ' A' ' 54' ' ' TYR . . . -136.26 -174.97 3.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.337 -0.847 . . . . 0.42999999999999999 110.939 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -83.16 16.88 2.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.68 -0.691 . . . . 2.1899999999999999 110.323 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.591 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 40.3 p90 -139.36 167.8 17.59 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 108.594 -0.891 . . . . 0.23999999999999999 108.594 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.916 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 27.1 Cg_exo -68.6 126.95 14.77 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.683 2.922 . . . . 0.31 113.762 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.032 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.9 mp -120.92 142.01 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.344 -0.613 . . . . 0.37 109.344 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.916 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 7.2 mmt -114.01 -154.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.876 0.695 . . . . 1.47 112.876 -164.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.448 ' O ' ' HD2' ' A' ' 75' ' ' PRO . . . -69.77 145.09 52.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.086 -0.961 . . . . 0.39000000000000001 111.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 56.4 mttt -73.4 109.79 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.645 -0.872 . . . . 1.6599999999999999 108.645 171.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.432 HD12 ' CB ' ' A' ' 116' ' ' HIS . 28.8 pt -121.69 157.57 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.34 -0.985 . . . . 0.46999999999999997 108.34 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 10.2 m120 -66.32 127.02 30.63 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.819 -0.808 . . . . 2.1600000000000001 108.819 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.626 ' O ' ' HB ' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -121.45 88.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 C-N-CA 119.746 -0.781 . . . . 0.38 109.006 167.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.694 ' OD1' ' HB1' ' A' ' 134' ' ' ALA . 16.4 t-20 173.14 179.09 0.09 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.066 -1.087 . . . . 1.98 108.066 168.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 48.29 -137.29 15.23 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.757 0.661 . . . . 0.78000000000000003 114.59 163.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -104.52 -6.95 20.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.462 -0.869 . . . . 1.98 110.186 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -84.14 -24.52 30.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.292 -0.867 . . . . 2.04 111.449 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.97 141.49 3.14 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 114.058 1.133 . . . . 0.47999999999999998 114.058 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.65 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 43.8 t-80 -48.75 139.71 11.41 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 114.894 -1.048 . . . . 0.41999999999999998 110.378 171.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.25 -42.55 46.88 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.899 2.399 . . . . 0.35999999999999999 112.789 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.65 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.3 tm? -54.81 -42.52 71.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.062 -0.517 . . . . 1.1000000000000001 110.647 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.415 ' OH ' HG22 ' A' ' 40' ' ' ILE . 1.0 OUTLIER -76.09 -30.24 58.23 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-O 119.445 -0.312 . . . . 1.49 111.596 176.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -58.09 -36.9 73.53 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.245 -0.582 . . . . 2.3700000000000001 109.755 170.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 67.6 t80 -69.21 -44.01 72.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 0.57999999999999996 110.642 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.4 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.5 mtt -65.67 -51.11 62.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.255 -0.429 . . . . 0.34000000000000002 110.696 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.566 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 27.8 mtpt -61.96 -40.47 95.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.623 -0.717 . . . . 0.93999999999999995 111.379 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.7 ptmm? -69.19 -35.92 76.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 2.1299999999999999 110.615 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 99.9 m -73.94 -46.68 42.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 0.46999999999999997 111.857 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.509 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 10.4 mmtt -137.17 98.57 10.24 Favored Pre-proline 0 C--N 1.321 -0.648 0 C-N-CA 120.778 -0.369 . . . . 1.75 111.677 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.524 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 44.6 Cg_endo -69.79 -28.09 25.53 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.853 2.369 . . . . 1.76 111.673 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.35 -139.56 14.51 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.859 -0.686 . . . . 2.3700000000000001 112.243 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 41.2 pt -84.11 -1.38 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.746 0.308 . . . . 3.5600000000000001 111.571 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.7 pt? -133.12 175.39 9.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.807 0.337 . . . . 2.7599999999999998 110.626 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -87.72 -150.92 0.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.031 -0.531 . . . . 2.8399999999999999 110.102 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.644 HG22 ' HB3' ' A' ' 134' ' ' ALA . 19.5 m 76.83 -35.5 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.865 0.466 . . . . 3.8999999999999999 112.095 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 40.0 mttp 65.16 4.41 2.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.709 0.804 . . . . 5.1299999999999999 111.319 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.694 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -117.49 178.63 4.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.203 0.816 . . . . 0.93000000000000005 113.203 -165.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.878 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 24.4 mm -112.98 84.4 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.054 -0.975 . . . . 1.05 111.454 -166.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -105.69 19.95 19.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.22 0.822 . . . . 1.5 113.22 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.878 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.21 168.95 18.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.873 0.368 . . . . 0.87 111.561 177.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.65 -156.61 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 125.678 1.591 . . . . 1.8 113.217 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.834 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 35.5 m-85 -27.4 -55.87 0.09 Allowed 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 125.136 1.374 . . . . 1.3700000000000001 114.412 -164.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.873 HG23 ' HA ' ' A' ' 155' ' ' SER . 25.0 m 41.58 96.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.444 0.905 . . . . 0.29999999999999999 113.444 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.7 ' HB2' HD12 ' A' ' 39' ' ' LEU . 35.1 p -86.48 149.26 25.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.507 -0.746 . . . . 0.80000000000000004 111.274 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.431 ' O ' HD13 ' A' ' 39' ' ' LEU . 9.5 m-85 -103.09 134.08 47.12 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.598 -0.89 . . . . 0.53000000000000003 108.598 167.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.925 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 28.5 tp -82.03 105.84 13.46 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.13 -0.693 . . . . 0.51000000000000001 109.13 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.818 ' HB ' HD12 ' A' ' 38' ' ' LEU . 11.3 mm -106.08 131.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.312 -0.625 . . . . 0.20000000000000001 109.312 -175.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -78.64 -179.17 6.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.997 -0.547 . . . . 1.3 110.83 -176.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.716 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 34.9 mtp180 -64.18 -17.65 63.73 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.115 0.413 . . . . 3.7799999999999998 112.115 -175.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.451 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 13.7 t70 -105.26 -16.74 14.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.37 0.605 . . . . 1.1799999999999999 109.664 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.541 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.87 32.66 4.34 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.151 -0.931 . . . . 0.23000000000000001 112.735 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.1 t -106.12 126.93 29.36 Favored Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 122.397 -0.472 . . . . 0.62 110.637 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.72 112.17 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.15 2.567 . . . . 0.29999999999999999 112.22 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.498 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 22.3 t -98.41 -33.42 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.23 -0.441 . . . . 0.27000000000000002 111.49 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 9.0 mm-40 -152.48 164.37 37.7 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.762 0.315 . . . . 1.22 110.966 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.566 ' NH2' ' HA ' ' A' ' 123' ' ' LYS . 18.0 ttm180 -129.37 98.87 5.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 1.75 109.836 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.925 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.4 m-85 -87.01 110.31 19.98 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.262 -0.644 . . . . 0.38 109.262 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.873 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.3 p -62.86 167.05 6.47 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 109.273 -0.64 . . . . 0.98999999999999999 109.273 176.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.808 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.6 Cg_endo -70.64 -10.19 27.35 Favored 'Trans proline' 0 CA--C 1.507 -0.828 0 C-N-CA 122.377 2.051 . . . . 0.66000000000000003 112.028 -163.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.32 -10.72 84.29 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.402 -1.272 . . . . 0.52000000000000002 111.178 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.46 137.03 34.78 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.431 -0.581 . . . . 0.42999999999999999 109.431 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -106.33 -169.56 1.59 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.498 -0.319 . . . . 1.25 111.006 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 21.4 t -50.4 -59.55 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.915 -0.584 . . . . 0.40999999999999998 112.376 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -67.65 -29.86 69.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.67 0.271 . . . . 3.4399999999999999 110.946 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.13 -38.93 77.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.053 -0.522 . . . . 1.8600000000000001 109.844 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.545 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 63.5 mt -83.12 -37.45 13.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.416 -0.811 . . . . 0.20999999999999999 110.967 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 47.9 mt-10 -57.18 -36.7 71.12 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.551 0.574 . . . . 0.88 112.551 -174.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.528 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.0 pt-20 -58.73 -27.99 65.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.928 0.395 . . . . 0.75 111.292 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.595 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.9 mmtp -104.78 -16.19 14.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.363 -0.38 . . . . 1.5800000000000001 110.924 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.3 tp -91.22 -44.69 9.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.23999999999999999 111.825 -171.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.738 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.7 mt -51.81 -49.23 84.7 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 112.608 0.596 . . . . 0.44 112.608 -175.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 54.2 Cg_exo -54.7 -39.37 89.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.024 1.816 . . . . 0.48999999999999999 112.6 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.9 mt -74.2 -35.97 63.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.437 -0.347 . . . . 0.70999999999999996 111.43 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.964 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 13.5 mt -57.12 -54.75 43.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.313 -0.625 . . . . 0.46000000000000002 109.313 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.98 -62.24 4.74 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.777 -1.101 . . . . 1.52 112.513 171.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -173.18 125.58 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.482 -0.562 . . . . 2.52 109.482 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -90.98 -57.04 2.95 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.906 0.384 . . . . 3.5600000000000001 110.898 -174.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.57 25.07 1.36 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.971 -0.558 . . . . 7.8600000000000003 110.66 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 C--O 1.248 1.007 0 O-C-N 123.767 0.667 . . . . 4.8099999999999996 110.748 -178.179 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.898 0 N-CA-C 112.869 -0.092 . . . . 5.5099999999999998 112.869 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.2 ptp -159.09 25.01 0.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.243 0.544 . . . . 5.0499999999999998 110.176 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.71 52.46 7.18 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.334 -0.936 . . . . 1.3700000000000001 111.004 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -70.85 -64.24 0.94 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 1.6799999999999999 110.324 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 m -126.09 170.5 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.995 -1.113 . . . . 0.65000000000000002 107.995 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.634 HD13 HG21 ' A' ' 144' ' ' ILE . 32.5 pt -52.22 -28.87 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 118.764 0.711 . . . . 0.29999999999999999 112.902 -173.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.763 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 14.8 m-85 -81.68 5.91 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.997 0.427 . . . . 0.27000000000000002 111.614 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.86 -19.7 62.61 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.021 -1.104 . . . . 1.96 108.021 171.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 49.9 m-85 -106.7 179.32 4.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.425 -1.261 . . . . 0.40000000000000002 110.531 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.85 148.09 43.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.518 -0.31 . . . . 2.77 110.201 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 30' ' ' LEU . 71.7 t -118.19 150.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.054 0.454 . . . . 0.73999999999999999 111.702 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.747 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 88.8 mt -108.16 143.38 37.02 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.131 -0.486 . . . . 0.71999999999999997 110.003 173.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.637 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 21.7 t70 -72.97 177.37 4.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.102 -0.954 . . . . 1.5900000000000001 108.764 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -52.94 -32.85 48.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.337 0.589 . . . . 0.52000000000000002 110.318 177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 22.5 t70 -79.49 -18.25 52.4 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.353 -0.839 . . . . 2.2200000000000002 112.029 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.747 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.1 m-70 87.41 6.01 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.853 0.861 . . . . 0.72999999999999998 111.851 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 2.8 ptmt -70.77 160.93 80.35 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.905 -1.146 . . . . 3.25 107.905 162.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.3 117.19 3.89 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 121.421 1.414 . . . . 0.85999999999999999 112.632 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.538 ' HB3' HG12 ' A' ' 20' ' ' VAL . 89.0 t80 -91.05 119.42 31.19 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.97 -0.752 . . . . 0.28000000000000003 108.97 170.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.628 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 67.1 t30 -73.81 84.68 1.67 Allowed 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.525 -0.47 . . . . 1.6499999999999999 110.002 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.729 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -62.35 -31.55 72.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.466 0.651 . . . . 0.25 110.469 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.763 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.6 p -77.2 -0.06 2.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.182 -0.917 . . . . 0.40999999999999998 113.203 -167.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.8 pt20 -78.91 -5.82 54.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.658 0.742 . . . . 1.24 109.202 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.556 ' HB3' HD13 ' A' ' 38' ' ' LEU . 92.8 m-70 -97.41 -1.07 45.14 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.908 -1.042 . . . . 0.38 108.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.681 ' HG2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -77.09 130.99 38.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.987 -1.461 . . . . 1.73 108.975 178.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' N ' ' HD2' ' A' ' 34' ' ' LYS . . . 109.87 -15.19 31.51 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.042 -0.823 . . . . 0.35999999999999999 111.042 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.8 m -136.17 155.04 77.7 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.064 -0.717 . . . . 1.1399999999999999 109.064 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.0 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 73.3 Cg_endo -77.73 154.72 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.004 1.803 . . . . 0.52000000000000002 111.8 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.62 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.3 pt? -158.96 159.92 35.43 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.248 0.546 . . . . 1.03 111.229 -176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -114.21 155.1 26.72 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.449 -0.796 . . . . 1.1000000000000001 109.236 173.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 72' ' ' LEU . 84.4 mt -141.29 119.12 8.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.558 -0.534 . . . . 0.20000000000000001 109.558 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.833 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 23.7 m-85 -105.59 123.67 48.29 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.909 -0.316 . . . . 0.23000000000000001 111.06 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.861 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.6 OUTLIER -78.56 92.25 4.67 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.829 -0.804 . . . . 1.28 108.829 168.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.585 HG11 ' CE1' ' A' ' 98' ' ' PHE . 2.9 p -108.06 131.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.935 0.717 . . . . 0.88 112.935 -166.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -58.08 110.71 0.99 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.718 -1.216 . . . . 0.52000000000000002 107.718 167.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.979 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -70.79 85.93 0.67 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.787 -1.097 . . . . 1.8400000000000001 113.563 -162.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 48.8 tptt 71.7 39.56 0.86 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.648 -0.705 . . . . 2.4300000000000002 110.204 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.2 p -154.23 142.28 20.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.787 -0.642 . . . . 0.98999999999999999 110.96 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.66 -130.0 10.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.521 -0.847 . . . . 1.0900000000000001 112.966 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -141.85 131.71 24.37 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.592 -0.521 . . . . 3.1600000000000001 109.592 -173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.447 HG22 ' CE1' ' A' ' 139' ' ' PHE . 72.6 p -83.09 109.69 17.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.627 0.727 . . . . 1.9399999999999999 109.791 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 1.069 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 26.4 mtpp -79.86 11.56 3.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.363 -0.835 . . . . 2.0299999999999998 111.2 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.93 6.21 28.4 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.64 -0.584 . . . . 0.46999999999999997 111.64 -173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.35 -42.62 10.25 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.286 -0.483 . . . . 0.34000000000000002 112.013 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 1.4 t80 -70.14 -47.43 61.74 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 0.56999999999999995 109.835 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 53.9 mp0 -56.17 -50.77 70.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.867 -1.06 . . . . 2.46 110.397 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.712 HG23 ' HA ' ' A' ' 160' ' ' VAL . 54.9 m -67.48 -47.15 70.88 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.824 -1.08 . . . . 0.33000000000000002 111.101 -176.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.872 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.66 -49.51 74.82 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.19 111.35 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.9 m -58.43 -48.41 80.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.448 -0.796 . . . . 0.29999999999999999 110.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.9 m -60.77 -46.85 88.86 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.301 -0.863 . . . . 1.0800000000000001 111.524 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.584 HD13 HD22 ' A' ' 39' ' ' LEU . 62.1 mt -59.05 -50.35 74.4 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.274 -0.421 . . . . 0.81000000000000005 111.183 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.528 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 15.0 t80 -47.01 -53.63 12.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.057 0.848 . . . . 0.33000000000000002 110.032 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -73.93 -34.99 64.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.217 -0.901 . . . . 1.76 111.452 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -75.97 -35.77 59.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.007 -0.542 . . . . 1.79 111.255 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.812 ' CD1' HD13 ' A' ' 171' ' ' LEU . 62.7 m-85 -118.15 15.43 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.805 1.039 . . . . 0.42999999999999999 113.805 -173.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 11.8 mmmt -59.54 -21.36 60.13 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.686 -0.406 . . . . 2.1099999999999999 110.388 171.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.87 -41.62 78.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.84 -0.618 . . . . 1.2 110.35 174.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.517 ' HG3' ' HB3' ' A' ' 171' ' ' LEU . 33.7 mm-40 -76.27 -10.56 59.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.972 -0.558 . . . . 1.8999999999999999 110.318 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.32 20.73 29.14 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 1.3200000000000001 110.868 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CE1' HD13 ' A' ' 39' ' ' LEU . 88.5 t80 -79.78 136.58 36.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.243 -0.479 . . . . 0.26000000000000001 110.628 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -130.82 145.85 52.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.382 -0.599 . . . . 0.51000000000000001 109.382 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.872 HG11 ' HB1' ' A' ' 57' ' ' ALA . 51.4 t -110.08 109.32 27.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.2 -0.667 . . . . 0.23999999999999999 109.2 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.612 ' HB2' HG12 ' A' ' 40' ' ' ILE . 23.8 mt -91.65 120.98 32.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.489 -0.93 . . . . 0.51000000000000001 108.489 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.073 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.82 112.92 25.43 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.221 -0.592 . . . . 0.28000000000000003 110.68 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.3 m-85 -97.12 110.63 54.95 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.54 -0.755 . . . . 0.34000000000000002 109.03 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.01 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.2 Cg_exo -58.91 169.78 3.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.395 2.73 . . . . 0.72999999999999998 111.365 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 69.7 m -111.2 136.34 50.4 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.889 1.07 . . . . 1.54 113.889 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 40.5 t30 -102.19 92.38 4.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 113.943 -1.48 . . . . 2.52 111.352 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.644 ' HA ' ' CG ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -58.57 -12.2 3.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.209 1.004 . . . . 3.1800000000000002 113.046 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -76.03 -17.85 59.49 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.449 0.642 . . . . 3.7999999999999998 109.659 -174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.866 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . -75.89 -36.69 41.04 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.099 -0.955 . . . . 1.45 112.007 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.91 -77.31 0.4 Allowed Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.17 -1.014 . . . . 1.4299999999999999 112.997 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.807 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -93.06 14.47 17.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.821 1.045 . . . . 1.4299999999999999 113.821 -165.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.644 ' CG ' ' HA ' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -61.91 159.89 32.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 118.682 0.674 . . . . 3.0600000000000001 111.782 -172.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.817 ' HG3' HG22 ' A' ' 135' ' ' ILE . 6.0 Cg_exo -34.55 162.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.846 1 C-N-CA 125.342 4.028 . . . . 1.6100000000000001 117.704 -171.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.33 10.43 85.99 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.325 -1.307 . . . . 1.3899999999999999 109.899 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.728 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 2.3 t-20 56.95 35.15 26.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.637 -0.781 . . . . 3.6899999999999999 110.26 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.728 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 9.2 pt-20 56.73 -6.22 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.321 1.448 . . . . 2.4700000000000002 113.744 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 86' ' ' ASN . 13.2 mm-40 -106.91 13.7 27.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.234 0.54 . . . . 3.6400000000000001 110.537 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.427 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 8.7 tp10 -91.47 -41.45 10.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.819 -0.808 . . . . 2.4199999999999999 108.819 172.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.567 HD13 ' SG ' ' A' ' 95' ' ' CYS . 18.6 mt -89.56 36.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.051 -0.977 . . . . 2.0499999999999998 110.321 -177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' HD2' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -89.6 5.53 45.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.535 -0.757 . . . . 4.0 111.294 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' HG2' ' HD2' ' A' ' 91' ' ' LYS . 11.3 pt-20 -160.36 29.77 0.16 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.447 -0.797 . . . . 3.1000000000000001 109.201 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 68.4 m-85 -141.43 167.62 21.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.518 -0.765 . . . . 1.9099999999999999 110.723 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.77 141.31 46.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.751 -1.574 . . . . 1.6499999999999999 106.751 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.633 ' HB2' HE22 ' A' ' 78' ' ' GLN . 24.9 m -128.79 116.94 20.26 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 118.514 -1.275 . . . . 0.91000000000000003 112.779 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.8 t -156.38 119.56 4.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.722 -1.127 . . . . 1.9199999999999999 109.804 168.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.3 mttp 54.52 100.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.062 0.764 . . . . 3.1800000000000002 113.062 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.658 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 37.9 p90 -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.776 -0.577 . . . . 1.74 110.688 176.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 68.15 145.81 0.05 OUTLIER 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.099 0.875 . . . . 3.0800000000000001 111.145 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.619 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -172.69 -173.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.41 . . . . 0.42999999999999999 112.083 -176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -83.67 -11.88 56.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 2.1899999999999999 110.155 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.814 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 39.0 p90 -113.34 169.04 6.86 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 115.405 -0.816 . . . . 0.23999999999999999 109.196 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.918 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 21.2 Cg_exo -71.41 122.12 8.36 Favored 'Trans proline' 0 N--CA 1.475 0.397 0 C-N-CA 123.556 2.837 . . . . 0.31 112.999 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.073 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.5 mp -110.79 139.65 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.909 -0.775 . . . . 0.37 108.909 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.918 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 10.1 mmt -112.07 -154.74 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.648 0.737 . . . . 1.47 112.909 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -71.63 133.78 45.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.674 -1.148 . . . . 0.39000000000000001 110.116 173.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.01 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttt -70.27 126.04 28.5 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.692 0.758 . . . . 1.6599999999999999 109.457 171.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.613 HG13 HG13 ' A' ' 110' ' ' VAL . 9.6 pt -121.47 167.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.262 -1.335 . . . . 0.46999999999999997 107.915 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.866 ' ND2' ' HA3' ' A' ' 80' ' ' GLY . 34.6 t-20 -85.28 63.97 8.4 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.434 -0.506 . . . . 2.1600000000000001 109.672 -175.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.793 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -64.55 88.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 120.727 -0.389 . . . . 0.38 110.799 -177.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.807 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 56.7 t30 173.05 178.63 0.09 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 1.98 108.243 167.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.04 -142.31 31.67 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 114.344 0.497 . . . . 0.78000000000000003 114.344 165.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -105.84 -1.63 24.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.589 0.709 . . . . 1.98 110.039 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -106.49 2.43 26.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.074 -0.967 . . . . 2.04 111.192 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -62.6 154.58 28.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.728 -0.669 . . . . 0.47999999999999998 112.242 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.681 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 33.7 t-80 -47.96 138.47 10.06 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 115.586 -0.734 . . . . 0.41999999999999998 110.046 172.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.12 -39.16 51.4 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.138 2.559 . . . . 0.35999999999999999 112.436 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.681 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -60.45 -39.63 88.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 1.1000000000000001 111.332 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.454 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.9 m-85 -75.61 -28.89 59.05 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 116.445 -0.343 . . . . 1.49 110.813 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.56 -36.91 74.66 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.867 -0.733 . . . . 2.3700000000000001 109.426 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 124' ' ' LYS . 50.9 t80 -71.77 -45.85 60.29 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.738 -0.385 . . . . 0.57999999999999996 110.6 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.49 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . 66.5 mtt -61.46 -54.92 37.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.314 -0.403 . . . . 0.34000000000000002 111.442 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.0 mtpt -62.97 -36.9 85.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.93999999999999995 111.359 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.35 -31.59 67.55 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.843 0.354 . . . . 2.1299999999999999 110.301 -179.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.514 HG21 ' HD2' ' A' ' 150' ' ' PRO . 97.3 m -73.89 -38.64 64.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.46999999999999997 111.256 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 151' ' ' VAL . 32.2 mmtm -134.35 113.34 12.2 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.867 0.365 . . . . 1.75 111.15 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.68 -54.34 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.186 2.591 . . . . 1.76 113.291 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.69 ' HA3' ' HB ' ' A' ' 132' ' ' THR . . . 141.43 -167.74 25.71 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.491 -0.861 . . . . 2.3700000000000001 112.189 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.0 pt -129.87 17.77 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 112.109 0.411 . . . . 3.5600000000000001 112.109 -175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.72 76.45 1.25 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.739 0.304 . . . . 2.7599999999999998 110.823 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 51.46 33.07 9.6 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.364 0.602 . . . . 2.8399999999999999 110.238 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.69 ' HB ' ' HA3' ' A' ' 128' ' ' GLY . 2.3 m -97.04 121.12 38.57 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.411 0.624 . . . . 3.8999999999999999 111.792 -167.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -122.43 -29.47 4.1 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.077 -0.965 . . . . 5.1299999999999999 108.659 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -122.88 176.38 6.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.559 -0.746 . . . . 0.93000000000000005 112.79 -173.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.854 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 49.2 mt -97.76 84.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 114.942 -1.027 . . . . 1.05 110.742 -171.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -108.61 25.28 11.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.524 0.564 . . . . 1.5 112.524 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.854 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.08 170.14 21.85 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.281 0.474 . . . . 0.87 112.281 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 44' ' ' ALA . 16.2 m120 -52.49 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.48 1.512 . . . . 1.8 113.41 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.833 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 68.5 m-85 -25.89 -59.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.399 0 C-N-CA 125.529 1.532 . . . . 1.3700000000000001 113.957 -165.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.913 HG23 ' HA ' ' A' ' 155' ' ' SER . 18.0 m 42.43 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.209 0.818 . . . . 0.29999999999999999 113.209 177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.696 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 15.0 p -87.1 151.94 22.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.546 -0.862 . . . . 0.80000000000000004 111.496 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -103.78 134.6 46.82 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.287 -1.005 . . . . 0.53000000000000003 108.287 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.701 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.2 tp -82.08 106.15 13.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.107 -0.701 . . . . 0.51000000000000001 109.107 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.634 HG21 HD13 ' A' ' 15' ' ' ILE . 16.0 mm -106.42 123.78 61.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.021 -0.536 . . . . 0.20000000000000001 109.736 -171.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -177.41 4.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.374 -0.376 . . . . 1.3 110.595 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.506 ' HB2' HD13 ' A' ' 176' ' ' LEU . 51.9 mtt-85 -66.27 -9.58 33.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.675 0.62 . . . . 3.7799999999999998 112.675 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -108.0 -21.91 12.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.1799999999999999 110.066 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 106.07 31.65 4.05 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.637 -0.792 . . . . 0.23000000000000001 112.698 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.48 121.29 41.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.891 -0.411 . . . . 0.62 109.891 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.514 ' HD2' HG21 ' A' ' 125' ' ' THR . 44.8 Cg_exo -58.07 116.39 3.2 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.992 2.462 . . . . 0.29999999999999999 112.223 176.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.609 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 31.8 t -96.07 -25.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.809 -0.632 . . . . 0.27000000000000002 110.275 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.65 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 9.0 mm-40 -156.29 159.03 38.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.371 -0.377 . . . . 1.22 111.246 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.489 HH11 ' HH2' ' A' ' 137' ' ' TRP . 20.3 ttm180 -120.65 97.02 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.471 -0.566 . . . . 1.75 109.471 168.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.701 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 52.6 m-85 -85.22 110.17 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.277 -0.638 . . . . 0.38 109.277 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.913 ' HA ' HG23 ' A' ' 140' ' ' THR . 91.4 p -63.39 166.25 9.33 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.831 -0.433 . . . . 0.98999999999999999 109.831 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.069 ' HG2' ' HD3' ' A' ' 51' ' ' LYS . 58.7 Cg_endo -72.07 -2.19 11.19 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.371 2.047 . . . . 0.66000000000000003 113.058 -163.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 51' ' ' LYS . . . -96.45 8.74 66.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.631 -0.713 . . . . 0.52000000000000002 112.317 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.61 140.17 30.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.79 0.329 . . . . 0.42999999999999999 110.249 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.488 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 57.3 m -86.76 170.68 11.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.199 -0.455 . . . . 1.25 111.309 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.712 ' HA ' HG23 ' A' ' 56' ' ' THR . 49.0 t -55.41 -51.82 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.397 . . . . 0.40999999999999998 111.584 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 161' ' ' LYS . 20.2 tptt -68.83 -26.84 65.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 3.4399999999999999 110.622 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.488 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.7 m-20 -64.19 -31.81 73.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.666 -0.697 . . . . 1.8600000000000001 110.27 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.757 HG21 HD21 ' A' ' 39' ' ' LEU . 59.1 mt -83.04 -45.15 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.902 -0.59 . . . . 0.20999999999999999 110.529 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 41.2 mt-10 -52.68 -39.01 61.51 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.839 0.681 . . . . 0.88 112.839 -176.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -55.52 -31.35 62.01 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.872 0.323 . . . . 0.75 111.872 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.65 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 72.3 mttt -106.32 -9.67 16.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.918 0.389 . . . . 1.5800000000000001 110.976 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 58.7 tp -91.52 -41.61 10.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 0.23999999999999999 111.775 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.757 ' HA ' HD12 ' A' ' 171' ' ' LEU . 71.6 mt -50.61 -48.71 81.71 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 112.998 0.74 . . . . 0.44 112.998 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.491 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.64 -32.39 90.36 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.099 1.866 . . . . 0.48999999999999999 112.745 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 151' ' ' VAL . 76.6 mt -80.8 -35.22 33.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.776 -0.193 . . . . 0.70999999999999996 110.865 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.0 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.2 mt -59.0 -41.48 87.77 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.697 -0.853 . . . . 0.46000000000000002 108.697 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.34 -81.14 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.21 -1.359 . . . . 1.52 111.129 162.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 24.5 t 179.64 152.68 0.43 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.762 0.315 . . . . 2.52 110.293 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.15 -45.84 7.69 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.773 0.32 . . . . 3.5600000000000001 110.472 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 175' ' ' ARG . 11.9 ptt-85 -157.95 9.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 7.8600000000000003 110.435 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 146' ' ' ARG . 6.5 mp . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.485 -0.769 . . . . 4.8099999999999996 110.17 -173.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 112.101 -0.4 . . . . 5.5099999999999998 112.101 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.9 ttp -72.92 125.54 27.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.788 0.327 . . . . 5.0499999999999998 110.503 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.48 51.98 3.33 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.796 -0.716 . . . . 1.3700000000000001 112.669 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.1 m -85.52 -32.21 22.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.219 0.533 . . . . 1.6799999999999999 110.563 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.6 p -142.91 172.21 13.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.65000000000000002 110.192 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.68 HD13 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -59.05 -29.64 41.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.418 0.525 . . . . 0.29999999999999999 112.418 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.79 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 36.5 m-85 -77.33 0.0 23.89 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.861 0.319 . . . . 0.27000000000000002 111.861 -172.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.7 -23.26 65.27 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.319 -0.993 . . . . 1.96 108.319 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 53.7 m-85 -102.67 174.61 5.81 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.731 -1.122 . . . . 0.40000000000000002 109.792 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -108.56 165.63 11.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.869 0.366 . . . . 2.77 110.658 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.579 HG23 HD13 ' A' ' 30' ' ' LEU . 73.8 t -135.66 151.79 30.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.577 -0.527 . . . . 0.73999999999999999 109.577 176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.869 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 66.8 mt -113.6 148.63 35.85 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.673 -0.492 . . . . 0.71999999999999997 109.673 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.653 ' CB ' ' HE3' ' A' ' 26' ' ' LYS . 5.8 t0 -78.49 -176.43 4.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.991 -1.114 . . . . 1.5900000000000001 107.991 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -56.96 -29.92 63.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.462 0.649 . . . . 0.52000000000000002 110.459 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 5.4 t70 -80.29 -20.01 45.36 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.324 -0.853 . . . . 2.2200000000000002 111.981 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.869 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 18.5 m-70 83.77 7.49 0.64 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.779 0.832 . . . . 0.72999999999999998 111.893 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.653 ' HE3' ' CB ' ' A' ' 22' ' ' ASP . 28.9 pttt -65.09 148.12 98.06 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 107.282 -1.377 . . . . 3.25 107.282 157.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 21' ' ' LEU . 19.0 Cg_endo -61.55 116.66 3.56 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.241 1.294 . . . . 0.85999999999999999 112.331 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.463 ' HB3' HG12 ' A' ' 20' ' ' VAL . 86.3 t80 -80.23 124.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.006 -0.997 . . . . 0.28000000000000003 110.333 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.627 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.7 t-20 -68.98 82.78 0.31 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.703 -0.68 . . . . 1.6499999999999999 109.757 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.79 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -72.45 -31.78 65.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.42 0.629 . . . . 0.25 110.136 -177.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.692 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 3.9 p -77.13 -0.36 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.333 -0.849 . . . . 0.40999999999999998 112.494 -169.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.7 pt20 -78.84 -9.4 59.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.566 0.698 . . . . 1.24 109.311 172.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -91.69 -7.97 48.36 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.156 -1.053 . . . . 0.38 108.156 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 21.3 ttpp -70.72 133.68 46.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.53 -1.214 . . . . 1.73 109.354 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.46 -5.35 54.86 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.024 -1.231 . . . . 0.35999999999999999 110.024 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 15.5 m -140.46 144.29 36.21 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.851 -0.796 . . . . 1.1399999999999999 108.851 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.063 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 52.6 Cg_endo -73.28 150.55 47.34 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.651 1.567 . . . . 0.52000000000000002 110.794 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.608 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -153.0 153.51 33.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.324 0.583 . . . . 1.03 111.089 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.779 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -108.33 152.69 24.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.982 -0.747 . . . . 1.1000000000000001 108.982 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 88.6 mt -137.29 118.21 17.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 109.417 -0.586 . . . . 0.20000000000000001 109.417 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.825 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -100.29 123.15 44.16 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.459 -0.337 . . . . 0.23000000000000001 110.532 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.65 ' HB2' HG21 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -82.41 90.8 6.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.041 -1.096 . . . . 1.28 108.041 168.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.663 HG11 ' HE2' ' A' ' 98' ' ' PHE . 2.2 p -112.2 132.42 60.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 112.575 0.583 . . . . 0.88 112.575 -163.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -64.52 102.12 0.52 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 106.938 -1.505 . . . . 0.52000000000000002 106.938 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.983 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 34.4 t -69.57 90.11 0.55 Allowed 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.432 -0.803 . . . . 1.8400000000000001 112.236 -165.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt 66.97 49.84 1.1 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.935 -1.03 . . . . 2.4300000000000002 110.813 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.557 ' SG ' HG23 ' A' ' 90' ' ' ILE . 16.9 m -135.75 126.43 27.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.719 -0.673 . . . . 0.98999999999999999 109.761 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.558 ' HA3' ' CD ' ' A' ' 89' ' ' GLU . . . 71.52 -129.91 17.43 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.902 -0.666 . . . . 1.0900000000000001 112.989 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.98 154.18 19.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.838 0.351 . . . . 3.1600000000000001 111.044 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.7 p -91.54 -24.49 19.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.317 -0.401 . . . . 1.9399999999999999 111.49 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 26.3 mtpp 64.04 3.75 1.8 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.644 -0.707 . . . . 2.0299999999999998 112.069 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.11 -5.01 41.65 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.814 -0.708 . . . . 0.46999999999999997 112.565 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -35.57 92.14 Favored Glycine 0 CA--C 1.505 -0.585 0 N-CA-C 111.982 -0.447 . . . . 0.34000000000000002 111.982 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.509 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -67.92 -48.81 64.94 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 110.286 -0.265 . . . . 0.56999999999999995 110.286 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.44 -52.87 62.16 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.473 0.654 . . . . 2.46 110.167 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 160' ' ' VAL . 34.7 m -63.11 -47.55 82.35 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.619 -1.173 . . . . 0.33000000000000002 111.32 -176.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.65 -46.96 87.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.829 0.347 . . . . 0.19 111.401 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.6 m -60.13 -53.68 54.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.778 -0.646 . . . . 0.29999999999999999 111.393 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 p -62.52 -42.03 99.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 1.0800000000000001 111.854 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.503 HD13 HD22 ' A' ' 39' ' ' LEU . 93.4 mt -58.92 -52.45 65.68 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 120.514 0.197 . . . . 0.81000000000000005 111.477 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.691 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 89.4 t80 -54.62 -47.16 73.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.915 -0.584 . . . . 0.33000000000000002 109.996 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -70.63 -41.03 72.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.533 -0.758 . . . . 1.76 111.394 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.32 -43.59 50.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.73 -0.668 . . . . 1.79 111.647 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.9 m-85 -102.19 4.5 39.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.728 1.01 . . . . 0.42999999999999999 113.728 -171.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -58.3 -30.08 66.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 2.1099999999999999 109.982 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.4 m -65.53 -26.4 67.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 1.2 111.484 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.2 13.16 32.81 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.877 0.37 . . . . 1.8999999999999999 111.095 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.71 63.42 1.84 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.95 -0.643 . . . . 1.3200000000000001 112.585 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.535 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 69.0 t80 -132.09 142.09 49.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.552 -0.166 . . . . 0.26000000000000001 110.552 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.608 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.16 143.29 50.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 110.129 -0.323 . . . . 0.51000000000000001 110.129 177.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.691 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 29.3 t -113.27 114.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.993 0.425 . . . . 0.23999999999999999 110.185 170.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 30.8 mt -100.47 122.44 43.2 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.978 -0.749 . . . . 0.51000000000000001 108.978 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.008 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -106.99 112.84 25.99 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.113 -0.635 . . . . 0.28000000000000003 110.252 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-30 -93.9 110.13 45.85 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.106 -1.072 . . . . 0.34000000000000002 108.106 177.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.087 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 36.3 Cg_exo -58.62 169.22 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.81 2.34 . . . . 0.72999999999999998 110.953 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.589 ' OG ' ' HB3' ' A' ' 83' ' ' GLU . 27.1 t -111.1 129.89 55.78 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 119.5 -0.88 . . . . 1.54 111.876 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.629 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 56.1 t30 -92.63 98.5 11.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.904 -1.498 . . . . 2.52 111.041 -173.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.87 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -54.36 -9.22 0.27 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.675 1.19 . . . . 3.1800000000000002 113.462 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -93.48 29.96 1.85 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.884 -0.598 . . . . 3.7999999999999998 111.142 -173.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.556 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . -113.62 -44.94 0.74 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.333 -0.936 . . . . 1.45 112.934 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.9 -42.86 1.27 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.715 -0.755 . . . . 1.4299999999999999 112.085 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.658 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.2 pm0 -135.96 46.28 2.33 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.155 0.428 . . . . 1.4299999999999999 112.155 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.87 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 2.5 mp0 -59.77 148.4 75.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 121.964 -0.46 . . . . 3.0600000000000001 110.225 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.972 ' HG3' HG22 ' A' ' 135' ' ' ILE . 11.1 Cg_exo -36.96 147.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.971 3.114 . . . . 1.6100000000000001 114.095 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.57 10.15 86.44 Favored Glycine 0 N--CA 1.44 -1.033 0 N-CA-C 108.981 -1.648 . . . . 1.3899999999999999 108.981 -168.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.635 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.8 t-20 52.71 47.42 24.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.048 -1.076 . . . . 3.6899999999999999 111.07 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 3.3 pt-20 66.56 -28.85 0.13 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.09 1.356 . . . . 2.4700000000000002 112.093 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.694 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 40.7 tt0 -68.7 -26.72 65.42 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.039 0.535 . . . . 3.6400000000000001 111.893 -170.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' CD ' ' HA3' ' A' ' 48' ' ' GLY . 3.0 tp10 -76.22 -14.74 60.13 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.242 0.544 . . . . 2.4199999999999999 110.9 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.557 HG23 ' SG ' ' A' ' 47' ' ' CYS . 1.9 mt -116.93 34.7 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.949 0.404 . . . . 2.0499999999999998 110.051 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.694 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 33.9 mtmm -64.03 -84.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.242 1.02 . . . . 4.0 111.264 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 7.0 pt-20 -77.81 -11.22 59.86 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.738 -1.574 . . . . 3.1000000000000001 110.284 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -91.4 158.2 16.65 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.035 -0.984 . . . . 1.9099999999999999 109.711 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.85 124.27 66.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.172 -0.677 . . . . 1.6499999999999999 109.172 171.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.645 ' HB2' HE22 ' A' ' 78' ' ' GLN . 14.3 m -90.41 120.05 31.2 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.565 0.698 . . . . 0.91000000000000003 111.05 -174.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -149.16 128.69 13.1 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.562 -1.199 . . . . 1.9199999999999999 108.029 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -14.07 104.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.775 1.297 . . . . 3.1800000000000002 113.525 -172.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.663 ' HE2' HG11 ' A' ' 43' ' ' VAL . 34.5 p90 -66.55 -20.74 66.09 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.04 -0.982 . . . . 1.74 111.365 -170.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 67.55 147.61 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 124.041 0.838 . . . . 3.0800000000000001 111.178 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.45 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -169.93 -154.69 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.105 0.479 . . . . 0.42999999999999999 112.22 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 -5.74 58.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.559 -0.746 . . . . 2.1899999999999999 109.884 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.789 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 45.4 p90 -128.28 164.8 35.24 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 115.182 -0.917 . . . . 0.23999999999999999 109.135 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 32.4 Cg_exo -66.33 109.03 1.48 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 123.658 2.906 . . . . 0.31 113.701 -178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mp -104.15 128.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 108.957 -0.757 . . . . 0.37 108.957 172.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.581 ' HE2' ' HA ' ' A' ' 105' ' ' MET . 0.5 OUTLIER -109.49 -148.64 0.43 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.852 0.686 . . . . 1.47 112.852 -160.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.754 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -75.54 136.81 40.56 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.168 -0.924 . . . . 0.39000000000000001 110.669 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.087 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 15.3 pttp -79.45 128.58 33.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.688 0.756 . . . . 1.6599999999999999 110.384 173.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.569 HG13 HG13 ' A' ' 110' ' ' VAL . 3.2 pt -122.77 160.69 25.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.312 -1.313 . . . . 0.46999999999999997 107.845 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.708 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.4 t-20 -75.93 82.66 2.83 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.187 -1.042 . . . . 2.1600000000000001 108.187 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.15 86.53 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 118.842 -1.143 . . . . 0.38 108.944 177.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.658 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 55.8 t30 172.44 178.57 0.08 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.545 -0.909 . . . . 1.98 108.545 170.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.28 -145.62 17.05 Favored Glycine 0 C--O 1.236 0.23 0 N-CA-C 115.211 0.844 . . . . 0.78000000000000003 115.211 163.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.46 -15.74 25.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.464 -0.868 . . . . 1.98 110.56 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -94.08 1.28 56.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.617 0.722 . . . . 2.04 110.529 -169.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.18 140.13 45.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.094 -0.957 . . . . 0.47999999999999998 112.346 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.552 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 45.1 t-80 -50.75 137.25 25.19 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.179 -0.919 . . . . 0.41999999999999998 110.502 172.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.516 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 1.4 Cg_endo -45.08 -45.52 14.34 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.89 2.393 . . . . 0.35999999999999999 112.792 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.552 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.8 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.942 -0.572 . . . . 1.1000000000000001 111.715 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 1.0 OUTLIER -75.89 -29.0 58.32 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 119.609 -0.234 . . . . 1.49 111.105 177.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.13 -43.36 78.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.886 -0.783 . . . . 2.3700000000000001 108.886 168.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 84.8 t80 -66.63 -45.09 80.2 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.569 0.543 . . . . 0.57999999999999996 110.652 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.508 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 67.1 mtt -63.83 -53.52 49.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.461 -0.336 . . . . 0.34000000000000002 111.31 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.47 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 26.4 mtpt -60.89 -41.59 96.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.93999999999999995 111.002 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.9 ptmt -71.12 -35.39 71.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 2.1299999999999999 111.108 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.1 m -75.79 -36.5 59.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.924 -0.58 . . . . 0.46999999999999997 111.189 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 9.5 mmtt -141.88 100.09 6.05 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 112.546 0.573 . . . . 1.75 112.546 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.636 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 11.8 Cg_endo -56.82 -29.97 83.29 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.251 2.634 . . . . 1.76 111.465 168.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.858 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 92.06 -130.53 10.35 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.912 -0.661 . . . . 2.3700000000000001 112.974 173.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.1 pt -95.75 10.55 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.932 0.396 . . . . 3.5600000000000001 111.254 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.13 -176.3 4.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.242 -0.435 . . . . 2.7599999999999998 110.563 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.37 -160.76 0.82 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.772 -0.649 . . . . 2.8399999999999999 110.019 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.9 m 76.12 -38.26 0.33 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.702 0.63 . . . . 3.8999999999999999 112.702 172.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.636 ' HG2' ' HB3' ' A' ' 127' ' ' PRO . 34.1 mtmm 68.4 1.89 3.1 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.711 0.805 . . . . 5.1299999999999999 111.02 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -103.64 174.02 6.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.119 0.485 . . . . 0.93000000000000005 111.892 -172.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.972 HG22 ' HG3' ' A' ' 84' ' ' PRO . 44.8 mt -114.95 94.6 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.488 -0.778 . . . . 1.05 110.568 -171.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -110.56 9.89 23.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.292 0.849 . . . . 1.5 113.292 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.874 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -140.04 168.91 18.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.783 0.66 . . . . 0.87 112.783 -177.047 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 22.5 m120 -43.67 -156.14 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 126.552 1.941 . . . . 1.8 115.494 173.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.825 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.2 m-85 -28.02 -55.19 0.11 Allowed 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 113.897 -1.501 . . . . 1.3700000000000001 113.386 -169.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.818 HG23 ' HA ' ' A' ' 155' ' ' SER . 18.9 m 40.2 96.97 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.386 0.884 . . . . 0.29999999999999999 113.386 175.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 7.7 p -85.2 152.7 23.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.789 -0.764 . . . . 0.80000000000000004 111.129 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 4.9 m-85 -102.61 162.42 12.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.215 -1.402 . . . . 0.53000000000000003 107.215 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.833 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 48.5 tp -107.32 105.07 14.85 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.603 -0.888 . . . . 0.51000000000000001 108.603 177.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.68 HG21 HD13 ' A' ' 15' ' ' ILE . 17.9 mm -103.78 119.8 52.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.844 -0.798 . . . . 0.20000000000000001 108.844 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.864 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -69.81 179.24 2.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 1.3 110.651 -176.106 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.654 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -57.99 -20.61 39.65 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.846 0.355 . . . . 3.7799999999999998 111.619 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.442 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 1.0 OUTLIER -109.12 -13.8 14.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.113 0.482 . . . . 1.1799999999999999 110.389 -167.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.532 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.51 32.61 4.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.782 -0.645 . . . . 0.23000000000000001 113.271 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 150' ' ' PRO . 59.3 t -109.15 118.93 50.05 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 122.466 -0.432 . . . . 0.62 110.165 175.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.445 ' HG3' ' HA ' ' A' ' 122' ' ' MET . 14.3 Cg_endo -61.48 112.26 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.674 2.249 . . . . 0.29999999999999999 111.969 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.3 t -94.47 -30.19 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.909 -0.587 . . . . 0.27000000000000002 111.14 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -154.51 165.13 37.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 1.22 110.916 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.858 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 14.5 ttm180 -134.18 98.5 4.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 1.75 109.854 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.833 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 9.3 m-85 -85.9 136.65 33.2 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.006 -1.109 . . . . 0.38 108.006 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.818 ' HA ' HG23 ' A' ' 140' ' ' THR . 25.2 p -79.83 178.72 2.17 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.748 -0.781 . . . . 0.98999999999999999 109.626 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.767 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 56.6 Cg_endo -67.05 -20.63 50.29 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.616 1.544 . . . . 0.66000000000000003 110.99 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.13 13.24 45.98 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.618 -1.174 . . . . 0.52000000000000002 112.17 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -86.36 139.67 30.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.901 0.381 . . . . 0.42999999999999999 110.52 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.0 p -90.1 163.93 14.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.163 -0.471 . . . . 1.25 110.882 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.4 t -49.9 -57.61 2.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 O-C-N 123.346 0.404 . . . . 0.40999999999999998 111.602 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 164' ' ' GLU . 18.7 ptpt -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.539 -0.301 . . . . 3.4399999999999999 111.517 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -66.94 -32.69 74.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.41 0.624 . . . . 1.8600000000000001 109.651 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.779 HG21 HD21 ' A' ' 39' ' ' LEU . 36.6 mt -82.06 -37.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.549 -0.75 . . . . 0.20999999999999999 110.049 173.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 46.9 mt-10 -57.96 -40.64 81.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.88 112.147 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.581 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 6.0 pt-20 -56.73 -31.35 64.46 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.651 -0.42 . . . . 0.75 111.551 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.581 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 23.0 mmmt -98.37 -16.95 19.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.104 0.478 . . . . 1.5800000000000001 110.289 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.595 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -92.94 -43.13 9.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.776 -0.647 . . . . 0.23999999999999999 111.765 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.835 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.3 mt -51.33 -49.89 79.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.463 0.542 . . . . 0.44 112.463 -176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 9.9 Cg_endo -54.26 -37.89 88.3 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.175 1.916 . . . . 0.48999999999999999 112.532 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 48.2 mt -76.97 -37.18 55.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.778 -0.192 . . . . 0.70999999999999996 111.462 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.063 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 10.1 mt -57.7 -48.38 79.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.819 -0.808 . . . . 0.46000000000000002 108.819 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.37 -66.91 2.49 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.278 -1.328 . . . . 1.52 112.675 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 176' ' ' LEU . 45.4 m -159.01 121.22 3.52 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.481 0.312 . . . . 2.52 110.49 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.864 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -92.96 -59.63 2.0 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.335 -0.546 . . . . 3.5600000000000001 109.99 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -92.18 -55.29 3.48 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 105.85 -1.907 . . . . 7.8600000000000003 105.85 159.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 173' ' ' SER . 2.6 tt . . . . . 0 C--O 1.252 1.214 0 CA-C-N 113.436 -1.711 . . . . 4.8099999999999996 107.439 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.766 -0.134 . . . . 5.5099999999999998 112.766 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ptm -139.56 -168.33 2.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.988 -0.745 . . . . 5.0499999999999998 108.988 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.63 -170.86 41.94 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 119.976 -1.107 . . . . 1.3700000000000001 112.669 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -65.4 -65.26 0.7 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.342 0.591 . . . . 1.6799999999999999 110.822 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.8 p -130.46 -173.66 3.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.817 -0.809 . . . . 0.65000000000000002 108.817 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 144' ' ' ILE . 17.7 pt -61.23 -25.8 37.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 0.29999999999999999 110.877 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.809 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 26.9 m-85 -83.91 2.34 39.06 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.27000000000000002 110.994 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.57 -20.95 63.65 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.795 -1.187 . . . . 1.96 107.795 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 42.4 m-85 -106.24 178.32 4.6 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.409 -1.269 . . . . 0.40000000000000002 109.668 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -124.86 149.19 47.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.43 -0.35 . . . . 2.77 110.321 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG23 HD13 ' A' ' 30' ' ' LEU . 77.5 t -114.7 145.56 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.14 0.495 . . . . 0.73999999999999999 111.785 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.952 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 77.5 mt -101.18 132.38 46.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.741 . . . . 0.71999999999999997 109.201 171.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.03 -170.33 1.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.562 . . . . 1.5900000000000001 109.481 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.9 57.03 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.619 -0.264 . . . . 0.52000000000000002 111.624 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -94.36 -4.13 49.1 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.249 -0.282 . . . . 2.2200000000000002 110.982 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.952 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 20.6 m-70 75.48 26.42 1.14 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.753 0.787 . . . . 0.72999999999999998 109.532 -177.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.634 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -87.82 147.11 40.37 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 105.309 -2.108 . . . . 3.25 105.309 165.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 113.89 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.707 0.931 . . . . 0.85999999999999999 111.953 -176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.446 ' HB3' HG12 ' A' ' 20' ' ' VAL . 80.5 t80 -82.24 116.76 21.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.081 -0.963 . . . . 0.28000000000000003 109.078 172.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.657 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -66.31 82.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.758 -0.655 . . . . 1.6499999999999999 109.734 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.809 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.3 pt? -70.53 -34.27 72.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.902 -0.59 . . . . 0.25 110.498 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.686 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.0 p -77.36 -0.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.348 -0.842 . . . . 0.40999999999999998 112.812 -168.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 14.9 pt20 -82.88 -6.47 59.47 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.964 -0.754 . . . . 1.24 108.964 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.468 ' O ' HD21 ' A' ' 38' ' ' LEU . 81.9 m-70 -94.82 -2.69 50.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.803 -1.184 . . . . 0.38 107.803 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -76.67 141.36 40.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.761 -1.108 . . . . 1.73 109.392 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.88 65.85 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 109.761 -1.336 . . . . 0.35999999999999999 109.761 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.646 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -129.11 143.03 47.21 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 114.349 -0.926 . . . . 1.1399999999999999 109.016 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.979 ' HG2' HD23 ' A' ' 171' ' ' LEU . 63.1 Cg_endo -77.72 142.05 19.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.145 1.897 . . . . 0.52000000000000002 111.133 173.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.041 HD22 HG22 ' A' ' 70' ' ' THR . 0.2 OUTLIER -139.44 162.84 34.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.218 0.533 . . . . 1.03 110.753 -172.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.691 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -117.86 149.98 39.95 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.692 -0.855 . . . . 1.1000000000000001 108.692 168.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -136.28 119.67 23.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.406 -0.59 . . . . 0.20000000000000001 109.406 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.796 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 25.2 m-85 -103.41 123.61 47.17 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 120.593 0.235 . . . . 0.23000000000000001 111.268 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.73 ' HB2' HG21 ' A' ' 110' ' ' VAL . 0.7 OUTLIER -81.24 91.79 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.415 -1.328 . . . . 1.28 107.415 167.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 2.4 p -107.6 140.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.522 0.934 . . . . 0.88 113.522 -159.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.663 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . . . -61.7 101.99 0.23 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.578 -1.192 . . . . 0.52000000000000002 108.444 167.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.971 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -68.4 87.43 0.3 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.67 -1.15 . . . . 1.8400000000000001 112.76 -170.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 tttm 78.21 -34.94 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.635 0.774 . . . . 2.4300000000000002 111.649 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -110.91 125.69 53.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.649 0.262 . . . . 0.98999999999999999 110.486 177.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 151.89 -136.32 5.42 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.558 -0.83 . . . . 1.0900000000000001 112.028 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.529 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 29.1 t80 -132.7 156.66 46.6 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.349 -0.612 . . . . 3.1600000000000001 109.349 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.5 p -119.25 114.7 22.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.338 0.589 . . . . 1.9399999999999999 110.535 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 18.3 ttmm -100.7 15.78 27.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.5 -0.773 . . . . 2.0299999999999998 109.822 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.13 18.93 9.35 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.906 -0.664 . . . . 0.46999999999999997 111.516 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 -52.24 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.316 -0.468 . . . . 0.34000000000000002 112.536 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.607 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -66.48 -48.69 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.18 0.514 . . . . 0.56999999999999995 109.945 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.544 ' HG2' ' H ' ' A' ' 56' ' ' THR . 1.6 pm0 -57.83 -53.47 57.88 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.017 -0.992 . . . . 2.46 110.892 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.544 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 95.0 m -64.14 -42.43 96.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 0.33000000000000002 111.483 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.71 -49.87 75.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.97 0.414 . . . . 0.19 111.001 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -60.19 -52.39 65.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.6 -0.727 . . . . 0.29999999999999999 111.353 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -59.84 -47.44 85.71 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.881 -0.599 . . . . 1.0800000000000001 111.63 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.505 HD13 HD22 ' A' ' 39' ' ' LEU . 77.9 mt -55.32 -50.85 68.53 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.424 0.154 . . . . 0.81000000000000005 111.326 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.77 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 40.1 t80 -46.78 -56.14 6.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.124 0.89 . . . . 0.33000000000000002 109.774 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 90.2 m-20 -74.19 -33.75 63.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.454 -0.794 . . . . 1.76 110.936 -170.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -70.43 -41.2 73.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.227 -0.897 . . . . 1.79 111.052 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.552 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.0 m-85 -118.14 14.06 13.92 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 114.076 1.139 . . . . 0.42999999999999999 114.076 -172.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.77 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 34.8 mtmt -56.78 -29.12 62.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.162 0.506 . . . . 2.1099999999999999 110.156 172.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -59.36 -40.26 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.436 -0.802 . . . . 1.2 111.464 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.07 8.22 27.73 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.698 0.285 . . . . 1.8999999999999999 110.967 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 83.82 67.9 1.43 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.581 -0.819 . . . . 1.3200000000000001 111.689 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 39' ' ' LEU . 73.8 t80 -133.77 135.06 43.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.651 0.262 . . . . 0.26000000000000001 110.668 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 1.041 HG22 HD22 ' A' ' 38' ' ' LEU . 4.2 t -131.15 140.81 50.01 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.85 -0.426 . . . . 0.51000000000000001 109.85 175.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.603 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 39.2 t -104.48 114.17 43.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.603 -0.517 . . . . 0.23999999999999999 109.603 171.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.618 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 13.8 mt -98.63 121.11 40.16 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.672 -0.862 . . . . 0.51000000000000001 108.672 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.017 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.67 120.1 41.46 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.302 -0.559 . . . . 0.28000000000000003 110.918 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.8 m-85 -105.5 109.24 62.98 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.417 -0.811 . . . . 0.34000000000000002 109.044 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.971 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 32.0 Cg_exo -60.68 168.72 6.47 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.661 2.907 . . . . 0.72999999999999998 111.614 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.7 t -123.12 135.72 54.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 115.312 1.597 . . . . 1.54 115.312 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.668 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 8.1 m-20 -70.03 64.01 0.23 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 111.73 -2.486 . . . . 2.52 109.508 168.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.71 HE21 ' HB3' ' A' ' 89' ' ' GLU . 6.9 mt-30 -63.9 -2.72 2.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.375 1.47 . . . . 3.1800000000000002 113.574 -174.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -107.96 30.08 6.68 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.896 -0.779 . . . . 3.7999999999999998 108.896 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.48 ' HA3' ' OD1' ' A' ' 109' ' ' ASN . . . -85.39 -57.06 2.28 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.124 -0.944 . . . . 1.45 113.503 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.09 -54.32 0.27 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.036 -0.602 . . . . 1.4299999999999999 112.157 -174.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.759 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -126.12 15.87 7.86 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 112.547 0.573 . . . . 1.4299999999999999 112.547 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.668 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 0.0 OUTLIER -61.39 161.9 16.85 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 120.783 0.325 . . . . 3.0600000000000001 111.83 -171.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 1.036 ' HG3' HG22 ' A' ' 135' ' ' ILE . 81.5 Cg_exo -51.09 174.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.987 2.458 . . . . 1.6100000000000001 114.805 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.14 18.21 78.73 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.942 -1.263 . . . . 1.3899999999999999 109.942 -174.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 19.8 m120 59.62 44.31 14.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.677 -0.762 . . . . 3.6899999999999999 110.958 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.507 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 12.0 pt-20 57.57 142.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.879 1.672 . . . . 2.4700000000000002 115.183 171.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 68.67 57.69 0.42 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.033 -1.44 . . . . 3.6400000000000001 111.183 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.71 ' HB3' HE21 ' A' ' 78' ' ' GLN . 11.6 tp10 -93.19 -27.92 16.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.732 0.641 . . . . 2.4199999999999999 112.732 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.711 HG12 ' SG ' ' A' ' 95' ' ' CYS . 2.1 mt -83.57 50.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.689 0.757 . . . . 2.0499999999999998 110.761 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 93' ' ' PHE . 11.4 mtmt -78.28 102.33 7.6 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.17 -0.923 . . . . 4.0 109.698 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.63 -26.22 0.19 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.721 0.808 . . . . 3.1000000000000001 110.562 -177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 91' ' ' LYS . 42.6 m-85 -69.26 174.22 4.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.608 -0.724 . . . . 1.9099999999999999 110.845 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 94' ' ' VAL . 4.8 p -128.66 111.01 22.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.013 -0.736 . . . . 1.6499999999999999 109.013 170.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.711 ' SG ' HG12 ' A' ' 90' ' ' ILE . 74.2 m -95.32 120.99 36.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 118.762 -1.175 . . . . 0.91000000000000003 110.775 -176.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.871 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 11.5 t -151.66 162.85 40.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.483 -1.69 . . . . 1.9199999999999999 108.335 -175.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.669 ' HD3' ' H ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.12 105.32 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.785 0.678 . . . . 3.1800000000000002 111.125 177.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.607 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 49.6 p90 -60.61 -23.84 65.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.737 -0.665 . . . . 1.74 111.377 -174.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? 69.75 131.69 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.994 0.808 . . . . 3.0800000000000001 111.132 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -155.9 -163.61 1.53 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.097 -0.502 . . . . 0.42999999999999999 112.191 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.44 -14.82 60.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 2.1899999999999999 110.064 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.733 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 47.0 p90 -115.32 168.11 8.81 Favored Pre-proline 0 N--CA 1.443 -0.802 0 CA-C-N 115.127 -0.942 . . . . 0.23999999999999999 109.495 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.878 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 22.6 Cg_exo -71.06 121.53 7.92 Favored 'Trans proline' 0 N--CA 1.478 0.574 0 C-N-CA 123.932 3.088 . . . . 0.31 113.058 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.017 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -114.55 137.13 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.939 -0.763 . . . . 0.37 108.939 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.878 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 7.8 mmt -111.75 -151.63 0.48 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.524 0.678 . . . . 1.47 112.678 -165.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.74 131.97 43.86 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.77 -1.104 . . . . 0.39000000000000001 110.764 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.871 ' HD3' ' HA ' ' A' ' 96' ' ' THR . 3.6 mtmt -64.95 122.02 16.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.932 -0.766 . . . . 1.6599999999999999 108.932 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.727 HG13 HG13 ' A' ' 110' ' ' VAL . 10.7 pt -122.17 149.84 25.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.641 -1.244 . . . . 0.46999999999999997 107.641 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.48 ' OD1' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -77.28 71.31 3.76 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.999 -0.741 . . . . 2.1600000000000001 108.999 -177.127 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.73 HG21 ' HB2' ' A' ' 42' ' ' ASN . 2.0 m -64.69 88.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-O 120.868 0.366 . . . . 0.38 110.854 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.759 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 47.9 t30 173.04 177.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.983 -1.117 . . . . 1.98 107.983 163.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.51 -136.85 21.85 Favored Glycine 0 CA--C 1.511 -0.181 0 C-N-CA 121.307 -0.473 . . . . 0.78000000000000003 113.675 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.29 -9.17 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.182 0.515 . . . . 1.98 110.369 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -83.09 -4.89 58.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.554 -0.748 . . . . 2.04 110.792 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 141.8 57.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.683 -0.69 . . . . 0.47999999999999998 111.817 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.638 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 46.3 t-80 -50.4 137.83 22.12 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.947 -1.024 . . . . 0.41999999999999998 110.281 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.71 -46.64 14.87 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.785 2.323 . . . . 0.35999999999999999 112.402 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.638 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.4 OUTLIER -57.15 -37.16 71.66 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.837 -0.62 . . . . 1.1000000000000001 111.804 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -30.7 58.28 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 121.076 -0.25 . . . . 1.49 110.945 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.05 -31.7 72.9 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.148 -0.621 . . . . 2.3700000000000001 109.927 171.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 68.0 t80 -70.88 -48.67 52.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 0.57999999999999996 110.391 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 67.1 mtt -63.77 -51.96 62.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.111 -0.495 . . . . 0.34000000000000002 111.058 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -58.33 -41.3 84.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.59 . . . . 0.93999999999999995 111.179 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.12 -30.13 66.12 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.748 0.309 . . . . 2.1299999999999999 110.614 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.503 HG21 ' HD2' ' A' ' 150' ' ' PRO . 85.2 m -75.27 -38.54 60.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.096 -0.502 . . . . 0.46999999999999997 111.007 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 35.7 mmtm -137.77 112.58 9.04 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.799 -0.182 . . . . 1.75 110.743 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.89 -19.83 17.73 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.111 2.541 . . . . 1.76 112.619 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.964 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 138.77 -171.74 23.41 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.598 -0.811 . . . . 2.3700000000000001 112.91 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.565 HD11 ' HA ' ' A' ' 154' ' ' PHE . 21.4 mt -68.56 -33.61 60.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.854 0.835 . . . . 3.5600000000000001 109.407 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.752 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.8 pt? -112.24 -157.44 0.62 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.078 -1.082 . . . . 2.7599999999999998 108.078 173.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.43 -87.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.657 -0.497 . . . . 2.8399999999999999 109.657 175.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.968 HG23 ' HE3' ' A' ' 136' ' ' LYS . 98.9 m 65.75 -62.25 0.24 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.386 0.884 . . . . 3.8999999999999999 113.386 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 132' ' ' THR . 60.6 tttp 73.56 -47.86 0.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.985 0.914 . . . . 5.1299999999999999 112.069 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.605 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -105.93 157.98 17.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.061 0.763 . . . . 0.93000000000000005 113.061 -168.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 1.036 HG22 ' HG3' ' A' ' 84' ' ' PRO . 28.8 mm -82.76 90.39 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.893 -1.049 . . . . 1.05 108.975 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.968 ' HE3' HG23 ' A' ' 132' ' ' THR . 17.5 ptpt -108.96 -3.2 17.69 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.611 0.597 . . . . 1.5 112.611 -170.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.882 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.24 169.95 14.74 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.54 0.571 . . . . 0.87 112.54 -172.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 49' ' ' TYR . 10.8 m120 -49.41 -156.87 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.845 1.658 . . . . 1.8 113.111 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.796 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 39.3 m-85 -27.57 -52.51 0.07 Allowed 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 114.74 1.385 . . . . 1.3700000000000001 114.74 -164.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.872 HG23 ' HA ' ' A' ' 155' ' ' SER . 17.3 m 39.38 102.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.899 1.074 . . . . 0.29999999999999999 113.899 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.692 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.4 p -90.48 155.93 18.56 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.596 -0.842 . . . . 0.80000000000000004 110.573 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 153' ' ' ARG . 17.6 m-85 -103.72 161.81 13.61 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.336 -1.357 . . . . 0.53000000000000003 107.336 163.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.806 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 55.5 tp -108.03 105.85 15.8 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.142 -0.688 . . . . 0.51000000000000001 109.142 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.75 HG21 HD13 ' A' ' 15' ' ' ILE . 16.5 mm -103.82 122.97 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 115.638 -0.71 . . . . 0.20000000000000001 109.206 -173.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.463 ' HB2' ' HB1' ' A' ' 174' ' ' ALA . 0.4 OUTLIER -76.93 -179.49 5.51 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.67 -0.412 . . . . 1.3 110.478 -177.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.414 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 91.5 mtt180 -57.27 -21.86 37.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.658 0.614 . . . . 3.7799999999999998 112.658 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -105.84 -17.33 14.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.297 0.57 . . . . 1.1799999999999999 109.762 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 103.71 34.15 3.9 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.345 -0.843 . . . . 0.23000000000000001 112.581 175.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.84 121.67 42.36 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.791 -0.448 . . . . 0.62 109.791 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.503 ' HD2' HG21 ' A' ' 125' ' ' THR . 31.5 Cg_exo -60.54 109.88 0.72 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.733 2.289 . . . . 0.29999999999999999 112.151 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -91.75 -31.23 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 0.27000000000000002 110.521 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.573 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.9 mm-40 -149.44 164.93 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.004 -0.544 . . . . 1.22 110.363 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.964 ' HB3' ' HA2' ' A' ' 128' ' ' GLY . 13.6 ttm180 -132.22 96.65 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.722 -0.844 . . . . 1.75 108.722 168.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.806 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 22.3 m-85 -86.57 108.73 18.71 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.299 -0.63 . . . . 0.38 109.299 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.872 ' HA ' HG23 ' A' ' 140' ' ' THR . 16.4 p -65.2 164.19 25.3 Favored Pre-proline 0 N--CA 1.444 -0.749 0 N-CA-C 109.596 -0.52 . . . . 0.98999999999999999 109.596 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.815 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 23.5 Cg_endo -61.59 -12.21 23.67 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.986 2.457 . . . . 0.66000000000000003 113.251 -163.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.71 -0.53 90.16 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.52 -0.764 . . . . 0.52000000000000002 112.459 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.19 134.67 35.66 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.894 -0.41 . . . . 0.42999999999999999 109.894 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 19.5 m -91.7 176.66 6.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.472 -0.331 . . . . 1.25 110.129 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.413 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 38.8 t -51.97 -52.1 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 0.40999999999999998 111.213 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -64.02 -36.71 84.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 3.4399999999999999 110.936 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.4 m-20 -57.35 -36.12 70.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.726 -0.67 . . . . 1.8600000000000001 110.232 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.691 HG21 HD21 ' A' ' 39' ' ' LEU . 74.5 mt -84.24 -43.5 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.342 -0.844 . . . . 0.20999999999999999 111.413 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 51.3 mt-10 -54.91 -38.53 67.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.493 0.553 . . . . 0.88 112.493 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.0 -18.37 45.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.035 0.383 . . . . 0.75 112.035 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.573 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 52.3 mttt -116.64 -10.14 11.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.097 0.475 . . . . 1.5800000000000001 110.472 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.1 tp -97.48 -44.36 6.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.681 -0.69 . . . . 0.23999999999999999 111.381 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 171' ' ' LEU . 69.4 mt -54.09 -49.28 90.83 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.225 0.454 . . . . 0.44 112.225 -175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 71.8 Cg_exo -51.7 -36.35 61.24 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.187 1.925 . . . . 0.48999999999999999 112.781 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.02 -36.15 56.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.475 -0.33 . . . . 0.70999999999999996 111.099 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.979 HD23 ' HG2' ' A' ' 37' ' ' PRO . 12.4 mt -60.13 -49.43 77.68 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.968 -0.753 . . . . 0.46000000000000002 108.968 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.22 -52.0 38.62 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 114.462 -1.244 . . . . 1.52 112.536 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.3 p 177.83 127.45 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.726 0.41 . . . . 2.52 110.235 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 145' ' ' ASP . . . -82.62 -43.18 17.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.443 0.64 . . . . 3.5600000000000001 109.711 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 175' ' ' ARG . 18.8 tpt180 -147.48 -53.62 0.21 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.873 -1.158 . . . . 7.8600000000000003 107.873 174.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 C--O 1.246 0.906 0 CA-C-N 114.775 -1.102 . . . . 4.8099999999999996 108.375 171.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.086 -0.406 . . . . 5.5099999999999998 112.086 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -126.81 18.26 7.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.968 0.413 . . . . 5.0499999999999998 110.298 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.96 81.78 1.24 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.919 -1.273 . . . . 1.3700000000000001 109.919 -168.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -44.84 -56.25 4.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.359 0.6 . . . . 1.6799999999999999 112.21 -174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 p -157.26 -174.68 5.01 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.334 -0.848 . . . . 0.65000000000000002 108.91 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.727 HD13 HG21 ' A' ' 144' ' ' ILE . 18.9 pt -60.61 -25.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.142 0.496 . . . . 0.29999999999999999 110.647 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.797 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 34.3 m-85 -80.64 3.61 21.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.198 -0.455 . . . . 0.27000000000000002 111.418 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -73.64 -16.35 61.23 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.905 -0.776 . . . . 1.96 108.905 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 52.0 m-85 -109.47 159.32 17.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.765 -1.107 . . . . 0.40000000000000002 110.328 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.14 143.82 31.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.935 0.398 . . . . 2.77 110.585 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG23 HD13 ' A' ' 30' ' ' LEU . 69.5 t -115.03 146.48 19.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.802 -0.635 . . . . 0.73999999999999999 111.114 -178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.843 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 7.1 mp -103.67 145.19 30.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.97 0.414 . . . . 0.71999999999999997 110.495 170.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -76.54 -176.52 3.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 1.5900000000000001 109.101 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' ' HE2' ' A' ' 97' ' ' LYS . . . -55.65 -34.43 64.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.002 0.429 . . . . 0.52000000000000002 110.796 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 8.1 t70 -82.85 -6.29 59.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 2.2200000000000002 111.141 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.843 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 8.8 m-70 74.1 21.52 2.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.92 0.867 . . . . 0.72999999999999998 110.066 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 11.4 mmpt? -87.25 128.19 56.27 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 106.426 -1.694 . . . . 3.25 106.426 164.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -43.44 115.27 0.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.253 1.968 . . . . 0.85999999999999999 113.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.491 ' HB3' HG12 ' A' ' 20' ' ' VAL . 74.7 t80 -79.32 124.39 28.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.349 -1.296 . . . . 0.28000000000000003 110.003 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.701 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.8 t-20 -72.84 82.93 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.316 -0.624 . . . . 1.6499999999999999 109.316 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.797 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.8 pt? -70.47 -32.05 69.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.316 0.579 . . . . 0.25 110.276 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.795 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.1 p -77.04 -0.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.249 -0.887 . . . . 0.40999999999999998 112.58 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.9 pt20 -82.72 -4.92 58.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.164 -0.68 . . . . 1.24 109.164 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.414 ' HB3' HD13 ' A' ' 38' ' ' LEU . 89.8 m-70 -94.62 -4.08 48.38 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.864 -1.062 . . . . 0.38 108.294 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HE2' ' CD2' ' A' ' 16' ' ' PHE . 38.6 ttmt -71.71 139.8 49.3 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.745 -1.116 . . . . 1.73 109.368 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' C ' ' HB3' ' A' ' 146' ' ' ARG . . . 104.98 -20.32 38.73 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.843 -0.903 . . . . 0.35999999999999999 110.843 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 m -132.76 144.32 52.38 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.773 -0.825 . . . . 1.1399999999999999 108.773 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 3.6 Cg_exo -73.36 154.82 51.16 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.164 1.91 . . . . 0.52000000000000002 111.262 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.653 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.3 pt? -156.35 151.66 26.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.35 0.595 . . . . 1.03 111.417 -172.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.841 HD21 HG21 ' A' ' 163' ' ' ILE . 6.5 mp -107.99 155.92 19.81 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.982 -0.748 . . . . 1.1000000000000001 108.982 173.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 95.0 mt -141.25 117.53 7.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.549 -0.537 . . . . 0.20000000000000001 109.549 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.924 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 11.3 m-85 -104.19 123.65 47.7 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 120.755 -0.378 . . . . 0.23000000000000001 110.512 -175.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 1.013 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.4 OUTLIER -82.5 91.97 6.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.271 -1.011 . . . . 1.28 108.271 168.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 75' ' ' PRO . 2.3 p -112.35 130.53 65.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 113.605 0.965 . . . . 0.88 113.605 -160.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 76' ' ' SER . . . -58.9 103.39 0.16 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.248 -1.39 . . . . 0.52000000000000002 107.248 165.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 1.056 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -68.72 76.98 0.3 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.878 -1.056 . . . . 1.8400000000000001 113.423 -163.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.824 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 62.2 tttm 71.75 67.55 0.15 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.501 -1.227 . . . . 2.4300000000000002 111.235 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.512 ' SG ' HG23 ' A' ' 90' ' ' ILE . 56.6 m -145.4 116.38 7.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.594 -0.73 . . . . 0.98999999999999999 110.453 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.79 -106.92 1.42 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.758 -0.655 . . . . 1.0900000000000001 114.03 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.47 155.94 18.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.306 0.574 . . . . 3.1600000000000001 112.254 -171.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.5 p -120.31 -21.4 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.643 -0.708 . . . . 1.9399999999999999 110.631 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 29.1 mmmt 67.48 0.33 2.13 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.58 -0.736 . . . . 2.0299999999999998 111.378 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 105.71 -0.28 39.41 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.985 -0.626 . . . . 0.46999999999999997 111.798 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.73 -38.83 90.13 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.694 -0.563 . . . . 0.34000000000000002 111.694 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.63 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -69.62 -48.51 59.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.915 -0.402 . . . . 0.56999999999999995 109.915 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 2.3 mp0 -54.95 -49.05 72.32 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.403 -0.817 . . . . 2.46 110.608 177.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 160' ' ' VAL . 90.9 m -67.31 -45.45 76.46 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.424 -0.807 . . . . 0.33000000000000002 110.52 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.797 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.62 -49.34 76.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.824 0.345 . . . . 0.19 111.531 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 m -59.74 -46.26 89.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.29999999999999999 110.852 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.612 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 77.6 m -66.51 -47.75 71.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.613 -0.721 . . . . 1.0800000000000001 111.033 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -57.21 -48.53 78.55 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.427 0.158 . . . . 0.81000000000000005 111.427 -178.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 70' ' ' THR . 43.5 t80 -55.43 -53.56 54.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.33000000000000002 110.962 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.612 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 2.8 p30 -72.02 -27.6 62.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.23 0.538 . . . . 1.76 110.539 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -78.02 -35.67 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.674 -0.694 . . . . 1.79 110.849 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.712 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.8 m-85 -118.62 13.03 13.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.66 0.985 . . . . 0.42999999999999999 113.66 -174.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -63.09 -21.37 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.905 0.383 . . . . 2.1099999999999999 110.774 173.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -64.03 -37.11 86.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.784 -0.644 . . . . 1.2 110.218 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -90.15 3.39 53.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.768 -0.651 . . . . 1.8999999999999999 110.703 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.03 11.32 57.74 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.092 -0.504 . . . . 1.3200000000000001 113.059 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.656 ' CE1' HD13 ' A' ' 39' ' ' LEU . 85.8 t80 -72.97 132.35 43.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.835 0.35 . . . . 0.26000000000000001 111.301 -175.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -123.18 135.61 54.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 109.58 -0.526 . . . . 0.51000000000000001 109.58 177.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.797 HG11 ' HB1' ' A' ' 57' ' ' ALA . 26.1 t -102.51 111.62 32.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.474 -0.565 . . . . 0.23999999999999999 109.474 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 24.4 mt -95.45 121.38 37.06 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.486 -0.931 . . . . 0.51000000000000001 108.486 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.88 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -111.73 112.23 23.77 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.905 -0.718 . . . . 0.28000000000000003 110.35 177.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.79 ' HD2' HD11 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -93.94 111.72 54.17 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.085 -1.08 . . . . 0.34000000000000002 108.085 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.056 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 23.2 Cg_exo -60.13 170.65 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.186 2.591 . . . . 0.72999999999999998 111.895 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.2 t -116.76 133.49 55.94 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.13 0.967 . . . . 1.54 113.166 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.483 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 63.8 t30 -102.65 91.63 4.28 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.738 -1.573 . . . . 2.52 109.665 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.608 ' H ' ' CD ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -56.74 -14.26 3.19 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.793 1.237 . . . . 3.1800000000000002 113.747 -167.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -73.81 -1.97 21.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.899 0.704 . . . . 3.7999999999999998 112.899 -171.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.73 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -87.08 32.75 3.98 Favored Glycine 0 CA--C 1.517 0.173 0 C-N-CA 120.429 -0.891 . . . . 1.45 113.001 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.58 -62.83 3.8 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.552 -0.619 . . . . 1.4299999999999999 111.552 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 82' ' ' GLN . 5.3 pm0 -130.98 101.25 5.53 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 120.914 0.387 . . . . 1.4299999999999999 110.699 178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 78' ' ' GLN . 10.1 mm-40 -95.14 167.32 13.11 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 109.884 -0.414 . . . . 3.0600000000000001 109.884 161.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.813 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 19.6 Cg_exo -44.61 159.32 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.204 2.603 . . . . 1.6100000000000001 114.942 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.9 21.76 70.58 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.188 -1.565 . . . . 1.3899999999999999 109.188 -169.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.9 OUTLIER 70.54 -64.15 0.38 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.212 -0.994 . . . . 3.6899999999999999 110.417 -175.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 2.1 pp20? -178.0 -30.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 2.4700000000000002 110.249 173.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.766 ' HA ' ' HG3' ' A' ' 91' ' ' LYS . 37.8 tt0 -74.41 -19.64 60.34 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.741 0.645 . . . . 3.6400000000000001 112.741 -170.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 8.8 tp10 -57.34 -61.11 2.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.966 0.412 . . . . 2.4199999999999999 110.504 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.552 ' CG2' ' HG2' ' A' ' 78' ' ' GLN . 3.2 mt -90.79 37.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.242 0.544 . . . . 2.0499999999999998 110.544 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.766 ' HG3' ' HA ' ' A' ' 88' ' ' GLU . 7.6 mmmm -85.09 -48.99 8.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.968 0.89 . . . . 4.0 110.59 176.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.46 -8.0 45.9 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.153 -1.385 . . . . 3.1000000000000001 110.105 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.426 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 53.2 m-85 -110.61 167.36 10.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.311 -0.858 . . . . 1.9099999999999999 109.826 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.7 p -128.88 126.06 64.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.239 0.542 . . . . 1.6499999999999999 109.547 172.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.64 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 55.1 m -102.75 123.98 47.43 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.988 -0.551 . . . . 0.91000000000000003 111.631 -174.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -146.36 118.97 8.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.095 0.474 . . . . 1.9199999999999999 110.824 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.83 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 93.8 mttt 66.87 -50.21 0.47 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.87 -1.059 . . . . 3.1800000000000002 113.471 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.824 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 68.7 -48.78 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.928 0.891 . . . . 1.74 110.659 -170.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.83 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 18.6 mtmt 66.07 146.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.139 0.576 . . . . 3.0800000000000001 112.192 171.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.464 ' HB2' ' HE1' ' A' ' 98' ' ' PHE . . . -164.66 -164.03 0.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.702 0.63 . . . . 0.42999999999999999 112.702 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -79.77 -11.9 59.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.401 -0.818 . . . . 2.1899999999999999 109.887 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.623 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 42.2 p90 -115.81 166.86 11.27 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.096 -0.957 . . . . 0.23999999999999999 109.177 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 33.3 Cg_exo -66.02 121.81 9.23 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.37 2.713 . . . . 0.31 112.815 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.88 HG13 ' HB3' ' A' ' 73' ' ' ALA . 1.5 mp -109.51 143.45 19.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.466 -0.568 . . . . 0.37 109.466 174.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.692 ' HG2' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -108.92 -160.52 0.72 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.389 0.885 . . . . 1.47 113.389 -165.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 108' ' ' ILE . . . -72.93 131.47 42.24 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.013 -0.994 . . . . 0.39000000000000001 110.042 173.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.925 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 12.0 pttt -70.61 115.04 9.31 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.898 0.856 . . . . 1.6599999999999999 108.752 168.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.79 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -125.54 160.86 31.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.339 -1.726 . . . . 0.46999999999999997 106.339 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.894 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.0 m120 -65.73 117.54 8.31 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 118.97 -1.092 . . . . 2.1600000000000001 109.064 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' A' ' 135' ' ' ILE . 1.7 m -116.57 88.25 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.733 -0.839 . . . . 0.38 108.733 170.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 1.7 t30 173.86 177.32 0.12 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.296 -1.372 . . . . 1.98 107.296 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.476 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 42.19 -135.54 3.62 Favored Glycine 0 N--CA 1.46 0.242 0 O-C-N 123.936 0.773 . . . . 0.78000000000000003 114.739 164.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.47 -11.72 16.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.146 -0.527 . . . . 1.98 110.821 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -81.87 -15.32 54.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 2.04 111.339 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.894 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.5 137.46 0.82 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.062 1.134 . . . . 0.47999999999999998 114.062 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.59 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 55.5 t-80 -50.19 140.77 16.52 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 114.969 -1.014 . . . . 0.41999999999999998 110.866 173.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.28 -46.92 11.22 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.189 2.593 . . . . 0.35999999999999999 112.922 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.59 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 20.2 tp -58.05 -36.02 72.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.176 -0.466 . . . . 1.1000000000000001 111.656 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 15.0 m-85 -75.51 -30.59 59.87 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 116.65 -0.25 . . . . 1.49 110.76 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 115' ' ' ALA . 33.9 mm-40 -64.01 -29.32 70.48 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.068 -0.653 . . . . 2.3700000000000001 109.721 169.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 86.7 t80 -75.29 -42.02 55.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.277 0.56 . . . . 0.57999999999999996 110.393 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.622 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 66.8 mtt -69.38 -49.3 56.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.921 -0.581 . . . . 0.34000000000000002 110.82 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 38.7 mtpt -60.17 -40.76 91.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.93999999999999995 111.062 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 21.6 ptmt -69.17 -35.72 76.59 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.82 0.343 . . . . 2.1299999999999999 110.804 -178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 150' ' ' PRO . 91.1 m -74.23 -44.81 51.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.46999999999999997 110.875 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 42.8 mmtt -129.47 103.34 17.93 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.189 -0.46 . . . . 1.75 110.215 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.694 ' HB2' ' HB ' ' A' ' 132' ' ' THR . 44.2 Cg_endo -69.05 -19.76 39.06 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.453 2.769 . . . . 1.76 113.435 -174.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 124.91 -157.38 19.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.648 -0.787 . . . . 2.3700000000000001 111.881 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.6 -66.57 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.707 0.254 . . . . 3.5600000000000001 110.865 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.6 pp -63.71 -40.11 95.97 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.032 0.444 . . . . 2.7599999999999998 110.967 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -144.12 101.15 3.67 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.898 -0.779 . . . . 2.8399999999999999 108.898 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 127' ' ' PRO . 22.4 p -79.78 131.16 35.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.663 -0.699 . . . . 3.8999999999999999 111.924 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 132' ' ' THR . 16.5 tppt? 155.53 -65.1 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.996 1.435 . . . . 5.1299999999999999 109.451 167.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.449 ' C ' HH12 ' A' ' 153' ' ' ARG . . . -147.47 -178.71 6.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.936 0.717 . . . . 0.93000000000000005 112.936 -168.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.828 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 38.8 mt -78.5 150.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.768 -1.106 . . . . 1.05 109.475 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -168.57 -1.99 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.597 0.592 . . . . 1.5 112.597 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.828 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -136.82 170.03 16.76 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.332 0.653 . . . . 0.87 111.113 -175.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.465 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 15.7 m120 -43.93 -158.24 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.376 1.47 . . . . 1.8 114.058 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.924 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 38.6 m-85 -27.76 -57.63 0.11 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 125.018 1.327 . . . . 1.3700000000000001 114.335 -167.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 1.013 ' HB ' HD21 ' A' ' 42' ' ' ASN . 10.6 m 42.94 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.111 0.782 . . . . 0.29999999999999999 113.111 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 25.6 p -86.64 152.11 22.86 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.169 -0.612 . . . . 0.80000000000000004 110.637 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.622 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 21.9 m-85 -103.76 133.17 49.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.719 -1.215 . . . . 0.53000000000000003 107.719 165.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 151' ' ' VAL . 25.3 tp -81.29 103.63 11.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.741 -0.837 . . . . 0.51000000000000001 108.741 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.727 HG21 HD13 ' A' ' 15' ' ' ILE . 13.5 mm -104.03 125.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.095 -0.706 . . . . 0.20000000000000001 109.095 -175.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.4 -179.93 7.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.728 -0.789 . . . . 1.3 110.09 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.432 ' HG3' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -55.27 -23.09 21.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.21 0.529 . . . . 3.7799999999999998 112.085 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.46 -17.28 18.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.107 -0.701 . . . . 1.1799999999999999 109.107 -165.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 100.45 25.19 8.89 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.751 -1.113 . . . . 0.23000000000000001 112.509 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 65.0 t -106.81 124.54 35.16 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.106 0.453 . . . . 0.62 110.429 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 125' ' ' THR . 34.9 Cg_exo -61.1 111.26 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.332 2.688 . . . . 0.29999999999999999 112.328 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.551 ' HB ' HD23 ' A' ' 143' ' ' LEU . 18.5 t -88.8 -28.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.212 -0.449 . . . . 0.27000000000000002 110.712 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.521 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 34.3 mm-40 -160.91 164.26 31.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 1.22 110.536 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.803 HH11 ' HH2' ' A' ' 137' ' ' TRP . 14.8 ttm180 -123.0 97.23 5.34 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.707 -0.479 . . . . 1.75 109.707 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.637 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 84.6 m-85 -82.15 108.59 15.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.531 -0.544 . . . . 0.38 109.531 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.852 ' HA ' HG23 ' A' ' 140' ' ' THR . 3.0 m -62.19 165.21 9.0 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 109.771 -0.455 . . . . 0.98999999999999999 109.771 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.814 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 44.2 Cg_endo -66.97 -8.21 21.0 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.624 2.216 . . . . 0.66000000000000003 112.686 -164.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.23 5.56 81.16 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.52000000000000002 111.865 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.0 133.51 35.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.903 0.382 . . . . 0.42999999999999999 110.072 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.546 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 51.0 m -86.99 171.44 10.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.134 -0.485 . . . . 1.25 111.342 -176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.465 ' HA ' HG23 ' A' ' 56' ' ' THR . 99.0 t -52.86 -58.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.828 -0.624 . . . . 0.40999999999999998 112.356 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 164' ' ' GLU . 18.6 tptm -72.44 -25.33 61.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 3.4399999999999999 110.597 -174.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 3.1 m-20 -61.08 -31.36 71.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.877 -0.602 . . . . 1.8600000000000001 110.557 178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.841 HG21 HD21 ' A' ' 39' ' ' LEU . 43.1 mt -83.17 -42.16 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.002 0.43 . . . . 0.20999999999999999 110.778 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.603 ' HB2' ' HD2' ' A' ' 161' ' ' LYS . 45.8 mt-10 -56.45 -34.5 66.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.88 112.293 -174.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.434 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.2 pt-20 -53.62 -32.16 50.1 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.725 0.298 . . . . 0.75 111.67 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HG2' ' HG3' ' A' ' 165' ' ' GLU . 47.5 mmtm -105.26 -14.19 15.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.339 -0.391 . . . . 1.5800000000000001 111.236 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 171' ' ' LEU . 65.1 tp -88.57 -42.52 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.505 -0.316 . . . . 0.23999999999999999 111.735 -175.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.744 ' HA ' HD12 ' A' ' 171' ' ' LEU . 78.5 mt -53.34 -48.56 92.13 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.418 0.525 . . . . 0.44 112.418 -176.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.525 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 50.1 Cg_exo -56.32 -26.69 63.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.318 2.012 . . . . 0.48999999999999999 112.902 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.38 -40.37 16.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.70999999999999996 110.65 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.955 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 16.7 mt -59.18 -48.96 79.68 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.547 0.689 . . . . 0.46000000000000002 109.617 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -73.4 38.83 0.85 Allowed Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.501 -1.227 . . . . 1.52 113.13 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 171' ' ' LEU . 69.1 m 69.07 116.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.56 0.744 . . . . 2.52 112.775 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.01 -17.03 44.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.493 0.663 . . . . 3.5600000000000001 109.433 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -129.47 -79.36 0.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.328 -0.99 . . . . 7.8600000000000003 108.328 171.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.953 -1.021 . . . . 4.8099999999999996 108.997 175.792 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.741 ' N ' ' HG ' ' A' ' 13' ' ' SER . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.12 -0.392 . . . . 5.5099999999999998 112.12 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 64.9 mtt 62.04 63.5 1.09 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.154 0.502 . . . . 5.0499999999999998 111.307 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.52 53.12 4.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 1.3700000000000001 113.239 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.741 ' HG ' ' N ' ' A' ' 10' ' ' GLY . 9.1 m -95.02 -39.3 10.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.587 0.708 . . . . 1.6799999999999999 109.793 175.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 p -157.85 175.14 14.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.858 -1.065 . . . . 0.65000000000000002 108.452 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.806 HD13 HG21 ' A' ' 144' ' ' ILE . 21.9 pt -55.24 -29.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.136 0.421 . . . . 0.29999999999999999 112.136 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.865 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 48.9 m-85 -75.84 -0.44 21.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.387 0.514 . . . . 0.27000000000000002 112.387 -172.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.28 -12.2 59.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.505 0.669 . . . . 1.96 109.266 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 72.6 m-85 -108.84 155.54 20.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.228 -0.896 . . . . 0.40000000000000002 111.085 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 29.9 tt0 -84.25 143.51 29.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.429 -0.805 . . . . 2.77 110.934 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 28' ' ' TYR . 72.5 t -125.45 146.17 31.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.762 0.315 . . . . 0.73999999999999999 110.461 173.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.975 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 90.4 mt -111.59 146.82 36.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.408 -0.36 . . . . 0.71999999999999997 110.264 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.39 174.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.745 0.653 . . . . 1.5900000000000001 109.482 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 97' ' ' LYS . . . -53.86 -31.05 48.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.321 0.582 . . . . 0.52000000000000002 109.959 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.17 4.06 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.35 -0.841 . . . . 2.2200000000000002 112.228 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.975 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 30.5 m-70 72.63 26.09 2.51 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.485 0.66 . . . . 0.72999999999999998 110.968 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 26' ' ' LYS . 38.5 mmtt -91.07 128.73 46.51 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 107.03 -1.47 . . . . 3.25 107.03 168.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -44.47 112.63 0.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.792 1.661 . . . . 0.85999999999999999 112.476 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HB3' HG12 ' A' ' 20' ' ' VAL . 68.8 t80 -79.39 123.72 27.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.669 -1.15 . . . . 0.28000000000000003 110.553 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.632 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 3.0 t-20 -73.68 81.92 1.56 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.495 -0.775 . . . . 1.6499999999999999 109.182 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.777 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.7 pt? -72.12 -32.25 66.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.471 0.653 . . . . 0.25 110.463 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.865 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 8.8 p -77.21 0.5 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.324 -0.853 . . . . 0.40999999999999998 112.735 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.3 pt20 -82.15 -5.87 58.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.387 0.613 . . . . 1.24 109.564 173.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -92.54 -1.2 57.11 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.137 -1.06 . . . . 0.38 108.137 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -76.17 141.26 41.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.348 -1.296 . . . . 1.73 109.297 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.92 -8.39 63.3 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.328 -1.109 . . . . 0.35999999999999999 110.328 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 20.1 m -140.68 146.08 43.0 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.088 -0.708 . . . . 1.1399999999999999 109.088 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.056 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.0 Cg_endo -73.5 154.81 50.43 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.765 1.643 . . . . 0.52000000000000002 111.153 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.614 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -155.09 152.47 29.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.396 0.617 . . . . 1.03 111.372 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.742 HD21 HG21 ' A' ' 163' ' ' ILE . 6.3 mp -107.83 151.48 25.69 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.567 -0.901 . . . . 1.1000000000000001 108.567 172.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 80.4 mt -140.68 116.72 7.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 109.553 -0.536 . . . . 0.20000000000000001 109.553 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.922 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 24.3 m-85 -103.29 123.28 46.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.219 0.325 . . . . 0.23000000000000001 111.244 -172.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.728 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -79.32 91.56 5.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.783 -0.821 . . . . 1.28 108.783 168.193 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.713 HG11 ' HE2' ' A' ' 98' ' ' PHE . 2.4 p -112.34 133.52 57.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.563 0.949 . . . . 0.88 113.563 -163.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.86 102.62 0.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.726 -1.212 . . . . 0.52000000000000002 107.726 167.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.976 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 30.1 t -72.08 97.23 1.88 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.088 0.773 . . . . 1.8400000000000001 113.088 -166.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt 73.84 38.19 0.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.743 0.652 . . . . 2.4300000000000002 111.218 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.1 m -141.79 157.67 44.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.596 -0.274 . . . . 0.98999999999999999 110.607 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.69 ' HA3' ' HG2' ' A' ' 89' ' ' GLU . . . 66.2 -118.34 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 O-C-N 123.632 0.583 . . . . 1.0900000000000001 113.678 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -129.21 174.83 9.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.546 0.689 . . . . 3.1600000000000001 111.782 -174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.661 HG22 ' HE1' ' A' ' 139' ' ' PHE . 7.8 p -133.22 116.72 16.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.058 -0.974 . . . . 1.9399999999999999 109.616 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.703 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 24.8 mtpp -83.86 17.07 2.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.059 -0.519 . . . . 2.0299999999999998 111.828 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.3 17.04 21.24 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.878 -0.677 . . . . 0.46999999999999997 111.89 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.42 -42.85 7.22 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.394 -0.431 . . . . 0.34000000000000002 112.131 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.555 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.1 t80 -67.12 -44.59 79.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.449 -0.574 . . . . 0.56999999999999995 109.449 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 23.6 mp0 -55.81 -55.03 37.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.023 -0.99 . . . . 2.46 110.086 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.515 ' CG2' HD12 ' A' ' 163' ' ' ILE . 98.6 m -67.62 -41.45 83.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.941 -1.027 . . . . 0.33000000000000002 111.284 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.724 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.78 -48.2 81.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.859 0.362 . . . . 0.19 110.813 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.6 m -61.29 -49.38 77.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.635 . . . . 0.29999999999999999 111.043 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.9 p -64.24 -47.32 80.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.813 -0.63 . . . . 1.0800000000000001 111.438 -177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.642 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.59 -45.44 91.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.64 -0.255 . . . . 0.81000000000000005 111.176 -177.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.814 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 85.4 t80 -53.07 -58.81 5.74 Favored 'General case' 0 C--O 1.222 -0.355 0 O-C-N 123.215 0.322 . . . . 0.33000000000000002 110.668 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -70.09 -36.18 74.7 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.697 -0.401 . . . . 1.76 111.802 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.01 -39.81 79.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 1.79 111.384 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.727 ' CD1' HD13 ' A' ' 171' ' ' LEU . 73.9 m-85 -108.32 4.95 25.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.42999999999999999 113.17 -174.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -59.03 -28.02 66.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 2.1099999999999999 110.397 173.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.4 m -65.65 -37.34 86.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.464 . . . . 1.2 111.144 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -88.45 1.44 54.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.92 0.391 . . . . 1.8999999999999999 111.107 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 88.94 66.0 1.28 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.951 -0.643 . . . . 1.3200000000000001 112.191 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 39' ' ' LEU . 71.9 t80 -132.05 140.07 48.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.503 0.192 . . . . 0.26000000000000001 110.594 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -128.27 140.22 52.0 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 120.898 0.38 . . . . 0.51000000000000001 110.381 177.116 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.814 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 25.4 t -109.74 117.88 55.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.963 0.411 . . . . 0.23999999999999999 110.521 169.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 20.3 mt -101.43 137.84 39.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.693 -0.854 . . . . 0.51000000000000001 108.693 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.056 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -122.45 116.34 23.79 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.349 -0.54 . . . . 0.28000000000000003 110.835 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.629 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -99.12 108.77 51.43 Favored Pre-proline 0 C--N 1.31 -1.115 0 N-CA-C 108.659 -0.867 . . . . 0.34000000000000002 108.659 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.129 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 31.6 Cg_exo -59.3 170.24 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.194 2.596 . . . . 0.72999999999999998 111.717 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 83' ' ' GLU . 46.0 t -115.0 135.79 53.84 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.892 0.853 . . . . 1.54 112.291 -177.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -90.16 104.55 17.11 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.708 -1.587 . . . . 2.52 109.791 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.855 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -65.13 -14.54 60.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.043 -0.98 . . . . 3.1800000000000002 111.321 -173.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -86.61 -1.61 57.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.642 -0.708 . . . . 3.7999999999999998 110.443 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 109' ' ' ASN . . . -71.16 -13.27 72.98 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.848 -0.692 . . . . 1.45 111.579 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.13 -61.55 0.47 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.041 -0.599 . . . . 1.4299999999999999 112.646 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.564 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.1 pm0 -112.56 20.96 16.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.53 0.567 . . . . 1.4299999999999999 112.53 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.855 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.5 OUTLIER -61.15 161.21 17.79 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 118.245 0.475 . . . . 3.0600000000000001 111.296 -170.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.728 ' HG3' HG22 ' A' ' 135' ' ' ILE . 81.6 Cg_exo -51.28 172.52 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.255 2.636 . . . . 1.6100000000000001 115.631 -168.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.43 13.98 74.33 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.054 -1.618 . . . . 1.3899999999999999 109.054 -168.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 13.1 m120 52.78 37.19 23.24 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 114.145 -1.028 . . . . 3.6899999999999999 111.324 -175.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 4.4 pt-20 61.44 -16.84 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.295 1.438 . . . . 2.4700000000000002 113.995 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -97.5 8.46 44.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.572 -0.705 . . . . 3.6400000000000001 112.261 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.69 ' HG2' ' HA3' ' A' ' 48' ' ' GLY . 27.9 tt0 -91.45 -39.42 11.98 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.304 -0.558 . . . . 2.4199999999999999 109.652 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.607 HD13 ' SG ' ' A' ' 95' ' ' CYS . 5.5 mt -96.88 19.79 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.874 -0.603 . . . . 2.0499999999999998 110.255 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -76.1 -10.26 59.28 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.53 0.681 . . . . 4.0 110.854 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.79 18.15 5.15 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.079 -0.964 . . . . 3.1000000000000001 109.639 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 65.8 m-85 -140.11 170.46 15.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.08 -0.964 . . . . 1.9099999999999999 109.837 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.91 126.7 67.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.771 -0.455 . . . . 1.6499999999999999 109.771 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.651 ' HB2' HE21 ' A' ' 78' ' ' GLN . 10.6 m -102.05 120.25 40.12 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.196 -0.456 . . . . 0.91000000000000003 111.6 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 t -154.27 122.09 5.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.101 -0.5 . . . . 1.9199999999999999 110.964 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.707 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 15.7 ptpt 32.31 84.43 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.867 1.062 . . . . 3.1800000000000002 113.867 174.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.713 ' HE2' HG11 ' A' ' 43' ' ' VAL . 15.5 p90 -66.77 -25.47 66.5 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.742 -0.599 . . . . 1.74 110.361 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 99' ' ' LYS . 71.3 mmtt 65.78 148.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.081 0.863 . . . . 3.0800000000000001 111.946 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -169.39 -164.74 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.736 0.643 . . . . 0.42999999999999999 112.736 -174.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -69.67 -24.68 63.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.365 -0.834 . . . . 2.1899999999999999 109.752 173.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.794 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 50.3 p90 -108.9 168.07 8.27 Favored Pre-proline 0 N--CA 1.438 -1.063 0 CA-C-N 114.575 -1.193 . . . . 0.23999999999999999 109.479 -175.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 1.008 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 16.4 Cg_exo -73.7 129.37 13.5 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.7 2.933 . . . . 0.31 113.186 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.056 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.9 mp -117.69 138.02 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.336 -0.616 . . . . 0.37 109.336 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 1.008 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.9 mmt -112.66 -156.59 0.59 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.837 0.827 . . . . 1.47 113.2 -164.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.796 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -65.96 137.99 57.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.494 -1.23 . . . . 0.39000000000000001 110.938 174.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.129 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.9 pttp -84.44 127.63 34.12 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.85 0.833 . . . . 1.6599999999999999 109.458 172.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -131.66 162.17 39.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 113.983 -1.462 . . . . 0.46999999999999997 107.769 -176.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.721 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 21.5 t-20 -75.81 83.61 2.76 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.857 -0.794 . . . . 2.1600000000000001 108.857 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.697 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -74.26 89.57 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 108.085 -1.08 . . . . 0.38 108.085 173.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.564 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 1.0 OUTLIER 175.02 179.52 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.474 -0.936 . . . . 1.98 108.474 -178.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 47.0 -144.0 5.02 Favored Glycine 0 N--CA 1.452 -0.264 0 O-C-N 124.313 1.008 . . . . 0.78000000000000003 115.512 156.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 11.5 pt-20 -102.81 -6.96 22.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.152 -1.024 . . . . 1.98 110.331 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -98.29 0.01 44.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.476 -0.784 . . . . 2.04 110.975 -170.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -50.79 138.89 17.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.311 -0.859 . . . . 0.47999999999999998 112.888 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.46 ' HE1' ' O ' ' A' ' 19' ' ' GLU . 51.2 t-80 -52.4 138.08 39.7 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.303 -0.862 . . . . 0.41999999999999998 110.313 172.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -44.39 -45.08 12.92 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.217 2.611 . . . . 0.35999999999999999 112.676 -178.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.444 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 2.0 tm? -54.72 -45.61 74.11 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.667 -0.697 . . . . 1.1000000000000001 111.189 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.468 ' OH ' HG22 ' A' ' 40' ' ' ILE . 2.5 m-85 -75.56 -29.74 59.47 Favored 'General case' 0 C--O 1.212 -0.885 0 O-C-N 122.295 -0.253 . . . . 1.49 111.451 177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 49.8 mt-10 -58.49 -39.42 79.97 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.946 -0.702 . . . . 2.3700000000000001 109.165 170.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 88.1 t80 -67.82 -44.0 78.27 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.293 0.371 . . . . 0.57999999999999996 110.597 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.456 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.3 mtt -65.02 -54.12 35.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.306 -0.406 . . . . 0.34000000000000002 111.033 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 36.7 mtpt -57.18 -39.94 76.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.735 -0.666 . . . . 0.93999999999999995 110.877 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.4 ptmt -74.83 -30.51 61.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.421 -0.354 . . . . 2.1299999999999999 111.534 -176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.58 HG21 ' HD2' ' A' ' 150' ' ' PRO . 94.3 m -64.36 -53.8 42.87 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.625 -0.43 . . . . 0.46999999999999997 110.314 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.698 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.8 ttmt -127.61 105.76 21.05 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.847 -0.427 . . . . 1.75 109.847 173.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.549 ' HB2' ' H ' ' A' ' 133' ' ' LYS . 32.6 Cg_endo -64.72 -17.85 60.76 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.202 2.601 . . . . 1.76 113.026 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.94 164.81 12.54 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.969 -1.11 . . . . 2.3700000000000001 112.729 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.1 pt -124.34 20.31 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.418 0.628 . . . . 3.5600000000000001 110.124 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 131' ' ' ALA . 2.0 pt? -164.94 -41.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 2.7599999999999998 109.024 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.53 ' N ' ' HG ' ' A' ' 130' ' ' LEU . . . -144.26 122.13 12.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.847 -1.168 . . . . 2.8399999999999999 107.847 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.2 p -86.36 -179.62 6.71 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.311 0.856 . . . . 3.8999999999999999 113.311 -169.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.549 ' H ' ' HB2' ' A' ' 127' ' ' PRO . 77.9 tttt 78.64 -91.26 0.02 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-N 113.86 -1.518 . . . . 5.1299999999999999 112.752 173.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -123.09 178.76 4.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 114.027 1.121 . . . . 0.93000000000000005 114.027 -162.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.872 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 50.4 mt -82.9 156.21 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 113.539 -1.664 . . . . 1.05 108.464 176.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -173.26 10.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.121 0.786 . . . . 1.5 113.121 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.872 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -141.62 171.26 14.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.763 0.425 . . . . 0.87 110.997 -177.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.433 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 17.6 m120 -45.53 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.179 1.392 . . . . 1.8 113.526 172.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.922 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 47.0 m-85 -27.87 -59.07 0.11 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 114.634 1.346 . . . . 1.3700000000000001 114.634 -166.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.79 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 11.6 m 45.11 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.913 0.779 . . . . 0.29999999999999999 112.954 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 13.7 p -89.87 150.19 22.32 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.538 -0.865 . . . . 0.80000000000000004 111.071 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.456 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.8 m-85 -102.72 135.84 43.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.895 -1.15 . . . . 0.53000000000000003 107.895 166.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.972 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 54.9 tp -82.13 105.13 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.015 -0.735 . . . . 0.51000000000000001 109.015 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 15' ' ' ILE . 14.9 mm -102.5 122.59 55.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.558 -0.746 . . . . 0.20000000000000001 109.04 -173.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.56 179.24 3.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.286 -0.415 . . . . 1.3 110.355 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.82 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 72.8 mtp180 -62.41 -15.33 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.262 0.467 . . . . 3.7799999999999998 112.262 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -109.03 -18.29 13.7 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.835 -0.541 . . . . 1.1799999999999999 110.236 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.499 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 112.06 34.07 2.06 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.579 -0.737 . . . . 0.23000000000000001 113.27 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 55.0 t -108.41 126.75 28.89 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 117.199 0.5 . . . . 0.62 110.595 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.58 ' HD2' HG21 ' A' ' 125' ' ' THR . 11.3 Cg_exo -69.22 97.48 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.073 2.515 . . . . 0.29999999999999999 112.072 174.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.95 -20.05 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.529 . . . . 0.27000000000000002 111.151 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.698 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 6.0 mm-40 -154.17 162.45 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.998 -0.371 . . . . 1.22 109.998 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -135.3 98.14 3.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.565 -0.531 . . . . 1.75 109.565 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.972 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 16.1 m-85 -88.56 125.06 34.61 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.772 ' HA ' HG23 ' A' ' 140' ' ' THR . 92.4 p -69.75 171.74 6.71 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 108.809 -0.811 . . . . 0.98999999999999999 108.809 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.79 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 37.8 Cg_endo -66.04 -8.89 21.42 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.92 1.747 . . . . 0.66000000000000003 112.293 -171.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.35 -4.9 83.17 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.231 -0.895 . . . . 0.52000000000000002 112.108 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.09 113.26 19.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.16 0.505 . . . . 0.42999999999999999 110.125 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.2 p -82.62 179.92 7.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.677 -0.692 . . . . 1.25 110.804 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.642 HG13 HD21 ' A' ' 60' ' ' LEU . 58.0 t -44.17 -57.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.747 -0.66 . . . . 0.40999999999999998 111.617 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -58.12 -39.45 78.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.773 -0.648 . . . . 3.4399999999999999 112.399 -175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.52 -31.1 70.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.472 0.653 . . . . 1.8600000000000001 110.087 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.742 HG21 HD21 ' A' ' 39' ' ' LEU . 46.0 mt -81.32 -42.52 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.242 -0.89 . . . . 0.20999999999999999 110.945 177.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 65.3 mt-10 -58.09 -36.32 72.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.43 -0.35 . . . . 0.88 111.902 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.3 pt-20 -63.71 -12.28 33.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 111.894 0.331 . . . . 0.75 111.894 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.624 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 32.8 mmtp -116.22 -23.06 8.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.427 . . . . 1.5800000000000001 110.694 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.8 tp -89.68 -37.16 14.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.398 0.518 . . . . 0.23999999999999999 112.398 -170.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.666 ' HA ' HD12 ' A' ' 171' ' ' LEU . 68.8 mt -50.75 -48.47 83.16 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 0.44 112.841 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 51.8 Cg_exo -55.11 -37.07 94.27 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.924 1.749 . . . . 0.48999999999999999 112.69 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.598 HD22 ' HB2' ' A' ' 174' ' ' ALA . 33.3 mt -78.95 -36.93 40.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.688 0.255 . . . . 0.70999999999999996 111.688 -175.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.056 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.9 mt -55.44 -50.69 69.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.586 0.707 . . . . 0.46000000000000002 109.216 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -48.85 -68.73 1.19 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.11 -1.405 . . . . 1.52 111.78 167.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.82 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 9.3 t 175.9 137.83 0.05 Allowed 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.691 0.282 . . . . 2.52 110.434 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.598 ' HB2' HD22 ' A' ' 170' ' ' LEU . . . -92.2 -31.11 15.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.207 0.527 . . . . 3.5600000000000001 109.937 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -87.0 -6.28 58.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.417 -0.81 . . . . 7.8600000000000003 110.581 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 173' ' ' SER . 82.7 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.836 -0.62 . . . . 4.8099999999999996 109.915 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.792 -0.523 . . . . 5.5099999999999998 111.792 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -81.62 92.64 6.59 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.909 -0.404 . . . . 5.0499999999999998 109.909 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.55 88.19 0.1 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.885 -0.598 . . . . 1.3700000000000001 112.742 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -107.96 -27.12 10.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 1.6799999999999999 110.421 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.6 p -137.25 167.61 21.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.63 -0.714 . . . . 0.65000000000000002 109.101 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.715 HD13 HG21 ' A' ' 144' ' ' ILE . 18.0 pt -61.57 -29.7 46.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.852 0.358 . . . . 0.29999999999999999 111.9 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.795 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 72.4 m-85 -76.5 1.52 16.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.264 0.468 . . . . 0.27000000000000002 112.264 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.39 -17.86 61.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.792 -0.818 . . . . 1.96 108.792 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' HD2' ' HB2' ' A' ' 117' ' ' PRO . 73.9 m-85 -99.73 159.99 14.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.991 -1.004 . . . . 0.40000000000000002 110.6 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -102.21 135.77 43.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 2.77 110.963 -172.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.605 HG23 HD13 ' A' ' 30' ' ' LEU . 89.3 t -114.35 146.63 18.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.294 0.568 . . . . 0.73999999999999999 111.731 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 86.3 mt -117.29 153.22 33.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.615 -0.72 . . . . 0.71999999999999997 110.24 176.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.6 176.72 1.4 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.206 -0.906 . . . . 1.5900000000000001 109.454 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -53.71 -32.04 50.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.299 0.571 . . . . 0.52000000000000002 110.065 173.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 1.7 m-20 -87.12 -3.91 59.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.62 -0.718 . . . . 2.2200000000000002 112.281 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.97 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 14.7 m-70 74.49 27.04 1.43 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.693 0.759 . . . . 0.72999999999999998 110.296 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -88.56 154.61 50.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.61 -1.626 . . . . 3.25 106.61 167.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.17 113.14 1.31 Allowed 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 121.047 1.164 . . . . 0.85999999999999999 112.916 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.505 ' HB3' HG12 ' A' ' 20' ' ' VAL . 60.3 t80 -89.91 117.53 28.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.411 -0.813 . . . . 0.28000000000000003 110.722 168.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.573 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.6 t-20 -72.87 84.97 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.587 -0.733 . . . . 1.6499999999999999 109.512 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.786 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.74 -32.35 67.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.002 0.43 . . . . 0.25 110.58 -176.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.795 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -76.54 -1.37 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 0.40999999999999998 112.699 -167.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 7.0 pt20 -80.75 -5.71 57.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.418 0.628 . . . . 1.24 109.724 172.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.425 ' HB3' HD13 ' A' ' 38' ' ' LEU . 81.9 m-70 -92.15 1.02 57.46 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.188 -1.041 . . . . 0.38 108.188 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HD3' ' CD2' ' A' ' 16' ' ' PHE . 22.8 ttpp -86.19 132.64 33.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.923 -1.035 . . . . 1.73 109.216 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.2 32.26 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.767 -1.333 . . . . 0.35999999999999999 109.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 18.1 m -139.84 149.64 59.85 Favored Pre-proline 0 N--CA 1.447 -0.579 0 N-CA-C 108.389 -0.967 . . . . 1.1399999999999999 108.389 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.04 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 61.1 Cg_endo -75.41 153.51 39.92 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.558 1.505 . . . . 0.52000000000000002 111.257 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.679 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.2 pt? -154.27 151.07 28.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.297 0.57 . . . . 1.03 111.295 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.791 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -109.64 154.9 22.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.567 -0.742 . . . . 1.1000000000000001 109.089 172.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 72.3 mt -140.87 121.56 13.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.75 -0.833 . . . . 0.20000000000000001 108.75 -176.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.06 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.3 m-85 -108.41 126.72 53.2 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.882 0.373 . . . . 0.23000000000000001 111.589 -171.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.669 ' ND2' HD13 ' A' ' 135' ' ' ILE . 0.6 OUTLIER -77.97 93.82 4.5 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.619 -1.252 . . . . 1.28 107.619 170.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.792 HG12 ' HA ' ' A' ' 139' ' ' PHE . 18.0 m -112.65 138.38 42.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 113.44 0.904 . . . . 0.88 113.44 -164.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.8 102.78 2.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.575 -1.639 . . . . 0.52000000000000002 106.575 163.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 1.039 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 32.3 t -60.12 94.07 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.69 -0.686 . . . . 1.8400000000000001 112.202 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 98' ' ' PHE . 24.7 tptp 63.46 19.29 11.61 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.502 0.668 . . . . 2.4300000000000002 110.516 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 93' ' ' PHE . 24.2 p -135.18 172.62 12.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.706 -0.679 . . . . 0.98999999999999999 109.846 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.17 -154.58 39.15 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.714 -0.755 . . . . 1.0900000000000001 112.796 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -110.72 111.9 23.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 3.1600000000000001 110.235 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.408 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 1.5 p -77.56 112.86 14.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.5 . . . . 1.9399999999999999 111.109 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.434 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -81.5 14.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 2.0299999999999998 111.062 178.06 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.2 8.38 38.75 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.976 -0.556 . . . . 0.46999999999999997 111.888 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.2 -39.04 96.73 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 111.987 -0.445 . . . . 0.34000000000000002 111.987 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.518 ' CZ ' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -66.71 -47.29 72.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 120.769 0.319 . . . . 0.56999999999999995 110.413 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.65 -45.58 92.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.742 -0.466 . . . . 2.46 109.742 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.662 ' HA ' HG22 ' A' ' 160' ' ' VAL . 73.2 m -59.74 -50.96 71.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.602 -0.726 . . . . 0.33000000000000002 111.032 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.891 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -61.57 -50.25 73.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.164 -0.471 . . . . 0.19 111.372 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 m -56.08 -46.77 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.958 0.409 . . . . 0.29999999999999999 111.252 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.661 ' HA ' ' ND2' ' A' ' 62' ' ' ASN . 90.6 m -64.49 -46.5 82.73 Favored 'General case' 0 C--N 1.337 0.036 0 CA-C-N 116.392 -0.367 . . . . 1.0800000000000001 111.156 -177.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 39' ' ' LEU . 71.4 mt -59.72 -49.72 76.63 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 120.722 0.296 . . . . 0.81000000000000005 110.622 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.668 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 14.8 t80 -50.33 -57.43 7.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.213 -0.903 . . . . 0.33000000000000002 109.651 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' HA ' ' A' ' 59' ' ' THR . 2.3 p30 -73.84 -29.07 61.92 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.755 -0.657 . . . . 1.76 111.738 -168.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.679 ' HD2' ' CE2' ' A' ' 64' ' ' TYR . 33.2 ttmt -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.641 0.258 . . . . 1.79 111.041 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.679 ' CE2' ' HD2' ' A' ' 63' ' ' LYS . 70.8 m-85 -116.73 10.43 14.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.892 1.071 . . . . 0.42999999999999999 113.892 -172.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 14.7 mtpp -64.02 -20.29 65.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.0 -0.68 . . . . 2.1099999999999999 109.991 172.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -61.19 -33.27 73.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.766 -0.652 . . . . 1.2 109.887 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.467 HE21 ' HD1' ' A' ' 64' ' ' TYR . 2.0 mp0 -95.31 11.78 31.39 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.914 -0.584 . . . . 1.8999999999999999 110.643 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.61 12.38 75.3 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.872 -0.603 . . . . 1.3200000000000001 113.042 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 37' ' ' PRO . 93.8 t80 -72.03 141.06 49.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.034 0.445 . . . . 0.26000000000000001 111.302 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -131.79 144.87 51.24 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.908 -0.587 . . . . 0.51000000000000001 109.714 176.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.891 HG11 ' HB1' ' A' ' 57' ' ' ALA . 41.4 t -112.26 117.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.605 -0.517 . . . . 0.23999999999999999 109.605 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 22.3 mt -100.28 121.11 40.95 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.735 -0.839 . . . . 0.51000000000000001 108.735 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.033 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -107.99 112.72 25.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.388 -0.525 . . . . 0.28000000000000003 110.608 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 5.1 m-85 -98.46 115.25 65.82 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 109.039 -0.726 . . . . 0.34000000000000002 109.039 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.039 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 19.6 Cg_exo -63.28 169.66 9.09 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.107 2.538 . . . . 0.72999999999999998 111.915 -177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t -128.99 155.4 45.43 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.519 -0.872 . . . . 1.54 112.165 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.705 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -114.83 71.52 0.76 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.248 -1.342 . . . . 2.52 109.087 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.986 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -45.55 -12.5 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 114.92 1.452 . . . . 3.1800000000000002 114.92 -173.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -79.12 -7.53 58.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.306 0.574 . . . . 3.7999999999999998 110.343 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.82 36.91 2.3 Favored Glycine 0 C--N 1.329 0.171 0 CA-C-N 115.975 -0.557 . . . . 1.45 113.735 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.34 -72.98 2.72 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.84 -0.695 . . . . 1.4299999999999999 112.789 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.71 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.6 pm0 -120.96 30.71 6.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.154 0.798 . . . . 1.4299999999999999 113.154 -172.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.986 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 6.0 mm-40 -62.34 145.11 94.59 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 119.596 -0.841 . . . . 3.0600000000000001 110.012 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.714 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 26.8 Cg_endo -70.92 179.02 4.66 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 121.925 1.75 . . . . 1.6100000000000001 111.892 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.489 ' H ' ' CA ' ' A' ' 137' ' ' TRP . . . 77.7 16.14 80.48 Favored Glycine 0 CA--C 1.498 -0.983 0 N-CA-C 110.095 -1.202 . . . . 1.3899999999999999 110.095 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 89' ' ' GLU . 1.0 OUTLIER 71.84 108.18 0.07 Allowed 'General case' 0 C--N 1.333 -0.138 0 O-C-N 125.093 1.113 . . . . 3.6899999999999999 109.752 -174.105 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 2.3 pm0 -52.72 156.08 2.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.672 -0.695 . . . . 2.4700000000000002 111.649 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 13.5 mm-40 72.84 21.7 3.28 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.651 -0.704 . . . . 3.6400000000000001 111.208 -174.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.667 ' HB3' ' HG2' ' A' ' 78' ' ' GLN . 10.1 tp10 -84.14 -11.0 57.31 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 116.109 -0.496 . . . . 2.4199999999999999 112.155 -175.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.912 HG13 ' HB2' ' A' ' 78' ' ' GLN . 6.6 mt -93.76 -7.09 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.508 -0.745 . . . . 2.0499999999999998 110.2 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -73.3 8.98 1.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.698 0.629 . . . . 4.0 112.698 -167.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.4 ' HG3' ' CD2' ' A' ' 93' ' ' PHE . 10.7 pt-20 -163.12 24.86 0.09 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.584 -0.895 . . . . 3.1000000000000001 108.584 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CD2' ' O ' ' A' ' 89' ' ' GLU . 51.9 m-85 -139.65 -178.48 5.43 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.522 -1.217 . . . . 1.9099999999999999 110.815 -171.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.416 HG12 ' HD2' ' A' ' 97' ' ' LYS . 62.3 t -128.43 110.86 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.884 -0.784 . . . . 1.6499999999999999 108.884 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.698 ' SG ' HG12 ' A' ' 90' ' ' ILE . 4.6 m -106.14 -158.13 0.64 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.634 -0.712 . . . . 0.91000000000000003 109.364 177.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.745 HG23 ' HG2' ' A' ' 75' ' ' PRO . 1.8 m -13.98 117.57 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 115.216 1.561 . . . . 1.9199999999999999 115.216 -140.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 6.1 ptmt 171.88 -31.48 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 111.477 -2.601 . . . . 3.1800000000000002 107.883 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.562 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -36.8 109.97 0.11 Allowed 'General case' 0 C--N 1.354 0.779 0 O-C-N 124.972 1.42 . . . . 1.74 111.387 -173.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 97' ' ' LYS . 73.4 mmtt -104.61 143.17 33.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.055 -0.975 . . . . 3.0800000000000001 110.262 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -145.15 -170.24 3.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.602 -0.272 . . . . 0.42999999999999999 110.979 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -75.02 -26.54 59.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.446 0.641 . . . . 2.1899999999999999 109.496 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.878 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 44.0 p90 -98.44 159.35 30.78 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 114.933 -1.03 . . . . 0.23999999999999999 109.544 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 38.8 Cg_exo -67.56 114.18 3.2 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 C-N-CA 124.091 3.194 . . . . 0.31 113.608 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.033 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mp -100.35 131.9 46.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 108.98 -0.748 . . . . 0.37 108.98 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.647 ' HE2' ' HA ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -117.03 -155.58 0.59 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.345 0.869 . . . . 1.47 113.345 -157.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.745 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -68.63 113.47 6.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.979 -1.01 . . . . 0.39000000000000001 111.177 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.007 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -61.99 139.87 58.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.401 0.62 . . . . 1.6599999999999999 109.602 171.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.539 HD12 ' CB ' ' A' ' 116' ' ' HIS . 0.6 OUTLIER -150.13 156.59 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.571 -1.27 . . . . 0.46999999999999997 107.571 -174.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.762 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 24.8 t-20 -67.84 93.99 0.43 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.102 -0.703 . . . . 2.1600000000000001 109.102 175.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.596 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -83.7 82.59 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.278 -0.969 . . . . 0.38 108.793 176.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.71 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 32.5 t30 170.68 -177.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.229 -1.026 . . . . 1.98 108.229 170.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 58.92 -141.74 46.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.438 -0.887 . . . . 0.78000000000000003 114.541 158.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.62 -15.95 16.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.683 0.754 . . . . 1.98 109.671 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.469 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 19.1 m120 -88.46 -5.64 58.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.607 -1.178 . . . . 2.04 110.912 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.762 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -45.37 126.43 6.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.298 -0.864 . . . . 0.47999999999999998 112.281 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.561 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 55.1 t-80 -47.47 133.79 10.13 Favored Pre-proline 0 C--O 1.221 -0.42 0 CA-C-O 118.535 -0.745 . . . . 0.41999999999999998 109.928 172.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.601 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 1.6 Cg_endo -42.11 -45.11 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.228 2.619 . . . . 0.35999999999999999 112.711 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.561 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 20.1 tp -54.77 -51.45 65.68 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.753 -0.658 . . . . 1.1000000000000001 111.584 175.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.746 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 22.9 m-85 -69.78 -31.5 69.47 Favored 'General case' 0 C--O 1.208 -1.096 0 CA-C-N 116.403 -0.362 . . . . 1.49 111.201 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.55 ' O ' ' HE3' ' A' ' 124' ' ' LYS . 1.4 mt-10 -55.18 -46.86 75.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.547 -0.909 . . . . 2.3700000000000001 108.547 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 85.8 t80 -64.6 -49.25 71.85 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.665 0.603 . . . . 0.57999999999999996 110.128 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.584 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 64.2 mtt -54.54 -51.58 64.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.123 -0.489 . . . . 0.34000000000000002 111.722 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.746 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 27.5 mtpt -61.3 -49.33 77.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.868 0.366 . . . . 0.93999999999999995 110.549 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 120' ' ' GLU . 16.7 ptpt -70.44 -31.66 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 2.1299999999999999 111.046 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.549 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.3 m -70.51 -40.58 73.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.429 -0.35 . . . . 0.46999999999999997 111.78 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.465 ' HD3' ' HD2' ' A' ' 127' ' ' PRO . 10.0 mmtt -144.74 117.79 5.53 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.53 . . . . 1.75 112.164 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.789 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 54.7 Cg_endo -72.65 -28.06 14.53 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.077 2.518 . . . . 1.76 111.93 174.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.775 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 85.33 -137.08 15.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.916 -0.659 . . . . 2.3700000000000001 112.856 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.1 pt -80.39 5.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.904 0.383 . . . . 3.5600000000000001 111.6 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.51 HD11 ' HZ2' ' A' ' 137' ' ' TRP . 2.3 pt? -146.5 128.9 15.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.086 -0.506 . . . . 2.7599999999999998 109.749 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.0 2.9 13.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.189 0.44 . . . . 2.8399999999999999 112.189 -175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.497 HG21 ' HE3' ' A' ' 136' ' ' LYS . 21.1 m -58.26 -32.02 67.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.264 -0.425 . . . . 3.8999999999999999 110.424 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.789 ' HG2' ' HB3' ' A' ' 127' ' ' PRO . 96.8 mttt 67.43 -5.88 0.7 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.34 -0.845 . . . . 5.1299999999999999 111.531 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 132' ' ' THR . . . -98.64 160.34 14.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.971 -0.559 . . . . 0.93000000000000005 111.645 -176.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.831 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 13.6 mt -105.1 105.86 19.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.537 -0.756 . . . . 1.05 109.659 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.497 ' HE3' HG21 ' A' ' 132' ' ' THR . 16.1 ptpt -133.01 26.67 4.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.142 0.793 . . . . 1.5 113.142 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.831 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -151.34 170.18 20.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.324 0.583 . . . . 0.87 111.995 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 139' ' ' PHE . 2.7 t-20 -49.73 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 1.8 112.751 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 1.06 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 10.5 m-85 -27.44 -50.99 0.06 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 125.342 1.457 . . . . 1.3700000000000001 114.794 -167.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.795 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 12.4 m 37.15 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.763 1.165 . . . . 0.29999999999999999 113.288 175.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 12.6 p -85.11 150.63 24.72 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.149 -0.621 . . . . 0.80000000000000004 111.412 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 5.5 m-85 -103.66 132.2 50.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.955 -1.128 . . . . 0.53000000000000003 107.955 165.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.608 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 20.7 tp -81.2 106.11 12.93 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.931 -0.766 . . . . 0.51000000000000001 108.931 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.715 HG21 HD13 ' A' ' 15' ' ' ILE . 18.7 mm -106.17 122.86 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.116 -0.698 . . . . 0.20000000000000001 109.116 -172.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.41 179.14 3.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.262 -0.426 . . . . 1.3 110.505 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.435 ' HD2' ' H ' ' A' ' 174' ' ' ALA . 61.4 mtt180 -59.25 -21.31 59.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.797 0.666 . . . . 3.7799999999999998 112.797 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -109.87 -10.08 14.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.151 0.5 . . . . 1.1799999999999999 110.733 -171.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.553 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 104.16 32.9 4.16 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.737 -0.744 . . . . 0.23000000000000001 113.375 174.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.3 t -107.22 122.43 41.41 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.695 -0.483 . . . . 0.62 109.695 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.549 ' HD2' HG21 ' A' ' 125' ' ' THR . 8.5 Cg_exo -68.1 118.02 5.33 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.476 2.118 . . . . 0.29999999999999999 111.178 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.57 ' HB ' HD23 ' A' ' 143' ' ' LEU . 32.6 t -97.22 -30.06 3.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.928 -0.578 . . . . 0.27000000000000002 110.632 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -154.83 165.31 37.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.094 -0.503 . . . . 1.22 111.261 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.775 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 12.7 ttm180 -132.25 98.61 4.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.698 -0.683 . . . . 1.75 109.358 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.652 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 24.5 m-85 -91.05 108.97 20.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.587 -0.523 . . . . 0.38 109.587 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.748 ' HA ' HG23 ' A' ' 140' ' ' THR . 10.5 p -61.19 163.25 11.04 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 109.806 -0.442 . . . . 0.98999999999999999 109.806 175.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.795 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 45.4 Cg_endo -65.46 -7.01 14.77 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.916 2.411 . . . . 0.66000000000000003 113.4 -162.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 51' ' ' LYS . . . -85.36 -10.66 76.97 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.302 -0.863 . . . . 0.52000000000000002 111.741 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -71.41 131.76 43.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.42999999999999999 110.17 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.439 ' HB2' ' OD1' ' A' ' 162' ' ' ASP . 48.9 m -81.57 168.96 17.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.79 -0.641 . . . . 1.25 111.12 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.662 HG22 ' HA ' ' A' ' 56' ' ' THR . 44.8 t -54.44 -51.16 52.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.40999999999999998 110.781 -177.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 161' ' ' LYS . 32.9 ttmt -65.37 -33.65 76.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.553 -0.748 . . . . 3.4399999999999999 110.868 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 159' ' ' SER . 1.6 m-20 -62.43 -31.77 72.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.349 -0.842 . . . . 1.8600000000000001 110.263 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.791 HG21 HD21 ' A' ' 39' ' ' LEU . 69.2 mt -82.89 -37.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.987 -0.552 . . . . 0.20999999999999999 110.908 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 56.5 mt-10 -57.83 -35.8 71.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.966 -0.561 . . . . 0.88 112.201 -175.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.99 -32.79 61.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.85 0.357 . . . . 0.75 111.459 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.533 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 47.1 mmtm -100.44 -17.07 17.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 1.5800000000000001 111.036 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 65.7 tp -88.35 -38.08 15.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.192 -0.458 . . . . 0.23999999999999999 111.407 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.841 ' HA ' HD12 ' A' ' 171' ' ' LEU . 85.0 mt -50.71 -52.5 55.93 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.835 0.68 . . . . 0.44 112.835 -175.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.6 Cg_endo -55.67 -34.26 89.91 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.095 1.863 . . . . 0.48999999999999999 112.673 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.76 -36.0 51.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.569 -0.287 . . . . 0.70999999999999996 110.84 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.04 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 24.5 mt -56.36 -57.03 14.01 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.07 -0.514 . . . . 0.46000000000000002 109.781 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -45.21 -61.05 3.74 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.265 -1.334 . . . . 1.52 112.927 172.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 21.9 t 177.48 126.06 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.652 -0.499 . . . . 2.52 109.652 175.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.435 ' H ' ' HD2' ' A' ' 146' ' ' ARG . . . -94.4 -40.21 10.05 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.065 0.459 . . . . 3.5600000000000001 110.602 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -167.99 -30.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.414 -0.812 . . . . 7.8600000000000003 108.968 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.299 -0.857 . . . . 4.8099999999999996 109.595 173.145 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 N-CA-C 111.911 -0.476 . . . . 5.5099999999999998 111.911 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt -132.83 29.18 4.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.52 0.676 . . . . 5.0499999999999998 109.606 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.47 42.1 0.12 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.402 -0.817 . . . . 1.3700000000000001 111.803 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 m -72.48 -59.07 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.327 0.584 . . . . 1.6799999999999999 109.969 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 p -141.99 177.57 8.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.361 -0.836 . . . . 0.65000000000000002 108.767 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.851 HD13 HG21 ' A' ' 144' ' ' ILE . 20.7 pt -57.37 -28.67 31.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 0.29999999999999999 111.235 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.876 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 33.5 m-85 -78.13 2.68 17.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.27000000000000002 111.447 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.07 -20.68 64.1 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.998 -1.112 . . . . 1.96 107.998 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' A' ' 117' ' ' PRO . 61.8 m-85 -111.56 172.36 6.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.284 -1.326 . . . . 0.40000000000000002 109.918 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -115.06 161.91 17.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.75 0.309 . . . . 2.77 110.606 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.487 HG23 HD13 ' A' ' 30' ' ' LEU . 61.2 t -128.52 141.69 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.98 0.419 . . . . 0.73999999999999999 111.303 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.931 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 51.0 mt -95.77 132.78 40.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.905 -0.589 . . . . 0.71999999999999997 109.703 171.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.29 177.75 1.04 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.184 -0.916 . . . . 1.5900000000000001 109.143 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.474 ' O ' ' HE3' ' A' ' 97' ' ' LYS . . . -51.76 -35.46 43.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.923 0.392 . . . . 0.52000000000000002 110.748 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -85.82 -3.51 58.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.947 -0.569 . . . . 2.2200000000000002 111.236 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.931 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 24.5 m-70 71.97 15.96 5.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.638 0.732 . . . . 0.72999999999999998 109.521 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -75.55 157.4 84.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 106.726 -1.583 . . . . 3.25 106.726 165.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.63 113.98 2.05 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 120.753 0.969 . . . . 0.85999999999999999 111.824 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.428 ' HB3' HG12 ' A' ' 20' ' ' VAL . 67.9 t80 -90.4 109.12 20.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.36 -0.836 . . . . 0.28000000000000003 109.324 170.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.9 t30 -70.93 85.66 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.613 -0.514 . . . . 1.6499999999999999 109.613 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.876 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -61.6 -29.56 70.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.629 -0.714 . . . . 0.25 111.079 -176.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.809 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 5.4 p -76.12 -0.85 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.425 -0.807 . . . . 0.40999999999999998 112.81 -167.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.2 pt20 -80.61 -5.53 56.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.265 0.555 . . . . 1.24 109.921 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.401 ' CG ' HG21 ' A' ' 70' ' ' THR . 83.4 m-70 -92.98 -5.7 50.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 108.324 -0.991 . . . . 0.38 108.324 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HZ3' ' HD2' ' A' ' 16' ' ' PHE . 16.6 ttmm -71.69 141.45 49.85 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.715 -1.13 . . . . 1.73 109.844 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.13 -12.87 55.66 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 109.895 -1.282 . . . . 0.35999999999999999 109.895 -172.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.462 ' C ' ' HA ' ' A' ' 146' ' ' ARG . 25.0 m -140.6 148.07 51.68 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 108.572 -0.899 . . . . 1.1399999999999999 108.572 177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.985 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 79.5 Cg_endo -75.35 162.43 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.835 1.69 . . . . 0.52000000000000002 110.996 176.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.684 ' CB ' HG22 ' A' ' 70' ' ' THR . 1.8 pt? -159.36 152.69 22.41 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 1.03 110.809 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.634 HD21 HG21 ' A' ' 163' ' ' ILE . 7.2 mp -107.38 148.41 29.12 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.996 -0.742 . . . . 1.1000000000000001 108.996 173.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 89.0 mt -134.16 119.74 32.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.152 -0.684 . . . . 0.20000000000000001 109.152 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 14.9 m-85 -104.01 130.09 51.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.615 -0.266 . . . . 0.23000000000000001 111.287 -173.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.737 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -83.79 93.8 8.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.938 -0.764 . . . . 1.28 108.938 167.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.8 m -107.13 140.32 25.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 O-C-N 121.438 -0.789 . . . . 0.88 113.073 -163.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 102.82 4.54 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.764 -1.569 . . . . 0.52000000000000002 106.764 164.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.776 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 39.0 t -74.01 94.3 2.35 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.109 0.781 . . . . 1.8400000000000001 113.109 -163.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 12.7 ttpp 65.11 45.27 3.08 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.7 -1.136 . . . . 2.4300000000000002 110.733 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.7 p -163.39 151.98 13.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 0.98999999999999999 110.334 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.493 ' HA3' ' CD ' ' A' ' 89' ' ' GLU . . . 73.96 -124.59 8.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.814 -0.707 . . . . 1.0900000000000001 113.593 173.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -107.19 136.89 46.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.351 0.596 . . . . 3.1600000000000001 112.142 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.561 HG22 ' CE1' ' A' ' 139' ' ' PHE . 55.2 p -116.72 94.03 4.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.87 -0.605 . . . . 1.9399999999999999 109.585 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 16.9 ttmm -78.17 41.21 0.37 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.283 -0.417 . . . . 2.0299999999999998 110.908 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.29 85.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.037 -0.602 . . . . 0.46999999999999997 112.775 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.95 -38.03 84.19 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 112.052 -0.419 . . . . 0.34000000000000002 112.052 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.599 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.6 t80 -71.74 -50.44 30.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.556 -0.322 . . . . 0.56999999999999995 110.688 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.35 -44.37 95.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.944 -0.571 . . . . 2.46 110.622 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -52.89 62.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 0.33000000000000002 110.97 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.66 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -56.7 -49.31 75.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.19 111.781 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.1 m -56.77 -47.15 80.78 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.967 -0.561 . . . . 0.29999999999999999 111.169 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.0 m -61.32 -48.89 79.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.627 -0.715 . . . . 1.0800000000000001 110.988 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 163' ' ' ILE . 51.5 mt -58.84 -52.04 67.42 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.244 -0.435 . . . . 0.81000000000000005 111.738 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 86.1 t80 -50.86 -52.77 38.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.527 0.517 . . . . 0.33000000000000002 110.323 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -73.76 -36.65 65.13 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.476 -0.784 . . . . 1.76 111.425 -170.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -74.93 -45.97 38.87 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.815 -0.629 . . . . 1.79 111.503 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.558 ' CD1' HD13 ' A' ' 171' ' ' LEU . 34.1 m-85 -101.94 -2.84 28.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 114.686 1.365 . . . . 0.42999999999999999 114.686 -168.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.635 ' HA ' ' H ' ' A' ' 69' ' ' PHE . 13.0 ptmm? -69.18 -15.45 63.4 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 119.487 -0.885 . . . . 2.1099999999999999 110.346 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -60.33 -33.2 72.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 1.2 109.979 172.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -101.55 10.24 40.48 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 116.357 -0.383 . . . . 1.8999999999999999 110.878 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.612 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 90.15 80.61 1.36 Allowed Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.97 -0.633 . . . . 1.3200000000000001 112.589 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.635 ' H ' ' HA ' ' A' ' 65' ' ' LYS . 69.9 t80 -151.97 141.89 22.07 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.928 -0.16 . . . . 0.26000000000000001 110.891 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.684 HG22 ' CB ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -131.93 149.74 52.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 110.021 -0.362 . . . . 0.51000000000000001 110.021 174.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.682 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 49.0 t -117.09 115.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.972 -0.381 . . . . 0.23999999999999999 109.972 172.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 18.4 mt -102.11 121.95 43.2 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.932 -0.766 . . . . 0.51000000000000001 108.932 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.995 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -110.9 114.25 27.43 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.096 0.474 . . . . 0.28000000000000003 110.656 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.769 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.0 m-85 -98.66 112.61 62.98 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 109.075 -0.713 . . . . 0.34000000000000002 109.075 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.908 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 46.3 Cg_exo -57.89 167.78 3.95 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.278 2.652 . . . . 0.72999999999999998 112.042 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 t -115.4 145.36 42.62 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.027 -0.669 . . . . 1.54 110.911 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.63 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 29.6 t30 -112.22 72.24 0.77 Allowed 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.541 -1.209 . . . . 2.52 108.987 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.947 ' HB2' HG13 ' A' ' 90' ' ' ILE . 15.5 mp0 -54.28 -13.73 0.96 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.134 -0.939 . . . . 3.1800000000000002 113.041 -173.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -66.84 -17.61 64.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.896 0.379 . . . . 3.7999999999999998 110.971 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -62.54 -27.3 69.43 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.699 -0.682 . . . . 1.45 112.167 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.75 -83.77 0.31 Allowed Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.848 -0.692 . . . . 1.4299999999999999 111.818 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.757 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.6 pm0 -89.57 24.66 2.22 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.641 0.608 . . . . 1.4299999999999999 112.641 -174.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.875 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 5.6 mm-40 -60.52 152.25 66.66 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 119.797 -0.761 . . . . 3.0600000000000001 110.565 -175.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.769 ' HG3' HG22 ' A' ' 135' ' ' ILE . 72.8 Cg_exo -55.04 -177.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.799 2.333 . . . . 1.6100000000000001 114.043 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.62 22.68 74.67 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.943 -1.263 . . . . 1.3899999999999999 109.943 -173.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.534 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 13.2 m120 63.53 28.04 15.18 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 114.708 -0.746 . . . . 3.6899999999999999 110.367 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 8.3 pt-20 59.9 161.53 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.521 1.528 . . . . 2.4700000000000002 113.564 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.529 ' HB3' ' CG ' ' A' ' 91' ' ' LYS . 8.2 mt-10 56.02 37.9 29.35 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 114.353 -1.294 . . . . 3.6400000000000001 111.42 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.493 ' CD ' ' HA3' ' A' ' 48' ' ' GLY . 3.2 tp10 -80.71 -15.33 56.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.649 -0.705 . . . . 2.4199999999999999 110.778 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.947 HG13 ' HB2' ' A' ' 78' ' ' GLN . 3.0 mt -101.07 9.6 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 2.0499999999999998 110.465 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.779 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 14.0 mmmm -65.81 123.9 21.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.409 -0.589 . . . . 4.0 109.409 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.779 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 8.0 pt-20 57.99 16.31 3.67 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.583 1.177 . . . . 3.1000000000000001 111.552 -174.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -125.93 177.71 6.17 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.368 -0.605 . . . . 1.9099999999999999 109.368 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.437 HG22 HG22 ' A' ' 96' ' ' THR . 9.1 p -130.26 116.76 37.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.319 -0.623 . . . . 1.6499999999999999 109.319 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.882 ' SG ' HG12 ' A' ' 90' ' ' ILE . 57.8 m -103.5 111.27 23.65 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 119.008 -1.077 . . . . 0.91000000000000003 108.992 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.437 HG22 HG22 ' A' ' 94' ' ' VAL . 3.3 t -158.96 120.27 3.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.926 -1.034 . . . . 1.9199999999999999 109.368 173.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 23' ' ' ALA . 42.7 mttp 45.86 86.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.222 0.823 . . . . 3.1800000000000002 113.222 172.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.704 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 49.8 p90 -64.58 -20.87 66.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.657 -0.497 . . . . 1.74 109.657 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 66.45 136.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.736 -1.12 . . . . 3.0800000000000001 111.424 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -165.06 -178.4 5.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.705 -0.68 . . . . 0.42999999999999999 110.881 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -88.32 32.84 0.75 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.657 -0.702 . . . . 2.1899999999999999 110.566 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.688 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 52.4 p90 -152.0 161.75 28.55 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 108.114 -1.069 . . . . 0.23999999999999999 108.114 175.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 36.9 Cg_exo -64.85 107.94 0.99 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 123.53 2.82 . . . . 0.31 114.189 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.995 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.3 mp -101.39 131.88 48.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.892 -0.781 . . . . 0.37 108.892 171.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.769 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 1.7 mmt -110.03 -151.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.924 0.712 . . . . 1.47 112.924 -162.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.495 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -75.14 144.58 42.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.391 -0.822 . . . . 0.39000000000000001 110.778 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.908 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 22.2 pttt -83.45 131.89 35.0 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.659 0.742 . . . . 1.6599999999999999 109.775 169.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' A' ' 116' ' ' HIS . 2.3 pt -136.59 159.22 37.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.78 -1.563 . . . . 0.46999999999999997 106.78 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.908 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 26.1 t-20 -70.65 95.45 1.1 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.904 -0.718 . . . . 2.1600000000000001 109.163 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.716 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -87.43 83.11 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 119.262 -0.975 . . . . 0.38 109.065 175.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.757 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 9.0 t-20 171.52 -178.5 0.05 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.367 -0.975 . . . . 1.98 108.367 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 53.2 -147.92 15.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 114.677 0.631 . . . . 0.78000000000000003 114.677 160.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.42 2.23 28.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.15 -0.525 . . . . 1.98 111.096 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.56 -3.46 36.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.253 -0.43 . . . . 2.04 110.92 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.908 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -46.53 139.3 5.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.189 -0.914 . . . . 0.47999999999999998 113.34 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.606 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 54.1 t-80 -51.31 137.31 29.81 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.259 -0.882 . . . . 0.41999999999999998 110.376 171.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.565 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -44.04 -46.5 11.04 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.114 2.542 . . . . 0.35999999999999999 112.526 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.657 HD11 ' HE3' ' A' ' 122' ' ' MET . 20.9 tp -58.63 -41.89 86.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.842 -0.617 . . . . 1.1000000000000001 111.762 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.487 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 3.7 m-85 -74.5 -29.98 61.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 119.561 -0.257 . . . . 1.49 110.781 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 117' ' ' PRO . 41.5 mt-10 -56.54 -43.59 80.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.645 -0.872 . . . . 2.3700000000000001 108.645 169.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 84.0 t80 -65.96 -46.57 77.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.54 0.525 . . . . 0.57999999999999996 110.745 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.657 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.4 mtt -62.72 -51.72 66.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.212 -0.449 . . . . 0.34000000000000002 111.02 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.563 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 34.7 mtpt -60.75 -45.24 95.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.93999999999999995 110.949 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 20.4 ptmt -68.69 -33.49 74.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.266 -0.425 . . . . 2.1299999999999999 111.299 -176.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.48 HG21 ' HD2' ' A' ' 150' ' ' PRO . 93.7 m -74.02 -50.28 20.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.072 -0.513 . . . . 0.46999999999999997 111.85 -175.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 6.1 tmtt? -139.85 104.35 6.86 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.682 -0.407 . . . . 1.75 111.437 -174.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.571 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 26.8 Cg_endo -65.19 -36.33 37.18 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.902 2.401 . . . . 1.76 111.97 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 92.97 -132.99 11.51 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.742 -0.742 . . . . 2.3700000000000001 113.557 172.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.34 153.27 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 122.785 0.434 . . . . 3.5600000000000001 111.057 -172.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 49.75 -163.97 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.221 1.008 . . . . 2.7599999999999998 112.507 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.2 56.18 3.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.492 0.663 . . . . 2.8399999999999999 109.885 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.601 HG21 ' HD2' ' A' ' 153' ' ' ARG . 11.3 m -67.76 -64.37 0.87 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.602 -0.726 . . . . 3.8999999999999999 110.309 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp 63.93 -72.31 0.06 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.914 0.759 . . . . 5.1299999999999999 110.487 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.91 177.12 4.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.961 -0.563 . . . . 0.93000000000000005 110.477 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.861 HG23 ' HZ3' ' A' ' 137' ' ' TRP . 17.6 mt -76.84 161.8 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.069 -1.086 . . . . 1.05 108.069 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -178.02 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.925 0.784 . . . . 1.5 112.146 -176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.861 ' HZ3' HG23 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.52 165.8 11.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.269 -0.423 . . . . 0.87 112.09 177.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -48.33 -154.41 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 126.083 1.753 . . . . 1.8 113.817 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.815 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.2 m-85 -28.49 -45.64 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 115.273 1.583 . . . . 1.3700000000000001 115.273 -163.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.96 HG23 ' HA ' ' A' ' 155' ' ' SER . 15.9 m 30.29 109.89 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.38 1.622 . . . . 0.29999999999999999 115.38 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 9.0 p -93.56 156.52 16.68 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.27 0.557 . . . . 0.80000000000000004 111.09 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 6.2 m-85 -102.43 166.47 10.53 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 107.018 -1.475 . . . . 0.53000000000000003 107.018 163.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.758 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 49.8 tp -112.83 104.77 12.78 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.763 -0.829 . . . . 0.51000000000000001 108.763 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.851 HG21 HD13 ' A' ' 15' ' ' ILE . 11.9 mm -103.05 125.22 57.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 109.11 -0.7 . . . . 0.20000000000000001 109.11 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 38.9 p30 -77.86 -176.35 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.8 -0.36 . . . . 1.3 111.684 -175.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.694 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 76.6 mtp180 -57.41 -24.4 55.24 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.626 0.602 . . . . 3.7799999999999998 112.626 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -109.52 -12.43 14.69 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.868 -0.733 . . . . 1.1799999999999999 110.494 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.542 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 109.24 34.35 2.54 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.814 -0.708 . . . . 0.23000000000000001 113.059 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 57.9 t -107.85 128.33 26.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.859 -0.423 . . . . 0.62 109.859 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.48 ' HD2' HG21 ' A' ' 125' ' ' THR . 4.8 Cg_exo -75.4 112.04 3.44 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.362 2.041 . . . . 0.29999999999999999 111.24 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.524 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 41.1 t -93.54 -23.94 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.27000000000000002 110.944 -177.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 1.2 mm-40 -156.65 166.11 34.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 1.22 111.042 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.601 ' HD2' HG21 ' A' ' 132' ' ' THR . 27.5 ttm180 -131.05 96.55 4.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.905 -0.776 . . . . 1.75 108.905 172.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.758 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 77.3 m-85 -82.42 110.07 17.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.775 -0.648 . . . . 0.38 109.519 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.96 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.4 m -61.85 168.4 3.61 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.879 -0.415 . . . . 0.98999999999999999 109.879 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.807 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 36.1 Cg_endo -60.93 -28.16 85.9 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.629 1.553 . . . . 0.66000000000000003 111.462 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.49 66.33 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.317 -1.31 . . . . 0.52000000000000002 112.681 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.64 112.03 6.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 110.045 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.7 m -74.81 174.66 8.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.895 -0.593 . . . . 1.25 110.828 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 69.0 t -48.59 -53.37 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.343 -0.389 . . . . 0.40999999999999998 111.679 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -66.17 -32.13 73.38 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.278 -0.419 . . . . 3.4399999999999999 111.498 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -63.71 -32.57 74.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.418 -0.586 . . . . 1.8600000000000001 109.418 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.634 HG21 HD21 ' A' ' 39' ' ' LEU . 63.2 mt -83.68 -39.83 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.322 -0.854 . . . . 0.20999999999999999 111.12 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.4 mt-10 -51.44 -44.14 62.25 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.234 0.457 . . . . 0.88 112.234 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 7.9 pt-20 -53.79 -33.57 56.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.123 0.416 . . . . 0.75 112.123 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.751 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.2 mmtm -102.18 -19.08 15.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.918 0.39 . . . . 1.5800000000000001 111.007 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 63.6 tp -84.14 -45.53 12.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 0.23999999999999999 111.349 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.76 ' HA ' HD12 ' A' ' 171' ' ' LEU . 74.3 mt -53.5 -48.11 94.02 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 112.281 0.474 . . . . 0.44 112.281 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.9 Cg_exo -53.54 -37.32 82.64 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.067 1.844 . . . . 0.48999999999999999 112.7 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.3 mt -78.87 -35.86 43.1 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 111.95 0.352 . . . . 0.70999999999999996 111.95 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.985 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 11.4 mt -55.51 -54.15 47.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.744 0.783 . . . . 0.46000000000000002 108.933 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.03 -45.74 94.77 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.211 -1.359 . . . . 1.52 113.539 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 p -164.14 125.38 2.24 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.835 0.817 . . . . 2.52 113.07 -172.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.689 ' HB2' ' H ' ' A' ' 146' ' ' ARG . . . -95.01 -58.05 2.26 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.668 0.747 . . . . 3.5600000000000001 110.009 172.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -136.53 -30.28 0.92 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.575 -1.269 . . . . 7.8600000000000003 107.575 171.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.7 tp . . . . . 0 C--O 1.251 1.141 0 CA-C-N 114.48 -1.236 . . . . 4.8099999999999996 107.881 166.541 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.559 -0.616 . . . . 5.5099999999999998 111.559 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 48.4 ttm -79.97 -33.57 39.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.025 0.441 . . . . 5.0499999999999998 109.847 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.86 97.54 1.76 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.802 -0.713 . . . . 1.3700000000000001 112.583 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -93.48 -36.2 12.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.516 -0.92 . . . . 1.6799999999999999 108.516 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.0 p -135.37 178.34 7.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.159 -0.928 . . . . 0.65000000000000002 109.494 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.71 HD13 HG21 ' A' ' 144' ' ' ILE . 21.4 pt -62.99 -26.42 40.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.241 0.543 . . . . 0.29999999999999999 110.632 175.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.793 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 45.7 m-85 -76.94 -6.06 51.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.8 -0.637 . . . . 0.27000000000000002 112.306 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -82.37 7.33 14.39 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.448 0.642 . . . . 1.96 109.352 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 89.2 m-85 -119.56 169.97 9.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.103 -0.953 . . . . 0.40000000000000002 110.051 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.7 tt0 -98.01 151.49 20.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.312 -0.404 . . . . 2.77 110.513 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 28' ' ' TYR . 72.6 t -130.46 136.29 58.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.011 0.434 . . . . 0.73999999999999999 110.507 172.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.729 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 96.4 mt -101.63 140.42 35.95 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.126 -0.694 . . . . 0.71999999999999997 109.126 172.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.04 -172.72 3.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.238 -0.653 . . . . 1.5900000000000001 109.238 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.46 66.35 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.779 0.323 . . . . 0.52000000000000002 111.229 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 25' ' ' HIS . 20.3 t70 -88.93 -12.16 42.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.192 -0.458 . . . . 2.2200000000000002 111.191 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.729 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 38.7 m-70 82.59 23.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 123.599 0.76 . . . . 0.72999999999999998 110.399 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -85.43 154.18 59.35 Favored Pre-proline 0 N--CA 1.443 -0.802 0 N-CA-C 105.693 -1.965 . . . . 3.25 105.693 165.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.68 114.38 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.812 0.969 . . . . 0.85999999999999999 111.904 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.578 ' HB3' HG12 ' A' ' 20' ' ' VAL . 75.3 t80 -86.74 111.25 20.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.407 -0.815 . . . . 0.28000000000000003 109.194 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.703 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 57.5 t30 -68.83 86.38 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.216 0.532 . . . . 1.6499999999999999 109.936 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.793 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -61.38 -35.96 78.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 0.25 111.378 -174.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 13.5 p -76.54 1.34 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.003 0.742 . . . . 0.40999999999999998 113.003 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.703 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.5 pt20 -74.73 -5.86 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.174 -0.954 . . . . 1.24 108.997 168.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -98.42 2.71 48.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.212 -1.033 . . . . 0.38 108.212 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 21.1 ttpt -81.07 142.46 33.31 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.848 -1.069 . . . . 1.73 109.642 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.06 79.48 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.804 -1.319 . . . . 0.35999999999999999 109.804 -170.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.645 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 16.3 m -132.54 146.87 63.32 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 114.111 -1.045 . . . . 1.1399999999999999 108.293 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.859 ' HG2' HD23 ' A' ' 171' ' ' LEU . 1.2 Cg_endo -79.56 149.58 21.29 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.737 1.625 . . . . 0.52000000000000002 110.238 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HB2' HG22 ' A' ' 70' ' ' THR . 2.1 pt? -151.93 149.91 29.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.302 0.572 . . . . 1.03 111.291 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -107.53 154.9 20.71 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.584 -0.895 . . . . 1.1000000000000001 108.584 172.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.487 HD12 HG13 ' A' ' 144' ' ' ILE . 69.4 mt -141.62 114.82 4.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.094 -0.706 . . . . 0.20000000000000001 109.094 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 18.1 m-85 -100.59 124.55 46.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 121.125 -0.23 . . . . 0.23000000000000001 110.78 -174.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.748 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -80.69 92.7 6.05 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.242 -0.651 . . . . 1.28 109.242 171.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.711 ' HA ' ' HA ' ' A' ' 139' ' ' PHE . 10.7 m -106.34 145.93 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 114.229 1.196 . . . . 0.88 114.229 -160.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.39 102.22 9.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.603 -1.628 . . . . 0.52000000000000002 106.603 160.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 95' ' ' CYS . 40.4 t -72.11 85.29 1.02 Allowed 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 112.563 0.579 . . . . 1.8400000000000001 112.563 -165.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 17.9 tppt? 75.4 23.31 1.53 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.739 0.78 . . . . 2.4300000000000002 110.638 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.9 m -123.52 129.33 51.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.238 -0.437 . . . . 0.98999999999999999 110.548 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 -115.87 4.62 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.862 -0.685 . . . . 1.0900000000000001 112.7 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -139.63 166.69 23.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.271 0.558 . . . . 3.1600000000000001 111.868 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.9 p -131.92 115.07 15.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.663 -0.699 . . . . 1.9399999999999999 110.372 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.721 ' HD2' ' HA3' ' A' ' 157' ' ' GLY . 28.0 ttmt -79.0 24.61 0.31 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.212 0.53 . . . . 2.0299999999999998 110.887 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.99 13.8 24.39 Favored Glycine 0 C--O 1.224 -0.522 0 CA-C-N 115.881 -0.6 . . . . 0.46999999999999997 112.38 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.71 -47.43 20.61 Favored Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 121.231 -0.509 . . . . 0.34000000000000002 112.175 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.649 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.7 t80 -69.67 -47.6 62.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.486 0.184 . . . . 0.56999999999999995 111.262 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -59.28 -47.11 86.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.069 0.462 . . . . 2.46 110.145 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.5 m -64.31 -45.99 85.51 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.385 -0.825 . . . . 0.33000000000000002 110.891 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.547 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -57.17 -49.31 76.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.979 0.419 . . . . 0.19 111.07 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.6 m -59.26 -51.3 70.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.615 -0.721 . . . . 0.29999999999999999 111.147 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 p -63.68 -39.27 93.9 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.42 . . . . 1.0800000000000001 111.914 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.495 ' HB3' ' HE2' ' A' ' 69' ' ' PHE . 88.5 mt -62.48 -51.66 66.59 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.442 0.163 . . . . 0.81000000000000005 110.996 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.836 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 71.6 t80 -51.96 -48.86 64.12 Favored 'General case' 0 C--O 1.22 -0.45 0 O-C-N 123.752 0.657 . . . . 0.33000000000000002 109.483 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.12 -43.29 74.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.536 -0.756 . . . . 1.76 111.687 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.61 -44.79 61.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.865 -0.607 . . . . 1.79 111.391 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.749 ' CD1' HD13 ' A' ' 171' ' ' LEU . 70.1 m-85 -100.91 6.3 43.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.402 0.89 . . . . 0.42999999999999999 113.402 -171.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 65' ' ' LYS . 7.5 mmmt -60.75 -25.17 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.987 0.422 . . . . 2.1099999999999999 110.279 171.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -65.88 -32.76 74.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.777 -0.647 . . . . 1.2 110.69 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -98.65 17.48 19.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.994 0.426 . . . . 1.8999999999999999 110.703 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.645 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 74.78 55.52 5.35 Favored Glycine 0 C--O 1.224 -0.488 0 CA-C-N 115.64 -0.709 . . . . 1.3200000000000001 112.845 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 59.7 t80 -117.15 140.0 50.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.633 0.254 . . . . 0.26000000000000001 110.781 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -128.36 138.98 52.61 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 120.907 0.384 . . . . 0.51000000000000001 110.556 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.836 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 39.4 t -110.91 121.11 63.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.887 0.375 . . . . 0.23999999999999999 110.242 171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' HE3' ' A' ' 105' ' ' MET . 21.3 mt -102.03 141.62 34.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.901 -0.778 . . . . 0.51000000000000001 108.901 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.015 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -125.98 124.75 41.43 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.11 0.481 . . . . 0.28000000000000003 110.222 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.676 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 4.4 m-85 -108.5 108.3 60.86 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.891 -0.595 . . . . 0.34000000000000002 109.686 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.611 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 41.7 Cg_exo -58.67 154.97 39.54 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.077 2.518 . . . . 0.72999999999999998 112.057 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.9 t -127.97 155.66 43.91 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.776 -0.647 . . . . 1.54 110.582 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -116.48 97.49 6.04 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.15 0.976 . . . . 2.52 109.937 -176.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.856 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 22.0 mp0 -56.4 -5.6 0.22 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.034 1.334 . . . . 3.1800000000000002 113.894 -175.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.516 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 92.5 m-85 -77.25 -10.92 59.72 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.342 -0.39 . . . . 3.7999999999999998 111.454 -174.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.33 -56.1 8.13 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.099 -0.572 . . . . 1.45 112.774 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.428 ' H ' ' CD ' ' A' ' 83' ' ' GLU . . . 154.2 -33.76 0.72 Allowed Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.631 -0.795 . . . . 1.4299999999999999 113.761 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.729 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -131.0 -6.22 3.93 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.344 1.072 . . . . 1.4299999999999999 113.04 -174.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.828 ' CD ' ' H ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -78.66 150.59 76.16 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 112.826 0.676 . . . . 3.0600000000000001 112.826 -164.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 36.9 Cg_exo -19.71 131.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.928 1 C-N-CA 126.875 5.05 . . . . 1.6100000000000001 116.878 -162.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.87 11.74 49.01 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.2 -1.56 . . . . 1.3899999999999999 109.2 -170.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.8 m120 69.83 -50.06 0.63 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.072 -1.064 . . . . 3.6899999999999999 111.117 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 175.29 153.31 0.14 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.513 0.508 . . . . 2.4700000000000002 110.112 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 66.3 2.7 2.48 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.047 1.129 . . . . 3.6400000000000001 114.047 164.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' O ' ' HD2' ' A' ' 93' ' ' PHE . 16.2 tt0 -56.92 -30.92 64.42 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.551 -0.718 . . . . 2.4199999999999999 111.518 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.856 ' HB ' ' HB2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -69.54 -4.03 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 114.575 1.324 . . . . 2.0499999999999998 114.575 175.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HD3' ' HG2' ' A' ' 88' ' ' GLU . 25.8 pttm -56.84 -21.63 30.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.979 0.733 . . . . 4.0 112.979 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -129.87 21.76 5.41 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.836 -0.62 . . . . 3.1000000000000001 110.155 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.465 ' HD2' ' O ' ' A' ' 89' ' ' GLU . 86.0 m-85 -141.84 170.91 14.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.32 -0.854 . . . . 1.9099999999999999 109.774 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 p -129.89 119.0 46.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.093 0.473 . . . . 1.6499999999999999 109.937 171.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.719 ' HB2' HD11 ' A' ' 90' ' ' ILE . 21.8 m -91.9 114.58 27.16 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 119.664 -0.814 . . . . 0.91000000000000003 110.758 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.409 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 8.3 t -157.07 118.47 3.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.135 -0.939 . . . . 1.9199999999999999 109.313 166.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HA ' HG21 ' A' ' 104' ' ' ILE . 27.4 mttm 70.15 -47.02 0.62 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.591 1.33 . . . . 3.1800000000000002 114.591 173.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.649 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 2.7 p90 58.04 -29.67 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.414 1.486 . . . . 1.74 111.548 -164.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.601 ' H ' ' C ' ' A' ' 97' ' ' LYS . 6.8 mtmt 71.51 125.47 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.245 1.018 . . . . 3.0800000000000001 111.739 170.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.547 ' HB2' ' HE1' ' A' ' 98' ' ' PHE . . . -154.02 -170.67 3.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.985 -0.552 . . . . 0.42999999999999999 112.035 -173.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.04 -6.28 58.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.732 -0.667 . . . . 2.1899999999999999 110.366 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.709 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 47.9 p90 -115.98 162.23 26.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 108.62 -0.882 . . . . 0.23999999999999999 108.62 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.794 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 37.8 Cg_exo -66.95 123.39 10.91 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 123.892 3.062 . . . . 0.31 113.675 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.015 HG13 ' HB3' ' A' ' 73' ' ' ALA . 4.0 mp -112.3 148.85 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.291 -0.633 . . . . 0.37 109.291 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.794 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 9.2 mmt -120.36 -154.75 0.59 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.447 0.906 . . . . 1.47 113.447 -164.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.462 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -69.42 154.07 42.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.667 -1.151 . . . . 0.39000000000000001 111.141 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.598 ' HG2' ' HB2' ' A' ' 75' ' ' PRO . 72.0 mttt -80.99 112.5 18.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.271 -0.64 . . . . 1.6599999999999999 109.271 174.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.41 HG13 HG13 ' A' ' 110' ' ' VAL . 30.9 pt -121.39 149.58 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.224 -1.028 . . . . 0.46999999999999997 108.224 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 1.7 t30 -81.74 60.51 4.69 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.831 -0.348 . . . . 2.1600000000000001 110.384 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -56.38 94.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 116.575 -0.284 . . . . 0.38 110.912 -178.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.818 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER 175.43 178.55 0.16 Allowed 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 110.207 -0.294 . . . . 1.98 110.207 175.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.91 -123.2 0.15 Allowed Glycine 0 C--N 1.334 0.438 0 O-C-N 125.115 1.509 . . . . 0.78000000000000003 115.192 160.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -107.01 -6.09 17.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 1.98 110.662 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -95.19 -6.9 40.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.386 -0.825 . . . . 2.04 112.308 -170.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB2' ' H ' ' A' ' 111' ' ' ASN . . . -57.56 146.38 30.4 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.214 0.82 . . . . 0.47999999999999998 113.214 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.476 ' HE1' ' O ' ' A' ' 19' ' ' GLU . 26.5 t-80 -50.56 141.06 17.68 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.242 -0.89 . . . . 0.41999999999999998 109.803 169.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 8.7 Cg_endo -51.08 -37.96 58.78 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.254 2.636 . . . . 0.35999999999999999 112.523 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.523 HD11 ' HE3' ' A' ' 122' ' ' MET . 14.6 tp -54.85 -45.38 74.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.119 0.485 . . . . 1.1000000000000001 111.074 173.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.489 ' CG ' HG12 ' A' ' 110' ' ' VAL . 3.3 m-85 -73.95 -28.1 61.33 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 116.079 -0.51 . . . . 1.49 110.974 176.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 39.7 mt-10 -56.23 -38.38 70.98 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.838 -0.745 . . . . 2.3700000000000001 109.468 168.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 76.2 t80 -69.95 -47.01 64.04 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.568 -0.453 . . . . 0.57999999999999996 110.488 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.523 ' HE3' HD11 ' A' ' 118' ' ' LEU . 66.9 mtt -61.48 -55.23 33.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.294 -0.412 . . . . 0.34000000000000002 111.241 -178.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 27.6 mtpt -58.59 -43.66 89.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.562 -0.744 . . . . 0.93999999999999995 111.411 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 15.0 ptmm? -70.1 -33.91 72.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.374 . . . . 2.1299999999999999 111.077 -176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.576 HG21 ' HD2' ' A' ' 150' ' ' PRO . 90.2 m -65.65 -46.56 78.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.394 -0.366 . . . . 0.46999999999999997 111.105 -176.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.631 ' HD3' ' HA ' ' A' ' 152' ' ' GLU . 27.9 tttm -143.13 120.09 6.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 1.75 109.95 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.772 ' HB2' ' HB ' ' A' ' 132' ' ' THR . 83.6 Cg_endo -84.32 2.7 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.024 2.483 . . . . 1.76 113.713 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.731 ' HA2' ' HB3' ' A' ' 153' ' ' ARG . . . 118.51 177.11 16.83 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.609 -0.805 . . . . 2.3700000000000001 112.865 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 60.6 mt -88.72 -54.84 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.408 . . . . 3.5600000000000001 110.251 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.857 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.7 pt? -77.12 -150.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 2.7599999999999998 110.433 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -44.68 106.19 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.167 0.508 . . . . 2.8399999999999999 111.534 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.772 ' HB ' ' HB2' ' A' ' 127' ' ' PRO . 32.1 p -89.95 139.67 30.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.496 -0.775 . . . . 3.8999999999999999 112.624 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -179.0 -71.02 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.424 -0.807 . . . . 5.1299999999999999 110.102 168.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -157.72 -169.07 2.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.324 -0.398 . . . . 0.93000000000000005 111.079 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.868 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 30.6 mm -70.13 161.95 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.512 -0.922 . . . . 1.05 108.512 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -177.42 -36.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.748 0.785 . . . . 1.5 110.334 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.868 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -95.64 171.41 8.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.731 -1.122 . . . . 0.87 111.717 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.424 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 18.5 m120 -48.13 -156.57 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.36 -1.746 . . . . 1.8 113.789 170.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 4.5 m-85 -29.32 -57.91 0.15 Allowed 'General case' 0 C--O 1.202 -1.428 0 C-N-CA 125.166 1.387 . . . . 1.3700000000000001 114.588 -165.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.938 HG23 ' HA ' ' A' ' 155' ' ' SER . 10.0 m 44.48 106.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.309 1.225 . . . . 0.29999999999999999 114.309 177.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 11.9 p -89.55 149.13 23.01 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.358 -0.839 . . . . 0.80000000000000004 111.458 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 14.3 m-85 -103.76 133.4 48.81 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.147 -1.057 . . . . 0.53000000000000003 108.147 163.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.794 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 16.3 tp -82.52 105.26 13.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.44 -0.578 . . . . 0.51000000000000001 109.44 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.71 HG21 HD13 ' A' ' 15' ' ' ILE . 10.6 mm -105.03 126.97 59.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.409 -0.589 . . . . 0.20000000000000001 109.409 -175.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 16.9 p30 -79.57 -175.16 4.64 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.837 -0.345 . . . . 1.3 111.47 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.607 ' HD2' ' OXT' ' A' ' 176' ' ' LEU . 91.8 mtt180 -64.54 -12.81 48.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.507 0.558 . . . . 3.7799999999999998 112.507 -176.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -109.73 -13.46 14.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.41 0.624 . . . . 1.1799999999999999 109.326 -170.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.407 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 100.52 28.07 7.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.175 -0.921 . . . . 0.23000000000000001 112.729 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.431 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 61.7 t -110.77 128.0 26.04 Favored Pre-proline 0 C--N 1.317 -0.839 0 O-C-N 122.538 -0.389 . . . . 0.62 110.388 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.576 ' HD2' HG21 ' A' ' 125' ' ' THR . 10.6 Cg_exo -68.94 106.09 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.97 2.447 . . . . 0.29999999999999999 112.174 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.3 t -89.41 -16.33 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.862 -0.608 . . . . 0.27000000000000002 110.589 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.631 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 5.2 mm-40 -160.73 165.67 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 1.22 110.717 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.731 ' HB3' ' HA2' ' A' ' 128' ' ' GLY . 19.6 ttm180 -137.56 98.28 3.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.94 -0.573 . . . . 1.75 109.531 170.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.794 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 44.3 m-85 -88.49 113.02 23.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.38 109.745 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.938 ' HA ' HG23 ' A' ' 140' ' ' THR . 3.8 m -64.56 166.14 12.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 109.775 -0.454 . . . . 0.98999999999999999 109.775 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.822 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 33.8 Cg_endo -65.34 -8.26 18.28 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.695 2.264 . . . . 0.66000000000000003 113.061 -165.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.721 ' HA3' ' HD2' ' A' ' 51' ' ' LYS . . . -93.24 3.25 72.43 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.433 -0.803 . . . . 0.52000000000000002 112.882 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.47 139.97 37.46 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.182 -0.303 . . . . 0.42999999999999999 110.182 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 94.7 p -83.58 171.11 13.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.25 111.034 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 39.7 t -55.52 -48.27 77.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.684 -0.487 . . . . 0.40999999999999998 109.684 175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -63.74 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.806 . . . . 3.4399999999999999 110.9 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.06 -37.73 69.67 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.95 -0.568 . . . . 1.8600000000000001 110.313 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.553 HG21 HD21 ' A' ' 39' ' ' LEU . 67.5 mt -82.51 -41.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 0.20999999999999999 111.399 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 52.0 mt-10 -56.37 -40.02 73.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.147 0.425 . . . . 0.88 112.147 -176.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 10.0 pt-20 -59.77 -22.71 62.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.821 0.304 . . . . 0.75 111.821 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.7 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 31.8 mmtp -107.23 -19.88 13.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.104 0.478 . . . . 1.5800000000000001 110.262 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.658 ' HG ' HD11 ' A' ' 171' ' ' LEU . 58.2 tp -84.73 -42.44 15.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.23999999999999999 111.32 -174.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.693 ' HA ' HD12 ' A' ' 171' ' ' LEU . 81.9 mt -53.24 -47.44 95.97 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.16 0.43 . . . . 0.44 112.16 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.5 Cg_exo -55.29 -23.28 36.74 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.624 2.216 . . . . 0.48999999999999999 113.327 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 55.3 mt -92.65 -40.31 10.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.634 0.254 . . . . 0.70999999999999996 110.964 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.859 HD23 ' HG2' ' A' ' 37' ' ' PRO . 10.7 mt -60.39 -48.51 81.46 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.092 -0.707 . . . . 0.46000000000000002 109.092 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.92 52.5 2.87 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.699 -1.137 . . . . 1.52 113.057 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p 57.24 119.37 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.991 1.316 . . . . 2.52 113.594 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.03 -19.41 21.58 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.235 0.541 . . . . 3.5600000000000001 110.718 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 175' ' ' ARG . 6.8 ptp85 179.26 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.954 -1.128 . . . . 7.8600000000000003 107.954 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.607 ' OXT' ' HD2' ' A' ' 146' ' ' ARG . 60.1 tp . . . . . 0 C--O 1.244 0.808 0 N-CA-C 106.804 -1.554 . . . . 4.8099999999999996 106.804 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.674 -0.57 . . . . 5.5099999999999998 111.674 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 mmt -76.37 101.19 5.43 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.369 -0.604 . . . . 5.0499999999999998 109.369 176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.77 109.4 2.76 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.979 -0.848 . . . . 1.3700000000000001 110.979 -172.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 m -61.53 -38.09 86.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.747 0.308 . . . . 1.6799999999999999 111.138 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.0 p -171.69 -176.96 1.88 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.292 -0.633 . . . . 0.65000000000000002 109.292 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.764 HD13 HG21 ' A' ' 144' ' ' ILE . 21.8 pt -62.34 -26.33 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.138 0.494 . . . . 0.29999999999999999 110.448 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.899 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 44.0 m-85 -79.02 -1.59 36.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.777 -0.647 . . . . 0.27000000000000002 111.556 -174.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.27 -16.1 61.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.443 -0.947 . . . . 1.96 108.443 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 47.5 m-85 -105.63 177.81 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.579 -1.191 . . . . 0.40000000000000002 109.658 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -126.13 148.47 49.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.692 0.282 . . . . 2.77 110.722 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG23 HD13 ' A' ' 30' ' ' LEU . 70.0 t -117.35 148.17 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.73999999999999999 111.33 -175.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.97 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 92.7 mt -102.82 137.73 40.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 0.71999999999999997 109.656 171.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 23' ' ' ALA . 19.7 t70 -72.98 -174.97 1.63 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.035 -0.728 . . . . 1.5900000000000001 109.035 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.424 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -55.48 -34.15 64.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.042 0.449 . . . . 0.52000000000000002 111.139 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 27.5 m-20 -93.82 3.03 56.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 2.2200000000000002 111.186 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.97 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 35.1 m-70 72.91 14.53 4.81 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.276 0.63 . . . . 0.72999999999999998 110.292 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 26' ' ' LYS . 10.4 mtmt -66.76 144.34 98.53 Favored Pre-proline 0 CA--C 1.511 -0.519 0 N-CA-C 106.252 -1.759 . . . . 3.25 106.252 163.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.81 113.76 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 CA-C-N 119.809 0.967 . . . . 0.85999999999999999 111.136 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.423 ' HB3' HG12 ' A' ' 20' ' ' VAL . 69.2 t80 -87.53 108.84 19.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.375 -0.83 . . . . 0.28000000000000003 109.124 172.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.65 ' OD1' HG12 ' A' ' 31' ' ' VAL . 62.6 t30 -66.57 95.59 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.132 -0.692 . . . . 1.6499999999999999 109.132 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.899 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.88 -30.23 67.63 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.627 -0.715 . . . . 0.25 110.611 -177.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.687 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 4.1 p -76.93 -4.06 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 0.40999999999999998 112.843 -166.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 27.8 pt20 -79.02 -4.99 52.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.565 0.698 . . . . 1.24 109.396 173.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.531 ' ND1' HG21 ' A' ' 70' ' ' THR . 84.8 m-70 -97.67 2.38 49.68 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.368 -0.975 . . . . 0.38 108.368 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -78.62 145.6 34.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.111 -0.95 . . . . 1.73 108.951 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.58 87.29 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.904 -1.278 . . . . 0.35999999999999999 109.904 -169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 t -132.27 133.05 23.31 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.64 -0.874 . . . . 1.1399999999999999 108.64 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.934 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 36.4 Cg_endo -69.56 146.02 60.16 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.305 1.337 . . . . 0.52000000000000002 109.803 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.566 ' CD2' ' HB ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -150.77 161.13 43.23 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.495 0.665 . . . . 1.03 111.743 -175.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.794 HD21 HG21 ' A' ' 163' ' ' ILE . 6.5 mp -111.96 154.01 25.91 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.977 -1.011 . . . . 1.1000000000000001 108.671 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 94.5 mt -140.54 115.16 6.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.291 -0.633 . . . . 0.20000000000000001 109.291 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.862 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 34.4 m-85 -99.72 123.4 43.94 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 121.047 -0.261 . . . . 0.23000000000000001 111.165 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.821 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.7 OUTLIER -80.41 91.56 5.72 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.197 -1.038 . . . . 1.28 108.197 167.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.4 p -116.11 137.7 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.733 1.012 . . . . 0.88 113.733 -162.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.08 108.85 1.96 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.267 -1.012 . . . . 0.52000000000000002 108.267 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.962 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 17.8 t -75.68 84.02 2.68 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.278 0.473 . . . . 1.8400000000000001 112.278 -169.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.696 ' HG3' ' HB2' ' A' ' 98' ' ' PHE . 52.2 mttm 73.15 29.92 1.66 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.18 -0.918 . . . . 2.4300000000000002 112.328 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -133.04 128.87 37.22 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.348 -0.612 . . . . 0.98999999999999999 109.348 174.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.549 ' HA3' ' CD ' ' A' ' 89' ' ' GLU . . . 90.93 -129.39 9.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.441 -0.885 . . . . 1.0900000000000001 113.387 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.33 161.82 26.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.011 0.91 . . . . 3.1600000000000001 113.353 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 t -125.22 154.0 42.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.387 -1.279 . . . . 1.9399999999999999 108.286 168.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -119.08 20.84 12.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.573 0.701 . . . . 2.0299999999999998 109.345 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 115.98 16.27 6.87 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 114.846 -1.07 . . . . 0.46999999999999997 111.584 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.21 -54.25 4.14 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.935 -0.466 . . . . 0.34000000000000002 111.935 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.654 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.4 t80 -65.92 -45.7 80.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.976 0.417 . . . . 0.56999999999999995 110.592 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -62.36 -46.63 87.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 2.46 110.541 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.465 ' CG2' HD12 ' A' ' 163' ' ' ILE . 98.5 m -67.75 -41.46 83.34 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.169 -0.468 . . . . 0.33000000000000002 110.859 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.728 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -59.13 -47.78 84.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.19 111.235 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 m -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.945 -0.571 . . . . 0.29999999999999999 111.125 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 p -62.54 -48.38 79.76 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.852 -0.613 . . . . 1.0800000000000001 111.203 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -59.05 -46.49 88.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 0.81000000000000005 111.596 -177.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.725 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 46.3 t80 -50.93 -58.71 5.32 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 123.389 0.43 . . . . 0.33000000000000002 110.595 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.571 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 91.9 m-20 -73.02 -30.61 63.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.076 0.399 . . . . 1.76 112.076 -173.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.8 -27.26 50.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.211 -0.45 . . . . 1.79 111.329 -174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.774 ' CD1' HD13 ' A' ' 171' ' ' LEU . 65.8 m-85 -122.17 5.2 9.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.687 0.995 . . . . 0.42999999999999999 113.687 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 35.3 mtmt -58.79 -28.92 66.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.983 0.421 . . . . 2.1099999999999999 110.33 173.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.0 p -61.12 -40.01 92.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.636 -0.711 . . . . 1.2 110.928 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -90.48 12.12 19.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.034 0.445 . . . . 1.8999999999999999 110.761 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.673 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.49 71.5 1.25 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.79 -0.641 . . . . 1.3200000000000001 112.133 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CE1' HD13 ' A' ' 39' ' ' LEU . 74.0 t80 -140.67 141.82 34.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.657 0.265 . . . . 0.26000000000000001 110.968 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.531 HG21 ' ND1' ' A' ' 33' ' ' HIS . 8.8 t -131.96 142.88 49.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.224 0.535 . . . . 0.51000000000000001 110.433 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.728 HG11 ' HB1' ' A' ' 57' ' ' ALA . 24.7 t -105.24 119.64 54.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.894 0.378 . . . . 0.23999999999999999 110.073 170.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.663 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 12.3 mt -104.69 128.06 52.64 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.891 -0.781 . . . . 0.51000000000000001 108.891 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -114.52 121.3 43.08 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.309 -0.556 . . . . 0.28000000000000003 110.878 178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.672 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -105.42 108.75 62.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.878 -0.786 . . . . 0.34000000000000002 108.878 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.962 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 50.9 Cg_exo -56.4 164.76 5.06 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.979 2.453 . . . . 0.72999999999999998 111.56 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t -121.58 135.82 54.98 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.031 -1.068 . . . . 1.54 113.046 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.64 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 18.2 t30 -91.21 78.09 5.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 112.782 -2.008 . . . . 2.52 109.103 175.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.823 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -60.33 -13.07 10.99 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.604 -0.725 . . . . 3.1800000000000002 112.217 -176.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -67.48 -15.46 63.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.119 -0.492 . . . . 3.7999999999999998 110.635 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.782 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -53.45 -61.62 6.83 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.632 -0.713 . . . . 1.45 113.011 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.96 -52.26 0.18 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.432 -0.89 . . . . 1.4299999999999999 112.646 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.676 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 4.6 pm0 -127.05 13.53 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.484 0.549 . . . . 1.4299999999999999 112.484 -175.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.823 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 3.4 mm-40 -61.55 153.57 69.39 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 116.103 -0.498 . . . . 3.0600000000000001 111.271 -167.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.646 ' HB3' ' O ' ' A' ' 137' ' ' TRP . 7.6 Cg_exo -32.58 159.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.5 1 C-N-CA 125.33 4.02 . . . . 1.6100000000000001 117.559 -171.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.818 ' HA3' ' HB2' ' A' ' 89' ' ' GLU . . . 81.59 27.77 45.94 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.974 -1.25 . . . . 1.3899999999999999 109.974 -174.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.657 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 20.3 m120 57.64 44.96 19.93 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 114.741 -0.73 . . . . 3.6899999999999999 110.677 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 8.8 pt-20 59.86 6.65 0.94 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.131 1.373 . . . . 2.4700000000000002 113.53 173.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.57 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 89.4 mt-10 -134.74 32.74 3.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.673 0.273 . . . . 3.6400000000000001 111.37 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.818 ' HB2' ' HA3' ' A' ' 85' ' ' GLY . 3.3 tp10 -86.01 -26.59 25.33 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.8 -0.36 . . . . 2.4199999999999999 111.549 -176.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.624 ' CD1' HE21 ' A' ' 78' ' ' GLN . 37.6 mt -105.3 49.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 122.072 0.939 . . . . 2.0499999999999998 109.404 173.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.695 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 50.3 mtmt -87.72 117.38 26.52 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.525 -0.916 . . . . 4.0 108.525 168.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 8.8 pt-20 57.05 16.79 3.06 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.3 1.0 . . . . 3.1000000000000001 111.781 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -114.21 172.46 6.99 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.761 -0.829 . . . . 1.9099999999999999 108.761 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.7 123.52 54.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.882 0.373 . . . . 1.6499999999999999 110.517 170.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' A' ' 90' ' ' ILE . 12.7 m -100.15 118.65 36.92 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.158 -0.617 . . . . 0.91000000000000003 110.654 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -152.85 118.39 5.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.474 -0.784 . . . . 1.9199999999999999 109.807 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' HG3' ' HE3' ' A' ' 99' ' ' LYS . 15.0 pttm 23.86 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.098 1.359 . . . . 3.1800000000000002 114.634 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.696 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -57.01 120.18 7.55 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.005 -1.85 . . . . 1.74 106.005 168.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HE3' ' HG3' ' A' ' 97' ' ' LYS . 9.3 mptt -79.44 164.44 23.97 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.702 -0.799 . . . . 3.0800000000000001 111.195 -173.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.621 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -172.67 -175.41 1.3 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.08 0.863 . . . . 0.42999999999999999 110.969 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.62 0.9 55.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.047 -0.524 . . . . 2.1899999999999999 110.903 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.685 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 49.9 p90 -121.36 168.4 11.17 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.655 -0.868 . . . . 0.23999999999999999 108.655 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.914 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.6 Cg_exo -69.95 116.92 4.8 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.505 2.803 . . . . 0.31 113.239 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.969 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.5 mp -109.01 140.22 28.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.934 -0.765 . . . . 0.37 108.934 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.914 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 8.8 mmt -113.68 -153.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.371 0.605 . . . . 1.47 112.488 -164.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.603 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.76 144.22 45.73 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.036 -0.983 . . . . 0.39000000000000001 110.477 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.942 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.7 pttp -80.67 127.77 32.86 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.652 -0.87 . . . . 1.6599999999999999 108.652 169.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.626 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -131.86 169.4 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.049 -1.463 . . . . 0.46999999999999997 107.049 -177.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.802 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 13.5 m120 -72.43 118.82 15.81 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.467 -0.938 . . . . 2.1600000000000001 108.467 172.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.714 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -116.97 86.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 119.453 -0.899 . . . . 0.38 108.914 168.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.676 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 13.2 t-20 171.61 178.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.911 -1.144 . . . . 1.98 107.911 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.09 -140.38 12.23 Favored Glycine 0 N--CA 1.448 -0.561 0 O-C-N 123.645 0.59 . . . . 0.78000000000000003 114.321 163.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -104.84 -2.62 24.51 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.9 -0.65 . . . . 1.98 110.254 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.06 -21.31 26.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.512 -0.767 . . . . 2.04 110.646 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.802 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -39.05 137.65 0.66 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.213 1.19 . . . . 0.47999999999999998 114.213 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.585 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 56.6 t-80 -49.79 139.09 16.96 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 115.233 -0.894 . . . . 0.41999999999999998 110.797 172.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -41.87 -49.73 5.43 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.193 2.595 . . . . 0.35999999999999999 112.938 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.585 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -55.91 -38.32 70.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.102 -0.499 . . . . 1.1000000000000001 112.138 177.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.431 ' OH ' HG22 ' A' ' 40' ' ' ILE . 3.5 m-85 -75.97 -30.0 58.46 Favored 'General case' 0 C--O 1.216 -0.71 0 O-C-N 122.35 -0.219 . . . . 1.49 111.003 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 43.7 mt-10 -57.64 -35.27 70.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.025 -0.731 . . . . 2.3700000000000001 109.025 169.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 66.9 t80 -71.38 -48.4 50.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.57999999999999996 110.309 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.529 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 67.5 mtt -63.09 -53.09 59.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.999 -0.546 . . . . 0.34000000000000002 111.624 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -56.72 -46.43 81.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.539 . . . . 0.93999999999999995 111.003 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 14.7 ptmm? -67.46 -32.29 73.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 2.1299999999999999 111.039 -176.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.526 HG21 ' HD2' ' A' ' 150' ' ' PRO . 93.0 m -72.76 -63.05 1.24 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 0.46999999999999997 111.828 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.597 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 5.4 tmtt? -125.78 115.62 24.57 Favored Pre-proline 0 C--N 1.324 -0.509 0 C-N-CA 120.924 -0.31 . . . . 1.75 110.843 -173.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.462 ' HA ' ' NH2' ' A' ' 153' ' ' ARG . 51.4 Cg_endo -71.39 -19.82 28.36 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.824 2.349 . . . . 1.76 112.09 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.713 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 99.42 -139.24 14.33 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.875 -0.678 . . . . 2.3700000000000001 113.169 174.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.4 mt -79.57 -65.79 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.924 0.392 . . . . 3.5600000000000001 110.055 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.1 pt? -90.81 144.9 25.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.158 -0.682 . . . . 2.7599999999999998 109.158 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.9 77.79 0.64 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.18 0.514 . . . . 2.8399999999999999 110.915 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.605 HG23 ' HG ' ' A' ' 130' ' ' LEU . 2.5 p -79.37 -16.94 55.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.809 -0.632 . . . . 3.8999999999999999 110.296 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 tptp 68.54 -59.29 0.46 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 124.187 0.929 . . . . 5.1299999999999999 110.219 -176.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.28 -172.45 2.85 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.716 -0.675 . . . . 0.93000000000000005 111.164 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.79 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 29.4 mm -76.02 170.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 108.809 -0.811 . . . . 1.05 108.809 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 135' ' ' ILE . 11.9 ptpt 177.47 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.609 0.718 . . . . 1.5 110.52 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.79 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.76 169.76 9.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.071 -0.968 . . . . 0.87 112.261 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.4 ' HB3' ' H ' ' A' ' 139' ' ' PHE . 22.0 m120 -48.91 -155.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.219 1.808 . . . . 1.8 113.959 172.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.862 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 22.8 m-85 -26.7 -58.43 0.09 Allowed 'General case' 0 C--O 1.205 -1.243 0 C-N-CA 125.419 1.488 . . . . 1.3700000000000001 113.929 -163.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.821 ' HB ' HD21 ' A' ' 42' ' ' ASN . 22.5 m 40.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.33 0.863 . . . . 0.29999999999999999 113.33 177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 18.9 p -85.57 148.38 25.96 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.004 -0.678 . . . . 0.80000000000000004 110.685 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 122' ' ' MET . 11.6 m-85 -102.34 130.34 49.05 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.036 -1.098 . . . . 0.53000000000000003 108.036 167.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.802 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 26.4 tp -80.99 106.17 12.78 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.976 -0.75 . . . . 0.51000000000000001 108.976 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.764 HG21 HD13 ' A' ' 15' ' ' ILE . 10.1 mm -105.06 128.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.442 -0.947 . . . . 0.20000000000000001 108.442 -175.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.446 ' HB2' HD12 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -76.95 -176.16 3.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.756 0.312 . . . . 1.3 110.884 -174.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.704 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 64.3 mtp180 -68.1 -6.48 23.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 3.7799999999999998 111.804 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -109.97 -21.13 12.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.501 0.667 . . . . 1.1799999999999999 109.528 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.513 ' HA2' HG22 ' A' ' 144' ' ' ILE . . . 102.98 32.96 4.49 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.967 -1.015 . . . . 0.23000000000000001 112.848 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 93.8 t -111.55 129.0 24.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.523 -0.547 . . . . 0.62 109.523 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.526 ' HD2' HG21 ' A' ' 125' ' ' THR . 15.0 Cg_exo -64.39 109.92 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.376 2.051 . . . . 0.29999999999999999 111.612 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.597 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 11.4 t -92.55 -22.09 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 0.27000000000000002 110.351 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 143' ' ' LEU . 7.3 mm-40 -153.75 163.99 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.262 0.554 . . . . 1.22 111.276 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.713 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 26.0 ttm180 -134.02 97.71 3.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.019 -0.991 . . . . 1.75 108.766 172.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.802 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 46.9 m-85 -90.84 113.75 25.99 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.057 -0.72 . . . . 0.38 109.057 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.741 ' HA ' HG23 ' A' ' 140' ' ' THR . 1.7 m -62.0 173.51 0.87 Allowed Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 110.011 -0.366 . . . . 0.98999999999999999 110.011 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.723 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 54.0 Cg_endo -64.54 -14.42 44.32 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.693 1.596 . . . . 0.66000000000000003 111.157 -174.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.54 2.41 82.56 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.466 -1.243 . . . . 0.52000000000000002 112.132 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 154' ' ' PHE . . . -81.32 127.39 32.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.816 0.341 . . . . 0.42999999999999999 110.547 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -178.9 5.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.126 -0.488 . . . . 1.25 110.589 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.439 ' HA ' HG23 ' A' ' 56' ' ' THR . 49.1 t -55.05 -58.87 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.40999999999999998 112.021 -175.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 162' ' ' ASP . 4.0 ptmm? -66.49 -28.32 68.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 3.4399999999999999 110.988 -174.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 161' ' ' LYS . 62.3 m-20 -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 1.8600000000000001 110.237 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.794 HG21 HD21 ' A' ' 39' ' ' LEU . 55.1 mt -82.54 -44.01 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.832 -0.622 . . . . 0.20999999999999999 110.369 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.5 ' O ' HG13 ' A' ' 168' ' ' ILE . 61.2 mt-10 -56.45 -40.12 74.29 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 112.162 0.43 . . . . 0.88 112.162 -176.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.36 -20.93 47.86 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.012 0.375 . . . . 0.75 112.012 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.637 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 63.1 mmtt -105.4 -25.71 12.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.587 0.232 . . . . 1.5800000000000001 110.456 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 44.4 tp -85.78 -34.73 21.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.23999999999999999 112.036 -169.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.719 ' HA ' HD12 ' A' ' 171' ' ' LEU . 81.4 mt -50.37 -48.03 81.85 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.271 0.471 . . . . 0.44 112.271 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 75.2 Cg_exo -51.81 -38.49 67.61 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.253 1.969 . . . . 0.48999999999999999 113.335 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 2.2 mm? -74.07 -42.45 60.17 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 121.076 -0.25 . . . . 0.70999999999999996 111.036 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.934 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 9.7 mt -57.06 -46.4 82.51 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.2 -0.667 . . . . 0.46000000000000002 109.2 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -50.8 -73.54 0.37 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.709 -1.132 . . . . 1.52 111.943 168.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 172' ' ' GLY . 22.9 t 175.28 135.56 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.668 0.387 . . . . 2.52 110.536 175.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.629 ' HB2' HD12 ' A' ' 170' ' ' LEU . . . -94.19 -47.59 6.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.832 -0.622 . . . . 3.5600000000000001 111.52 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -149.29 19.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.172 0.51 . . . . 7.8600000000000003 110.717 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.3 tp . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.321 -0.847 . . . . 4.8099999999999996 109.773 -176.388 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.94 0 N-CA-C 112.534 -0.226 . . . . 5.5099999999999998 112.534 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.1 ttt -111.06 -27.8 8.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.157 0.504 . . . . 5.0499999999999998 110.15 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.42 25.25 68.56 Favored Glycine 0 C--O 1.227 -0.31 0 CA-C-N 115.648 -0.705 . . . . 1.3700000000000001 113.191 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -69.27 -45.77 68.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.053 0.454 . . . . 1.6799999999999999 110.974 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.8 p -153.2 173.36 15.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 0.65000000000000002 109.199 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.792 HD13 HG21 ' A' ' 144' ' ' ILE . 25.9 pt -56.0 -32.3 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.29999999999999999 111.583 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.809 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 47.4 m-85 -71.17 -14.31 62.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.27000000000000002 111.97 -172.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -69.6 -15.02 63.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.312 0.577 . . . . 1.96 109.655 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 86.2 m-85 -103.66 174.13 6.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.342 -0.844 . . . . 0.40000000000000002 111.528 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 10.5 tt0 -91.74 152.09 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.21 -0.904 . . . . 2.77 110.895 -177.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.609 HG12 ' HB3' ' A' ' 28' ' ' TYR . 93.7 t -138.78 145.45 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.119 0.485 . . . . 0.73999999999999999 110.413 169.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.924 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 69.3 mt -119.91 148.12 43.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.706 -0.679 . . . . 0.71999999999999997 109.472 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.66 ' HB3' ' HE3' ' A' ' 26' ' ' LYS . 14.5 t70 -78.88 -173.96 3.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.917 -0.771 . . . . 1.5900000000000001 108.917 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.675 ' HB1' ' HG2' ' A' ' 97' ' ' LYS . . . -52.76 -27.0 15.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.338 0.496 . . . . 0.52000000000000002 112.338 -172.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.86 25.0 10.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.289 0.477 . . . . 2.2200000000000002 112.289 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.924 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 46.0 m-70 72.38 9.2 5.82 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 121.658 0.742 . . . . 0.72999999999999998 110.538 171.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.66 ' HE3' ' HB3' ' A' ' 22' ' ' ASP . 23.9 mtmt -64.25 135.64 96.42 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 106.811 -1.551 . . . . 3.25 106.811 165.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -56.61 114.17 1.79 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.208 1.272 . . . . 0.85999999999999999 112.226 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.609 ' HB3' HG12 ' A' ' 20' ' ' VAL . 46.3 t80 -93.61 110.06 21.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.495 -0.775 . . . . 0.28000000000000003 111.011 175.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.556 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.6 t30 -71.5 93.26 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.136 -0.69 . . . . 1.6499999999999999 109.136 175.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.794 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -69.17 -27.77 65.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.019 -0.537 . . . . 0.25 111.261 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.809 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 9.7 p -76.73 -1.47 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 113.181 0.808 . . . . 0.40999999999999998 113.181 -166.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 26.8 pt20 -78.13 -5.39 51.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.319 0.58 . . . . 1.24 109.65 172.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -95.35 4.58 53.25 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.7 -0.852 . . . . 0.38 108.7 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HE3' ' CG2' ' A' ' 31' ' ' VAL . 31.1 ttmt -78.61 146.64 34.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.289 -0.869 . . . . 1.73 110.048 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.23 5.28 89.09 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.043 -1.223 . . . . 0.35999999999999999 110.043 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.659 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 19.7 m -141.96 139.13 17.69 Favored Pre-proline 0 N--CA 1.446 -0.668 0 CA-C-N 114.416 -0.892 . . . . 1.1399999999999999 108.877 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.953 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 59.7 Cg_endo -72.85 150.55 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.625 1.55 . . . . 0.52000000000000002 110.805 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.67 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -153.32 151.41 29.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.198 0.523 . . . . 1.03 111.003 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.771 HD21 HG21 ' A' ' 163' ' ' ILE . 6.7 mp -107.25 152.75 23.68 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.735 -0.839 . . . . 1.1000000000000001 108.735 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 81.0 mt -140.76 114.66 5.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.974 -0.75 . . . . 0.20000000000000001 108.974 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.778 ' CD2' ' HB3' ' A' ' 139' ' ' PHE . 21.2 m-85 -102.66 122.99 45.54 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.861 -0.336 . . . . 0.23000000000000001 110.747 -173.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.942 HD21 ' HB ' ' A' ' 140' ' ' THR . 0.3 OUTLIER -80.92 91.78 6.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.374 -0.973 . . . . 1.28 108.374 168.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 139' ' ' PHE . 2.5 p -110.61 131.99 60.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 113.167 0.803 . . . . 0.88 113.167 -163.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 111.92 2.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.259 -1.385 . . . . 0.52000000000000002 107.259 167.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 1.068 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -75.43 64.33 1.56 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.501 0.926 . . . . 1.8400000000000001 113.501 -161.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.858 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 1.1 tppp? 76.73 52.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.728 1.211 . . . . 2.4300000000000002 112.503 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -145.91 131.25 18.58 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.02 -0.733 . . . . 0.98999999999999999 109.02 170.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.78 -82.77 1.62 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.631 -0.795 . . . . 1.0900000000000001 113.947 173.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -137.33 166.51 23.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.87 0.335 . . . . 3.1600000000000001 111.295 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.7 p -134.65 -41.35 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.199 -0.455 . . . . 1.9399999999999999 111.745 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.586 ' HD2' ' HG2' ' A' ' 156' ' ' PRO . 27.5 ttmt 71.15 0.56 3.47 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.873 0.869 . . . . 2.0299999999999998 112.227 175.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.33 39.24 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.71 -0.757 . . . . 0.46999999999999997 112.829 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.35 74.82 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 111.542 -0.623 . . . . 0.34000000000000002 111.542 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 139' ' ' PHE . 1.1 t80 -71.42 -56.6 5.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 120.837 0.351 . . . . 0.56999999999999995 110.416 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.92 -43.51 91.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.05 -0.523 . . . . 2.46 110.755 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' HA ' ' A' ' 160' ' ' VAL . 94.0 m -63.63 -49.28 73.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.805 -0.634 . . . . 0.33000000000000002 111.11 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.36 -46.13 91.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 0.19 111.719 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.565 HG23 ' HB2' ' A' ' 101' ' ' GLU . 22.6 m -62.24 -47.75 82.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 0.29999999999999999 111.284 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.2 p -64.0 -41.93 97.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.326 -0.397 . . . . 1.0800000000000001 111.045 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.516 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 82.3 mt -58.21 -52.92 63.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 116.335 -0.393 . . . . 0.81000000000000005 110.605 175.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.533 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 60.4 t80 -50.41 -56.58 10.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.387 -0.824 . . . . 0.33000000000000002 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -70.9 -32.12 68.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 1.76 112.145 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -83.88 -47.08 11.44 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.788 -0.365 . . . . 1.79 111.538 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.699 ' CD1' HD13 ' A' ' 171' ' ' LEU . 63.1 m-85 -96.61 7.44 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.33 0.863 . . . . 0.42999999999999999 113.33 -170.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.63 -25.11 62.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.417 . . . . 2.1099999999999999 109.916 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.6 t -59.93 -34.78 73.69 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.451 -0.795 . . . . 1.2 111.363 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.576 ' N ' HE21 ' A' ' 67' ' ' GLN . 0.0 OUTLIER -95.85 6.13 49.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.935 0.398 . . . . 1.8999999999999999 110.897 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 81.64 67.22 1.53 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.63 -0.795 . . . . 1.3200000000000001 111.433 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CE1' HD13 ' A' ' 39' ' ' LEU . 80.1 t80 -131.52 136.44 47.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.394 -0.224 . . . . 0.26000000000000001 110.394 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.67 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -128.91 146.73 50.87 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 110.066 -0.346 . . . . 0.51000000000000001 110.066 178.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.846 HG11 ' HB1' ' A' ' 57' ' ' ALA . 38.4 t -114.08 113.01 42.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.801 -0.444 . . . . 0.23999999999999999 109.801 169.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 27.0 mt -95.79 121.58 37.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.576 -0.898 . . . . 0.51000000000000001 108.576 176.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.032 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -109.07 112.36 24.5 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.064 -0.654 . . . . 0.28000000000000003 110.573 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.878 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 2.5 m-85 -96.22 108.16 39.77 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 109.041 -0.726 . . . . 0.34000000000000002 109.041 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.078 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 32.3 Cg_exo -61.25 171.02 4.44 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.811 3.007 . . . . 0.72999999999999998 112.114 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.4 t -129.98 135.62 48.5 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.875 1.065 . . . . 1.54 113.875 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.516 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 71.1 m-20 -103.69 95.49 6.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.268 -1.333 . . . . 2.52 109.358 169.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.794 ' HB3' ' H ' ' A' ' 88' ' ' GLU . 1.6 mp0 -59.31 -10.72 3.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.915 0.709 . . . . 3.1800000000000002 112.915 -178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -66.26 -10.51 42.89 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.565 0.346 . . . . 3.7999999999999998 111.845 -173.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -68.12 -35.16 82.91 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.689 -0.767 . . . . 1.45 111.676 175.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.67 -62.31 0.63 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.916 -0.659 . . . . 1.4299999999999999 112.732 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.673 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 5.4 pm0 -103.78 7.43 37.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.387 -0.525 . . . . 1.4299999999999999 111.892 -172.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.696 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 1.5 mm-40 -59.76 144.87 84.84 Favored Pre-proline 0 C--N 1.31 -1.12 0 N-CA-C 107.717 -1.216 . . . . 3.0600000000000001 107.717 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.711 ' HD3' ' O ' ' A' ' 110' ' ' VAL . 8.2 Cg_exo -16.64 145.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 126.722 4.948 . . . . 1.6100000000000001 116.697 -159.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 136' ' ' LYS . . . -46.65 -19.15 0.44 Allowed Glycine 0 N--CA 1.468 0.79 0 CA-C-N 114.228 -1.351 . . . . 1.3899999999999999 115.367 -164.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' HB3' ' HB2' ' A' ' 89' ' ' GLU . 13.8 m120 -52.8 -28.89 24.6 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.832 0.316 . . . . 3.6899999999999999 111.267 168.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 11.3 pt-20 18.85 118.04 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 127.25 2.22 . . . . 2.4700000000000002 115.514 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.794 ' H ' ' HB3' ' A' ' 78' ' ' GLN . 34.3 tt0 62.08 34.77 16.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.404 -1.271 . . . . 3.6400000000000001 109.39 -174.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 86' ' ' ASN . 5.6 tp10 -73.73 -12.77 60.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.388 -0.824 . . . . 2.4199999999999999 109.253 175.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.803 HG12 ' SG ' ' A' ' 95' ' ' CYS . 1.6 mt -96.86 23.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.346 -0.843 . . . . 2.0499999999999998 110.183 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.769 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . 13.4 ptmt -74.76 106.62 6.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.67 -0.493 . . . . 4.0 109.67 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.89 -31.67 0.22 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.579 0.751 . . . . 3.1000000000000001 110.401 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 68.3 m-85 -68.44 168.3 13.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.417 -0.586 . . . . 1.9099999999999999 109.417 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.23 117.01 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.162 0.506 . . . . 1.6499999999999999 110.873 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.803 ' SG ' HG12 ' A' ' 90' ' ' ILE . 97.1 m -99.62 115.46 29.46 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 120.194 -0.602 . . . . 0.91000000000000003 109.854 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.3 m -155.59 119.31 4.47 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.365 -0.834 . . . . 1.9199999999999999 109.728 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.687 ' O ' HG21 ' A' ' 104' ' ' ILE . 63.2 mttp 68.84 -44.35 0.52 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 113.699 1.0 . . . . 3.1800000000000002 113.699 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.858 ' HA ' ' HB2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER 65.67 -32.23 0.16 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.076 0.951 . . . . 1.74 111.077 -168.262 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.812 ' HE2' ' HA ' ' A' ' 99' ' ' LYS . 8.3 mmpt? 72.93 127.63 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.094 0.958 . . . . 3.0800000000000001 111.892 171.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.862 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -161.07 -173.18 3.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.423 0.63 . . . . 0.42999999999999999 112.629 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HB2' HG23 ' A' ' 58' ' ' THR . 48.6 mt-10 -93.33 9.1 37.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.006 -0.997 . . . . 2.1899999999999999 111.66 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.738 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 32.1 p90 -128.71 173.73 5.28 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.575 -0.898 . . . . 0.23999999999999999 108.575 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 24.0 Cg_exo -70.39 100.25 0.88 Allowed 'Trans proline' 0 N--CA 1.474 0.332 0 C-N-CA 123.156 2.57 . . . . 0.31 113.232 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.032 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.8 mp -94.96 133.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.606 -0.887 . . . . 0.37 108.606 173.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.878 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.9 OUTLIER -106.46 -160.02 0.72 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.439 -0.8 . . . . 1.47 111.979 -163.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.562 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -73.16 132.53 43.36 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.574 -0.739 . . . . 0.39000000000000001 110.067 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.078 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 19.7 pttt -69.82 121.52 17.42 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.485 0.66 . . . . 1.6599999999999999 109.347 172.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.455 HG13 HG13 ' A' ' 110' ' ' VAL . 11.7 pt -120.54 170.96 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-N 114.797 -1.092 . . . . 0.46999999999999997 108.532 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 3.8 m120 -78.68 69.46 4.86 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.848 -0.614 . . . . 2.1600000000000001 110.379 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.711 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -73.09 85.18 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 118.704 -1.198 . . . . 0.38 110.829 -177.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.673 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 38.1 t30 171.33 178.42 0.06 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.686 -1.227 . . . . 1.98 107.686 160.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 54.83 -146.86 26.51 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.82 -0.705 . . . . 0.78000000000000003 114.687 164.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.22 -15.02 29.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -0.716 . . . . 1.98 110.672 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.24 -12.92 58.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.755 -0.657 . . . . 2.04 111.376 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -49.29 135.64 16.81 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.994 0.739 . . . . 0.47999999999999998 112.994 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -51.16 131.96 31.71 Favored Pre-proline 0 C--O 1.226 -0.137 0 CA-C-O 118.389 -0.815 . . . . 0.41999999999999998 109.178 169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.55 ' HB2' ' HD2' ' A' ' 18' ' ' PHE . 4.0 Cg_exo -38.79 -43.67 2.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.346 2.697 . . . . 0.35999999999999999 112.924 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.559 HD11 ' HE3' ' A' ' 122' ' ' MET . 30.9 tp -54.22 -47.1 72.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.664 -0.698 . . . . 1.1000000000000001 112.09 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.436 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.2 m-85 -73.96 -29.04 61.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 119.469 -0.301 . . . . 1.49 111.276 177.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.39 -39.31 72.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.353 -0.939 . . . . 2.3700000000000001 108.581 168.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 80.4 t80 -68.38 -45.06 73.74 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.181 -0.463 . . . . 0.57999999999999996 110.635 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.559 ' HE3' HD11 ' A' ' 118' ' ' LEU . 67.1 mtt -65.2 -55.75 16.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.579 -0.282 . . . . 0.34000000000000002 111.302 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.8 mtpt -57.07 -42.62 80.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.93999999999999995 110.904 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 13.6 ptmm? -69.82 -37.11 76.13 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.302 -0.408 . . . . 2.1299999999999999 110.922 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 150' ' ' PRO . 92.4 m -64.73 -39.44 93.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.46999999999999997 111.392 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 18.6 ttmm -152.57 107.89 2.74 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 112.716 0.635 . . . . 1.75 112.716 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 153' ' ' ARG . 78.3 Cg_endo -81.73 170.0 14.59 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.906 2.404 . . . . 1.76 110.759 166.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.802 ' HA2' HG22 ' A' ' 132' ' ' THR . . . 165.86 151.78 6.88 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.541 -1.314 . . . . 2.3700000000000001 113.403 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.751 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 66.6 mt 78.54 123.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 123.908 0.883 . . . . 3.5600000000000001 112.295 172.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 129' ' ' ILE . 2.7 pp 58.19 -64.99 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.533 1.533 . . . . 2.7599999999999998 113.481 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.588 ' HB3' ' HE3' ' A' ' 136' ' ' LYS . . . -138.18 101.38 4.39 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.099 -0.704 . . . . 2.8399999999999999 109.099 178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.802 HG22 ' HA2' ' A' ' 128' ' ' GLY . 16.6 p -72.18 103.71 3.42 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.34 0.867 . . . . 3.8999999999999999 113.34 -169.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 127' ' ' PRO . 20.4 ttmm 175.18 -53.54 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.394 -0.821 . . . . 5.1299999999999999 110.657 169.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.543 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -123.98 179.86 4.68 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.709 1.003 . . . . 0.93000000000000005 113.709 -160.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.805 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.9 mt -93.23 103.14 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 114.388 -1.278 . . . . 1.05 110.199 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.588 ' HE3' ' HB3' ' A' ' 131' ' ' ALA . 36.2 mmtt -106.83 0.6 24.14 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.708 0.633 . . . . 1.5 112.708 -167.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.805 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -155.62 171.86 19.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.157 0.799 . . . . 0.87 113.157 -163.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.609 ' HB2' ' HG3' ' A' ' 156' ' ' PRO . 16.3 m120 -46.3 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.096 -1.865 . . . . 1.8 114.103 167.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.778 ' HB3' ' CD2' ' A' ' 41' ' ' TYR . 62.1 m-85 -27.37 -59.06 0.1 Allowed 'General case' 0 C--O 1.204 -1.334 0 C-N-CA 125.158 1.383 . . . . 1.3700000000000001 113.003 -167.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.942 ' HB ' HD21 ' A' ' 42' ' ' ASN . 10.1 m 38.48 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.397 0.888 . . . . 0.29999999999999999 113.397 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.685 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 12.1 p -85.51 152.93 22.8 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.055 -0.52 . . . . 0.80000000000000004 111.358 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -103.0 135.23 45.08 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.581 -1.266 . . . . 0.53000000000000003 107.581 163.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 170' ' ' LEU . 25.4 tp -81.12 105.45 12.34 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.625 -0.88 . . . . 0.51000000000000001 108.625 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.792 HG21 HD13 ' A' ' 15' ' ' ILE . 19.2 mm -101.17 123.78 54.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.478 -0.783 . . . . 0.20000000000000001 108.973 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 0.8 OUTLIER -75.77 -179.8 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 1.3 110.529 -175.675 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 173' ' ' SER . 52.8 mtt180 -62.61 -13.56 32.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.585 0.587 . . . . 3.7799999999999998 112.585 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -108.32 -17.58 13.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.201 0.524 . . . . 1.1799999999999999 110.278 -172.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.533 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 103.16 34.44 3.96 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.616 -0.72 . . . . 0.23000000000000001 112.971 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -118.7 123.84 28.83 Favored Pre-proline 0 C--N 1.316 -0.85 0 O-C-N 122.635 -0.332 . . . . 0.62 110.276 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' ' 125' ' ' THR . 75.5 Cg_exo -53.94 112.98 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.34 2.693 . . . . 0.29999999999999999 112.97 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.417 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.9 t -92.5 -30.32 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.768 -0.651 . . . . 0.27000000000000002 110.475 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' HA ' ' CD ' ' A' ' 126' ' ' LYS . 61.3 mm-40 -155.61 164.07 39.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.36 -0.382 . . . . 1.22 111.027 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.494 ' CZ ' ' HA ' ' A' ' 127' ' ' PRO . 16.7 ttm180 -127.24 102.15 6.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.495 -0.557 . . . . 1.75 109.495 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.604 ' HZ ' ' HB2' ' A' ' 166' ' ' LYS . 36.8 m-85 -98.5 117.15 32.28 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.105 -0.702 . . . . 0.38 109.105 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.909 ' HA ' HG23 ' A' ' 140' ' ' THR . 53.7 p -69.99 178.22 1.1 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 118.77 0.714 . . . . 0.98999999999999999 110.171 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.745 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 71.0 Cg_endo -68.24 -14.88 41.58 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.758 1.638 . . . . 0.66000000000000003 111.122 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.26 13.76 43.58 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.52000000000000002 112.047 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.55 132.21 40.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.921 0.391 . . . . 0.42999999999999999 110.611 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.524 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 32.1 m -82.87 164.03 20.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.108 -0.496 . . . . 1.25 110.778 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.457 ' HA ' HG23 ' A' ' 56' ' ' THR . 28.9 t -52.23 -54.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.40999999999999998 111.791 -176.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 161' ' ' LYS . 25.9 tptt -69.78 -26.16 64.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.096 0.474 . . . . 3.4399999999999999 110.729 -174.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 159' ' ' SER . 21.6 m-20 -67.11 -29.66 69.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.672 -0.695 . . . . 1.8600000000000001 110.105 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 39' ' ' LEU . 62.7 mt -82.7 -40.83 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.354 -0.384 . . . . 0.20999999999999999 110.541 174.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 48.4 mt-10 -56.07 -35.52 67.07 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.777 0.658 . . . . 0.88 112.777 -176.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 9.3 pt-20 -58.03 -26.38 62.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.75 111.202 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.604 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 48.3 mmtm -105.09 -14.1 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.039 0.447 . . . . 1.5800000000000001 110.335 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.661 ' HB3' ' HA ' ' A' ' 164' ' ' GLU . 68.1 tp -95.16 -41.52 9.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 0.23999999999999999 112.13 -171.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.76 ' HA ' HD12 ' A' ' 171' ' ' LEU . 74.3 mt -51.56 -53.26 52.05 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 112.821 0.674 . . . . 0.44 112.821 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 53.0 Cg_exo -56.92 -30.0 84.25 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.946 1.764 . . . . 0.48999999999999999 112.553 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 143' ' ' LEU . 58.7 mt -81.22 -32.51 33.39 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.612 -0.267 . . . . 0.70999999999999996 111.147 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.953 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.0 mt -58.57 -50.81 72.43 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.115 -0.698 . . . . 0.46000000000000002 109.115 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 173' ' ' SER . . . -50.3 -57.28 10.51 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.41 -1.268 . . . . 1.52 112.344 169.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.488 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 22.9 t 178.06 137.39 0.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.663 -0.495 . . . . 2.52 109.663 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.506 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -93.49 -34.34 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.444 0.64 . . . . 3.5600000000000001 109.925 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -168.28 -34.99 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.684 -1.144 . . . . 7.8600000000000003 108.107 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 C--O 1.248 0.992 0 CA-C-N 114.652 -1.158 . . . . 4.8099999999999996 108.811 172.526 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.158 -0.377 . . . . 5.5099999999999998 112.158 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 48.9 ttp -143.1 51.35 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.569 -0.901 . . . . 5.0499999999999998 108.569 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.33 73.55 1.1 Allowed Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.068 -0.969 . . . . 1.3700000000000001 113.528 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.9 t -87.78 -29.16 21.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.462 -0.94 . . . . 1.6799999999999999 108.462 171.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 p -145.81 156.76 43.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.839 -1.073 . . . . 0.65000000000000002 108.806 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 144' ' ' ILE . 16.6 pt -56.32 -22.11 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 113.442 0.904 . . . . 0.29999999999999999 113.442 -170.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.81 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 69.5 m-85 -83.17 1.04 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.028 0.381 . . . . 0.27000000000000002 112.028 -172.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.89 -20.71 61.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.776 -0.824 . . . . 1.96 108.776 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 77.3 m-85 -95.38 156.91 16.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.964 -1.016 . . . . 0.40000000000000002 110.571 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' O ' ' HE1' ' A' ' 116' ' ' HIS . 36.6 tt0 -101.27 141.87 33.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.906 -0.588 . . . . 2.77 110.189 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.509 HG23 HD13 ' A' ' 30' ' ' LEU . 64.3 t -114.61 150.62 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.785 0.326 . . . . 0.73999999999999999 110.914 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.826 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 85.2 mt -108.28 133.89 51.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.175 -0.466 . . . . 0.71999999999999997 110.161 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.98 176.88 2.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.103 -0.953 . . . . 1.5900000000000001 109.775 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.561 ' HB1' ' HD3' ' A' ' 97' ' ' LYS . . . -51.48 -29.99 18.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.126 0.488 . . . . 0.52000000000000002 110.847 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' A' ' 26' ' ' LYS . 22.5 t70 -96.78 1.34 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 2.2200000000000002 111.649 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.826 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 34.2 m-70 74.94 12.51 3.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.058 0.543 . . . . 0.72999999999999998 110.825 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 10.7 mmpt? -69.92 146.04 94.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 106.067 -1.827 . . . . 3.25 106.067 165.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.45 113.04 1.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 119.762 0.951 . . . . 0.85999999999999999 110.985 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.451 ' HB3' HG12 ' A' ' 20' ' ' VAL . 65.6 t80 -79.28 128.23 33.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.283 -0.871 . . . . 0.28000000000000003 110.47 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.659 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 2.4 t-20 -76.99 81.88 3.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.604 -0.725 . . . . 1.6499999999999999 109.255 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.81 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 1.9 pt? -71.13 -33.8 70.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.42 0.629 . . . . 0.25 110.31 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.684 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.6 p -77.6 -0.86 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.179 -0.919 . . . . 0.40999999999999998 112.611 -168.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 9.3 pt20 -82.79 -6.41 59.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.064 -0.717 . . . . 1.24 109.064 173.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.528 ' HB3' HD13 ' A' ' 38' ' ' LEU . 91.9 m-70 -93.67 -2.3 54.12 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.38 108.398 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -78.12 142.38 38.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.788 -1.096 . . . . 1.73 110.187 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.0 -19.09 25.65 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.35999999999999999 110.508 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 70.1 m -141.84 139.13 17.84 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.585 -0.894 . . . . 1.1399999999999999 108.585 177.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.694 ' HG2' ' HA ' ' A' ' 171' ' ' LEU . 24.5 Cg_exo -65.35 153.48 78.05 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.738 2.292 . . . . 0.52000000000000002 112.289 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' A' ' 33' ' ' HIS . 2.3 pt? -154.63 159.25 40.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.302 -0.863 . . . . 1.03 109.766 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -113.69 157.77 21.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.967 -0.382 . . . . 1.1000000000000001 109.967 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 72' ' ' LEU . 93.3 mt -141.97 116.46 5.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 115.715 -0.675 . . . . 0.20000000000000001 109.621 -176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.929 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 15.8 m-85 -103.16 123.58 46.96 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.134 -0.226 . . . . 0.23000000000000001 111.038 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.614 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -79.31 92.89 5.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.354 -0.98 . . . . 1.28 108.354 168.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.6 p -112.95 131.57 64.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 112.95 0.722 . . . . 0.88 112.95 -163.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 90' ' ' ILE . . . -54.61 114.22 1.6 Allowed 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.18 -1.044 . . . . 0.52000000000000002 108.18 169.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.995 ' HB3' ' HB3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.62 81.28 2.61 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.366 -1.288 . . . . 1.8400000000000001 113.191 -162.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 98' ' ' PHE . 42.8 tptt 72.66 50.6 0.17 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.003 -0.999 . . . . 2.4300000000000002 109.872 177.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 p -163.16 143.76 9.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.7 -0.682 . . . . 0.98999999999999999 111.233 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.79 -155.64 35.5 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.82 -0.627 . . . . 1.0900000000000001 113.258 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -95.32 147.52 23.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.123 0.487 . . . . 3.1600000000000001 110.612 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.7 p -88.69 -27.08 21.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.925 -0.579 . . . . 1.9399999999999999 112.208 -174.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.911 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 30.2 mtpp 65.8 -4.07 0.66 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.369 0.668 . . . . 2.0299999999999998 112.069 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.67 0.01 29.06 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.116 -0.564 . . . . 0.46999999999999997 112.429 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.02 -34.84 77.29 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.373 -0.441 . . . . 0.34000000000000002 112.294 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.628 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.0 OUTLIER -73.03 -47.57 43.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.722 0.296 . . . . 0.56999999999999995 110.224 -176.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.81 -41.78 99.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.685 -0.487 . . . . 2.46 109.685 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 160' ' ' VAL . 98.8 m -64.03 -48.31 76.81 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.422 -0.808 . . . . 0.33000000000000002 110.633 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.903 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -62.44 -50.54 71.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.362 -0.381 . . . . 0.19 111.606 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.6 m -54.79 -48.91 72.11 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.29999999999999999 111.083 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.5 m -63.69 -45.72 88.73 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.205 -0.452 . . . . 1.0800000000000001 111.336 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 64.5 mt -60.33 -52.09 66.74 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 111.842 0.312 . . . . 0.81000000000000005 111.842 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.78 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 59.5 t80 -52.1 -46.68 65.35 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.33000000000000002 109.422 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -73.31 -37.09 66.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.255 0.55 . . . . 1.76 111.081 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -73.49 -33.33 64.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.343 -0.844 . . . . 1.79 111.74 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.005 ' HB3' HE21 ' A' ' 67' ' ' GLN . 72.3 m-85 -121.88 14.15 10.74 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 114.471 1.286 . . . . 0.42999999999999999 114.471 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.78 ' HG3' ' O ' ' A' ' 61' ' ' TYR . 21.5 mtmm -57.52 -26.52 61.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.899 -0.72 . . . . 2.1099999999999999 110.385 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 m -57.16 -41.23 78.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.813 -0.631 . . . . 1.2 111.708 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 1.005 HE21 ' HB3' ' A' ' 64' ' ' TYR . 4.6 pp0? -91.89 -4.33 54.88 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.573 -0.451 . . . . 1.8999999999999999 111.038 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.23 20.0 7.3 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.823 -0.703 . . . . 1.3200000000000001 114.069 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.901 ' HB2' ' NE2' ' A' ' 67' ' ' GLN . 75.2 t80 -77.28 137.33 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.037 0.418 . . . . 0.26000000000000001 111.306 -178.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 2.4 t -132.01 142.31 49.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.839 -0.801 . . . . 0.51000000000000001 108.839 173.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.903 HG11 ' HB1' ' A' ' 57' ' ' ALA . 40.8 t -105.56 105.87 19.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.933 -0.765 . . . . 0.23999999999999999 108.933 169.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.654 ' HB2' HG12 ' A' ' 40' ' ' ILE . 25.6 mt -89.53 120.92 31.26 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.174 -1.047 . . . . 0.51000000000000001 108.174 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.062 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.6 112.23 24.47 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.073 -0.651 . . . . 0.28000000000000003 110.216 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.795 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 1.4 m-85 -95.55 108.05 37.15 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 108.605 -0.887 . . . . 0.34000000000000002 108.605 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.995 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 35.9 Cg_exo -59.82 168.92 5.04 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.35 2.7 . . . . 0.72999999999999998 111.397 -178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.485 ' HB2' HE22 ' A' ' 78' ' ' GLN . 37.4 m -114.41 134.59 54.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.625 1.202 . . . . 1.54 113.847 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.635 ' C ' ' HG3' ' A' ' 83' ' ' GLU . 42.4 t30 -93.04 64.62 3.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.348 -1.751 . . . . 2.52 109.679 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.759 ' HA ' ' HB2' ' A' ' 83' ' ' GLU . 0.9 OUTLIER -53.06 -13.7 0.5 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.351 0.871 . . . . 3.1800000000000002 113.351 -173.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -70.28 -19.19 63.12 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.341 0.591 . . . . 3.7999999999999998 110.317 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.842 ' HA3' HD21 ' A' ' 109' ' ' ASN . . . -62.21 -47.92 86.38 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.303 -0.862 . . . . 1.45 112.462 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.71 -58.15 0.6 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.901 -1.142 . . . . 1.4299999999999999 113.016 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.825 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -93.34 11.81 26.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.421 0.61 . . . . 1.4299999999999999 112.216 -175.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.759 ' HB2' ' HA ' ' A' ' 78' ' ' GLN . 26.3 mm-40 -62.22 149.37 87.21 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 120.422 -0.511 . . . . 3.0600000000000001 111.95 -172.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.987 ' HG3' HG22 ' A' ' 135' ' ' ILE . 9.1 Cg_exo -36.5 165.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.905 3.736 . . . . 1.6100000000000001 116.258 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.49 82.13 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.802 -1.319 . . . . 1.3899999999999999 109.802 -171.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.581 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 2.3 t-20 54.97 30.45 14.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.336 -0.932 . . . . 3.6899999999999999 110.853 -177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 2.8 pt-20 64.88 -14.19 0.1 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.732 1.213 . . . . 2.4700000000000002 112.877 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -85.2 -15.57 43.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.702 0.287 . . . . 3.6400000000000001 111.323 -169.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -79.88 -61.51 1.97 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.987 -0.285 . . . . 2.4199999999999999 110.895 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.797 HG12 ' SG ' ' A' ' 95' ' ' CYS . 3.0 mt -84.82 58.91 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 122.952 1.358 . . . . 2.0499999999999998 110.511 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 91' ' ' LYS . 25.8 mmmt -73.95 -78.02 0.1 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.894 -1.503 . . . . 4.0 110.569 168.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -92.3 19.02 7.46 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.25 -0.886 . . . . 3.1000000000000001 111.074 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 90' ' ' ILE . 97.9 m-85 -107.66 168.87 8.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.308 -0.626 . . . . 1.9099999999999999 109.308 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 p -128.72 151.82 36.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.484 -0.561 . . . . 1.6499999999999999 109.484 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.797 ' SG ' HG12 ' A' ' 90' ' ' ILE . 60.6 m -138.72 122.81 17.97 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.696 -0.401 . . . . 0.91000000000000003 112.071 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.1 t -149.42 119.65 7.29 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.892 -0.594 . . . . 1.9199999999999999 110.27 171.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HD3' ' HB1' ' A' ' 23' ' ' ALA . 25.7 pttt 28.44 89.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.764 1.226 . . . . 3.1800000000000002 114.297 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.743 ' HZ ' ' CZ ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -60.79 131.4 50.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.853 -1.165 . . . . 1.74 107.853 170.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 99' ' ' LYS . 11.2 mptt -91.35 147.62 22.91 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.394 -0.523 . . . . 3.0800000000000001 111.213 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -158.54 -166.76 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.847 0.717 . . . . 0.42999999999999999 111.33 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -81.62 -34.1 31.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.373 0.606 . . . . 2.1899999999999999 110.507 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.743 ' CZ ' ' HZ ' ' A' ' 98' ' ' PHE . 29.4 p90 -84.46 166.74 31.07 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 115.287 -0.87 . . . . 0.23999999999999999 109.774 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 23.5 Cg_exo -72.1 103.12 1.44 Allowed 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.018 3.145 . . . . 0.31 113.571 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.062 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.6 mp -94.66 134.25 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.884 -0.784 . . . . 0.37 108.884 173.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.795 ' HG3' ' CE1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -109.01 -154.22 0.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 1.47 112.522 -163.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . . . -74.9 135.55 41.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.218 -0.901 . . . . 0.39000000000000001 110.23 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.981 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . 13.5 pttp -73.36 125.1 27.07 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.713 0.768 . . . . 1.6599999999999999 108.997 171.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.499 HG13 HG13 ' A' ' 110' ' ' VAL . 12.1 pt -122.17 174.36 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 106.914 -1.513 . . . . 0.46999999999999997 106.914 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.842 HD21 ' HA3' ' A' ' 80' ' ' GLY . 6.7 m120 -83.86 81.17 8.89 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.035 -0.666 . . . . 2.1600000000000001 109.868 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.614 HG11 ' HB3' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -79.29 84.12 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 118.468 -1.293 . . . . 0.38 109.085 177.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.825 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 56.5 t30 170.35 179.5 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.418 -1.327 . . . . 1.98 107.418 166.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.68 ' HA3' ' HG3' ' A' ' 82' ' ' GLN . . . 56.81 -152.07 23.9 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 115.615 1.006 . . . . 0.78000000000000003 115.615 160.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.11 -20.9 22.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.148 -1.026 . . . . 1.98 110.695 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -92.94 6.58 47.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.538 -0.755 . . . . 2.04 110.564 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.828 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -56.09 141.98 38.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.885 -1.052 . . . . 0.47999999999999998 113.299 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.598 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 35.6 t-80 -54.25 135.25 60.23 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-N 115.477 -0.783 . . . . 0.41999999999999998 109.087 167.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.16 -33.29 73.85 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.416 2.744 . . . . 0.35999999999999999 112.85 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.598 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.7 tm? -62.32 -43.21 99.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 1.1000000000000001 109.941 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.544 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 2.0 m-85 -75.59 -30.48 59.61 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 116.449 -0.341 . . . . 1.49 110.851 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.53 -41.15 76.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.89 -0.724 . . . . 2.3700000000000001 109.206 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 69.7 t80 -65.81 -45.7 81.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.94 0.4 . . . . 0.57999999999999996 110.442 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.504 ' HB3' ' CD2' ' A' ' 142' ' ' PHE . 67.3 mtt -65.38 -53.29 45.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.144 -0.48 . . . . 0.34000000000000002 111.806 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 119' ' ' TYR . 23.4 mtpt -59.19 -39.21 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.93999999999999995 110.644 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 18.3 ptmt -74.62 -36.84 62.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 2.1299999999999999 111.031 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.499 HG21 ' HD2' ' A' ' 150' ' ' PRO . 96.0 m -70.55 -43.24 69.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.4 -0.363 . . . . 0.46999999999999997 111.916 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.634 ' HE3' ' O ' ' A' ' 151' ' ' VAL . 4.9 tmtt? -137.18 100.71 9.46 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.422 -0.511 . . . . 1.75 111.484 -176.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 126' ' ' LYS . 2.7 Cg_endo -47.53 -52.91 7.23 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.203 3.269 . . . . 1.76 113.463 173.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.93 -154.46 24.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.723 -1.227 . . . . 2.3700000000000001 113.566 174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.4 mt -73.98 -62.19 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.155 0.502 . . . . 3.5600000000000001 110.37 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.814 HD23 ' H ' ' A' ' 130' ' ' LEU . 2.1 pt? -87.89 -165.3 1.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.203 -1.036 . . . . 2.7599999999999998 108.203 172.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -50.76 -56.01 14.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.202 -0.295 . . . . 2.8399999999999999 110.202 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.531 HG21 ' HD2' ' A' ' 153' ' ' ARG . 6.8 m 63.71 -78.57 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.432 -0.804 . . . . 3.8999999999999999 112.003 172.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.8 tttm 69.61 -70.02 0.15 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.674 0.79 . . . . 5.1299999999999999 111.933 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.507 ' HB1' ' OD1' ' A' ' 111' ' ' ASN . . . -109.69 -179.77 3.91 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.145 0.424 . . . . 0.93000000000000005 112.145 -173.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.987 HG22 ' HG3' ' A' ' 84' ' ' PRO . 38.5 mt -103.75 88.83 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.638 -0.71 . . . . 1.05 110.261 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -117.15 28.15 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.644 0.609 . . . . 1.5 112.644 -173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.849 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -154.14 169.49 23.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.05 0.452 . . . . 0.87 112.075 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -51.28 -155.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.869 1.668 . . . . 1.8 113.471 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.929 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 53.1 m-85 -24.86 -57.68 0.05 Allowed 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 125.451 1.5 . . . . 1.3700000000000001 114.212 -165.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.772 HG23 ' HA ' ' A' ' 155' ' ' SER . 23.1 m 38.08 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.275 0.842 . . . . 0.29999999999999999 113.275 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.635 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . 11.9 p -84.34 152.18 24.26 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.094 -0.642 . . . . 0.80000000000000004 111.532 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 122' ' ' MET . 7.9 m-85 -103.5 134.88 46.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.023 -1.102 . . . . 0.53000000000000003 108.023 165.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.771 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 22.2 tp -82.0 104.7 12.55 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.063 -0.717 . . . . 0.51000000000000001 109.063 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 15' ' ' ILE . 18.4 mm -102.8 124.12 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.602 -0.726 . . . . 0.20000000000000001 109.26 -175.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 174' ' ' ALA . 1.1 p-10 -78.7 -175.1 4.23 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.864 -0.334 . . . . 1.3 111.374 -175.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.618 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 47.8 mtp180 -57.11 -26.01 59.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.831 0.348 . . . . 3.7799999999999998 111.912 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -108.5 -12.49 15.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.119 0.485 . . . . 1.1799999999999999 110.829 -168.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.568 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 99.22 44.65 2.33 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.393 -0.908 . . . . 0.23000000000000001 113.512 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 62.9 t -119.16 127.87 26.25 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 109.301 -0.629 . . . . 0.62 109.301 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.499 ' HD2' HG21 ' A' ' 125' ' ' THR . 11.5 Cg_exo -68.07 111.68 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.499 2.133 . . . . 0.29999999999999999 111.383 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.634 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.8 t -94.96 -25.97 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.32 -0.4 . . . . 0.27000000000000002 110.844 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.508 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 59.2 mm-40 -151.08 164.16 37.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.869 0.366 . . . . 1.22 111.032 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.531 ' HD2' HG21 ' A' ' 132' ' ' THR . 23.3 ttm180 -129.98 97.02 4.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.702 -0.851 . . . . 1.75 108.702 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.771 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 49.9 m-85 -88.89 108.66 19.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.461 -0.57 . . . . 0.38 109.461 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.772 ' HA ' HG23 ' A' ' 140' ' ' THR . 88.0 p -63.35 167.3 6.92 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.357 -0.609 . . . . 0.98999999999999999 109.357 176.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.911 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 9.0 Cg_exo -67.61 -8.99 23.92 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.799 2.333 . . . . 0.66000000000000003 112.197 -164.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.93 -1.46 89.78 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 114.72 -1.127 . . . . 0.52000000000000002 111.897 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -87.58 138.06 31.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.955 0.407 . . . . 0.42999999999999999 110.43 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.57 172.44 8.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.191 -0.459 . . . . 1.25 110.536 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.437 ' HA ' HG23 ' A' ' 56' ' ' THR . 40.9 t -52.07 -44.88 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 0.40999999999999998 111.07 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 161' ' ' LYS . 33.1 ttpt -66.41 -38.33 87.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.351 -0.841 . . . . 3.4399999999999999 110.846 -175.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -62.64 -32.35 73.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.8600000000000001 109.962 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 39' ' ' LEU . 59.1 mt -82.8 -43.18 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.20999999999999999 111.184 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 167' ' ' LEU . 33.2 mt-10 -55.54 -36.92 67.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.991 0.737 . . . . 0.88 112.991 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -59.58 -26.16 65.18 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.761 -0.376 . . . . 0.75 111.637 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.448 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 71.5 mmtt -102.06 -17.72 15.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.221 0.534 . . . . 1.5800000000000001 110.155 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.641 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 66.7 tp -87.64 -49.28 7.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.683 . . . . 0.23999999999999999 111.946 -172.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 70.1 mt -53.04 -48.09 93.24 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 112.596 0.591 . . . . 0.44 112.596 -174.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 168' ' ' ILE . 10.0 Cg_endo -53.62 -42.65 64.27 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.116 1.877 . . . . 0.48999999999999999 112.403 175.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.62 -44.23 82.61 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.526 -0.306 . . . . 0.70999999999999996 110.996 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.827 HD22 ' NE2' ' A' ' 67' ' ' GLN . 46.5 mt -55.73 -51.46 67.28 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.448 0.642 . . . . 0.46000000000000002 109.671 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -48.85 -63.05 4.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 114.16 -1.382 . . . . 1.52 113.062 168.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.4 p -169.72 119.84 0.65 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.049 0.424 . . . . 2.52 111.086 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -94.14 -58.68 2.16 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 121.015 0.436 . . . . 3.5600000000000001 110.743 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -132.03 11.95 4.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.134 -1.061 . . . . 7.8600000000000003 108.134 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 C--O 1.251 1.159 0 CA-C-N 113.819 -1.537 . . . . 4.8099999999999996 107.304 -175.321 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 112.048 -0.421 . . . . 5.5099999999999998 112.048 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -106.62 -23.87 12.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.97 0.414 . . . . 5.0499999999999998 110.526 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.97 136.42 2.34 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.947 -0.644 . . . . 1.3700000000000001 111.975 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 m -56.09 -48.75 75.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.167 0.508 . . . . 1.6799999999999999 111.232 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -161.12 -177.86 6.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.574 -0.739 . . . . 0.65000000000000002 109.301 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.666 HD13 HG21 ' A' ' 144' ' ' ILE . 20.8 pt -60.6 -27.54 40.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.741 0.305 . . . . 0.29999999999999999 111.671 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.783 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 42.4 m-85 -77.73 6.49 7.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.003 0.43 . . . . 0.27000000000000002 111.652 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.89 -9.02 59.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.659 -0.867 . . . . 1.96 108.659 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 121' ' ' TYR . 80.0 m-85 -116.61 149.8 39.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.824 -1.08 . . . . 0.40000000000000002 109.811 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -99.98 146.47 26.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.835 0.35 . . . . 2.77 111.01 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -114.13 145.83 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.73999999999999999 110.942 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.019 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 74.9 mt -99.31 134.65 41.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.088 -0.708 . . . . 0.71999999999999997 109.088 170.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.06 -174.9 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.872 -0.788 . . . . 1.5900000000000001 108.872 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 1.098 ' HB1' ' HD2' ' A' ' 97' ' ' LYS . . . -54.33 -29.98 49.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.218 0.532 . . . . 0.52000000000000002 111.381 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.99 11.65 35.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.012 -0.54 . . . . 2.2200000000000002 111.76 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 1.019 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 22.3 m-70 69.46 12.3 8.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.232 0.613 . . . . 0.72999999999999998 110.593 176.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.792 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 11.2 mmpt? -75.83 145.85 78.66 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 106.563 -1.643 . . . . 3.25 106.563 165.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.92 114.52 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.267 1.311 . . . . 0.85999999999999999 112.314 -173.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -85.83 115.72 23.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.355 -0.838 . . . . 0.28000000000000003 109.602 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -71.39 96.07 1.42 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.654 -0.869 . . . . 1.6499999999999999 108.654 173.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.75 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.4 pt? -75.61 -29.64 59.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.722 0.772 . . . . 0.25 109.562 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.783 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 11.7 p -77.5 -0.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.619 -1.173 . . . . 0.40999999999999998 113.207 -166.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -81.7 -4.57 56.59 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.399 -0.593 . . . . 1.24 109.399 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -93.98 4.67 53.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.333 -0.988 . . . . 0.38 108.333 177.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.619 ' HE3' HG23 ' A' ' 31' ' ' VAL . 36.4 ttmt -82.28 130.48 35.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.99 -1.005 . . . . 1.73 109.138 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 0.61 58.7 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.158 -1.177 . . . . 0.35999999999999999 110.158 -171.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 14.3 m -138.23 139.31 25.08 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.587 -0.894 . . . . 1.1399999999999999 108.587 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.097 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 40.5 Cg_endo -73.94 150.7 44.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.572 1.515 . . . . 0.52000000000000002 110.41 174.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.625 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.9 pt? -154.4 153.5 31.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.307 0.575 . . . . 1.03 111.62 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 163' ' ' ILE . 6.4 mp -108.11 148.82 29.29 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.638 -0.875 . . . . 1.1000000000000001 108.638 170.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 84.5 mt -132.07 119.51 40.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.573 -0.529 . . . . 0.20000000000000001 109.573 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 141' ' ' SER . 26.5 m-85 -101.5 130.4 47.75 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.23000000000000001 111.399 -172.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.735 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -90.58 93.31 9.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.503 -1.295 . . . . 1.28 107.503 174.012 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 139' ' ' PHE . 3.5 m -109.01 143.79 18.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 0.88 112.468 -163.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.88 17.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.653 -1.61 . . . . 0.52000000000000002 106.653 165.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.665 ' OG ' ' HB3' ' A' ' 95' ' ' CYS . 3.2 p -74.02 86.33 1.82 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.844 -0.616 . . . . 1.8400000000000001 112.294 -165.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 66.18 44.69 2.5 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.208 -0.905 . . . . 2.4300000000000002 110.385 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.9 p -164.0 133.62 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.567 -0.742 . . . . 0.98999999999999999 110.81 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.15 -149.04 18.29 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.505 -0.855 . . . . 1.0900000000000001 113.869 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -96.54 111.3 23.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 122.694 0.398 . . . . 3.1600000000000001 111.275 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.9 p -66.6 -34.52 78.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.703 0.26 . . . . 1.9399999999999999 111.703 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.8 ' HB2' ' HB2' ' A' ' 156' ' ' PRO . 31.1 mtpp 66.32 -3.32 0.84 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.443 0.697 . . . . 2.0299999999999998 112.536 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.446 ' HA2' ' OE2' ' A' ' 55' ' ' GLU . . . 109.38 3.55 30.94 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.886 -0.673 . . . . 0.46999999999999997 112.464 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 139' ' ' PHE . . . -72.38 -39.46 57.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.225 -0.512 . . . . 0.34000000000000002 111.828 -176.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.737 ' CE1' ' HE2' ' A' ' 98' ' ' PHE . 1.5 t80 -69.18 -51.6 36.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.172 -0.307 . . . . 0.56999999999999995 110.172 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.446 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 1.6 mp0 -51.78 -52.01 52.08 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.37 0.605 . . . . 2.46 110.707 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -64.41 -46.72 82.02 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.899 -1.046 . . . . 0.33000000000000002 110.88 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -58.87 -48.14 82.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.137 -0.483 . . . . 0.19 111.262 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -58.48 -50.27 74.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.703 -0.681 . . . . 0.29999999999999999 110.419 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.7 m -63.0 -43.28 99.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.263 -0.88 . . . . 1.0800000000000001 111.597 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.522 HD13 HD22 ' A' ' 39' ' ' LEU . 76.2 mt -61.34 -50.27 73.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.372 0.138 . . . . 0.81000000000000005 111.372 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.727 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.1 t80 -53.67 -49.62 67.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.159 0.504 . . . . 0.33000000000000002 109.83 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -73.02 -31.24 64.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.613 -0.721 . . . . 1.76 111.869 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -79.34 -45.59 19.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.225 -0.443 . . . . 1.79 111.267 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.625 ' CD1' HD13 ' A' ' 171' ' ' LEU . 69.2 m-85 -104.19 8.03 36.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.592 0.96 . . . . 0.42999999999999999 113.592 -170.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -25.0 65.03 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.02 0.438 . . . . 2.1099999999999999 110.144 170.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.0 t -59.26 -40.14 85.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.497 -0.774 . . . . 1.2 110.727 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.8 14.38 23.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.963 0.411 . . . . 1.8999999999999999 111.247 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.625 ' O ' ' HD2' ' A' ' 37' ' ' PRO . . . 79.21 59.4 2.74 Favored Glycine 0 C--O 1.223 -0.533 0 CA-C-N 115.916 -0.583 . . . . 1.3200000000000001 112.651 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.504 ' CZ ' HD13 ' A' ' 39' ' ' LEU . 67.3 t80 -123.88 139.27 54.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.492 0.187 . . . . 0.26000000000000001 111.121 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.625 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -127.71 144.49 51.08 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 120.82 0.343 . . . . 0.51000000000000001 110.255 177.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.727 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 27.2 t -114.05 119.47 61.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.95 -0.389 . . . . 0.23999999999999999 109.95 169.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.523 ' HB3' ' HE3' ' A' ' 105' ' ' MET . 19.8 mt -103.36 121.57 43.05 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.188 -0.671 . . . . 0.51000000000000001 109.188 178.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.012 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.02 132.25 53.73 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.364 -0.534 . . . . 0.28000000000000003 110.431 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.597 ' CE1' ' HG3' ' A' ' 105' ' ' MET . 6.2 m-85 -112.19 108.44 55.03 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-O 121.231 0.538 . . . . 0.34000000000000002 110.711 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.601 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 64.1 Cg_exo -47.85 139.53 19.34 Favored 'Trans proline' 0 CA--C 1.514 -0.476 0 C-N-CA 124.781 3.654 . . . . 0.72999999999999998 112.136 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 15.7 m -122.25 155.13 36.54 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 118.633 -1.227 . . . . 1.54 114.268 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.527 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 88.7 m-20 -106.12 85.86 2.27 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 113.235 -1.802 . . . . 2.52 110.679 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.98 ' HB2' HG13 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -58.61 -4.03 0.37 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.596 0.758 . . . . 3.1800000000000002 113.0 176.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -84.61 8.37 17.03 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.233 0.539 . . . . 3.7999999999999998 109.837 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.536 ' HA3' ' ND2' ' A' ' 109' ' ' ASN . . . -77.32 -74.12 1.01 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.674 -0.694 . . . . 1.45 114.442 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.43 -41.58 0.24 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.649 -0.786 . . . . 1.4299999999999999 112.175 -170.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.095 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -135.13 14.24 3.55 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.765 -0.256 . . . . 1.4299999999999999 111.273 176.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.729 ' HG2' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -60.31 151.01 70.2 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 3.0600000000000001 111.07 -173.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.759 ' HG3' HG22 ' A' ' 135' ' ' ILE . 32.6 Cg_exo -64.22 173.17 5.4 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.599 2.199 . . . . 1.6100000000000001 112.952 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.56 19.02 57.61 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.899 -1.28 . . . . 1.3899999999999999 109.899 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.28 65.66 0.49 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.403 -0.898 . . . . 3.6899999999999999 110.705 -177.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 1.6 pm0 20.08 117.15 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 116.2 1.926 . . . . 2.4700000000000002 116.2 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 49.1 mm-40 82.43 40.97 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.71 -1.132 . . . . 3.6400000000000001 111.68 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.703 ' HB3' ' HG2' ' A' ' 78' ' ' GLN . 6.5 tp10 -75.27 -33.47 61.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.877 0.325 . . . . 2.4199999999999999 111.877 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.98 HG13 ' HB2' ' A' ' 78' ' ' GLN . 2.8 mt -76.27 34.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.415 0.626 . . . . 2.0499999999999998 111.075 -177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 89' ' ' GLU . 12.5 pttp -78.3 -17.74 56.18 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.804 0.811 . . . . 4.0 110.725 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.48 18.76 1.19 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.375 -1.284 . . . . 3.1000000000000001 110.071 -173.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -135.38 174.02 11.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.664 -0.698 . . . . 1.9099999999999999 110.432 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 94' ' ' VAL . 7.4 p -130.32 111.95 22.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.353 -1.351 . . . . 1.6499999999999999 107.353 166.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.665 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 33.8 m -98.15 120.97 39.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 118.864 -1.135 . . . . 0.91000000000000003 111.26 -174.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.856 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 12.1 t -139.61 156.94 46.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.899 -1.5 . . . . 1.9199999999999999 107.568 177.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 1.098 ' HD2' ' HB1' ' A' ' 23' ' ' ALA . 5.7 pttt -39.08 101.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.835 0.71 . . . . 3.1800000000000002 111.299 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.737 ' HE2' ' CE1' ' A' ' 54' ' ' TYR . 5.5 p90 -61.95 135.72 57.67 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.133 -1.432 . . . . 1.74 107.133 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -94.12 143.75 26.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.694 -0.802 . . . . 3.0800000000000001 110.467 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.436 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -145.99 -162.03 1.43 Allowed 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.055 0.847 . . . . 0.42999999999999999 111.428 -174.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -95.55 -5.37 42.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.826 -0.625 . . . . 2.1899999999999999 110.042 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.718 ' HE2' ' HB2' ' A' ' 73' ' ' ALA . 39.1 p90 -118.79 170.72 6.12 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.23999999999999999 108.912 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HB2' ' HE1' ' A' ' 105' ' ' MET . 23.0 Cg_exo -71.19 125.83 11.78 Favored 'Trans proline' 0 N--CA 1.479 0.659 0 C-N-CA 123.599 2.866 . . . . 0.31 113.292 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.012 HG13 ' HB3' ' A' ' 73' ' ' ALA . 3.1 mp -120.9 140.64 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.338 -0.616 . . . . 0.37 109.338 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.735 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 10.9 mmt -111.1 -151.28 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 1.47 113.717 -163.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -73.73 163.71 27.61 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.247 -0.888 . . . . 0.39000000000000001 111.528 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.856 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 82.4 mttt -87.74 112.38 22.34 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.853 -0.425 . . . . 1.6599999999999999 109.853 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' SER . 14.7 pt -122.17 164.08 19.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.216 -0.661 . . . . 0.46999999999999997 109.216 177.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 55.4 t-20 -96.43 80.33 3.15 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.692 -0.855 . . . . 2.1600000000000001 108.692 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 42' ' ' ASN . 1.0 OUTLIER -65.88 91.47 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 C-N-CA 120.132 -0.627 . . . . 0.38 110.298 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 1.095 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 0.5 OUTLIER 174.25 172.33 0.2 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.055 -0.35 . . . . 1.98 110.055 172.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.581 ' HA3' ' HG3' ' A' ' 82' ' ' GLN . . . 51.15 -133.69 32.95 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 123.944 0.777 . . . . 0.78000000000000003 114.917 160.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -105.57 3.95 29.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.218 -0.991 . . . . 1.98 109.978 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -106.54 -5.56 18.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.959 -1.018 . . . . 2.04 110.958 -169.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -63.15 147.23 51.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.971 -0.559 . . . . 0.47999999999999998 112.354 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.541 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 44.7 t-80 -50.36 136.06 23.6 Favored Pre-proline 0 C--O 1.225 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.41999999999999998 109.412 168.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 120' ' ' GLU . 6.0 Cg_endo -49.37 -32.25 25.6 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.693 2.928 . . . . 0.35999999999999999 113.438 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.554 HD11 ' HE3' ' A' ' 122' ' ' MET . 22.4 tp -66.33 -39.5 89.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.383 . . . . 1.1000000000000001 110.901 175.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.749 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 4.5 m-85 -73.98 -31.13 62.85 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 116.433 -0.349 . . . . 1.49 110.283 175.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 117' ' ' PRO . 34.2 mm-40 -56.22 -42.68 77.64 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.09 -0.707 . . . . 2.3700000000000001 109.09 168.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.694 ' O ' ' HG2' ' A' ' 124' ' ' LYS . 90.1 t80 -65.26 -52.6 53.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.979 0.419 . . . . 0.57999999999999996 111.557 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.554 ' HE3' HD11 ' A' ' 118' ' ' LEU . 55.6 mtt -64.41 -49.17 72.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.558 0.694 . . . . 0.34000000000000002 110.871 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.79 ' HA ' ' HG2' ' A' ' 127' ' ' PRO . 4.6 tmtt? -70.74 -26.62 63.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.805 -1.089 . . . . 0.93999999999999995 112.075 -174.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 19.8 ptmt -75.75 -27.59 58.16 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.85 0.357 . . . . 2.1299999999999999 110.228 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.42 HG21 ' HD2' ' A' ' 150' ' ' PRO . 23.5 m -68.32 -60.43 2.46 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.703 0.631 . . . . 0.46999999999999997 112.703 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.85 ' H ' ' HD2' ' A' ' 127' ' ' PRO . 25.9 tttp -122.49 -55.45 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 119.173 -1.011 . . . . 1.75 113.629 -172.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.85 ' HD2' ' H ' ' A' ' 126' ' ' LYS . 90.7 Cg_endo -68.66 176.75 5.52 Favored 'Trans proline' 0 C--N 1.334 -0.235 0 C-N-CA 123.569 2.846 . . . . 1.76 111.961 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' A' ' 133' ' ' LYS . . . 90.91 -27.17 9.29 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 116.031 -0.531 . . . . 2.3700000000000001 112.104 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.0 pt -56.22 -22.59 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.387 0.884 . . . . 3.5600000000000001 113.387 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.567 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.5 pt? -122.41 19.75 10.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.562 0.208 . . . . 2.7599999999999998 111.562 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 70.62 -50.8 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.601 0.563 . . . . 2.8399999999999999 111.697 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.461 ' HA ' ' CE ' ' A' ' 136' ' ' LYS . 11.4 m -44.24 -56.27 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.745 0.783 . . . . 3.8999999999999999 111.607 177.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.764 ' O ' ' HB2' ' A' ' 127' ' ' PRO . 97.8 mttt -81.7 12.45 3.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.918 -1.037 . . . . 5.1299999999999999 112.169 -173.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.456 ' C ' HG13 ' A' ' 135' ' ' ILE . . . -86.63 24.08 1.52 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.988 0.423 . . . . 0.93000000000000005 109.961 175.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.976 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 1.1 mt 65.84 138.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.708 -1.133 . . . . 1.05 110.151 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.461 ' CE ' ' HA ' ' A' ' 132' ' ' THR . 0.2 OUTLIER -178.6 -37.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.582 0.706 . . . . 1.5 110.851 -175.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.976 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -97.18 170.08 9.36 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.054 -0.976 . . . . 0.87 111.663 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.573 ' HB3' ' HD1' ' A' ' 139' ' ' PHE . 0.6 OUTLIER -52.56 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.839 1.422 . . . . 1.8 114.839 175.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.616 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 16.3 m-85 -28.42 -34.65 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 127.089 2.156 . . . . 1.3700000000000001 115.904 -167.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 1.086 HG23 ' HA ' ' A' ' 155' ' ' SER . 8.6 m 13.46 105.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.027 1.491 . . . . 0.29999999999999999 115.027 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.48 158.85 20.88 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.746 0.784 . . . . 0.80000000000000004 111.982 -174.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.616 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 16.3 m-85 -102.84 169.32 8.67 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.245 -1.391 . . . . 0.53000000000000003 107.245 162.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.624 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 46.3 tp -116.5 105.94 13.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.753 -0.832 . . . . 0.51000000000000001 108.753 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.666 HG21 HD13 ' A' ' 15' ' ' ILE . 13.4 mm -108.36 122.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.486 -0.561 . . . . 0.20000000000000001 109.486 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -178.92 4.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.893 -0.323 . . . . 1.3 110.549 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.677 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 75.8 mtp180 -67.84 -6.6 22.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.184 -0.462 . . . . 3.7799999999999998 112.164 -174.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -108.78 -22.29 12.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.491 0.662 . . . . 1.1799999999999999 109.376 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 104.42 34.2 3.69 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.877 -1.056 . . . . 0.23000000000000001 112.67 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 68.5 t -110.55 129.35 24.04 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.93 0.365 . . . . 0.62 110.569 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 149' ' ' VAL . 22.9 Cg_exo -65.21 107.99 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.149 2.566 . . . . 0.29999999999999999 112.063 176.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.465 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 t -94.81 -12.1 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.136 -0.484 . . . . 0.27000000000000002 110.893 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -177.53 167.41 2.24 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.135 0.493 . . . . 1.22 111.815 -179.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.805 ' NH2' HG12 ' A' ' 135' ' ' ILE . 15.2 ttm-85 -134.17 116.4 15.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.06 -0.973 . . . . 1.75 109.788 172.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 163' ' ' ILE . 12.4 m-85 -104.09 134.15 47.82 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 108.393 -0.966 . . . . 0.38 108.393 176.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 1.086 ' HA ' HG23 ' A' ' 140' ' ' THR . 52.7 p -76.33 176.36 3.41 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.114 0.87 . . . . 0.98999999999999999 109.764 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.876 ' HG3' ' H ' ' A' ' 140' ' ' THR . 7.0 Cg_exo -69.11 -16.61 40.42 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.366 1.377 . . . . 0.66000000000000003 110.749 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.57 89.4 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.6 -1.182 . . . . 0.52000000000000002 111.89 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.92 133.48 36.21 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.564 -0.532 . . . . 0.42999999999999999 109.564 176.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 13.5 m -78.59 160.02 27.8 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.855 -0.611 . . . . 1.25 110.657 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 164' ' ' GLU . 58.1 t -50.04 -50.71 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.729 0.3 . . . . 0.40999999999999998 110.486 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.745 -0.661 . . . . 3.4399999999999999 111.779 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -65.81 -31.48 72.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.413 0.625 . . . . 1.8600000000000001 109.733 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.827 HG21 HD21 ' A' ' 39' ' ' LEU . 54.0 mt -81.38 -41.7 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.527 -0.76 . . . . 0.20999999999999999 110.189 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 45.0 mt-10 -55.76 -40.81 73.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.88 112.209 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.409 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 4.6 pt-20 -58.33 -27.62 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.75 111.6 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.538 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . 49.6 mttp -104.28 -12.98 16.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 1.5800000000000001 110.645 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 62.2 tp -93.38 -41.99 9.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 0.23999999999999999 111.534 -174.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.72 ' HA ' HD12 ' A' ' 171' ' ' LEU . 79.5 mt -53.28 -48.97 90.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.489 0.551 . . . . 0.44 112.489 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 40.2 Cg_exo -59.05 -22.72 65.28 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.149 1.899 . . . . 0.48999999999999999 113.04 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.52 -39.1 14.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.543 0.211 . . . . 0.70999999999999996 110.734 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.097 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 15.4 mt -56.95 -53.47 57.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 0.46000000000000002 109.271 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.49 51.75 2.23 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 114.565 -1.198 . . . . 1.52 113.741 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.9 m 69.55 112.37 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.556 0.742 . . . . 2.52 112.625 175.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.02 -57.92 2.49 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.24 0.543 . . . . 3.5600000000000001 110.343 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.645 ' HG3' HD22 ' A' ' 176' ' ' LEU . 1.5 ptm180 -134.55 -26.64 1.39 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.732 -0.84 . . . . 7.8600000000000003 108.732 172.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.645 HD22 ' HG3' ' A' ' 175' ' ' ARG . 3.9 mm? . . . . . 0 C--O 1.248 0.982 0 CA-C-N 114.949 -1.023 . . . . 4.8099999999999996 108.411 168.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 111.734 -0.546 . . . . 5.5099999999999998 111.734 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 92.9 mmm -136.89 134.65 37.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.923 -0.399 . . . . 5.0499999999999998 109.923 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.71 46.9 93.56 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.138 -0.553 . . . . 1.3700000000000001 113.249 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -90.52 -45.57 8.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.091 0.472 . . . . 1.6799999999999999 110.097 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 94.0 p -125.17 170.1 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.186 -0.672 . . . . 0.65000000000000002 109.186 175.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.737 HD13 HG21 ' A' ' 144' ' ' ILE . 32.1 pt -59.91 -27.48 38.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.021 0.438 . . . . 0.29999999999999999 111.34 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.902 ' HD1' ' HG ' ' A' ' 30' ' ' LEU . 55.4 m-85 -76.56 -1.75 29.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.508 0.559 . . . . 0.27000000000000002 112.508 -171.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 -17.16 58.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.477 0.656 . . . . 1.96 109.578 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 121' ' ' TYR . 87.1 m-85 -98.59 175.3 6.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 0.40000000000000002 110.764 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -110.44 133.83 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 2.77 110.272 -176.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 28' ' ' TYR . 77.5 t -115.22 149.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.933 0.397 . . . . 0.73999999999999999 110.927 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.904 ' HB3' ' HA ' ' A' ' 25' ' ' HIS . 2.3 mp -114.98 141.1 48.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.927 -0.579 . . . . 0.71999999999999997 109.87 176.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.96 175.57 1.16 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.516 -0.765 . . . . 1.5900000000000001 109.327 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 105' ' ' MET . . . -47.54 -39.74 17.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.912 0.387 . . . . 0.52000000000000002 111.685 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.05 8.53 39.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 116.18 -0.464 . . . . 2.2200000000000002 112.218 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.904 ' HA ' ' HB3' ' A' ' 21' ' ' LEU . 23.0 m-70 72.21 26.08 2.8 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.501 0.667 . . . . 0.72999999999999998 110.37 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -84.87 132.62 45.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 105.791 -1.929 . . . . 3.25 105.791 167.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.27 112.63 0.84 Allowed 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.106 1.204 . . . . 0.85999999999999999 112.588 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' HB3' HG12 ' A' ' 20' ' ' VAL . 55.7 t80 -86.95 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.014 -0.993 . . . . 0.28000000000000003 110.515 174.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 64.8 t30 -78.32 90.19 4.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.308 -0.627 . . . . 1.6499999999999999 109.308 178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.902 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.5 pt? -65.31 -28.52 69.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 0.25 111.339 -174.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.836 ' HA ' ' CD1' ' A' ' 16' ' ' PHE . 6.0 p -76.46 -1.04 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 113.064 0.764 . . . . 0.40999999999999998 113.064 -166.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 4.1 pt20 -78.85 -5.05 52.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.304 0.573 . . . . 1.24 109.68 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -99.16 18.3 17.79 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.025 -1.102 . . . . 0.38 108.025 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -96.89 146.35 25.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.33 -1.305 . . . . 1.73 109.464 177.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.42 -10.62 67.13 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.072 -1.211 . . . . 0.35999999999999999 110.072 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.596 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 51.1 m -141.75 146.98 43.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 108.359 -0.978 . . . . 1.1399999999999999 108.359 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.002 ' HG3' ' HA ' ' A' ' 171' ' ' LEU . 72.3 Cg_endo -75.22 159.77 40.2 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.918 1.745 . . . . 0.52000000000000002 111.404 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 70' ' ' THR . 1.7 pt? -154.5 151.58 29.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.269 0.557 . . . . 1.03 111.071 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.546 HD21 HG21 ' A' ' 163' ' ' ILE . 6.0 mp -108.07 155.64 20.15 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.618 -0.882 . . . . 1.1000000000000001 108.618 170.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 86.9 mt -141.03 119.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.415 -0.587 . . . . 0.20000000000000001 109.415 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.003 ' HD2' ' HB3' ' A' ' 139' ' ' PHE . 21.0 m-85 -105.77 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.273 0.358 . . . . 0.23000000000000001 111.435 -172.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.569 HD21 ' HE1' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -77.91 92.81 4.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.575 -1.269 . . . . 1.28 107.575 169.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 75' ' ' PRO . 2.8 p -113.21 127.54 70.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.425 -0.91 . . . . 0.88 112.634 -167.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 76' ' ' SER . . . -65.98 101.94 0.74 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.102 -1.444 . . . . 0.52000000000000002 107.102 168.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.822 ' HB2' ' HB3' ' A' ' 75' ' ' PRO . 26.6 t -67.54 92.68 0.32 Allowed 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.124 -0.944 . . . . 1.8400000000000001 112.056 -163.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.611 ' HG2' ' HA ' ' A' ' 98' ' ' PHE . 6.1 mmtm 73.88 31.78 1.17 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.331 0.652 . . . . 2.4300000000000002 110.866 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.3 m -137.24 140.53 41.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 0.98999999999999999 110.612 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.3 -149.53 29.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.951 -0.642 . . . . 1.0900000000000001 113.643 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -102.55 128.03 49.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.055 0.455 . . . . 3.1600000000000001 111.43 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.629 HG22 ' HE1' ' A' ' 139' ' ' PHE . 3.7 p -71.9 -33.05 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 1.9399999999999999 111.872 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HD3' ' HG2' ' A' ' 156' ' ' PRO . 28.7 mtpp 64.88 3.96 2.26 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.71 0.633 . . . . 2.0299999999999998 112.71 173.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.82 45.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.46999999999999997 112.078 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.04 -31.09 62.22 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.955 -0.458 . . . . 0.34000000000000002 111.955 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.734 ' CE1' ' HE1' ' A' ' 98' ' ' PHE . 1.2 t80 -76.51 -52.82 9.04 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 120.5 0.191 . . . . 0.56999999999999995 110.697 -175.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.09 -39.45 92.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.891 0.377 . . . . 2.46 110.677 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.567 HG23 ' HA ' ' A' ' 160' ' ' VAL . 95.9 m -66.55 -46.22 76.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.33000000000000002 110.846 177.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.665 ' HB1' HG11 ' A' ' 71' ' ' VAL . . . -60.63 -46.77 89.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.045 0.45 . . . . 0.19 110.828 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 62.3 m -58.52 -50.38 73.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.455 -0.793 . . . . 0.29999999999999999 111.133 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -64.43 -44.31 91.59 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.303 -0.408 . . . . 1.0800000000000001 111.578 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 86.4 mt -57.92 -52.4 65.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.68 0.252 . . . . 0.81000000000000005 111.68 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.743 ' HD1' ' H ' ' A' ' 71' ' ' VAL . 76.9 t80 -54.42 -49.37 70.11 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 121.202 0.525 . . . . 0.33000000000000002 109.88 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.02 -34.99 66.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.634 -0.712 . . . . 1.76 111.786 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.12 -47.54 20.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.381 -0.372 . . . . 1.79 111.29 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.673 ' CD1' HD13 ' A' ' 171' ' ' LEU . 60.8 m-85 -99.34 6.28 46.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.601 0.963 . . . . 0.42999999999999999 113.601 -171.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -59.41 -28.78 67.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 2.1099999999999999 110.958 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -63.18 -35.36 80.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.13 -0.486 . . . . 1.2 111.272 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -94.56 2.93 55.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.971 0.415 . . . . 1.8999999999999999 111.162 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 36' ' ' SER . . . 90.01 74.1 1.28 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.794 -0.717 . . . . 1.3200000000000001 112.176 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 74.0 t80 -138.15 140.94 40.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.559 0.219 . . . . 0.26000000000000001 110.526 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -131.08 142.55 50.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 120.56 0.219 . . . . 0.51000000000000001 110.433 178.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.743 ' H ' ' HD1' ' A' ' 61' ' ' TYR . 42.2 t -110.84 115.02 48.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.614 -0.513 . . . . 0.23999999999999999 109.614 169.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.684 HD22 ' HE3' ' A' ' 105' ' ' MET . 25.1 mt -98.46 121.49 40.46 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.83 -0.804 . . . . 0.51000000000000001 108.83 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.958 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -108.46 115.95 31.06 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.567 -0.453 . . . . 0.28000000000000003 110.191 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.749 ' HD2' HD11 ' A' ' 108' ' ' ILE . 3.3 m-85 -97.65 107.59 40.52 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 115.949 -0.569 . . . . 0.34000000000000002 109.558 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.822 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 71.2 Cg_exo -51.59 160.04 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.685 2.923 . . . . 0.72999999999999998 112.486 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.68 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 48.3 m -112.52 138.59 49.07 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.357 -0.838 . . . . 1.54 111.483 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -106.76 103.28 12.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.17 -0.923 . . . . 2.52 111.191 -173.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.679 ' HA ' ' CD ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -62.45 -10.4 11.51 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.584 1.154 . . . . 3.1800000000000002 114.04 -172.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -71.2 32.35 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 114.455 1.28 . . . . 3.7999999999999998 114.455 -169.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.64 74.05 1.08 Allowed Glycine 0 CA--C 1.492 -1.363 0 CA-C-O 122.171 0.873 . . . . 1.45 112.471 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 1.06 ' HA3' HD22 ' A' ' 109' ' ' ASN . . . -157.83 20.66 0.37 Allowed Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 109.257 -1.537 . . . . 1.4299999999999999 109.257 174.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.654 ' HG2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 38.08 42.68 0.49 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 125.61 1.418 . . . . 1.4299999999999999 110.865 -173.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.679 ' CD ' ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -62.16 158.07 48.6 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.559 -0.746 . . . . 3.0600000000000001 112.097 -169.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.691 ' HD3' ' O ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -18.23 120.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 1 C-N-CA 126.348 4.699 . . . . 1.6100000000000001 115.701 -174.961 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.98 -2.21 61.55 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.341 -1.503 . . . . 1.3899999999999999 109.341 -166.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 82' ' ' GLN . 5.4 t-20 56.37 48.74 16.4 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.432 -0.884 . . . . 3.6899999999999999 109.572 -175.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.412 ' HB3' ' OE2' ' A' ' 83' ' ' GLU . 9.6 pt-20 50.26 -174.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.896 1.278 . . . . 2.4700000000000002 111.212 -171.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 43.3 tt0 70.88 -18.49 0.26 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.845 0.458 . . . . 3.6400000000000001 111.743 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 87' ' ' GLU . 27.3 tt0 -85.85 -22.2 27.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.982 -0.748 . . . . 2.4199999999999999 108.982 172.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.733 HD13 ' SG ' ' A' ' 95' ' ' CYS . 15.2 mt -106.37 37.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.244 -0.889 . . . . 2.0499999999999998 110.953 176.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -92.3 133.22 36.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.824 -0.806 . . . . 4.0 108.824 169.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 3.8 pt-20 68.03 -19.53 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.213 1.005 . . . . 3.1000000000000001 111.25 -173.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 91' ' ' LYS . 72.2 m-85 -90.16 151.27 21.65 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.708 -0.849 . . . . 1.9099999999999999 108.708 170.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.81 135.85 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.517 -0.92 . . . . 1.6499999999999999 108.517 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.733 ' SG ' HD13 ' A' ' 90' ' ' ILE . 31.9 m -110.29 122.16 47.01 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.418 -0.913 . . . . 0.91000000000000003 112.046 -172.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.604 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 3.6 t -152.88 117.55 5.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 1.9199999999999999 110.836 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.609 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 79.9 mttt 65.27 -46.37 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.208 1.558 . . . . 3.1800000000000002 115.208 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.734 ' HE1' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 62.33 -32.72 0.1 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 1.74 110.834 -171.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.609 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 18.7 mtmt 65.35 108.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.211 1.004 . . . . 3.0800000000000001 113.272 165.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 104' ' ' ILE . . . -136.02 -171.84 2.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.749 -1.114 . . . . 0.42999999999999999 111.487 -174.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.88 26.93 4.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.045 -0.525 . . . . 2.1899999999999999 110.771 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.654 ' HE1' ' HB2' ' A' ' 73' ' ' ALA . 36.0 p90 -142.97 166.06 22.63 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.871 -1.159 . . . . 0.23999999999999999 107.871 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 71' ' ' VAL . 39.8 Cg_exo -63.09 122.8 11.16 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.342 2.695 . . . . 0.31 113.297 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.958 HG13 ' HB3' ' A' ' 73' ' ' ALA . 2.4 mp -117.37 142.8 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.513 -0.551 . . . . 0.37 109.513 174.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.712 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 10.3 mmt -116.54 -153.8 0.54 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.288 0.847 . . . . 1.47 113.288 -166.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.728 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . . . -70.47 149.65 46.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.885 -1.052 . . . . 0.39000000000000001 111.321 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 75' ' ' PRO . 29.3 mttt -82.29 109.77 16.85 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.026 -1.101 . . . . 1.6599999999999999 108.026 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.749 HD11 ' HD2' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -122.14 162.94 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 108.736 -0.838 . . . . 0.46999999999999997 108.736 -179.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 1.06 HD22 ' HA3' ' A' ' 81' ' ' GLY . 15.9 m120 -78.85 70.02 5.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.872 -0.604 . . . . 2.1600000000000001 110.95 -174.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.691 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -69.68 87.83 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 C-N-CA 118.883 -1.127 . . . . 0.38 108.703 175.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.571 ' HB3' ' HG2' ' A' ' 82' ' ' GLN . 0.7 OUTLIER 170.97 179.95 0.05 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.845 -1.168 . . . . 1.98 107.845 175.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.35 -143.03 9.88 Favored Glycine 0 CA--C 1.507 -0.412 0 N-CA-C 115.644 1.018 . . . . 0.78000000000000003 115.644 153.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -105.41 -10.19 17.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.342 -0.929 . . . . 1.98 110.984 -173.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -95.3 -2.15 49.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 2.04 111.949 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' A' ' 109' ' ' ASN . . . -42.65 134.5 3.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.507 0.928 . . . . 0.47999999999999998 113.507 177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.599 ' ND1' ' HB3' ' A' ' 118' ' ' LEU . 47.6 t-80 -51.29 140.14 24.44 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.568 -0.742 . . . . 0.41999999999999998 110.655 171.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 4.0 Cg_endo -47.69 -46.02 22.22 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.918 2.412 . . . . 0.35999999999999999 112.813 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.599 ' HB3' ' ND1' ' A' ' 116' ' ' HIS . 1.5 tm? -54.68 -40.76 69.43 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.987 -0.552 . . . . 1.1000000000000001 110.641 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.427 ' CD2' HD12 ' A' ' 108' ' ' ILE . 10.1 m-85 -76.7 -28.65 55.95 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.337 -0.392 . . . . 1.49 111.86 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 53.2 mt-10 -55.48 -42.55 74.54 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.715 -0.846 . . . . 2.3700000000000001 108.715 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 71.7 t80 -65.03 -49.69 69.17 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 123.585 0.553 . . . . 0.57999999999999996 110.627 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.429 ' CE ' HD11 ' A' ' 118' ' ' LEU . 64.5 mtt -62.46 -53.06 60.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.743 0.306 . . . . 0.34000000000000002 111.263 -177.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -56.64 -43.08 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.93999999999999995 111.218 -177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 121' ' ' TYR . 16.7 ptmt -73.87 -34.32 64.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.018 0.437 . . . . 2.1299999999999999 111.244 -176.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 150' ' ' PRO . 77.5 m -73.88 -44.1 56.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 0.46999999999999997 111.394 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 26.9 mmtt -136.96 102.9 9.09 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.842 -0.343 . . . . 1.75 111.627 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.969 ' HB2' ' HB ' ' A' ' 132' ' ' THR . 60.4 Cg_endo -73.58 -19.73 21.25 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.12 2.546 . . . . 1.76 112.138 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.669 ' HA3' ' HB3' ' A' ' 153' ' ' ARG . . . 83.39 -106.84 2.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.135 -0.555 . . . . 2.3700000000000001 113.672 172.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.678 HG13 ' HG ' ' A' ' 130' ' ' LEU . 26.8 pt -134.36 -176.62 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.369 0.268 . . . . 3.5600000000000001 110.857 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.678 ' HG ' HG13 ' A' ' 129' ' ' ILE . 36.2 mt 64.67 -151.75 0.28 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.717 0.636 . . . . 2.7599999999999998 110.165 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.68 86.29 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.663 -0.866 . . . . 2.8399999999999999 108.663 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.969 ' HB ' ' HB2' ' A' ' 127' ' ' PRO . 31.9 p -67.08 114.46 5.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.251 -0.886 . . . . 3.8999999999999999 111.787 -171.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -160.68 -55.24 0.05 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.0 0.428 . . . . 5.1299999999999999 110.143 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -157.46 -161.77 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.609 0.596 . . . . 0.93000000000000005 112.609 -174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.799 ' HA ' ' CZ3' ' A' ' 137' ' ' TRP . 39.6 mt -90.13 155.74 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.315 -0.857 . . . . 1.05 109.612 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -173.99 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.935 0.398 . . . . 1.5 111.829 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.799 ' CZ3' ' HA ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -143.37 169.06 18.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.499 -0.318 . . . . 0.87 111.296 -177.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -154.37 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.656 1.583 . . . . 1.8 113.349 176.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 1.003 ' HB3' ' HD2' ' A' ' 41' ' ' TYR . 54.6 m-85 -25.17 -49.91 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 115.216 1.561 . . . . 1.3700000000000001 115.216 -166.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.835 ' OG1' ' HD3' ' A' ' 156' ' ' PRO . 10.6 m 32.2 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.839 1.199 . . . . 0.29999999999999999 113.59 176.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 10.3 p -84.79 149.02 26.03 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.026 -0.67 . . . . 0.80000000000000004 111.265 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.569 ' HE1' HD21 ' A' ' 42' ' ' ASN . 3.5 m-85 -104.0 133.34 49.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.236 -1.024 . . . . 0.53000000000000003 108.236 166.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.931 ' HB2' ' HE1' ' A' ' 154' ' ' PHE . 34.7 tp -81.56 105.15 12.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.922 -0.77 . . . . 0.51000000000000001 108.922 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.737 HG21 HD13 ' A' ' 15' ' ' ILE . 15.8 mm -104.8 124.98 59.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 0.20000000000000001 109.151 -174.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.673 ' OD2' ' HB ' ' A' ' 149' ' ' VAL . 12.2 p30 -74.13 -178.12 3.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.766 0.317 . . . . 1.3 111.176 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.638 ' HG2' ' HD3' ' A' ' 37' ' ' PRO . 50.2 mtp180 -65.87 -12.78 57.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.426 0.528 . . . . 3.7799999999999998 112.426 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.948 ' HB3' HH21 ' A' ' 175' ' ' ARG . 35.1 t0 -110.61 -14.33 14.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.26 0.552 . . . . 1.1799999999999999 109.966 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.486 ' CA ' HG12 ' A' ' 15' ' ' ILE . . . 106.88 31.03 4.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.388 -0.824 . . . . 0.23000000000000001 113.034 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.673 ' HB ' ' OD2' ' A' ' 145' ' ' ASP . 89.9 t -112.56 129.5 24.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 117.209 0.504 . . . . 0.62 110.225 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 125' ' ' THR . 7.9 Cg_exo -70.88 118.29 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.627 2.218 . . . . 0.29999999999999999 111.725 178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.69 -26.07 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 0.27000000000000002 110.825 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -157.75 165.7 34.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.095 -0.502 . . . . 1.22 110.135 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.669 ' HB3' ' HA3' ' A' ' 128' ' ' GLY . 18.0 ttm180 -134.97 116.98 15.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.941 -0.392 . . . . 1.75 109.941 171.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.931 ' HE1' ' HB2' ' A' ' 143' ' ' LEU . 3.4 m-85 -101.93 116.63 33.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.992 -0.744 . . . . 0.38 108.992 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.789 ' HA ' HG23 ' A' ' 140' ' ' THR . 97.7 p -64.5 164.8 17.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.494 0.588 . . . . 0.98999999999999999 109.518 176.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.835 ' HD3' ' OG1' ' A' ' 140' ' ' THR . 35.3 Cg_endo -64.76 -9.04 19.47 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.94 2.427 . . . . 0.66000000000000003 113.17 -164.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -93.62 24.13 27.28 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.491 -0.777 . . . . 0.52000000000000002 112.051 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.74 30.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.42999999999999999 110.635 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.2 m -81.54 158.76 24.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.71 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.567 ' HA ' HG23 ' A' ' 56' ' ' THR . 21.5 t -49.56 -50.6 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.388 0.613 . . . . 0.40999999999999998 109.919 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 165' ' ' GLU . 6.2 ttpp -59.92 -40.43 88.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.656 -1.157 . . . . 3.4399999999999999 111.038 -177.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -63.52 -30.48 71.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.126 -0.943 . . . . 1.8600000000000001 110.454 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.546 HG21 HD21 ' A' ' 39' ' ' LEU . 61.4 mt -82.63 -43.6 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.954 -0.566 . . . . 0.20999999999999999 110.887 175.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 160' ' ' VAL . 48.5 mt-10 -56.13 -38.84 71.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.88 112.108 -175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 161' ' ' LYS . 5.4 pt-20 -62.33 -19.33 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 0.75 112.058 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -106.32 -17.25 14.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.289 0.566 . . . . 1.5800000000000001 110.019 178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 171' ' ' LEU . 67.7 tp -94.11 -44.01 8.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 0.23999999999999999 111.909 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.778 ' HA ' HD12 ' A' ' 171' ' ' LEU . 63.4 mt -51.79 -47.26 91.02 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.846 0.684 . . . . 0.44 112.846 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 168' ' ' ILE . 64.2 Cg_exo -54.29 -39.59 86.18 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.987 1.792 . . . . 0.48999999999999999 112.823 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.74 -34.55 58.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.503 -0.317 . . . . 0.70999999999999996 111.801 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.002 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 14.2 mt -54.85 -54.73 38.58 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 121.463 0.649 . . . . 0.46000000000000002 109.554 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -56.0 -51.87 52.74 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.221 -1.354 . . . . 1.52 113.266 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.0 p -165.11 131.2 2.75 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.409 0.605 . . . . 2.52 111.976 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.582 ' CB ' ' HB2' ' A' ' 145' ' ' ASP . . . -93.99 -29.9 15.0 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.606 0.717 . . . . 3.5600000000000001 110.118 174.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.948 HH21 ' HB3' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -178.6 -24.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.531 -1.655 . . . . 7.8600000000000003 106.531 -179.197 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 N--CA 1.442 -0.849 0 CA-C-N 113.448 -1.706 . . . . 4.8099999999999996 106.682 167.535 . . . . . . . . 0 0 . 1 stop_ save_